Citrus Sinensis ID: 043053
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1058 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LHP4 | 1141 | Receptor-like protein kin | yes | no | 0.977 | 0.906 | 0.729 | 0.0 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.938 | 0.874 | 0.677 | 0.0 | |
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.914 | 0.887 | 0.513 | 0.0 | |
| C0LGF5 | 1072 | Probable LRR receptor-lik | no | no | 0.896 | 0.884 | 0.484 | 0.0 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.928 | 0.891 | 0.393 | 0.0 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.920 | 0.866 | 0.387 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.910 | 0.874 | 0.384 | 0.0 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.853 | 0.867 | 0.387 | 1e-178 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.857 | 0.905 | 0.386 | 1e-177 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.907 | 0.768 | 0.378 | 1e-175 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1508 bits (3903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 764/1048 (72%), Positives = 886/1048 (84%), Gaps = 14/1048 (1%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
F+T+I I+SVPLQL +P NL +F+ LQ L IS ANLTG++P +GDC+GL VLD SSN L
Sbjct: 82 FITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGL 141
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VG +P SL KL NLE LILNSNQLTGKIP ++S C L+ L+LFDN L G+IP ELG+LS
Sbjct: 142 VGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLS 201
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
LE +R GGNK+I G+IP+E+GDCSN+T LGLA+T VSG+LP+SLGKL KL+TLSIYTTM
Sbjct: 202 GLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTM 261
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
ISGEIP+++GNCSELV LFLYENSLSGSIP EIG+L KLE+LFLWQNSLVG IPEEIGNC
Sbjct: 262 ISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNC 321
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
++LKMID SLN LSG+IP SIG LS LEEFMISDN SGSIP ++N ++LVQLQLD NQ
Sbjct: 322 SNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQ 381
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
ISGLIP E+G L+KLT+FFAW NQLEGSIP LA C++LQALDLS NSLT ++P+GLF L
Sbjct: 382 ISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFML 441
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
+NLTKLLLISN +SG IP EIGNCSSLVRLR+G NRI G IP IG LK +NFLD SSNR
Sbjct: 442 RNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNR 501
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
L G VPDEIG C+ELQMIDLS+N+L+GSLPN +SSLSGLQVLDVS N+FSG+IPASLGRL
Sbjct: 502 LHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRL 561
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
VSLNK+ILSKNLFSG IP+SLG+CS LQLLDL SN+L+G +P ELG IE LEIALNLS N
Sbjct: 562 VSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSN 621
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
LTG IP++I++LNKLSILDLSHN LEG+L PLA ++NLVSLNISYN F+GYLPDNKLFR
Sbjct: 622 RLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFR 681
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QLSP DL GN+ LCSS +DSCFL+ GL ++ D R+RKL++ +ALLITLTV + I
Sbjct: 682 QLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLG-DDGDASRTRKLRLTLALLITLTVVLMI 740
Query: 661 MGTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
+G A+IRARR + ++ DSELG+++ WQFTPFQKLNFSV+Q+++CLV+ NVIGKGCSGVV
Sbjct: 741 LGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVV 800
Query: 721 YRADMDNGEVIAVKKLWPTTMAAANGCSDEKS-GVRDSFSAEIKTLGSIRHKNIVRFLGC 779
YRAD+DNGEVIAVKKLWP A NG DEK+ VRDSFSAE+KTLG+IRHKNIVRFLGC
Sbjct: 801 YRADVDNGEVIAVKKLWP---AMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGC 857
Query: 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVH 839
CWNRN RLLMYDYMPNGSLGSLLHER G++L+W+LRY+ILLGAAQGLAYLHHDC+PPIVH
Sbjct: 858 CWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVH 917
Query: 840 RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKS 899
RDIKANNILIGL+FEPYIADFGLAKLVD+GD R SNTVAGSYGYIAPEYGY MKITEKS
Sbjct: 918 RDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKS 977
Query: 900 DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG-IQVLDPSLLSRPESEIDEMLQ 958
DVYSYGVVVLEVLTGKQPIDPT+P+G H+VDWVRQ +G ++VLD +L SR E+E DEM+Q
Sbjct: 978 DVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQ 1037
Query: 959 ALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGS-PAAANVQENKNSS 1017
LG ALLCVN+SPDERPTMKDVAAMLKEIK EREEYAKVD+LLK S P +QE +
Sbjct: 1038 VLGTALLCVNSSPDERPTMKDVAAMLKEIKQEREEYAKVDLLLKKSPPPTTTMQEECRKN 1097
Query: 1018 GVL-----ATSSSKPAVTLHP--KSNNT 1038
++ A SSSK KSNNT
Sbjct: 1098 EMMMIPAAAASSSKEMRREERLLKSNNT 1125
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1367 bits (3538), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 677/1000 (67%), Positives = 820/1000 (82%), Gaps = 7/1000 (0%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
VTEI + SV L LP P N+SSF LQ LVIS+ NLTG+I +IGDC LIV+D SSN+L
Sbjct: 83 LVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSL 142
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VG +PSSLGKL NL+EL LNSN LTGKIP EL +C SL+ L +FDN L+ N+P ELG++S
Sbjct: 143 VGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKIS 202
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
LE +RAGGN ++ GKIP E+G+C N+ LGLA T++SGSLP SLG+LSKLQ+LS+Y+TM
Sbjct: 203 TLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTM 262
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+SGEIP E+GNCSEL++LFLY+N LSG++P E+GKL+ LE++ LWQN+L G IPEEIG
Sbjct: 263 LSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFM 322
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
SL ID S+N SGTIP S G LS L+E M+S NN++GSIP+ L+N T LVQ Q+D NQ
Sbjct: 323 KSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQ 382
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
ISGLIPPEIG+L +L +F WQN+LEG+IP LA C NLQALDLS N LT S+PAGLFQL
Sbjct: 383 ISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQL 442
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
+NLTKLLLISN ISG IP EIGNC+SLVRLR+ NNRI G IP+ IG L+ L+FLDLS N
Sbjct: 443 RNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENN 502
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
LSG VP EI +C +LQM++LS+NTLQG LP SLSSL+ LQVLDVS N +G+IP SLG L
Sbjct: 503 LSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHL 562
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
+SLN++ILSKN F+G IPSSLG C++LQLLDLSSN ++G++P EL I+ L+IALNLS N
Sbjct: 563 ISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWN 622
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
L G IP +ISALN+LS+LD+SHN L G+L+ L+ L+NLVSLNIS+N+F+GYLPD+K+FR
Sbjct: 623 SLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFR 682
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QL ++ GN GLCS SCF+SN + + + V S +L++AI LLI++T +A+
Sbjct: 683 QLIGAEMEGNNGLCSKGFRSCFVSNSSQ---LTTQRGV-HSHRLRIAIGLLISVTAVLAV 738
Query: 661 MGTFALIRARRAMKDDDDSELGDS-WPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGV 719
+G A+IRA++ ++DD+DSE G++ W WQFTPFQKLNF+VE VLKCLV+ NVIGKGCSG+
Sbjct: 739 LGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGI 798
Query: 720 VYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779
VY+A+M N EVIAVKKLWP T+ N + SGVRDSFSAE+KTLGSIRHKNIVRFLGC
Sbjct: 799 VYKAEMPNREVIAVKKLWPVTVPNLNE-KTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGC 857
Query: 780 CWNRNNRLLMYDYMPNGSLGSLLHERTG-NALEWELRYQILLGAAQGLAYLHHDCVPPIV 838
CWN+N RLLMYDYM NGSLGSLLHER+G +L WE+RY+I+LGAAQGLAYLHHDCVPPIV
Sbjct: 858 CWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIV 917
Query: 839 HRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEK 898
HRDIKANNILIG +FEPYI DFGLAKLVDDGDFARSSNT+AGSYGYIAPEYGY MKITEK
Sbjct: 918 HRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEK 977
Query: 899 SDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQ 958
SDVYSYGVVVLEVLTGKQPIDPTIPDG H+VDWV++ + IQV+D L +RPESE++EM+Q
Sbjct: 978 SDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQ 1037
Query: 959 ALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVD 998
LGVALLC+N P++RPTMKDVAAML EI EREE KVD
Sbjct: 1038 TLGVALLCINPIPEDRPTMKDVAAMLSEICQEREESMKVD 1077
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 934 bits (2415), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/1013 (51%), Positives = 689/1013 (68%), Gaps = 45/1013 (4%)
Query: 2 VTEITIQSVPLQLPIP-TNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
V+EI ++ + LQ +P T+L S K L +L +S NLTG IP +IGD L +LD S N+L
Sbjct: 70 VSEIQLKGMDLQGSLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSL 129
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
G +P + +L L+ L LN+N L G IP+E+ N L +L+LFDN L+G IP +G L
Sbjct: 130 SGDIPVEIFRLKKLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELK 189
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
NL+ +RAGGNK++ G++P E+G+C N+ LGLA+T +SG LPAS+G L ++QT++IYT++
Sbjct: 190 NLQVLRAGGNKNLRGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSL 249
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+SG IP EIG C+EL +L+LY+NS+SGSIP IG LKKL+ L LWQN+LVG IP E+GNC
Sbjct: 250 LSGPIPDEIGYCTELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNC 309
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
L +IDFS N L+GTIP S G L L+E +S N +SG+IP L N T L L++D N
Sbjct: 310 PELWLIDFSENLLTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNL 369
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
I+G IP + L LT+FFAWQN+L G+IP +L+ C LQA+DLS+NSL+ S+P +F L
Sbjct: 370 ITGEIPSLMSNLRSLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGL 429
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
+NLTKLLL+SND+SG IPP+IGNC++L RLR+ NR+AG IP EIG LK LNF+D+S NR
Sbjct: 430 RNLTKLLLLSNDLSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENR 489
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
L GS+P I C L+ +DL N+L GSL + S L+ +D SDN S +P +G L
Sbjct: 490 LVGSIPPAISGCESLEFLDLHTNSLSGSLLGTTLPKS-LKFIDFSDNALSSTLPPGIGLL 548
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
L K+ L+KN SG IP + C SLQLL+L N +G +P ELGQI +L I+LNLSCN
Sbjct: 549 TELTKLNLAKNRLSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCN 608
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
G IP++ S L L +LD+SHN+L GNLN L L NLVSLNISYN F+G LP+ FR
Sbjct: 609 RFVGEIPSRFSDLKNLGVLDVSHNQLTGNLNVLTDLQNLVSLNISYNDFSGDLPNTPFFR 668
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
+L +DLA N GL ++SN A + R S +++ I +L+ +T + +
Sbjct: 669 RLPLSDLASNRGL--------YISN---AISTRPDPTTRNSSVVRLTILILVVVTAVLVL 717
Query: 661 MGTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
M + L+RAR A K E+ DS W+ T +QKL+FS++ ++K L ANVIG G SGVV
Sbjct: 718 MAVYTLVRARAAGKQLLGEEI-DS--WEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVV 774
Query: 721 YRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780
YR + +GE +AVKK+W S E+SG +F++EIKTLGSIRH+NIVR LG C
Sbjct: 775 YRITIPSGESLAVKKMW----------SKEESG---AFNSEIKTLGSIRHRNIVRLLGWC 821
Query: 781 WNRNNRLLMYDYMPNGSLGSLLH-ERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVH 839
NRN +LL YDY+PNGSL S LH G ++WE RY ++LG A LAYLHHDC+P I+H
Sbjct: 822 SNRNLKLLFYDYLPNGSLSSRLHGAGKGGCVDWEARYDVVLGVAHALAYLHHDCLPTIIH 881
Query: 840 RDIKANNILIGLEFEPYIADFGLAKLVDDG-----DFARSSNT--VAGSYGYIAPEYGYM 892
D+KA N+L+G FEPY+ADFGLA+ + D A+ +N +AGSYGY+APE+ M
Sbjct: 882 GDVKAMNVLLGPHFEPYLADFGLARTISGYPNTGIDLAKPTNRPPMAGSYGYMAPEHASM 941
Query: 893 MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR-----QKKGIQVLDPSLLS 947
+ITEKSDVYSYGVV+LEVLTGK P+DP +P G+H+V WVR +K ++LDP L
Sbjct: 942 QRITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVKWVRDHLAEKKDPSRLLDPRLDG 1001
Query: 948 RPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH---EREEYAKV 997
R +S + EMLQ L VA LCV+ +ERP MKDV AML EI+H R E K+
Sbjct: 1002 RTDSIMHEMLQTLAVAFLCVSNKANERPLMKDVVAMLTEIRHIDVGRSETEKI 1054
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 836 bits (2160), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/978 (48%), Positives = 646/978 (66%), Gaps = 30/978 (3%)
Query: 34 ANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELS 93
NL+G IP G L +LD SSN+L G +PS LG+L L+ LILN+N+L+G IP ++S
Sbjct: 101 TNLSGPIPPSFGKLTHLRLLDLSSNSLSGPIPSELGRLSTLQFLILNANKLSGSIPSQIS 160
Query: 94 NCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLA 153
N +L+ L L DN L G+IP+ G L +L++ R GGN ++ G IPA+LG N+T LG A
Sbjct: 161 NLFALQVLCLQDNLLNGSIPSSFGSLVSLQQFRLGGNTNLGGPIPAQLGFLKNLTTLGFA 220
Query: 154 DTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEI 213
+ +SGS+P++ G L LQTL++Y T ISG IP ++G CSEL +L+L+ N L+GSIP E+
Sbjct: 221 ASGLSGSIPSTFGNLVNLQTLALYDTEISGTIPPQLGLCSELRNLYLHMNKLTGSIPKEL 280
Query: 214 GKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMIS 273
GKL+K+ L LW NSL G IP EI NC+SL + D S N L+G IP +G L LE+ +S
Sbjct: 281 GKLQKITSLLLWGNSLSGVIPPEISNCSSLVVFDVSANDLTGDIPGDLGKLVWLEQLQLS 340
Query: 274 DNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTL 333
DN +G IP L+N ++L+ LQLD N++SG IP +IG L L FF W+N + G+IPS+
Sbjct: 341 DNMFTGQIPWELSNCSSLIALQLDKNKLSGSIPSQIGNLKSLQSFFLWENSISGTIPSSF 400
Query: 334 ASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVG 393
+C++L ALDLS N LT +P LF L+ L+KLLL+ N +SG +P + C SLVRLRVG
Sbjct: 401 GNCTDLVALDLSRNKLTGRIPEELFSLKRLSKLLLLGNSLSGGLPKSVAKCQSLVRLRVG 460
Query: 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSL 453
N+++G IP+EIG L+ L FLDL N SG +P EI + T L+++D+ +N + G +P L
Sbjct: 461 ENQLSGQIPKEIGELQNLVFLDLYMNHFSGGLPYEISNITVLELLDVHNNYITGDIPAQL 520
Query: 454 SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLS 513
+L L+ LD+S N F+G IP S G L LNK+IL+ NL +G IP S+ L LLDLS
Sbjct: 521 GNLVNLEQLDLSRNSFTGNIPLSFGNLSYLNKLILNNNLLTGQIPKSIKNLQKLTLLDLS 580
Query: 514 SNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPL 573
N L+G +P ELGQ+ +L I L+LS N TG IP S L +L LDLS N L G++ L
Sbjct: 581 YNSLSGEIPQELGQVTSLTINLDLSYNTFTGNIPETFSDLTQLQSLDLSSNSLHGDIKVL 640
Query: 574 AQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLAS 633
L +L SLNIS N F+G +P F+ +S T N LC S S+ G
Sbjct: 641 GSLTSLASLNISCNNFSGPIPSTPFFKTISTTSYLQNTNLCHSLDGITCSSHTG------ 694
Query: 634 NENDVRRSRKLKVAIALLITLTVAMAIMGTFALI-RARRAMKDDDDSELGD------SWP 686
+N+ +S K+ VA+ +I ++ +AI+ + LI R K +S S+P
Sbjct: 695 -QNNGVKSPKI-VALTAVILASITIAILAAWLLILRNNHLYKTSQNSSSSPSTAEDFSYP 752
Query: 687 WQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANG 746
W F PFQKL +V ++ L D NVIGKGCSG+VY+A++ NG+++AVKKLW T
Sbjct: 753 WTFIPFQKLGITVNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAVKKLWKT-----KD 807
Query: 747 CSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT 806
++E DSF+AEI+ LG+IRH+NIV+ LG C N++ +LL+Y+Y PNG+L LL
Sbjct: 808 NNEEGESTIDSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQ--- 864
Query: 807 GNA-LEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865
GN L+WE RY+I +GAAQGLAYLHHDCVP I+HRD+K NNIL+ ++E +ADFGLAKL
Sbjct: 865 GNRNLDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKL 924
Query: 866 -VDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD 924
++ ++ + + VAGSYGYIAPEYGY M ITEKSDVYSYGVV+LE+L+G+ ++P I D
Sbjct: 925 MMNSPNYHNAMSRVAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGRSAVEPQIGD 984
Query: 925 GSHVVDWVRQKKG-----IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKD 979
G H+V+WV++K G + VLD L P+ + EMLQ LG+A+ CVN SP ERPTMK+
Sbjct: 985 GLHIVEWVKKKMGTFEPALSVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSPVERPTMKE 1044
Query: 980 VAAMLKEIKHEREEYAKV 997
V +L E+K EE+ K
Sbjct: 1045 VVTLLMEVKCSPEEWGKT 1062
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 679 bits (1753), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/1033 (39%), Positives = 594/1033 (57%), Gaps = 51/1033 (4%)
Query: 2 VTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLV 61
V + + S+ L + ++ HL+ L +S L+G IP +IG+C L +L ++N
Sbjct: 75 VLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFD 134
Query: 62 GTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSN 121
G +P +GKL +LE LI+ +N+++G +PVE+ N SL +L+ + N ++G +P +G L
Sbjct: 135 GEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKR 194
Query: 122 LEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMI 181
L RAG N I G +P+E+G C ++ LGLA Q+SG LP +G L KL + ++
Sbjct: 195 LTSFRAGQNM-ISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEF 253
Query: 182 SGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCT 241
SG IP EI NC+ L +L LY+N L G IP E+G L+ LE L+L++N L G IP EIGN +
Sbjct: 254 SGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLS 313
Query: 242 SLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQI 301
IDFS N+L+G IPL +G + LE + +N ++G+IP L+ NL +L L N +
Sbjct: 314 YAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINAL 373
Query: 302 SGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQ 361
+G IP L L + +QN L G+IP L S+L LD+S N L+ +P+ L
Sbjct: 374 TGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHS 433
Query: 362 NLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRL 421
N+ L L +N++SG+IP I C +LV+LR+ N + G P + + ++L NR
Sbjct: 434 NMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRF 493
Query: 422 SGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNR------------- 468
GS+P E+G+C+ LQ + L+ N G LP + LS L L++S N+
Sbjct: 494 RGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCK 553
Query: 469 -----------FSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQL 517
FSG +P+ +G L L + LS N SG IP +LG S L L + N
Sbjct: 554 MLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLF 613
Query: 518 TGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNL-NPLAQL 576
GS+P ELG + L+IALNLS N LTG IP ++S L L L L++N L G + + A L
Sbjct: 614 NGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANL 673
Query: 577 DNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNE- 635
+L+ N SYN TG +P L R +S + GNEGLC + C + ++ +
Sbjct: 674 SSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKP 730
Query: 636 NDVRRSRKLKVAIALLITLTVAMAIMGTFALIRARRAM----KDDDDSELGDSWPWQFTP 691
+R S+ + + A++ +++ + + + + R R + +D SE+ S F P
Sbjct: 731 GGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEM--SLDIYFPP 788
Query: 692 FQKLNFS-VEQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDE 750
+ F + ++ V+G+G G VY+A + G +AVKKL A+N
Sbjct: 789 KEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKL------ASNHEGGN 842
Query: 751 KSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNAL 810
+ V +SF AEI TLG+IRH+NIV+ G C ++ + LL+Y+YMP GSLG +LH+ + N L
Sbjct: 843 NNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCN-L 901
Query: 811 EWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870
+W R++I LGAAQGLAYLHHDC P I HRDIK+NNIL+ +FE ++ DFGLAK++D
Sbjct: 902 DWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM-P 960
Query: 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930
++S + +AGSYGYIAPEY Y MK+TEKSD+YSYGVV+LE+LTGK P+ P I G VV+
Sbjct: 961 HSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP-IDQGGDVVN 1019
Query: 931 WVR---QKKGIQ--VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
WVR ++ + VLD L E + ML L +ALLC + SP RP+M+ V ML
Sbjct: 1020 WVRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLI 1079
Query: 986 EIKHEREEYAKVD 998
E + E +D
Sbjct: 1080 ESERSEGEQEHLD 1092
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 660 bits (1704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/1026 (38%), Positives = 582/1026 (56%), Gaps = 52/1026 (5%)
Query: 2 VTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLV 61
VT + + S+ L + ++ +L L ++ LTG IP +IG+C L V+ ++N
Sbjct: 87 VTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFG 146
Query: 62 GTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSN 121
G++P + KL L + +N+L+G +P E+ + +L +L+ + N L G +P LG L+
Sbjct: 147 GSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNK 206
Query: 122 LEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMI 181
L RAG N D G IP E+G C N+ LGLA +SG LP +G L KLQ + ++
Sbjct: 207 LTTFRAGQN-DFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKF 265
Query: 182 SGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCT 241
SG IP +IGN + L +L LY NSL G IP EIG +K L++L+L+QN L G IP+E+G +
Sbjct: 266 SGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLS 325
Query: 242 SLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQI 301
+ IDFS N LSG IP+ + +SEL + N ++G IP L+ NL +L L N +
Sbjct: 326 KVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSL 385
Query: 302 SGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQ 361
+G IPP L+ + + N L G IP L S L +D S N L+ +P + Q
Sbjct: 386 TGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQS 445
Query: 362 NLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRL 421
NL L L SN I G+IPP + C SL++LRV NR+ G P E+ L L+ ++L NR
Sbjct: 446 NLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRF 505
Query: 422 SGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSG----------------------- 458
SG +P EIG C +LQ + L+ N +LPN +S LS
Sbjct: 506 SGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCK 565
Query: 459 -LQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQL 517
LQ LD+S N F G +P LG L L + LS+N FSG IP ++G + L L + N
Sbjct: 566 MLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLF 625
Query: 518 TGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNL-NPLAQL 576
+GS+P +LG + +L+IA+NLS N +G IP +I L+ L L L++N L G + L
Sbjct: 626 SGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENL 685
Query: 577 DNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLAS-NE 635
+L+ N SYN TG LP ++F+ ++ T GN+GLC SC S+ ++S
Sbjct: 686 SSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKA 745
Query: 636 NDVRRSRKLKVAIALLIT---LTVAMAIMGTFALIRARRAMKDDDDSELGDSWPWQFTPF 692
RR R + + +++ L +A+ + + D + +S + F P
Sbjct: 746 GSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIY-FVPK 804
Query: 693 QKLNFSVEQVL---KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSD 749
++ F+V+ +L K D+ ++G+G G VY+A M +G+ IAVKKL +
Sbjct: 805 ER--FTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNN----N 858
Query: 750 EKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR--NNRLLMYDYMPNGSLGSLLHERTG 807
+ +SF AEI TLG IRH+NIVR C+++ N+ LL+Y+YM GSLG LLH
Sbjct: 859 NSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKS 918
Query: 808 NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867
++++W R+ I LGAA+GLAYLHHDC P I+HRDIK+NNILI FE ++ DFGLAK++D
Sbjct: 919 HSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVID 978
Query: 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSH 927
++S + VAGSYGYIAPEY Y MK+TEK D+YS+GVV+LE+LTGK P+ P + G
Sbjct: 979 M-PLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQP-LEQGGD 1036
Query: 928 VVDWVR-----QKKGIQVLDPSLLSRPESEI--DEMLQALGVALLCVNASPDERPTMKDV 980
+ W R ++LDP L++ E ++ + M+ +A+LC +SP +RPTM++V
Sbjct: 1037 LATWTRNHIRDHSLTSEILDP-YLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREV 1095
Query: 981 AAMLKE 986
ML E
Sbjct: 1096 VLMLIE 1101
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 653 bits (1685), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/1032 (38%), Positives = 585/1032 (56%), Gaps = 69/1032 (6%)
Query: 2 VTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLV 61
VT + + + L + + L+ L +S ++G IP D+ C L VLD +N
Sbjct: 69 VTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFH 128
Query: 62 GTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSN 121
G +P L + L++L L N L G IP ++ N SL++L+++ N L G IP + +L
Sbjct: 129 GVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQ 188
Query: 122 LEEMRAGGNKDIVGKIPAELGDCSNMTALGLADT------------------------QV 157
L +RAG N G IP+E+ C ++ LGLA+ ++
Sbjct: 189 LRIIRAGRN-GFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRL 247
Query: 158 SGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLK 217
SG +P S+G +S+L+ L+++ +G IP EIG +++ L+LY N L+G IP EIG L
Sbjct: 248 SGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLI 307
Query: 218 KLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNV 277
E+ +N L G IP+E G+ +LK++ N L G IP +G L+ LE+ +S N +
Sbjct: 308 DAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRL 367
Query: 278 SGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCS 337
+G+IP L LV LQL NQ+ G IPP IG S +V N L G IP+
Sbjct: 368 NGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQ 427
Query: 338 NLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRI 397
L L L N L+ ++P L ++LTKL+L N ++GS+P E+ N +L L + N +
Sbjct: 428 TLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWL 487
Query: 398 AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLS 457
+G I ++G LK L L L++N +G +P EIG+ T++ ++S N L G +P L S
Sbjct: 488 SGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCV 547
Query: 458 GLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQL 517
+Q LD+S N+FSG I LG+LV L + LS N +G IP S G + L L L N L
Sbjct: 548 TIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLL 607
Query: 518 TGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLD 577
+ ++P+ELG++ +L+I+LN+S N L+G IP + L L IL L+ NKL G + A +
Sbjct: 608 SENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIP--ASIG 665
Query: 578 NLVSL---NISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSCF-LSNDGKAGLAS 633
NL+SL NIS N G +PD +F+++ ++ AGN GLC+S++ C L + L
Sbjct: 666 NLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNW 725
Query: 634 NENDVRRSRKLKVAIALLITLTVAMAIMGTFALIRARR----AMKDDDDSELGDSWPWQF 689
N +R + L + ++I + +G I+ R A++D ++ DS+
Sbjct: 726 LINGSQRQKILTIT-CIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSY---- 780
Query: 690 TPFQKLNFSVEQVLKCLVDAN-------VIGKGCSGVVYRADMDNGEVIAVKKLWPTTMA 742
F K F+ + LVDA V+G+G G VY+A+M GEVIAVKKL +
Sbjct: 781 -YFPKKGFTYQG----LVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKL----NS 831
Query: 743 AANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL 802
G S + +SF AEI TLG IRH+NIV+ G C+++N+ LL+Y+YM GSLG L
Sbjct: 832 RGEGASSD-----NSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQL 886
Query: 803 HERTGNA-LEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861
N L+W RY+I LGAA+GL YLHHDC P IVHRDIK+NNIL+ F+ ++ DFG
Sbjct: 887 QRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFG 946
Query: 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921
LAKL+D +++S + VAGSYGYIAPEY Y MK+TEK D+YS+GVV+LE++TGK P+ P
Sbjct: 947 LAKLIDL-SYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP- 1004
Query: 922 IPDGSHVVDWVRQK-----KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT 976
+ G +V+WVR+ I++ D L + + + EM L +AL C + SP RPT
Sbjct: 1005 LEQGGDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPT 1064
Query: 977 MKDVAAMLKEIK 988
M++V AM+ E +
Sbjct: 1065 MREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 627 bits (1616), Expect = e-178, Method: Compositional matrix adjust.
Identities = 381/983 (38%), Positives = 535/983 (54%), Gaps = 80/983 (8%)
Query: 28 TLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGK 87
+L +S NL+G IP I L+ L+ S N+L G+ P+S+ L L L ++ N
Sbjct: 85 SLDLSHRNLSGRIPIQIRYLSSLLYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSS 144
Query: 88 IPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNM 147
P +S K L+ F N G +P+++ RL LEE+ GG+ G+IPA G +
Sbjct: 145 FPPGISKLKFLKVFNAFSNNFEGLLPSDVSRLRFLEELNFGGSY-FEGEIPAAYGGLQRL 203
Query: 148 TALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSG 207
+ LA + G LP LG L++LQ + I +G IP+E S L + SLSG
Sbjct: 204 KFIHLAGNVLGGKLPPRLGLLTELQHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSG 263
Query: 208 SIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSEL 267
S+P E+G L LE LFL+QN G IPE N SLK++DFS N LSG+IP G S L
Sbjct: 264 SLPQELGNLSNLETLFLFQNGFTGEIPESYSNLKSLKLLDFSSNQLSGSIP---SGFSTL 320
Query: 268 EEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEG 327
+ NL L L +N +SG +P IG L +LT F W N G
Sbjct: 321 K---------------------NLTWLSLISNNLSGEVPEGIGELPELTTLFLWNNNFTG 359
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSL 387
+P L S L+ +D+S+NS T ++P+ L L KL+L SN G +P + C SL
Sbjct: 360 VLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEGELPKSLTRCESL 419
Query: 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG 447
R R NNR+ G IP G L+ L F+DLS+NR + +P + LQ ++LS N
Sbjct: 420 WRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVLQYLNLSTNFFHR 479
Query: 448 SLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSL 507
LP ++ LQ+ S + G+IP +G C S
Sbjct: 480 KLPENIWKAPNLQIFSASFSNLIGEIPNYVG-------------------------CKSF 514
Query: 508 QLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE 567
++L N L G++P ++G E L + LNLS N L G IP +IS L ++ +DLSHN L
Sbjct: 515 YRIELQGNSLNGTIPWDIGHCEKL-LCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLT 573
Query: 568 GNL-NPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSCFLSND 626
G + + + + N+SYN+ G +P F L+P+ + NEGLC S+
Sbjct: 574 GTIPSDFGSSKTITTFNVSYNQLIGPIPSGS-FAHLNPSFFSSNEGLCGDLVGKPCNSDR 632
Query: 627 GKAGLASNENDVRRSRKLKVAIALLITLTVAMAIMGTFALIRARRAMK-------DDDDS 679
AG A + + R K A A++ L A+ + G F L+ A R + D
Sbjct: 633 FNAGNADIDGHHKEERPKKTAGAIVWILAAAIGV-GFFVLVAATRCFQKSYGNRVDGGGR 691
Query: 680 ELGDSWPWQFTPFQKLNFSVEQVLKCLVDA-NVIGKGCSGVVYRADMDNGEVIAVKKLWP 738
GD PW+ T FQ+LNF+ + V++CL N++G G +G VY+A+M NGE+IAVKKLW
Sbjct: 692 NGGDIGPWKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWG 751
Query: 739 TTMAAANG-CSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGS 797
NG KSGV AE+ LG++RH+NIVR LGCC NR+ +L+Y+YMPNGS
Sbjct: 752 KN--KENGKIRRRKSGVL----AEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGS 805
Query: 798 LGSLLH---ERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE 854
L LLH + A EW YQI +G AQG+ YLHHDC P IVHRD+K +NIL+ +FE
Sbjct: 806 LDDLLHGGDKTMTAAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFE 865
Query: 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG 914
+ADFG+AKL+ + S + VAGSYGYIAPEY Y +++ +KSD+YSYGV++LE++TG
Sbjct: 866 ARVADFGVAKLIQTDE---SMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITG 922
Query: 915 KQPIDPTIPDGSHVVDWVRQKKGI-----QVLDPSLLSRPESEIDEMLQALGVALLCVNA 969
K+ ++P +G+ +VDWVR K +VLD S+ +EM Q L +ALLC +
Sbjct: 923 KRSVEPEFGEGNSIVDWVRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSR 982
Query: 970 SPDERPTMKDVAAMLKEIKHERE 992
SP +RP M+DV +L+E K +R+
Sbjct: 983 SPTDRPPMRDVLLILQEAKPKRK 1005
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 622 bits (1604), Expect = e-177, Method: Compositional matrix adjust.
Identities = 385/997 (38%), Positives = 557/997 (55%), Gaps = 90/997 (9%)
Query: 22 SFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNS 81
S +H+ +L +S NL+G++ D+ L L ++N + G +P + L+ L L L++
Sbjct: 67 SLRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSN 126
Query: 82 NQLTGKIPVELSN-CKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAE 140
N G P ELS+ +LR L L++N L G++P L L+ L + GGN GKIPA
Sbjct: 127 NVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNY-FSGKIPAT 185
Query: 141 LGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSI-YTTMISGEIPAEIGNCSELVSLF 199
G + L ++ +++G +P +G L+ L+ L I Y +P EIGN SELV
Sbjct: 186 YGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFD 245
Query: 200 LYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPL 259
L+G IPPEIGKL+KL+ LFL N+ G I +E+G +SLK +D
Sbjct: 246 AANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMD------------ 293
Query: 260 SIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFF 319
+S+N +G IP + + NL L L N++ G IP IG + +L V
Sbjct: 294 ------------LSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQ 341
Query: 320 AWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPP 379
W+N GSIP L L LDLS N LT ++P + L L+ + N + GSIP
Sbjct: 342 LWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPD 401
Query: 380 EIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCT-ELQMI 438
+G C SL R+R+G N + G IP+E+ GL L+ ++L N L+G +P G + +L I
Sbjct: 402 SLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQI 461
Query: 439 DLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIP 498
LS+N L GSLP ++ +LSG+Q L + N+FSG IP +GRL L+K+ S NLFSG I
Sbjct: 462 SLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIA 521
Query: 499 SSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSI 558
+ C L +DLS N+L+G +P EL ++ L LNLS N L G IP I
Sbjct: 522 PEISRCKLLTFVDLSRNELSGDIPNELTGMKILNY-LNLSRNHLVGSIPVTI-------- 572
Query: 559 LDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRK 618
A + +L S++ SYN +G +P F + T GN LC
Sbjct: 573 ---------------ASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYL 617
Query: 619 DSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAIMGTFALIRARRAMKDDDD 678
C GK S+ + + KL + + LL ++ AI+ A+I+AR ++++ +
Sbjct: 618 GPC-----GKGTHQSHVKPLSATTKLLLVLGLLFC-SMVFAIV---AIIKAR-SLRNASE 667
Query: 679 SELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWP 738
++ W+ T FQ+L+F+ + VL L + N+IGKG +G+VY+ M G+++AVK+L
Sbjct: 668 AK-----AWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRL-- 720
Query: 739 TTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSL 798
TM+ +G S + F+AEI+TLG IRH++IVR LG C N LL+Y+YMPNGSL
Sbjct: 721 ATMS--HGSSHDHG-----FNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 773
Query: 799 GSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858
G +LH + G L W RY+I L AA+GL YLHHDC P IVHRD+K+NNIL+ FE ++A
Sbjct: 774 GEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVA 833
Query: 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918
DFGLAK + D + + +AGSYGYIAPEY Y +K+ EKSDVYS+GVV+LE++TGK+P+
Sbjct: 834 DFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPV 893
Query: 919 DPTIPDGSHVVDWVRQKKG------IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPD 972
DG +V WVR ++V+D L S P + E+ VALLCV
Sbjct: 894 G-EFGDGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVP---VHEVTHVFYVALLCVEEQAV 949
Query: 973 ERPTMKDVAAMLKEIKH---EREEYAKVDMLLKGSPA 1006
ERPTM++V +L EI +++ A+ D+ K +PA
Sbjct: 950 ERPTMREVVQILTEIPKIPLSKQQAAESDVTEK-APA 985
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 617 bits (1590), Expect = e-175, Method: Compositional matrix adjust.
Identities = 389/1028 (37%), Positives = 563/1028 (54%), Gaps = 68/1028 (6%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
IP L ++L+ L +++ +LTG IP +G+ L L +N L G +P SL L NL+
Sbjct: 231 IPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQ 290
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAEL-GRLSNLEEMRAGGNKDIV 134
L L++N LTG+IP E N L L+L +N L+G++P + +NLE++ G + +
Sbjct: 291 TLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQ-LS 349
Query: 135 GKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSE 194
G+IP EL C ++ L L++ ++GS+P +L +L +L L ++ + G + I N +
Sbjct: 350 GEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTN 409
Query: 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLS 254
L L LY N+L G +P EI L+KLE LFL++N G IP+EIGNCTSLKMID N
Sbjct: 410 LQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFE 469
Query: 255 GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSK 314
G IP SIG L EL + N + G +PA+L N L L L NQ+SG IP G L
Sbjct: 470 GEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKG 529
Query: 315 LTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDIS 374
L + N L+G++P +L S NL ++LSHN L ++ L + + +N
Sbjct: 530 LEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHP-LCGSSSYLSFDVTNNGFE 588
Query: 375 GSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTE 434
IP E+GN +L RLR+G N++ G IP +G ++ L+ LD+SSN L+G++P ++ C +
Sbjct: 589 DEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKK 648
Query: 435 LQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF------------------------S 470
L IDL++N L G +P L LS L L +S N+F +
Sbjct: 649 LTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLN 708
Query: 471 GQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEA 530
G IP +G L +LN + L KN FSG +P ++G S L L LS N LTG +P+E+GQ++
Sbjct: 709 GSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQD 768
Query: 531 LEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNL-NPLAQLDNLVSLNISYNKF 589
L+ AL+LS N TG IP+ I L+KL LDLSHN+L G + + + +L LN+S+N
Sbjct: 769 LQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNL 828
Query: 590 TGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSC--FLSNDGKAGLASNENDVRRSRKLKVA 647
G L K F + GN GLC S C SN+ + GL++ + + A
Sbjct: 829 GGKL--KKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTA 886
Query: 648 IALLITLTVAMAIMGTFALIR----ARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVL 703
I L+I L +A+ + A S P K + E ++
Sbjct: 887 IGLMI-LVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIM 945
Query: 704 KC---LVDANVIGKGCSGVVYRADMDNGEVIAVKK-LWPTTMAAANGCSDEKSGVRDSFS 759
+ L + +IG G SG VY+A+++NGE +AVKK LW + + SFS
Sbjct: 946 EATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMS-----------NKSFS 994
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNN--RLLMYDYMPNGSLGSLLH------ERTGNALE 811
E+KTLG IRH+++V+ +G C +++ LL+Y+YM NGS+ LH E+ L+
Sbjct: 995 REVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLD 1054
Query: 812 WELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGD 870
WE R +I +G AQG+ YLHHDCVPPIVHRDIK++N+L+ E ++ DFGLAK L ++ D
Sbjct: 1055 WEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCD 1114
Query: 871 FARSSNT-VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVV 929
SNT A SYGYIAPEY Y +K TEKSDVYS G+V++E++TGK P D +V
Sbjct: 1115 TNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMV 1174
Query: 930 DWVRQKKGI------QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983
WV + +++DP L E D Q L +AL C SP ERP+ +
Sbjct: 1175 RWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDS 1234
Query: 984 LKEIKHER 991
L + + R
Sbjct: 1235 LLHVYNNR 1242
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1058 | ||||||
| 255554216 | 1145 | Leucine-rich repeat receptor protein kin | 1.0 | 0.924 | 0.842 | 0.0 | |
| 224075593 | 1146 | predicted protein [Populus trichocarpa] | 0.999 | 0.922 | 0.834 | 0.0 | |
| 224053453 | 1152 | predicted protein [Populus trichocarpa] | 0.999 | 0.917 | 0.835 | 0.0 | |
| 147766422 | 1182 | hypothetical protein VITISV_031044 [Viti | 0.995 | 0.890 | 0.816 | 0.0 | |
| 359477844 | 1135 | PREDICTED: receptor-like protein kinase | 0.995 | 0.927 | 0.816 | 0.0 | |
| 356502639 | 1139 | PREDICTED: receptor-like protein kinase | 0.972 | 0.903 | 0.769 | 0.0 | |
| 357487781 | 1243 | Receptor-like protein kinase [Medicago t | 0.979 | 0.833 | 0.765 | 0.0 | |
| 449505032 | 1198 | PREDICTED: receptor-like protein kinase | 0.955 | 0.843 | 0.764 | 0.0 | |
| 449442503 | 1217 | PREDICTED: receptor-like protein kinase | 0.955 | 0.830 | 0.764 | 0.0 | |
| 449433199 | 1136 | PREDICTED: receptor-like protein kinase | 0.962 | 0.896 | 0.731 | 0.0 |
| >gi|255554216|ref|XP_002518148.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] gi|223542744|gb|EEF44281.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1726 bits (4469), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 896/1064 (84%), Positives = 977/1064 (91%), Gaps = 6/1064 (0%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
FVTEI IQSVPLQLP+P NLSSF+ L LVISDANLTG+IP DIG+ V L VLD SSN+L
Sbjct: 82 FVTEINIQSVPLQLPVPLNLSSFRSLSKLVISDANLTGTIPIDIGNSVSLTVLDLSSNSL 141
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VGT+P S+G+L NLE+LILNSNQLTGKIP ELSNC SL+ LLLFDN L+G IP ELG+LS
Sbjct: 142 VGTIPESIGQLQNLEDLILNSNQLTGKIPTELSNCTSLKNLLLFDNRLSGYIPTELGKLS 201
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
+LE +RAGGNKDIVGKIP ELGDCSN+T LGLADT+VSGSLP S GKLSKLQTLSIYTTM
Sbjct: 202 SLEVLRAGGNKDIVGKIPDELGDCSNLTVLGLADTRVSGSLPVSFGKLSKLQTLSIYTTM 261
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+SGEIPA+IGNCSELV+LFLYENSLSGSIPPEIGKLKKLE+L LWQNSLVG IPEEIGNC
Sbjct: 262 LSGEIPADIGNCSELVNLFLYENSLSGSIPPEIGKLKKLEQLLLWQNSLVGVIPEEIGNC 321
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
TSLKMID SLNSLSGTIP SIG L ELEEFMIS+NNVSGSIP++L+NATNL+QLQLDTNQ
Sbjct: 322 TSLKMIDLSLNSLSGTIPSSIGSLVELEEFMISNNNVSGSIPSDLSNATNLLQLQLDTNQ 381
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
ISGLIPPE+GMLSKL VFFAWQNQLEGSIP +LA CSNLQALDLSHNSLT S+P GLFQL
Sbjct: 382 ISGLIPPELGMLSKLNVFFAWQNQLEGSIPFSLARCSNLQALDLSHNSLTGSIPPGLFQL 441
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
QNLTKLLLISNDISGSIPPEIGNCSSLVRLR+GNNRIAG IP+EIG L+ LNFLDLSSNR
Sbjct: 442 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRLGNNRIAGGIPKEIGHLRNLNFLDLSSNR 501
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
LSGSVPDEIG CTELQMIDLS+NT++GSLPNSLSSLSGLQVLD+S N+FSGQ+PAS GRL
Sbjct: 502 LSGSVPDEIGSCTELQMIDLSNNTVEGSLPNSLSSLSGLQVLDISINQFSGQVPASFGRL 561
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
+SLNK+ILS+N FSG IP S+ LCSSLQLLDL+SN+L+GS+PMELG++EALEIALNLS N
Sbjct: 562 LSLNKLILSRNSFSGAIPPSISLCSSLQLLDLASNELSGSIPMELGRLEALEIALNLSYN 621
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
GLTGPIP ISAL KLSILDLSHNKLEG+L+ L+ LDNLVSLN+SYN FTGYLPDNKLFR
Sbjct: 622 GLTGPIPPPISALTKLSILDLSHNKLEGDLSHLSGLDNLVSLNVSYNNFTGYLPDNKLFR 681
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QLSP DLAGN+GLCSS KDSCFLS+ G+ GL N ND+R+SRKLK+AIALLITLTVAM I
Sbjct: 682 QLSPADLAGNQGLCSSLKDSCFLSDIGRTGLQRNGNDIRQSRKLKLAIALLITLTVAMVI 741
Query: 661 MGTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
MGTFA+IRARR ++DDD+S LGDSWPWQFTPFQKLNFSV+Q+L+ LVD NVIGKGCSG+V
Sbjct: 742 MGTFAIIRARRTIRDDDESVLGDSWPWQFTPFQKLNFSVDQILRSLVDTNVIGKGCSGIV 801
Query: 721 YRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780
YRADM+NG+VIAVKKLWP TMA NGC+DEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC
Sbjct: 802 YRADMENGDVIAVKKLWPNTMATTNGCNDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 861
Query: 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840
WNRN RLLMYDYMPNGSLGSLLHERTGNALEW+LRYQILLGAA+GLAYLHHDCVPPIVHR
Sbjct: 862 WNRNTRLLMYDYMPNGSLGSLLHERTGNALEWDLRYQILLGAAEGLAYLHHDCVPPIVHR 921
Query: 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD 900
DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD
Sbjct: 922 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD 981
Query: 901 VYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK-GIQVLDPSLLSRPESEIDEMLQA 959
VYSYGVVVLEVLTGKQPIDPTIP+G HV DWVRQKK GI+VLDPSLLSRP EIDEM+QA
Sbjct: 982 VYSYGVVVLEVLTGKQPIDPTIPEGLHVADWVRQKKGGIEVLDPSLLSRPGPEIDEMMQA 1041
Query: 960 LGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGSPAAANVQENKNS-SG 1018
LG+ALLCVN+SPDERPTMKDVAAMLKEIKHEREEYAKVDMLLK SPAAA ENKNS +G
Sbjct: 1042 LGIALLCVNSSPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKASPAAAADTENKNSRNG 1101
Query: 1019 VLA-TSSSKPAVT---LHPKSNNTSFSASSLFYSSSSGSRIGFK 1058
V A TSSSKP T L+PKSNN+SFSASSL YSSS +++GFK
Sbjct: 1102 VPATTSSSKPQQTMANLYPKSNNSSFSASSLLYSSSRNAKMGFK 1145
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075593|ref|XP_002304699.1| predicted protein [Populus trichocarpa] gi|222842131|gb|EEE79678.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1707 bits (4421), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 885/1061 (83%), Positives = 967/1061 (91%), Gaps = 4/1061 (0%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
FVTEI IQSVPLQ+P NLSSF L LVISDAN+TG+IP DIGDC+ L +D SSN+L
Sbjct: 87 FVTEINIQSVPLQIPFSLNLSSFHFLSKLVISDANITGTIPVDIGDCLSLKFIDLSSNSL 146
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VGT+P+S+GKL NLE LILNSNQLTGKIPVEL +C L+ LLLFDN LAG IP ELG+LS
Sbjct: 147 VGTIPASIGKLQNLENLILNSNQLTGKIPVELCSCFRLKNLLLFDNRLAGYIPPELGKLS 206
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
+L+ +RAGGNKDI+GK+P EL DCS +T LGLADT++SGSLP SLGKLSKLQTLSIYTTM
Sbjct: 207 SLQVLRAGGNKDIIGKVPDELADCSKLTVLGLADTRISGSLPVSLGKLSKLQTLSIYTTM 266
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+SGEIP ++GNCSELV+LFLYENSLSGSIPPEIGKL KLE+L LWQNSL+GAIPEEIGNC
Sbjct: 267 LSGEIPPDLGNCSELVNLFLYENSLSGSIPPEIGKLHKLEQLLLWQNSLIGAIPEEIGNC 326
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
TSLKMID SLNSLSGTIP+SIGGL +LEEFMISDNNVSGSIP++L+NATNL+QLQLDTNQ
Sbjct: 327 TSLKMIDLSLNSLSGTIPISIGGLFQLEEFMISDNNVSGSIPSDLSNATNLLQLQLDTNQ 386
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
ISGLIPPE+GMLSKLTVFFAWQNQLEGSIPS+LASCS+LQALDLSHNSLT S+P GLFQL
Sbjct: 387 ISGLIPPELGMLSKLTVFFAWQNQLEGSIPSSLASCSSLQALDLSHNSLTGSIPPGLFQL 446
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
QNLTKLL+ISNDISG++PPEIGNCSSLVRLR+GNNRIAG IP+EIGGL LNFLDLSSNR
Sbjct: 447 QNLTKLLMISNDISGALPPEIGNCSSLVRLRLGNNRIAGTIPKEIGGLGILNFLDLSSNR 506
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
LSG VPDEIG CTELQMIDLS+N LQG LPNSLSSL+GLQVLDVS N+F+GQIPAS GRL
Sbjct: 507 LSGPVPDEIGSCTELQMIDLSNNILQGPLPNSLSSLTGLQVLDVSANQFTGQIPASFGRL 566
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
SLNK++LS+N FSG IP SLGL SSLQLLDLSSN LTGS+PMELGQIE LEIALNLSCN
Sbjct: 567 TSLNKLMLSRNSFSGSIPLSLGLSSSLQLLDLSSNGLTGSIPMELGQIETLEIALNLSCN 626
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
LTGPIP QIS+L LSILDLSHNKLEG+L+PLA+LDNLVSLNISYN F GYLPDNKLFR
Sbjct: 627 RLTGPIPPQISSLTMLSILDLSHNKLEGHLSPLAELDNLVSLNISYNAFIGYLPDNKLFR 686
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QLSPTDL GN+GLCSS +DSCFL + + GL NEND R+SRKLK+A+ALLITLTVAM I
Sbjct: 687 QLSPTDLVGNQGLCSSIRDSCFLKDADRTGLPRNENDTRQSRKLKLALALLITLTVAMVI 746
Query: 661 MGTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
MG A++RARR ++DDDDSELGDSWPWQFTPFQKLNFSV+QVL+CLVD NVIGKGCSGVV
Sbjct: 747 MGAIAIMRARRTIRDDDDSELGDSWPWQFTPFQKLNFSVDQVLRCLVDTNVIGKGCSGVV 806
Query: 721 YRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780
YRADMDNGEVIAVKKLWP TMAA+NGC+DEK VRDSFS E+KTLGSIRHKNIVRFLGCC
Sbjct: 807 YRADMDNGEVIAVKKLWPNTMAASNGCNDEKCSVRDSFSTEVKTLGSIRHKNIVRFLGCC 866
Query: 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840
WNRN RLLMYDYMPNGSLGSLLHE+TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR
Sbjct: 867 WNRNTRLLMYDYMPNGSLGSLLHEKTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 926
Query: 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD 900
DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD
Sbjct: 927 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD 986
Query: 901 VYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK-GIQVLDPSLLSRPESEIDEMLQA 959
VYSYGVVVLEVLTGKQPIDPTIPDG HVVDWVRQK+ GI+VLDPSLL RP SEI+EM+QA
Sbjct: 987 VYSYGVVVLEVLTGKQPIDPTIPDGLHVVDWVRQKRGGIEVLDPSLLPRPASEIEEMMQA 1046
Query: 960 LGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGSPAAANVQENKNSSGV 1019
LG+ALLCVN+SPDERP MKDVAAMLKEIKHEREEYAKVD+LLKGSPA N QENK SSGV
Sbjct: 1047 LGIALLCVNSSPDERPNMKDVAAMLKEIKHEREEYAKVDVLLKGSPATDN-QENKKSSGV 1105
Query: 1020 L-ATSSSKPAV-TLHPKSNNTSFSASSLFYSSSSGSRIGFK 1058
+ ATSSSKP +L+PKS N+SFS SSL YSSSS S+ GFK
Sbjct: 1106 VPATSSSKPVTQSLYPKSKNSSFSVSSLLYSSSSNSKTGFK 1146
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053453|ref|XP_002297823.1| predicted protein [Populus trichocarpa] gi|222845081|gb|EEE82628.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1695 bits (4389), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 886/1061 (83%), Positives = 968/1061 (91%), Gaps = 4/1061 (0%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
FVTEI IQSVPLQ+P NLSSF+ L L+ISDAN+TG+IP DIGDC+ L +D SSN+L
Sbjct: 93 FVTEINIQSVPLQIPFSLNLSSFQSLSKLIISDANITGTIPVDIGDCMSLKFIDLSSNSL 152
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VGT+P+S+GKL NLE+LI NSNQLTGKIPVE+SNC L+ LLLFDN L G IP ELG+L
Sbjct: 153 VGTIPASIGKLQNLEDLIFNSNQLTGKIPVEISNCIRLKNLLLFDNRLVGYIPPELGKLF 212
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
+L+ +RAGGNKDI+GK+P ELGDCSN+T LGLADT++SGSLP SLGKLSKLQ+LSIYTTM
Sbjct: 213 SLKVLRAGGNKDIIGKVPDELGDCSNLTVLGLADTRISGSLPVSLGKLSKLQSLSIYTTM 272
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+SGEIP ++GNCSELV+LFLYENSLSGSIPPEIGKL KLE+L LW+NSLVG IPEEIGNC
Sbjct: 273 LSGEIPPDLGNCSELVNLFLYENSLSGSIPPEIGKLHKLEQLLLWKNSLVGPIPEEIGNC 332
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
TSLKMID SLNSLSGTIP+SIGGL +L EFMIS+NN SGSIP+N++NATNL+QLQLDTNQ
Sbjct: 333 TSLKMIDLSLNSLSGTIPVSIGGLFQLVEFMISNNNFSGSIPSNISNATNLMQLQLDTNQ 392
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
ISGLIPPE+GMLSKLTVFFAWQNQLEGSIPS+LASCSNLQALDLSHNSLT S+P GLFQL
Sbjct: 393 ISGLIPPELGMLSKLTVFFAWQNQLEGSIPSSLASCSNLQALDLSHNSLTGSIPPGLFQL 452
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
QNLTKLLLISNDISG++PPEIGNCSSLVRLR+GNNRIAG IP+EIGGL LNFLDLSSNR
Sbjct: 453 QNLTKLLLISNDISGALPPEIGNCSSLVRLRLGNNRIAGTIPKEIGGLGILNFLDLSSNR 512
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
LSG VPDEIG+CTELQMIDLS+N LQG L NSLSSL+GLQVLD S N+F+GQIPAS GRL
Sbjct: 513 LSGPVPDEIGNCTELQMIDLSNNILQGPLSNSLSSLTGLQVLDASTNQFTGQIPASFGRL 572
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
+SLNK+ILS+N FSG IP SLGL SSLQLLDLSSN LTGS+PMELG IE LEIALNLS N
Sbjct: 573 MSLNKLILSRNSFSGSIPLSLGLSSSLQLLDLSSNGLTGSIPMELGHIETLEIALNLSSN 632
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
GLTGPIP QISAL +LSILDLSHNKLEG L+PLA LDNLVSLNISYN FTGYLPDNKLFR
Sbjct: 633 GLTGPIPPQISALTRLSILDLSHNKLEGQLSPLAGLDNLVSLNISYNNFTGYLPDNKLFR 692
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QLSPTDLAGN+GLCSS +DSCFL++ +AGL NEND+RRSR+LK+A+ALLITLTVAM I
Sbjct: 693 QLSPTDLAGNQGLCSSIQDSCFLNDVDRAGLPRNENDLRRSRRLKLALALLITLTVAMVI 752
Query: 661 MGTFALIRARRAMK-DDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGV 719
MGT A+IRARR ++ DDDDSELGDSWPWQFTPFQKLNFSV+QVL+CLVD NVIGKGCSGV
Sbjct: 753 MGTIAIIRARRTIRDDDDDSELGDSWPWQFTPFQKLNFSVDQVLRCLVDTNVIGKGCSGV 812
Query: 720 VYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779
VYRADMDNGEVIAVKKLWP MAAANGC DEK GVRDSFS E+KTLGSIRHKNIVRFLGC
Sbjct: 813 VYRADMDNGEVIAVKKLWPNAMAAANGCDDEKCGVRDSFSTEVKTLGSIRHKNIVRFLGC 872
Query: 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVH 839
CWNRN RLLMYDYMPNGSLGSLLHERTGNAL+WELRYQILLGAAQG+AYLHHDCVPPIVH
Sbjct: 873 CWNRNTRLLMYDYMPNGSLGSLLHERTGNALQWELRYQILLGAAQGVAYLHHDCVPPIVH 932
Query: 840 RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKS 899
RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKS
Sbjct: 933 RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKS 992
Query: 900 DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK-GIQVLDPSLLSRPESEIDEMLQ 958
DVYSYGVVVLEVLTGKQPIDPTIPDG HVVDWVRQK+ GI+VLDPSLLSRP SEI+EM+Q
Sbjct: 993 DVYSYGVVVLEVLTGKQPIDPTIPDGLHVVDWVRQKRGGIEVLDPSLLSRPASEIEEMMQ 1052
Query: 959 ALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGSPAAANVQENKNSSG 1018
ALG+ALLCVN+SPDERP MKDVAAMLKEIKHEREEYAKVD+LLKGSPA N QENK SSG
Sbjct: 1053 ALGIALLCVNSSPDERPNMKDVAAMLKEIKHEREEYAKVDVLLKGSPAPDN-QENKKSSG 1111
Query: 1019 VLATSSSKPAV-TLHPKSNNTSFSASSLFYSSSSGSRIGFK 1058
V ATSSSK A +L PKSNN+SFSA S YSSSS S+ GFK
Sbjct: 1112 VPATSSSKAATQSLFPKSNNSSFSAFSSLYSSSSNSKTGFK 1152
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147766422|emb|CAN73805.1| hypothetical protein VITISV_031044 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1662 bits (4303), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 865/1060 (81%), Positives = 964/1060 (90%), Gaps = 7/1060 (0%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
FVTEI IQSV L+LPIP+NLSSF+ LQ LVISDAN+TG+IP +IG C L ++D SSN+L
Sbjct: 126 FVTEINIQSVHLELPIPSNLSSFQFLQKLVISDANITGTIPPEIGGCTALRIIDLSSNSL 185
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VGT+P+SLGKL LE+L+LNSNQLTGKIPVELSNC +LR LLLFDN L GNIP +LG+LS
Sbjct: 186 VGTIPASLGKLQKLEDLVLNSNQLTGKIPVELSNCLNLRNLLLFDNRLGGNIPPDLGKLS 245
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
NLE +RAGGNK+I GKIPAELG+CSN+T LGLADTQVSGSLPASLGKLS+LQTLSIYTTM
Sbjct: 246 NLEVIRAGGNKEITGKIPAELGECSNLTVLGLADTQVSGSLPASLGKLSRLQTLSIYTTM 305
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+SGEIP +IGNCSELV+L+LYENSLSGS+PPE+GKL+KL+ LFLWQN+LVG IPEEIGNC
Sbjct: 306 LSGEIPPDIGNCSELVNLYLYENSLSGSVPPELGKLQKLQTLFLWQNTLVGVIPEEIGNC 365
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
+SL+MID SLNSLSGTIP S+G LSEL+EFMIS+NNVSGSIP+ L+NA NL+QLQLDTNQ
Sbjct: 366 SSLQMIDLSLNSLSGTIPPSLGDLSELQEFMISNNNVSGSIPSVLSNARNLMQLQLDTNQ 425
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
ISGLIPP++G LSKL VFFAW NQLEGSIPSTLA+C NLQ LDLSHNSLT ++P+GLFQL
Sbjct: 426 ISGLIPPDLGKLSKLGVFFAWDNQLEGSIPSTLANCRNLQVLDLSHNSLTGTIPSGLFQL 485
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
QNLTKLLLISNDISG+IPPEIGNCSSLVR+R+GNNRI G IPR+IGGLK LNFLDLS NR
Sbjct: 486 QNLTKLLLISNDISGTIPPEIGNCSSLVRMRLGNNRITGGIPRQIGGLKNLNFLDLSRNR 545
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
LSGSVPDEI CTELQM+DLS+N L+G LPNSLSSLSGLQVLDVS NR +GQIPAS GRL
Sbjct: 546 LSGSVPDEIESCTELQMVDLSNNILEGPLPNSLSSLSGLQVLDVSVNRLTGQIPASFGRL 605
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
VSLNK+ILS+N SG IP SLGLCSSLQLLDLSSN+L GS+PMEL QIEALEIALNLSCN
Sbjct: 606 VSLNKLILSRNSLSGSIPPSLGLCSSLQLLDLSSNELFGSIPMELSQIEALEIALNLSCN 665
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
GLTGPIP QISALNKLSILDLSHNKLEGNL PLA+LDNLVSLNISYN FTGYLPDNKLFR
Sbjct: 666 GLTGPIPTQISALNKLSILDLSHNKLEGNLIPLAKLDNLVSLNISYNNFTGYLPDNKLFR 725
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QL DLAGN+GLCS +DSCFL++ GL N+++VR+SRKLK+AIALLIT+TVA+ I
Sbjct: 726 QLPAIDLAGNQGLCSWGRDSCFLND--VTGLTRNKDNVRQSRKLKLAIALLITMTVALVI 783
Query: 661 MGTFALIRARRAMKDDDDSEL-GDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGV 719
MGT A+IRAR ++ DDDSEL GDSWPWQFTPFQKLNFSVEQ+L+CLVD+NVIGKGCSGV
Sbjct: 784 MGTIAVIRARTTIRGDDDSELGGDSWPWQFTPFQKLNFSVEQILRCLVDSNVIGKGCSGV 843
Query: 720 VYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779
VYRADMDNGEVIAVKKLWPT M AANG +D KSGVRDSFSAE+KTLGSIRHKNIVRFLGC
Sbjct: 844 VYRADMDNGEVIAVKKLWPTAMGAANGDND-KSGVRDSFSAEVKTLGSIRHKNIVRFLGC 902
Query: 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVH 839
CWNRN RLLMYDYMPNGSLGSLLHE+ GN+LEW LRYQIL+GAAQGLAYLHHDCVPPIVH
Sbjct: 903 CWNRNTRLLMYDYMPNGSLGSLLHEKAGNSLEWGLRYQILMGAAQGLAYLHHDCVPPIVH 962
Query: 840 RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKS 899
RDIKANNILIGLEFEPYIADFGLAKLV+D DFARSSNTVAGSYGYIAPEYGYMMKITEKS
Sbjct: 963 RDIKANNILIGLEFEPYIADFGLAKLVNDADFARSSNTVAGSYGYIAPEYGYMMKITEKS 1022
Query: 900 DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK-GIQVLDPSLLSRPESEIDEMLQ 958
DVYSYG+VVLEVLTGKQPIDPTIPDG HVVDWVRQKK G++VLDPSLL RPESE+DEM+Q
Sbjct: 1023 DVYSYGIVVLEVLTGKQPIDPTIPDGLHVVDWVRQKKGGVEVLDPSLLCRPESEVDEMMQ 1082
Query: 959 ALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGSPAAANVQENKNSSG 1018
ALG+ALLCVN+SPDERPTMKDVAAMLKEIKHERE+YAKVD+LLKG P A ++Q+NK+SSG
Sbjct: 1083 ALGIALLCVNSSPDERPTMKDVAAMLKEIKHEREDYAKVDVLLKGFP-ATDIQDNKSSSG 1141
Query: 1019 -VLATSSSKPAVTLHPKSNNTSFSASSLFYSSSSGSRIGF 1057
+SS+ +L+PKSNNTSFSASSL YSSSS ++GF
Sbjct: 1142 APATSSSTPTTQSLYPKSNNTSFSASSLLYSSSSNGKMGF 1181
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477844|ref|XP_002283104.2| PREDICTED: receptor-like protein kinase 2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1639 bits (4245), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 865/1060 (81%), Positives = 962/1060 (90%), Gaps = 7/1060 (0%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
FVTEI IQSV L+LPIP+NLSSF+ LQ LVISDAN+TG+IP +I C L ++D SSN+L
Sbjct: 79 FVTEINIQSVHLELPIPSNLSSFQFLQKLVISDANITGTIPPEIVGCTALRIIDLSSNSL 138
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VGT+P+SLGKL LE+L+LNSNQLTGKIPVELSNC +LR LLLFDN L GNIP +LG+LS
Sbjct: 139 VGTIPASLGKLQKLEDLVLNSNQLTGKIPVELSNCLNLRNLLLFDNRLGGNIPPDLGKLS 198
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
NLE +RAGGNK+I GKIPAELG+CSN+T LGLADTQVSGSLPASLGKLS+LQTLSIYTTM
Sbjct: 199 NLEVIRAGGNKEITGKIPAELGECSNLTVLGLADTQVSGSLPASLGKLSRLQTLSIYTTM 258
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+SGEIP +IGNCSELV+L+LYENSLSGS+PPE+GKL+KL+ L LWQN+LVG IPEEIGNC
Sbjct: 259 LSGEIPPDIGNCSELVNLYLYENSLSGSVPPELGKLQKLQTLLLWQNTLVGVIPEEIGNC 318
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
+SL+MID SLNSLSGTIP S+G LSEL+EFMIS+NNVSGSIP+ L+NA NL+QLQLDTNQ
Sbjct: 319 SSLQMIDLSLNSLSGTIPPSLGDLSELQEFMISNNNVSGSIPSVLSNARNLMQLQLDTNQ 378
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
ISGLIPPE+G LSKL VFFAW NQLEGSIPSTLA+C NLQ LDLSHNSLT ++P+GLFQL
Sbjct: 379 ISGLIPPELGKLSKLGVFFAWDNQLEGSIPSTLANCRNLQVLDLSHNSLTGTIPSGLFQL 438
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
QNLTKLLLISNDISG+IPPEIGNCSSLVR+R+GNNRI G IPR+IGGLK LNFLDLS NR
Sbjct: 439 QNLTKLLLISNDISGTIPPEIGNCSSLVRMRLGNNRITGGIPRQIGGLKNLNFLDLSRNR 498
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
LSGSVPDEI CTELQM+DLS+N L+G LPNSLSSLSGLQVLDVS NR +GQIPAS GRL
Sbjct: 499 LSGSVPDEIESCTELQMVDLSNNILEGPLPNSLSSLSGLQVLDVSVNRLTGQIPASFGRL 558
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
VSLNK+ILS+N SG IP SLGLCSSLQLLDLSSN+L GS+PMEL QIEALEIALNLSCN
Sbjct: 559 VSLNKLILSRNSLSGSIPPSLGLCSSLQLLDLSSNELFGSIPMELSQIEALEIALNLSCN 618
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
GLTGPIP QISALNKLSILDLSHNKLEGNL PLA+LDNLVSLNISYN FTGYLPDNKLFR
Sbjct: 619 GLTGPIPTQISALNKLSILDLSHNKLEGNLIPLAKLDNLVSLNISYNNFTGYLPDNKLFR 678
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QL DLAGN+GLCS +DSCFL++ GL N+++VR+SRKLK+AIALLIT+TVA+ I
Sbjct: 679 QLPAIDLAGNQGLCSWGRDSCFLND--VTGLTRNKDNVRQSRKLKLAIALLITMTVALVI 736
Query: 661 MGTFALIRARRAMKDDDDSEL-GDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGV 719
MGT A+IRAR ++ DDDSEL GDSWPWQFTPFQKLNFSVEQ+L+CLVD+NVIGKGCSGV
Sbjct: 737 MGTIAVIRARTTIRGDDDSELGGDSWPWQFTPFQKLNFSVEQILRCLVDSNVIGKGCSGV 796
Query: 720 VYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779
VYRADMDNGEVIAVKKLWPT M AANG +D KSGVRDSFSAE+KTLGSIRHKNIVRFLGC
Sbjct: 797 VYRADMDNGEVIAVKKLWPTAMGAANGDND-KSGVRDSFSAEVKTLGSIRHKNIVRFLGC 855
Query: 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVH 839
CWNRN RLLMYDYMPNGSLGSLLHE+ GN+LEW LRYQILLGAAQGLAYLHHDCVPPIVH
Sbjct: 856 CWNRNTRLLMYDYMPNGSLGSLLHEKAGNSLEWGLRYQILLGAAQGLAYLHHDCVPPIVH 915
Query: 840 RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKS 899
RDIKANNILIGLEFEPYIADFGLAKLV+D DFARSSNTVAGSYGYIAPEYGYMMKITEKS
Sbjct: 916 RDIKANNILIGLEFEPYIADFGLAKLVNDADFARSSNTVAGSYGYIAPEYGYMMKITEKS 975
Query: 900 DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK-GIQVLDPSLLSRPESEIDEMLQ 958
DVYSYG+VVLEVLTGKQPIDPTIPDG HVVDWVRQKK G++VLDPSLL RPESE+DEM+Q
Sbjct: 976 DVYSYGIVVLEVLTGKQPIDPTIPDGLHVVDWVRQKKGGVEVLDPSLLCRPESEVDEMMQ 1035
Query: 959 ALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGSPAAANVQENKNSSG 1018
ALG+ALLCVN+SPDERPTMKDVAAMLKEIKHERE+YAKVD+LLKG P A ++Q+NK+SSG
Sbjct: 1036 ALGIALLCVNSSPDERPTMKDVAAMLKEIKHEREDYAKVDVLLKGFP-ATDIQDNKSSSG 1094
Query: 1019 -VLATSSSKPAVTLHPKSNNTSFSASSLFYSSSSGSRIGF 1057
+SS+ +L+PKSNNTSFSASSL YSSSS ++GF
Sbjct: 1095 APATSSSTPTTQSLYPKSNNTSFSASSLLYSSSSNGKMGF 1134
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502639|ref|XP_003520125.1| PREDICTED: receptor-like protein kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1612 bits (4175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 800/1040 (76%), Positives = 910/1040 (87%), Gaps = 11/1040 (1%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
VTEITIQS+ L+LPIP+NLSSF LQ LVISDANLTG+IP DIG C L V+D SSNNL
Sbjct: 88 LVTEITIQSIALELPIPSNLSSFHSLQKLVISDANLTGTIPSDIGHCSSLTVIDLSSNNL 147
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VG++P S+GKL NL+ L LNSNQLTGKIPVELSNC L+ ++LFDN ++G IP ELG+LS
Sbjct: 148 VGSIPPSIGKLQNLQNLSLNSNQLTGKIPVELSNCIGLKNVVLFDNQISGTIPPELGKLS 207
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
LE +RAGGNKDIVGKIP E+G+CSN+T LGLADT++SGSLPASLG+L++LQTLSIYTTM
Sbjct: 208 QLESLRAGGNKDIVGKIPQEIGECSNLTVLGLADTRISGSLPASLGRLTRLQTLSIYTTM 267
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+SGEIP E+GNCSELV LFLYENSLSGSIP E+G+LKKLE+LFLWQN LVGAIPEEIGNC
Sbjct: 268 LSGEIPPELGNCSELVDLFLYENSLSGSIPSELGRLKKLEQLFLWQNGLVGAIPEEIGNC 327
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
T+L+ IDFSLNSLSGTIP+S+GGL ELEEFMISDNNVSGSIP++L+NA NL QLQ+DTNQ
Sbjct: 328 TTLRKIDFSLNSLSGTIPVSLGGLLELEEFMISDNNVSGSIPSSLSNAKNLQQLQVDTNQ 387
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
+SGLIPPE+G LS L VFFAWQNQLEGSIPS+L +CSNLQALDLS N+LT S+P GLFQL
Sbjct: 388 LSGLIPPELGQLSSLMVFFAWQNQLEGSIPSSLGNCSNLQALDLSRNALTGSIPVGLFQL 447
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
QNLTKLLLI+NDISG IP EIG+CSSL+RLR+GNNRI G IP+ I LK+LNFLDLS NR
Sbjct: 448 QNLTKLLLIANDISGFIPNEIGSCSSLIRLRLGNNRITGSIPKTIRSLKSLNFLDLSGNR 507
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
LSG VPDEIG CTELQMID S N L+G LPNSLSSLS +QVLD S N+FSG +PASLGRL
Sbjct: 508 LSGPVPDEIGSCTELQMIDFSSNNLEGPLPNSLSSLSSVQVLDASSNKFSGPLPASLGRL 567
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
VSL+K+ILS NLFSGPIP+SL LCS+LQLLDLSSN+L+GS+P ELG+IE LEIALNLSCN
Sbjct: 568 VSLSKLILSNNLFSGPIPASLSLCSNLQLLDLSSNKLSGSIPAELGRIETLEIALNLSCN 627
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
L+G IPAQ+ ALNKLSILD+SHN+LEG+L PLA+LDNLVSLN+SYNKF+G LPDNKLFR
Sbjct: 628 SLSGIIPAQMFALNKLSILDISHNQLEGDLQPLAELDNLVSLNVSYNKFSGCLPDNKLFR 687
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QL+ D N+GL SCF+ + GK G N NDVR+SR++K+AI LLI LTV M
Sbjct: 688 QLASKDFTENQGL------SCFMKDSGKTGETLNGNDVRKSRRIKLAIGLLIALTVIMIA 741
Query: 661 MGTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
MG A+I+ARR ++ DDDSELGDSWPWQF PFQKLNFSVEQVL+CL + N+IGKGCSGVV
Sbjct: 742 MGITAVIKARRTIR-DDDSELGDSWPWQFIPFQKLNFSVEQVLRCLTERNIIGKGCSGVV 800
Query: 721 YRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780
Y+A+MDNGEVIAVKKLWPTT+ + KSG+RDSFS E+KTLGSIRHKNIVRFLGC
Sbjct: 801 YKAEMDNGEVIAVKKLWPTTIDEGEAFKEGKSGIRDSFSTEVKTLGSIRHKNIVRFLGCY 860
Query: 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840
WNR RLL++DYMPNGSL SLLHERTGN+LEWELRY+ILLGAA+GLAYLHHDCVPPIVHR
Sbjct: 861 WNRKTRLLIFDYMPNGSLSSLLHERTGNSLEWELRYRILLGAAEGLAYLHHDCVPPIVHR 920
Query: 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD 900
DIKANNILIGLEFEPYIADFGLAKLVDDGDF RSSNTVAGSYGYIAPEYGYMMKITEKSD
Sbjct: 921 DIKANNILIGLEFEPYIADFGLAKLVDDGDFGRSSNTVAGSYGYIAPEYGYMMKITEKSD 980
Query: 901 VYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS-LLSRPESEIDEMLQA 959
VYSYG+V+LEVLTGKQPIDPTIPDG HVVDWVRQKKG++VLDPS LLSRPESEI+EM+QA
Sbjct: 981 VYSYGIVLLEVLTGKQPIDPTIPDGLHVVDWVRQKKGLEVLDPSLLLSRPESEIEEMMQA 1040
Query: 960 LGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGSPAAANVQENKNSSGV 1019
LG+ALLCVN+SPDERPTM+D+AAMLKEIKHERE+YAK D+LLKGSPA NK+ GV
Sbjct: 1041 LGIALLCVNSSPDERPTMRDIAAMLKEIKHEREDYAKFDVLLKGSPANGACG-NKSIGGV 1099
Query: 1020 LATSSSKPAV--TLHPKSNN 1037
L TSSS V TL K++N
Sbjct: 1100 LPTSSSSVPVMQTLKTKNDN 1119
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357487781|ref|XP_003614178.1| Receptor-like protein kinase [Medicago truncatula] gi|355515513|gb|AES97136.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1590 bits (4118), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 800/1045 (76%), Positives = 906/1045 (86%), Gaps = 9/1045 (0%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
FVTEI IQS+ LQLPIP+NLSSF L LVISD+NLTG+IP DIGDC L V+D S NNL
Sbjct: 78 FVTEINIQSITLQLPIPSNLSSFPFLDKLVISDSNLTGTIPSDIGDCSSLTVIDLSFNNL 137
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VG++PSS+GKL NL L LNSNQLTGKIP E+S+C SL+ L LFDN L G+IP LG+LS
Sbjct: 138 VGSIPSSIGKLENLVNLSLNSNQLTGKIPFEISDCISLKNLHLFDNQLGGSIPNSLGKLS 197
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
LE +RAGGNKDIVGKIP E+G+CSN+T LGLADT++SGSLP S GKL KLQTLSIYTTM
Sbjct: 198 KLEVLRAGGNKDIVGKIPEEIGECSNLTVLGLADTRISGSLPVSFGKLKKLQTLSIYTTM 257
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+SGEIP E+GNCSELV LFLYENSLSGSIP EIGKLKKLE+LFLWQN LVGAIP EIGNC
Sbjct: 258 LSGEIPKELGNCSELVDLFLYENSLSGSIPSEIGKLKKLEQLFLWQNGLVGAIPNEIGNC 317
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
+SL+ ID SLNSLSGTIPLS+G L ELEEFMISDNNVSGSIPA L+NA NL QLQ+DTNQ
Sbjct: 318 SSLRNIDLSLNSLSGTIPLSLGSLLELEEFMISDNNVSGSIPATLSNAENLQQLQVDTNQ 377
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
+SGLIPPEIG LS L VFFAWQNQLEGSIPS+L +CS LQALDLS NSLT S+P+GLFQL
Sbjct: 378 LSGLIPPEIGKLSNLLVFFAWQNQLEGSIPSSLGNCSKLQALDLSRNSLTGSIPSGLFQL 437
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
QNLTKLLLISNDISGSIP EIG+C SL+RLR+GNNRI G IP+ IG L+ LNFLDLS NR
Sbjct: 438 QNLTKLLLISNDISGSIPSEIGSCKSLIRLRLGNNRITGSIPKTIGNLRNLNFLDLSGNR 497
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
LS VPDEI C +LQMID S N L+GSLPNSLSSLS LQVLD S N+FSG +PASLGRL
Sbjct: 498 LSAPVPDEIRSCVQLQMIDFSSNNLEGSLPNSLSSLSSLQVLDASFNKFSGPLPASLGRL 557
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
VSL+K+I NLFSGPIP+SL LCS+LQL+DLSSNQLTGS+P ELG+IEALEIALNLS N
Sbjct: 558 VSLSKLIFGNNLFSGPIPASLSLCSNLQLIDLSSNQLTGSIPAELGEIEALEIALNLSFN 617
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
L+G IP QIS+LNKLSILDLSHN+LEG+L L+ LDNLVSLN+SYNKFTGYLPDNKLFR
Sbjct: 618 LLSGTIPPQISSLNKLSILDLSHNQLEGDLQTLSDLDNLVSLNVSYNKFTGYLPDNKLFR 677
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QL+ DL GN+GLC+S +DSCF+ + K +A N+N++R+SR++K+A+ LLI LTV M +
Sbjct: 678 QLTSKDLTGNQGLCTSGQDSCFVLDSSKTDMALNKNEIRKSRRIKLAVGLLIALTVVMLL 737
Query: 661 MGTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
MG A+I+ARR ++ DDDSELGDSWPWQF PFQKLNFSVEQ+L+CL+D N+IGKGCSGVV
Sbjct: 738 MGITAVIKARRTIR-DDDSELGDSWPWQFIPFQKLNFSVEQILRCLIDRNIIGKGCSGVV 796
Query: 721 YRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780
YR +MDNGEVIAVKKLWP D KSGVRDSFSAE+K LGSIRHKNIVRFLGCC
Sbjct: 797 YRGEMDNGEVIAVKKLWPIATDEGEALKDYKSGVRDSFSAEVKALGSIRHKNIVRFLGCC 856
Query: 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840
WN+ RLL++DYMPNGSL S+LHERTG++L+WELR++ILLG+A+GLAYLHHDCVPPIVHR
Sbjct: 857 WNKKTRLLIFDYMPNGSLSSVLHERTGSSLDWELRFRILLGSAEGLAYLHHDCVPPIVHR 916
Query: 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD 900
DIKANNILIGLEFEPYIADFGLAKLVDDGD RSSNTVAGSYGYIAPEYGYMMKITEKSD
Sbjct: 917 DIKANNILIGLEFEPYIADFGLAKLVDDGDVGRSSNTVAGSYGYIAPEYGYMMKITEKSD 976
Query: 901 VYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQAL 960
VYSYGVV+LEVLTGKQPIDPTIPDG HVVDWVRQK+G++VLDP+LLSRPESEI+EM+QAL
Sbjct: 977 VYSYGVVLLEVLTGKQPIDPTIPDGLHVVDWVRQKRGLEVLDPTLLSRPESEIEEMIQAL 1036
Query: 961 GVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGSPAAANVQENKNSSGVL 1020
G+ALLCVN+SPDERPTM+D+AAMLKEIK+EREEYAK D+LLKGSPA N + VL
Sbjct: 1037 GIALLCVNSSPDERPTMRDIAAMLKEIKNEREEYAKFDVLLKGSPA--------NEAKVL 1088
Query: 1021 ATSSSKPAVTLHPKSNNTSFSASSL 1045
ATSSS A+ KSNNTSFS SSL
Sbjct: 1089 ATSSSASAMQSFNKSNNTSFSVSSL 1113
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449505032|ref|XP_004162357.1| PREDICTED: receptor-like protein kinase 2-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1568 bits (4059), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 774/1012 (76%), Positives = 893/1012 (88%), Gaps = 1/1012 (0%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
FVTEI I S+PL LP P+NLSSF LQ LVISDANLTG IP DIGD L ++D SSN L
Sbjct: 53 FVTEINIISIPLHLPFPSNLSSFHSLQRLVISDANLTGPIPSDIGDSSELTLIDLSSNTL 112
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VGT+PS++GKL LE+L+LNSNQLTGK P+EL++CK+L+ LLLFDN L+G IP+E+GR+
Sbjct: 113 VGTIPSTIGKLQKLEDLVLNSNQLTGKFPIELTDCKALKNLLLFDNRLSGGIPSEMGRMG 172
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
NLE RAGGN+DI+G+IP E+G+C N++ LGLADT+VSGSLP S+G+L KLQTLSIYTTM
Sbjct: 173 NLEIFRAGGNRDIIGEIPEEIGNCRNLSILGLADTRVSGSLPNSIGRLQKLQTLSIYTTM 232
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
ISGEIP E+GNCSELV+LFLYENSLSG+IP EIGKLKKLE+LFLWQN L G IP EIG+C
Sbjct: 233 ISGEIPPELGNCSELVNLFLYENSLSGTIPKEIGKLKKLEQLFLWQNELTGTIPPEIGDC 292
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
SLK ID SLNSLSG IPL++GGLS LEEFMIS NNVSG+IP NL+NATNL+QLQLD+N+
Sbjct: 293 VSLKKIDISLNSLSGAIPLTLGGLSLLEEFMISSNNVSGTIPLNLSNATNLLQLQLDSNE 352
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
ISGLIPPE+GML KL VFFAWQNQLEGSIP +L++CSNLQALDLSHNSLT SVP GLF L
Sbjct: 353 ISGLIPPELGMLRKLNVFFAWQNQLEGSIPWSLSNCSNLQALDLSHNSLTGSVPPGLFHL 412
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
QNLTKLLLISNDISG++PP++GNC+SL+R+R+G+NRIAG IP IG L++L+FLDLS N
Sbjct: 413 QNLTKLLLISNDISGTLPPDVGNCTSLIRMRLGSNRIAGEIPNSIGALRSLDFLDLSGNH 472
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
LSG +P EIG+C L+MIDLS+N L+G LP SLSSLS LQVLDVS N+F G+IPASLG+L
Sbjct: 473 LSGFLPAEIGNCRALEMIDLSNNALKGPLPESLSSLSQLQVLDVSSNQFDGEIPASLGQL 532
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
VSLNK+IL++N FSG IP+SL LCSSLQLLDLSSNQLTG++P+ELG I++LEIALNLSCN
Sbjct: 533 VSLNKLILARNTFSGTIPTSLKLCSSLQLLDLSSNQLTGNLPIELGLIQSLEIALNLSCN 592
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
G TG +P+Q+S L KLS+LDLSHN+++G+L PLA LDNLV LNIS+N FTGYLPDNKLFR
Sbjct: 593 GFTGTLPSQMSGLTKLSVLDLSHNRVDGDLKPLAGLDNLVVLNISFNNFTGYLPDNKLFR 652
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QLSPTDLAGN GLCSS +DSCF + GL+ + +D R SRKLK+AIALLI LTV M +
Sbjct: 653 QLSPTDLAGNIGLCSSIRDSCFSTELSGKGLSKDGDDARTSRKLKLAIALLIVLTVVMTV 712
Query: 661 MGTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
MG A+IRA R M D+DSELG++WPWQFTPFQKLNFSVE+VL+ LVD+NVIGKGCSG+V
Sbjct: 713 MGVIAVIRA-RTMIQDEDSELGETWPWQFTPFQKLNFSVEEVLRRLVDSNVIGKGCSGMV 771
Query: 721 YRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780
YRA+MDNG+VIAVKKLWPT MA N +D+KSGVRDSFSAE+KTLGSIRHKNIVRFLGCC
Sbjct: 772 YRAEMDNGDVIAVKKLWPTMMATDNNYNDDKSGVRDSFSAEVKTLGSIRHKNIVRFLGCC 831
Query: 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840
NRN +LLMYDYMPNGSLGSLLHER GNALEW+LRYQILLGAAQGLAYLHHDCVPPIVHR
Sbjct: 832 SNRNTKLLMYDYMPNGSLGSLLHERNGNALEWDLRYQILLGAAQGLAYLHHDCVPPIVHR 891
Query: 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD 900
DIKANNILIGLEFE YIADFGLAKL+D+GDF RSSNTVAGSYGYIAPEYGYMMKITEKSD
Sbjct: 892 DIKANNILIGLEFEAYIADFGLAKLIDNGDFGRSSNTVAGSYGYIAPEYGYMMKITEKSD 951
Query: 901 VYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQAL 960
VYSYGVVV+EVLTGKQPIDPTIPDG H+VDWVR+ +G +VLD SL SRPE+EI+EM+Q L
Sbjct: 952 VYSYGVVVIEVLTGKQPIDPTIPDGLHIVDWVRRNRGDEVLDQSLQSRPETEIEEMMQVL 1011
Query: 961 GVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGSPAAANVQE 1012
G+ALLCVN+SPDERPTMKDV AMLKEIKHEREEYAKVD+LLK S + AN +E
Sbjct: 1012 GIALLCVNSSPDERPTMKDVEAMLKEIKHEREEYAKVDVLLKASSSPANGEE 1063
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449442503|ref|XP_004139021.1| PREDICTED: receptor-like protein kinase 2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1567 bits (4057), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 774/1012 (76%), Positives = 893/1012 (88%), Gaps = 1/1012 (0%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
FVTEI I S+PL LP P+NLSSF LQ LVISDANLTG IP DIGD L ++D SSN L
Sbjct: 72 FVTEINIISIPLHLPFPSNLSSFHSLQRLVISDANLTGPIPSDIGDSSELTLIDLSSNTL 131
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VGT+PS++GKL LE+L+LNSNQLTGK P+EL++CK+L+ LLLFDN L+G IP+E+GR+
Sbjct: 132 VGTIPSTIGKLQKLEDLVLNSNQLTGKFPIELTDCKALKNLLLFDNRLSGGIPSEMGRMG 191
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
NLE RAGGN+DI+G+IP E+G+C N++ LGLADT+VSGSLP S+G+L KLQTLSIYTTM
Sbjct: 192 NLEIFRAGGNRDIIGEIPEEIGNCRNLSILGLADTRVSGSLPNSIGRLQKLQTLSIYTTM 251
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
ISGEIP E+GNCSELV+LFLYENSLSG+IP EIGKLKKLE+LFLWQN L G IP EIG+C
Sbjct: 252 ISGEIPPELGNCSELVNLFLYENSLSGTIPKEIGKLKKLEQLFLWQNELTGTIPPEIGDC 311
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
SLK ID SLNSLSG IPL++GGLS LEEFMIS NNVSG+IP NL+NATNL+QLQLD+N+
Sbjct: 312 VSLKKIDISLNSLSGAIPLTLGGLSLLEEFMISSNNVSGTIPLNLSNATNLLQLQLDSNE 371
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
ISGLIPPE+GML KL VFFAWQNQLEGSIP +L++CSNLQALDLSHNSLT SVP GLF L
Sbjct: 372 ISGLIPPELGMLRKLNVFFAWQNQLEGSIPWSLSNCSNLQALDLSHNSLTGSVPPGLFHL 431
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
QNLTKLLLISNDISG++PP++GNC+SL+R+R+G+NRIAG IP IG L++L+FLDLS N
Sbjct: 432 QNLTKLLLISNDISGTLPPDVGNCTSLIRMRLGSNRIAGEIPNSIGALRSLDFLDLSGNH 491
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
LSG +P EIG+C L+MIDLS+N L+G LP SLSSLS LQVLDVS N+F G+IPASLG+L
Sbjct: 492 LSGFLPAEIGNCRALEMIDLSNNALKGPLPESLSSLSQLQVLDVSSNQFDGEIPASLGQL 551
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
VSLNK+IL++N FSG IP+SL LCSSLQLLDLSSNQLTG++P+ELG I++LEIALNLSCN
Sbjct: 552 VSLNKLILARNTFSGTIPTSLKLCSSLQLLDLSSNQLTGNLPIELGLIQSLEIALNLSCN 611
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
G TG +P+Q+S L KLS+LDLSHN+++G+L PLA LDNLV LNIS+N FTGYLPDNKLFR
Sbjct: 612 GFTGTLPSQMSGLTKLSVLDLSHNRVDGDLKPLAGLDNLVVLNISFNNFTGYLPDNKLFR 671
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QLSPTDLAGN GLCSS +DSCF + GL+ + +D R SRKLK+AIALLI LTV M +
Sbjct: 672 QLSPTDLAGNIGLCSSIRDSCFSTELSGKGLSKDGDDARTSRKLKLAIALLIVLTVVMTV 731
Query: 661 MGTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
MG A+IRA R M D+DSELG++WPWQFTPFQKLNFSVE+VL+ LVD+NVIGKGCSG+V
Sbjct: 732 MGVIAVIRA-RTMIQDEDSELGETWPWQFTPFQKLNFSVEEVLRRLVDSNVIGKGCSGMV 790
Query: 721 YRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780
YRA+MDNG+VIAVKKLWPT MA N +D+KSGVRDSFSAE+KTLGSIRHKNIVRFLGCC
Sbjct: 791 YRAEMDNGDVIAVKKLWPTMMATDNNYNDDKSGVRDSFSAEVKTLGSIRHKNIVRFLGCC 850
Query: 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840
NRN +LLMYDYMPNGSLGSLLHER GNALEW+LRYQILLGAAQGLAYLHHDCVPPIVHR
Sbjct: 851 SNRNTKLLMYDYMPNGSLGSLLHERNGNALEWDLRYQILLGAAQGLAYLHHDCVPPIVHR 910
Query: 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD 900
DIKANNILIGLEFE YIADFGLAKL+D+GDF RSSNTVAGSYGYIAPEYGYMMKITEKSD
Sbjct: 911 DIKANNILIGLEFEAYIADFGLAKLIDNGDFGRSSNTVAGSYGYIAPEYGYMMKITEKSD 970
Query: 901 VYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQAL 960
VYSYGVVV+EVLTGKQPIDPTIPDG H+VDWVR+ +G +VLD SL SRPE+EI+EM+Q L
Sbjct: 971 VYSYGVVVIEVLTGKQPIDPTIPDGLHIVDWVRRNRGDEVLDQSLQSRPETEIEEMMQVL 1030
Query: 961 GVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGSPAAANVQE 1012
G+ALLCVN+SPDERPTMKDV AMLKEIKHEREEYAKVD+LLK S + AN +E
Sbjct: 1031 GIALLCVNSSPDERPTMKDVEAMLKEIKHEREEYAKVDVLLKASSSPANGEE 1082
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433199|ref|XP_004134385.1| PREDICTED: receptor-like protein kinase 2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1528 bits (3955), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 751/1027 (73%), Positives = 875/1027 (85%), Gaps = 9/1027 (0%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
FVT+I+IQ VPL+LP+P+NLSSF+ LQ LV+S AN+TG IP DIG+C L+VLD S NNL
Sbjct: 78 FVTDISIQFVPLRLPLPSNLSSFRFLQKLVVSGANVTGKIPDDIGNCTELVVLDLSFNNL 137
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VG++P S+G L LE+LILN NQLTG IP EL C SL+ L +FDN L+G +P ++G+L
Sbjct: 138 VGSIPGSIGNLRKLEDLILNGNQLTGSIPAELGFCSSLKNLFIFDNLLSGFLPPDIGKLE 197
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
NLE +RAGGNK+I G+IP E G+CS + LGLADT++SG LP+SLGKL L+TLSIYTT+
Sbjct: 198 NLEVLRAGGNKEITGEIPPEFGNCSKLALLGLADTRISGRLPSSLGKLKNLRTLSIYTTL 257
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+SGEIP+++GNCSELV L+LYEN LSGSIPP+IG LKKLE+LFLWQN+L+GAIP+EIGNC
Sbjct: 258 LSGEIPSDLGNCSELVDLYLYENRLSGSIPPQIGDLKKLEQLFLWQNNLIGAIPKEIGNC 317
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
+SL+ IDFSLN LSGT+PL++G LS+LEEFMISDNNVSGSIP++L++A NL+QLQ D NQ
Sbjct: 318 SSLRRIDFSLNYLSGTLPLTLGKLSKLEEFMISDNNVSGSIPSSLSDAKNLLQLQFDNNQ 377
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
ISGLIPPE+G LSKLTV AWQNQLEGSIP +L CS+L+A+DLSHNSLT +P+GLFQL
Sbjct: 378 ISGLIPPELGTLSKLTVLLAWQNQLEGSIPESLEGCSSLEAIDLSHNSLTGVIPSGLFQL 437
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
+NL+KLLLISNDISG IPPEIGN SSLVRLR+GNNRI G IPR IG L +L+FLDLS NR
Sbjct: 438 RNLSKLLLISNDISGPIPPEIGNGSSLVRLRLGNNRITGGIPRTIGRLSSLDFLDLSGNR 497
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
+SG +PDEIG+C ELQMIDLS+N L+G LPNSL+SLS LQV DVS NRF G++P S G L
Sbjct: 498 ISGPLPDEIGNCKELQMIDLSYNALEGPLPNSLASLSELQVFDVSSNRFLGELPGSFGSL 557
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
VSLNK++L NL SG IP SLGLCS LQ LDLS+N TG++P+ELGQ++ LEIALNLS N
Sbjct: 558 VSLNKLVLRANLLSGSIPPSLGLCSGLQRLDLSNNHFTGNIPVELGQLDGLEIALNLSNN 617
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
L GPIP Q+SAL KLS+LDLS N LEG+L PLA L NLVSLNISYN F+GYLPDNKLFR
Sbjct: 618 ELYGPIPPQMSALTKLSVLDLSRNNLEGDLKPLAGLSNLVSLNISYNNFSGYLPDNKLFR 677
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QLSPTDL GNE LCSS +DSCF S DG +GL N N+VR S KLK+AIALL+ LT M I
Sbjct: 678 QLSPTDLTGNERLCSSIRDSCF-SMDG-SGLTRNGNNVRLSHKLKLAIALLVALTFVMMI 735
Query: 661 MGTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
MG A++RARR + DDDDSELGD WPWQFTPFQKLNFSV+QVL+ L+D+NVIGKGCSGVV
Sbjct: 736 MGIIAVVRARRNIIDDDDSELGDKWPWQFTPFQKLNFSVDQVLRSLIDSNVIGKGCSGVV 795
Query: 721 YRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780
YRAD+ NGE IAVKKLWPT AAA+G +DEK VRDSFS E+KTLG IRHKNIVRFLGCC
Sbjct: 796 YRADIGNGETIAVKKLWPTISAAADGYTDEKPRVRDSFSTEVKTLGLIRHKNIVRFLGCC 855
Query: 781 WNRNNRLLMYDYMPNGSLGSLLHERTG--NALEWELRYQILLGAAQGLAYLHHDCVPPIV 838
WN+N RLLMYDYMPNGSLGSLLHER G +AL+W LRY+ILLGAAQGLAYLHHDCVP IV
Sbjct: 856 WNKNTRLLMYDYMPNGSLGSLLHERGGKNDALDWGLRYKILLGAAQGLAYLHHDCVPAIV 915
Query: 839 HRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEK 898
HRDIKANNIL+GL+FEPYIADFGLAKLVD+G+F RSSNTVAGSYGYIAPEYGYMMKITEK
Sbjct: 916 HRDIKANNILVGLDFEPYIADFGLAKLVDEGNFGRSSNTVAGSYGYIAPEYGYMMKITEK 975
Query: 899 SDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQ 958
SDVYS+GVVVLEVLTGKQPIDPTIP G HVVDWVRQKKG+ VLD +LLSRPESEI+EM+Q
Sbjct: 976 SDVYSFGVVVLEVLTGKQPIDPTIPGGLHVVDWVRQKKGVGVLDSALLSRPESEIEEMMQ 1035
Query: 959 ALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGSPAAANVQENKNSSG 1018
LG+ALLCVN SPDERP MKDVAAMLKEIK E + +K+D+ ++G + QENK G
Sbjct: 1036 VLGIALLCVNFSPDERPNMKDVAAMLKEIKQETD--SKIDVFVEG---GCDGQENKRPRG 1090
Query: 1019 VLATSSS 1025
VLA +++
Sbjct: 1091 VLAMATA 1097
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1058 | ||||||
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.977 | 0.906 | 0.697 | 0.0 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.937 | 0.874 | 0.641 | 0.0 | |
| TAIR|locus:2131518 | 1091 | AT4G26540 [Arabidopsis thalian | 0.681 | 0.660 | 0.473 | 9.6e-176 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.890 | 0.864 | 0.397 | 6.9e-173 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.907 | 0.854 | 0.367 | 8.7e-166 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.907 | 0.871 | 0.371 | 6.2e-165 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.900 | 0.865 | 0.373 | 1e-164 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.849 | 0.902 | 0.362 | 6.9e-150 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.869 | 0.894 | 0.354 | 3.8e-149 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.893 | 0.852 | 0.361 | 3.1e-147 |
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3684 (1301.9 bits), Expect = 0., P = 0.
Identities = 731/1048 (69%), Positives = 847/1048 (80%)
Query: 1 FVTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
F+T+I I+SVPLQL +P NL +F+ LQ L IS ANLTG++P +GDC+GL VLD SSN L
Sbjct: 82 FITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGL 141
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
VG +P SL KL NLE LILNSNQLTGKIP ++S C L+ L+LFDN L G+IP ELG+LS
Sbjct: 142 VGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLS 201
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
LE +R GGNK+I G+IP+E+GDCSN+T LGLA+T VSG+LP+SLGKL KL+TLSIYTTM
Sbjct: 202 GLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTM 261
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
ISGEIP+++GNCSELV LFLYENSLSGSIP EIG+L KLE+LFLWQNSLVG IPEEIGNC
Sbjct: 262 ISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNC 321
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
++LKMID SLN LSG+IP SIG LS LEEFMISDN SGSIP ++N ++LVQLQLD NQ
Sbjct: 322 SNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQ 381
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGXXXX 360
ISGLIP E+G L+KLT+FFAW NQLEGSIP LA C++LQALDLS NSLT ++P+G
Sbjct: 382 ISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFML 441
Query: 361 XXXXXXXXISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
ISN +SG IP EIGNCSSLVRLR+G NRI G IP IG LK +NFLD SSNR
Sbjct: 442 RNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNR 501
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTXXXXXXXXXXXXXXXXVLDVSDNRFSGQIPASLGRL 480
L G VPDEIG C+ELQMIDLS+N+ VLDVS N+FSG+IPASLGRL
Sbjct: 502 LHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRL 561
Query: 481 VSLNKIILSKNLFSGPIPXXXXXXXXXXXXXXXXNQLTGSVPMELGQIEALEIALNLSCN 540
VSLNK+ILSKNLFSG IP N+L+G +P ELG IE LEIALNLS N
Sbjct: 562 VSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSN 621
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
LTG IP++I++LNKLSILDLSHN LEG+L PLA ++NLVSLNISYN F+GYLPDNKLFR
Sbjct: 622 RLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFR 681
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
QLSP DL GN+ LCSS +DSCFL+ GL ++ D R+RKL++ +ALLITLTV + I
Sbjct: 682 QLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLG-DDGDASRTRKLRLTLALLITLTVVLMI 740
Query: 661 MGTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
+G A+IRARR + ++ DSELG+++ WQFTPFQKLNFSV+Q+++CLV+ NVIGKGCSGVV
Sbjct: 741 LGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVV 800
Query: 721 YRADMDNGEVIAVKKLWPTTMAAANGCSDEKS-GVRDSFSAEIKTLGSIRHKNIVRFLGC 779
YRAD+DNGEVIAVKKLWP A NG DEK+ VRDSFSAE+KTLG+IRHKNIVRFLGC
Sbjct: 801 YRADVDNGEVIAVKKLWP---AMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGC 857
Query: 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVH 839
CWNRN RLLMYDYMPNGSLGSLLHER G++L+W+LRY+ILLGAAQGLAYLHHDC+PPIVH
Sbjct: 858 CWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVH 917
Query: 840 RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKS 899
RDIKANNILIGL+FEPYIADFGLAKLVD+GD R SNTVAGSYGYIAPEYGY MKITEKS
Sbjct: 918 RDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKS 977
Query: 900 DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG-IQVLDPSLLSRPESEIDEMLQ 958
DVYSYGVVVLEVLTGKQPIDPT+P+G H+VDWVRQ +G ++VLD +L SR E+E DEM+Q
Sbjct: 978 DVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQ 1037
Query: 959 ALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKGSPA-AANVQEN--KN 1015
LG ALLCVN+SPDERPTMKDVAAMLKEIK EREEYAKVD+LLK SP +QE KN
Sbjct: 1038 VLGTALLCVNSSPDERPTMKDVAAMLKEIKQEREEYAKVDLLLKKSPPPTTTMQEECRKN 1097
Query: 1016 SSGVL---ATSSSKPAVTLHP--KSNNT 1038
++ A SSSK KSNNT
Sbjct: 1098 EMMMIPAAAASSSKEMRREERLLKSNNT 1125
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3297 (1165.7 bits), Expect = 0., P = 0.
Identities = 641/999 (64%), Positives = 780/999 (78%)
Query: 2 VTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLV 61
VTEI + SV L LP P N+SSF LQ LVIS+ NLTG+I +IGDC LIV+D SSN+LV
Sbjct: 84 VTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLV 143
Query: 62 GTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSN 121
G +PSSLGKL NL+EL LNSN LTGKIP EL +C SL+ L +FDN L+ N+P ELG++S
Sbjct: 144 GEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKIST 203
Query: 122 LEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMI 181
LE +RAGGN ++ GKIP E+G+C N+ LGLA T++SGSLP SLG+LSKLQ+LS+Y+TM+
Sbjct: 204 LESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTML 263
Query: 182 SGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCT 241
SGEIP E+GNCSEL++LFLY+N LSG++P E+GKL+ LE++ LWQN+L G IPEEIG
Sbjct: 264 SGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMK 323
Query: 242 SLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQI 301
SL ID S+N SGTIP S G LS L+E M+S NN++GSIP+ L+N T LVQ Q+D NQI
Sbjct: 324 SLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQI 383
Query: 302 SGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGXXXXX 361
SGLIPPEIG+L +L +F WQN+LEG+IP LA C NLQALDLS N LT S+PAG
Sbjct: 384 SGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLR 443
Query: 362 XXXXXXXISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRL 421
ISN ISG IP EIGNC+SLVRLR+ NNRI G IP+ IG L+ L+FLDLS N L
Sbjct: 444 NLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNL 503
Query: 422 SGSVPDEIGDCTELQMIDLSHNTXXXXXXXXXXXXXXXXVLDVSDNRFSGQIPASLGRLV 481
SG VP EI +C +LQM++LS+NT VLDVS N +G+IP SLG L+
Sbjct: 504 SGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLI 563
Query: 482 SLNKIILSKNLFSGPIPXXXXXXXXXXXXXXXXNQLTGSVPMELGQIEALEIALNLSCNG 541
SLN++ILSKN F+G IP N ++G++P EL I+ L+IALNLS N
Sbjct: 564 SLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNS 623
Query: 542 LTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQ 601
L G IP +ISALN+LS+LD+SHN L G+L+ L+ L+NLVSLNIS+N+F+GYLPD+K+FRQ
Sbjct: 624 LDGFIPERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQ 683
Query: 602 LSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAIM 661
L ++ GN GLCS SCF+SN + + + V S +L++AI LLI++T +A++
Sbjct: 684 LIGAEMEGNNGLCSKGFRSCFVSNSSQL---TTQRGVH-SHRLRIAIGLLISVTAVLAVL 739
Query: 662 GTFALIRARRAMKDDDDSELGDS-WPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
G A+IRA++ ++DD+DSE G++ W WQFTPFQKLNF+VE VLKCLV+ NVIGKGCSG+V
Sbjct: 740 GVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIV 799
Query: 721 YRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780
Y+A+M N EVIAVKKLWP T+ N + SGVRDSFSAE+KTLGSIRHKNIVRFLGCC
Sbjct: 800 YKAEMPNREVIAVKKLWPVTVPNLNE-KTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCC 858
Query: 781 WNRNNRLLMYDYMPNGSLGSLLHERTGN-ALEWELRYQILLGAAQGLAYLHHDCVPPIVH 839
WN+N RLLMYDYM NGSLGSLLHER+G +L WE+RY+I+LGAAQGLAYLHHDCVPPIVH
Sbjct: 859 WNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVH 918
Query: 840 RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKS 899
RDIKANNILIG +FEPYI DFGLAKLVDDGDFARSSNT+AGSYGYIAPEYGY MKITEKS
Sbjct: 919 RDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKS 978
Query: 900 DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQA 959
DVYSYGVVVLEVLTGKQPIDPTIPDG H+VDWV++ + IQV+D L +RPESE++EM+Q
Sbjct: 979 DVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQT 1038
Query: 960 LGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVD 998
LGVALLC+N P++RPTMKDVAAML EI EREE KVD
Sbjct: 1039 LGVALLCINPIPEDRPTMKDVAAMLSEICQEREESMKVD 1077
|
|
| TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1707 (606.0 bits), Expect = 9.6e-176, P = 9.6e-176
Identities = 349/737 (47%), Positives = 472/737 (64%)
Query: 2 VTEITIQSVPLQLPIP-TNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL 60
V+EI ++ + LQ +P T+L S K L +L +S NLTG IP +IGD L +LD S N+L
Sbjct: 70 VSEIQLKGMDLQGSLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSL 129
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
G +P + +L L+ L LN+N L G IP+E+ N L +L+LFDN L+G IP +G L
Sbjct: 130 SGDIPVEIFRLKKLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELK 189
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
NL+ +RAGGNK++ G++P E+G+C N+ LGLA+T +SG LPAS+G L ++QT++IYT++
Sbjct: 190 NLQVLRAGGNKNLRGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSL 249
Query: 181 ISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+SG IP EIG C+EL +L+LY+NS+SGSIP IG LKKL+ L LWQN+LVG IP E+GNC
Sbjct: 250 LSGPIPDEIGYCTELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNC 309
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
L +IDFS N L+GTIP S G L L+E +S N +SG+IP L N T L L++D N
Sbjct: 310 PELWLIDFSENLLTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNL 369
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGXXXX 360
I+G IP + L LT+FFAWQN+L G+IP +L+ C LQA+DLS+NSL+ S+P
Sbjct: 370 ITGEIPSLMSNLRSLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGL 429
Query: 361 XXXXXXXXISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
+SND+SG IPP+IGNC++L RLR+ NR+AG IP EIG LK LNF+D+S NR
Sbjct: 430 RNLTKLLLLSNDLSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENR 489
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTXXXXXXXXXXXXXXXXVLDVSDNRFSGQIPASLGRL 480
L GS+P I C L+ +DL H +D SDN S +P +G L
Sbjct: 490 LVGSIPPAISGCESLEFLDL-HTNSLSGSLLGTTLPKSLKFIDFSDNALSSTLPPGIGLL 548
Query: 481 VSLNKIILSKNLFSGPIPXXXXXXXXXXXXXXXXNQLTGSVPMELGQIEALEIALNLSCN 540
L K+ L+KN SG IP N +G +P ELGQI +L I+LNLSCN
Sbjct: 549 TELTKLNLAKNRLSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCN 608
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600
G IP++ S L L +LD+SHN+L GNLN L L NLVSLNISYN F+G LP+ FR
Sbjct: 609 RFVGEIPSRFSDLKNLGVLDVSHNQLTGNLNVLTDLQNLVSLNISYNDFSGDLPNTPFFR 668
Query: 601 QLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAI 660
+L +DLA N GL ++SN A + R S +++ I +L+ +T + +
Sbjct: 669 RLPLSDLASNRGL--------YISN---AISTRPDPTTRNSSVVRLTILILVVVTAVLVL 717
Query: 661 MGTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVV 720
M + L+RAR A K E+ DSW + T +QKL+FS++ ++K L ANVIG G SGVV
Sbjct: 718 MAVYTLVRARAAGKQLLGEEI-DSW--EVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVV 774
Query: 721 YRADMDNGEVIAVKKLW 737
YR + +GE +AVKK+W
Sbjct: 775 YRITIPSGESLAVKKMW 791
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1680 (596.4 bits), Expect = 6.9e-173, P = 6.9e-173
Identities = 396/995 (39%), Positives = 569/995 (57%)
Query: 38 GSIPF-DIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCK 96
G +P ++ L +L +S NL G++P LG L LE L L N L+G+IPV++ K
Sbjct: 85 GPLPATNLRQIKSLTLLSLTSVNLTGSIPKELGDLSELEVLDLADNSLSGEIPVDIFKLK 144
Query: 97 SLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQ 156
L+ L L N L G IP+ELG L NL E+ NK + G+IP +G+ N+ +
Sbjct: 145 KLKILSLNTNNLEGVIPSELGNLVNLIELTLFDNK-LAGEIPRTIGELKNLEIFRAGGNK 203
Query: 157 -VSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGK 215
+ G LP +G L TL + T +SG +PA IGN ++ ++ LY + LSG IP EIG
Sbjct: 204 NLRGELPWEIGNCESLVTLGLAETSLSGRLPASIGNLKKVQTIALYTSLLSGPIPDEIGN 263
Query: 216 LKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDN 275
+L+ L+L+QNS+ G+IP +G L+ + N+L G IP +G EL +S+N
Sbjct: 264 CTELQNLYLYQNSISGSIPVSMGRLKKLQSLLLWQNNLVGKIPTELGTCPELFLVDLSEN 323
Query: 276 NVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLAS 335
++G+IP + N NL +LQL NQ+SG IP E+ +KLT NQ+ G IP +
Sbjct: 324 LLTGNIPRSFGNLPNLQELQLSVNQLSGTIPEELANCTKLTHLEIDNNQISGEIPPLIGK 383
Query: 336 CSNLQALDLSHNSLTASVPAGXXXXXXXXXXXXISNDISGSIPPEIGNCSSLVRLRVGNN 395
++L N LT +P N++SGSIP I +L +L + +N
Sbjct: 384 LTSLTMFFAWQNQLTGIIPESLSQCQELQAIDLSYNNLSGSIPNGIFEIRNLTKLLLLSN 443
Query: 396 RIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTXXXXXXXXXXX 455
++G IP +IG L L L+ NRL+G++P EIG+ L ID+S N
Sbjct: 444 YLSGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDISENRLIGNIPPEISG 503
Query: 456 XXXXXVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPXXXXXXXXXXXXXXXXN 515
+D+ N +G +P +L + SL I LS N +G +P N
Sbjct: 504 CTSLEFVDLHSNGLTGGLPGTLPK--SLQFIDLSDNSLTGSLPTGIGSLTELTKLNLAKN 561
Query: 516 QLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSI-LDLSHNKLEGNL-NPL 573
+ +G +P E+ +L++ LNL NG TG IP ++ + L+I L+LS N G + +
Sbjct: 562 RFSGEIPREISSCRSLQL-LNLGDNGFTGEIPNELGRIPSLAISLNLSCNHFTGEIPSRF 620
Query: 574 AQLDNLVSLNISYNKFTG---YLPD--NKLFRQLSPTDLAGN-EGLCSSRKD--SCFLSN 625
+ L NL +L++S+NK G L D N + +S + +G RK S SN
Sbjct: 621 SSLTNLGTLDVSHNKLAGNLNVLADLQNLVSLNISFNEFSGELPNTLFFRKLPLSVLESN 680
Query: 626 DGKAGLASNENDVR-RSRK-LKVAIALLITLTVAMAIMGTFALIRARRAMKDDDDSELGD 683
G EN ++ R R +KV +++L+ +V + +M + L++A+R + EL D
Sbjct: 681 KGLFISTRPENGIQTRHRSAVKVTMSILVAASVVLVLMAVYTLVKAQRITGKQE--EL-D 737
Query: 684 SWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAA 743
SW + T +QKL+FS++ ++K L ANVIG G SGVVYR + +GE +AVKK+W
Sbjct: 738 SW--EVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRVTIPSGETLAVKKMW------ 789
Query: 744 ANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLH 803
S E++ +F++EI TLGSIRH+NI+R LG C NRN +LL YDY+PNGSL SLLH
Sbjct: 790 ----SKEENR---AFNSEINTLGSIRHRNIIRLLGWCSNRNLKLLFYDYLPNGSLSSLLH 842
Query: 804 ---ERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860
+ +G A +WE RY ++LG A LAYLHHDC+PPI+H D+KA N+L+G FE Y+ADF
Sbjct: 843 GAGKGSGGA-DWEARYDVVLGVAHALAYLHHDCLPPILHGDVKAMNVLLGSRFESYLADF 901
Query: 861 GLAKLVD-----DGDFARSSNT--VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 913
GLAK+V DGD ++ SN +AGSYGY+APE+ M ITEKSDVYSYGVV+LEVLT
Sbjct: 902 GLAKIVSGEGVTDGDSSKLSNRPPLAGSYGYMAPEHASMQHITEKSDVYSYGVVLLEVLT 961
Query: 914 GKQPIDPTIPDGSHVVDWVR-----QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVN 968
GK P+DP +P G+H+V WVR +K ++LDP L R + + EMLQ L V+ LCV+
Sbjct: 962 GKHPLDPDLPGGAHLVQWVRDHLAGKKDPREILDPRLRGRADPIMHEMLQTLAVSFLCVS 1021
Query: 969 ASPDERPTMKDVAAMLKEIKHEREEYAKVDMLLKG 1003
+RP MKD+ AMLKEI+ + ++ DM+ KG
Sbjct: 1022 NKASDRPMMKDIVAMLKEIRQFDMDRSESDMI-KG 1055
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1613 (572.9 bits), Expect = 8.7e-166, P = 8.7e-166
Identities = 363/988 (36%), Positives = 550/988 (55%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
IP + + L+ + +++ GSIP +I L + +N L G LP +G L+NLE
Sbjct: 125 IPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLE 184
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
EL+ +N LTG +P L N L N +GNIP E+G+ NL+ + N I G
Sbjct: 185 ELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNF-ISG 243
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSEL 195
++P E+G + + L + SG +P +G L+ L+TL++Y + G IP+EIGN L
Sbjct: 244 ELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSL 303
Query: 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSG 255
L+LY+N L+G+IP E+GKL K+ E+ +N L G IP E+ + L+++ N L+G
Sbjct: 304 KKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTG 363
Query: 256 TIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKL 315
IP + L L + +S N+++G IP N T++ QLQL N +SG+IP +G+ S L
Sbjct: 364 IIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPL 423
Query: 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGXXXXXXXXXXXXISNDISG 375
V +NQL G IP + SNL L+L N + ++P G + N ++G
Sbjct: 424 WVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTG 483
Query: 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTEL 435
P E+ +L + + NR +G +P EIG + L L L++N+ S ++P+EI + L
Sbjct: 484 QFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNL 543
Query: 436 QMIDLSHNTXXXXXXXXXXXXXXXXVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495
++S N+ LD+S N F G +P LG L L + LS+N FSG
Sbjct: 544 VTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSG 603
Query: 496 PIPXXXXXXXXXXXXXXXXNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNK 555
IP N +GS+P +LG + +L+IA+NLS N +G IP +I L+
Sbjct: 604 NIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHL 663
Query: 556 LSILDLSHNKLEGNL-NPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLC 614
L L L++N L G + L +L+ N SYN TG LP ++F+ ++ T GN+GLC
Sbjct: 664 LMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLC 723
Query: 615 SSRKDSCFLSNDGKAGLAS-NENDVRRSRKLKVAIALLITLTVAM-AIMGTFAL--IRAR 670
SC S+ ++S RR R + + +++ +++ + AI+ F +
Sbjct: 724 GGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPT 783
Query: 671 RAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVL---KCLVDANVIGKGCSGVVYRADMDN 727
D + +S + F P K F+V+ +L K D+ ++G+G G VY+A M +
Sbjct: 784 APYVHDKEPFFQESDIY-FVP--KERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPS 840
Query: 728 GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR--NN 785
G+ IAVKKL + G ++ + +SF AEI TLG IRH+NIVR C+++ N+
Sbjct: 841 GKTIAVKKL----ESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNS 896
Query: 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKAN 845
LL+Y+YM GSLG LLH ++++W R+ I LGAA+GLAYLHHDC P I+HRDIK+N
Sbjct: 897 NLLLYEYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSN 956
Query: 846 NILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYG 905
NILI FE ++ DFGLAK++D ++S + VAGSYGYIAPEY Y MK+TEK D+YS+G
Sbjct: 957 NILIDENFEAHVGDFGLAKVIDM-PLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFG 1015
Query: 906 VVVLEVLTGKQPIDPTIPDGSHVVDWVRQ-----KKGIQVLDPSLLSRPESEI--DEMLQ 958
VV+LE+LTGK P+ P + G + W R ++LDP L++ E ++ + M+
Sbjct: 1016 VVLLELLTGKAPVQP-LEQGGDLATWTRNHIRDHSLTSEILDP-YLTKVEDDVILNHMIT 1073
Query: 959 ALGVALLCVNASPDERPTMKDVAAMLKE 986
+A+LC +SP +RPTM++V ML E
Sbjct: 1074 VTKIAVLCTKSSPSDRPTMREVVLMLIE 1101
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1605 (570.0 bits), Expect = 6.2e-165, P = 6.2e-165
Identities = 368/991 (37%), Positives = 543/991 (54%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
IP + + L+ L +++ G IP +IG V L L +N + G+LP +G L +L
Sbjct: 113 IPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLS 172
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
+L+ SN ++G++P + N K L N ++G++P+E+G +L + N+ + G
Sbjct: 173 QLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQ-LSG 231
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSEL 195
++P E+G ++ + L + + SG +P + + L+TL++Y + G IP E+G+ L
Sbjct: 232 ELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSL 291
Query: 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSG 255
L+LY N L+G+IP EIG L E+ +N+L G IP E+GN L+++ N L+G
Sbjct: 292 EFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTG 351
Query: 256 TIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKL 315
TIP+ + L L + +S N ++G IP L LQL N +SG IPP++G S L
Sbjct: 352 TIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDL 411
Query: 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGXXXXXXXXXXXXISNDISG 375
V N L G IPS L SN+ L+L N+L+ ++P G N++ G
Sbjct: 412 WVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVG 471
Query: 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTEL 435
P + ++ + +G NR G IPRE+G L L L+ N +G +P EIG ++L
Sbjct: 472 RFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQL 531
Query: 436 QMIDLSHNTXXXXXXXXXXXXXXXXVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495
+++S N LD+ N FSG +P+ +G L L + LS N SG
Sbjct: 532 GTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSG 591
Query: 496 PIPXXXXXXXXXXXXXXXXNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNK 555
IP N GS+P ELG + L+IALNLS N LTG IP ++S L
Sbjct: 592 TIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVM 651
Query: 556 LSILDLSHNKLEGNL-NPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLC 614
L L L++N L G + + A L +L+ N SYN TG +P L R +S + GNEGLC
Sbjct: 652 LEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLC 708
Query: 615 SSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAIMGTFALIRAR--RA 672
+ C + ++ + RS K+ +AI + V++ ++ + R R
Sbjct: 709 GPPLNQCIQTQPFAPSQSTGKPGGMRSSKI-IAITAAVIGGVSLMLIALIVYLMRRPVRT 767
Query: 673 M----KDDDDSELGDSWPWQFTPFQKLNFS-VEQVLKCLVDANVIGKGCSGVVYRADMDN 727
+ +D SE+ S F P + F + ++ V+G+G G VY+A +
Sbjct: 768 VASSAQDGQPSEM--SLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPA 825
Query: 728 GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL 787
G +AVKKL A+N + V +SF AEI TLG+IRH+NIV+ G C ++ + L
Sbjct: 826 GYTLAVKKL------ASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNL 879
Query: 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNI 847
L+Y+YMP GSLG +LH+ + N L+W R++I LGAAQGLAYLHHDC P I HRDIK+NNI
Sbjct: 880 LLYEYMPKGSLGEILHDPSCN-LDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNI 938
Query: 848 LIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVV 907
L+ +FE ++ DFGLAK++D ++S + +AGSYGYIAPEY Y MK+TEKSD+YSYGVV
Sbjct: 939 LLDDKFEAHVGDFGLAKVIDM-PHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVV 997
Query: 908 VLEVLTGKQPIDPTIPDGSHVVDWVR---QKKGIQ--VLDPSLLSRPESEIDEMLQALGV 962
+LE+LTGK P+ P I G VV+WVR ++ + VLD L E + ML L +
Sbjct: 998 LLELLTGKAPVQP-IDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKI 1056
Query: 963 ALLCVNASPDERPTMKDVAAMLKEIKHEREE 993
ALLC + SP RP+M+ V ML I+ ER E
Sbjct: 1057 ALLCTSVSPVARPSMRQVVLML--IESERSE 1085
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1603 (569.3 bits), Expect = 1.0e-164, P = 1.0e-164
Identities = 371/992 (37%), Positives = 552/992 (55%)
Query: 15 PIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNL 74
PIP +LS + L+ L + G IP + + L L N L G++P +G L +L
Sbjct: 106 PIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSL 165
Query: 75 EELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIV 134
+EL++ SN LTG IP ++ + LR + N +G IP+E+ +L+ + N +
Sbjct: 166 QELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENL-LE 224
Query: 135 GKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSE 194
G +P +L N+T L L ++SG +P S+G +S+L+ L+++ +G IP EIG ++
Sbjct: 225 GSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTK 284
Query: 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLS 254
+ L+LY N L+G IP EIG L E+ +N L G IP+E G+ +LK++ N L
Sbjct: 285 MKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILL 344
Query: 255 GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSK 314
G IP +G L+ LE+ +S N ++G+IP L LV LQL NQ+ G IPP IG S
Sbjct: 345 GPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSN 404
Query: 315 LTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGXXXXXXXXXXXXISNDIS 374
+V N L G IP+ L L L N L+ ++P N ++
Sbjct: 405 FSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLT 464
Query: 375 GSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTE 434
GS+P E+ N +L L + N ++G I ++G LK L L L++N +G +P EIG+ T+
Sbjct: 465 GSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTK 524
Query: 435 LQMIDLSHNTXXXXXXXXXXXXXXXXVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFS 494
+ ++S N LD+S N+FSG I LG+LV L + LS N +
Sbjct: 525 IVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLT 584
Query: 495 GPIPXXXXXXXXXXXXXXXXNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALN 554
G IP N L+ ++P+ELG++ +L+I+LN+S N L+G IP + L
Sbjct: 585 GEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQ 644
Query: 555 KLSILDLSHNKLEGNLNPLAQLDNLVSL---NISYNKFTGYLPDNKLFRQLSPTDLAGNE 611
L IL L+ NKL G + P A + NL+SL NIS N G +PD +F+++ ++ AGN
Sbjct: 645 MLEILYLNDNKLSGEI-P-ASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNH 702
Query: 612 GLCSSRKDSC---FLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAIMGTFALIR 668
GLC+S++ C +D K N + + +K+ ++I + +G I+
Sbjct: 703 GLCNSQRSHCQPLVPHSDSKLNWLINGS---QRQKILTITCIVIGSVFLITFLGLCWTIK 759
Query: 669 ARR----AMKDDDDSELGDSW--PWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYR 722
R A++D ++ DS+ P + +Q L V+ D V+G+G G VY+
Sbjct: 760 RREPAFVALEDQTKPDVMDSYYFPKKGFTYQGL---VDATRNFSEDV-VLGRGACGTVYK 815
Query: 723 ADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782
A+M GEVIAVKKL + G S + +SF AEI TLG IRH+NIV+ G C++
Sbjct: 816 AEMSGGEVIAVKKL----NSRGEGASSD-----NSFRAEISTLGKIRHRNIVKLYGFCYH 866
Query: 783 RNNRLLMYDYMPNGSLGSLLHERTGNAL-EWELRYQILLGAAQGLAYLHHDCVPPIVHRD 841
+N+ LL+Y+YM GSLG L N L +W RY+I LGAA+GL YLHHDC P IVHRD
Sbjct: 867 QNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRD 926
Query: 842 IKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDV 901
IK+NNIL+ F+ ++ DFGLAKL+D +++S + VAGSYGYIAPEY Y MK+TEK D+
Sbjct: 927 IKSNNILLDERFQAHVGDFGLAKLIDLS-YSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 985
Query: 902 YSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK-----KGIQVLDPSLLSRPESEIDEM 956
YS+GVV+LE++TGK P+ P + G +V+WVR+ I++ D L + + + EM
Sbjct: 986 YSFGVVLLELITGKPPVQP-LEQGGDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEM 1044
Query: 957 LQALGVALLCVNASPDERPTMKDVAAMLKEIK 988
L +AL C + SP RPTM++V AM+ E +
Sbjct: 1045 SLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1463 (520.1 bits), Expect = 6.9e-150, P = 6.9e-150
Identities = 338/932 (36%), Positives = 503/932 (53%)
Query: 66 SSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEM 125
S G ++ + L+S L G P + +L L L++N++ +P + +L+ +
Sbjct: 54 SCAGDFSSVTSVDLSSANLAGPFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTL 113
Query: 126 RAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEI 185
N + G++P L D + L L SG +PAS GK L+ LS+ ++ G I
Sbjct: 114 DLSQNL-LTGELPQTLADIPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTI 172
Query: 186 PAEIGNCSELVSLFLYENSLSGS-IPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLK 244
P +GN S L L L N S S IPPE G L LE ++L + LVG IP+ +G + L
Sbjct: 173 PPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLV 232
Query: 245 MIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGL 304
+D +LN L G IP S+GGL+ + + + +N+++G IP L N +L L NQ++G
Sbjct: 233 DLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGK 292
Query: 305 IPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGXXXXXXXX 364
IP E+ + L ++N LEG +P+++A NL + + N LT +P
Sbjct: 293 IPDELCRVP-LESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLR 351
Query: 365 XXXXISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGS 424
N+ SG +P ++ L L + +N +G+IP + ++L + L+ NR SGS
Sbjct: 352 WLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGS 411
Query: 425 VPDEIGDCTELQMIDLSHNTXXXXXXXXXXXXXXXXVLDVSDNRFSGQIPASLGRLVSLN 484
VP + +++L +N+ +L +S+N F+G +P +G L +LN
Sbjct: 412 VPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLN 471
Query: 485 KIILSKNLFSGPIPXXXXXXXXXXXXXXXXNQLTGSVPMELGQIEALEIALNLSCNGLTG 544
++ S N FSG +P NQ +G + + + L LNL+ N TG
Sbjct: 472 QLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLN-ELNLADNEFTG 530
Query: 545 PIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSP 604
IP +I +L+ L+ LDLS N G + Q L LN+SYN+ +G LP + L + +
Sbjct: 531 KIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSLKLNQLNLSYNRLSGDLPPS-LAKDMYK 589
Query: 605 TDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAIMGTF 664
GN GLC K C N+ K V R + V A+++ VA +
Sbjct: 590 NSFIGNPGLCGDIKGLCGSENEAK-----KRGYVWLLRSIFVLAAMVLLAGVAWFYF-KY 643
Query: 665 ALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRAD 724
+ RAM+ W F KL FS ++L+ L + NVIG G SG VY+
Sbjct: 644 RTFKKARAMERSK---------WTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVV 694
Query: 725 MDNGEVIAVKKLWPTTMAAANGCSDEKS---GVRD-SFSAEIKTLGSIRHKNIVRFLGCC 780
+ NGE +AVK+LW ++ C EK GV+D +F AE++TLG IRHKNIV+ CC
Sbjct: 695 LTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCC 754
Query: 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840
R+ +LL+Y+YMPNGSLG LLH G L W+ R++I+L AA+GL+YLHHD VPPIVHR
Sbjct: 755 STRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVHR 814
Query: 841 DIKANNILIGLEFEPYIADFGLAKLVD-DGDFARSSNTVAGSYGYIAPEYGYMMKITEKS 899
DIK+NNILI ++ +ADFG+AK VD G +S + +AGS GYIAPEY Y +++ EKS
Sbjct: 815 DIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKS 874
Query: 900 DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV---RQKKGIQ-VLDPSLLSRPESEIDE 955
D+YS+GVV+LE++T K+P+DP + + +V WV +KGI+ V+DP L S + EI +
Sbjct: 875 DIYSFGVVILEIVTRKRPVDPELGE-KDLVKWVCSTLDQKGIEHVIDPKLDSCFKEEISK 933
Query: 956 MLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+L V LLC + P RP+M+ V ML+EI
Sbjct: 934 ILN---VGLLCTSPLPINRPSMRRVVKMLQEI 962
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1456 (517.6 bits), Expect = 3.8e-149, P = 3.8e-149
Identities = 338/954 (35%), Positives = 506/954 (53%)
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
+L+L++ L+G + ++ + SL+ L L +NA ++P L L++L+ + N G
Sbjct: 81 KLLLSNMNLSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNLTSLKVIDVSVNS-FFG 139
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSEL 195
P LG + +T + + SG LP LG + L+ L G +P+ N L
Sbjct: 140 TFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNL 199
Query: 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSG 255
L L N+ G +P IG+L LE + L N +G IPEE G T L+ +D ++ +L+G
Sbjct: 200 KFLGLSGNNFGGKVPKVIGELSSLETIILGYNGFMGEIPEEFGKLTRLQYLDLAVGNLTG 259
Query: 256 TIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKL 315
IP S+G L +L + N ++G +P L T+LV L L NQI+G IP E+G L L
Sbjct: 260 QIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNL 319
Query: 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGXXXXXXXXXXXXISNDISG 375
+ +NQL G IPS +A NL+ L+L NSL S+P SN +SG
Sbjct: 320 QLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGKNSPLKWLDVSSNKLSG 379
Query: 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTEL 435
IP + +L +L + NN +G IP EI TL + + N +SGS+P GD L
Sbjct: 380 DIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDLPML 439
Query: 436 QMIDLSHNTXXXXXXXXXXXXXXXXVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495
Q ++L+ N +D+S N S + +S+ +L I S N F+G
Sbjct: 440 QHLELAKNNLTGKIPDDIALSTSLSFIDISFNHLSS-LSSSIFSSPNLQTFIASHNNFAG 498
Query: 496 PIPXXXXXXXXXXXXXXXXNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNK 555
IP N +G +P + E L ++LNL N L G IP ++ ++
Sbjct: 499 KIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEKL-VSLNLKSNQLVGEIPKALAGMHM 557
Query: 556 LSILDLSHNKLEGNLNP-LAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLC 614
L++LDLS+N L GN+ L L LN+S+NK G +P N LF + P DL GN GLC
Sbjct: 558 LAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGPIPSNMLFAAIDPKDLVGNNGLC 617
Query: 615 SSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALLI--TLTVAMAIM---GTFALIR- 668
C S L++ + R ++ ++ VAM +M G + R
Sbjct: 618 GGVLPPCSKS----LALSAKGRNPGRIHVNHAVFGFIVGTSVIVAMGMMFLAGRWIYTRW 673
Query: 669 ---ARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRADM 725
+ A + + + WPW+ FQ+L F+ +L + ++N+IG G G+VY+A++
Sbjct: 674 DLYSNFAREYIFCKKPREEWPWRLVAFQRLCFTAGDILSHIKESNIIGMGAIGIVYKAEV 733
Query: 726 DNGEV--IAVKKLWPTTMAAANGCSD--EKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781
+ +AVKKLW + + N D ++ D E+ LG +RH+NIV+ LG
Sbjct: 734 MRRPLLTVAVKKLWRSP-SPQNDIEDHHQEEDEEDDILREVNLLGGLRHRNIVKILGYVH 792
Query: 782 NRNNRLLMYDYMPNGSLGSLLHERTGNAL--EWELRYQILLGAAQGLAYLHHDCVPPIVH 839
N +++Y+YMPNG+LG+ LH + L +W RY + +G QGL YLH+DC PPI+H
Sbjct: 793 NEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQGLNYLHNDCYPPIIH 852
Query: 840 RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKS 899
RDIK+NNIL+ E IADFGLAK++ + + + VAGSYGYIAPEYGY +KI EKS
Sbjct: 853 RDIKSNNILLDSNLEARIADFGLAKMMLHKN--ETVSMVAGSYGYIAPEYGYTLKIDEKS 910
Query: 900 DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK----KGIQ-VLDPSLLSRPESEID 954
D+YS GVV+LE++TGK PIDP+ D VV+W+R+K + ++ V+D S+ + I+
Sbjct: 911 DIYSLGVVLLELVTGKMPIDPSFEDSIDVVEWIRRKVKKNESLEEVIDASIAGDCKHVIE 970
Query: 955 EMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKV--DM-LLKGSP 1005
EML AL +ALLC P +RP+++DV ML E K R+ +V D+ + + SP
Sbjct: 971 EMLLALRIALLCTAKLPKDRPSIRDVITMLAEAKPRRKSVCQVAGDLPIFRNSP 1024
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 1438 (511.3 bits), Expect = 3.1e-147, P = 3.1e-147
Identities = 356/985 (36%), Positives = 519/985 (52%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
IP L + ++L+ L + +L G P + L + F+ N L G++PS++G + L
Sbjct: 132 IPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELT 191
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
L L+ NQ +G +P L N +L++L L DN L G +P L L NL + N +VG
Sbjct: 192 TLWLDDNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNS-LVG 250
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSEL 195
IP + C + + L++ Q +G LP LG + L+ ++ +SG IP+ G ++L
Sbjct: 251 AIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKL 310
Query: 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSG 255
+L+L N SG IPPE+GK K + +L L QN L G IP E+G + L+ + N+LSG
Sbjct: 311 DTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSG 370
Query: 256 TIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKL 315
+PLSI + L+ + NN+SG +P ++ LV L L N +G+IP ++G S L
Sbjct: 371 EVPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSL 430
Query: 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGXXXXXXXXXXXXISNDISG 375
V +N G IP L S L+ L L +N L SVP+ N++ G
Sbjct: 431 EVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRG 490
Query: 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTEL 435
+P + +L+ + N G IP +G LK + + LSSN+LSGS+P E+G +L
Sbjct: 491 GLPDFVEK-QNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKL 549
Query: 436 QMIDLSHNTXXXXXXXXXXXXXXXXVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495
+ ++LSHN LD S N +G IP++LG L L K+ L +N FSG
Sbjct: 550 EHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSG 609
Query: 496 PIPXXXXXXXXXXXXXXXXNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNK 555
IP N L G +P +G ++AL +LNLS N L G +P + L
Sbjct: 610 GIPTSLFQSNKLLNLQLGGNLLAGDIP-PVGALQALR-SLNLSSNKLNGQLPIDLGKLKM 667
Query: 556 LSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKL-FRQLSPTDLAGNEGLC 614
L LD+SHN L G L L+ + +L +NIS+N F+G +P + F SPT +GN LC
Sbjct: 668 LEELDVSHNNLSGTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLC 727
Query: 615 SSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIAL--LITLTVAMAIMGTFALIRARRA 672
+ C DG LA E+ + R ++ L TL +AM ++G I
Sbjct: 728 IN----C--PADG---LACPESSILRPCNMQSNTGKGGLSTLGIAMIVLGALLFIICLFL 778
Query: 673 MKDDDDSELGDSWPWQFTPFQKLNFSV-EQVLKC---LVDANVIGKGCSGVVYRADMDNG 728
S Q+ + S+ +VL+ L D VIGKG G +Y+A +
Sbjct: 779 FSAFLFLHCKKSVQEIAISAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKATLSPD 838
Query: 729 EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR-L 787
+V AVKKL T + NG S VR EI+T+G +RH+N+++ L W R L
Sbjct: 839 KVYAVKKLVFTGIK--NG---SVSMVR-----EIETIGKVRHRNLIK-LEEFWLRKEYGL 887
Query: 788 LMYDYMPNGSLGSLLHERTG-NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANN 846
++Y YM NGSL +LHE L+W R+ I +G A GLAYLH DC P IVHRDIK N
Sbjct: 888 ILYTYMENGSLHDILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMN 947
Query: 847 ILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGV 906
IL+ + EP+I+DFG+AKL+D + SNTV G+ GY+APE + + +SDVYSYGV
Sbjct: 948 ILLDSDLEPHISDFGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGV 1007
Query: 907 VVLEVLTGKQPIDPTIPDGSHVVDWVR----QKKGIQ-VLDPSLLSR--PESEIDEMLQA 959
V+LE++T K+ +DP+ + +V WVR Q IQ ++DPSLL S ++++ +A
Sbjct: 1008 VLLELITRKKALDPSFNGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEA 1067
Query: 960 LGVALLCVNASPDERPTMKDVAAML 984
L +AL C D+RPTM+DV L
Sbjct: 1068 LSLALRCAEKEVDKRPTMRDVVKQL 1092
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9LHP4 | RCH2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7290 | 0.9773 | 0.9062 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1058 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-154 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-67 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-66 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-43 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-16 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 3e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 481 bits (1240), Expect = e-154
Identities = 312/948 (32%), Positives = 467/948 (49%), Gaps = 81/948 (8%)
Query: 50 LIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSN-CKSLRKLLLFDNAL 108
++ +D S N+ G + S++ +L ++ + L++NQL+G IP ++ SLR L L +N
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 109 AGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKL 168
G+IP G + NLE + N + G+IP ++G S++ L L + G +P SL L
Sbjct: 131 TGSIPR--GSIPNLETLDLSNNM-LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 169 SKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNS 228
+ L+ L++ + + G+IP E+G L ++L N+LSG IP EIG L L L L N+
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN 247
Query: 229 LVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANA 288
L G IP +GN +L+ + N LSG IP SI L +L +SDN++SG IP +
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307
Query: 289 TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNS 348
NL L L +N +G IP + L +L V W N+ G IP L +NL LDLS N+
Sbjct: 308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN 367
Query: 349 LTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGL 408
LT +P GL NL KL+L SN + G IP +G C SL R+R+ +N +G +P E L
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427
Query: 409 KTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNR 468
+ FLD+S+N L G + D LQM+ L+ N G LP+S S L+ LD+S N+
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQ 486
Query: 469 FSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQI 528
FSG +P LG L L ++ LS+N SG IP L C L LDLS NQL+G
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ-------- 538
Query: 529 EALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP-LAQLDNLVSLNISYN 587
IPA S + LS LDLS N+L G + L +++LV +NIS+N
Sbjct: 539 -----------------IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN 581
Query: 588 KFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKV- 646
G LP F ++ + +AGN LC S GL +R RK
Sbjct: 582 HLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS---------GLPP----CKRVRKTPSW 628
Query: 647 --AIALLITLTVAMAIMG-TFALIRARRAMKDDDDSELGDSWPWQF--TPFQKLNFSVEQ 701
I + + +A++ F IR R ++ +W QF + K + ++
Sbjct: 629 WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSK-SITIND 687
Query: 702 VLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAE 761
+L L + NVI +G G Y+ + V K E + V S+E
Sbjct: 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVK--------------EINDVNSIPSSE 733
Query: 762 IKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLG 821
I +G ++H NIV+ +G C + L+++Y+ +L +L L WE R +I +G
Sbjct: 734 IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIG 788
Query: 822 AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
A+ L +LH C P +V ++ I+I + EP++ L L+ + S
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------CTDTKCFIS 841
Query: 882 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941
Y+APE ITEKSD+Y +G++++E+LTGK P D +V+W R L
Sbjct: 842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL 901
Query: 942 ----DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
DPS+ +E+++ + +AL C P RP DV L+
Sbjct: 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 243 bits (621), Expect = 9e-67
Identities = 150/425 (35%), Positives = 239/425 (56%), Gaps = 9/425 (2%)
Query: 191 NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEI-GNCTSLKMIDFS 249
N S +VS+ L ++SG I I +L ++ + L N L G IP++I +SL+ ++ S
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 250 LNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEI 309
N+ +G+IP G + LE +S+N +SG IP ++ + ++L L L N + G IP +
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184
Query: 310 GMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLI 369
L+ L NQL G IP L +L+ + L +N+L+ +P + L +L L L+
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244
Query: 370 SNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI 429
N+++G IP +GN +L L + N+++G IP I L+ L LDLS N LSG +P+ +
Sbjct: 245 YNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304
Query: 430 GDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILS 489
L+++ L N G +P +L+SL LQVL + N+FSG+IP +LG+ +L + LS
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS 364
Query: 490 KNLFSGPIPSSLGLCSSLQL--LDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIP 547
N +G IP GLCSS L L L SN L G +P LG +L + L N +G +P
Sbjct: 365 TNNLTGEIPE--GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR-RVRLQDNSFSGELP 421
Query: 548 AQISALNKLSILDLSHNKLEGNLNPLA-QLDNLVSLNISYNKFTGYLPDNKLFRQLSPTD 606
++ + L + LD+S+N L+G +N + +L L+++ NKF G LPD+ ++L D
Sbjct: 422 SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLD 481
Query: 607 LAGNE 611
L+ N+
Sbjct: 482 LSRNQ 486
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 4e-66
Identities = 148/420 (35%), Positives = 223/420 (53%), Gaps = 8/420 (1%)
Query: 5 ITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTL 64
+T+ S L IP L K L+ + + NL+G IP++IG L LD NNL G +
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 65 PSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEE 124
PSSLG L NL+ L L N+L+G IP + + + L L L DN+L+G IP + +L NLE
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312
Query: 125 MRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGE 184
+ N + GKIP L + L L + SG +P +LGK + L L + T ++GE
Sbjct: 313 LHLFSN-NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
Query: 185 IPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLK 244
IP + + L L L+ NSL G IP +G + L + L NS G +P E +
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVY 431
Query: 245 MIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGL 304
+D S N+L G I + L+ ++ N G +P + + L L L NQ SG
Sbjct: 432 FLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGA 490
Query: 305 IPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLT 364
+P ++G LS+L +N+L G IP L+SC L +LDLSHN L+ +PA ++ L+
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550
Query: 365 KLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGS 424
+L L N +SG IP +GN SLV++ + +N + G +P T FL ++++ ++G+
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP------STGAFLAINASAVAGN 604
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 45/286 (15%)
Query: 711 VIGKGCSGVVYRA-----DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+G+G G VY+ +AVK L + F E + +
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ----------IEEFLREARIM 55
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
+ H NIV+ LG C +++ +YMP G L L + L L A+G
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT---VAGSY 882
+ YL +HRD+ A N L+G I+DFGL++ + D D+ + +
Sbjct: 116 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR--- 169
Query: 883 GYIAPE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGI 938
++APE G K T KSDV+S+GV++ E+ T G++P + V++++++
Sbjct: 170 -WMAPESLKEG---KFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEVLEYLKKGY-- 221
Query: 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
L +P + E+ + + L C P++RPT ++ +L
Sbjct: 222 ------RLPKPPNCPPELYK---LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 84/279 (30%), Positives = 123/279 (44%), Gaps = 39/279 (13%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G G VY+A G+++AVK L EKS + EI+ L +
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKK---------RSEKSKKDQTARREIRILRRLS 56
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQGL 826
H NIVR + ++++ L+ +Y G L L + E E + QIL +GL
Sbjct: 57 HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLS-EDEAKKIALQIL----RGL 111
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIA 886
YLH + I+HRD+K NIL+ IADFGLAK + S T G+ Y+A
Sbjct: 112 EYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMA 166
Query: 887 PE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941
PE GY K DV+S GV++ E+LTGK P + +R+ G +
Sbjct: 167 PEVLLGGNGY----GPKVDVWSLGVILYELLTGKPPFSGENILDQLQL--IRRILGPPLE 220
Query: 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
S E + L L + P +RPT +++
Sbjct: 221 FDEPKWSSGS---EEAKDLIKKCLNKD--PSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 6e-47
Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 46/286 (16%)
Query: 711 VIGKGCSGVVYRA-----DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+G+G G VY+ +AVK L + F E + +
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ----------IEEFLREARIM 55
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
+ H N+V+ LG C ++ +YM G L S L + L L A+G
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARG 114
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT---VAGSY 882
+ YL +HRD+ A N L+G I+DFGL++ + D D+ R +
Sbjct: 115 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR--- 168
Query: 883 GYIAPE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGI 938
++APE G K T KSDV+S+GV++ E+ T G+QP P + + V+++++
Sbjct: 169 -WMAPESLKEG---KFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSN-EEVLEYLKNGY-- 220
Query: 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
L +P + E+ + L C P++RPT ++ +L
Sbjct: 221 ------RLPQPPNCPPELYD---LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-46
Identities = 67/202 (33%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G+G G VY A D G+ +A+K + ++ S + + EI+ L + H
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK----------EDSSSLLEELLREIEILKKLNH 50
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
NIV+ G + N+ L+ +Y GSL LL E G L + +ILL +GL YLH
Sbjct: 51 PNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLH 109
Query: 831 HDCVPPIVHRDIKANNILIG-LEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE- 888
+ I+HRD+K NIL+ + +ADFGL+KL+ T+ G+ Y+APE
Sbjct: 110 SN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--SLLKTIVGTPAYMAPEV 164
Query: 889 YGYMMKITEKSDVYSYGVVVLE 910
+EKSD++S GV++ E
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 6e-46
Identities = 88/278 (31%), Positives = 133/278 (47%), Gaps = 44/278 (15%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
++G+G G VY A D D GE++AVK + +G S+E+ ++ EI+ L S+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSV------ELSGDSEEEL---EALEREIRILSSL 56
Query: 769 RHKNIVRFLGCCWNRNN---RLLMYDYMPNGSLGSLLHERTGNALEWEL--RY--QILLG 821
+H NIVR+ G + + + +Y+ GSL SLL + L + +Y QIL
Sbjct: 57 QHPNIVRYYGSERDEEKNTLNIFL-EYVSGGSLSSLL--KKFGKLPEPVIRKYTRQIL-- 111
Query: 822 AAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
+GLAYLH + IVHRDIK NIL+ + +ADFG AK + D + + +V G
Sbjct: 112 --EGLAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 881 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940
+ ++APE + +D++S G V+E+ TGK P W +
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP-------------WSELGNPMAA 212
Query: 941 LDPSLLSRPESEIDEML--QALGVALLCVNASPDERPT 976
L S EI E L +A C+ P +RPT
Sbjct: 213 LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 7e-45
Identities = 79/288 (27%), Positives = 122/288 (42%), Gaps = 38/288 (13%)
Query: 710 NVIGKGCSGVVYRA---DMDNGEVI-AVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+G+G G VY+ D AVK L D R F E + +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL----------KEDASEEERKDFLKEARVM 50
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNA-------LEWELRYQI 818
+ H N+VR LG C L+ +YM G L L + L +
Sbjct: 51 KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTV 878
+ A+G+ YL VHRD+ A N L+G + I+DFGL++ V D D+ R
Sbjct: 111 AIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGG 167
Query: 879 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937
++APE T KSDV+S+GV++ E+ T G P P + + V++++R
Sbjct: 168 KLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY-PGLSN-EEVLEYLR---- 221
Query: 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
L +PE DE+ + + L C P++RPT ++ L+
Sbjct: 222 ----KGYRLPKPEYCPDELYE---LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 84/281 (29%), Positives = 127/281 (45%), Gaps = 47/281 (16%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+G G VY A D G+++A+K + + R+ EIK L +
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKK----------KKIKKDRERILREIKILKKL 54
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQG 825
+H NIVR + + L+ +Y G L LL +R G E E R QIL
Sbjct: 55 KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQIL----SA 109
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
L YLH IVHRD+K NIL+ + +ADFGLA+ +D G+ T G+ Y+
Sbjct: 110 LEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYM 163
Query: 886 APE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939
APE YG D++S GV++ E+LTGK P P +++ ++ +
Sbjct: 164 APEVLLGKGYGK------AVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPK 213
Query: 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
P PE +I + L LL + P++R T ++
Sbjct: 214 PPFPP----PEWDISPEAKDLIRKLLVKD--PEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 83/288 (28%), Positives = 125/288 (43%), Gaps = 49/288 (17%)
Query: 711 VIGKGCSGVVYRA----DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+G+G G VY+ D + E +AVK L R+ F E +
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE----------REEFLEEASIM 55
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
+ H NIVR LG C ++ +YMP G L L + G L + Q+ L A+G
Sbjct: 56 KKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKG 114
Query: 826 LAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
+ YL + VHRD+ A N L+ I+DFGL++ + + D+ R +
Sbjct: 115 MEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW 170
Query: 885 IAPE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQV 940
+APE G K T KSDV+S+GV++ E+ T G+QP V++ +
Sbjct: 171 MAPESLKDG---KFTSKSDVWSFGVLLWEIFTLGEQPYP--GMSNEEVLELLEDGY---- 221
Query: 941 LDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERPTMKDVAAML 984
L RPE E+ + MLQ C P++RPT ++ L
Sbjct: 222 ----RLPRPENCPDELYELMLQ-------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 68/212 (32%), Positives = 114/212 (53%), Gaps = 23/212 (10%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
++IG+G GVVY+ +++ G+ +A+K++ + K S EI L ++
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI---------KEEALKSIMQEIDLLKNL 56
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQG 825
+H NIV+++G ++ ++ +Y NGSL ++ + G E + YQ+L QG
Sbjct: 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVL----QG 111
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
LAYLH ++HRDIKA NIL + +ADFG+A ++D + +V G+ ++
Sbjct: 112 LAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDASVVGTPYWM 166
Query: 886 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
APE M + SD++S G V+E+LTG P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 37/220 (16%)
Query: 708 DANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
IGKG G VY+A G+ +A+K + E ++ EI+ L
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVI-----------KLESKEKKEKIINEIQILK 52
Query: 767 SIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
+H NIV++ G + + + L ++ ++ GSL LL E ++ Y + +G
Sbjct: 53 KCKHPNIVKYYGS-YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-VCKELLKG 110
Query: 826 LAYLH--HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
L YLH I+HRDIKA NIL+ + E + DFGL+ + D ++ NT+ G+
Sbjct: 111 LEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT---KARNTMVGTPY 162
Query: 884 YIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
++APE Y Y K+D++S G+ +E+ GK P
Sbjct: 163 WMAPEVINGKPYDY------KADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 89/287 (31%), Positives = 141/287 (49%), Gaps = 37/287 (12%)
Query: 707 VDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
V +IGKG G VY A ++ GE++AVK++ A S +K V + +EI+TL
Sbjct: 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMV-KALRSEIETL 62
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
+ H NIV++LG + +Y+P GS+GS L RT E +L +G
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVLEG 120
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
LAYLH I+HRD+KA+N+L+ + I+DFG++K DD + ++ GS ++
Sbjct: 121 LAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 886 APE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939
APE GY K+ D++S G VVLE+ G++P W ++ I
Sbjct: 178 APEVIHSYSQGYSAKV----DIWSLGCVVLEMFAGRRP-------------WSDEEA-IA 219
Query: 940 VLDP--SLLSRP--ESEIDEMLQALGVALL--CVNASPDERPTMKDV 980
+ + S P ++ L + + L C +PD RPT +++
Sbjct: 220 AMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 79/277 (28%), Positives = 125/277 (45%), Gaps = 46/277 (16%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+G+G SGVVY+ G++ A+KK+ + DE+ R E+KTL S
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKI--------HVDGDEE--FRKQLLRELKTLRSCE 57
Query: 770 HKNIVRFLGC-CWNRNNRLLMYDYMPNGSLGSLLHERTG---NALEWELRYQILLGAAQG 825
+V+ G +++ +YM GSL LL + L + QIL +G
Sbjct: 58 SPYVVKCYGAFYKEGEISIVL-EYMDGGSLADLLKKVGKIPEPVLA-YIARQIL----KG 111
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
L YLH I+HRDIK +N+LI + E IADFG++K++++ NT G+ Y+
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYM 167
Query: 886 APE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939
+PE Y Y +D++S G+ +LE GK P P + +
Sbjct: 168 SPERIQGESYSY------AADIWSLGLTLLECALGKFPFLP-----PGQPSFFELMQ--A 214
Query: 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT 976
+ D S P E + ++ C+ P +RP+
Sbjct: 215 ICDGPPPSLPAEEFSPEFRDF-IS-ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 83/272 (30%), Positives = 126/272 (46%), Gaps = 42/272 (15%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G G V+ + +AVK L P TM+ +F E + + +RH
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE------------AFLQEAQIMKKLRHD 61
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLG-AAQ---GLA 827
+V+ C ++ +YM GSL L G L R L+ AAQ G+A
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKL----RLPQLVDMAAQIAEGMA 117
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGYIA 886
YL +HRD+ A NIL+G IADFGLA+L++D ++ AR + A
Sbjct: 118 YLESRNY---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTA 172
Query: 887 PEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQ-KKGIQVLDPS 944
PE + T KSDV+S+G+++ E++T G+ P G + + Q ++G ++ P
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY-----PGMTNREVLEQVERGYRMPRPP 227
Query: 945 LLSRPESEIDEMLQALGVALLCVNASPDERPT 976
+ PE D MLQ C + P+ERPT
Sbjct: 228 --NCPEELYDLMLQ-------CWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 81/294 (27%), Positives = 129/294 (43%), Gaps = 36/294 (12%)
Query: 710 NVIGKGCSGVVYRADMDN-----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
+G+G G V D GE +AVK L + R F EI+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH----------SGEEQHRSDFEREIEI 59
Query: 765 LGSIRHKNIVRFLGCCW--NRNNRLLMYDYMPNGSLGSLLHE-RTGNALEWELRY--QIL 819
L ++ H+NIV++ G C + L+ +Y+P+GSL L R L+ L + QI
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI- 118
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV-DDGDFARSSNTV 878
+G+ YL +HRD+ A NIL+ E I+DFGLAK++ +D D+
Sbjct: 119 ---CKGMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 879 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT----GKQPIDPTIPDGSHVVDWVRQ 934
+ APE K + SDV+S+GV + E+ T + P + +
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV 232
Query: 935 KKGIQVLDPSL-LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+ +++L L RP S DE+ + LC A P +RP+ D+ ++ +
Sbjct: 233 TRLLELLKEGERLPRPPSCPDEVYDLM---KLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 85/305 (27%), Positives = 132/305 (43%), Gaps = 49/305 (16%)
Query: 703 LKCLVDANVIGKGCSGVVYRADMDNG------EVIAVKKLWPTTMAAANGCSDEKSGVRD 756
+V +G+G G V+ + + E++AVK L T A R
Sbjct: 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA----------RK 53
Query: 757 SFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL--HERTGNAL---- 810
F E + L + +H+NIV+F G C + +++++YM +G L L H L
Sbjct: 54 DFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPD 113
Query: 811 --EWELR----YQILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862
EL QI + A G+ YL H VHRD+ N L+G + I DFG+
Sbjct: 114 SPMGELTLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGM 168
Query: 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT 921
++ V D+ R ++ PE K T +SDV+S+GVV+ E+ T GKQP
Sbjct: 169 SRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228
Query: 922 IPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVA 981
V++ + Q G LL RP + E+ + L C P +R +KD+
Sbjct: 229 --SNEEVIECITQ--GR------LLQRPRTCPSEVYD---IMLGCWKRDPQQRINIKDIH 275
Query: 982 AMLKE 986
L++
Sbjct: 276 ERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 93/286 (32%), Positives = 134/286 (46%), Gaps = 54/286 (18%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G G G VY ++D+G+ AVK++ + A+ + V+ EI L ++H
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEV-----SLADDGQTGQEAVKQ-LEQEIALLSKLQH 61
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR-Y--QILLGAAQGLA 827
NIV++LG +N + + +P GSL LL ++ G+ E +R Y QILL GL
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTRQILL----GLE 116
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
YLH VHRDIK NIL+ +ADFG+AK V + FA+S GS ++AP
Sbjct: 117 YLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS---FKGSPYWMAP 170
Query: 888 E-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940
E YG +D++S G VLE+ TGK P W Q +G+
Sbjct: 171 EVIAQQGGYGL------AADIWSLGCTVLEMATGKPP-------------W-SQLEGVAA 210
Query: 941 LDPSLLSRPESEIDEML--QALGVALLCVNASPDERPTMKDVAAML 984
+ S+ I + L +A L C+ P RPT AA L
Sbjct: 211 VFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPT----AAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (279), Expect = 3e-26
Identities = 85/353 (24%), Positives = 131/353 (37%), Gaps = 30/353 (8%)
Query: 711 VIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G+G G VY A D V A+K L + KS + F EI+ L S+ H
Sbjct: 7 KLGEGSFGEVYLA-RDRKLV-ALKVL--------AKKLESKSKEVERFLREIQILASLNH 56
Query: 771 -KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER-TGNALEWELRYQILLGAAQGLAY 828
NIV+ + + L+ +Y+ GSL LL + L IL L Y
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 829 LHHDCVPPIVHRDIKANNILIGLE-FEPYIADFGLAKLVDDGDFARS----SNTVAGSYG 883
LH I+HRDIK NIL+ + + DFGLAKL+ D S +T G+ G
Sbjct: 117 LHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 884 YIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQP--IDPTIPDGSHVVDWVRQKKGI 938
Y+APE + + SD++S G+ + E+LTG P + S + + +
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE-LPT 232
Query: 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVD 998
L L I + L LL + P R + + ++ +
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKD--PKNRLSSSS--DLSHDLLAHLKLKESDL 288
Query: 999 MLLKGSPAAANVQENKNSSGVLATSSSKPAVTLHPKSNNTSFSASSLFYSSSS 1051
L +A ++ + S SS + S +
Sbjct: 289 SDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGV 341
|
Length = 384 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 70/212 (33%), Positives = 118/212 (55%), Gaps = 12/212 (5%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+IG G G VY + +GE++AVK++ +A+ D K + D+ + EI L ++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQV-ELPSVSASSK-DRKRSMLDALAREIALLKELQ 64
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H+NIV++LG + ++ + +Y+P GS+ +LL+ A E L + +GL YL
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYL 122
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT----VAGSYGYI 885
H+ I+HRDIK NIL+ + I+DFG++K ++ + +N + GS ++
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 886 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
APE T K+D++S G +V+E+LTGK P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGC-SDEKSGVRDSFSAEIKTLGSIRH 770
IGKG G VY+ + +AVK C S ++ F E + L H
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKT-----------CRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
NIV+ +G C + ++ + +P GSL + L + N L + Q+ L AA G+ YL
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE-- 888
+HRD+ A N L+G I+DFG+++ + G + S + APE
Sbjct: 111 SKNC---IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 889 -YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947
YG + T +SDV+SYG+++ E + P Q+ ++ +
Sbjct: 168 NYG---RYTSESDVWSYGILLWETFSLGDTPYP---------GMSNQQTRERIESGYRMP 215
Query: 948 RPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988
P+ +E+ + + L C P+ RP+ + + E++
Sbjct: 216 APQLCPEEIYRLM---LQCWAYDPENRPSF---SEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 710 NVIGKGCSGVVYRAD-MDNGEVIAVKKL----WPTTMAAANGCSDEKSGVRDSFSAEIKT 764
VIG G + VVY A + N E +A+K++ T++ D E++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV--------------DELRKEVQA 52
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL-HERTGNALEWELRYQILLGAA 823
+ H N+V++ + L+ Y+ GSL ++ L+ + +L
Sbjct: 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL-AKLVDDGD-FARSSNTVAGS 881
+GL YLH + +HRDIKA NIL+G + IADFG+ A L D GD + T G+
Sbjct: 113 KGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 882 YGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
++APE +GY K+D++S+G+ +E+ TG P
Sbjct: 170 PCWMAPEVMEQVHGY----DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 85/291 (29%), Positives = 123/291 (42%), Gaps = 42/291 (14%)
Query: 704 KCLVDANVIGKGCSGVVYRADMD-NGE---VIAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
+ VIG G G V R + G+ +A+K L G SD++ R F
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA-------GSSDKQ---RLDFL 53
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQIL 819
E +G H NI+R G +++ +YM NGSL L E G +L
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGML 112
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVA 879
G A G+ YL VHRD+ A NIL+ ++DFGL++ ++D + ++ T
Sbjct: 113 RGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---ATYTTK 166
Query: 880 GSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVR 933
G G I APE K T SDV+S+G+V+ EV++ G++P D
Sbjct: 167 G--GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW----------DMSN 214
Query: 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
Q V D L P + L L L C +ERPT + + L
Sbjct: 215 QDVIKAVEDGYRLPPPM-DCPSALYQL--MLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
N IGKG GVV++ + V A+K++ + M + + + E + L +
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR----EREEAID-----EARVLAKL 56
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALE----WELRYQILLGAAQ 824
I+R+ ++ ++ +Y NG L LL + G L W QILL
Sbjct: 57 DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL---- 112
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV-DDGDFARSSNTVAGSYG 883
GLA+LH I+HRDIK+ N+ + I D G+AKL+ D+ +FA NT+ G+
Sbjct: 113 GLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA---NTIVGTPY 166
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
Y++PE EKSDV++ GVV+ E TGK P D
Sbjct: 167 YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 90/306 (29%), Positives = 138/306 (45%), Gaps = 62/306 (20%)
Query: 712 IGKGCSGVV----YRADMDN-GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
+GKG G V Y DN GEV+AVKKL +T +RD F EI+ L
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST----------AEHLRD-FEREIEILK 60
Query: 767 SIRHKNIVRFLGCCWN---RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
S++H NIV++ G C++ RN RL+M +Y+P GSL L ++ L+ ++LL A+
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRNLRLVM-EYLPYGSLRDYL-QKHRERLDHR---KLLLYAS 115
Query: 824 Q---GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV-DDGDFARSSNTVA 879
Q G+ YL VHRD+ NIL+ E I DFGL K++ D ++ +
Sbjct: 116 QICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172
Query: 880 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT----GKQPID----------PTIPDG 925
+ APE K + SDV+S+GVV+ E+ T P
Sbjct: 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232
Query: 926 SHVVDWVRQKKGIQVLDPSLLSRPES---EIDEMLQALGVALLCVNASPDERPTMKDVAA 982
H+++ ++ L P EI ++ C N P +RP+ ++A
Sbjct: 233 YHLIELLKNN--------GRLPAPPGCPAEIYAIM------KECWNNDPSQRPSFSELAL 278
Query: 983 MLKEIK 988
++ I+
Sbjct: 279 QVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 82/279 (29%), Positives = 121/279 (43%), Gaps = 39/279 (13%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
IGKG G V D +V AVK L + S +F AE + ++RH
Sbjct: 14 IGKGEFGDVMLGDYRGQKV-AVKCL------------KDDSTAAQAFLAEASVMTTLRHP 60
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
N+V+ LG N ++ +YM GSL L R + + L +G+ YL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY--GYIAPEY 889
VHRD+ A N+L+ + ++DFGLAK S +G + APE
Sbjct: 121 K---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEA 170
Query: 890 GYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948
K + KSDV+S+G+++ E+ + G+ P P IP VV V +KG + +
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPL-KDVVPHV--EKGYR------MEA 220
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
PE E+ + V C P +RPT K + L I
Sbjct: 221 PEGCPPEVYK---VMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 75/275 (27%), Positives = 117/275 (42%), Gaps = 45/275 (16%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G GVV+ +A+K + M+ D F E K + + H
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS------------EDDFIEEAKVMMKLSHP 59
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ----GLA 827
N+V+ G C + ++ +YM NG L + L ER G +L + LL +
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAME 114
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT---VAGSYGY 884
YL + +HRD+ A N L+G + ++DFGLA+ V D + S T V +
Sbjct: 115 YLESNGF---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA--- 168
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
PE + + KSDV+S+GV++ EV + GK P + S VV+ V G ++ P
Sbjct: 169 -PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF--SNSEVVESVSA--GYRLYRP 223
Query: 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMK 978
L I C + P++RP K
Sbjct: 224 KLAPTEVYTI---------MYSCWHEKPEDRPAFK 249
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 72/216 (33%), Positives = 113/216 (52%), Gaps = 20/216 (9%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+GKG G VY + G++IAVK++ + +N + EK + E+ L S++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQV---ELDTSNVLAAEKE--YEKLQEEVDLLKSLK 60
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQGL 826
H NIV++LG C + N + +++P GS+ S+L R G E QIL G+
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQIL----DGV 115
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD----DGDFARSSNTVAGSY 882
AYLH++CV VHRDIK NN+++ + DFG A+ + G + ++ G+
Sbjct: 116 AYLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918
++APE KSD++S G V E+ TGK P+
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 42/225 (18%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
N IG G G VY A ++D GE++AVK++ D + E+K L +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEI---------RIQDNDPKTIKEIADEMKVLELL 56
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWEL--RY--QILLGAAQ 824
+H N+V++ G +R + +Y G+L LL G L+ + Y Q+L +
Sbjct: 57 KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLL----E 110
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIG----LEFEPYIADFGLAK-LVDDGDFARSS-NTV 878
GLAYLH IVHRDIK NI + ++ DFG A L ++ ++
Sbjct: 111 GLAYLHSH---GIVHRDIKPANIFLDHNGVIKL----GDFGCAVKLKNNTTTMGEEVQSL 163
Query: 879 AGSYGYIAPEYGYMMKITEKS------DVYSYGVVVLEVLTGKQP 917
AG+ Y+APE ++ + D++S G VVLE+ TGK+P
Sbjct: 164 AGTPAYMAPE---VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 76/274 (27%), Positives = 119/274 (43%), Gaps = 39/274 (14%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G+G G VY+A + G+V+A+K + P EI L
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV-PVE------------EDLQEIIKEISILKQCD 56
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
IV++ G + + ++ +Y GS+ ++ + T L E IL +GL YL
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA-KLVDDGDFARSSNTVAGSYGYIAPE 888
H + +HRDIKA NIL+ E + +ADFG++ +L D NTV G+ ++APE
Sbjct: 116 HSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM---AKRNTVIGTPFWMAPE 169
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQP---IDPTIPDGSHVVDWVRQKKGIQVLDPSL 945
+ K+D++S G+ +E+ GK P I P +R I P
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP-----------MRAIFMIPNKPPPT 218
Query: 946 LSRPESEIDEMLQALGVALLCVNASPDERPTMKD 979
LS PE E + C+ P+ERP+
Sbjct: 219 LSDPEKWSPEFNDFVK---KCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 78/276 (28%), Positives = 130/276 (47%), Gaps = 31/276 (11%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G+GC G V+ + +A+K L P TM+ ++F E + + +RH+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------------EAFLQEAQVMKKLRHE 61
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
+V+ + ++ +YM GSL L G L + A G+AY+
Sbjct: 62 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY 891
VHRD++A NIL+G +ADFGLA+L++D ++ + + APE
Sbjct: 121 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 176
Query: 892 MMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE 950
+ T KSDV+S+G+++ E+ T G+ P + V+D V ++G ++ P PE
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQV--ERGYRMPCPP--ECPE 230
Query: 951 SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
S D M Q C P+ERPT + + A L++
Sbjct: 231 SLHDLMCQ-------CWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 71/293 (24%), Positives = 118/293 (40%), Gaps = 62/293 (21%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IGKG G VY +G++ +K+ + +N E+ D+ + E+K L +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKE-----IDLSNMSEKER---EDALN-EVKILKKL 56
Query: 769 RHKNIVRFLGCCWNRNNRLL--MYDYMPNGSLGSLLHERTGNALE------WELRYQILL 820
H NI+++ + +L M +Y G L + ++ + Q+ L
Sbjct: 57 NHPNIIKYYES-FEEKGKLCIVM-EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114
Query: 821 GAAQGLAYLH--HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFARSSNT 877
L YLH I+HRDIK NI + + DFG++K L D A T
Sbjct: 115 A----LKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KT 162
Query: 878 VAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931
V G+ Y++PE Y Y KSD++S G V+ E+ T K P + +
Sbjct: 163 VVGTPYYLSPELCQNKPYNY------KSDIWSLGCVLYELCTLKHPFEGENLLE--LALK 214
Query: 932 VRQKKGIQVLDPSLLSRPESE-IDEMLQALGVALLCVNASPDERPTMKDVAAM 983
+ + + + PS S + +LQ P+ERP++ +
Sbjct: 215 ILKGQYPPI--PSQYSSELRNLVSSLLQ----------KDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 40/271 (14%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G G V+ +N +AVK L P TM F AE + + +RH
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP------------KDFLAEAQIMKKLRHP 61
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGA--AQGLAYL 829
+++ C ++ + M GSL L G AL+ L I + A A G+AYL
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK--LPQLIDMAAQVASGMAYL 119
Query: 830 --HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGYIA 886
+ +HRD+ A N+L+G +ADFGLA+++ + + AR + A
Sbjct: 120 EAQN-----YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTA 172
Query: 887 PEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSL 945
PE + + KSDV+S+G+++ E++T G+ P P + + V+ V Q G ++ P
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY-PGMT-NAEVLQQVDQ--GYRMPCPP- 227
Query: 946 LSRPESEIDEMLQALGVALLCVNASPDERPT 976
P+ D ML C PD+RPT
Sbjct: 228 -GCPKELYDIMLD-------CWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 1e-22
Identities = 87/301 (28%), Positives = 137/301 (45%), Gaps = 50/301 (16%)
Query: 711 VIGKGCSGVV--YRADMDN---GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
V+G+G G V Y D N GE++AVK L C + + EI L
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-------KRECGQQN---TSGWKKEINIL 60
Query: 766 GSIRHKNIVRFLGCCWNRNNR--LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
++ H+NIV++ GCC + + L+ +Y+P LGSL + L Q+LL A
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVP---LGSLRDYLPKHKLNLA---QLLLFAQ 114
Query: 824 Q---GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG-DFARSSNTVA 879
Q G+AYLH +HRD+ A N+L+ + I DFGLAK V +G ++ R
Sbjct: 115 QICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 880 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG-- 937
+ A E K + SDV+S+GV + E+LT D + + K+G
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH---CDSKQSPPKKFEEMIGPKQGQM 228
Query: 938 -----IQVLDPSL-LSRPES---EIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988
I++L+ + L P++ E+ +++ C RPT + + +LKE+
Sbjct: 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKN------CWETEAKFRPTFRSLIPILKEMH 282
Query: 989 H 989
H
Sbjct: 283 H 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 72/269 (26%), Positives = 118/269 (43%), Gaps = 32/269 (11%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G G V+ N +A+K L + + F E++ L +RHK
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKIL-----------KSDDLLKQQDFQKEVQALKRLRHK 62
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
+++ C ++ + M GSL + L G L + A+G+AYL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY 891
+HRD+ A NIL+G + +ADFGLA+L+ + D SS+ Y + APE
Sbjct: 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKI-PYKWTAPEAAS 177
Query: 892 MMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQ-KKGIQVLDPSLLSRP 949
+ KSDV+S+G+++ E+ T G+ P G + + Q G ++ P P
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPY-----PGMNNHEVYDQITAGYRM--PCPAKCP 230
Query: 950 ESEIDEMLQALGVALLCVNASPDERPTMK 978
+ ML+ C A P++RP+ K
Sbjct: 231 QEIYKIMLE-------CWAAEPEDRPSFK 252
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 6e-22
Identities = 84/292 (28%), Positives = 129/292 (44%), Gaps = 66/292 (22%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDS--FSAEIKTLGS 767
V+GKG G+VY A D+ IA+K++ + R EI
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEI-------------PERDSRYVQPLHEEIALHSY 61
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE--LRY---QILLGA 822
++H+NIV++LG + + +P GSL +LL + G + E + + QIL
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL--- 118
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY-----IADFGLAKLVDDGDFARSSNT 877
+GL YLH + IVHRDIK +N+L+ Y I+DFG +K + + T
Sbjct: 119 -EGLKYLHDN---QIVHRDIKGDNVLV----NTYSGVVKISDFGTSKRL--AGINPCTET 168
Query: 878 VAGSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPDGSHV 928
G+ Y+APE YG +D++S G ++E+ TGK P I+ P +
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYG------APADIWSLGCTIVEMATGKPPFIELGEPQAAMF 222
Query: 929 VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
K G+ + P + PES E A L C PD+R + D+
Sbjct: 223 ------KVGMFKIHPEI---PESLSAE---AKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 75/275 (27%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
L +G G SGVV + G+++AVK + + ++ E+
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR----------LEINEAIQKQILRELDI 52
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
L IV F G +N + + +YM GSL +L E G E L +I + +
Sbjct: 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-KIAVAVLK 111
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA-KLVDDGDFARSSNTVAGSYG 883
GL YLH I+HRD+K +NIL+ + + DFG++ +LV+ + T G+
Sbjct: 112 GLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS-----LAKTFVGTSS 164
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
Y+APE + KSD++S G+ ++E+ TG+ P P + + + I P
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE---LLQYIVNEPP 221
Query: 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMK 978
L P + Q LC+ P ERP+ K
Sbjct: 222 PRL--PSGKFSPDFQDF--VNLCLIKDPRERPSYK 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 8e-22
Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 41/292 (14%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSG-VRDSFSAEIKTLGSIRH 770
+G+G G VY+ GE+ + T A + V+ F E + + ++H
Sbjct: 13 LGEGAFGKVYK-----GELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL--------------HERTGNALEWELRY 816
NIV LG C ++++Y+ +G L L E ++L+
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 817 QILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS 874
I + A G+ YL HH VHRD+ A N L+G I+DFGL++ + D+ R
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 875 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVR 933
+ ++ PE K T +SD++S+GVV+ E+ + G QP V++ +R
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF--SNQEVIEMIR 240
Query: 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
+ Q+L P P M++ C N P RP KD+ L+
Sbjct: 241 SR---QLL-PCPEDCPARVYALMIE-------CWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 76/276 (27%), Positives = 133/276 (48%), Gaps = 31/276 (11%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G+GC G V+ + +A+K L P TM ++F E + + +RH
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP------------EAFLQEAQIMKKLRHD 61
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
+V + ++ ++M GSL L E G L+ + A G+AY+
Sbjct: 62 KLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY 891
+HRD++A NIL+G IADFGLA+L++D ++ + + APE
Sbjct: 121 ---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 176
Query: 892 MMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE 950
+ T KSDV+S+G+++ E++T G+ P + V++ V ++G ++ P PE
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVLEQV--ERGYRM--PCPQGCPE 230
Query: 951 SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
S + E+++ LC PDERPT + + + L++
Sbjct: 231 S-LHELMK------LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 77/299 (25%), Positives = 132/299 (44%), Gaps = 54/299 (18%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+IG+G G VYR + G V+A+K + T D+ S ++ E+ L +R
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTP------DDDVSDIQR----EVALLSQLR 57
Query: 770 H---KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQ--ILLGAAQ 824
NI ++ G ++ +Y GS+ +L+ + G E +Y I+
Sbjct: 58 QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAE---KYISVIIREVLV 112
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
L Y+H ++HRDIKA NIL+ + DFG+A L++ RS T G+ +
Sbjct: 113 ALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS--TFVGTPYW 167
Query: 885 IAPEYGYMMKITE------KSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938
+APE ITE K+D++S G+ + E+ TG P D + + + K
Sbjct: 168 MAPEV-----ITEGKYYDTKADIWSLGITIYEMATGNPPYSDV--DAFRAMMLIPKSK-- 218
Query: 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKV 997
P L ++ ++L+ A C++ P ER + +++ K IK ++K
Sbjct: 219 ---PPRL---EDNGYSKLLREFVAA--CLDEEPKERLSAEELLKS-KWIK----AHSKT 264
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 79/277 (28%), Positives = 134/277 (48%), Gaps = 33/277 (11%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G G V+ + +AVK L P TM+ +SF E + + +RH
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP------------ESFLEEAQIMKKLRHD 61
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
+V+ + ++ +YM GSL L + G AL+ + A G+AY+
Sbjct: 62 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYG 890
+HRD+++ NIL+G IADFGLA+L++D ++ AR + APE
Sbjct: 121 ---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAA 175
Query: 891 YMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRP 949
+ T KSDV+S+G+++ E++T G+ P P + + V++ V ++G ++ P P
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPY-PGM-NNREVLEQV--ERGYRMPCPQ--DCP 229
Query: 950 ESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
S + MLQ C P+ERPT + + + L++
Sbjct: 230 ISLHELMLQ-------CWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 48/297 (16%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G GVVY+A D GE++A+KK+ + K+ +R EIK L + H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE----GIPKTALR-----EIKLLKELNH 57
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTG--NALEWELRYQILLGAAQGLAY 828
NI++ L ++ + L++++M + + G +L YQ+L QGLA+
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLL----QGLAF 113
Query: 829 LH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
H H I+HRD+K N+LI E +ADFGLA+ ++ V + Y AP
Sbjct: 114 CHSHG----ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRW-YRAP 167
Query: 888 EYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR------------Q 934
E K + D++S G + E+L+ + P P S + +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR----PLFPGKSEIDQLFKIFRTLGTPDPEVW 223
Query: 935 KKGIQVLDPSLLSRPE---SEIDEML-----QALGVALLCVNASPDERPTMKDVAAM 983
K + S P+ + ++ QAL + ++ P +R T + A
Sbjct: 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 24/221 (10%)
Query: 705 CLVDANVIGKGCSGVVYRADMD---NGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSA 760
+ VIG G G V+R + EV +A+K L P G ++++ R F +
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKP-------GYTEKQ---RQDFLS 55
Query: 761 EIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILL 820
E +G H NI+R G +++ +YM NG+L L + G ++L +L
Sbjct: 56 EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLR 114
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
G A G+ YL VHRD+ A NIL+ E ++DFGL+++++ D + T +G
Sbjct: 115 GIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE--DDPEGTYTTSG 169
Query: 881 S---YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 917
+ APE K T SDV+S+G+V+ EV++ G++P
Sbjct: 170 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 3e-21
Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 48/225 (21%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSG-----VRDSFSAEIKTL 765
IG+G G VY+A + GE++A+KK+ +EK G +R EIK L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM---------ENEKEGFPITAIR-----EIKLL 52
Query: 766 GSIRHKNIVRFLGCCWN--RNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILL 820
+RH NIVR + + + ++++YM + L LL E +++ Q+L
Sbjct: 53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLL- 110
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
+GL YLH + I+HRDIK +NILI + +ADFGLA+ + A +N V
Sbjct: 111 ---EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT 164
Query: 881 SYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918
+ Y PE YG + D++S G ++ E+ GK PI
Sbjct: 165 LW-YRPPELLLGATRYGP------EVDMWSVGCILAELFLGK-PI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 39/221 (17%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRD--SFSAEIKTLGSI 768
+G+G G VY D+D G +AVK++ D ++ + EI+ L ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQV--------PFDPDSPETKKEVNALECEIQLLKNL 61
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL--HERTGNALEWELRYQILLGAAQGL 826
+H+ IV++ GC + + +YMP GS+ L + + + QIL +G+
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGV 117
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD----DGDFARSSNTVAGSY 882
YLH + IVHRDIK NIL + DFG +K + G +S V G+
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS---VTGTP 171
Query: 883 GYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+++PE YG K+DV+S G V+E+LT K P
Sbjct: 172 YWMSPEVISGEGYG------RKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 5e-21
Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 48/289 (16%)
Query: 712 IGKGCSGVVYRAD------MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+G+G G V +A+ + +AVK L + + S +E++ +
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKML------KDDATEKDLS----DLVSEMEMM 69
Query: 766 GSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLG--- 821
I +HKNI+ LG C ++ +Y +G+L L R
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 822 -----------AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870
A+G+ +L +HRD+ A N+L+ + IADFGLA+ + D
Sbjct: 130 TQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186
Query: 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVV 929
+ R + ++APE + T +SDV+S+GV++ E+ T G P P IP +
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPV-EELF 244
Query: 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMK 978
+++ + +P++ E+ + C + P +RPT K
Sbjct: 245 KLLKEGY--------RMEKPQNCTQEL---YHLMRDCWHEVPSQRPTFK 282
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 9e-21
Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 711 VIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+G G G VY+ + GE + + P + N + K+ V F E + S+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKI----PVAIKILNETTGPKANVE--FMDEALIMASMD 67
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H ++VR LG C + +L+ MP+G L +HE N + +L + A+G+ YL
Sbjct: 68 HPHLVRLLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYL 125
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY 889
+VHRD+ A N+L+ I DFGLA+L++ + +++ ++A E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 890 GYMMKITEKSDVYSYGVVVLEVLT-GKQPID--PT--IPDGSHVVDWVRQKKGIQVLDPS 944
+ K T +SDV+SYGV + E++T G +P D PT IPD +KG ++ P
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD--------LLEKGERLPQP- 233
Query: 945 LLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEY 994
P ID + V + C D RP K++AA + + + Y
Sbjct: 234 ----PICTIDVYM----VMVKCWMIDADSRPKFKELAAEFSRMARDPQRY 275
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 9e-21
Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+GKG G V D G++ A+K L + + E L I H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEV--------EHTLTERNILSRINH 52
Query: 771 KNIVRFLGCCWNRNNRLLM-YDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGL 826
IV+ L + +L + +Y P G L S L + G E R+ +I+L L
Sbjct: 53 PFIVK-LHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLA----L 106
Query: 827 AYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
YLH I++RD+K NIL+ + + DFGLAK + +NT G+ Y+
Sbjct: 107 EYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYL 160
Query: 886 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
APE + D +S GV++ E+LTGK P
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 70/266 (26%), Positives = 121/266 (45%), Gaps = 31/266 (11%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
IG G G+V+ +A+K + M+ + F E + + + H
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS------------EEDFIEEAQVMMKLSHP 59
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
+V+ G C R+ L++++M +G L L + G E + L +G+AYL
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLES 118
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY 891
V +HRD+ A N L+G ++DFG+ + V D + S+ T + +PE
Sbjct: 119 SNV---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT-KFPVKWSSPEVFS 174
Query: 892 MMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE 950
K + KSDV+S+GV++ EV + GK P + S VV+ + G ++ P L S+
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENR--SNSEVVETI--NAGFRLYKPRLASQ-- 228
Query: 951 SEIDEMLQALGVALLCVNASPDERPT 976
+ E++Q C P++RP+
Sbjct: 229 -SVYELMQH------CWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 80/294 (27%), Positives = 121/294 (41%), Gaps = 58/294 (19%)
Query: 712 IGKGCSGVVYRADMDN--GEVI--AVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGS 767
+G G GVV R + G+VI AVK L SD+ S + D F E + S
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCL----------KSDKLSDIMDDFLKEAAIMHS 52
Query: 768 IRHKNIVRFLGCCWNRNNRLLM-YDYMPNGSLGSLLHERTGNALE----WELRYQILLGA 822
+ H+N++R G + L+M + P GSL L + + QI
Sbjct: 53 LDHENLIRLYGVV--LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI---- 106
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFARSSNTVAGS 881
A G+ YL +HRD+ A NIL+ + + I DFGL + L + D +
Sbjct: 107 ANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP 163
Query: 882 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQV 940
+ + APE + SDV+ +GV + E+ T G++P W G Q+
Sbjct: 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP-------------WA-GLSGSQI 209
Query: 941 L-----DPSLLSRPE---SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
L + L RPE +I ++ L C +P +RPT + L E
Sbjct: 210 LKKIDKEGERLERPEACPQDIYNVM------LQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 86/280 (30%), Positives = 133/280 (47%), Gaps = 26/280 (9%)
Query: 728 GEVIAVKKLWP-TTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR 786
G V VK + T MA KS VR E++ + R IV F G N NN
Sbjct: 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78
Query: 787 LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANN 846
+ ++M GSL + + G + E+ +I + +GL YL++ V I+HRDIK +N
Sbjct: 79 CMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSN 134
Query: 847 ILIGLEFEPYIADFGLAKLVDDGDFARS-SNTVAGSYGYIAPEYGYMMKITEKSDVYSYG 905
IL+ + + DFG++ G+ S ++T G+ Y++PE K T KSDV+S G
Sbjct: 135 ILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLG 189
Query: 906 VVVLEVLTGKQPID--PTIPDGS----HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQA 959
+ ++E+ GK P DG ++D ++Q +Q P L P S+ E L+
Sbjct: 190 ISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI--VQEPPPRL---PSSDFPEDLRD 244
Query: 960 LGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDM 999
C+ P ERPT + + AM I+ R + VD+
Sbjct: 245 F--VDACLLKDPTERPTPQQLCAMPPFIQALRA--SNVDL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 76/297 (25%), Positives = 124/297 (41%), Gaps = 53/297 (17%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWP---TTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+G G V+ A+ N L P + A + R F E + L +
Sbjct: 13 LGEGAFGKVFLAECHN--------LLPEQDKMLVAVKALKEASESARQDFQREAELLTVL 64
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSL----------GSLLHERTGNALEWELRYQI 818
+H++IVRF G C L++++YM +G L +L A Q+
Sbjct: 65 QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 819 LLGAAQ---GLAYL---HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFA 872
L A+Q G+ YL H VHRD+ N L+G I DFG+++ + D+
Sbjct: 125 LAIASQIASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 178
Query: 873 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDW 931
R ++ PE K T +SD++S+GVV+ E+ T GKQP + ++
Sbjct: 179 RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL--SNTEAIEC 236
Query: 932 VRQKKGIQVLDPSLLSRPE---SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
+ Q + L RP E+ ++Q C P +R +KD+ + L+
Sbjct: 237 ITQGRE--------LERPRTCPPEVYAIMQG------CWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 76/292 (26%), Positives = 123/292 (42%), Gaps = 45/292 (15%)
Query: 712 IGKGCSGVVYRADMDN---GEV---IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+G+G G+VY GE +A+K T A+ R F E +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIK----TVNENAS------MRERIEFLNEASVM 63
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWEL-----RYQILL 820
++VR LG L++ + M G L S L R A + +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 821 GAAQ---GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT 877
AA+ G+AYL VHRD+ A N ++ + I DFG+ + + + D+ R
Sbjct: 124 MAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 878 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSH--VVDWVRQ 934
++APE T KSDV+S+GVV+ E+ T +QP S+ V+ +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP----YQGLSNEEVLKF--- 233
Query: 935 KKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
V+D L PE+ D++L+ + +C +P RPT ++ + LK+
Sbjct: 234 -----VIDGGHLDLPENCPDKLLE---LMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 7e-20
Identities = 78/291 (26%), Positives = 131/291 (45%), Gaps = 42/291 (14%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTT---MAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+G G V+ A+ N L PT + A D R F E + L ++
Sbjct: 13 LGEGAFGKVFLAECYN--------LSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 64
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNAL----------EWELRY-Q 817
+H++IV+F G C + + +++++YM +G L L +A+ + EL Q
Sbjct: 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 818 ILLGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS 874
+L A+Q G+ YL VHRD+ N L+G I DFG+++ V D+ R
Sbjct: 125 MLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 875 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVR 933
++ PE K T +SDV+S+GV++ E+ T GKQP + V++ +
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--TEVIECIT 239
Query: 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
Q + +L RP E+ + L C P +R +K++ +L
Sbjct: 240 QGR--------VLERPRVCPKEVYD---IMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 37/222 (16%)
Query: 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
+ IG+G SG VY+A D G+ +A+KK+ + ++ EI
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM------------RLRKQNKELIINEILI 68
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLG 821
+ +H NIV + + ++ +YM GSL ++ + E ++ Y ++L
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-- 126
Query: 822 AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
QGL YLH ++HRDIK++NIL+ + +ADFG A + R N+V G+
Sbjct: 127 --QGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGT 179
Query: 882 YGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
++APE YG K D++S G++ +E+ G+ P
Sbjct: 180 PYWMAPEVIKRKDYG------PKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 67/225 (29%), Positives = 100/225 (44%), Gaps = 41/225 (18%)
Query: 711 VIGKGCSGVVYRA----DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
V+G G G VY+ + + ++ +A+K L T AN E +
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN----------KEILDEAYVM 63
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGN-----ALEWELRYQILL 820
S+ H ++VR LG C + +L+ MP G L + N L W + QI
Sbjct: 64 ASVDHPHVVRLLGICLSSQVQLIT-QLMPLGCLLDYVRNHKDNIGSQYLLNWCV--QI-- 118
Query: 821 GAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTV 878
A+G++YL +VHRD+ A N+L+ I DFGLAKL+D +
Sbjct: 119 --AKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE---KEYHA 168
Query: 879 AGS---YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 919
G ++A E T KSDV+SYGV V E++T G +P +
Sbjct: 169 EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWP---TTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+G G V+ A+ N L P + A D R F E + L ++
Sbjct: 13 LGEGAFGKVFLAECYN--------LCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNAL-------EWELRYQILLG 821
+H++IV+F G C + +++++YM +G L L +A+ EL +L
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 822 AAQ----GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT 877
AQ G+ YL VHRD+ N L+G I DFG+++ V D+ R
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 878 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKK 936
++ PE K T +SDV+S GVV+ E+ T GKQP + V++ + Q +
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--SNNEVIECITQGR 239
Query: 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+L RP + E+ + L C P R +K++ ++L+ +
Sbjct: 240 --------VLQRPRTCPKEVYDLM---LGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 37/276 (13%)
Query: 710 NVIGKGCSGVVYRADMDN-GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+ +G G G VY +AVK L TM + F E + I
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------------EEFLKEAAVMKEI 59
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
+H N+V+ LG C ++ ++M G+L L E + + + + + Y
Sbjct: 60 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 119
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS---YGYI 885
L +HRD+ A N L+G +ADFGL++L+ + AG+ +
Sbjct: 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH----AGAKFPIKWT 172
Query: 886 APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944
APE K + KSDV+++GV++ E+ T G P P I D S V + + +KG ++ P
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PGI-DLSQVYELL--EKGYRMERPE 228
Query: 945 LLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
P + M C +P +RP+ ++
Sbjct: 229 --GCPPKVYELMRA-------CWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 25/233 (10%)
Query: 750 EKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNA 809
E S D F E K + + H+ +V+ G C + ++ +YM NG L + L E G
Sbjct: 38 EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE-HGKR 96
Query: 810 LEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG 869
+ ++ +G+AYL +HRD+ A N L+ + ++DFGL++ V D
Sbjct: 97 FQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153
Query: 870 DFARSSNT---VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDG 925
++ S + V S PE K + KSDV+++GV++ EV + GK P + +
Sbjct: 154 EYTSSVGSKFPVRWS----PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF--NN 207
Query: 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMK 978
S V+ V Q G+++ P L S + + C + +ERPT +
Sbjct: 208 SETVEKVSQ--GLRLYRPHLASE---------KVYAIMYSCWHEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 75/226 (33%), Positives = 106/226 (46%), Gaps = 23/226 (10%)
Query: 697 FSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVR 755
FS + K D IG G G VY A D+ EV+A+KK M+ + S+EK
Sbjct: 8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKK-----MSYSGKQSNEK---W 59
Query: 756 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR 815
E++ L +RH N + + GC + L+ +Y GS +L E E+
Sbjct: 60 QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA 118
Query: 816 YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
I GA QGLAYLH +HRDIKA NIL+ +ADFG A LV +
Sbjct: 119 -AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVS------PA 168
Query: 876 NTVAGSYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPI 918
N+ G+ ++APE M + K DV+S G+ +E+ K P+
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 81/307 (26%), Positives = 132/307 (42%), Gaps = 77/307 (25%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+G+G GVV + + GE++A+KK S++ V+ + E+K L +R
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF---------KESEDDEDVKKTALREVKVLRQLR 58
Query: 770 HKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLH--ERTGNALEWE----LRYQILLGA 822
H+NIV R RL L+++Y+ +LL E + L + +Q+L
Sbjct: 59 HENIVNLKEAF-RRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLL--- 110
Query: 823 AQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
Q +AY H H+ I+HRDIK NIL+ + DFG A+ + + ++ VA
Sbjct: 111 -QAIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR 165
Query: 882 YGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD--WV 932
+ Y APE YG + DV++ G ++ E+L G +P+ P G +D ++
Sbjct: 166 W-YRAPELLVGDTNYG------KPVDVWAIGCIMAELLDG-EPLFP----GDSDIDQLYL 213
Query: 933 RQK-------------------KGIQVLDP----SLLSRPESEIDEMLQALGVALLCVNA 969
QK G+ +P SL R ++ A L ++
Sbjct: 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMD- 272
Query: 970 SPDERPT 976
P ER T
Sbjct: 273 -PKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 80/301 (26%), Positives = 128/301 (42%), Gaps = 53/301 (17%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSG-VRDSFSAEIKTLGSIRH 770
IG+G G V++A + P TM A +E S ++ F E + H
Sbjct: 13 IGQGAFGRVFQA-----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH 67
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY-------------- 816
NIV+ LG C L+++YM G L L R+ A
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 817 ------QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870
I A G+AYL VHRD+ N L+G IADFGL++ + D
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSH-- 927
+ ++S A ++ PE + + T +SDV++YGVV+ E+ + G QP +H
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM----AHEE 240
Query: 928 VVDWVRQKKGIQVLDPSLLSRPE---SEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
V+ +VR D ++LS P+ E+ +++ LC + P +RP+ + +L
Sbjct: 241 VIYYVR--------DGNVLSCPDNCPLELYNLMR------LCWSKLPSDRPSFASINRIL 286
Query: 985 K 985
+
Sbjct: 287 Q 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 71/275 (25%), Positives = 120/275 (43%), Gaps = 49/275 (17%)
Query: 728 GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL 787
G+V + AAA E + F EI L +H NIV + N
Sbjct: 19 GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78
Query: 788 LMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGLAYLHHDCVPPIVHRDIKA 844
++ ++ G+L S++ E E ++RY Q+L + L +LH ++HRD+KA
Sbjct: 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML----EALNFLHSH---KVIHRDLKA 131
Query: 845 NNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE-----------YGYMM 893
NIL+ L+ + +ADFG++ R T G+ ++APE Y Y
Sbjct: 132 GNILLTLDGDVKLADFGVSAKNKSTLQKRD--TFIGTPYWMAPEVVACETFKDNPYDY-- 187
Query: 894 KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE--- 950
K+D++S G+ ++E+ + P H ++ +R I +P L +P
Sbjct: 188 ----KADIWSLGITLIELAQMEPP--------HHELNPMRVLLKILKSEPPTLDQPSKWS 235
Query: 951 SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
S ++ L++ C+ PD+RPT A +LK
Sbjct: 236 SSFNDFLKS------CLVKDPDDRPT---AAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G G V+ +N +AVK L P TM+ +F E + +++H
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV------------QAFLEEANLMKTLQHD 61
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
+VR ++ +YM GSL L G + A+G+AY+
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYG 890
+HRD++A N+L+ IADFGLA++++D ++ AR + APE
Sbjct: 122 K---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAI 176
Query: 891 YMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRP 949
T KSDV+S+G+++ E++T GK P P S+ ++G + + R
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIP----YPGMSNSDVMSALQRGYR------MPRM 226
Query: 950 ESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
E+ DE+ + C +ERPT + ++L +
Sbjct: 227 ENCPDELYD---IMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 705 CLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
C+ VIG G G V R + + K+ + EK R F +E
Sbjct: 5 CVKIEEVIGAGEFGEVCRGRLK----LPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASI 58
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
+G H NI+ G +++ ++M NG+L S L + G +L +L G A
Sbjct: 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VGMLRGIAA 117
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG- 883
G+ YL VHRD+ A NIL+ ++DFGL++ ++D S T S G
Sbjct: 118 GMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD---TSDPTYTSSLGG 171
Query: 884 -----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 917
+ APE K T SDV+SYG+V+ EV++ G++P
Sbjct: 172 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 6e-19
Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G+G GVVY+A D GE++A+KK+ +E+ G+ + EI L ++H
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRL---------DNEEEGIPSTALREISLLKELKH 57
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQGLA 827
NIV+ L L+++Y L L +R G ++ YQ+L +GLA
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL----RGLA 112
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
Y H I+HRD+K NILI + +ADFGLA+
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
N IG+G G+VYRA D +GE++A+KK+ M +E+ G+ S EI L ++
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKV---RM------DNERDGIPISSLREITLLLNL 63
Query: 769 RHKNIVRFLGCCWNR--NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGL 826
RH NIV + ++ L+ +Y L SLL E +++ ++L +GL
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVK-CLMLQLLRGL 121
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIA 886
YLH + I+HRD+K +N+L+ + IADFGLA+ + V + Y A
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRA 176
Query: 887 PE--YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920
PE G T D+++ G ++ E+L K P+ P
Sbjct: 177 PELLLG-CTTYTTAIDMWAVGCILAELLAHK-PLLP 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 70/278 (25%), Positives = 125/278 (44%), Gaps = 33/278 (11%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IGKG G V + +G+++ K++ M EK + +E+ L +
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-------TEKE--KQQLVSEVNILREL 56
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMP---NGSLGSLLHE--RTGNALEWELRYQILLGAA 823
+H NIVR+ +R+N+ L Y M G L L+ + + +E E ++IL
Sbjct: 57 KHPNIVRYYDRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 824 QGLAYLHHDCVPP--IVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
L H+ P ++HRD+K NI + + DFGLAK++ + T G+
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGT 173
Query: 882 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941
Y++PE M EKSD++S G ++ E+ P + + + K+G
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR----NQLQLASKIKEGKF-- 227
Query: 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKD 979
+ R SE++E++++ +N PD+RP+ ++
Sbjct: 228 -RRIPYRYSSELNEVIKS------MLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 39/274 (14%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G GVV+ W + A +E + + F E K + + H
Sbjct: 12 LGSGQFGVVHLGK------------WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHP 59
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ----GLA 827
+V+ G C + ++ ++M NG L + L +R G +L +LL Q G+
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGME 114
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
YL + +HRD+ A N L+ ++DFG+ + V D ++ SS+ + P
Sbjct: 115 YLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPP 170
Query: 888 EYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLL 946
E K + KSDV+S+GV++ EV T GK P + VV+ + +G ++ P L
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEMI--SRGFRLYRPKLA 226
Query: 947 SRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
S E V C + P+ RPT ++
Sbjct: 227 SMTVYE---------VMYSCWHEKPEGRPTFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-18
Identities = 40/89 (44%), Positives = 61/89 (68%)
Query: 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473
L L + L G +P++I LQ I+LS N+++G++P SL S++ L+VLD+S N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 474 PASLGRLVSLNKIILSKNLFSGPIPSSLG 502
P SLG+L SL + L+ N SG +P++LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 83/315 (26%), Positives = 140/315 (44%), Gaps = 55/315 (17%)
Query: 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
+ +V+ + +G+G G V + + N +I K T+ +K +R E++
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALK----TITTDPNPDLQKQILR-----ELE 51
Query: 764 TLGSIRHKNIVRFLGCCWNRNN---RLLMYDYMPNGSLGSLLHE---RTGNALEWELRYQ 817
S + IV++ G + ++ + M +Y GSL S+ + R G E L +
Sbjct: 52 INKSCKSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLG-K 109
Query: 818 ILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS-SN 876
I +GL+YLH I+HRDIK +NIL+ + + + DFG++ G+ S +
Sbjct: 110 IAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAG 161
Query: 877 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936
T G+ Y+APE + SDV+S G+ +LEV + P P+G +
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF---PPEGEPPL------G 212
Query: 937 GIQVLD-------PSLLSRPESEI---DEMLQALGVALLCVNASPDERPTMKDVAAMLK- 985
I++L P L P + I +E + C+ P RPT D ML+
Sbjct: 213 PIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPWD---MLEH 266
Query: 986 -EIKHEREEYAKVDM 999
IK + ++ KV+M
Sbjct: 267 PWIKAQMKK--KVNM 279
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 86/321 (26%), Positives = 132/321 (41%), Gaps = 52/321 (16%)
Query: 691 PFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVK-------KLWPTTMAA 743
P Q LNF VE+ +G+G G V+ + D + + K P +A
Sbjct: 3 PRQPLNF-VEK----------LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAV 51
Query: 744 ANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLH 803
D R+ F E+K L + NI R LG C ++ +YM NG L L
Sbjct: 52 KVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQ 111
Query: 804 ER---TGNALEWE--LRYQILLG-AAQ---GLAYL-HHDCVPPIVHRDIKANNILIGLEF 853
+ T L + LL A Q G+ YL + VHRD+ N L+G +
Sbjct: 112 KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATRNCLVGKNY 167
Query: 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 913
IADFG+++ + D+ R ++A E + K T KSDV+++GV + E+LT
Sbjct: 168 TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
Query: 914 --GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS---LLSRP---ESEIDEMLQALGVALL 965
+QP + + D V + G D L RP +I E+ L
Sbjct: 228 LCREQPYE-HLTD-----QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYEL------MLE 275
Query: 966 CVNASPDERPTMKDVAAMLKE 986
C ++RPT +++ L+
Sbjct: 276 CWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G Y+A D+ G ++AVK++ S E+ V ++ EI+ + +
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQV-----TYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY--QILLGAAQGLA 827
H +I+R LG ++ L ++M GS+ LL + + Y Q+L +GL+
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLS 117
Query: 828 YLHHDCVPPIVHRDIKANNILI---GLEFEPYIADFGLA-----KLVDDGDFARSSNTVA 879
YLH + I+HRD+K N+LI G IADFG A K G+F +
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEF---QGQLL 169
Query: 880 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G+ ++APE + DV+S G V++E+ T K P
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 70/278 (25%), Positives = 131/278 (47%), Gaps = 35/278 (12%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G G V+ A + +AVK + P +M+ ++F AE + +++H
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV------------EAFLAEANVMKTLQHD 61
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
+V+ L + ++ ++M GSL L G+ A+G+A++
Sbjct: 62 KLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYG 890
+HRD++A NIL+ IADFGLA++++D ++ AR + APE
Sbjct: 121 R---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAI 175
Query: 891 YMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQ-KKGIQVLDPSLLSR 948
T KSDV+S+G++++E++T G+ P G + +R ++G ++ P +
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPY-----PGMSNPEVIRALERGYRM--PRPENC 228
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
PE + M++ C P+ERPT + + ++L +
Sbjct: 229 PEELYNIMMR-------CWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 71/220 (32%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI 762
K D IG G G VY A D+ N EV+A+KK M+ + S+EK E+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKK-----MSYSGKQSNEK---WQDIIKEV 66
Query: 763 KTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGA 822
+ L +RH N +++ GC + L+ +Y GS LL E E+ + GA
Sbjct: 67 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGA 124
Query: 823 AQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
QGLAYLH H+ ++HRD+KA NIL+ + DFG A ++ +N G+
Sbjct: 125 LQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGT 174
Query: 882 YGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPI 918
++APE M + K DV+S G+ +E+ K P+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 47/225 (20%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVK--KLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
IG G G VY+A D+ GE++A+K KL P D+ ++ EI L
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---------DDFEIIQQ----EISMLK 55
Query: 767 SIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
RH NIV + G + R ++L ++ +Y GSL + G E ++ Y + +G
Sbjct: 56 ECRHPNIVAYFG-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-VCRETLKG 113
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVA------ 879
LAYLH +HRDIK NIL+ + + +ADFG++ A+ + T+A
Sbjct: 114 LAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVS--------AQLTATIAKRKSFI 162
Query: 880 GSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G+ ++APE GY K D+++ G+ +E+ + P
Sbjct: 163 GTPYWMAPEVAAVERKGGY----DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-18
Identities = 81/313 (25%), Positives = 133/313 (42%), Gaps = 45/313 (14%)
Query: 705 CLVDANVIGKGCSGVVYRADMDNGEVIA-------VKKLWPTTMAAANGCSDEKSGVRDS 757
L+ +G+G G V+ ++ N + + V+K P +A D R+
Sbjct: 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND 65
Query: 758 FSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLH-----ERTGNALEW 812
F E+K L ++ NI+R LG C + + ++ +YM NG L L ++ N +
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 813 E--------LRYQILLGAA----QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860
+ Y LL A G+ YL VHRD+ N L+G IADF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT--GKQPI 918
G+++ + GD+ R ++A E M K T SDV+++GV + E+L +QP
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 919 DPTIPDGSHVVD-----WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDE 973
+ D V++ + Q + + + P + E+ MLQ C + E
Sbjct: 243 G-ELTD-EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYEL--MLQ-------CWSRDCRE 291
Query: 974 RPTMKDVAAMLKE 986
RP+ D+ A L E
Sbjct: 292 RPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 75/249 (30%), Positives = 114/249 (45%), Gaps = 38/249 (15%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++G+G G VY D D G +AVK++ + S E S ++ EI+ L ++R
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQV------PFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 770 HKNIVRFLGCCWNRNNRLL--MYDYMPNGSLGSLLHERTGNALEWELRY--QILLGAAQG 825
H IV++ GC + + L +YMP GS+ L RY QIL QG
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QG 118
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS-NTVAGSYGY 884
++YLH + IVHRDIK NIL + DFG +K + + + +V G+ +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK-----------------QPIDPTIPDG-- 925
++PE K+DV+S V+E+LT K QP P +PDG
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235
Query: 926 SHVVDWVRQ 934
D+++Q
Sbjct: 236 DACRDFLKQ 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 77/279 (27%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 711 VIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IGKG G V D G +AVK + A A F AE + +RH
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA-------------FLAEASVMTQLRH 58
Query: 771 KNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
N+V+ LG L ++ +YM GSL L R + L + + L + + YL
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY 889
+ VHRD+ A N+L+ + ++DFGL K + + + +T + APE
Sbjct: 119 EAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEA 170
Query: 890 GYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948
K + KSDV+S+G+++ E+ + G+ P P IP V R +KG ++ P
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVV---PRVEKGYKMDAPD--GC 224
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
P D M Q C + RP+ + L+ I
Sbjct: 225 PPVVYDVMKQ-------CWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 6e-18
Identities = 73/219 (33%), Positives = 104/219 (47%), Gaps = 23/219 (10%)
Query: 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI 762
K D IG G G VY A D+ EV+A+KK M+ + S+EK E+
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKK-----MSYSGKQSNEK---WQDIIKEV 76
Query: 763 KTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGA 822
K L I+H N + + GC + L+ +Y GS LL E E+ I GA
Sbjct: 77 KFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGA 134
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
QGLAYLH ++HRDIKA NIL+ + +ADFG A + +N+ G+
Sbjct: 135 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS------PANSFVGTP 185
Query: 883 GYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPI 918
++APE M + K DV+S G+ +E+ K P+
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI- 768
VIG+G G VY+A G+++A+K + DE+ + E L
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDII--------EDEE----EEIKEEYNILRKYS 60
Query: 769 RHKNIVRFLGCCWNRNNR-------LLMYDYMPNGSLGSLLH--ERTGNALEWELRYQIL 819
H NI F G +N L+M + GS+ L+ + G L+ E IL
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVM-ELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVA 879
+GLAYLH + V +HRDIK NIL+ E + DFG++ +D R NT
Sbjct: 120 RETLRGLAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR--NTFI 174
Query: 880 GSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G+ ++APE +SDV+S G+ +E+ GK P
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 55/165 (33%), Positives = 84/165 (50%), Gaps = 6/165 (3%)
Query: 755 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWEL 814
R F +E +G H NI+ G +++ +YM NGSL + L + G +L
Sbjct: 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL 108
Query: 815 RYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFAR 873
+L G A G+ YL VHRD+ A NIL+ ++DFGL++ L DD + A
Sbjct: 109 -VGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164
Query: 874 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 917
++ + APE K T SDV+SYG+V+ EV++ G++P
Sbjct: 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 80/284 (28%), Positives = 122/284 (42%), Gaps = 59/284 (20%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKK--LWPTTMAAANGCSDEKSGVRDSFSAEIKTLGS 767
IGKG G VY+A D +V+A+K L +E + EI+ L
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDL------------EEAEDEIEDIQQEIQFLSQ 55
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLA 827
R I ++ G + ++ +Y GS LL + G E + + IL GL
Sbjct: 56 CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAF-ILREVLLGLE 112
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
YLH + +HRDIKA NIL+ E + +ADFG++ + R NT G+ ++AP
Sbjct: 113 YLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR--NTFVGTPFWMAP 167
Query: 888 EY----GYMMKITEKSDVYSYGVVVLEVLTGKQP---IDPT-----IPDGSHVVDWVRQK 935
E GY EK+D++S G+ +E+ G+ P + P IP K
Sbjct: 168 EVIKQSGY----DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-----------K 212
Query: 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKD 979
L+ + S+P + LC+N P ERP+ K+
Sbjct: 213 NNPPSLEGNKFSKPFKDFVS---------LCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 79/282 (28%), Positives = 122/282 (43%), Gaps = 55/282 (19%)
Query: 720 VYRADMDNGEVI--AVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777
VY M +G+ + AVK L +AA + F E + + H IVR +
Sbjct: 15 VYL--MKSGKEVEVAVKTLKQEHIAAG----------KKEFLREASVMAQLDHPCIVRLI 62
Query: 778 GCCWNRNNRLLMYDYMPNGSLGSLLHER----TGNALEWELRYQILLGAAQGLAYLHHDC 833
G C L+M + P G L L +R + E Q+ A G+AYL
Sbjct: 63 GVCKGEPLMLVM-ELAPLGPLLKYLKKRREIPVSDLKELAH--QV----AMGMAYLESK- 114
Query: 834 VPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG-DFARSSNTVAGSY--GYIAPEYG 890
VHRD+ A N+L+ + I+DFG+++ + G D+ R+ T AG + + APE
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA--TTAGRWPLKWYAPECI 170
Query: 891 YMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQV---LDPSL- 945
K + KSDV+SYGV + E + G +P + KG +V L+
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKP--------------YGEMKGAEVIAMLESGER 216
Query: 946 LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
L RPE E+ + L C P++RPT ++ + +
Sbjct: 217 LPRPEECPQEIYS---IMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 81/285 (28%), Positives = 130/285 (45%), Gaps = 33/285 (11%)
Query: 710 NVIGKGCSGVVYRA---DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
VIGKG G VY D D ++ AVK L N +D + + F E +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--------NRITDLEE--VEQFLKEGIIM 50
Query: 766 GSIRHKNIVRFLGCCW-NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
H N++ LG C + + L++ YM +G L + + T N +L L A+
Sbjct: 51 KDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-IGFGLQVAK 109
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY-- 882
G+ YL VHRD+ A N ++ F +ADFGLA+ + D ++ N
Sbjct: 110 GMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942
++A E K T KSDV+S+GV++ E++T P P + D + ++ Q G ++L
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYLLQ--GRRLLQ 223
Query: 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
P P E+ ML C + P+ RPT ++ + +++I
Sbjct: 224 PEYCPDPLYEV--MLS-------CWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 70/217 (32%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
V + IG G G VY A + EV+AVKK M+ + ++EK E+K
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKK-----MSYSGKQTNEK---WQDIIKEVKF 74
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
L ++H N + + GC + L+ +Y GS LL E E+ I GA Q
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQ 132
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
GLAYLH ++HRDIKA NIL+ + +ADFG A + +N+ G+ +
Sbjct: 133 GLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYW 183
Query: 885 IAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPI 918
+APE M + K DV+S G+ +E+ K P+
Sbjct: 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 74/278 (26%), Positives = 131/278 (47%), Gaps = 35/278 (12%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G G V+ + +A+K L +M+ ++F AE + ++H
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP------------EAFLAEANLMKQLQHP 61
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
+VR L + ++ +YM NGSL L G L + A+G+A++
Sbjct: 62 RLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE- 119
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYG 890
+HRD++A NIL+ IADFGLA+L++D ++ AR + APE
Sbjct: 120 --RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAI 175
Query: 891 YMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSL-LSR 948
T KSDV+S+G+++ E++T G+ P P + + IQ L+ + R
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPY-PGM----------TNPEVIQNLERGYRMPR 224
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
P++ +E+ + + LC P+ERPT + + ++L++
Sbjct: 225 PDNCPEELYE---LMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 82/293 (27%), Positives = 135/293 (46%), Gaps = 55/293 (18%)
Query: 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+V+A G S V + +AVK L PT S E R++ +E+K +
Sbjct: 51 VVEATAYGLSKSDAVMK--------VAVKMLKPTAH------SSE----REALMSELKIM 92
Query: 766 GSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE----LRYQILL 820
+ H+NIV LG C L++ +Y G L + L + + L E YQ+
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV-- 150
Query: 821 GAAQGLAYL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVA 879
A+G+A+L +C+ HRD+ A N+L+ I DFGLA+ D SN V
Sbjct: 151 --AKGMAFLASKNCI----HRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVV 199
Query: 880 -GS----YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVR 933
G+ ++APE + T +SDV+SYG+++ E+ + G P P +P S +
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY-PGMPVDSKFYKLI- 257
Query: 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
K+G ++ P EI ++++ C +A P +RPT K + ++ +
Sbjct: 258 -KEGYRMAQPEHAPA---EIYDIMKT------CWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 35/214 (16%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G G+V++A D + GE +A+KK+ + + G+ + EIK L + +H
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRL---------EGGIPNQALREIKALQACQH 58
Query: 771 KNIVRFL------GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR--YQILLGA 822
+V+ L +L+ +YMP L +L + E +++ ++LL
Sbjct: 59 PYVVKLLDVFPHGSGF------VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK- 110
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
G+AY+H + I+HRD+K N+LI + IADFGLA+L + + S+ VA +
Sbjct: 111 --GVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TR 164
Query: 883 GYIAPE--YGYMMKITEKSDVYSYGVVVLEVLTG 914
Y APE YG K D+++ G + E+L G
Sbjct: 165 WYRAPELLYG-ARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-17
Identities = 83/317 (26%), Positives = 139/317 (43%), Gaps = 47/317 (14%)
Query: 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAA------NGCSDEKSGVRDSFS 759
LV +G+GC G V RA E + K P + +D+ S
Sbjct: 14 LVLGKPLGEGCFGQVVRA-----EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEW------- 812
+K +G +HKNI+ LG C ++ +Y G+L L R ++
Sbjct: 69 ELMKLIG--KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 813 ---ELRYQILLG----AAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
+L ++ L+ A+G+ YL C+ HRD+ A N+L+ + IADFGLA+
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRRCI----HRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 923
V D D+ + ++ ++APE + T +SDV+S+G+++ E+ T G P P IP
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY-PGIP 241
Query: 924 DGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983
V + + + +D +P + E+ + C +A P +RPT K +
Sbjct: 242 ----VEELFKLLREGHRMD-----KPSNCTHEL---YMLMRECWHAVPTQRPTFKQLVEA 289
Query: 984 LKEIKHE-REEYAKVDM 999
L ++ EEY + M
Sbjct: 290 LDKVLAAVSEEYLDLSM 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 70/260 (26%), Positives = 114/260 (43%), Gaps = 40/260 (15%)
Query: 748 SDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL--HER 805
D R+ F EIK + ++ NI+R L C + ++ +YM NG L L HE
Sbjct: 56 EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEP 115
Query: 806 TGNALEWELR---YQILLGAA----QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858
A + ++ Y L+ A G+ YL VHRD+ N L+G + IA
Sbjct: 116 QEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIA 172
Query: 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT--GKQ 916
DFG+++ + GD+ R +++ E + K T SDV+++GV + E+LT +Q
Sbjct: 173 DFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232
Query: 917 PIDPTIPDGSHVVD----------WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLC 966
P S + D + Q + + + P+L P+S ML C
Sbjct: 233 PY-------SQLSDEQVIENTGEFFRDQGRQVYLPKPALC--PDSLYKLMLS-------C 276
Query: 967 VNASPDERPTMKDVAAMLKE 986
+ ERP+ +++ A L E
Sbjct: 277 WRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 69/244 (28%), Positives = 111/244 (45%), Gaps = 39/244 (15%)
Query: 750 EKSGVRDSFSA---EIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT 806
++SG R +F + +GS+ H IVR LG C + +L+ P GSL + +
Sbjct: 46 DRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT-QLSPLGSLLDHVRQHR 103
Query: 807 GNALEWELRYQILLG----AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862
+ L Q LL A+G+ YL +VHR++ A NIL+ + IADFG+
Sbjct: 104 DS-----LDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGV 155
Query: 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID-- 919
A L+ D + ++A E + T +SDV+SYGV V E+++ G +P
Sbjct: 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
Query: 920 --PTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM 977
+PD +KG ++ P + + ID + V + C + RPT
Sbjct: 216 RPHEVPD--------LLEKGERLAQPQICT-----IDVYM----VMVKCWMIDENVRPTF 258
Query: 978 KDVA 981
K++A
Sbjct: 259 KELA 262
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 711 VIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGC-SDEKSGVRDSFSAEIKTLGSIR 769
++GKG G V++ + + +AVK C D ++ F +E + L
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKT-----------CKEDLPQELKIKFLSEARILKQYD 50
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H NIV+ +G C R ++ + +P G S L ++ + L+ + + L AA G+AYL
Sbjct: 51 HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYL 109
Query: 830 H-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
+C+ HRD+ A N L+G I+DFG+++ DDG ++ SS + APE
Sbjct: 110 ESKNCI----HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPE 164
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947
+ + +SDV+SYG+++ E + G P P + + Q+ QV +S
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFSLGVCPY-PGMTN---------QQAREQVEKGYRMS 214
Query: 948 RPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
P+ D++ + V C + P+ RP ++
Sbjct: 215 CPQKCPDDVYK---VMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-17
Identities = 73/247 (29%), Positives = 115/247 (46%), Gaps = 40/247 (16%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++G+G G VY D+D G +A K++ + S E S + EI+ L +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQV------QFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 770 HKNIVRFLGCCWNRNNRLL--MYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLA 827
H+ IV++ GC +R + L +YMP GS+ L + AL + + +G++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMS 120
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD----DGDFARSSNTVAGSYG 883
YLH + IVHRDIK NIL + DFG +K + G RS V G+
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS---VTGTPY 174
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK-----------------QPIDPTIPDGS 926
+++PE K+DV+S G V+E+LT K QP +P +P S
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP--S 232
Query: 927 HVVDWVR 933
H+ + R
Sbjct: 233 HISEHAR 239
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 70/276 (25%), Positives = 119/276 (43%), Gaps = 30/276 (10%)
Query: 711 VIGKGCSG--VVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
V+GKG G +YR D+ V+ W + R EI L +
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVV-----WKEV-----NLTRLSEKERRDALNEIVILSLL 56
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
+H NI+ + + N L+ +Y G+L + + G E E+ L ++Y
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
+H I+HRDIK NI + + DFG++K++ G + TV G+ Y++PE
Sbjct: 117 IHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPE 171
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948
+K KSD+++ G V+ E+LT K+ D T P ++V + Q V+
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVVKIVQGNYTPVVSVY---- 225
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
SE+ ++ + + P++RPT +V
Sbjct: 226 -SSELISLVHS------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI 762
L+ L +IG+G G V + + G+ +AVK + A A F E
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA-------------FLEET 50
Query: 763 KTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGA 822
+ + HKN+VR LG + ++M + M G+L + L R + Q L
Sbjct: 51 AVMTKLHHKNLVRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV 109
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
A+G+ YL +VHRD+ A NIL+ + ++DFGLA++ + +
Sbjct: 110 AEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVG-----SMGVDNSKLPV 161
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 917
+ APE K + KSDV+SYGV++ EV + G+ P
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 9e-17
Identities = 35/89 (39%), Positives = 60/89 (67%)
Query: 390 LRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSL 449
L + N + G IP +I L+ L ++LS N + G++P +G T L+++DLS+N+ GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 450 PNSLSSLSGLQVLDVSDNRFSGQIPASLG 478
P SL L+ L++L+++ N SG++PA+LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-16
Identities = 58/151 (38%), Positives = 83/151 (54%), Gaps = 8/151 (5%)
Query: 446 QGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSL-GLC 504
QG N+ S + + D+S SG+I +++ RL + I LS N SGPIP +
Sbjct: 61 QGITCNNSSRVVSI---DLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 505 SSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHN 564
SSL+ L+LS+N TGS+P G I LE L+LS N L+G IP I + + L +LDL N
Sbjct: 118 SSLRYLNLSNNNFTGSIPR--GSIPNLE-TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174
Query: 565 KLEGNLNP-LAQLDNLVSLNISYNKFTGYLP 594
L G + L L +L L ++ N+ G +P
Sbjct: 175 VLVGKIPNSLTNLTSLEFLTLASNQLVGQIP 205
|
Length = 968 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 76/292 (26%), Positives = 128/292 (43%), Gaps = 40/292 (13%)
Query: 711 VIGKGCSGVVYRADMDNGEV----IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
++G+G G V + + +AVK TM E F +E +
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVK-----TMKLDIHTYSEIEE----FLSEAACMK 56
Query: 767 SIRHKNIVRFLGCCWNRNNR------LLMYDYMPNGSLGS-LLHERTGNALEWELRYQIL 819
H N+++ +G C+ ++ +++ +M +G L S LL+ R G E L Q L
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-LPLQTL 115
Query: 820 L----GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
L A G+ YL + +HRD+ A N ++ + +ADFGL+K + GD+ R
Sbjct: 116 LKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG 172
Query: 876 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935
+IA E T KSDV+++GV + E+ T Q P + + + D++R
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHG 231
Query: 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+ L +PE +DE+ + C A P +RPT + +L+ I
Sbjct: 232 --------NRLKQPEDCLDELYDLM---YSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-16
Identities = 47/111 (42%), Positives = 66/111 (59%), Gaps = 2/111 (1%)
Query: 438 IDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPI 497
+ L + L+G +PN +S L LQ +++S N G IP SLG + SL + LS N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 498 PSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN-GLTGPIP 547
P SLG +SL++L+L+ N L+G VP LG + N + N GL G IP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IP 532
|
Length = 623 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 79/299 (26%), Positives = 134/299 (44%), Gaps = 65/299 (21%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G GVV++ + + G+++A+KK S++ ++ EI+ L ++H
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVE---------SEDDPVIKKIALREIRMLKQLKH 59
Query: 771 KNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHE--RTGNALEWELRYQILLGAAQGLA 827
N+V + + R +L L+++Y + ++L+E + + L +I+ Q +
Sbjct: 60 PNLVNLIEV-FRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 828 YLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIA 886
+ H H+C+ HRD+K NILI + + + DFG A+++ ++ VA + Y A
Sbjct: 115 FCHKHNCI----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDY-TDYVATRW-YRA 168
Query: 887 PE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD---WVRQKK 936
PE YG DV++ G V E+LTG QP+ P G VD +R+
Sbjct: 169 PELLVGDTQYG------PPVDVWAIGCVFAELLTG-QPLWP----GKSDVDQLYLIRKTL 217
Query: 937 G------IQVLDPSL----LSRPESEIDEML---------QALGVALLCVNASPDERPT 976
G Q+ + LS PE E E L AL C+ P ER +
Sbjct: 218 GDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-16
Identities = 95/305 (31%), Positives = 148/305 (48%), Gaps = 15/305 (4%)
Query: 288 ATNLVQLQLDT-NQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSH 346
+ + +L L+ + L+P + L L + L + L +LDL+
Sbjct: 44 SVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNL 102
Query: 347 NSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGN-CSSLVRLRVGNNRIAGLIPREI 405
N L +++ L +L NLT L L +N+I+ IPP IG S+L L + +N+I +P +
Sbjct: 103 NRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPL 159
Query: 406 GGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVS 465
L L LDLS N LS +P + + + L +DLS N + LP + LS L+ LD+S
Sbjct: 160 RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217
Query: 466 DNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMEL 525
+N ++ +SL L +L+ + LS N +P S+G S+L+ LDLS+NQ+ S L
Sbjct: 218 NNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSL 273
Query: 526 GQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNIS 585
G + L L+LS N L+ +P L L +L L L L++ NI
Sbjct: 274 GSLTNLR-ELDLSGNSLSNALPLIALLLLLLELLLN--LLLTLKALELKLNSILLNNNIL 330
Query: 586 YNKFT 590
N T
Sbjct: 331 SNGET 335
|
Length = 394 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 756 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR------LLMYDYMPNGSLGS-LLHERTGN 808
+ F +E + H N++R +G C +++ +M +G L S LL+ R G+
Sbjct: 45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104
Query: 809 A---LEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865
L ++ + + A G+ YL +HRD+ A N ++ +ADFGL+K
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKK 161
Query: 866 VDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG 925
+ +GD+ R +IA E T KSDV+S+GV + E+ T Q P + +
Sbjct: 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-EN 220
Query: 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
S + D++RQ + L +P +D + + C +P +RP+ + + L+
Sbjct: 221 SEIYDYLRQG--------NRLKQPPDCLDGLYSLMSS---CWLLNPKDRPSFETLRCELE 269
Query: 986 EI 987
+
Sbjct: 270 KA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 75/289 (25%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 711 VIGKGCSGVVYRA--DMDNGEVIAVKKLWPTTMAAANGCSDEKSG-VRDSFSAEIKTLGS 767
IG+G G VY+ E IAV A C + S VR+ F E +
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAV---------AVKTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE----LRYQILLGAA 823
H +IV+ +G ++M + P G L S L + +L+ YQ+ +
Sbjct: 64 FDHPHIVKLIGVITENPVWIVM-ELAPLGELRSYL-QVNKYSLDLASLILYSYQL----S 117
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
LAYL VHRDI A N+L+ + DFGL++ ++D + ++S
Sbjct: 118 TALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS-KGKLPIK 173
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942
++APE + T SDV+ +GV + E+L G +P V+ I ++
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF-----------QGVKNNDVIGRIE 222
Query: 943 P-SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
L P + L +L C P +RP ++ A L +I E
Sbjct: 223 NGERLPMPPN-CPPTLYSL--MTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 72/247 (29%), Positives = 113/247 (45%), Gaps = 38/247 (15%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++G+G G VY D D G +AVK++ + S E S ++ EI+ L ++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQV------QFDPESPETSKEVNALECEIQLLKNLL 62
Query: 770 HKNIVRFLGCCWNRNNRLL--MYDYMPNGSLGSLLHERTGNALEWELRY--QILLGAAQG 825
H+ IV++ GC + R L ++MP GS+ L +Y QIL +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EG 118
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS-NTVAGSYGY 884
++YLH + IVHRDIK NIL + DFG +K + + + +V G+ +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK-----------------QPIDPTIPDGSH 927
++PE K+D++S G V+E+LT K QP +P +P H
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP--PH 233
Query: 928 VVDWVRQ 934
V D R
Sbjct: 234 VSDHCRD 240
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 79/296 (26%), Positives = 132/296 (44%), Gaps = 42/296 (14%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWP---TTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+GC G V A E + + K P T+A D +E++ + I
Sbjct: 23 LGEGCFGQVVMA-----EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 77
Query: 769 -RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEW----------ELRYQ 817
+HKNI+ LG C ++ +Y G+L L R +E+ ++ ++
Sbjct: 78 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 818 ILLGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFA 872
L+ A+G+ YL C+ HRD+ A N+L+ IADFGLA+ V++ D+
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193
Query: 873 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDW 931
+ + ++APE + T +SDV+S+GV++ E+ T G P P IP V +
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP----VEEL 248
Query: 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+ K +D +P + +E+ + C +A P RPT K + L I
Sbjct: 249 FKLLKEGHRMD-----KPANCTNELYMMMRD---CWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 37/285 (12%)
Query: 712 IGKGCSGVVYRADMDNG--EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG-SI 768
+G G G VY+ N ++A+K++ A + + D S E+ + +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVS-EVTIIKEQL 66
Query: 769 RHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSL---LHERTGNALE---WELRYQILLG 821
RH NIVR+ + N+RL ++ D + LG L E+ E W + Q++L
Sbjct: 67 RHPNIVRYYKT-FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 822 AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
L YLH + IVHRD+ NNI++G + + I DFGLAK S V G+
Sbjct: 126 ----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS---VVGT 176
Query: 882 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT--IPDGSHVVDWVRQKKGIQ 939
Y PE EK+DV+++G ++ ++ T + P T + + +V+
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE--------A 228
Query: 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
V +P PE E + V C+ + RP + V+AM+
Sbjct: 229 VYEP----LPEGMYSEDVT--DVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-16
Identities = 69/213 (32%), Positives = 108/213 (50%), Gaps = 28/213 (13%)
Query: 712 IGKGCSGVV----YRADMDN-GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
+G+G G V Y + DN GE +AVK L P + N +D K EI+ L
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKK--------EIEILR 61
Query: 767 SIRHKNIVRFLGCC---WNRNNRLLMYDYMPNGSLGSLLHERTGNA--LEWELRYQILLG 821
++ H+NIV++ G C +L+M +++P+GSL L R N L+ +L+Y + +
Sbjct: 62 NLYHENIVKYKGICTEDGGNGIKLIM-EFLPSGSLKEYL-PRNKNKINLKQQLKYAVQI- 118
Query: 822 AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV-DDGDFARSSNTVAG 880
+G+ YL VHRD+ A N+L+ E + I DFGL K + D ++ + +
Sbjct: 119 -CKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 881 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 913
+ APE K SDV+S+GV + E+LT
Sbjct: 175 PVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 9/189 (4%)
Query: 738 PTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGS 797
P +A +D R+ F EIK + +++ NI+R LG C + + ++ +YM NG
Sbjct: 44 PVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 798 LGSLLHERT-------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG 850
L L +R N + +L A Q + + + VHRD+ N L+G
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 851 LEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLE 910
+ IADFG+++ + GD+ R ++A E + K T SDV+++GV + E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 911 V--LTGKQP 917
+ L +QP
Sbjct: 224 MFTLCKEQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 77/293 (26%), Positives = 131/293 (44%), Gaps = 36/293 (12%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RH 770
+G+GC G V A+ + K P T+A D +E++ + I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNK--PVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEW----------ELRYQILL 820
KNI+ LG C ++ +Y G+L L R +++ +L ++ L+
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 821 G----AAQGLAYL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
A+G+ YL C+ HRD+ A N+L+ + IADFGLA+ V + D+ + +
Sbjct: 138 SCAYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 876 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQ 934
++APE + T +SDV+S+GV++ E+ T G P P IP V + +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIP----VEELFKL 248
Query: 935 KKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
K +D +P + E+ + C +A P +RPT K + L +
Sbjct: 249 LKEGHRMD-----KPANCTHELYM---IMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 86/296 (29%), Positives = 131/296 (44%), Gaps = 46/296 (15%)
Query: 710 NVIGKGCSGVVYRA---DMD---NGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI 762
N +G G G VY D+ +G + +AVK L G +D++ + F E
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL-------RKGATDQE---KKEFLKEA 50
Query: 763 KTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLH----ERTGNALEW--ELRY 816
+ + H NIV+ LG C + ++ + M G L S L ER G L EL
Sbjct: 51 HLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL-L 109
Query: 817 QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP-----YIADFGLAKLVDDGDF 871
I L A+G YL +HRD+ A N L+ + I DFGLA+ + D+
Sbjct: 110 DICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
Query: 872 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVD 930
R ++APE K T +SDV+S+GV++ E+LT G+QP P + + V+
Sbjct: 167 YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-PAL-NNQEVLQ 224
Query: 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
V +Q +PE+ D++ Q + C P ERPT + +L+
Sbjct: 225 HVTAGGRLQ--------KPENCPDKIYQLM---TNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 26/166 (15%)
Query: 761 EIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---Q 817
E + L H IV+ ++ ++ +Y G L ++L +R G E+ R+
Sbjct: 43 EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIAC 101
Query: 818 ILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT 877
++L YLH+ I++RD+K N+L+ + DFG AK + G + + T
Sbjct: 102 VVLA----FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWT 151
Query: 878 VAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G+ Y+APE Y + D +S G+++ E+LTG+ P
Sbjct: 152 FCGTPEYVAPEIILNKGYDFS------VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 72/289 (24%), Positives = 115/289 (39%), Gaps = 42/289 (14%)
Query: 713 GKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKN 772
GK G +Y MD+ +++A+K L G F E + + H N
Sbjct: 19 GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG----------EFQQEASLMAELHHPN 68
Query: 773 IVRFLGCCWNRNNRLLMYDYMPNGSLGSLL-----HERTG----------NALEWELRYQ 817
IV LG ++++Y+ G L L H G ++L+
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 818 ILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT 877
I + A G+ YL VH+D+ A NILIG + I+D GL++ + D+ R
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 878 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKK 936
++ PE K + SD++S+GVV+ E+ + G QP V++ VR+++
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF--SNQEVIEMVRKRQ 243
Query: 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
LL E M + C P RP KD+ L+
Sbjct: 244 --------LLPCSEDCPPRMYSLMTE---CWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 28/162 (17%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLGSI 768
+G+G VVY+A D + G ++A+KK+ A K G+ +F+A EIK L +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA------KDGI--NFTALREIKLLQEL 59
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY------QILLGA 822
+H NI+ L +++N L++++M L ++ ++ + +L
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDK-------SIVLTPADIKSYMLMT 111
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
+GL YLH + I+HRD+K NN+LI + +ADFGLA+
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 712 IGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+GKG G VY+ + + + A+K++ +M+ R+ EI+ L S+ H
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE---------REDAVNEIRILASVNH 58
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAY 828
NI+ + + N ++ +Y P G L + +R + + ++I + +GL
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
LH I+HRD+K+ NIL+ I D G++K++ + T G+ Y+APE
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPE 171
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ KSD++S G ++ E+ T P
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 82/302 (27%), Positives = 135/302 (44%), Gaps = 42/302 (13%)
Query: 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWP---TTMAAANGCSDEKSGVRDSFSAEI 762
LV +G+GC G V A E I + K P T +A SD +E+
Sbjct: 20 LVLGKPLGEGCFGQVVMA-----EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEM 74
Query: 763 KTLGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEW--------- 812
+ + I +HKNI+ LG C ++ +Y G+L L R +E+
Sbjct: 75 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 813 -ELRYQILLG----AAQGLAYL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV 866
+L ++ L+ A+G+ YL C+ HRD+ A N+L+ + IADFGLA+ +
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 867 DDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDG 925
D+ + + ++APE + T +SDV+S+GV++ E+ T G P P +P
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP-- 247
Query: 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
V + + K +D +P + +E+ + C +A P +RPT K + L
Sbjct: 248 --VEELFKLLKEGHRMD-----KPSNCTNELYMMMRD---CWHAVPSQRPTFKQLVEDLD 297
Query: 986 EI 987
I
Sbjct: 298 RI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 74/261 (28%), Positives = 118/261 (45%), Gaps = 44/261 (16%)
Query: 752 SGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHE------- 804
S +RD S E L + H ++++ G C LL+ +Y GSL S L E
Sbjct: 45 SELRDLLS-EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPS 103
Query: 805 -------RTGNAL----EWELRYQILLGAA----QGLAYLHHDCVPPIVHRDIKANNILI 849
R + L E L L+ A +G+ YL +VHRD+ A N+L+
Sbjct: 104 YLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLV 160
Query: 850 GLEFEPYIADFGLAKLV--DDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVV 907
+ I+DFGL++ V +D RS + ++A E + T +SDV+S+GV+
Sbjct: 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVL 218
Query: 908 VLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLC 966
+ E++T G P P I + K G + + RPE+ +EM + L C
Sbjct: 219 LWEIVTLGGNPY-PGIAPERL---FNLLKTGYR------MERPENCSEEMYN---LMLTC 265
Query: 967 VNASPDERPTMKDVAAMLKEI 987
PD+RPT D++ L+++
Sbjct: 266 WKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 75/270 (27%), Positives = 116/270 (42%), Gaps = 32/270 (11%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IGKG G VY+ D EV+A+K + DE ++ EI L
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIK------IIDLEEAEDEIEDIQQ----EITVLSQCDS 61
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
I R+ G ++ +Y+ GS LL LE IL +GL YLH
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLH 118
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
+ +HRDIKA N+L+ + + +ADFG+A + D R NT G+ ++APE
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVI 173
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE 950
K+D++S G+ +E+ G+ P P V+ + + P+L +
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHP--MRVLFLIPKNS-----PPTLEGQYS 226
Query: 951 SEIDEMLQALGVALLCVNASPDERPTMKDV 980
E ++A C+N P RPT K++
Sbjct: 227 KPFKEFVEA------CLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 712 IGKGCSGVVYRADMDN-GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
I KG G V+ A + G++ A+K + M N D E L +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKN--------QVDQVLTERDILSQAQS 52
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGLA 827
+V+ + N L+ +Y+P G L SLL G+ E R +I+L L
Sbjct: 53 PYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN-VGSLDEDVARIYIAEIVLA----LE 107
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL------VDDGDFARSSNTVAGS 881
YLH + I+HRD+K +NILI + DFGL+K+ ++ D + + G+
Sbjct: 108 YLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 882 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
YIAPE ++ D +S G ++ E L G P
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G GVVY+A + GEV+A+KK+ T E GV + EI L + H
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDT---------ETEGVPSTAIREISLLKELNH 58
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
NIV+ L N L+++++ + L + + + L L QGLA+ H
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
V +HRD+K N+LI E +ADFGLA+ G R+ + Y APE
Sbjct: 118 SHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL 172
Query: 891 YMMKI-TEKSDVYSYGVVVLEVLTGK 915
K + D++S G + E++T +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 50/234 (21%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++G+G G+V + + G+++A+KK S++ V+ EI+ L +R
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLE---------SEDDKMVKKIAMREIRMLKQLR 58
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H+N+V + + L+++++ + L L E+ N L+ + L +G+ +
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 830 H-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG----- 883
H H+ I+HRDIK NIL+ G+ KL D G FAR+ Y
Sbjct: 117 HSHN----IIHRDIKPENILVSQS--------GVVKLCDFG-FARTLAAPGEVYTDYVAT 163
Query: 884 --YIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928
Y APE YG + D+++ G +V E+LTG +P P S +
Sbjct: 164 RWYRAPELLVGDTKYGRAV------DIWAVGCLVTEMLTG----EPLFPGDSDI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 31/235 (13%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
I KG G VY A G+ A+K L + M A N + + V+ AE +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN----QVTNVK----AERAIMMIQGE 55
Query: 771 K-NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY--QILLGAAQGLA 827
+ + +++ L+ +Y+ G SL+ G +W +Y +++LG +
Sbjct: 56 SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG----VE 111
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
LH I+HRDIK N+LI + DFGL++ + + G+ Y+AP
Sbjct: 112 DLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAP 162
Query: 888 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG------SHVVDWVRQKK 936
E + + SD +S G V+ E L G P PD S ++W + K
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVK 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 29/225 (12%)
Query: 704 KCLVDANVIGKGCSGVVYRA-----DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDS 757
+ +G G G VY D D E+ +AVK L CS++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-------PESCSEQD---ESD 55
Query: 758 FSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHE---RTGNALEWEL 814
F E + H+NIVR +G + R R ++ + M G L S L E R +
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTM 115
Query: 815 R--YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI---GLEFEPYIADFGLAKLVDDG 869
+ A+G YL + +HRDI A N L+ G IADFG+A+ +
Sbjct: 116 KDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172
Query: 870 DFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLT 913
+ R ++ PE ++ I T K+DV+S+GV++ E+ +
Sbjct: 173 SYYRKGGRAMLPIKWMPPE-AFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 712 IGKGCSGVVYR-ADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-R 769
IGKG G VY+ + +G + AVK L P S V + AE L S+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPI------------SDVDEEIEAEYNILQSLPN 77
Query: 770 HKNIVRFLGCCWNRNNRL-----LMYDYMPNGSLGSLLHE--RTGNALEWELRYQILLGA 822
H N+V+F G + + + L+ + GS+ L+ G L+ + IL GA
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
GL +LH++ I+HRD+K NNIL+ E + DFG++ + R NT G+
Sbjct: 138 LLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTP 192
Query: 883 GYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTGKQPI 918
++APE Y + DV+S G+ +E+ G P+
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-14
Identities = 35/81 (43%), Positives = 54/81 (66%)
Query: 205 LSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGL 264
L G IP +I KL+ L+ + L NS+ G IP +G+ TSL+++D S NS +G+IP S+G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 265 SELEEFMISDNNVSGSIPANL 285
+ L ++ N++SG +PA L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-14
Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G GVV + +I +KL + K +R+ E++ L
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEI---------KPAIRNQIIRELQVLHECNSP 63
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
IV F G ++ + ++M GSL +L E + E+ ++ + +GLAYL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLA-KLVDDGDFARSSNTVAGSYGYIAPEYG 890
I+HRD+K +NIL+ E + DFG++ +L+D +N+ G+ Y++PE
Sbjct: 122 K--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERL 174
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928
+ +SD++S G+ ++E+ G+ PI P PD +
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 73/298 (24%), Positives = 129/298 (43%), Gaps = 51/298 (17%)
Query: 712 IGKGCSGVVYRA---DMDNGEV---IAVKKLWPTTMAAANGCSDEKSGVRD--SFSAEIK 763
+G+G G+VY D+ GE +AVK + +E + +R+ F E
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTV------------NESASLRERIEFLNEAS 61
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLH------ERTGNALEWELRYQ 817
+ ++VR LG L++ + M +G L S L E L+
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 818 ILLGA--AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
I + A A G+AYL+ VHRD+ A N ++ +F I DFG+ + + + D+ R
Sbjct: 122 IQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 876 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQ 934
++APE T SD++S+GVV+ E+ + +QP V+ +
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--SNEQVLKF--- 233
Query: 935 KKGIQVLDPSLLSRPES---EIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989
V+D L +P++ + ++++ +C +P RPT ++ +LK+ H
Sbjct: 234 -----VMDGGYLDQPDNCPERVTDLMR------MCWQFNPKMRPTFLEIVNLLKDDLH 280
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 73/280 (26%), Positives = 129/280 (46%), Gaps = 36/280 (12%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G G VY+A +A K+ T S+E+ + + EI+ L + H
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-------SEEE---LEDYMVEIEILATCNHP 69
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
IV+ LG + +M ++ P G++ +++ E E +++ I + L YLH
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLHS 128
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY 891
I+HRD+KA N+L+ L+ + +ADFG++ + + ++ G+ ++APE
Sbjct: 129 M---KIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 892 --MMKITE---KSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLL 946
MK T K+D++S G+ ++E+ + P H ++ +R I +P L
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPP--------HHELNPMRVLLKIAKSEPPTL 235
Query: 947 SRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
S+P E L AL + P+ RP+ AA L E
Sbjct: 236 SQPSKWSMEFRDFLKTAL---DKHPETRPS----AAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-14
Identities = 32/77 (41%), Positives = 50/77 (64%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
IP ++S +HLQ++ +S ++ G+IP +G L VLD S N+ G++P SLG+L +L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 76 ELILNSNQLTGKIPVEL 92
L LN N L+G++P L
Sbjct: 494 ILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 53/237 (22%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVR-----DSFSAEIKT 764
+IG+G V A + + + A+K L +K + E +
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKIL-------------DKRQLIKEKKVKYVKIEKEV 54
Query: 765 LGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY--QILLG 821
L + H I++ + N + +Y PNG L + + + Y +ILL
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA 114
Query: 822 AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVA-- 879
L YLH I+HRD+K NIL+ + I DFG AK++D S+ A
Sbjct: 115 ----LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 880 ----------------GSYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQP 917
G+ Y++PE ++ + SD+++ G ++ ++LTGK P
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPE---LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 80/296 (27%), Positives = 124/296 (41%), Gaps = 60/296 (20%)
Query: 712 IGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IGKG VVY+A + +G V+A+KK+ M D K+ R EI L + H
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEM------MDAKA--RQDCLKEIDLLKQLDH 61
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSL----------GSLLHERTGNALEWELRYQILL 820
N++++L N ++ + G L L+ ERT W+ Q+
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT----IWKYFVQL-- 115
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVA- 879
L ++H I+HRDIK N+ I + D GL + SS T A
Sbjct: 116 --CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKTTAA 163
Query: 880 ----GSYGYIAPEY----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931
G+ Y++PE GY KSD++S G ++ E+ + P D ++
Sbjct: 164 HSLVGTPYYMSPERIHENGYNF----KSDIWSLGCLLYEMAALQSPFY---GDKMNLYSL 216
Query: 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
K I+ D L P E L+ L V+ C+N P++RP + V + KE+
Sbjct: 217 C---KKIEKCDYPPL--PADHYSEELRDL-VS-RCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 62/259 (23%), Positives = 113/259 (43%), Gaps = 19/259 (7%)
Query: 728 GEVIAVKKLWPTTMAAANGCSDE-KSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR 786
GEV + + T A C + ++ F E + L H NIVR +G C +
Sbjct: 9 GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 68
Query: 787 LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANN 846
++ + + G + L G L+ + Q++ AA G+ YL +HRD+ A N
Sbjct: 69 YIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHC---IHRDLAARN 124
Query: 847 ILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGV 906
L+ + I+DFG+++ +DG +A + + APE + + +SDV+S+G+
Sbjct: 125 CLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGI 184
Query: 907 VVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALL 965
++ E + G P + S+ ++G+++ P L P++ M +
Sbjct: 185 LLWEAFSLGAVP----YANLSNQQTREAIEQGVRLPCPELC--PDAVYRLMER------- 231
Query: 966 CVNASPDERPTMKDVAAML 984
C P +RP+ V L
Sbjct: 232 CWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-14
Identities = 72/282 (25%), Positives = 123/282 (43%), Gaps = 32/282 (11%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IGKG G V++ D +V+A+K + DE ++ EI L
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKII------DLEEAEDEIEDIQQ----EITVLSQCDS 61
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
+ ++ G ++ +Y+ GS LL R G E+++ +L +GL YLH
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIA-TMLKEILKGLDYLH 118
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
+ +HRDIKA N+L+ + + +ADFG+A + D R NT G+ ++APE
Sbjct: 119 SE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVI 173
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE 950
K+D++S G+ +E+ G+ P P V+ + + P+L
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHP--MRVLFLIPKNNP-----PTLTGEFS 226
Query: 951 SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992
E + A C+N P RPT K++ +K+ ++
Sbjct: 227 KPFKEFIDA------CLNKDPSFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 711 VIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
V+G+G G+V+ + + + K P DE R + E + L + H
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT----KDE----RLAAQNECQVLKLLSH 58
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
NI+ + +++ +Y P G+L + +R + L+ + IL Q L LH
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED---TILHFFVQILLALH 115
Query: 831 HDCVPPIVHRDIKANNILIGL-EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY 889
H I+HRD+K NIL+ + I DFG++K++ A TV G+ YI+PE
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPEL 172
Query: 890 GYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
+KSD+++ G V+ E+ + K+ +
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 46/234 (19%)
Query: 698 SVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRD 756
SV++ + L N I +G GVVYRA D GE++A+KKL M EK G
Sbjct: 3 SVDE-YEKL---NRIEEGTYGVVYRARDKKTGEIVALKKL---KM------EKEKEGFPI 49
Query: 757 SFSAEIKTLGSIRHKNIVRF----LGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEW 812
+ EI L ++H NIV +G N + ++ +Y+ + L SL+ L+
Sbjct: 50 TSLREINILLKLQHPNIVTVKEVVVGS--NLDKIYMVMEYVEH-DLKSLMETMKQPFLQS 106
Query: 813 E---LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG 869
E L Q+L G+A+LH + I+HRD+K +N+L+ I DFGLA+
Sbjct: 107 EVKCLMLQLL----SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159
Query: 870 DFARSSNTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQ 916
+ V + Y APE Y + D++S G + E+LT K
Sbjct: 160 LKPYTQLVV--TLWYRAPELLLGAKEY------STAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G SG V+ A D+ G+ +A+K++ + +K ++ EI + +++
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI-----------NLQKQPKKELIINEILVMKELKN 75
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
NIV FL + ++ +Y+ GSL ++ E + + + Q L +LH
Sbjct: 76 PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA---AVCRECLQALEFLH 132
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
+ ++HRDIK++N+L+G++ + DFG + RS T+ G+ ++APE
Sbjct: 133 AN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVV 187
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQP 917
K D++S G++ +E++ G+ P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 68/296 (22%), Positives = 118/296 (39%), Gaps = 52/296 (17%)
Query: 711 VIGKGCSGVVYRADMDNGE------VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
+G+G G V+ A E ++ VK L N S+ F E+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSE--------FRRELDM 61
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE----------- 813
+ HKN+VR LG C ++ +Y G L L + +
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 814 LRYQILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF 871
L QI A G+ +L VHRD+ A N L+ + E ++ L+K V + ++
Sbjct: 122 LCTQI----ALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172
Query: 872 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVD 930
+ N + ++APE + KSDV+S+GV++ EV T G+ P + D +
Sbjct: 173 YKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF-YGLSDEEVLNR 230
Query: 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
Q +++ P P + +++ C +P +RP+ ++ + L E
Sbjct: 231 --LQAGKLELPVPE--GCPSR-LYKLMTR------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 55/168 (32%), Positives = 81/168 (48%), Gaps = 27/168 (16%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G+G G VY+A + G V+A+KK+ M +EK G + EIK L ++H
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI---LM------HNEKDGFPITALREIKILKKLKH 66
Query: 771 KNIVRFLGCCWNR-----NNRLLMYDYMP--NGSLGSLLHERTGNALEWELR---YQILL 820
N+V + R R +Y P + L LL + E +++ Q+L
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL- 125
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868
+G+ YLH + I+HRDIKA NILI + IADFGLA+ D
Sbjct: 126 ---EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 61/225 (27%), Positives = 88/225 (39%), Gaps = 49/225 (21%)
Query: 710 NVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
VIGKG G V D ++ A+K M C EK VR+ + E + L +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMK-----YMNKQK-C-VEKGSVRNVLN-ERRILQEL 57
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ---- 824
H +V + N L+ D + G L + L ++ Q
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLL------------LGGDLRYHLSQKVKFSEEQVKFW 105
Query: 825 ------GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTV 878
L YLH I+HRDIK +NIL+ + +I DF +A V + +
Sbjct: 106 ICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTST 159
Query: 879 AGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+G+ GY+APE Y D +S GV E L GK+P
Sbjct: 160 SGTPGYMAPEVLCRQGYSV------AVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 69/273 (25%), Positives = 112/273 (41%), Gaps = 54/273 (19%)
Query: 755 RDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHE--------- 804
RD F+ E++ L + H NI+ LG C +R L +Y P+G+L L +
Sbjct: 52 RD-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 110
Query: 805 -----RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859
T + L + A+G+ YL +HRD+ A NIL+G + IAD
Sbjct: 111 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 167
Query: 860 FGLAKLVDDGDFARSSNTVAG-SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 917
FGL++ G T+ ++A E T SDV+SYGV++ E+++ G P
Sbjct: 168 FGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
Query: 918 --------IDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNA 969
+ +P G R +K + D E+ ++++ C
Sbjct: 224 YCGMTCAELYEKLPQG------YRLEKPLNCDD---------EVYDLMRQ------CWRE 262
Query: 970 SPDERPTMKDVAAMLKEIKHEREEYAKVDMLLK 1002
P ERP+ + L + ER+ Y + K
Sbjct: 263 KPYERPSFAQILVSLNRMLEERKTYVNTTLYEK 295
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 70/230 (30%), Positives = 110/230 (47%), Gaps = 46/230 (20%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG+G G VY+A D D GE++A+KK+ +EK G + EIK L +
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKV---------RLDNEKEGFPITAIREIKILRQL 63
Query: 769 RHKNIVRFLGCCWNRNNRL----------LMYDYMPNGSLGSLLHERTGNALEWELRY-- 816
H+NIV ++ + L L+++YM + +G LL + E ++
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-LLESGLVHFSEDHIKSFM 122
Query: 817 -QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
Q+L +GL Y H +HRDIK +NIL+ + + +ADFGLA+L + + +
Sbjct: 123 KQLL----EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 876 NTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918
N V + Y PE YG + DV+S G ++ E+ T K+PI
Sbjct: 176 NKVITLW-YRPPELLLGEERYGPAI------DVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 33/286 (11%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRD--SFSAEIKTLGSIR 769
+G+G G+VY G V K P T A +E + +R+ F E +
Sbjct: 14 LGQGSFGMVYE-----GIAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFN 67
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLH----ERTGNALEW--ELRYQILLGA- 822
++VR LG L++ + M G L S L E N ++ L+ I +
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 823 -AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
A G+AYL+ + VHRD+ A N ++ +F I DFG+ + + + D+ R
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 882 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQV 940
+++PE T SDV+S+GVV+ E+ T +QP V+ + V
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--SNEQVLRF--------V 234
Query: 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
++ LL +P++ D + + + +C +P RP+ ++ + +KE
Sbjct: 235 MEGGLLDKPDNCPDMLFELM---RMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 3e-13
Identities = 54/166 (32%), Positives = 78/166 (46%), Gaps = 26/166 (15%)
Query: 760 AEIKTLGSIRHKNIVRFLGCCW-NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQI 818
E + L SIRH +V G + N L+M +Y+P G L S L ++G E
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQDDSNLYLVM-EYVPGGELFSHL-RKSGRFPE----PVA 103
Query: 819 LLGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
AAQ L YLH IV+RD+K N+L+ + I DFG AK V +
Sbjct: 104 RFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY---- 156
Query: 876 NTVAGSYGYIAPEY----GYMMKITEKSDVYSYGVVVLEVLTGKQP 917
T+ G+ Y+APE GY + D ++ G+++ E+L G P
Sbjct: 157 -TLCGTPEYLAPEIILSKGY----GKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 3e-13
Identities = 71/251 (28%), Positives = 104/251 (41%), Gaps = 72/251 (28%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA-----EIK 763
IG G GVV A D G +A+KK+ D A EIK
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--------------DDLIDAKRILREIK 51
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLL----------MY---DYMPNGSLGSLLHE--RTGN 808
L +RH+NI+ L +L +Y + M + LH+ ++
Sbjct: 52 LLRHLRHENIIGLL--------DILRPPSPEDFNDVYIVTELME-----TDLHKVIKSPQ 98
Query: 809 ALEWE----LRYQILLGAAQGLAYLH--HDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862
L + YQIL G L YLH + ++HRD+K +NIL+ + I DFGL
Sbjct: 99 PLTDDHIQYFLYQILRG----LKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGL 149
Query: 863 AKLVDDGDFARSSNT--VAGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
A+ VD + + T V + Y APE + T+ D++S G + E+LT K P+
Sbjct: 150 ARGVDPDEDEKGFLTEYVVTRW-YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLF 207
Query: 920 PTIPDGSHVVD 930
P G +D
Sbjct: 208 P----GRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 47/231 (20%)
Query: 712 IGKGCSGVVYRADMDN---GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG+G G VY+A N G+ A+KK G ++ +G+ S EI L +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF--------KGDKEQYTGISQSACREIALLREL 59
Query: 769 RHKNIVRFLGCCWNRNNRL--LMYDYMPNGSLGSLLHERTGNALEW------ELRYQILL 820
+H+N+V + ++ L++DY + + R + L +QIL
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL- 118
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY----IADFGLAKLVDD--GDFARS 874
G+ YLH + ++HRD+K NIL+ E I D GLA+L + A
Sbjct: 119 ---NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA-D 171
Query: 875 SNTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918
+ V + Y APE Y T+ D+++ G + E+LT + PI
Sbjct: 172 LDPVVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTLE-PI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 36/291 (12%)
Query: 711 VIGKGCSGVVYRA----DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
V+G G G VY+ + + ++ +A+K+L T AN + D E +
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN------KEILD----EAYVM 63
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGN-ALEWELRYQILLGAAQ 824
S+ + ++ R LG C +L+ MP G L + E N ++ L + + + A+
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI--AK 120
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
G+ YL +VHRD+ A N+L+ I DFGLAKL+ + + +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
+A E T +SDV+SYGV V E++T G +P D IP S + + +KG ++ P
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIP-ASEISSIL--EKGERLPQP 233
Query: 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEY 994
P ID + + + C D RP +++ ++ + + Y
Sbjct: 234 -----PICTIDVYM----IMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 275
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 4e-13
Identities = 59/199 (29%), Positives = 85/199 (42%), Gaps = 41/199 (20%)
Query: 707 VDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI--- 762
+ IG+G G VY+A D++ G +A+KK+ E G+ S EI
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKV--------RVPLSE-EGIPLSTLREIALL 52
Query: 763 KTLGSIRHKNIVRFLGCC--WNRNNRLLMY-----------DYMPNGSLGSLLHERTGNA 809
K L S H NIVR L C + L + Y+ L E +
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD- 111
Query: 810 LEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG 869
L Q+L +G+ +LH IVHRD+K NIL+ + + IADFGLA++
Sbjct: 112 ----LMRQLL----RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY--- 157
Query: 870 DFARSSNTVAGSYGYIAPE 888
F + +V + Y APE
Sbjct: 158 SFEMALTSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G SG VY A D+ G+ +A+K++ + ++ ++ EI + +H
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-----------NLQQQPKKELIINEILVMRENKH 75
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
NIV +L + ++ +Y+ GSL ++ E ++ + Q L +LH
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH 132
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
+ V +HRDIK++NIL+G++ + DFG + RS T+ G+ ++APE
Sbjct: 133 SNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVV 187
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQP 917
K D++S G++ +E++ G+ P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 74/303 (24%), Positives = 123/303 (40%), Gaps = 52/303 (17%)
Query: 711 VIGKGCSGVVYRA----DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
V+G G G VY+ D +N ++ +A+K L T AN E +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN----------KEILDEAYVM 63
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTG-----NALEWELRYQILL 820
+ + R LG C +L+ MP G L + E + L W + QI
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDLLNWCV--QI-- 118
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
A+G++YL +VHRD+ A N+L+ I DFGLA+L+D + ++
Sbjct: 119 --AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173
Query: 881 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQ 939
++A E + T +SDV+SYGV V E++T G +P D GI
Sbjct: 174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-----------------GIP 216
Query: 940 VLD-PSLLSRPESEIDEMLQALGVALL---CVNASPDERPTMKDVAAMLKEIKHEREEYA 995
+ P LL + E + + V ++ C + RP +++ + + +
Sbjct: 217 AREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFV 276
Query: 996 KVD 998
+
Sbjct: 277 VIQ 279
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-13
Identities = 34/90 (37%), Positives = 50/90 (55%)
Query: 149 ALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGS 208
LGL + + G +P + KL LQ++++ I G IP +G+ + L L L NS +GS
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 209 IPPEIGKLKKLEELFLWQNSLVGAIPEEIG 238
IP +G+L L L L NSL G +P +G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-12
Identities = 35/89 (39%), Positives = 49/89 (55%)
Query: 294 LQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASV 353
L LD + G IP +I L L N + G+IP +L S ++L+ LDLS+NS S+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 354 PAGLFQLQNLTKLLLISNDISGSIPPEIG 382
P L QL +L L L N +SG +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 79/318 (24%), Positives = 126/318 (39%), Gaps = 64/318 (20%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRD--SFSAEIKTLGS 767
+VIG+G G V RA +KK M AA E + D F+ E++ L
Sbjct: 8 DVIGEGNFGQVIRA--------MIKKD-GLKMNAAIKMLKEFASENDHRDFAGELEVLCK 58
Query: 768 I-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER--------------TGNALEW 812
+ H NI+ LG C NR + +Y P G+L L + T + L
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 813 ELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFA 872
+ Q A G+ YL +HRD+ A N+L+G IADFGL++ G+
Sbjct: 119 QQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR----GEEV 171
Query: 873 RSSNTVAG-SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP--------IDPTI 922
T+ ++A E T KSDV+S+GV++ E+++ G P + +
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
Query: 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAA 982
P G + +P + DE+ + + C P ERP ++
Sbjct: 232 PQGYR------------------MEKPRNCDDEVYELMR---QCWRDRPYERPPFAQISV 270
Query: 983 MLKEIKHEREEYAKVDML 1000
L + R+ Y + +
Sbjct: 271 QLSRMLEARKAYVNMALF 288
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 69/266 (25%), Positives = 108/266 (40%), Gaps = 36/266 (13%)
Query: 738 PTTMAAANGCSDEKSG-VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNG 796
T A D+ G +R+ F E ++H NIV LG +++ Y +
Sbjct: 34 QTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 797 SLGSLL-----HERTGN---------ALEWELRYQILLGAAQGLAYL--HHDCVPPIVHR 840
L L H G+ LE I+ A G+ +L HH +VH+
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHK 148
Query: 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD 900
D+ N+L+ + I+D GL + V D+ + +++PE K + SD
Sbjct: 149 DLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSD 208
Query: 901 VYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQA 959
++SYGVV+ EV + G QP V++ +R + QVL P P ML+
Sbjct: 209 IWSYGVVLWEVFSYGLQPYCGY--SNQDVIEMIRNR---QVL-PCPDDCPAWVYTLMLE- 261
Query: 960 LGVALLCVNASPDERPTMKDVAAMLK 985
C N P RP KD+ + L+
Sbjct: 262 ------CWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-12
Identities = 53/170 (31%), Positives = 79/170 (46%), Gaps = 14/170 (8%)
Query: 755 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLL-MYDYMPNGSLGSLLHERTGNALEWE 813
R F E + H NIV L L +++Y+P +L +L AL
Sbjct: 22 RARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL--AADGALPAG 79
Query: 814 LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI---GLEFEPYIADFGLAKL---VD 867
+++L LA H+ IVHRD+K NI++ G+ + DFG+ L V
Sbjct: 80 ETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR 136
Query: 868 DGDFARSSNT--VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 915
D D A + T V G+ Y APE +T SD+Y++G++ LE LTG+
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 71/232 (30%), Positives = 102/232 (43%), Gaps = 55/232 (23%)
Query: 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
L N IG G G VY+ G + A+K ++ G ++ VR EI+
Sbjct: 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY--------GNHED--TVRRQICREIEI 125
Query: 765 LGSIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELR---YQILL 820
L + H N+V+ ++ N + ++ ++M GSL E T A E L QIL
Sbjct: 126 LRDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVARQIL- 178
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG----LAKLVDDGDFARSSN 876
G+AYLH IVHRDIK +N+LI IADFG LA+ +D N
Sbjct: 179 ---SGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD------PCN 226
Query: 877 TVAGSYGYIAPEY-----------GYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ G+ Y++PE GY D++S GV +LE G+ P
Sbjct: 227 SSVGTIAYMSPERINTDLNHGAYDGY------AGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 36/82 (43%), Positives = 52/82 (63%)
Query: 183 GEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTS 242
G IP +I L S+ L NS+ G+IPP +G + LE L L NS G+IPE +G TS
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 243 LKMIDFSLNSLSGTIPLSIGGL 264
L++++ + NSLSG +P ++GG
Sbjct: 492 LRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-12
Identities = 66/231 (28%), Positives = 106/231 (45%), Gaps = 29/231 (12%)
Query: 693 QKLNFSVEQVLKCLVDANVIGKGCSGVV-YRADMDNGEVIAVKKLWPTTMAAANGCSDEK 751
Q++N ++ +V D +G G G V D G +A+KKL+ + K
Sbjct: 4 QEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFA----K 59
Query: 752 SGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDY---MP--NGSLGSLL-HER 805
R E++ L ++H+N++ L + +D+ MP LG L+ HE+
Sbjct: 60 RAYR-----ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK 114
Query: 806 TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865
L YQ+L +GL Y+H I+HRD+K N+ + + E I DFGLA+
Sbjct: 115 LSEDRIQFLVYQML----KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167
Query: 866 VDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 915
D + + V + Y APE M T+ D++S G ++ E+LTGK
Sbjct: 168 TD----SEMTGYVVTRW-YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 32/270 (11%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IGKG G V++ D +V+A+K + DE ++ EI L
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIK------IIDLEEAEDEIEDIQQ----EITVLSQCDS 61
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
+ ++ G ++ +Y+ GS LL L+ IL +GL YLH
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH 118
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
+ +HRDIKA N+L+ E +ADFG+A + D R NT G+ ++APE
Sbjct: 119 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVI 173
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE 950
K+D++S G+ +E+ G+ P P V+ + + P+L
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHP--MKVLFLIPKNN-----PPTLEGNYS 226
Query: 951 SEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ E ++A C+N P RPT K++
Sbjct: 227 KPLKEFVEA------CLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 63/244 (25%), Positives = 117/244 (47%), Gaps = 31/244 (12%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G G VY+A V+A K+ T S+E+ + + EI L S H
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK-------SEEE---LEDYMVEIDILASCDHP 62
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
NIV+ L + NN ++ ++ G++ +++ E E ++R + + L YLH
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHE 121
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY 891
+ I+HRD+KA NIL L+ + +ADFG++ + + ++ G+ ++APE
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEV-V 175
Query: 892 MMKITE------KSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSL 945
M + ++ K+DV+S G+ ++E+ + P H ++ +R I +P
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPP--------HHELNPMRVLLKIAKSEPPT 227
Query: 946 LSRP 949
L++P
Sbjct: 228 LAQP 231
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 73/231 (31%), Positives = 103/231 (44%), Gaps = 40/231 (17%)
Query: 707 VDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
VD +G G G+V A D G+ +A+KK+ K R E+K L
Sbjct: 13 VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLA----KRTYR-----ELKLL 63
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHE-RTGNALEWEL----RYQILL 820
+RH+NI+ + + Y LG+ LH T LE + YQIL
Sbjct: 64 KHLRHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL- 118
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
+GL Y+H V VHRD+K +NILI + I DFGLA++ D + + V+
Sbjct: 119 ---RGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYVST 168
Query: 881 SYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928
Y Y APE M+ K + D++S G + E+L GK P P HV
Sbjct: 169 RY-YRAPE--IMLTWQKYDVEVDIWSAGCIFAEMLEGK----PLFPGKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G SG VY A D+ G+ +A+K++ + ++ ++ EI + ++
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-----------NLQQQPKKELIINEILVMRENKN 75
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
NIV +L + ++ +Y+ GSL ++ E ++ + Q L +LH
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLH 132
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
+ ++HRDIK++NIL+G++ + DFG + RS T+ G+ ++APE
Sbjct: 133 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVV 187
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQP 917
K D++S G++ +E++ G+ P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 56/174 (32%), Positives = 88/174 (50%), Gaps = 11/174 (6%)
Query: 746 GCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER 805
GCSD++ R F AE TLG H NIVR G N +++ +YM NG+L S L +
Sbjct: 44 GCSDKQ---RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH 100
Query: 806 TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865
G + +L +L G A G+ YL VH+ + A+ +L+ + I+ F +L
Sbjct: 101 EGQLVAGQL-MGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RL 154
Query: 866 VDDGDFARSSNTVAGSYG-YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 917
+D A + S + APE + SDV+S+G+V+ EV++ G++P
Sbjct: 155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 90/303 (29%), Positives = 126/303 (41%), Gaps = 51/303 (16%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIGKG GVV A D GE +A+KK+ SD +R EIK L +R
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKI----NDVFEHVSDATRILR-----EIKLLRLLR 57
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHE--RTGNALEWE----LRYQILLGAA 823
H +IV + R Y+ + S LH+ + + L E YQ+L
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL---- 113
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK--LVDDGDFARSSNTVAGS 881
+ L Y+H V HRD+K NIL + + I DFGLA+ D ++ VA
Sbjct: 114 RALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 882 YGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPIDP---------TIPD-----G 925
+ Y APE + K T D++S G + EVLTGK P+ P I D
Sbjct: 171 W-YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGTPS 228
Query: 926 SHVVDWVRQKKGIQVL------DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKD 979
+ VR +K + L P S+ D + L LL + P +RPT ++
Sbjct: 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFD--PKDRPTAEE 286
Query: 980 VAA 982
A
Sbjct: 287 ALA 289
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 53/158 (33%), Positives = 76/158 (48%), Gaps = 22/158 (13%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G GVVY+A D GE++A+KK+ E GV + EI L + H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI---------RLETEDEGVPSTAIREISLLKELNH 57
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMP---NGSLGSLLHERTGNALEWELRYQILLGAAQGLA 827
NIVR L + N L+++++ + S L YQ+L QG+A
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIA 113
Query: 828 YLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
Y H H ++HRD+K N+LI E +ADFGLA+
Sbjct: 114 YCHSHR----VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK 771
+G G GVV++ +I +KL + K +R+ E++ L
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEI---------KPAIRNQIIRELQVLHECNSP 63
Query: 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH 831
IV F G ++ + ++M GSL +L ++ G E ++ ++ + +GL YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPE-QILGKVSIAVIKGLTYLRE 121
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLA-KLVDDGDFARSSNTVAGSYGYIAPEYG 890
I+HRD+K +NIL+ E + DFG++ +L+D +N+ G+ Y++PE
Sbjct: 122 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERL 174
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928
+ +SD++S G+ ++E+ G+ PI P PD +
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 14/173 (8%)
Query: 751 KSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNAL 810
K +R+ E+K L IV F G ++ + ++M GSL +L ++ G
Sbjct: 39 KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIP 97
Query: 811 EWELRYQILLGAAQGLAYLH--HDCVPPIVHRDIKANNILIGLEFEPYIADFGLA-KLVD 867
E + +I + +GL YL H I+HRD+K +NIL+ E + DFG++ +L+D
Sbjct: 98 E-NILGKISIAVLRGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152
Query: 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920
+N+ G+ Y++PE T +SD++S G+ ++E+ G+ PI P
Sbjct: 153 S-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 712 IGKGCSGVVYRA--DMDNGE-VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G G G V + M E +AVK L N +D ++D E + +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-------KNDNNDP--ALKDELLREANVMQQL 53
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL----HERTGNALEWELRYQILLGAAQ 824
+ IVR +G C + L+M + G L L H N E L +Q+ +
Sbjct: 54 DNPYIVRMIGICEAESWMLVM-ELAELGPLNKFLQKNKHVTEKNITE--LVHQV----SM 106
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFARSSNTVAGSYG 883
G+ YL VHRD+ A N+L+ + I+DFGL+K L D ++ ++
Sbjct: 107 GMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942
+ APE K + KSDV+S+GV++ E + G++P G+ V + +
Sbjct: 164 WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--KGNEVTQMIESGE------ 215
Query: 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
+ P+ EM + LC DERP V L+
Sbjct: 216 --RMECPQRCPPEMYDLMK---LCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 50/190 (26%), Positives = 79/190 (41%), Gaps = 38/190 (20%)
Query: 761 EIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER------TGNALEWEL 814
E + L + H I+R ++ ++ +Y+P G L S L TG E+
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110
Query: 815 RYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS 874
L YLH IV+RD+K NIL+ E + DFG AK + D +
Sbjct: 111 --------VCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW--- 156
Query: 875 SNTVAGSYGYIAPEYGYMMKITEKS-----DVYSYGVVVLEVLTGKQPIDPTIPDG---- 925
T+ G+ Y+APE I K D ++ G+++ E+L G P P G
Sbjct: 157 --TLCGTPEYLAPEV-----IQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK 209
Query: 926 --SHVVDWVR 933
+ +++ R
Sbjct: 210 ILAGKLEFPR 219
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 32/216 (14%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVK--KLWPTTMAAANGCSDEKSGVRDSFS---AEIKTL 765
+G G G VY+A ++ GE+ AVK KL P D FS EI +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPG----------------DDFSLIQQEIFMV 60
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
+H NIV + G +R + +Y GSL + H TG E ++ Y + QG
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAY-VCRETLQG 118
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
LAYLH +HRDIK NIL+ + +ADFG+A + A+ + + Y ++
Sbjct: 119 LAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKI-TATIAKRKSFIGTPY-WM 173
Query: 886 APEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPI 918
APE + K + D+++ G+ +E+ + P+
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 27/200 (13%)
Query: 748 SDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER-- 805
++ + VRD E + + + + IVR +G C L+M + G L L +
Sbjct: 32 NENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVM-EMASGGPLNKFLSGKKD 90
Query: 806 ---TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862
N +E L +Q+ + G+ YL VHRD+ A N+L+ + I+DFGL
Sbjct: 91 EITVSNVVE--LMHQV----SMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGL 141
Query: 863 AKLV--DDGDF-ARSSNTVAGSY--GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ 916
+K + DD + ARS AG + + APE K + +SDV+SYG+ + E + G++
Sbjct: 142 SKALGADDSYYKARS----AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQK 197
Query: 917 PIDPTIPDGSHVVDWVRQKK 936
P G V+ ++ Q K
Sbjct: 198 PYKKM--KGPEVMSFIEQGK 215
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-12
Identities = 33/90 (36%), Positives = 50/90 (55%)
Query: 341 ALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGL 400
L L + L +P + +L++L + L N I G+IPP +G+ +SL L + N G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 401 IPREIGGLKTLNFLDLSSNRLSGSVPDEIG 430
IP +G L +L L+L+ N LSG VP +G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-11
Identities = 88/306 (28%), Positives = 129/306 (42%), Gaps = 61/306 (19%)
Query: 188 EIGNCSELVSLFLYENSLSGSIPPEIGKLK-KLEELFLWQNSLVGAIPEEIGNCTSLKMI 246
E+ + L SL L N+++ IPP IG LK L+EL L N + ++P + N +LK +
Sbjct: 111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNL 168
Query: 247 DFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIP 306
D S N LS +P L+N +NL L L N+IS +P
Sbjct: 169 DLSFNDLS-------------------------DLPKLLSNLSNLNNLDLSGNKIS-DLP 202
Query: 307 PEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKL 366
PEI +LS L N + + S+L++ NL L+LS+N L
Sbjct: 203 PEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE---------------- 245
Query: 367 LLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVP 426
+P IGN S+L L + NN+I+ +G L L LDLS N LS ++P
Sbjct: 246 ---------DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALP 294
Query: 427 DEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKI 486
L+++ TL+ S L +L + P +L L SLN +
Sbjct: 295 LIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGE----TSSPEALSILESLNNL 350
Query: 487 ILSKNL 492
N
Sbjct: 351 WTLDNA 356
|
Length = 394 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 51/207 (24%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G SG VY A D+ G+ +A++++ + ++ ++ EI + ++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-----------NLQQQPKKELIINEILVMRENKN 76
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
NIV +L + ++ +Y+ GSL ++ E ++ + Q L +LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH 133
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
+ ++HRDIK++NIL+G++ + DFG + RS+ + G+ ++APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV 188
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQP 917
K D++S G++ +E++ G+ P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 34/227 (14%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G G V++A + + E++A+K++ D+ GV S EI L ++H
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV---------RLDDDDEGVPSSALREICLLKELKH 58
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNG------SLGSLLHERTGNALEWELRYQILLGAAQ 824
KNIVR + L+++Y S + + +Q+L +
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF----MFQLL----K 110
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
GLA+ H V +HRD+K N+LI E +ADFGLA+ G R + + Y
Sbjct: 111 GLAFCHSHNV---LHRDLKPQNLLINKNGELKLADFGLARAF--GIPVRCYSAEVVTLWY 165
Query: 885 IAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930
P+ + K+ S D++S G + E+ +P+ P G+ V D
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP----GNDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-11
Identities = 29/79 (36%), Positives = 47/79 (59%)
Query: 375 GSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTE 434
G IP +I L + + N I G IP +G + +L LDLS N +GS+P+ +G T
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 435 LQMIDLSHNTLQGSLPNSL 453
L++++L+ N+L G +P +L
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI- 768
++G G G VY+ + G++ A+K + T DE+ ++ EI L
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--------GDEEEEIKQ----EINMLKKYS 60
Query: 769 RHKNIVRFLGCCWNRN------NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGA 822
H+NI + G +N L+ ++ GS+ L+ GN L+ E I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
+GL++LH ++HRDIK N+L+ E + DFG++ +D R NT G+
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTP 175
Query: 883 GYIAPEYGYMMKITE--------KSDVYSYGVVVLEVLTGKQPI 918
++APE ++ E KSD++S G+ +E+ G P+
Sbjct: 176 YWMAPE---VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 42/227 (18%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI- 768
V+G G G VY+ + G++ A+K + + DE+ ++ EI L
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVM--------DVTEDEEEEIK----LEINMLKKYS 70
Query: 769 RHKNIVRFLGCCWNR-----NNRL-LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGA 822
H+NI + G + +++L L+ ++ GS+ L+ GNAL+ + I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
+GLA+LH ++HRDIK N+L+ E + DFG++ +D R NT G+
Sbjct: 131 LRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTP 185
Query: 883 GYIAPE-----------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918
++APE Y Y +SD++S G+ +E+ G P+
Sbjct: 186 YWMAPEVIACDENPDATYDY------RSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG+G G +Y A + E +K++ T M EK + E+ L ++
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-----KEKEASKK----EVILLAKMK 57
Query: 770 HKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ---G 825
H NIV F + N RL ++ +Y G L ++ + G + QIL Q G
Sbjct: 58 HPNIVTFFAS-FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED---QILSWFVQISLG 113
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLE-FEPYIADFGLAKLVDDG-DFARSSNTVAGSYG 883
L ++H I+HRDIK+ NI + + DFG+A+ ++D + A T G+
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY---TCVGTPY 167
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
Y++PE K+D++S G V+ E+ T K P +
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-11
Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 56/295 (18%)
Query: 738 PTTMA-AANGCSDEKSGVRDSF------------SAEIKTLGSIRHKNIVRFLGCCWNRN 784
PTT A A SD K V F +E+ L + H IV+ + +
Sbjct: 79 PTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138
Query: 785 NRLLMYDYMPNGSLGSLLHERTGNAL---EWE---LRYQILLGAAQGLAYLHHDCVPPIV 838
LL+ +Y G L + +R L E+E L YQI+L L +H ++
Sbjct: 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA----LDEVHSRK---MM 191
Query: 839 HRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEK 898
HRD+K+ NI + + DFG +K D +++ G+ Y+APE + ++K
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251
Query: 899 SDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQ 958
+D++S GV++ E+LT +P P ++ V K DP + ++
Sbjct: 252 ADMWSLGVILYELLTLHRPFKG--PSQREIMQQVLYGK----YDPF-----PCPVSSGMK 300
Query: 959 ALGVALLCVNASPDERPT---------MKDVAAMLKEI--------KHEREEYAK 996
AL LL N P RPT +K VA + ++I H+REE +
Sbjct: 301 ALLDPLLSKN--PALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILR 353
|
Length = 478 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 5e-11
Identities = 58/181 (32%), Positives = 86/181 (47%), Gaps = 52/181 (28%)
Query: 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKL------WPTTMAAANGCSDEKSG 753
+V+K L G G G VY A + + GE++A+KK+ W +E
Sbjct: 2 KVIKQL------GDGTFGSVYLARNKETGELVAIKKMKKKFYSW-----------EECMN 44
Query: 754 VRDSFSAEIKTLGSI-RHKNIVR----FLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTG 807
+R E+K+L + H NIV+ F N+ L +++YM G+L L+ +R G
Sbjct: 45 LR-----EVKSLRKLNEHPNIVKLKEVFR-----ENDELYFVFEYM-EGNLYQLMKDRKG 93
Query: 808 NAL-EWELR---YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863
E +R YQIL QGLA++H HRD+K N+L+ IADFGLA
Sbjct: 94 KPFSESVIRSIIYQIL----QGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLA 146
Query: 864 K 864
+
Sbjct: 147 R 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-11
Identities = 85/328 (25%), Positives = 136/328 (41%), Gaps = 76/328 (23%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IGKG G VY A D +A+KK+ S+ ++ F E K + H
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKI-------REDLSENPL-LKKRFLREAKIAADLIH 61
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMP---NGSLGSLLHE-RTGNALEWELRYQILLGA---- 822
IV C + + +Y MP +L SLL +L EL + +GA
Sbjct: 62 PGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 823 ----AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL------------V 866
+ Y+H ++HRD+K +NIL+GL E I D+G A V
Sbjct: 119 FHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 867 DDGDFARSSNT----VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI 922
D+ + SS T + G+ Y+APE + +E +D+Y+ GV++ ++LT P
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY---- 231
Query: 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPES-----EIDEMLQALGVALLCVNASPDERPTM 977
R+KKG ++ ++ P EI L +A+ + P ER
Sbjct: 232 ----------RRKKGRKISYRDVILSPIEVAPYREIPPFLSQ--IAMKALAVDPAER--- 276
Query: 978 KDVAAMLKEIKHEREEYAKVDMLLKGSP 1005
+ ++E+K + E + L+GSP
Sbjct: 277 ---YSSVQELKQDLEPH------LQGSP 295
|
Length = 932 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+G+G GVV + + E++A+KK S+E V+++ E+K L +++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKD---------SEENEEVKETTLRELKMLRTLK 58
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQGL 826
+NIV R L+++Y+ L LL E ++R YQ++ + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLI----KAI 113
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIA 886
+ H + IVHRDIK N+LI + DFG A+ + +G A + VA + Y +
Sbjct: 114 HWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRS 169
Query: 887 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920
PE + D++S G ++ E+ G QP+ P
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG-QPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 71/270 (26%), Positives = 109/270 (40%), Gaps = 73/270 (27%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG G GVV A D +G+ +A+KK+ A D + + + E+K L +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKI-----PHA---FDVPTLAKRTLR-ELKILRHFK 62
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLG-----------SLLHE--RTGNALEWEL-- 814
H NI+ P G+ S LH + L E
Sbjct: 63 HDNIIAIRDI------------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIR 110
Query: 815 --RYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFA 872
YQ+L +GL Y+H V +HRD+K +N+L+ + E I DFG+A+ +
Sbjct: 111 YFLYQLL----RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLS----- 158
Query: 873 RSSNTVAGSY--------GYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIP 923
SS T + Y APE + + T D++S G + E+L G++ + P
Sbjct: 159 -SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP--- 213
Query: 924 DGSHVVDWVRQKKGIQVLDPSLLSRPESEI 953
G + V Q K I S+L P E+
Sbjct: 214 -GKNYVH---QLKLIL----SVLGSPSEEV 235
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 36/223 (16%)
Query: 710 NVIGKGCSGVVYRADMDNGEV---IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
+VIG+G G V +A + + A+K++ A+ + D F+ E++ L
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRD--------FAGELEVLC 50
Query: 767 SI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER--------------TGNALE 811
+ H NI+ LG C +R L +Y P+G+L L + T + L
Sbjct: 51 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 110
Query: 812 WELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF 871
+ A+G+ YL +HRD+ A NIL+G + IADFGL++ G
Sbjct: 111 SQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQE 163
Query: 872 ARSSNTVAG-SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 913
T+ ++A E T SDV+SYGV++ E+++
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 1e-10
Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 46/223 (20%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR- 769
+GKG G+V++A D EV+A+KK++ A +D + R EI L +
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIF----DAFRNATDAQRTFR-----EIMFLQELGD 65
Query: 770 HKNIVRFLGCCWNRNNR--LLMYDYMPNGSLGSLLHE--RTGNALEWELRYQI--LLGAA 823
H NIV+ L N++ L+++YM + LH R + RY + LL A
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYME-----TDLHAVIRANILEDVHKRYIMYQLLKA- 119
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT----VA 879
L Y+H V +HRD+K +NIL+ + +ADFGLA+ + + + + VA
Sbjct: 120 --LKYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 880 GSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGK 915
+ Y APE Y T+ D++S G ++ E+L GK
Sbjct: 175 TRW-YRAPEILLGSTRY------TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 712 IGKGCSG-VVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G G + ++G+ +K++ S R+ E+ L +++H
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEI---------NISKMSPKEREESRKEVAVLSNMKH 58
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
NIV++ N ++ DY G L ++ + G + QIL Q L
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED---QILDWFVQICLALK 115
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG-DFARSSNTVAGSYGYIAPEY 889
H I+HRDIK+ NI + + + DFG+A++++ + AR T G+ Y++PE
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR---TCIGTPYYLSPEI 172
Query: 890 GYMMKITEKSDVYSYGVVVLEVLTGKQ 916
KSD+++ G V+ E+ T K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 36/287 (12%)
Query: 712 IGKGCSGVVYRADMDNGEVIA---VKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG G G V + G A VK+L A+A DE+ F E++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKEL----RASAT--PDEQ----LLFLQEVQPYREL 52
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSL-GSLLHERTGNALEWELRYQILLG--AAQG 825
H N+++ LG C LL+ ++ P G L L R A + + A G
Sbjct: 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
L +LH +H D+ N + + I D+GLA D+ + + A ++
Sbjct: 113 LLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169
Query: 886 APEYG-------YMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937
APE T+KS+++S GV + E+ T QP P + D V+ V +++
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSD-EQVLKQVVREQD 227
Query: 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
I++ P L + E++Q C P+ RPT ++V +L
Sbjct: 228 IKLPKPQLDLKYSDRWYEVMQ------FCW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 36/226 (15%)
Query: 706 LVDANVIGKGCSGVVYRADM---DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI 762
L D IG+G G V + M +G ++AVK++ T DEK R ++
Sbjct: 6 LKDLGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTV--------DEKEQKRLLMDLDV 55
Query: 763 KTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSL---LHERTGNALEWELRYQIL 819
+ S IV+F G + + + + M + SL ++E + + E+ +I
Sbjct: 56 -VMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIA 113
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA-KLVDDGDFARSSNTV 878
+ + L YL + I+HRD+K +NIL+ + DFG++ +LVD A++ +
Sbjct: 114 VATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS--IAKTRD-- 167
Query: 879 AGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEVLTGKQP 917
AG Y+APE GY ++ SDV+S G+ + EV TGK P
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVR----SDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR- 769
IGKG G V++ + NG AVK L P + + AE L ++
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPI------------HDIDEEIEAEYNILKALSD 73
Query: 770 HKNIVRFLGCCWNRNNR-----LLMYDYMPNGSLGSLLHE--RTGNALEWELRYQILLGA 822
H N+V+F G + ++ + L+ + GS+ L+ + G +E + IL A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
GL +LH + +HRD+K NNIL+ E + DFG++ + R NT G+
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTP 188
Query: 883 GYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937
++APE + DV+S G+ +E+ G P+ P +R
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--------MRALFK 240
Query: 938 IQVLDPSLLSRPE---SEIDEMLQALGVALLCVNASPDERPTMKDV 980
I P L +PE +E ++ ++ C+ ++RPT+ D+
Sbjct: 241 IPRNPPPTLHQPELWSNEFNDFIRK------CLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVK--KLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG G G VY+A +++ GE+ A+K KL P EI +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF-------------AVVQQEIIMMKDC 63
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
+H NIV + G R+ + ++ GSL + H TG E ++ Y + QGL Y
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAY-VSRETLQGLYY 121
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVA------GSY 882
LH +HRDIK NIL + D G KL D G A+ + T+A G+
Sbjct: 122 LHSKGK---MHRDIKGANIL--------LTDNGHVKLADFGVSAQITATIAKRKSFIGTP 170
Query: 883 GYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPI 918
++APE + + + D+++ G+ +E+ + P+
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
GL +LH I++RD+K +N+L+ + IADFG+ K +G+ ++T G+ Y
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDY 162
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
IAPE K E D +S+GV++ E+L G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G+G G V+ A D GE++A+K++ + + N E V E L + +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLN----EVRHV----LTERDILTTTKS 60
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQI--LLGAAQGLAY 828
+ +V+ L + L +Y+P G +LL+ G E R+ + + A L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHE 119
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
L +HRD+K N LI + DFGL+K +N+V GS Y+APE
Sbjct: 120 LG------YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPE 168
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD 924
D +S G ++ E L G P + P+
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN 204
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 33/82 (40%), Positives = 49/82 (59%)
Query: 229 LVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANA 288
L G IP +I L+ I+ S NS+ G IP S+G ++ LE +S N+ +GSIP +L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 289 TNLVQLQLDTNQISGLIPPEIG 310
T+L L L+ N +SG +P +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG G G VY+A D +G +A+K + T +G S VR+ A +K L + H
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQT--NEDGLP--LSTVREV--ALLKRLEAFDH 61
Query: 771 KNIVRFLGCCWN-RNNR----LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
NIVR + C R +R L+++++ + L + L + L E ++ +G
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
L +LH +C IVHRD+K NIL+ + +ADFGLA++ + V + Y
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYR 174
Query: 886 APEYGYMMKITEKSDVYSYGVVVLEVLTGK 915
APE D++S G + E+ K
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 43/254 (16%)
Query: 693 QKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKL---WPTTMAAANGCS 748
+++N +V ++ + +G G G V A D GE +A+KKL + + + A
Sbjct: 4 EEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFA----- 58
Query: 749 DEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDY---MPNGSLGSLLHER 805
K R E+ L ++H+N++ L + + D+ MP + + L +
Sbjct: 59 --KRAYR-----ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP--YMQTDLQKI 109
Query: 806 TGNALEWE----LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861
G+ L + L YQ+L GL Y+H I+HRD+K N+ + + E I DFG
Sbjct: 110 MGHPLSEDKVQYLVYQML----CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFG 162
Query: 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 920
LA+ D A + V + Y APE M + D++S G ++ E+LTGK
Sbjct: 163 LARHAD----AEMTGYVVTRW-YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK----- 212
Query: 921 TIPDGSHVVDWVRQ 934
T+ G +D + Q
Sbjct: 213 TLFKGKDYLDQLTQ 226
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-10
Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 47/227 (20%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G G+V A + + E +A+KK+ A + D K +R EIK L + H
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI----ANAFDNRIDAKRTLR-----EIKLLRHLDH 63
Query: 771 KNIVRFLGCCW-----NRNNRLLMYDYMPNGSLGSLLHE--RTGNALEWE----LRYQIL 819
+N++ N+ ++Y+ M LH+ R+ L + YQ+L
Sbjct: 64 ENVIAIKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD-GDFARSSNTV 878
+GL Y+H ++HRD+K +N+L+ + I DFGLA+ + GDF + V
Sbjct: 119 ----RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYV 169
Query: 879 AGSYGYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920
+ Y APE Y I DV+S G + E+L G++P+ P
Sbjct: 170 VTRW-YRAPELLLNCSEYTTAI----DVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 71/270 (26%), Positives = 127/270 (47%), Gaps = 37/270 (13%)
Query: 693 QKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEK 751
Q+LN ++ +V + + + +G G G V A D G +AVKKL + + K
Sbjct: 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA----K 61
Query: 752 SGVRDSFSAEIKTLGSIRHKNIVRFL-----GCCWNRNNRLLMYDYMPNGSLGSLL--HE 804
R E++ L ++H+N++ L N + + ++ L +++ +
Sbjct: 62 RTYR-----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 116
Query: 805 RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
T + +++ L YQIL +GL Y+H I+HRD+K +N+ + + E I DFGLA+
Sbjct: 117 LTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 168
Query: 865 LVDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 923
DD + VA + Y APE M + D++S G ++ E+LTG+ T+
Sbjct: 169 HTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-----TLF 218
Query: 924 DGSHVVDWVRQ-KKGIQVLDPSLLSRPESE 952
G+ +D ++ + + LL + SE
Sbjct: 219 PGTDHIDQLKLILRLVGTPGAELLKKISSE 248
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-10
Identities = 55/171 (32%), Positives = 79/171 (46%), Gaps = 35/171 (20%)
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS---SNTVAG 880
Q L +HH ++HRDIK+ NIL+ GL KL GDF S + TV+
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILL--------CSNGLVKL---GDFGFSKMYAATVSD 199
Query: 881 SYG--------YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932
G Y+APE ++K+D++S GV++ E+LT K+P DG ++ + V
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-----DGENMEE-V 253
Query: 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983
K DP P S EM Q + ALL + P RP+ + M
Sbjct: 254 MHKTLAGRYDP----LPPSISPEM-QEIVTALLS--SDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-10
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
GL +LH IV+RD+K +NIL+ + IADFG+ K GD A++ T G+ Y
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT-CTFCGTPDY 162
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
IAPE K D +S+GV++ E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 28/171 (16%)
Query: 823 AQGLAYL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
AQG+ +L +C+ HRD+ A N+L+ I DFGLA+ D SN V
Sbjct: 222 AQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272
Query: 882 YG-----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQK 935
++APE + T +SDV+SYG+++ E+ + GK P P I S V K
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY-PGILVNSKFYKMV--K 329
Query: 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
+G Q +SRP+ E+ + +C N P ERPT ++ +++
Sbjct: 330 RGYQ------MSRPDFAPPEIYS---IMKMCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 1/90 (1%)
Query: 53 LDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNI 112
L + L G +P+ + KL +L+ + L+ N + G IP L + SL L L N+ G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 113 PAELGRLSNLEEMRAGGNKDIVGKIPAELG 142
P LG+L++L + GN + G++PA LG
Sbjct: 483 PESLGQLTSLRILNLNGNS-LSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G +G+V A + +G +AVK + K R+ E+ + +H
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM-----------DLRKQQRRELLFNEVVIMRDYQH 77
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
+N+V ++ +++ G+L ++ + L E + Q L YLH
Sbjct: 78 QNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLH 134
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
V +HRDIK+++IL+ L+ ++DFG + D + + V Y ++APE
Sbjct: 135 SQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLVGTPY-WMAPEVI 189
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ D++S G++V+E++ G+ P
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 712 IGKGCSGVVYRA-DMDNG-EVIAVKKLWPTTMAAANGCSDEK---SGVRDSFSAEIKTLG 766
IG+G G V++A D+ NG +A+K++ T +E S +R+ A ++ L
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-------GEEGMPLSTIREV--AVLRHLE 59
Query: 767 SIRHKNIVRFLGCCW----NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGA 822
+ H N+VR C +R +L + + L + L + + E ++
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
+GL +LH V VHRD+K NIL+ + +ADFGLA++ F + +V +
Sbjct: 120 LRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 173
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 915
Y APE D++S G + E+ K
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 711 VIGKGCSGVVYRADMDNGE-VIAVKKL--WPTTMAAANGCSDEKSGVRDSFSAEIKTLGS 767
VIG+G G V + N + V A+K L W A C F E L +
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC----------FREERDVLVN 57
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQI--LLGAAQG 825
++ I + NN L+ DY G L +LL + E R+ + ++ A
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG-LAKLVDDGDFARSSNTVAGSYGY 884
+ LH+ VHRDIK +NIL+ + +ADFG KL++DG S+ G+ Y
Sbjct: 118 VHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSVAVGTPDY 169
Query: 885 IAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQP 917
I+PE M K + D +S GV + E+L G+ P
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 65/294 (22%), Positives = 123/294 (41%), Gaps = 44/294 (14%)
Query: 711 VIGKGCSGVVYRA----DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
++GKG G V A + + + +AVK L A SD + +R E +
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKML----KADIFSSSDIEEFLR-----EAACMK 56
Query: 767 SIRHKNIVRFLGCCWNRNNR------LLMYDYMPNGSLGS-LLHERTGN---ALEWELRY 816
H N+++ +G + +++ +M +G L + LL R G L +
Sbjct: 57 EFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116
Query: 817 QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSN 876
+ ++ A G+ YL +HRD+ A N ++ +ADFGL+K + GD+ R
Sbjct: 117 RFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 877 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG---SHVVDWVR 933
++A E T SDV+++GV + E++T Q + + ++++ R
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233
Query: 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
K+ L+ ++ E++ C + P RP+ + + L+ I
Sbjct: 234 LKQPPDCLE---------DVYELMCQ------CWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 711 VIGKGCSGVVYRADMDN-GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAE---IKTLG 766
V+G+G G V A+ GE+ A+K L + A DE +S E +T
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA----RDEV----ESLMCEKRIFETAN 57
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAA 823
S RH +V C ++ + +Y G L ++H T E + ++LG
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLG-- 113
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
L YLH + IV+RD+K +N+L+ E IADFGL K + F ++T G+
Sbjct: 114 --LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPE 166
Query: 884 YIAPEYGYMMKITEKS-----DVYSYGVVVLEVLTGKQP 917
++APE +TE S D + GV++ E+L G+ P
Sbjct: 167 FLAPEV-----LTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 51/225 (22%), Positives = 86/225 (38%), Gaps = 38/225 (16%)
Query: 711 VIGKGCSGV----VYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
+IGK + + + ++AVKK + + CS E EI T
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKK---INLDS---CSKEDL---KLLQQEIITSR 54
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGL 826
++H NI+ ++ + ++ M GS LL L IL L
Sbjct: 55 QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNAL 114
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG--------DFARSSNTV 878
Y+H +HR +KA++IL+ + + ++ + + DF +SS
Sbjct: 115 DYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 879 AGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+++PE GY EKSD+YS G+ E+ G P
Sbjct: 172 ---LPWLSPEVLQQNLQGY----NEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 51/161 (31%), Positives = 72/161 (44%), Gaps = 27/161 (16%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G GVVY+A D E IA+KK+ E GV + EI L ++H
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI---------RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR------YQILLGAAQ 824
NIVR + L+++Y+ L H + R YQIL +
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQIL----R 113
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPY-IADFGLAK 864
G+AY H ++HRD+K N+LI +ADFGLA+
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 66/247 (26%), Positives = 110/247 (44%), Gaps = 45/247 (18%)
Query: 693 QKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEK 751
+ F + IG+G G V++A +++A+KK+ M +EK
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV---LM------ENEK 51
Query: 752 SGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR---NNR-----LLMYDYMPNGSLGSLLH 803
G + EIK L ++H+N+V + C + NR L++++ + L LL
Sbjct: 52 EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS 110
Query: 804 ERTGNALEWELR--YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861
+ E++ ++LL GL Y+H + I+HRD+KA NILI + +ADFG
Sbjct: 111 NKNVKFTLSEIKKVMKMLL---NGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164
Query: 862 LAK---LVDDGDFARSSNTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEV 911
LA+ L + R +N V + Y PE YG D++ G ++ E+
Sbjct: 165 LARAFSLSKNSKPNRYTNRVVTLW-YRPPELLLGERDYG------PPIDMWGAGCIMAEM 217
Query: 912 LTGKQPI 918
T + PI
Sbjct: 218 WT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 712 IGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G +G+V A + +G+++AVKK+ K R+ E+ + +H
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM-----------DLRKQQRRELLFNEVVIMRDYQH 76
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
+N+V + ++ +++ G+L ++ T + E + L + L+ LH
Sbjct: 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLH 133
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
V +HRDIK+++IL+ + ++DFG V + R + V Y ++APE
Sbjct: 134 AQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPY-WMAPELI 188
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ + D++S G++V+E++ G+ P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 74/280 (26%), Positives = 105/280 (37%), Gaps = 75/280 (26%)
Query: 698 SVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKL---WPTTMAAANGCSDEKSG 753
S VLK + IG G G+V A D G+ +A+KKL + A K
Sbjct: 10 STFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHA-------KRA 62
Query: 754 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGS------------- 800
R E+ + + HKNI+ L + P SL
Sbjct: 63 YR-----ELVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDA 105
Query: 801 ---------LLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL 851
L HER L YQ+L G + +LH I+HRD+K +NI++
Sbjct: 106 NLCQVIQMDLDHERMSYLL-----YQMLCG----IKHLHS---AGIIHRDLKPSNIVVKS 153
Query: 852 EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 911
+ I DFGLA+ F + V Y Y APE M E D++S G ++ E+
Sbjct: 154 DCTLKILDFGLARTAGT-SFMMTPYVVT-RY-YRAPEVILGMGYKENVDIWSVGCIMGEM 210
Query: 912 LTGKQPIDPTIPDGSHVVDWVRQKKGIQVL---DPSLLSR 948
+ G P H+ W K I+ L +SR
Sbjct: 211 IRGTV----LFPGTDHIDQW---NKIIEQLGTPSDEFMSR 243
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 78/288 (27%), Positives = 125/288 (43%), Gaps = 21/288 (7%)
Query: 17 PTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEE 76
+ L +L +L + + N+T P L LD S N + +LPS L L NL+
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKN 167
Query: 77 LILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGK 136
L L+ N L+ +P LSN +L L L ++P E+ LS LEE+ N I +
Sbjct: 168 LDLSFNDLS-DLPKLLSNLSNLNNLDL-SGNKISDLPPEIELLSALEELDLSNNSII--E 223
Query: 137 IPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELV 196
+ + L + N++ L L++ ++ LP S+G LS L+TL + IS + +G+ + L
Sbjct: 224 LLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLR 280
Query: 197 SLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGT 256
L L NSLS ++P L LE L +L E+ + L + N
Sbjct: 281 ELDLSGNSLSNALPLIALLLLLLELLLNLLLTL---KALELKLNSILLNNNILSN----- 332
Query: 257 IPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGL 304
G S E I ++ + N + +NL + + G
Sbjct: 333 -----GETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIGS 375
|
Length = 394 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 39/277 (14%)
Query: 711 VIGKGCSGVV----YRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
V+GKG G V +R D G+ +KKL N E R + E + L
Sbjct: 7 VVGKGSYGEVSLVRHRTD---GKQYVIKKL-----NLRNASRRE----RKAAEQEAQLLS 54
Query: 767 SIRHKNIVRFLGCCWNRNNRLL--MYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
++H NIV + W + LL + + G L L E+ G L + + A
Sbjct: 55 QLKHPNIVAYRES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAM 113
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG-DFARSSNTVAGSYG 883
L YLH I+HRD+K N+ + + D G+A+++++ D A +T+ G+
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPY 167
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
Y++PE KSDV++ G V E+ T K + D + +V + + K P
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK--DMNSLVYRIIEGK-----LP 220
Query: 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ E+ E++ + ++ P++RP++K +
Sbjct: 221 PMPKDYSPELGELIATM------LSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 32/178 (17%)
Query: 816 YQILLGAAQGLAYL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS 874
YQ+ A+G+++L +C+ HRD+ A NIL+ I DFGLA+ D
Sbjct: 221 YQV----AKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLAR-----DIRND 267
Query: 875 SNTVAGSYG-----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHV 928
SN V ++APE + T +SDV+SYG+++ E+ + G P P +P S
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-PGMPVDSKF 326
Query: 929 VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
+ K+G ++L PE EM + C +A P +RPT K + ++++
Sbjct: 327 YKMI--KEGYRMLS------PECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLGSI 768
+G+G VY+ NG+++A+K + +M G F+A E L +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI---SMKTEEGVP---------FTAIREASLLKGL 60
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQG 825
+H NIV + +++YM + L + + G + +R +Q+L +G
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLL----RG 115
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
LAY+H I+HRD+K N+LI E +ADFGLA+ SS V + Y
Sbjct: 116 LAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYR 170
Query: 886 APEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDPTIPD 924
P+ ++ T+ S D++ G + +E+L G QP P + D
Sbjct: 171 PPD--VLLGATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G +G+V A + G+ +AVKK+ K R+ E+ + H
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM-----------DLRKQQRRELLFNEVVIMRDYHH 78
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
+N+V + ++ +++ G+L ++ T + E + L + L+YLH
Sbjct: 79 ENVVDMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLH 135
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
+ V +HRDIK+++IL+ + ++DFG V R S + G+ ++APE
Sbjct: 136 NQGV---IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVI 190
Query: 891 YMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ + D++S G++V+E++ G+ P
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 32/213 (15%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G +G+V A D G +AVKK+ K R+ E+ + +H
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-----------DLRKQQRRELLFNEVVIMRDYQH 75
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
NIV + ++ +++ G+L ++ T + E + L + L++LH
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLH 132
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE-- 888
V +HRDIK+++IL+ + ++DFG V + R + V Y ++APE
Sbjct: 133 AQGV---IHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPY-WMAPEVI 187
Query: 889 ----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
YG TE D++S G++V+E++ G+ P
Sbjct: 188 SRLPYG-----TE-VDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSNTVAGS 881
A GL +LH I++RD+K +N+++ E IADFG+ K + G R T G+
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR---TFCGT 164
Query: 882 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
YIAPE + D +++GV++ E+L G+ P D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-09
Identities = 30/79 (37%), Positives = 45/79 (56%)
Query: 279 GSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSN 338
G IP +++ +L + L N I G IPP +G ++ L V N GSIP +L ++
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 339 LQALDLSHNSLTASVPAGL 357
L+ L+L+ NSL+ VPA L
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 711 VIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+GKG G V A+ E+ A+K L + + + E + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--------ECTMVEKRVLALQD 58
Query: 770 HKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLH-ERTGNALEWELRYQILLGAAQ--- 824
+ L C+ +RL + +Y+ G L + H ++ G E Q + AA+
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKE----PQAVFYAAEISV 112
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK--LVDDGDFARSSNTVAGSY 882
GL +LH I++RD+K +N+++ E IADFG+ K +VD ++ T G+
Sbjct: 113 GLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD----GVTTRTFCGTP 165
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
YIAPE + D ++YGV++ E+L G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 20/172 (11%)
Query: 823 AQGLAYL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFARSSNTVAG 880
A+G+ +L C+ HRD+ A NIL+ I DFGLA+ + D D+ R +
Sbjct: 184 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 881 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQ 939
++APE + T +SDV+S+GV++ E+ + G P P + R K G +
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-PGVQINEEFCQ--RLKDGTR 295
Query: 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991
+ P + PE + L C P ERPT + +L ++ E
Sbjct: 296 MRAPENAT-PE--------IYRIMLACWQGDPKERPTFSALVEILGDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 8e-09
Identities = 86/310 (27%), Positives = 131/310 (42%), Gaps = 37/310 (11%)
Query: 53 LDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNI 112
LD + N L S L +L NL L L++N +T IP + K
Sbjct: 98 LDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLK---------------- 139
Query: 113 PAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQ 172
SNL+E+ NK + +P+ L + N+ L L+ +S LP L LS L
Sbjct: 140 -------SNLKELDLSDNK--IESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN 189
Query: 173 TLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGA 232
L + IS ++P EI S L L L NS+ + + LK L L L N+ +
Sbjct: 190 NLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLEL-SNNKLED 246
Query: 233 IPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLV 292
+PE IGN ++L+ +D S N +S S+G L+ L E +S N++S ++P L+
Sbjct: 247 LPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLI--ALLLLL 302
Query: 293 QLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTAS 352
L ++ L E+ + S L + E S P L+ +L L N+L S
Sbjct: 303 LELLLNLLLT-LKALELKLNSILLNNN-ILSNGETSSPEALSILESLNNLWTLDNALDES 360
Query: 353 VPAGLFQLQN 362
Sbjct: 361 NLNRYIVKNP 370
|
Length = 394 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-09
Identities = 38/131 (29%), Positives = 63/131 (48%), Gaps = 14/131 (10%)
Query: 825 GLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSNTVAGSY 882
GL +LH I++RD+K +N+L+ E IADFG+ K + G +++T G+
Sbjct: 108 GLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTFCGTP 160
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942
YIAPE D ++ GV++ E+L G+ P + D + + + +V
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE--GDDEDELFQSILED---EVRY 215
Query: 943 PSLLSRPESEI 953
P LS+ I
Sbjct: 216 PRWLSKEAKSI 226
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-09
Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
GL +LH I++RD+K +N+++ + IADFG+ K GD ++T G+ Y
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDY 162
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
IAPE +K T D +S+GV++ E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 79/279 (28%), Positives = 115/279 (41%), Gaps = 46/279 (16%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+GKG G VY+ G +A+K++ DE F+ I L I H
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--------DESK-----FNQIIMEL-DILH 54
Query: 771 K----NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHE--RTGNALEWELRYQILLGAAQ 824
K IV F G + + +YM GSL L T E LR +I +
Sbjct: 55 KAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVK 113
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS-SNTVAGSYG 883
GL +L + I+HRD+K N+L+ + + DFG++ G+ S + T G
Sbjct: 114 GLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQS 166
Query: 884 YIAPEY---GYMMKI---TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937
Y+APE G + T +SDV+S G+ +LE+ G+ P P + Q
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSA 221
Query: 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT 976
I DP L P D+ A C+N P+ RPT
Sbjct: 222 IVDGDPPTL--PSGYSDD---AQDFVAKCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 62/227 (27%), Positives = 92/227 (40%), Gaps = 47/227 (20%)
Query: 711 VIGKGCSGVVYRADMDNGEVIAVKKL---WPTTMAAANGCSDEKSGVRDSFSAEIKTLGS 767
VIG+G G V M + E I K+ W A C E+
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE---------------- 51
Query: 768 IRHKNIVRFLGCCW---------NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQI 818
+N++ C W + N L+ DY G L +LL + E R+ I
Sbjct: 52 ---RNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI 108
Query: 819 --LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG-LAKLVDDGDFARSS 875
++ A + LH+ VHRDIK +N+L+ + +ADFG K+ DG S
Sbjct: 109 AEMVLAIHSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV--QS 160
Query: 876 NTVAGSYGYIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQP 917
+ G+ YI+PE M K + D +S GV + E+L G+ P
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 66/257 (25%), Positives = 97/257 (37%), Gaps = 85/257 (33%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIG+G G V+ D D G+V A+K L + M ++ + VR AE L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK----RNQIAHVR----AERDILADAD 59
Query: 770 HKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRYQIL--------- 819
IV+ L + L L+ +YMP G L +LL +R +
Sbjct: 60 SPWIVK-LYYSFQDEEHLYLVMEYMPGGDLMNLL-----------IRKDVFPEETARFYI 107
Query: 820 ------LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFAR 873
L + L + +HRDIK +NILI + +ADFGL K ++
Sbjct: 108 AELVLALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158
Query: 874 S---------------------------SNTVAGSYGYIAPE------YGYMMKITEKSD 900
+N+ G+ YIAPE YG + D
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL------ECD 212
Query: 901 VYSYGVVVLEVLTGKQP 917
+S GV++ E+L G P
Sbjct: 213 WWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 15/155 (9%)
Query: 838 VHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFARSSNTVAGSYGYIAPEYGYMMKIT 896
+HRD+ A NIL+ I DFGLA+ + D D+ R + ++APE + T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPESIFDKVYT 253
Query: 897 EKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDE 955
+SDV+S+GV++ E+ + G P P ++ R+ K + + + PE E
Sbjct: 254 TQSDVWSFGVLLWEIFSLGASP----YPGVQIDEEFCRRLK-----EGTRMRAPEYATPE 304
Query: 956 MLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
+ + L C + +P++RPT ++ +L ++ E
Sbjct: 305 IYSIM---LDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 79/276 (28%), Positives = 126/276 (45%), Gaps = 49/276 (17%)
Query: 693 QKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKL---WPTTMAAANGCS 748
Q+LN +V +V + + +G G G V A D G +A+KKL + + + A
Sbjct: 4 QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA----- 58
Query: 749 DEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC---CWNRNNRLLMYDYMP--NGSLGSLLH 803
K R E++ L + H+N++ L + + +Y L +++
Sbjct: 59 --KRTYR-----ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK 111
Query: 804 ER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861
+ + + +++ L YQIL +GL Y+H I+HRD+K +NI + + E I DFG
Sbjct: 112 CQKLSDDHIQF-LVYQIL----RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFG 163
Query: 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDP 920
LA+ DD + VA + Y APE M + D++S G ++ E+LTGK
Sbjct: 164 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK----T 214
Query: 921 TIPDGSHVVDWVRQKKGIQVL----DPSLLSRPESE 952
P GS D + Q K I L D LL + SE
Sbjct: 215 LFP-GS---DHIDQLKRIMNLVGTPDEELLQKISSE 246
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 29/81 (35%), Positives = 43/81 (53%)
Query: 253 LSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGML 312
L G IP I L L+ +S N++ G+IP +L + T+L L L N +G IP +G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 313 SKLTVFFAWQNQLEGSIPSTL 333
+ L + N L G +P+ L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 39/297 (13%)
Query: 696 NFSVEQVLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGV 754
NF +E+ IG+G VYRA + +G +A+KK+ + A
Sbjct: 3 NFRIEKK---------IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKA-------- 45
Query: 755 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL-HERTGNALEWE 813
R EI L + H N++++ N ++ + G L ++ H + L E
Sbjct: 46 RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE 105
Query: 814 ---LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870
+Y + L +A L ++H ++HRDIK N+ I + D GL +
Sbjct: 106 KTVWKYFVQLCSA--LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160
Query: 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930
A ++++ G+ Y++PE + KSD++S G ++ E+ + P G +
Sbjct: 161 TA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNL 213
Query: 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+ KK Q P L P E L+ L +C+N P++RP + V + K +
Sbjct: 214 YSLCKKIEQCDYPPL---PSDHYSEELRQL--VNMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 21/113 (18%)
Query: 817 QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA-KLVDDGDFARSS 875
+I + + L YLH ++HRD+K +N+LI + + DFG++ LVD +
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-----VA 159
Query: 876 NTV-AGSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
T+ AG Y+APE GY + KSDV+S G+ ++E+ TG+ P D
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+ IG+G G+V A G +A+KK+ P E EIK L
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPF----------EHQTFCQRTLREIKILRRF 60
Query: 769 RHKNIVRFL-----GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
+H+NI+ L + N+ ++ + M + + N YQIL
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL---- 116
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT------ 877
+GL Y+H V +HRD+K +N+L+ + I DFGLA++ D +T
Sbjct: 117 RGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIAD----PEHDHTGFLTEY 169
Query: 878 VAGSYGYIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDP 920
VA + Y APE K K+ D++S G ++ E+L+ + P+ P
Sbjct: 170 VATRW-YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFP 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 58/239 (24%), Positives = 113/239 (47%), Gaps = 25/239 (10%)
Query: 758 FSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSL-GSLLHERTGNALEWELR- 815
F E + S++H N+++ LG C LL+ ++ P G L G L R + +
Sbjct: 42 FLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT 101
Query: 816 -YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS 874
++ A GL +LH + +H D+ N L+ + I D+GL+ D+ +
Sbjct: 102 LQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158
Query: 875 SNTVAGSYGYIAPE-----YGYMMKI--TEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGS 926
+ + +IAPE +G ++ + T++S+V+S GV + E+ G QP + D
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY-RHLSD-E 216
Query: 927 HVVDWVRQKKGIQVLDPSLLSRPESEI-DEMLQALGVALLCVNASPDERPTMKDVAAML 984
V+ + +++ +++ P L P S+ E++Q + P++RP+ ++V +L
Sbjct: 217 QVLTYTVREQQLKLPKP-RLKLPLSDRWYEVMQFCWL-------QPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 68/288 (23%), Positives = 122/288 (42%), Gaps = 42/288 (14%)
Query: 712 IGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G VYRA + + + +A+KK+ M A R EI L + H
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKA--------RQDCVKEIDLLKQLNH 61
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGS----------LLHERTGNALEWELRYQILL 820
N++++L N ++ + G L L+ ERT W +Y + L
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT----VW--KYFVQL 115
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
+A + ++H ++HRDIK N+ I + D GL + A ++++ G
Sbjct: 116 CSA--VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVG 168
Query: 881 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940
+ Y++PE + KSD++S G ++ E+ + P D ++ ++ + Q
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLFSLCQKIE--QC 223
Query: 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988
P L P E L+ L +C+ PD+RP + V + K++
Sbjct: 224 DYPPL---PTEHYSEKLREL--VSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G GVVY+ + G+++A+KK+ E+ GV + EI L ++H
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI---------RLESEEEGVPSTAIREISLLKELQH 58
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWEL----RYQILLGAAQGL 826
NIV + L+++++ L G ++ EL YQIL QG+
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGI 114
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
+ H V +HRD+K N+LI + +ADFGLA+
Sbjct: 115 LFCHSRRV---LHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 63/240 (26%), Positives = 99/240 (41%), Gaps = 62/240 (25%)
Query: 707 VDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+D +G G +G+V+ A D D + +AVKK+ T K +R EIK +
Sbjct: 8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD------PQSVKHALR-----EIKII 56
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT----GNALEWELR------ 815
+ H NIV+ + L +GSL + +E +L
Sbjct: 57 RRLDHDNIVKVYEVLGPSGSDL-------TEDVGSLTELNSVYIVQEYMETDLANVLEQG 109
Query: 816 -----------YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE-FEPYIADFGLA 863
YQ+L +GL Y+H V +HRD+K N+ I E I DFGLA
Sbjct: 110 PLSEEHARLFMYQLL----RGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLA 162
Query: 864 KLVDDGDFARS---SNTVAGSYGYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTGK 915
++VD ++ S + + Y +P Y T+ D+++ G + E+LTGK
Sbjct: 163 RIVDP-HYSHKGYLSEGLVTKW-YRSPRLLLSPNNY----TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 711 VIGKGCSGVVY--RADM--DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKT 764
V+G+G G V+ R D G++ A+K L T+ VRD E
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-----------VRDRVRTKMERDI 51
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
L + H IV+ L+ D++ G L + L + E ++++ L A
Sbjct: 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKF-YLAELAL 109
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
L +LH I++RD+K NIL+ E + DFGL+K D + + + + G+ Y
Sbjct: 110 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEY 164
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+APE T+ +D +S+GV++ E+LTG P
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 752 SGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALE 811
S V DS E L ++H NIV F + ++ +Y G L + + G
Sbjct: 40 SAVEDS-RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFP 98
Query: 812 WELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD-GD 870
+ Q + G+ ++H V +HRDIK+ NI + + + DFG A+L+ G
Sbjct: 99 EDTILQWFVQMCLGVQHIHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155
Query: 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+A T G+ Y+ PE M KSD++S G ++ E+ T K P
Sbjct: 156 YA---CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 70/256 (27%), Positives = 105/256 (41%), Gaps = 43/256 (16%)
Query: 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA 760
VLK IG G G+V A D G +AVKKL + K R
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL----SRPFQNQTHAKRAYR----- 69
Query: 761 EIKTLGSIRHKNIVRFLGCCWNR------NNRLLMYDYMPNGSLGSLLHERTGNALEWEL 814
E+ L + HKNI+ L + + L+ + M + +L ++H + L
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYL 128
Query: 815 RYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS 874
YQ+L G + +LH I+HRD+K +NI++ + I DFGLA+
Sbjct: 129 LYQMLCG----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-------C 174
Query: 875 SNTVAGSY----GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930
+N + Y Y APE M E D++S G ++ E++ G T H+
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT----DHIDQ 230
Query: 931 WVRQKKGIQVL-DPSL 945
W K I+ L PS
Sbjct: 231 W---NKVIEQLGTPSA 243
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-08
Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 510 LDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGN 569
L L + L G +P ++ ++ L+ ++NLS N + G IP + ++ L +LDLS+N G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 570 L-NPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPT--DLAGNEGLC 614
+ L QL +L LN++ N +G +P R L + N GLC
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529
|
Length = 623 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-08
Identities = 39/130 (30%), Positives = 56/130 (43%), Gaps = 21/130 (16%)
Query: 817 QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSS 875
QIL +GL YLH I+HRD+K NI I + I D G A+ V F
Sbjct: 165 QIL----EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--- 214
Query: 876 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT---------GKQPIDPTIPDGS 926
+AG+ APE K K+D++S G+V+ E+L P + S
Sbjct: 215 -GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273
Query: 927 HVVDWVRQKK 936
H++ + K
Sbjct: 274 HLLKIISTLK 283
|
Length = 357 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 24/167 (14%)
Query: 823 AQGLAYL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFARSSNTVAG 880
A+G+ +L C+ HRD+ A NIL+ I DFGLA+ + D D+ R +
Sbjct: 189 AKGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 881 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWV--RQKKG 937
++APE + T +SDV+S+GV++ E+ + G P G + + R K+G
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEG 298
Query: 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
+ + P+ EM Q + L C + P +RPT ++ L
Sbjct: 299 TR------MRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 7e-08
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 712 IGKGCSGVVYR-ADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG G GVV+ D +G+ +A+KK+ P C K R E+K L +H
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSC---KRVFR-----ELKMLCFFKH 58
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHE--RTGNALEWE----LRYQILLGAAQ 824
N++ L + Y+ + S LH+ + L + YQIL +
Sbjct: 59 DNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL----R 114
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
GL YLH I+HRDIK N+L+ I DFGLA++ + + + V Y Y
Sbjct: 115 GLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 885 IAPEYGYMM---KITEKSDVYSYGVVVLEVLTGK 915
APE +M T D++S G + E+L +
Sbjct: 171 RAPE--ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 712 IGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGV-RDSFSAEIKTLGSIR 769
IG G G VY+ G V+AVK++ G +E + D ++ L S
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM------RRTGNKEENKRILMD---LDV-VLKSHD 72
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
IV+ G ++ + + M + L +R + ++ ++ + + L YL
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL 130
Query: 830 --HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA-KLVDDGDFARSSNTVAGSYGYIA 886
H ++HRD+K +NIL+ + DFG++ +LVD RS AG Y+A
Sbjct: 131 KEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS----AGCAAYMA 182
Query: 887 PEYGYMMKITEK---------SDVYSYGVVVLEVLTGKQP 917
PE +I +DV+S G+ ++E+ TG+ P
Sbjct: 183 PE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-07
Identities = 64/233 (27%), Positives = 111/233 (47%), Gaps = 33/233 (14%)
Query: 693 QKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEK 751
Q+LN +V +V + + +G G G V A D + +AVKKL + +
Sbjct: 4 QELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA----- 58
Query: 752 SGVRDSFSAEIKTLGSIRHKNIVRFL------GCCWNRNNRLLMYDYMPNGSLGSLL--H 803
R ++ E++ L ++H+N++ L N N L+ + M L +++
Sbjct: 59 ---RRTYR-ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ 113
Query: 804 ERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863
+ + +++ L YQ+L +GL Y+H I+HRD+K +N+ + + E I DFGLA
Sbjct: 114 KLSDEHVQF-LIYQLL----RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA 165
Query: 864 KLVDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 915
+ DD + VA + Y APE M + D++S G ++ E+L GK
Sbjct: 166 RQADD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 712 IGKGCSGVVYRA---DMDNGEVIAVKKLWPTTMAAANGCSDE---KSGVRDSFSAEIKTL 765
+G+G G+V A + E +A+KK+ N S + K +R E+K L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI-------TNVFSKKILAKRALR-----ELKLL 55
Query: 766 GSIR-HKNIVRF--LGCCWNRN-NRLLMYDYMPNGSLGSLLH--ERTGNALEWELRYQIL 819
R HKNI + + N N L +Y+ + L ++ + +A YQIL
Sbjct: 56 RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS---SN 876
G L Y+H V +HRD+K N+L+ + E I DFGLA+ + + +
Sbjct: 116 CG----LKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE 168
Query: 877 TVAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGK 915
VA + Y APE M+ + DV+S G ++ E+L K
Sbjct: 169 YVATRW-YRAPE--IMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 711 VIGKGCSGVVY----RADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
V+G G G V+ D G++ A+K L T+ +K+ + E + L
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV-------QKAKTAEHTRTERQVLE 59
Query: 767 SIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGA 822
++R + L + + +L L+ DY+ G L + L++R + E E+R +I+L
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLA- 117
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
L +LH I++RDIK NIL+ E + DFGL+K + R + + G+
Sbjct: 118 ---LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTI 170
Query: 883 GYIAPEY------GYMMKITEKSDVYSYGVVVLEVLTGKQP 917
Y+APE G+ + D +S GV+ E+LTG P
Sbjct: 171 EYMAPEVIRGGSGGH----DKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 41/218 (18%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G+G VY+ + GE++A+K++ D + G + EI + ++H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH----------LDAEEGTPSTAIREISLMKELKH 57
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPN---------GSLGSLLHERTGNALEWELRYQILLG 821
+NIVR N +L+++YM G G+L + YQ+L
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKS-----FTYQLL-- 110
Query: 822 AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG- 880
+G+A+ H + ++HRD+K N+LI E +ADFGLA+ F NT +
Sbjct: 111 --KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR-----AFGIPVNTFSNE 160
Query: 881 --SYGYIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGK 915
+ Y AP+ + S D++S G ++ E++TG+
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 711 VIGKGCSGVVYR----ADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
V+G G G V+ + D+G++ A+K L T+ +K+ + E + L
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV-------QKAKTTEHTRTERQVLE 59
Query: 767 SIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGA-AQ 824
IR + L + + +L L+ DY+ G L + L +R E QI G
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVL 116
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
L +LH I++RDIK NIL+ + DFGL+K + + R+ + G+ Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEY 172
Query: 885 IAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+AP+ G + D +S GV++ E+LTG P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 26/85 (30%), Positives = 47/85 (55%)
Query: 130 NKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI 189
N+ + G IP ++ ++ ++ L+ + G++P SLG ++ L+ L + +G IP +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 190 GNCSELVSLFLYENSLSGSIPPEIG 214
G + L L L NSLSG +P +G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 26/63 (41%), Positives = 36/63 (57%), Gaps = 1/63 (1%)
Query: 534 ALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP-LAQLDNLVSLNISYNKFTGY 592
L L GL G IP IS L L ++LS N + GN+ P L + +L L++SYN F G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 593 LPD 595
+P+
Sbjct: 482 IPE 484
|
Length = 623 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 37/272 (13%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
++G G G VY+A + ++AVK + P D ++ +E++ L
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVI-PL---------DITVELQKQIMSELEILYKC 56
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSL---GSLLHERTGNALEWELRYQILLGAAQG 825
I+ F G + N + ++M GSL + G +I + +G
Sbjct: 57 DSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG---------RIAVAVVKG 107
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA-KLVDDGDFARSSNTVAGSYGY 884
L YL I+HRD+K +N+L+ + + DFG++ +LV+ + T G+ Y
Sbjct: 108 LTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-----IAKTYVGTNAY 159
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944
+APE + SDV+S G+ +E+ G+ P P I + ++ + I DP
Sbjct: 160 MAPERISGEQYGIHSDVWSLGISFMELALGRFPY-PQIQKNQGSLMPLQLLQCIVDEDPP 218
Query: 945 LLSRPESEIDEMLQALGVALLCVNASPDERPT 976
+L P + E + C+ P ERP
Sbjct: 219 VL--PVGQFSEKF--VHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 3e-07
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 24/155 (15%)
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
+ N ++ +L+ DY+ +G L LL L +I+ + L L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK--KEGKLSEAEVKKIIRQLVEALNDL 125
Query: 830 H-HDCVPPIVHRDIKANNILI-GLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
H H+ I+H DIK N+L + Y+ D+GL K++ + + G+ Y +P
Sbjct: 126 HKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TPSCYDGTLDYFSP 175
Query: 888 EYGYMMKITEKS-----DVYSYGVVVLEVLTGKQP 917
E KI + D ++ GV+ E+LTGK P
Sbjct: 176 E-----KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
GL LH + V+RD+K NIL+ I+D GLA + +G+ R G+ GY
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGY 167
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+APE + T D + G ++ E++ G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 49/140 (35%), Positives = 72/140 (51%), Gaps = 26/140 (18%)
Query: 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQI--LLGAAQGLAYLH-HDCVPPIVHRDIKA 844
L+ DYM G L L ++ G E ++ I L+ A L +LH +D IV+RD+K
Sbjct: 73 LVTDYMSGGELFWHL-QKEGRFSEDRAKFYIAELVLA---LEHLHKYD----IVYRDLKP 124
Query: 845 NNILIGLEFEPYIADFGLAK--LVDDGDFARSSNTVAGSYGYIAPEY-----GYMMKITE 897
NIL+ + DFGL+K L D+ +++NT G+ Y+APE GY T+
Sbjct: 125 ENILLDATGHIALCDFGLSKANLTDN----KTTNTFCGTTEYLAPEVLLDEKGY----TK 176
Query: 898 KSDVYSYGVVVLEVLTGKQP 917
D +S GV+V E+ G P
Sbjct: 177 HVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSNTVAGS 881
A GL +LH I++RD+K +N+++ E IADFG+ K + DG ++ T G+
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGT 164
Query: 882 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
YIAPE + D +++GV++ E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 711 VIGKGCSGVVYRADMDN-GEVIAVKKL--WPTTMAAANGCSDEKSGVRDSFSAEIKTLGS 767
VIG+G G V M N G+V A+K L W A C F E L +
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC----------FREERDVLVN 57
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWEL-RYQI--LLGAAQ 824
+ I + NN L+ DY G L +LL + + L ++ R+ + ++ A
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVLAID 116
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG-LAKLVDDGDFARSSNTVAGSYG 883
+ L + VHRDIK +N+L+ +ADFG +L+ DG SN G+
Sbjct: 117 SVHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ--SNVAVGTPD 168
Query: 884 YIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQP 917
YI+PE M + + D +S GV + E+L G+ P
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 45/175 (25%), Positives = 89/175 (50%), Gaps = 24/175 (13%)
Query: 816 YQILLGAAQGLAYL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFAR 873
YQ+ A+G+ +L +CV HRD+ A N+L+ I DFGLA+ ++ D ++
Sbjct: 244 YQV----ARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 874 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWV 932
+T ++APE + T SDV+SYG+++ E+ + G P I D + +
Sbjct: 296 KGSTFL-PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---YN 351
Query: 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+ K G + +++P+ E+ + + C N+ P++RP+ ++ +++ +
Sbjct: 352 KIKSGYR------MAKPDHATQEVYD---IMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+GKG G V A + ++G + AVK L + + V + + E + L R
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-------QDDDVECTMT-EKRILSLAR 53
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL-HERTGNALEWELRYQILLGAAQ---G 825
+ + L CC+ +RL NG G L+ H + + E R + AA+
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNG--GDLMFHIQKSRRFD-EARARFY--AAEITSA 108
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGY 884
L +LH I++RD+K +N+L+ E +ADFG+ K +G F ++++T G+ Y
Sbjct: 109 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDY 162
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
IAPE M D ++ GV++ E+L G P +
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 8e-07
Identities = 23/60 (38%), Positives = 27/60 (45%)
Query: 49 GLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNAL 108
L LD S+N L + L NL+ L L+ N LT P S SLR L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 67/276 (24%), Positives = 105/276 (38%), Gaps = 65/276 (23%)
Query: 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
V +G G G V A +D + A+K L + N + K AE
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVK--------AERDI 54
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQI--LLGA 822
L ++ +VR +++N + DY+P G + SLL R G E R+ I L A
Sbjct: 55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL-IRMGIFPEDLARFYIAELTCA 113
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL---------AKLVDDGDFAR 873
+ + + +HRDIK +NILI + + DFGL +K GD R
Sbjct: 114 VESVHKMG------FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVR 167
Query: 874 S------------------------------------SNTVAGSYGYIAPEYGYMMKITE 897
++++ G+ YIAPE T+
Sbjct: 168 QDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227
Query: 898 KSDVYSYGVVVLEVLTGKQPIDPTIPDGSH--VVDW 931
D +S GV++ E+L G+ P P + V++W
Sbjct: 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 9e-07
Identities = 80/328 (24%), Positives = 120/328 (36%), Gaps = 115/328 (35%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR- 769
IG+G V +A G+ A+K + KS + + EI+ L +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM----------KKHFKSLEQVNNLREIQALRRLSP 56
Query: 770 HKNIVRFLGCCWNR-NNRL-----LM----YDYMPNGSLGSLLHERTGNALEWELRYQIL 819
H NI+R + ++R RL LM Y+ + G L +R + + YQ+L
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYELI-KGRKRPLPEKRVKSYM-----YQLL 110
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVA 879
L ++H + I HRDIK NILI + KL D G +
Sbjct: 111 KS----LDHMHRN---GIFHRDIKPENILI---------KDDILKLADFG-------SCR 147
Query: 880 GSYG------YI------APE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920
G Y YI APE YG M D+++ G V E+L+ + P
Sbjct: 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKM------DIWAVGCVFFEILS----LFP 197
Query: 921 TIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEML-------------QALGVALLCV 967
P G++ +D Q I +L P++E+ + + G+ L
Sbjct: 198 LFP-GTNELD---QIAKIH----DVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLP 249
Query: 968 NAS--------------PDERPTMKDVA 981
NAS PDER T K
Sbjct: 250 NASAEGLDLLKKLLAYDPDERITAKQAL 277
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 45/136 (33%), Positives = 69/136 (50%), Gaps = 17/136 (12%)
Query: 795 NGSLGSLLH--ERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852
NG G L H +R G R+ A+ L L + +++RD+K NIL L+
Sbjct: 76 NG--GELFHHLQREGRFDLSRARFYT----AELLCALENLHKFNVIYRDLKPENIL--LD 127
Query: 853 FEPYIA--DFGLAKL-VDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVL 909
++ +IA DFGL KL + D D +NT G+ Y+APE T+ D ++ GV++
Sbjct: 128 YQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLY 184
Query: 910 EVLTGKQPI-DPTIPD 924
E+LTG P D + +
Sbjct: 185 EMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 47/140 (33%), Positives = 69/140 (49%), Gaps = 24/140 (17%)
Query: 792 YMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL 851
+M GS SLL + L IL GA +GL YLH + +HR+IKA++ILI
Sbjct: 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISG 136
Query: 852 EFEPYIADFG-LAKLVDDG-------DFARSSNTVAGSYGYIAPE------YGYMMKITE 897
+ ++ L LV +G DF + S +V +++PE YGY +
Sbjct: 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYGYNV---- 189
Query: 898 KSDVYSYGVVVLEVLTGKQP 917
KSD+YS G+ E+ TG+ P
Sbjct: 190 KSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 822 AAQ---GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTV 878
AA+ GL LH + IV+RD+K NIL+ I+D GLA + +G+ R
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR--- 161
Query: 879 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G+ GY+APE + T D + G ++ E++ GK P
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 50/232 (21%)
Query: 712 IGKGCSGVVYRADMDNGE---VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+G G VY+A +G+ A+K++ E +G+ S EI L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI-------------EGTGISMSACREIALLREL 55
Query: 769 RHKNIVRFLGCCWNRNNR--LLMYDYMPNGSLGSLLHERTGNA----------LEWELRY 816
+H N++ + ++R L++DY + + R A + L Y
Sbjct: 56 KHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLY 115
Query: 817 QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY----IADFGLAKLVDD---- 868
QIL G+ YLH + V +HRD+K NIL+ E IAD G A+L +
Sbjct: 116 QIL----DGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 869 -GDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPI 918
D + V ++ Y APE + T+ D+++ G + E+LT +PI
Sbjct: 169 LADL----DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 711 VIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
V+GKG G V++ D G++ A+K L T+ ++K AE L
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-----RNQKDTAHTK--AERNILE 55
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAA 823
+++H IV + L+ +Y+ G L L ER G +E + +I L
Sbjct: 56 AVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACFYLSEISLA-- 112
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFARSSNTVAGSY 882
L +LH I++RD+K NIL+ + + DFGL K + +G ++T G+
Sbjct: 113 --LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV---THTFCGTI 164
Query: 883 GYIAPEYGYMMKITEKS------DVYSYGVVVLEVLTGKQP 917
Y+APE I +S D +S G ++ ++LTG P
Sbjct: 165 EYMAPE------ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 71/264 (26%), Positives = 115/264 (43%), Gaps = 39/264 (14%)
Query: 711 VIGKGCSGVVYR----ADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
V+G G G V+ D G++ A+K L + +K+ + E L
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-------QKAKTVEHTRTERNVLE 59
Query: 767 SIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGA 822
+R + L + +L L+ DY+ G + + L++R N E E+R+ +I+L
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILA- 117
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
L +LH IV+RDIK NIL+ E + DFGL+K + R+ + G+
Sbjct: 118 ---LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY-SFCGTI 170
Query: 883 GYIAPEYGYMMKITEKS------DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936
Y+APE I K D +S G+++ E+LTG P T+ + V ++
Sbjct: 171 EYMAPEI-----IRGKGGHGKAVDWWSLGILIFELLTGASPF--TLEGERNTQSEVSRR- 222
Query: 937 GIQVLDPSLLSRPESEIDEMLQAL 960
I DP S E ++L L
Sbjct: 223 -ILKCDPPFPSFIGPEAQDLLHKL 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 51/156 (32%), Positives = 78/156 (50%), Gaps = 26/156 (16%)
Query: 814 LRYQILLG----AAQGLAYL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868
L Y L+G A G+ +L +CV HRD+ A N+LI I DFGLA+
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLAR---- 287
Query: 869 GDFARSSNTVA-GS----YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 922
D R SN ++ GS ++APE + T SDV+S+G+++ E+ T G P P +
Sbjct: 288 -DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY-PEL 345
Query: 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQ 958
P + + K+G ++ P+ S EI E++Q
Sbjct: 346 PMNEQFYNAI--KRGYRMAKPAHAS---DEIYEIMQ 376
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 43/142 (30%), Positives = 64/142 (45%), Gaps = 11/142 (7%)
Query: 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRD 841
+++N L+ +Y P G L SLL+ E ++ + A+ + +H VHRD
Sbjct: 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYL----AELVLAIHSVHQMGYVHRD 127
Query: 842 IKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKS-- 899
IK N+LI +ADFG A + S V G+ YIAPE M K
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDGKGTY 186
Query: 900 ----DVYSYGVVVLEVLTGKQP 917
D +S GV+ E++ G+ P
Sbjct: 187 GVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 50/232 (21%)
Query: 712 IGKGCSGVVYRADMDNGEV---IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+G G VY+A +G+ A+K++ E +G+ S EI L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI-------------EGTGISMSACREIALLREL 55
Query: 769 RHKNIVRFLGCCWNRNNR--LLMYDYMPNGSLGSLLHERTGNA----------LEWELRY 816
+H N++ + +R L++DY + + R A + L Y
Sbjct: 56 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 115
Query: 817 QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY----IADFGLAKLVDD---- 868
QIL G+ YLH + V +HRD+K NIL+ E IAD G A+L +
Sbjct: 116 QIL----DGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 869 -GDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPI 918
D + V ++ Y APE + T+ D+++ G + E+LT +PI
Sbjct: 169 LADL----DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 27/225 (12%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSG-VRDSFSA--EIKTL 765
+G+G G V +A D G+++A+KK+ ++ + G F+ E+K +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
I+H+NI+ + + L+ D M L ++ + L ILL G
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKI--RLTESQVKCILLQILNG 131
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA----------KLVDDGDFARSS 875
L LH +HRD+ NI I + IADFGLA L D R
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 876 NTVAG--SYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGK 915
+ + Y APE +M K D++S G + E+LTGK
Sbjct: 189 EMTSKVVTLWYRAPE--LLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 30/155 (19%)
Query: 777 LGCCWNRNNRL-LMYDYMPNGSLGSLLH-ERTGNALEWELRY---QILLGAAQGLAYLHH 831
L C+ +RL + +++ G L + H +R E R+ +I L L +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLA----LNFLHE 114
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSNTVAGSYGYIAPE-- 888
I++RD+K +N+L+ E + D+G+ K + GD +++T G+ YIAPE
Sbjct: 115 R---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEIL 168
Query: 889 ----YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
YG+ + D ++ GV++ E++ G+ P D
Sbjct: 169 RGEDYGFSV------DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 52/235 (22%), Positives = 92/235 (39%), Gaps = 38/235 (16%)
Query: 757 SFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLH-ERTGNALEWELR 815
+F + + HK++V+ G C N ++ +Y+ G L LH E+ +L W+L
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCVRDENIMVE-EYVKFGPLDVFLHREKNNVSLHWKL- 104
Query: 816 YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI---GLEFEPYIADFGLAKLVDDGDFA 872
+ A L YL +VH ++ NIL+ GL KL D G
Sbjct: 105 -DVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP----FIKLSDPG-IP 155
Query: 873 RSSNTVA---GSYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGS 926
+ + +IAPE +T +D +S+G +LE+ + G++P+
Sbjct: 156 ITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS------- 208
Query: 927 HVVDWVRQKKGIQVLDPSLLSRPES-EIDEMLQALGVALLCVNASPDERPTMKDV 980
+K D L P+ E+ ++ C P +RP+ + +
Sbjct: 209 ---TLSSSEKERFYQDQHRLPMPDCAELANLINQ------CWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 67/276 (24%), Positives = 108/276 (39%), Gaps = 65/276 (23%)
Query: 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
V +G G G V A +D + A+K L + N + K AE
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVK--------AERDI 54
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQI--LLGA 822
L ++ +V+ +++N + DY+P G + SLL R E R+ I L A
Sbjct: 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-IRMEVFPEVLARFYIAELTLA 113
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL-------------------- 862
+ + + +HRDIK +NILI L+ + DFGL
Sbjct: 114 IESVHKMG------FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIR 167
Query: 863 ------AKLVDD------GDFARS-------------SNTVAGSYGYIAPEYGYMMKITE 897
+ L DD GD ++ ++++ G+ YIAPE T+
Sbjct: 168 QDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227
Query: 898 KSDVYSYGVVVLEVLTGKQPIDPTIPDGSH--VVDW 931
D +S GV++ E+L G+ P P + V++W
Sbjct: 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 3e-06
Identities = 73/277 (26%), Positives = 115/277 (41%), Gaps = 48/277 (17%)
Query: 239 NCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDT 298
N T L++ L ++ IP I L I DNN S+P NL N+ L ++
Sbjct: 179 NKTELRLKILGLTTIPACIPEQITTL-------ILDNNELKSLPENLQ--GNIKTLYANS 229
Query: 299 NQISGL---IPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPA 355
NQ++ + +P I + + E +P L S LQ+LDL HN ++ +P
Sbjct: 230 NQLTSIPATLPDTIQEME-----LSINRITE--LPERLPSA--LQSLDLFHNKISC-LPE 279
Query: 356 GLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLD 415
L + L L + N I ++P + S + L V +N + L GLKTL +
Sbjct: 280 NL--PEELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLPPGLKTLEAGE 334
Query: 416 LSSNRLSGSVPDEIGDCT---------------ELQMIDLSHNTLQGSLPNSLSSLSGLQ 460
+ L S+P E+ + +D+S N L +LP +L + LQ
Sbjct: 335 NALTSLPASLPPELQVLDVSKNQITVLPETLPPTITTLDVSRNALT-NLPENLP--AALQ 391
Query: 461 VLDVSDN---RFSGQIPASLGRLVSLNKIILSKNLFS 494
++ S N R +P G +II+ N FS
Sbjct: 392 IMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS 428
|
Length = 754 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 33/145 (22%)
Query: 788 LMYDYMPNGSLGSLLHERTGN---ALEWELRY--QILLGAAQGLAYLHHDCVPPIVHRDI 842
++ +YMP G L +L+ N +W Y +++L L +H +HRD+
Sbjct: 120 MVMEYMPGGDLVNLM----SNYDIPEKWARFYTAEVVLA----LDAIHS---MGFIHRDV 168
Query: 843 KANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE----------YGYM 892
K +N+L+ +ADFG +D R V G+ YI+PE YG
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYG-- 225
Query: 893 MKITEKSDVYSYGVVVLEVLTGKQP 917
+ D +S GV + E+L G P
Sbjct: 226 ----RECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
GL LH + IV+RD+K NIL+ I+D GLA V +G + G+ GY
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGY 167
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+APE + T D ++ G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 17/98 (17%)
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
L YLH +V+RD+K N+++ + I DFGL K + + T G+ Y+
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 162
Query: 886 APE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
APE YG + D + GVV+ E++ G+ P
Sbjct: 163 APEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 40/124 (32%), Positives = 60/124 (48%), Gaps = 30/124 (24%)
Query: 816 YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS- 874
+Q+L +GLAY H ++HRD+K N+LI E +ADFGLA+ A+S
Sbjct: 110 FQLL----RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-------AKSV 155
Query: 875 -----SNTVAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDPTIPDGS 926
SN V + Y P+ ++ TE S D++ G + E+ TG+ P P +
Sbjct: 156 PSKTYSNEVVTLW-YRPPD--VLLGSTEYSTSLDMWGVGCIFYEMATGR----PLFPGST 208
Query: 927 HVVD 930
V D
Sbjct: 209 DVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 6e-06
Identities = 24/60 (40%), Positives = 33/60 (55%), Gaps = 2/60 (3%)
Query: 411 LNFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469
L LDLS+NRL+ +PD L+++DLS N L P + S L L+ LD+S N
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-06
Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 30/155 (19%)
Query: 777 LGCCWNRNNRL-LMYDYMPNGSLGSLLH-ERTGNALEWELRYQILLGAAQ---GLAYLHH 831
L C+ +RL L+ +Y+ G L + H +R E R+ AA+ L +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFY----AAEICIALNFLHE 114
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSNTVAGSYGYIAPE-- 888
I++RD+K +N+L+ + + D+G+ K + GD +++T G+ YIAPE
Sbjct: 115 R---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAPEIL 168
Query: 889 ----YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
YG+ + D ++ GV++ E++ G+ P D
Sbjct: 169 RGEEYGFSV------DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-06
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 712 IGKGCSGVVYRADMDNGEV--IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G G V A N + +A+K+ K D +E K L I
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRF--------EKSKIIKQKQVDHVFSERKILNYIN 89
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL--HERTGNALEWELRYQILLGAAQGLA 827
H V G + + L+ +++ G + L ++R N + QI+L + L
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IFEYLQ 148
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
L+ IV+RD+K N+L+ + + DFG AK+VD + T+ G+ YIAP
Sbjct: 149 SLN------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY-----TLCGTPEYIAP 197
Query: 888 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
E + + +D ++ G+ + E+L G P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-06
Identities = 38/116 (32%), Positives = 63/116 (54%), Gaps = 4/116 (3%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+P+ L + +L+ L +S +L+ +P + + L LD S N + LP + L LE
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD-LSGNKISDLPPEIELLSALE 212
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNK 131
EL L++N + ++ LSN K+L L L +N L ++P +G LSNLE + N+
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ 266
|
Length = 394 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 27/180 (15%)
Query: 761 EIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILL 820
E+ L +++H NIV L+++Y+ + L L + GN + +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMF 110
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS------ 874
+GL+Y H I+HRD+K N+LI + E +ADFGLA+ A+S
Sbjct: 111 QLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR-------AKSVPTKTY 160
Query: 875 SNTVAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDP--TIPDGSHVV 929
SN V + Y P+ ++ TE S D++ G ++ E+ TG+ P+ P T+ + H++
Sbjct: 161 SNEVVTLW-YRPPD--VLLGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
GL L + IV+RD+K NIL+ I+D GLA + +G+ R G+ GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR---VGTVGY 167
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+APE K T D + G ++ E++ G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 66/260 (25%), Positives = 118/260 (45%), Gaps = 37/260 (14%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+IG+G G VY D G++ A+K L + G ++ + + + S+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---------ETLALNERIMLSLV 51
Query: 770 HKNIVRFLGC---CWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGA 822
F+ C ++ ++L + D M G L L + G E E+R+ +I+LG
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILG- 109
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS-NTVAGS 881
L ++H+ V V+RD+K NIL+ I+D GLA DF++ + G+
Sbjct: 110 ---LEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGT 158
Query: 882 YGYIAPEYGYMMKIT---EKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938
+GY+APE + K T +D +S G ++ ++L G P H +D + +
Sbjct: 159 HGYMAPE--VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV 216
Query: 939 QVLDPSLLSRPESEIDEMLQ 958
++ D S +S ++ +LQ
Sbjct: 217 ELPD-SFSPELKSLLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 756 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHE--RTGNALEW 812
+ E L + H IV + C + NR+ + +++ G L + L + R N +
Sbjct: 63 QHVAQEKSILMELSHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK 121
Query: 813 ELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFA 872
+++L YLH I++RD+K N+L+ + + DFG AK V D F
Sbjct: 122 FYHAELVLA----FEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF- 173
Query: 873 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
T+ G+ Y+APE + D ++ GV++ E + G P
Sbjct: 174 ----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 756 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL----LMYDYMPNGSLGSLL-HERTGNAL 810
D EIK L I NI++ G + + L L+ +Y G L +L E+ L
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---L 119
Query: 811 EWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870
++ + + + +GL L+ P ++++ + + L+ ++ I GL K++
Sbjct: 120 SFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177
Query: 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
F + V SY + + + T K D+YS GVV+ E+ TGK P +
Sbjct: 178 FKNVNFMVYFSYKMLNDIFS---EYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
L +LH V ++RD+K +NIL+ E +ADFG+ K ++ T G+ YI
Sbjct: 109 LMFLHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYI 163
Query: 886 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
APE ++ D ++ GV++ E++ G+ P +
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-05
Identities = 18/60 (30%), Positives = 25/60 (41%)
Query: 314 KLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDI 373
L N+L NL+ LDLS N+LT+ P L +L L L N++
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 777 LGCCWNRNNRLL-MYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVP 835
L C+ +RL + +Y+ G L + H + L E + L YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHER--- 115
Query: 836 PIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSNTVAGSYGYIAPE------ 888
I++RD+K +N+L+ E + D+G+ K + GD +++T G+ YIAPE
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGED 172
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
YG+ + D ++ GV++ E++ G+ P D
Sbjct: 173 YGFSV------DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 81/370 (21%), Positives = 144/370 (38%), Gaps = 75/370 (20%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIG+G G V D G V A+K L M EK V AE L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-------EKEQV-GHIRAERDILVEAD 59
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER---TGNALEWELRYQIL-LGAAQG 825
+V+ ++ N L+ +++P G + +LL ++ T ++ + +L + +
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA---KLVDDGDFARSSN------ 876
L + +HRDIK +N+L+ + ++DFGL K +F R+ N
Sbjct: 120 LGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170
Query: 877 ------------------------TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 912
+ G+ YIAPE + D +S GV++ E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 913 TGKQPIDPTIPDGSH--VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNAS 970
G P P ++ V++W +L+ PE I E + L + C
Sbjct: 231 IGYPPFCSETPQETYKKVMNW----------KETLIFPPEVPISEKAKDLILRFCCEWEH 280
Query: 971 PDERPTMKDVA--AMLKEI--KHEREEYAKVDMLLKGSPAAANVQENKNSSGVLATSSSK 1026
P ++++ + + +H RE A + + +K +N E +S +L +
Sbjct: 281 RIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSD-ILKPTV-- 337
Query: 1027 PAVTLHPKSN 1036
A + HP+++
Sbjct: 338 -ATSNHPETD 346
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 60/208 (28%)
Query: 773 IVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLA--YLH 830
+V+ +++N + DY+P G + SLL R G E R+ I A A +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-IRLGIFEEDLARFYI---AELTCAIESVH 118
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGL---------AKLVDDGDFAR-------- 873
+HRDIK +NILI + + DFGL +K GD R
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 874 ------------------------SSNTVAGSYGYIAPEY----GYMMKITEKSDVYSYG 905
++++ G+ YIAPE GY T+ D +S G
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY----TQLCDWWSVG 231
Query: 906 VVVLEVLTGKQPIDPTIPDGSH--VVDW 931
V++ E+L G+ P P + V++W
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 791 DYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGLAYLHHDCVPPIVHRDIKANNI 847
D M G L L + G E E+R+ +I+LG L ++H+ V V+RD+K NI
Sbjct: 77 DLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILG----LEHMHNRFV---VYRDLKPANI 128
Query: 848 LIGLEFEPYIADFGLAKLVDDGDFARSS-NTVAGSYGYIAPE-YGYMMKITEKSDVYSYG 905
L+ I+D GLA DF++ + G++GY+APE + +D +S G
Sbjct: 129 LLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLG 183
Query: 906 VVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQAL 960
++ ++L G P H +D + + L E+ +L+ L
Sbjct: 184 CMLFKLLRGHSPFRQHKTKDKHEID-----RMTLTMAVELPDSFSPELRSLLEGL 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 41/153 (26%), Positives = 66/153 (43%), Gaps = 19/153 (12%)
Query: 779 CCWNRNNRLLM-YDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPI 837
C + L M +Y+ G +LL + AL ++ L YLH+ I
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLALEYLHN---YGI 122
Query: 838 VHRDIKANNILIGLEFEPYIADFGLAKL--------VDDGDFARSS-----NTVAGSYGY 884
VHRD+K +N+LI + DFGL+K+ + +G + + V G+ Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
IAPE + D ++ G+++ E L G P
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 45/218 (20%)
Query: 712 IGKGCSGVVY-----RADMDNG----EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI 762
+GKG G VY +A + + I V +L P AN E
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN--------------QEA 53
Query: 763 KTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHE--RTGNAL------EWEL 814
+ L + H IV+F R+ ++ +Y L L E TG L EW +
Sbjct: 54 QLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI 113
Query: 815 RYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFAR 873
Q+LLG + Y+H I+HRD+KA NI + I DFG+++ L+ D A
Sbjct: 114 --QLLLG----VHYMH---QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLA- 162
Query: 874 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 911
T G+ Y++PE KSD++S G ++ E+
Sbjct: 163 --TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 822 AAQ---GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTV 878
AAQ GL +LH IV+RD+K N+L+ I+D GLA + G +
Sbjct: 101 AAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR--- 154
Query: 879 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
AG+ GY+APE D ++ G + E++ G+ P
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-05
Identities = 58/242 (23%), Positives = 101/242 (41%), Gaps = 42/242 (17%)
Query: 761 EIKTLGSIRHKNIVRFLGCCWNRNNRLL--MYDYMPNGSLGSLLHE--RTGNALEWELRY 816
E+ + ++HKNIVR++ N+ N+ L + ++ G L + + + +E
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 817 QILLGAAQGLAYLHHDCVPP----IVHRDIKANNILIG---------------LEFEPY- 856
I LAY H+ P ++HRD+K NI + L P
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 857 -IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKIT----EKSDVYSYGVVVLEV 911
I DFGL+K + A S G+ Y +PE ++ T +KSD+++ G ++ E+
Sbjct: 182 KIGDFGLSKNIGIESMAHS---CVGTPYYWSPE--LLLHETKSYDDKSDMWALGCIIYEL 236
Query: 912 LTGKQPIDPTIPDGSHVVDWVR--------QKKGIQVLDPSLLSRPESEIDEMLQALGVA 963
+GK P + + R + K + +L +LL+ E LQ LG
Sbjct: 237 CSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ 296
Query: 964 LL 965
++
Sbjct: 297 II 298
|
Length = 1021 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 761 EIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILL 820
E+ L ++H NIV + L+++Y+ + L L + GN++ L
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDD-CGNSINMHNVKLFLF 111
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS------ 874
+GL Y H ++HRD+K N+LI E +ADFGLA+ A+S
Sbjct: 112 QLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR-------AKSIPTKTY 161
Query: 875 SNTVAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDP--TIPDGSHVV 929
SN V + Y P+ ++ T+ S D++ G + E+ TG+ P+ P T+ + H +
Sbjct: 162 SNEVVTLW-YRPPD--ILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 15/208 (7%)
Query: 711 VIGKGCSGVVYRADMDNGEVI-AVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIGKG G V A E AVK L + +K + S L +++
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL-------KKKEEKHIMSERNVLLKNVK 54
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H +V + + DY+ G L L +R LE R+ A L YL
Sbjct: 55 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPRARFYAA-EIASALGYL 112
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY 889
H IV+RD+K NIL+ + + DFGL K ++ + +++T G+ Y+APE
Sbjct: 113 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEV 167
Query: 890 GYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ D + G V+ E+L G P
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 63/243 (25%), Positives = 93/243 (38%), Gaps = 55/243 (22%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++GKG G V+ G++ A+K L M N R EI L ++
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRN------KVKRVLTEQEI--LATLD 59
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNAL-EWELRY---QILLGAAQG 825
H + L+ DY P G L LL + G L E R+ ++LL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA---- 115
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS----------- 874
L YLH + IV+RD+K NIL+ ++DF L+K D S
Sbjct: 116 LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 875 ----------------SNTVAGSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTG 914
SN+ G+ YIAPE G+ D ++ G+++ E+L G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH----GSAVDWWTLGILLYEMLYG 228
Query: 915 KQP 917
P
Sbjct: 229 TTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
GL +LH I++RD+K N+L+ + I+D GLA + DG + AG+ G
Sbjct: 108 SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPG 162
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
++APE + D ++ GV + E++ + P
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-05
Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 761 EIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE----LRY 816
E+ L ++H NIV + L+++Y+ + L + + GN + Y
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDD-CGNIMSMHNVKIFLY 111
Query: 817 QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSN 876
QIL +GLAY H ++HRD+K N+LI E +ADFGLA+ S+
Sbjct: 112 QIL----RGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE 164
Query: 877 TVAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDP--TIPDGSHVV 929
V + Y P+ ++ +E S D++ G + E+ +G+ P+ P T+ D H++
Sbjct: 165 VV--TLWYRPPD--VLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-05
Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 19/210 (9%)
Query: 711 VIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL-GSI 768
VIGKG G V A +G AVK L T+ K ++ AE L ++
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL--------KKKEQNHIMAERNVLLKNL 53
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLH-ERTGNALEWELRYQILLGAAQGLA 827
+H +V + DY+ G L H +R LE R+ A +
Sbjct: 54 KHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAA-EVASAIG 110
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
YLH I++RD+K NIL+ + + DFGL K + + +++T G+ Y+AP
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAP 165
Query: 888 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
E D + G V+ E+L G P
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 712 IGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G+G VY+ NG+++A+K + E+ G + E L ++H
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIR----------LQEEEGTPFTAIREASLLKGLKH 62
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH 830
NIV + L+++Y+ + L + + G L E L +GL+Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIH 120
Query: 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
I+HRD+K N+LI E +ADFGLA+ S+ V + Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPD-- 173
Query: 891 YMMKITEKS---DVYSYGVVVLEVLTG 914
++ TE S D++ G + +E++ G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 28/168 (16%)
Query: 777 LGCCWNRNNRLLM-YDYMPNGSLGSLLHERTGNALEWELRYQ----ILLGAAQGLAYLHH 831
L C + + L M +YMP G L +L+ +W Y + L A +
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAEVVLALDAIHSMG---- 162
Query: 832 DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY-- 889
++HRD+K +N+L+ +ADFG +D+ R +T G+ YI+PE
Sbjct: 163 -----LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR-CDTAVGTPDYISPEVLK 216
Query: 890 -----GYMMKITEKSDVYSYGVVVLEVLTGKQPI--DPTIPDGSHVVD 930
GY + + D +S GV + E+L G P D + S ++D
Sbjct: 217 SQGGDGYYGR---ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 32/232 (13%)
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL-----HERTGNALEWELRYQILLGA 822
++H NI++ LG C LL+++Y G L S L H R L + ++
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEI 108
Query: 823 AQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
A G+ ++H H+ +H D+ N + + + D+G+ D+ + +
Sbjct: 109 AAGVTHMHKHN----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164
Query: 882 YGYIAPE-----YGYMMKI--TEKSDVYSYGVVVLEVL-TGKQPIDPTIPDGSHVVDWVR 933
++APE +G ++ T+ S+V++ GV + E+ QP + D V++ V
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY-SHLSD-REVLNHVI 222
Query: 934 QKKGIQVLDPSLLSRPESE-IDEMLQALGVALLCVNASPDERPTMKDVAAML 984
+ + +++ P L P SE E+LQ C SP++R T ++V +L
Sbjct: 223 KDQQVKLFKPQ-LELPYSERWYEVLQ------FCW-LSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 52/233 (22%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G G VY+A D + G+++A+KK ++ G+ + EI L +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK---------TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 771 KN-IVRFLGCCWNRNNR-----LLMYDYMPNGSLGSLLHERTGNALEWE------LRYQI 818
IVR L L+++Y+ + + G YQ+
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY-IADFGLAKLVDDGDFARSSNT 877
L +G+A+ H V +HRD+K N+L+ + IAD GL R+ +
Sbjct: 120 L----KGVAHCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGL---------GRAFSI 163
Query: 878 VAGSYG-------YIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDP 920
SY Y APE ++ T S D++S G + E+ KQP+ P
Sbjct: 164 PVKSYTHEIVTLWYRAPE--VLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFP 213
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIGKG G V A +G+ AVK L + E+ + + +K +++
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK----EQKHIMAERNVLLK---NVK 54
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGL 826
H +V + + DY+ G L L +R + E R+ +I A L
Sbjct: 55 HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHL-QRERSFPEPRARFYAAEI----ASAL 109
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIA 886
YLH I++RD+K NIL+ + + DFGL K + + +++++T G+ Y+A
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLA 164
Query: 887 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
PE D + G V+ E+L G P
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 66/295 (22%), Positives = 119/295 (40%), Gaps = 40/295 (13%)
Query: 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI 762
L L+ G+ G++ E + VK + + S+ + E
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-------KDHASEIQ---VTLLLQES 59
Query: 763 KTLGSIRHKNIVRFLGCCWNRNNR-LLMYDYMPNGSLGSLL----HERTGNALEWELRYQ 817
L + H+NI+ L C ++Y YM G+L L N +
Sbjct: 60 CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119
Query: 818 ILLGA--AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
+ + A G++YLH ++H+DI A N +I E + I D L++ + D+
Sbjct: 120 VHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 876 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP---IDPTIPDGSHVVDW 931
+ ++A E + + SDV+S+GV++ E++T G+ P IDP + +
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----FEMAAY 231
Query: 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
+ K G + L++P + DE+ V C P+ERP+ + L +
Sbjct: 232 L--KDGYR------LAQPINCPDELFA---VMACCWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 20/59 (33%), Positives = 29/59 (49%)
Query: 435 LQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLF 493
L+ +DLS+N L + L L+VLD+S N + P + L SL + LS N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 20/58 (34%), Positives = 28/58 (48%)
Query: 386 SLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHN 443
+L L + NNR+ + GL L LDLS N L+ P+ L+ +DLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 702 VLKCLVDANVIGKGCSGVV---YRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSF 758
VLK + IG G G+V Y A +D +A+KKL + K R
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKL----SRPFQNQTHAKRAYR--- 65
Query: 759 SAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYD-YMPNGSLGSLLHERTGNALEWELRYQ 817
E+ + + HKNI+ L + + D Y+ + + L + L+ E
Sbjct: 66 --ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123
Query: 818 ILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT 877
+L G+ +LH I+HRD+K +NI++ + I DFGLA+ G +
Sbjct: 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY 178
Query: 878 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 915
V Y Y APE M E D++S G ++ E++ K
Sbjct: 179 VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 41/131 (31%), Positives = 59/131 (45%), Gaps = 19/131 (14%)
Query: 801 LLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860
L HER L YQ+L G + +LH I+HRD+K +NI++ + I DF
Sbjct: 123 LDHERMSYLL-----YQMLCG----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 170
Query: 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920
GLA+ G + V Y Y APE M E D++S G ++ E++ G
Sbjct: 171 GLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV---- 223
Query: 921 TIPDGSHVVDW 931
P H+ W
Sbjct: 224 LFPGTDHIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 712 IGKGCSGVVYRADMDN-GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+GKG G V + N G++ A KKL + +G EK + E + L +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG---EKMAL-----LEKEILEKVNS 52
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ---GLA 827
IV ++ + L+ M G L ++ LE E +++ +AQ G+
Sbjct: 53 PFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME---RVIHYSAQITCGIL 109
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
+LH IV+RD+K N+L+ + ++D GLA + DG ++ AG+ GY+AP
Sbjct: 110 HLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAP 163
Query: 888 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
E + D ++ G + E++ G+ P
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 26/163 (15%)
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNAL-EWELRYQILLGAAQGLAY 828
H NIV + N ++ +M GS L+ + + E + Y IL G + L Y
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY-ILQGVLKALDY 116
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADF-GLAKLVDDG-------DFARSSNTVAG 880
+HH VHR +KA++ILI ++ + Y++ +++ G DF + S V
Sbjct: 117 IHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKV-- 171
Query: 881 SYGYIAPEY------GYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+++PE GY KSD+YS G+ E+ G P
Sbjct: 172 -LPWLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 5/95 (5%)
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
A L YLH IV+RD+K NIL+ + + DFGL K + + ++ T G+
Sbjct: 106 ASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTP 160
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
Y+APE D + G V+ E+L G P
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 71/254 (27%), Positives = 112/254 (44%), Gaps = 60/254 (23%)
Query: 710 NVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
N+IG G GVVY A +D E +A+KK+ D + R E+ + ++
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV----------LQDPQYKNR-----ELLIMKNL 116
Query: 769 RHKNIV----RFLGCCWNRNNRLL----MYDYMPNGSLGSLLH-ERTGNALEWEL----R 815
H NI+ + C+ +N + + + +++P + H R +AL L
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 816 YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP-----YIADFGLAKLVDDGD 870
YQ+ + LAY+H I HRD+K N+LI +P + DFG AK + G
Sbjct: 177 YQL----CRALAYIHSKF---ICHRDLKPQNLLI----DPNTHTLKLCDFGSAKNLLAGQ 225
Query: 871 FARSSNTVAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDPTIPDGSH 927
RS + + + Y APE M+ T + D++S G ++ E++ G P S
Sbjct: 226 --RSVSYICSRF-YRAPE--LMLGATNYTTHIDLWSLGCIIAEMILGY----PIFSGQSS 276
Query: 928 VVDWVRQKKGIQVL 941
V VR IQVL
Sbjct: 277 VDQLVRI---IQVL 287
|
Length = 440 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 23/206 (11%)
Query: 722 RADMDNGEVIAVKKLWPTTMAAANGCSDEKS--------GVRDSFSAEIKTLGSIRHKNI 773
RA ++ ++ P A C D K+ G R + E L +I H +I
Sbjct: 86 RAGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSI 145
Query: 774 VRFLGC-CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHD 832
++ G +N+ L++ Y + L L + A+ L + + + YLH +
Sbjct: 146 IQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDILAIE--RSVLRAIQYLHEN 201
Query: 833 CVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIA---PEY 889
I+HRDIKA NI I + + DFG A D ++N G G IA PE
Sbjct: 202 ---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD----INANKYYGWAGTIATNAPEL 254
Query: 890 GYMMKITEKSDVYSYGVVVLEVLTGK 915
D++S G+V+ E+ T
Sbjct: 255 LARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 60/261 (22%), Positives = 103/261 (39%), Gaps = 57/261 (21%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIG+G G V D G + A+K L M EK V AE L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-------EKEQVA-HIRAERDILVEAD 59
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER---TGNALEWELRYQIL-LGAAQG 825
+V+ ++ N L+ +++P G + +LL ++ + A ++ + +L + A
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA---KLVDDGDFARS-------- 874
L + +HRDIK +N+L+ + ++DFGL K +F R+
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 875 ----------------------SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 912
+ + G+ YIAPE + D +S GV++ E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 913 TGKQPIDPTIPDGSH--VVDW 931
G P P ++ V++W
Sbjct: 231 IGYPPFCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSNTVAGSYG 883
L YLH + +V+RD+K N+++ + I DFGL K + DG + T G+
Sbjct: 107 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKTFCGTPE 161
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
Y+APE D + GVV+ E++ G+ P
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-04
Identities = 30/82 (36%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIK 843
NN L+ +Y+ G + SLLH E ++Y + A L YLH I+HRD+K
Sbjct: 77 NNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--ISEVALALDYLHRH---GIIHRDLK 131
Query: 844 ANNILIGLEFEPYIADFGLAKL 865
+N+LI E + DFGL+K+
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 5e-04
Identities = 20/61 (32%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 362 NLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
NL L L +N ++ IP +L L + N + + P GL +L LDLS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 421 L 421
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSNTVAGSYGY 884
L YLH V V+RDIK N+++ + I DFGL K + DG + T G+ Y
Sbjct: 108 LEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK---TFCGTPEY 161
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+APE D + GVV+ E++ G+ P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 9/95 (9%)
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK--LVDDGDFARSSNTVAGSY 882
L YLH IV+RD+K N+++ + I DFGL K + D A + T G+
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD----AATMKTFCGTP 159
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
Y+APE D + GVV+ E++ G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 6/100 (6%)
Query: 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTV 878
LL A LAYLH I+HRD+K NI + + DFG A +D
Sbjct: 194 LLEA---LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247
Query: 879 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918
+G+ +PE + K+D++S G+V+ E+ +
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 9e-04
Identities = 37/141 (26%), Positives = 62/141 (43%), Gaps = 25/141 (17%)
Query: 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQ----ILLGAAQGLAYLHHDCVPPIVHRDIK 843
++ +YMP G L +L+ +W Y + L A + + +HRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLALDAIHSMGF---------IHRDVK 169
Query: 844 ANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY-------GYMMKIT 896
+N+L+ +ADFG ++ R +T G+ YI+PE GY +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGR-- 226
Query: 897 EKSDVYSYGVVVLEVLTGKQP 917
+ D +S GV + E+L G P
Sbjct: 227 -ECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 34/118 (28%), Positives = 49/118 (41%), Gaps = 14/118 (11%)
Query: 798 LGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857
+ L+ W + L A LH + IV RD+ NNIL+ +
Sbjct: 76 ISKFLNIPEECVKRWAAEMVVALDA------LHRE---GIVCRDLNPNNILLDDRGHIQL 126
Query: 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 915
F V+D S + A Y APE G + + TE D +S G ++ E+LTGK
Sbjct: 127 TYFSRWSEVED-----SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 21/57 (36%), Positives = 29/57 (50%), Gaps = 3/57 (5%)
Query: 535 LNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP--LAQLDNLVSLNISYNKF 589
L+LS N LT L L +LDLS N L ++P + L +L SL++S N
Sbjct: 5 LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.7 bits (86), Expect = 0.002
Identities = 17/36 (47%), Positives = 25/36 (69%), Gaps = 1/36 (2%)
Query: 555 KLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFT 590
L LDLS+N++ +L PL+ L NL +L++S NK T
Sbjct: 2 NLETLDLSNNQIT-DLPPLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 64/292 (21%), Positives = 100/292 (34%), Gaps = 75/292 (25%)
Query: 159 GSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNC---SELVSLFLYENSLSGSIPPEIGK 215
SL L K LQ L + + + + + S L L L N L + K
Sbjct: 71 QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130
Query: 216 -LK----KLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEF 270
LK LE+L L +N L GA S +L+ + + L EL
Sbjct: 131 GLKDLPPALEKLVLGRNRLEGA----------------SCEALAKALR-ANRDLKELN-- 171
Query: 271 MISDNNVSGSIPANLANA----TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLE 326
+++N + + LA NL L L+ N ++ + G + L
Sbjct: 172 -LANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT-----DEGA-----------SALA 214
Query: 327 GSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSS 386
TLAS +L+ L+L N+LT AG L + I S
Sbjct: 215 E----TLASLKSLEVLNLGDNNLTD---AGAAALASALLSPNI----------------S 251
Query: 387 LVRLRVGNNRI----AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTE 434
L+ L + N I A + + ++L LDL N+ + +
Sbjct: 252 LLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLL 303
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.003
Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 18/98 (18%)
Query: 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT- 877
LL A + Y+H + I+HRDIK N+L+ + + DFG A FAR S +
Sbjct: 269 LLSA---IDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAAC------FARGSWST 316
Query: 878 -----VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLE 910
+AG+ APE T D++S G+V+ E
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.003
Identities = 37/161 (22%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 761 EIKTLGSIRHKNIVRFLGCCWNRNNRLL--------MYDYMPNGSLGSLLHERTGNALEW 812
EI LG + H+NI++ + N + +Y +M + + + L
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-----DWKDRPLLK 267
Query: 813 ELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFA 872
+ R I+ + Y+H ++HRDIK NI + + + + DFG A + A
Sbjct: 268 QTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 873 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 913
V G+ +PE E +D++S G+++L++L+
Sbjct: 324 FDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 63/255 (24%), Positives = 103/255 (40%), Gaps = 72/255 (28%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIG+G G V D G + A+KKL + M ++ + VR AE L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE----KEQVAHVR----AERDILAEAD 59
Query: 770 HKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNAL-EWELRYQI-----LLGA 822
+ +V+ L + N L L+ +Y+P G + +LL ++ + E E R+ I + +
Sbjct: 60 NPWVVK-LYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDS 116
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD---DGDFARSSN--- 876
L Y +HRDIK +N+L+ + ++DFGL + +F R +
Sbjct: 117 IHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 877 ------------------------------TVAGSYGYIAPE----YGYMMKITEKSDVY 902
+ G+ YIAPE GY ++ D +
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY----NKECDWW 223
Query: 903 SYGVVVLEVLTGKQP 917
S GV++ E+L G P
Sbjct: 224 SLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1058 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.32 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.26 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.19 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.19 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.17 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.16 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.11 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.11 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.04 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.0 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.95 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.64 | |
| KOG4341 | 483 | consensus F-box protein containing LRR [General fu | 98.64 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.57 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.56 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.41 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-104 Score=1023.71 Aligned_cols=872 Identities=35% Similarity=0.586 Sum_probs=623.6
Q ss_pred CcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccc-cchhhhHHhhhhccccCCChhhhcccccchhhh
Q 043053 48 VGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELS-NCKSLRKLLLFDNALAGNIPAELGRLSNLEEMR 126 (1058)
Q Consensus 48 ~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~-~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~ 126 (1058)
.+++.|+|++|++++.+|..+..+++|++|+|++|++.+.+|..+. .+++|++|+|++|.+.+.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 3678888888888877888888888888888888888777777654 788888888888877766664 3466677777
Q ss_pred cCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCC
Q 043053 127 AGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLS 206 (1058)
Q Consensus 127 l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~ 206 (1058)
+++|. +.+.+|..++.+++|++|++++|.+.+..|..++++++|++|++++|.+.+.+|..++++++|+.|+|++|.+.
T Consensus 147 Ls~n~-~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 147 LSNNM-LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred CcCCc-ccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 77665 33456666777777777777777776677777777777777777777777777777777777777777777777
Q ss_pred CCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCcccccc
Q 043053 207 GSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLA 286 (1058)
Q Consensus 207 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 286 (1058)
+.+|..|+++++|++|++++|.+.+..|..|+++++|++|++++|.+.+..|..+.++++|++|++++|.+.+..|..+.
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~ 305 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence 67777777777777777777777767777777777777777777777766777777777777777777777766777777
Q ss_pred ccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhh
Q 043053 287 NATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKL 366 (1058)
Q Consensus 287 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 366 (1058)
++++|+.|++++|.+.+..|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|++.+..|..+..+++|+.|
T Consensus 306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L 385 (968)
T PLN00113 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385 (968)
T ss_pred CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEE
Confidence 77777777777777776666666666667777776666666666666667777777777777766666666666666666
Q ss_pred hccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccC
Q 043053 367 LLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446 (1058)
Q Consensus 367 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 446 (1058)
++++|.+.+..|..+..+++|+.|++++|++++..|..|..+++|++|++++|.+++..|..+..+++|+.|++++|++.
T Consensus 386 ~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~ 465 (968)
T PLN00113 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF 465 (968)
T ss_pred ECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceee
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhh
Q 043053 447 GSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELG 526 (1058)
Q Consensus 447 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 526 (1058)
+.+|..+ ..++|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.|+|++|.+++
T Consensus 466 ~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~------- 537 (968)
T PLN00113 466 GGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSG------- 537 (968)
T ss_pred eecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccc-------
Confidence 6555544 34566666666666666666666666666666666666666666666666666666666666655
Q ss_pred hhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCC-CcccccCcceeEEEecccccccCCCccccccCCCc
Q 043053 527 QIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNL-NPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPT 605 (1058)
Q Consensus 527 ~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 605 (1058)
.+|..|.++++|+.|||++|++++.+ ..+..+++|+.|++++|+++|.+|....|..+...
T Consensus 538 ------------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~ 599 (968)
T PLN00113 538 ------------------QIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS 599 (968)
T ss_pred ------------------cCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChh
Confidence 44555677889999999999999854 57888999999999999999999999999999999
Q ss_pred cccCCcccccCCCC----CCcccCCCCCCCCCCCcccccccccchhHHHHHHHHHHHHHHHHHHHHHHHhccccCCCCC-
Q 043053 606 DLAGNEGLCSSRKD----SCFLSNDGKAGLASNENDVRRSRKLKVAIALLITLTVAMAIMGTFALIRARRAMKDDDDSE- 680 (1058)
Q Consensus 606 ~~~~n~~~c~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~rr~~~~~~~~~- 680 (1058)
++.||+.+|+.... .|.. .++...+.+++++++++++++++++.+++++++|+..+....+
T Consensus 600 ~~~~n~~lc~~~~~~~~~~c~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (968)
T PLN00113 600 AVAGNIDLCGGDTTSGLPPCKR--------------VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVEN 665 (968)
T ss_pred hhcCCccccCCccccCCCCCcc--------------ccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccc
Confidence 99999999986422 2311 0011112222222232222222222222222222211111111
Q ss_pred CCCCCCCc-ccccccccccHHHHHhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHH
Q 043053 681 LGDSWPWQ-FTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSF 758 (1058)
Q Consensus 681 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~ 758 (1058)
....+... +.......++++++...+...++||+|+||.||+|.. .++..||||++.... ...
T Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------------~~~ 730 (968)
T PLN00113 666 EDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN---------------SIP 730 (968)
T ss_pred ccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc---------------ccc
Confidence 11111111 1111112356777888899999999999999999954 679999999874221 111
Q ss_pred HHHHHHHcccCCCcccceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeE
Q 043053 759 SAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIV 838 (1058)
Q Consensus 759 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 838 (1058)
.+|++.+++++|||||+++|++.+++..|+||||+++|+|.++++. ++|..+.+|+.|+|+|++|||..+.++|+
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 805 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVV 805 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCee
Confidence 3568899999999999999999999999999999999999999963 78999999999999999999976666999
Q ss_pred eCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 043053 839 HRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918 (1058)
Q Consensus 839 HrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 918 (1058)
||||||+||+++.++.+++. ||....... .....||+.|+|||+..+..++.++|||||||++|||++|+.||
T Consensus 806 H~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~ 878 (968)
T PLN00113 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878 (968)
T ss_pred cCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence 99999999999999888875 665443221 12336889999999999999999999999999999999999999
Q ss_pred CCCCCCChhHHHHHHhhcC----ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 919 DPTIPDGSHVVDWVRQKKG----IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
+...........|.+.... ....++...........++.++++++.+||+.||++||||+|+++.|+++..
T Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 879 DAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 7655444556666553321 1233444433333344566677789999999999999999999999987654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-62 Score=627.30 Aligned_cols=539 Identities=36% Similarity=0.533 Sum_probs=505.8
Q ss_pred CCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhc-CcccCCEEeccccCCCCccccccccchhhhHH
Q 043053 23 FKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLG-KLHNLEELILNSNQLTGKIPVELSNCKSLRKL 101 (1058)
Q Consensus 23 ~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~-~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L 101 (1058)
...++.|+|+++.+.+.+|..+..+++|++|+|++|++++.+|..+. ++.+|++|+|++|++.+.+|. +.+++|++|
T Consensus 68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L 145 (968)
T PLN00113 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL 145 (968)
T ss_pred CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence 35799999999999999999999999999999999999989998876 999999999999999988885 568999999
Q ss_pred hhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeecccc
Q 043053 102 LLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMI 181 (1058)
Q Consensus 102 ~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i 181 (1058)
+|++|.+.+.+|..++++++|++|++++|. +.+.+|..++++++|++|++++|.+.+..|..++++++|+.|++++|.+
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 224 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNV-LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCc-ccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence 999999998999999999999999999996 4568899999999999999999999999999999999999999999999
Q ss_pred ccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccc
Q 043053 182 SGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSI 261 (1058)
Q Consensus 182 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~ 261 (1058)
.+.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|.+.+..|..+.++++|++|++++|.+.+.+|..+
T Consensus 225 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~ 304 (968)
T PLN00113 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304 (968)
T ss_pred CCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccc
Q 043053 262 GGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQA 341 (1058)
Q Consensus 262 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 341 (1058)
.++++|+.|++++|.+.+..|..+..+++|+.|++++|.+.+..|..++.+++|+.|++++|++++.+|..+..+++|+.
T Consensus 305 ~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~ 384 (968)
T PLN00113 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384 (968)
T ss_pred cCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccC
Q 043053 342 LDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRL 421 (1058)
Q Consensus 342 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 421 (1058)
|++++|++.+..|..+..+++|+.|++++|++++..|..|.++++|+.|++++|.+++..+..+..+++|++|+|++|++
T Consensus 385 L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~ 464 (968)
T PLN00113 385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464 (968)
T ss_pred EECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCcee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcc
Q 043053 422 SGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSL 501 (1058)
Q Consensus 422 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 501 (1058)
.+..|..+. .++|+.|++++|++++..|..|.++++|+.|+|++|++.+.+|..+..+++|+.|+|++|.+++.+|..|
T Consensus 465 ~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 543 (968)
T PLN00113 465 FGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASF 543 (968)
T ss_pred eeecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhH
Confidence 988887664 5899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCCcccccCccee
Q 043053 502 GLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVS 581 (1058)
Q Consensus 502 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~ 581 (1058)
..+++|+.|+|++|++++.+|..+ .++++|+.|++++|++++.++....+..+..
T Consensus 544 ~~l~~L~~L~Ls~N~l~~~~p~~l-------------------------~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~ 598 (968)
T PLN00113 544 SEMPVLSQLDLSQNQLSGEIPKNL-------------------------GNVESLVQVNISHNHLHGSLPSTGAFLAINA 598 (968)
T ss_pred hCcccCCEEECCCCcccccCChhH-------------------------hcCcccCEEeccCCcceeeCCCcchhcccCh
Confidence 999999999999999997766554 5677899999999999987766555556666
Q ss_pred EEEeccccc
Q 043053 582 LNISYNKFT 590 (1058)
Q Consensus 582 L~l~~N~l~ 590 (1058)
..+.+|+..
T Consensus 599 ~~~~~n~~l 607 (968)
T PLN00113 599 SAVAGNIDL 607 (968)
T ss_pred hhhcCCccc
Confidence 667788743
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=389.82 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=213.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+.+..++||+|..|+|||+ +..+++.+|+|++... .++..++++.+|+++++..+||+||++||+|+.
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~----------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN----------IDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc----------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 44566789999999999999 5567899999999433 456678999999999999999999999999999
Q ss_pred CCC-ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 783 RNN-RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 783 ~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
+.. ..++||||++|+|+++++.. +.+++....+|+.+|++||.|||+ + +||||||||+|||++..|+||||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccc
Confidence 884 99999999999999999874 679999999999999999999996 5 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|.++...+. ...+++||..|||||.+.+..|+.++||||||++++|+.+|++||....+......+.+.... ..
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv--~~ 297 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV--DE 297 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh--cC
Confidence 999877653 456889999999999999999999999999999999999999999765332222222222111 11
Q ss_pred cCCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 941 LDPSLLSR-PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 941 ~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
..|.++.. ...+.. +++..|+++||.+||+++|++++-.-.+.+
T Consensus 298 ppP~lP~~~fS~ef~------~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 298 PPPRLPEGEFSPEFR------SFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCCCcccCCHHHH------HHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 22333332 333333 356669999999999999999876544433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=412.65 Aligned_cols=278 Identities=44% Similarity=0.805 Sum_probs=229.2
Q ss_pred HHHHHhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 699 VEQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 699 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
....++.|...++||+|+||.||+|...+|+.||||++.... ... ..+|..|++++.+++|||+|+++|
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~----------~~~-~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNS----------GQG-EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCC----------Ccc-hhHHHHHHHHHhcCCCcCcccEEE
Confidence 345568999999999999999999999999999999874321 111 456999999999999999999999
Q ss_pred EEEcCCC-ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeee
Q 043053 779 CCWNRNN-RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857 (1058)
Q Consensus 779 ~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl 857 (1058)
||.+.+. .++|+||+++|+|.++++.....+++|.+|++||.++|+||+|||..+.+.||||||||+|||+|+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9999884 999999999999999999754338899999999999999999999998889999999999999999999999
Q ss_pred eccccceeccCCCcccccccc-cCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC-CChhHHHHHHhh
Q 043053 858 ADFGLAKLVDDGDFARSSNTV-AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP-DGSHVVDWVRQK 935 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~-~~~~~~~~~~~~ 935 (1058)
+|||+|+...... ...... .||.+|+|||+...+..+.|+|||||||++.|+++|+.|.+...+ ....+..|....
T Consensus 219 sDFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999996554311 111122 799999999999999999999999999999999999999886542 233466665332
Q ss_pred ----cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 936 ----KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 936 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
...+.+|+.+..........+.++..++.+|++.+|.+||+|.||++.|+.+..
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 345677887763222212566667779999999999999999999998855543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=399.21 Aligned_cols=261 Identities=34% Similarity=0.563 Sum_probs=211.9
Q ss_pred ccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC-
Q 043053 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN- 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 784 (1058)
....+.+|+|+||+||+|.+.....||||++..... .....++|.+|+.+|.+++|||||+++|++.++.
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~---------~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDF---------DDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhc---------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 344556999999999999998545599999965422 1222789999999999999999999999999887
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCC-eEeCCCCCCcEEEcCCC-Ceeeecccc
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPP-IVHRDIKANNILIGLEF-EPYIADFGL 862 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivHrDikp~Nill~~~~-~~kl~DfGl 862 (1058)
..++||||+++|+|.++++......+++..+.+|+.|||+||.|||+. + ||||||||+|||++.++ ++||+|||+
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 789999999999999999875568899999999999999999999999 7 99999999999999998 999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY--MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
++...... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....+ .++...+.. ..
T Consensus 191 sr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~----~~ 262 (362)
T KOG0192|consen 191 SREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVV----GG 262 (362)
T ss_pred ceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh----cC
Confidence 98765432 2334478999999999999 56999999999999999999999999987654 222222221 11
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
..+.+....+. .+ ..++..||+.||+.||++.+++..|+.+.....
T Consensus 263 ~Rp~~p~~~~~---~l---~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 263 LRPPIPKECPP---HL---SSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCCCccCCH---HH---HHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 22333332232 22 236677999999999999999999998866433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=399.53 Aligned_cols=253 Identities=30% Similarity=0.416 Sum_probs=217.5
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+|...++||+|||+.||++ +..+|+.||+|++.+..+ .+...++.+.+||++.++|+|||||+++++|++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l--------~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED 89 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL--------KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED 89 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh--------cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec
Confidence 67999999999999999999 558999999999976543 355678899999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..|+|.|+|+.|+|..++++ .+++++.+++.+.+||+.|+.|||+. +|+|||||-.|+|++++.+|||+|||+
T Consensus 90 s~nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 90 SNNVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred CCceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccce
Confidence 9999999999999999999985 58899999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|......+ ....+.+|||.|+|||++....++..+||||+||++|.|+.|++||+.. .+.+.+...+..+...
T Consensus 165 At~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~~Ik~~~Y~~ 237 (592)
T KOG0575|consen 165 ATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYNKIKLNEYSM 237 (592)
T ss_pred eeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHHHHHhcCccc
Confidence 99887653 3455789999999999999999999999999999999999999999743 3333344333333333
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
|... .. .+.++|..+|++||.+|||+++|+.+-.
T Consensus 238 P~~l---s~------~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 238 PSHL---SA------EAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred cccc---CH------HHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 3321 22 2345777899999999999999997643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=383.45 Aligned_cols=264 Identities=24% Similarity=0.335 Sum_probs=211.3
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.+.|...+.+|+|+||.|-+| ..++|+.||||++.+....... . ........++|+++|++++||+||+++++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s---~-~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCS---R-AIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccc---c-cccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 5577889999999999999999 8889999999999655433211 1 111234468999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC---CCeee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE---FEPYI 857 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~---~~~kl 857 (1058)
..++..|+||||++||+|.+++-. .+.+.+..-..+++|++.|+.|||+. ||+||||||+|||+..+ ..+||
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEe
Confidence 999999999999999999999986 46677888889999999999999999 99999999999999766 67999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccccCCCC---cccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHh
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKIT---EKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1058)
+|||+|+....+. -+.+.+||+.|.|||++.+..++ .+.|+||+||++|-+++|.+||.....+.. +.+.+.+
T Consensus 321 tDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l~eQI~~ 396 (475)
T KOG0615|consen 321 TDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-LKEQILK 396 (475)
T ss_pred cccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-HHHHHhc
Confidence 9999999887543 45688999999999998866433 478999999999999999999986543321 2222222
Q ss_pred hcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 935 KKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
. .....++.+..-..+++++|.+||..||++|||++|++++-+.
T Consensus 397 G--------~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 397 G--------RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred C--------cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 1 1112222222333456678999999999999999999987554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=364.34 Aligned_cols=252 Identities=21% Similarity=0.334 Sum_probs=203.4
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee-EE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG-CC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~ 780 (1058)
...|.+.++||+|+||+|||+ +..+|..||.|.+.... -+...++....|+.++++++|||||++++ .+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~---------md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM---------MDAKARQDCVKEISLLKQLNHPNIVQYYAHSF 88 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh---------ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence 467888999999999999999 78899999999986332 34566889999999999999999999999 44
Q ss_pred EcCCC-ceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCC--eEeCCCCCCcEEEcCCCCe
Q 043053 781 WNRNN-RLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPP--IVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 781 ~~~~~-~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDikp~Nill~~~~~~ 855 (1058)
.++.. .++|||||++|+|...++.. .+..+++..+|+++.|++.||+++|.... + |+||||||.||+++.+|.|
T Consensus 89 ~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvv 167 (375)
T KOG0591|consen 89 IEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVV 167 (375)
T ss_pred hccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCce
Confidence 44444 79999999999999999753 36779999999999999999999999432 5 8899999999999999999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||+++.+.... ......+|||.||+||.+.+.+|+.|+||||+||++|||+.-+.||.+. .-..+...+.+.
T Consensus 168 KLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qg 243 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQG 243 (375)
T ss_pred eeccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcC
Confidence 999999999887654 3345678999999999999999999999999999999999999999754 112222222221
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMK 978 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ 978 (1058)
...+.|.....+-+ ..++..|+.+||+.||+..
T Consensus 244 --------d~~~~p~~~YS~~l--~~li~~ci~vd~~~RP~t~ 276 (375)
T KOG0591|consen 244 --------DYPPLPDEHYSTDL--RELINMCIAVDPEQRPDTV 276 (375)
T ss_pred --------CCCCCcHHHhhhHH--HHHHHHHccCCcccCCCcc
Confidence 11122222222222 2367789999999999843
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=377.00 Aligned_cols=204 Identities=31% Similarity=0.511 Sum_probs=182.4
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
..+|...+.||+|+||+||+| ...++..||||.+.+... .....+.+..|+.+++.++|||||++++++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---------NKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 356778888999999999999 556789999999965421 3345678899999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC------CCe
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE------FEP 855 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~------~~~ 855 (1058)
.++..|+|||||+||||.+|++.+ +.+++..+..++.|+|.|+++||++ +||||||||+|||++.. -.+
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceE
Confidence 999999999999999999999974 5899999999999999999999999 99999999999999865 458
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 923 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 923 (1058)
||+|||+|+...++. ...+.+|++-|||||+++...|+.|+|+||+|+++|+|++|+.||+...+
T Consensus 155 KIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 155 KIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred EecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 999999999887653 34578999999999999999999999999999999999999999986543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=392.69 Aligned_cols=257 Identities=29% Similarity=0.491 Sum_probs=216.1
Q ss_pred hccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 705 CLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
.+...+.||+|.||+||.|.+.....||||.+... ....+.|.+|+++|++++|++||+++|++..++
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~------------~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG------------SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc------------ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 44567899999999999999997889999998533 233578999999999999999999999999988
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..||||||++.|+|.+|++...+..+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence 999999999999999999987778899999999999999999999999 99999999999999999999999999999
Q ss_pred eccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
...+..+ .......-+..|.|||.+....++.|||||||||+||||+| |+.||... ...++.+.+.+..
T Consensus 352 ~~~d~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--sn~ev~~~le~Gy------- 421 (468)
T KOG0197|consen 352 LIGDDEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--SNEEVLELLERGY------- 421 (468)
T ss_pred ccCCCce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--CHHHHHHHHhccC-------
Confidence 6555443 33344446779999999999999999999999999999999 89998755 3344444444332
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
..++|+.+.+++. ++|..||+.+|++|||++.+...++++...
T Consensus 422 -Rlp~P~~CP~~vY---~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 422 -RLPRPEGCPDEVY---ELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -cCCCCCCCCHHHH---HHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 2333444444443 478889999999999999999888877543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=389.86 Aligned_cols=486 Identities=29% Similarity=0.471 Sum_probs=403.5
Q ss_pred ccccCCCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchh
Q 043053 18 TNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKS 97 (1058)
Q Consensus 18 ~~~~~~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~ 97 (1058)
..+|.-..++.|++++|.++ .+..++..+..|++|++++|+++ ++|.+++.+..++.|+.++|++. ++|..++.+.+
T Consensus 39 e~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~ 115 (565)
T KOG0472|consen 39 ENWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLIS 115 (565)
T ss_pred hhhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhh
Confidence 46777889999999999998 67788999999999999999999 99999999999999999999998 99999999999
Q ss_pred hhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeee
Q 043053 98 LRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIY 177 (1058)
Q Consensus 98 L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~ 177 (1058)
|++|+.+.|.+. .+|++++.+..|+.|+..+|. +..+|..++.|.+|..|++.+|++. .+|...-+++.|++|+..
T Consensus 116 l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~--i~slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~ 191 (565)
T KOG0472|consen 116 LVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQ--ISSLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCN 191 (565)
T ss_pred hhhhhcccccee-ecCchHHHHhhhhhhhccccc--cccCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccc
Confidence 999999999998 999999999999999999988 7899999999999999999999999 555555559999999999
Q ss_pred ccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCcc-ccCcCCccEEEeecCCCcCc
Q 043053 178 TTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEE-IGNCTSLKMIDFSLNSLSGT 256 (1058)
Q Consensus 178 ~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-l~~l~~L~~L~L~~n~l~~~ 256 (1058)
.|.++ .+|..++.+.+|+.|+|..|++. .+| .|..|..|.+|+++.|++. .+|.. ..++++|..|||..|+++ .
T Consensus 192 ~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e 266 (565)
T KOG0472|consen 192 SNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-E 266 (565)
T ss_pred hhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-c
Confidence 99887 89999999999999999999999 677 8999999999999999998 55555 559999999999999998 7
Q ss_pred CCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCccccc--chhhhhhc--cCcccC---C--
Q 043053 257 IPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGML--SKLTVFFA--WQNQLE---G-- 327 (1058)
Q Consensus 257 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l--~~L~~L~l--~~N~l~---~-- 327 (1058)
.|..++.+.+|++||+++|.|+ ..|..++++ .|+.|.+.+|.+..+--+.+..- .-|++|.- ..-.++ +
T Consensus 267 ~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~ 344 (565)
T KOG0472|consen 267 VPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGT 344 (565)
T ss_pred CchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccc
Confidence 8999999999999999999999 578889999 99999999999865422222211 11233321 000110 0
Q ss_pred ----C-CC---hhhhccCcccccccccccccccCccccccccc---chhhhccccCCCCCCCCCccCCCCCcE-EEccCc
Q 043053 328 ----S-IP---STLASCSNLQALDLSHNSLTASVPAGLFQLQN---LTKLLLISNDISGSIPPEIGNCSSLVR-LRVGNN 395 (1058)
Q Consensus 328 ----~-~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N 395 (1058)
. .+ .....+.+.+.|++++-+++ .+|...|...+ .+..+++.|++. .+|..+..++.+.+ +.+++|
T Consensus 345 e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn 422 (565)
T KOG0472|consen 345 ETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNN 422 (565)
T ss_pred cccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcC
Confidence 0 11 12234457788888888888 57877776555 778888899888 67777777776654 455555
Q ss_pred cccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcc
Q 043053 396 RIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPA 475 (1058)
Q Consensus 396 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 475 (1058)
.+. .+|..+..+++|..|+|++|-+. .+|..++.+..|+.|++++|+|. .+|..+..+..|+.+-.++|++....|.
T Consensus 423 ~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~ 499 (565)
T KOG0472|consen 423 KIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPS 499 (565)
T ss_pred ccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChH
Confidence 554 56778888899999999988887 67888888888999999999888 5888888888888888888888866666
Q ss_pred cccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhh
Q 043053 476 SLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMEL 525 (1058)
Q Consensus 476 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~ 525 (1058)
.+.++.+|..|||.+|.+. .+|..+++|.+|++|+++||++. .|...
T Consensus 500 ~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr~~ 546 (565)
T KOG0472|consen 500 GLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPRHQ 546 (565)
T ss_pred HhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--CCHHH
Confidence 6888889999999999887 67888999999999999999987 45443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=394.67 Aligned_cols=263 Identities=30% Similarity=0.508 Sum_probs=222.7
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
...+..+.||+|+||+||+|... +...||||.++.. .+.+..++|+||+++++.++|||||+++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~----------a~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK----------AENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc----------ccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 45567789999999999999432 3567999998533 3444789999999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKAN 845 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~ 845 (1058)
|+|.+++.+++|+|||..|||.+||+.+. ..+++..+.+.||.|||.||+||-++ .+|||||.++
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATR 632 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATR 632 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhh
Confidence 99999999999999999999999997532 23388999999999999999999999 9999999999
Q ss_pred cEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043053 846 NILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPD 924 (1058)
Q Consensus 846 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 924 (1058)
|+||+++..|||+|||+++..-..++++......-+.+|||||.+..++++.+||||||||+|||+++ |+.||.+..
T Consensus 633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-- 710 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-- 710 (774)
T ss_pred hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--
Confidence 99999999999999999998877777766545556789999999999999999999999999999999 999998763
Q ss_pred ChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 925 GSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
..++.+.+++.. +.+.|+.+..++. .+|..||+..|++||+++||...|+......+
T Consensus 711 n~EVIe~i~~g~--------lL~~Pe~CP~~vY---~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 711 NQEVIECIRAGQ--------LLSCPENCPTEVY---SLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred hHHHHHHHHcCC--------cccCCCCCCHHHH---HHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 345555555433 3455555555554 48899999999999999999999988765433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.12 Aligned_cols=265 Identities=28% Similarity=0.346 Sum_probs=209.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|+..++||.|..++||+| ....++.||||++... +.....+.+++|++.|+.++||||++++..|..
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE----------kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE----------KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh----------hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 67899999999999999999 6778899999999543 233347899999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...|+||.||.+|++.++++..-...+++..+..|.+++++||.|||.+ |.||||||+.||||+.+|.|||+|||.
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999999999999987777899999999999999999999999 999999999999999999999999998
Q ss_pred ceec-cCCCccccc-ccccCcCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 863 AKLV-DDGDFARSS-NTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 863 ~~~~-~~~~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
+... ..+...... .+.+||+.|||||++.. ..|+.|+||||||++..||.+|..||....|.. +.-.-.+..
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~tLqn~-- 248 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLTLQND-- 248 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHHhcCC--
Confidence 6544 333222222 67789999999999553 468999999999999999999999998664421 111111111
Q ss_pred cccCCCCCCCCchhHH--HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 939 QVLDPSLLSRPESEID--EMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~--~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
...+. ....+.+-. --..+..++..|+.+||++|||+++++++-..-
T Consensus 249 -pp~~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk 297 (516)
T KOG0582|consen 249 -PPTLL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK 297 (516)
T ss_pred -CCCcc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence 00000 011111100 011334567789999999999999999765433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=356.04 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=205.9
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.+.|++.++||+|+||+||.+ +..+++.+|+|++.+.... .....+...+|..++.+++||.||+++..|.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv--------~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIV--------EKKEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhh--------hhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 468899999999999999999 6678999999999766442 2234678899999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++..|+|+||+.||.|...|++ .+.+++..+.-++..|+.||.|||+. +|||||+||+|||+|.+|+++|+|||
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccc
Confidence 99999999999999999999986 47899999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc-c
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ-V 940 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~ 940 (1058)
+++...... ..+.+++||+.|||||++.+..|+..+|.||+|+++|||++|.+||... +...+++...... .
T Consensus 171 L~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~I~~~k~~ 243 (357)
T KOG0598|consen 171 LCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDKILKGKLP 243 (357)
T ss_pred cchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHHHhcCcCC
Confidence 998654432 3455689999999999999999999999999999999999999999754 2222232222111 1
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC----CHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERP----TMKDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP----t~~~v~~~ 983 (1058)
..+. -...+ +.+++...+..||++|. ++.+|.++
T Consensus 244 ~~p~---~ls~~------ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 244 LPPG---YLSEE------ARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred CCCc---cCCHH------HHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 1111 11222 23466668999999995 55665543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=344.31 Aligned_cols=262 Identities=22% Similarity=0.348 Sum_probs=206.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|+...++|+|+||+|||+ ...+|+.||||++... ++++...+-..||++++++++|+|+|.++.+|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es---------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES---------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC---------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 56788889999999999999 6668999999999533 4566778889999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....++|+|||+. ++.+-+... ...++...+.+++.|+++|+.|+|++ ++|||||||+|||++.+|.+||||||+
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence 9999999999988 666666554 45678889999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc-----
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK----- 936 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~----- 936 (1058)
|+...... ...+..+.|..|.|||.+.+ .+|....||||+||++.||++|.+-|.+..+ -+++. .++...
T Consensus 148 AR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD-iDQLy-~I~ktLG~L~p 223 (396)
T KOG0593|consen 148 ARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD-IDQLY-LIRKTLGNLIP 223 (396)
T ss_pred hHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch-HHHHH-HHHHHHcccCH
Confidence 99887322 34567788999999998776 7899999999999999999999988865422 11111 111100
Q ss_pred -------------CccccCCCCCCCCc-hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 -------------GIQVLDPSLLSRPE-SEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 -------------~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+.....+.-....+ ....-..-+++++..|++.||++|++-+|++.+
T Consensus 224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00111111110000 011111245779999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.52 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=208.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 781 (1058)
.+|.+++.||.|+|++|++| +..+++.+|||++.+.... ++.-.+.+.+|-.+|.+| .||.|+++|..|.
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii--------ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII--------KEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHH--------hhcccchhhHHHHHHHHhhCCCCeEEEEEEee
Confidence 67889999999999999999 7788999999999655432 223346678899999999 7999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
++...|+|+||+++|+|.++|+.. +.+++..++.++.+|+.|++|||++ |||||||||+|||+|+||+++|+|||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFG 219 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFG 219 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecc
Confidence 999999999999999999999874 7899999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcc---------cc--cccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH
Q 043053 862 LAKLVDDGDFA---------RS--SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 862 l~~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 930 (1058)
.|+.+.+.... .. ...++||..|.+||++.+...++.+|+|||||++|+|+.|.+||.... .+..
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N----eyli 295 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN----EYLI 295 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc----HHHH
Confidence 99877542211 11 245899999999999999999999999999999999999999997542 1221
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+.+ +..++-.+....+... .+++.+.|..||.+|+|+++|.++.
T Consensus 296 Fqk----I~~l~y~fp~~fp~~a------~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 296 FQK----IQALDYEFPEGFPEDA------RDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHH----HHHhcccCCCCCCHHH------HHHHHHHHccCccccccHHHHhhCc
Confidence 111 1122233333333333 3356667999999999999999865
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=373.88 Aligned_cols=458 Identities=30% Similarity=0.428 Sum_probs=379.3
Q ss_pred hhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCC
Q 043053 114 AELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCS 193 (1058)
Q Consensus 114 ~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~ 193 (1058)
+..+.-.-|+.|.++.|. ...+.+.+.++..|++|++.+|++. ++|.+++++.+++.|+.+.|++. ++|+.++++.
T Consensus 39 e~wW~qv~l~~lils~N~--l~~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~ 114 (565)
T KOG0472|consen 39 ENWWEQVDLQKLILSHND--LEVLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLI 114 (565)
T ss_pred hhhhhhcchhhhhhccCc--hhhccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhh
Confidence 334455567777888777 5666777888888888888888887 88888999999999999999887 8888899999
Q ss_pred CccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecc
Q 043053 194 ELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMIS 273 (1058)
Q Consensus 194 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 273 (1058)
+|+.|+.+.|.+. .+|+.++.+..|+.|+..+|++. ..|+.+.++.+|..|++.+|++....|..+. |+.|++||..
T Consensus 115 ~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~ 191 (565)
T KOG0472|consen 115 SLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCN 191 (565)
T ss_pred hhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccc
Confidence 9999999999888 78888888889999999999888 6788888888999999999998865555555 8899999998
Q ss_pred cCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccC
Q 043053 274 DNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASV 353 (1058)
Q Consensus 274 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 353 (1058)
.|.++ .+|..++.+.+|..|+|..|+|... | +|.+++.|.+|+++.|+|.....+...+++++..|||.+|+++ .+
T Consensus 192 ~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~l-P-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 192 SNLLE-TLPPELGGLESLELLYLRRNKIRFL-P-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred hhhhh-cCChhhcchhhhHHHHhhhcccccC-C-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cC
Confidence 88887 6778889999999999999999854 4 8999999999999999998554455568899999999999998 68
Q ss_pred cccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccc------------------------------
Q 043053 354 PAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR------------------------------ 403 (1058)
Q Consensus 354 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~------------------------------ 403 (1058)
|..+..+.+|.+||+++|.|+ ..|..++++ .|+.|.+.+|.+..+-.+
T Consensus 268 Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e 345 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTE 345 (565)
T ss_pred chHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccc
Confidence 999998999999999999998 577788988 899999998877522110
Q ss_pred --------c---ccCccccceeeccCccCCCCCCCcccCCcc---cchhhccCCccCCCCccccccCCCCC-eeecCCCc
Q 043053 404 --------E---IGGLKTLNFLDLSSNRLSGSVPDEIGDCTE---LQMIDLSHNTLQGSLPNSLSSLSGLQ-VLDVSDNR 468 (1058)
Q Consensus 404 --------~---~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~L~~N~ 468 (1058)
. ...+.+.+.|+++.-+++ .+|+....... .+..+++.|++.+ +|..+..+..+. .+.+++|.
T Consensus 346 ~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~e-lPk~L~~lkelvT~l~lsnn~ 423 (565)
T KOG0472|consen 346 TAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCE-LPKRLVELKELVTDLVLSNNK 423 (565)
T ss_pred ccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhh-hhhhhHHHHHHHHHHHhhcCc
Confidence 0 112346778888888888 45554433333 7888999999984 787777776664 45666776
Q ss_pred cccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCc
Q 043053 469 FSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPA 548 (1058)
Q Consensus 469 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~ 548 (1058)
++ .+|..++.+++|..|+|++|.+. .+|..++.+..|+.|++|.|++. .+|.....+..++ .+-.+.|++....+.
T Consensus 424 is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE-tllas~nqi~~vd~~ 499 (565)
T KOG0472|consen 424 IS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE-TLLASNNQIGSVDPS 499 (565)
T ss_pred cc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHH-HHHhccccccccChH
Confidence 65 89999999999999999999998 68899999999999999999998 8898887777776 366677999988888
Q ss_pred cccccccccEEecCCCcccCCCCcccccCcceeEEEeccccc
Q 043053 549 QISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFT 590 (1058)
Q Consensus 549 ~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~ 590 (1058)
.+.+|.+|..|||.+|.|...++.+.++++|++|+++||+|.
T Consensus 500 ~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 500 GLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 899999999999999999999999999999999999999998
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=351.17 Aligned_cols=265 Identities=28% Similarity=0.419 Sum_probs=205.0
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcc--cCCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGS--IRHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~ 781 (1058)
......++||+|.||.||||.+. ++.||||++... .++.|+.|-++++. |+|+||++++++-.
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--------------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--------------EKQSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH--------------HHHHHHhHHHHHhccCccchhHHHhhchhc
Confidence 34456679999999999999887 599999998432 35677777666654 57999999999887
Q ss_pred cCC----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCC------CCeEeCCCCCCcEEEcC
Q 043053 782 NRN----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCV------PPIVHRDIKANNILIGL 851 (1058)
Q Consensus 782 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~------~~ivHrDikp~Nill~~ 851 (1058)
..+ .+++|+||.+.|+|.+|++. ..++|....+|+..+++||+|||+... |+|+|||||++|||+..
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~ 351 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN 351 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence 655 78999999999999999986 579999999999999999999998644 68999999999999999
Q ss_pred CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCC------CCcccchhhHHHHHHHHHhCCCCCCC-C---
Q 043053 852 EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK------ITEKSDVYSYGVVVLEVLTGKQPIDP-T--- 921 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvvl~elltg~~P~~~-~--- 921 (1058)
|+++.|+|||+|..+..+.........+||.+|||||++.+.- .-.+.||||+|.|+|||++++.-++. .
T Consensus 352 DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~ 431 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE 431 (534)
T ss_pred CCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc
Confidence 9999999999999988766556666789999999999976542 22368999999999999997655431 1
Q ss_pred -----------CCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 922 -----------IPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 922 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
+|.-.++...+-++ ..+|.+...+... ..+..+.+.+..||+.||+.|.|+.-+.+.+.++...
T Consensus 432 Yqlpfe~evG~hPt~e~mq~~VV~k----K~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 432 YQLPFEAEVGNHPTLEEMQELVVRK----KQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred ccCchhHHhcCCCCHHHHHHHHHhh----ccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 11112222222222 2233333322221 3334445678889999999999999999988887654
Q ss_pred h
Q 043053 991 R 991 (1058)
Q Consensus 991 ~ 991 (1058)
.
T Consensus 507 ~ 507 (534)
T KOG3653|consen 507 W 507 (534)
T ss_pred C
Confidence 3
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=358.62 Aligned_cols=261 Identities=31% Similarity=0.445 Sum_probs=203.5
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
..|...+.||+|+||+||++ ..++|+..|||.+... .....+.+.+|+.++.+++|||||+++|....
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~-----------~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~ 85 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE-----------DSPTSESLEREIRILSRLNHPNIVQYYGSSSS 85 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc-----------cchhHHHHHHHHHHHHhCCCCCEEeeCCcccc
Confidence 45778899999999999999 5556999999987432 11126779999999999999999999998555
Q ss_pred CC--CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC-CCCeeeec
Q 043053 783 RN--NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-EFEPYIAD 859 (1058)
Q Consensus 783 ~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~D 859 (1058)
.. .+++.|||+++|+|.+++....+ .+++..+.+.++||++||+|||++ |||||||||+|||++. ++.+||+|
T Consensus 86 ~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 86 RENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred ccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEecc
Confidence 54 58999999999999999998654 899999999999999999999999 9999999999999999 79999999
Q ss_pred cccceeccC-CCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDD-GDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||+++.... ...........||+.|||||++..+ ...+++||||+||++.||+||+.||... ........ ....
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~--~ig~- 237 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALL--LIGR- 237 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHH--HHhc-
Confidence 999987663 1222334467899999999998853 3445999999999999999999999753 11111111 1111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
....|.++...+.+ +.+++..|+..||++||||++++++.......
T Consensus 238 -~~~~P~ip~~ls~~------a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 238 -EDSLPEIPDSLSDE------AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -cCCCCCCCcccCHH------HHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 11223333333332 23467779999999999999999976554433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=358.10 Aligned_cols=267 Identities=22% Similarity=0.252 Sum_probs=209.1
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCccccee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFL 777 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 777 (1058)
-.+.++|...+.||.|.||+||+| ...+|+.||||++..... .+..-.=.||+..++++. |||||++.
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~----------s~ee~~nLREvksL~kln~hpniikL~ 75 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY----------SWEECMNLREVKSLRKLNPHPNIIKLK 75 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc----------cHHHHHHHHHHHHHHhcCCCCcchhhH
Confidence 346789999999999999999999 677899999999865422 122233468999999999 99999999
Q ss_pred eEEEcCC-CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 778 GCCWNRN-NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 778 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
+++.+.+ ..|+|||||+. +|+++++++ +..+++..++.|+.||++||+|+|++ |+.|||+||+|||+.....+|
T Consensus 76 Evi~d~~~~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iK 150 (538)
T KOG0661|consen 76 EVIRDNDRILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIK 150 (538)
T ss_pred HHhhccCceEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeE
Confidence 9999988 88999999966 999999987 78999999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCcccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH---
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG-YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV--- 932 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~--- 932 (1058)
|+|||+||.+.... ..+..+.|..|.|||++ +...|+.+.||||+|||++|+.+-++-|.+... .+++....
T Consensus 151 iaDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~VL 226 (538)
T KOG0661|consen 151 IADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEVL 226 (538)
T ss_pred ecccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHHh
Confidence 99999999887653 34567889999999975 567889999999999999999999988865421 11111100
Q ss_pred ---------HhhcCccccCCCCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 933 ---------RQKKGIQVLDPSLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 933 ---------~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
+.......+.-.+....+..+. ...++.+++.+|+.+||++||||+|++++--
T Consensus 227 GtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 227 GTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred CCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 0000000111111111111111 2234566888999999999999999998653
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=372.35 Aligned_cols=380 Identities=25% Similarity=0.238 Sum_probs=225.1
Q ss_pred cEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccC
Q 043053 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDN 275 (1058)
Q Consensus 196 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 275 (1058)
+.|++++|++...-+..|.++++|++++|.+|.++ .+|...+...+|+.|+|.+|.|+.+-...+..++.|+.|||+.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 44666666666555555666666666666666665 45554444455666666666666555555556666666666666
Q ss_pred ccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcc
Q 043053 276 NVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPA 355 (1058)
Q Consensus 276 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 355 (1058)
.|+.+....|..-.++++|+|++|+|+.+..+.|..+.+|..|.|++|+|+...+..|..++.|+.|+|..|+|.-.---
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l 239 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL 239 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhh
Confidence 66655555555555666666666666666666666666666666666666655555555566666666666665522233
Q ss_pred cccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCccc
Q 043053 356 GLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTEL 435 (1058)
Q Consensus 356 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 435 (1058)
.|.++++|+.|.|..|+|+......|..|.++++|+|..|++..+...++-+|+.|+.|+||+|.|..+.++.+...++|
T Consensus 240 tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL 319 (873)
T KOG4194|consen 240 TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL 319 (873)
T ss_pred hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccc
Confidence 44455555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred chhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCC---cccCCcccccccc
Q 043053 436 QMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPS---SLGLCSSLQLLDL 512 (1058)
Q Consensus 436 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~l 512 (1058)
++|+|++|+|+...+..|..|.+|++|+|++|+++..-...|..+.+|++|||++|.|+..+.+ .|.++++|+.|++
T Consensus 320 ~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l 399 (873)
T KOG4194|consen 320 KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRL 399 (873)
T ss_pred eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheee
Confidence 5555555555555555555555555555555555544444555555555555555555543322 3444555555555
Q ss_pred cCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCC-CCcccccCcceeEEEecccccc
Q 043053 513 SSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGN-LNPLAQLDNLVSLNISYNKFTG 591 (1058)
Q Consensus 513 ~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~l~~L~~L~l~~N~l~~ 591 (1058)
.||+| ..+...+|.++++|++|||.+|.|.+. +.+|..+ +|+.|-+..-.+-|
T Consensus 400 ~gNql-------------------------k~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflC 453 (873)
T KOG4194|consen 400 TGNQL-------------------------KSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLC 453 (873)
T ss_pred cCcee-------------------------eecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEE
Confidence 55555 445556788888899999999988774 4677777 88888887777777
Q ss_pred cCCCccccccC
Q 043053 592 YLPDNKLFRQL 602 (1058)
Q Consensus 592 ~~~~~~~~~~~ 602 (1058)
.|...+..+|+
T Consensus 454 DCql~Wl~qWl 464 (873)
T KOG4194|consen 454 DCQLKWLAQWL 464 (873)
T ss_pred eccHHHHHHHH
Confidence 77665544444
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=345.24 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=218.6
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
...+|++.+.||+|.||+|-+| +...|+.||||.|++... ++++..-.+++|+++|..++||||+.+|.+|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI--------kdeqDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI--------KDEQDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc--------ccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 4468889999999999999999 778899999999976643 4556678899999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
...+...+||||..+|.|+||+.++ +.+++..+..+++||..|+.|+|.+ ++||||+|.+|||+|.++.+||+||
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence 9999999999999999999999874 7899999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
|++-.+..+.+ .++++|++-|.+||...+.+|. +..|.||+||+||.++.|.+||++. +....+++.....
T Consensus 198 GLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs~Ga 269 (668)
T KOG0611|consen 198 GLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQISRGA 269 (668)
T ss_pred chhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhhccc
Confidence 99998876543 4578999999999999999885 7899999999999999999999753 3444455554444
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
...|..... +..+|+||+..+|++|.|+.+|..+-+
T Consensus 270 YrEP~~PSd----------A~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 270 YREPETPSD----------ASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ccCCCCCch----------HHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 444433221 334889999999999999999987653
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=369.78 Aligned_cols=369 Identities=20% Similarity=0.210 Sum_probs=308.4
Q ss_pred CceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeeccc
Q 043053 147 MTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQ 226 (1058)
Q Consensus 147 L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 226 (1058)
-+.|++++|.+....+..|.++++|+.+++..|.++ .+|...+...+|+.|+|.+|.|+.+-.+.+..++.|+.|||+.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 356888888888788888888888888888888887 7887777777788888888888866666777888888888888
Q ss_pred ccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCC
Q 043053 227 NSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIP 306 (1058)
Q Consensus 227 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 306 (1058)
|.|....-..|..-.++++|+|++|.|+......|.++.+|..|.|++|+|+...+..|..+++|+.|+|..|+|.-+.-
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 88886555667777788888888888888778888888888888888888888778888888888888888888886667
Q ss_pred CcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCC
Q 043053 307 PEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSS 386 (1058)
Q Consensus 307 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 386 (1058)
-.|.++++|+.|.|..|.|......+|.++.+++.|+|+.|+++..-..++++++.|+.|+|++|.|..+.++.+..+++
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk 318 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK 318 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc
Confidence 78888888888888888888888888888888888888888888777788888888888888888888888888888888
Q ss_pred CcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCc---cccccCCCCCeee
Q 043053 387 LVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLP---NSLSSLSGLQVLD 463 (1058)
Q Consensus 387 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~ 463 (1058)
|++|+|++|+|+...+..|..|..|++|.|++|+|+.+-..+|..+++|+.|||++|.|+..+. ..|.+|++|+.|+
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 8888888888888888888888888888888888887777888888888888888888875544 3577888888888
Q ss_pred cCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcc
Q 043053 464 VSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQL 517 (1058)
Q Consensus 464 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 517 (1058)
|.+|+|..+...+|..+.+|++|+|.+|.|..+-|++|..+ .|++|.+..-.+
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF 451 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence 88888885555788888888888888888888888888888 888887765433
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=356.32 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=208.4
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...++||+|+||.||+| +..+++.||+|++... ..+...+++++|+.++.+++++||.++|+.+..+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le----------~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE----------EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechh----------hcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 4566689999999999999 8889999999999644 3445578899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...|++||||.||++.+.++. +..+++....-|.+++..|+.|+|.+ +.+|||||+.||++..+|.||++|||.+
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred ccHHHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence 999999999999999999986 35558888888999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
........ ...+++||+.|||||++.+..|+.|+||||+|++.|||.+|.+|+...+|...-+ .......|
T Consensus 159 ~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------lIpk~~PP 229 (467)
T KOG0201|consen 159 GQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------LIPKSAPP 229 (467)
T ss_pred eeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------eccCCCCC
Confidence 88766543 3378899999999999999999999999999999999999999998776622110 01111223
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+.......+.+ ++..|+++||+.||+|.+++++
T Consensus 230 ~L~~~~S~~~kE------FV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKE------FVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHH------HHHHHhhcCcccCcCHHHHhhh
Confidence 333333333333 5566999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=362.26 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=208.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
..|...+.||+|+.|.||.| +..+++.||||++... .+..++-+..|+.+|+..+|+|||.+++.|..
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-----------~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv 341 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-----------KQPKKELLLNEILVMRDLHHPNIVNFLDSYLV 341 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEec-----------cCCchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence 56777789999999999999 7788999999998433 33346778899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..|+||||++||+|.|.+.. ..+++.++..|++.+++||+|||.+ +|+|||||.+|||++.+|.+||+|||+
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGF 415 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGF 415 (550)
T ss_pred cceeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeee
Confidence 9999999999999999999975 5599999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+..+.... ....+.+|||.|||||+.....|++|.||||||++++||+.|.+||-...|- .....+...... .
T Consensus 416 caqi~~~~--~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--rAlyLIa~ng~P---~ 488 (550)
T KOG0578|consen 416 CAQISEEQ--SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNGTP---K 488 (550)
T ss_pred eecccccc--CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--HHHHHHhhcCCC---C
Confidence 98877654 2455778999999999999999999999999999999999999999754332 222222222211 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
-.........+. ++..+||..||++||++.|++++-
T Consensus 489 lk~~~klS~~~k------dFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 489 LKNPEKLSPELK------DFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred cCCccccCHHHH------HHHHHHhhcchhcCCCHHHHhcCh
Confidence 111222333333 356679999999999999999863
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.48 Aligned_cols=242 Identities=29% Similarity=0.475 Sum_probs=201.3
Q ss_pred cccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCc
Q 043053 707 VDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR 786 (1058)
Q Consensus 707 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 786 (1058)
...+.||.|+-|.||.|+.. ++.||||+++ +.=..+|.-+++++||||+.+.|+|.....+
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~------------------elkETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVR------------------ELKETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHh------------------hhhhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 44678999999999999988 7899999873 2224678899999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceec
Q 043053 787 LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV 866 (1058)
Q Consensus 787 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~ 866 (1058)
+||||||+.|-|.+.++. +..+.......|..+||.||.|||.+ .|||||||.-||||..+..|||+|||.++..
T Consensus 188 CIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred EEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhh
Confidence 999999999999999987 46788899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCC
Q 043053 867 DDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLL 946 (1058)
Q Consensus 867 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1058)
.+. .....++||..|||||++...+.+.|.||||||||||||+||..||....... +....+...+.-.++
T Consensus 263 ~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwGVGsNsL~LpvP 333 (904)
T KOG4721|consen 263 SDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWGVGSNSLHLPVP 333 (904)
T ss_pred hhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEeccCCcccccCc
Confidence 543 34456889999999999999999999999999999999999999997542110 111222233332222
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 947 SRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 947 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
..++ +-+++ ++++||+..|..||++.+++.+++-.
T Consensus 334 stcP----~Gfkl--L~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 334 STCP----DGFKL--LLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCc----hHHHH--HHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 2222 22333 67889999999999999999998643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=361.61 Aligned_cols=262 Identities=29% Similarity=0.409 Sum_probs=207.6
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+++...+.||+|.||+||+|.+. ..||||++.... -..+..+.|+.|+.++++-+|.||+-+.||+..+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~---------pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDD---------PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred HHhhccceeccccccceeecccc--cceEEEEEecCC---------CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 45567889999999999999886 368999985442 2344689999999999999999999999999887
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
.. .||+-+|+|-+|+.+++-. ...++..+.+.||+|||+||.|||.+ +|||||+|..||++.+++.|||+|||++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 76 9999999999999999975 47899999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
.....-..........|...|||||+++. .+|++.+||||||+|+|||++|..||....++ + +.-..+...
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--q----IifmVGrG~ 609 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--Q----IIFMVGRGY 609 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--h----eEEEecccc
Confidence 75433211122334457889999999764 46899999999999999999999999833221 1 111122222
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
+.+........+..++. .++..||..++++||.+.+|+..|+++...
T Consensus 610 l~pd~s~~~s~~pk~mk---~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 610 LMPDLSKIRSNCPKAMK---RLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cCccchhhhccCHHHHH---HHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 22332222233333443 367789999999999999999998887664
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=371.36 Aligned_cols=262 Identities=27% Similarity=0.440 Sum_probs=215.6
Q ss_pred hhccccceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
....+.++||.|.||+||+|.++ ....||||.++.. ..+..+.+|..|+.+|.++.||||+++.|+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----------ytekqrrdFL~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----------YTEKQRRDFLSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC----------ccHHHHhhhhhhhhhcccCCCCcEEEEEEE
Confidence 45567899999999999999554 2356999998533 456678999999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
.......+||+|||++|+|+.||+.++ +.+.+-+...+.++||.||.||.+. ++|||||.++|||++.+..+||+|
T Consensus 699 VTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsD 774 (996)
T KOG0196|consen 699 VTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSD 774 (996)
T ss_pred EecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecc
Confidence 999999999999999999999999875 6699999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccc--cCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhc
Q 043053 860 FGLAKLVDDGDFARSSNTV--AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
||+++..+++. ....++. .-+.+|.|||.+...+++.++||||||+|+||.++ |..||.+.. +.++...+++..
T Consensus 775 FGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--NQdVIkaIe~gy 851 (996)
T KOG0196|consen 775 FGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVIKAIEQGY 851 (996)
T ss_pred ccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--hHHHHHHHHhcc
Confidence 99999876543 2222222 23679999999999999999999999999999887 999997653 334444444432
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~ 993 (1058)
. -|..++.| . .+..+|..||++|..+||.++||+..|..+-.....
T Consensus 852 R----LPpPmDCP----~---aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 852 R----LPPPMDCP----A---ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred C----CCCCCCCc----H---HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 1 12222222 2 244588899999999999999999999988665443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=356.46 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=207.5
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.|||| +..+.+.||+|.+.+. ...+...+.+.+|++++++++|||||.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~---------gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS---------GRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhc---------CCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 57888899999999999999 6667899999998544 2445557889999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....|+|+||+.| +|..++.. .+.++++.+..|+.|+..||.|||+. +|+|||+||+|||+++.|.+|+||||+
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 9999999999987 99999986 57899999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+...... ...+...|||-|||||+..+.+|+..+|+||+||++|||++|++||... .+.+.++..... +
T Consensus 147 Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d---~ 216 (808)
T KOG0597|consen 147 ARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKD---P 216 (808)
T ss_pred hhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcC---C
Confidence 99765533 4456778999999999999999999999999999999999999999643 233333322211 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
...+.....+.. .++...+.+||..|.|..+++.+-
T Consensus 217 v~~p~~~S~~f~------nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 217 VKPPSTASSSFV------NFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred CCCcccccHHHH------HHHHHHhhcChhhcccHHHHhcCh
Confidence 111122222222 345557999999999999988753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=321.87 Aligned_cols=260 Identities=26% Similarity=0.357 Sum_probs=206.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+++|+|.||.||+| +..+|+.||||++... ...+.......||+..++.++|+||+.++++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~---------~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLG---------NAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecc---------ccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 46788899999999999999 8889999999999644 2344456678999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+...+|+||++. +|+..++.. ...++..++..++.++++|++|+|++ .|+||||||.|+|++.+|.+||+|||+
T Consensus 73 ~~~l~lVfEfm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 73 KSNLSLVFEFMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred CCceEEEEEeccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence 9999999999987 999999875 57899999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc---
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI--- 938 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--- 938 (1058)
|+.+..... ..+..+-|..|.|||.+.+. .|+...||||.||++.||+-|.+-|.+.. +-+++....+.-...
T Consensus 148 Ar~f~~p~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-DidQL~~If~~LGTP~~~ 224 (318)
T KOG0659|consen 148 ARFFGSPNR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-DIDQLSKIFRALGTPTPD 224 (318)
T ss_pred hhccCCCCc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-hHHHHHHHHHHcCCCCcc
Confidence 999887653 33344789999999987765 68999999999999999999876665432 222222222211100
Q ss_pred --------------c-ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 --------------Q-VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 --------------~-~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. ...+......+.... .+++++..++..||.+|++++|++++
T Consensus 225 ~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~---d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 225 QWPEMTSLPDYVKIQQFPKPPLNNLFPAASS---DALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cCccccccccHHHHhcCCCCccccccccccH---HHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 000011101111112 34678889999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.03 Aligned_cols=259 Identities=24% Similarity=0.308 Sum_probs=207.8
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGC 779 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 779 (1058)
....|...+.||+|+||+|+.| ...+|+.||||++....... .. ....+.+.+|+.++++++ ||||++++++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~-----~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev 88 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSS-----KS-QKLDELIKREISILRRLRSHPNIIRLLEV 88 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccc-----cc-cccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence 4468899999999999999999 66788999999765431110 11 234567779999999999 9999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC-CCeeee
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE-FEPYIA 858 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~-~~~kl~ 858 (1058)
+.....+|+||||+.||+|.+++.. .+.+.+..+.++++|++.|++|+|++ ||+||||||+||+++.+ +.+||+
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEe
Confidence 9999999999999999999999987 47788899999999999999999999 99999999999999999 999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK-IT-EKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|||++..... ......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .....+...
T Consensus 164 DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----~~~l~~ki~ 236 (370)
T KOG0583|consen 164 DFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----VPNLYRKIR 236 (370)
T ss_pred ccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----HHHHHHHHh
Confidence 9999987741 124556889999999999999877 75 78999999999999999999998632 111122211
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
.....-|.... .. ++..++.+|+.+||.+|+|+.+++.+-+.
T Consensus 237 ~~~~~~p~~~~--S~------~~~~Li~~mL~~~P~~R~t~~~i~~h~w~ 278 (370)
T KOG0583|consen 237 KGEFKIPSYLL--SP------EARSLIEKMLVPDPSTRITLLEILEHPWF 278 (370)
T ss_pred cCCccCCCCcC--CH------HHHHHHHHHcCCCcccCCCHHHHhhChhh
Confidence 11111121111 22 23447778999999999999999965443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=352.02 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=206.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|+..++||+||||+||.| +..+|..+|+|++.+..+. .....+.++.|-.+|....+|.||++|..|.+
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~--------~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML--------KKNQVEHVRAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH--------hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence 57889999999999999999 6778999999999776543 33456788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..|+||||++||++..+|.. .+.+++..+...+.+++-|++.+|+. |+|||||||+|+|||..|++||+|||+
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccc
Confidence 9999999999999999999986 47899999999999999999999999 999999999999999999999999999
Q ss_pred ceeccC----------------------CCccc-----c------------------cccccCcCCccCccccccCCCCc
Q 043053 863 AKLVDD----------------------GDFAR-----S------------------SNTVAGSYGYIAPEYGYMMKITE 897 (1058)
Q Consensus 863 ~~~~~~----------------------~~~~~-----~------------------~~~~~gt~~y~aPE~~~~~~~~~ 897 (1058)
+.-+.. .+... . ....+|||.|||||++.+..|+.
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 843211 01110 0 12367999999999999999999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCCCCCh--hHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC
Q 043053 898 KSDVYSYGVVVLEVLTGKQPIDPTIPDGS--HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERP 975 (1058)
Q Consensus 898 ~~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP 975 (1058)
.+|.||+|||+|||+.|.+||....|... .+..|...-... ... ... .++.++|.+|+. ||+.|.
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP---~~~---~~s------~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP---EEV---DLS------DEAKDLITRLLC-DPENRL 434 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC---CcC---ccc------HHHHHHHHHHhc-CHHHhc
Confidence 99999999999999999999987766432 334443322111 111 111 334557777777 999997
Q ss_pred ---CHHHHHHHH
Q 043053 976 ---TMKDVAAML 984 (1058)
Q Consensus 976 ---t~~~v~~~l 984 (1058)
.++||.++-
T Consensus 435 G~~G~~EIK~HP 446 (550)
T KOG0605|consen 435 GSKGAEEIKKHP 446 (550)
T ss_pred CcccHHHHhcCC
Confidence 477777654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=362.24 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=202.1
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
++|.+.++||+|+||.||+|.. .+++.||||++... ......+.+.+|+.++.++ +||||+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~niv~~ 76 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG----------ATASEHKALMSELKILIHIGNHLNVVNL 76 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc----------cchHHHHHHHHHHHHHHHhccCcceeeE
Confidence 5788999999999999999953 23568999988532 1223356789999999999 89999999
Q ss_pred eeEEEcCC-CceEEEEecCCCChhhhhhhcC-------------------------------------------------
Q 043053 777 LGCCWNRN-NRLLMYDYMPNGSLGSLLHERT------------------------------------------------- 806 (1058)
Q Consensus 777 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------- 806 (1058)
++++...+ ..++||||+++|+|.++++...
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (338)
T cd05102 77 LGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS 156 (338)
T ss_pred EeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence 99887654 5789999999999999987531
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCccccc
Q 043053 807 -----------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875 (1058)
Q Consensus 807 -----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~ 875 (1058)
..++++..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 233 (338)
T cd05102 157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 233 (338)
T ss_pred cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcc
Confidence 13477888999999999999999998 9999999999999999999999999999865433222222
Q ss_pred ccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHH
Q 043053 876 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEID 954 (1058)
Q Consensus 876 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 954 (1058)
....++..|+|||++.+..++.++|||||||++|||++ |..||...... ........... ........+ .
T Consensus 234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~-----~~~~~~~~~---~ 304 (338)
T cd05102 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGT-----RMRAPENAT---P 304 (338)
T ss_pred cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcCC-----CCCCCCCCC---H
Confidence 33456789999999998899999999999999999997 99999754322 12222111111 111111111 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 955 EMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 955 ~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
.+..++.+||+.||++|||+.++++.|+++..
T Consensus 305 ---~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 305 ---EIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23457888999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=346.01 Aligned_cols=265 Identities=29% Similarity=0.420 Sum_probs=219.2
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+...++++||+|-||+|..+....+..||||++++. .....+.+|.+|+++|.+++|||||+++|+|..+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~----------a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD----------ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcc----------cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 345678999999999999998887899999999754 3444578999999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+.+++||||+++|+|.+|+.++...........+|+.|||.||+||.+. ++||||+.++|+|++.++++||+|||++
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 9999999999999999999886544456666778999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT--GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+-.-.+++.+.....+-+.+|||||.+.-++++.++|||+||+++||+++ ...||...+++ ++.+-.... .....
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~-~~~~~ 761 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEF-FRDQG 761 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhh-cCCCC
Confidence 98877887777777778899999999999999999999999999999877 67898765432 222111110 01111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
......+|..+...+. +++..||..|-++||+++++..+|++.
T Consensus 762 ~~~~l~~P~~cp~~ly---elml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLY---ELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHH---HHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2233445555555554 478999999999999999999988764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=342.65 Aligned_cols=272 Identities=22% Similarity=0.290 Sum_probs=207.0
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcc---cchHHHHHHHHHHHcccCCCcccc
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEK---SGVRDSFSAEIKTLGSIRHKNIVR 775 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~ 775 (1058)
...+++|+..+.||+|.||.|-+| +..+++.||||++.+............. ..-.+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 456789999999999999999999 6778999999999766544433322222 122468999999999999999999
Q ss_pred eeeEEEcC--CCceEEEEecCCCChhhhhhhcCCCC-CCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 776 FLGCCWNR--NNRLLMYDYMPNGSLGSLLHERTGNA-LEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 776 ~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
++.+..++ +..|+|+|||..|.+...=. ..+ +.+.+++++++++..||+|||.+ |||||||||+|+|++++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 99999764 56799999999888765432 344 89999999999999999999999 99999999999999999
Q ss_pred CCeeeeccccceeccCCC---cccccccccCcCCccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043053 853 FEPYIADFGLAKLVDDGD---FARSSNTVAGSYGYIAPEYGYMMK----ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG 925 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 925 (1058)
|+|||+|||.+..+..+. ........+|||.|+|||.+.+.. .+.+.||||+||+||.|+.|+.||....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--- 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--- 323 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---
Confidence 999999999998663221 112233478999999999876632 3568899999999999999999997431
Q ss_pred hhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
..+...... ...+......++.+.. .+++.++|++||+.|.+..+|..+.+..+.
T Consensus 324 --~~~l~~KIv-----n~pL~fP~~pe~~e~~--kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 --ELELFDKIV-----NDPLEFPENPEINEDL--KDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred --HHHHHHHHh-----cCcccCCCcccccHHH--HHHHHHHhhcChhheeehhhheecceeccC
Confidence 111111111 1111111111233333 347888999999999999999988765443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=355.29 Aligned_cols=252 Identities=27% Similarity=0.360 Sum_probs=208.7
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.-|..++-||+|+.|.|..| +..+|+.+|||++.+.. .-.+.....+.+|+-+|+-+.||||+++|+++++
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--------~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~ 83 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--------ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN 83 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccc--------ccccccccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence 34677889999999999999 77899999999995442 2334456788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
...+|+|.||++||-|.+++.+ .+++++..+.++++||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+
T Consensus 84 ~~~lylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred CceEEEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccce
Confidence 9999999999999999999987 47899999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
|....++ ....+.||++.|+|||++.+.+|. .++||||.|||||.|++|+.||++. ..............-
T Consensus 159 AsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlKV~~G~f~ 230 (786)
T KOG0588|consen 159 ASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLKVQRGVFE 230 (786)
T ss_pred eecccCC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHHHHcCccc
Confidence 9876554 345678999999999999999885 7899999999999999999999732 222222222211111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
-| ...+.+ +.+++++|+..||++|.|++||.++..
T Consensus 231 MP---s~Is~e------aQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 231 MP---SNISSE------AQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred CC---CcCCHH------HHHHHHHHhccCccccccHHHHhhCch
Confidence 11 222222 344677799999999999999998753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=343.82 Aligned_cols=265 Identities=25% Similarity=0.350 Sum_probs=209.5
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
...+.|+..+.||+|.||.||+| +..+|+.||+|+++.. ..++.......|||.+|+++.||||+++.+.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d---------~~~~~~~~t~~REI~ILr~l~HpNIikL~ei 184 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFD---------NEKEGFPITAIREIKILRRLDHPNIIKLEEI 184 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecc---------cCCCcchHHHHHHHHHHHhcCCCcccceeeE
Confidence 34467788899999999999999 8889999999999654 2456667888999999999999999999999
Q ss_pred EEcC--CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeee
Q 043053 780 CWNR--NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857 (1058)
Q Consensus 780 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl 857 (1058)
..+. ...|+|+|||+. ||.-++... +..+++.++..++.|++.||+|+|++ ||+|||||.+|||||.+|.+||
T Consensus 185 vt~~~~~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 185 VTSKLSGSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred EEecCCceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEe
Confidence 9876 678999999988 998888753 56899999999999999999999999 9999999999999999999999
Q ss_pred eccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
+|||+|+.+..... ...+..+-|..|.|||.+.+ ..|+.+.|+||.|||+.||+.|++.|.+...- .++-..++...
T Consensus 260 aDFGLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcG 337 (560)
T KOG0600|consen 260 ADFGLARFYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCG 337 (560)
T ss_pred ccccceeeccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhC
Confidence 99999998876543 33567778999999998775 47999999999999999999999999765321 11111111100
Q ss_pred --Cc-----------cccCCCCCCCCchhHHHH-----HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 --GI-----------QVLDPSLLSRPESEIDEM-----LQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 --~~-----------~~~~~~~~~~~~~~~~~~-----~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. ..+.+. ......+.+. ..+++++..+|..||++|.||.+++..
T Consensus 338 SP~e~~W~~~kLP~~~~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 338 SPTEDYWPVSKLPHATIFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCChhccccccCCcccccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00 001110 0111222222 234668888999999999999999863
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=314.43 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=215.0
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.+.|++++.||+|-||.||.| ..+++-.||+|++.+... .......++.+|+++-+.++||||+++|+||.
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi--------~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI--------LKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH--------HHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 467899999999999999999 667789999999976643 34456789999999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+....|+++||..+|++...++++....+++...+.+..|+|.|+.|+|.. ++|||||||+|+|++.++..|++|||
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCC
Confidence 999999999999999999999987788899999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
.+..... ....+.+||..|.|||+..+..++...|+|++|++.||++.|..||.... .. +.++........
T Consensus 170 wsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~----etYkrI~k~~~~ 240 (281)
T KOG0580|consen 170 WSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HS----ETYKRIRKVDLK 240 (281)
T ss_pred ceeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hH----HHHHHHHHcccc
Confidence 9876542 33457889999999999999999999999999999999999999998653 11 222222222233
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.| ...... +.+++..|+.++|.+|.+..|++++-+
T Consensus 241 ~p---~~is~~------a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 241 FP---STISGG------AADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred CC---cccChh------HHHHHHHHhccCccccccHHHHhhhHH
Confidence 33 222222 334677799999999999999988754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.22 Aligned_cols=270 Identities=29% Similarity=0.403 Sum_probs=218.1
Q ss_pred HHHHhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc--CCCccccee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI--RHKNIVRFL 777 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~ 777 (1058)
..+.++....+.||+|.||+||+|++. |+.||||+|... ..+.+.+|.++++.. +|+||+.++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--------------dE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--------------DERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc--------------chhhhhhHHHHHHHHHhccchhhhhh
Confidence 345578889999999999999999998 999999999532 134566777776654 899999999
Q ss_pred eEEEcCC----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhccccc-----CCCCeEeCCCCCCcEE
Q 043053 778 GCCWNRN----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHD-----CVPPIVHRDIKANNIL 848 (1058)
Q Consensus 778 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivHrDikp~Nil 848 (1058)
++-..+. +.|+|++|.+.|+|.||+.+ ..++....++++..+|.||+|||.. +-|.|.|||||+.|||
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 9876543 35899999999999999986 6789999999999999999999964 4489999999999999
Q ss_pred EcCCCCeeeeccccceeccCCC--cccccccccCcCCccCccccccCCC------CcccchhhHHHHHHHHHhC------
Q 043053 849 IGLEFEPYIADFGLAKLVDDGD--FARSSNTVAGSYGYIAPEYGYMMKI------TEKSDVYSYGVVVLEVLTG------ 914 (1058)
Q Consensus 849 l~~~~~~kl~DfGl~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwSlGvvl~elltg------ 914 (1058)
+.+++.+.|+|+|+|....... .....+..+||.+|||||++...-. -..+||||||.|+||+..+
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 9999999999999998776542 2334567889999999998764321 1358999999999999863
Q ss_pred ----CCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 915 ----KQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 915 ----~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
+.||.+..|.+..+.+ ++.....+.+.|.+..++.. .+.+..+.++|+.||..+|..|-|+-.+.+.+.++..
T Consensus 429 ~eey~~Pyyd~Vp~DPs~ee-MrkVVCv~~~RP~ipnrW~s-~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSDPSFEE-MRKVVCVQKLRPNIPNRWKS-DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ehhhcCCcccCCCCCCCHHH-HhcceeecccCCCCCccccc-CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 4688887776666554 44455566677776665443 3556666779999999999999999999999888764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=377.91 Aligned_cols=259 Identities=28% Similarity=0.436 Sum_probs=212.3
Q ss_pred hccccceeccccceEEEEEEec--CCc----EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 705 CLVDANVIGKGCSGVVYRADMD--NGE----VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
..+..+.||+|+||.||+|... .|. .||||.+.+. .+++...+|.+|+.+|+.++|||||+++|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----------~~~~~~~~Fl~Ea~~m~~f~HpNiv~liG 762 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----------SSEQEVSDFLKEALLMSKFDHPNIVSLIG 762 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----------CCHHHHHHHHHHHHHHhcCCCcceeeEEE
Confidence 4566789999999999999543 343 3899988543 35566889999999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcC-----CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERT-----GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
++.+....++++|||+||+|..||++.+ ...+.....+.++.|||+|+.||+++ ++|||||.++|+|++...
T Consensus 763 v~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r 839 (1025)
T KOG1095|consen 763 VCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERR 839 (1025)
T ss_pred eecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccC
Confidence 9999999999999999999999998742 45688899999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHH-H
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVD-W 931 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~-~ 931 (1058)
.|||+|||+|+.+-..++++......-...|||||.+.+..++.|+|||||||++||++| |..||... ...++.. +
T Consensus 840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~--~n~~v~~~~ 917 (1025)
T KOG1095|consen 840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR--SNFEVLLDV 917 (1025)
T ss_pred cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc--chHHHHHHH
Confidence 999999999997666666555444445679999999999999999999999999999999 88999754 2233333 2
Q ss_pred HHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.+.. . ...|+.+.+.+ +++|..||+.+|++||++..+++.+..+...
T Consensus 918 ~~gg----R-----L~~P~~CP~~l---y~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 918 LEGG----R-----LDPPSYCPEKL---YQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HhCC----c-----cCCCCCCChHH---HHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 2222 1 22233333333 3588999999999999999999977766544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=319.63 Aligned_cols=203 Identities=26% Similarity=0.367 Sum_probs=183.7
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|+..+.||.|+||.|..+ ...+|..+|+|++.+..+. +....+....|..+++.+.||.++++++.+.
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV--------klKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV--------KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH--------HHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 467888999999999999999 5567999999999655432 2334577888999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+.+..|+||||++||.|.++++. .+.+++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEecc
Confidence 99999999999999999999987 47899999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 923 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 923 (1058)
.|+.... .+.+.+|||.|+|||++....+..++|-|||||++|||+.|.+||....+
T Consensus 190 FAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 190 FAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 9998764 25578999999999999999999999999999999999999999986544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=356.65 Aligned_cols=260 Identities=26% Similarity=0.394 Sum_probs=204.9
Q ss_pred cccceeccccceEEEEEEecC--C--cE-EEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 707 VDANVIGKGCSGVVYRADMDN--G--EV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 707 ~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
...++||+|+||.||+|.+.. + .. ||||..... .........+|.+|+++|++++|||||++||++.
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~--------~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS--------SELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeeccc--------ccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 445899999999999995443 2 23 899987531 1134556889999999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
.+..+++|||+|+||+|.++++... ..++..++.+++.++|.||+|||++ ++|||||.++|+|++.++.+||+|||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999999753 3699999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
+++.-. .+........-+.+|+|||.+....+++++|||||||++||+++ |..||.+... ..+..++... .
T Consensus 308 Ls~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v~~kI~~~----~ 379 (474)
T KOG0194|consen 308 LSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEVKAKIVKN----G 379 (474)
T ss_pred cccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--HHHHHHHHhc----C
Confidence 987543 11111112245679999999999999999999999999999999 8889976532 2333333111 1
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
.........+ .++. .++..||..+|++||+|.++.+.++.+.....
T Consensus 380 ~r~~~~~~~p---~~~~---~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 380 YRMPIPSKTP---KELA---KVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ccCCCCCCCH---HHHH---HHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1111111222 2222 25668999999999999999999998876544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=345.73 Aligned_cols=255 Identities=22% Similarity=0.252 Sum_probs=200.7
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
|...+.||+|+||+||+| ...+|+.||||.+..... ........+.+|++++++++|++|+++++++.+.+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~ 73 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--------KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh--------hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC
Confidence 677889999999999999 556899999999854321 11223456789999999999999999999999999
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 999999999999999988765455789999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1058)
...... ......||..|+|||++.+..++.++||||+||++|||++|+.||........ ...+..... .....
T Consensus 151 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~--~~~~~ 223 (285)
T cd05631 151 QIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVK--EDQEE 223 (285)
T ss_pred EcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhh--ccccc
Confidence 754322 22345799999999999999999999999999999999999999975432211 111111100 00011
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHH
Q 043053 945 LLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAML 984 (1058)
Q Consensus 945 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~l 984 (1058)
.....+. .+..++..||+.||++||+ +++++++-
T Consensus 224 ~~~~~s~------~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 224 YSEKFSE------DAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred CCccCCH------HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 1111122 2345788899999999997 78887753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=347.93 Aligned_cols=263 Identities=29% Similarity=0.432 Sum_probs=200.9
Q ss_pred hhccccceeccccceEEEEEEec-----------------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-----------------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 766 (1058)
++|.+.+.||+|+||.||+|... ++..||+|.+... .......+|.+|+++++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~ 74 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD----------ANKNARNDFLKEVKILS 74 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC----------CCHHHHHHHHHHHHHHh
Confidence 57888999999999999999543 2346999988532 12334678999999999
Q ss_pred ccCCCcccceeeEEEcCCCceEEEEecCCCChhhhhhhcC-----------------CCCCCHHHHHHHHHHHHHHhhcc
Q 043053 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT-----------------GNALEWELRYQILLGAAQGLAYL 829 (1058)
Q Consensus 767 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~L 829 (1058)
+++||||+++++++.+.+..++||||+++|+|.+++.... ...+++..+++++.|++.||+||
T Consensus 75 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 154 (304)
T cd05096 75 RLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL 154 (304)
T ss_pred hcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999986431 13468889999999999999999
Q ss_pred cccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHH
Q 043053 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVL 909 (1058)
Q Consensus 830 H~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ 909 (1058)
|+. +|+||||||+||+++.++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|
T Consensus 155 H~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 231 (304)
T cd05096 155 SSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231 (304)
T ss_pred HHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHH
Confidence 999 99999999999999999999999999998765544333333455688999999998888999999999999999
Q ss_pred HHHh--CCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 910 EVLT--GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 910 ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
||++ +..||..... .............. ........++.... .+.+++.+||+.||++|||+++|.+.|+
T Consensus 232 el~~~~~~~p~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 232 EILMLCKEQPYGELTD--EQVIENAGEFFRDQ-GRQVYLFRPPPCPQ---GLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHccCCCCCCcCCH--HHHHHHHHHHhhhc-cccccccCCCCCCH---HHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 9987 5667764422 22222211110000 00000111111112 2345788899999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=344.01 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=211.6
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.+|+|+||.++.+ ...++..+++|.+.... ..+..++....|+.++++++|||||.+.+.|.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~---------~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~ 73 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEK---------LTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE 73 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccc---------cCchhhHHHHHHHHHHHhccCCCeeeeccchh
Confidence 357888999999999999999 45567889999996442 23444568889999999999999999999999
Q ss_pred cCCC-ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 782 NRNN-RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 782 ~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
+++. .+|||+||+||++.+.+.++++..++++.+.+|+.|++.|+.|||+. .|+|||||+.||++++++.|||+||
T Consensus 74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDf 150 (426)
T KOG0589|consen 74 EDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDF 150 (426)
T ss_pred cCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecch
Confidence 9888 89999999999999999988788999999999999999999999998 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+|+...+.. ......+||+.||.||.+.+.+|..|+||||+||++|||++-+.+|.... -..+..-+-+..
T Consensus 151 GlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--m~~Li~ki~~~~---- 222 (426)
T KOG0589|consen 151 GLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--MSELILKINRGL---- 222 (426)
T ss_pred hhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--hHHHHHHHhhcc----
Confidence 9999887654 23457889999999999999999999999999999999999999997542 222222111111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
-..+ +.....++ ..++..|+.++|..||++.+++...
T Consensus 223 -~~Pl---p~~ys~el---~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 223 -YSPL---PSMYSSEL---RSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred -CCCC---CccccHHH---HHHHHHHhhcCCccCCCHHHHhhCh
Confidence 1112 22222223 2367789999999999999999863
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=377.61 Aligned_cols=505 Identities=27% Similarity=0.358 Sum_probs=349.3
Q ss_pred EEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCC-hhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhcc
Q 043053 29 LVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLP-SSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNA 107 (1058)
Q Consensus 29 L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp-~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n~ 107 (1058)
+|.+.++++ .+|..+..-..|..|++++|-+. ..| +.+.+..+|+.|||++|++. ..|..+..+.+|+.|+++.|.
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 677888877 78888877777899999999776 444 34556677999999999987 889999999999999999998
Q ss_pred ccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCc
Q 043053 108 LAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPA 187 (1058)
Q Consensus 108 ~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~ 187 (1058)
+. .+|.+++++.+|++|.+.+|. ...+|..+..+.+|++|+++.|++. ..|..+..++.+..+..++|.....
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~--l~~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~--- 152 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNR--LQSLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR--- 152 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccch--hhcCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh---
Confidence 87 788888888888888888776 5666666666666666666666665 6666666666666666666621111
Q ss_pred cccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCc
Q 043053 188 EIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSEL 267 (1058)
Q Consensus 188 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 267 (1058)
++... .+.++|..|.+.+.++..+..++. .|+|++|.+. ...+.++.+|+.|.+..|++.... -..++|
T Consensus 153 -lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l 221 (1081)
T KOG0618|consen 153 -LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSL 221 (1081)
T ss_pred -hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcch
Confidence 11111 555666666665555555555544 5666666554 123445555555655555554211 122444
Q ss_pred ceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccc
Q 043053 268 EEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHN 347 (1058)
Q Consensus 268 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 347 (1058)
+.|+.++|.+....+ -..-.+|+++++++|++++ +|+++..+.+|+.|+..+|
T Consensus 222 ~~L~a~~n~l~~~~~--------------------------~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N 274 (1081)
T KOG0618|consen 222 TALYADHNPLTTLDV--------------------------HPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHN 274 (1081)
T ss_pred heeeeccCcceeecc--------------------------ccccccceeeecchhhhhc-chHHHHhcccceEecccch
Confidence 555555554441111 1122345555556666553 4588999999999999999
Q ss_pred cccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccc-cceeeccCccCCCCCC
Q 043053 348 SLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKT-LNFLDLSSNRLSGSVP 426 (1058)
Q Consensus 348 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~ 426 (1058)
+++ .+|..++...+|+.|.+.+|.+. .+|+...+++.|++|+|..|+|...++..|.-+.. |+.|..+.|++....-
T Consensus 275 ~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~ 352 (1081)
T KOG0618|consen 275 RLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPS 352 (1081)
T ss_pred hHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccc
Confidence 997 68999999999999999999998 67778888999999999999999877766666655 8999999999985442
Q ss_pred CcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcc
Q 043053 427 DEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSS 506 (1058)
Q Consensus 427 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 506 (1058)
..=...+.|+.|++.+|.|+...-..+.+.++|+.|+|++|+|.......+.++..|++|+||+|+++ .+|..+..++.
T Consensus 353 ~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~ 431 (1081)
T KOG0618|consen 353 YEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGR 431 (1081)
T ss_pred ccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhh
Confidence 23335678999999999998877778899999999999999998555566788899999999999998 67888889999
Q ss_pred cccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcc-cCCCCcccccCcceeEEEe
Q 043053 507 LQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKL-EGNLNPLAQLDNLVSLNIS 585 (1058)
Q Consensus 507 L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~l~~L~~L~l~ 585 (1058)
|+.|...+|+|. ..| .+.+++.+. .+|+|+|+|+...-..-..-++|++|||++|.- .-....+..+..+..+++.
T Consensus 432 L~tL~ahsN~l~-~fP-e~~~l~qL~-~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~ 508 (1081)
T KOG0618|consen 432 LHTLRAHSNQLL-SFP-ELAQLPQLK-VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDIT 508 (1081)
T ss_pred hHHHhhcCCcee-ech-hhhhcCcce-EEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecc
Confidence 999999999987 555 554444443 355555555544222222224555555555542 2122334444444444444
Q ss_pred cc
Q 043053 586 YN 587 (1058)
Q Consensus 586 ~N 587 (1058)
-|
T Consensus 509 ~~ 510 (1081)
T KOG0618|consen 509 LN 510 (1081)
T ss_pred cC
Confidence 44
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.18 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=208.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+-|.++++||+|+||.||+| +..+|+.||||++.- +...+++.+|+.+|++++.|+||++||.|..
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-------------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK 99 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-------------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFK 99 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-------------cchHHHHHHHHHHHHHcCCchhhhhhhhhcc
Confidence 34667889999999999999 778899999998842 2347889999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....|+|||||-.|+..|.++.+ ++++.+..+..|+++-++||+|||.. .-||||||+.|||++.+|.+|++|||.
T Consensus 100 ~sDLWIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 100 HSDLWIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred CCceEeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccc
Confidence 99999999999999999999875 68899999999999999999999998 779999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|....+. .....++.||+.|||||++..-.|..++||||+|++..||..|++||.+-+|....+ -+..-.
T Consensus 176 AGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------MIPT~P 245 (502)
T KOG0574|consen 176 AGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------MIPTKP 245 (502)
T ss_pred cchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------eccCCC
Confidence 9766542 233467889999999999999999999999999999999999999998765532111 011111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
|.....|+...+++ -++++.|+-+.|++|-|+-++.++
T Consensus 246 PPTF~KPE~WS~~F---~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 246 PPTFKKPEEWSSEF---NDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCChHhhhhHH---HHHHHHHhcCCHHHHHHHHHHhhh
Confidence 22222333333333 347889999999999999988875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=339.14 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=198.1
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc----CC
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN----RN 784 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 784 (1058)
...||+|++|.||+|.. +|+.||||++.... .......+.|.+|+.++++++||||+++++++.+ ..
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFH--------KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccc--------cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 36899999999999977 48999999985431 1122335788899999999999999999999876 34
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||+++|+|.++++.. ..+++..+.+++.|++.|++|+|+.. +++||||||+||+++.++.+||+|||+++
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 578999999999999999863 57899999999999999999999731 77899999999999999999999999988
Q ss_pred eccCCCcccccccccCcCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....+ ......+.... ..
T Consensus 172 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~~~~~i~~~~----~~ 240 (283)
T PHA02988 172 ILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEIYDLIINKN----NS 240 (283)
T ss_pred hhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcC----CC
Confidence 654322 23468899999999876 6789999999999999999999999975422 22222221111 11
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
+......+. .+.+++.+||+.||++|||++++++.|++++.
T Consensus 241 ~~~~~~~~~------~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 LKLPLDCPL------EIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCcCcH------HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111111222 23347888999999999999999999988753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=352.81 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=202.8
Q ss_pred HhhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVR 775 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 775 (1058)
.++|.+.+.||+|+||.||+|.. .++..||||++... ......+.+.+|+++++.+ +||||++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~----------~~~~~~~~~~~Ei~il~~l~~HpnIv~ 103 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS----------AHLTEREALMSELKVLSYLGNHINIVN 103 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC----------cCcHHHHHHHHHHHHHHHhcCCcceee
Confidence 35788999999999999999942 34668999988532 1223356788999999999 7999999
Q ss_pred eeeEEEcCCCceEEEEecCCCChhhhhhhcC-------------------------------------------------
Q 043053 776 FLGCCWNRNNRLLMYDYMPNGSLGSLLHERT------------------------------------------------- 806 (1058)
Q Consensus 776 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------- 806 (1058)
+++++.+.+..++||||+++|+|.++++...
T Consensus 104 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 183 (375)
T cd05104 104 LLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA 183 (375)
T ss_pred eeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence 9999999999999999999999999986532
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 807 ------------------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 807 ------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
...+++..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~ 260 (375)
T cd05104 184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGL 260 (375)
T ss_pred ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCcc
Confidence 12578899999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ......++.....
T Consensus 261 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-~~~~~~~~~~~~~---- 335 (375)
T cd05104 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-DSKFYKMIKEGYR---- 335 (375)
T ss_pred ceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-hHHHHHHHHhCcc----
Confidence 986654322122223345678999999999999999999999999999998 8889865422 2222332222111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
+......+ . ++.+++.+||+.||++||+++++++.|++
T Consensus 336 -~~~~~~~~---~---~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 -MLSPECAP---S---EMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -CCCCCCCC---H---HHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11111111 1 23457888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.41 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=210.8
Q ss_pred hhccccceeccccceEEEEEEec---CCc--EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD---NGE--VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
+..+..++||.|.||.||+|.+. .|+ .||||..+.. ......+.|..|+.+|+.++|||||+++|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d----------~t~d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD----------CTPDDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC----------CChhhHHHHHHHHHHHHhCCCcchhheee
Confidence 34456789999999999999443 233 4788876533 23344789999999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++.+ ...|+|||.++-|.|.+|++.. ...++......++.||+.||+|||+. ++|||||..+|||+.....||++
T Consensus 459 v~~e-~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 459 VCVE-QPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred eeec-cceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence 9975 5789999999999999999875 47789999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++..+..+++... ...-+..|||||-+.-.+++.++|||.|||.+||++. |..||.+....+. .-
T Consensus 534 DFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--I~------- 603 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--IG------- 603 (974)
T ss_pred ccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--EE-------
Confidence 99999999887776554 4445779999999999999999999999999999988 9999987643221 10
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
..-.....+.|+.+... ++.++.+||+.+|.+||++.++...|.++..+..
T Consensus 604 -~iEnGeRlP~P~nCPp~---LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 604 -HIENGERLPCPPNCPPA---LYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred -EecCCCCCCCCCCCChH---HHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 01112222333333333 3458899999999999999999999998876543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=348.76 Aligned_cols=245 Identities=20% Similarity=0.242 Sum_probs=196.0
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceE
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLL 788 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 788 (1058)
++||+|+||.||+| +..+|+.||||++..... ........+.+|+.++++++||||+++++++..++..|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--------IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCF 72 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEE
Confidence 47999999999999 556799999999854321 122334677899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccC
Q 043053 789 MYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 789 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~ 868 (1058)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 73 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 73 VMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 9999999999999976 35789999999999999999999999 999999999999999999999999999875322
Q ss_pred CCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCC
Q 043053 869 GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948 (1058)
Q Consensus 869 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1058)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+... .......
T Consensus 148 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~~~~~------~~~~p~~ 217 (323)
T cd05571 148 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILME------EIRFPRT 217 (323)
T ss_pred CC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--HHHHHHHHHcC------CCCCCCC
Confidence 21 22345679999999999999999999999999999999999999996432 11111111111 1111112
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043053 949 PESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAM 983 (1058)
Q Consensus 949 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~ 983 (1058)
.+. .+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~------~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSP------EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCH------HHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 222 234477889999999999 78998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=310.24 Aligned_cols=257 Identities=23% Similarity=0.290 Sum_probs=208.3
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|++.++||+|+|+.||++ ...+|+.+|+|.+...... ....+++.+|+++-+.++|||||++.+.+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~---------~~~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---------ARDFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc---------cccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 367888899999999999999 7889999999988544322 224688999999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC---CCCeeee
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL---EFEPYIA 858 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~---~~~~kl~ 858 (1058)
+....|+|+|+++||+|..-|-.+ ...++..+-...+||++|+.|+|.+ +|||||+||+|+++-. ..-+|++
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeec
Confidence 999999999999999997666543 5678888899999999999999999 9999999999999953 3468999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
|||+|.....+ ......+|||+|||||+....+|+..+|||+.||+||-++.|++||.+.. ...+.+.+ ..+.
T Consensus 156 ~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I--~~g~ 228 (355)
T KOG0033|consen 156 DFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQI--KAGA 228 (355)
T ss_pred ccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHH--hccc
Confidence 99999988743 34557889999999999999999999999999999999999999997531 11222211 2222
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
-.+++..++...+ ++.+++++|+..||.+|.|+.|++.+-+-
T Consensus 229 yd~~~~~w~~is~------~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 229 YDYPSPEWDTVTP------EAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred cCCCCcccCcCCH------HHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 3333333333333 23457788999999999999999876543
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=355.78 Aligned_cols=260 Identities=23% Similarity=0.325 Sum_probs=204.3
Q ss_pred hhccccceeccccceEEEEEEecCC-cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeE-E
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNG-EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGC-C 780 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~ 780 (1058)
.++++.++|.+|||+.||.|....+ ..||+|++... ++.....+.+||++|++|+ |+|||.+++. .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----------de~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----------DEEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----------CHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 4567789999999999999955544 99999998532 5566889999999999998 9999999993 3
Q ss_pred Ec------CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC
Q 043053 781 WN------RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE 854 (1058)
Q Consensus 781 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~ 854 (1058)
.. ...+++.||||+||.|-|++..+....+++.++++|+.|+++|+++||.. .|+|||||||-+||||..+|.
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCC
Confidence 22 12457999999999999999987777799999999999999999999986 558999999999999999999
Q ss_pred eeeeccccceeccCCCc-------ccccccccCcCCccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043053 855 PYIADFGLAKLVDDGDF-------ARSSNTVAGSYGYIAPEYG---YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD 924 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 924 (1058)
.||||||.|........ ....-....|+.|.|||++ .+..+++|+||||+||+||-|+....||+.....
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 99999999864322110 0001123478999999974 4778999999999999999999999999854221
Q ss_pred ChhHHHHHHhhcCccccCCCCCCCC-chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 925 GSHVVDWVRQKKGIQVLDPSLLSRP-ESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
.++.......+ +...+. +..+|+.||++||++||++.+|+..+.++.....
T Consensus 265 --------------aIlng~Y~~P~~p~ys~~---l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 265 --------------AILNGNYSFPPFPNYSDR---LKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred --------------eEEeccccCCCCccHHHH---HHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 11111111111 222222 3347888999999999999999999988866543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=351.87 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=201.7
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
++|++.+.||+|+||.||+|.. .++..||||++... ......+.+.+|+++++.+ +|||||++
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~il~~l~~h~nIv~~ 107 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS----------AHTDEREALMSELKILSHLGQHKNIVNL 107 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCC----------CCHHHHHHHHHHHHHHHhhccCCceeeE
Confidence 5788999999999999999842 23357999998532 1223356788999999999 79999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcC--------------------------------------------------
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERT-------------------------------------------------- 806 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------- 806 (1058)
++++...+..++||||+++|+|.++++...
T Consensus 108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (374)
T cd05106 108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV 187 (374)
T ss_pred eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence 999999999999999999999999986421
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccC
Q 043053 807 ------------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 807 ------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~ 868 (1058)
..++++..+++++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 13478889999999999999999998 999999999999999999999999999986544
Q ss_pred CCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 869 GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 869 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ......... . .+....
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~--~---~~~~~~ 338 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRG--Y---QMSRPD 338 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcc--c---CccCCC
Confidence 322122223345678999999988899999999999999999997 999997543221 111111111 1 111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
..+. .+.+++.+||+.||++|||+.++++.|+++
T Consensus 339 ~~~~------~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPP------EIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 234577889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=349.15 Aligned_cols=249 Identities=21% Similarity=0.260 Sum_probs=200.6
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|.+.+.||+|+||.||+| ...+++.||||++..... ......+.+.+|+.++++++||||+++++++.+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI--------LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--------hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 67899999999999999999 445789999999854321 122345678999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 90 ENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred CCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999999999999863 5688999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+ ......+.. ..
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~---~~--- 231 (329)
T PTZ00263 165 AKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIYEKILA---GR--- 231 (329)
T ss_pred ceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHHHHHhc---CC---
Confidence 98764422 245699999999999998899999999999999999999999975321 111111111 11
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~l 984 (1058)
.......+. .+.+++..||+.||.+||+ +++++.+-
T Consensus 232 ~~~p~~~~~------~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 232 LKFPNWFDG------RARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred cCCCCCCCH------HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 111111121 2345788899999999997 67777653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=350.29 Aligned_cols=257 Identities=23% Similarity=0.285 Sum_probs=202.3
Q ss_pred hccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||.||+|. ..+++.||||++..... ........+.+|++++.+++||||+++++++.++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~ 73 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--------FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD 73 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--------hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC
Confidence 58889999999999999994 45689999999854321 1223356788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 999999999999999999975 35688999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
+.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....+. .....+..... ....+
T Consensus 149 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~-~~~~~ 220 (333)
T cd05600 149 KGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ETWENLKYWKE-TLQRP 220 (333)
T ss_pred ccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--HHHHHHHhccc-cccCC
Confidence 76543 233567999999999999889999999999999999999999999754221 11111111110 00011
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
........... .+.+++.+||..+|++||++++++++..
T Consensus 221 ~~~~~~~~~s~---~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 221 VYDDPRFNLSD---EAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred CCCccccccCH---HHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 11100000111 2345778899999999999999998643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=347.10 Aligned_cols=200 Identities=28% Similarity=0.454 Sum_probs=175.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|+..+.||+|+||.||+| +..+|..||+|.+... ......+.+.+|++++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE----------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc----------cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 57888999999999999999 5557889999988532 123345789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++|+|.+++... ..+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 99999999999999999999763 56889999999999999999999852 699999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+...... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 151 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 151 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 8765432 223456999999999999989999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=344.13 Aligned_cols=246 Identities=21% Similarity=0.227 Sum_probs=196.1
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceE
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLL 788 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 788 (1058)
+.||+|+||.||+| +..+|+.||||++..... ........+.+|+++++.++||||+++++++..++..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 72 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI--------IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCF 72 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEE
Confidence 46999999999999 556799999999854321 122345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccC
Q 043053 789 MYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 789 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~ 868 (1058)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 73 v~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 73 VMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 9999999999999875 35689999999999999999999999 999999999999999999999999999875332
Q ss_pred CCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCC
Q 043053 869 GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948 (1058)
Q Consensus 869 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1058)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .... ...... ...+...
T Consensus 148 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--~~~~---~~~~~~---~~~~p~~ 217 (328)
T cd05593 148 DA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLF---ELILME---DIKFPRT 217 (328)
T ss_pred cc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--HHHH---HHhccC---CccCCCC
Confidence 21 223346799999999999988999999999999999999999999975321 1111 111111 1111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 043053 949 PESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAML 984 (1058)
Q Consensus 949 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l 984 (1058)
.+. .+.+++.+||++||++|| ++.+++++-
T Consensus 218 ~~~------~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 218 LSA------DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCH------HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 222 233477889999999997 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=339.65 Aligned_cols=261 Identities=19% Similarity=0.284 Sum_probs=197.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+| +..+++.||+|++.... .......+.+|++++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH----------EEGAPCTAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc----------cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 56888999999999999999 55678999999885321 12234567899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++ +|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 75 ERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred CCeEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence 8889999999975 999998754 35678999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC--c-
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG--I- 938 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~- 938 (1058)
++...... .......|++.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....+..... .
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 225 (288)
T cd07871 150 ARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE--ELHLIFRLLGTPTE 225 (288)
T ss_pred eeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCh
Confidence 97654322 22234568999999998765 568899999999999999999999997542211 1111111000 0
Q ss_pred -------------cccCCCCCCCCchh--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 -------------QVLDPSLLSRPESE--IDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 -------------~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
....+.....+... ........+++.+|+++||.+|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000000 0001234568889999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=344.64 Aligned_cols=246 Identities=22% Similarity=0.250 Sum_probs=195.2
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceE
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLL 788 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 788 (1058)
+.||+|+||.||+| +..+|+.||+|++..... ........+.+|++++++++||||+++++++...+..|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 72 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEE
Confidence 47999999999999 556799999999864321 122335677889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccC
Q 043053 789 MYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 789 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~ 868 (1058)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 73 v~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 73 VMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 9999999999998875 35789999999999999999999999 999999999999999999999999999875322
Q ss_pred CCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCC
Q 043053 869 GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948 (1058)
Q Consensus 869 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1058)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .......
T Consensus 148 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~~~~~~~------~~~~p~~ 217 (323)
T cd05595 148 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILME------EIRFPRT 217 (323)
T ss_pred CC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHhcC------CCCCCCC
Confidence 21 222345799999999999988999999999999999999999999975422 1111111110 1111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 043053 949 PESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAML 984 (1058)
Q Consensus 949 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l 984 (1058)
.+.. +.+++..||+.||++|| ++.+++++-
T Consensus 218 ~~~~------~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 218 LSPE------AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCHH------HHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 2222 23477789999999998 888888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.60 Aligned_cols=248 Identities=23% Similarity=0.265 Sum_probs=199.6
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||.||+| +..+++.||+|++..... ......+.+.+|++++++++||||+++++++.++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 73 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV--------IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ 73 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH--------hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC
Confidence 5788899999999999999 555799999999853311 1122356788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++|+|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcc
Confidence 9999999999999999999763 5689999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
+..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....+ ......+.... .
T Consensus 149 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~------~ 215 (291)
T cd05612 149 KKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGIYEKILAGK------L 215 (291)
T ss_pred hhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC------c
Confidence 865432 2245689999999999988899999999999999999999999975422 12222111111 1
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAML 984 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~l 984 (1058)
......+. .+.+++.+||+.||.+||+ +++++++-
T Consensus 216 ~~~~~~~~------~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 216 EFPRHLDL------YAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred CCCccCCH------HHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 11111121 2345788899999999995 88887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.20 Aligned_cols=270 Identities=24% Similarity=0.284 Sum_probs=208.9
Q ss_pred cHHHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccce
Q 043053 698 SVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRF 776 (1058)
Q Consensus 698 ~~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 776 (1058)
.-.+-+++|+..+.|++|.||.||+| +.++++.||+|+++... +.+...-...|||.++.+.+|||||.+
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek---------ek~GFPItsLREIniLl~~~H~NIV~v 140 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK---------EKEGFPITSLREINILLKARHPNIVEV 140 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc---------ccCCCcchhHHHHHHHHhcCCCCeeee
Confidence 34455678999999999999999999 77889999999996552 444555677899999999999999999
Q ss_pred eeEEEc--CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC
Q 043053 777 LGCCWN--RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE 854 (1058)
Q Consensus 777 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~ 854 (1058)
-.+... -+..|+|||||+. +|.+++... ..++...++..+..|+++|++|||.+ .|+|||+||+|+|++..|.
T Consensus 141 kEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~ 215 (419)
T KOG0663|consen 141 KEVVVGSNMDKIYIVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGI 215 (419)
T ss_pred EEEEeccccceeeeeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCc
Confidence 988764 3568999999988 999999875 47899999999999999999999999 9999999999999999999
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
+||+|||+|+.++.+- ...+..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+... ..++...++
T Consensus 216 lKiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-~dQl~~If~ 292 (419)
T KOG0663|consen 216 LKIADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-IDQLDKIFK 292 (419)
T ss_pred EEecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-HHHHHHHHH
Confidence 9999999999987753 456677889999999987765 689999999999999999999998875422 112222111
Q ss_pred hhc-CccccCC-----------CCCCCCchhHHH----H---HHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 934 QKK-GIQVLDP-----------SLLSRPESEIDE----M---LQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 934 ~~~-~~~~~~~-----------~~~~~~~~~~~~----~---~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
... ..+..-| .+...+...... . -...+++...+..||.+|.||.|.+++=
T Consensus 293 llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 293 LLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred HhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 111 0000000 001111111110 0 1234577778999999999999998753
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=349.19 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=202.9
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~ 776 (1058)
++|.+.++||+|+||.||+|... .+..||||++... ......+.+.+|+++++++. ||||+++
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----------~~~~~~~~~~~Ei~~l~~l~~HpnIv~l 106 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT----------ARSSEKQALMSELKIMTHLGPHLNIVNL 106 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC----------CChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 57889999999999999999532 2346999998533 12234578999999999996 9999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcC--------------------------------------------------
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERT-------------------------------------------------- 806 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------- 806 (1058)
++++.+....|+||||+++|+|.++++...
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 999999999999999999999999886421
Q ss_pred --------------------------------------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCC
Q 043053 807 --------------------------------------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDI 842 (1058)
Q Consensus 807 --------------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDi 842 (1058)
...+++..+..++.|+++|++|||+. +|+||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~di 263 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDL 263 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCC
Confidence 12477888899999999999999998 9999999
Q ss_pred CCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 043053 843 KANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT 921 (1058)
Q Consensus 843 kp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 921 (1058)
||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999999999987644322222334457789999999988889999999999999999997 99999754
Q ss_pred CCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 922 IPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
..+. .....+.... ........+ . .+.+++.+||+.||++||++.++.+.++++.
T Consensus 344 ~~~~-~~~~~~~~~~-----~~~~~~~~~---~---~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 344 IVDS-TFYNKIKSGY-----RMAKPDHAT---Q---EVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred chhH-HHHHHHhcCC-----CCCCCccCC---H---HHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 3221 1111111110 111111111 2 2345788899999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=330.41 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=201.1
Q ss_pred hhccccceeccccceEEEEEEe----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||.||+|.. ..+..||+|.+... ......+.+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG----------CSDKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC----------CCHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 5688899999999999999954 34678999988532 122335678999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+..++..++||||+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d 150 (266)
T cd05064 75 ITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG 150 (266)
T ss_pred EecCCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence 99999999999999999999999764 35789999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
||.+........ .......++..|+|||+..+..++.++|||||||++||+++ |..||....+ ......+....
T Consensus 151 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~~~-- 225 (266)
T cd05064 151 FRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--QDVIKAVEDGF-- 225 (266)
T ss_pred Ccccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHCCC--
Confidence 998765432211 11122345678999999998999999999999999999775 9999975422 22222222211
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
........+. .+.+++..||+.+|++||+++++.+.+..+
T Consensus 226 ---~~~~~~~~~~------~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ---RLPAPRNCPN------LLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCCH------HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111111122 233477889999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=334.24 Aligned_cols=257 Identities=26% Similarity=0.474 Sum_probs=204.8
Q ss_pred hhccccceeccccceEEEEEEecC-C-----cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDN-G-----EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|++.+.||+|+||.||+|.... + ..||+|.+... .......+|.+|++.+++++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~----------~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 74 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN----------AEPKVQQEFRQEAELMSDLQHPNIVCLL 74 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC----------CCHHHHHHHHHHHHHHHhcCCcccceEE
Confidence 578889999999999999995432 2 57999987422 2233457799999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTG--------------NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIK 843 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik 843 (1058)
+++......+++|||+++|+|.+++..... ..+++..++.++.|++.|++|||+. +++|||||
T Consensus 75 ~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlk 151 (283)
T cd05048 75 GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLA 151 (283)
T ss_pred EEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 999988889999999999999999975321 4578899999999999999999999 99999999
Q ss_pred CCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 043053 844 ANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 922 (1058)
Q Consensus 844 p~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 922 (1058)
|+||+++.++.++|+|||+++.....+.........+++.|+|||+..+..++.++|||||||++|||++ |..||....
T Consensus 152 p~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 152 ARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred cceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999987654443333445567889999999988889999999999999999998 999997543
Q ss_pred CCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
+ ......+..... +......+ . .+..++.+||+.||++||++++|+++|+.
T Consensus 232 ~--~~~~~~i~~~~~-----~~~~~~~~---~---~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 232 N--QEVIEMIRSRQL-----LPCPEDCP---A---RVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H--HHHHHHHHcCCc-----CCCcccCC---H---HHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2 223322222111 11111122 2 23347788999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=337.01 Aligned_cols=262 Identities=21% Similarity=0.292 Sum_probs=198.7
Q ss_pred hccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||.||+|. ..+++.||||++.... ......+.+.+|++++++++||||+++++++..+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE---------ENEEVKETTLRELKMLRTLKQENIVELKEAFRRR 72 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc---------ccccchhhHHHHHHHHHhCCCccccchhhhEecC
Confidence 68889999999999999994 4578899999885331 2233457788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||++++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 73 GKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred CEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 999999999998777655433 35689999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc-------
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK------- 936 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~------- 936 (1058)
........ .......|++.|+|||++.+..++.++||||+||++|||++|+.||...... ..... +....
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-~~~~~-~~~~~~~~~~~~ 224 (287)
T cd07848 148 RNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-DQLFT-IQKVLGPLPAEQ 224 (287)
T ss_pred cccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHhhCCCCHHH
Confidence 87643321 2223456899999999999888999999999999999999999999754211 11111 00000
Q ss_pred --------CccccCCCCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 --------GIQVLDPSLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 --------~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.................. -...+.+++.+||++||++|||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000000 01235568899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=332.60 Aligned_cols=251 Identities=29% Similarity=0.522 Sum_probs=195.3
Q ss_pred ccceeccccceEEEEEEec-----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 708 DANVIGKGCSGVVYRADMD-----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 708 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
..+.||.|+||.||+|.+. .+..|+||.+... ......+.|.+|++.+++++||||++++|++..
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~ 72 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS----------SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE 72 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT----------SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc----------cccccceeeeecccccccccccccccccccccc
Confidence 4678999999999999665 4677999998432 233347899999999999999999999999998
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..++||||+++|+|.++++......+++..+++|+.||++||+|||+. +++||||+++||+++.++.+||+|||+
T Consensus 73 ~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~ 149 (259)
T PF07714_consen 73 NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGL 149 (259)
T ss_dssp SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 88899999999999999999986567899999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+................+...|+|||.+.+..++.++||||||+++|||++ |+.||... ........+.+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~~~~~~---- 223 (259)
T PF07714_consen 150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKLKQGQR---- 223 (259)
T ss_dssp GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHHHTTEE----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc----
Confidence 987744333333444557789999999998889999999999999999999 78898654 22333333322211
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.......+. . +..++..||+.||++|||+.++++.|
T Consensus 224 -~~~~~~~~~---~---~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -LPIPDNCPK---D---IYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBTTSBH---H---HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ceeccchhH---H---HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111122222 2 23477889999999999999999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=345.28 Aligned_cols=246 Identities=20% Similarity=0.238 Sum_probs=195.0
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceE
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLL 788 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 788 (1058)
+.||+|+||.||+| +..+|+.||+|++..... ........+.+|+++++.++||||+++++++..++..|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~l 72 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--------VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 72 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEE
Confidence 46999999999999 556899999999854321 122334677889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 789 MYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 789 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 73 v~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 73 VMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9999999999998875 3578999999999999999999997 6 99999999999999999999999999987543
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ......
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~~i~~~------~~~~p~ 217 (325)
T cd05594 148 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILME------EIRFPR 217 (325)
T ss_pred CCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--HHHHHHHhcC------CCCCCC
Confidence 221 222345699999999999988999999999999999999999999975421 1111111111 111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAML 984 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l 984 (1058)
..+. .+.+++.+||+.||++|+ ++++++++-
T Consensus 218 ~~~~------~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 218 TLSP------EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCCH------HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 1222 233477889999999996 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=327.66 Aligned_cols=251 Identities=25% Similarity=0.440 Sum_probs=201.8
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|++.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG------------AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC------------CccHHHHHHHHHHHHHCCCCCceeEEEEEccC
Confidence 567888999999999999998888889999987422 22246789999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+
T Consensus 72 ~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~ 147 (256)
T cd05114 72 KPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMT 147 (256)
T ss_pred CCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCc
Confidence 99999999999999999997643 4689999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......++..|+|||+..+..++.++||||||+++|||++ |+.||.... .......+.+.. ....
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i~~~~--~~~~ 222 (256)
T cd05114 148 RYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMISRGF--RLYR 222 (256)
T ss_pred cccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCC--CCCC
Confidence 86543322 11223345678999999988889999999999999999999 899996542 222222222211 1111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+.. .+ ..+.+++.+||+++|++||+++++++.|
T Consensus 223 ~~~---~~------~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKL---AS------MTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCC---CC------HHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111 11 1345688899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=342.37 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=202.0
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
++|.+.++||+|+||.||+|.. .+++.||+|++... ......+.+.+|++++.++ +|+||+++
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~----------~~~~~~~~~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG----------ATASEYKALMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC----------CCHHHHHHHHHHHHHHHhhccCcchhhe
Confidence 4788999999999999999932 23578999988532 1122346778899999999 79999999
Q ss_pred eeEEEcC-CCceEEEEecCCCChhhhhhhcC-------------------------------------------------
Q 043053 777 LGCCWNR-NNRLLMYDYMPNGSLGSLLHERT------------------------------------------------- 806 (1058)
Q Consensus 777 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------- 806 (1058)
++++... ...++||||+++|+|.+++....
T Consensus 77 ~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (337)
T cd05054 77 LGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV 156 (337)
T ss_pred eeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhc
Confidence 9988654 55789999999999999986432
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccc
Q 043053 807 ----------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSN 876 (1058)
Q Consensus 807 ----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~ 876 (1058)
...+++..+..++.||+.|++|||+. +|+||||||+|||++.++.++|+|||+++............
T Consensus 157 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~ 233 (337)
T cd05054 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233 (337)
T ss_pred ccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhcc
Confidence 12689999999999999999999999 99999999999999999999999999998764432222233
Q ss_pred cccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHH
Q 043053 877 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDE 955 (1058)
Q Consensus 877 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 955 (1058)
...++..|+|||++.+..++.++|||||||++|||++ |..||....+.+ .......... . +.. +.....
T Consensus 234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~--~---~~~---~~~~~~- 303 (337)
T cd05054 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGT--R---MRA---PEYATP- 303 (337)
T ss_pred CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccC--C---CCC---CccCCH-
Confidence 4456778999999999999999999999999999998 999997543222 2222221111 0 111 111112
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 956 MLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 956 ~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
.+.+++.+||+.+|++||++.+++++|+++.+
T Consensus 304 --~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 --EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred --HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 34457888999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=341.16 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=192.6
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHH---cccCCCcccceeeEEE
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL---GSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~ 781 (1058)
|.+.+.||+|+||.||+| ...+++.||||++..... ......+.+.+|++++ ++++||||+++++++.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~ 72 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--------IARDEVESLMCEKRIFETANSERHPFLVNLFACFQ 72 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE
Confidence 567889999999999999 556789999999854321 1122345666676554 5678999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
..+..|+||||+++|+|..+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 73 ~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 73 TEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCccc
Confidence 99999999999999999988864 4689999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+++...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .
T Consensus 147 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~---~-- 217 (324)
T cd05589 147 LCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--EEVFDSIVND---E-- 217 (324)
T ss_pred CCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC---C--
Confidence 987533221 223456799999999999998999999999999999999999999975421 1121111111 1
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~ 983 (1058)
.......+. .+.+++.+||+.||++|| ++.+++++
T Consensus 218 -~~~p~~~~~------~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 -VRYPRFLSR------EAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -CCCCCCCCH------HHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111111122 233478889999999999 46666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=339.56 Aligned_cols=264 Identities=20% Similarity=0.273 Sum_probs=197.8
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+|. ..+++.||||++... ........+.+|+.++++++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ----------EEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccc----------cccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 578899999999999999994 457899999998532 112224567889999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence 999999999995 5888888754 35688899999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc---
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI--- 938 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--- 938 (1058)
++...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+...............
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
T cd07869 150 ARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227 (303)
T ss_pred ceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence 87543322 22334568999999998765 4578899999999999999999999975432111111111100000
Q ss_pred --------cccCCCCCC-CCchhHHH-------HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 939 --------QVLDPSLLS-RPESEIDE-------MLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 939 --------~~~~~~~~~-~~~~~~~~-------~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
....+.... ..+..... ...+.+++..|++.||++|||+.|++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~ 289 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence 000000000 00000100 11344688899999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=341.06 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=200.1
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 780 (1058)
.++|...++||+|+||+|++| ...+++.+|||++.+..+. .....+..+.|.+++.... ||.+++++.+|
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il--------~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL--------QRDEVESLMCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee--------ccccHHHHHHHHHHHHHhccCCeEeeccccc
Confidence 467899999999999999999 5557899999999766442 2233577788888887775 99999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
..++..|+||||+.||++..+.+ ...+++..+.-+|..|+.||+|||++ ||||||||-+|||+|.+|.+||+||
T Consensus 439 QT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADF 512 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADF 512 (694)
T ss_pred ccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccc
Confidence 99999999999999999655554 36799999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+++.-... ...+.+++|||.|||||++.+..|+.+.|-|||||++|||+.|..||.+. ++..+-+.+. ..+.
T Consensus 513 GlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~FdsI~---~d~~ 585 (694)
T KOG0694|consen 513 GLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEVFDSIV---NDEV 585 (694)
T ss_pred ccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHh---cCCC
Confidence 999864422 24677899999999999999999999999999999999999999999865 2333322222 1122
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM 977 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~ 977 (1058)
..|... + .++..|+++.+.++|++|.-+
T Consensus 586 ~yP~~l---s------~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFL---S------KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcc---c------HHHHHHHHHHhccCcccccCC
Confidence 222222 1 234557888999999999854
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=341.18 Aligned_cols=243 Identities=22% Similarity=0.260 Sum_probs=191.9
Q ss_pred eccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEE
Q 043053 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMY 790 (1058)
Q Consensus 712 lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 790 (1058)
||+|+||.||+| +..+++.||+|++..... ........+.+|+.++++++||||+++++++..++..|+||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 72 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI--------VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVL 72 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEE
Confidence 699999999999 555789999999854321 12234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCC
Q 043053 791 DYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870 (1058)
Q Consensus 791 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~ 870 (1058)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 73 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 73 AFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 99999999999976 35689999999999999999999999 99999999999999999999999999987543222
Q ss_pred cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCc
Q 043053 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE 950 (1058)
Q Consensus 871 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1058)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+..... ........+
T Consensus 148 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~---~~~~~~~~~ 217 (312)
T cd05585 148 --DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQE---PLRFPDGFD 217 (312)
T ss_pred --CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcC---CCCCCCcCC
Confidence 223456799999999999999999999999999999999999999975321 1111111110 111111222
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 043053 951 SEIDEMLQALGVALLCVNASPDERPT---MKDVAAM 983 (1058)
Q Consensus 951 ~~~~~~~~~~~l~~~cl~~dP~~RPt---~~~v~~~ 983 (1058)
. .+.+++..||+.||++||+ +.+++.+
T Consensus 218 ~------~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 R------DAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred H------HHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 2 2334778899999999986 4555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=348.23 Aligned_cols=257 Identities=19% Similarity=0.196 Sum_probs=196.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+|.+.+.||+|+||.||+| +..+++.||+|+.. ...+.+|++++++++||||+++++++..
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------------~~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------------RGGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------------hhhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 46999999999999999999 67789999999642 2346789999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++|||++. ++|.+++... ..+++..++.++.|++.||+|||+. +||||||||+||+++.++.+||+|||+
T Consensus 155 ~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~ 228 (391)
T PHA03212 155 NKFTCLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGA 228 (391)
T ss_pred CCeeEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCc
Confidence 999999999995 6899988763 5688999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC------ChhHHHHHHhhc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD------GSHVVDWVRQKK 936 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~------~~~~~~~~~~~~ 936 (1058)
++...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+...+....
T Consensus 229 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g 307 (391)
T PHA03212 229 ACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSG 307 (391)
T ss_pred cccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhc
Confidence 97543221 12233467999999999999889999999999999999999999887532210 111111111000
Q ss_pred C----------------------ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 937 G----------------------IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 937 ~----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
. .....+...............+..++.+||+.||++|||++|++++-
T Consensus 308 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred CChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 0 00000000000000111122455688999999999999999999754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=319.39 Aligned_cols=265 Identities=26% Similarity=0.358 Sum_probs=203.0
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
...|...+.||+|+||.|+.| +..+|+.||||++.... +..-..++..||+.+++.++|+||+.+++.+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F---------~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF---------ENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh---------hchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 355666789999999999999 77889999999996332 34455788899999999999999999999986
Q ss_pred c-----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 782 N-----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 782 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
. -...|+|+|+|+. +|...++. +..++...+.-+..|+++||.|+|+. +|+|||+||+|++++.+..+|
T Consensus 92 p~~~~~f~DvYiV~elMet-DL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lK 165 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELMET-DLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLK 165 (359)
T ss_pred cccccccceeEEehhHHhh-HHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEE
Confidence 5 2456999999954 99999986 35599999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCC--------------
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPT-------------- 921 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~-------------- 921 (1058)
|+|||+|+...........+..+.|..|.|||.+. ...|+.+.||||+||++.||++|++-|.+.
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 99999999886532223456778899999999754 668999999999999999999999988653
Q ss_pred CCCChhHHHHHHhhcCccccCCCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 922 IPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.|++. ....+........+ ......+...... -..+++++.+||..||.+|+|++|++++-
T Consensus 246 tP~~e-~l~~i~s~~ar~yi-~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 246 TPSEE-DLQKIRSEKARPYI-KSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred CCCHH-HHHHhccHHHHHHH-HhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 12111 11111100000000 0001111111111 12356688889999999999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=344.87 Aligned_cols=205 Identities=25% Similarity=0.344 Sum_probs=176.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|+..+.||+|+||+||+| +..+++.||||++..... ........+.+|+.++.+++||+|+++++++.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~ 72 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--------LEKEQVGHIRAERDILVEADSLWVVKMFYSFQD 72 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH--------HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 36788999999999999999 556789999999854321 122335678899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....|+||||++||+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 73 KLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred CCeEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccC
Confidence 9999999999999999999976 35789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcc---------------------------------cccccccCcCCccCccccccCCCCcccchhhHHHHHH
Q 043053 863 AKLVDDGDFA---------------------------------RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVL 909 (1058)
Q Consensus 863 ~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ 909 (1058)
++........ ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 8754321100 0112457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCC
Q 043053 910 EVLTGKQPIDPT 921 (1058)
Q Consensus 910 elltg~~P~~~~ 921 (1058)
||++|+.||...
T Consensus 228 ell~G~~Pf~~~ 239 (363)
T cd05628 228 EMLIGYPPFCSE 239 (363)
T ss_pred HHHhCCCCCCCC
Confidence 999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.39 Aligned_cols=267 Identities=24% Similarity=0.326 Sum_probs=211.5
Q ss_pred HHHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccce
Q 043053 699 VEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRF 776 (1058)
Q Consensus 699 ~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~ 776 (1058)
..+....|...+.+|+|..++|-++ ...+|..+|+|++...... ..++......+.-.+|+.+++++. ||+|+++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~---~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l 88 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATT---ESGETPYEMREATRQEISILRQVMGHPYIIDL 88 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccc---cCCccHHHHHHHHHHHHHHHHHhcCCCcEEEe
Confidence 3456678899999999999999998 7778999999998543221 112223344567788999999996 9999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
.++|..+...++|+|.|+.|.|.|++.+. ..+++....+|++|+.+|++|||.. +|||||+||+|||++++.++|
T Consensus 89 ~D~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 89 QDVYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred eeeccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceE
Confidence 99999999999999999999999999874 6789999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 930 (1058)
|+|||.++...++. .....+|||+|+|||.+.. ..|+...|+||.||++|.++.|++||... .++.-
T Consensus 164 isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----kQmlM 236 (411)
T KOG0599|consen 164 ISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----KQMLM 236 (411)
T ss_pred EeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----HHHHH
Confidence 99999999888764 4557899999999997653 34677899999999999999999999632 11111
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
..--. ........+...+-.....+++.+|++.||.+|.|++|++++-..
T Consensus 237 LR~Im------eGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 237 LRMIM------EGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred HHHHH------hcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 10001 111111112222222334568888999999999999999987554
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.93 Aligned_cols=257 Identities=23% Similarity=0.274 Sum_probs=198.8
Q ss_pred hccccceeccccceEEEEEEe----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeE
Q 043053 705 CLVDANVIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGC 779 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 779 (1058)
+|++.+.||+|+||.||+|.. .+++.||+|++...... ......+.+.+|+.++++++ ||+|++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~ 73 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-------QKAKTVEHTRTERNVLEHVRQSPFLVTLHYA 73 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh-------hhhhHHHHHHHHHHHHHhccCCCCcccEEEE
Confidence 377889999999999999854 36889999998543211 22334567889999999995 9999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+..++..++||||+++|+|.+++..+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 74 FQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EecCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEee
Confidence 99999999999999999999999763 5689999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .........
T Consensus 149 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~-- 224 (332)
T cd05614 149 FGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRIL-- 224 (332)
T ss_pred CcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHh--
Confidence 999986543322 122345799999999998765 478899999999999999999999975422211 111111111
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAML 984 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l 984 (1058)
..++......+.. +.+++.+||+.||++|| ++++++++-
T Consensus 225 -~~~~~~~~~~~~~------~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 225 -KCDPPFPSFIGPE------AQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred -cCCCCCCCCCCHH------HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 1122222222222 23467789999999999 677777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=345.20 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=192.8
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||.||+| +..+++.||||++... ......+.+.+|++++++++|+||+++++++.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 142 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----------HEDTVRRQICREIEILRDVNHPNVVKCHDMFD 142 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC----------CcHHHHHHHHHHHHHHHhCCCCCcceeeeEec
Confidence 356777889999999999999 4557899999998432 23344678999999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
..+..++||||+++|+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 143 ~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG 213 (353)
T PLN00034 143 HNGEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFG 213 (353)
T ss_pred cCCeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccc
Confidence 999999999999999987542 345677889999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
+++...... .......||..|+|||++.. ...+.++|||||||++|||++|+.||....... .........
T Consensus 214 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~ 289 (353)
T PLN00034 214 VSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAIC 289 (353)
T ss_pred cceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHh
Confidence 998764322 22334579999999998643 234568999999999999999999997432211 111111110
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. ..+......+. ++.+++.+||+.||++|||++|++++
T Consensus 290 ~~--~~~~~~~~~~~------~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 MS--QPPEAPATASR------EFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cc--CCCCCCCccCH------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01111111111 23457888999999999999999985
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=332.86 Aligned_cols=249 Identities=31% Similarity=0.437 Sum_probs=200.8
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|...+.||.|+||.||-| +..+.+.||||++..... .....-.++.+|+..+++++|||+|.+-|+|..
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK--------Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--------QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeecccccc--------ccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 45677789999999999999 778899999999854321 222334788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...|+|||||-| +-.|++.-. .+++.+..+..|..+.++||+|||+. +.||||||+.|||+++.|.|||+|||.
T Consensus 98 e~TaWLVMEYClG-SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 98 EHTAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred cchHHHHHHHHhc-cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence 9999999999955 888888654 47788899999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
|....+ ...++|||.|||||++. .+.|+-++||||+|++-.|+...++|+.... .......+.+..
T Consensus 173 Asi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--AMSALYHIAQNe--- 241 (948)
T KOG0577|consen 173 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNE--- 241 (948)
T ss_pred hhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--HHHHHHHHHhcC---
Confidence 987654 34788999999999864 5679999999999999999999999986441 122222222221
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.|.+.. ..+.+.+ ..++..|+++-|.+|||.++++.+
T Consensus 242 --sPtLqs--~eWS~~F---~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 --SPTLQS--NEWSDYF---RNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred --CCCCCC--chhHHHH---HHHHHHHHhhCcccCCcHHHHhhc
Confidence 222221 1222222 347778999999999999998864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=343.70 Aligned_cols=250 Identities=21% Similarity=0.265 Sum_probs=199.9
Q ss_pred HhhccccceeccccceEEEEEEec-C-CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMD-N-GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
.++|.+.+.||+|+||.||+|... + +..||+|++..... ......+.+.+|+++++.++||||+++++++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--------IKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh--------hhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 467899999999999999999543 3 36899998854321 1223356788999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+++..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecC
Confidence 9999999999999999999999763 5689999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....+ ......+.. ...
T Consensus 176 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~i~~--~~~- 245 (340)
T PTZ00426 176 GFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--LLIYQKILE--GII- 245 (340)
T ss_pred CCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--HHHHHHHhc--CCC-
Confidence 999865432 2345799999999999988899999999999999999999999975422 111111111 111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAML 984 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l 984 (1058)
......+. .+.+++.+|++.||++|+ +++++.++-
T Consensus 246 ---~~p~~~~~------~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 246 ---YFPKFLDN------NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred ---CCCCCCCH------HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 11111122 123478889999999995 888888763
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=337.92 Aligned_cols=262 Identities=24% Similarity=0.397 Sum_probs=203.4
Q ss_pred hhccccceeccccceEEEEEEe-cCCc----EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGE----VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
.+|...+.||+|+||.||+|.+ .+++ .||||++... ......+++.+|+.+++.++||||++++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~niv~~~g 76 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------TSPKANKEILDEAYVMASVDNPHVCRLLG 76 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----------CCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4688899999999999999954 3444 3899987422 22334578899999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++... ..++|+||+++|+|.++++.. ...+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 77 ~~~~~-~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~ 151 (316)
T cd05108 77 ICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKIT 151 (316)
T ss_pred EEcCC-CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEc
Confidence 98764 578999999999999999864 34688999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...........
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~~~~~~~- 228 (316)
T cd05108 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGE- 228 (316)
T ss_pred cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhCCC-
Confidence 9999987654332222223345678999999999999999999999999999998 9999975321 12222222111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~ 993 (1058)
. .. .++.... ....++..||+.+|++||++.+++..+.++......
T Consensus 229 -~---~~---~~~~~~~---~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~ 274 (316)
T cd05108 229 -R---LP---QPPICTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 274 (316)
T ss_pred -C---CC---CCCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence 0 01 1111111 234578889999999999999999998887655443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=326.96 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=206.0
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++.+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG------------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC------------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 678899999999999999998777889999987422 12357889999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.++++......+++..+..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence 9999999999999999999876567789999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......++..|+|||+.....++.++|||||||++|+|++ |+.||.... .......+.... .
T Consensus 151 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~-----~ 222 (261)
T cd05072 151 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQRGY-----R 222 (261)
T ss_pred eecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHHHcCC-----C
Confidence 87654322 11223346778999999988889999999999999999998 999996432 122222222111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
.......+ . .+.+++.+||+.+|++||+++++.+.|++
T Consensus 223 ~~~~~~~~---~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 MPRMENCP---D---ELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCC---H---HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11111111 1 23457888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.84 Aligned_cols=200 Identities=26% Similarity=0.458 Sum_probs=174.1
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|+..+.||+|+||.||+| +..++..+|+|.+... ......+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE----------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc----------cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 67889999999999999999 4457889999987432 122345779999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++|+|.+++.. ...+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 9999999999999999999976 356889999999999999999999741 799999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 151 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 151 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred chhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 8755332 223456899999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=318.99 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=205.5
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCc-ccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKN-IVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~ 780 (1058)
...|...++||+|+||+||+| ...+|+.||+|+++... +.+.......+|+.+++.++|+| ||++++++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~---------~~EG~P~taiREisllk~L~~~~~iv~L~dv~ 80 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEF---------EEEGVPSTAIREISLLKRLSHANHIVRLHDVI 80 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccc---------cccCCCchhhHHHHHHHHhCCCcceEEEEeee
Confidence 566777889999999999999 67789999999996542 23456677899999999999999 99999999
Q ss_pred EcCC------CceEEEEecCCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 781 WNRN------NRLLMYDYMPNGSLGSLLHERTG--NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 781 ~~~~------~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
.... ..++|+||++. +|..++..... ..++...+..+..|+++||+|||++ +|+||||||+|||++++
T Consensus 81 ~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~ 156 (323)
T KOG0594|consen 81 HTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSS 156 (323)
T ss_pred eecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCC
Confidence 8876 67899999977 99999987543 3577788999999999999999999 99999999999999999
Q ss_pred CCeeeeccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHH
Q 043053 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 931 (1058)
|.+||+|||+|+.+.-+. ...+..++|..|.|||++.+. .|+...||||+||+++||++++.-|.+..+ ..+....
T Consensus 157 G~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~I 233 (323)
T KOG0594|consen 157 GVLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRI 233 (323)
T ss_pred CcEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHH
Confidence 999999999999665322 446678899999999998876 789999999999999999999988875432 1111111
Q ss_pred HHhhcCc-----------cccCCCCCCCC-chhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 932 VRQKKGI-----------QVLDPSLLSRP-ESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 932 ~~~~~~~-----------~~~~~~~~~~~-~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+..... ...+....... +..... .....+++.+|++.+|.+|.|++.++.+
T Consensus 234 f~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 234 FRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111100 00111111111 111111 1245568888999999999999999986
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=343.15 Aligned_cols=257 Identities=22% Similarity=0.269 Sum_probs=199.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+| +..+|+.||+|++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~ 72 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL--------LAQETVSFFEEERDILSISNSPWIPQLQYAFQD 72 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence 35888999999999999999 556799999999864321 122345778899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 73 KDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred CCeEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCC
Confidence 99999999999999999999864 35789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY------MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
+........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..+.. +....
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~-i~~~~ 225 (330)
T cd05601 149 AARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNN-IMNFQ 225 (330)
T ss_pred CeECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHH-HHcCC
Confidence 987654322 1223456899999999876 456788999999999999999999999754221 11111 11110
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
...........+.. +.+++..|+. +|++||++++++++-
T Consensus 226 --~~~~~~~~~~~~~~------~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 226 --RFLKFPEDPKVSSD------FLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred --CccCCCCCCCCCHH------HHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 00100000111222 2346677887 999999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=345.61 Aligned_cols=256 Identities=22% Similarity=0.300 Sum_probs=197.5
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||+||+| +..+|+.||||++..... ........+.+|+++++.++||||+++++++.++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~ 73 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM--------LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE 73 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC
Confidence 6888999999999999999 556789999999854321 1223456788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccc
Confidence 9999999999999999999763 5689999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCccc------------------------------------ccccccCcCCccCccccccCCCCcccchhhHHHH
Q 043053 864 KLVDDGDFAR------------------------------------SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVV 907 (1058)
Q Consensus 864 ~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvv 907 (1058)
+......... .....+||+.|+|||++.+..++.++|||||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 228 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence 7543211000 0113469999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHH
Q 043053 908 VLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT---MKDVAAML 984 (1058)
Q Consensus 908 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt---~~~v~~~l 984 (1058)
+|||++|..||....+ ......+..... ....+.. ...+. .+.+++.+|+. +|.+|++ +++++++-
T Consensus 229 l~el~~G~~Pf~~~~~--~~~~~~i~~~~~-~~~~~~~-~~~s~------~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 229 MYEMLVGYPPFCSDNP--QETYRKIINWKE-TLQFPDE-VPLSP------EAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred HHHhhcCCCCCCCCCH--HHHHHHHHcCCC-ccCCCCC-CCCCH------HHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9999999999975432 111111111110 0000110 01122 22345666786 9999998 88887753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=339.36 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=194.6
Q ss_pred ceeccccceEEEEEEe----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCC
Q 043053 710 NVIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 785 (1058)
+.||+|+||.||+|.. .+++.||||++...... ........+.+|++++++++||||+++++++..++.
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-------RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-------hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 6899999999999954 46889999998543211 122334677899999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
.|+||||+++|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 75 LYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred EEEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 9999999999999999976 35678888999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCC
Q 043053 866 VDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSL 945 (1058)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1058)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. . ...+
T Consensus 150 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--~~~~~~~~~--~----~~~~ 219 (323)
T cd05584 150 SIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--KKTIDKILK--G----KLNL 219 (323)
T ss_pred cccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--HHHHHHHHc--C----CCCC
Confidence 43322 223345799999999999988899999999999999999999999975421 111111111 1 1111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 043053 946 LSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAML 984 (1058)
Q Consensus 946 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l 984 (1058)
....+. .+.+++.+||++||++|| ++.+++++-
T Consensus 220 ~~~~~~------~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 220 PPYLTP------EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CCCCCH------HHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 111121 234578889999999999 788887753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=331.47 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=211.3
Q ss_pred hccccceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++...++||.|.||.||.|.|+ ..-.||||.+... .-..++|.+|+.+|+.++|||+|+++|+|..+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED------------tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc------------chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 3455689999999999999665 4567999998533 33478999999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
..+|||+|||..|+|.||+++.....++.-..+.+|.||+.||+||..+ ++||||+.++|+|+.++..|||+|||++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 9999999999999999999987777788888899999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+.+..+.+ .......-...|.|||-+.-..++.|+|||+|||+|||+.| |..||.+. +-.++....+...
T Consensus 413 RlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--dlSqVY~LLEkgy------ 483 (1157)
T KOG4278|consen 413 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYGLLEKGY------ 483 (1157)
T ss_pred hhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--cHHHHHHHHhccc------
Confidence 98876554 23334445779999999988899999999999999999999 88888543 2222222222221
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.+..++.+... .+.+|+.||++.|.+||+++|+.+.++.+....
T Consensus 484 --RM~~PeGCPpk---VYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 484 --RMDGPEGCPPK---VYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred --cccCCCCCCHH---HHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 12233333333 345788999999999999999999998775543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=345.55 Aligned_cols=256 Identities=26% Similarity=0.329 Sum_probs=201.6
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||+||+| +..+|+.||||++..... ........+.+|++++..++||||+++++++.++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--------IKRNQIAHVRAERDILADADSPWIVKLYYSFQDE 73 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--------hhccHHHHHHHHHHHHHhcCCCCccchhhheecC
Confidence 6888999999999999999 555799999999854321 1223457889999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCC
Confidence 9999999999999999999864 6789999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCC---------------------------cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCC
Q 043053 864 KLVDDGD---------------------------FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQ 916 (1058)
Q Consensus 864 ~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~ 916 (1058)
....... .........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 7654432 0112334569999999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHH
Q 043053 917 PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT-MKDVAAML 984 (1058)
Q Consensus 917 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~~v~~~l 984 (1058)
||...... .....+.... .....+.. ...+. .+..++..|+. ||.+||+ +++++++.
T Consensus 229 Pf~~~~~~--~~~~~i~~~~-~~~~~p~~-~~~~~------~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 229 PFYSDTLQ--ETYNKIINWK-ESLRFPPD-PPVSP------EAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CCCCCCHH--HHHHHHhccC-CcccCCCC-CCCCH------HHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 99754321 1111111100 00001111 11122 23346677997 9999999 99999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=302.73 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=202.1
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.+|+|||+-||.+ ...+++.+|+|++.-. ..+..+..++|++..++++||||++++++...
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~-----------~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH-----------SQEDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeecc-----------chHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 68999999999999999999 5678899999998432 23457888999999999999999999998764
Q ss_pred CC-----CceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 783 RN-----NRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 783 ~~-----~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
+. ..|++++|...|+|.+.+.... +..+++.+.+.|+.+|++||++||+.. |+++||||||.||++.+++.+
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCce
Confidence 43 3799999999999999997643 557999999999999999999999983 369999999999999999999
Q ss_pred eeeccccceeccCCCcc-------cccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043053 856 YIADFGLAKLVDDGDFA-------RSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG 925 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 925 (1058)
++.|||.++...-.... ........|..|.|||.+. +...++++|||||||++|+|+.|..||+.....+
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 99999998754321100 0112334688999999765 4567889999999999999999999997543322
Q ss_pred hhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
..+.-.+.. ..... | +...... .+..++.+|++.||.+||++.+++..++.+
T Consensus 249 gSlaLAv~n-~q~s~--P----~~~~yse---~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 GSLALAVQN-AQISI--P----NSSRYSE---ALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred CeEEEeeec-ccccc--C----CCCCccH---HHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 222111100 00111 1 1111112 234578899999999999999999988764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=325.10 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=203.8
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|++|.||+|...+++.||+|.+... ....+++.+|++++++++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG------------TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC------------cccHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 568889999999999999997777888999988532 12246789999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++++|.+++....+..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence 9999999999999999999875556789999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......++..|+|||+..+..++.++||||||+++|||++ |+.||....+ ......+.... .
T Consensus 151 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~-----~ 222 (261)
T cd05068 151 RVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQQVDQGY-----R 222 (261)
T ss_pred EEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCC-----C
Confidence 87653221 11122233468999999998889999999999999999999 9999975421 12222121111 0
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
.......+ . .+.+++.+||+.+|++||+++++.+.|++
T Consensus 223 ~~~~~~~~---~---~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCP---K---ELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCC---H---HHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11111111 1 23457888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=324.77 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=204.1
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+|.+.+.||+|+||.||+| ...+++.||+|.+... ....+++.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------------chHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 46788899999999999999 5556889999987421 2235678999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++++|.+++.......+++..++.++.|+++|++|||+. +++||||||+||++++++.+||+|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~ 150 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 150 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcc
Confidence 99999999999999999999875556789999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+......... ......++..|+|||+..+..++.++|||||||++|||++ |..||.... ........... .
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~~-----~ 222 (263)
T cd05052 151 SRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKG-----Y 222 (263)
T ss_pred ccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCC-----C
Confidence 9876543321 1122334668999999988899999999999999999998 899986432 12222222111 1
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
.+......+. .+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 223 ~~~~~~~~~~------~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPP------KVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCH------HHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111111122 234478889999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=328.43 Aligned_cols=260 Identities=26% Similarity=0.386 Sum_probs=201.7
Q ss_pred hhccccceeccccceEEEEEEe-cCCc----EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGE----VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|...+.||+|+||+||+|.+ .+++ .||+|.+... .......++..|+..++++.||||+++++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR----------SGRQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc----------cchHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4678889999999999999954 4455 3667765321 12233467888999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++. ....++||||+++|+|.+++... ...+++..+..|+.||+.|++|||+. +++||||||+||+++.++.+||+
T Consensus 77 ~~~-~~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~ 151 (279)
T cd05111 77 ICP-GASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIA 151 (279)
T ss_pred EEC-CCccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEc
Confidence 875 45578999999999999999764 35789999999999999999999998 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++...............++..|+|||+..+..++.++||||||+++|||++ |+.||....+ ......+.....
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~ 229 (279)
T cd05111 152 DFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKGER 229 (279)
T ss_pred CCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCc
Confidence 9999987654332223334557789999999988889999999999999999998 9999975422 222233222111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
...+. ..+ .....++..||..||++|||+.|+.+.+..+....
T Consensus 230 --~~~~~---~~~------~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 230 --LAQPQ---ICT------IDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred --CCCCC---CCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 11111 111 12344778899999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=331.48 Aligned_cols=262 Identities=22% Similarity=0.332 Sum_probs=194.1
Q ss_pred hhccccceeccccceEEEEEEe-c-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc---CCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-D-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI---RHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~ 778 (1058)
++|.+.+.||+|+||.||+|.. . +++.||||++.... ........+.+|+.+++.+ +||||+++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~ 71 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---------GEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 71 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEeccc---------CCCCchHHHHHHHHHHHhhcccCCCCcceEEE
Confidence 3688899999999999999954 3 46889999885331 1122234566777776665 6999999999
Q ss_pred EEEc-----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 779 CCWN-----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 779 ~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
++.. ....++||||++ ++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 72 VCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 147 (290)
T ss_pred EEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCC
Confidence 8852 345789999996 5999999876556789999999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
.+||+|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.. +.
T Consensus 148 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~-i~ 222 (290)
T cd07862 148 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGK-IL 222 (290)
T ss_pred CEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHH-HH
Confidence 9999999999876443 2234556899999999998888999999999999999999999999754221 11111 11
Q ss_pred hhcCcc---c-------cCCCCCCCCchhHHHH-----HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 934 QKKGIQ---V-------LDPSLLSRPESEIDEM-----LQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 934 ~~~~~~---~-------~~~~~~~~~~~~~~~~-----~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...... . ........+....... ....+++.+||+.||++|||+.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 110000 0 0000000011111111 123458899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=340.02 Aligned_cols=240 Identities=24% Similarity=0.265 Sum_probs=186.4
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHH-HHcccCCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK-TLGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
+.||+|+||+||+| +..+|+.||||++..... .......++..|.. +++.++||||+++++++...+..|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~ 72 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI--------LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLY 72 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--------hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEE
Confidence 47999999999999 556799999999854321 11122344455544 568899999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 73 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 73 FVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred EEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 99999999999999976 35789999999999999999999999 99999999999999999999999999987533
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....... ......
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~---~~~i~~~---~~~~~~ 217 (323)
T cd05575 148 EHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--AEM---YDNILNK---PLRLKP 217 (323)
T ss_pred cCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--HHH---HHHHHcC---CCCCCC
Confidence 221 223456799999999999999999999999999999999999999975321 111 1111110 011111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTMK 978 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ 978 (1058)
..+. .+.+++.+|++.||++||++.
T Consensus 218 ~~~~------~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISV------SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCH------HHHHHHHHHhhcCHHhCCCCC
Confidence 1122 234477889999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=328.92 Aligned_cols=256 Identities=30% Similarity=0.498 Sum_probs=203.0
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|.+.+.||+|+||.||+|... +++.||||.+... ......+.+.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 74 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET----------ASNDARKDFEREAELLTNFQHENIVKFY 74 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc----------CCHHHHHHHHHHHHHHHhcCCCCchhee
Confidence 56788899999999999999543 3578999987432 1222457899999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKAN 845 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~ 845 (1058)
+++......++||||+++|+|.++++... ...+++..+..++.|++.|++|+|+. +++||||||+
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~ 151 (280)
T cd05049 75 GVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATR 151 (280)
T ss_pred eEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---Ceeccccccc
Confidence 99999999999999999999999997532 24578999999999999999999999 9999999999
Q ss_pred cEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043053 846 NILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPD 924 (1058)
Q Consensus 846 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 924 (1058)
||+++.++.++|+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||....
T Consensus 152 nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-- 229 (280)
T cd05049 152 NCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-- 229 (280)
T ss_pred eEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--
Confidence 99999999999999999986544332222334456789999999999999999999999999999998 999986542
Q ss_pred ChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 925 GSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.......+.... . +......+. .+.+++..||+.||++||++.|+++.|+
T Consensus 230 ~~~~~~~~~~~~----~-~~~~~~~~~------~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 230 NEEVIECITQGR----L-LQRPRTCPS------EVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHHHcCC----c-CCCCCCCCH------HHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 222222222111 0 111111122 2345788899999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=324.33 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=200.8
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||+||+|+...+..+|||.+... ....+++.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------------SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC------------cccHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 568888999999999999998777778999987422 12246789999999999999999999999988
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++.... ..+++..++.++.||+.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 72 ~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 72 RPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred CCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccc
Confidence 88999999999999999997643 3689999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......++..|+|||+..+..++.++||||||+++|||++ |..||....+ ......+.+...
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~----- 219 (256)
T cd05113 148 RYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEKVSQGLR----- 219 (256)
T ss_pred eecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHhcCCC-----
Confidence 86544322 11222345678999999988889999999999999999998 9999975422 222222222111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+......+ ..+.+++.+||+++|++||++.++++.+
T Consensus 220 ~~~~~~~~------~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 220 LYRPHLAS------EKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCCCCC------HHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 11111111 2334578889999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=341.73 Aligned_cols=262 Identities=27% Similarity=0.334 Sum_probs=193.5
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||.||+| +..+|+.||||++.... .......++.+|++++++++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF---------EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh---------ccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 4788899999999999999 56679999999885321 1222345788999999999999999999988643
Q ss_pred C-----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 784 N-----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 784 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
. ..|+||||+. ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+
T Consensus 72 ~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~ 145 (338)
T cd07859 72 SRREFKDIYVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKIC 145 (338)
T ss_pred CCCCCceEEEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEc
Confidence 2 3699999995 699999875 35689999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCc-ccccccccCcCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 859 DFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 859 DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+...
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~ 223 (338)
T cd07859 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDL 223 (338)
T ss_pred cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHH
Confidence 9999986533221 112234579999999998765 6788999999999999999999999965321 1100000000
Q ss_pred cC------------------ccccCCCCCCCCchhH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 KG------------------IQVLDPSLLSRPESEI-DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 ~~------------------~~~~~~~~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+ ...+............ .....+.+++.+||+.||++|||++|++++
T Consensus 224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 0000000000000000 000123458889999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=332.32 Aligned_cols=255 Identities=22% Similarity=0.259 Sum_probs=200.1
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|+..++||+|+||+||+| ...+++.||||++..... ........+.+|++++++++||||+++++++..+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--------KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh--------hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC
Confidence 3677899999999999999 456789999999854321 1122345678899999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 73 DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999999998765456789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... .... +.... .....
T Consensus 150 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~-~~~~~--~~~~~ 222 (285)
T cd05605 150 VEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREE-VERRV--KEDQE 222 (285)
T ss_pred eecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHH-HHHHh--hhccc
Confidence 8754322 1234568999999999988889999999999999999999999997542211 1111 11110 00111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAM 983 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~ 983 (1058)
......+. .+.+++..||+.||++|| ++++++++
T Consensus 223 ~~~~~~~~------~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSE------AARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCH------HHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11111111 233478889999999999 78888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=335.18 Aligned_cols=244 Identities=23% Similarity=0.325 Sum_probs=189.4
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 787 (1058)
++||+|+||.||+| ...+++.||||++..... ......+.+..|..++... +||||+++++++..++..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~ 72 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV--------LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLF 72 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEE
Confidence 47999999999999 455688999999864321 1122344556677776654 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||++||+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 73 lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 73 FVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999999999999999763 5689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. ..+....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~------~~~~~~~ 217 (316)
T cd05592 148 NGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DELFDSILN------DRPHFPR 217 (316)
T ss_pred CCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc------CCCCCCC
Confidence 322 233456799999999999988999999999999999999999999975421 111111111 1111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTMK-DVAA 982 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~-~v~~ 982 (1058)
..+. .+.+++..||+.||++||++. ++.+
T Consensus 218 ~~~~------~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WISK------EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCH------HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1222 223477789999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=343.91 Aligned_cols=257 Identities=24% Similarity=0.320 Sum_probs=196.3
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...+.||+|+||+||+| +..+++.||||++..... ......+.+.+|++++++++||||+++++++.++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--------~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 73 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV--------LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK 73 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC
Confidence 4778899999999999999 667789999999854321 1223456789999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..|+||||++||+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 74 DNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 9999999999999999999763 5688999999999999999999998 9999999999999999999999999997
Q ss_pred eeccCCC---c------------------------------------------ccccccccCcCCccCccccccCCCCcc
Q 043053 864 KLVDDGD---F------------------------------------------ARSSNTVAGSYGYIAPEYGYMMKITEK 898 (1058)
Q Consensus 864 ~~~~~~~---~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 898 (1058)
+...... . .......+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 5431100 0 001123579999999999998889999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHh--ccCCCCCCCCC
Q 043053 899 SDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALL--CVNASPDERPT 976 (1058)
Q Consensus 899 ~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--cl~~dP~~RPt 976 (1058)
+|||||||++|||++|+.||....+... ...+..... ....+. ....+.+ +.+++.+ |+..+|..||+
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~i~~~~~-~~~~~~-~~~~s~~------~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTET--QLKVINWEN-TLHIPP-QVKLSPE------AVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHH--HHHHHcccc-ccCCCC-CCCCCHH------HHHHHHHHccCcccccCCCC
Confidence 9999999999999999999975432211 111111000 000111 0111222 2223433 66777778999
Q ss_pred HHHHHHHH
Q 043053 977 MKDVAAML 984 (1058)
Q Consensus 977 ~~~v~~~l 984 (1058)
+++++++-
T Consensus 299 ~~~~l~hp 306 (381)
T cd05626 299 ADDIKAHP 306 (381)
T ss_pred HHHHhcCc
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=358.59 Aligned_cols=265 Identities=23% Similarity=0.297 Sum_probs=202.0
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+|.+.++||+|+||.||+| +..+|+.||||++.... ...+...+++.+|++++++++||||+++++++.+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l--------~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d 73 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL--------SENPLLKKRFLREAKIAADLIHPGIVPVYSICSD 73 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc--------ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee
Confidence 47889999999999999999 55679999999985331 1223446789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcC---------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERT---------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
++..++||||++||+|.+++.... ....++..+.+++.||++||+|||+. +|+||||||+||+++.++
T Consensus 74 ~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg 150 (932)
T PRK13184 74 GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFG 150 (932)
T ss_pred CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCC
Confidence 999999999999999999986421 23456778899999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCc----------------ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 043053 854 EPYIADFGLAKLVDDGDF----------------ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P 917 (1058)
.++|+|||+++....... .......+||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999986621110 0111235699999999999999999999999999999999999999
Q ss_pred CCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHhhhhh
Q 043053 918 IDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-TMKDVAAMLKEIKHE 990 (1058)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-t~~~v~~~l~~~~~~ 990 (1058)
|...... .... .... ..+........... .+..++.+|++.||++|| +++++.+.++.....
T Consensus 231 F~~~~~~--ki~~-~~~i-----~~P~~~~p~~~iP~---~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 231 YRRKKGR--KISY-RDVI-----LSPIEVAPYREIPP---FLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCcchh--hhhh-hhhc-----cChhhccccccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9753221 1110 0000 01110000001111 223477889999999996 566777777765443
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=338.56 Aligned_cols=240 Identities=25% Similarity=0.261 Sum_probs=185.6
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHH-HHHcccCCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI-KTLGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
++||+|+||.||+| +..+++.||+|++..... ........+.+|. .+++.++||||+++++++.+.+..|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~ 72 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI--------LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLY 72 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--------HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEE
Confidence 47999999999999 456789999999854321 1112234455555 4678899999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 73 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 73 FVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred EEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 99999999999988875 35688888999999999999999998 99999999999999999999999999987532
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .... ....... ......
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~---~~~i~~~---~~~~~~ 217 (321)
T cd05603 148 EPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--VSQM---YDNILHK---PLQLPG 217 (321)
T ss_pred CCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--HHHH---HHHHhcC---CCCCCC
Confidence 221 22345679999999999998889999999999999999999999997542 1111 1111111 011111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTMK 978 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ 978 (1058)
... . .+.+++.+|++.||.+||++.
T Consensus 218 ~~~---~---~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKT---V---AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCC---H---HHHHHHHHHccCCHhhcCCCC
Confidence 111 1 234578889999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=352.54 Aligned_cols=253 Identities=20% Similarity=0.265 Sum_probs=200.8
Q ss_pred hhccccceeccccceEEEEE-EecC-CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDN-GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
..|...+.||+|+||.||+| +..+ ++.||+|++.. ........+.+|+.+++.++|||||++++++.
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-----------~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~ 135 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-----------NDERQAAYARSELHCLAACDHFGIVKHFDDFK 135 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-----------CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 35889999999999999999 4444 67888887632 12333467788999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
.++..|+||||+++|+|.++++.. ...++++..+..++.|++.||+|+|+. +|+||||||+|||++.++.+||+|
T Consensus 136 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~D 212 (478)
T PTZ00267 136 SDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGD 212 (478)
T ss_pred ECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEe
Confidence 999999999999999999988642 245688999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+...
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--~~~~~~~~~~~---- 286 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--QREIMQQVLYG---- 286 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC----
Confidence 999987654332233445679999999999999999999999999999999999999996432 11222111111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...+ .....+ . .+..++..||+.||++||++++++.+
T Consensus 287 ~~~~-~~~~~s---~---~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 287 KYDP-FPCPVS---S---GMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCC-CCccCC---H---HHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1111 111111 1 23457788999999999999999753
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.31 Aligned_cols=257 Identities=28% Similarity=0.413 Sum_probs=204.1
Q ss_pred hhccccceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|+..+.||+|+||+||+|... +...||||.+... .......+|.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG----------SSDKQRLDFLTEASIMGQFDHPNIIRLEGV 73 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC----------CChHHHHHHHHHHHHHHhCCCCCcceEeEE
Confidence 56888999999999999999653 2457999987532 223345788999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+...+..++||||+++|+|.+++.... ..+++..+.+++.|++.|++|||+. +|+||||||+||+++.++.++++|
T Consensus 74 ~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~d 149 (266)
T cd05033 74 VTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD 149 (266)
T ss_pred EecCCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECc
Confidence 999999999999999999999997643 4789999999999999999999998 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
||+++...............++..|+|||...+..++.++||||||+++|||++ |..||.... .......+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~-- 225 (266)
T cd05033 150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--NQDVIKAVEDGY-- 225 (266)
T ss_pred cchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--HHHHHHHHHcCC--
Confidence 999987753222122223345678999999988889999999999999999998 999996442 222222222111
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
..+. ....+. .+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 --~~~~-~~~~~~------~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 --RLPP-PMDCPS------ALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCC-CCCCCH------HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 111121 234578889999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.90 Aligned_cols=240 Identities=26% Similarity=0.318 Sum_probs=190.8
Q ss_pred ceeccccceEEEEEEe----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCC
Q 043053 710 NVIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 785 (1058)
+.||+|+||.||++.. .+|+.||+|++..... .......+.+|++++++++||||+++++++.+++.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 72 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGK 72 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh---------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCE
Confidence 5799999999999843 4689999999854321 12234567889999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
.|+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 73 LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred EEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 9999999999999999975 35689999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCC
Q 043053 866 VDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSL 945 (1058)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1058)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ...
T Consensus 148 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~i~~~~------~~~ 217 (318)
T cd05582 148 SIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KETMTMILKAK------LGM 217 (318)
T ss_pred cCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--HHHHHHHHcCC------CCC
Confidence 54321 223346799999999999888899999999999999999999999975421 11111111110 111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 043053 946 LSRPESEIDEMLQALGVALLCVNASPDERPTMKD 979 (1058)
Q Consensus 946 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~ 979 (1058)
....+. .+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~------~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSP------EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCH------HHHHHHHHHhhcCHhHcCCCCC
Confidence 111122 2334778899999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=325.71 Aligned_cols=262 Identities=20% Similarity=0.318 Sum_probs=207.1
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+| ...+++.||||.+.... .........+.+|++++++++||||+++++++.+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE--------MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE 73 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc--------cCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE
Confidence 46888999999999999999 45578999999874321 1223445678999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+..++||||+++|+|.+++... ....+++..+..++.|+++|++|||+. +++||||||+||+++.++.++++||
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999988642 235578999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|++....... .......|++.|+|||+..+..++.++||||+|+++|||++|+.||.....+.......+....
T Consensus 151 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 224 (267)
T cd08228 151 GLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD---- 224 (267)
T ss_pred ccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC----
Confidence 9988765432 1223446889999999998888899999999999999999999999654332222222211110
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
.+.. +.... ...+.+++.+||+.+|++||++.++++.+++++
T Consensus 225 -~~~~---~~~~~--~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 -YPPL---PTEHY--SEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CCCC---Chhhc--CHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111 11111 122345788899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=345.05 Aligned_cols=256 Identities=21% Similarity=0.267 Sum_probs=195.1
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||+||+| +..+++.||||++..... ......+.+.+|++++++++||||+++++++.++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~ 73 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--------FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA 73 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH--------HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 5788999999999999999 566899999999854321 1223456788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999999975 35688999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCc------------cc---------------------------------ccccccCcCCccCccccccCCCCcc
Q 043053 864 KLVDDGDF------------AR---------------------------------SSNTVAGSYGYIAPEYGYMMKITEK 898 (1058)
Q Consensus 864 ~~~~~~~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~ 898 (1058)
+.+..... .. .....+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 228 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence 64321100 00 0012469999999999998899999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCC---C
Q 043053 899 SDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDER---P 975 (1058)
Q Consensus 899 ~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R---P 975 (1058)
+||||+||++|||++|+.||....+ ......+..... ....+.. ..... .+.+++..|+. +|.+| +
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~-~~~~p~~-~~~s~------~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENS--HETYRKIINWRE-TLYFPDD-IHLSV------EAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCH--HHHHHHHHccCC-ccCCCCC-CCCCH------HHHHHHHHHhc-CHhhcCCCC
Confidence 9999999999999999999975422 111111111000 0000100 01111 23346677887 66665 6
Q ss_pred CHHHHHHHH
Q 043053 976 TMKDVAAML 984 (1058)
Q Consensus 976 t~~~v~~~l 984 (1058)
++.+++.+-
T Consensus 298 ~~~~~l~hp 306 (377)
T cd05629 298 GAHEIKSHP 306 (377)
T ss_pred CHHHHhcCC
Confidence 999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=337.64 Aligned_cols=239 Identities=22% Similarity=0.303 Sum_probs=189.3
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 787 (1058)
+.||+|+||+||+| ...+++.||||++.+... ......+.+..|..++..+ +||||+++++++...+..|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 72 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--------LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLF 72 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--------hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEE
Confidence 47999999999999 455789999999854321 1223456777888888876 6999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 73 iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 73 FVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred EEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 999999999999998763 5689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.. ... ....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--~~~~~~~i~~---~~~---~~~~ 217 (320)
T cd05590 148 FNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAILN---DEV---VYPT 217 (320)
T ss_pred cCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--HHHHHHHHhc---CCC---CCCC
Confidence 221 22335679999999999998899999999999999999999999997542 1222222211 111 1111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTM 977 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~ 977 (1058)
..+. .+.+++..||+.||++||++
T Consensus 218 ~~~~------~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQ------DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCH------HHHHHHHHHcccCHHHCCCC
Confidence 1122 23457788999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=328.20 Aligned_cols=257 Identities=25% Similarity=0.433 Sum_probs=202.1
Q ss_pred hhccccceeccccceEEEEEEe-----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
+.|++.+.||+|+||.||+|.. ..+..||+|.+... ........+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 74 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI----------NNPQQWGEFQQEASLMAELHHPNIVCLLG 74 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC----------CCHHHHHHHHHHHHHHhhCCCCCeeeEEE
Confidence 5678889999999999999953 35678999988532 22233467899999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcC---------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCC
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERT---------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIK 843 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik 843 (1058)
++..+...|+||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++|||||
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk 151 (283)
T cd05090 75 VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLA 151 (283)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ceehhccc
Confidence 9999999999999999999999986321 23478899999999999999999999 99999999
Q ss_pred CCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 043053 844 ANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 922 (1058)
Q Consensus 844 p~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 922 (1058)
|+||+++.++.+||+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||....
T Consensus 152 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred cceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999987644332233334456778999999988889999999999999999998 999986542
Q ss_pred CCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
+ ....+.+..... .......+ . .+..++.+||++||++||++.++.+.++.
T Consensus 232 ~--~~~~~~~~~~~~-----~~~~~~~~---~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 232 N--QEVIEMVRKRQL-----LPCSEDCP---P---RMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H--HHHHHHHHcCCc-----CCCCCCCC---H---HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 222222222111 11111112 2 23347788999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=337.61 Aligned_cols=251 Identities=21% Similarity=0.268 Sum_probs=194.0
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 787 (1058)
++||+|+||.||+| ...+++.||||++..... ......+.+.+|+.++.++ +||||+++++++.++...|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~--------~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~ 72 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV--------NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLF 72 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEE
Confidence 47999999999999 556789999999864321 1223456788999999998 6999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 73 lv~e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 73 FVIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred EEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 99999999999998875 35789999999999999999999999 99999999999999999999999999987432
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC---ChhHHHHHHhhcCccccCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD---GSHVVDWVRQKKGIQVLDPS 944 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 944 (1058)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||+..... ......+..+..... ...
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 223 (329)
T cd05588 148 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIR 223 (329)
T ss_pred cCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCC
Confidence 211 2233567999999999999999999999999999999999999999642211 111111111111100 011
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHH
Q 043053 945 LLSRPESEIDEMLQALGVALLCVNASPDERPT------MKDVAAM 983 (1058)
Q Consensus 945 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt------~~~v~~~ 983 (1058)
.....+. .+.+++..||+.||.+||+ +++++++
T Consensus 224 ~p~~~~~------~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 IPRSLSV------KASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCH------HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1111111 2345778899999999997 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.97 Aligned_cols=253 Identities=21% Similarity=0.352 Sum_probs=201.5
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 782 (1058)
+.|++.+.||+||.+.||++...+.+.+|+|++... ..+.....-|..|+..|.+++ |.+||++|+|-..
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~---------~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL---------EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh---------hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 578889999999999999998888889999887433 245667899999999999997 9999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||=+- +|..+|+.+......| .++.++.|++.|+.++|.+ ||||.||||.|+|+- .|.+||+|||+
T Consensus 432 d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGI 505 (677)
T KOG0596|consen 432 DGYLYMVMECGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGI 505 (677)
T ss_pred CceEEEEeecccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeech
Confidence 9999999998754 9999999875555556 6778999999999999999 999999999999985 68999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCC-----------CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHH
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK-----------ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 931 (1058)
|..+..+...-.....+||+.|||||.+.... .++++||||+||+||+|+.|+.||..- ...
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-------~n~ 578 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-------INQ 578 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-------HHH
Confidence 99887655444455678999999999765432 567899999999999999999999632 211
Q ss_pred HHhhcCccccCC--CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 932 VRQKKGIQVLDP--SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 932 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+.....+...+. ++...++. . .+.++|..||..||++||++.+++++
T Consensus 579 ~aKl~aI~~P~~~Iefp~~~~~--~---~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 IAKLHAITDPNHEIEFPDIPEN--D---ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHhhcCCCccccccCCCCc--h---HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 111111111111 11111111 1 15568889999999999999999985
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=328.00 Aligned_cols=248 Identities=22% Similarity=0.259 Sum_probs=192.8
Q ss_pred eccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEE
Q 043053 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMY 790 (1058)
Q Consensus 712 lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 790 (1058)
||+|+||.||++ ...+|+.||+|++..... ........+..|++++++++||||+++++++..+...++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~ 72 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL--------KKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVM 72 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHh--------hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEE
Confidence 699999999999 456799999999854321 11122345567999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCC
Q 043053 791 DYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870 (1058)
Q Consensus 791 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~ 870 (1058)
||++||+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 73 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 73 SLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred ecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence 999999999998765556789999999999999999999998 99999999999999999999999999988665432
Q ss_pred cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCc
Q 043053 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE 950 (1058)
Q Consensus 871 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1058)
......|+..|+|||++.+..++.++||||+||++|||++|+.||....... ............. ... .....+
T Consensus 150 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~-~~~-~~~~~~ 223 (277)
T cd05607 150 ---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDE-VKF-EHQNFT 223 (277)
T ss_pred ---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccc-ccc-ccccCC
Confidence 2234568999999999988889999999999999999999999997542211 1111111111100 000 001112
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 951 SEIDEMLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 951 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
. ...+++..||++||++||+++|+++
T Consensus 224 ~------~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 224 E------ESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred H------HHHHHHHHHhccCHhhCCCCccchh
Confidence 2 2345788899999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=332.79 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=211.3
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCccccee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFL 777 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 777 (1058)
+.+...|.+.+.||+|.||.||++ ...+|+.+|+|++.+.... .....+.+.+|+.+|+++. |||||.++
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~--------~~~~~~~v~~Ev~il~~l~~hpniv~l~ 102 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR--------GKEDREDVRREVAILQQLSGHPNIVQLK 102 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc--------ccccHHHHHHHHHHHHhccCCCCEEEEE
Confidence 445578899999999999999999 5556999999999655321 1224578999999999999 99999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC----C
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE----F 853 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~----~ 853 (1058)
++|.+....++|||+|.||.|.+.+... .+++..+..++.|++.|++|+|+. ||+|||+||+|+|+... +
T Consensus 103 ~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~ 176 (382)
T KOG0032|consen 103 DAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSG 176 (382)
T ss_pred EEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCC
Confidence 9999999999999999999999999875 399999999999999999999998 99999999999999643 4
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
.+|++|||++.....+ ......+||+.|+|||+.....|+..+||||+||++|.|++|..||.......... . +
T Consensus 177 ~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~-i- 250 (382)
T KOG0032|consen 177 RIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-A-I- 250 (382)
T ss_pred cEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-H-H-
Confidence 7999999999988762 45668899999999999999999999999999999999999999998654322211 1 1
Q ss_pred hhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.... ..+...+...+.+ .+.+++..|+..||.+|+|+.+++++.+
T Consensus 251 -~~~~----~~f~~~~w~~is~--~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 251 -LRGD----FDFTSEPWDDISE--SAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred -HcCC----CCCCCCCccccCH--HHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 1111 1112222222222 2344778899999999999999999743
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=337.49 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=193.8
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 787 (1058)
++||+|+||.||+| ...+++.||||++..... ......+.+..|++++..+ +||||+++++++..++..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~ 72 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--------LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLF 72 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEE
Confidence 46999999999999 455688999999854321 1223356677889888866 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 73 lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 73 FVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999999875 35688999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....+ ......+.. .....+ .
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--~~~~~~i~~---~~~~~p---~ 217 (321)
T cd05591 148 LNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--DDLFESILH---DDVLYP---V 217 (321)
T ss_pred cCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--HHHHHHHHc---CCCCCC---C
Confidence 322 223355799999999999988999999999999999999999999975422 122211111 111111 1
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERP-------TMKDVAAML 984 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RP-------t~~~v~~~l 984 (1058)
..+. .+.+++..||+.||++|| ++++++++-
T Consensus 218 ~~~~------~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 218 WLSK------EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCCH------HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 1122 234577889999999999 778887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=329.55 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=200.5
Q ss_pred HhhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccce
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRF 776 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 776 (1058)
.++|+..+.||+|+||.||+|... .+..||||++... .......++.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~iv~~ 74 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA----------ASMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc----------CCHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 467899999999999999998532 3567999987422 122335678999999999999999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEE
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nil 848 (1058)
++++.++...++||||+++|+|.++++... ...+++..+..++.|+++|++|||+. +++||||||+||+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil 151 (277)
T cd05062 75 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 151 (277)
T ss_pred EEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEE
Confidence 999999899999999999999999997532 12467888999999999999999998 9999999999999
Q ss_pred EcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChh
Q 043053 849 IGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSH 927 (1058)
Q Consensus 849 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~ 927 (1058)
+++++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....+ ..
T Consensus 152 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~ 229 (277)
T cd05062 152 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQ 229 (277)
T ss_pred EcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HH
Confidence 99999999999999876544332222223446788999999988889999999999999999999 7889865422 22
Q ss_pred HHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 928 VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
....+..... +......+ . .+.+++.+||+.||++|||+.|+++.++
T Consensus 230 ~~~~~~~~~~-----~~~~~~~~---~---~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 VLRFVMEGGL-----LDKPDNCP---D---MLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcCCc-----CCCCCCCC---H---HHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 2222211110 11111111 1 2345788999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.13 Aligned_cols=261 Identities=27% Similarity=0.452 Sum_probs=206.7
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
+.|.+.+.||+|+||+||++.. .++..+|+|.+... .....+.+.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----------SDNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----------CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5688899999999999999953 23466899987422 223456899999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC-----------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCc
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT-----------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANN 846 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~N 846 (1058)
+++...+..++||||+++++|.++++... ...+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~N 150 (288)
T cd05093 74 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRN 150 (288)
T ss_pred EEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcce
Confidence 99999999999999999999999997532 23589999999999999999999998 99999999999
Q ss_pred EEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 043053 847 ILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDG 925 (1058)
Q Consensus 847 ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 925 (1058)
|++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....+
T Consensus 151 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-- 228 (288)
T cd05093 151 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-- 228 (288)
T ss_pred EEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999986544332223334456789999999998889999999999999999998 8999865432
Q ss_pred hhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
......+..... .......+. .+.+++.+||+.||.+|||+.++.+.++.+....
T Consensus 229 ~~~~~~i~~~~~-----~~~~~~~~~------~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 229 NEVIECITQGRV-----LQRPRTCPK------EVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HHHHHHHHcCCc-----CCCCCCCCH------HHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 222222222110 111111111 2455888999999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=336.93 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=192.6
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 787 (1058)
+.||+|+||.||+| ...+++.||+|++.+... ......+.+.+|+.++.++ +||||+++++++..++..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 72 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV--------NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 72 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh--------cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEE
Confidence 47999999999999 456789999999854321 1223456778899988877 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 73 lv~E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 73 FVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred EEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 99999999999998875 35789999999999999999999999 99999999999999999999999999987533
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC---ChhHHHHHHhhcCccccCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD---GSHVVDWVRQKKGIQVLDPS 944 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 944 (1058)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+........ ...
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~ 223 (329)
T cd05618 148 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIR 223 (329)
T ss_pred CCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCC
Confidence 221 2233467999999999999999999999999999999999999999632111 111111111111100 111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 043053 945 LLSRPESEIDEMLQALGVALLCVNASPDERPTM------KDVAAM 983 (1058)
Q Consensus 945 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~------~~v~~~ 983 (1058)
+...... .+.+++.+||+.||++||++ ++++++
T Consensus 224 ~p~~~~~------~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 IPRSLSV------KAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCH------HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1111111 23457888999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=329.13 Aligned_cols=249 Identities=20% Similarity=0.244 Sum_probs=193.2
Q ss_pred eccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEE
Q 043053 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMY 790 (1058)
Q Consensus 712 lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 790 (1058)
||+|+||+||+| +..+++.||||++..... ......+.+..|++++++++||||+++.+++..+...++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 72 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL--------KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVM 72 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH--------hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEE
Confidence 699999999999 556789999999854321 11223467788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccC
Q 043053 791 DYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 791 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~ 868 (1058)
||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 73 e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 73 TIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred eCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 999999999887542 245689999999999999999999999 999999999999999999999999999986654
Q ss_pred CCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCC
Q 043053 869 GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948 (1058)
Q Consensus 869 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1058)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............ .......
T Consensus 150 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~---~~~~~~~ 223 (280)
T cd05608 150 GQ--SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILND---SVTYPDK 223 (280)
T ss_pred CC--ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhccc---CCCCccc
Confidence 32 22334578999999999999999999999999999999999999997542211 111111111100 0111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043053 949 PESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAM 983 (1058)
Q Consensus 949 ~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~ 983 (1058)
.+. .+.+++..||+.||++|| ++++++++
T Consensus 224 ~~~------~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSP------ASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCH------HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 122 233477789999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=335.31 Aligned_cols=244 Identities=22% Similarity=0.294 Sum_probs=192.5
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC-CcccceeeEEEc
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH-KNIVRFLGCCWN 782 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~ 782 (1058)
+|.+.+.||+|+||.||+| +..+++.||||++..... ......+.+..|++++..+.| ++|+++++++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~ 72 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--------IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 72 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc
Confidence 4778899999999999999 555688999999864321 122345678889999999976 468889999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 73 MDRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCc
Confidence 99999999999999999999763 5688999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... .
T Consensus 148 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i~~~------~ 217 (324)
T cd05587 148 CKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELFQSIMEH------N 217 (324)
T ss_pred ceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHcC------C
Confidence 87532221 223355799999999999999999999999999999999999999975421 1222211111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTM 977 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~ 977 (1058)
.......+. .+.+++.+||++||.+|++.
T Consensus 218 ~~~~~~~~~------~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 VSYPKSLSK------EAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCH------HHHHHHHHHhhcCHHHcCCC
Confidence 111111222 23457788999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=351.40 Aligned_cols=255 Identities=23% Similarity=0.296 Sum_probs=201.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+| +..+|+.||||++.... ..+.....+.+|+..+..++|+||+++++.+..
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~---------~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG---------MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc---------CCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 68999999999999999999 56689999999985331 223345678899999999999999999887754
Q ss_pred CC--------CceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 783 RN--------NRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 783 ~~--------~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
.+ ..++||||+++|+|.++++.+. ...+++..+..++.|++.||+|+|+. +|+||||||+|||++.+
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSN 179 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCC
Confidence 32 2579999999999999997532 45789999999999999999999999 99999999999999999
Q ss_pred CCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~ 254 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVM 254 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHH
Confidence 99999999999876543222333456799999999999999999999999999999999999999974321 1112
Q ss_pred HhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..... .... ......+. .+..++..||+.||++||++.+++++
T Consensus 255 ~~~~~-~~~~-~~~~~~~~------~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HKTLA-GRYD-PLPPSISP------EMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHhc-CCCC-CCCCCCCH------HHHHHHHHHcccChhhCcCHHHHHhC
Confidence 21111 0111 11111222 23347788999999999999999875
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=334.23 Aligned_cols=245 Identities=32% Similarity=0.492 Sum_probs=197.8
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceE
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLL 788 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 788 (1058)
-++|+|.||+||-| +..+...+|||.+. +++....+-+..||...++++|.|||+++|.+.+++..-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIp-----------ekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kI 649 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIP-----------EKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKI 649 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecc-----------cccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEE
Confidence 37999999999999 77777889999884 2344445678899999999999999999999998888889
Q ss_pred EEEecCCCChhhhhhhcCCCCC--CHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc-CCCCeeeecccccee
Q 043053 789 MYDYMPNGSLGSLLHERTGNAL--EWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG-LEFEPYIADFGLAKL 865 (1058)
Q Consensus 789 v~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~-~~~~~kl~DfGl~~~ 865 (1058)
.||.++||+|.++++..- +++ .+.+.--+.+||++||.|||+. .|||||||-+|||++ ..|.+||+|||.++.
T Consensus 650 FMEqVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKR 725 (1226)
T KOG4279|consen 650 FMEQVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKR 725 (1226)
T ss_pred EeecCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchh
Confidence 999999999999999864 444 6777778899999999999999 999999999999996 578999999999987
Q ss_pred ccCCCcccccccccCcCCccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 866 VDDGDFARSSNTVAGSYGYIAPEYGYMM--KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
...-. ..+.++.||..|||||++..+ .|..++|||||||++.||.||++||...... +.+-+ ..+.-...|
T Consensus 726 LAgin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAAMF---kVGmyKvHP 798 (1226)
T KOG4279|consen 726 LAGIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAAMF---KVGMYKVHP 798 (1226)
T ss_pred hccCC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHhhh---hhcceecCC
Confidence 75433 456678899999999998765 5788999999999999999999999765332 22211 112222223
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
.++ .++. .++..++.+|+.+||.+||++.++++
T Consensus 799 ~iP----eels--aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIP----EELS--AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCc----HHHH--HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 222 2222 23345888999999999999999986
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=340.50 Aligned_cols=257 Identities=21% Similarity=0.240 Sum_probs=198.9
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| ...+++.||+|++..... ......+.+.+|+.+++.++||||+++++++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM--------IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--------hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 367899999999999999999 556789999999853311 11223456889999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
++...|+||||++||+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 114 DDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecc
Confidence 99999999999999999999975 3578888899999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM----KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 188 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~~~ 264 (370)
T cd05596 188 TCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMDHKN 264 (370)
T ss_pred ceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--HHHHHHHHcCCC
Confidence 9987644321 122356799999999987653 478899999999999999999999975422 111111111100
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDE--RPTMKDVAAML 984 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~~v~~~l 984 (1058)
....+.. ...+. .+.+++..|++.+|++ ||++++++++-
T Consensus 265 -~~~~~~~-~~~s~------~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 265 -SLTFPDD-IEISK------QAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred -cCCCCCc-CCCCH------HHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0000100 01111 2344777899999988 99999998874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=327.22 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=206.1
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|...+.||+|+||.||+|.. .++..+|+|.+... .....+.+.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-----------TLAARKDFQREAELLTNLQHEHIVKFY 73 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-----------cHHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 5688889999999999999953 23566889987422 223346789999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIK 843 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik 843 (1058)
+++...+..++||||+++++|.+++.... ...+++..++.++.|++.|++|||++ +|+|||||
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk 150 (291)
T cd05094 74 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLA 150 (291)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccC
Confidence 99999999999999999999999997532 24588999999999999999999999 99999999
Q ss_pred CCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 043053 844 ANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 922 (1058)
Q Consensus 844 p~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 922 (1058)
|+||+++.++.++|+|||++................++..|+|||+..+..++.++||||||+++|||++ |+.||....
T Consensus 151 p~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 151 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred cceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999976544332233344557889999999998889999999999999999999 999986542
Q ss_pred CCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
+ ....+....... +......+ . .+.+++.+||+.||++||+++++++.++++...
T Consensus 231 ~--~~~~~~~~~~~~-----~~~~~~~~---~---~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 231 N--TEVIECITQGRV-----LERPRVCP---K---EVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H--HHHHHHHhCCCC-----CCCCccCC---H---HHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 2 222222211111 01111111 1 234578889999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=312.83 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=209.0
Q ss_pred hhccccceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|...+.||+|.-|+||.++.. ++..+|+|++.+.... ......+.+.|-++|+.+.||.++.+|+.|..
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~--------~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA--------SRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh--------hhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 56777889999999999999554 5689999999766543 23345678889999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+|||||+||+|....+++.+..+++..++-+|..|+-||+|||-. |||+|||||+||||.++|++-|+||.+
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDL 225 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDL 225 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccc
Confidence 99999999999999999999999999999999999999999999999999 999999999999999999999999999
Q ss_pred ceeccC---------------------------------CCc---------------------ccccccccCcCCccCcc
Q 043053 863 AKLVDD---------------------------------GDF---------------------ARSSNTVAGSYGYIAPE 888 (1058)
Q Consensus 863 ~~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE 888 (1058)
+..... ... ......++||-.|.|||
T Consensus 226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE 305 (459)
T KOG0610|consen 226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE 305 (459)
T ss_pred cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence 742210 000 01123467999999999
Q ss_pred ccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccC
Q 043053 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVN 968 (1058)
Q Consensus 889 ~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 968 (1058)
++.+...+.+.|-|+|||++|||+.|+.||.+....+ .+...+.+ ++.+...+ .-...+.++|+..|.
T Consensus 306 vI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~~-------~l~Fp~~~----~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 306 VIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVGQ-------PLKFPEEP----EVSSAAKDLIRKLLV 373 (459)
T ss_pred eeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhcC-------CCcCCCCC----cchhHHHHHHHHHhc
Confidence 9999999999999999999999999999998764322 22222222 11222211 223345668888999
Q ss_pred CCCCCCCC----HHHHHHHH
Q 043053 969 ASPDERPT----MKDVAAML 984 (1058)
Q Consensus 969 ~dP~~RPt----~~~v~~~l 984 (1058)
+||.+|.- ++||.++-
T Consensus 374 KdP~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRHP 393 (459)
T ss_pred cChhhhhccccchHHhhcCc
Confidence 99999997 78887653
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=333.52 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=190.8
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 787 (1058)
++||+|+||.||+| ...+|+.||||++...... .....+.+..|..++... +||+|+++++++.+.+..|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 72 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--------IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLF 72 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--------hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEE
Confidence 47999999999999 4557899999998543211 112345667788887754 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||+++...
T Consensus 73 lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 73 FVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred EEECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 99999999999999976 35688999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+... .+....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--~~~~~~~~~~~------~~~~~~ 217 (316)
T cd05620 148 FGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--EDELFESIRVD------TPHYPR 217 (316)
T ss_pred cCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC------CCCCCC
Confidence 221 22345679999999999999999999999999999999999999997542 12222211111 111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTMK-DVAAM 983 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~-~v~~~ 983 (1058)
.... ++.+++..||+.||++||++. ++.++
T Consensus 218 ~~~~------~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 218 WITK------ESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCH------HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1222 234477889999999999984 56543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=330.43 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=201.0
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
..|.+.+.||+|+||.||+|... .+..||||++... ......+.+.+|+.++.+++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 74 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK----------AEGPLREEFKHEAMMRSRLQHPNIVCLL 74 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC----------CCHHHHHHHHHHHHHHhcCCCCCcCeEE
Confidence 45777889999999999999543 3578999998522 1223457789999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIK 843 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik 843 (1058)
+++......++++||+++++|.+++.... ...+++..+.+++.|++.||+|+|+. +|+|||||
T Consensus 75 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlk 151 (283)
T cd05091 75 GVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLA 151 (283)
T ss_pred EEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence 99999999999999999999999985321 23578889999999999999999999 99999999
Q ss_pred CCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 043053 844 ANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 922 (1058)
Q Consensus 844 p~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 922 (1058)
|+||++++++.+||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||....
T Consensus 152 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 231 (283)
T cd05091 152 TRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231 (283)
T ss_pred hhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999886544333223334456789999999988889999999999999999998 888886532
Q ss_pred CCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
. ....+.+..... .......+ .+ +..++..||+.+|++||++++|++.|+.
T Consensus 232 ~--~~~~~~i~~~~~-----~~~~~~~~---~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 232 N--QDVIEMIRNRQV-----LPCPDDCP---AW---VYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H--HHHHHHHHcCCc-----CCCCCCCC---HH---HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2 222222222111 11111122 22 2347888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.80 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=195.0
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceE
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLL 788 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 788 (1058)
+.||+|+||.||+| ...+++.||+|.+... ........+.+|++++++++||||+++++++......++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 70 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 70 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc----------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEE
Confidence 46999999999999 4557999999987422 223345789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccC
Q 043053 789 MYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 789 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~ 868 (1058)
||||+++++|.++++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 71 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 146 (252)
T cd05084 71 VMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEED 146 (252)
T ss_pred EEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccc
Confidence 99999999999999754 35689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 869 GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 869 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
...........++..|+|||.+.+..++.++||||+|+++|||++ |..||....+ ........... ......
T Consensus 147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~~~~~~~~~~-----~~~~~~ 219 (252)
T cd05084 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQTREAIEQGV-----RLPCPE 219 (252)
T ss_pred ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--HHHHHHHHcCC-----CCCCcc
Confidence 221111112223567999999988889999999999999999998 8888864422 11111111110 111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
..+ . .+.+++.+||+.+|++|||+.++.+.|+
T Consensus 220 ~~~---~---~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCP---D---AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCC---H---HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111 1 3345788899999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.33 Aligned_cols=262 Identities=21% Similarity=0.338 Sum_probs=206.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+| ...+++.||||.+..... ......+++.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--------MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 73 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh--------hhHHHHHHHHHHHHHHHHccCCchhhhhheeEe
Confidence 46788899999999999999 456899999998743211 223345788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
++..++||||+++++|.++++.. ....+++..++.++.|+++|++|||+. +++|+||||+||+++.++.++++||
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999998742 245689999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|++....... .......|+..|+|||+..+..++.++||||||+++|+|++|..||.....+.......+.. .
T Consensus 151 g~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~-- 223 (267)
T cd08229 151 GLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ---C-- 223 (267)
T ss_pred hhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc---C--
Confidence 9987654432 12234568899999999988889999999999999999999999996543221111111111 0
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
..+.. +...... .+..++.+||+.||++|||+.+|++.++++.
T Consensus 224 ~~~~~---~~~~~~~--~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 DYPPL---PSDHYSE--ELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCC---CcccccH--HHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01111 1111111 2334778899999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.29 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=203.6
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
++|...+.||+|+||.||+|... ....+|+|.+... .......++.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD----------ATEKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC----------CCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 57888999999999999999543 2367999987532 1223356789999999999 79999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhc--------------CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCC
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHER--------------TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDI 842 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDi 842 (1058)
++++..++..++||||+++|+|.++++.+ ....+++..++.++.|++.|++|||+. +|+||||
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dl 158 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDL 158 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccc
Confidence 99999999999999999999999999652 245689999999999999999999998 9999999
Q ss_pred CCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 043053 843 KANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT 921 (1058)
Q Consensus 843 kp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~ 921 (1058)
||+||+++.++.+||+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999999999999987654433222333345678999999988889999999999999999998 99998643
Q ss_pred CCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 922 IPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
.. ........... ... .+..... .+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 239 ~~--~~~~~~~~~~~-----~~~---~~~~~~~---~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PV--EELFKLLKEGY-----RME---KPQNCTQ---ELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CH--HHHHHHHHcCC-----cCC---CCCCCCH---HHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 21 12222211111 011 1111112 2345888899999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=316.44 Aligned_cols=256 Identities=27% Similarity=0.341 Sum_probs=192.7
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...+++|.|+||.||+| ...+++.||||++.... +.-.+|+++|+.++|||||++.-+|...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---------------r~knrEl~im~~l~HpNIV~L~~~f~~~ 89 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---------------RYKNRELQIMRKLDHPNIVRLLYFFSSS 89 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC---------------CcCcHHHHHHHhcCCcCeeeEEEEEEec
Confidence 5677899999999999999 44567999999986441 1225899999999999999999988643
Q ss_pred C-----CceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC-CCe
Q 043053 784 N-----NRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE-FEP 855 (1058)
Q Consensus 784 ~-----~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~-~~~ 855 (1058)
. ...+||||++. +|.++++.. .+..++.-.+.-+..|+.+|++|||+. +|+||||||+|+|+|.+ |.+
T Consensus 90 ~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~L 165 (364)
T KOG0658|consen 90 TESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVL 165 (364)
T ss_pred CCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeE
Confidence 2 22589999987 999999852 246677777888999999999999998 99999999999999987 899
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1058)
||||||.|+....+.. .....-|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.. ...++...++-
T Consensus 166 KicDFGSAK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~ 241 (364)
T KOG0658|consen 166 KICDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKV 241 (364)
T ss_pred EeccCCcceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHH
Confidence 9999999998876542 2345578899999987765 68999999999999999999999997642 22333333221
Q ss_pred hc-----Ccccc--------CCCCCCCCchh---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 935 KK-----GIQVL--------DPSLLSRPESE---IDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 935 ~~-----~~~~~--------~~~~~~~~~~~---~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
-. .+..+ .+.+...+... ...-.+.++++.+++..+|.+|.++.|++++
T Consensus 242 lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 242 LGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11 00001 11111111000 0111234567888999999999999999874
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.13 Aligned_cols=255 Identities=26% Similarity=0.432 Sum_probs=206.3
Q ss_pred HhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
..+|...+.||.|+||.||+|....++.+|+|.+... .......+.+|+++++.++||||+++++++..
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 73 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-----------DLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc-----------chhhHHHHHHHHHHHhcCCCcchhheeeeEec
Confidence 3568889999999999999997777999999998532 22235678999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....++||||+++|+|.++++......+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||.
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence 99999999999999999999876667789999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+........ ......++..|+|||+..+..++.++||||||+++|+|++ |+.||.... .......+... .
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~-----~ 221 (261)
T cd05148 151 ARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQITAG-----Y 221 (261)
T ss_pred hhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHHhC-----C
Confidence 976644321 1223446778999999988889999999999999999998 899996542 11222222211 1
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
.+......+ . .+.+++.+||+.||++|||++++++.|+.
T Consensus 222 ~~~~~~~~~---~---~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCP---Q---EIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCC---H---HHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111111111 2 23457888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=343.69 Aligned_cols=256 Identities=23% Similarity=0.294 Sum_probs=195.0
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|++.+.||+|+||.||+| +..+++.||||++..... ......+.+.+|++++++++||||+++++++.++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~ 73 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV--------LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK 73 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH--------HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 5888999999999999999 556789999999854321 1122356788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 9999999999999999999763 5688899999999999999999999 9999999999999999999999999997
Q ss_pred eeccCCC-----------------------------------------cccccccccCcCCccCccccccCCCCcccchh
Q 043053 864 KLVDDGD-----------------------------------------FARSSNTVAGSYGYIAPEYGYMMKITEKSDVY 902 (1058)
Q Consensus 864 ~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 902 (1058)
..+.... ........+||+.|+|||++.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 5321000 00011235799999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC---CHHH
Q 043053 903 SYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERP---TMKD 979 (1058)
Q Consensus 903 SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP---t~~~ 979 (1058)
|+||++|||++|+.||....+.. ....+.. ... .............. .+++.+|+ .+|.+|+ ++.+
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~--~~~~i~~-~~~-~~~~~~~~~~s~~~------~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAE--TQLKVIN-WET-TLHIPSQAKLSREA------SDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHH--HHHHHhc-cCc-cccCCCCCCCCHHH------HHHHHHHh-cCHhhcCCCCCHHH
Confidence 99999999999999997553211 1111111 000 01100111112222 22444454 4999999 8899
Q ss_pred HHHHH
Q 043053 980 VAAML 984 (1058)
Q Consensus 980 v~~~l 984 (1058)
++++-
T Consensus 298 ll~h~ 302 (376)
T cd05598 298 IKAHP 302 (376)
T ss_pred HhCCC
Confidence 98763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.33 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=201.2
Q ss_pred hhccccceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+-|.++..||-|+||.||+|..+ ++-..|.|+|. -+.+...++|.-||++++.+.||+||++++.|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-----------tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~ 100 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-----------TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF 100 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-----------ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc
Confidence 34667788999999999999544 44455667763 2345567899999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|++.|||.||-+..++-+- +..+.+.++.-+++|++.||.|||++ +|||||+|+.|||++-+|.++|+|||.
T Consensus 101 enkLwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGV 176 (1187)
T KOG0579|consen 101 ENKLWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGV 176 (1187)
T ss_pred cCceEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccc
Confidence 99999999999999999988775 57899999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYG-----YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+...... ......++|||.|||||+. .+.+|+.++||||||++|.||..+.+|-....|. ..+. .
T Consensus 177 SAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-----RVll---K 246 (1187)
T KOG0579|consen 177 SAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLL---K 246 (1187)
T ss_pred cccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-----HHHH---H
Confidence 7543321 2344678899999999974 4678999999999999999999999997654321 1111 1
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+..-+|.....|..+.. .+-++...|+.+||..||++++++++-
T Consensus 247 iaKSePPTLlqPS~Ws~---~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 247 IAKSEPPTLLQPSHWSR---SFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred HhhcCCCcccCcchhhh---HHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 12223333333333322 233466679999999999999998753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=332.08 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=207.4
Q ss_pred hhccccceeccccceEEEEEEec--CCc--EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD--NGE--VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++....++||+|+||.|++|.|. +|+ .||||.++... -.....+|.+|+.+|.+|+|||++++||+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~----------l~~~mddflrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS----------LNAIMDDFLREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc----------cchhHHHHHHHHHHHHhccCcceeEEeee
Confidence 34455689999999999999554 444 48999886442 22267899999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
..+ ....+|||.++.|+|.+.++......+.......++.|||.||+||..+ ++||||+.++|+++-....|||+|
T Consensus 180 Vl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 180 VLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred ecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeec
Confidence 887 7789999999999999999986667889999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||+.+-....+. +.......-.+.|+|||.+....++.++|||+|||++|||++ |..||.+. .+.++.+.+.
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--~g~qIL~~iD---- 329 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--RGIQILKNID---- 329 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--CHHHHHHhcc----
Confidence 999998766543 222333445679999999999999999999999999999999 88999765 2233333222
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+.+...++..+.+++. +++..||..+|++|||+..|++.+
T Consensus 330 ----~~erLpRPk~csedIY---~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 ----AGERLPRPKYCSEDIY---QIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ----ccccCCCCCCChHHHH---HHHHHhccCCccccccHHHHHHhH
Confidence 2334455666655554 488999999999999999998543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=333.46 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=193.6
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 787 (1058)
+.||+|+||+||+| ...+++.||||++..... ........+.+|+++++.+ +||||+++++++.+.+..|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~ 72 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--------LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLF 72 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEE
Confidence 46999999999999 455688999999864421 1223356678899998888 6999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 73 lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 73 FVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred EEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 999999999999998763 5789999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... ......+|++.|+|||++.+..++.++||||+||++|||++|+.||.... .......+... . .....
T Consensus 148 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--~~~~~~~i~~~---~---~~~~~ 217 (318)
T cd05570 148 LGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--EDELFQSILED---E---VRYPR 217 (318)
T ss_pred cCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcC---C---CCCCC
Confidence 221 22234568999999999999999999999999999999999999997432 12222211111 1 11111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTM-----KDVAAM 983 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~-----~~v~~~ 983 (1058)
..+. .+.+++.+||+.||++||++ .+++++
T Consensus 218 ~~~~------~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSK------EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCH------HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1122 23457888999999999999 777764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=319.50 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=203.7
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+.|.+.++||+|+||.||+|...+++.||+|.+... ....+++.+|+.++++++||||+++++++. .
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG------------SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCC------------CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 678889999999999999998888899999988422 123467899999999999999999999874 5
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++....+..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence 5689999999999999999876567789999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ............ .
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~-----~ 221 (260)
T cd05067 150 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNLERGY-----R 221 (260)
T ss_pred eecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHcCC-----C
Confidence 87653322 12223346778999999988889999999999999999999 999997542 222222222211 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
.......+. .+.+++.+||+.+|++||+++++...|+.
T Consensus 222 ~~~~~~~~~------~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPE------ELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCH------HHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111111122 24457888999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=325.05 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=203.1
Q ss_pred HhhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccce
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRF 776 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 776 (1058)
.++|.+.+.||+|+||.||+|... .+..||+|.+... ........+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----------~~~~~~~~~~~e~~~l~~~~~~~i~~~ 74 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN----------ASMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc----------cCHHHHHHHHHHHHHHHhCCCCceeEE
Confidence 367888999999999999999543 3478999987422 222335678899999999999999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEE
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nil 848 (1058)
++++......++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+
T Consensus 75 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nil 151 (277)
T cd05032 75 LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCM 151 (277)
T ss_pred EEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEE
Confidence 999999999999999999999999997532 23478899999999999999999998 9999999999999
Q ss_pred EcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChh
Q 043053 849 IGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSH 927 (1058)
Q Consensus 849 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~ 927 (1058)
++.++.+||+|||+++.....+.........++..|+|||...+..++.++|||||||++||+++ |..||.... ...
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~ 229 (277)
T cd05032 152 VAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--NEE 229 (277)
T ss_pred EcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--HHH
Confidence 99999999999999886654433233334557889999999988889999999999999999998 999986432 222
Q ss_pred HHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 928 VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
...+..... .+......+ . .+.+++.+||+.+|++|||+.++++.|+
T Consensus 230 ~~~~~~~~~-----~~~~~~~~~---~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 VLKFVIDGG-----HLDLPENCP---D---KLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHhcCC-----CCCCCCCCC---H---HHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 333222111 111111111 2 2345788899999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.23 Aligned_cols=251 Identities=28% Similarity=0.430 Sum_probs=199.3
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.+|.+.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG------------AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC------------CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 457788999999999999997777788999987422 12245788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++++|.++++... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+|++|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~ 147 (256)
T cd05059 72 RPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLA 147 (256)
T ss_pred CceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccc
Confidence 99999999999999999997643 4689999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+...+... .......++..|+|||...+..++.++||||||+++|||++ |+.||....+ ......+.. .. .
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~--~~---~ 219 (256)
T cd05059 148 RYVLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVVESVSA--GY---R 219 (256)
T ss_pred eecccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHHHc--CC---c
Confidence 86543221 11112234568999999998889999999999999999999 8999975422 111111111 11 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.......+. .+.+++.+||+.+|++|||+.++++.+
T Consensus 220 ~~~~~~~~~------~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPT------EVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCH------HHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111111122 344588889999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=321.93 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=190.3
Q ss_pred ceeccccceEEEEEEec---CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCc
Q 043053 710 NVIGKGCSGVVYRADMD---NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR 786 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 786 (1058)
+.||+|+||.||+|... ++..+|+|.+... ........+.+|+.++++++||||+++++++.+....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 70 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS----------ASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY 70 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCC----------CChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCc
Confidence 36899999999999543 3467899987433 1122345788999999999999999999999998899
Q ss_pred eEEEEecCCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 787 LLMYDYMPNGSLGSLLHERT---GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 787 ~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
++||||+++|+|.++++... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 71 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 71 LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred EEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccc
Confidence 99999999999999997532 23567788889999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhh
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMM-------KITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
+...............|+..|+|||++.+. .++.++||||||+++|||++ |+.||....+. .........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~ 225 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--QVLTYTVRE 225 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHhhc
Confidence 765443322223345578899999987532 35789999999999999996 99999754322 221111111
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.......+......+.. ...++..|| .+|++|||+++|++.|.
T Consensus 226 ~~~~~~~~~~~~~~~~~------~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 QQLKLPKPRLKLPLSDR------WYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCCCccCCCCChH------HHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11112222222112221 233667798 58999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=322.20 Aligned_cols=257 Identities=25% Similarity=0.458 Sum_probs=200.0
Q ss_pred ccccceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 706 LVDANVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
|.+.+.||+|+||.||+|... .+..||||++.... ......+.+.+|++.++.++||||+++++++.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 71 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI---------HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCF 71 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc---------CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeec
Confidence 467789999999999999543 24779999885321 12234568999999999999999999999887
Q ss_pred cCCC------ceEEEEecCCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC
Q 043053 782 NRNN------RLLMYDYMPNGSLGSLLHERT----GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL 851 (1058)
Q Consensus 782 ~~~~------~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~ 851 (1058)
.... .++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++
T Consensus 72 ~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~ 148 (273)
T cd05035 72 EASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLRE 148 (273)
T ss_pred cCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECC
Confidence 6554 689999999999999985432 34689999999999999999999998 9999999999999999
Q ss_pred CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHH
Q 043053 852 EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 930 (1058)
++.+||+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||.... ......
T Consensus 149 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~~~~~~ 226 (273)
T cd05035 149 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NHEIYD 226 (273)
T ss_pred CCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHH
Confidence 99999999999987655443222333445678999999988889999999999999999999 888986542 222222
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
+..... .... +..... .+.+++.+||+.||++||++.++++.|+++
T Consensus 227 ~~~~~~-----~~~~---~~~~~~---~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YLRHGN-----RLKQ---PEDCLD---ELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHcCC-----CCCC---CcCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 222211 1111 111112 345578889999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=333.00 Aligned_cols=244 Identities=24% Similarity=0.339 Sum_probs=190.6
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 787 (1058)
+.||+|+||+||+| +..+++.||||++...... .....+.+..|..++... +||||+++++++.+++..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~ 72 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--------MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLF 72 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--------hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEE
Confidence 46999999999999 4556889999998543211 112345567788888764 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 73 lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 73 FVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 999999999999999763 5688999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+... .+....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--~~~~~~~i~~~------~~~~~~ 217 (316)
T cd05619 148 LGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--EEELFQSIRMD------NPCYPR 217 (316)
T ss_pred CCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC------CCCCCc
Confidence 222 12234579999999999999899999999999999999999999997542 12222222111 111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTMK-DVAA 982 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~-~v~~ 982 (1058)
..+. .+.+++.+||+.||++||++. ++.+
T Consensus 218 ~~~~------~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTR------EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCH------HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1121 234577889999999999996 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=333.68 Aligned_cols=244 Identities=21% Similarity=0.275 Sum_probs=192.3
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEc
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWN 782 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 782 (1058)
+|.+.+.||+|+||.||+| +..+++.||||++..... ......+.+..|..++..+ +|++|+++++++.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~ 72 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--------IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT 72 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec
Confidence 3678899999999999999 555788999999864321 1222345677788888777 48999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 73 MDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred CCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCC
Confidence 99999999999999999998763 5688999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 148 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~~~------ 217 (323)
T cd05616 148 CKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEHN------ 217 (323)
T ss_pred ceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC------
Confidence 87543222 223356799999999999999999999999999999999999999975422 22222221111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTM 977 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~ 977 (1058)
......... .+.+++.+|++.||++|+++
T Consensus 218 ~~~p~~~s~------~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSK------EAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCH------HHHHHHHHHcccCHHhcCCC
Confidence 111111122 23457888999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=321.29 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=201.0
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.+|.+.++||+|+||.||+|...++..||+|++... ....+++.+|++++++++||||+++++++. .
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~------------~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC------------ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 568899999999999999997766678999988532 112467899999999999999999999874 4
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++|+|.++++......+++..+..++.|+++||+|+|+. +++||||||+||+++.++.++|+|||.+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence 5679999999999999999865556689999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......++..|+|||+..+..++.++||||||+++|||++ |..||....+ ......... .. .
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--~~~~~~~~~--~~---~ 221 (262)
T cd05071 150 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVER--GY---R 221 (262)
T ss_pred eecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--HHHHHHHhc--CC---C
Confidence 86654332 11223446778999999988889999999999999999999 8888865422 111111111 00 0
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
.......+ ..+.+++.+||++||++||+++++.+.|++.
T Consensus 222 ~~~~~~~~------~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECP------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccC------HHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11111111 2234688899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=318.86 Aligned_cols=253 Identities=28% Similarity=0.455 Sum_probs=201.7
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|++|+++++++. .
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~------------~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT------------MSPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC------------CCHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 5788899999999999999987788889999885321 12467899999999999999999999875 4
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++++|.++++......+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||.+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence 5689999999999999999875556789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
........ .......++..|+|||+..+..++.++||||||+++|||++ |..||.... ............ .
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~-----~ 221 (260)
T cd05070 150 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQVERGY-----R 221 (260)
T ss_pred eeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCC-----C
Confidence 87644321 11122335678999999888889999999999999999999 889996532 122222222111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
.......+ ..+.+++.+||+++|++|||++++.+.|++
T Consensus 222 ~~~~~~~~------~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCP------ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCC------HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111111 234458888999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=337.81 Aligned_cols=257 Identities=20% Similarity=0.252 Sum_probs=195.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+| ...+++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM--------IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 67889999999999999999 445788999999853211 122234668899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 9999999999999999999975 3578899999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMM----KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
+........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..........
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~ 266 (370)
T cd05621 189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMDHKNSL 266 (370)
T ss_pred ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCccc
Confidence 987644322 223456799999999988654 3778999999999999999999999754211 1111111111100
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDE--RPTMKDVAAMLK 985 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~~v~~~l~ 985 (1058)
. . +. ....... +..++..|+..++.+ ||++++++++-.
T Consensus 267 ~-~-p~-~~~~s~~------~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 267 N-F-PE-DVEISKH------AKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred C-C-CC-cccCCHH------HHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 0 0 00 0011111 223566678755543 889999988643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=342.72 Aligned_cols=204 Identities=26% Similarity=0.347 Sum_probs=174.1
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...+.||+|+||+||+| +..+++.||||++..... ......+.+.+|++++++++||||+++++++.++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~--------~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~ 73 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV--------LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 73 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh--------hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC
Confidence 5788999999999999999 556789999999854321 1223456889999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 74 DNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCC
Confidence 9999999999999999999763 5688899999999999999999999 9999999999999999999999999997
Q ss_pred eeccCCC---------------------------------------------cccccccccCcCCccCccccccCCCCcc
Q 043053 864 KLVDDGD---------------------------------------------FARSSNTVAGSYGYIAPEYGYMMKITEK 898 (1058)
Q Consensus 864 ~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 898 (1058)
+.+.... ........+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 5321000 0001123569999999999999999999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCC
Q 043053 899 SDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 899 ~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+||||+||++|||++|+.||...
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCC
Confidence 99999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=357.69 Aligned_cols=485 Identities=28% Similarity=0.336 Sum_probs=348.4
Q ss_pred CCccccCCCCCcEEEccCCcCCCCCC-CCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCcccccccc
Q 043053 16 IPTNLSSFKHLQTLVISDANLTGSIP-FDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSN 94 (1058)
Q Consensus 16 ~p~~~~~~~~L~~L~l~~~~~~~~~p-~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~ 94 (1058)
+|..+-.-..++.|++++|-+. ..| +.+.++.+|+.||+++|.+. ..|..+..+.+|+.|+++.|.+. ..|.+..+
T Consensus 13 ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~ 89 (1081)
T KOG0618|consen 13 IPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSN 89 (1081)
T ss_pred cchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhh
Confidence 4555555566777888887765 444 22456667888888888877 78888888888888888888777 67777888
Q ss_pred chhhhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCcccee
Q 043053 95 CKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTL 174 (1058)
Q Consensus 95 l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L 174 (1058)
+.+|++|+|..|.+. .+|.++..+++|+.|++++|. ....|.-+..++.+..+..++|..... ++... .+.+
T Consensus 90 ~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~--f~~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~ 161 (1081)
T KOG0618|consen 90 MRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNH--FGPIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKL 161 (1081)
T ss_pred hhcchhheeccchhh-cCchhHHhhhcccccccchhc--cCCCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhh
Confidence 888888888777776 788888888888888888877 567777777788888888887722212 22222 7777
Q ss_pred eeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCc
Q 043053 175 SIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLS 254 (1058)
Q Consensus 175 ~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 254 (1058)
++..|.+.+.++.++.+++. .|+|+.|.+. . ..+..+.+|+.|....|++... --..++|+.|+.++|.++
T Consensus 162 ~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~ 232 (1081)
T KOG0618|consen 162 DLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLT 232 (1081)
T ss_pred hhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcce
Confidence 77777777777777777766 6888888776 2 2355777788888888877522 223467888888888777
Q ss_pred CcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhh
Q 043053 255 GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLA 334 (1058)
Q Consensus 255 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 334 (1058)
...+. .--.+|+++++++|++++ .|.+++.+.+|+.|+..+|+++ ..|..+...++|+.|.+.+|.+. -+|....
T Consensus 233 ~~~~~--p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le 307 (1081)
T KOG0618|consen 233 TLDVH--PVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLE 307 (1081)
T ss_pred eeccc--cccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCccc
Confidence 32221 123567888888888874 4588888888888888888885 45777777888888888888887 4455677
Q ss_pred ccCcccccccccccccccCcccccc-c-ccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccc
Q 043053 335 SCSNLQALDLSHNSLTASVPAGLFQ-L-QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLN 412 (1058)
Q Consensus 335 ~l~~L~~L~Ls~N~l~~~~~~~~~~-l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 412 (1058)
+++.|+.|||..|+|. ..|..+.. . ..|..|+.+.|.+.......=...+.|+.|++.+|.+++..-..+.+.+.|+
T Consensus 308 ~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLK 386 (1081)
T KOG0618|consen 308 GLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLK 386 (1081)
T ss_pred ccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhcccccee
Confidence 7888888888888888 45555443 2 2377888888888744322223456788888888888876666778888888
Q ss_pred eeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCccccccccccccccccccc
Q 043053 413 FLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNL 492 (1058)
Q Consensus 413 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 492 (1058)
.|+|++|+|.......+.++..|++|+||+|+|+ .+|.....+..|++|...+|++. ..| .+..++.|+.+|+|.|+
T Consensus 387 VLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~ 463 (1081)
T KOG0618|consen 387 VLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNN 463 (1081)
T ss_pred eeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccch
Confidence 8888888887666666778888888888888888 47788888888888888888887 566 77888888888888888
Q ss_pred CCCCCCCcccCCcccccccccCCcccCCCChhhhhhH
Q 043053 493 FSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIE 529 (1058)
Q Consensus 493 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 529 (1058)
|+...-..-...++|++||++||.-...-...|..+.
T Consensus 464 L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~ 500 (1081)
T KOG0618|consen 464 LSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLK 500 (1081)
T ss_pred hhhhhhhhhCCCcccceeeccCCcccccchhhhHHhh
Confidence 8754332222337888888888875323333343333
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=334.18 Aligned_cols=243 Identities=25% Similarity=0.256 Sum_probs=186.3
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHH-HHHcccCCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI-KTLGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
+.||+|+||+||+| +..+++.||+|++...... .......+..|. .+++.++||||+++++++...+..|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~ 72 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL--------KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 72 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH--------hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEE
Confidence 47999999999999 5557889999998543211 111223444444 4568889999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++.. ...+.+..+..++.||++||+|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 73 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 73 FVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 99999999999999976 35678888889999999999999999 99999999999999999999999999987543
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... . .....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~--~----~~~~~ 217 (325)
T cd05602 148 EHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDNILNK--P----LQLKP 217 (325)
T ss_pred cCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--HHHHHHHHhC--C----cCCCC
Confidence 221 223456799999999999999999999999999999999999999975321 1111111111 0 11111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTMKDVA 981 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~ 981 (1058)
..+. .+.+++.+|++.||.+||++.+.+
T Consensus 218 ~~~~------~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 NITN------SARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCH------HHHHHHHHHcccCHHHCCCCCCCH
Confidence 1222 233467789999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=326.38 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=204.2
Q ss_pred HhhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVR 775 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 775 (1058)
.++|.+.+.||+|+||.||+|.. ..+..||||.+... ......+.+.+|+++++++ +||||++
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~iv~ 103 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT----------AHSSEREALMSELKIMSHLGNHENIVN 103 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc----------CChHHHHHHHHHHHHHHhccCCCCcce
Confidence 36799999999999999999943 23457999987432 1223457889999999999 7999999
Q ss_pred eeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 776 FLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 776 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
+++++...+..++||||+++|+|.++++......+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+
T Consensus 104 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~ 180 (302)
T cd05055 104 LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV 180 (302)
T ss_pred EEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeE
Confidence 999999999999999999999999999865445589999999999999999999998 99999999999999999999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 934 (1058)
+++|||+++...............++..|+|||++.+..++.++||||+||++|||++ |..||...... .........
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~~~~~ 259 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIKE 259 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHHHHHc
Confidence 9999999986543321112223346788999999998889999999999999999998 99998754321 122222211
Q ss_pred hcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 935 KKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
.. .+......+ . .+.+++.+||+++|++|||+.++++.+++.
T Consensus 260 ~~-----~~~~~~~~~---~---~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GY-----RMAQPEHAP---A---EIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CC-----cCCCCCCCC---H---HHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11 111111111 1 344588889999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=354.43 Aligned_cols=258 Identities=22% Similarity=0.292 Sum_probs=196.9
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
....+|.+.+.||+|+||+||+| +..++..||+|.+.... ........|..|+.++++++|||||+++++
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~---------l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG---------LKEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc---------cCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 34578999999999999999999 55678889999885331 123345788999999999999999999998
Q ss_pred EEcC--CCceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCC----CCeEeCCCCCCcEEEcC
Q 043053 780 CWNR--NNRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCV----PPIVHRDIKANNILIGL 851 (1058)
Q Consensus 780 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivHrDikp~Nill~~ 851 (1058)
|... ..+|+||||+++|+|.+++.... ...+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 8653 45799999999999999997532 3579999999999999999999998521 25999999999999964
Q ss_pred C-----------------CCeeeeccccceeccCCCcccccccccCcCCccCcccccc--CCCCcccchhhHHHHHHHHH
Q 043053 852 E-----------------FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVL 912 (1058)
Q Consensus 852 ~-----------------~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~ell 912 (1058)
+ +.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 2 358999999998654322 2234579999999998754 45789999999999999999
Q ss_pred hCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 913 TGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 913 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+|+.||..... ....+...... ..... ...+. .+.+++..||+.+|++||++.|++.+
T Consensus 238 TGk~PF~~~~~----~~qli~~lk~~--p~lpi-~~~S~------eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 238 SGKTPFHKANN----FSQLISELKRG--PDLPI-KGKSK------ELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HCCCCCCcCCc----HHHHHHHHhcC--CCCCc-CCCCH------HHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 99999974321 11212111111 01111 11111 23457788999999999999999853
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=320.74 Aligned_cols=262 Identities=22% Similarity=0.340 Sum_probs=206.5
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+|.. .+|+.||+|.+..... ......+.+.+|++++++++|++|+++++++.+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~ 73 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM--------MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE 73 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc--------cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 4688899999999999999944 4899999998853211 122346789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+..++||||+++|+|.+++... ....+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 74 NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEecc
Confidence 99999999999999999998642 245689999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|++....... .......|+..|+|||...+..++.++|||||||++|+|++|+.||................. .
T Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~ 224 (267)
T cd08224 151 GLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC----D 224 (267)
T ss_pred ceeeeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----C
Confidence 9987654432 112345688899999999888899999999999999999999999965432211111111111 0
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
..+ .+..... ....+++.+||+.+|++|||+.++++.++++.
T Consensus 225 ~~~----~~~~~~~--~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 YPP----LPADHYS--EELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCC----CChhhcC--HHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111 1111111 12345788899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=332.53 Aligned_cols=196 Identities=28% Similarity=0.353 Sum_probs=175.1
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CC-----cccce
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HK-----NIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~ 776 (1058)
-+|.+.++||+|+||.|-+| +..+++.||||+++. ......+-..|+.+|..++ |. |+|++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN------------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN------------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc------------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 38999999999999999999 889999999999953 3345677788999999997 53 89999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC--C
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF--E 854 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~--~ 854 (1058)
+++|...++.|||+|.++. +|+++++......++...++.|+.||+.||.+||+. +|||+||||+|||+...+ .
T Consensus 254 ~d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred eeccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCc
Confidence 9999999999999999965 999999998888899999999999999999999999 999999999999997543 7
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 920 (1058)
+||+|||.|+.....- . ..+-+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus 330 vKVIDFGSSc~~~q~v----y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQRV----Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred eeEEecccccccCCcc----e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 9999999999765432 2 55678899999999999999999999999999999999777754
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=322.39 Aligned_cols=260 Identities=24% Similarity=0.385 Sum_probs=203.0
Q ss_pred hhccccceeccccceEEEEEE-ecCCc----EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGE----VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|...++||+|+||+||+|. ..+|+ .||+|++... ......+.+.+|+.+++.+.||||+++++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----------TSPKANKEILDEAYVMAGVGSPYVCRLLG 76 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC----------CCHHHHHHHHHHHHHHHhcCCCCCceEEE
Confidence 578889999999999999995 44555 4899987432 22334578899999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++.. ...+++|||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 77 ~~~~-~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~ 151 (279)
T cd05109 77 ICLT-STVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT 151 (279)
T ss_pred EEcC-CCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence 9875 4578999999999999999764 35689999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||.... ......++.....
T Consensus 152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~ 229 (279)
T cd05109 152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLEKGER 229 (279)
T ss_pred CCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCc
Confidence 9999987654322112223345678999999988889999999999999999998 899986542 2223333332211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
. ......+ . .+.+++..||+.||++||++.++++.++++....
T Consensus 230 ~-----~~~~~~~---~---~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 L-----PQPPICT---I---DVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred C-----CCCccCC---H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1 1111111 1 2345788899999999999999999888776544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=334.16 Aligned_cols=261 Identities=24% Similarity=0.359 Sum_probs=200.0
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
++|.+.+.||+|+||.||+|.. .+++.||||++... ........+.+|+.++.++ +||||+++
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~niv~~ 76 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----------ATHSEHRALMSELKILIHIGHHLNVVNL 76 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC----------CChHHHHHHHHHHHHHHhccCCccHhhh
Confidence 5789999999999999999942 45788999998532 1222356788999999999 68999999
Q ss_pred eeEEEcC-CCceEEEEecCCCChhhhhhhcC-------------------------------------------------
Q 043053 777 LGCCWNR-NNRLLMYDYMPNGSLGSLLHERT------------------------------------------------- 806 (1058)
Q Consensus 777 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------- 806 (1058)
++++... ...++||||+++|+|.++++...
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (343)
T cd05103 77 LGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK 156 (343)
T ss_pred cceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence 9988654 45789999999999999986421
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCC
Q 043053 807 ----------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870 (1058)
Q Consensus 807 ----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~ 870 (1058)
...+++..+.+++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~ 233 (343)
T cd05103 157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 233 (343)
T ss_pred ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCc
Confidence 12468888899999999999999999 99999999999999999999999999987654322
Q ss_pred cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCC
Q 043053 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRP 949 (1058)
Q Consensus 871 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1058)
.........++..|+|||+..+..++.++||||||+++|||++ |..||...... ......+.... . .......
T Consensus 234 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~--~---~~~~~~~ 307 (343)
T cd05103 234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGT--R---MRAPDYT 307 (343)
T ss_pred chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhccC--C---CCCCCCC
Confidence 2122223346678999999988889999999999999999997 99998654222 11111111111 0 1111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 950 ESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 950 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
+ . .+..++..||+.||++|||+.+++++|+.+.+
T Consensus 308 ~---~---~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 T---P---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred C---H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 1 23457888999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=326.65 Aligned_cols=264 Identities=26% Similarity=0.396 Sum_probs=199.4
Q ss_pred hhccccceeccccceEEEEEEecC---------------CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDN---------------GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 768 (1058)
++|.+.+.||+|+||.||+|.... ...||+|++... ........|.+|+++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~ei~~l~~l 74 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD----------VTKTARNDFLKEIKIMSRL 74 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC----------CCHHHHHHHHHHHHHHHhC
Confidence 578899999999999999985432 235899988532 1223456799999999999
Q ss_pred CCCcccceeeEEEcCCCceEEEEecCCCChhhhhhhcC----------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeE
Q 043053 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT----------GNALEWELRYQILLGAAQGLAYLHHDCVPPIV 838 (1058)
Q Consensus 769 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 838 (1058)
+||||+++++++......++||||+++++|.+++.... ...+++..+++++.|++.|++|||+. +++
T Consensus 75 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~ 151 (295)
T cd05097 75 KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFV 151 (295)
T ss_pred CCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Cee
Confidence 99999999999999999999999999999999986531 12468899999999999999999999 999
Q ss_pred eCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh--CCC
Q 043053 839 HRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT--GKQ 916 (1058)
Q Consensus 839 HrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--g~~ 916 (1058)
||||||+||+++.++.+||+|||++................++..|+|||+..+..++.++|||||||++|||++ |..
T Consensus 152 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~ 231 (295)
T cd05097 152 HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ 231 (295)
T ss_pred ccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999976544332222333456779999999988889999999999999999998 567
Q ss_pred CCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 917 PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 917 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
||..... .............. ........++.... .+.+++.+||+.||++||++++|++.|++
T Consensus 232 p~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 232 PYSLLSD--EQVIENTGEFFRNQ-GRQIYLSQTPLCPS---PVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCcccCh--HHHHHHHHHhhhhc-cccccCCCCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 7764322 12111111100000 00000011111111 34558889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=322.18 Aligned_cols=260 Identities=22% Similarity=0.324 Sum_probs=206.6
Q ss_pred hhccccceeccccceEEEEEEecC-----CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDN-----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|.+.+.||+|+||.||+|.... +..||+|++... ......+.+.+|+.++++++||||+++++
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----------ASEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----------CCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 678889999999999999996554 688999987422 23344678899999999999999999999
Q ss_pred EEEc-CCCceEEEEecCCCChhhhhhhcCC------CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC
Q 043053 779 CCWN-RNNRLLMYDYMPNGSLGSLLHERTG------NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL 851 (1058)
Q Consensus 779 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~ 851 (1058)
++.. +...++++||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~ 152 (280)
T cd05043 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDE 152 (280)
T ss_pred EEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcC
Confidence 8776 4678999999999999999976432 4689999999999999999999998 9999999999999999
Q ss_pred CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHH
Q 043053 852 EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 930 (1058)
++.+|++|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||....+ .....
T Consensus 153 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~ 230 (280)
T cd05043 153 ELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAA 230 (280)
T ss_pred CCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHH
Confidence 99999999999986654432222233456778999999988889999999999999999999 9999975422 22333
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
+..... ........+. .+.+++.+||..||++|||+.++++.|+++..
T Consensus 231 ~~~~~~-----~~~~~~~~~~------~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 231 YLKDGY-----RLAQPINCPD------ELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHcCC-----CCCCCCcCCH------HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222211 1111111122 23457888999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=321.48 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=187.2
Q ss_pred ceeccccceEEEEEEecC---CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCc
Q 043053 710 NVIGKGCSGVVYRADMDN---GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR 786 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 786 (1058)
+.||+|+||+||+|.... ...+|+|.+... ........+.+|++.++.++||||+++++++......
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~ 70 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----------ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPY 70 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc----------CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCce
Confidence 368999999999995432 356888876422 2233356788999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 787 LLMYDYMPNGSLGSLLHERT---GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 787 ~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
++||||+++|+|.+++.... ....++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 71 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 147 (269)
T cd05042 71 LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA 147 (269)
T ss_pred EEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccc
Confidence 99999999999999997643 23356788899999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccc-------cCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhh
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGY-------MMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
................++..|+|||+.. ...++.++||||+||++|||++ |..||....+ ..........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~ 225 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVLKQVVRE 225 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhhc
Confidence 7543332222223445677899999864 3456789999999999999999 7888864422 1111111111
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.......+......+... ..++..|| .||++|||+++|++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~------~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 QDIKLPKPQLDLKYSDRW------YEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCccCCCCcccccCCHHH------HHHHHHHh-cCcccccCHHHHHHHh
Confidence 111222222222222222 23556688 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=336.16 Aligned_cols=260 Identities=25% Similarity=0.356 Sum_probs=201.5
Q ss_pred HhhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVR 775 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~ 775 (1058)
.++|.+.+.||+|+||.||+|.+. .+..||||++... ......+.+.+|+.++.++. |||||+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----------~~~~~~~~~~~E~~~l~~l~~H~niv~ 105 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST----------ARSSEKQALMSELKIMSHLGPHLNIVN 105 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC----------CChhHHHHHHHHHHHHHhcCCCCCeEE
Confidence 357888999999999999999643 3468999998532 12223457899999999997 999999
Q ss_pred eeeEEEcCCCceEEEEecCCCChhhhhhhcC-------------------------------------------------
Q 043053 776 FLGCCWNRNNRLLMYDYMPNGSLGSLLHERT------------------------------------------------- 806 (1058)
Q Consensus 776 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------- 806 (1058)
+++++..++..++||||+++|+|.++++...
T Consensus 106 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (401)
T cd05107 106 LLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE 185 (401)
T ss_pred EEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence 9999999999999999999999999996531
Q ss_pred -----------------------------------------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEe
Q 043053 807 -----------------------------------------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVH 839 (1058)
Q Consensus 807 -----------------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 839 (1058)
...+++..+..++.|++.||+|||+. +|+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH 262 (401)
T cd05107 186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVH 262 (401)
T ss_pred ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCc
Confidence 12367788899999999999999998 9999
Q ss_pred CCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 043053 840 RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 918 (1058)
Q Consensus 840 rDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~ 918 (1058)
|||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999986543221122223457889999999988889999999999999999998 88998
Q ss_pred CCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 919 DPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
..... .......+... . .+......+ . .+.+++..||+++|.+||+++++++.|+++
T Consensus 343 ~~~~~-~~~~~~~~~~~--~---~~~~p~~~~---~---~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 343 PELPM-NEQFYNAIKRG--Y---RMAKPAHAS---D---EIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CCCCc-hHHHHHHHHcC--C---CCCCCCCCC---H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 64321 11111111111 0 111111111 1 234577889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=330.78 Aligned_cols=205 Identities=27% Similarity=0.310 Sum_probs=174.1
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+|. ..+++.||||++.+... ......+.+.+|+.++..++|+||+++++++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM--------LKRAETACFREERDVLVNGDRRWITNLHYAFQD 72 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--------hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 368889999999999999994 55789999999854211 122335678899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 73 ENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred CCeEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCc
Confidence 99999999999999999999753 35688999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+........ .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 149 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 149 CLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred eeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 876544321 12233569999999998763 45678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=335.75 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=210.8
Q ss_pred ccccceeccccceEEEEE-EecCCc----EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGE----VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
....++||+|+||+||+| ....|+ +||+|++... ...+..+++.+|+.+|.+++|||+++++|++
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~----------t~~~~s~e~LdeAl~masldHpnl~RLLgvc 767 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF----------TSPKASIELLDEALRMASLDHPNLLRLLGVC 767 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc----------CCchhhHHHHHHHHHHhcCCCchHHHHhhhc
Confidence 345789999999999999 444443 5888887533 2344568999999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.... ..+|++|+++|+|.||++.+ +..+-....+.|..|||+||.|||++ ++|||||.++|||+.+...+|+.||
T Consensus 768 ~~s~-~qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdf 842 (1177)
T KOG1025|consen 768 MLST-LQLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDF 842 (1177)
T ss_pred ccch-HHHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEec
Confidence 8665 88999999999999999986 46778888899999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
|+++.....+.........-.+.|||-|.+....++.++|||||||++||++| |..|++.... ..+...++.
T Consensus 843 gla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--~eI~dlle~----- 915 (1177)
T KOG1025|consen 843 GLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--EEIPDLLEK----- 915 (1177)
T ss_pred chhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--HHhhHHHhc-----
Confidence 99998877665555555556778999999999999999999999999999999 9999976522 222222222
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEY 994 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~~ 994 (1058)
+...+.|+-+.-+. +.++.+||..|++.||+++++...+.++......+
T Consensus 916 ---geRLsqPpiCtiDV---y~~mvkCwmid~~~rp~fkel~~~fs~~ardpqry 964 (1177)
T KOG1025|consen 916 ---GERLSQPPICTIDV---YMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRY 964 (1177)
T ss_pred ---cccCCCCCCccHHH---HHHHHHHhccCcccCccHHHHHHHHHHHhcCcceE
Confidence 12234444443333 34788999999999999999999887765554433
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=324.98 Aligned_cols=262 Identities=28% Similarity=0.452 Sum_probs=199.3
Q ss_pred hhccccceeccccceEEEEEEec-----------------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-----------------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 766 (1058)
++|++.+.||+|+||.||+|... ++..||+|++... .......++.+|+.+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----------~~~~~~~~~~~E~~~l~ 74 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----------ANKNARNDFLKEIKIMS 74 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----------CCHHHHHHHHHHHHHHH
Confidence 56889999999999999998432 2346899987432 22334578999999999
Q ss_pred ccCCCcccceeeEEEcCCCceEEEEecCCCChhhhhhhcC---------CCCCCHHHHHHHHHHHHHHhhcccccCCCCe
Q 043053 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT---------GNALEWELRYQILLGAAQGLAYLHHDCVPPI 837 (1058)
Q Consensus 767 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 837 (1058)
+++|+||+++++++...+..++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. ++
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i 151 (296)
T cd05095 75 RLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NF 151 (296)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 9999999999999999999999999999999999997532 13467889999999999999999999 99
Q ss_pred EeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh--CC
Q 043053 838 VHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT--GK 915 (1058)
Q Consensus 838 vHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--g~ 915 (1058)
+||||||+||+++.++.++|+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~ 231 (296)
T cd05095 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE 231 (296)
T ss_pred ecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999986544332222233445678999999888889999999999999999998 77
Q ss_pred CCCCCCCCCCh--hHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 916 QPIDPTIPDGS--HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 916 ~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
.||....+... ....+.... ......+. +..... .+.+++.+||+.||++||++.++.+.|++
T Consensus 232 ~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 232 QPYSQLSDEQVIENTGEFFRDQ-GRQVYLPK----PALCPD---SLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCccccChHHHHHHHHHHHhhc-cccccCCC----CCCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 88864422110 001111111 00111111 111112 23457889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=321.62 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=199.7
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|.+.+.||+|+||.||+|... .+..||+|.+... ........|.+|+.++++++|+||++++
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES----------CSEQDESDFLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC----------CCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 67888999999999999999553 4678999987422 1223346789999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC-----CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT-----GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
+++.+....++||||+++|+|.+++.... ...+++..+.+++.||+.|++|||+. +++||||||+||+++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~ 152 (277)
T cd05036 76 GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK 152 (277)
T ss_pred EEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEecc
Confidence 99999899999999999999999997642 13589999999999999999999999 99999999999999876
Q ss_pred C---CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhH
Q 043053 853 F---EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHV 928 (1058)
Q Consensus 853 ~---~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 928 (1058)
+ .+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ...
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--~~~ 230 (277)
T cd05036 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEV 230 (277)
T ss_pred CCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHH
Confidence 5 599999999987644332222223334568999999998899999999999999999997 9999975422 222
Q ss_pred HHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 929 VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
...+..... .......+ . .+.+++.+||+.+|++||++++++++|.
T Consensus 231 ~~~~~~~~~-----~~~~~~~~---~---~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 MEFVTGGGR-----LDPPKGCP---G---PVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHcCCc-----CCCCCCCC---H---HHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 222211111 11111111 1 2345788899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=324.12 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=201.6
Q ss_pred ccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 706 LVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
|++.+.||+|+||.||+|... ....+|+|.+... ......+++.+|+.++++++||||++++++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 71 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----------ASSSELRDLLSEFNLLKQVNHPHVIKLYGA 71 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC----------CCHHHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 677889999999999999432 2356888887432 122235678999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCe
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERT----------------------GNALEWELRYQILLGAAQGLAYLHHDCVPPI 837 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 837 (1058)
+..++..++||||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +|
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i 148 (290)
T cd05045 72 CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KL 148 (290)
T ss_pred EecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 999999999999999999999986421 23578999999999999999999998 99
Q ss_pred EeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCC
Q 043053 838 VHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ 916 (1058)
Q Consensus 838 vHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~ 916 (1058)
+||||||+||++++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..
T Consensus 149 vH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 228 (290)
T cd05045 149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228 (290)
T ss_pred ehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999986543322222233446778999999988889999999999999999998 999
Q ss_pred CCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 917 PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 917 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
||....+ ....++..... ........+ . .+..++..||+.+|++||+++++++.|+++..
T Consensus 229 p~~~~~~--~~~~~~~~~~~-----~~~~~~~~~---~---~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 229 PYPGIAP--ERLFNLLKTGY-----RMERPENCS---E---EMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCH--HHHHHHHhCCC-----CCCCCCCCC---H---HHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 9965422 22333222211 111111111 2 23457888999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=340.13 Aligned_cols=258 Identities=18% Similarity=0.198 Sum_probs=195.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
..|.+.+.||+|+||.||+| +...++.||||... ...+.+|++++++++|+|||++++++..
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----------------~~~~~~E~~iL~~L~HpnIv~l~~~~~~ 231 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----------------YASSVHEARLLRRLSHPAVLALLDVRVV 231 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----------------ccCHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 36888999999999999999 55568899999642 1345689999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++|||++. ++|.+++... ...+++..++.|+.|+++||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 232 ~~~~~lv~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGl 306 (461)
T PHA03211 232 GGLTCLVLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGA 306 (461)
T ss_pred CCEEEEEEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCC
Confidence 999999999995 6999988754 35799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC------CChhHHHHHHhhc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP------DGSHVVDWVRQKK 936 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~------~~~~~~~~~~~~~ 936 (1058)
++...............||..|+|||++.+..++.++|||||||++|||++|..|+..... ....+...+.+..
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~ 386 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ 386 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence 9876443222222345799999999999999999999999999999999998876543211 1122222222211
Q ss_pred Cc-cccCC--------------------CCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 GI-QVLDP--------------------SLLSR-PESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ~~-~~~~~--------------------~~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. ....+ ..... +......-..+.+++.+||+.||.+|||+.|++++
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 387 VHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 10 00000 00000 00000001134568889999999999999999986
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=316.70 Aligned_cols=253 Identities=27% Similarity=0.462 Sum_probs=201.0
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||.||+|....+..+|+|.+... ....+.+.+|++++++++|||++++++++. .
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG------------TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-E 72 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC------------CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-C
Confidence 568888999999999999997777778999987432 123467899999999999999999999875 4
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.++++......+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccc
Confidence 5679999999999999999875556689999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......++..|+|||+..+..++.++||||||+++|||++ |..||....+ .....++.... .
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~-----~ 221 (260)
T cd05069 150 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQVERGY-----R 221 (260)
T ss_pred eEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC-----C
Confidence 87644321 11223346778999999988889999999999999999999 8999975422 12222221111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
+......+ ..+.+++.+||++||++||+++++.+.|++
T Consensus 222 ~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCP------ESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccC------HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11111111 223457888999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=326.90 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=203.6
Q ss_pred HhhccccceeccccceEEEEEEec--------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMD--------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNI 773 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 773 (1058)
.++|.+.+.||+|+||.||+|... .+..+|+|.+... .......++.+|+++++++ +||||
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~e~~~l~~l~~h~~i 86 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----------ATEKDLSDLISEMEMMKMIGKHKNI 86 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC----------CChHHHHHHHHHHHHHHHhcCCCCE
Confidence 367999999999999999999532 2356999988532 1223456788999999999 79999
Q ss_pred cceeeEEEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEe
Q 043053 774 VRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVH 839 (1058)
Q Consensus 774 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 839 (1058)
+++++++...+..|+||||+++|+|.+++..+. ...+++..+.+++.|++.||+|||+. +++|
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H 163 (307)
T cd05098 87 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIH 163 (307)
T ss_pred eeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999999997642 13588999999999999999999998 9999
Q ss_pred CCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 043053 840 RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 918 (1058)
Q Consensus 840 rDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~ 918 (1058)
|||||+||+++.++.+||+|||.++...............++..|+|||+..+..++.++||||+||++|||++ |..||
T Consensus 164 ~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~ 243 (307)
T cd05098 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243 (307)
T ss_pred ccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999876543322222222335578999999988889999999999999999998 88888
Q ss_pred CCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 919 DPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.... ............ ........+ . .+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 244 ~~~~--~~~~~~~~~~~~-----~~~~~~~~~---~---~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 244 PGVP--VEELFKLLKEGH-----RMDKPSNCT---N---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CcCC--HHHHHHHHHcCC-----CCCCCCcCC---H---HHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 6432 122222222111 011111111 2 233478889999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=337.08 Aligned_cols=201 Identities=29% Similarity=0.362 Sum_probs=170.7
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+.++|...+.||+|+||.||+| +..+|+.||||++.... ........+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF---------QNQTHAKRAYRELVLLKCVNHKNIISLLNV 88 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc---------cchhHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence 46689999999999999999999 55679999999985331 123345678899999999999999999999
Q ss_pred EEcCC------CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 780 CWNRN------NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 780 ~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
+...+ ..|+||||+++ ++.+.++. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~ 160 (359)
T cd07876 89 FTPQKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 160 (359)
T ss_pred eccCCCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCC
Confidence 86543 46899999975 67666643 478888999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
.+||+|||+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 161 ~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 161 TLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CEEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999754332 2223457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=326.01 Aligned_cols=263 Identities=27% Similarity=0.436 Sum_probs=202.1
Q ss_pred hhccccceeccccceEEEEEEecC-----------------CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDN-----------------GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 766 (1058)
++|.+.+.||+|+||.||+|.... +..||+|++... ......+.+.+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~----------~~~~~~~~~~~e~~~l~ 74 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD----------ASDNAREDFLKEVKILS 74 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc----------cCHHHHHHHHHHHHHHH
Confidence 578889999999999999985432 245899987533 12244678999999999
Q ss_pred ccCCCcccceeeEEEcCCCceEEEEecCCCChhhhhhhcC---------CCCCCHHHHHHHHHHHHHHhhcccccCCCCe
Q 043053 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT---------GNALEWELRYQILLGAAQGLAYLHHDCVPPI 837 (1058)
Q Consensus 767 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 837 (1058)
+++||||+++++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i 151 (296)
T cd05051 75 RLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NF 151 (296)
T ss_pred hcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cc
Confidence 9999999999999999999999999999999999997642 12689999999999999999999998 99
Q ss_pred EeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh--CC
Q 043053 838 VHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT--GK 915 (1058)
Q Consensus 838 vHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--g~ 915 (1058)
+||||||+||+++.++.++|+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 231 (296)
T cd05051 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231 (296)
T ss_pred cccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence 9999999999999999999999999986554433333344556789999999888889999999999999999998 67
Q ss_pred CCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 916 QPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 916 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.||.... ................. ......+..... ++.+++.+||+.||++|||+.++++.|+
T Consensus 232 ~p~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 232 QPYEHLT--DQQVIENAGHFFRDDGR-QIYLPRPPNCPK---DIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCcC--hHHHHHHHHhccccccc-cccCCCccCCCH---HHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 7886432 12222211111000000 000111111112 3455888999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=324.97 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=203.9
Q ss_pred HhhccccceeccccceEEEEEEe--------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM--------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNI 773 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 773 (1058)
.++|.+.+.||+|+||.||+|.. .++..||+|.+... ......+.+.+|+.+++.+ +||||
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----------ATEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----------cchHHHHHHHHHHHHHHhhccCCCc
Confidence 46788999999999999999953 13457999987422 1223357889999999999 79999
Q ss_pred cceeeEEEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEe
Q 043053 774 VRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVH 839 (1058)
Q Consensus 774 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 839 (1058)
+++++++......++||||+++|+|.+++.... ...+++..+..++.||++|++|||+. +++|
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH 160 (304)
T cd05101 84 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIH 160 (304)
T ss_pred hheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceee
Confidence 999999999999999999999999999997632 23578889999999999999999999 9999
Q ss_pred CCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 043053 840 RDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 918 (1058)
Q Consensus 840 rDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~ 918 (1058)
|||||+||+++.++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||
T Consensus 161 ~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred cccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999987654332222333456778999999988889999999999999999998 78888
Q ss_pred CCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 919 DPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
.... .......+.... . .......+ . .+..++.+||+++|++|||+.++++.|+++..
T Consensus 241 ~~~~--~~~~~~~~~~~~---~--~~~~~~~~---~---~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 241 PGIP--VEELFKLLKEGH---R--MDKPANCT---N---ELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ccCC--HHHHHHHHHcCC---c--CCCCCCCC---H---HHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 6432 112222111111 0 01111111 2 23447888999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=324.57 Aligned_cols=264 Identities=28% Similarity=0.398 Sum_probs=197.7
Q ss_pred ccccceeccccceEEEEEE-----ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 706 LVDANVIGKGCSGVVYRAD-----MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
|...+.||+|+||+||++. ..+++.||+|.+... ......+.+.+|++++++++||||+++++++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE----------CGQQNTSGWKKEINILKTLYHENIVKYKGCC 75 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc----------cChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4888999999999998753 246788999988532 1223457788999999999999999999988
Q ss_pred EcC--CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 781 WNR--NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 781 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
... ...++||||+++|+|.+++.. ..+++..++.++.|+++|++|||+. +|+||||||+||+++.++.++|+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~ 149 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIG 149 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEe
Confidence 754 357899999999999999975 3589999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcc-cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++....+... .......++..|+|||+..+..++.++||||||+++|||++|+.||...................
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05080 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229 (283)
T ss_pred ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence 99999866543211 11222345677999999988889999999999999999999999986542211111100000000
Q ss_pred c----cccCCCC-CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 938 I----QVLDPSL-LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 938 ~----~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
. ...+... ...+.... ..+..++..||+++|++|||++++++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 230 VVRLIELLERGMRLPCPKNCP---QEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhhcCCCCCCCCCCC---HHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0 0000000 00011111 23445788899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=321.56 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=200.5
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|...+.||+|+||.||+|.. .++..+|+|.+.. ......+.+.+|++++++++|+||++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----------ASESARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-----------CCHHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 5677889999999999999943 2456789998742 2233457899999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCC-------------CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTG-------------NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKA 844 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp 844 (1058)
+++...+..++||||+++|+|.++++.... ..+++..++.++.|++.|++|||+. +++||||||
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp 150 (280)
T cd05092 74 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLAT 150 (280)
T ss_pred EEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccH
Confidence 999999999999999999999999976421 3578999999999999999999998 999999999
Q ss_pred CcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043053 845 NNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 923 (1058)
Q Consensus 845 ~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 923 (1058)
+||++++++.+||+|||+++...............+++.|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 151 ~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 151 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred hhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 999999999999999999976544332222333446788999999988889999999999999999998 8999864422
Q ss_pred CChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 924 DGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
............ .......+. .+.+++.+||+.||++||+++++++.|+
T Consensus 231 --~~~~~~~~~~~~-----~~~~~~~~~------~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 231 --TEAIECITQGRE-----LERPRTCPP------EVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --HHHHHHHHcCcc-----CCCCCCCCH------HHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 122222211111 111111122 2335778899999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=323.33 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=196.2
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...++||+|+||.||+| +..+++.||+|++... ......+++.+|++++++++||||+++++++..+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD----------ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC----------CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 5778899999999999999 5678899999987422 1223456789999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|..+. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred CEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 9999999999999997552 367888899999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChh--HHHHHHhhcCcccc
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSH--VVDWVRQKKGIQVL 941 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~--~~~~~~~~~~~~~~ 941 (1058)
...... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......... ...+...... ..
T Consensus 143 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 216 (279)
T cd06619 143 TQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD--ED 216 (279)
T ss_pred eecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc--cC
Confidence 765432 223457899999999999888999999999999999999999999753221111 0111111000 00
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.+.... .... ..+.+++.+||+.+|++||++++++++..
T Consensus 217 ~~~~~~--~~~~---~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 217 PPVLPV--GQFS---EKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CCCCCC--CcCC---HHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 111110 0011 12345788899999999999999988643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=325.95 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=202.3
Q ss_pred hhccccceeccccceEEEEEEec--------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCccc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD--------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIV 774 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 774 (1058)
++|.+.+.||+|+||.||+|... .+..||+|.+... ......+.+.+|+++++++ +||||+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~iv 81 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----------ATDKDLADLISEMELMKLIGKHKNII 81 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC----------CChHHHHHHHHHHHHHHhccCCCCee
Confidence 57889999999999999999531 2456899987432 1223456788999999999 599999
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeC
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 840 (1058)
++++++......++||||+++|+|.+++.... ...+++..+.+++.|++.|++|||+. +++||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~ 158 (314)
T cd05099 82 NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHR 158 (314)
T ss_pred eEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeec
Confidence 99999998888999999999999999997532 24588999999999999999999998 99999
Q ss_pred CCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 043053 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 919 (1058)
Q Consensus 841 Dikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 919 (1058)
||||+||+++.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred cccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986644322222222334568999999988889999999999999999999 889986
Q ss_pred CCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 920 PTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
.... ............ ... +..... ++.+++.+||+.+|++|||+.++++.++++..
T Consensus 239 ~~~~--~~~~~~~~~~~~-----~~~---~~~~~~---~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 239 GIPV--EELFKLLREGHR-----MDK---PSNCTH---ELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CCCH--HHHHHHHHcCCC-----CCC---CCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 4321 222222221110 111 111112 23347888999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=324.63 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=200.5
Q ss_pred HhhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccce
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRF 776 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 776 (1058)
.++|.+.++||+|+||.||+|... .+..||+|.+... ........+.+|+.++++++||||+++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i~~~ 74 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----------ASLRERIEFLNEASVMKGFTCHHVVRL 74 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc----------CCHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 368899999999999999998432 2457999987422 122234568899999999999999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEE
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nil 848 (1058)
++++.+....++||||+++|+|.++++... ....++..+..++.|++.|++|||+. +|+||||||+||+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nil 151 (288)
T cd05061 75 LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCM 151 (288)
T ss_pred EEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEE
Confidence 999999999999999999999999997532 23456778889999999999999998 9999999999999
Q ss_pred EcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChh
Q 043053 849 IGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSH 927 (1058)
Q Consensus 849 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~ 927 (1058)
++.++.++++|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||..... ..
T Consensus 152 i~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~~ 229 (288)
T cd05061 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQ 229 (288)
T ss_pred EcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--HH
Confidence 99999999999999886544332222233345778999999998889999999999999999998 7889865422 22
Q ss_pred HHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 928 VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
....+.... . .......+ ..+.+++.+||+.||++|||+.++++.++..
T Consensus 230 ~~~~~~~~~---~--~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 230 VLKFVMDGG---Y--LDQPDNCP------ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHHcCC---C--CCCCCCCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 222221111 0 11111111 1344578889999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=315.95 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=199.1
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc-
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN- 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 782 (1058)
++|.+.+.||+|+||.||+|... |..||+|.+... ...+.+.+|+.++++++|+|++++++++..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-------------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 57888999999999999999765 788999987321 235678999999999999999999997654
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||+++|+|.++++......+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCcc
Confidence 45679999999999999999876555689999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++...... ....++..|+|||+..+..++.++|||||||++|||++ |+.||... ........+....
T Consensus 149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~----- 216 (256)
T cd05082 149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGY----- 216 (256)
T ss_pred ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCC-----
Confidence 87543321 23345678999999988889999999999999999997 99998643 2222222222211
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
.+......+. .+.+++.+||+.+|++|||++++++.|+++
T Consensus 217 ~~~~~~~~~~------~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 KMDAPDGCPP------VVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCH------HHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1111112222 234578889999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=328.17 Aligned_cols=261 Identities=18% Similarity=0.308 Sum_probs=196.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+| +..+++.||+|++.... .......+.+|++++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 75 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH----------EEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 75 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc----------cCCcchhHHHHHHHHHhCCCCCcceEEEEEee
Confidence 56888999999999999999 45578899999885331 12223567789999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++ +|.+++... +..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 150 (309)
T cd07872 76 DKSLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGL 150 (309)
T ss_pred CCeEEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcccc
Confidence 9999999999975 898888754 35688999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC--c-
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG--I- 938 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~- 938 (1058)
++...... .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....... ......+.... .
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~ 227 (309)
T cd07872 151 ARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEE 227 (309)
T ss_pred ceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHH
Confidence 87654322 12234567899999998765 467889999999999999999999997543211 11111000000 0
Q ss_pred -----------ccc-CCCCCCCC----chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 939 -----------QVL-DPSLLSRP----ESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 939 -----------~~~-~~~~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
... .+.....+ ....+ ....+++.+|++.||.+|||++|++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLD--TEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred HHhhhcchhhhhhhhcCccCCCchhhhccCCC--HHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 000 00000000 00001 1235688899999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=325.68 Aligned_cols=264 Identities=26% Similarity=0.416 Sum_probs=203.3
Q ss_pred hhccccceeccccceEEEEEEe-cCCc--EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGE--VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 779 (1058)
+.|.+.+.||+|+||.||+|.. .++. .+|+|.+... ........+.+|++++.++ +||||++++++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc----------CCHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 5788899999999999999954 4454 4577765321 1233457889999999999 89999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCC
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKAN 845 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~ 845 (1058)
+..++..|+||||+++|+|.++++... ...+++..++.++.|+++|++|||+. +++||||||+
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~ 153 (303)
T cd05088 77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAAR 153 (303)
T ss_pred ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---Cccccccchh
Confidence 999999999999999999999997532 23578999999999999999999998 9999999999
Q ss_pred cEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043053 846 NILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPD 924 (1058)
Q Consensus 846 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 924 (1058)
||+++.++.+||+|||++...... .......++..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 154 Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~- 229 (303)
T cd05088 154 NILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC- 229 (303)
T ss_pred eEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-
Confidence 999999999999999998643211 11122234678999999888889999999999999999998 9999964422
Q ss_pred ChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhhhh
Q 043053 925 GSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAK 996 (1058)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~~~~ 996 (1058)
.......... .........+ . .+.+++.+||+.+|++||+++++++.++++...+..+..
T Consensus 230 -~~~~~~~~~~-----~~~~~~~~~~---~---~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~ 289 (303)
T cd05088 230 -AELYEKLPQG-----YRLEKPLNCD---D---EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 289 (303)
T ss_pred -HHHHHHHhcC-----CcCCCCCCCC---H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhh
Confidence 1111111110 0111111111 1 234588899999999999999999999988777665544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=322.60 Aligned_cols=254 Identities=22% Similarity=0.258 Sum_probs=198.2
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
|...+.||+|+||+||+| ...+++.||+|.+..... ......+.+.+|++++++++|++|+++++++..++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~ 73 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--------KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD 73 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--------hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC
Confidence 566789999999999999 556789999998854321 12223456788999999999999999999999999
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||+++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~ 150 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcce
Confidence 999999999999999998765455799999999999999999999998 99999999999999999999999999987
Q ss_pred eccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1058)
...... ......|+..|+|||++.+..++.++|+||+||++|||++|+.||....+.. ....+...... ....
T Consensus 151 ~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~~---~~~~ 223 (285)
T cd05632 151 KIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVLE---TEEV 223 (285)
T ss_pred ecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhhc---cccc
Confidence 654322 1234568999999999988889999999999999999999999997542211 11111111111 1111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 043053 945 LLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAM 983 (1058)
Q Consensus 945 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~ 983 (1058)
.....+. .+.+++..||+.||++||+ +++++.+
T Consensus 224 ~~~~~~~------~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 YSAKFSE------EAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCccCCH------HHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1111122 2234778899999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.34 Aligned_cols=254 Identities=24% Similarity=0.314 Sum_probs=197.8
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||.||+|. ..+++.||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-----------PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-----------ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 578899999999999999994 567899999988422 11234568899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++++|.++++. ...+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 78 ~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~ 152 (267)
T cd06646 78 REKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGV 152 (267)
T ss_pred CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999999999999975 35689999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
+....... .......|+..|+|||.+. ...++.++||||+||++|||++|+.||....+.... . .... .
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~----~~~~-~ 224 (267)
T cd06646 153 AAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-F----LMSK-S 224 (267)
T ss_pred ceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-e----eeec-C
Confidence 98664322 1223456889999999874 345678999999999999999999999644321110 0 0000 0
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
...+........ ....+.+++.+||+.+|++||+++++++++
T Consensus 225 ~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 NFQPPKLKDKTK---WSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCCccccc---cCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111111111111 112344578889999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=317.22 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=203.0
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|+||.||+| ...+++.||+|.+.... ......+.+.+|++++++++||||+++++++.+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK---------MNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh---------CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 3677889999999999999 45578999999874321 1233467899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++++|.++++......+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 9999999999999999999876567889999999999999999999998 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
+...... .......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ........... ..+
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~-----~~~ 219 (256)
T cd08529 149 KLLSDNT--NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGALILKIIRG-----VFP 219 (256)
T ss_pred eeccCcc--chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcC-----CCC
Confidence 8665432 12234568899999999998889999999999999999999999997542 11211111111 011
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
......+ ..+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~------~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYS------QQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccC------HHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111111 123457888999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=324.10 Aligned_cols=255 Identities=23% Similarity=0.267 Sum_probs=199.6
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
|+..+.||+|+||.||+| +..+++.||||.+..... ......+.+.+|+.++++++|++|+++++++.+.+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~ 73 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--------KKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc--------cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC
Confidence 567789999999999999 666899999998854321 12223456778999999999999999999999999
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeecccee
Confidence 999999999999999999765455689999999999999999999998 99999999999999999999999999987
Q ss_pred eccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1058)
...... ......|+..|+|||++.+..++.++||||+||++|+|++|+.||......... ........ .....
T Consensus 151 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~---~~~~~ 223 (285)
T cd05630 151 HVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVK---EVQEE 223 (285)
T ss_pred ecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhh---hhhhh
Confidence 654322 122456899999999999889999999999999999999999999754322110 00000000 00111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHH
Q 043053 945 LLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAML 984 (1058)
Q Consensus 945 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~l 984 (1058)
.....+. ...+++..||+.||++||| ++|++++-
T Consensus 224 ~~~~~~~------~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 224 YSEKFSP------DARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred cCccCCH------HHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 1111222 2345778899999999999 78888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.47 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=195.7
Q ss_pred cccceeccccceEEEEEEecC-Cc--EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 707 VDANVIGKGCSGVVYRADMDN-GE--VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 707 ~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.+.+.||+|+||.||+|.... +. .||+|.+.... ......+.+.+|++++++++||||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---------CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQT 72 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccC
Confidence 467899999999999995543 33 58999874321 2233467889999999999999999999987432
Q ss_pred ------CCceEEEEecCCCChhhhhhhc----CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 784 ------NNRLLMYDYMPNGSLGSLLHER----TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 784 ------~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
...++||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 149 (272)
T cd05075 73 VESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENM 149 (272)
T ss_pred CcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCC
Confidence 2458999999999999987432 234589999999999999999999998 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHH
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 932 (1058)
.+||+|||+++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||.... .......+
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~ 227 (272)
T cd05075 150 NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIYDYL 227 (272)
T ss_pred CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH
Confidence 999999999987654332222233456778999999998899999999999999999999 788986532 22222222
Q ss_pred HhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
..... ... ++...+ .+.+++.+||++||++|||++++++.|+++
T Consensus 228 ~~~~~-----~~~---~~~~~~---~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 RQGNR-----LKQ---PPDCLD---GLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCC-----CCC---CCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 21111 011 111112 234588899999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=341.74 Aligned_cols=258 Identities=23% Similarity=0.291 Sum_probs=190.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...++||+|+||.||+| ...+++.||||++... .....+|+.++++++|||||++++++..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---------------~~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---------------PQYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---------------cchHHHHHHHHHhcCCCCCcceeeeEee
Confidence 46899999999999999999 5567899999987422 1234579999999999999999998753
Q ss_pred C--------CCceEEEEecCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 783 R--------NNRLLMYDYMPNGSLGSLLHE--RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 783 ~--------~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
. ...++||||+++ ++.+++.. .....+++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~ 206 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPN 206 (440)
T ss_pred cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCC
Confidence 2 135689999975 78777753 2346789999999999999999999999 99999999999999976
Q ss_pred C-CeeeeccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH
Q 043053 853 F-EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 853 ~-~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 930 (1058)
+ .+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..
T Consensus 207 ~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~ 282 (440)
T PTZ00036 207 THTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVR 282 (440)
T ss_pred CCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHH
Confidence 5 79999999998664432 22345689999999987654 6899999999999999999999999754321 11211
Q ss_pred HHHhhcCc----------cccCCCCCCCCchhHHH------HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 931 WVRQKKGI----------QVLDPSLLSRPESEIDE------MLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 931 ~~~~~~~~----------~~~~~~~~~~~~~~~~~------~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.+...... ...+............. ..++.+++.+||..||.+|||+.|++++-
T Consensus 283 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 11110000 00000000000000000 12355688999999999999999999754
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=331.59 Aligned_cols=246 Identities=21% Similarity=0.255 Sum_probs=190.5
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 787 (1058)
+.||+|+||+||+| ...+++.||||++..... ......+.+.+|+.++.++ +||+|+++++++.+.+..|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 72 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV--------HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLF 72 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEE
Confidence 47999999999999 556789999999864321 1223456788999999888 5999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++.. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 73 lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 73 LVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 99999999999998875 35689999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC-hhHHHHHHhhcCccccCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG-SHVVDWVRQKKGIQVLDPSLL 946 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 946 (1058)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+..+..... .....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p 223 (327)
T cd05617 148 GPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIP 223 (327)
T ss_pred CCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCC
Confidence 221 22335679999999999999999999999999999999999999996432211 11111111111100 01111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHH
Q 043053 947 SRPESEIDEMLQALGVALLCVNASPDERPTMK 978 (1058)
Q Consensus 947 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ 978 (1058)
...+. .+.+++.+||+.||++|+++.
T Consensus 224 ~~~~~------~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSV------KASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCH------HHHHHHHHHhccCHHHcCCCC
Confidence 11111 234577889999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=334.35 Aligned_cols=258 Identities=21% Similarity=0.227 Sum_probs=196.1
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| ...+++.||+|++..... ......+.+.+|+.+++.++||||+++++++.
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~--------~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--------IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh--------hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 378999999999999999999 555789999999853211 12223466889999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
++...|+||||+++|+|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999999975 3478888999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM----KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+++....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+........
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~- 264 (371)
T cd05622 188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKN- 264 (371)
T ss_pred ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC-
Confidence 9987643321 223456799999999997654 3788999999999999999999999754211 11111111111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDE--RPTMKDVAAMLK 985 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~~v~~~l~ 985 (1058)
..........+.. +..++..|+..++.+ ||++++++++..
T Consensus 265 --~~~~~~~~~~s~~------~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 265 --SLTFPDDNDISKE------AKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred --cccCCCcCCCCHH------HHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 0110001111222 234666788744433 789999988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=326.94 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=201.0
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||.||+| ...++..+|+|.+... .......++.+|++++++++||||+++++++.++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE----------IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc----------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 5788999999999999999 5557888999987422 1223456788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++++|.++++.. ..+++..+..++.|+++||+|||+.. +++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999999999999763 56889999999999999999999731 8999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC-cccc-
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG-IQVL- 941 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~- 941 (1058)
...... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||..... .....+...... ....
T Consensus 148 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 221 (308)
T cd06615 148 GQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKE 221 (308)
T ss_pred cccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccC
Confidence 755332 12345789999999998888899999999999999999999999964321 111111111000 0000
Q ss_pred --------------------------CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 942 --------------------------DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 942 --------------------------~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
.......+.... -..+..++.+||..+|++|||+.+++++.....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAF--SDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCccc--CHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 000000000000 112446889999999999999999998765433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.96 Aligned_cols=254 Identities=24% Similarity=0.423 Sum_probs=203.6
Q ss_pred HhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.++|.+.+.||+|+||.||+|....+..+|+|.+... ....+.+.+|++++++++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC------------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 3578899999999999999998777888999987422 2235688999999999999999999999887
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
...++||||+++|+|.+++........++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcc
Confidence 7789999999999999999876566789999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+........ .......++..|+|||++....++.++|||||||++|++++ |+.||.... ......+..+....
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~~~--- 222 (260)
T cd05073 149 ARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRM--- 222 (260)
T ss_pred eeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCCC---
Confidence 976644322 12223346678999999988889999999999999999999 899997532 22233332222111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
......+ ..+.+++.+||+++|++||++.++.+.|+.
T Consensus 223 --~~~~~~~------~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 --PRPENCP------EELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCcccCC------HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111111 124457888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=335.61 Aligned_cols=201 Identities=26% Similarity=0.337 Sum_probs=170.9
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+.++|...+.||+|+||.||+| +...++.||||++.... ......+.+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 84 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---------QNQTHAKRAYRELVLMKCVNHKNIISLLNV 84 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc---------cChHHHHHHHHHHHHHHHhCCCchhceeee
Confidence 46689999999999999999999 55678999999885331 223345678899999999999999999998
Q ss_pred EEcCC------CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 780 CWNRN------NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 780 ~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
+.... ..|+||||+++ ++.+++.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~ 156 (355)
T cd07874 85 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 156 (355)
T ss_pred eeccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCC
Confidence 86433 46899999975 67777653 478899999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 157 TLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred CEEEeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999865432 2223457899999999999989999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=329.43 Aligned_cols=205 Identities=25% Similarity=0.289 Sum_probs=174.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+| ...+++.||+|++..... ........+.+|+.++..++|++|+++++++.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~ 72 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM--------LKRAETACFREERNVLVNGDCQWITTLHYAFQD 72 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH--------HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 36888999999999999999 455788999998853211 122334668899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||++||+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 73 ENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccc
Confidence 99999999999999999999763 35688999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 149 CLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred eeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 986654321 12234569999999998765 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.79 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=194.9
Q ss_pred eeccccceEEEEEEe---cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCce
Q 043053 711 VIGKGCSGVVYRADM---DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 711 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
.||+|+||.||+|.+ .++..+|+|++... .......+++.+|+.++++++||||+++++++. .+..+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~---------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 71 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND---------NNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWM 71 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC---------CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcE
Confidence 589999999999943 46788999987432 123345678999999999999999999999875 45678
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++... ..+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 72 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 72 LVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence 999999999999999753 5689999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCcc-cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCCCC
Q 043053 868 DGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSL 945 (1058)
Q Consensus 868 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1058)
..... .......++..|+|||+.....++.++|||||||++|||++ |..||.... .......+.... .+..
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~i~~~~-----~~~~ 219 (257)
T cd05116 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--GNEVTQMIESGE-----RMEC 219 (257)
T ss_pred CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCC-----CCCC
Confidence 43211 11223345679999999888888999999999999999998 999997542 222233222211 1111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 946 LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 946 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
....+. .+.+++.+||+.||++||++++|++.|+..
T Consensus 220 ~~~~~~------~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 PQRCPP------EMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCH------HHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111222 233578889999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.62 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=195.8
Q ss_pred ceeccccceEEEEEEe-cC---CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCC
Q 043053 710 NVIGKGCSGVVYRADM-DN---GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~-~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 785 (1058)
++||+|+||.||+|.. .. +..||+|.+.... .....+++.+|+++++++.||||+++++++. .+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 69 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH----------IAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEP 69 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEeccccc----------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCc
Confidence 4799999999999943 22 2689999885331 1134578899999999999999999999875 456
Q ss_pred ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
.++||||+++|+|.+++... ..+++..+..++.|++.|++|||.. +++||||||+||+++.++.+||+|||+++.
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~ 144 (257)
T cd05060 70 LMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRA 144 (257)
T ss_pred eEEEEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccce
Confidence 79999999999999999864 4789999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCcc-cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 866 VDDGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 866 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
....... .......++..|+|||+..+..++.++||||||+++|||++ |..||.... ......++.+....
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~~~~----- 217 (257)
T cd05060 145 LGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESGERL----- 217 (257)
T ss_pred eecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcCCcC-----
Confidence 6543321 11122234568999999988889999999999999999998 999997542 23333333322111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
......+ ..+.+++.+||+.+|++||++.++.+.|+.+.
T Consensus 218 ~~~~~~~------~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECP------QEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1111111 13445888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=315.04 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=196.1
Q ss_pred ceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEE
Q 043053 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLM 789 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 789 (1058)
++||+|+||.||+|...+++.||+|++... ........+.+|++++++++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED----------LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCc----------CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 478999999999998778899999987532 1223345788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCC
Q 043053 790 YDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG 869 (1058)
Q Consensus 790 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~ 869 (1058)
|||+++|+|.+++... ...+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+||+|||++......
T Consensus 71 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 71 MELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred EECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 9999999999999764 35678999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCC
Q 043053 870 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948 (1058)
Q Consensus 870 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1058)
.. .......++..|+|||+..+..++.++||||||+++||+++ |..||..... ......+.... .......
T Consensus 147 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--~~~~~~~~~~~-----~~~~~~~ 218 (250)
T cd05085 147 IY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--QQAREQVEKGY-----RMSCPQK 218 (250)
T ss_pred cc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCC-----CCCCCCC
Confidence 21 11222345678999999988889999999999999999998 9999975422 12221111111 1111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 949 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.+ ..+.+++.+||+.+|++||++.++.+.+.
T Consensus 219 ~~------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CP------DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CC------HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11 13345788899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=323.84 Aligned_cols=257 Identities=30% Similarity=0.498 Sum_probs=201.2
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|...+.||+|+||.||+|... ++..||+|++... .......++.+|+.++++++||||++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----------ASADMQADFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC----------cCHHHHHHHHHHHHHHHhcCCCchheEE
Confidence 56888899999999999999542 5688999988532 1223457799999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC--------------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCe
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------------GNALEWELRYQILLGAAQGLAYLHHDCVPPI 837 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 837 (1058)
+++..++..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. ++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i 151 (288)
T cd05050 75 GVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KF 151 (288)
T ss_pred EEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 99999999999999999999999997431 13478889999999999999999998 99
Q ss_pred EeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCC
Q 043053 838 VHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ 916 (1058)
Q Consensus 838 vHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~ 916 (1058)
+||||||+||+++.++.++|+|||++................++..|+|||+..+..++.++|||||||++|||++ |..
T Consensus 152 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~ 231 (288)
T cd05050 152 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231 (288)
T ss_pred ecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876544332222233345678999999988889999999999999999998 888
Q ss_pred CCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 917 PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 917 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
||..... ......+.... . ...+.... .++.+++.+||+.||++|||+.|+++.|++
T Consensus 232 p~~~~~~--~~~~~~~~~~~---~-----~~~~~~~~---~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 232 PYYGMAH--EEVIYYVRDGN---V-----LSCPDNCP---LELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCCCH--HHHHHHHhcCC---C-----CCCCCCCC---HHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 8864422 12222222111 1 11111111 234458889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=316.04 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=200.9
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|++.+.||+|+||.||++ ...+++.+|+|.+... ......+.+.+|+.++++++||||+++++++.++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 70 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP----------KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD 70 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcC----------cchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC
Confidence 4678899999999999999 5557899999987432 1223457788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++.......+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++++|||.+
T Consensus 71 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 71 GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcc
Confidence 9999999999999999999765566789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
....... .......|++.|+|||+..+..++.++|+||||+++|+|++|..||..... .......... . ..
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~~~~~-~---~~- 218 (255)
T cd08219 148 RLLTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--KNLILKVCQG-S---YK- 218 (255)
T ss_pred eeecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--HHHHHHHhcC-C---CC-
Confidence 8664432 122345688999999999988899999999999999999999999975321 1111111111 0 11
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
......+. .+.+++.+||+.||++||++.+++..
T Consensus 219 ~~~~~~~~------~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSY------ELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCH------HHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11111111 23457888999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=331.72 Aligned_cols=241 Identities=24% Similarity=0.252 Sum_probs=187.2
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHH-HHcccCCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK-TLGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
+.||+|+||+||+| +..+|+.||||++..... ........+.+|.. +++.++||||+++++++..++..|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~ 72 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV--------LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLY 72 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEE
Confidence 46999999999999 556799999999854321 11223345555654 567789999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 73 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 73 FVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred EEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 99999999999998875 45789999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. .. .....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~~~~--~~----~~~~~ 217 (325)
T cd05604 148 AQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--AEMYDNILH--KP----LVLRP 217 (325)
T ss_pred CCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--HHHHHHHHc--CC----ccCCC
Confidence 221 223456799999999999999999999999999999999999999975421 111111111 11 11111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTMKD 979 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~ 979 (1058)
.... .+.+++..|++.+|.+||++.+
T Consensus 218 ~~~~------~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 GASL------TAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCH------HHHHHHHHHhccCHHhcCCCCC
Confidence 1111 2345778899999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.17 Aligned_cols=255 Identities=27% Similarity=0.472 Sum_probs=204.8
Q ss_pred HhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.++|.+.+.||+|+||.||+|...+++.||||.+... ....+++.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG------------TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC------------ccCHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 3678899999999999999997777889999988532 1235678999999999999999999999998
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....++||||+++++|.+++.......+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcccc
Confidence 88999999999999999999876556789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++....... .......++..|+|||...+..++.++||||+|+++|||++ |+.||.... .......+... .
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~~~~--~--- 221 (261)
T cd05034 150 ARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQVERG--Y--- 221 (261)
T ss_pred ceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcC--C---
Confidence 987654221 11122335678999999988889999999999999999998 999996432 12222222111 1
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
........+ . .+.+++.+||+.+|++||+++++.+.++.
T Consensus 222 ~~~~~~~~~---~---~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCP---E---ELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCC---H---HHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111111111 1 23457888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=327.96 Aligned_cols=205 Identities=27% Similarity=0.310 Sum_probs=173.3
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||++. ..+++.||+|++..... ........+..|+.++..++|++|+++++++.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--------LKRAETACFREERDVLVNGDNQWITTLHYAFQD 72 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH--------HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec
Confidence 368889999999999999994 45678899999853211 122234568899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||+++|+|.++++.. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 73 ENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred CCEEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecch
Confidence 99999999999999999999763 35689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 149 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred heecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 876543221 2223457999999999875 345788999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=336.33 Aligned_cols=259 Identities=24% Similarity=0.299 Sum_probs=195.7
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|+||.||+| +..+|+.||||++.... ......+++.+|+++++.++||||+++++++..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---------QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc---------cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 3677899999999999999 45689999999884321 1223356788999999999999999999999876
Q ss_pred C-----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 784 N-----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 784 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
. ..|+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~ 145 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKIC 145 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEec
Confidence 6 6799999996 588888865 35789999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++....... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||....+. .....+....+
T Consensus 146 Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g 222 (372)
T cd07853 146 DFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLG 222 (372)
T ss_pred cccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcC
Confidence 9999986543321 223345688999999998764 4788999999999999999999999754321 11111100000
Q ss_pred -------------------ccccCC-CC---CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 938 -------------------IQVLDP-SL---LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 938 -------------------~~~~~~-~~---~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.....+ .. ....... ...+.+++.+||+.||++|||+.|++++-
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQA---THEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCC---CHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 000000 00 0000000 12345688899999999999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=324.11 Aligned_cols=262 Identities=23% Similarity=0.287 Sum_probs=192.9
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc---CCCcccceeeEE
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI---RHKNIVRFLGCC 780 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~ 780 (1058)
+|.+.+.||+|+||+||+| +..+++.||+|.+.... ........+.+|+++++++ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQT---------NEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCc---------CCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 4778899999999999999 55679999999885331 1122234556777777665 699999999988
Q ss_pred EcC-----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 781 WNR-----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 781 ~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
... ...++||||+++ +|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQV 147 (288)
T ss_pred ccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 642 346899999975 999999875556689999999999999999999999 99999999999999999999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||+++...... ......||..|+|||++.+..++.++||||+||++|||++|+.||...... ..........
T Consensus 148 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~ 223 (288)
T cd07863 148 KLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLI 223 (288)
T ss_pred EECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHh
Confidence 999999998664322 223456899999999998888999999999999999999999999654221 1111111100
Q ss_pred c--Ccccc-------CCCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 K--GIQVL-------DPSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 ~--~~~~~-------~~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. ..... .............. ...+.+++.+|+++||++|||+.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 224 GLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00000 00000000000000 1123458889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=328.25 Aligned_cols=244 Identities=22% Similarity=0.283 Sum_probs=191.9
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEcC
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNR 783 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 783 (1058)
|...+.||+|+||+||+| +..+|+.||+|++..... ......+.+..|+.+++.+. |++|+++++++.+.
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--------IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV 73 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC
Confidence 667889999999999999 556799999999854321 12223466788999988886 57888899999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 74 DRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccc
Confidence 9999999999999999999763 5689999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....+ ......+.... .
T Consensus 149 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i~~~~------~ 218 (323)
T cd05615 149 KEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQSIMEHN------V 218 (323)
T ss_pred cccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC------C
Confidence 7543222 122345699999999999988899999999999999999999999975422 22222221111 1
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMK 978 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~ 978 (1058)
......+. .+.+++.+||+.+|.+|++..
T Consensus 219 ~~p~~~~~------~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 SYPKSLSK------EAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCccCCH------HHHHHHHHHcccCHhhCCCCC
Confidence 11111111 234578889999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=336.71 Aligned_cols=260 Identities=19% Similarity=0.218 Sum_probs=199.0
Q ss_pred HhhccccceeccccceEEEEEEe---cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM---DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
..+|.+.+.||+|+||.||+|.. ..++.||||.+... ..+.+|++++++++||||++++++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------------~~~~~E~~il~~l~h~~iv~~~~~ 154 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------------KTPGREIDILKTISHRAIINLIHA 154 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------------ccHHHHHHHHHhcCCCCccceeee
Confidence 35799999999999999999943 34678999987321 234689999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+......++|||++. ++|.+++.. ...+++..++.++.|++.||+|||+. +||||||||+|||++.++.++|+|
T Consensus 155 ~~~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~D 228 (392)
T PHA03207 155 YRWKSTVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGD 228 (392)
T ss_pred EeeCCEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcc
Confidence 999999999999995 589998853 46789999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC--hhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG--SHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~ 937 (1058)
||+++...............||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+...++....
T Consensus 229 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~ 308 (392)
T PHA03207 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308 (392)
T ss_pred CccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence 999986654433333345679999999999999899999999999999999999999997543221 111111111000
Q ss_pred c--------------------cccCCCCCCCCchhHH---HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 938 I--------------------QVLDPSLLSRPESEID---EMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 938 ~--------------------~~~~~~~~~~~~~~~~---~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
. ....+... .+..+. .-..+..++.+||..||++|||+.+++.+-..
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYT--IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred CccccCCccchhHHHHHHhhcccccCCcc--ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 0 00000000 000000 01234457888999999999999999987544
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.34 Aligned_cols=255 Identities=30% Similarity=0.434 Sum_probs=198.8
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
|+..+.||+|+||+||+| +..+++.||+|.+.... ..........+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE---------IEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT---------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc---------ccccccchhhhhhhccccccccccccccccccccc
Confidence 677899999999999999 55567789999985432 12222334456999999999999999999999999
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||+++++|.+++.. ...+++..+..++.|+++||++||+. +|+||||||+||+++.++.++|+|||.+.
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 99999999999999999983 46789999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCcccccccccCcCCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
.... .........++..|+|||+.. +..++.++||||+|+++|+|++|..||... ....................
T Consensus 147 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~ 222 (260)
T PF00069_consen 147 KLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSDDQLEIIEKILKRPLPSS 222 (260)
T ss_dssp ESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHHHHHHHHHHHHHTHHHHH
T ss_pred cccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc--cchhhhhhhhhccccccccc
Confidence 6421 123445667899999999988 888999999999999999999999999754 11111111211111000000
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..... .. ...+.+++..||+.||++||++.+++++
T Consensus 223 ~~~~~--~~---~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 SQQSR--EK---SEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHT--TS---HHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccc--hh---HHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00 1344557888999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=334.02 Aligned_cols=201 Identities=26% Similarity=0.344 Sum_probs=171.1
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+.++|...+.||+|+||.||+| +...++.||||++.... ......+.+.+|+.+++.++||||++++++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~ 91 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---------QNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc---------cCchhHHHHHHHHHHHHhcCCCCcccccee
Confidence 45689999999999999999999 56678999999985331 223345678899999999999999999998
Q ss_pred EEcC------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 780 CWNR------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 780 ~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
+... ...|+||||+++ +|.+++.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 92 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 163 (364)
T cd07875 92 FTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 163 (364)
T ss_pred ecccccccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCC
Confidence 7643 346999999965 78777753 478889999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
.+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 164 ~~kL~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 164 TLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred cEEEEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 9999999999865432 1223457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=333.35 Aligned_cols=205 Identities=24% Similarity=0.351 Sum_probs=175.7
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|+..+.||+|+||.||+| ...+++.||||++..... ........+.+|+.++.+++||+|+++++++.++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 73 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--------LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK 73 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--------hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 5788899999999999999 556789999999854321 1223457888999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..|+||||++||+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCC
Confidence 999999999999999999976 35689999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCc---------------------------------ccccccccCcCCccCccccccCCCCcccchhhHHHHHHH
Q 043053 864 KLVDDGDF---------------------------------ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLE 910 (1058)
Q Consensus 864 ~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~e 910 (1058)
+....... .......+||+.|+|||++.+..++.++||||+||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye 228 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence 75432110 001123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC
Q 043053 911 VLTGKQPIDPTI 922 (1058)
Q Consensus 911 lltg~~P~~~~~ 922 (1058)
|++|+.||....
T Consensus 229 l~tG~~Pf~~~~ 240 (360)
T cd05627 229 MLIGYPPFCSET 240 (360)
T ss_pred cccCCCCCCCCC
Confidence 999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.71 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=200.7
Q ss_pred hhccccceeccccceEEEEEEec-CC---cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-NG---EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
+.|+..+.||+|+||.||+|... ++ ..+|+|.+... ......+.+..|++++++++||||++++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG----------YTEKQRQDFLSEASIMGQFSHHNIIRLEGV 74 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc----------CCHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence 46788899999999999999543 33 37999987432 122345778999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+...+..++||||+++++|.++++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 150 (268)
T cd05063 75 VTKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD 150 (268)
T ss_pred EccCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence 99999999999999999999999764 35789999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCccc-ccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDFAR-SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||++.......... .......+..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~~~- 227 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGF- 227 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhcCC-
Confidence 99987664332111 1112223567999999988889999999999999999997 9999964422 22222221110
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
..+.. ..... ...+++.+||+.+|++||++.++++.|+++
T Consensus 228 ---~~~~~----~~~~~---~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ---RLPAP----MDCPS---AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCC----CCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111 11112 234578889999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.47 Aligned_cols=249 Identities=30% Similarity=0.430 Sum_probs=202.2
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+.|.+.+.||+|+||.||+|... |+.||||.+... ....+++.+|+.++++++|+||+++++++.+.
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDD------------STAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccc------------hhHHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 56788899999999999999765 889999998432 11467899999999999999999999999988
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++++|.++++......+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence 8999999999999999999876555799999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+...... ....++..|+|||+..+..++.++||||||+++|||++ |..||.... ............ .
T Consensus 150 ~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~-----~ 217 (256)
T cd05039 150 KEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPHVEKGY-----R 217 (256)
T ss_pred ccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhcCC-----C
Confidence 8663321 12335678999999988889999999999999999997 999996442 122222221111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
.......+ . .+.+++.+||..+|++|||+.++++.|+.
T Consensus 218 ~~~~~~~~---~---~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCP---P---EVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCC---H---HHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11111111 1 23457888999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.62 Aligned_cols=249 Identities=23% Similarity=0.380 Sum_probs=193.2
Q ss_pred eeccccceEEEEEEec---CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCce
Q 043053 711 VIGKGCSGVVYRADMD---NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 711 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
.||+|+||.||+|... .+..||+|++... ......+.+.+|+.++++++||||+++++++. .+..+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~ 70 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----------NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALM 70 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc----------cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeE
Confidence 3899999999999543 3557999987432 22334578999999999999999999999875 45789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++... ...+++..+++++.|++.|++|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 71 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 146 (257)
T cd05115 71 LVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALG 146 (257)
T ss_pred EEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCcccccc
Confidence 999999999999999754 35789999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCCCC
Q 043053 868 DGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSL 945 (1058)
Q Consensus 868 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1058)
.... ........++..|+|||+..+..++.++|||||||++||+++ |..||....+ ......+.+... +..
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~-----~~~ 219 (257)
T cd05115 147 ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEVMSFIEQGKR-----LDC 219 (257)
T ss_pred CCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHCCCC-----CCC
Confidence 3321 111222234678999999888889999999999999999996 9999975422 222222222111 111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 946 LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 946 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
....+ . ++.+++..||..+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~---~---~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECP---P---EMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCC---H---HHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11111 2 233478889999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.64 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=200.5
Q ss_pred hhccccceeccccceEEEEEEec-CC---cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-NG---EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+|.+.+.||+|+||.||+|... ++ ..||||.+... ......++|..|+.++++++||||++++++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 73 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----------YTEKQRRDFLSEASIMGQFDHPNIIHLEGV 73 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----------CCHHHHHHHHHHHHHHHhCCCcCcceEEEE
Confidence 46788999999999999999543 33 36999987432 233446789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+..+...++||||+++|+|.++++.. ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~d 149 (269)
T cd05065 74 VTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD 149 (269)
T ss_pred ECCCCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECC
Confidence 99999999999999999999999764 35689999999999999999999998 999999999999999999999999
Q ss_pred cccceeccCCCccccccc-c--cCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhh
Q 043053 860 FGLAKLVDDGDFARSSNT-V--AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||++.............. . ..+..|+|||+..+..++.++||||+||++|||++ |..||.... ......++...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i~~~ 227 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAIEQD 227 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHHHcC
Confidence 999876543321111111 1 12457999999998889999999999999999886 999997542 22333333221
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
. ........+. .+.+++..||+.+|++||++.+++..|+.+
T Consensus 228 ~-----~~~~~~~~~~------~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 Y-----RLPPPMDCPT------ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C-----cCCCcccCCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1111111122 233477889999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=325.93 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=202.4
Q ss_pred hhccccceeccccceEEEEEEec--------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCccc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD--------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIV 774 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 774 (1058)
.+|.+.+.||+|+||.||+|... .+..||+|.+... ......+++.+|+++++++ +||||+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----------ATDKDLSDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----------cCHHHHHHHHHHHHHHHhhcCCCCee
Confidence 47889999999999999999432 1236899987422 1223457899999999999 799999
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeC
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 840 (1058)
++++++..+...++||||+++|+|.+++.... ...+++..+..++.|+++||+|||+. +|+||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~ 158 (334)
T cd05100 82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHR 158 (334)
T ss_pred eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecc
Confidence 99999999989999999999999999997532 23578899999999999999999998 99999
Q ss_pred CCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 043053 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 919 (1058)
Q Consensus 841 Dikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 919 (1058)
||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 159 DLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred ccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999987654332222233345678999999999899999999999999999998 888886
Q ss_pred CCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 920 PTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
.... ......+.... .... +..... .+..++.+||+.+|++||++.++++.|+.+..
T Consensus 239 ~~~~--~~~~~~~~~~~-----~~~~---~~~~~~---~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 239 GIPV--EELFKLLKEGH-----RMDK---PANCTH---ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCCH--HHHHHHHHcCC-----CCCC---CCCCCH---HHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 4321 11211111111 1111 111112 23457888999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.54 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=200.6
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|...+.||+|++|.||+| ...+++.||+|.+...... .......+.+.+|++++++++||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS------PETKKEVNALECEIQLLKNLQHERIVQYYGCLRD 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc------hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence 35788999999999999999 5567999999987533210 1112234678999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~ 150 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGA 150 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 99999999999999999999763 5688999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCccc-ccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFAR-SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++......... ......|+..|+|||+..+..++.++||||+|+++|||++|+.||..... .......... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~----~~ 224 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--MAAIFKIATQ----PT 224 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--HHHHHHHhcc----CC
Confidence 87654322111 11234578899999999988899999999999999999999999964321 1111111111 11
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+......+. .+..++..||..+|++|||+.+++++
T Consensus 225 ~~~~~~~~~~------~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 NPQLPSHVSP------DARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCccCCH------HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1112212222 23347788999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.98 Aligned_cols=263 Identities=29% Similarity=0.453 Sum_probs=202.8
Q ss_pred hhccccceeccccceEEEEEE-ecCCc----EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGE----VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|...+.||+|+||.||+|. ..+|+ .||+|.+... .......++.+|+.++++++||||+++++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~~~~l~h~niv~~~~ 76 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET----------TGPKANVEFMDEALIMASMDHPHLVRLLG 76 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc----------CCHHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 467788999999999999994 44554 4688877422 12233457899999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++... ..++|+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 77 ~~~~~-~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~ 151 (303)
T cd05110 77 VCLSP-TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT 151 (303)
T ss_pred EEcCC-CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEc
Confidence 98654 467999999999999999764 34688999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++...............++..|+|||+..+..++.++|||||||++|||++ |+.||.... ......+......
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~ 229 (303)
T cd05110 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEKGER 229 (303)
T ss_pred cccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCCC
Confidence 9999987654332222233446778999999988889999999999999999997 899996432 2223333322111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEY 994 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~~ 994 (1058)
. ......+ ..+..++..||..+|++||+++++++.++++......+
T Consensus 230 ---~--~~~~~~~------~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (303)
T cd05110 230 ---L--PQPPICT------IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRY 275 (303)
T ss_pred ---C--CCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhh
Confidence 0 0111111 23445788899999999999999999998876554443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.21 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=185.9
Q ss_pred eeccccceEEEEEEecCCc---EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCce
Q 043053 711 VIGKGCSGVVYRADMDNGE---VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 711 ~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
.||+|+||.||+|...++. .+++|.+... ......+.+.+|+..++.++||||+++++++.+....+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 71 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----------ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----------CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccE
Confidence 5899999999999544333 4556655321 12234578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 788 LMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
+||||+++|+|.++++... ....++..+..++.||++||+|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred EEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccc
Confidence 9999999999999997632 23467777889999999999999998 999999999999999999999999999864
Q ss_pred ccCCCcccccccccCcCCccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 866 VDDGDFARSSNTVAGSYGYIAPEYGYM-------MKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
..............|+..|+|||+... ..++.++|||||||++|||++ |..||....+ ......+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~~ 226 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHVIKDQQ 226 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHhhcc
Confidence 332222222334568899999998643 245779999999999999997 5668754321 111111112222
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
....++......... ...++..|| .+|++||+++++++.|
T Consensus 227 ~~~~~~~~~~~~~~~------~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 227 VKLFKPQLELPYSER------WYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cccCCCccCCCCcHH------HHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 223333333322222 233666799 6799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=320.97 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=200.0
Q ss_pred hhccccceeccccceEEEEEEe-----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
+.|++.+.||+|+||.||.|.. .++..||+|.+... ......+.+.+|++++++++||||+++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE----------SGGNHIADLKKEIEILRNLYHENIVKYKG 73 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc----------ccHHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 3467889999999999999953 45788999998533 12334578999999999999999999999
Q ss_pred EEEcC--CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 779 CCWNR--NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 779 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
++... ...++||||++|++|.+++.+. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++
T Consensus 74 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~ 149 (284)
T cd05079 74 ICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 149 (284)
T ss_pred EEecCCCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEE
Confidence 98775 5678999999999999999764 34689999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC----------CC
Q 043053 857 IADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP----------DG 925 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~----------~~ 925 (1058)
|+|||+++....... ........++..|+|||+..+..++.++|||||||++|||++++.|+..... ..
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05079 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ 229 (284)
T ss_pred ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc
Confidence 999999986644321 1122345577789999999888899999999999999999998876532211 00
Q ss_pred hhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
.....+......... ...+... ...+.+++.+||+.+|++|||++++++.++++
T Consensus 230 ~~~~~~~~~~~~~~~-----~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 230 MTVTRLVRVLEEGKR-----LPRPPNC---PEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccHHHHHHHHHcCcc-----CCCCCCC---CHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 011111111110000 0011111 12345588899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.51 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=195.9
Q ss_pred ceeccccceEEEEEEec--CC--cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCC
Q 043053 710 NVIGKGCSGVVYRADMD--NG--EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 785 (1058)
++||+|++|.||+|... .+ ..||||.+.... .....+.+.+|++.+++++||||+++++++.. ..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 69 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK----------LSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HP 69 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcc----------cHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-Ce
Confidence 46899999999999543 23 368999885432 11456889999999999999999999999988 88
Q ss_pred ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
.++||||+++|+|.+++.......+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~ 146 (257)
T cd05040 70 LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRA 146 (257)
T ss_pred EEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccc
Confidence 89999999999999999875435789999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 866 VDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 866 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
...... ........++..|+|||+..+..++.++|||||||++|||++ |+.||..... ......+... ...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~-~~~---- 219 (257)
T cd05040 147 LPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQILKKIDKE-GER---- 219 (257)
T ss_pred ccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHhc-CCc----
Confidence 654221 112223457789999999988889999999999999999998 9999964422 1222222111 000
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
...+..... .+.+++.+||+.+|++||+++++++.|.
T Consensus 220 --~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 --LERPEACPQ---DIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCCccCCH---HHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011111112 2344788899999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.56 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=199.8
Q ss_pred hhccccceeccccceEEEEEEec-CCc--EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-NGE--VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 779 (1058)
++|.+.++||+|+||.||+|... ++. .+|+|.+... ......+.+.+|++++.++ +||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 71 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----------ASENDHRDFAGELEVLCKLGHHPNIINLLGA 71 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc----------CCHHHHHHHHHHHHHHHhhcCCCchhheEEE
Confidence 56888999999999999999543 343 4688876421 1223356789999999999 69999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCC
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKAN 845 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~ 845 (1058)
+......++||||+++|+|.++++... ...+++..++.++.|++.|++|||+. +|+||||||+
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~ 148 (297)
T cd05089 72 CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAAR 148 (297)
T ss_pred EccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcc
Confidence 999899999999999999999997532 13588999999999999999999998 9999999999
Q ss_pred cEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043053 846 NILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPD 924 (1058)
Q Consensus 846 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 924 (1058)
||+++.++.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||....+
T Consensus 149 Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~- 224 (297)
T cd05089 149 NVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC- 224 (297)
T ss_pred eEEECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 999999999999999998643211 11112223567999999988889999999999999999997 9999975422
Q ss_pred ChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 925 GSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
........+. ..+......+ . .+.+++.+||+.+|.+||+++++++.++.+.....
T Consensus 225 -~~~~~~~~~~-----~~~~~~~~~~---~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 225 -AELYEKLPQG-----YRMEKPRNCD---D---EVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred -HHHHHHHhcC-----CCCCCCCCCC---H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1222211111 1111111111 1 23457888999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=322.63 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=201.4
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
.+...+|...+.||+|+||.||+| +..+++.||+|.+... .....+.+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~v~~~~~ 84 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-----------QQPKKELIINEILVMRENKNPNIVNYLD 84 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecC-----------CcchHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344468889999999999999999 4567899999987432 1223567889999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++..+...++||||+++++|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~ 158 (296)
T cd06654 85 SYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT 158 (296)
T ss_pred EEEeCCEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEC
Confidence 99998999999999999999999964 4578999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
|||++....... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+... ...+.. ..
T Consensus 159 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~--~~- 232 (296)
T cd06654 159 DFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIAT--NG- 232 (296)
T ss_pred ccccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhc--CC-
Confidence 999987654322 122344688999999999888889999999999999999999999975433211 111110 00
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+.. ..+. .+.. .+.+++.+||.++|++||++.+++++
T Consensus 233 ---~~~~-~~~~-~~~~--~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 233 ---TPEL-QNPE-KLSA--IFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---CCCC-CCcc-ccCH--HHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0111 0111 1111 23457888999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=322.79 Aligned_cols=261 Identities=29% Similarity=0.402 Sum_probs=204.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+| ...+|+.||+|++... ......+.+.+|+++++.++||||+++++++..
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG----------AKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec----------CcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 56788899999999999999 5557899999987432 223446789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....++||||+++|+|.++++.. +.+++..+..++.+++.|+.|||+.. +++||||||+||+++.++.++|+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCc
Confidence 99999999999999999998763 56899999999999999999999731 899999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC------hhHHHHHHhhc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG------SHVVDWVRQKK 936 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~------~~~~~~~~~~~ 936 (1058)
+...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+.. .....+.....
T Consensus 151 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd06620 151 SGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226 (284)
T ss_pred ccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence 8654321 1234568999999999888889999999999999999999999997543211 11112222211
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
.. ..+.+. .... ...+.+++.+||++||++|||++|++++...++.
T Consensus 227 ~~--~~~~~~---~~~~--~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 227 QE--PPPRLP---SSDF--PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hc--cCCCCC---chhc--CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 10 011111 1101 1124457888999999999999999987655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=315.02 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=204.3
Q ss_pred hhccccceeccccceEEEEEEe-cCCc----EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGE----VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
.+|...+.||+|+||.||+|.. .+|+ .||+|.+... .......++.+|++++++++||||+++++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE----------TSPKANKEILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC----------CCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 5778889999999999999954 3343 5889987433 12334578899999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++.. ...++||||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 77 ~~~~-~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~ 151 (279)
T cd05057 77 ICLS-SQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKIT 151 (279)
T ss_pred EEec-CceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEEC
Confidence 9987 7889999999999999999864 34589999999999999999999998 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||.++...............++..|+|||......++.++||||||+++||+++ |+.||....+ ......+....
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~- 228 (279)
T cd05057 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEKGE- 228 (279)
T ss_pred CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhCCC-
Confidence 9999987654322112222334678999999988889999999999999999998 9999975422 22222222111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~ 993 (1058)
. ...+.... .....++..||..+|.+||++.++++.++++.....+
T Consensus 229 --~-----~~~~~~~~---~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~ 274 (279)
T cd05057 229 --R-----LPQPPICT---IDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQR 274 (279)
T ss_pred --C-----CCCCCCCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcc
Confidence 0 01111111 1234578889999999999999999999988654443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=313.05 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=201.5
Q ss_pred hhccccceeccccceEEEEEEec-C---CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-N---GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+|++.+.||+|+||.||+|... + +..+|+|.+... ......+.+.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG----------YTEKQRRDFLSEASIMGQFDHPNIIHLEGV 73 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC----------CCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 57888999999999999999542 2 337999987432 122345789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+..++..++||||+++|+|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~d 149 (267)
T cd05066 74 VTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSD 149 (267)
T ss_pred EecCCccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCC
Confidence 99999999999999999999999764 35689999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcc-cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||++......... .......++..|+|||++.+..++.++||||||+++||+++ |..||..... ......+.+..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~~~- 226 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIEEGY- 226 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHhCCC-
Confidence 9999876543211 11122234568999999998889999999999999999886 9999975422 22222222211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
........+. .+.+++.+||+.+|.+||++.++++.|+++
T Consensus 227 ----~~~~~~~~~~------~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----RLPAPMDCPA------ALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----cCCCCCCCCH------HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111111111 234578889999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.04 Aligned_cols=251 Identities=26% Similarity=0.467 Sum_probs=199.8
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.+|++.+.||+|+||.||+|...+++.+|+|.+... .....++.+|++++++++||+|+++++++...
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG------------AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC------------CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence 467788999999999999997777889999987432 11246789999999999999999999999998
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++|+|.++++.. ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcce
Confidence 9999999999999999999764 34678999999999999999999998 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......++.+|+|||+..+..++.++||||+|+++|||++ |+.||.... .......... ......
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~--~~~~~~ 222 (256)
T cd05112 148 RFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--NSEVVETINA--GFRLYK 222 (256)
T ss_pred eecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHhC--CCCCCC
Confidence 76543321 11223335678999999988889999999999999999998 999996432 1122221111 111111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+.. .+ ..+.+++.+||+.+|++|||+.++++.+
T Consensus 223 ~~~---~~------~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 PRL---AS------QSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCC---CC------HHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111 11 2345588999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=330.93 Aligned_cols=244 Identities=24% Similarity=0.258 Sum_probs=184.8
Q ss_pred eccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc---CCCcccceeeEEEcCCCce
Q 043053 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI---RHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 712 lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 787 (1058)
||+|+||+||+| +..+++.||||++..... ........+..|..++.+. +||||+++++++.++...|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~ 72 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--------VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLY 72 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--------hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEE
Confidence 699999999999 556799999999854321 1112234455666666655 6999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++|+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.++|+|||+++...
T Consensus 73 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 73 LVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred EEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 99999999999999875 35689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLL 946 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (1058)
... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+.. ....+..
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--~~~~~~i~~--~~~~~~~--- 218 (330)
T cd05586 148 TDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--QQMYRNIAF--GKVRFPK--- 218 (330)
T ss_pred CCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--HHHHHHHHc--CCCCCCC---
Confidence 222 223456799999999988754 478999999999999999999999975421 111111111 1000100
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCC----CHHHHHHH
Q 043053 947 SRPESEIDEMLQALGVALLCVNASPDERP----TMKDVAAM 983 (1058)
Q Consensus 947 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RP----t~~~v~~~ 983 (1058)
...+. ...+++.+||++||++|| ++.+++++
T Consensus 219 ~~~~~------~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 NVLSD------EGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ccCCH------HHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 01111 123477889999999998 56666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.08 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=202.4
Q ss_pred HHHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 699 VEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 699 ~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
+.+..++|...+.||+|+||.||+| +..+++.||+|.+... .....+.+.+|+.+++.++||||++++
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~i~~~~ 82 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ-----------QQPKKELIINEILVMRENKNPNIVNYL 82 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC-----------ccchHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3455578999999999999999999 4568999999988422 122346788999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeee
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl 857 (1058)
+++..++..++||||+++++|.+++.+ ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l 156 (297)
T cd06656 83 DSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKL 156 (297)
T ss_pred EEEecCCEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999999965 4578999999999999999999998 9999999999999999999999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+|||++....... .......+++.|+|||...+..++.++|||||||++|+|++|+.||....+...... ...
T Consensus 157 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~ 229 (297)
T cd06656 157 TDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IAT 229 (297)
T ss_pred CcCccceEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----ecc
Confidence 9999987654332 122345688999999999888899999999999999999999999975433211100 000
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. ..+.. ..+ ..... .+.+++.+||+.+|++||++++++++
T Consensus 230 ~--~~~~~-~~~-~~~~~--~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 230 N--GTPEL-QNP-ERLSA--VFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred C--CCCCC-CCc-cccCH--HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00110 011 11111 12347788999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.84 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=197.7
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||.||+| +..+++.||+|++... .......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~-----------~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~ 76 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-----------PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC-----------chhHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 357888899999999999999 5567899999987422 1223456889999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
..+..++||||+++++|.++++.. ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd06645 77 RRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFG 151 (267)
T ss_pred eCCEEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcce
Confidence 999999999999999999999763 5789999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
++....... .......|+..|+|||++. ...++.++||||+||++|+|++|+.||....+.. ..... ...
T Consensus 152 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~--~~~-- 224 (267)
T cd06645 152 VSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLM--TKS-- 224 (267)
T ss_pred eeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhh--hcc--
Confidence 987654321 2223456899999999874 4557889999999999999999999986543211 11111 000
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...+........... .+.+++.+||+.+|++||++++++++
T Consensus 225 -~~~~~~~~~~~~~~~---~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 225 -NFQPPKLKDKMKWSN---SFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -CCCCCcccccCCCCH---HHHHHHHHHccCCchhCcCHHHHhcC
Confidence 011111110000111 23457888999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.63 Aligned_cols=258 Identities=27% Similarity=0.392 Sum_probs=200.9
Q ss_pred hccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 705 CLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
+|+..+.||+|+||+||+|...+++.+|||.+...... ........+.+.+|++++++++|+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN-----VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc-----hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC
Confidence 47888999999999999997778999999988533211 0112233467899999999999999999999999999
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||.+.
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 150 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhH
Confidence 999999999999999999763 4678999999999999999999998 99999999999999999999999999987
Q ss_pred eccCCC----cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 865 LVDDGD----FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 865 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
...... .........|+..|+|||+..+..++.++||||+|+++|+|++|+.||...... ....... ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~-~~~~ 225 (265)
T cd06631 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAMFYIG-AHRG 225 (265)
T ss_pred hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHHHHhh-hccC
Confidence 543211 111223456899999999999888999999999999999999999999743211 1111111 1111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..+......+. .+..++.+||+.+|++||++.+++.+
T Consensus 226 ~~~~~~~~~~~------~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 LMPRLPDSFSA------AAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCCCCCH------HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11222222222 23447888999999999999998763
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=326.75 Aligned_cols=202 Identities=23% Similarity=0.287 Sum_probs=168.0
Q ss_pred ccceeccc--cceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 708 DANVIGKG--CSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 708 ~~~~lG~G--~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
+.++||+| +||+||++ +..+|+.||||++.... ......+.+.+|+++++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA---------CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh---------ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 35789999 78999999 66789999999985331 12234567888999999999999999999999999
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999999999999999765455689999999999999999999998 99999999999999999999999998754
Q ss_pred eccCCCc-c----cccccccCcCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 865 LVDDGDF-A----RSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 865 ~~~~~~~-~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
....... . .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 3322110 0 01123356788999999875 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.06 Aligned_cols=249 Identities=29% Similarity=0.479 Sum_probs=200.1
Q ss_pred ceeccccceEEEEEEec-C---CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCC
Q 043053 710 NVIGKGCSGVVYRADMD-N---GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 785 (1058)
+.||+|+||.||+|... . +..||+|.+.... .....+.+.+|++.+++++|+||+++++++.....
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 70 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA----------SEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP 70 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc----------chhHHHHHHHHHHHHhhcCCCChheeeeeecCCCc
Confidence 47999999999999544 3 8889999985431 11246889999999999999999999999999889
Q ss_pred ceEEEEecCCCChhhhhhhcC-------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 786 RLLMYDYMPNGSLGSLLHERT-------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
.++||||+++++|.++++... ...+++..++.++.|+++|++|||+. +++||||||+||+++.++.++|+
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~ 147 (262)
T cd00192 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKIS 147 (262)
T ss_pred eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEc
Confidence 999999999999999998742 36789999999999999999999998 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||.+................++..|+|||......++.++||||+|+++|||++ |..||.... ...........
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~-- 223 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYLRKG-- 223 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcC--
Confidence 9999987655432233445567889999999888889999999999999999999 699997652 22232222221
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
. ........+ . .+.+++.+||+.+|++|||+.+++++|
T Consensus 224 ~---~~~~~~~~~---~---~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 224 Y---RLPKPEYCP---D---ELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred C---CCCCCccCC---h---HHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1 111111111 1 334578889999999999999999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=329.23 Aligned_cols=190 Identities=24% Similarity=0.277 Sum_probs=164.0
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
..|.+.+.||+|+||.||+| +..+++.||+|+... .....|+.++++++||||+++++++..
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------------~~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------------GTTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------------cccHHHHHHHHhCCCCCCcChhheEEe
Confidence 46899999999999999999 445678899997521 123569999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....++||||+. |+|.+++... ...+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 129 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 129 GAITCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred CCeeEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence 999999999995 5899988754 46789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 918 (1058)
++..... .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 204 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 204 AQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 8753322 1223456999999999999999999999999999999999966554
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=323.76 Aligned_cols=196 Identities=26% Similarity=0.376 Sum_probs=160.4
Q ss_pred cceeccccceEEEEEEec---CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC--
Q 043053 709 ANVIGKGCSGVVYRADMD---NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR-- 783 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 783 (1058)
.++||+|+||+||+|... +++.||+|.+... .....+.+|++++++++||||+++++++...
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 72 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-------------GISMSACREIALLRELKHPNVISLQKVFLSHAD 72 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-------------CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCC
Confidence 468999999999999543 5688999988422 1234578999999999999999999998653
Q ss_pred CCceEEEEecCCCChhhhhhhcC-------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE----cCC
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERT-------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI----GLE 852 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill----~~~ 852 (1058)
...++||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.+
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~ 148 (317)
T cd07868 73 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred cEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCc
Confidence 456899999964 8888875321 23588999999999999999999999 99999999999999 456
Q ss_pred CCeeeeccccceeccCCCc-ccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 853 FEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+.+||+|||+++....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 7899999999987654321 122345678999999999876 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=311.76 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=201.3
Q ss_pred hhccccceeccccceEEEEEEecC----CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDN----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|...+.||+|+||.||+|...+ ...||||..... ......+.+.+|++++++++||||++++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~----------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC----------TSPSVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc----------CCHHHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 467888999999999999995432 346899987432 123345789999999999999999999998
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+.+ ...++||||+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|
T Consensus 76 ~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d 150 (270)
T cd05056 76 ITE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGD 150 (270)
T ss_pred EcC-CCcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEcc
Confidence 865 5578999999999999999764 34689999999999999999999998 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
||+++........ ......++..|+|||......++.++||||||+++||+++ |..||..... ............
T Consensus 151 ~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~~~~~~- 226 (270)
T cd05056 151 FGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--NDVIGRIENGER- 226 (270)
T ss_pred Cceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHcCCc-
Confidence 9999866543221 1223335578999999888889999999999999999986 9999975432 222222222111
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.......+ . .+.+++.+|+..+|++|||+.++++.|+.+..+
T Consensus 227 ----~~~~~~~~---~---~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 227 ----LPMPPNCP---P---TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----CCCCCCCC---H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111112 2 234478889999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.63 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=195.7
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
...|...+.||+|+||.||+| ...+++.||+|.+... ......+.+|+.++.++ +||||+++++++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~------------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 72 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------GDEEEEIKQEINMLKKYSHHRNIATYYGAF 72 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC------------CccHHHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence 356788889999999999999 4567899999987422 12246788999999998 699999999998
Q ss_pred EcC------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC
Q 043053 781 WNR------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE 854 (1058)
Q Consensus 781 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~ 854 (1058)
... ...|+||||+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||++++++.
T Consensus 73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~ 149 (272)
T cd06637 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 149 (272)
T ss_pred eecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCC
Confidence 753 3478999999999999999875556789999999999999999999999 9999999999999999999
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHH
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVV 929 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 929 (1058)
++|+|||++....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||....+..
T Consensus 150 ~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~---- 223 (272)
T cd06637 150 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---- 223 (272)
T ss_pred EEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----
Confidence 9999999988654322 2234566899999999875 3457889999999999999999999996542211
Q ss_pred HHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
....... ...........+ . .+.+++.+||..+|.+|||+++++++
T Consensus 224 ~~~~~~~--~~~~~~~~~~~~---~---~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 224 ALFLIPR--NPAPRLKSKKWS---K---KFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHHHHhc--CCCCCCCCCCcC---H---HHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1111110 000011111111 1 23457888999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.63 Aligned_cols=263 Identities=18% Similarity=0.279 Sum_probs=196.8
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+| +..+++.||+|.+... ........+.+|+.++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~ 75 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLE----------HEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 75 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecc----------cccCchhHHHHHHHHHHhcCCCCcceEEEEEec
Confidence 57899999999999999999 4457899999988432 122234567889999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||++ ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 76 EKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred CCeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcc
Confidence 999999999997 5999988764 35688999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC---c
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG---I 938 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~---~ 938 (1058)
+....... .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+..... .
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~ 226 (301)
T cd07873 151 ARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTE 226 (301)
T ss_pred hhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCh
Confidence 87644322 12234457899999998765 35788999999999999999999999754221 11111111000 0
Q ss_pred cc----------cCCCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 939 QV----------LDPSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 939 ~~----------~~~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.. ............... ...+.+++.+|++.||.+|||++|++++-.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 227 ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00 000000000000000 012345888999999999999999998543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=317.14 Aligned_cols=263 Identities=23% Similarity=0.297 Sum_probs=195.6
Q ss_pred hccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...+.||+|++|.||+|. ..+++.||||++.... ......+.+.+|+.++++++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---------EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc---------ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 37788999999999999994 4579999999885331 2233356788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERT-GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
...++||||++ ++|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccc
Confidence 99999999997 58999887533 36789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc---
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI--- 938 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--- 938 (1058)
+....... .......+++.|+|||++.+. .++.++||||+|+++|||++|+.||....... ............
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~ 224 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTED 224 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChh
Confidence 87654321 222344678999999987654 56889999999999999999999997542211 111110000000
Q ss_pred --------cccCCCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 --------QVLDPSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 --------~~~~~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
....+............ ..++.+++.+||+.||++|||+.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000000000 1123458889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.85 Aligned_cols=247 Identities=27% Similarity=0.421 Sum_probs=197.0
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+.|.+.+.||+|+||.||++.. +++.||+|.+... ...+.+.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-------------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc-------------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 5788999999999999999965 5788999987421 2346789999999999999999999998654
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
..++||||+++|+|.+++.......+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~ 147 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLA 147 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccc
Confidence 579999999999999999876556789999999999999999999998 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
...... ......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ........... .
T Consensus 148 ~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~-----~ 215 (254)
T cd05083 148 RVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--KEVKECVEKGY-----R 215 (254)
T ss_pred eecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHhCCC-----C
Confidence 764332 112334578999999988889999999999999999998 9999965422 12222221111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
+......+ . .+.+++.+||+.+|++||+++++++.+++
T Consensus 216 ~~~~~~~~---~---~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 MEPPEGCP---A---DVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCcCC---H---HHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11111111 1 23457888999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.08 Aligned_cols=250 Identities=28% Similarity=0.401 Sum_probs=200.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|...+.||+|+||.||+| ...+++.||+|.+... ......+.+.+|++++++++||||+++++++..
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE----------EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK 73 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccc----------cchHHHHHHHHHHHHHHcCCCCccHhhhccccc
Confidence 45777889999999999999 5567889999987432 122345789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||+++++|.+++.. ..+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++++|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06642 74 GTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred CCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccc
Confidence 9999999999999999999864 4689999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||....+.. ...+.... ..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~-----~~ 218 (277)
T cd06642 148 AGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKN-----SP 218 (277)
T ss_pred cccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcC-----CC
Confidence 87654432 12223458889999999998889999999999999999999999997543221 11111110 11
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+......+ ..+.+++.+||+.+|++||++.+++++-
T Consensus 219 ~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 219 PTLEGQYS------KPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCCcccC------HHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 11111111 1234578889999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=354.20 Aligned_cols=254 Identities=30% Similarity=0.416 Sum_probs=204.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
-+|.....||.|.||.||.| ...+|+..|||-+.-.. ........+.+|+.++..++|||+|++||+-..
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~---------~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQD---------SDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCc---------cccccCcchHHHHHHHHhccCccccccCceeec
Confidence 36777889999999999999 88899999999885332 224456788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..+|.||||++|+|.+.+.. ++-.++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccc
Confidence 9999999999999999999975 35567777778899999999999999 999999999999999999999999999
Q ss_pred ceeccCCC--cccccccccCcCCccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 863 AKLVDDGD--FARSSNTVAGSYGYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 863 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|..+.+.. .........||+.|||||++.+.. ...++||||+|||+.||+||+.||.....+ ......+....
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~~gh- 1458 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVAAGH- 1458 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHhccC-
Confidence 98876542 233445678999999999988654 567899999999999999999999754322 22222222111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.|.++.+... ...+++..|+..||++|+++.|++++
T Consensus 1459 ----~Pq~P~~ls~------~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 ----KPQIPERLSS------EGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----CCCCchhhhH------hHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2333322222 23447788999999999999988775
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=329.59 Aligned_cols=262 Identities=23% Similarity=0.298 Sum_probs=195.9
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++.++|...+.||+|+||.||+| +..+++.||||++.... ......+.+.+|++++++++||||++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---------QSLIHARRTYRELRLLKHMKHENVIGLLDV 82 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---------hhhHHHHHHHHHHHHHHhcCCCchhhhhhh
Confidence 45678999999999999999999 56678999999885331 112234567899999999999999999998
Q ss_pred EEcC------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 780 CWNR------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 780 ~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
+... ...|++||++ +++|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~ 155 (343)
T cd07878 83 FTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDC 155 (343)
T ss_pred hcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCC
Confidence 7543 3458999988 7799988864 4689999999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ..+..+.
T Consensus 156 ~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~ 229 (343)
T cd07878 156 ELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIM 229 (343)
T ss_pred CEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHH
Confidence 9999999999865432 234568999999999876 56889999999999999999999999643211 1111111
Q ss_pred HhhcCc-------------cccCCCCCCCCchhHHHH-----HHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 933 RQKKGI-------------QVLDPSLLSRPESEIDEM-----LQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 933 ~~~~~~-------------~~~~~~~~~~~~~~~~~~-----~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
...... ..........+....... ..+.+++.+|++.||++|||+.|++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 230 EVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred HHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 100000 000000000111111100 1234688899999999999999999763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=315.42 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=196.0
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|++.+.||+|+||.||+| ...++..+|+|.+... .....+.+.+|+++++.++||||+++++++..+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~ 74 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----------SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE 74 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----------CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC
Confidence 3677889999999999999 4456888899987422 223457789999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+|++|||++
T Consensus 75 ~~~~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~ 150 (282)
T cd06643 75 NNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS 150 (282)
T ss_pred CEEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccc
Confidence 9999999999999999988653 35789999999999999999999998 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||....+. ...... ......
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~-~~~~~~ 226 (282)
T cd06643 151 AKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-RVLLKI-AKSEPP 226 (282)
T ss_pred ccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-HHHHHH-hhcCCC
Confidence 7543321 2233456899999999873 445778999999999999999999999754221 111111 111100
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
. .......+. .+.+++.+||+.||++||++++++++-
T Consensus 227 ~---~~~~~~~~~------~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 227 T---LAQPSRWSS------EFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred C---CCCccccCH------HHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0 001111111 234578889999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=312.54 Aligned_cols=259 Identities=29% Similarity=0.486 Sum_probs=200.1
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||.||+| +..+++.||+|.+......... ........+.+.+|++++++++||||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASS--KDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccch--hHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Confidence 4678899999999999999 5567899999988543211000 011223346789999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999999763 5688999999999999999999998 9999999999999999999999999998
Q ss_pred eeccCCCc----ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 864 KLVDDGDF----ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 864 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
+....... ........|+..|+|||+..+..++.++||||+|+++|+|++|+.||..... .. . +.... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~--~-~~~~~--~ 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--LQ--A-IFKIG--E 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--HH--H-HHHHh--c
Confidence 86653211 1111234588999999999888889999999999999999999999975421 11 1 11111 1
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...+......+. .+..++.+||++||++||++.+++++
T Consensus 227 ~~~~~~~~~~~~------~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 NASPEIPSNISS------EAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCCCcCCcccCH------HHHHHHHHHccCCchhCcCHHHHhhC
Confidence 112222222222 23347788999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=311.01 Aligned_cols=239 Identities=19% Similarity=0.361 Sum_probs=185.1
Q ss_pred ceeccccceEEEEEEecC-------------CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccce
Q 043053 710 NVIGKGCSGVVYRADMDN-------------GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRF 776 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 776 (1058)
+.||+|+||.||+|.... ...||+|++... .......+.+|+.+++.++||||+++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----------~~~~~~~~~~~~~~l~~l~hp~iv~~ 69 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----------HRDISLAFFETASMMRQVSHKHIVLL 69 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----------hhhHHHHHHHHHHHHHhCCCCCEeeE
Confidence 468999999999995432 235888876432 22345678899999999999999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC--
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE-- 854 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~-- 854 (1058)
++++..+...++||||+++|+|..++... ...+++..+++++.||++|++|||+. +|+||||||+||+++.++.
T Consensus 70 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~ 145 (262)
T cd05077 70 YGVCVRDVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDG 145 (262)
T ss_pred EEEEecCCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccC
Confidence 99999998999999999999999988754 35689999999999999999999999 9999999999999987664
Q ss_pred -----eeeeccccceeccCCCcccccccccCcCCccCccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCCCCCCChh
Q 043053 855 -----PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVL-TGKQPIDPTIPDGSH 927 (1058)
Q Consensus 855 -----~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~ell-tg~~P~~~~~~~~~~ 927 (1058)
++++|||++..... .....++..|+|||++. +..++.++|||||||++|||+ +|..||.......
T Consensus 146 ~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-- 217 (262)
T cd05077 146 ECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-- 217 (262)
T ss_pred CCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--
Confidence 89999999865432 12345788999999876 566889999999999999998 5888886432211
Q ss_pred HHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 928 VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
........ . .. ...... .+.+++.+||+.||++||++.++++.+
T Consensus 218 ~~~~~~~~--~-----~~---~~~~~~---~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 KERFYEGQ--C-----ML---VTPSCK---ELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHHhcC--c-----cC---CCCChH---HHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11111100 0 00 111112 234588899999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=309.97 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=199.1
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|++.+.||+|++|.||+| +..+++.||+|++.... ......+.+.+|++++++++|+|++++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN---------ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh---------cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 4788999999999999999 55568899999984321 1233456789999999999999999999987644
Q ss_pred C-CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 784 N-NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 784 ~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+ ..++||||+++++|.+++.......+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccc
Confidence 4 578999999999999999875556789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......|++.|+|||+..+..++.++||||+|+++|+|++|+.||..... ... ....... . .
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~---~~~~~~~-~-~ 219 (257)
T cd08223 149 ARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--NSL---VYRIIEG-K-L 219 (257)
T ss_pred eEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHH---HHHHHhc-C-C
Confidence 98764322 222345688999999999998999999999999999999999999974321 111 1111100 0 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+......+. .+.+++.+||+.+|++|||+.+++++
T Consensus 220 ~~~~~~~~~------~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSP------ELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCH------HHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111111111 24457888999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=315.42 Aligned_cols=262 Identities=28% Similarity=0.420 Sum_probs=201.6
Q ss_pred hhccccceeccccceEEEEEEec-----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
+.|...+.||+|+||.||+|... ++..||||++.... .....+.|.+|+++++++.||||+++++
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~----------~~~~~~~~~~ei~~l~~l~~~~i~~~~~ 73 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG----------EEQHRSDFEREIEILRTLDHENIVKYKG 73 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEecccc----------chHHHHHHHHHHHHHHhCCCCChheEEe
Confidence 45677899999999999999543 47889999985331 1134678999999999999999999999
Q ss_pred EEEc--CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 779 CCWN--RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 779 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
++.. +...++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~ 149 (284)
T cd05038 74 VCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVK 149 (284)
T ss_pred eeecCCCCceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEE
Confidence 9887 55789999999999999999864 24689999999999999999999998 999999999999999999999
Q ss_pred eeccccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChh--------
Q 043053 857 IADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSH-------- 927 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~-------- 927 (1058)
++|||.+........ ........++..|+|||...+..++.++||||||+++|||++|+.|+.........
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 999999987653221 11122234566799999998888999999999999999999999998653221100
Q ss_pred --HHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 928 --VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 928 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
...+......... ...+.... .++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 230 ~~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 230 MIVTRLLELLKEGER-----LPRPPSCP---DEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccHHHHHHHHHcCCc-----CCCCccCC---HHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111110000 00111111 2345588899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.29 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=200.7
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+|. ..+++.+|+|.+... .....+.+.+|++++++++||||+++++++.+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-----------PGDDFEIIQQEISMLKECRHPNIVAYFGSYLR 71 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC-----------chhhHHHHHHHHHHHHhCCCCChhceEEEEEe
Confidence 468889999999999999994 456888999988422 12246789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....+++|||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.
T Consensus 72 ~~~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~ 147 (262)
T cd06613 72 RDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGV 147 (262)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECcccc
Confidence 99999999999999999998764 35688999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
+....... .......++..|+|||...+. .++.++||||+|+++|||++|+.||....+... ... ... .
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~-~~~----~ 219 (262)
T cd06613 148 SAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFL-ISK----S 219 (262)
T ss_pred chhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHh----c
Confidence 87654321 122345688899999998776 788999999999999999999999975432111 111 111 1
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...+....... .....+.+++.+||..+|.+|||+.+++.+
T Consensus 220 ~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 220 NFPPPKLKDKE---KWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cCCCccccchh---hhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01111111111 112234568899999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=309.00 Aligned_cols=252 Identities=26% Similarity=0.370 Sum_probs=202.6
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|+..++||+|+||.||.+ ...+++.+++|.+.... ......+++.+|++++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR---------LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc---------cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 4788899999999999999 56678999999874331 1234457788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++.......+++..+..++.|+++|++|||+. +++||||+|+||+++.++.+||+|||.+
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 9999999999999999999875556789999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
........ ......|++.|+|||+..+..++.++||||+|+++|||++|..||....+ ......+... ...+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~~~~----~~~~ 220 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVVKIVQG----NYTP 220 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcC----CCCC
Confidence 87644331 23345689999999999888889999999999999999999999975322 1111111111 0111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. ....+ . .+..++.+||+.+|++||++.+++++
T Consensus 221 ~-~~~~~---~---~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 V-VSVYS---S---ELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred C-ccccC---H---HHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1 11111 1 23447788999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=308.21 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=196.3
Q ss_pred ceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEE
Q 043053 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLM 789 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 789 (1058)
++||+|+||.||+|....++.||+|.+.... .....+.+.+|+++++++.||||+++++++......++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTL----------PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccC----------CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 4689999999999966559999999875331 113457899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCC
Q 043053 790 YDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG 869 (1058)
Q Consensus 790 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~ 869 (1058)
|||+++++|.++++.. ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.++|+|||.+......
T Consensus 71 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 71 MELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred EEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 9999999999999764 34678999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCC
Q 043053 870 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948 (1058)
Q Consensus 870 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1058)
..........++..|+|||+..+..++.++||||||+++|||++ |..||....+ ........... .......
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~~~~~-----~~~~~~~ 219 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIESGY-----RMPAPQL 219 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHHhcCC-----CCCCCcc
Confidence 22222222334667999999888889999999999999999999 8888865422 12222211111 0111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 949 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.+ ..+.+++.+||..+|++|||+.|+++.|+
T Consensus 220 ~~------~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CP------EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CC------HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11 13445888899999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=313.49 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=191.4
Q ss_pred ceeccccceEEEEEEe-cCCc--EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCC
Q 043053 710 NVIGKGCSGVVYRADM-DNGE--VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~-~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 785 (1058)
++||+|+||.||+|.. .++. .+|+|.+... ......+.+.+|++++.++ +||||+++++++.....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 70 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 70 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----------CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC
Confidence 4689999999999954 3444 4688877421 1223456889999999999 79999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC
Q 043053 786 RLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL 851 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~ 851 (1058)
.++||||+++|+|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||++++
T Consensus 71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~ 147 (270)
T cd05047 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 147 (270)
T ss_pred ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcC
Confidence 999999999999999997532 13478999999999999999999998 9999999999999999
Q ss_pred CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHH
Q 043053 852 EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 930 (1058)
++.+|++|||++...... ........+..|+|||+.....++.++|||||||++|||++ |..||..... .....
T Consensus 148 ~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~ 222 (270)
T cd05047 148 NYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYE 222 (270)
T ss_pred CCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--HHHHH
Confidence 999999999998632211 11112234567999999988889999999999999999997 9999964321 11111
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
..... . ........+ . .+.+++.+||+.+|.+|||++++++.|+++.
T Consensus 223 ~~~~~---~--~~~~~~~~~---~---~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 KLPQG---Y--RLEKPLNCD---D---EVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHhCC---C--CCCCCCcCC---H---HHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111 0 011111111 1 2345888899999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=289.10 Aligned_cols=270 Identities=21% Similarity=0.297 Sum_probs=202.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 781 (1058)
++......||.|..|.||++ ...+|..+|||.++.. .+.+..+++.+.++++..-+ +|+||+.+|||.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt----------~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT----------GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc----------CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 44566778999999999999 4556899999999755 33445678888888877765 899999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
.+...++.||.|.. ....+++. ..+++++..+-++...+.+||.||.+++ +|+|||+||+|||+|+.|.+|+||||
T Consensus 162 ~n~dV~IcMelMs~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 162 TNTDVFICMELMST-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred eCchHHHHHHHHHH-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccc
Confidence 99999999999843 55555554 3577999999999999999999998885 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
++-..-+. ...+...|-+.|||||.+.- ..|+-++||||||++++|+.||..||.....+. .....+.+..
T Consensus 238 IsGrlvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e~ltkvln~e-- 311 (391)
T KOG0983|consen 238 ISGRLVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-EVLTKVLNEE-- 311 (391)
T ss_pred ccceeecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-HHHHHHHhcC--
Confidence 98766543 23345568899999998764 367889999999999999999999998753332 2222222211
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhhhhhhhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDML 1000 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~~~~~~~~ 1000 (1058)
.|.+.... ....+ ..+++..|+.+|+.+||.+.+++++---...+..+....+|.
T Consensus 312 ---PP~L~~~~-gFSp~---F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF 366 (391)
T KOG0983|consen 312 ---PPLLPGHM-GFSPD---FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWF 366 (391)
T ss_pred ---CCCCCccc-CcCHH---HHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHH
Confidence 12222111 11122 233566799999999999999998754444444444334443
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=315.77 Aligned_cols=263 Identities=29% Similarity=0.427 Sum_probs=196.3
Q ss_pred hhccccceeccccceEEEEEEe-----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
+.|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 72 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----------TAEHLRDFEREIEILKSLQHDNIVKYKG 72 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----------CHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence 3677889999999999999853 36889999987422 2334578899999999999999999999
Q ss_pred EEEcC--CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 779 CCWNR--NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 779 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
++... ...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 73 VCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVK 148 (284)
T ss_pred EEccCCCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEE
Confidence 87543 4578999999999999999754 35689999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcc-cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 857 IADFGLAKLVDDGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
|+|||+++........ .......++..|+|||+..+..++.++|||||||++|||++|..|+...... ........
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~ 225 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGND 225 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccc
Confidence 9999999866443211 1111223445699999998888999999999999999999988776432110 00000000
Q ss_pred cCc--------cccC-CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 936 KGI--------QVLD-PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 936 ~~~--------~~~~-~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
... .... ......+..... .+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 226 KQGQMIVYHLIELLKNNGRLPAPPGCPA---EIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccchHHHHHHHhcCCcCCCCCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000 0000 000011111112 234578889999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=339.72 Aligned_cols=196 Identities=21% Similarity=0.265 Sum_probs=162.2
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC------Ccccc
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH------KNIVR 775 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~ 775 (1058)
.++|.+.++||+|+||+||+| +..+++.||||++... ......+..|+++++.++| .++++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~------------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV------------PKYTRDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc------------hhhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence 367999999999999999999 5567889999998421 1123445667777766654 45889
Q ss_pred eeeEEEcC-CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEEcCCC
Q 043053 776 FLGCCWNR-NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 776 ~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill~~~~ 853 (1058)
+++++..+ ..+++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ . +||||||||+|||++.++
T Consensus 196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSD 269 (467)
T ss_pred eEEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCC
Confidence 99988765 4578999988 77999998763 578999999999999999999997 5 999999999999998765
Q ss_pred ----------------CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 043053 854 ----------------EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917 (1058)
Q Consensus 854 ----------------~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P 917 (1058)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 499999998764322 23456799999999999999999999999999999999999999
Q ss_pred CCCC
Q 043053 918 IDPT 921 (1058)
Q Consensus 918 ~~~~ 921 (1058)
|+..
T Consensus 345 f~~~ 348 (467)
T PTZ00284 345 YDTH 348 (467)
T ss_pred CCCC
Confidence 9754
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=311.30 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=194.2
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...+.||+|+||.||+| +..+++.||+|++..... ........+.+.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPE------SPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR 76 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcC------CchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence 5778899999999999999 556789999998753321 011223456789999999999999999999988753
Q ss_pred --CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 784 --NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 784 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
...+++|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 77 ~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 77 AEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCC
Confidence 4568999999999999999763 4588999999999999999999998 99999999999999999999999999
Q ss_pred cceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 862 LAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 862 l~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
+++....... ........++..|+|||++.+..++.++||||+||++|||++|+.||..... ... +.... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~-~~~~~-~~~ 225 (266)
T cd06651 152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAA-IFKIA-TQP 225 (266)
T ss_pred CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHH-HHHHh-cCC
Confidence 9875533111 1112234588999999999988899999999999999999999999975421 111 11111 111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..+......+..... ++ .||..+|++||+++|++.+
T Consensus 226 ~~~~~~~~~~~~~~~------li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 TNPQLPSHISEHARD------FL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCCCchhcCHHHHH------HH-HHhcCChhhCcCHHHHhcC
Confidence 122222111222221 33 5888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=311.16 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=199.7
Q ss_pred hhccccceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+|... +++.||+|.+... ...+++.+|++++++++||||+++++++.+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~ 69 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------------EDLQEIIKEISILKQCDSPYIVKYYGSYFK 69 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------------HHHHHHHHHHHHHHhCCCCcEeeeeeeeec
Confidence 46888899999999999999554 5889999987422 116789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...|++|||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||+
T Consensus 70 ~~~~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~ 145 (256)
T cd06612 70 NTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGV 145 (256)
T ss_pred CCcEEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEccccc
Confidence 99999999999999999999754 46789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......|+..|+|||+..+..++.++||||||+++|+|++|+.||....+... ...... ...
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~~~~-----~~~ 216 (256)
T cd06612 146 SGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFMIPN-----KPP 216 (256)
T ss_pred chhcccCc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhhhcc-----CCC
Confidence 88665432 122344588899999999888899999999999999999999999975432111 100000 000
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+. ...+.. .. ..+.+++.+||+.||++|||+.+++++
T Consensus 217 ~~-~~~~~~-~~--~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 217 PT-LSDPEK-WS--PEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CC-CCchhh-cC--HHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11 111111 11 123457888999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=311.94 Aligned_cols=265 Identities=30% Similarity=0.449 Sum_probs=198.4
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|+||.||+| +..+|+.||+|.+......... .........+.+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~-~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGR-HDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcc-cchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 4778899999999999999 5567899999987532211000 0001122346788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.++++.. ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999999864 5789999999999999999999998 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMK--ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+...............|+..|+|||+..... ++.++|+||+|+++||+++|..||...... ......... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~-~~~~~~ 233 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-AAMFKLGNK-RSAPPI 233 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-HHHHHhhcc-ccCCcC
Confidence 7654322112233456889999999877654 788999999999999999999999643211 111111101 001111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+......+ ..+.+++..||+++|++||++++++++
T Consensus 234 ~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 PPDVSMNLS------PVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CccccccCC------HHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111111 223447788999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=316.01 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=200.7
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||.|+||.||+| +..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-----------KQPKKELIINEILVMKELKNPNIVNFLDSFL 86 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc-----------cCchHHHHHHHHHHHHhcCCCceeeeeeeEe
Confidence 357889999999999999999 5678999999988422 2233567889999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
..+..++||||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg 160 (296)
T cd06655 87 VGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFG 160 (296)
T ss_pred cCceEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence 99999999999999999999864 4589999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++........ ......|+..|+|||...+..++.++|||||||++|+|++|+.||....+.. ......... .
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--~~~~~~~~~-~--- 232 (296)
T cd06655 161 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYLIATNG-T--- 232 (296)
T ss_pred cchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcC-C---
Confidence 9876543321 1234468899999999988889999999999999999999999997543211 111111110 0
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+. ...+..... .+.+++.+||..||++||++.+++++-
T Consensus 233 -~~-~~~~~~~~~---~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 233 -PE-LQNPEKLSP---IFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred -cc-cCCcccCCH---HHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 00 011111111 233478889999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=308.78 Aligned_cols=251 Identities=20% Similarity=0.305 Sum_probs=205.6
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+..-|...+.||+|.|+.|-.| +.-+|+.||||++.+... +......+.+|++.|+-++|||||++|.+.
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl---------D~~st~hlfqEVRCMKLVQHpNiVRLYEVi 86 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---------DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI 86 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc---------chhhhhHHHHHHHHHHHhcCcCeeeeeehh
Confidence 3345777789999999999999 666899999999976643 344567899999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc-CCCCeeeec
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG-LEFEPYIAD 859 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~-~~~~~kl~D 859 (1058)
......|+|+|.-++|+|.|||-.+ ...+.++.+.+++.||+.|+.|+|+. .+||||+||+||.+- +-|-|||.|
T Consensus 87 DTQTKlyLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 87 DTQTKLYLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred cccceEEEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeee
Confidence 9999999999999999999999876 46789999999999999999999999 889999999999875 568999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
||++-.+.++ ...++.+|+..|-|||++.+..|. ++.||||+||+||-+++|+.||+...+.+. + ..+-..+
T Consensus 163 FGFSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-L-TmImDCK-- 235 (864)
T KOG4717|consen 163 FGFSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-L-TMIMDCK-- 235 (864)
T ss_pred ccccccCCCc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-h-hhhhccc--
Confidence 9999888765 456688999999999999988886 678999999999999999999986543221 1 1111110
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
..++..... ++.++|..|+..||.+|.+.++|+.
T Consensus 236 ----YtvPshvS~------eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 ----YTVPSHVSK------ECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ----ccCchhhhH------HHHHHHHHHHhcCchhhccHHHHhc
Confidence 111112222 2344677799999999999999875
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=311.82 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=201.1
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|+..+.||+|+||.||++ ...+|+.||+|.+.... ......+++.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK---------MSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHh---------CChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 4788899999999999999 55678999999884321 1223356889999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++++|.+++.......+++..+.+++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 9999999999999999999875555689999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
....... .......|++.|+|||+..+..++.++|||||||++|+|++|+.||..... ...+....... .+
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~--~~ 219 (256)
T cd08218 149 RVLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGS--YP 219 (256)
T ss_pred eecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCC--CC
Confidence 8664432 112234588899999999888899999999999999999999999964321 11111111100 11
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
......+. .+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~------~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSY------DLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCH------HHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111111 23457888999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.09 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=190.4
Q ss_pred ceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc-CC
Q 043053 710 NVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN-RN 784 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~ 784 (1058)
+.||+|+||.||+|... .+..||+|.+... ......+.+.+|+.+++.++||||+++++++.. +.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----------TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc----------CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC
Confidence 46899999999999542 2457999987421 122345788899999999999999999997764 55
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||+++|+|.+++... ....++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 71 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~ 146 (262)
T cd05058 71 SPLVVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLAR 146 (262)
T ss_pred CcEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccc
Confidence 679999999999999999764 34567788889999999999999998 99999999999999999999999999987
Q ss_pred eccCCCcc--cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 865 LVDDGDFA--RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG-KQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 865 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
........ .......++..|+|||+..+..++.++|||||||++|||++| ..||... .............
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~~~----- 219 (262)
T cd05058 147 DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVYLLQGR----- 219 (262)
T ss_pred cccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhcCC-----
Confidence 55432211 111233467789999999888899999999999999999995 4555432 1222222221111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
.+......+ . .+.+++..||+.+|++||++.++++.++++.
T Consensus 220 ~~~~~~~~~---~---~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 RLLQPEYCP---D---PLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCCCcCC---H---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011111111 1 2345788899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=311.80 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=199.7
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
+.|...+.||+|+||.||+|..+ ..+.||+|.+... ......+.+.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 74 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----------KDENLQSEFRRELDMFRKLSHKNVVRLL 74 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----------cchHHHHHHHHHHHHHHhcCCcceeeeE
Confidence 56788899999999999999643 3467899977422 2223467899999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCC-------CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTG-------NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG 850 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~ 850 (1058)
+++.+....++||||+++|+|.++++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~ 151 (275)
T cd05046 75 GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVS 151 (275)
T ss_pred EEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEe
Confidence 999998899999999999999999976431 2689999999999999999999999 999999999999999
Q ss_pred CCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHH
Q 043053 851 LEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVV 929 (1058)
Q Consensus 851 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 929 (1058)
.++.++++|||++........ .......++..|+|||...+..++.++||||||+++|+|++ |..||..... ....
T Consensus 152 ~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~ 228 (275)
T cd05046 152 SQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVL 228 (275)
T ss_pred CCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHH
Confidence 999999999999875433221 12233456788999999888888999999999999999999 7889864321 2222
Q ss_pred HHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
........ . .......+. .+.+++.+||+.+|++|||+.++++.+.
T Consensus 229 ~~~~~~~~-~---~~~~~~~~~------~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 229 NRLQAGKL-E---LPVPEGCPS------RLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHcCCc-C---CCCCCCCCH------HHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 22221111 0 001111111 2344788899999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.52 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=196.7
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|++.+.||+|+||.||+|. ..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----------SEEELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 568888999999999999994 456899999987422 23346788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||+++++|..++.+. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~ 156 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGV 156 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999999888654 35689999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+....... .......+++.|+|||++. ...++.++|||||||++|||++|..||....+. .....+ ..
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~----~~ 229 (292)
T cd06644 157 SAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKI----AK 229 (292)
T ss_pred ceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHH----hc
Confidence 87543321 2223456889999999874 345678999999999999999999999654221 111111 11
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. .+.. ..+... ...+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~--~~~~-~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 230 SE--PPTL-SQPSKW---SMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CC--CccC-CCCccc---CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 10 1111 011111 1123457888999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=314.98 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=195.9
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceee
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLG 778 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 778 (1058)
+..++|.+.+.||+|+||.||+| +..+++.+|+|++... ......+.+|+.+++++ +||||+++++
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~------------~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI------------HDIDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc------------cchHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 35578999999999999999999 5567899999987421 12235678899999999 6999999999
Q ss_pred EEEc-----CCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC
Q 043053 779 CCWN-----RNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL 851 (1058)
Q Consensus 779 ~~~~-----~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~ 851 (1058)
++.. +...++||||+++|+|.+++... ....+++..+..++.|+++|+.|||+. +|+||||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~ 159 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT 159 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence 8842 34579999999999999988642 245688999999999999999999998 9999999999999999
Q ss_pred CCCeeeeccccceeccCCCcccccccccCcCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh
Q 043053 852 EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS 926 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 926 (1058)
++.++|+|||+++...... .......|+..|+|||++. +..++.++||||+||++|||++|+.||....+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~- 236 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR- 236 (286)
T ss_pred CCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-
Confidence 9999999999988664332 1223456899999999875 3457889999999999999999999997543211
Q ss_pred hHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 927 HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
........ ..+.. ..+..... .+..++.+||+.||++|||+.+++++.
T Consensus 237 ---~~~~~~~~---~~~~~-~~~~~~~~---~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 ---ALFKIPRN---PPPTL-HQPELWSN---EFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---HHhhcccc---CCCcc-cCCCCcCH---HHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11110000 00111 01111111 234578889999999999999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.00 Aligned_cols=263 Identities=21% Similarity=0.296 Sum_probs=195.0
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|+..+.||+|+||.||+| +..+|+.||+|++.... ........+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~---------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------DDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc---------ccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 4778899999999999999 55679999999885331 1223345678899999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||++ ++|.+++... ...+++..++.++.||++||+|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 99999999997 4888888654 35689999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc----
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI---- 938 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---- 938 (1058)
+...... .......++..|+|||++.+. .++.++||||+||++|||++|+.|+.........+....+.....
T Consensus 147 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07839 147 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES 224 (284)
T ss_pred hccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHH
Confidence 8654322 222345678999999987764 468899999999999999999999754322111111110000000
Q ss_pred -----cccCCCCCCCCch--hHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 -----QVLDPSLLSRPES--EID-----EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 -----~~~~~~~~~~~~~--~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...+......... ... -...+.+++.+||+.||.+|||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000000000 000 01233458889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=312.56 Aligned_cols=251 Identities=29% Similarity=0.444 Sum_probs=194.8
Q ss_pred ceeccccceEEEEEEecC-------CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 710 NVIGKGCSGVVYRADMDN-------GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.||+|+||.||+|...+ ++.+|||.+... ........+.+|++++++++||||+++++++..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----------ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL 70 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc----------cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC
Confidence 368999999999995432 257899987422 122345688999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhc-----CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC----
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHER-----TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF---- 853 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~---- 853 (1058)
.+..++||||+++|+|.++++.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++
T Consensus 71 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~ 147 (269)
T cd05044 71 NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDAD 147 (269)
T ss_pred CCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCC
Confidence 88999999999999999999753 234578999999999999999999998 999999999999999887
Q ss_pred -CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHH
Q 043053 854 -EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDW 931 (1058)
Q Consensus 854 -~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 931 (1058)
.++++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.... .......
T Consensus 148 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~ 225 (269)
T cd05044 148 RVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQH 225 (269)
T ss_pred cceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHH
Confidence 899999999976544332222233446789999999998899999999999999999998 999996432 1222222
Q ss_pred HHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
+..... ... +..... .+.+++.+||..+|++||+++++.+.|++
T Consensus 226 ~~~~~~-----~~~---~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 VTAGGR-----LQK---PENCPD---KIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HhcCCc-----cCC---cccchH---HHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 211110 011 111112 23458889999999999999999998753
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=314.96 Aligned_cols=256 Identities=24% Similarity=0.349 Sum_probs=197.5
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||.||+|.. .+++.||+|.+... ......+.+.+|++++++++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 70 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE----------LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc----------cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec
Confidence 3678889999999999999944 47999999987422 122335688999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERT-GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
++..++||||+++++|.++++... ...+++..+..++.|+++|+.|||+. .+|+||||||+||+++.++.++|+|||
T Consensus 71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecC
Confidence 999999999999999999987532 24689999999999999999999963 189999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM------KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
.+...... ......|++.|+|||++.+. .++.++||||+||++|+|++|+.||...... .........
T Consensus 149 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~ 222 (286)
T cd06622 149 VSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSAI 222 (286)
T ss_pred CcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHHHH
Confidence 98765332 22344688899999987543 3478999999999999999999999754221 111111111
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
. ....+......+. .+..++.+||+.+|++||++++++.+-.
T Consensus 223 ~--~~~~~~~~~~~~~------~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 223 V--DGDPPTLPSGYSD------DAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred h--hcCCCCCCcccCH------HHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 1 0011112111122 2234778899999999999999998644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=311.82 Aligned_cols=238 Identities=18% Similarity=0.327 Sum_probs=184.0
Q ss_pred eeccccceEEEEEEecC-------------------------CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHH
Q 043053 711 VIGKGCSGVVYRADMDN-------------------------GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765 (1058)
Q Consensus 711 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 765 (1058)
.||+|+||.||+|.... ...||+|++... .......+.+|+.++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----------~~~~~~~~~~~~~~~ 70 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-----------HRDIALAFFETASLM 70 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-----------HHHHHHHHHHHHHHH
Confidence 68999999999995321 134888887432 122346788999999
Q ss_pred cccCCCcccceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCC
Q 043053 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKAN 845 (1058)
Q Consensus 766 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~ 845 (1058)
++++||||+++++++.++...++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+
T Consensus 71 ~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~ 146 (274)
T cd05076 71 SQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAK 146 (274)
T ss_pred hcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcc
Confidence 9999999999999999999999999999999999998753 45688999999999999999999998 9999999999
Q ss_pred cEEEcCCC-------CeeeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHH-hCCC
Q 043053 846 NILIGLEF-------EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVL-TGKQ 916 (1058)
Q Consensus 846 Nill~~~~-------~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~ell-tg~~ 916 (1058)
||++++++ .++++|||.+...... ....++..|+|||++.+ ..++.++||||||+++|||+ +|+.
T Consensus 147 Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 220 (274)
T cd05076 147 NILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV 220 (274)
T ss_pred cEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99997654 3799999987644221 12357788999998765 56789999999999999995 6999
Q ss_pred CCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 917 PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 917 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
||....+.. ...+..... .... .... .+.+++.+||+.+|++|||+.++++.|
T Consensus 221 p~~~~~~~~--~~~~~~~~~-------~~~~---~~~~---~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 221 PLKERTPSE--KERFYEKKH-------RLPE---PSCK---ELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CccccChHH--HHHHHHhcc-------CCCC---CCCh---HHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 997543321 122221111 0011 1111 234578899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=312.73 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=200.7
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
..|+..+.||+|+||.||+|. ..+++.||+|.+... ........+.+|+.+++++.||||+++++++.+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE----------EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc----------ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 457778899999999999994 457899999987422 122345788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||+++|+|.+++.. ..+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~ 147 (277)
T cd06640 74 GTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred CCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEccccc
Confidence 9999999999999999999864 4588899999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+........ ......++..|+|||++.+..++.++|+|||||++|||++|..||....+.. ....... ...
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~-----~~~ 218 (277)
T cd06640 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--VLFLIPK-----NNP 218 (277)
T ss_pred ceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--Hhhhhhc-----CCC
Confidence 976654321 2233468889999999988889999999999999999999999997543211 1110100 001
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
+.... . ....+.+++..||+.+|++||++.+++.+-.
T Consensus 219 ~~~~~---~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 219 PTLTG---E---FSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CCCch---h---hhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 11111 1 1123445888999999999999999988644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=314.11 Aligned_cols=253 Identities=24% Similarity=0.364 Sum_probs=198.1
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|++++++++||||+++++++..
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----------SEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec
Confidence 5688899999999999999954 57899999987422 22345678999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...|+||||+++++|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~ 149 (280)
T cd06611 74 ENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGV 149 (280)
T ss_pred CCeEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCcc
Confidence 99999999999999999998764 35689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+....... .......|++.|+|||+.. +..++.++||||||+++|||++|+.||....+. ..... .....
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~-~~~~~- 224 (280)
T cd06611 150 SAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLK-ILKSE- 224 (280)
T ss_pred chhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHH-HhcCC-
Confidence 87543322 2223456899999999864 345678999999999999999999999754221 11111 11100
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.+.. ..+..... .+.+++..||+.+|++||++.+++++-
T Consensus 225 ----~~~~-~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 225 ----PPTL-DQPSKWSS---SFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred ----CCCc-CCcccCCH---HHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 0111 11111111 233477889999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=311.88 Aligned_cols=252 Identities=29% Similarity=0.404 Sum_probs=201.9
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||.|+||.||+| ...+++.||+|.+... ........+.+|+++++.++|+||+++++++.++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE----------EAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecc----------ccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 5778899999999999999 4557899999987422 1223356788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++|+||+++++|.++++.. .+++..++.++.|++.|++|||+. +++||||+|+||+++.++.++++|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999999999753 789999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
+...... .......|++.|+|||+..+..++.++||||||+++|+|++|+.||....+. .....+... ..+
T Consensus 146 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~-----~~~ 216 (274)
T cd06609 146 GQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLFLIPKN-----NPP 216 (274)
T ss_pred eeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHHHhhhc-----CCC
Confidence 8765432 2223456888999999999888999999999999999999999999754321 111111111 111
Q ss_pred CCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 944 SLLSR-PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 944 ~~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
..... .+. .+.+++.+||..+|++|||+++++++-.-.
T Consensus 217 ~~~~~~~~~------~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~ 255 (274)
T cd06609 217 SLEGNKFSK------PFKDFVSLCLNKDPKERPSAKELLKHKFIK 255 (274)
T ss_pred CCcccccCH------HHHHHHHHHhhCChhhCcCHHHHhhChhhc
Confidence 11111 111 234477889999999999999998864433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=321.84 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=198.1
Q ss_pred cccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCC
Q 043053 707 VDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 707 ~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 785 (1058)
....+||+|+|-+|||| +..+|-.||--.+....+ .+.+...++|..|+.+++.|+|||||++|+++.+...
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~-------~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV-------TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN 115 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHh-------hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence 45678999999999999 877888888544422211 1345556899999999999999999999999987665
Q ss_pred --ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC-CCeeeecccc
Q 043053 786 --RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE-FEPYIADFGL 862 (1058)
Q Consensus 786 --~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~-~~~kl~DfGl 862 (1058)
..+|+|.+..|+|..|.++. +.........|++||++||.|||++ .|+|||||||-+||+|+.+ |.|||+|.|+
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence 67899999999999999874 6688889999999999999999997 5699999999999999865 7999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+..... ....++|||.|||||+.. ..|+...||||||+++.||+|+..||...... ++.++.... ...
T Consensus 193 Atl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~----AQIYKKV~S--GiK 261 (632)
T KOG0584|consen 193 ATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP----AQIYKKVTS--GIK 261 (632)
T ss_pred HHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH----HHHHHHHHc--CCC
Confidence 9977653 233578999999999865 78999999999999999999999999865432 233332211 111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
|.-..... -.++..+|.+|+.. ..+|||+.|+++.
T Consensus 262 P~sl~kV~-----dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 262 PAALSKVK-----DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHhhccC-----CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 21111111 12344578889999 9999999999874
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.24 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=200.4
Q ss_pred hccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||.|++|.||+|. ..+++.+|+|.+... .......++.+|++++++++||||+++++++.+.
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 71 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD----------PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC----------CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence 57888999999999999994 457899999987532 2223467899999999999999999999998654
Q ss_pred --CCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 784 --NNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 784 --~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
...++||||+++++|.+++... ....+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEee
Confidence 3579999999999999987642 245688999999999999999999998 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC---CChhHHHHHHhhc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP---DGSHVVDWVRQKK 936 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~---~~~~~~~~~~~~~ 936 (1058)
||++....... .....++..|+|||...+..++.++||||+|+++|+|++|+.||..... .......+.....
T Consensus 149 fg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 149 FGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred ccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 99987544321 1234578899999999888999999999999999999999999975522 1122223222211
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
. +.....+.........+.+++.+||+.+|++|||+.|++++-.
T Consensus 225 ~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 225 N-----PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred c-----hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 1 1111111100111123456889999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=314.78 Aligned_cols=263 Identities=22% Similarity=0.324 Sum_probs=198.1
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|+..+.||+|+||.||+|.. .+|+.||+|++.... ......+.+.+|++++++++||||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE---------DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc---------cCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 3688889999999999999944 468999999874321 122334678899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....++||||+++++|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 9999999999999888887754 35689999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC----
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG---- 937 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~---- 937 (1058)
+........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||....+.+ ...........
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 223 (286)
T cd07847 147 ARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPR 223 (286)
T ss_pred ceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChH
Confidence 987654321 2233457889999998765 457889999999999999999999997543211 11111110000
Q ss_pred -------ccc----cCCCCCCCCc--hhH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 -------IQV----LDPSLLSRPE--SEI-DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 -------~~~----~~~~~~~~~~--~~~-~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
... ..+......+ ... .....+.+++.+||+++|++||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 0000000000 000 001234568899999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.53 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=200.7
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|+||.||+| ...+++.+|||.+.... ........+.+|++++++++||||+++++.+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ---------MTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc---------cccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 4788899999999999999 55678999999985331 1233467899999999999999999999999988
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-Ceeeecccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-EPYIADFGL 862 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~DfGl 862 (1058)
+..++||||+++++|.+++.......+++..+..++.|+++|++|||+. +++||||||+||+++.++ .+|++|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 8999999999999999999876556789999999999999999999999 999999999999998654 689999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... ......|+..|+|||...+..++.++||||||+++|+|++|+.||...... .......... .
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~-----~ 218 (256)
T cd08220 149 SKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGT-----F 218 (256)
T ss_pred ceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHhcC-----C
Confidence 98765432 222356889999999998888899999999999999999999999754221 1221111111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.......+. .+..++..||+++|++|||+.+++++
T Consensus 219 ~~~~~~~~~------~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSP------DLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCH------HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111111122 23457788999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=317.38 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=195.2
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|...+.||+|++|.||+|. ..+++.||||.+.... .......+.+|++++++++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH----------EEGAPFTAIREASLLKDLKHANIVTLHDIIHT 74 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccc----------ccCCchhHHHHHHHHhhCCCcceeeEEEEEec
Confidence 578889999999999999994 4578999999885331 11123456789999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..++||||+++ +|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 75 KKTLTLVFEYLDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred CCeEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccc
Confidence 9999999999975 999998764 34789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC--cc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG--IQ 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~ 939 (1058)
++...... .......++..|+|||+..+ ..++.++||||+|+++|+|++|+.||................... ..
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 150 ARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred ccccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence 87543221 11223356889999998765 457889999999999999999999996543111111111100000 00
Q ss_pred c----------cCCCCCCCCch-------hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 V----------LDPSLLSRPES-------EIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~----------~~~~~~~~~~~-------~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. ........... .........+++.+|++++|++|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 00000000000 01111344568899999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.30 Aligned_cols=366 Identities=26% Similarity=0.396 Sum_probs=214.8
Q ss_pred ccCCCCCcEEEccCCcCC-CCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhh
Q 043053 20 LSSFKHLQTLVISDANLT-GSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSL 98 (1058)
Q Consensus 20 ~~~~~~L~~L~l~~~~~~-~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L 98 (1058)
++-++.+|-.|+++|.+. +..|.++.+++.++.|.|..+++. .+|+.++.|.+|++|.+++|++. .+-+.++.|+.|
T Consensus 3 tgVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~L 80 (1255)
T KOG0444|consen 3 TGVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRL 80 (1255)
T ss_pred ccccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhh
Confidence 455677888899999997 468999999999999999999998 89999999999999999999988 677888899999
Q ss_pred hHHhhhhccccC-CChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCcc-ccCCCccceeee
Q 043053 99 RKLLLFDNALAG-NIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPAS-LGKLSKLQTLSI 176 (1058)
Q Consensus 99 ~~L~L~~n~~~~-~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~-l~~l~~L~~L~l 176 (1058)
|.+.+.+|++.. .+|..|-+|..|.+|+++.|. ..+.|..+..-+++-.|+|++|+|. .+|.. |.+|+.|-.|+|
T Consensus 81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNq--L~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQ--LREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred HHHhhhccccccCCCCchhcccccceeeecchhh--hhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcc
Confidence 999999988763 355666666666666666655 5555655555555666666666554 33332 344555555555
Q ss_pred eccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeeccccccc-CCCCccccCcCCccEEEeecCCCcC
Q 043053 177 YTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLV-GAIPEEIGNCTSLKMIDFSLNSLSG 255 (1058)
Q Consensus 177 ~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~n~l~~ 255 (1058)
++|++. .+|..+..+..|++|+|++|.+.-.--..+..+++|+.|.+++.+-+ ..+|..+..+.+|..+|+|.|.+.
T Consensus 158 S~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp- 235 (1255)
T KOG0444|consen 158 SNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP- 235 (1255)
T ss_pred ccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-
Confidence 555554 44444555555555555555443222222334444555555543321 234444555555555555555554
Q ss_pred cCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCC-CCChhhh
Q 043053 256 TIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEG-SIPSTLA 334 (1058)
Q Consensus 256 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~ 334 (1058)
..|..+.++++|+.|+||+|+|+ .+......-.+|+.|+|+.|+++ ..|.+++.+++|+.|++.+|+++- -+|+.++
T Consensus 236 ~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIG 313 (1255)
T KOG0444|consen 236 IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIG 313 (1255)
T ss_pred cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchh
Confidence 44555555555555555555554 22223333344555555555554 334455555555555555554431 1344444
Q ss_pred ccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCcc
Q 043053 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNR 396 (1058)
Q Consensus 335 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 396 (1058)
.+.+|+.+..++|.+. .+|.+++.+.+|+.|.|++|++. .+|+++.-++.|+.|||.+|.
T Consensus 314 KL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 314 KLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred hhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 5555555555555444 44555555555555555555444 344444444555555554443
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.12 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=201.9
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||.|+||+||+|. ..++..+|+|++... ......+.+.+|++.++.++|+||+++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLE----------KCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV 70 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccC----------CcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee
Confidence 368889999999999999995 457889999988432 112246789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTG-NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+...++||||+++++|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||
T Consensus 71 ~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~ 147 (267)
T cd06610 71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFG 147 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence 9999999999999999999976432 5689999999999999999999998 99999999999999999999999999
Q ss_pred cceeccCCCcc--cccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 862 LAKLVDDGDFA--RSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 862 l~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
++......... .......|+..|+|||++... .++.++|+|||||++|||++|+.||....+. .........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~---- 222 (267)
T cd06610 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQN---- 222 (267)
T ss_pred hHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcC----
Confidence 98766543321 122345689999999988766 7889999999999999999999999754322 111111111
Q ss_pred cccCCCCCCCCc-hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 QVLDPSLLSRPE-SEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 ~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..+....... ... .....+++..||+.||++||++.+++++
T Consensus 223 --~~~~~~~~~~~~~~--~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 --DPPSLETGADYKKY--SKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred --CCCCcCCccccccc--cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0111111100 011 1123457888999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=311.41 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=201.7
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|+..+.||+|+||.||+| ...+++.||+|.+... ......+++.+|++++++++||||+++++++..+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE----------INEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecc----------cChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 5677889999999999999 4457899999988533 1224457889999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
...++||||+++++|.+++.... ..+++..+.+++.|+++|++|+|+ . +++||||||+||+++.++.++|+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999998643 678999999999999999999999 7 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .....++..|+|||+..+..++.++||||+|+++|+|++|+.||..............+..... ..
T Consensus 148 ~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 221 (265)
T cd06605 148 SGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE--PP 221 (265)
T ss_pred chhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC--CC
Confidence 87553321 1126688999999999888999999999999999999999999975432222222222222111 11
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+.... ... ...+.+++..||..+|++|||+.+++.+-
T Consensus 222 ~~~~~---~~~--~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 258 (265)
T cd06605 222 PRLPS---GKF--SPDFQDFVNLCLIKDPRERPSYKELLEHP 258 (265)
T ss_pred CCCCh---hhc--CHHHHHHHHHHcCCCchhCcCHHHHhhCc
Confidence 11111 101 11234578889999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.02 Aligned_cols=237 Identities=20% Similarity=0.360 Sum_probs=185.9
Q ss_pred ceeccccceEEEEEEecC-C----------cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 710 NVIGKGCSGVVYRADMDN-G----------EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
+.||+|+||.||+|.... + ..|++|.+... ......+.+|+.++++++||||+++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 68 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD------------HRDSLAFFETASLMSQLSHKHLVKLYG 68 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc------------hhhHHHHHHHHHHHHcCCCcchhheee
Confidence 468999999999995543 3 24777765322 111678899999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-----
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF----- 853 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~----- 853 (1058)
++.. ...++||||+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 69 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~ 143 (259)
T cd05037 69 VCVR-DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGY 143 (259)
T ss_pred EEec-CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCC
Confidence 9988 77899999999999999998642 3789999999999999999999998 999999999999999888
Q ss_pred --CeeeeccccceeccCCCcccccccccCcCCccCccccccC--CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhH
Q 043053 854 --EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM--KITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHV 928 (1058)
Q Consensus 854 --~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 928 (1058)
.++++|||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||....+. ..
T Consensus 144 ~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~ 215 (259)
T cd05037 144 VPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EK 215 (259)
T ss_pred ceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hH
Confidence 799999999876543 1234567789999998776 78899999999999999999 57777654321 11
Q ss_pred HHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 929 VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
..+.... .....+.. ..+.+++.+||..+|++|||+.++++.|
T Consensus 216 ~~~~~~~--------~~~~~~~~-----~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 216 ERFYQDQ--------HRLPMPDC-----AELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHhcC--------CCCCCCCc-----hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1111110 00111111 3345688899999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=319.48 Aligned_cols=196 Identities=26% Similarity=0.378 Sum_probs=160.0
Q ss_pred cceeccccceEEEEEEec---CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc--C
Q 043053 709 ANVIGKGCSGVVYRADMD---NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN--R 783 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 783 (1058)
..+||+|+||+||+|... ++..||+|.+... .....+.+|++++++++||||+++++++.. +
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 72 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-------------GISMSACREIALLRELKHPNVIALQKVFLSHSD 72 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC-------------CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC
Confidence 468999999999999654 4578999987422 123467899999999999999999999864 4
Q ss_pred CCceEEEEecCCCChhhhhhhc-------CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE----cCC
Q 043053 784 NNRLLMYDYMPNGSLGSLLHER-------TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI----GLE 852 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill----~~~ 852 (1058)
...++||||+++ +|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.+
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 148 (317)
T cd07867 73 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred CeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCC
Confidence 556899999865 888887532 123588999999999999999999999 99999999999999 556
Q ss_pred CCeeeeccccceeccCCCc-ccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 853 FEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+.+||+|||+++....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 7899999999987654321 122334578999999998876 45789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.02 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=197.0
Q ss_pred ccccceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 706 LVDANVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
|.+.+.||+|+||.||+|... +++.||||++.... ......+++.+|++++++++||||+++++++.
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI---------FSSSDIEEFLREAACMKEFDHPNVIKLIGVSL 71 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc---------CChHHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 566789999999999999532 46889999885331 22334677899999999999999999999886
Q ss_pred cCC------CceEEEEecCCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC
Q 043053 782 NRN------NRLLMYDYMPNGSLGSLLHERT----GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL 851 (1058)
Q Consensus 782 ~~~------~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~ 851 (1058)
..+ ..++++||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~ 148 (273)
T cd05074 72 RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNE 148 (273)
T ss_pred cCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcC
Confidence 532 2378999999999998875321 23578899999999999999999998 9999999999999999
Q ss_pred CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHH
Q 043053 852 EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 930 (1058)
++.+|++|||.++...............+++.|++||...+..++.++||||||+++|||++ |+.||.... ......
T Consensus 149 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--~~~~~~ 226 (273)
T cd05074 149 NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--NSEIYN 226 (273)
T ss_pred CCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--HHHHHH
Confidence 99999999999986644332222233446678999999988889999999999999999999 888886432 122222
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
++..... . ..+..... .+.+++.+||+.+|++||++.++++.|+.+
T Consensus 227 ~~~~~~~-----~---~~~~~~~~---~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 YLIKGNR-----L---KQPPDCLE---DVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHcCCc-----C---CCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2221110 0 01111112 344588889999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=315.08 Aligned_cols=263 Identities=26% Similarity=0.359 Sum_probs=197.0
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...+.||.|+||.||+| +..+|+.||||++.... ......+.+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc---------cccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 3778899999999999999 45578999999885331 1223346788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+. ++|.+++.......+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 99999999996 5899999776567789999999999999999999998 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC-cccc
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG-IQVL 941 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~ 941 (1058)
....... .......++..|+|||+..+.. ++.++||||||+++|||++|+.||...... .......+.... ....
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 224 (284)
T cd07860 148 RAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVV 224 (284)
T ss_pred hhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhh
Confidence 7654322 2223345788999999876644 588999999999999999999999654221 111111111000 0000
Q ss_pred C----------CCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 D----------PSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~----------~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. ............. -..+.+++.+||+.||++|||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 225 WPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 0000000000000 0123458889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=315.52 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=197.4
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
..+.|.....||+|+||.||++ ...++..||||++... .....+.+.+|+..+++++||||+++++.+
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~ 88 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----------KQQRRELLFNEVVIMRDYHHENVVDMYNSY 88 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----------hHHHHHHHHHHHHHHHhCCCCcHHHHHHhe
Confidence 3345555678999999999999 4557899999987322 223456789999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
..++..++||||+++++|.+++.. ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.++|+||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~df 162 (292)
T cd06658 89 LVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDF 162 (292)
T ss_pred ecCCeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccC
Confidence 999999999999999999998864 4588999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|++....... .......|+..|+|||+..+..++.++||||||+++|||++|+.||....+ ......+...
T Consensus 163 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~----- 233 (292)
T cd06658 163 GFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRIRDN----- 233 (292)
T ss_pred cchhhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhc-----
Confidence 9987543322 222345689999999999888899999999999999999999999975422 1111111111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..+...... . ... .+..++..||..||.+|||+++++++
T Consensus 234 ~~~~~~~~~-~-~~~--~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 234 LPPRVKDSH-K-VSS--VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCcccccc-c-cCH--HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111110 0 111 22346778999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=314.52 Aligned_cols=263 Identities=20% Similarity=0.285 Sum_probs=194.8
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|.+.+.||+|+||.||+| +..+|+.||+|++... ........+.+|++++++++|+||+++++++..
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMK----------TEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEeccc----------CcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 57888999999999999999 5567899999998433 122234567889999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||+. +++.+++... ...+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 149 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGL 149 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccc
Confidence 889999999996 6888777653 34578888899999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc-----
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK----- 936 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~----- 936 (1058)
++...... .......++..|+|||++.+. .++.++|||||||++|||++|+.||+...+.............
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 150 ARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227 (291)
T ss_pred ccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence 87543322 122344578999999988754 5788999999999999999999999754321111111100000
Q ss_pred ------CccccCCCCC-CCCchh-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 ------GIQVLDPSLL-SRPESE-------IDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ------~~~~~~~~~~-~~~~~~-------~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
......+... ...... ......+.+++.+|++.||++|||++|++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000 000000 0112234567888999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.47 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=193.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.+.....||+|+||.||+| +..++..||+|.+... .....+.+.+|+.++++++|+||+++++++..
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----------DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE 76 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-----------CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence 34445568999999999999 4567888999987422 22345688999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCC--CHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC-CCCeeeec
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNAL--EWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-EFEPYIAD 859 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~D 859 (1058)
++..++||||+++++|.++++... ..+ ++..+..++.|+++|++|||+. +|+||||||+||+++. ++.++|+|
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEec
Confidence 999999999999999999998642 334 7888899999999999999998 9999999999999986 67999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK--ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||.+....... .......|++.|+|||+..+.. ++.++||||+|+++|+|++|+.||....... ...+...
T Consensus 153 fg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~--- 225 (268)
T cd06624 153 FGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVG--- 225 (268)
T ss_pred chhheecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhh---
Confidence 99987654322 1222345889999999876543 7889999999999999999999996532211 1111111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.....+....... + .+..++.+||+.+|++|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~---~---~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 226 MFKIHPEIPESLS---A---EAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhccCCCCCcccC---H---HHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0011111111111 1 23447888999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.08 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=198.7
Q ss_pred ccccceeccccceEEEEEEec-C----CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 706 LVDANVIGKGCSGVVYRADMD-N----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+++.+.||+|+||.||+|... . +..||+|++... ......+.+..|++.+++++|+||+++++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED----------ADEQQIEEFLREARIMRKLDHPNIVKLLGVC 70 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC----------CChHHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence 356789999999999999554 3 388999998433 1222567899999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+.+..++||||+++++|.+++.......+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++||
T Consensus 71 ~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~df 147 (258)
T smart00219 71 TEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDF 147 (258)
T ss_pred cCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEccc
Confidence 9999999999999999999999865433389999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
|++............ ...+++.|+|||...+..++.++||||+|+++|+|++ |..||... ......+.......
T Consensus 148 g~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~~-- 222 (258)
T smart00219 148 GLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEYLKKGYR-- 222 (258)
T ss_pred CCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCC--
Confidence 999877654322221 2337789999999988889999999999999999998 78888643 22222222222111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.......+ . .+.+++.+||+.||++|||+.++++.|
T Consensus 223 ---~~~~~~~~---~---~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ---LPKPENCP---P---EIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCCcCC---H---HHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111111 2 234477889999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=320.83 Aligned_cols=201 Identities=29% Similarity=0.421 Sum_probs=174.1
Q ss_pred ccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
|...+.||+||||.||+|+ ..+|+.||||.+.... ...-.+...+|++++++++|||||+++++-.+..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----------SLRPRERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc----------ccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 4556789999999999995 7899999999996542 2233678899999999999999999999876543
Q ss_pred ------CceEEEEecCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc--CCC--
Q 043053 785 ------NRLLMYDYMPNGSLGSLLHERT-GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG--LEF-- 853 (1058)
Q Consensus 785 ------~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~--~~~-- 853 (1058)
...+|||||.||||...+++.. ...+++.+.+.+..+++.||.|||++ |||||||||.||++- .+|
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~ 161 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQS 161 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCce
Confidence 3589999999999999998643 56799999999999999999999999 999999999999983 344
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTI 922 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 922 (1058)
.-||+|||.|+..+++. .....+||..|.+||... .+.|+..+|.|||||++|+++||..||.+..
T Consensus 162 IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 162 IYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred EEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 47999999999887654 567889999999999888 5888999999999999999999999997653
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=314.34 Aligned_cols=258 Identities=21% Similarity=0.244 Sum_probs=197.2
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|+||.||+| ...+++.||+|.+..... ......+.+.+|+++++.++||||+++++++..+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL--------ILRNQIQQVFVERDILTFAENPFVVSMFCSFETK 73 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh--------hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC
Confidence 5788899999999999999 555688999998853321 1223456788999999999999999999999998
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||++||+|.+++... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.++++|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCc
Confidence 8899999999999999999763 5689999999999999999999998 9999999999999999999999999998
Q ss_pred eeccCCC-------------cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH
Q 043053 864 KLVDDGD-------------FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 864 ~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 930 (1058)
+...... .........|+..|+|||++.+..++.++||||||+++|||++|..||....+ . +
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--~---~ 223 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--E---E 223 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---H
Confidence 6421100 00011234578899999999888899999999999999999999999974422 1 1
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
+...........+......+. .+..++.+||+.||++||++.++.+.++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~------~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 LFGQVISDDIEWPEGDEALPA------DAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHhcccCCCCccccCCH------HHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 122211111111111111122 23457888999999999996555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.34 Aligned_cols=248 Identities=24% Similarity=0.300 Sum_probs=199.1
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+| ...+++.||+|++..... ......+.+.+|++++++++||||+++++++.+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI--------VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD 72 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh--------hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc
Confidence 36788899999999999999 555789999998854321 122345778999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||+++++|.++++.. ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||+
T Consensus 73 ~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 73 DSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred CCeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999999764 6789999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+...... .....|++.|+|||...+...+.++||||||+++|+|++|+.||.... .......... . .
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~--~----~ 214 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILE--G----K 214 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhc--C----C
Confidence 8876443 234468899999999888888999999999999999999999997542 1111111111 1 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~ 983 (1058)
.......+. .+.+++.+||..||.+|| +++|++++
T Consensus 215 ~~~~~~~~~------~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 VRFPSFFSP------DAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCccCCH------HHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111111122 223477789999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=309.61 Aligned_cols=239 Identities=18% Similarity=0.332 Sum_probs=184.3
Q ss_pred ceeccccceEEEEEEec-CC-------cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 710 NVIGKGCSGVVYRADMD-NG-------EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
+.||+|+||.||+|... .+ ..||+|.+... .....+.+..|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 69 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-----------HRNYSESFFEAASMMSQLSHKHLVLNYGVCV 69 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-----------hHHHHHHHHHHHHHHHhCCCCChhheeeEEE
Confidence 46999999999999442 22 34777776321 2234567889999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC-------
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE------- 854 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~------- 854 (1058)
.++..++||||+++|+|.++++.. ...+++..+..++.||+.|++|||+. +|+||||||+||+++.++.
T Consensus 70 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~ 145 (258)
T cd05078 70 CGDESIMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPP 145 (258)
T ss_pred eCCCcEEEEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCc
Confidence 989999999999999999999864 34689999999999999999999999 9999999999999988765
Q ss_pred -eeeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCC-CCCCCCCCCChhHHHH
Q 043053 855 -PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGK-QPIDPTIPDGSHVVDW 931 (1058)
Q Consensus 855 -~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~ 931 (1058)
++++|||.+...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .||....+. .....
T Consensus 146 ~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~~~ 217 (258)
T cd05078 146 FIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQF 217 (258)
T ss_pred eEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHHHH
Confidence 589999988654332 23457889999999876 45788999999999999999985 555433211 11111
Q ss_pred HHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
... ......... .++.+++..||+.||++|||++++++.|
T Consensus 218 ~~~-------~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 218 YED-------RHQLPAPKW------TELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHc-------cccCCCCCc------HHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 111 011111111 1234578889999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.41 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=194.5
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|...+.||+|+||.||+| +..+++.||||.+..... ........+.+.+|++++++++||||+++++++.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 75 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPE------SPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD 75 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcC------CcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence 36788899999999999999 556789999998743210 01122345788999999999999999999998876
Q ss_pred C--CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 783 R--NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 783 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
. ...++||||+++|+|.+++... ..+++..+.+++.|++.||+|||+. +++||||||+||+++.++.++|+||
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Df 150 (265)
T cd06652 76 PMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDF 150 (265)
T ss_pred CCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcC
Confidence 4 4568999999999999999763 4578888999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcc-cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 861 GLAKLVDDGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 861 Gl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
|+++........ .......|+..|+|||+..+..++.++|||||||++|||++|+.||..... ... ..... ..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~-~~~~~-~~ 224 (265)
T cd06652 151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAA-IFKIA-TQ 224 (265)
T ss_pred ccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHH-HHHHh-cC
Confidence 998765432111 122334588999999999888899999999999999999999999974311 111 11111 11
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...+.. +. ... ..+..++.+|+. +|++||++++++++
T Consensus 225 ~~~~~~---~~-~~~--~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 PTNPVL---PP-HVS--DHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCCC---ch-hhC--HHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111111 11 111 123346677884 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.72 Aligned_cols=254 Identities=29% Similarity=0.426 Sum_probs=195.5
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGC 779 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 779 (1058)
..++|.+.+.||+|+||.||+| ...+++.+|+|++... ....+.+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~------------~~~~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------------SDVDEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc------------ccHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 3467999999999999999999 5567899999987422 22346778899999999 79999999999
Q ss_pred EEcC-----CCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 780 CWNR-----NNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 780 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
+... ...++||||+++|+|.++++.. ....+++..++.++.|++.|++|||+. +++||||||+||+++.+
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~ 164 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE 164 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence 8754 3479999999999999998642 245789999999999999999999998 99999999999999999
Q ss_pred CCeeeeccccceeccCCCcccccccccCcCCccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChh
Q 043053 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSH 927 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 927 (1058)
+.+||+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||....+. ..
T Consensus 165 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~ 241 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KT 241 (291)
T ss_pred CCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HH
Confidence 9999999999876543221 12344688999999987543 3678999999999999999999999754221 11
Q ss_pred HHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 928 VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+..+.+. . .+.. ..+..... .+.+++.+||+.+|++||++.+++++
T Consensus 242 ~~~~~~~-~-----~~~~-~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 LFKIPRN-P-----PPTL-LHPEKWCR---SFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHhcC-C-----CCCC-CcccccCH---HHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111110 0 0111 11111111 24458889999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=312.65 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=195.8
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
|.....||+|+||.||+| +..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 91 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR-----------KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE 91 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec-----------ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC
Confidence 334457999999999999 4557899999987422 1223567889999999999999999999999999
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||+++++|.+++.. ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 92 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 92 ELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred eEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHh
Confidence 99999999999999998864 4589999999999999999999999 99999999999999999999999999987
Q ss_pred eccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1058)
...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||....+ ......+..... ....
T Consensus 166 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~---~~~~ 238 (297)
T cd06659 166 QISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPP---PKLK 238 (297)
T ss_pred hccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCC---CCcc
Confidence 554322 122345689999999999888899999999999999999999999974422 122211111110 0001
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 945 LLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 945 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.....+. .+.+++..||+.+|++||++.+++++-
T Consensus 239 ~~~~~~~------~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 239 NAHKISP------VLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred ccCCCCH------HHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 1111111 233477889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.40 Aligned_cols=253 Identities=28% Similarity=0.421 Sum_probs=196.0
Q ss_pred HhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
.++|...+.||+|+||.||+|.. .+++.+|+|++... ....+++.+|+++++++ .|+||+++++++
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~------------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 72 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------------EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC------------chhHHHHHHHHHHHHHhcCCCChheEEEEE
Confidence 46889999999999999999954 56889999987422 12346789999999999 699999999999
Q ss_pred EcCC------CceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 781 WNRN------NRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 781 ~~~~------~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
.... ..++||||+++++|.++++... ...+++..+..++.|+++|++|||+. +++||||+|+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~ 149 (275)
T cd06608 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKN 149 (275)
T ss_pred EecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccC
Confidence 7654 3799999999999999987543 46789999999999999999999999 99999999999999999
Q ss_pred CCeeeeccccceeccCCCcccccccccCcCCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChh
Q 043053 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSH 927 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 927 (1058)
+.++|+|||.+....... .......|+..|+|||++.. ..++.++||||+||++|+|++|+.||....+. ..
T Consensus 150 ~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~ 226 (275)
T cd06608 150 AEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RA 226 (275)
T ss_pred CeEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HH
Confidence 999999999987654322 22334568899999998653 34678899999999999999999999743221 11
Q ss_pred HHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 928 VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.... ... ..+.. ..+... ...+.+++.+||..||++|||+.+++++
T Consensus 227 ~~~~---~~~---~~~~~-~~~~~~---~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 227 LFKI---PRN---PPPTL-KSPENW---SKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HHHh---hcc---CCCCC-Cchhhc---CHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 110 01111 111111 1123457888999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.03 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=199.7
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|+..+.||+|+||.||+| +..+++.||+|++...... ........+.+.+|+.++++++|+||+++++++.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-----SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC-----chhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence 3677899999999999999 5578999999988533110 011223457899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-Ceeeecccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-EPYIADFGL 862 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~DfGl 862 (1058)
+..++||||+++++|.+++... .++++..+..++.|++.|++|||+. +++||||||+||+++.++ .++|+|||.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 9999999999999999999763 5688999999999999999999999 999999999999998776 599999999
Q ss_pred ceeccCCCcc--cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 863 AKLVDDGDFA--RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 863 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
+......... .......|+..|+|||++.+..++.++||||+|+++|+|++|..||....... ....+.+... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~ 227 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLALIFKIAS--AT 227 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHHHHHHhc--cC
Confidence 8766543111 11223468899999999988889999999999999999999999996432211 1111111111 01
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..+......+ ..+.+++.+||..+|++||++.+++.+
T Consensus 228 ~~~~~~~~~~------~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 TAPSIPEHLS------PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCCCchhhC------HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1111111111 123447788999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=306.11 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=199.6
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|...+.||+|+||.||+| ...+++.||||.+... ......+.+.+|+..+++++||||+++++++..
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 73 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----------EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----------cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe
Confidence 45778889999999999999 4567899999987422 122345788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||+++|+|.+++.. ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||+
T Consensus 74 ~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~ 147 (277)
T cd06641 74 DTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 147 (277)
T ss_pred CCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeeccc
Confidence 9999999999999999999864 4689999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+........ ......|+..|+|||...+..++.++|+|||||++|+|++|..||....+ ......+... ..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~-----~~ 218 (277)
T cd06641 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--MKVLFLIPKN-----NP 218 (277)
T ss_pred ceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--HHHHHHHhcC-----CC
Confidence 876644321 12234688899999999888889999999999999999999999974322 1111111111 01
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+......+. .+.+++.+||+.+|++||++.+++++-
T Consensus 219 ~~~~~~~~~------~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 219 PTLEGNYSK------PLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred CCCCcccCH------HHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 111111222 233477889999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.01 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=197.5
Q ss_pred hccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|+||.||+|. ..+++.||||++...... .........+..|++++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERK------EAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccc------cccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence 46778899999999999994 557899999998644221 01223456678899999999999999999999998
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+ +|+|.++++... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 75 ~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~ 149 (298)
T cd07841 75 SNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLA 149 (298)
T ss_pred CEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceee
Confidence 8999999999 889999997642 4789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc----
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI---- 938 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---- 938 (1058)
+...... .......+++.|+|||.+.+ ..++.++|||||||++|||++|..||....+. .............
T Consensus 150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 150 RSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEEN 226 (298)
T ss_pred eeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhh
Confidence 8765432 22233456788999998754 45788999999999999999998777643221 1111111100000
Q ss_pred ----cccCCCC--CCCCchhH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 ----QVLDPSL--LSRPESEI-----DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 ----~~~~~~~--~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
....... ...+.... .....+.+++.+||++||++|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000 00000000 011234568899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=310.12 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=194.9
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
...|++.+.||+|+||.||+| ...+++.||+|++... .....++..|+.+++++ +||||+++++++
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------EDEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------------hHHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 367888899999999999999 5567899999987321 22346788999999999 699999999998
Q ss_pred Ec------CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC
Q 043053 781 WN------RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE 854 (1058)
Q Consensus 781 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~ 854 (1058)
.. ....++||||+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 53 34579999999999999999876566788999999999999999999999 9999999999999999999
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHH
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVV 929 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 929 (1058)
++|+|||++....... .......|++.|+|||++. +..++.++||||+||++|||++|+.||....+....
T Consensus 160 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-- 235 (282)
T cd06636 160 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-- 235 (282)
T ss_pred EEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh--
Confidence 9999999987553221 1223456899999999875 346788999999999999999999999754321110
Q ss_pred HHHHhhcCccccCCCC-CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 930 DWVRQKKGIQVLDPSL-LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 930 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...... ..+.. ....+ ..+.+++.+||+.||.+|||+.+++++
T Consensus 236 --~~~~~~---~~~~~~~~~~~------~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 --FLIPRN---PPPKLKSKKWS------KKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --hhHhhC---CCCCCcccccC------HHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000000 01111 01111 134457888999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.58 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=199.3
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|+||.||+| ...+|..||+|.+..... .....+.+.+|++++++++|+||+++++++...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM---------PVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc---------cchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 4778899999999999999 555689999998854321 122356788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-Ceeeecccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-EPYIADFGL 862 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~DfGl 862 (1058)
...++||||+++++|.+++.......+++..+..++.|+++|++|||+. +++||||||+||++++++ .++++|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 9999999999999999999875555689999999999999999999998 999999999999999886 469999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......|++.|+|||+..+..++.++||||||+++|||++|..||..... ..++..... ....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~~ 220 (257)
T cd08225 149 ARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQ-GYFA 220 (257)
T ss_pred chhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhc-ccCC
Confidence 87664432 122234588999999999888899999999999999999999999964321 112221111 1111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
......+. .+.+++.+||..+|++|||+.+++++
T Consensus 221 -~~~~~~~~------~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -PISPNFSR------DLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCH------HHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11111111 23457788999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=305.01 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=199.2
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||.|+||.||+| +..+++.||+|.+.... ......+++..|++++++++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---------MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc---------CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 3677899999999999999 56678999999874321 2233457788999999999999999999988643
Q ss_pred --CCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhccc-----ccCCCCeEeCCCCCCcEEEcCCCC
Q 043053 784 --NNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLH-----HDCVPPIVHRDIKANNILIGLEFE 854 (1058)
Q Consensus 784 --~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivHrDikp~Nill~~~~~ 854 (1058)
...+++|||+++++|.+++... ....+++..++.++.|+++|++||| +. +++||||||+||+++.++.
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNN 148 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCC
Confidence 4568999999999999999753 2467899999999999999999999 66 9999999999999999999
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHh
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1058)
+|++|||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.... .......+..
T Consensus 149 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~ 224 (265)
T cd08217 149 VKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKE 224 (265)
T ss_pred EEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhc
Confidence 99999999987654331 1234568999999999988889999999999999999999999997542 2222222211
Q ss_pred hcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 935 KKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. .+.+....+. .+.+++.+|++.+|++||++.+|+++
T Consensus 225 ~~-----~~~~~~~~~~------~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GK-----FRRIPYRYSS------ELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CC-----CCCCccccCH------HHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 1111111121 23457888999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=310.46 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=200.0
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| +..+++.||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~ 86 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-----------QQPKKELIINEILVMRENKHPNIVNYLDSYL 86 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-----------cchHHHHHHHHHHHHhhcCCCCeeehhheee
Confidence 478899999999999999999 4567889999987422 2233577899999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
..+..|+||||+++++|.+++.+ ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg 160 (293)
T cd06647 87 VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG 160 (293)
T ss_pred eCCcEEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCc
Confidence 99999999999999999999975 3578999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++........ ......|++.|+|||+..+..++.++||||||+++|++++|+.||....+... ... ... ..
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~-~~~-~~---- 231 (293)
T cd06647 161 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL-IAT-NG---- 231 (293)
T ss_pred ceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eee-hhc-CC----
Confidence 9876544321 22344688999999998888889999999999999999999999975432111 000 000 00
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.+... ....... ...+++..||+.+|++||++.+++.+-
T Consensus 232 ~~~~~--~~~~~~~--~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 232 TPELQ--NPEKLSA--IFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCCCC--CccccCH--HHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 01110 1111111 234578889999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=313.38 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=196.4
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+|.. .+++.||+|++.... ......+.+.+|++++++++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE---------DDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc---------CcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 3678889999999999999954 468999999874331 122345678899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||++++++.++... ...+++..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence 9999999999999999887764 34589999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC----
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG---- 937 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~---- 937 (1058)
+....... .......++..|+|||+..+ ..++.++||||||+++|||++|+.||...... ............
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~ 223 (286)
T cd07846 147 ARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPR 223 (286)
T ss_pred eeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchh
Confidence 88764432 22334568899999998765 44678999999999999999999998643211 110000000000
Q ss_pred -------c----cccCCCCCCCCchh---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 -------I----QVLDPSLLSRPESE---IDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 -------~----~~~~~~~~~~~~~~---~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. ....+......+.. ..-...+.+++.+||+.+|++||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 00000000000000 0001234458889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=308.22 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=198.5
Q ss_pred hccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||.||+|. ..+|+.||||++.... ......+.+.+|+.++++++||||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~---------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR---------LEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccc---------ccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 47788999999999999994 4578999999885331 1223457889999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+ +++|.+++... ...+++..++.++.|+++||+|||+. +++||||||+||+++.++.++++|||.+
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 9999999999 99999999764 36789999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc---
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ--- 939 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--- 939 (1058)
........ .......|+..|+|||++.+. .++.++||||+|+++|||++|..||....+ ..... .........
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~-~~~~~~~~~~~~ 223 (286)
T cd07832 147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLA-IVFRTLGTPNEE 223 (286)
T ss_pred ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHH-HHHHHcCCCChH
Confidence 87654321 223345689999999987654 468899999999999999999887764321 11111 111100000
Q ss_pred ---------ccCC-CCCCCCchhH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 ---------VLDP-SLLSRPESEI-----DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ---------~~~~-~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.... .......... .....+.+++.+|++.+|++||++++++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0000000000 001334568889999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.35 Aligned_cols=253 Identities=28% Similarity=0.391 Sum_probs=198.5
Q ss_pred hccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|+||.||+|.. .+++.||+|.+..... ........+.+.+|++++++++||||+++++++.++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADD------GQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccc------cccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence 467789999999999999954 4799999998743211 011233457899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++++|.++++.. ..+++..+..++.|+++|++|||+. +++||||+|+||+++.++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~ 149 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMA 149 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999999999999763 4688999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
....... ......|+..|+|||...... ++.++|+||||+++|+|++|+.||....+ .... ....... ..
T Consensus 150 ~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-~~~~---~~~~~~~--~~ 220 (258)
T cd06632 150 KQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-VAAV---FKIGRSK--EL 220 (258)
T ss_pred eeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-HHHH---HHHHhcc--cC
Confidence 8654432 223456889999999887666 88999999999999999999999975431 1111 1111100 01
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+......+. .+.+++.+||+.+|++||++.+++.+
T Consensus 221 ~~~~~~~~~------~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 PPIPDHLSD------EAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CCcCCCcCH------HHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111111122 22347788999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=304.15 Aligned_cols=262 Identities=24% Similarity=0.375 Sum_probs=200.2
Q ss_pred hccccceeccccceEEEEEEec--CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcc-cCCCcccceeeEEE
Q 043053 705 CLVDANVIGKGCSGVVYRADMD--NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGS-IRHKNIVRFLGCCW 781 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~ 781 (1058)
.|++.+.||+|+||.||+|... .++.+|||.+.......... .........++.+|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~-~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKD-KRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccc-cccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 3677889999999999999554 47889999885432211100 01223345677889988875 78999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
+++..++||||+++++|.+++... ....+++..+++++.|++.|+.|||+ . +++||||||+||+++.++.++|+
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEe
Confidence 999999999999999999988542 24568999999999999999999996 5 89999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
|||.+....... ......|+..|+|||+..+..++.++||||||+++|||++|+.||.... ............
T Consensus 157 dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~~~-- 229 (269)
T cd08528 157 DFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--MLSLATKIVEAV-- 229 (269)
T ss_pred cccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--HHHHHHHHhhcc--
Confidence 999998755432 2345568899999999998889999999999999999999999996432 111111111110
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
..+......+. .+.+++.+||+.||++||++.|+.++++
T Consensus 230 --~~~~~~~~~~~------~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 --YEPLPEGMYSE------DVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --CCcCCcccCCH------HHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111111111 2345788899999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=287.73 Aligned_cols=260 Identities=23% Similarity=0.268 Sum_probs=202.9
Q ss_pred ccHHHHHhhccc-cceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcc
Q 043053 697 FSVEQVLKCLVD-ANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNI 773 (1058)
Q Consensus 697 ~~~~~~~~~~~~-~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni 773 (1058)
|....++++|.+ .++||-|-.|.|-.+ +..+|+.+|+|++... ...++|++..-... ||||
T Consensus 54 ~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----------------~KARrEVeLHw~~s~h~~i 117 (400)
T KOG0604|consen 54 FKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----------------PKARREVELHWMASGHPHI 117 (400)
T ss_pred hhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----------------HHHHhHhhhhhhhcCCCce
Confidence 333446667765 368999999999999 7778999999998522 34578888766664 9999
Q ss_pred cceeeEEEc----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE
Q 043053 774 VRFLGCCWN----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI 849 (1058)
Q Consensus 774 v~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill 849 (1058)
|.++++|.. .....+|||.++||.|.+.++++....+++.++..|.+||+.|++|||+. +|.||||||+|+|.
T Consensus 118 V~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLy 194 (400)
T KOG0604|consen 118 VSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLY 194 (400)
T ss_pred EEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheee
Confidence 999999864 34457999999999999999998888999999999999999999999999 99999999999999
Q ss_pred cC---CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh
Q 043053 850 GL---EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS 926 (1058)
Q Consensus 850 ~~---~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 926 (1058)
+. +..+||+|||+|+..... ....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.......
T Consensus 195 t~t~~na~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a- 270 (400)
T KOG0604|consen 195 TTTSPNAPLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA- 270 (400)
T ss_pred ecCCCCcceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-
Confidence 64 457999999999876542 33456778999999999999999999999999999999999999998653211
Q ss_pred hHHHHHHhhcCccccCCCCCCCCchhHHHH-HHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 927 HVVDWVRQKKGIQVLDPSLLSRPESEIDEM-LQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
+..-++.+. .......|.++.++. ..+.++++..+..+|.+|.|+.+++++-+
T Consensus 271 -ispgMk~rI-----~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 271 -ISPGMKRRI-----RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred -CChhHHhHh-----hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 111111111 111122333333322 22345888899999999999999987653
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=311.72 Aligned_cols=272 Identities=22% Similarity=0.321 Sum_probs=199.3
Q ss_pred cccHHHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccc
Q 043053 696 NFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIV 774 (1058)
Q Consensus 696 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 774 (1058)
.+.+.+..++|...+.||+|+||.||+| +..+++.||||.+.... ........+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~iv 74 (310)
T cd07865 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---------EKEGFPITALREIKILQLLKHENVV 74 (310)
T ss_pred cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccC---------CcCCchhHHHHHHHHHHhCCCCCcc
Confidence 4456667789999999999999999999 55579999999874321 1222345667899999999999999
Q ss_pred ceeeEEEcCCC--------ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCc
Q 043053 775 RFLGCCWNRNN--------RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANN 846 (1058)
Q Consensus 775 ~~~~~~~~~~~--------~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~N 846 (1058)
++++++..... .++||||+.+ +|.+++... ...+++..++.++.|++.|++|||+. +++||||||+|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~n 149 (310)
T cd07865 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAAN 149 (310)
T ss_pred ceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHH
Confidence 99999876543 4999999965 888888653 34689999999999999999999999 99999999999
Q ss_pred EEEcCCCCeeeeccccceeccCCCc--ccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 043053 847 ILIGLEFEPYIADFGLAKLVDDGDF--ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIP 923 (1058)
Q Consensus 847 ill~~~~~~kl~DfGl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 923 (1058)
|+++.++.+||+|||++........ ........++..|+|||++.+. .++.++||||||+++|||++|+.||....+
T Consensus 150 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 150 ILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred EEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999976543221 1122345678899999987654 468899999999999999999999975422
Q ss_pred CChhHHHHHHhhcCc---cc---------cCC-CCCCCCchhHH-------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 924 DGSHVVDWVRQKKGI---QV---------LDP-SLLSRPESEID-------EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 924 ~~~~~~~~~~~~~~~---~~---------~~~-~~~~~~~~~~~-------~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
......+....+. .. .+. ........... ....+.+++.+||+.||++|||+++++++
T Consensus 230 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 230 --QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred --HHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1111111111100 00 000 00000000000 01234568999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=310.69 Aligned_cols=265 Identities=18% Similarity=0.206 Sum_probs=181.7
Q ss_pred hhccccceeccccceEEEEEEecC----CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDN----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||+||+|.... +..+|+|+.........................+...+..+.|++|++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999996543 4556666532110000000000000001122334455667789999999997
Q ss_pred EEcCC----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 780 CWNRN----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 780 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
+.... ..+++||++.. ++.+.+... ...++..+..|+.|+++|++|||+. +|+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 76543 23678888744 777776542 3457888899999999999999998 99999999999999999999
Q ss_pred eeeccccceeccCCCc-----ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhH--
Q 043053 856 YIADFGLAKLVDDGDF-----ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV-- 928 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~-- 928 (1058)
+|+|||+|+.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 9999999987643211 111233569999999999999999999999999999999999999997653222111
Q ss_pred --HHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 929 --VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 929 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.++..+..... . . ....+. .+.+++..||+.+|++||+++++++.+
T Consensus 246 ~~~~~~~~~~~~~-~--~-~~~~~~------~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDFIKRLHEGK-I--K-IKNANK------FIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHHHhhhhh-h--c-cCCCCH------HHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111111100 0 0 111122 233467779999999999999998865
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=312.51 Aligned_cols=256 Identities=24% Similarity=0.296 Sum_probs=199.8
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|+||.||+| ...+++.||+|.+..... ......+.+.+|++++++++||||+++++.+...
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM--------IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE 73 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc--------chHHHHHHHHHHHHHHHhCCCCCchhheeeeecC
Confidence 6788899999999999999 445689999999854321 1123456789999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+.+++|.+++.......+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 150 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLS 150 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchh
Confidence 9999999999999999999876567899999999999999999999998 9999999999999999999999999998
Q ss_pred eeccCCCcc---------------------------cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCC
Q 043053 864 KLVDDGDFA---------------------------RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQ 916 (1058)
Q Consensus 864 ~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~ 916 (1058)
......... .......|+..|+|||+..+..++.++||||||+++|+|++|+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence 754322100 01123468899999999998889999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC----HHHHHHH
Q 043053 917 PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT----MKDVAAM 983 (1058)
Q Consensus 917 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt----~~~v~~~ 983 (1058)
||...... ......... ........ . ....+.+++.+||+.||++||+ +++++.+
T Consensus 231 pf~~~~~~-~~~~~~~~~-------~~~~~~~~-~---~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 231 PFKGSNRD-ETFSNILKK-------EVTFPGSP-P---VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCchH-HHHHHHhcC-------CccCCCcc-c---cCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 99754221 111111100 00111110 0 1123345788899999999999 6666664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=312.23 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=203.0
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
...|...+.||+|.|++|..| +..++..||||.+.+... +....+.+.+|+++|..+.|||||+++.+..
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l---------n~~~~~k~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL---------NPSKRQKLGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc---------ChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence 356788899999999999999 667899999999976532 3334566899999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
.+...|+||||+.+|.+.+|+... +...+..+..++.|+.+|++|+|++ .|||||||++|||++.+..+||+|||
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccc
Confidence 999999999999999999999874 4556688899999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
++..+..+ ....+.+|++.|+|||++.+..| .+.+|+||+|+++|.|+.|..||++..-.. .+......
T Consensus 201 fS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------Lr~rvl~g- 270 (596)
T KOG0586|consen 201 FSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------LRPRVLRG- 270 (596)
T ss_pred cceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc------ccchheee-
Confidence 99988754 34567899999999999998876 579999999999999999999998542111 00000000
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.-.+......+ +-+++++++-.+|.+|++.+++.+.-
T Consensus 271 -k~rIp~~ms~d------ce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 271 -KYRIPFYMSCD------CEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred -eecccceeech------hHHHHHHhhccCccccCCHHHhhhhc
Confidence 01111111122 22355667889999999999988643
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=310.13 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=198.1
Q ss_pred hccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|+..+.||+|+||.||+|. ..+++.||||++.... ......+.+.+|++++++++|+||+++++++..+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE---------DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK 72 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc---------ccccchhHHHHHHHHHHhcCCCCeeehhheEEEC
Confidence 58889999999999999994 4568899999885331 2234467899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||++++.+..+... ...+++..+..++.||+.|++|||+. +++||||+|+||++++++.+||+|||++
T Consensus 73 ~~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 73 GRLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred CEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecc
Confidence 999999999998777666544 35589999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC-----
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG----- 937 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~----- 937 (1058)
........ .......++..|+|||+..+. .++.++||||||+++|+|++|+.||...... ..... ......
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~-~~~~~~~~~~~ 224 (288)
T cd07833 148 RALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYL-IQKCLGPLPPS 224 (288)
T ss_pred cccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHHhCCCCHH
Confidence 87654332 123345688999999998887 7889999999999999999999999743211 11110 000000
Q ss_pred -------ccccCC-CCCCCC-chhHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 -------IQVLDP-SLLSRP-ESEID------EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 -------~~~~~~-~~~~~~-~~~~~------~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...... ...... ..... ...++.+++..||+.+|++||++++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 000000 00000 01334568899999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=285.03 Aligned_cols=253 Identities=22% Similarity=0.272 Sum_probs=203.0
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
.++.|...++||+|.||+|..+ ...+|+.+|+|++++....++ ...+.-..|-++++..+||.+..+-..|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak--------dEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK--------DEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh--------HHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 4578999999999999999999 667899999999976654321 2235556789999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
...+..++||||+.||.|.-.+.+ ...++++..+-....|..||.|||++ +||+||+|.+|.|+|+||++||+||
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence 999999999999999999988865 46788888888999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+++.-. .+...+.+++|||.|+|||++.+..|..+.|-|.+|||+|||++|+.||... +...+.+.+...
T Consensus 313 GLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~--dh~kLFeLIl~e----- 383 (516)
T KOG0690|consen 313 GLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK--DHEKLFELILME----- 383 (516)
T ss_pred ccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc--chhHHHHHHHhh-----
Confidence 9997432 2345677899999999999999999999999999999999999999999754 222222222111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~ 983 (1058)
+-.++.....+... +....+.+||.+|. .+.||.++
T Consensus 384 -d~kFPr~ls~eAkt------LLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 -DLKFPRTLSPEAKT------LLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -hccCCccCCHHHHH------HHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 12222233333333 34456899999995 45565543
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=309.10 Aligned_cols=259 Identities=26% Similarity=0.326 Sum_probs=195.6
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
|+..+.||.|++|.||+| +..+|..||+|++.... ..+...+.+.+|++++++++||||+++++++.+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET---------EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc---------ccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 567789999999999999 55689999999885331 12233467889999999999999999999999999
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||++ ++|.+++.......+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 9999999995 6999999875445789999999999999999999998 99999999999999999999999999987
Q ss_pred eccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc-----
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI----- 938 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~----- 938 (1058)
...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||....+. .......+.....
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07835 148 AFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVW 224 (283)
T ss_pred ccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHh
Confidence 553321 122334578899999987654 5688999999999999999999999754221 1111111110000
Q ss_pred -------------ccc-CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 -------------QVL-DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 -------------~~~-~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
... .+......+.. ...+.+++.+||+.||++|||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQDLSKVVPNL---DEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhchhhhhhcccccccchhhhcCCC---CHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00000000000 0234458889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=305.50 Aligned_cols=247 Identities=21% Similarity=0.238 Sum_probs=185.8
Q ss_pred eeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHH---HcccCCCcccceeeEEEcCCCc
Q 043053 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT---LGSIRHKNIVRFLGCCWNRNNR 786 (1058)
Q Consensus 711 ~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~ 786 (1058)
+||+|+||.||+| +..+++.+|+|.+...... .......+.+|..+ +...+||+|+.+++++..++..
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--------MKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKL 72 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccc--------cchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeE
Confidence 4899999999999 4567899999988543211 11112333444433 3344799999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceec
Q 043053 787 LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV 866 (1058)
Q Consensus 787 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~ 866 (1058)
++||||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||++...
T Consensus 73 ~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 73 CFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 9999999999999998763 5689999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCcccccccccCcCCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCC
Q 043053 867 DDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSL 945 (1058)
Q Consensus 867 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1058)
.... .....|+..|+|||+.. +..++.++||||+||++|||++|..||............ ... ......+
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~--~~~~~~~ 218 (279)
T cd05633 148 SKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMT--LTVNVEL 218 (279)
T ss_pred cccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH---HHh--hcCCcCC
Confidence 4321 22346899999999876 456789999999999999999999999754332222111 111 0111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHH
Q 043053 946 LSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAMLK 985 (1058)
Q Consensus 946 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l~ 985 (1058)
....+. .+.+++..||+.||++|| ++++++++..
T Consensus 219 ~~~~~~------~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 219 PDSFSP------ELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred ccccCH------HHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 111121 233467889999999999 5998887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=304.52 Aligned_cols=251 Identities=25% Similarity=0.311 Sum_probs=199.8
Q ss_pred hccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||.||+|. ..+++.||+|.+..... ......+.+.+|++++++++||||+++++++.++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 72 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC--------VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE 72 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh--------cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC
Confidence 47888999999999999994 45799999999854321 1223467899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++++|.+++... ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++|+|||.+
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 73 ENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred CeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccc
Confidence 9999999999999999999764 5789999999999999999999998 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
....... ......|+..|+|||+..+..++.++|+||+|+++|+|++|+.||...... ...+....... ..+
T Consensus 148 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~~ 219 (258)
T cd05578 148 TKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET--ADV 219 (258)
T ss_pred cccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc--ccc
Confidence 7665432 223456888999999998888999999999999999999999999755322 11111111110 111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH--HHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTM--KDVAA 982 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~--~~v~~ 982 (1058)
......+ ..+.+++.+||+.||.+||++ +|+.+
T Consensus 220 ~~~~~~~------~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 220 LYPATWS------TEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcccCc------HHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1111111 223457888999999999999 66543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=300.49 Aligned_cols=254 Identities=22% Similarity=0.243 Sum_probs=202.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|..-++||+|+||.||-+ ...+|+.+|.|++.++.. +......-...|-+++.++..+.||.+-.+|..
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi--------Kkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI--------KKRKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH--------HHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 45667789999999999999 667899999999866543 233344566789999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..++||..|.||+|.-.|-......+++..+.-+|.+|+.||++||+. +||+||+||+|||+|+.|+++|+|.|+
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccce
Confidence 99999999999999999888776667899999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHH--HHhhcCccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW--VRQKKGIQV 940 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~--~~~~~~~~~ 940 (1058)
|..+..+. .....+||.+|||||++.+..|+...|-||+||++|||+.|+.||..... .+.+ +.+.. ..
T Consensus 334 Avei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke----Kvk~eEvdrr~--~~ 404 (591)
T KOG0986|consen 334 AVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE----KVKREEVDRRT--LE 404 (591)
T ss_pred EEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh----hhhHHHHHHHH--hc
Confidence 99887764 33455899999999999999999999999999999999999999964321 1111 11111 11
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~ 983 (1058)
..........++.. ++.+..+++||.+|. .+++|.++
T Consensus 405 ~~~ey~~kFS~eak------slc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAK------SLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred chhhcccccCHHHH------HHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 11122222333333 345556899999986 55666654
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=304.98 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=196.7
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC---CCcccceeeEE
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR---HKNIVRFLGCC 780 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~ 780 (1058)
.|...+.||+|+||.||+| ...+++.||+|.+... ......+++.+|+.++++++ |||++++++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~ 71 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD----------TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY 71 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC----------CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee
Confidence 4677889999999999999 4567899999987532 12233567889999999997 99999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
..+...++||||+++++|.++++. ..+++..++.++.|++.|++|||+. +|+||||+|+||+++.++.++++||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 72 LKGPRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred eeCCEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccC
Confidence 998899999999999999999865 3689999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
|++....... .......|+..|+|||...+ ..++.++|||||||++|+|++|+.||...... ........
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~-- 216 (277)
T cd06917 146 GVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIPK-- 216 (277)
T ss_pred CceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhcccc--
Confidence 9998765433 22234568899999998764 45688999999999999999999999754221 11111000
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...+.+... ... ..+.+++.+||+.||++||++.+++.+
T Consensus 217 ~~~~~~~~~--~~~---~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 217 SKPPRLEDN--GYS---KLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCCCcc--cCC---HHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 011111111 011 233457888999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=305.96 Aligned_cols=253 Identities=24% Similarity=0.364 Sum_probs=190.7
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHH-HcccCCCcccceeeEEEc
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT-LGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~ 782 (1058)
+|.+.+.||+|+||.||+| +..+|+.||+|++.... ......++..|+.. ++..+||||+++++++..
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV----------NSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC----------CcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 5788899999999999999 55579999999885331 11123455556654 666789999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
+...++||||++ |+|.+++... ....+++..++.++.|++.|++|||++ .+++||||||+||+++.++.+||+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999996 5898888652 235789999999999999999999985 28999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|++....... ......|+..|+|||++.+ ..++.++|+||+||++|||++|+.||.............. .
T Consensus 149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~-- 222 (283)
T cd06617 149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-E-- 222 (283)
T ss_pred cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-h--
Confidence 9988654321 1233468889999998764 4468899999999999999999999964322111111111 1
Q ss_pred CccccCCCCCC-CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 937 GIQVLDPSLLS-RPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 937 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
...+.... ..+ . .+..++..||..+|++||++++++++-.
T Consensus 223 ---~~~~~~~~~~~~---~---~l~~li~~~l~~~p~~Rp~~~~il~~~~ 263 (283)
T cd06617 223 ---EPSPQLPAEKFS---P---EFQDFVNKCLKKNYKERPNYPELLQHPF 263 (283)
T ss_pred ---cCCCCCCccccC---H---HHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 11111111 111 1 2345788899999999999999988543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.07 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=201.9
Q ss_pred hccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|++|.||+|.. .+++.||||++.... .....+.+.+|++.+.+++|+||+++++++..+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG----------DEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc----------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 577889999999999999944 469999999885331 114467899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
...++||||+++++|.+++... ..+++..++.++.|+++|++|+|+ . +++||||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence 9999999999999999999864 678999999999999999999999 8 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC-CChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP-DGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~ 941 (1058)
+........ ......++..|+|||...+..++.++||||||+++|+|++|+.||....+ ........+... .
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----~ 219 (264)
T cd06623 147 SKVLENTLD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-----P 219 (264)
T ss_pred ceecccCCC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-----C
Confidence 887654321 12245688999999999888899999999999999999999999976532 111222211111 1
Q ss_pred CCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 DPSLLSR-PESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+..... .+. .+..++..||+++|++||++.+++++
T Consensus 220 ~~~~~~~~~~~------~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 PPSLPAEEFSP------EFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCcccCCH------HHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111111 122 23346778999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.91 Aligned_cols=254 Identities=29% Similarity=0.429 Sum_probs=199.5
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|+||.||+| ...+++.||+|.+.... ..+...+.+.+|++++++++|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD---------NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcc---------cchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 4788899999999999999 45578999999985331 1234578899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++|+||+++++|.+++... ..+++..+..++.|+++|++|||+. +++||||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999999999763 4578999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccc--cccccCcCCccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 864 KLVDDGDFARS--SNTVAGSYGYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 864 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
........... .....++..|+|||+..+.. ++.++||||||+++||+++|+.||...... .........
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~---- 221 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGA---- 221 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhc----
Confidence 87654332111 12356789999999988766 788999999999999999999999754221 111111111
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
...+...... .-.....+++.+||+.+|++||++.+++.
T Consensus 222 -~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 -GHKPPIPDSL----QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCCccc----ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111111 00112335788899999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=310.74 Aligned_cols=254 Identities=29% Similarity=0.407 Sum_probs=196.8
Q ss_pred HhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.+.|...+.||+|+||+||+|. ..+++.||+|++.... .......+++.+|+++++.++||||+++++++.
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--------KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc--------cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 3568888999999999999994 4578999999874321 112233467889999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++..++||||++ |++.+++... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence 9999999999997 5887877643 35689999999999999999999998 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
++...... ....|++.|+|||++. ...++.++||||||+++|||++|+.||....+. ..........
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--~~~~~~~~~~-- 230 (307)
T cd06607 161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQND-- 230 (307)
T ss_pred cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--HHHHHHhcCC--
Confidence 98765332 2346888999999874 456788999999999999999999999644211 1111111100
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
.+... .... ...+.+++.+||+.+|++||++.+++.+....
T Consensus 231 ---~~~~~---~~~~--~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 231 ---SPTLS---SNDW--SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred ---CCCCC---chhh--CHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 01111 1111 11345578899999999999999999865433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=304.25 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=196.1
Q ss_pred hccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|++|.||+|. ..+++.||+|++... .....+.+.+|+.++++++||||+++++++...
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~ 88 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-----------KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG 88 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-----------chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC
Confidence 34556799999999999994 567899999987321 222356788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++|+||+++++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++++|||.+
T Consensus 89 ~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~ 162 (285)
T cd06648 89 DELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC 162 (285)
T ss_pred CeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccc
Confidence 999999999999999999976 4588999999999999999999999 9999999999999999999999999988
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
....... .......|++.|+|||+..+..++.++||||||+++|||++|+.||....+ . ......... ..+
T Consensus 163 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~---~~~~~~~~~--~~~ 233 (285)
T cd06648 163 AQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--L---QAMKRIRDN--LPP 233 (285)
T ss_pred hhhccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--H---HHHHHHHhc--CCC
Confidence 7544322 122345689999999999888899999999999999999999999975322 1 111111111 011
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. ....... ..+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~-~~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 234 KL-KNLHKVS---PRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CC-cccccCC---HHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11 1111011 134457888999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=305.56 Aligned_cols=248 Identities=22% Similarity=0.250 Sum_probs=192.7
Q ss_pred eccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEE
Q 043053 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMY 790 (1058)
Q Consensus 712 lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 790 (1058)
||+|+||+||+| +..+|+.||+|.+..... ........+.+|++++++++||||+++++++...+..|+||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 72 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--------KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVM 72 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--------hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEE
Confidence 699999999999 556799999998854321 12223456778999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCC
Q 043053 791 DYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870 (1058)
Q Consensus 791 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~ 870 (1058)
||+++++|.+++.......+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 73 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~- 148 (277)
T cd05577 73 TLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG- 148 (277)
T ss_pred ecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-
Confidence 999999999999875555789999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCc
Q 043053 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE 950 (1058)
Q Consensus 871 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1058)
.......++..|+|||+..+..++.++||||+|+++|+|++|+.||....... .......... ..........+
T Consensus 149 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~ 222 (277)
T cd05577 149 --KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTL---EMAVEYPDKFS 222 (277)
T ss_pred --CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhccc---cccccCCccCC
Confidence 22234567889999999888889999999999999999999999997543211 1111111111 01111111112
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043053 951 SEIDEMLQALGVALLCVNASPDERP-----TMKDVAAM 983 (1058)
Q Consensus 951 ~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~ 983 (1058)
. .+.+++.+||+.||++|| ++.+++.+
T Consensus 223 ~------~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 223 P------EAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred H------HHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 2 234577889999999999 66667653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=329.88 Aligned_cols=279 Identities=17% Similarity=0.191 Sum_probs=191.5
Q ss_pred HHHHhhccccceeccccceEEEEEEec--CCcEEEEEecCccccc------ccCCCCCcccchHHHHHHHHHHHcccCCC
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRADMD--NGEVIAVKKLWPTTMA------AANGCSDEKSGVRDSFSAEIKTLGSIRHK 771 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 771 (1058)
..+.++|.+.+.||+|+||+||+|..+ .+..+++|.+...... ...............+.+|++++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345688999999999999999998433 2333333311100000 00000011223456789999999999999
Q ss_pred cccceeeEEEcCCCceEEEEecCCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEE
Q 043053 772 NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT---GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 772 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nil 848 (1058)
|||++++++..++..|+|||++. +++.+++.... ........+..|+.|++.||+|||+. +||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 99999999999999999999995 58888775421 12234566778999999999999999 9999999999999
Q ss_pred EcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCCCCC-Ch
Q 043053 849 IGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPD-GS 926 (1058)
Q Consensus 849 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P-~~~~~~~-~~ 926 (1058)
++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ |...... ..
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999987654322 122345799999999999999999999999999999999998764 4322111 11
Q ss_pred hHHHHHHhhcCccccCCCCCC---------------CCchhHHHH-------HHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 927 HVVDWVRQKKGIQVLDPSLLS---------------RPESEIDEM-------LQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~-------~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.+...+.... ........ .....+... ..+.+++.+|++.||.+|||+.|++++-
T Consensus 379 ~~~~~~~~~~---~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 379 QLLKIIDSLS---VCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHhcc---cChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 2222111110 00000000 000000001 1223467789999999999999999865
Q ss_pred Hh
Q 043053 985 KE 986 (1058)
Q Consensus 985 ~~ 986 (1058)
..
T Consensus 456 ~f 457 (501)
T PHA03210 456 LF 457 (501)
T ss_pred hh
Confidence 44
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=316.20 Aligned_cols=201 Identities=27% Similarity=0.361 Sum_probs=170.6
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+.++|...+.||+|+||.||+| +..+++.||||++.... ......+.+.+|+.++++++||||++++++
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---------QNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc---------cChhHHHHHHHHHHHHHhcCCCCCcceeee
Confidence 35688999999999999999999 55689999999874321 122334677889999999999999999998
Q ss_pred EEcC------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 780 CWNR------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 780 ~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
+... ...|+||||+.+ +|.+++... +++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~ 155 (353)
T cd07850 84 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 155 (353)
T ss_pred eccCCCccccCcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCC
Confidence 8643 246999999964 888888642 88899999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
.+||+|||+++...... ......++..|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 156 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 156 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 99999999998764422 223456889999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=311.31 Aligned_cols=264 Identities=27% Similarity=0.356 Sum_probs=196.4
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||.||+| +..+|+.||+|++.... ........+.+|+.++++++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN---------ERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEecc---------CCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 467899999999999999999 55679999999884321 12222345678999999999999999999987
Q ss_pred cC--CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 782 NR--NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 782 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
.. +..++||||+++ +|.+++... ...+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~d 151 (309)
T cd07845 77 GKHLDSIFLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIAD 151 (309)
T ss_pred cCCCCeEEEEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 65 457999999965 899888754 36789999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
||.+....... .......++..|+|||++.+ ..++.++||||+||++|||++|+.||....+ ......+......
T Consensus 152 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~ 227 (309)
T cd07845 152 FGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGT 227 (309)
T ss_pred cceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCC
Confidence 99998765432 12223346788999998765 4578999999999999999999999975422 1111111111100
Q ss_pred --cccC-----------CCCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 939 --QVLD-----------PSLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 939 --~~~~-----------~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.... ......+..... ......+++.+|+++||++|||+.+++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred CChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000 000000000000 012345688999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.81 Aligned_cols=361 Identities=26% Similarity=0.405 Sum_probs=225.8
Q ss_pred hhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCc
Q 043053 125 MRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENS 204 (1058)
Q Consensus 125 L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~ 204 (1058)
.++++|.--.+..|.....++.++.|.|...++. .+|..++.|.+|++|++.+|++. .+-..+..++.|+.+.+..|+
T Consensus 12 vDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~ 89 (1255)
T KOG0444|consen 12 VDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNN 89 (1255)
T ss_pred ccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccc
Confidence 3444443223445555555666666666666664 66666666666666666666665 444556666667777777666
Q ss_pred CCCC-CCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccc
Q 043053 205 LSGS-IPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPA 283 (1058)
Q Consensus 205 l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 283 (1058)
+... +|..+.++..|+.|+|++|++. ..|..+..-+++-.|+||+|+|..+....|.++..|-.||||+|++. .+|.
T Consensus 90 LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPP 167 (1255)
T KOG0444|consen 90 LKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPP 167 (1255)
T ss_pred cccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCH
Confidence 6432 4556666677777777777766 55666666666667777777766433344556666666667766666 4555
Q ss_pred cccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccC-CCCChhhhccCcccccccccccccccCccccccccc
Q 043053 284 NLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLE-GSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQN 362 (1058)
Q Consensus 284 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 362 (1058)
....+.+|+.|.|++|.+....-..+..+++|.+|.+++.+-+ ..+|.++..+.||..+|+|.|.+. .+|..++.+++
T Consensus 168 Q~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~ 246 (1255)
T KOG0444|consen 168 QIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRN 246 (1255)
T ss_pred HHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhh
Confidence 5666666667777776665444444445566666666654432 245666777777777777777776 57777777777
Q ss_pred chhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCC-CCCCcccCCcccchhhcc
Q 043053 363 LTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG-SVPDEIGDCTELQMIDLS 441 (1058)
Q Consensus 363 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~ 441 (1058)
|+.|+|++|+|+. +....+...+|++|+|+.|+++ ..|+++..|+.|+.|.+.+|+++- -+|..++.+.+|+.+..+
T Consensus 247 LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aa 324 (1255)
T KOG0444|consen 247 LRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAA 324 (1255)
T ss_pred hheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhh
Confidence 7777777777763 3334455566666666666666 346666666666666666666542 255666666666666666
Q ss_pred CCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCC
Q 043053 442 HNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFS 494 (1058)
Q Consensus 442 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 494 (1058)
+|.+. ..|+.++.+..|+.|.|+.|++- .+|+.+.-++.|+.|+|..|+--
T Consensus 325 nN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 325 NNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred ccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 66666 56666666666666666666665 56666666666666666666544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=332.68 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=192.1
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
.+...+|++.++||+||||.|||+ ..-+|+.+|||+|.... .......+.+|+..+++++|||||++|.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----------s~~~~skI~rEVk~LArLnHpNVVRYys 544 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----------SDKLYSKILREVKLLARLNHPNVVRYYS 544 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----------HHHHHHHHHHHHHHHhhcCCcceeeeeh
Confidence 456788899999999999999999 44589999999996442 3344678899999999999999999975
Q ss_pred EEEc-------------------------------------------------------C--------------------
Q 043053 779 CCWN-------------------------------------------------------R-------------------- 783 (1058)
Q Consensus 779 ~~~~-------------------------------------------------------~-------------------- 783 (1058)
.+.+ .
T Consensus 545 AWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~d 624 (1351)
T KOG1035|consen 545 AWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSD 624 (1351)
T ss_pred hhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccc
Confidence 4310 0
Q ss_pred --------------------------------------------CCceEEEEecCCCChhhhhhhcCCCCC-CHHHHHHH
Q 043053 784 --------------------------------------------NNRLLMYDYMPNGSLGSLLHERTGNAL-EWELRYQI 818 (1058)
Q Consensus 784 --------------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l-~~~~~~~i 818 (1058)
...||=||||+..++.+++++.. .. .....|++
T Consensus 625 edg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~--~~~~~d~~wrL 702 (1351)
T KOG1035|consen 625 EDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH--FNSQRDEAWRL 702 (1351)
T ss_pred ccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc--cchhhHHHHHH
Confidence 01367899999977888887532 22 57788999
Q ss_pred HHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc----------------CCCcccccccccCcC
Q 043053 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD----------------DGDFARSSNTVAGSY 882 (1058)
Q Consensus 819 ~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~----------------~~~~~~~~~~~~gt~ 882 (1058)
+++|++||+|+|+. |||||||||.||++++++.|||+|||+|+... .+......+..+||.
T Consensus 703 FreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTa 779 (1351)
T KOG1035|consen 703 FREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTA 779 (1351)
T ss_pred HHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccccccee
Confidence 99999999999999 99999999999999999999999999998621 011122456778999
Q ss_pred CccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHH
Q 043053 883 GYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQA 959 (1058)
Q Consensus 883 ~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 959 (1058)
-|+|||++.+.. |+.|+|+||+|||++||+. ||.... .-+..+..-+ ++.++....-..+++...
T Consensus 780 lYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM----ERa~iL~~LR-----~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 780 LYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM----ERASILTNLR-----KGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred eeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH----HHHHHHHhcc-----cCCCCCCcccccccchHH
Confidence 999999877654 9999999999999999996 565331 1111111111 112211111122334444
Q ss_pred HHHHHhccCCCCCCCCCHHHHHH
Q 043053 960 LGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 960 ~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
..+++++++.||.+||||.|++.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhh
Confidence 56899999999999999999885
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=308.97 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=192.9
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEc
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWN 782 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 782 (1058)
.|...+.||+|+||.||++ ...+++.||+|.+.... .......+.+|+.++.++. ||||+++++++..
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV----------DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc----------ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 4556789999999999999 55678999999885331 1234567899999999997 9999999999999
Q ss_pred CCCceEEEEecCCCChhhhh---hhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 783 RNNRLLMYDYMPNGSLGSLL---HERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+...+++|||+.. ++.++. .......+++..+..++.|+++|++|||+. .+|+||||||+||+++.++.++|+|
T Consensus 75 ~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 75 EGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred CCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEee
Confidence 8899999999864 665543 333346789999999999999999999973 2899999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
||+++...... ......|+..|+|||++.+. .++.++||||+||++|||++|+.||.... .......+..
T Consensus 152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~ 224 (288)
T cd06616 152 FGISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVV 224 (288)
T ss_pred cchhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhc
Confidence 99987654322 12234588999999998766 68899999999999999999999996432 1111111111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.. ..+........ .....+.+++.+||+++|++|||+++++++-
T Consensus 225 ~~--~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 225 KG--DPPILSNSEER--EFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CC--CCCcCCCcCCC--ccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 10 11111111100 0111344578899999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.56 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=194.5
Q ss_pred eccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEE
Q 043053 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMY 790 (1058)
Q Consensus 712 lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 790 (1058)
||+|+||.||+| ...+++.||+|++..... ......+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 72 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--------VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLM 72 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc--------hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEE
Confidence 699999999999 445689999999854321 12234578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCC
Q 043053 791 DYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870 (1058)
Q Consensus 791 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~ 870 (1058)
||+++++|.+++... ..+++..+..++.|+++|++|+|+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 73 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 73 EYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred ecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 999999999999763 4588999999999999999999998 99999999999999999999999999998765432
Q ss_pred cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCc
Q 043053 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE 950 (1058)
Q Consensus 871 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1058)
......|+..|+|||...+..++.++|+||+|+++|+|++|..||.....+.......+.... .........+
T Consensus 148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 220 (262)
T cd05572 148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN----GKLEFPNYID 220 (262)
T ss_pred ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC----CCCCCCcccC
Confidence 223346889999999988888999999999999999999999999765422222211111100 0111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 043053 951 SEIDEMLQALGVALLCVNASPDERPT-----MKDVAAM 983 (1058)
Q Consensus 951 ~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~ 983 (1058)
. .+..++..||+.+|++||+ ++|++++
T Consensus 221 ---~---~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 221 ---K---AAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred ---H---HHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 1 3345788899999999999 7777663
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=289.07 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=198.0
Q ss_pred ccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCC
Q 043053 708 DANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 708 ~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 785 (1058)
....||.|+||+|+|- ....|+..|||+|+.. ..+...+++..|.+...+- ++||||++||+...++.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~----------n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSN----------NIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeec----------cchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 3568999999999998 6778999999999754 2345567888888775555 59999999999999999
Q ss_pred ceEEEEecCCCChhhhhh---hcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 786 RLLMYDYMPNGSLGSLLH---ERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.|+.||.|+- ++..+.+ ..+...+++...-.|+.-...||.||-+.. .||||||||+|||++..|.+||||||+
T Consensus 138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccc
Confidence 9999999954 7665543 334567889988899999999999998874 899999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
+-...+. ...+..+|-..|||||.+.. ..|.-++||||+|++|||+.||..||..-. .+ .++......
T Consensus 215 cGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~----sv---feql~~Vv~ 284 (361)
T KOG1006|consen 215 CGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD----SV---FEQLCQVVI 284 (361)
T ss_pred hHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH----HH---HHHHHHHHc
Confidence 8765432 22345568889999998763 347889999999999999999999997432 22 222222333
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+|+.......+......+..++..|+.+|-..||.++++.++
T Consensus 285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 4555554444444444455567888999999999999998864
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=305.24 Aligned_cols=262 Identities=21% Similarity=0.359 Sum_probs=196.5
Q ss_pred hccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|+..+.||+|++|.||+|. ..+|+.||||++.... .....+.+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 70 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA----------EEGTPSTAIREISLMKELKHENIVRLHDVIHTE 70 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc----------cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC
Confidence 47788999999999999994 4578999999885331 122346678899999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERT-GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+..++||||+++ +|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||+
T Consensus 71 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~ 146 (284)
T cd07836 71 NKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGL 146 (284)
T ss_pred CcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecch
Confidence 999999999985 8999887543 34689999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh------
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK------ 935 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~------ 935 (1058)
+....... .......++..|+|||++.+ ..++.++||||+||++|+|++|+.||...... .......+..
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~ 223 (284)
T cd07836 147 ARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTES 223 (284)
T ss_pred hhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChh
Confidence 87554321 12234457889999998765 35688999999999999999999999754321 1111111110
Q ss_pred -----cCccccCCCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 -----KGIQVLDPSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 -----~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.................... ...+.+++..|++.||++||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00001111111111111111 1234468889999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=312.98 Aligned_cols=206 Identities=25% Similarity=0.353 Sum_probs=169.4
Q ss_pred hccccceeccccceEEEEEEe-c--CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 705 CLVDANVIGKGCSGVVYRADM-D--NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~-~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
+|.+.+.||+|+||.||+|.. . +++.||+|.+..... ......+.+.+|+.++++++||||+++++++.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--------QYTGISQSACREIALLRELKHENVVSLVEVFL 72 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--------cccCccHHHHHHHHHHHhcCCCCccceEEEEe
Confidence 477888999999999999954 3 589999999864311 12233467789999999999999999999999
Q ss_pred cC--CCceEEEEecCCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC----C
Q 043053 782 NR--NNRLLMYDYMPNGSLGSLLHERT---GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL----E 852 (1058)
Q Consensus 782 ~~--~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~----~ 852 (1058)
+. ...++||||+++ ++.+++.... ...+++..++.++.|++.|++|||+. +|+||||||+||+++. +
T Consensus 73 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 73 EHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPER 148 (316)
T ss_pred CCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCcc
Confidence 87 778999999975 7777775422 23688999999999999999999999 9999999999999999 8
Q ss_pred CCeeeeccccceeccCCCc-ccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 043053 853 FEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTI 922 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~ 922 (1058)
+.+||+|||+++....... ........++..|+|||+..+. .++.++|||||||++|+|++|+.||....
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9999999999886543221 1223345688999999987654 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=306.11 Aligned_cols=264 Identities=24% Similarity=0.307 Sum_probs=194.8
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|++|+||+| +..+|+.||+|++.... ......+.+.+|++++++++||||+++++++.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ---------EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc---------ccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 46888999999999999999 44578999999874331 122345678899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC-CCCeeeeccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-EFEPYIADFG 861 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~DfG 861 (1058)
....|+||||++ +++.+++........++..+..++.||+.||+|||+. +++||||||+||+++. ++.+||+|||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 999999999996 5888888765445578889999999999999999999 9999999999999985 4579999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc--Cc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK--GI 938 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~ 938 (1058)
++....... .......+++.|+|||++.+. .++.++||||+||++|+|++|+.||....+. ........... ..
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~ 225 (294)
T PLN00009 149 LARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNE 225 (294)
T ss_pred cccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCh
Confidence 997654321 222344678899999987654 5788999999999999999999999754221 11111111000 00
Q ss_pred cccC---------CCCCCCCchhH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 QVLD---------PSLLSRPESEI-----DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 ~~~~---------~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.... ........... .....+.+++.+|++.+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00000000000 001123457888999999999999999874
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=307.60 Aligned_cols=263 Identities=20% Similarity=0.275 Sum_probs=192.6
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEc
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWN 782 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 782 (1058)
+|...+.||+|+||.||+| ...+++.||||++.... ........+.+|+.++++++ ||||+++++++..
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~---------~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 72 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM---------DEEGIPPTALREISLLQMLSESIYIVRLLDVEHV 72 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc---------cccCCchHHHHHHHHHHHccCCCCccceeeeEee
Confidence 5788899999999999999 45679999999874331 12233467888999999995 6999999999887
Q ss_pred CCC-----ceEEEEecCCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC-CC
Q 043053 783 RNN-----RLLMYDYMPNGSLGSLLHERT---GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-EF 853 (1058)
Q Consensus 783 ~~~-----~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-~~ 853 (1058)
.+. .|+||||+++ +|.+++.... ...+++..++.++.||++||+|||+. +|+||||||+||+++. ++
T Consensus 73 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 73 EEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred cCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCC
Confidence 655 7999999986 8999886532 24689999999999999999999999 9999999999999998 88
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
.+||+|||+++...... .......+++.|+|||+..+ ..++.++||||||+++|+|++|..||....+. .......
T Consensus 149 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~ 225 (295)
T cd07837 149 LLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-QQLLHIF 225 (295)
T ss_pred eEEEeecccceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHH
Confidence 99999999987653321 12223457889999998765 45789999999999999999999999754221 1111111
Q ss_pred HhhcC-ccccCCC---------CCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 933 RQKKG-IQVLDPS---------LLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 933 ~~~~~-~~~~~~~---------~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..... .....+. .....+.... -...+.+++.+||++||++||++++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 10000 0000000 0000000000 11234568889999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=306.51 Aligned_cols=254 Identities=29% Similarity=0.431 Sum_probs=196.7
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|...+.||+|+||.||+|. ..++..||+|++.... .........+.+|++++++++|||++++++++.+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--------KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC--------CCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 447778899999999999994 5578999999874321 1222345678999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||++| ++.+++... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||+
T Consensus 97 ~~~~~lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 97 EHTAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred CCeEEEEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 9999999999975 888877643 45689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
+..... .....|++.|+|||++. ...++.++|||||||++|||++|+.||...... .....+.....
T Consensus 172 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~--- 241 (317)
T cd06635 172 ASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNES--- 241 (317)
T ss_pred ccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccC---
Confidence 875432 22446889999999864 456788999999999999999999998653211 11111111100
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
+.. ....... .+.+++.+||+.+|.+||++.+++++.....
T Consensus 242 ---~~~---~~~~~~~--~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 ---PTL---QSNEWSD--YFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---CCC---CCccccH--HHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 0111111 2345788899999999999999998765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=306.70 Aligned_cols=203 Identities=29% Similarity=0.352 Sum_probs=171.2
Q ss_pred HhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|+..+.||+|+||.||+|.. .+++.+|+|.+.... ..+.....+.+|++++++++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 74 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---------EKEGFPITSLREINILLKLQHPNIVTVKEVVV 74 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecc---------ccccchhhHHHHHHHHHhcCCCCEEEEEEEEE
Confidence 35788899999999999999944 568999999985332 12233456788999999999999999999988
Q ss_pred cC--CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 782 NR--NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 782 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
.. ...|+||||+++ +|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|
T Consensus 75 ~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d 149 (293)
T cd07843 75 GSNLDKIYMVMEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICD 149 (293)
T ss_pred ecCCCcEEEEehhcCc-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEee
Confidence 77 788999999975 999998764 34689999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
||++....... .......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||...
T Consensus 150 ~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 150 FGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred cCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99998765432 222344578899999987654 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=307.11 Aligned_cols=264 Identities=18% Similarity=0.190 Sum_probs=193.0
Q ss_pred ccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCce
Q 043053 708 DANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 708 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
+.+.+|.|+++.||++.. +++.||||++.... ......+.+.+|++++++++||||+++++++.+.+..+
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~---------~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDS---------CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELY 75 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccc---------cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEE
Confidence 344455566665565544 69999999985321 22334678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
++|||+++|+|.+++.......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+....
T Consensus 76 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred EEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeec
Confidence 999999999999999876556789999999999999999999999 99999999999999999999999999887553
Q ss_pred CCCc-----ccccccccCcCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc--
Q 043053 868 DGDF-----ARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI-- 938 (1058)
Q Consensus 868 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-- 938 (1058)
.... ........++..|+|||++.+ ..++.++|||||||++|||++|+.||....+.. ...+........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 231 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLL 231 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCcccc
Confidence 3211 112234457889999998765 357889999999999999999999997542211 111111100000
Q ss_pred ------------c-----ccCCCCCCCCchh--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 939 ------------Q-----VLDPSLLSRPESE--IDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 939 ------------~-----~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
. ..++......... ..-...+.+++..||+.||++|||+++++++-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0 0000000000000 011123456889999999999999999998644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=301.15 Aligned_cols=257 Identities=23% Similarity=0.241 Sum_probs=190.3
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEcC
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNR 783 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 783 (1058)
|.+.+.||+|+||.||+| ...+++.||+|++.... .........+|+.++.++. ||||+++++++.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~----------~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 70 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----------KSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR 70 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc----------CCchhhhHHHHHHHHhhcCCCCCccceEEEEecC
Confidence 567789999999999999 55678999999875331 1111234457899999886 99999999999887
Q ss_pred --CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 784 --NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 784 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+..++||||++ |++.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||
T Consensus 71 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 71 KTGRLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred CCCcEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecc
Confidence 78899999997 4888888764 35789999999999999999999999 9999999999999999 999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc----
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK---- 936 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~---- 936 (1058)
+++...... ......++..|+|||+.. +..++.++||||+||++|||++|..||....+ .....+.....
T Consensus 145 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~ 219 (282)
T cd07831 145 SCRGIYSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPD 219 (282)
T ss_pred cccccccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCC
Confidence 998664332 122345789999999754 45578899999999999999999999965422 11111111100
Q ss_pred --------CccccCCCCCCCCchhH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 --------GIQVLDPSLLSRPESEI-----DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 --------~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
................+ .....+.+++.+||+++|++||++++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000000 112345568899999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=311.70 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=194.2
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| +..+|+.||||++... ........+.+|+.++++++||||+++++++.
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 73 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF----------EHQTFCQRTLREIKILRRFKHENIIGILDIIR 73 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc----------ccchhHHHHHHHHHHHHhCCCCCcCchhheee
Confidence 367899999999999999999 5667999999988432 12234567889999999999999999999876
Q ss_pred cCC-----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 782 NRN-----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 782 ~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
... ..++||||+++ ++.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 74 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~k 146 (336)
T cd07849 74 PPSFESFNDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLK 146 (336)
T ss_pred cccccccceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEE
Confidence 543 46899999965 88888764 4689999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCc-ccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHh
Q 043053 857 IADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1058)
|+|||++........ ........|+..|+|||++.+ ..++.++||||+||++|+|++|+.||..... ......+..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~ 224 (336)
T cd07849 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILG 224 (336)
T ss_pred ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH
Confidence 999999986543221 112234568999999998654 5678899999999999999999999964321 111110100
Q ss_pred hcCc---ccc-----------CCCCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 935 KKGI---QVL-----------DPSLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 935 ~~~~---~~~-----------~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.... +.. ............. ....+.+++.+||+.||++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 000 0000000000000 11234568899999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=308.06 Aligned_cols=200 Identities=25% Similarity=0.286 Sum_probs=163.9
Q ss_pred ceeccc--cceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCc
Q 043053 710 NVIGKG--CSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR 786 (1058)
Q Consensus 710 ~~lG~G--~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 786 (1058)
..||+| +||+||+| +..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN---------CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc---------CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 356666 99999999 55689999999875321 1223457899999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceec
Q 043053 787 LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV 866 (1058)
Q Consensus 787 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~ 866 (1058)
++||||+.+|++.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+...
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 9999999999999999875455689999999999999999999998 9999999999999999999999999865432
Q ss_pred cCCCcc-----cccccccCcCCccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 867 DDGDFA-----RSSNTVAGSYGYIAPEYGYMM--KITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 867 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
...... .......++..|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 211100 011122356679999998763 4788999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=299.24 Aligned_cols=246 Identities=21% Similarity=0.242 Sum_probs=185.9
Q ss_pred eeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHH---HHHHcccCCCcccceeeEEEcCCCc
Q 043053 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAE---IKTLGSIRHKNIVRFLGCCWNRNNR 786 (1058)
Q Consensus 711 ~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~ 786 (1058)
+||+|+||.||+| ...+++.||+|.+...... .......+..| +..++...||+|+++++++.+++..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--------MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 72 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccc--------cchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEE
Confidence 4899999999999 5567899999988543211 11111223333 3445556799999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceec
Q 043053 787 LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV 866 (1058)
Q Consensus 787 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~ 866 (1058)
++||||++||+|.+++.. ...+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 73 ~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 73 SFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 999999999999998875 35789999999999999999999998 9999999999999999999999999998755
Q ss_pred cCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCC
Q 043053 867 DDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSL 945 (1058)
Q Consensus 867 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 945 (1058)
... ......|+..|+|||+..+. .++.++||||+||++|||++|+.||............ .... ...+..
T Consensus 148 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--~~~~---~~~~~~ 218 (278)
T cd05606 148 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTL---TMAVEL 218 (278)
T ss_pred Ccc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH--HHhh---ccCCCC
Confidence 432 12245689999999998744 6889999999999999999999999765322211111 1111 111222
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 043053 946 LSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAML 984 (1058)
Q Consensus 946 ~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l 984 (1058)
....+. .+.+++.+|+..+|.+|| ++.+++++-
T Consensus 219 ~~~~s~------~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 219 PDSFSP------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred CCcCCH------HHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 222222 334567789999999999 999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=301.65 Aligned_cols=248 Identities=21% Similarity=0.329 Sum_probs=199.1
Q ss_pred cceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCce
Q 043053 709 ANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
.++||+|.||+||-| +.++|+.||||+|.+..+.. ....+++.|+.+++.++||.||.+...|+..+..+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~---------kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT---------KQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC---------chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 589999999999999 77899999999997665432 22478899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC---CCeeeeccccce
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE---FEPYIADFGLAK 864 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~---~~~kl~DfGl~~ 864 (1058)
+|||-+. |+..+.|-....+.+++....-++.||+.||.|||.+ +|||+|+||+|||+... -.+||||||.|+
T Consensus 640 VVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 640 VVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 9999994 5877777766678899999999999999999999999 99999999999999654 379999999999
Q ss_pred eccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1058)
.+.+..+. ..++|||.|+|||+++...|...-|+||+||++|.-++|..||.... +..+.++.. .-...+.
T Consensus 716 iIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----dIndQIQNA--aFMyPp~ 786 (888)
T KOG4236|consen 716 IIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----DINDQIQNA--AFMYPPN 786 (888)
T ss_pred ecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----chhHHhhcc--ccccCCC
Confidence 99876543 36789999999999999999999999999999999999999997542 222222221 1122233
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 945 LLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 945 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.+...+. .++++|...++..-.+|-+.++.+.+.
T Consensus 787 PW~eis~------~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 787 PWSEISP------EAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred chhhcCH------HHHHHHHHHHHHHHHHhcchHhhccch
Confidence 3332222 234455556777778888887766543
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=296.27 Aligned_cols=246 Identities=20% Similarity=0.271 Sum_probs=187.9
Q ss_pred HHHhhcccccee--ccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 701 QVLKCLVDANVI--GKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 701 ~~~~~~~~~~~l--G~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
+..+.|.+.+.+ |+|+||.||++ ...+++.+|+|.+..... .. .|+.....+ +||||+++
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--------------~~--~e~~~~~~~~~h~~iv~~ 74 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF--------------NA--IEPMVHQLMKDNPNFIKL 74 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc--------------ch--hhHHHHHHhhcCCCEEEE
Confidence 344566676666 99999999999 556788999998743211 00 122222222 69999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-Ce
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-EP 855 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-~~ 855 (1058)
++++..++..++||||+++|+|.+++... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++ .+
T Consensus 75 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~ 149 (267)
T PHA03390 75 YYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRI 149 (267)
T ss_pred EEEEecCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeE
Confidence 99999999999999999999999999864 4789999999999999999999999 999999999999999998 99
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
+|+|||+++..... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||............+....
T Consensus 150 ~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 223 (267)
T PHA03390 150 YLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ 223 (267)
T ss_pred EEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh
Confidence 99999998765432 234588999999999988899999999999999999999999985433322222222221
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT-MKDVAAM 983 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~~v~~~ 983 (1058)
. .........+. .+.+++..||+++|.+||+ +++++++
T Consensus 224 ~----~~~~~~~~~~~------~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 Q----KKLPFIKNVSK------NANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred c----ccCCcccccCH------HHHHHHHHHhccChhhCCchHHHHhcC
Confidence 1 01111111122 2345677899999999996 6888754
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=300.79 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=200.2
Q ss_pred HHhhccccceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
..+.|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++.+++++|+||+++++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 84 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK------------QNKELIINEILIMKDCKHPNIVDYYDSY 84 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCc------------hhHHHHHHHHHHHHHCCCCCeeEEEEEE
Confidence 3456778889999999999999544 78999999884321 1457789999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
..+...|+||||+++++|.+++.... ..+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~ 160 (286)
T cd06614 85 LVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADF 160 (286)
T ss_pred EECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECcc
Confidence 99999999999999999999998743 4799999999999999999999998 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|.+....... .......++..|+|||+..+..++.++|||||||++|+|++|+.||....+. ..... ... ...
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~-~~~-~~~-- 233 (286)
T cd06614 161 GFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFL-ITT-KGI-- 233 (286)
T ss_pred chhhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHh-cCC--
Confidence 9986554322 1223345788999999998888999999999999999999999999743221 11111 111 000
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+.... +..... .+..++.+||+.+|.+||++.+++++.
T Consensus 234 --~~~~~-~~~~~~---~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 234 --PPLKN-PEKWSP---EFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred --CCCcc-hhhCCH---HHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 11110 100111 234578889999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=294.65 Aligned_cols=254 Identities=30% Similarity=0.421 Sum_probs=202.1
Q ss_pred hccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|++|.||+|.. .+++.|++|++.... ......+.+.+|++++++++||||+++++++...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG---------DSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 367789999999999999954 479999999985432 1134568899999999999999999999999988
Q ss_pred --CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 784 --NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 784 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
...++||||+++++|.+++... ..+++..++.++.|+++|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~ 146 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFG 146 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccc
Confidence 7889999999999999999864 3889999999999999999999998 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
.+................++..|+|||...+...+.++||||||+++|+|++|..||..... .......... ...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~--~~~ 221 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYKIGS--SGE 221 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHhccc--cCC
Confidence 99877654321123345688999999999888899999999999999999999999975431 1111111110 001
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+......+ ..+.+++.+|++.+|++||++.+++.+
T Consensus 222 ~~~~~~~~~------~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLS------EEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccC------HHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111111111 223447788999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=310.03 Aligned_cols=266 Identities=24% Similarity=0.329 Sum_probs=195.2
Q ss_pred HHHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceee
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLG 778 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 778 (1058)
.+.++|.+.+.||+|+||.||+|. ..+++.||||++.... ........+.+|+.+++++ +||||+++++
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~---------~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~ 74 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF---------RNATDAQRTFREIMFLQELGDHPNIVKLLN 74 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc---------CcchhhhhhhHHHHHHHHhcCCCCccceee
Confidence 456789999999999999999994 4578999999885321 1222345677899999999 9999999999
Q ss_pred EEEcCC--CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 779 CCWNRN--NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 779 ~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
++...+ ..|+||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~k 147 (337)
T cd07852 75 VIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVK 147 (337)
T ss_pred eeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEE
Confidence 986543 5799999997 4999988752 688999999999999999999998 999999999999999999999
Q ss_pred eeccccceeccCCCcc---cccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 857 IADFGLAKLVDDGDFA---RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
|+|||++......... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....+. .......
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-~~~~~~~ 226 (337)
T cd07852 148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-NQLEKII 226 (337)
T ss_pred EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence 9999999866443221 22334568999999998754 45788999999999999999999999643221 1110000
Q ss_pred Hhhc--------------CccccC---CCCCCCCchhHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 933 RQKK--------------GIQVLD---PSLLSRPESEID-EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 933 ~~~~--------------~~~~~~---~~~~~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.... ....+. ............ ....+.+++.+||+.||++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 000000 000000000000 01234558889999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=304.83 Aligned_cols=264 Identities=25% Similarity=0.322 Sum_probs=196.5
Q ss_pred HHHHhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
+...+.|++.+.||+|+||.||+|.. .+|+.||||++.... ........+.+|++++++++||||+++++
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~~~e~~~~~~l~h~~i~~~~~ 73 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN---------EKEGFPITAIREIKILRQLNHRNIVNLKE 73 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecc---------cccCchHHHHHHHHHHHhCCCCCeeeeeh
Confidence 34567899999999999999999954 568999999885331 12233467788999999999999999999
Q ss_pred EEEcCC----------CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEE
Q 043053 779 CCWNRN----------NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 779 ~~~~~~----------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nil 848 (1058)
++.+.. ..++||||+++ ++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nil 148 (302)
T cd07864 74 IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNIL 148 (302)
T ss_pred eecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 987654 67999999976 777777654 35689999999999999999999999 9999999999999
Q ss_pred EcCCCCeeeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChh
Q 043053 849 IGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSH 927 (1058)
Q Consensus 849 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 927 (1058)
+++++.+||+|||++........ .......++..|+|||+..+ ..++.++||||+||++|||++|+.||..... ...
T Consensus 149 i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~ 226 (302)
T cd07864 149 LNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQ 226 (302)
T ss_pred ECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHH
Confidence 99999999999999986644321 12223456788999998764 4568899999999999999999999975321 111
Q ss_pred HHHHHHhhcCccc--cCCCCC-------------------CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 928 VVDWVRQKKGIQV--LDPSLL-------------------SRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 928 ~~~~~~~~~~~~~--~~~~~~-------------------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+.. +........ .-+... ...... ...+.+++..||+.||++||++.+++.+
T Consensus 227 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 227 LEL-ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI---PTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHH-HHHHhCCCChhhcccccccccccccccccccccchhhhcCCC---CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 111110000 000000 000000 1234568888999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=325.48 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=206.7
Q ss_pred hccccceeccccceEEEEEEec--------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccc
Q 043053 705 CLVDANVIGKGCSGVVYRADMD--------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVR 775 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~ 775 (1058)
+..+.+.+|+|+||.||+|... ....||||.+... ......+.+..|+++|+.+. |+||+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~----------~~~~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKEN----------ASSSEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccc----------cCcHHHHHHHHHHHHHHHhcCCcchhh
Confidence 3355669999999999999432 1456999988544 22355789999999999995 999999
Q ss_pred eeeEEEcCCCceEEEEecCCCChhhhhhhcC------C--------CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCC
Q 043053 776 FLGCCWNRNNRLLMYDYMPNGSLGSLLHERT------G--------NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRD 841 (1058)
Q Consensus 776 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrD 841 (1058)
++|++..++..++|+||++.|+|.++++..+ . ..+.....+.++.|||.|++||++. ++||||
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRD 443 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRD 443 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchh
Confidence 9999999899999999999999999998754 0 2388899999999999999999999 999999
Q ss_pred CCCCcEEEcCCCCeeeeccccceeccCCCcccccccc-cCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 043053 842 IKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTV-AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 919 (1058)
Q Consensus 842 ikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 919 (1058)
+.++|||++++..+||+|||+|+.....++....... .-...|||||.+....++.++|||||||++||+++ |..||.
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999977665544322111 12456999999999999999999999999999999 889987
Q ss_pred CCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 920 PTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
+. +....+.++++.... ...|..+.+++ +.+|+.||+.+|++||++.++++.++...
T Consensus 524 ~~-~~~~~l~~~l~~G~r--------~~~P~~c~~ei---Y~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 524 GI-PPTEELLEFLKEGNR--------MEQPEHCSDEI---YDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CC-CcHHHHHHHHhcCCC--------CCCCCCCCHHH---HHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 53 223333444443322 22333333444 45889999999999999999999998853
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=299.93 Aligned_cols=260 Identities=23% Similarity=0.330 Sum_probs=194.6
Q ss_pred ccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEcC
Q 043053 706 LVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNR 783 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 783 (1058)
|.+.+.||+|+||+||+|.. .+++.||||++.... .........+|+..+++++ ||||+++++++.++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 70 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----------YSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN 70 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhc----------cchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC
Confidence 56788999999999999955 468899999875331 1112234567999999999 99999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+ +|+|.+++.......+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 71 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 71 DELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred CcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccc
Confidence 9999999999 78999999875445789999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH------------
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD------------ 930 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~------------ 930 (1058)
....... ......++..|+|||+.. ...++.++|+||||+++|||++|+.||....... .+..
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 222 (283)
T cd07830 147 REIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQD 222 (283)
T ss_pred eeccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhh
Confidence 8665432 223456888999999875 4457889999999999999999999996542211 1100
Q ss_pred HHHhhcCccccCCCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
|.......................+ ...+.+++.+||+.+|++|||+.|++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 1000000000111111111111111 1235568999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=295.14 Aligned_cols=255 Identities=27% Similarity=0.361 Sum_probs=194.5
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|.+.+.||+|+||.||+| +..+++.||+|.+..... ..........+.+|++++++++||||+++++++.+.
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 76 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD------SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP 76 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcc------cchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence 5788999999999999999 556799999998732210 012233457889999999999999999999998764
Q ss_pred --CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 784 --NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 784 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
...++||||+++++|.+++... ..+++..+.+++.|++.|++|||+. +++||||||+||+++.++.++|+|||
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 151 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccc
Confidence 3478999999999999999763 4588999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 862 LAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 862 l~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
+++....... ........|+..|+|||+..+..++.++|||||||++|||++|+.||..... ... +.+.. ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~-~~~~~-~~~ 225 (264)
T cd06653 152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAA-IFKIA-TQP 225 (264)
T ss_pred cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHH-HHHHH-cCC
Confidence 9986533111 0112245688999999999888889999999999999999999999974321 111 11111 111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..+........ .+.+++.+||. +|.+||++.+++.+
T Consensus 226 ~~~~~p~~~~~------~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 TKPMLPDGVSD------ACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCCCcccCH------HHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11222221122 23346777998 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=300.92 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=193.5
Q ss_pred cceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCce
Q 043053 709 ANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
..+||+|+||.||+|. ..+++.||||++... .....+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----------KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 93 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----------chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEE
Confidence 3689999999999994 467899999987321 2234577899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+....
T Consensus 94 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 94 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167 (292)
T ss_pred EEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence 99999999999998854 4578999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
... .......|+..|+|||+..+..++.++|+||+|+++|+|++|..||..... ............. .... ..
T Consensus 168 ~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~--~~~~-~~ 240 (292)
T cd06657 168 KEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP--KLKN-LH 240 (292)
T ss_pred ccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCc--ccCC-cc
Confidence 322 122345688999999998888889999999999999999999999974321 1222222111100 0000 01
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..+. .+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~------~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSP------SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCH------HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1111 23346778999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=293.65 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=202.4
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||.|+||.||+| +..+++.||+|++.... ......+.+.+|++++++++|||++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN---------MSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc---------CChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 4778899999999999999 55578999999984331 2234567889999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+..++||||+++++|.++++... ...+++..+..++.++++|++|||+. +++||||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCcc
Confidence 99999999999999999998753 47799999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
.+....... .......|++.|+|||...+..++.++||||+|+++|+|++|+.||..... .......... .
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~----~- 219 (258)
T cd08215 149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--LELALKILKG----Q- 219 (258)
T ss_pred ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--HHHHHHHhcC----C-
Confidence 998765533 122345688999999998888899999999999999999999999965421 1111111111 0
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+......+. .+.+++.+||..+|++|||+.+++++
T Consensus 220 ~~~~~~~~~~------~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSS------ELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCH------HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111222 23447788999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=299.22 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=195.2
Q ss_pred ccccceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc---CCCcccceeeEEE
Q 043053 706 LVDANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI---RHKNIVRFLGCCW 781 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~ 781 (1058)
|.+.+.||+|+||.||+|... +++.||+|++.... ........+.+|+.+++++ .||||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPL---------SEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccc---------ccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 567889999999999999654 58999999985331 1222345666788777666 5999999999998
Q ss_pred cCCC-----ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 782 NRNN-----RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 782 ~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
..+. .+++|||+.+ +|.+++.......+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++
T Consensus 72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred eccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEE
Confidence 8776 8999999975 899998765445689999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|+|||.+....... ......++..|+|||+..+..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 148 l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~ 223 (287)
T cd07838 148 IADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIG 223 (287)
T ss_pred EeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcC
Confidence 99999998764432 122345788999999999888999999999999999999999999754321 12222221111
Q ss_pred Cc-------------cccCCCCCCCCchhH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 GI-------------QVLDPSLLSRPESEI-DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ~~-------------~~~~~~~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. ..........+.... .-.....+++.+||+.||++||++++++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 000000000011111 111334568899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=295.53 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=184.4
Q ss_pred ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHH-HcccCCCcccceeeEEEcCCCce
Q 043053 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT-LGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
+.||+|+||.||+| ...+|+.||||++..... ........+..|..+ ....+|+||+++++++..++..|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM--------IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLY 73 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh--------hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEE
Confidence 56899999999999 556789999998853321 111122334455544 44558999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceecc
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
+||||+++++|.++++.. ..+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||+++...
T Consensus 74 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 74 LVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999999999999763 5688999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCC
Q 043053 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947 (1058)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (1058)
. .....|+..|+|||...+..++.++||||+|+++|||++|..||..... ........... ....+....
T Consensus 149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~--~~~~~~~~~ 218 (260)
T cd05611 149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--DAVFDNILSRR--INWPEEVKE 218 (260)
T ss_pred c------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcc--cCCCCcccc
Confidence 3 2234588899999998888889999999999999999999999975422 11111111111 011111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 948 RPESEIDEMLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 948 ~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
..+. .+.+++.+||+.+|++||++.++.+
T Consensus 219 ~~~~------~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 219 FCSP------EAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cCCH------HHHHHHHHHccCCHHHccCCCcHHH
Confidence 1111 2345788899999999997754444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=291.96 Aligned_cols=249 Identities=28% Similarity=0.423 Sum_probs=199.6
Q ss_pred ccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
|...+.||+|++|.||+|.. .+++.+++|++.... ....+.+.+|++++++++||+|+++++++....
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 70 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES-----------KEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD 70 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc-----------hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 67788999999999999954 478999999985331 134678999999999999999999999999999
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++++||+++++|.+++.... ..+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||.+.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccc
Confidence 9999999999999999997642 5789999999999999999999998 99999999999999999999999999988
Q ss_pred eccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1058)
....... .....|+..|+|||+..+..++.++||||||+++|+|++|+.||....+. ........ .. .+.
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-~~----~~~ 216 (253)
T cd05122 147 QLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIAT-NG----PPG 216 (253)
T ss_pred ccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh-cC----CCC
Confidence 7654321 33556889999999998888899999999999999999999999754221 11111111 10 111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 945 LLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 945 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..... ... ..+.+++..||+.||++|||+.+++++
T Consensus 217 ~~~~~-~~~---~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 217 LRNPE-KWS---DEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCccc-ccC---HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111 001 123447788999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=296.56 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=200.7
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|++.+.||+|+||.||++ +..+++.+|+|++.... .......++.+|++++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS---------MSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh---------ccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 4778899999999999999 55678999999885332 1223456788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
...++||||+++++|.+++.... ...+++..++.++.|+++|++|||+. +++||||+|+||+++.++.+|++|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeecc
Confidence 99999999999999999987632 35689999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++...... ......|+..|+|||...+..++.++|+||+|+++|||++|+.||..... ......+... ..
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~----~~ 218 (256)
T cd08530 149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRYKVQRG----KY 218 (256)
T ss_pred chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcC----CC
Confidence 99876543 22234588999999999988899999999999999999999999975422 1121111111 01
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+... .. ....+.+++.+||+.+|++||++.+++++
T Consensus 219 -~~~~---~~---~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 -PPIP---PI---YSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CCCc---hh---hCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111 11 11224557888999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=308.76 Aligned_cols=267 Identities=23% Similarity=0.284 Sum_probs=197.0
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+| +..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 75 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTLRELKILRHFKHDNIIAIRDILRP 75 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc---------ccccchHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence 67888999999999999999 55679999999885321 122345677889999999999999999998763
Q ss_pred ----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 783 ----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 783 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
....++||||+. |+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 ~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 76 PGADFKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred cCCCCceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEec
Confidence 345699999995 5999998753 5589999999999999999999998 99999999999999999999999
Q ss_pred ccccceeccCCCcc--cccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 859 DFGLAKLVDDGDFA--RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 859 DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
|||++......... .......|+..|+|||++.+ ..++.++||||+||++|||++|+.||...... ... ..+...
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~-~~~~~~ 227 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQL-KLILSV 227 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHH-HHHHHH
Confidence 99999765432211 11234568899999998765 45789999999999999999999999654221 011 100000
Q ss_pred cCc---cc-----------cCCCCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 936 KGI---QV-----------LDPSLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 936 ~~~---~~-----------~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
.+. .. .............. ....+.+++..||+.+|++||++++++.+...-
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 000 00 00000000000000 112345688899999999999999999865443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=299.36 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=192.6
Q ss_pred hhccccceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 781 (1058)
+.|.+.+.||+|+||.||+|... +++.||||.+... .......++.+|+.++.+.. ||||+++++++.
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~----------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT----------GNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEecc----------CChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 56788999999999999999654 5899999998532 12223456677887776665 999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+....|+||||+. +++.+++... ...+++..+..++.|+++|++|||+. .+|+||||+|+||+++.++.+||+|||
T Consensus 85 ~~~~~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 85 TDSDVFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred cCCeEEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccc
Confidence 9999999999985 4787777653 35789999999999999999999973 189999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK----ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
++....... ......++..|+|||++.+.. ++.++||||||+++|||++|+.||...... ...........
T Consensus 161 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~- 235 (296)
T cd06618 161 ISGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEE- 235 (296)
T ss_pred cchhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcCC-
Confidence 987654322 122345788999999887553 788999999999999999999999643211 11111111111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
.+.... ...... .+.+++.+||+.||++||++.+++++...
T Consensus 236 ----~~~~~~-~~~~~~---~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 236 ----PPSLPP-NEGFSP---DFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred ----CCCCCC-CCCCCH---HHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 011110 000111 23457888999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=280.15 Aligned_cols=207 Identities=27% Similarity=0.366 Sum_probs=173.1
Q ss_pred HHHhhccccceeccccceEEEEEE-ecC----CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccc
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRAD-MDN----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVR 775 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 775 (1058)
+...+|+....||+|.||.||+|. .++ ...+|+|++.... +.........+|+..++.++||||+.
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~k---------d~tGiS~SAcREiaL~REl~h~nvi~ 91 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEK---------DGTGISMSACREIALLRELKHPNVIS 91 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccC---------CCCCcCHHHHHHHHHHHHhcCCcchh
Confidence 345679999999999999999993 222 2368999985331 23344567789999999999999999
Q ss_pred eeeEEEc-CCCceEEEEecCCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC
Q 043053 776 FLGCCWN-RNNRLLMYDYMPNGSLGSLLHERT---GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL 851 (1058)
Q Consensus 776 ~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~ 851 (1058)
+..++.. +...++++||.+. +|...|+-++ ...++...+..|+.||+.|+.|||++ =|+|||+||.|||+..
T Consensus 92 Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmg 167 (438)
T KOG0666|consen 92 LVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMG 167 (438)
T ss_pred HHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEec
Confidence 9999987 6778999999988 9999997532 46789999999999999999999998 7889999999999988
Q ss_pred C----CCeeeeccccceeccCCCcc-cccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 043053 852 E----FEPYIADFGLAKLVDDGDFA-RSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDP 920 (1058)
Q Consensus 852 ~----~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~ 920 (1058)
+ |+|||+|||+++.+.+.-.. ...+.++-|..|.|||.+.+. .|+++.||||.||++.||++-.+-|..
T Consensus 168 dgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 168 DGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 8 89999999999988764322 245667789999999987765 589999999999999999998887754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=281.21 Aligned_cols=265 Identities=21% Similarity=0.301 Sum_probs=215.6
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
.++....++-+|.||.||+|-+ .+.+.|.||.+... ..+-....+..|.-.+..+.|||+.++.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~----------AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH----------ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc----------ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 3566677899999999999933 33455777776422 2334467888999999999999999999
Q ss_pred eEEEcC-CCceEEEEecCCCChhhhhhhc------CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc
Q 043053 778 GCCWNR-NNRLLMYDYMPNGSLGSLLHER------TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG 850 (1058)
Q Consensus 778 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~ 850 (1058)
+++.++ +..++++.+..-|+|..|++.- ....+...+...++.|++.|++|||++ ++||.||.++|++||
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 998764 5568999999999999999821 134567778888999999999999999 999999999999999
Q ss_pred CCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHH
Q 043053 851 LEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVV 929 (1058)
Q Consensus 851 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 929 (1058)
+..+|||+|-.+++...+.++....+..-.+..||+||.+....|+.++|||||||++|||+| |+.||..-.| ..+.
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--fEm~ 508 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--FEME 508 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--HHHH
Confidence 999999999999999999998888888888999999999999999999999999999999999 9999976533 3333
Q ss_pred HHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 043053 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEY 994 (1058)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~~ 994 (1058)
.+++.. .....|..+.+++.. +|..||..+|++||+++|++..|.++..+...|
T Consensus 509 ~ylkdG--------yRlaQP~NCPDeLf~---vMacCWallpeeRPsf~Qlv~cLseF~~qlt~Y 562 (563)
T KOG1024|consen 509 HYLKDG--------YRLAQPFNCPDELFT---VMACCWALLPEERPSFSQLVICLSEFHTQLTRY 562 (563)
T ss_pred HHHhcc--------ceecCCCCCcHHHHH---HHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhc
Confidence 333332 223344555566655 788899999999999999999999887665443
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=291.25 Aligned_cols=249 Identities=30% Similarity=0.471 Sum_probs=200.0
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|...+.||+|++|.||+| +..+++.||+|.+.... ..+...+.+.+|++++++++|||++++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---------IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc---------cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 4678899999999999999 55578899999985432 1224567899999999999999999999999998
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 8999999999999999999764 6789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
........ ......++..|+|||...+..++.++||||+|+++|+|++|+.||....+ ......... ...+
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~---~~~~ 217 (254)
T cd06627 147 TKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQ---DDHP 217 (254)
T ss_pred eecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc---cCCC
Confidence 87655332 12345688999999998877788999999999999999999999975421 111111111 1111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
......+. .+..++.+||..+|++|||+.+++.
T Consensus 218 ~~~~~~~~------~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISP------ELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCH------HHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12222222 2234778899999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=300.80 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=200.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 781 (1058)
++|...+.||+|+||.||+| ...+++.||+|++..... ......+.+.+|++++++++ ||||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 72 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL--------IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ 72 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc--------cchHHHHHHHHHHHHHHhcccCCCchhHHHHhc
Confidence 36888899999999999999 455799999998854321 12233577889999999999 999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
..+..++||||+++++|.+++... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 73 DEENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred CCceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCc
Confidence 999999999999999999999863 4799999999999999999999998 99999999999999999999999999
Q ss_pred cceeccCCCcc------------------cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 043053 862 LAKLVDDGDFA------------------RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 923 (1058)
Q Consensus 862 l~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 923 (1058)
++......... .......|+..|+|||+..+..++.++||||+|+++|++++|+.||....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~- 226 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN- 226 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-
Confidence 98765443211 22234567899999999888888999999999999999999999997542
Q ss_pred CChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH----HHHHHH
Q 043053 924 DGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM----KDVAAM 983 (1058)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~----~~v~~~ 983 (1058)
......... . .........+. ...+++..||+.+|++||++ .+++++
T Consensus 227 -~~~~~~~~~---~---~~~~~~~~~~~------~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 227 -EYLTFQKIL---K---LEYSFPPNFPP------DAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -HHHHHHHHH---h---cCCCCCCccCH------HHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 111111111 0 01111111111 23457888999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=299.86 Aligned_cols=261 Identities=25% Similarity=0.313 Sum_probs=196.3
Q ss_pred ccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC-
Q 043053 706 LVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR- 783 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 783 (1058)
|.+.+.||+|+||.||+|.. .+++.+|+|++.... ........+.+|++++++++|||++++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 56778999999999999954 468999999985431 1233456788999999999999999999999887
Q ss_pred -CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 784 -NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 784 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+..++||||+++ +|.+++... ...+++..++.++.|+++|++|||+. +++|+||||+||++++++.++++|||.
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~ 146 (287)
T cd07840 72 KGSIYMVFEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGL 146 (287)
T ss_pred CCcEEEEeccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccc
Confidence 788999999975 899988764 25789999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc-
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV- 940 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~- 940 (1058)
+........ .......++..|+|||...+ ..++.++||||||+++|||++|+.||..... ......+........
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~~~~~~~~ 223 (287)
T cd07840 147 ARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFELCGSPTD 223 (287)
T ss_pred eeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCch
Confidence 987655321 12234457889999997664 4578999999999999999999999975432 111111111000000
Q ss_pred -cCCC-----------CCCCCch----hHHH--HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 941 -LDPS-----------LLSRPES----EIDE--MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 941 -~~~~-----------~~~~~~~----~~~~--~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..+. ....... .... ...+.+++..||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 0000000 0111 2345678999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=308.01 Aligned_cols=259 Identities=22% Similarity=0.274 Sum_probs=194.7
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||+||+| +..+++.||||.+.... ........+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF---------DNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc---------cccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 457889999999999999999 56679999999885321 12223456778999999999999999999886
Q ss_pred cC-----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 782 NR-----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 782 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
.. ...|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 75 PPHREAFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred cccccccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEE
Confidence 54 24699999996 689998875 35689999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
|+|||+++...... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..........
T Consensus 149 L~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~ 224 (337)
T cd07858 149 ICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITEL 224 (337)
T ss_pred ECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHH
Confidence 99999998664432 12234567889999998764 4688999999999999999999999964321 1000000000
Q ss_pred c---------------Cc-------cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 K---------------GI-------QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 ~---------------~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. .. ...++......+. ....+.+++.+||+.+|++|||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPH---ANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHccc---CCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 00 0000000000001 11234568899999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-33 Score=279.25 Aligned_cols=259 Identities=22% Similarity=0.282 Sum_probs=195.8
Q ss_pred cceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEcCCCc
Q 043053 709 ANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNRNNR 786 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 786 (1058)
.+.||+|+||.|..+ ...+|..+|||++.+. ....+.++.+|++++.+.+ |+||++++++|.++...
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-----------~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-----------PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC-----------CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 368999999999999 8889999999998432 2345788999999999997 99999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC---Ceeeeccccc
Q 043053 787 LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF---EPYIADFGLA 863 (1058)
Q Consensus 787 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~---~~kl~DfGl~ 863 (1058)
|+|||-+.||+|...|+++ ..+++..+.++.++|+.||.|||.+ ||.|||+||+|||-.... -||||||.+.
T Consensus 152 YLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred EEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccc
Confidence 9999999999999999874 6799999999999999999999999 999999999999997665 4799999986
Q ss_pred eeccCC-----CcccccccccCcCCccCcccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC-----ChhH
Q 043053 864 KLVDDG-----DFARSSNTVAGSYGYIAPEYG-----YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD-----GSHV 928 (1058)
Q Consensus 864 ~~~~~~-----~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~-----~~~~ 928 (1058)
.-.... .......+.+|+..|||||+. ....|+.++|.||+|||+|-|++|..||.+.-.. ....
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 533211 112233467799999999963 2346788999999999999999999999754221 1111
Q ss_pred HHHHHhhcCccccCCCCCCCCchhHHHH-HHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 929 VDWVRQKKGIQVLDPSLLSRPESEIDEM-LQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
...- +....+.+.......|+.+...+ -.+.+++...+..|+..|-++.+++.+-
T Consensus 307 Cr~C-Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 307 CRVC-QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred cHHH-HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 1100 11111111222223333332222 1234466777889999999999988743
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=300.12 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=195.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|...+.||+|+||.||+| ...+++.||+|.+.... ........++.+|+++++.++|+|++++++++..
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 86 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--------KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc--------ccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence 45777889999999999999 45578899999874321 1122334678899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||+. |++.+++... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++++|||+
T Consensus 87 ~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 87 EHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred CCeeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccc
Confidence 999999999996 5888877653 35689999999999999999999998 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
+...... ....|+..|+|||++. ...++.++|||||||++|+|++|+.||...... ..........
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~--- 230 (308)
T cd06634 162 ASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNE--- 230 (308)
T ss_pred ceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHhhcC---
Confidence 8765432 2346888999999864 345788999999999999999999998643211 1111111100
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
.+... ..... ..+..++.+||+.+|++||++.+++.+.....
T Consensus 231 --~~~~~---~~~~~--~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 231 --SPALQ---SGHWS--EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred --CCCcC---ccccc--HHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 01110 11111 12345788899999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=298.67 Aligned_cols=261 Identities=28% Similarity=0.369 Sum_probs=197.3
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
|...+.||+|++|.||+| ...+++.+|+|++.... ........+.+|++++++++|+||+++++++..+.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---------ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc---------ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 566789999999999999 44578999999885331 12234578889999999999999999999999999
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||+++ ++.+++... ...+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|||.+.
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 99999999975 898888764 36789999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc-cccC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI-QVLD 942 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~ 942 (1058)
...... .......++..|+|||...+. .++.++||||+|+++|+|++|+.||..... .............. ....
T Consensus 147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd05118 147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPDPEVW 223 (283)
T ss_pred ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCchHhc
Confidence 765533 122334578899999988776 788999999999999999999999964321 11111111100000 0000
Q ss_pred C-----------CCCCCCchhH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 P-----------SLLSRPESEI-----DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~-----------~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+ .......... .-..++.+++..||++||.+||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 0000000000 112345568999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=296.48 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=192.7
Q ss_pred eccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEE
Q 043053 712 IGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMY 790 (1058)
Q Consensus 712 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 790 (1058)
||+|+||.||+|.. .+|+.||+|.+..... ......+.+.+|++++++++||||+++++.+..+...|+||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 72 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--------IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVM 72 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh--------hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEE
Confidence 68999999999955 4699999998854321 12244678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCC
Q 043053 791 DYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870 (1058)
Q Consensus 791 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~ 870 (1058)
||+++++|.++++.. ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 73 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 73 EYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 999999999999864 4789999999999999999999998 99999999999999999999999999987543321
Q ss_pred c------ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCC
Q 043053 871 F------ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944 (1058)
Q Consensus 871 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1058)
. ........++..|+|||+..+..++.++||||||+++|++++|..||....+ ......... .. ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~---~~-~~-- 219 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--EEIFQNILN---GK-IE-- 219 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhc---CC-cC--
Confidence 1 1122345688899999998888889999999999999999999999975432 111111111 01 11
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 945 LLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 945 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
...... ....+..++..||+.+|++|||+.++.+.+
T Consensus 220 ~~~~~~----~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 220 WPEDVE----VSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCcccc----CCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 111110 011234578889999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-33 Score=289.85 Aligned_cols=266 Identities=24% Similarity=0.360 Sum_probs=202.6
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+-++|-...+||+|||++||+| +....+.||||+-.... .+..++++...+...+|.++.+.+.||.||++|+||
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK----~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNK----NWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhcc----chhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 4578888999999999999999 88889999999754332 222344556677889999999999999999999999
Q ss_pred E-cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC---CCCee
Q 043053 781 W-NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL---EFEPY 856 (1058)
Q Consensus 781 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~---~~~~k 856 (1058)
. +.+.++-|+|||+|.+|.-|++. ...+++..+..|+.||+.||.||.+.. ++|||-|+||.|||+-. -|.+|
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeE
Confidence 7 45677899999999999999987 467899999999999999999999874 59999999999999953 47899
Q ss_pred eeccccceeccCCCcc-----cccccccCcCCccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChh
Q 043053 857 IADFGLAKLVDDGDFA-----RSSNTVAGSYGYIAPEYGYMM----KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSH 927 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 927 (1058)
|+|||+++.++...+. ..+....||..|++||++.-. +.+.|.||||+||++|.++.|+.||........
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd- 692 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD- 692 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-
Confidence 9999999988765432 224456799999999976532 467899999999999999999999975432211
Q ss_pred HHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 928 VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
+.+.-......++--|. .+.... ++..+|++|++..-++|.+..++..
T Consensus 693 ILqeNTIlkAtEVqFP~-KPvVss------eAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPP-KPVVSS------EAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHhhhchhcceeccCCC-CCccCH------HHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11110000011111110 111111 2334788899999999988777654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=299.49 Aligned_cols=248 Identities=29% Similarity=0.409 Sum_probs=192.4
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...+.||+|+||+||+| ...+++.||+|++.... .......+.+.+|++++++++|||++++++++.+.
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 93 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG--------KQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE 93 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccc--------cCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 3666788999999999999 44578999999885331 11223346788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...|+||||+. |++.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 99999999996 5888887653 35689999999999999999999999 9999999999999999999999999998
Q ss_pred eeccCCCcccccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
..... .....|+..|+|||++. ...++.++|||||||++|||++|..||....+ ............
T Consensus 169 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~~--- 237 (313)
T cd06633 169 SKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNDS--- 237 (313)
T ss_pred cccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCC---
Confidence 64322 23456889999999874 45678899999999999999999999965422 111111111110
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
........+. .+.+++.+||+++|.+||++.+++.+
T Consensus 238 -~~~~~~~~~~------~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -PTLQSNEWTD------SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCCccccCH------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111111 23457888999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=297.45 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=194.2
Q ss_pred ccccceeccccceEEEEEEe----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 706 LVDANVIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
|++.+.||+|+||.||+|.. .+|+.||+|++..... .......+.+.+|+++++++ +|++|+++++++
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-------~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-------VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-------hhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 67789999999999999954 4689999999854321 12233457788999999999 499999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
..+...++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeC
Confidence 9888899999999999999999763 5688999999999999999999998 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM--KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
|++........ .......|+..|+|||+..+. .++.++||||||+++|+|++|+.||...... .....+.......
T Consensus 150 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~ 227 (290)
T cd05613 150 GLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKS 227 (290)
T ss_pred ccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhcc
Confidence 99986544321 122345688999999987653 4678999999999999999999999643221 1112222211111
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAM 983 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~ 983 (1058)
.+......+. .+..++.+||+.||++|| ++.++..+
T Consensus 228 ---~~~~~~~~~~------~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ---EPPYPQEMSA------LAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---CCCCCccCCH------HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1111111111 233477889999999997 66666554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=299.10 Aligned_cols=259 Identities=23% Similarity=0.267 Sum_probs=197.8
Q ss_pred ccccceeccccceEEEEEEe----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 706 LVDANVIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
|...+.||+|+||.||+|.. .+++.||||++..... .......+.+.+|++++.++ +||+|+++++++
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-------~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-------VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-------HhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 67789999999999999843 3578899998853321 12233456788999999999 599999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
..+...++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df 149 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDF 149 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEEC
Confidence 9988999999999999999998753 5688999999999999999999998 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK--ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
|+++....... .......|+..|+|||...+.. .+.++||||||+++|||++|..||....... ......+.....
T Consensus 150 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~ 227 (288)
T cd05583 150 GLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS 227 (288)
T ss_pred ccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc
Confidence 99876544321 1122345889999999877654 6789999999999999999999996432211 111111111111
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
.+......+. .+.+++.+||+.||++|||+.++.+.++..
T Consensus 228 ---~~~~~~~~~~------~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ---KPPFPKTMSA------EARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---CCCCCcccCH------HHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1111111111 234477889999999999998887776554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=304.26 Aligned_cols=266 Identities=26% Similarity=0.306 Sum_probs=193.0
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| ...+++.||||++.... ........+.+|++++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN---------EKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEecc---------CCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 478999999999999999999 55578999999885331 11222346678999999999999999999876
Q ss_pred cCC--------CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 782 NRN--------NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 782 ~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
+.. ..++||||+.+ ++.+.+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~ 152 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQG 152 (311)
T ss_pred cccccccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 543 35899999965 777777643 45799999999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcc---------cccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 043053 854 EPYIADFGLAKLVDDGDFA---------RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 923 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 923 (1058)
.++|+|||+++........ .......|++.|+|||+..+ ..++.++|||||||++|||++|+.||.....
T Consensus 153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999765432211 11233457889999998765 4578899999999999999999999975422
Q ss_pred CChhHHHHHHhhcC------------ccccCCCCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 924 DGSHVVDWVRQKKG------------IQVLDPSLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 924 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. ............ ....+.......+.... ....+.+++.+|++.||++|||+.+++.+
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 233 I-DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred H-HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1 111111110000 00000000000000000 01234568899999999999999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=307.98 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=205.5
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 781 (1058)
+.|++.++||+|.+|.||++ ..++|+.+|||+..+. +...+++..|.++++... |||++.+||+|.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~------------~d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT------------EDEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC------------ccccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 46788899999999999999 6678999999987543 333567788999998885 999999999986
Q ss_pred c-----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 782 N-----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 782 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
. ++..|+|||||.||+..|+++...+..+.|+.+..|++.++.|+++||.. .++|||||-.|||++.++.||
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 3 56789999999999999999987788999999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHH
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 931 (1058)
++|||.+...+..- ....+.+|||.|||||++... .|+.++|+||+|++..||.-|.+|+.+.+|...-
T Consensus 164 LvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL---- 237 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL---- 237 (953)
T ss_pred Eeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh----
Confidence 99999998776543 445678899999999987643 4677899999999999999999999877653211
Q ss_pred HHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
-.+..-.|.-..++.. +..++-++|..|+.+|.++||++.+++++
T Consensus 238 ----F~IpRNPPPkLkrp~k---Ws~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 ----FLIPRNPPPKLKRPKK---WSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----ccCCCCCCccccchhh---HHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111111112222333 33444558889999999999999988764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=318.52 Aligned_cols=258 Identities=24% Similarity=0.236 Sum_probs=200.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|.+.++||+|+||.|..+ ...+++.||+|++.+-.+. +.....-|..|-++|..-..+-|+++..+|.+
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl--------Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML--------KRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh--------hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 67899999999999999999 4567899999998653321 23446789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+.+.|+||||++||+|-.++.... .+++..+.-++..|.-||..+|+. |+|||||||+|||+|..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999998753 788888889999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc----c-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY----M-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+-.+...+. -.....+|||.|++||++. + +.|++.+|-||+||++|||+.|..||... .++.-+.....
T Consensus 222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~ 295 (1317)
T KOG0612|consen 222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMN 295 (1317)
T ss_pred HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhc
Confidence 876664332 3445678999999999854 3 57899999999999999999999999743 22222222111
Q ss_pred c-cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHHHhh
Q 043053 938 I-QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT---MKDVAAMLKEI 987 (1058)
Q Consensus 938 ~-~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt---~~~v~~~l~~~ 987 (1058)
. ..+.-+-....+.+..+++. . +--+|+.|.. +.++..+....
T Consensus 296 hk~~l~FP~~~~VSeeakdLI~------~-ll~~~e~RLgrngiedik~HpFF~ 342 (1317)
T KOG0612|consen 296 HKESLSFPDETDVSEEAKDLIE------A-LLCDREVRLGRNGIEDIKNHPFFE 342 (1317)
T ss_pred hhhhcCCCcccccCHHHHHHHH------H-HhcChhhhcccccHHHHHhCcccc
Confidence 1 01100001113333444443 2 2237888877 99998876443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=306.19 Aligned_cols=263 Identities=24% Similarity=0.315 Sum_probs=195.3
Q ss_pred HHHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 699 VEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 699 ~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
+..+.++|.+.+.||+|+||.||+| +..+|+.||||++.... ......+.+.+|++++++++||||++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 80 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---------QSELFAKRAYRELRLLKHMKHENVIGLL 80 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---------cchHHHHHHHHHHHHHHhcCCCCcccee
Confidence 3445578999999999999999999 56689999999874321 2233456788999999999999999999
Q ss_pred eEEEcCC------CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC
Q 043053 778 GCCWNRN------NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL 851 (1058)
Q Consensus 778 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~ 851 (1058)
+++.... .+++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~ 153 (343)
T cd07880 81 DVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNE 153 (343)
T ss_pred eeecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 9987543 348999999 7799988864 4689999999999999999999998 9999999999999999
Q ss_pred CCCeeeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH
Q 043053 852 EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 930 (1058)
++.++++|||++...... .....+++.|+|||++.+ ..++.++|+||+|+++|++++|+.||...... .....
T Consensus 154 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~ 227 (343)
T cd07880 154 DCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLME 227 (343)
T ss_pred CCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 999999999998765432 223457889999998765 45788999999999999999999999754211 11111
Q ss_pred HHHhhcC-c------------cccCCCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 931 WVRQKKG-I------------QVLDPSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 931 ~~~~~~~-~------------~~~~~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
....... . ......+.......... ...+.+++.+|++.||++|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0 00000000000000000 1124568889999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=304.55 Aligned_cols=262 Identities=25% Similarity=0.299 Sum_probs=197.5
Q ss_pred hccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||.||+|. ..+++.||||++.... ......+.+.+|+.++++++||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---------DDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc---------ccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 47788999999999999995 4568999999885331 1233457889999999999999999999998876
Q ss_pred C-----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 784 N-----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 784 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
. ..|+||||+++ +|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.++|+
T Consensus 72 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~ 145 (330)
T cd07834 72 SPEDFNDVYIVTELMET-DLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKIC 145 (330)
T ss_pred CcccccceEEEecchhh-hHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEc
Confidence 5 67999999974 899998753 4799999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCc-ccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 859 DFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 859 DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|||.+........ ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||...... .....+....
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~ 223 (330)
T cd07834 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVL 223 (330)
T ss_pred ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhc
Confidence 9999987655321 0122345678899999998877 7899999999999999999999999754221 1111111100
Q ss_pred Ccccc------C--------CCCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 GIQVL------D--------PSLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ~~~~~------~--------~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+.... . ............ ....+.+++.+||+++|++||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred CCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000 0 000000000000 01234558889999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=294.30 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=193.4
Q ss_pred hccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|.+.+.||+|+||.||+|.. ..+..+++|++...... +.......++.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVG------ELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccc------ccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence 477889999999999999944 44555666665332110 11223345677899999999999999999999988
Q ss_pred CCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
...++||||+++++|.+++... ....+++..++.++.|+++|++|||+. +++||||||+||+++. +.++++|||
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g 150 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFG 150 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccC
Confidence 8999999999999999998752 246789999999999999999999998 9999999999999975 579999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
.+....... .......|++.|+|||...+..++.++|+||||+++|+|++|..||.... ......... ...
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~--~~~ 221 (260)
T cd08222 151 VSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIV--EGP 221 (260)
T ss_pred ceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHH--cCC
Confidence 987664432 22234558889999999888888999999999999999999999996431 111111111 011
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+......+ . .+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~~~~~~---~---~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 TPSLPETYS---R---QLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCcchhc---H---HHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111111111 1 23457888999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=304.87 Aligned_cols=263 Identities=24% Similarity=0.289 Sum_probs=193.6
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
..+.++|...+.||+|+||.||+| +..+++.||+|++.... ......+.+.+|+.++++++||||+++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---------QSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc---------hhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 344578999999999999999999 56789999999885321 12223467889999999999999999999
Q ss_pred EEEcC------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 779 CCWNR------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 779 ~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
++... ...+++++++ +++|.++++. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED 156 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCC
Confidence 88643 2357888877 7899988864 3589999999999999999999999 99999999999999999
Q ss_pred CCeeeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHH
Q 043053 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 931 (1058)
+.+||+|||+++.... ......|+..|+|||+..+ ..++.++||||+||++|||++|+.||...... ......
T Consensus 157 ~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~ 230 (345)
T cd07877 157 CELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLI 230 (345)
T ss_pred CCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence 9999999999876432 2234568899999998765 46788999999999999999999999643211 111111
Q ss_pred HHhhc-CccccCCCC------------CCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 932 VRQKK-GIQVLDPSL------------LSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 932 ~~~~~-~~~~~~~~~------------~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
..... ......+.. ...+..... ....+.+++..|++.||.+||++.+++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 11000 000000000 000000000 011234688899999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=305.47 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=189.9
Q ss_pred HhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
..+|...+.||+|+||.||+|. ..+|+.||||++.... ..+.....+.+|++++++++||||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---------QSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc---------ccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 3678889999999999999994 5679999999885331 12233467889999999999999999999987
Q ss_pred cCC------CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 782 NRN------NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 782 ~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
... .+++||||+.. ++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred ccccCCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 543 35899999964 7776652 4588999999999999999999999 99999999999999999999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1058)
+|+|||+++.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+......
T Consensus 157 kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~ 230 (342)
T cd07879 157 KILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKV 230 (342)
T ss_pred EEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh
Confidence 9999999875432 1224467889999998766 46788999999999999999999999754211 111110000
Q ss_pred hc--------------CccccCCCCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 935 KK--------------GIQVLDPSLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 935 ~~--------------~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. ...... .....+..... ....+.+++.+||+.||++||++++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 231 TGVPGPEFVQKLEDKAAKSYIK-SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred cCCCCHHHHHHhcccchHHHHh-hcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000 00000000000 01124468889999999999999999965
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=324.62 Aligned_cols=149 Identities=30% Similarity=0.416 Sum_probs=132.3
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
+++|.+.+.||+|+||.||+| +..+++.||||++..... ........+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM--------INKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc--------cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 467899999999999999999 555789999999854321 22334578899999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
.....|+||||++|++|.++++.. ..+++..++.|+.||+.||+|||.. +||||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 999999999999999999999763 5688999999999999999999998 99999999999999999999999999
Q ss_pred cce
Q 043053 862 LAK 864 (1058)
Q Consensus 862 l~~ 864 (1058)
+++
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=250.27 Aligned_cols=199 Identities=27% Similarity=0.420 Sum_probs=174.5
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...++||+|.||+||+| .+.+++.||+|+++.. ++++.+.....+|+-+++.++|+|||++++....+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrld---------dddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLD---------DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEecc---------CCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 4566789999999999999 6678999999998654 45677788899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
....+|+|||.. +|..|...- .+.++.+.+..++.|+++|+.|+|++ ++.|||+||+|.+|+.+|+.|++|||++
T Consensus 74 kkltlvfe~cdq-dlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 74 KKLTLVFEFCDQ-DLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred ceeEEeHHHhhH-HHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence 999999999955 999988764 57889999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPID 919 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~ 919 (1058)
+.++-.. +.....+-|..|.+|.++.+.+ |+...|+||-||++.|+.....|..
T Consensus 149 rafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 149 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred hhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 9775432 3445667899999999988765 7889999999999999998555543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=303.09 Aligned_cols=273 Identities=22% Similarity=0.223 Sum_probs=194.4
Q ss_pred hhcc-ccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCC---CCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLV-DANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGC---SDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~-~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|. ..+.||+|+||+||+| +..+++.||||++........... ..........+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 4578999999999999 556799999999854322110000 0000011235789999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++..++..++||||++ |+|.+++.. ...+++.....++.|++.|++|||+. +|+||||||+||+++.++.++++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999997 599999875 35689999999999999999999998 99999999999999999999999
Q ss_pred ccccceeccCCCc------------ccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043053 859 DFGLAKLVDDGDF------------ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG 925 (1058)
Q Consensus 859 DfGl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 925 (1058)
|||.++....... ........++..|+|||++.+. .++.++||||+||++|||++|+.||....+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 9999986652110 0112233468899999988764 4688999999999999999999999754321
Q ss_pred hhHHHHHHhhcCc--cc---------cCCCCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 926 SHVVDWVRQKKGI--QV---------LDPSLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 926 ~~~~~~~~~~~~~--~~---------~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
............. .. ..+..... +.... ....+.+++..||+.+|++||++++++.+-
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRK-PKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCC-cccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 1111111100000 00 00000000 00000 012345688899999999999999998753
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=298.67 Aligned_cols=259 Identities=25% Similarity=0.320 Sum_probs=193.8
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.++|...+.||+|+||.||+| +..+++.||||++.... ......+.+.+|++++++++||||+++++++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 78 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF---------STPVLAKRTYRELKLLKHLRHENIISLSDIF 78 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc---------cccchhHHHHHHHHHHHhcCCCCeeeEeeeE
Confidence 4578999999999999999999 56689999999875331 1223456788999999999999999999998
Q ss_pred Ec-CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 781 WN-RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 781 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
.. ....++||||+ +++|.++++. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|
T Consensus 79 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 79 ISPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred ecCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCc
Confidence 76 45678999998 5689988864 4578888899999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHh----
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ---- 934 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~---- 934 (1058)
||.+...... .....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||....+. .....+.+.
T Consensus 152 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~ 225 (328)
T cd07856 152 FGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTP 225 (328)
T ss_pred cccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence 9998754321 123457889999998765 56889999999999999999999999654221 011110000
Q ss_pred -------hc---CccccCCCCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 935 -------KK---GIQVLDPSLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 935 -------~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. ..... ............ ....+.+++.+||+.+|++||++++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 226 PDDVINTICSENTLRFV-QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CHHHHHhccchhhHHHH-hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000 000000000000 01234568888999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=303.84 Aligned_cols=260 Identities=24% Similarity=0.304 Sum_probs=194.0
Q ss_pred HHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.++|...+.||+|+||.||+|. ..+++.||||++.... ......+.+.+|+.++++++||||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---------QSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---------chhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 45678999999999999999994 4568999999875321 1222346678899999999999999999988
Q ss_pred EcCCC------ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC
Q 043053 781 WNRNN------RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE 854 (1058)
Q Consensus 781 ~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~ 854 (1058)
...+. .++|+||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCE 156 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCC
Confidence 76554 79999999 6699999875 4689999999999999999999998 9999999999999999999
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
++|+|||++...... .....++..|+|||...+ ..++.++||||+||++|||++|+.||...... ..+.....
T Consensus 157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~ 230 (343)
T cd07851 157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMN 230 (343)
T ss_pred EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Confidence 999999998765432 234467889999998765 46788999999999999999999999643221 11111111
Q ss_pred hhcC-ccccC------------CCCCCCCchhH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 934 QKKG-IQVLD------------PSLLSRPESEI-----DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 934 ~~~~-~~~~~------------~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.... ...+. ........... .....+.+++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 00000 00000000000 011245568899999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=301.56 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=189.5
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+|...+.||.|+||.||+| +..+|+.||+|++... .....+.+.+|++++++++||||+++++++..
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~-----------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~ 73 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT-----------DPQSVKHALREIKIIRRLDHDNIVKVYEVLGP 73 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC-----------CCchHHHHHHHHHHHHhcCCCcchhhHhhhcc
Confidence 67889999999999999999 5667999999987432 12345778899999999999999999987654
Q ss_pred C--------------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEE
Q 043053 783 R--------------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 783 ~--------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nil 848 (1058)
. ...++||||++ ++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nil 146 (342)
T cd07854 74 SGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVF 146 (342)
T ss_pred cccccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEE
Confidence 3 24689999997 589888864 4688999999999999999999998 9999999999999
Q ss_pred EcC-CCCeeeeccccceeccCCCcc-cccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043053 849 IGL-EFEPYIADFGLAKLVDDGDFA-RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG 925 (1058)
Q Consensus 849 l~~-~~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 925 (1058)
++. ++.++++|||.++........ .......|+..|+|||+..+ ..++.++|||||||++|+|++|+.||....+..
T Consensus 147 i~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 226 (342)
T cd07854 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226 (342)
T ss_pred EcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 985 457899999999765432111 11123457889999997654 567889999999999999999999997542211
Q ss_pred hhHHHHHHhhcCc-------------ccc--CCCCCCCCchhH--HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 926 SHVVDWVRQKKGI-------------QVL--DPSLLSRPESEI--DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 926 ~~~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~--~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
............ ... .......+.... .-...+.+++..||+.||++|||+.+++.+
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 227 -QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred -HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 111000000000 000 000000000000 001234568889999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=291.91 Aligned_cols=260 Identities=27% Similarity=0.370 Sum_probs=196.1
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
|...+.||+|+||.||+| ...+++.||+|++.... ......+.+..|++++++++|+||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---------EEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc---------ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 456788999999999999 44569999999985432 12334567889999999999999999999999999
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++||||++ ++|.+++.... ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||.++
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 9999999997 59999998642 5689999999999999999999999 99999999999999999999999999987
Q ss_pred eccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc-------
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK------- 936 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~------- 936 (1058)
...... .......++..|+|||+..+. .++.++||||||+++|||++|+.||...... .....+....
T Consensus 147 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 222 (282)
T cd07829 147 AFGIPL--RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQILGTPTEES 222 (282)
T ss_pred ccCCCc--cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHhCCCcHHH
Confidence 654432 122334567889999988766 7889999999999999999999999653211 1111110000
Q ss_pred -----CccccCCCCCCCCchhH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 -----GIQVLDPSLLSRPESEI-----DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 -----~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.....+........... .....+.+++..||..||++||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000000000 001235668899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-33 Score=270.13 Aligned_cols=274 Identities=23% Similarity=0.339 Sum_probs=204.7
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
+....|....+||+|.||+||+| ...+|+.||+|++... .+++.......+|+.++..++|+|++.++..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme---------neKeGfpitalreikiL~~lkHenv~nliEi 84 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME---------NEKEGFPITALREIKILQLLKHENVVNLIEI 84 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh---------ccccCCcHHHHHHHHHHHHhcchhHHHHHHH
Confidence 34466777889999999999999 5667888999987543 2456666778899999999999999999988
Q ss_pred EEc--------CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC
Q 043053 780 CWN--------RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL 851 (1058)
Q Consensus 780 ~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~ 851 (1058)
|.. ....|+||++|+. +|.-++... ...++..++.++..++..||.|+|+. .|+|||+||+||||+.
T Consensus 85 c~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~ 159 (376)
T KOG0669|consen 85 CRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITK 159 (376)
T ss_pred HhhccCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcC
Confidence 753 2346999999987 898888654 46789999999999999999999999 9999999999999999
Q ss_pred CCCeeeeccccceeccCCC--cccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhH
Q 043053 852 EFEPYIADFGLAKLVDDGD--FARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 928 (1058)
+|.+||+|||+++.+...+ .....+..+-|..|.+||.+.+ ..|+++.|||+-||++.||++|.+-+..... .+-
T Consensus 160 dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqq 237 (376)
T KOG0669|consen 160 DGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQ 237 (376)
T ss_pred CceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHH
Confidence 9999999999997664332 1222455667999999997664 5789999999999999999999988875432 122
Q ss_pred HHHHHhhcC---ccccC-------------CCCCCCCchhH-HHHH------HHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 929 VDWVRQKKG---IQVLD-------------PSLLSRPESEI-DEML------QALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 929 ~~~~~~~~~---~~~~~-------------~~~~~~~~~~~-~~~~------~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
...+.+..+ .+.+. +.+...-...+ +.+. .+++++..++..||.+|+++++++.+-.
T Consensus 238 l~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 238 LHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred HHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 222222111 00000 00000000001 1111 4567888899999999999999998766
Q ss_pred hhhhh
Q 043053 986 EIKHE 990 (1058)
Q Consensus 986 ~~~~~ 990 (1058)
..+..
T Consensus 318 F~kdp 322 (376)
T KOG0669|consen 318 FWKDP 322 (376)
T ss_pred hhcCC
Confidence 55443
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=283.85 Aligned_cols=239 Identities=26% Similarity=0.302 Sum_probs=190.8
Q ss_pred eccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEE
Q 043053 712 IGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMY 790 (1058)
Q Consensus 712 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 790 (1058)
||+|+||.||++. ..+++.+|+|.+..... ......+.+..|++++++++||||+++++.+..+...++||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 72 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--------IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVL 72 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh--------cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEE
Confidence 6999999999994 44689999998854421 22234678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCC
Q 043053 791 DYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870 (1058)
Q Consensus 791 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~ 870 (1058)
||+++++|.+++... ..+++..+..++.|+++|+.|+|+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 73 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 73 EYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 999999999999764 4689999999999999999999998 99999999999999999999999999988765432
Q ss_pred cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCc
Q 043053 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE 950 (1058)
Q Consensus 871 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (1058)
.......++..|+|||...+...+.++|+||||+++|++++|..||.... .......+.. .........+
T Consensus 148 --~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~------~~~~~~~~~~ 217 (250)
T cd05123 148 --SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED--RKEIYEKILK------DPLRFPEFLS 217 (250)
T ss_pred --CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHhc------CCCCCCCCCC
Confidence 12345568889999999988888999999999999999999999996442 1222222111 1111111112
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 043053 951 SEIDEMLQALGVALLCVNASPDERPTMKD 979 (1058)
Q Consensus 951 ~~~~~~~~~~~l~~~cl~~dP~~RPt~~~ 979 (1058)
. ...+++..||..||++||++++
T Consensus 218 ~------~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 P------EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred H------HHHHHHHHHhcCCHhhCCCccc
Confidence 1 2234788899999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=291.00 Aligned_cols=210 Identities=28% Similarity=0.404 Sum_probs=179.8
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...+.||-|+||+|.++ +..+...+|.|.+++..+. ........+.|-++|+....+-||++|..|.+.
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl--------~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL--------MRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH--------hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 4777899999999999999 6666778999999766442 234467788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+.+|+||||++||++-++|-+ -+-+++..++-++..+..|+++.|.. |+|||||||+|||||.+|.+||+|||++
T Consensus 702 dnLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred CceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccc
Confidence 999999999999999998876 36788898888999999999999999 9999999999999999999999999998
Q ss_pred eec---------cCCCccc-------------------------------ccccccCcCCccCccccccCCCCcccchhh
Q 043053 864 KLV---------DDGDFAR-------------------------------SSNTVAGSYGYIAPEYGYMMKITEKSDVYS 903 (1058)
Q Consensus 864 ~~~---------~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 903 (1058)
+-+ .+++..+ .....+||+.|+|||++....++..+|-||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 422 1111000 012457999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCChh
Q 043053 904 YGVVVLEVLTGKQPIDPTIPDGSH 927 (1058)
Q Consensus 904 lGvvl~elltg~~P~~~~~~~~~~ 927 (1058)
.|||||||+.|+.||....|.+.+
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcce
Confidence 999999999999999888776543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=295.76 Aligned_cols=202 Identities=26% Similarity=0.330 Sum_probs=164.5
Q ss_pred hccccceeccccceEEEEEEe-cC--CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEE
Q 043053 705 CLVDANVIGKGCSGVVYRADM-DN--GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCC 780 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~-~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 780 (1058)
+|.+.+.||+|+||.||+|.. .+ +..||+|++.... ......+.+.+|++++++++ ||||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 71 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---------SKKILAKRALRELKLLRHFRGHKNITCLYDMD 71 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc---------ccchhHHHHHHHHHHHHHhcCCCChheeeeee
Confidence 477889999999999999944 34 7889999874321 12223567889999999995 99999999875
Q ss_pred EcC----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 781 WNR----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 781 ~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
... ...+++|||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++
T Consensus 72 ~~~~~~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 72 IVFPGNFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred eeccccCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEE
Confidence 432 34688899985 699999865 45789999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcc--cccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 857 IADFGLAKLVDDGDFA--RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
|+|||+++........ .......|+..|+|||+..+ ..++.++||||+||++|+|++|+.||...
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 9999999865432211 11234568999999998765 56889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=278.49 Aligned_cols=220 Identities=22% Similarity=0.207 Sum_probs=173.4
Q ss_pred ccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEEEec
Q 043053 715 GCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYM 793 (1058)
Q Consensus 715 G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 793 (1058)
|.+|.||+| +..+++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 67 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHA 67 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecC
Confidence 899999999 66789999999985331 2234555555567999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCccc
Q 043053 794 PNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFAR 873 (1058)
Q Consensus 794 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~ 873 (1058)
++|+|.+++... ..+++..+..++.|+++|++|+|+. +|+||||||+||+++.++.++++|||.+......
T Consensus 68 ~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---- 138 (237)
T cd05576 68 EGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---- 138 (237)
T ss_pred CCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----
Confidence 999999999764 4589999999999999999999998 9999999999999999999999999987655432
Q ss_pred ccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhH
Q 043053 874 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEI 953 (1058)
Q Consensus 874 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 953 (1058)
.....++..|+|||+..+..++.++||||+|+++|||++|+.|+....... ... . ........+
T Consensus 139 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~~~---~--~~~~~~~~~--- 202 (237)
T cd05576 139 -CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------NTH---T--TLNIPEWVS--- 202 (237)
T ss_pred -cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------ccc---c--ccCCcccCC---
Confidence 123446778999999888888999999999999999999998875321100 000 0 001111111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHH
Q 043053 954 DEMLQALGVALLCVNASPDERPTMK 978 (1058)
Q Consensus 954 ~~~~~~~~l~~~cl~~dP~~RPt~~ 978 (1058)
..+..++.+|++.||++||++.
T Consensus 203 ---~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 203 ---EEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred ---HHHHHHHHHHccCCHHHhcCCC
Confidence 1234578889999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=293.06 Aligned_cols=242 Identities=22% Similarity=0.259 Sum_probs=191.0
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 781 (1058)
+.|.....+|.|+|+.|-++ ...+++..+||++... ..+-.+|+.++... .||||+++.+.+.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---------------~~~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---------------ADDNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccc---------------ccccccccchhhhhcCCCcceeecceec
Confidence 55667777999999999998 7778899999998432 12335667666555 5999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE-cCCCCeeeecc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI-GLEFEPYIADF 860 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill-~~~~~~kl~Df 860 (1058)
+....|+|||++.||-+.+.+.... .....+..|+.+|+.|+.|||++ |+||||+||+|||+ +..+.++|+||
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence 9999999999999999888887632 22267778999999999999998 99999999999999 68899999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|.++..... ..+.+-|..|.|||+.....|++++|+||+|++||+|++|+.||... |.+..... ...
T Consensus 461 G~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~-P~~~ei~~----~i~--- 527 (612)
T KOG0603|consen 461 GFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH-PAGIEIHT----RIQ--- 527 (612)
T ss_pred chhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC-CchHHHHH----hhc---
Confidence 999876553 33456788999999999999999999999999999999999999754 33322211 111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
.+......+. .+.+++.+||+.||.+||+|+++..+-..
T Consensus 528 -~~~~s~~vS~------~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 -MPKFSECVSD------EAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -CCccccccCH------HHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1111112222 23457778999999999999999886544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=251.91 Aligned_cols=203 Identities=25% Similarity=0.415 Sum_probs=168.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 781 (1058)
+.......||+|++|.|-+. ...+|...|||.+... -..+..++..+|+.+..+. .+|.+|.+||.+.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t----------vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT----------VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh----------cChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 34455678999999999988 5668999999999644 2234567788888876665 5999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHE--RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
++...|+.||.|+- +|..+.++ ..+..+++...-+||..|.+||.|||++. .+||||+||+|||++.+|+||+||
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence 99999999999965 88887664 24678999999999999999999999984 899999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccc----cCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTI 922 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 922 (1058)
||.+-...+.- ..+...|-..|||||.+. ...|+-|+||||+|++++||.++++||+.-.
T Consensus 193 FGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 193 FGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 99998765532 122345778999999754 3468899999999999999999999997543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=276.38 Aligned_cols=259 Identities=20% Similarity=0.253 Sum_probs=203.4
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-C-C----cccc
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-H-K----NIVR 775 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~ 775 (1058)
..+|.+.+.+|+|.||.|-++ +..++..||||+++.. ...++...-|+++++++. + | -+|+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------------~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------------DKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------------HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 688999999999999999999 7777999999999533 234667788999999994 2 2 4788
Q ss_pred eeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC----
Q 043053 776 FLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL---- 851 (1058)
Q Consensus 776 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~---- 851 (1058)
+.+||...+..++|+|.+ |-++.++++.....+++..++..|+.|++++++|||+. +++|-|+||+||++.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 889999999999999998 66999999987778899999999999999999999999 9999999999999932
Q ss_pred ----------------CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 043053 852 ----------------EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 915 (1058)
Q Consensus 852 ----------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~ 915 (1058)
+..++|+|||.|+..... ....+.|..|.|||++.+-.++.++||||+||||+|+.+|.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 235899999999865442 24677899999999999999999999999999999999999
Q ss_pred CCCCCCCCCChhHHHHHHhhcC-----------------ccccC--C--------CCCCCCc-------hhHHHHHHHHH
Q 043053 916 QPIDPTIPDGSHVVDWVRQKKG-----------------IQVLD--P--------SLLSRPE-------SEIDEMLQALG 961 (1058)
Q Consensus 916 ~P~~~~~~~~~~~~~~~~~~~~-----------------~~~~~--~--------~~~~~~~-------~~~~~~~~~~~ 961 (1058)
.-|+... +..++ ..++...+ ...++ . .....+. ..-.+..++.+
T Consensus 307 ~LFqtHe-n~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 307 TLFQTHE-NLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred eecccCC-cHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 9987543 21222 11111000 00000 0 0000010 11134556788
Q ss_pred HHHhccCCCCCCCCCHHHHHHHH
Q 043053 962 VALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 962 l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+++.|+..||.+|+|+.|++.+-
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSHP 407 (415)
T ss_pred HHHHHHccCccccccHHHHhcCH
Confidence 99999999999999999998753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=284.71 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=203.6
Q ss_pred hhccccceeccccceEEEEEEecCCc-EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGE-VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
..+.....||-|+||.|-.+.....+ .+|+|.+.+.... +....+.+..|-.+|...+.|.||++|-.|.+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV--------dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV--------DTKQQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc--------chhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 45566778999999999999665433 4888888655432 33456788899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....|+.||-|-||.++..++.+ +.++..++.-++..+.+|++|||++ +||+||+||+|.+++.+|-+||.|||.
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhh
Confidence 99999999999999999999874 7889999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+.+..+ ..+.+++|||.|.|||++.+..++.++|.||+|+++||+++|.+||....|. ...+.+. ++.+.+.
T Consensus 567 AKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--ktYn~IL--kGid~i~ 639 (732)
T KOG0614|consen 567 AKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--KTYNLIL--KGIDKIE 639 (732)
T ss_pred HHHhccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--HHHHHHH--hhhhhhh
Confidence 9988775 4566889999999999999999999999999999999999999999866432 1111111 1222211
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHHh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAMLKE 986 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~l~~ 986 (1058)
- +.+.... +.++++..+..+|.+|.- +.+|.++-+.
T Consensus 640 ~--Pr~I~k~------a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 640 F--PRRITKT------ATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred c--ccccchh------HHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 1 1111111 233566667889999974 6677666544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=271.74 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=191.1
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 781 (1058)
..|.+..+||+|+||.|-.| +..+.+.+|||++++..+.... + .+--..|-++++-- +-|.++++..+|.
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD-----D---vectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD-----D---VECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecC-----c---ccceehhhhheecCCCCchHHHHHHHhh
Confidence 56888999999999999999 5556788999999776543221 1 12223455666655 4789999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
.-+..|+||||+.||+|--.+++ -+.+.+..+.-+|..||-||-+||++ |||+||+|.+|||++.+|.+||+|||
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecc
Confidence 99999999999999999888876 46788888899999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+++.---++ ..+.+++|||.|+|||.+.-.+|+.++|-|||||+||||+.|+.||++. ++..+.+.+.... ..
T Consensus 496 mcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~elF~aI~ehn---vs 568 (683)
T KOG0696|consen 496 MCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQAIMEHN---VS 568 (683)
T ss_pred cccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHcc---Cc
Confidence 997433222 4566889999999999999999999999999999999999999999875 3333333332221 11
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERP 975 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP 975 (1058)
-|.-. + . ++..++..-+.+.|.+|.
T Consensus 569 yPKsl---S---k---EAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 YPKSL---S---K---EAVAICKGLLTKHPGKRL 593 (683)
T ss_pred Ccccc---c---H---HHHHHHHHHhhcCCcccc
Confidence 12111 1 1 233456667889999995
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=298.30 Aligned_cols=247 Identities=29% Similarity=0.398 Sum_probs=189.0
Q ss_pred ccccceeccccce-EEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEcC
Q 043053 706 LVDANVIGKGCSG-VVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNR 783 (1058)
Q Consensus 706 ~~~~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 783 (1058)
|...+++|.|+.| .||+|... |+.||||++.... .+...+||+.++.-+ |||||++|+.-.++
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--------------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~ 575 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--------------FDFAQREIQLLQESDEHPNVIRYYCSEQDR 575 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--------------HHHHHHHHHHHHhccCCCceEEEEeeccCC
Confidence 3445789999998 46999887 8999999985432 456789999999885 99999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC---C--CCee
Q 043053 784 NNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL---E--FEPY 856 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~---~--~~~k 856 (1058)
...|+..|.|.. +|.|++... ..........+.+..|+++||+|||+. +|||||+||+||||+. + .+++
T Consensus 576 qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~ 651 (903)
T KOG1027|consen 576 QFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAK 651 (903)
T ss_pred ceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEE
Confidence 999999999955 999999863 111111134567889999999999998 9999999999999976 3 4789
Q ss_pred eeccccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCChhHHHHHHh
Q 043053 857 IADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG-KQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~ 934 (1058)
|+|||+++....+.. .....+..||.+|+|||++.....+.++||||+||++|+.++| .+||.....-+.. .+..
T Consensus 652 iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N---Il~~ 728 (903)
T KOG1027|consen 652 ISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN---ILTG 728 (903)
T ss_pred ecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh---hhcC
Confidence 999999998765432 2335667899999999999988888899999999999999995 9999754211111 1111
Q ss_pred hcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 935 KKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
......+.+ .. ++ .+.++|.+|++++|..||+|.+|+.+-
T Consensus 729 ~~~L~~L~~------~~--d~--eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 729 NYTLVHLEP------LP--DC--EAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred ccceeeecc------Cc--hH--HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 111111111 11 11 456688999999999999999998754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=305.61 Aligned_cols=260 Identities=19% Similarity=0.194 Sum_probs=166.4
Q ss_pred HhhccccceeccccceEEEEEEe-cC----CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM-DN----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
.++|...+.||+|+||.||+|.. .+ +..||||++.... ..+.+..| .+....+.+++.++
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-------------~~e~~~~e--~l~~~~~~~~~~~~ 195 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-------------AVEIWMNE--RVRRACPNSCADFV 195 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-------------hhHHHHHH--HHHhhchhhHHHHH
Confidence 46899999999999999999954 45 7899999874221 11111111 11122222332222
Q ss_pred eE------EEcCCCceEEEEecCCCChhhhhhhcCC------------------CCCCHHHHHHHHHHHHHHhhcccccC
Q 043053 778 GC------CWNRNNRLLMYDYMPNGSLGSLLHERTG------------------NALEWELRYQILLGAAQGLAYLHHDC 833 (1058)
Q Consensus 778 ~~------~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~i~~~l~~LH~~~ 833 (1058)
.. ...+...++||||+++++|.+++..... .......+..++.|++.||+|||+.
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~- 274 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST- 274 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-
Confidence 21 1345678999999999999999875321 1112344567999999999999998
Q ss_pred CCCeEeCCCCCCcEEEcC-CCCeeeeccccceeccCCCcccccccccCcCCccCccccccC-------------------
Q 043053 834 VPPIVHRDIKANNILIGL-EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM------------------- 893 (1058)
Q Consensus 834 ~~~ivHrDikp~Nill~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------- 893 (1058)
+|+||||||+|||++. ++.+||+|||+++....+.. .......|++.|+|||.+...
T Consensus 275 --gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l 351 (566)
T PLN03225 275 --GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 351 (566)
T ss_pred --CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchh
Confidence 9999999999999986 57999999999986543321 233456789999999964322
Q ss_pred ---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc-CccccCCCCCCCCchhHHH--------HHHHHH
Q 043053 894 ---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK-GIQVLDPSLLSRPESEIDE--------MLQALG 961 (1058)
Q Consensus 894 ---~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--------~~~~~~ 961 (1058)
.+..++||||+||++|||+++..|++.. ...+...+.... ....+..........+... .....+
T Consensus 352 ~~~~~~~k~DVwSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d 428 (566)
T PLN03225 352 WQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE 428 (566)
T ss_pred ccccCCCCcccHHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHH
Confidence 2344679999999999999987765421 001111111000 0000000000001111111 011235
Q ss_pred HHHhccCCCCCCCCCHHHHHHHH
Q 043053 962 VALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 962 l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
++.+|++.||++|||+++++++-
T Consensus 429 Li~~mL~~dP~kR~ta~e~L~Hp 451 (566)
T PLN03225 429 LLKSMMRFKGRQRISAKAALAHP 451 (566)
T ss_pred HHHHHccCCcccCCCHHHHhCCc
Confidence 88899999999999999999863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=250.99 Aligned_cols=256 Identities=19% Similarity=0.265 Sum_probs=193.9
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCccccee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFL 777 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 777 (1058)
-++.+.|.+.+.+|+|.||.+-.+ +..+.+.+++|.+..+ ....++|.+|...--.+. |.||+.-|
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p------------~tt~~dF~rEfhY~~~Ls~H~hIi~tY 87 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP------------QTTQADFVREFHYSFFLSPHQHIIDTY 87 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc------------hhhHHHHHHHhccceeeccchhhhHHH
Confidence 356688999999999999999999 5567788999988533 335789999998776675 99999988
Q ss_pred eE-EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc-C-CCC
Q 043053 778 GC-CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG-L-EFE 854 (1058)
Q Consensus 778 ~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~-~-~~~ 854 (1058)
+. |...+.++++|||++.|+|.+-+.. ..+.+....+++.|+++|+.|||++ ++||||||.+||||- . ..+
T Consensus 88 ~vaFqt~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~r 161 (378)
T KOG1345|consen 88 EVAFQTSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYR 161 (378)
T ss_pred HHHhhcCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccE
Confidence 75 4556778899999999999998864 4577888899999999999999999 999999999999994 3 348
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHH
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVV 929 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 929 (1058)
+||||||.++..+.. .....-+..|.|||..... ...+.+|||.||+++|.++||+.||+...-....++
T Consensus 162 vKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~ 236 (378)
T KOG1345|consen 162 VKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW 236 (378)
T ss_pred EEeeecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence 999999998765431 1122345689999964432 346789999999999999999999997766677777
Q ss_pred HHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+|..-.......-|.......+ +++.+.++-+.++|++|--..++.+..
T Consensus 237 ~~~~w~~rk~~~~P~~F~~fs~------~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 237 EWEQWLKRKNPALPKKFNPFSE------KALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred HHHHHhcccCccCchhhcccCH------HHHHHHHHhcCCcccccchhHHHHHHH
Confidence 7776554433333333322222 223345567899999995444444443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=277.35 Aligned_cols=204 Identities=22% Similarity=0.317 Sum_probs=177.1
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC---CCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR---HKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~ 779 (1058)
..|...+.+|.|+||.|+.| +.++...|+||.|.+...-...+.++.+- -.+..|+++|.+++ |+||++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkL---GtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKL---GTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhccccc---CccchhHHHHHHhhhcCccchhhhhhe
Confidence 45788899999999999999 55567789999998776554443333332 34568999999997 9999999999
Q ss_pred EEcCCCceEEEEec-CCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 780 CWNRNNRLLMYDYM-PNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
|++++.+|++||-. +|.+|.++|..+ ..+++..+..|++||+.|+++||+. ||||||||-+||.++.+|-+||+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence 99999999999985 566899999864 6789999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID 919 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltg~~P~~ 919 (1058)
|||.|....++. ...++||..|.|||++.+.+|- ..-||||+|++||.++....||.
T Consensus 713 dfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999998877654 4578999999999999999885 56899999999999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=286.56 Aligned_cols=270 Identities=19% Similarity=0.237 Sum_probs=178.2
Q ss_pred HhhccccceeccccceEEEEEEe-----------------cCCcEEEEEecCcccccccCCCCC---cccchHHHHHHHH
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM-----------------DNGEVIAVKKLWPTTMAAANGCSD---EKSGVRDSFSAEI 762 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~~---~~~~~~~~~~~E~ 762 (1058)
.++|.+.++||+|+||.||+|.. ..++.||||++............. ......+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 45799999999999999999943 245689999985321100000000 0011123445678
Q ss_pred HHHcccCCCcc-----cceeeEEEc--------CCCceEEEEecCCCChhhhhhhcC----------------------C
Q 043053 763 KTLGSIRHKNI-----VRFLGCCWN--------RNNRLLMYDYMPNGSLGSLLHERT----------------------G 807 (1058)
Q Consensus 763 ~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~----------------------~ 807 (1058)
.++.+++|.++ +++++++.. .+..|+||||+++|+|.++++... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 88888876554 677777753 345799999999999999987421 1
Q ss_pred CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCc
Q 043053 808 NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887 (1058)
Q Consensus 808 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aP 887 (1058)
...++..+..++.|+++||+|+|+. +|+||||||+||+++.++.+||+|||+++....+.. .......+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 2346788899999999999999998 999999999999999999999999999976543221 112223458899999
Q ss_pred cccccCCC----------------------CcccchhhHHHHHHHHHhCCC-CCCCCCCCC-------hhHHHHHHhhcC
Q 043053 888 EYGYMMKI----------------------TEKSDVYSYGVVVLEVLTGKQ-PIDPTIPDG-------SHVVDWVRQKKG 937 (1058)
Q Consensus 888 E~~~~~~~----------------------~~~~DvwSlGvvl~elltg~~-P~~~~~~~~-------~~~~~~~~~~~~ 937 (1058)
|.+..... ..+.||||+||++|+|++|.. ||....... .....|.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~- 458 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG- 458 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc-
Confidence 98653221 134799999999999999875 665321111 11112211111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASP---DERPTMKDVAAML 984 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP---~~RPt~~~v~~~l 984 (1058)
...+-........ ...+++.+++..+| .+|+|++|+++|-
T Consensus 459 -~~~~~~~~d~~s~------~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 459 -QKYDFSLLDRNKE------AGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred -cCCCcccccccCh------HHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 1111111111111 23346666787655 6899999998864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=253.20 Aligned_cols=203 Identities=22% Similarity=0.291 Sum_probs=174.7
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
.+.|...++||+|+|++|-.+ ..++.+.+|+|++.+.-+. +.+..+-.+.|-.+..+. +||.+|.+..+|
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~n--------ddedidwvqtek~vfe~asn~pflvglhscf 320 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVN--------DDEDIDWVQTEKHVFEQASNNPFLVGLHSCF 320 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcC--------CcccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence 367888999999999999999 4557889999998665431 222234456677777666 599999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
..+...++|.||++||+|--.+++ ...++++.+.-+...|+-||.|||++ |||+||+|.+|||+|..|.+|++|+
T Consensus 321 qtesrlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred cccceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeeccc
Confidence 999999999999999999877765 46789999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 920 (1058)
|+++.--.+ ...+.+++|||.|+|||.+.+..|....|-|++||+++||+.|+.||+-
T Consensus 396 gmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 396 GMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred chhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 998753222 2456789999999999999999999999999999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=262.33 Aligned_cols=239 Identities=28% Similarity=0.371 Sum_probs=189.3
Q ss_pred cceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEEEecC
Q 043053 716 CSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMP 794 (1058)
Q Consensus 716 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 794 (1058)
+||.||+|... +|+.+|+|++.... .....+.+.+|++.+++++|+||+++++++......++||||++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 70 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEK----------IKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCD 70 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccc----------cccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCC
Confidence 58999999554 58999999985331 11116899999999999999999999999999899999999999
Q ss_pred CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccc
Q 043053 795 NGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS 874 (1058)
Q Consensus 795 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~ 874 (1058)
+++|.+++... ..+++..++.++.++++|++|||+. +++|+||+|+||+++.++.++++|||.+....... .
T Consensus 71 ~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~ 142 (244)
T smart00220 71 GGDLFDLLKKR--GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---L 142 (244)
T ss_pred CCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---c
Confidence 99999999764 2389999999999999999999999 99999999999999999999999999998765532 2
Q ss_pred cccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHH
Q 043053 875 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEID 954 (1058)
Q Consensus 875 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 954 (1058)
.....++..|+|||...+..++.++||||+|+++|++++|..||.... +.....+........ ........+ .
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~---~ 215 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPP---FPPPEWKIS---P 215 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCC---CccccccCC---H
Confidence 345568889999999988888999999999999999999999997531 222222222211100 000000011 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 955 EMLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 955 ~~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
.+..++.+||..+|++||++.++++
T Consensus 216 ---~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 ---EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ---HHHHHHHHHccCCchhccCHHHHhh
Confidence 3345788899999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=254.67 Aligned_cols=199 Identities=28% Similarity=0.367 Sum_probs=169.0
Q ss_pred cccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC--
Q 043053 707 VDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR-- 783 (1058)
Q Consensus 707 ~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 783 (1058)
+..+.||-|+||.||.+ +-++|+.||.|++.... ..-...+.+.+|+.++..++|.|++..++...-.
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf---------q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF---------QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHH---------HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 34578999999999999 77789999999985332 2334568899999999999999999998876543
Q ss_pred ---CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 784 ---NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 784 ---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
...|+|+|.+.. +|..++-. ...++.+.+.-+..||++||.|||+. +|.||||||.|.|++.+..+|||||
T Consensus 127 dfFqEiYV~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 127 SFFQELYVLTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred hHHHHHHHHHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccc
Confidence 235889999966 88888876 46788888999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
|+++..+..+ ...++..+-|..|.|||.+++. .|+.+.||||+||++.|++.++.-|...
T Consensus 201 GLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 201 GLARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred ccccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 9999765543 3556677789999999998875 5889999999999999999999888754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=261.66 Aligned_cols=131 Identities=24% Similarity=0.359 Sum_probs=116.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-----C---Cccc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-----H---KNIV 774 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv 774 (1058)
.+|.+.++||-|.|++||+| +..+.+.||+|+.+ ..+...+....||.++++++ | .+||
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK------------SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK------------SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe------------hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 58999999999999999999 88899999999984 23445677889999999994 2 3799
Q ss_pred ceeeEEEc----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE
Q 043053 775 RFLGCCWN----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI 849 (1058)
Q Consensus 775 ~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill 849 (1058)
++++.|.. +.+.++|+|++ |.+|..+|.......++...+.+|++||+.||.|||+.| ||||-||||+|||+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 99999975 44569999999 779999999877888999999999999999999999996 99999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=239.02 Aligned_cols=257 Identities=23% Similarity=0.295 Sum_probs=197.4
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 780 (1058)
.+.|++.+++|+|-+++||.| ...+.++++||++.+. ..+.+.+|+.+++.++ ||||+++++..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--------------kkkKIkREikIL~nL~gg~NIi~L~DiV 102 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--------------KKKKIKREIKILQNLRGGPNIIKLLDIV 102 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--------------HHHHHHHHHHHHHhccCCCCeeehhhhh
Confidence 367888999999999999999 6778899999998654 2578899999999998 99999999999
Q ss_pred EcCC--CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-Ceee
Q 043053 781 WNRN--NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-EPYI 857 (1058)
Q Consensus 781 ~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl 857 (1058)
.++. ...+|+||+.+.+...+.. .++...+.....++++||.|+|+. ||+|||+||.|||||... .+++
T Consensus 103 ~Dp~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 103 KDPESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred cCccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeee
Confidence 8754 4579999999877766653 466677788999999999999999 999999999999999754 7999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
+|+|+|..+.++. .....+.+..|.-||.+.+- .|+..-|+|||||++..|+..+.||-......++++...+-..
T Consensus 175 IDWGLAEFYHp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 175 IDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG 251 (338)
T ss_pred eecchHhhcCCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence 9999999887653 23455677888999987654 5778899999999999999999999766555555544322111
Q ss_pred -----------CccccCCCCCC---C-----C----chhHHH--HHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 937 -----------GIQVLDPSLLS---R-----P----ESEIDE--MLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 937 -----------~~~~~~~~~~~---~-----~----~~~~~~--~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.. .++|.... + + ..+-.. ..++++++...+..|..+|||++|++++-.
T Consensus 252 t~el~~Yl~KY~i-~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hpy 324 (338)
T KOG0668|consen 252 TDELYAYLNKYQI-DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPY 324 (338)
T ss_pred hHHHHHHHHHHcc-CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCch
Confidence 11 12222111 0 0 000000 124566777789999999999999987643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=247.12 Aligned_cols=257 Identities=25% Similarity=0.302 Sum_probs=195.6
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
..+|.....+|.|+- .|-.| +.-.++.||+|+...+. ......++..+|...+..+.|+||++++.+|.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf---------~n~~~akra~rel~l~~~v~~~nii~l~n~ft 85 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF---------QNQTHAKRAYRELKLMKCVNHKNIISLLNVFT 85 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc---------ccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence 357888889999998 66666 77789999999885441 22334567789999999999999999999996
Q ss_pred cC------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 782 NR------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 782 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
-. ...|+|||++.. +|...+.. .++-.+...|..|++.|++|+|+. ||+|||+||+||++..++.+
T Consensus 86 P~~~l~~~~e~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~l 157 (369)
T KOG0665|consen 86 PQKTLEEFQEVYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTL 157 (369)
T ss_pred ccccHHHHHhHHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhhe
Confidence 43 345999999965 99988873 467788899999999999999999 99999999999999999999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||.|||+|+..... -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+. .+..+|.+..
T Consensus 158 Ki~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~ 230 (369)
T KOG0665|consen 158 KILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKII 230 (369)
T ss_pred eeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHH
Confidence 99999999865432 3556778899999999999888999999999999999999999888632 2222222111
Q ss_pred cCcccc--------------------------------CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 KGIQVL--------------------------------DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 ~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...... |.-+....+....+.-.+.+++.+||-.||++|.++++++.+
T Consensus 231 ~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 231 EQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 100000 000111111111112233457888999999999999999986
Q ss_pred H
Q 043053 984 L 984 (1058)
Q Consensus 984 l 984 (1058)
-
T Consensus 311 P 311 (369)
T KOG0665|consen 311 P 311 (369)
T ss_pred C
Confidence 4
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-28 Score=266.69 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=199.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|....++|.|.+|.|||| +..+++..|||++.... ....+-+++|+-+++..+|||||.++|.+..
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-----------~dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-----------GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccC-----------CccccccccceeeeecCCCcChHHHHhhhhh
Confidence 56778889999999999999 77789999999985432 2234567889999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..|++||||.||+|.|..+- -+++++.++..+.+...+|++|+|+. +=+|||||-.||++++.|.+|++|||.
T Consensus 84 ~dklwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred hcCcEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCc
Confidence 9999999999999999999876 47899999999999999999999999 889999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYG---YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
+-.+... ......+.||+.|||||+. ....|..++|||+.|++..|+-.-+.|.....|....+ . ....
T Consensus 159 saqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~---L---mTkS 230 (829)
T KOG0576|consen 159 SAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF---L---MTKS 230 (829)
T ss_pred hhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH---H---hhcc
Confidence 8765432 2334567899999999974 45678899999999999999998888865544422111 1 1112
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
.++|.-......... .+-++++.|+.++|++||++..++.
T Consensus 231 ~~qpp~lkDk~kws~---~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTLKDKTKWSE---FFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcccCCccchH---HHHHHHHHHhcCCCccCCChhhhee
Confidence 223322222222111 2233666799999999999987765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=240.08 Aligned_cols=211 Identities=33% Similarity=0.516 Sum_probs=180.0
Q ss_pred eccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEE
Q 043053 712 IGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMY 790 (1058)
Q Consensus 712 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 790 (1058)
||+|++|.||++... +++.+++|++..... ....+.+.+|++.++.++|++|+++++++......+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~ 70 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS----------SSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVM 70 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccc----------hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEE
Confidence 689999999999554 589999999854321 113578999999999999999999999999988999999
Q ss_pred EecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC-CCCeeeeccccceeccCC
Q 043053 791 DYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-EFEPYIADFGLAKLVDDG 869 (1058)
Q Consensus 791 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~DfGl~~~~~~~ 869 (1058)
||+++++|.+++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++++|||.+......
T Consensus 71 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 71 EYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred ecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 9999999999997642 4689999999999999999999999 9999999999999999 899999999999876543
Q ss_pred CcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCC
Q 043053 870 DFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948 (1058)
Q Consensus 870 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 948 (1058)
.. ......+...|++||..... .++.++|+|++|+++|+|
T Consensus 147 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------- 187 (215)
T cd00180 147 KS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------- 187 (215)
T ss_pred cc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------
Confidence 21 22345578899999998776 788899999999999999
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 949 ~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.....++..|++.+|++||+++++++.
T Consensus 188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 123447778999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=250.97 Aligned_cols=260 Identities=20% Similarity=0.234 Sum_probs=202.3
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC------CCccc
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR------HKNIV 774 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv 774 (1058)
+-.+|.+....|+|-|++|.+| +...|..||||+|+...+ ..+.=.+|+++|++|. --|++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~------------M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV------------MHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH------------HhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 3468999999999999999999 777789999999975433 3455578999999995 23899
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC-
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT-GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE- 852 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~- 852 (1058)
+++-.|....++|+|+|-+.. +|.++++... ...+....+..++.|+.-||..|-.. +|+|.||||+|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence 999999999999999999965 9999998643 45688889999999999999999998 99999999999999875
Q ss_pred CCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
..+||||||.|........ +.+.-+..|.|||++.+.+|+...|+||+||+|||+.||+.-|.+.+.. ++..+.
T Consensus 574 ~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN--~MLrl~ 647 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN--QMLRLF 647 (752)
T ss_pred ceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH--HHHHHH
Confidence 4789999999987665332 2334566899999999999999999999999999999999998765322 111111
Q ss_pred Hhhc---------------------------------------CccccCC------CCCC---CCchhHHHHHHHHHHHH
Q 043053 933 RQKK---------------------------------------GIQVLDP------SLLS---RPESEIDEMLQALGVAL 964 (1058)
Q Consensus 933 ~~~~---------------------------------------~~~~~~~------~~~~---~~~~~~~~~~~~~~l~~ 964 (1058)
-..+ ....+.| .+.. -+........++.++..
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 1000 0000111 0111 23334455566777889
Q ss_pred hccCCCCCCCCCHHHHHHH
Q 043053 965 LCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 965 ~cl~~dP~~RPt~~~v~~~ 983 (1058)
.|+..||++|.|..+++++
T Consensus 728 kml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHhccChhhcCCHHHHhcC
Confidence 9999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=237.23 Aligned_cols=200 Identities=33% Similarity=0.453 Sum_probs=171.4
Q ss_pred ccccceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 784 (1058)
|...+.||+|++|.||+|... +++.+|+|.+..... ....+.+.+|++.+++++|+|++++++++....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~ 70 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKT----------EKQREEFLREIRILKKLKHPNIVKLYGVFEDPE 70 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccc----------hHHHHHHHHHHHHHHhCCCCChhhheeeeecCC
Confidence 456789999999999999554 489999999854321 024678999999999999999999999999889
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..++++||+++++|.+++.... ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++++|||.+.
T Consensus 71 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 71 PLYLVMEYCEGGDLFDYLRKKG-GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred ceEEEEeccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 9999999999999999998642 2288999999999999999999999 99999999999999999999999999998
Q ss_pred eccCCCcccccccccCcCCccCcccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYG-YMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 920 (1058)
....... .......++..|++||.. ....++.++|||+||+++|||++|+.||..
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 7654320 122345678899999988 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=243.60 Aligned_cols=266 Identities=24% Similarity=0.375 Sum_probs=199.2
Q ss_pred HHHHHhhccccceeccccceEEEEE-Eec---CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcc
Q 043053 699 VEQVLKCLVDANVIGKGCSGVVYRA-DMD---NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNI 773 (1058)
Q Consensus 699 ~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni 773 (1058)
...+.+.|..+++||.|.|++||+| ... ..+.||+|.+.... ...++..|++++..+. +.||
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-------------~p~ri~~El~~L~~~gG~~ni 97 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-------------SPSRILNELEMLYRLGGSDNI 97 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-------------CchHHHHHHHHHHHhccchhh
Confidence 4556688999999999999999999 333 57889999996542 3467899999999997 9999
Q ss_pred cceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC-
Q 043053 774 VRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE- 852 (1058)
Q Consensus 774 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~- 852 (1058)
+++.+++..++...+||||++..+-.++... ++...+...++.+..||+++|.. |||||||||+|++++..
T Consensus 98 ~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t 169 (418)
T KOG1167|consen 98 IKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRT 169 (418)
T ss_pred hcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccccc
Confidence 9999999999999999999999999888865 56788889999999999999999 99999999999999854
Q ss_pred CCeeeeccccceeccCCC----------------------------------ccc--------ccccccCcCCccCcccc
Q 043053 853 FEPYIADFGLAKLVDDGD----------------------------------FAR--------SSNTVAGSYGYIAPEYG 890 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~----------------------------------~~~--------~~~~~~gt~~y~aPE~~ 890 (1058)
++-.|.|||+|...+... +.. ......||++|.|||++
T Consensus 170 ~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL 249 (418)
T KOG1167|consen 170 QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVL 249 (418)
T ss_pred CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHH
Confidence 678999999996221100 000 01134699999999987
Q ss_pred cc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH--------hhc----C------------------cc
Q 043053 891 YM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR--------QKK----G------------------IQ 939 (1058)
Q Consensus 891 ~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~--------~~~----~------------------~~ 939 (1058)
.. ...+++.||||.||++..+++++.||.....+.....+.+. +.. . ..
T Consensus 250 ~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~ 329 (418)
T KOG1167|consen 250 FRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFE 329 (418)
T ss_pred hhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchh
Confidence 64 45789999999999999999999999765444333322211 000 0 00
Q ss_pred ccC-CCCCCC-----CchhHHHHH--HHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 940 VLD-PSLLSR-----PESEIDEML--QALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 940 ~~~-~~~~~~-----~~~~~~~~~--~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.++ ...... ......+.. .++++..+|+..||.+|.|+++++++--
T Consensus 330 s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 330 TLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred ccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 000 000000 000011111 4577899999999999999999998643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-27 Score=244.14 Aligned_cols=387 Identities=22% Similarity=0.272 Sum_probs=253.6
Q ss_pred CccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeec-CCCcCcCCccccccCCcceeec
Q 043053 194 ELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSL-NSLSGTIPLSIGGLSELEEFMI 272 (1058)
Q Consensus 194 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l 272 (1058)
.-+.++|..|+|+.+.+..|+.+++|+.|+|++|.|+.+.|++|..+++|..|-+-+ |+|+...-..|+++..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 456778888888866667788888888888888888877788888887777666555 7787666677788888888888
Q ss_pred ccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcc------------cCCCCChhhhccCccc
Q 043053 273 SDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQ------------LEGSIPSTLASCSNLQ 340 (1058)
Q Consensus 273 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~------------l~~~~~~~~~~l~~L~ 340 (1058)
.-|++.-+..+.|..+++|..|.+.+|.+..+...+|..+..++.+.+..|. +....+..+++.....
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 8888887777888888888888888888877766678888888888887776 2233444555666666
Q ss_pred ccccccccccccCcccccc-cccchhhhccccCCCCCCC-CCccCCCCCcEEEccCccccCCccccccCccccceeeccC
Q 043053 341 ALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIP-PEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSS 418 (1058)
Q Consensus 341 ~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 418 (1058)
-..+.++++..+.+..|.. +..+..=..+.+....+.| ..|..+++|+.|+|++|+|+++-+.+|.++..+++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 6666666666544444432 1222221222222222333 3577778888888888888877777888888888888888
Q ss_pred ccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCC-----cccc-----------ccccc
Q 043053 419 NRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI-----PASL-----------GRLVS 482 (1058)
Q Consensus 419 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~-----------~~l~~ 482 (1058)
|+|..+....|.++..|+.|+|.+|+|+.+.|.+|..+..|..|+|-.|.+.-.- .+++ ..-..
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~ 387 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGF 387 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCch
Confidence 8877666677777888888888888887777778888888888887777653100 0000 01123
Q ss_pred ccccccccccCCC---CCCCccc---------CCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccc
Q 043053 483 LNKIILSKNLFSG---PIPSSLG---------LCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQI 550 (1058)
Q Consensus 483 L~~L~Ls~N~l~~---~~~~~~~---------~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~ 550 (1058)
++.+.++.+.+.. ..|++.+ .++-+....=-.|+....+|..+. .-...+++.+|.++.+ |..
T Consensus 388 ~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP---~d~telyl~gn~~~~v-p~~- 462 (498)
T KOG4237|consen 388 VRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIP---VDVTELYLDGNAITSV-PDE- 462 (498)
T ss_pred hccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCC---chhHHHhcccchhccc-CHH-
Confidence 4455555554431 1222111 122233322222322224444332 2223578888888854 443
Q ss_pred cccccccEEecCCCcccCCC-CcccccCcceeEEEecc
Q 043053 551 SALNKLSILDLSHNKLEGNL-NPLAQLDNLVSLNISYN 587 (1058)
Q Consensus 551 ~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~l~~N 587 (1058)
.+.+| .+||++|+++..- ..|.+++.|.+|-|++|
T Consensus 463 -~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 463 -LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred -HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 56677 8999999998754 57888888999988887
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-27 Score=242.40 Aligned_cols=388 Identities=21% Similarity=0.239 Sum_probs=306.7
Q ss_pred ccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeeccc-ccccCCCCccccCcCCccEEEe
Q 043053 170 KLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQ-NSLVGAIPEEIGNCTSLKMIDF 248 (1058)
Q Consensus 170 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L 248 (1058)
.-..++|..|.|+...+.+|+.+++|+.|||++|.|+.+.|..|..+++|.+|-+.+ |+|+...-+.|++|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 356788999999988888999999999999999999988999999999998887766 9999777778999999999999
Q ss_pred ecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCc------------ccCcCCCcccccchhh
Q 043053 249 SLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ------------ISGLIPPEIGMLSKLT 316 (1058)
Q Consensus 249 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~------------i~~~~~~~~~~l~~L~ 316 (1058)
.-|++.......|..+++|..|.+.+|.+..+.-..|..+..++.+++..|. +....|..++++.-..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 9999998888999999999999999999996666699999999999999998 3334555667776666
Q ss_pred hhhccCcccCCCCChhhhcc-CcccccccccccccccCcc-cccccccchhhhccccCCCCCCCCCccCCCCCcEEEccC
Q 043053 317 VFFAWQNQLEGSIPSTLASC-SNLQALDLSHNSLTASVPA-GLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394 (1058)
Q Consensus 317 ~L~l~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 394 (1058)
-..+.++++..+.+..|... ..+..=-.+.+....+.|. .|..+++|++|+|++|+|+++.+.+|.++..+++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 67777777777766666543 2222222233333334554 577899999999999999999999999999999999999
Q ss_pred ccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCC---C--Cccc-----------cccCCC
Q 043053 395 NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG---S--LPNS-----------LSSLSG 458 (1058)
Q Consensus 395 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~---~--~~~~-----------~~~l~~ 458 (1058)
|+|..+....|.++..|+.|+|.+|+|+...|.+|..+..|..|+|-.|.+-- + +-++ -..-..
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~ 387 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGF 387 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCch
Confidence 99999988999999999999999999999999999999999999999987741 0 0011 112234
Q ss_pred CCeeecCCCccccC---Cccccc---------ccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhh
Q 043053 459 LQVLDVSDNRFSGQ---IPASLG---------RLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELG 526 (1058)
Q Consensus 459 L~~L~L~~N~l~~~---~~~~~~---------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 526 (1058)
++.+.++++.+... .|++.+ ..+-+.+..=-.|+....+|..+. ..-.+|++.+|.++ .+|.+
T Consensus 388 ~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP--~d~telyl~gn~~~-~vp~~-- 462 (498)
T KOG4237|consen 388 VRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIP--VDVTELYLDGNAIT-SVPDE-- 462 (498)
T ss_pred hccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCC--chhHHHhcccchhc-ccCHH--
Confidence 66777777766421 222221 122333333333333335666554 35678999999998 78887
Q ss_pred hhHHHHHHHhhccCCCCCCCCccccccccccEEecCCC
Q 043053 527 QIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHN 564 (1058)
Q Consensus 527 ~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N 564 (1058)
.+..+ .+++|+|++.......|.++++|..|-|++|
T Consensus 463 ~~~~l--~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 463 LLRSL--LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred HHhhh--hcccccCceehhhcccccchhhhheeEEecC
Confidence 45555 5999999999999999999999999999987
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=218.44 Aligned_cols=172 Identities=21% Similarity=0.213 Sum_probs=130.7
Q ss_pred CChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCccccc
Q 043053 796 GSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875 (1058)
Q Consensus 796 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~ 875 (1058)
|+|.++++.+ +..+++..++.|+.|+++||+|||+. + ||+||+++.++.+++ ||.++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence 6899999864 45799999999999999999999998 5 999999999999999 9998865432
Q ss_pred ccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHH
Q 043053 876 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDE 955 (1058)
Q Consensus 876 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 955 (1058)
...||+.|||||++.+..++.++|||||||++|||++|+.||............+....... .+... .......+
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~ 137 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD---DPRDR-SNLESVSA 137 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC---Ccccc-ccHHHHHh
Confidence 12588999999999999999999999999999999999999975433222233222221111 11100 11112222
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 956 MLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 956 ~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
...+.+++.+||+.+|++||++.++++++..+..+
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 12456789999999999999999999998776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-25 Score=274.95 Aligned_cols=198 Identities=16% Similarity=0.223 Sum_probs=141.2
Q ss_pred ccCC-CcccceeeEEE-------cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeE
Q 043053 767 SIRH-KNIVRFLGCCW-------NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIV 838 (1058)
Q Consensus 767 ~l~h-~niv~~~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 838 (1058)
.++| +||+++++++. ..+..+.+|||+ +++|.++++.. ...+++..++.++.||++||+|||++ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4456 68888888872 234567888987 55999999753 45689999999999999999999999 999
Q ss_pred eCCCCCCcEEEcC-------------------CCCeeeeccccceeccCCC--------------cccccccccCcCCcc
Q 043053 839 HRDIKANNILIGL-------------------EFEPYIADFGLAKLVDDGD--------------FARSSNTVAGSYGYI 885 (1058)
Q Consensus 839 HrDikp~Nill~~-------------------~~~~kl~DfGl~~~~~~~~--------------~~~~~~~~~gt~~y~ 885 (1058)
||||||+|||++. ++.+|++|||+++...... .........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 4456677777765422100 000112245889999
Q ss_pred CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHh
Q 043053 886 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALL 965 (1058)
Q Consensus 886 aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 965 (1058)
|||++.+..++.++|||||||++|||++|..|+.... ...... ... ...+.. .........++.+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~-~~~----~~~~~~-------~~~~~~~~~~~~~ 247 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSL-RHR----VLPPQI-------LLNWPKEASFCLW 247 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHH-HHh----hcChhh-------hhcCHHHHHHHHH
Confidence 9999999999999999999999999999988864221 111111 110 111111 1112223457788
Q ss_pred ccCCCCCCCCCHHHHHHHH
Q 043053 966 CVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 966 cl~~dP~~RPt~~~v~~~l 984 (1058)
||+++|.+||++.|++++.
T Consensus 248 ~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred hCCCChhhCcChHHHhhch
Confidence 9999999999999998643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=211.60 Aligned_cols=264 Identities=20% Similarity=0.225 Sum_probs=202.4
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEc
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWN 782 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 782 (1058)
.|.++++||+|+||+.+.| .+-+++.||||.=... ...-++..|.+..+.+. .++|..+|.+..+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-------------S~APQLrdEYr~YKlL~g~~GIP~vYYFGqe 95 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-------------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQE 95 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc-------------CCcchHHHHHHHHHHHcCCCCCCceeeeccc
Confidence 5788999999999999999 7788999999964222 22456788888888886 7999999999988
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-----Ceee
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-----EPYI 857 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-----~~kl 857 (1058)
+....+|||.+ |.+|+|+..- .+..++..++..||.|++.-++|+|++ .+|.|||||+|+||+..+ .+.+
T Consensus 96 G~~NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihi 170 (449)
T KOG1165|consen 96 GKYNILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHI 170 (449)
T ss_pred cchhhhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEE
Confidence 88899999999 8899998864 367899999999999999999999999 999999999999997543 5889
Q ss_pred eccccceeccCCCc-----ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 858 ADFGLAKLVDDGDF-----ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
+|||+|+.+.+... .+......||.+||+-..+.+...+.+.|+-|+|-++.+.+.|..||++...+... +.+
T Consensus 171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK--~kY 248 (449)
T KOG1165|consen 171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK--EKY 248 (449)
T ss_pred EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH--HHH
Confidence 99999998876542 23345567999999999999999999999999999999999999999986543221 111
Q ss_pred HhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
+. .+...-...+...+.....++...+..++ ..+-++-|+++-+...+..+.....
T Consensus 249 eK-IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 249 EK-IGETKRSTPIEVLCEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred HH-hccccccCCHHHHHhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhcC
Confidence 11 11111111111112223344544444444 4578888999988888777655443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-24 Score=205.78 Aligned_cols=262 Identities=20% Similarity=0.246 Sum_probs=200.9
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 780 (1058)
...|..++.||.|+||.+|.| ...+|+.||||+=.. .....++..|..+.+.++ ...|..+..|+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-------------~a~hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-------------KAKHPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-------------cCCCcchhHHHHHHHHhccCCCCchhhhhc
Confidence 367899999999999999999 788899999997422 222456788999999998 46788888888
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC---CCeee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE---FEPYI 857 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~---~~~kl 857 (1058)
.+.....+|||.+ |.+|.++..-. ...++..+++-.|-|++.-++|+|.+ ++|||||||+|+|.+-+ ..+.+
T Consensus 81 ~e~~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 81 TEKDYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred cccccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEE
Confidence 8888899999999 88999998753 46788999999999999999999999 99999999999999754 46899
Q ss_pred eccccceeccCCC-----cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh-hHHHH
Q 043053 858 ADFGLAKLVDDGD-----FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS-HVVDW 931 (1058)
Q Consensus 858 ~DfGl~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~ 931 (1058)
+|||+|+.+.+.. ..+......||.+|.+--...+...+.+.|+-|+|+++.+.-.|..||++..+... +..+.
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk 235 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK 235 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence 9999998775432 12334456799999999888888899999999999999999999999997654321 11111
Q ss_pred HHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
+.. .........+....+.+..-.+ ..|-..--++-|+..-+.+.++-+..
T Consensus 236 I~E-kK~s~~ie~LC~G~P~EF~myl------~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 236 ISE-KKMSTPIEVLCKGFPAEFAMYL------NYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHH-hhcCCCHHHHhCCCcHHHHHHH------HHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 111 1222222333334444333333 34777888899998888877765543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-23 Score=227.50 Aligned_cols=262 Identities=19% Similarity=0.254 Sum_probs=193.5
Q ss_pred hccccceeccccceEEEEEEecCC--cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC----Ccccceee
Q 043053 705 CLVDANVIGKGCSGVVYRADMDNG--EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH----KNIVRFLG 778 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~ 778 (1058)
+|.+.+.||+|+||.||.|..... ..+|+|...... ... ...+..|+.++..+.. +++..+++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~----------~~~-~~~l~~E~~vl~~l~~~~~~~~~~~~~~ 87 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKEL----------GSK-PSVLKIEIQVLKKLEKKNGPSHFPKLLD 87 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecc----------cCC-CccchhHHHHHHHHhhhcCCCCCCEEEE
Confidence 799999999999999999954432 578888763221 111 1267888888888873 69999999
Q ss_pred EE-EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC-----
Q 043053 779 CC-WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE----- 852 (1058)
Q Consensus 779 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~----- 852 (1058)
.+ ..+...|+||+.+ |.+|.++.+......++..++.+|+.|++.+|+++|+. |++||||||+|++++..
T Consensus 88 ~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~ 163 (322)
T KOG1164|consen 88 HGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEV 163 (322)
T ss_pred eccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCccc
Confidence 99 4777889999998 88999988766568899999999999999999999999 99999999999999865
Q ss_pred CCeeeeccccce--eccCCC-----cccc-cccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043053 853 FEPYIADFGLAK--LVDDGD-----FARS-SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD 924 (1058)
Q Consensus 853 ~~~kl~DfGl~~--~~~~~~-----~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~ 924 (1058)
..+++.|||+++ .+.... ..+. .....||.+|+++.++.+...+++.|+||+++++.|+..|..||......
T Consensus 164 ~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 164 RTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred ceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 358999999998 332211 1111 23566999999999999999999999999999999999999999755322
Q ss_pred ChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 925 GSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.. ... +.+......... .....+.+...+.. .+-..+..++|.+..+...+++....
T Consensus 244 ~~-~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 244 DL-KSK-FEKDPRKLLTDR-FGDLKPEEFAKILE------YIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ch-HHH-HHHHhhhhcccc-ccCCChHHHHHHHH------HhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11 111 111111111111 12222333333332 24457899999999999988776554
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=264.96 Aligned_cols=339 Identities=20% Similarity=0.272 Sum_probs=220.6
Q ss_pred CccccCCCccceeeeeccc------cccccCccccCCC-CccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCC
Q 043053 162 PASLGKLSKLQTLSIYTTM------ISGEIPAEIGNCS-ELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIP 234 (1058)
Q Consensus 162 ~~~l~~l~~L~~L~l~~n~------i~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 234 (1058)
+..|.+|.+|+.|.++.+. +...+|..+..++ +|+.|++.++.+. .+|..| ...+|+.|+|.+|++. .++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 4457778888888886553 2224566666654 5888888888776 667666 4678888888888876 566
Q ss_pred ccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccch
Q 043053 235 EEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSK 314 (1058)
Q Consensus 235 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 314 (1058)
..+..+++|+.|+|++|.....+| .++.+++|+.|++++|.....+|..+.++++|+.|++++|..-...|..+ ++++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 667788888888888775444555 36778888888888876555677778888888888888765444445444 5777
Q ss_pred hhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCC-------CCCCCCccCCCCC
Q 043053 315 LTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDIS-------GSIPPEIGNCSSL 387 (1058)
Q Consensus 315 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-------~~~~~~~~~l~~L 387 (1058)
|+.|++++|.....+|.. ..+|++|++++|.+. .+|..+ .+++|++|.+.++... ...+..+...++|
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL 780 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL 780 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence 777777777544444432 356777888888776 455543 4667777777664321 1112222334567
Q ss_pred cEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCC
Q 043053 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN 467 (1058)
Q Consensus 388 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 467 (1058)
+.|+|++|.....+|..++++++|+.|+|++|..-+.+|..+ .+++|+.|+|++|..-..+|.. ..+|+.|+|++|
T Consensus 781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n 856 (1153)
T PLN03210 781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT 856 (1153)
T ss_pred hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence 777777776655566677777777777777654333455544 5667777777776433334432 245677777777
Q ss_pred ccccCCccccccccccccccccc-ccCCCCCCCcccCCcccccccccCCc
Q 043053 468 RFSGQIPASLGRLVSLNKIILSK-NLFSGPIPSSLGLCSSLQLLDLSSNQ 516 (1058)
Q Consensus 468 ~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~l~~N~ 516 (1058)
.++ .+|..+..+++|+.|+|++ |++. .+|..+..+++|+.|+++++.
T Consensus 857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 776 5666677777777777776 3343 455556666677777776663
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=265.97 Aligned_cols=346 Identities=21% Similarity=0.306 Sum_probs=188.4
Q ss_pred ChhhcCcccCCEEeccccCCC------Cccccccccch-hhhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCC
Q 043053 65 PSSLGKLHNLEELILNSNQLT------GKIPVELSNCK-SLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKI 137 (1058)
Q Consensus 65 p~~l~~l~~L~~L~L~~n~~~------~~~p~~l~~l~-~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l 137 (1058)
+.++.+|.+|+.|.+..+... ..+|..+..++ +|+.|.+.++.+. .+|..+ ...+|++|++.+|. +..+
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~--l~~L 626 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSK--LEKL 626 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcc--cccc
Confidence 345566666666666544321 12444444432 2555555444443 444444 23445555554443 3344
Q ss_pred CccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCC
Q 043053 138 PAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLK 217 (1058)
Q Consensus 138 ~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 217 (1058)
+..+..+++|+.|+++++.....+| .++.+++|++|++.+|.....+|..++++++|+.|++++|.....+|..+ +++
T Consensus 627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~ 704 (1153)
T PLN03210 627 WDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLK 704 (1153)
T ss_pred ccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCC
Confidence 4444445555555555443322333 24445555555555544434455555555555555555543332344333 445
Q ss_pred CcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhc
Q 043053 218 KLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLD 297 (1058)
Q Consensus 218 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 297 (1058)
+|+.|++++|.....+|.. .++|+.|++++|.+. .+|..+ .+++|++|.+.++.... ..
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~-l~--------------- 763 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK-LW--------------- 763 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh-cc---------------
Confidence 5555555554333222221 234445555555443 223222 23444444444322110 00
Q ss_pred CCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCC
Q 043053 298 TNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSI 377 (1058)
Q Consensus 298 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 377 (1058)
+.+....+..+...++|+.|++++|.....+|..++++++|+.|++++|..-+.+|..+ .+++|++|++++|.....+
T Consensus 764 -~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~ 841 (1153)
T PLN03210 764 -ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTF 841 (1153)
T ss_pred -ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccc
Confidence 01111112223334567777777776666677788888888888888765444566655 6788888888887554444
Q ss_pred CCCccCCCCCcEEEccCccccCCccccccCccccceeeccC-ccCCCCCCCcccCCcccchhhccCCc
Q 043053 378 PPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSS-NRLSGSVPDEIGDCTELQMIDLSHNT 444 (1058)
Q Consensus 378 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~l~~N~ 444 (1058)
|.. ..+|+.|+|++|.|+. .|..+..+++|++|+|++ |++. .+|..+..+++|+.|++++|.
T Consensus 842 p~~---~~nL~~L~Ls~n~i~~-iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 842 PDI---STNISDLNLSRTGIEE-VPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ccc---ccccCEeECCCCCCcc-ChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 443 3578889999998885 477888889999999988 4565 566677888888888888874
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-24 Score=210.02 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=190.2
Q ss_pred ccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCC
Q 043053 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 785 (1058)
.....+|.+...|+.|+|+++ |..+++|++.-. +......++|..|.-.++-+.||||++++|.|..+..
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr---------~~t~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVR---------EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred hhhhhhhccCCCccccccccc-Ccchhhhhhhhh---------hcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 344567889999999999998 666667776322 1122234688999999999999999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
..++..|++.|+|+..+++...-..+..++.+++.++|+|++|||+.. |-|----+.+..|++|++.+++|+ ++-+++
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kf 339 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKF 339 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-ccccee
Confidence 999999999999999999987778899999999999999999999973 233344689999999999988775 122221
Q ss_pred ccCCCcccccccccCcCCccCccccccCCCC---cccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 866 VDDGDFARSSNTVAGSYGYIAPEYGYMMKIT---EKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
........-.|.||+||.++..+-+ .++|+|||++++||+.|...||.+..|.+.... ...+.+.
T Consensus 340 ------sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk------ialeglr 407 (448)
T KOG0195|consen 340 ------SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK------IALEGLR 407 (448)
T ss_pred ------eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh------hhhcccc
Confidence 1122234457899999998876543 479999999999999999999987655432221 1223333
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
+.+++... ..+.+ ++.-|++.||.+||.++.|+-.|+.+.
T Consensus 408 v~ippgis---~hm~k---lm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 408 VHIPPGIS---RHMNK---LMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccCCCCcc---HHHHH---HHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 44333333 33333 445599999999999999998887653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=224.66 Aligned_cols=181 Identities=20% Similarity=0.171 Sum_probs=135.5
Q ss_pred HHHhhccccceeccccceEEEEEEec--CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRADMD--NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
.+..+|...+.||+|+||+||+|... +++.||||++..... ........+.|.+|++++++++|+||++.+.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~------~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVP------WWSKPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccc------ccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 34578999999999999999999543 578889998742210 0012234577999999999999999986332
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCC-CCCcEEEcCCCCeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDI-KANNILIGLEFEPYI 857 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDi-kp~Nill~~~~~~kl 857 (1058)
. .+..|+||||++|++|... .. .. ...++.|+++||+|+|+. ||+|||| ||+|||++.++.+||
T Consensus 89 ~---~~~~~LVmE~~~G~~L~~~-~~--~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 89 A---TGKDGLVRGWTEGVPLHLA-RP--HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred E---cCCcEEEEEccCCCCHHHh-Cc--cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEE
Confidence 2 2457999999999999732 11 11 146788999999999999 9999999 999999999999999
Q ss_pred eccccceeccCCCccc------ccccccCcCCccCccccccCC------CCcccchh
Q 043053 858 ADFGLAKLVDDGDFAR------SSNTVAGSYGYIAPEYGYMMK------ITEKSDVY 902 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 902 (1058)
+|||+|+.+....... ......+++.|+|||++.... .+..+|-|
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999775533111 124567899999999876443 23346766
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-23 Score=241.11 Aligned_cols=259 Identities=20% Similarity=0.230 Sum_probs=190.8
Q ss_pred cccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCC
Q 043053 707 VDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 707 ~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 785 (1058)
...+++|.|++|.|+.+ +.......+.|.++.. .. ..+........+..|.-+-..++|||++..+..+.+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~----~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK----PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC----CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 45678999999988887 4444555566654311 00 011222333447889999999999999988888877777
Q ss_pred ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
.+-+||||++ +|..++.+. ..+....+..+++|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+..
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred chhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCccee
Confidence 7667999999 999999863 5688888899999999999999999 999999999999999999999999999987
Q ss_pred ccCCCcc--cccccccCcCCccCccccccCCCCc-ccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 866 VDDGDFA--RSSNTVAGSYGYIAPEYGYMMKITE-KSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 866 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+..+... ......+|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||.........+.+. .......
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-~~~~~~~--- 545 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-NYSDQRN--- 545 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-ccccccc---
Confidence 6654332 4566788999999999999999976 5899999999999999999998664443322100 0000000
Q ss_pred CCCCCCCchhHHH-HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 943 PSLLSRPESEIDE-MLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 943 ~~~~~~~~~~~~~-~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
....+...... -.....++.+++++||.+|.|+++|++
T Consensus 546 --~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 --IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00001111111 112234788899999999999999986
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-22 Score=235.58 Aligned_cols=266 Identities=29% Similarity=0.365 Sum_probs=170.0
Q ss_pred ccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeeccc
Q 043053 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISD 274 (1058)
Q Consensus 195 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 274 (1058)
-..|+|++|.++ .+|..+. ++|+.|++.+|+++. +|. .+++|++|+|++|+|+. +|.. .++|+.|++++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccC
Confidence 445556665555 4454443 245555555555552 332 13455555555555552 2221 23444444444
Q ss_pred CccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCc
Q 043053 275 NNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVP 354 (1058)
Q Consensus 275 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 354 (1058)
|. |+.+ |.. .++|+.|++++|+++.. |. ..++|+.|++++|+|++ +|
T Consensus 272 N~------------------------L~~L-p~l---p~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~-Lp 318 (788)
T PRK15387 272 NP------------------------LTHL-PAL---PSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLAS-LP 318 (788)
T ss_pred Cc------------------------hhhh-hhc---hhhcCEEECcCCccccc-cc---cccccceeECCCCcccc-CC
Confidence 44 4432 111 13344455555555532 22 23567888888888874 44
Q ss_pred ccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcc
Q 043053 355 AGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTE 434 (1058)
Q Consensus 355 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 434 (1058)
... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|+++ |.. ..+|+.|++++|+|++ +|.. ..+
T Consensus 319 ~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~-LP~l---~~~ 383 (788)
T PRK15387 319 ALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTS-LPAL---PSG 383 (788)
T ss_pred CCc---ccccccccccCcccc-cccc---ccccceEecCCCccCCC-CCC---Ccccceehhhcccccc-Cccc---ccc
Confidence 322 357778888888874 4432 24788999999999865 332 3578888999999884 5543 357
Q ss_pred cchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccC
Q 043053 435 LQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSS 514 (1058)
Q Consensus 435 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 514 (1058)
|+.|++++|+|++ +|.. .++|+.|++++|+|++ +|..+ .+|+.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus 384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 8899999999986 5543 3578999999999984 66543 46888999999998 6788899999999999999
Q ss_pred CcccCCCChhhhhh
Q 043053 515 NQLTGSVPMELGQI 528 (1058)
Q Consensus 515 N~l~~~~p~~~~~l 528 (1058)
|+|++.+|..+..+
T Consensus 455 N~Ls~~~~~~L~~l 468 (788)
T PRK15387 455 NPLSERTLQALREI 468 (788)
T ss_pred CCCCchHHHHHHHH
Confidence 99998777766433
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.9e-22 Score=234.42 Aligned_cols=263 Identities=28% Similarity=0.390 Sum_probs=145.5
Q ss_pred cceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeec
Q 043053 171 LQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSL 250 (1058)
Q Consensus 171 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 250 (1058)
-..|+++++.++ .+|..+. ++|+.|++.+|+++ .+|.. +++|++|+|++|+++. +|.. .++|+.|++++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeeccC
Confidence 445556666555 4555443 25666666666666 34432 3566666666666663 3322 24666666666
Q ss_pred CCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCC
Q 043053 251 NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIP 330 (1058)
Q Consensus 251 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 330 (1058)
|.+.. +|.. .++|+.|++++|+++. +|. ..++|+.|+|++|+|+++ |.. ..+|+.|++++|++++ +|
T Consensus 272 N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP 338 (788)
T PRK15387 272 NPLTH-LPAL---PSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-LP 338 (788)
T ss_pred Cchhh-hhhc---hhhcCEEECcCCcccc-ccc---cccccceeECCCCccccC-CCC---cccccccccccCcccc-cc
Confidence 66653 3322 2456666677776663 332 235667777777776653 221 1245556666666654 23
Q ss_pred hhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccc
Q 043053 331 STLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKT 410 (1058)
Q Consensus 331 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 410 (1058)
.. ..+|+.|+|++|+|+. +|.. ..+|+.|++++|+|+. +|.. ..+|+.|+|++|+|+++ |.. .++
T Consensus 339 ~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~L-P~l---~s~ 403 (788)
T PRK15387 339 TL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSL-PVL---PSE 403 (788)
T ss_pred cc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCC-CCc---ccC
Confidence 21 1367777777777773 4432 2456666777777663 3432 24566677777766653 222 245
Q ss_pred cceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccc
Q 043053 411 LNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL 477 (1058)
Q Consensus 411 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 477 (1058)
|+.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|..+.++++|+.|+|++|+|++..+..+
T Consensus 404 L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 404 LKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 6666666666663 3432 234556666666666 355556666666666666666665444433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-19 Score=205.31 Aligned_cols=262 Identities=28% Similarity=0.343 Sum_probs=196.3
Q ss_pred ccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCC-cccceeeEEEcCC
Q 043053 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK-NIVRFLGCCWNRN 784 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~ 784 (1058)
|...+.||.|+||.||++... ..+|+|.+..... ........+.+|+..++.+.|+ +|+++++.+....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~--------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLE--------SKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhc--------cchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC
Confidence 567789999999999999665 7889998854421 1113578899999999999988 7999999997777
Q ss_pred CceEEEEecCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-Ceeeecccc
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTG-NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-EPYIADFGL 862 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~DfGl 862 (1058)
..+++++|+.++++.+++..... ..+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.
T Consensus 72 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~ 148 (384)
T COG0515 72 SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGL 148 (384)
T ss_pred EEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCc
Confidence 78999999999999977765321 2688999999999999999999999 999999999999999988 799999999
Q ss_pred ceeccCCCccc----ccccccCcCCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCC--ChhHHHHHH
Q 043053 863 AKLVDDGDFAR----SSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD--GSHVVDWVR 933 (1058)
Q Consensus 863 ~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~--~~~~~~~~~ 933 (1058)
++......... ......|+..|+|||...+ ..+....|+||+|++++++++|..||...... .......+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 228 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence 98665433221 3456789999999999887 57888999999999999999999997654321 122222222
Q ss_pred hhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..... ........... .........++..|+..+|..|.++.+....
T Consensus 229 ~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 229 ELPTP-SLASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred hcCCc-ccccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 21111 00111111100 0111223346777899999999998887764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-21 Score=195.42 Aligned_cols=173 Identities=11% Similarity=0.093 Sum_probs=133.0
Q ss_pred HhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHH------HHHHHHHHHcccCCCcccce
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRD------SFSAEIKTLGSIRHKNIVRF 776 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~------~~~~E~~~l~~l~h~niv~~ 776 (1058)
..+|...+++|.|+||.||.++. ++..+|||.+++... ..+.... .+.+|++.+.++.||+|..+
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~--------~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVK--------RTERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcC--------chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 36789999999999999999866 477899999965432 1122222 26899999999999999999
Q ss_pred eeEEEcC--------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEE
Q 043053 777 LGCCWNR--------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 777 ~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nil 848 (1058)
.+++... ...++||||++|.+|.++.. .+. ....+++.++..+|+. |++|||+||+||+
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nil 167 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFI 167 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEE
Confidence 9987643 34689999999999988742 222 3456999999999999 9999999999999
Q ss_pred EcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHH
Q 043053 849 IGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 912 (1058)
Q Consensus 849 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ell 912 (1058)
++.++ ++++|||..+....... . ..+.....+..++|+||||+++.-..
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a---~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKA---K-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EeCCC-EEEEECCCcccccchhh---H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 99988 99999998865532111 0 01333444567899999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=189.99 Aligned_cols=152 Identities=20% Similarity=0.213 Sum_probs=112.5
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecCcccccccCC---------------CCCcccchHHHHHHHHHHHcccCCCcc
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANG---------------CSDEKSGVRDSFSAEIKTLGSIRHKNI 773 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------------~~~~~~~~~~~~~~E~~~l~~l~h~ni 773 (1058)
.+.||+|+||.||+|...+|+.||||++++........ .............+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999976789999999996542211000 000000012234569999999988887
Q ss_pred cceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcc-cccCCCCeEeCCCCCCcEEEcCC
Q 043053 774 VRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL-HHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 774 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHrDikp~Nill~~~ 852 (1058)
.....+.. ...++||||++|+++...... ...+++..+..++.|++.+|+|+ |+. ||+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 55443332 234899999999877655332 35688999999999999999999 687 999999999999998 5
Q ss_pred CCeeeeccccceeccC
Q 043053 853 FEPYIADFGLAKLVDD 868 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~ 868 (1058)
+.++|+|||+|.....
T Consensus 154 ~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 GKLYIIDVSQSVEHDH 169 (190)
T ss_pred CcEEEEEccccccCCC
Confidence 7899999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=224.84 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=146.0
Q ss_pred CCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhh
Q 043053 24 KHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLL 103 (1058)
Q Consensus 24 ~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L 103 (1058)
++.++|++++++++ .+|..+. .+|+.|+|++|+|+ .+|..+. .+|++|+|++|+++ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 45678888888887 6787664 47888888888888 7887664 58888888888887 6676543 36777777
Q ss_pred hhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeecccccc
Q 043053 104 FDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISG 183 (1058)
Q Consensus 104 ~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~ 183 (1058)
++|.+. .+|..+. ++|+.|++++|. +..+|..+. ++ |+.|++++|+++
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~--L~~LP~~l~--~s------------------------L~~L~Ls~N~Lt- 296 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNK--ISCLPENLP--EE------------------------LRYLSVYDNSIR- 296 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCc--cCccccccC--CC------------------------CcEEECCCCccc-
Confidence 777776 5665543 345555555544 334444332 24 444455444444
Q ss_pred ccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccc
Q 043053 184 EIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGG 263 (1058)
Q Consensus 184 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~ 263 (1058)
.+|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|.++. +|..+. ++|+.|+|++|+++ .+|..+.
T Consensus 297 ~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp- 366 (754)
T PRK15370 297 TLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP- 366 (754)
T ss_pred cCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc-
Confidence 2332221 24555555555555 2333222 456666666666553 343332 46666666666665 3443332
Q ss_pred cCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcc----cccchhhhhhccCcccC
Q 043053 264 LSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEI----GMLSKLTVFFAWQNQLE 326 (1058)
Q Consensus 264 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~----~~l~~L~~L~l~~N~l~ 326 (1058)
++|+.|++++|+++. +|..+. ..|+.|++++|++..+ |..+ ..++++..|++.+|.++
T Consensus 367 -~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~~L-P~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 -PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLVRL-PESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred -CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcccC-chhHHHHhhcCCCccEEEeeCCCcc
Confidence 466666666666663 333332 2577777777777643 3333 33456667777777765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.9e-20 Score=192.17 Aligned_cols=236 Identities=22% Similarity=0.318 Sum_probs=152.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC----------Cc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH----------KN 772 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~n 772 (1058)
..+...+.||.|+++.||.+ +-.+|+.+|||++.... +......+++++|......+.+ -.
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--------~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--------DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--------TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--------ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 34567889999999999999 66779999999985442 1333456888888877766433 23
Q ss_pred ccceeeEEEc---------C---C-----CceEEEEecCCCChhhhhhh---cCC--CCCCHHHHHHHHHHHHHHhhccc
Q 043053 773 IVRFLGCCWN---------R---N-----NRLLMYDYMPNGSLGSLLHE---RTG--NALEWELRYQILLGAAQGLAYLH 830 (1058)
Q Consensus 773 iv~~~~~~~~---------~---~-----~~~lv~e~~~~gsL~~~l~~---~~~--~~l~~~~~~~i~~~i~~~l~~LH 830 (1058)
++-.++.... . . ..+++|+-+.+ ||.+++.. ... ..+....+..+..|+++.+++||
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 3333333321 1 1 23678888854 88887642 211 23445566777899999999999
Q ss_pred ccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCcccccc--------CCCCcccchh
Q 043053 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM--------MKITEKSDVY 902 (1058)
Q Consensus 831 ~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvw 902 (1058)
+. |+||+||||+|++++.+|.++|+||+.....+... . ....+..|.+||.... ..++.+.|.|
T Consensus 163 ~~---GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~--~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW 234 (288)
T PF14531_consen 163 SY---GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY--R---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAW 234 (288)
T ss_dssp HT---TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE--E---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred hc---ceEecccceeeEEEcCCCCEEEcChHHHeecCcee--e---ccCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence 99 99999999999999999999999999876544311 1 1335578999997543 3567889999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCC
Q 043053 903 SYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDER 974 (1058)
Q Consensus 903 SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 974 (1058)
++|+++|.|++|+.||+...+.... +.....+. .+.+.++. ++..+++++|.+|
T Consensus 235 ~LG~~ly~lWC~~lPf~~~~~~~~~---------------~~~f~~C~-~~Pe~v~~--LI~~lL~~~~~~R 288 (288)
T PF14531_consen 235 QLGITLYSLWCGRLPFGLSSPEADP---------------EWDFSRCR-DMPEPVQF--LIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHSS-STCCCGGGSTS---------------GGGGTTSS----HHHHH--HHHHHT-SSGGGS
T ss_pred HHHHHHHHHHHccCCCCCCCccccc---------------cccchhcC-CcCHHHHH--HHHHHccCCcccC
Confidence 9999999999999999865332111 00122333 44444443 7778999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=178.89 Aligned_cols=191 Identities=14% Similarity=0.077 Sum_probs=139.9
Q ss_pred cccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEcCCC
Q 043053 707 VDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 707 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 785 (1058)
.+...|++|+||+||.+.. .+.+++.+.+...... ...-....+.+|+++++++. |++|++++++ ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~-------~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~ 72 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWW-------LRGVAWWLARREALALRQLDGLPRTPRLLHW----DG 72 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhh-------hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC
Confidence 3567899999999998866 4778877766322100 00111226889999999996 5889999886 45
Q ss_pred ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCC-CCCcEEEcCCCCeeeeccccce
Q 043053 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDI-KANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDi-kp~Nill~~~~~~kl~DfGl~~ 864 (1058)
.+++|||++|.+|...... . ...++.|++++++++|+. ||+|||| ||+|||++.++.++|+|||++.
T Consensus 73 ~~lvmeyI~G~~L~~~~~~---~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPPR---G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred EEEEEeeecCccHHhhhhh---h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 6999999999998754321 1 135778999999999999 9999999 7999999999999999999998
Q ss_pred eccCCCcc----c--c-----cccccCcCCccCccccccC-CCC-cccchhhHHHHHHHHHhCCCCCCCC
Q 043053 865 LVDDGDFA----R--S-----SNTVAGSYGYIAPEYGYMM-KIT-EKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 865 ~~~~~~~~----~--~-----~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
........ . . ......++.|++|+...-. ..+ ...+-++-|+-+|.++|++.|....
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 65543210 0 0 1123367888888853322 223 4678889999999999999887543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=182.99 Aligned_cols=151 Identities=21% Similarity=0.244 Sum_probs=114.1
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecCcccccccC---------CCCC------cccchHHHHHHHHHHHcccCCCcc
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAAN---------GCSD------EKSGVRDSFSAEIKTLGSIRHKNI 773 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~------~~~~~~~~~~~E~~~l~~l~h~ni 773 (1058)
.+.||+|+||.||+|...+|+.||||++.+....... .... ........+.+|++.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999997668999999998654211000 0000 000112345689999999999988
Q ss_pred cceeeEEEcCCCceEEEEecCCCChhhh-hhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEEcC
Q 043053 774 VRFLGCCWNRNNRLLMYDYMPNGSLGSL-LHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILIGL 851 (1058)
Q Consensus 774 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill~~ 851 (1058)
.....+... ..++||||++|+++... +. ...++...+.+++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 655554433 34899999998865443 33 2457788899999999999999999 8 999999999999999
Q ss_pred CCCeeeeccccceeccC
Q 043053 852 EFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~ 868 (1058)
++.++|+|||+++....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.1e-20 Score=219.19 Aligned_cols=246 Identities=26% Similarity=0.475 Sum_probs=166.6
Q ss_pred cccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhccccCCChhhhcccccchhhhcC
Q 043053 49 GLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAG 128 (1058)
Q Consensus 49 ~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~ 128 (1058)
+...|++++++++ .+|..+. .+|+.|+|++|+++ .+|..+. ++|++|++++|.+.
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt------------------- 233 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT------------------- 233 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-------------------
Confidence 3455666666665 5555443 35666666666655 4454432 34555555555444
Q ss_pred CCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCC
Q 043053 129 GNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGS 208 (1058)
Q Consensus 129 ~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~ 208 (1058)
.+|..+. .+|+.|++++|++. .+|..+. .+|+.|++++|++. .+|..+. ++|+.|+|++|+++ .
T Consensus 234 -------sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~ 297 (754)
T PRK15370 234 -------SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-T 297 (754)
T ss_pred -------cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-c
Confidence 3443332 25677777777776 5666554 47888899888887 5676554 58999999999998 4
Q ss_pred CCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCcccccccc
Q 043053 209 IPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANA 288 (1058)
Q Consensus 209 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 288 (1058)
+|..+. ++|+.|++++|.+.. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|++.. +|..+ .
T Consensus 298 LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~l--p 366 (754)
T PRK15370 298 LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETL--P 366 (754)
T ss_pred Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhh--c
Confidence 665543 479999999999984 555443 689999999999985 565553 799999999999984 55544 3
Q ss_pred ccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhh----hccCccccccccccccc
Q 043053 289 TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTL----ASCSNLQALDLSHNSLT 350 (1058)
Q Consensus 289 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~ 350 (1058)
++|+.|+|++|+++.+ |..+. ..|+.|++++|+++. +|..+ ..++++..|++.+|.+.
T Consensus 367 ~~L~~LdLs~N~Lt~L-P~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 PTITTLDVSRNALTNL-PENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCcCEEECCCCcCCCC-CHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence 6899999999999865 43332 367778888888773 34333 33456667777777665
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=186.73 Aligned_cols=197 Identities=22% Similarity=0.289 Sum_probs=136.2
Q ss_pred CCCcccceeeEEEc---------------------------CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHH
Q 043053 769 RHKNIVRFLGCCWN---------------------------RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLG 821 (1058)
Q Consensus 769 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 821 (1058)
+|||||++.++|.+ +...|+||..++. +|.+|+..+ ..+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999988743 2235899998865 999999863 3455566678999
Q ss_pred HHHHhhcccccCCCCeEeCCCCCCcEEEc--CCC--CeeeeccccceeccCCC----cccccccccCcCCccCccccccC
Q 043053 822 AAQGLAYLHHDCVPPIVHRDIKANNILIG--LEF--EPYIADFGLAKLVDDGD----FARSSNTVAGSYGYIAPEYGYMM 893 (1058)
Q Consensus 822 i~~~l~~LH~~~~~~ivHrDikp~Nill~--~~~--~~kl~DfGl~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~ 893 (1058)
+++|+.|||++ ||.|||+|++|||+. +|+ ...|+|||.+---+... +........|.-.-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 999999999999994 343 46899999875333211 22222344577889999986644
Q ss_pred CC------CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhcc
Q 043053 894 KI------TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCV 967 (1058)
Q Consensus 894 ~~------~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 967 (1058)
+- -.|+|.|+.|.+.||+++...||......--+... ++ +..-|.+.+..+....+ ++...+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yq-----e~qLPalp~~vpp~~rq------lV~~lL 494 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQ-----ESQLPALPSRVPPVARQ------LVFDLL 494 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hh-----hhhCCCCcccCChHHHH------HHHHHh
Confidence 31 24899999999999999999999863211111111 11 11123444444444333 455579
Q ss_pred CCCCCCCCCHHHHHHHH
Q 043053 968 NASPDERPTMKDVAAML 984 (1058)
Q Consensus 968 ~~dP~~RPt~~~v~~~l 984 (1058)
+.||.+|++..-....+
T Consensus 495 ~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 495 KRDPSKRVSPNIAANVL 511 (598)
T ss_pred cCCccccCCccHHHhHH
Confidence 99999999876554443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-20 Score=217.52 Aligned_cols=249 Identities=22% Similarity=0.233 Sum_probs=177.8
Q ss_pred hccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHH---HHHHHHcccCCCcccceeeEEE
Q 043053 705 CLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFS---AEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
++...+.+|.+.|=+|.+|+...|. |+||++.+.. ..-..+.|. .|++ ...++|||.+++.-+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~----------p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQD----------PTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccC----------CCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 5777899999999999999888787 8899985442 122233333 3444 55568999999998877
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
.....|+|-+|+.. +|+|.+..+ ..+...+..-|+.|++.|+..+|.. ||+|||||.+|||++.=+-+.|+||.
T Consensus 92 t~kAAylvRqyvkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred hhHHHHHHHHHHhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence 78888999999976 999999763 5677788888999999999999999 99999999999999999999999997
Q ss_pred cceec--cC---CCcccccccccCcCCccCcccccc----------CC-CCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043053 862 LAKLV--DD---GDFARSSNTVAGSYGYIAPEYGYM----------MK-ITEKSDVYSYGVVVLEVLT-GKQPIDPTIPD 924 (1058)
Q Consensus 862 l~~~~--~~---~~~~~~~~~~~gt~~y~aPE~~~~----------~~-~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 924 (1058)
.-+.. .. +++..-.++...-..|+|||.+.. .. .+++-||||+||+++|+++ |++||.-.
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--- 242 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--- 242 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---
Confidence 65432 11 122222233344558999996543 12 5678899999999999998 78888521
Q ss_pred ChhHHHHHHhhcCccccCCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 925 GSHVVDWVRQKKGIQVLDPSLLSR-PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
++..+.... .......... ... ....++..|++.||++|.++++.++.-+
T Consensus 243 --QL~aYr~~~---~~~~e~~Le~Ied~------~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 243 --QLLAYRSGN---ADDPEQLLEKIEDV------SLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred --HHHhHhccC---ccCHHHHHHhCcCc------cHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 222111110 0000000000 111 2234677799999999999999987643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.8e-19 Score=196.95 Aligned_cols=216 Identities=25% Similarity=0.468 Sum_probs=163.7
Q ss_pred HcccCCCcccceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCe-EeCCCC
Q 043053 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPI-VHRDIK 843 (1058)
Q Consensus 765 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-vHrDik 843 (1058)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... ...++|.....+.++++.||+|+|.. .| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 45678999999999999999999999999999999999863 57789999999999999999999997 44 899999
Q ss_pred CCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCC-------CCcccchhhHHHHHHHHHhCCC
Q 043053 844 ANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK-------ITEKSDVYSYGVVVLEVLTGKQ 916 (1058)
Q Consensus 844 p~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGvvl~elltg~~ 916 (1058)
+.|+++|....+|++|||+.................-..-|.|||.+.+.. .+.++||||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987664311111112223455799999877531 4667999999999999999999
Q ss_pred CCCCCCCCC--hhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 917 PIDPTIPDG--SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 917 P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
||+...... ......++. .......|.+.... +... ..+.++..||..+|++||+++++...++.+..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~~--e~~~--~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-GGSNPFRPSIELLN--ELPP--ELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh-cCCCCcCcchhhhh--hcch--HHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 998643322 233333333 12223333333221 1111 35568899999999999999999887766544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-19 Score=202.89 Aligned_cols=188 Identities=28% Similarity=0.354 Sum_probs=157.5
Q ss_pred eeccccceEEEEE----EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEcCCC
Q 043053 711 VIGKGCSGVVYRA----DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 711 ~lG~G~~g~Vy~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 785 (1058)
++|+|+||.|+.+ ....|..+|.|+.++.+..... +.....|..++...+ ||.+|++...+..+..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~---------~~~t~~er~il~~~~~~~f~v~lhyafqt~~k 71 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD---------RTHTKQERIILAFVHNTPFLVKLHYAFQTDGK 71 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc---------ccccccHHHHHhhccCCCceeeeeeeeccccc
Confidence 4799999999976 2345777999988766543211 125567788888887 9999999999999999
Q ss_pred ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
.+++++|..||+|...+.. ...+++.........++-|++++|+. +|+|||+|++||+++.+|.+++.|||+++.
T Consensus 72 l~l~ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 72 LYLILDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred hhHhhhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence 9999999999999988865 35566677777788889999999999 999999999999999999999999999986
Q ss_pred ccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 043053 866 VDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920 (1058)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 920 (1058)
.-... ..+||..|||||++. .+..++|-||||++.+||++|..||..
T Consensus 147 ~v~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 147 AVKEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hHhhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 54432 128999999999988 567889999999999999999999975
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-18 Score=206.00 Aligned_cols=251 Identities=22% Similarity=0.237 Sum_probs=185.5
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC---CCcccceeeEE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR---HKNIVRFLGCC 780 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~ 780 (1058)
+.|.+.+.+|+|+||+||+|...+|+.||+|+=.+.... +|.-=.+++.+++ -+-|..+..++
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--------------EfYI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--------------EFYICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--------------eeeehHHHHHhhchhhhcchHHHHHHH
Confidence 578889999999999999997777999999986554322 2222234444554 34566666777
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC-------CC
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-------EF 853 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-------~~ 853 (1058)
.-.+.-++|+||.+.|+|.+++.. .+.++|..++.++.|++..+++||.. +||||||||+|+||.. .-
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred ccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence 778888999999999999999984 57899999999999999999999999 9999999999999953 23
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
.++|+|||.+-.+.--.........++|-.+-.+|+..+++++..+|.|.++.+++.|+.|+.- +
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~---------------q 903 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM---------------E 903 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH---------------H
Confidence 6899999998654432222455677899999999999999999999999999999999999742 1
Q ss_pred hhcCc-cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 043053 934 QKKGI-QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993 (1058)
Q Consensus 934 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~ 993 (1058)
...+. ...+.. . +.....++... +....|+.|-..=|...++...++++..+..+
T Consensus 904 ~~~g~~~~~~~~-~--~Ry~~~~~W~~--~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 904 VKNGSSWMVKTN-F--PRYWKRDMWNK--FFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred hcCCcceecccc-c--hhhhhHHHHHH--HHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 11111 111111 1 11112333332 44556776666667888888888877665544
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-20 Score=171.53 Aligned_cols=167 Identities=33% Similarity=0.598 Sum_probs=92.6
Q ss_pred ccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccc
Q 043053 357 LFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQ 436 (1058)
Q Consensus 357 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 436 (1058)
++.+.+++.|.|++|+++ .+|+.+..+.+|+.|++.+|+|+.+ |..++.+++|+.|+++-|++. +.|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~l-p~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEEL-PTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhc-Chhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 334445555555555555 4444555555555555555555532 445555555555555555554 5555555555555
Q ss_pred hhhccCCccCC-CCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCC
Q 043053 437 MIDLSHNTLQG-SLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSN 515 (1058)
Q Consensus 437 ~L~l~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 515 (1058)
.|||.+|++.. .+|..|..+..|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.+.+|++|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 55555555532 35555555555555555555554 55555555555555555555554 45566666666666666666
Q ss_pred cccCCCChhhhhhH
Q 043053 516 QLTGSVPMELGQIE 529 (1058)
Q Consensus 516 ~l~~~~p~~~~~l~ 529 (1058)
+++ .+|.+++++.
T Consensus 184 rl~-vlppel~~l~ 196 (264)
T KOG0617|consen 184 RLT-VLPPELANLD 196 (264)
T ss_pred eee-ecChhhhhhh
Confidence 665 4555554443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-20 Score=172.88 Aligned_cols=167 Identities=31% Similarity=0.467 Sum_probs=123.0
Q ss_pred CCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhccccCCChhhhcccccch
Q 043053 44 IGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLE 123 (1058)
Q Consensus 44 l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~ 123 (1058)
+-.+.+++.|-||+|+++ .+|..|..|.+|+.|++++|+++ ++|.+++.+++|++|++.-|++. .+|++||.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 344556667777777776 66777777777777777777776 67777777777777777777766 6777777777777
Q ss_pred hhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCC
Q 043053 124 EMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYEN 203 (1058)
Q Consensus 124 ~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n 203 (1058)
.|++..|+.-...+|..+..++.|+.|++++|.+. .+|..++++++||.|.++.|.+. .+|.+++.+++|++|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 77777776555677887888888888888888876 77778888888888888777766 67777888888888888888
Q ss_pred cCCCCCCCCcCCC
Q 043053 204 SLSGSIPPEIGKL 216 (1058)
Q Consensus 204 ~l~~~~~~~~~~l 216 (1058)
+++ .+|..++.+
T Consensus 184 rl~-vlppel~~l 195 (264)
T KOG0617|consen 184 RLT-VLPPELANL 195 (264)
T ss_pred eee-ecChhhhhh
Confidence 777 556555543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=170.69 Aligned_cols=136 Identities=19% Similarity=0.251 Sum_probs=105.0
Q ss_pred cccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-----CCCcccceeeEEE
Q 043053 707 VDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-----RHKNIVRFLGCCW 781 (1058)
Q Consensus 707 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~ 781 (1058)
...+.||+|+||.||. .-.++.. +||++... .....+.+.+|+.+++.+ .||||++++|++.
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~-----------~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~e 71 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHR-----------GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVE 71 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEecc-----------ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEE
Confidence 3467899999999996 3344444 79987532 112356799999999999 5799999999998
Q ss_pred cCC---C-ceEEEEe--cCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHh-hcccccCCCCeEeCCCCCCcEEEcCC--
Q 043053 782 NRN---N-RLLMYDY--MPNGSLGSLLHERTGNALEWELRYQILLGAAQGL-AYLHHDCVPPIVHRDIKANNILIGLE-- 852 (1058)
Q Consensus 782 ~~~---~-~~lv~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivHrDikp~Nill~~~-- 852 (1058)
++. . +.+|||| +++|+|.+++++. .+++. ..++.+++.++ +|||++ +||||||||+|||++..
T Consensus 72 t~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~ 143 (210)
T PRK10345 72 TDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISE 143 (210)
T ss_pred eCCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCC
Confidence 864 2 2378999 6679999999652 35555 35677888777 999999 99999999999999743
Q ss_pred --CCeeeeccccc
Q 043053 853 --FEPYIADFGLA 863 (1058)
Q Consensus 853 --~~~kl~DfGl~ 863 (1058)
+.++|+||+.+
T Consensus 144 ~~~~~~LiDg~G~ 156 (210)
T PRK10345 144 SEVIPVVCDNIGE 156 (210)
T ss_pred CCCcEEEEECCCC
Confidence 37999995443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=173.36 Aligned_cols=153 Identities=18% Similarity=0.185 Sum_probs=113.7
Q ss_pred ccccceeccccceEEEEEE--ecCCcEEEEEecCcccccccCC-------------CCCcccchHHHHHHHHHHHcccCC
Q 043053 706 LVDANVIGKGCSGVVYRAD--MDNGEVIAVKKLWPTTMAAANG-------------CSDEKSGVRDSFSAEIKTLGSIRH 770 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~~~-------------~~~~~~~~~~~~~~E~~~l~~l~h 770 (1058)
|.+.+.||+|+||.||+|. ..+|+.||||++.......... ...........+.+|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6778899999999999996 5789999999986432110000 000001122456789999999975
Q ss_pred C--cccceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCC-eEeCCCCCCcE
Q 043053 771 K--NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPP-IVHRDIKANNI 847 (1058)
Q Consensus 771 ~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivHrDikp~Ni 847 (1058)
. .+.+++++ ...++||||++|+++..+... ........+..++.|++.+++++|.. + |+||||||+||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 3 34444442 245899999999888776532 23456666789999999999999999 8 99999999999
Q ss_pred EEcCCCCeeeeccccceeccC
Q 043053 848 LIGLEFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 848 ll~~~~~~kl~DfGl~~~~~~ 868 (1058)
+++ ++.++++|||.+.....
T Consensus 181 li~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEE-CCCEEEEEChhhhccCC
Confidence 999 88999999999875443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.9e-20 Score=204.56 Aligned_cols=112 Identities=23% Similarity=0.332 Sum_probs=64.2
Q ss_pred cCCCCCcEEEccCccccCCc----cccccCccccceeeccCccCCCCCCCccc-----CCcccchhhccCCccCC----C
Q 043053 382 GNCSSLVRLRVGNNRIAGLI----PREIGGLKTLNFLDLSSNRLSGSVPDEIG-----DCTELQMIDLSHNTLQG----S 448 (1058)
Q Consensus 382 ~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~----~ 448 (1058)
..+++|+.|++++|.+++.. ...+..+++|++|++++|.+++.....+. ..+.|+.|++++|.++. .
T Consensus 190 ~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~ 269 (319)
T cd00116 190 KANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKD 269 (319)
T ss_pred HhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHH
Confidence 33456666666666665332 22344556677777777766542222221 13577777777777752 2
Q ss_pred CccccccCCCCCeeecCCCccccC----Cccccccc-ccccccccccccC
Q 043053 449 LPNSLSSLSGLQVLDVSDNRFSGQ----IPASLGRL-VSLNKIILSKNLF 493 (1058)
Q Consensus 449 ~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l-~~L~~L~Ls~N~l 493 (1058)
+...+..+++|+++++++|.++.. ....+... ..|+.|++.+|++
T Consensus 270 l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 270 LAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 334455567778888888877743 22333333 5777777777754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-19 Score=202.64 Aligned_cols=157 Identities=23% Similarity=0.305 Sum_probs=105.8
Q ss_pred ccchhhhccccCCCC----CCCCCccCCCCCcEEEccCccccCC----ccccccCccccceeeccCccCCCCC----CCc
Q 043053 361 QNLTKLLLISNDISG----SIPPEIGNCSSLVRLRVGNNRIAGL----IPREIGGLKTLNFLDLSSNRLSGSV----PDE 428 (1058)
Q Consensus 361 ~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~ 428 (1058)
++|+.|++++|.+++ ..+..+..+.+|++|++++|.+++. .+..+..+++|++|+|++|.+++.. +..
T Consensus 137 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 216 (319)
T cd00116 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAET 216 (319)
T ss_pred CCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHH
Confidence 344444444444442 1223455667788888888888742 2334555679999999999887432 334
Q ss_pred ccCCcccchhhccCCccCCCCccccc-----cCCCCCeeecCCCcccc----CCcccccccccccccccccccCCCC---
Q 043053 429 IGDCTELQMIDLSHNTLQGSLPNSLS-----SLSGLQVLDVSDNRFSG----QIPASLGRLVSLNKIILSKNLFSGP--- 496 (1058)
Q Consensus 429 ~~~l~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~--- 496 (1058)
+..+++|+.|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++|+.+++++|.++..
T Consensus 217 ~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~ 296 (319)
T cd00116 217 LASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQ 296 (319)
T ss_pred hcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHH
Confidence 56778899999999998853333332 23789999999998862 2334556668899999999999854
Q ss_pred -CCCcccCC-cccccccccCCcc
Q 043053 497 -IPSSLGLC-SSLQLLDLSSNQL 517 (1058)
Q Consensus 497 -~~~~~~~l-~~L~~L~l~~N~l 517 (1058)
....+... +.|+.|++.+|++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 297 LLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHHhhcCCchhhcccCCCCC
Confidence 33444444 6888999988864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.2e-17 Score=168.53 Aligned_cols=142 Identities=18% Similarity=0.301 Sum_probs=115.6
Q ss_pred ceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEE
Q 043053 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLM 789 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 789 (1058)
+.||+|++|.||+|.. .|..|+||+......... ..........+.+|++++..+.|++|.....++......++|
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHP---ELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcCh---HHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEE
Confidence 5799999999999976 578899998653321100 001112235688999999999999998888888778888999
Q ss_pred EEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 790 YDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 790 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
|||++|++|.+++.... + .+..++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999986531 1 7789999999999999999 999999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.6e-16 Score=164.45 Aligned_cols=148 Identities=19% Similarity=0.130 Sum_probs=111.2
Q ss_pred ccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCC-----------CCcccchHHHHHHHHHHHcccCCC--c
Q 043053 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGC-----------SDEKSGVRDSFSAEIKTLGSIRHK--N 772 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~h~--n 772 (1058)
|...+.||+|+||.||+|...+|+.||||++........... ..........+.+|..++.++.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 667789999999999999777899999998754321100000 000011223477899999999887 4
Q ss_pred ccceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 773 IVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 773 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
++..++ ....++||||++|++|.+.... .....++.++++++.++|+. +|+||||||+||+++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 444443 2456999999999999776431 23467889999999999998 99999999999999999
Q ss_pred CCeeeeccccceeccC
Q 043053 853 FEPYIADFGLAKLVDD 868 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~ 868 (1058)
+.++|+|||.+.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999875544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-16 Score=187.25 Aligned_cols=144 Identities=19% Similarity=0.287 Sum_probs=114.2
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
..|...+.||+|+||+||+|.+.. +.+++|+......... ..+.....+++.+|++++++++|++++..+.++..+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHP---ELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC-ccceeEEEecccccch---hHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 445678999999999999997653 4455554322211100 001122346789999999999999999888888887
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||++|++|.+++. ....++.++++++.|||+. +++|||+||+||++ .++.++|+|||++
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 78899999999999999885 2467899999999999999 99999999999999 6789999999998
Q ss_pred ee
Q 043053 864 KL 865 (1058)
Q Consensus 864 ~~ 865 (1058)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-17 Score=180.52 Aligned_cols=174 Identities=24% Similarity=0.390 Sum_probs=130.7
Q ss_pred CceEEEEecCCCChhhhhhhc-CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 785 NRLLMYDYMPNGSLGSLLHER-TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
..|+.|++|.-.+|.+|+.++ .....++.....++.|++.|++| + +.+|||+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999743 35667889999999999999999 5 8899999999999999999999999998
Q ss_pred eeccCCC----cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 864 KLVDDGD----FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 864 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
....... .....+...||..||+||.+.+..|+.|+||||+|++++|+++ -..+++.. .. .. ....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----~t---~~-d~r~ 474 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----AT---LT-DIRD 474 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----Hh---hh-hhhc
Confidence 8765543 2234556779999999999999999999999999999999998 22222211 00 00 0011
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v 980 (1058)
..++|... .+...-..+..+++.+.|.+||++.++
T Consensus 475 g~ip~~~~-------~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 475 GIIPPEFL-------QDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred CCCChHHh-------hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 12222222 222233456777899999999954443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.6e-16 Score=164.98 Aligned_cols=138 Identities=22% Similarity=0.386 Sum_probs=109.8
Q ss_pred eeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEE
Q 043053 711 VIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMY 790 (1058)
Q Consensus 711 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 790 (1058)
.||+|+||.||+|.. +|..|++|+......... ..+......++.+|++++..++|+++.....++......++||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHP---ELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCc---hHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEE
Confidence 489999999999985 478899998643211100 0011122467889999999999988776666666777789999
Q ss_pred EecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 791 DYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 791 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
||++|++|.+++.... . .++.++++++.++|+. +++|||++|+||+++ ++.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999999886421 1 7899999999999999 999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.5e-17 Score=189.89 Aligned_cols=258 Identities=24% Similarity=0.268 Sum_probs=194.4
Q ss_pred hhccccceeccccceEEEEEEe--cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEE
Q 043053 704 KCLVDANVIGKGCSGVVYRADM--DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCC 780 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 780 (1058)
..|.+.+-||+|+|+.|-.+.. .....+|+|.+.... ......+....|..+-..+. |+|++++++..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~ 90 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS 90 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---------CccchhhhcCccccccccccccccccccCCcc
Confidence 4566677799999999998844 344556666653321 23344566667888888887 99999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhccc-ccCCCCeEeCCCCCCcEEEcCCC-Ceeee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEF-EPYIA 858 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivHrDikp~Nill~~~~-~~kl~ 858 (1058)
.+.+.+++++||.+||++.+.+........+...+-..+.|+..++.|+| .. ++.||||||+|.+++..+ ..+++
T Consensus 91 ~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~ 167 (601)
T KOG0590|consen 91 SSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIA 167 (601)
T ss_pred CCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCC
Confidence 99999999999999999999994222225666677789999999999999 77 999999999999999999 99999
Q ss_pred ccccceeccC-CCcccccccccC-cCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 859 DFGLAKLVDD-GDFARSSNTVAG-SYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 859 DfGl~~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
|||+|..+.. ..........+| ++.|+|||...+. ...+..|+||.|+++..+++|..||+........+..|....
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~ 247 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK 247 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc
Confidence 9999998877 455556667778 9999999998874 456789999999999999999999986655444444444332
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
.. .....+..... ..+++...++..+|..|.+..++..
T Consensus 248 ~~---~~~~~~~~~~~------~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GR---FTQLPWNSISD------QAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cc---cccCccccCCh------hhhhcccccccCCchhccccccccc
Confidence 11 00111111111 2233556678899999999888765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=5e-16 Score=181.70 Aligned_cols=208 Identities=23% Similarity=0.285 Sum_probs=138.9
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
..|..++.|..|++|.||.+++ .+.+.+|+| +.+... +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----------------ilRn--ilt~a~npfvv-------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----------------ILRN--ILTFAGNPFVV-------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch----------------hhhc--cccccCCccee--------
Confidence 5677889999999999999944 456778884 422211 0110 22222333333
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
|+-.+.++.. ++++.+. +.+++|+|+. +|+|||+||+|.+|+.-|.+|++|||+
T Consensus 136 -------------gDc~tllk~~--g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgL 189 (1205)
T KOG0606|consen 136 -------------GDCATLLKNI--GPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGL 189 (1205)
T ss_pred -------------chhhhhcccC--CCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhh
Confidence 4555555542 3333332 7889999999 999999999999999999999999999
Q ss_pred ceeccCC--------C-----cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHH
Q 043053 863 AKLVDDG--------D-----FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVV 929 (1058)
Q Consensus 863 ~~~~~~~--------~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 929 (1058)
++..-.. . ..-....++||+.|.|||++....|....|-|++|+++||.+.|+.||.+.+|++ -+.
T Consensus 190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg 268 (1205)
T KOG0606|consen 190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFG 268 (1205)
T ss_pred hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHh
Confidence 8643210 0 0111345689999999999999999999999999999999999999999876542 122
Q ss_pred HHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC
Q 043053 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERP 975 (1058)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP 975 (1058)
.++...... ... ....+.+..+ ++.+.++.+|..|-
T Consensus 269 ~visd~i~w---pE~-dea~p~Ea~d------li~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 269 QVISDDIEW---PEE-DEALPPEAQD------LIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhhccc---ccc-CcCCCHHHHH------HHHHHHHhChHhhc
Confidence 222222111 111 1222333333 44456888898885
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.3e-15 Score=150.47 Aligned_cols=148 Identities=21% Similarity=0.221 Sum_probs=100.0
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCC---------c----ccchHHHHHHHHHHHcccCCCc--c
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSD---------E----KSGVRDSFSAEIKTLGSIRHKN--I 773 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~---------~----~~~~~~~~~~E~~~l~~l~h~n--i 773 (1058)
.+.||+|+||+||+|...+++.||||++............. . ..........|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999977789999999886432110000000 0 0000011245666666665433 4
Q ss_pred cceeeEEEcCCCceEEEEecCCCChhhh-hhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEEcC
Q 043053 774 VRFLGCCWNRNNRLLMYDYMPNGSLGSL-LHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILIGL 851 (1058)
Q Consensus 774 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill~~ 851 (1058)
.+.+++ ...++||||++++++... +... ... ..+..++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 444443 246999999999654321 2111 011 5577899999999999999 7 999999999999999
Q ss_pred CCCeeeeccccceeccC
Q 043053 852 EFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~ 868 (1058)
++.++++|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2e-14 Score=152.10 Aligned_cols=146 Identities=20% Similarity=0.212 Sum_probs=109.2
Q ss_pred cceec-cccceEEEEEEecCCcEEEEEecCcccccccCC--CCCcccchHHHHHHHHHHHcccCCCcc--cceeeEEEcC
Q 043053 709 ANVIG-KGCSGVVYRADMDNGEVIAVKKLWPTTMAAANG--CSDEKSGVRDSFSAEIKTLGSIRHKNI--VRFLGCCWNR 783 (1058)
Q Consensus 709 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~ 783 (1058)
...|| .|+.|+||.+... +..++||.+.......+.. ...........+.+|++++.+++|++| ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 56788 9999999999776 7789999885432211100 000112335678999999999998875 6777765443
Q ss_pred CC-c---eEEEEecCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 784 NN-R---LLMYDYMPN-GSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 784 ~~-~---~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
.. . ++||||++| .+|.+++.. ..++.. .+.++++++.+||+. ||+||||||+|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 22 2 599999997 689998864 234443 357899999999999 99999999999999999999999
Q ss_pred cccccee
Q 043053 859 DFGLAKL 865 (1058)
Q Consensus 859 DfGl~~~ 865 (1058)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.6e-14 Score=141.32 Aligned_cols=135 Identities=19% Similarity=0.160 Sum_probs=113.4
Q ss_pred ccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC--CcccceeeEEEcCCC
Q 043053 708 DANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH--KNIVRFLGCCWNRNN 785 (1058)
Q Consensus 708 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~ 785 (1058)
+.+.||+|.++.||++.... ..++||.+.... . ...+.+|+..++.++| .+++++++++...+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~------------~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~ 67 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSRE------------K-GADREREVAILQLLARKGLPVPKVLASGESDGW 67 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCC------------c-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc
Confidence 35789999999999997764 789999874321 1 4678999999999986 599999998888888
Q ss_pred ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
.+++|||++++.+..+ +......++.+++++++++|.....+++|||++|+||++++++.++++|||.++.
T Consensus 68 ~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 68 SYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999999999877655 4556678899999999999986445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.9e-13 Score=157.38 Aligned_cols=163 Identities=17% Similarity=0.192 Sum_probs=110.1
Q ss_pred cHHHHHhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccC--------------CCCC-----cccc----h
Q 043053 698 SVEQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAAN--------------GCSD-----EKSG----V 754 (1058)
Q Consensus 698 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~-----~~~~----~ 754 (1058)
..++++..|. .+.||.|++|.||+|...+|+.||||+.++....... .... .... .
T Consensus 112 ~~~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~ 190 (437)
T TIGR01982 112 PLEELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEF 190 (437)
T ss_pred CHHHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHH
Confidence 4455556555 4789999999999999999999999998654211000 0000 0000 0
Q ss_pred ------HHHHHHHHHHHcccC----CCcccceeeEE-EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHH
Q 043053 755 ------RDSFSAEIKTLGSIR----HKNIVRFLGCC-WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823 (1058)
Q Consensus 755 ------~~~~~~E~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~ 823 (1058)
.-+|.+|++.+.+++ |..-+.+-.++ ......++||||++|++|.++...... .. .+.+++.+++
T Consensus 191 ~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~ 266 (437)
T TIGR01982 191 EKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLA 266 (437)
T ss_pred HHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHH
Confidence 013666777777763 22222332233 224557999999999999998754211 12 2345666666
Q ss_pred H-HhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccC
Q 043053 824 Q-GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 824 ~-~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~ 868 (1058)
. .+..+|.. |++|+|+||.||+++.+++++++|||++....+
T Consensus 267 ~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 267 RSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6 46788988 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.6e-14 Score=156.48 Aligned_cols=189 Identities=31% Similarity=0.470 Sum_probs=130.7
Q ss_pred hhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccc
Q 043053 318 FFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRI 397 (1058)
Q Consensus 318 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 397 (1058)
.+++.|++. .+|..++.+..|+.+.|+.|.+. .+|..+.++..|++|+|+.|+++ ..|..++.|+ |+.|.+++|++
T Consensus 80 aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl 155 (722)
T KOG0532|consen 80 ADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKL 155 (722)
T ss_pred hhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCcc
Confidence 333444433 34555555566666666666666 56666666667777777777776 5666677665 78888888888
Q ss_pred cCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccc
Q 043053 398 AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL 477 (1058)
Q Consensus 398 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 477 (1058)
+. .|..++.+..|..||.+.|.+. .+|..++.+.+|+.|++..|++.. +|..+..| .|..||+|.|+++ .+|..|
T Consensus 156 ~~-lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~~L-pLi~lDfScNkis-~iPv~f 230 (722)
T KOG0532|consen 156 TS-LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELCSL-PLIRLDFSCNKIS-YLPVDF 230 (722)
T ss_pred cc-CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHhCC-ceeeeecccCcee-ecchhh
Confidence 74 4667777788888888888887 667778888888888888888874 56666654 4778888888887 788888
Q ss_pred cccccccccccccccCCCCCCCccc---CCcccccccccCCc
Q 043053 478 GRLVSLNKIILSKNLFSGPIPSSLG---LCSSLQLLDLSSNQ 516 (1058)
Q Consensus 478 ~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~l~~N~ 516 (1058)
.+|..|++|-|.+|++. ..|..+. ...-.++|+....+
T Consensus 231 r~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 231 RKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred hhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 88888888888888887 4454443 22334566666554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.7e-14 Score=154.54 Aligned_cols=213 Identities=27% Similarity=0.424 Sum_probs=165.4
Q ss_pred EEEccCCcCCCCCCCCC--CCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhh
Q 043053 28 TLVISDANLTGSIPFDI--GDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFD 105 (1058)
Q Consensus 28 ~L~l~~~~~~~~~p~~l--~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~ 105 (1058)
+|.|++-++. ..|..- -.+..-...||+.|++. ++|..++.+..|+.|.|..|.+. .+|..++++..|++|+|+.
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 3455555554 344321 34555567888899888 89988888888999999888887 7888899999999999999
Q ss_pred ccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeecccccccc
Q 043053 106 NALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEI 185 (1058)
Q Consensus 106 n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~ 185 (1058)
|++. .+|..++.|. |+.|-+++|+ ...+|+.++.+..|..|+.+.|.+. .+|..++.+.+|+.|.++.|++. .+
T Consensus 131 NqlS-~lp~~lC~lp-Lkvli~sNNk--l~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~l 204 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP-LKVLIVSNNK--LTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DL 204 (722)
T ss_pred chhh-cCChhhhcCc-ceeEEEecCc--cccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hC
Confidence 9888 8888888885 8888888887 7788888888888888888888887 78888888888888888888887 67
Q ss_pred CccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCcccc---CcCCccEEEeecCC
Q 043053 186 PAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIG---NCTSLKMIDFSLNS 252 (1058)
Q Consensus 186 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~---~l~~L~~L~L~~n~ 252 (1058)
|++++. -.|..||++.|++. .+|-.|.+|+.|++|.|.+|.+. ..|..+. ...=.++|+..-|+
T Consensus 205 p~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 205 PEELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred CHHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 777774 45888899999888 78888888899999999888887 4454442 22334555555553
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.5e-13 Score=153.46 Aligned_cols=161 Identities=14% Similarity=0.199 Sum_probs=104.7
Q ss_pred ccHHHHHhhccccceeccccceEEEEEEecC-CcEEEEEecCccccccc------------------CC-CCCccc----
Q 043053 697 FSVEQVLKCLVDANVIGKGCSGVVYRADMDN-GEVIAVKKLWPTTMAAA------------------NG-CSDEKS---- 752 (1058)
Q Consensus 697 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~------------------~~-~~~~~~---- 752 (1058)
-..++++..|+. +.||+|++|.||+|...+ |+.||||+.++...... .. ..-+-.
T Consensus 113 ~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~ 191 (537)
T PRK04750 113 GPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA 191 (537)
T ss_pred CCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence 456777788887 899999999999998776 99999999976521100 00 000000
Q ss_pred chHH------HHHHHHHHHcccC----CCcccceeeEEEc-CCCceEEEEecCCCChhhhhhhcCCC----CCCHHHHHH
Q 043053 753 GVRD------SFSAEIKTLGSIR----HKNIVRFLGCCWN-RNNRLLMYDYMPNGSLGSLLHERTGN----ALEWELRYQ 817 (1058)
Q Consensus 753 ~~~~------~~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~----~l~~~~~~~ 817 (1058)
+..+ +|.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++-.-...+ .+....+..
T Consensus 192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence 1111 3455665555553 4444444444433 45678999999999998753211111 233333333
Q ss_pred HHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC----CeeeeccccceeccC
Q 043053 818 ILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF----EPYIADFGLAKLVDD 868 (1058)
Q Consensus 818 i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~----~~kl~DfGl~~~~~~ 868 (1058)
++.|+ +.. |++|+|+||.||+++.++ +++++|||++.....
T Consensus 272 ~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 FFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 44444 345 999999999999999988 999999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-12 Score=147.44 Aligned_cols=251 Identities=24% Similarity=0.255 Sum_probs=182.0
Q ss_pred hhccccceecc--ccceEEEEEE---ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCccccee
Q 043053 704 KCLVDANVIGK--GCSGVVYRAD---MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~--G~~g~Vy~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 777 (1058)
..+...+.+|. |.+|.||.+. ..++..+|+|+-.... ........=.+|+...+.++ |++.++.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~---------s~p~~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF---------SPPLDSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCC---------CCccccccccchhhcccccCccccccccC
Confidence 45667788999 9999999994 4678889999742221 11112233356777777776 99999988
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHH----HhhcccccCCCCeEeCCCCCCcEEEcCC-
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ----GLAYLHHDCVPPIVHRDIKANNILIGLE- 852 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivHrDikp~Nill~~~- 852 (1058)
..+...+..++-+|++. .++.++.+.. ...++....+.+..+..+ |+.++|.. +++|-|+||.||+...+
T Consensus 185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDW 259 (524)
T ss_pred cccccCCcceeeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccc
Confidence 88888899999999994 6898888764 455788888889999988 99999999 99999999999999999
Q ss_pred CCeeeeccccceeccCCCccccc---ccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHH
Q 043053 853 FEPYIADFGLAKLVDDGDFARSS---NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVV 929 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 929 (1058)
...+++|||+...+..+.+.... ....|...|++||...+ .++.++|+|++|.++.+..++..+..... ..
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----~~ 333 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK-----NS 333 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC-----CC
Confidence 89999999999988776643322 22257889999998655 46789999999999999999876553221 11
Q ss_pred HHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 043053 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAA 982 (1058)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~ 982 (1058)
.|.+..... +..+........... .+..+++.+|..|++++.+.+
T Consensus 334 ~W~~~r~~~--ip~e~~~~~s~~l~~------~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 SWSQLRQGY--IPLEFCEGGSSSLRS------VTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred Ccccccccc--CchhhhcCcchhhhh------HHHHhcCcchhhhhHHHHHhc
Confidence 222222111 112222222222111 455689999999999887765
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.3e-12 Score=151.03 Aligned_cols=175 Identities=35% Similarity=0.514 Sum_probs=71.9
Q ss_pred hhhhHHhhhhccccCCChhhhcccc-cchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCcccee
Q 043053 96 KSLRKLLLFDNALAGNIPAELGRLS-NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTL 174 (1058)
Q Consensus 96 ~~L~~L~L~~n~~~~~~p~~l~~l~-~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L 174 (1058)
+.++.|++.+|.++ .+|...+.+. +|+.|++++|. +..+|..++.+++|+.|++++|++. .+|...+.+++|+.|
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~--i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L 191 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK--IESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccc--hhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence 34444444444443 3443333332 44444444443 3333333444444444444444443 333333344444444
Q ss_pred eeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCc
Q 043053 175 SIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLS 254 (1058)
Q Consensus 175 ~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 254 (1058)
++++|++. .+|..+..+..|++|.+++|.+. ..+..+.+++++..|.+.+|++. ..+..++.+++++.|++++|.++
T Consensus 192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 192 DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc
Confidence 44444443 33333333333444444444322 23333444444444444444443 12333444444444444444444
Q ss_pred CcCCccccccCCcceeecccCccCC
Q 043053 255 GTIPLSIGGLSELEEFMISDNNVSG 279 (1058)
Q Consensus 255 ~~~~~~~~~l~~L~~L~l~~n~l~~ 279 (1058)
.... ++.+.+++.|++++|.+..
T Consensus 269 ~i~~--~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 269 SISS--LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred cccc--ccccCccCEEeccCccccc
Confidence 2221 4444444444444444443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.5e-12 Score=150.57 Aligned_cols=199 Identities=34% Similarity=0.491 Sum_probs=127.0
Q ss_pred EEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccch-hhhHHhhhhccccCCChhhhcccccchhhhcCCC
Q 043053 52 VLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCK-SLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGN 130 (1058)
Q Consensus 52 ~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~-~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~ 130 (1058)
.|+++.+.+. ..+..+..+..+..|++.+|+++ .+|.....+. +|+.|++++|.+. .+|..++.+++|+.|+++.|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4666666654 34444555566666666666666 5666666663 6666666666666 56666666666666666666
Q ss_pred ccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCC
Q 043053 131 KDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIP 210 (1058)
Q Consensus 131 ~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 210 (1058)
. +..+|...+.+++|+.|++++|++. .+|..+.....|++|.+++|.+. ..+..+.++.++..|.+.+|++. .++
T Consensus 174 ~--l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 174 D--LSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred h--hhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 6 5566665556666777777777666 56665555666777777776433 45556666677777777777666 335
Q ss_pred CCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCcc
Q 043053 211 PEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLS 260 (1058)
Q Consensus 211 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 260 (1058)
..++.+++|+.|++++|.+... +. ++.+.+|+.|++++|.+....+..
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred chhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhh
Confidence 6666777777777777777633 22 667777777777777776554443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.8e-12 Score=131.78 Aligned_cols=206 Identities=22% Similarity=0.314 Sum_probs=140.0
Q ss_pred HHHHcccCCCcccceeeEEEcCC-----CceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCC
Q 043053 762 IKTLGSIRHKNIVRFLGCCWNRN-----NRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCV 834 (1058)
Q Consensus 762 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 834 (1058)
...+-++.|-|||++..|+.+.+ ...++.||++.|++..++++.+ ...+....-.+|+.||..||.|||+ +.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 44555667999999999987643 3578999999999999998633 4567777778999999999999999 46
Q ss_pred CCeEeCCCCCCcEEEcCCCCeeeeccccceecc--CCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHH
Q 043053 835 PPIVHRDIKANNILIGLEFEPYIADFGLAKLVD--DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 912 (1058)
Q Consensus 835 ~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ell 912 (1058)
|.|+|+++.-+-|++..+|-+|++----..... ............+-++|.|||.......+.++|||+||+...||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 799999999999999988888874211110000 000011122345678999999988888889999999999999999
Q ss_pred hCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 913 TGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 913 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.+..--..... .-..+........ .....+ ..+.+..|++..|..||+|.+++.+.
T Consensus 277 ilEiq~tnseS--~~~~ee~ia~~i~-~len~l-------------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSES--KVEVEENIANVII-GLENGL-------------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcc--eeehhhhhhhhee-eccCcc-------------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 87653211100 0000000000000 000000 01255669999999999999887653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.8e-11 Score=115.23 Aligned_cols=151 Identities=18% Similarity=0.260 Sum_probs=118.9
Q ss_pred ccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCce
Q 043053 708 DANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 708 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 787 (1058)
....+-||+-+.|+++.+. |+...||.-.++..... .-+..-.+++..+|++.+.+++--.|.-..-++.+.....
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP---~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHP---ALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ 86 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccch---HHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe
Confidence 4568899999999999887 88888886544433211 1122234577889999999998667777777788888889
Q ss_pred EEEEecCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC---Ceeeeccccc
Q 043053 788 LMYDYMPN-GSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF---EPYIADFGLA 863 (1058)
Q Consensus 788 lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~---~~kl~DfGl~ 863 (1058)
++|||++| .++.+++.+..............+..|-+.+.-||.. +|||||+.++||++..++ .+.++|||++
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecch
Confidence 99999977 4899999876655555555578899999999999999 999999999999997765 3589999998
Q ss_pred ee
Q 043053 864 KL 865 (1058)
Q Consensus 864 ~~ 865 (1058)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.4e-12 Score=151.60 Aligned_cols=65 Identities=40% Similarity=0.632 Sum_probs=37.8
Q ss_pred CCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCCh
Q 043053 459 LQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPM 523 (1058)
Q Consensus 459 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 523 (1058)
++.|+|++|.++|.+|..+..+++|+.|+|++|.|.+.+|..+..+++|+.|+|++|+++|.+|.
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~ 484 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCch
Confidence 45555566665555555555555666666666666555555555666666666666655554443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.5e-13 Score=140.09 Aligned_cols=225 Identities=20% Similarity=0.241 Sum_probs=137.5
Q ss_pred ccccCCCCCcEEEccCCcCCC----CCCCCCCCCCcccEEecCCC---CCCCCCChhh-------cCcccCCEEeccccC
Q 043053 18 TNLSSFKHLQTLVISDANLTG----SIPFDIGDCVGLIVLDFSSN---NLVGTLPSSL-------GKLHNLEELILNSNQ 83 (1058)
Q Consensus 18 ~~~~~~~~L~~L~l~~~~~~~----~~p~~l~~l~~L~~L~l~~~---~i~~~lp~~l-------~~l~~L~~L~L~~n~ 83 (1058)
+.+.++..++.|+||+|.+.. .+...+...+.|+..++|+- ...+++|+.+ ..++.|++||||.|-
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 345678899999999998832 34455677889999999885 3444677655 455799999999998
Q ss_pred CCCccccc----cccchhhhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccc
Q 043053 84 LTGKIPVE----LSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSG 159 (1058)
Q Consensus 84 ~~~~~p~~----l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~ 159 (1058)
+....+.. +..+..|++|+|.+|.+.-.--..+++ .|.+|. .+. -.+.-++|+++...+|++.+
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k--------k~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK--------KAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh--------ccCCCcceEEEEeecccccc
Confidence 87554444 457889999999999876211122333 233333 111 12334678888888887763
Q ss_pred cCCc----cccCCCccceeeeecccccccc----CccccCCCCccEEEccCCcCCCC----CCCCcCCCCCcceeecccc
Q 043053 160 SLPA----SLGKLSKLQTLSIYTTMISGEI----PAEIGNCSELVSLFLYENSLSGS----IPPEIGKLKKLEELFLWQN 227 (1058)
Q Consensus 160 ~~~~----~l~~l~~L~~L~l~~n~i~~~~----~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n 227 (1058)
.... .|...+.|+.+.++.|.|.... ...+..|++|+.|||.+|.++.. +...++.+++|+.|++++|
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 3322 2444566777777776654322 23455677777777777766532 2234455566666666666
Q ss_pred cccCCCCccc-----cCcCCccEEEeecCCCc
Q 043053 228 SLVGAIPEEI-----GNCTSLKMIDFSLNSLS 254 (1058)
Q Consensus 228 ~l~~~~~~~l-----~~l~~L~~L~L~~n~l~ 254 (1058)
.+.......| ...++|+.|.+.+|.|+
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred ccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 6654433332 12345555555555554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.8e-11 Score=123.54 Aligned_cols=130 Identities=15% Similarity=0.099 Sum_probs=96.3
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccc-ceeeEEEcCCCce
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIV-RFLGCCWNRNNRL 787 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~ 787 (1058)
.+.++.|.++.||++... ++.|++|...... .....+.+|+.+++.+.+.+++ +++++. ....+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~------------~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~ 67 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT------------ELLINRENEAENSKLAAEAGIGPKLYYFD--PETGV 67 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCc------------ccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCe
Confidence 467899999999999766 7889999864221 1123567899999988755544 444433 33468
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccC--CCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDC--VPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
+||||++|.++.+.- .....++.+++++++.||... ..+++|||++|.||+++ ++.++++|||.+.
T Consensus 68 lv~e~i~G~~l~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 68 LITEFIEGSELLTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEEEecCCCcccccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 999999998876531 011345678999999999983 12369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.5e-11 Score=118.69 Aligned_cols=149 Identities=16% Similarity=0.142 Sum_probs=103.8
Q ss_pred cceeccccceEEEEEEec-------CCcEEEEEecCcccccccC-------CCCC----cccchHHHHH----HHHHHHc
Q 043053 709 ANVIGKGCSGVVYRADMD-------NGEVIAVKKLWPTTMAAAN-------GCSD----EKSGVRDSFS----AEIKTLG 766 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~-------~~~~----~~~~~~~~~~----~E~~~l~ 766 (1058)
...||.|--+.||.|... .+..+|||+.+.....-+. +... .+....+.+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999999543 3579999988543221110 0000 0122234444 8999999
Q ss_pred ccCC--CcccceeeEEEcCCCceEEEEecCCCChhh-hhhhcCCCCCCHHHHHHHHHHHHHHhhcc-cccCCCCeEeCCC
Q 043053 767 SIRH--KNIVRFLGCCWNRNNRLLMYDYMPNGSLGS-LLHERTGNALEWELRYQILLGAAQGLAYL-HHDCVPPIVHRDI 842 (1058)
Q Consensus 767 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHrDi 842 (1058)
++.. -.+.+++++ ...++||||+.++.+.. .++. ..++......+..+++.++..+ |.. ++||||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 9963 466666654 56799999997654422 2322 2344556677889999999999 787 9999999
Q ss_pred CCCcEEEcCCCCeeeeccccceeccC
Q 043053 843 KANNILIGLEFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 843 kp~Nill~~~~~~kl~DfGl~~~~~~ 868 (1058)
++.||+++ ++.++++|||.+.....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 57899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.5e-10 Score=131.24 Aligned_cols=168 Identities=18% Similarity=0.237 Sum_probs=126.9
Q ss_pred EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEEEEecCCCChhhhhh
Q 043053 724 DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLH 803 (1058)
Q Consensus 724 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 803 (1058)
...++.+|.|.+.... .....+...+-++.++.++||+|+++++.+..++..|+|+|-+. .|..+++
T Consensus 33 ~k~~~~~vsVF~~~~~-----------~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk 99 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRS-----------NGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK 99 (690)
T ss_pred eeccCCceEEEEEeCC-----------CchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH
Confidence 5566888888876322 11335667778899999999999999999999999999999983 6788887
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCC
Q 043053 804 ERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883 (1058)
Q Consensus 804 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~ 883 (1058)
+. ....+.-.+.||+.||.|||..+ +++|++|.-+-|+++..|+.||++|-++........ ......---.
T Consensus 100 ~l-----~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s 170 (690)
T KOG1243|consen 100 EL-----GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIES 170 (690)
T ss_pred Hh-----HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhc
Confidence 63 24555667899999999999774 899999999999999999999999998865433221 1111122234
Q ss_pred ccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 043053 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 915 (1058)
Q Consensus 884 y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~ 915 (1058)
|..|+.+.... -..|.|-||+++||++.|.
T Consensus 171 ~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 171 FDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 66666544332 3469999999999999993
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=7.1e-11 Score=113.60 Aligned_cols=139 Identities=24% Similarity=0.356 Sum_probs=106.9
Q ss_pred ceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCceEE
Q 043053 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLM 789 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 789 (1058)
..+++|+-+.+|.+.+. |..+++|.-.++..... .-+..-..++-.+|+.++.+++--.|...+-+..+++...++
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p---~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHP---ELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCCh---HHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEE
Confidence 46789999999999776 55567775433322211 011122346678899999999877777777778888899999
Q ss_pred EEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 790 YDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 790 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
|||++|..|.+++.+. ...++..+-.-+.-||.. ||||+|+.++||++..++ +.++|||++..
T Consensus 78 me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999999999763 245666777778889999 999999999999997654 99999999874
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.5e-12 Score=129.08 Aligned_cols=131 Identities=29% Similarity=0.356 Sum_probs=78.6
Q ss_pred cccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhh
Q 043053 360 LQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMID 439 (1058)
Q Consensus 360 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 439 (1058)
...|++|+|++|.|+ .+.+...-++.++.|++++|.|..+ ..+..+++|+.||||+|.++ ...++-..+-+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 355666666666666 4445556666777777777777654 23666777777777777766 3333334455666666
Q ss_pred ccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccC
Q 043053 440 LSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 440 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
|+.|.|... ..++.+.+|..||+++|+|.... --..++.++-|+.|.|.+|++.+
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ld-----------------------eV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELD-----------------------EVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHH-----------------------HhcccccccHHHHHhhcCCCccc
Confidence 666666532 34555666666666666664211 11345566667777777777764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.1e-09 Score=116.77 Aligned_cols=285 Identities=15% Similarity=0.164 Sum_probs=176.6
Q ss_pred cccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE-----
Q 043053 707 VDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC----- 780 (1058)
Q Consensus 707 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~----- 780 (1058)
...+.||+|+-+.+|-.--. +..+.|+++.+.... + .+.+..|... .||-+-.-+.|=
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~-------------~-aqk~a~la~~p~~p~~~~rvaWPqa~L~ 77 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAA-------------Q-AQKVAELAATPDAPLLNYRVAWPQATLH 77 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchH-------------H-HHHHHHhccCCCCcchhhhhcccHHHhh
Confidence 34678999999999976222 122347665443221 1 1223334443 466544322221
Q ss_pred -EcC-CCceEEEEecCCCC-hhhhhh----hcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 781 -WNR-NNRLLMYDYMPNGS-LGSLLH----ERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 781 -~~~-~~~~lv~e~~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
-++ ....+.|..++|.- ...+.. ++......|....++++.+|.+.+.||.. |.+-||+.++|+|+.+++
T Consensus 78 G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~ 154 (637)
T COG4248 78 GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDS 154 (637)
T ss_pred CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCc
Confidence 122 22567888887652 222222 12245678999999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccc-----cccCCCCcccchhhHHHHHHHHHhC-CCCCCCCC-----
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTG-KQPIDPTI----- 922 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~~~~~DvwSlGvvl~elltg-~~P~~~~~----- 922 (1058)
.|.+.|-..-....++ ......+|...|.+||. +.+..-+...|.|.+||++++++.| ++||.+..
T Consensus 155 ~V~LVdsDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a 231 (637)
T COG4248 155 KVVLVDSDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA 231 (637)
T ss_pred eEEEEcccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence 9999986554433332 33445679999999995 3355567789999999999999986 99997531
Q ss_pred C--CChhHHH--HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHHHhhhhhhhhhhh
Q 043053 923 P--DGSHVVD--WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNA--SPDERPTMKDVAAMLKEIKHEREEYAK 996 (1058)
Q Consensus 923 ~--~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~--dP~~RPt~~~v~~~l~~~~~~~~~~~~ 996 (1058)
+ .+..+.. +...........+.....+-..+.-.+++ +..+|+.. .+.-|||++..+..|.++.++....+.
T Consensus 232 p~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqA--lF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v 309 (637)
T COG4248 232 PNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQA--LFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTV 309 (637)
T ss_pred CCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHH--HHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhh
Confidence 1 1111110 00000111112222222222222233333 34456643 467899999999999999998888777
Q ss_pred hhhhccCChhhhhccccCC
Q 043053 997 VDMLLKGSPAAANVQENKN 1015 (1058)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~ 1015 (1058)
...+....+-....++..+
T Consensus 310 ~a~H~y~~hl~~CPwCa~~ 328 (637)
T COG4248 310 SAMHVYPVHLTDCPWCALD 328 (637)
T ss_pred cccccccCCCCCCchhhhc
Confidence 6666555554444444443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.7e-12 Score=155.36 Aligned_cols=268 Identities=23% Similarity=0.240 Sum_probs=127.6
Q ss_pred CCcEEEccCCc--CCCCCCC-CCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHH
Q 043053 25 HLQTLVISDAN--LTGSIPF-DIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKL 101 (1058)
Q Consensus 25 ~L~~L~l~~~~--~~~~~p~-~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L 101 (1058)
.|++|-+.++. +. .++. .+..++.|++|||++|.--+.+|++|++|.+||+|+|+++.+. .+|..+++|++|.+|
T Consensus 546 ~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred ccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 46666666654 32 2332 2455666666666666332366666666666666666666665 666666666666666
Q ss_pred hhhhccccCCChhhhcccccchhhhcCCCc-cccCCCCccccCCCCCceecccCccccccCCccccCCCccc----eeee
Q 043053 102 LLFDNALAGNIPAELGRLSNLEEMRAGGNK-DIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQ----TLSI 176 (1058)
Q Consensus 102 ~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~-~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~----~L~l 176 (1058)
++..+.....+|..+..|++|++|.+.... ........++.++.+|+.+....... .+-..+..++.|. .+.+
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~ 701 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSI 701 (889)
T ss_pred ccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhh
Confidence 666655443444555556666666655432 11122233344444444444422221 1111122222222 2222
Q ss_pred eccccccccCccccCCCCccEEEccCCcCCCCCCCCcCC------CCCcceeecccccccCCCCccccCcCCccEEEeec
Q 043053 177 YTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGK------LKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSL 250 (1058)
Q Consensus 177 ~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~------l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 250 (1058)
..+... ..+..+..+.+|+.|.+.++.+.......... ++++..+...++... ..+.+....++|+.|.+.+
T Consensus 702 ~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~ 779 (889)
T KOG4658|consen 702 EGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVS 779 (889)
T ss_pred cccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEec
Confidence 222221 33445566666666666666654322222111 122333333333222 1222233346666666666
Q ss_pred CCCcCcCCccccccCCcceeecccCccCCC-ccccccccccchhhhhcC
Q 043053 251 NSLSGTIPLSIGGLSELEEFMISDNNVSGS-IPANLANATNLVQLQLDT 298 (1058)
Q Consensus 251 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~ 298 (1058)
+.....+......+..+.++.+..+.+.+. .-...+.++++..+.+..
T Consensus 780 ~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~ 828 (889)
T KOG4658|consen 780 CRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSF 828 (889)
T ss_pred ccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCc
Confidence 655544444445555555555555555543 233344444444444433
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=8.2e-12 Score=144.42 Aligned_cols=195 Identities=28% Similarity=0.326 Sum_probs=82.1
Q ss_pred CCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchh
Q 043053 214 GKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQ 293 (1058)
Q Consensus 214 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 293 (1058)
..+++|+.|++.+|.+... ...+..+++|++|++++|+|+...+ +..++.|+.|++++|.|.. ...+..+++|+.
T Consensus 92 ~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~ 166 (414)
T KOG0531|consen 92 SKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISD--ISGLESLKSLKL 166 (414)
T ss_pred ccccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hhhccchhhheeccCcchh--ccCCccchhhhc
Confidence 3334444444444444321 1113334444444444444442211 2233334444444444431 122333445555
Q ss_pred hhhcCCcccCcCC-CcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccc--cchhhhccc
Q 043053 294 LQLDTNQISGLIP-PEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQ--NLTKLLLIS 370 (1058)
Q Consensus 294 L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~ 370 (1058)
+++++|++..+.+ . ...+.+++.+++.+|.+..+ ..+..+..+..+++..|.++...+ +..+. +|+.+++++
T Consensus 167 l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~ 241 (414)
T KOG0531|consen 167 LDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSG 241 (414)
T ss_pred ccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhccc
Confidence 5555555544333 1 34444445555555544422 223334444445666666653222 22222 256666666
Q ss_pred cCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccC
Q 043053 371 NDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRL 421 (1058)
Q Consensus 371 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 421 (1058)
|.+.. .+..+..+..+..|++.+|++... ..+.....+..+.++.|.+
T Consensus 242 n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~ 289 (414)
T KOG0531|consen 242 NRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKL 289 (414)
T ss_pred Ccccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchh
Confidence 66652 223344444555555555554432 1233333444444444443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.5e-12 Score=145.87 Aligned_cols=228 Identities=28% Similarity=0.323 Sum_probs=106.2
Q ss_pred ccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCccc
Q 043053 261 IGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQ 340 (1058)
Q Consensus 261 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 340 (1058)
+..+.+|+.|++.+|.|..+. ..+..+++|++|+|++|+|+.+ ..+..++.|+.|++.+|.|+.+ ..+..+.+|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISDI--SGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchhhcc-cchhhhhcchheeccccccccc--cchhhccchhhheeccCcchhc--cCCccchhhh
Confidence 334444444444444444211 1144455555555555555443 2233333344444444444322 2233355555
Q ss_pred ccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCcc
Q 043053 341 ALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420 (1058)
Q Consensus 341 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 420 (1058)
.+++++|++..+.+.....+.+++.+.+.+|.+. .+ ..+..+..+..+++..|.
T Consensus 166 ~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~------------------------~i--~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 166 LLDLSYNRIVDIENDELSELISLEELDLGGNSIR------------------------EI--EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred cccCCcchhhhhhhhhhhhccchHHHhccCCchh------------------------cc--cchHHHHHHHHhhccccc
Confidence 5555555555322200233444444444444443 22 223333333333444444
Q ss_pred CCCCCCCcccCCc--ccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCC--
Q 043053 421 LSGSVPDEIGDCT--ELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGP-- 496 (1058)
Q Consensus 421 l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-- 496 (1058)
++...+ +..+. .|+.+++++|.+.. .+..+..+.++..|++.+|++... ..+.....+..+.+..|++...
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 294 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEA 294 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhh
Confidence 442211 11112 25566666666552 224455566666666666666422 2234445556666666665521
Q ss_pred -CCCc-ccCCcccccccccCCcccCCCChh
Q 043053 497 -IPSS-LGLCSSLQLLDLSSNQLTGSVPME 524 (1058)
Q Consensus 497 -~~~~-~~~l~~L~~L~l~~N~l~~~~p~~ 524 (1058)
.... ....+.+..+.+.+|++....+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
T KOG0531|consen 295 ISQEYITSAAPTLVTLTLELNPIRKISSLD 324 (414)
T ss_pred hhccccccccccccccccccCccccccccc
Confidence 1111 445677888888888887655543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.4e-11 Score=149.28 Aligned_cols=203 Identities=23% Similarity=0.295 Sum_probs=135.6
Q ss_pred cCCCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCC--CCCCCCh-hhcCcccCCEEeccccCCCCccccccccchh
Q 043053 21 SSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNN--LVGTLPS-SLGKLHNLEELILNSNQLTGKIPVELSNCKS 97 (1058)
Q Consensus 21 ~~~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~--i~~~lp~-~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~ 97 (1058)
.+....|...+-++++. .++... .++.|+.|-+..|. +. .++. .|..++.|++|||++|.-.+++|..+++|.+
T Consensus 520 ~~~~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~ 596 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVH 596 (889)
T ss_pred cchhheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhh
Confidence 33467788888888876 455443 34479999999986 55 4554 4778999999999999777799999999999
Q ss_pred hhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCcccc--ccCCccccCCCccceee
Q 043053 98 LRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVS--GSLPASLGKLSKLQTLS 175 (1058)
Q Consensus 98 L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~--~~~~~~l~~l~~L~~L~ 175 (1058)
||+|+|+++.+. .+|.++++|+.|.+|++..+... ..+|..+..+++|++|.+...... ...-..+.++.+|+.+.
T Consensus 597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l-~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls 674 (889)
T KOG4658|consen 597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRL-ESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLS 674 (889)
T ss_pred hhcccccCCCcc-ccchHHHHHHhhheecccccccc-ccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhe
Confidence 999999999998 99999999999999999887632 334555666888888888765422 22223344445555555
Q ss_pred eeccccccccCccccCCCCcc----EEEccCCcCCCCCCCCcCCCCCcceeecccccccC
Q 043053 176 IYTTMISGEIPAEIGNCSELV----SLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVG 231 (1058)
Q Consensus 176 l~~n~i~~~~~~~l~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 231 (1058)
...... .+...+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++.+..
T Consensus 675 ~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 675 ITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred eecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence 433322 1222233333333 2232222222 344556667777777777776653
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3e-12 Score=133.27 Aligned_cols=135 Identities=23% Similarity=0.313 Sum_probs=99.8
Q ss_pred CCCCCcEEEccCccccCCc----cccccCccccceeeccCccCCCC----CCCcccCCcccchhhccCCccCC----CCc
Q 043053 383 NCSSLVRLRVGNNRIAGLI----PREIGGLKTLNFLDLSSNRLSGS----VPDEIGDCTELQMIDLSHNTLQG----SLP 450 (1058)
Q Consensus 383 ~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~----~~~ 450 (1058)
.-+.|+++..++|++..-. ...|...+.|+.+.+++|.|... ....|..+++|+.|||.+|-++. .+.
T Consensus 155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La 234 (382)
T KOG1909|consen 155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA 234 (382)
T ss_pred CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence 4478999999999997432 34567778999999999988632 22357788999999999998874 355
Q ss_pred cccccCCCCCeeecCCCccccCCccccc-----ccccccccccccccCCC----CCCCcccCCcccccccccCCcc
Q 043053 451 NSLSSLSGLQVLDVSDNRFSGQIPASLG-----RLVSLNKIILSKNLFSG----PIPSSLGLCSSLQLLDLSSNQL 517 (1058)
Q Consensus 451 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~l~~N~l 517 (1058)
.+++.+++|++|+++++.++..-...|. ..++|+.|.|.+|.|+. .+...+...+.|..|+|++|++
T Consensus 235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 6788888999999999998765444332 35788888888888862 1223444567788888888888
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.8e-11 Score=123.99 Aligned_cols=134 Identities=20% Similarity=0.246 Sum_probs=70.0
Q ss_pred cccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCc
Q 043053 164 SLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSL 243 (1058)
Q Consensus 164 ~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 243 (1058)
.+-..+.|+.|+|++|.|+ .+.++..-++.++.|+++.|.+.. +. .+..+++|+.|||++|.++ ....+=..+-+.
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3344455566666666554 444455555566666666666552 22 2555566666666666555 333333445555
Q ss_pred cEEEeecCCCcCcCCccccccCCcceeecccCccCCCc-cccccccccchhhhhcCCcccC
Q 043053 244 KMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSI-PANLANATNLVQLQLDTNQISG 303 (1058)
Q Consensus 244 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~N~i~~ 303 (1058)
++|.|++|.|.. -..++++-+|..||+++|+|.... ...+++++-|++|.|.+|.+.+
T Consensus 355 KtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 355 KTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 566666665542 123445555555666666555322 2345555555555555555553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.6e-11 Score=132.92 Aligned_cols=249 Identities=17% Similarity=0.121 Sum_probs=170.9
Q ss_pred HhhccccceeccccceEEEEEEe--cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeE
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM--DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGC 779 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 779 (1058)
..+|..+..||.|.|+.|++... .++..+++|......... .....-..|+.+...+. |.++++++..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~---------~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF---------ASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch---------HhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 35677889999999999999843 467888998774332211 11122245666666664 8999998888
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC-CCeeee
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE-FEPYIA 858 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~-~~~kl~ 858 (1058)
+......|+=-|||+++++...+.- ...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred ccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcc
Confidence 8777778899999999998877632 45678888899999999999999998 99999999999999886 788999
Q ss_pred ccccceeccCCCcccccccccCcCCcc--CccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYI--APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|||....+.- .. .......+++ +|+......+..+.|+||||..+.|..+|..--.. ..+|....
T Consensus 410 ~~~~~t~~~~----~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~~~~~~i~- 476 (524)
T KOG0601|consen 410 DFGCWTRLAF----SS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------GVQSLTIR- 476 (524)
T ss_pred ccccccccce----ec-ccccccccccccchhhccccccccccccccccccccccccCcccCcc-------cccceeee-
Confidence 9999864221 11 1222333444 55556677788999999999999999998642211 11111111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
.......+.... +...+...+..+++..||.+.++..+.+..
T Consensus 477 ------~~~~p~~~~~~~---~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 477 ------SGDTPNLPGLKL---QLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ------cccccCCCchHH---hhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 111111122111 122244457889999999988877655443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-11 Score=130.54 Aligned_cols=185 Identities=24% Similarity=0.250 Sum_probs=78.7
Q ss_pred CCCCcceeecccccccCCCC-ccccCcCCccEEEeecCCCcCcCC--ccccccCCcceeecccCccCCCccc-ccccccc
Q 043053 215 KLKKLEELFLWQNSLVGAIP-EEIGNCTSLKMIDFSLNSLSGTIP--LSIGGLSELEEFMISDNNVSGSIPA-NLANATN 290 (1058)
Q Consensus 215 ~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~ 290 (1058)
++++|+...|.++.+..... +....|++++.|||+.|-+....+ .....+++|+.|+++.|++...... .-..++.
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 34555555555554442111 234455555566666555543222 1123455555555555554421111 1113344
Q ss_pred chhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccc
Q 043053 291 LVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLIS 370 (1058)
Q Consensus 291 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 370 (1058)
|+.|.|+.|.++.- .+......+++|+.|+|..|....+.......+..|++|+|++
T Consensus 199 lK~L~l~~CGls~k-----------------------~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~ 255 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWK-----------------------DVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSN 255 (505)
T ss_pred hheEEeccCCCCHH-----------------------HHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccC
Confidence 55555555554421 0111223344555555555532212222222344455555555
Q ss_pred cCCCCCC-CCCccCCCCCcEEEccCccccCCcccc------ccCccccceeeccCccCC
Q 043053 371 NDISGSI-PPEIGNCSSLVRLRVGNNRIAGLIPRE------IGGLKTLNFLDLSSNRLS 422 (1058)
Q Consensus 371 N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~------~~~l~~L~~L~Ls~N~l~ 422 (1058)
|++.... ....+.++.|+.|+++.+.|.++.-.. ....++|++|+++.|+|.
T Consensus 256 N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 256 NNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred CcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 5443211 123444555555555555554331111 123355555555555553
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.9e-11 Score=118.28 Aligned_cols=107 Identities=29% Similarity=0.416 Sum_probs=26.5
Q ss_pred CCCCCcEEEccCccccCCcccccc-CccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCcccc-ccCCCCC
Q 043053 383 NCSSLVRLRVGNNRIAGLIPREIG-GLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSL-SSLSGLQ 460 (1058)
Q Consensus 383 ~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~ 460 (1058)
++.++++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+.+. .+..++.|+.|++++|+|+.+ ...+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCcc-ccchHHhCCcCC
Confidence 334455555555555543 2233 3455555555555555321 244445555555555555432 2222 2344555
Q ss_pred eeecCCCccccCCcccccccccccccccccccCCCCC-CCcccCCcccccccccCCccc
Q 043053 461 VLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPI-PSSLGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 461 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~ 518 (1058)
+|+|++|+| .... -..+..+++|+.|++.+|+++
T Consensus 92 ~L~L~~N~I------------------------~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 92 ELYLSNNKI------------------------SDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EEE-TTS---------------------------SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred EEECcCCcC------------------------CChHHhHHHHcCCCcceeeccCCccc
Confidence 555555554 3211 134456677777788888776
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.2e-10 Score=117.28 Aligned_cols=144 Identities=20% Similarity=0.248 Sum_probs=109.7
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCC--cccceeeEEEcCC--
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK--NIVRFLGCCWNRN-- 784 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~-- 784 (1058)
.+.+|.|.++.||++...+|+.+++|...... .......+.+|+++++.+++. .+.+++.+.....
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~----------~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~ 72 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGA----------LLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVL 72 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcc----------cCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCcc
Confidence 36789999999999977767899999874321 111345788999999999763 4577777766542
Q ss_pred -CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccC------------------------------
Q 043053 785 -NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDC------------------------------ 833 (1058)
Q Consensus 785 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------ 833 (1058)
..++||||++|+++.+.+.. ..++......++.++++++.+||+..
T Consensus 73 ~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (223)
T cd05154 73 GTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS 149 (223)
T ss_pred CCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence 56899999999988886642 34667777788888888888888531
Q ss_pred -----------------------CCCeEeCCCCCCcEEEcC--CCCeeeecccccee
Q 043053 834 -----------------------VPPIVHRDIKANNILIGL--EFEPYIADFGLAKL 865 (1058)
Q Consensus 834 -----------------------~~~ivHrDikp~Nill~~--~~~~kl~DfGl~~~ 865 (1058)
...++|||++|.||+++. ++.+.++||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.8e-11 Score=116.56 Aligned_cols=108 Identities=33% Similarity=0.418 Sum_probs=37.8
Q ss_pred ccccchhhhccccCCCCCCCCCcc-CCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcc-cCCcccc
Q 043053 359 QLQNLTKLLLISNDISGSIPPEIG-NCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI-GDCTELQ 436 (1058)
Q Consensus 359 ~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~ 436 (1058)
+..++++|+|.+|.|+.+ +.++ .+.+|+.|+|++|.|+.+ +.+..++.|+.|++++|+|+.+ +..+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCC
Confidence 444677777777777743 2344 467788888888888865 3577788888888888888744 3334 3578888
Q ss_pred hhhccCCccCCCC-ccccccCCCCCeeecCCCcccc
Q 043053 437 MIDLSHNTLQGSL-PNSLSSLSGLQVLDVSDNRFSG 471 (1058)
Q Consensus 437 ~L~l~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~ 471 (1058)
.|+|++|+|.... -..+..+++|+.|+|.+|.++.
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 8888888886532 1456778888888888888863
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2e-11 Score=130.52 Aligned_cols=209 Identities=19% Similarity=0.113 Sum_probs=113.9
Q ss_pred CCCCcccEEecCCCCCCCCCC--hhhcCcccCCEEeccccCCCCc--cccccccchhhhHHhhhhccccCCChhhhcccc
Q 043053 45 GDCVGLIVLDFSSNNLVGTLP--SSLGKLHNLEELILNSNQLTGK--IPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120 (1058)
Q Consensus 45 ~~l~~L~~L~l~~~~i~~~lp--~~l~~l~~L~~L~L~~n~~~~~--~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~ 120 (1058)
.+++.|+...|.++.+. ..+ +....|++++.|||++|=+... +-.-...||+|+.|+|+.|.+....-..
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~----- 191 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSN----- 191 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcccc-----
Confidence 45667777777777665 444 2555677777777777755532 2233456777777777777665111100
Q ss_pred cchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCcc-ccCCCccceeeeeccccccccCccccCCCCccEEE
Q 043053 121 NLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPAS-LGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLF 199 (1058)
Q Consensus 121 ~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~-l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~ 199 (1058)
.-..+++|+.|.|++|.++...... +..+++|+.|+|..|.....-.....-++.|+.||
T Consensus 192 -------------------~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~Ld 252 (505)
T KOG3207|consen 192 -------------------TTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELD 252 (505)
T ss_pred -------------------chhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcc
Confidence 0113455566666666665333322 23456666666666642222233344455666666
Q ss_pred ccCCcCCCCC-CCCcCCCCCcceeecccccccCCC-Ccc-----ccCcCCccEEEeecCCCcCcC-CccccccCCcceee
Q 043053 200 LYENSLSGSI-PPEIGKLKKLEELFLWQNSLVGAI-PEE-----IGNCTSLKMIDFSLNSLSGTI-PLSIGGLSELEEFM 271 (1058)
Q Consensus 200 L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~-~~~-----l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~ 271 (1058)
|++|.+.+.. ....+.++.|+.|+++.|.+...- |+. ...+++|++|++..|+|...- ...+..+++|+.|.
T Consensus 253 Ls~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~ 332 (505)
T KOG3207|consen 253 LSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLR 332 (505)
T ss_pred ccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhh
Confidence 6666665321 134556666666666666665321 111 234566777777777664321 12344556666666
Q ss_pred cccCccC
Q 043053 272 ISDNNVS 278 (1058)
Q Consensus 272 l~~n~l~ 278 (1058)
+..|.+.
T Consensus 333 ~~~n~ln 339 (505)
T KOG3207|consen 333 ITLNYLN 339 (505)
T ss_pred ccccccc
Confidence 6666665
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2e-10 Score=135.62 Aligned_cols=209 Identities=26% Similarity=0.288 Sum_probs=152.1
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
..+.+.+.+-+-+|++|.++-+ ....|...++|+.........+ ..+...++-.+.-..++|-+++....+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~--------~~~s~r~~s~~~i~p~~P~v~~~~~s~ 873 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN--------DYESIRSKSNILITPRSPAVVRSFPSF 873 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccc--------cccccCCccCccccCCCCceecccCCC
Confidence 3456677778899999999988 4445655555554222111111 112223333333344567777776666
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
......++||+|+.+++|...++.. +..+.+........+.++.+|||.. .+.|||++|.|.+...++..+++||
T Consensus 874 ~~rsP~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~ 948 (1205)
T KOG0606|consen 874 PCRSPLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDF 948 (1205)
T ss_pred CCCCCcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcc
Confidence 6677889999999999999999864 4555556666777788999999997 7899999999999999999999999
Q ss_pred ccceeccC-------------------------CC----cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHH
Q 043053 861 GLAKLVDD-------------------------GD----FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 911 (1058)
Q Consensus 861 Gl~~~~~~-------------------------~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~el 911 (1058)
|......- .. .........||+.|.|||...+......+|.|++|++++|.
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhh
Confidence 84322110 00 00113345699999999999999999999999999999999
Q ss_pred HhCCCCCCCCCC
Q 043053 912 LTGKQPIDPTIP 923 (1058)
Q Consensus 912 ltg~~P~~~~~~ 923 (1058)
++|..||....+
T Consensus 1029 l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 1029 LTGIPPFNAETP 1040 (1205)
T ss_pred hcCCCCCCCcch
Confidence 999999987654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.1e-10 Score=133.98 Aligned_cols=113 Identities=37% Similarity=0.597 Sum_probs=89.1
Q ss_pred ccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccc
Q 043053 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILS 489 (1058)
Q Consensus 410 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 489 (1058)
.++.|+|++|.+.+.+|..++.+++|+.|+|++|.|++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 46777888888888888888888888888888888887788888888888888888888888888888888888888888
Q ss_pred cccCCCCCCCcccCC-cccccccccCCcccCCCC
Q 043053 490 KNLFSGPIPSSLGLC-SSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 490 ~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~p 522 (1058)
+|++++.+|..+..+ .++..+++++|......|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 888888888777653 456778888887654444
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.2e-08 Score=102.48 Aligned_cols=137 Identities=24% Similarity=0.261 Sum_probs=86.4
Q ss_pred EEEEEEecCCcEEEEEecCcccccc---------cCC------CCCcccchHHHHHHHHHHHcccCCC--cccceeeEEE
Q 043053 719 VVYRADMDNGEVIAVKKLWPTTMAA---------ANG------CSDEKSGVRDSFSAEIKTLGSIRHK--NIVRFLGCCW 781 (1058)
Q Consensus 719 ~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~------~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 781 (1058)
.||.|...+|..+|||..+.....- ... .............+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899988889999999875421110 000 0112223346778999999999855 566666542
Q ss_pred cCCCceEEEEecC--CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhc-ccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 782 NRNNRLLMYDYMP--NGSLGSLLHERTGNALEWELRYQILLGAAQGLAY-LHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 782 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
..++||||++ |..+.. +... .++......++.+++..+.. +|.. ||||||+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~---~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDV---DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHC---GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhh-HHhc---cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 4689999998 544544 3321 11234455677788776555 4677 99999999999999877 99999
Q ss_pred ccccceecc
Q 043053 859 DFGLAKLVD 867 (1058)
Q Consensus 859 DfGl~~~~~ 867 (1058)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=2e-08 Score=107.38 Aligned_cols=151 Identities=13% Similarity=0.098 Sum_probs=102.5
Q ss_pred ceeccccceEEEEEEecCCcEEEEEecCcccccc-cCCCCCcccchHHHHHHHHHHHcccCCC--cccceeeEEEc----
Q 043053 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAA-ANGCSDEKSGVRDSFSAEIKTLGSIRHK--NIVRFLGCCWN---- 782 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~---- 782 (1058)
+++-......|+++... |+.|.||......... ..... .-..-...+.+|...+.++... .++++++++..
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~-~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLL-SLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhc-ccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 44554444557777664 7889999764332110 00000 0001122478999999888533 33444556543
Q ss_pred -CCCceEEEEecCCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC-------CC
Q 043053 783 -RNNRLLMYDYMPNG-SLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-------EF 853 (1058)
Q Consensus 783 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-------~~ 853 (1058)
....++|||++++. +|.+++........+...+..++.++++.+..||.. ||+|||++++|||++. +.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 22358999999886 799998643234456677789999999999999999 9999999999999975 46
Q ss_pred Ceeeecccccee
Q 043053 854 EPYIADFGLAKL 865 (1058)
Q Consensus 854 ~~kl~DfGl~~~ 865 (1058)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998753
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.4e-09 Score=85.25 Aligned_cols=58 Identities=34% Similarity=0.569 Sum_probs=25.7
Q ss_pred CcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCc
Q 043053 387 LVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNT 444 (1058)
Q Consensus 387 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 444 (1058)
|++|++++|+|+.+.+..|.++++|++|++++|+++.+.|+.|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4444444444444444444444444444444444444444444444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.9e-09 Score=85.56 Aligned_cols=61 Identities=38% Similarity=0.611 Sum_probs=41.1
Q ss_pred cccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCcc
Q 043053 409 KTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469 (1058)
Q Consensus 409 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 469 (1058)
++|++|++++|+|+.+.+..|..+++|+.|++++|+++.+.+.+|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566677777777666666666677777777777777666666666677777777666654
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.4e-07 Score=96.75 Aligned_cols=146 Identities=21% Similarity=0.161 Sum_probs=98.4
Q ss_pred cccceeccccceEEEEEEecCCcEEEEEecCcc--cccccCCC---------CCcccchHHHHHHHHHHHcccCCC--cc
Q 043053 707 VDANVIGKGCSGVVYRADMDNGEVIAVKKLWPT--TMAAANGC---------SDEKSGVRDSFSAEIKTLGSIRHK--NI 773 (1058)
Q Consensus 707 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~h~--ni 773 (1058)
.++..||.|--|.||.|....|.++|||.=+-. ++...... ...-...+...++|.++|.++.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 456899999999999998888999999953211 11110000 011123356778999999999744 67
Q ss_pred cceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 774 VRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 774 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
.+.+++ +...+||||++|--|...- ++....-.|+..|++-+...-.. ||||||+.+-||++++||
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence 776653 4678999999996665432 11222233444444444444455 999999999999999999
Q ss_pred Ceeeeccccceec
Q 043053 854 EPYIADFGLAKLV 866 (1058)
Q Consensus 854 ~~kl~DfGl~~~~ 866 (1058)
.+.++||--+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 9999999765433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.2e-07 Score=109.76 Aligned_cols=163 Identities=17% Similarity=0.211 Sum_probs=103.9
Q ss_pred cHHHHHhhccccceeccccceEEEEEEecCCcEEEEEecCccccccc--------------CCCCC-----cccchH---
Q 043053 698 SVEQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAA--------------NGCSD-----EKSGVR--- 755 (1058)
Q Consensus 698 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~-----~~~~~~--- 755 (1058)
..++++..|. .+.|+.++-|.||+|..++|+.||||+.++.-.... ..... .-.+..
T Consensus 120 ~iee~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~ 198 (517)
T COG0661 120 PIEELFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEF 198 (517)
T ss_pred CHHHHHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHH
Confidence 4555566654 378999999999999999999999999976432210 00000 001111
Q ss_pred -------HHHHHHHHHHcccC-----CCcccceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHH
Q 043053 756 -------DSFSAEIKTLGSIR-----HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823 (1058)
Q Consensus 756 -------~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~ 823 (1058)
-++.+|+..+.+++ .|.|.-..=|........++|||++|..+.+...-.. ...+.. .++..++
T Consensus 199 ~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~ 274 (517)
T COG0661 199 EKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLV 274 (517)
T ss_pred HHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHH
Confidence 23556776666663 3333222222233567799999999999999853322 334422 2333333
Q ss_pred HH-hhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccC
Q 043053 824 QG-LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 824 ~~-l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~ 868 (1058)
++ +..+-.. |+.|.|.+|.||+++.+|++.+.|||+.....+
T Consensus 275 ~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 275 RAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22 2222234 899999999999999999999999999876654
|
|
| >KOG4341 consensus F-box protein containing LRR [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=7.1e-10 Score=118.26 Aligned_cols=276 Identities=20% Similarity=0.195 Sum_probs=184.1
Q ss_pred CCcEEEccCCcCCCCCC--CCCCCCCcccEEecCCC-CCCCCCChhhc-CcccCCEEecccc-CCCCcccc-ccccchhh
Q 043053 25 HLQTLVISDANLTGSIP--FDIGDCVGLIVLDFSSN-NLVGTLPSSLG-KLHNLEELILNSN-QLTGKIPV-ELSNCKSL 98 (1058)
Q Consensus 25 ~L~~L~l~~~~~~~~~p--~~l~~l~~L~~L~l~~~-~i~~~lp~~l~-~l~~L~~L~L~~n-~~~~~~p~-~l~~l~~L 98 (1058)
.|+.|.++|+.-.+.-+ .....|+++++|++.+| +|++..-.++. .+.+|++|+|..| .++...-. ....|++|
T Consensus 139 ~lk~LSlrG~r~v~~sslrt~~~~CpnIehL~l~gc~~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~~Lk~la~gC~kL 218 (483)
T KOG4341|consen 139 FLKELSLRGCRAVGDSSLRTFASNCPNIEHLALYGCKKITDSSLLSLARYCRKLRHLNLHSCSSITDVSLKYLAEGCRKL 218 (483)
T ss_pred ccccccccccccCCcchhhHHhhhCCchhhhhhhcceeccHHHHHHHHHhcchhhhhhhcccchhHHHHHHHHHHhhhhH
Confidence 58999999987654322 33478999999999999 67766666665 6899999999997 44433333 34589999
Q ss_pred hHHhhhhc-cccCCCh-hhhcccccchhhhcCCCccccCCCCcccc-CCCCCceecccCc-cccccCCccc-cCCCccce
Q 043053 99 RKLLLFDN-ALAGNIP-AELGRLSNLEEMRAGGNKDIVGKIPAELG-DCSNMTALGLADT-QVSGSLPASL-GKLSKLQT 173 (1058)
Q Consensus 99 ~~L~L~~n-~~~~~~p-~~l~~l~~L~~L~l~~~~~~~~~l~~~l~-~l~~L~~L~l~~~-~~~~~~~~~l-~~l~~L~~ 173 (1058)
++|+++.| .+.+... .-..++++|+.+.+.||.....+...... .+.-+..+++..| ++++..-..+ ..+.+||.
T Consensus 219 ~~lNlSwc~qi~~~gv~~~~rG~~~l~~~~~kGC~e~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~~~c~~lq~ 298 (483)
T KOG4341|consen 219 KYLNLSWCPQISGNGVQALQRGCKELEKLSLKGCLELELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIACGCHALQV 298 (483)
T ss_pred HHhhhccCchhhcCcchHHhccchhhhhhhhcccccccHHHHHHHhccChHhhccchhhhccccchHHHHHhhhhhHhhh
Confidence 99999998 4444333 33556888999988888644333222232 3666777777666 3443332223 34788999
Q ss_pred eeeeccc-cccccCccc-cCCCCccEEEccCCc-CCCCCCCCcC-CCCCcceeecccccccCC--CCccccCcCCccEEE
Q 043053 174 LSIYTTM-ISGEIPAEI-GNCSELVSLFLYENS-LSGSIPPEIG-KLKKLEELFLWQNSLVGA--IPEEIGNCTSLKMID 247 (1058)
Q Consensus 174 L~l~~n~-i~~~~~~~l-~~l~~L~~L~L~~n~-l~~~~~~~~~-~l~~L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~ 247 (1058)
|..+++. +++..-.++ .++.+|+.|.++.|+ +++.....++ +++.|+.+++..+..... +...-.+++.|+.|.
T Consensus 299 l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C~~lr~ls 378 (483)
T KOG4341|consen 299 LCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNCPRLRVLS 378 (483)
T ss_pred hcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCCchhccCC
Confidence 9998874 333333344 478999999999996 4444444454 578999999998866422 122234678999999
Q ss_pred eecCCCc-CcC----CccccccCCcceeecccCccC-CCccccccccccchhhhhcCCc
Q 043053 248 FSLNSLS-GTI----PLSIGGLSELEEFMISDNNVS-GSIPANLANATNLVQLQLDTNQ 300 (1058)
Q Consensus 248 L~~n~l~-~~~----~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~ 300 (1058)
|++|... +.. ...-.++..|+.+.++++... ...-..+..+++|+.++|-+++
T Consensus 379 lshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~~q 437 (483)
T KOG4341|consen 379 LSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLITDATLEHLSICRNLERIELIDCQ 437 (483)
T ss_pred hhhhhhhhhhhhhhhhhccccccccceeeecCCCCchHHHHHHHhhCcccceeeeechh
Confidence 9988643 221 122345778888888888654 2333556666777777666654
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.3e-10 Score=112.67 Aligned_cols=178 Identities=22% Similarity=0.218 Sum_probs=114.7
Q ss_pred ccCCEEeccccCCCC-ccccccccchhhhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCCCcc-ccCCCCCce
Q 043053 72 HNLEELILNSNQLTG-KIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAE-LGDCSNMTA 149 (1058)
Q Consensus 72 ~~L~~L~L~~n~~~~-~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~-l~~l~~L~~ 149 (1058)
..||+||||+..++- .+-.-++.|.+|+.|.|.++++.+.+...+++=.+|+.|++++|..+....... +..|+.|..
T Consensus 185 sRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~ 264 (419)
T KOG2120|consen 185 SRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDE 264 (419)
T ss_pred hhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhh
Confidence 358899999888772 355557789999999999999888888888888999999999888665443332 556888888
Q ss_pred ecccCccccccCCcc-ccC-CCccceeeeeccccc---cccCccccCCCCccEEEccCC-cCCCCCCCCcCCCCCcceee
Q 043053 150 LGLADTQVSGSLPAS-LGK-LSKLQTLSIYTTMIS---GEIPAEIGNCSELVSLFLYEN-SLSGSIPPEIGKLKKLEELF 223 (1058)
Q Consensus 150 L~l~~~~~~~~~~~~-l~~-l~~L~~L~l~~n~i~---~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~ 223 (1058)
|+|++|.+....... +.. -.+|+.|+|+++.-. ..+..-...+++|.+|||++| .++......|.+++.|++|.
T Consensus 265 LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lS 344 (419)
T KOG2120|consen 265 LNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLS 344 (419)
T ss_pred cCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeee
Confidence 888888765332222 222 235777777765211 111222346677777777776 34433334455677777777
Q ss_pred cccccccCCCCcc---ccCcCCccEEEeecC
Q 043053 224 LWQNSLVGAIPEE---IGNCTSLKMIDFSLN 251 (1058)
Q Consensus 224 L~~n~l~~~~~~~---l~~l~~L~~L~L~~n 251 (1058)
++.|+. .+|.. +...|+|.+||+.++
T Consensus 345 lsRCY~--i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 345 LSRCYD--IIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred hhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence 777754 33433 344556666665544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.6e-07 Score=91.33 Aligned_cols=145 Identities=13% Similarity=0.075 Sum_probs=105.0
Q ss_pred eeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC--CcccceeeEEEc--C--C
Q 043053 711 VIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH--KNIVRFLGCCWN--R--N 784 (1058)
Q Consensus 711 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~--~--~ 784 (1058)
--|+||.+.|++.... |..+-+|+-.......- .-+.....|.+|...+.++.. -.+.+++.+... + .
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~-----r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~ 98 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSV-----RYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEW 98 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccc-----cCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCce
Confidence 4578999999998776 45688887531111100 013346789999999999963 234444422222 1 1
Q ss_pred CceEEEEecCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC--eeeeccc
Q 043053 785 NRLLMYDYMPN-GSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE--PYIADFG 861 (1058)
Q Consensus 785 ~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~--~kl~DfG 861 (1058)
..++|+|-++| .+|.+++....-.+.+...+..++.+++++++-||+. |+.|+|+.+.||+++.++. ++++||-
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 24799998753 4899998764444567788889999999999999999 9999999999999987676 9999997
Q ss_pred cce
Q 043053 862 LAK 864 (1058)
Q Consensus 862 l~~ 864 (1058)
-++
T Consensus 176 k~r 178 (216)
T PRK09902 176 KSR 178 (216)
T ss_pred ccc
Confidence 655
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.6e-07 Score=93.96 Aligned_cols=107 Identities=23% Similarity=0.311 Sum_probs=85.7
Q ss_pred HHHHHHHHHHHcccC--CCcccceeeEEEcCC----CceEEEEecCCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHhh
Q 043053 755 RDSFSAEIKTLGSIR--HKNIVRFLGCCWNRN----NRLLMYDYMPNG-SLGSLLHERTGNALEWELRYQILLGAAQGLA 827 (1058)
Q Consensus 755 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~ 827 (1058)
.....+|...+.++. .=.+.+.+++..... ..++|+|++++. +|.+++.... ..+......++.++++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 456788888888885 334566667666532 238999999984 7999997632 2566677899999999999
Q ss_pred cccccCCCCeEeCCCCCCcEEEcCCC---Ceeeeccccceec
Q 043053 828 YLHHDCVPPIVHRDIKANNILIGLEF---EPYIADFGLAKLV 866 (1058)
Q Consensus 828 ~LH~~~~~~ivHrDikp~Nill~~~~---~~kl~DfGl~~~~ 866 (1058)
-||.. ||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.3e-09 Score=122.99 Aligned_cols=179 Identities=28% Similarity=0.297 Sum_probs=79.8
Q ss_pred CccccccCCcceeecccCccCCCcccccccc-ccchhhhhcCCccc---CcC---CCcccc---cchhhhhhccCcccCC
Q 043053 258 PLSIGGLSELEEFMISDNNVSGSIPANLANA-TNLVQLQLDTNQIS---GLI---PPEIGM---LSKLTVFFAWQNQLEG 327 (1058)
Q Consensus 258 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~N~i~---~~~---~~~~~~---l~~L~~L~l~~N~l~~ 327 (1058)
|-.+..+.+|+.|.+.++.|.. ...+..+ ..|++|-..+. +. .+. ...|.+ ..+|...+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~S-l~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHNS-LDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhcc-HHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 5566778888888888888763 2222222 34444443221 11 000 000110 123444444455544
Q ss_pred CCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccC
Q 043053 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGG 407 (1058)
Q Consensus 328 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 407 (1058)
.+..++.-++.|+.|||++|+++. +. .+..+++|++|||++|.+....--....+. |..|+|+||.++.+ ..+.+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~ 252 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIEN 252 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHh
Confidence 333444445555555555555542 11 444455555555555555422111122222 55555555555433 23444
Q ss_pred ccccceeeccCccCCCC-CCCcccCCcccchhhccCCcc
Q 043053 408 LKTLNFLDLSSNRLSGS-VPDEIGDCTELQMIDLSHNTL 445 (1058)
Q Consensus 408 l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l 445 (1058)
|.+|+.||+++|-|.+. .-..+..+..|+.|+|.+|.+
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 55555555555544421 011133344444555555544
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.5e-09 Score=119.68 Aligned_cols=180 Identities=24% Similarity=0.266 Sum_probs=107.6
Q ss_pred CccccCcCCccEEEeecCCCcCcCCcccccc-CCcceeecccCccCC---Ccc---ccccc---cccchhhhhcCCcccC
Q 043053 234 PEEIGNCTSLKMIDFSLNSLSGTIPLSIGGL-SELEEFMISDNNVSG---SIP---ANLAN---ATNLVQLQLDTNQISG 303 (1058)
Q Consensus 234 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~---~~~---~~~~~---l~~L~~L~L~~N~i~~ 303 (1058)
|-.+....+|++|.|.+|.+.. ...+..+ .+|++|.-+ |.+.. .+. ..+++ -..|...+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 4445666778888888777763 1111111 234444322 22210 000 11111 124666777777776
Q ss_pred cCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccC
Q 043053 304 LIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGN 383 (1058)
Q Consensus 304 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 383 (1058)
....++.-++.++.|+|++|+++... .+..++.|+.|||++|.++ .+|..-..-.+|..|.+.+|.++.. ..+.+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~tL--~gie~ 252 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALTTL--RGIEN 252 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeecccHHHhh--hhHHh
Confidence 34566777778888888888877543 6777778888888888887 3443322223477788888877643 34667
Q ss_pred CCCCcEEEccCccccCCcc-ccccCccccceeeccCccCC
Q 043053 384 CSSLVRLRVGNNRIAGLIP-REIGGLKTLNFLDLSSNRLS 422 (1058)
Q Consensus 384 l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~ 422 (1058)
+.+|+.||+++|-|.+... ..+..|..|+.|+|.+|.+-
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7778888888887764311 23455677778888888774
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.8e-08 Score=112.61 Aligned_cols=151 Identities=23% Similarity=0.305 Sum_probs=96.9
Q ss_pred HHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCC-ccc------ccccccCcCCccCcccccc
Q 043053 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD-FAR------SSNTVAGSYGYIAPEYGYM 892 (1058)
Q Consensus 820 ~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~-~~~------~~~~~~gt~~y~aPE~~~~ 892 (1058)
.+++.|+.|+|.. +++||++|.|++|.+++.+.+|++.|+.+....++. +.. ......-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4455999999987 599999999999999999999999999876544421 111 1112234568999999999
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCC-CCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCC
Q 043053 893 MKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASP 971 (1058)
Q Consensus 893 ~~~~~~~DvwSlGvvl~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 971 (1058)
...+.++|+||+|+++|.+..|..+ +...... ......+..-... .-......+.+..+.+. +.+..++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~--~~~~~~~~~~~~~--~~~~s~~~p~el~~~l~------k~l~~~~ 253 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL--LSYSFSRNLLNAG--AFGYSNNLPSELRESLK------KLLNGDS 253 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc--chhhhhhcccccc--cccccccCcHHHHHHHH------HHhcCCc
Confidence 8889999999999999999955444 3322111 1101011000000 00011223333333333 3689999
Q ss_pred CCCCCHHHHHH
Q 043053 972 DERPTMKDVAA 982 (1058)
Q Consensus 972 ~~RPt~~~v~~ 982 (1058)
..||++.++..
T Consensus 254 ~~rp~~~~l~~ 264 (700)
T KOG2137|consen 254 AVRPTLDLLLS 264 (700)
T ss_pred ccCcchhhhhc
Confidence 99998776653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.4e-06 Score=96.29 Aligned_cols=168 Identities=18% Similarity=0.296 Sum_probs=126.5
Q ss_pred cceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc----CCCceEEE
Q 043053 716 CSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN----RNNRLLMY 790 (1058)
Q Consensus 716 ~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 790 (1058)
--.+.||+ ...+|..|+.|+++-... .....-..-+++++++.|+|||++.++|.. +...++|+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~-----------~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvY 356 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD-----------QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVY 356 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc-----------cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEE
Confidence 34578999 677899999999843211 111122456888999999999999998873 34568999
Q ss_pred EecCCC-Chhhhhhh-------------cCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 791 DYMPNG-SLGSLLHE-------------RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 791 e~~~~g-sL~~~l~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
+|.++. +|.++--. ..+...++...|.++.|++.||.++|+. |+.-+=+.|.+|+++.+.+++
T Consensus 357 DYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIr 433 (655)
T KOG3741|consen 357 DYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIR 433 (655)
T ss_pred ecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEE
Confidence 998863 67765421 1244678899999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCC
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQ 916 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~ 916 (1058)
|+..|.......+. .+| +.+ -.+-|.-.||.++..|.||..
T Consensus 434 iS~C~i~Dvl~~d~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 434 ISGCGIMDVLQEDP--------------TEP--LES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred EecccceeeecCCC--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhccc
Confidence 99888876654432 011 111 135689999999999999964
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1058 | ||||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-55 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-16 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-55 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-16 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-22 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-22 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-09 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 4e-09 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 4e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-08 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-07 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 7e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-08 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 5e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-08 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 4e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 7e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 1e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 4fcg_A | 328 | Structure Of The Leucine-Rich Repeat Domain Of The | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-04 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 4e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-04 |
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FCG|A Chain A, Structure Of The Leucine-Rich Repeat Domain Of The Type Iii Effector Xcv3220 (Xopl) Length = 328 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1058 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 0.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-171 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-150 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-118 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-25 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-119 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-106 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-83 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-59 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-14 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-13 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-10 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-115 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-104 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-91 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-86 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-74 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-72 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-52 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-111 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-105 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-78 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-46 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-99 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-99 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-92 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-89 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-74 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-52 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-37 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-22 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-91 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-79 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-70 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-68 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-56 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-42 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-30 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-25 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-85 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-77 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-76 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 5e-74 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-69 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-78 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-71 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-65 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-51 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-47 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-44 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-12 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-09 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-73 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-67 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-67 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-60 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-29 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-29 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-61 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 8e-61 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-60 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-60 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-58 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-55 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-54 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-49 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-35 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-17 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-60 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-47 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-32 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-09 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 6e-60 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-59 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-58 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 8e-57 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-55 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-53 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-45 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-17 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-58 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-58 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-57 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-57 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-56 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-25 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-23 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-54 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-53 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-50 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-49 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-39 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-36 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-36 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-26 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-24 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-53 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-53 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-52 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-52 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-50 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-48 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-48 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-47 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-21 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-52 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-51 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-46 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-44 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-43 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-40 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-31 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-18 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-51 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-51 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-48 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-38 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-34 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 9e-27 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 9e-18 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 9e-08 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-46 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-45 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-43 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-38 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-38 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-34 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-45 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-43 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-42 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-42 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-11 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 6e-43 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 8e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-25 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 9e-42 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-41 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-41 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-37 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 7e-37 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-35 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-18 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-40 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 7e-40 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-39 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-39 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-36 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-29 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-28 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-26 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-15 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-13 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-39 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-38 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 9e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-37 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-36 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-31 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-27 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-22 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-37 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-37 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-37 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 5e-37 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-36 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-34 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-28 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-24 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-12 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-36 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-36 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-36 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 6e-36 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-35 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-35 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-35 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-35 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-35 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-35 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-35 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-35 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-35 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-35 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-35 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-35 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-35 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-34 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-05 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-34 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-34 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-34 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-34 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 6e-34 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-32 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-29 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 8e-21 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-34 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 9e-34 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-33 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-33 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-33 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-33 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-33 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-33 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-33 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-33 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-33 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-33 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 5e-33 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-33 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-33 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 8e-33 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 8e-33 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-32 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-32 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-32 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-32 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-32 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-32 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-32 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-32 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 6e-28 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-23 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-21 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-15 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-12 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-32 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 7e-32 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 8e-32 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-31 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-31 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-31 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-31 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-31 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-31 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-31 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-26 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-13 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-12 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-31 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-31 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-30 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-30 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-31 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-30 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-30 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-16 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-30 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-30 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-28 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-19 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-17 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-08 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-30 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-29 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-29 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-29 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-29 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 4e-29 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-29 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 9e-29 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-28 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-24 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-21 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-20 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-19 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-15 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-28 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-28 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-28 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-24 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 7e-17 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-16 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-14 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-08 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 5e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-27 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-27 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-20 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-15 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-27 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-27 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-26 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-20 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-14 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-08 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-27 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-27 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-27 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-27 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 9e-27 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 9e-27 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-25 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-21 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-17 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-17 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-26 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-26 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-26 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-26 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-25 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-19 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 5e-26 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 8e-26 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 9e-26 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-25 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-25 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-24 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-24 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 8e-24 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-23 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 9e-22 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-21 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-16 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-11 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-06 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-23 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-23 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-23 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-11 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-10 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-22 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 6e-16 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 6e-13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-10 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 7e-06 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-22 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-22 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-21 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-21 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-21 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-21 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-21 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-21 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-21 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-21 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-19 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 9e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-04 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 5e-21 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 5e-21 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 5e-21 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-19 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-08 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 6e-21 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-21 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 8e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-20 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-09 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-07 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-20 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-20 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-20 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-20 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-20 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-20 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-20 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-19 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-18 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 7e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 9e-09 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-05 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-20 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-20 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 7e-20 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 8e-20 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 8e-20 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-19 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-19 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-19 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-19 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-19 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-19 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-19 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-08 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-19 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-19 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-19 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-19 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-07 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-18 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-18 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-18 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-18 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-18 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 7e-18 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 7e-18 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 7e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-08 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 8e-18 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-17 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-17 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 5e-08 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-04 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-17 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-17 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-17 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-17 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-17 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-17 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-17 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-17 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-17 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 6e-17 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 8e-17 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-06 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-06 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-16 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-16 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-16 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-16 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-16 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-16 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-16 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-16 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-16 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-15 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-15 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-15 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-15 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-15 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-15 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-04 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-04 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-04 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-04 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 5e-15 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 7e-15 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-14 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-14 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-14 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-13 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-13 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-13 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-13 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 8e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-05 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-13 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 6e-04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 5e-13 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-10 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 5e-10 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 5e-08 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 9e-13 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 5e-09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 7e-06 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-12 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 6e-12 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 6e-12 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-11 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 8e-11 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 7e-05 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 6e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 8e-11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 9e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-10 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-04 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-05 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-10 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-10 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-09 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-09 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 1e-09 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 5e-09 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 1e-05 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-04 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 5e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-05 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-09 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 7e-04 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 9e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 9e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-04 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 1e-08 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 7e-06 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 3e-04 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 7e-04 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 3e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 3e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 7e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-06 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 8e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-07 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 3e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 3e-05 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 4e-07 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-07 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-07 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 6e-07 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 3e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 4e-06 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 9e-06 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-05 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 8e-05 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-04 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 4e-04 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 6e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 586 bits (1513), Expect = 0.0
Identities = 188/615 (30%), Positives = 300/615 (48%), Gaps = 23/615 (3%)
Query: 12 LQLPIPT-NLSSFKHLQTLVISDANLTGSIPFDI---GDCVGLIVLDFSSNNLVGTLPSS 67
L P L+ L +S +++G+ C L L S N + G +
Sbjct: 138 LDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-- 195
Query: 68 LGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRA 127
+ + NLE L ++SN + IP L +C +L+ L + N L+G+ + + L+ +
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNI 254
Query: 128 GGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASL-GKLSKLQTLSIYTTMISGEIP 186
N+ VG IP ++ L LA+ + +G +P L G L L + G +P
Sbjct: 255 SSNQ-FVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311
Query: 187 AEIGNCSELVSLFLYENSLSGSIPPE-IGKLKKLEELFLWQNSLVGAIPEEIGNCT-SLK 244
G+CS L SL L N+ SG +P + + K++ L+ L L N G +PE + N + SL
Sbjct: 312 PFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLL 371
Query: 245 MIDFSLNSLSGTIPLSIGG--LSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQIS 302
+D S N+ SG I ++ + L+E + +N +G IP L+N + LV L L N +S
Sbjct: 372 TLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431
Query: 303 GLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQN 362
G IP +G LSKL W N LEG IP L L+ L L N LT +P+GL N
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN 491
Query: 363 LTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLS 422
L + L +N ++G IP IG +L L++ NN +G IP E+G ++L +LDL++N +
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551
Query: 423 GSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN--RFSGQIPASLGRL 480
G++P + + ++ N + G + + + + N F G L RL
Sbjct: 552 GTIPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
+ N ++ ++ G + S+ LD+S N L+G +P E+G + L I LNL N
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFI-LNLGHN 666
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNL-NPLAQLDNLVSLNISYNKFTGYLPDNKLF 599
++G IP ++ L L+ILDLS NKL+G + ++ L L +++S N +G +P+ F
Sbjct: 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF 726
Query: 600 RQLSPTDLAGNEGLC 614
P N GLC
Sbjct: 727 ETFPPAKFLNNPGLC 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 521 bits (1343), Expect = e-171
Identities = 172/624 (27%), Positives = 280/624 (44%), Gaps = 48/624 (7%)
Query: 2 VTEITIQSVPLQL---PIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSN 58
VT I + S PL + + ++L S L++L +S++++ GS+ L LD S N
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRN 110
Query: 59 NLVGTLPS--SLGKLHNLEELILNSNQLTGKIPVE-LSNCKSLRKLLLFDNALAGNIPAE 115
+L G + + SLG L+ L ++SN L V SL L L N+++G
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
Query: 116 LGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLS 175
+ L ++ ++SG + + + L+ L
Sbjct: 171 WVLSDGC----------------------GELKHLAISGNKISGDVD--VSRCVNLEFLD 206
Query: 176 IYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPE 235
+ + S IP +G+CS L L + N LSG I +L+ L + N VG IP
Sbjct: 207 VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265
Query: 236 EIGNCTSLKMIDFSLNSLSGTIPLSIGG-LSELEEFMISDNNVSGSIPANLANATNLVQL 294
SL+ + + N +G IP + G L +S N+ G++P + + L L
Sbjct: 266 L--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL 323
Query: 295 QLDTNQISGLIPPE-IGMLSKLTVFFAWQNQLEGSIPSTLASCS-NLQALDLSHNSLTAS 352
L +N SG +P + + + L V N+ G +P +L + S +L LDLS N+ +
Sbjct: 324 ALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP 383
Query: 353 VPAGLFQ--LQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKT 410
+ L Q L +L L +N +G IPP + NCS LV L + N ++G IP +G L
Sbjct: 384 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK 443
Query: 411 LNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470
L L L N L G +P E+ L+ + L N L G +P+ LS+ + L + +S+NR +
Sbjct: 444 LRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT 503
Query: 471 GQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEA 530
G+IP +GRL +L + LS N FSG IP+ LG C SL LDL++N G++P + +
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS- 562
Query: 531 LEIALNLSCNGLTGPIPAQISALNKLSILDLSHN--KLEGNLNP-LAQLDNLVSLNISYN 587
++ N + G I + N + +G + L +L NI+
Sbjct: 563 ----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618
Query: 588 KFTGYLPDN-KLFRQLSPTDLAGN 610
+ G+ + D++ N
Sbjct: 619 VYGGHTSPTFDNNGSMMFLDMSYN 642
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 465 bits (1199), Expect = e-150
Identities = 161/547 (29%), Positives = 262/547 (47%), Gaps = 23/547 (4%)
Query: 72 HNLEELILNSNQLT---GKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAG 128
+ + L+S L + L + L L L ++ + G++ ++L +
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 129 GNKDIVGKIPA--ELGDCSNMTALGLADTQVSGSLPASLG-KLSKLQTLSIYTTMISGEI 185
N + G + LG CS + L ++ + S G KL+ L+ L + ISG
Sbjct: 109 RN-SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN 167
Query: 186 PAEI---GNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTS 242
C EL L + N +SG + + + LE L + N+ IP +G+C++
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSA 224
Query: 243 LKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQIS 302
L+ +D S N LSG +I +EL+ IS N G IP +L L L N+ +
Sbjct: 225 LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFT 282
Query: 303 GLIPPEI-GMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAG-LFQL 360
G IP + G LT N G++P SCS L++L LS N+ + +P L ++
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 342
Query: 361 QNLTKLLLISNDISGSIPPEIGNCS-SLVRLRVGNNRIAGLIPREIGG--LKTLNFLDLS 417
+ L L L N+ SG +P + N S SL+ L + +N +G I + TL L L
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402
Query: 418 SNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL 477
+N +G +P + +C+EL + LS N L G++P+SL SLS L+ L + N G+IP L
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
Query: 478 GRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNL 537
+ +L +IL N +G IPS L C++L + LS+N+LTG +P +G++E L I L L
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI-LKL 521
Query: 538 SCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP-LAQLDNLVSLNISYNKFTGYLPDN 596
S N +G IPA++ L LDL+ N G + + + ++ N K Y+ ++
Sbjct: 522 SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKND 581
Query: 597 KLFRQLS 603
+ ++
Sbjct: 582 GMKKECH 588
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 380 bits (977), Expect = e-118
Identities = 147/445 (33%), Positives = 214/445 (48%), Gaps = 19/445 (4%)
Query: 164 SLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELF 223
K++ + S + + + + + + L SLFL + ++GS+ L L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLD 106
Query: 224 LWQNSLVGAIPE--EIGNCTSLKMIDFSLNSLSGTIPLSIG-GLSELEEFMISDNNVSGS 280
L +NSL G + +G+C+ LK ++ S N+L +S G L+ LE +S N++SG+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 281 IPANLA---NATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCS 337
L L + N+ISG + + L N IP L CS
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCS 223
Query: 338 NLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRI 397
LQ LD+S N L+ + L L + SN G IPP SL L + N+
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF 281
Query: 398 AGLIPREIGG-LKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLP-NSLSS 455
G IP + G TL LDLS N G+VP G C+ L+ + LS N G LP ++L
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
Query: 456 LSGLQVLDVSDNRFSGQIPASLGRL-VSLNKIILSKNLFSGPIPSSLGLC--SSLQLLDL 512
+ GL+VLD+S N FSG++P SL L SL + LS N FSGPI +L ++LQ L L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401
Query: 513 SSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP 572
+N TG +P L L L+LS N L+G IP+ + +L+KL L L N LEG +
Sbjct: 402 QNNGFTGKIPPTLSNCSELVS-LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 573 -LAQLDNLVSLNISYNKFTGYLPDN 596
L + L +L + +N TG +P
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSG 485
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-25
Identities = 46/166 (27%), Positives = 68/166 (40%), Gaps = 10/166 (6%)
Query: 452 SLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLD 511
++ + + N + +SL L L + LS + +G + +SL LD
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 512 LSSNQLTGSVP--MELGQIEALEIALNLSCNGLTGPIPAQISA-LNKLSILDLSHNKLEG 568
LS N L+G V LG L+ LN+S N L P LN L +LDLS N + G
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKF-LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 569 ----NLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGN 610
L L IS NK +G + ++ L D++ N
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVDVSRC-VNLEFLDVSSN 210
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-119
Identities = 91/567 (16%), Positives = 183/567 (32%), Gaps = 54/567 (9%)
Query: 44 IGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTG----KIPVELSNCKSLR 99
+ + L G +P ++G+L LE L L S+ P +S S
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 100 KLLLFDNALAGNIPAELGRL--SNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQV 157
+ R S+L + + I T +G +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ-KSIKKSSRITLKDTQIGQLSNNI 195
Query: 158 SGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLK 217
+ + ++ +L+KL+ + + E E + + LK
Sbjct: 196 T-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLK 249
Query: 218 KLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSL--------SGTIPLSIGGLSELEE 269
L ++ ++ + +P + +++I+ + N +++
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 270 FMISDNN-VSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGS 328
I NN + + +L L L+ NQ+ G P G KL NQ+
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEI 368
Query: 329 IPSTLASCSNLQALDLSHNSLTASVPAGLF--QLQNLTKLLLISNDISG-------SIPP 379
+ ++ L +HN L +P + ++ + N+I + P
Sbjct: 369 PANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 380 EIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG-------SVPDEIGDC 432
++ + + NN+I+ L+ ++L N L+ + +
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487
Query: 433 TELQMIDLSHNTLQGSLPNSL--SSLSGLQVLDVSDNRFSGQIPASLGRLVSL------N 484
L IDL N L L + ++L L +D+S N FS P +L N
Sbjct: 488 YLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545
Query: 485 KIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTG 544
+ N P + LC SL L + SN + V ++ + + L++ N
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP--NISV-LDIKDNPNIS 601
Query: 545 PIPAQISALNKLSILDLSHNKLEGNLN 571
+ + + + L ++K +
Sbjct: 602 IDLSYVCPYIEAGMYMLFYDKTQDIRG 628
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-106
Identities = 87/608 (14%), Positives = 178/608 (29%), Gaps = 76/608 (12%)
Query: 56 SSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAE 115
+ SL + L L +G++P + L L L + N
Sbjct: 65 ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 116 LGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKL--SKLQT 173
P + + + + S L
Sbjct: 125 ---------------------GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163
Query: 174 LSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAI 233
I + I + + N+++ + + +L KL + ++ + V
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 234 PEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQ 293
E + T L L +L + + + +P L +
Sbjct: 223 ICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 294 LQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTA-S 352
+ + N+ Q + + + +Q + + +N+L
Sbjct: 278 INVACNRGISGE----------------QLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321
Query: 353 VPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLN 412
V L +++ L L + N + G P G+ L L + N+I + G + +
Sbjct: 322 VETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVE 380
Query: 413 FLDLSSNRLSGSVPD--EIGDCTELQMIDLSHNTLQG-------SLPNSLSSLSGLQVLD 463
L + N+L +P+ + + + ID S+N + L + + ++
Sbjct: 381 NLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSIN 439
Query: 464 VSDNRFSGQIPASLGRLVSLNKIILSKNLFSG-------PIPSSLGLCSSLQLLDLSSNQ 516
+S+N+ S L+ I L N+ + + L +DL N+
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499
Query: 517 LTG-SVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSIL------DLSHNKLEGN 569
LT S + L ++LS N + P Q + L D N+
Sbjct: 500 LTKLSDDFRATTLPYLVG-IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557
Query: 570 LNP-LAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSCFLSNDGK 628
+ +L L I N + + + +S D+ N + C G
Sbjct: 558 WPEGITLCPSLTQLQIGSNDIRK-VNEK-ITPNISVLDIKDNPNISIDLSYVCPYIEAGM 615
Query: 629 AGLASNEN 636
L ++
Sbjct: 616 YMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 1e-83
Identities = 81/507 (15%), Positives = 155/507 (30%), Gaps = 83/507 (16%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+ + L+ + ++ + + + T L +L
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLT 252
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
++ + + K+P L ++ + + N R + E+++
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACN-----------RGISGEQLKDDWQ----- 296
Query: 136 KIPAELGDCSNMTALGLADTQ-VSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSE 194
A+ + + + + + SL K+ KL L + G++P G+ +
Sbjct: 297 -ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIK 354
Query: 195 LVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQNSLVGAIPE--EIGNCTSLKMIDFSLN 251
L SL L N ++ IP G +++E L N L IP + + + + IDFS N
Sbjct: 355 LASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYN 412
Query: 252 SLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGM 311
+ + N+ + L NQIS
Sbjct: 413 EIGSVDG-----------------KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFST 455
Query: 312 LSKLTVFFAWQNQLEG-------SIPSTLASCSNLQALDLSHNSLTASVPAGLF--QLQN 362
S L+ N L + L ++DL N LT + L
Sbjct: 456 GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPY 514
Query: 363 LTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLS 422
L + L N S P + N S+L + N D NR
Sbjct: 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ------------------RDAQGNRTL 555
Query: 423 GSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVS 482
P+ I C L + + N ++ + + + VLD+ DN + + +
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIE 612
Query: 483 LNKIILSKNLFSGPIPSSLGLCSSLQL 509
+L + + C +L +
Sbjct: 613 AGMYMLFYDK-----TQDIRGCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-59
Identities = 75/401 (18%), Positives = 127/401 (31%), Gaps = 60/401 (14%)
Query: 15 PIPTNLSSFKHLQTLVISDANLT--------GSIPFDIGDCVGLIVLDFSSNNL-VGTLP 65
+PT L + +Q + ++ D + ++ NNL +
Sbjct: 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 66 SSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAEL-GRLSNLEE 124
+SL K+ L L NQL GK+P + L L L N + IPA G +E
Sbjct: 324 TSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVEN 381
Query: 125 MRAGGNKDIVGKIPA--ELGDCSNMTALGLADTQVSG-------SLPASLGKLSKLQTLS 175
+ NK + IP + S M+A+ + ++ L + K + +++
Sbjct: 382 LSFAHNK--LKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSIN 439
Query: 176 IYTTMISGEIPAEIGNCSELVSLFLYENSLSG-------SIPPEIGKLKKLEELFLWQNS 228
+ IS S L S+ L N L+ L + L N
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499
Query: 229 LVGAIPEEI--GNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLA 286
L + ++ L ID S NS S P S L+ F I +
Sbjct: 500 LTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ----------- 546
Query: 287 NATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSH 346
N+ P I + LT N + + + N+ LD+
Sbjct: 547 -------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKD 596
Query: 347 NSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSL 387
N + + + +L + +I C +L
Sbjct: 597 NPNISIDLSYVCPYIEAGMYMLFYDKTQ-----DIRGCDAL 632
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-14
Identities = 17/136 (12%), Positives = 42/136 (30%), Gaps = 8/136 (5%)
Query: 463 DVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG--- 519
+ + + Q SL + + L SG +P ++G + L++L L S+
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 520 -SVPMELGQIEALEIALNLSCNGLTGPIPAQISALN--KLSILDLSHNKLEGNLNPLAQL 576
P + + E + L ++ + + ++ +++
Sbjct: 123 LFGPKGISANMSDEQ-KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181
Query: 577 D-NLVSLNISYNKFTG 591
+ N T
Sbjct: 182 TLKDTQIGQLSNNITF 197
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-13
Identities = 19/137 (13%), Positives = 44/137 (32%), Gaps = 12/137 (8%)
Query: 14 LPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVL------DFSSNNLVGTLPSS 67
L ++ +L + +S + + P + L D N + P
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEG 561
Query: 68 LGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRA 127
+ +L +L + SN + + ++ ++ L + DN + +
Sbjct: 562 ITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYML 618
Query: 128 GGNK--DIVGKIPAELG 142
+K DI G ++
Sbjct: 619 FYDKTQDIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-10
Identities = 16/100 (16%), Positives = 26/100 (26%), Gaps = 3/100 (3%)
Query: 7 IQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPS 66
P Q + L F P I C L L SN++ +
Sbjct: 525 FSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNE 583
Query: 67 SLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDN 106
+ N+ L + N + +LF +
Sbjct: 584 KI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 370 bits (951), Expect = e-115
Identities = 127/620 (20%), Positives = 209/620 (33%), Gaps = 39/620 (6%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+P +L ++ L ++ L + L LD N + P KL L+
Sbjct: 19 VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLK 76
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
L L N+L+ + C +L +L L N++ + NL + N +
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG-LSS 135
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLG--KLSKLQTLSIYTTMISGEIPAEIGNCS 193
N+ L L++ ++ L S L+ L + + I P
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 194 ELVSLFLYENSLSGSIPPEIG---KLKKLEELFLWQNSLVGAIPEEIGNC--TSLKMIDF 248
L LFL L S+ ++ + L L + L T+L M+D
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 249 SLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTN--------- 299
S N+L+ S L +LE F + NN+ +L N+ L L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 300 QISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT-ASVPAGLF 358
+ + L L N + G + NL+ L LS++ + ++ F
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 359 Q---LQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIP-REIGGLKTLNFL 414
L L L N IS L L +G N I + +E GL+ + +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 415 DLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG--SLPNSLSSLSGLQVLDVSDNRFSGQ 472
LS N+ + LQ + L L+ S P+ L L +LD+S+N +
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495
Query: 473 IPASLGRLVSLNKIILSKN--------LFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPME 524
L L L + L N G L S L +L+L SN
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 525 LGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLA---QLDNLVS 581
+ L+I ++L N L + + L L+L N + + NL
Sbjct: 556 FKDLFELKI-IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTE 613
Query: 582 LNISYNKFTGYLPDNKLFRQ 601
L++ +N F F
Sbjct: 614 LDMRFNPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 341 bits (878), Expect = e-104
Identities = 121/614 (19%), Positives = 207/614 (33%), Gaps = 34/614 (5%)
Query: 2 VTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLV 61
+T + + L+ N + + L +L + ++ P L VL+ N L
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 62 GTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSN 121
+ NL EL L SN + K+L L L N L+ +L N
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 122 LEEMRAGGNKDIVGKIPAELGDCSNM--TALGLADTQVSGSLPASLGKLSKLQTLSIYTT 179
L+E+ NK I EL +N L L+ Q+ P + +L L +
Sbjct: 147 LQELLLSNNK-IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 180 MISGEIPAEIG---NCSELVSLFLYENSLSGSIPPEIGKLK--KLEELFLWQNSLVGAIP 234
+ + ++ + + +L L + LS + LK L L L N+L
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 235 EEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEE---------FMISDNNVSGSIPANL 285
+ L+ N++ S+ GL + IS ++ +
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 286 ANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLA----SCSNLQA 341
L L ++ N I G+ L L + + + S L
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385
Query: 342 LDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPP-EIGNCSSLVRLRVGNNRIAGL 400
L+L+ N ++ L +L L L N+I + E ++ + + N+ L
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 401 IPREIGGLKTLNFLDLSSNRLSG--SVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSG 458
+ +L L L L S P L ++DLS+N + + L L
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505
Query: 459 LQVLDVSDNRFS--------GQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLL 510
L++LD+ N + G L L L+ + L N F L+++
Sbjct: 506 LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII 565
Query: 511 DLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQIS-ALNKLSILDLSHNKLEGN 569
DL N L +L+ LNL N +T A L+ LD+ N +
Sbjct: 566 DLGLNNLNTLPASVFNNQVSLKS-LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624
Query: 570 LNPLAQLDNLVSLN 583
+A N ++
Sbjct: 625 CESIAWFVNWINET 638
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = 1e-91
Identities = 106/542 (19%), Positives = 187/542 (34%), Gaps = 53/542 (9%)
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKD 132
+ E + +LT ++P +L ++ L L N L A R S L + G N
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN-- 59
Query: 133 IVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNC 192
+S P KL L+ L++ +S C
Sbjct: 60 -----------------------TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96
Query: 193 SELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNS 252
+ L L L NS+ K K L L L N L +L+ + S N
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 253 LSGTIP--LSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIG 310
+ L I S L++ +S N + P L L L+ Q+ + ++
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216
Query: 311 M---LSKLTVFFAWQNQLEGSIPSTLASC--SNLQALDLSHNSLTASVPAGLFQLQNLTK 365
+ + + +QL + +T +NL LDLS+N+L L L
Sbjct: 217 LELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY 276
Query: 366 LLLISNDISGSIPPEIGNCSSLVRLRVGNN---------RIAGLIPREIGGLKTLNFLDL 416
L N+I + ++ L + + + + LK L L++
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336
Query: 417 SSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLS----SLSGLQVLDVSDNRFSGQ 472
N + G + L+ + LS++ + + + S L +L+++ N+ S
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396
Query: 473 IPASLGRLVSLNKIILSKNLFSGPIP-SSLGLCSSLQLLDLSSNQLTGSVPMELGQIEAL 531
+ L L + L N + ++ + LS N+ + +L
Sbjct: 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSL 456
Query: 532 EIALNLSCNGLTG--PIPAQISALNKLSILDLSHNKLEG-NLNPLAQLDNLVSLNISYNK 588
+ L L L P+ L L+ILDLS+N + N + L L+ L L++ +N
Sbjct: 457 QR-LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515
Query: 589 FT 590
Sbjct: 516 LA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 3e-86
Identities = 92/466 (19%), Positives = 168/466 (36%), Gaps = 25/466 (5%)
Query: 160 SLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKL 219
+P L + + L++ + A S+L SL + N++S P KL L
Sbjct: 18 QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75
Query: 220 EELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSG 279
+ L L N L + CT+L + NS+ L +S N +S
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGML--SKLTVFFAWQNQLEGSIPSTLASCS 337
+ NL +L L N+I L E+ + S L NQ++ P +
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 338 NLQALDLSHNSLTASVPAGLF---QLQNLTKLLLISNDISGSIPPEIGNC--SSLVRLRV 392
L L L++ L S+ L ++ L L ++ +S + ++L L +
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 393 GNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSL--- 449
N + + L L + L N + + ++ ++L + + S+
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 450 ------PNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGL 503
S L L+ L++ DN G L++L + LS + S ++
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 504 C----SSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQ-ISALNKLSI 558
S L +L+L+ N+++ + LE+ L+L N + + Q L +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV-LDLGLNEIGQELTGQEWRGLENIFE 434
Query: 559 LDLSHNKLEG-NLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLS 603
+ LS+NK N A + +L L + F+ L
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 6e-74
Identities = 94/532 (17%), Positives = 164/532 (30%), Gaps = 52/532 (9%)
Query: 3 TEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVG---LIVLDFSSNN 59
++ + S ++ P + L L +++ L S+ + + + L S++
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
Query: 60 LVGTLPSSLGKLH--NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELG 117
L T ++ L NL L L+ N L + L L N + L
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293
Query: 118 RLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIY 177
L N+ L + T ++ + S L L+ L++
Sbjct: 294 GLFNVR----------------YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNME 337
Query: 178 TTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIG----KLKKLEELFLWQNSLVGAI 233
I G L L L + S L L L +N +
Sbjct: 338 DNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE 397
Query: 234 PEEIGNCTSLKMIDFSLNSLSGTIPLS-IGGLSELEEFMISDNNVSGSIPANLANATNLV 292
+ L+++D LN + + GL + E +S N + A +L
Sbjct: 398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
Query: 293 QLQLDTNQISGL--IPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT 350
+L L + + P L LT+ N + L L+ LDL HN+L
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
Query: 351 ASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKT 410
L + G + S L L + +N + L
Sbjct: 518 R----------------LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561
Query: 411 LNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLS-SLSGLQVLDVSDNRF 469
L +DL N L+ + L+ ++L N + + L LD+ N F
Sbjct: 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
Query: 470 SGQIPASLGRLVSLNK-----IILSKNLFSGPIPSSLGLCSSLQLLDLSSNQ 516
+ + +N+ LS + P G ++L D SS +
Sbjct: 622 DCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGF--PVRLFDTSSCK 671
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 7e-72
Identities = 92/431 (21%), Positives = 165/431 (38%), Gaps = 40/431 (9%)
Query: 219 LEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVS 278
E L +P+++ T++ +++ + N L + S+L + N +S
Sbjct: 6 HEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 279 GSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSN 338
P L L L N++S L + LT N ++ + N
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 339 LQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIG--NCSSLVRLRVGNNR 396
L LDLSHN L+++ QL+NL +LLL +N I E+ SSL +L + +N+
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 397 IAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD---CTELQMIDLSHNTLQGSLPNSL 453
I P + L L L++ +L S+ +++ T ++ + LS++ L + +
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 454 SSL--SGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLD 511
L + L +LD+S N + S L L L N SL +++ L+
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 512 LSSN---------QLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLS 562
L + L ++ LE LN+ N + G + L L L LS
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEH-LNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 563 HNKLEGNLNPLAQLDN-----LVSLNISYNKFTGYLPD---------------NKLFRQL 602
++ + L LN++ NK + D N++ ++L
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 603 SPTDLAGNEGL 613
+ + G E +
Sbjct: 422 TGQEWRGLENI 432
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-52
Identities = 77/275 (28%), Positives = 109/275 (39%), Gaps = 16/275 (5%)
Query: 338 NLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRI 397
+ + D SH LT VP L N+T L L N + S L L VG N I
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 398 AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLS 457
+ L P L L L+L N LS CT L + L N++Q N
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 458 GLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLC--SSLQLLDLSSN 515
L LD+S N S + +L +L +++LS N L + SSL+ L+LSSN
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 516 QLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQIS---ALNKLSILDLSHNKLEGNLNP 572
Q+ P I L L L+ L + ++ A + L LS+++L +
Sbjct: 182 QIKEFSPGCFHAIGRLFG-LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST-TSN 239
Query: 573 LA----QLDNLVSLNISYNKFTGYLPDNKLFRQLS 603
+ NL L++SYN D F L
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGND--SFAWLP 272
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-111
Identities = 127/341 (37%), Positives = 190/341 (55%), Gaps = 39/341 (11%)
Query: 675 DDDDSELGDSWPWQFTPFQKL-----NFSVEQVLKCLVDANVIGKGCSGVVYRADMDNGE 729
++D E+ +F+ ++L NFS + N++G+G G VY+ + +G
Sbjct: 6 AEEDPEVHLGQLKRFS-LRELQVASDNFS---------NKNILGRGGFGKVYKGRLADGT 55
Query: 730 VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLM 789
++AVK+L + G F E++ + H+N++R G C RLL+
Sbjct: 56 LVAVKRL----------KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105
Query: 790 YDYMPNGSLGSLLHERTGN--ALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNI 847
Y YM NGS+ S L ER + L+W R +I LG+A+GLAYLH C P I+HRD+KA NI
Sbjct: 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165
Query: 848 LIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVV 907
L+ EFE + DFGLAKL+D D + V G+ G+IAPEY K +EK+DV+ YGV+
Sbjct: 166 LLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 224
Query: 908 VLEVLTGKQPIDPTIP---DGSHVVDWVR----QKKGIQVLDPSLLSRPESEIDEMLQAL 960
+LE++TG++ D D ++DWV+ +KK ++D L + E E+ Q +
Sbjct: 225 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE--EVEQLI 282
Query: 961 GVALLCVNASPDERPTMKDVAAMLK-EIKHER-EEYAKVDM 999
VALLC +SP ERP M +V ML+ + ER EE+ K +M
Sbjct: 283 QVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEM 323
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 340 bits (875), Expect = e-105
Identities = 120/591 (20%), Positives = 207/591 (35%), Gaps = 33/591 (5%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
IP NL + L +S L + L VLD S + + L +L
Sbjct: 22 IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
LIL N + S SL+KL+ + LA +G L L+E+ N
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQ----TLSIYTTMISGEIPAEIGN 191
K+P + +N+ L L+ ++ L L ++ +L + ++ I
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFK 198
Query: 192 CSELVSLFLYENSLSGSIPPE-IGKLKKLEELFLWQNSLVGA------IPEEIGNCTSLK 244
L L L N S ++ I L LE L + +L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 245 MIDFSLNSLS---GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQI 301
+ +F L L I L+ + F + + + L+L +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316
Query: 302 SGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTAS--VPAGLFQ 359
++ L +LT +G + +L+ LDLS N L+ F
Sbjct: 317 GQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 360 LQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREI-GGLKTLNFLDLSS 418
+L L L N + + L L ++ + + + L+ L +LD+S
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 419 NRLSGSVPDEIGDCTELQMIDLSHNTLQGSL-PNSLSSLSGLQVLDVSDNRFSGQIPASL 477
+ + L+++ ++ N+ Q + P+ + L L LD+S + P +
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 478 GRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIE-ALEIALN 536
L SL + +S N F +SLQ+LD S N + S EL +L LN
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF-LN 549
Query: 537 LSCNGLTGPIPAQ--ISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNIS 585
L+ N Q + + L + ++E Q ++SLNI+
Sbjct: 550 LTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 2e-78
Identities = 96/500 (19%), Positives = 160/500 (32%), Gaps = 57/500 (11%)
Query: 143 DCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYE 202
C L ++ +LP S + L + + + EL L L
Sbjct: 13 QCME---LNF--YKIPDNLPFST------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 203 NSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIG 262
+ L L L L N + +SL+ + +L+ IG
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 263 GLSELEEFMISDNN-VSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAW 321
L L+E ++ N S +P +N TNL L L +N+I + ++ +L ++ +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 322 ----QNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGS 376
N + P L L L +N + +V Q L L L+ +
Sbjct: 182 LDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 377 I---PPEIGNCSSLVRLRVGNNRIAGL------IPREIGGLKTLNFLDLSSNRLSGSVPD 427
+ L L + R+A L I L ++ L S +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD- 299
Query: 428 EIGDCTELQMIDLSHNTL-------------------QGSLPNSLSSLSGLQVLDVSDNR 468
Q ++L + +G S L L+ LD+S N
Sbjct: 300 -FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358
Query: 469 --FSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPME-L 525
F G S SL + LS N + S+ L+ LD + L
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 526 GQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP--LAQLDNLVSLN 583
+ L L++S + L+ L +L ++ N + N P +L NL L+
Sbjct: 418 LSLRNLIY-LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 584 ISYNKFTGYLPDNKLFRQLS 603
+S + P F LS
Sbjct: 477 LSQCQLEQLSPT--AFNSLS 494
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-46
Identities = 76/432 (17%), Positives = 128/432 (29%), Gaps = 51/432 (11%)
Query: 3 TEITIQSVPLQLPIPTN-LSSFKHLQTLVISDANLTGSI---PFDIGDCVGLIVLDFSSN 58
++T+++ L + + L+ + FD GL L
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 59 NL------VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNI 112
L + + L N+ L S + S + L L +
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFP 320
Query: 113 PAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQ 172
+L L L T G S L L+
Sbjct: 321 TLKLKSLKRLT------------------------------FTSNKGGNAFSEVDLPSLE 350
Query: 173 TLSIYTTMIS--GEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLV 230
L + +S G + L L L N + + L++LE L ++L
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409
Query: 231 GAIPEEI-GNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPAN-LANA 288
+ + +L +D S GLS LE ++ N+ + +
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469
Query: 289 TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNS 348
NL L L Q+ L P LS L V N ++LQ LD S N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 349 LTASVPAGLFQL-QNLTKLLLISNDISGSIPPE--IGNCSSLVRLRVGNNRIAGLIPREI 405
+ S L +L L L ND + + + + +L V R+ P +
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 406 GGLKTLNFLDLS 417
G+ L+ +++
Sbjct: 590 QGMPVLSL-NIT 600
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = 1e-99
Identities = 98/326 (30%), Positives = 157/326 (48%), Gaps = 35/326 (10%)
Query: 675 DDDDSELGDSWPWQFTPFQKL-----NFSVEQVLKCLVDANVIGKGCSGVVYRADMDNGE 729
++ E+ D+ F+ F +L NF + N +G+G GVVY+ ++N
Sbjct: 1 ENKSLEVSDTRFHSFS-FYELKNVTNNFDERPISV---GGNKMGEGGFGVVYKGYVNNTT 56
Query: 730 VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLM 789
V AVKKL + F EIK + +H+N+V LG + ++ L+
Sbjct: 57 V-AVKKLAAMVDITTEELKQQ-------FDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108
Query: 790 YDYMPNGSLGSLLHERTGNA-LEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNIL 848
Y YMPNGSL L G L W +R +I GAA G+ +LH + +HRDIK+ NIL
Sbjct: 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANIL 165
Query: 849 IGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM--KITEKSDVYSYGV 906
+ F I+DFGLA+ + ++ + G+ Y+APE + +IT KSD+YS+GV
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA---LRGEITPKSDIYSFGV 222
Query: 907 VVLEVLTGKQPIDPTIPDGSHVVDWVR-----QKKGIQVLDPSLLSRPESEIDEMLQALG 961
V+LE++TG +D ++D +K +D + +
Sbjct: 223 VLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKMNDADS---TSVEAMYS 278
Query: 962 VALLCVNASPDERPTMKDVAAMLKEI 987
VA C++ ++RP +K V +L+E+
Sbjct: 279 VASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 314 bits (808), Expect = 4e-99
Identities = 102/307 (33%), Positives = 157/307 (51%), Gaps = 26/307 (8%)
Query: 691 PFQKLNFSVEQVL---KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGC 747
PF+ + + +IG G G VY+ + +G +A+K+ P
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP--------- 73
Query: 748 SDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTG 807
+ G+ + F EI+TL RH ++V +G C RN +L+Y YM NG+L L+
Sbjct: 74 -ESSQGIEE-FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 808 NA--LEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865
+ WE R +I +GAA+GL YLH I+HRD+K+ NIL+ F P I DFG++K
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 866 VDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG 925
+ D S V G+ GYI PEY ++TEKSDVYS+GVV+ EVL + I ++P
Sbjct: 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 926 S-HVVDWVR--QKKG--IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
++ +W G Q++DP+L + E + + A+ C+ S ++RP+M DV
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPE--SLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 981 AAMLKEI 987
L+
Sbjct: 307 LWKLEYA 313
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = 1e-92
Identities = 95/563 (16%), Positives = 189/563 (33%), Gaps = 52/563 (9%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+L + + L ++ G +P IG L VL F +++ + + +
Sbjct: 315 PGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPD 374
Query: 76 ELILNSNQLTGKIP-VELSNCKSLRKLLLFDNALAGN---IPAELGRLSNLEEMRAGGNK 131
+++ + L + L L +A+ N P + +L++ + G
Sbjct: 375 MSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLT 434
Query: 132 DIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGN 191
+ + I + + + + A++ + A + + N
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQ-----YENEELSWSN 489
Query: 192 CSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVG---------AIPEEIGNCTS 242
+L + LY +P + L +L+ L + N + + ++
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 243 LKMIDFSLNSLSG-TIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQI 301
+++ N+L S+ + +L N V + A L L+LD NQI
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQI 607
Query: 302 SGLIPPEIG-MLSKLTVFFAWQNQLEGSIPST--LASCSNLQALDLSHNSLT-----ASV 353
IP + ++ N+L+ IP+ S + ++D S+N + S
Sbjct: 608 EE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISC 665
Query: 354 PAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGL-------IPREIG 406
++ N + + L N+I S + + + NN + +
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725
Query: 407 GLKTLNFLDLSSNRLSGSVPDEI--GDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVL-- 462
L +DL N+L+ S+ D+ L +D+S+N S P + S L+
Sbjct: 726 NTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGI 783
Query: 463 ----DVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518
D NR Q P + SL ++ + N + L L +LD++ N
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEK--LTPQLYILDIADNPNI 840
Query: 519 -GSVPMELGQIEALEIALNLSCN 540
V IEA L
Sbjct: 841 SIDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = 5e-89
Identities = 71/576 (12%), Positives = 165/576 (28%), Gaps = 57/576 (9%)
Query: 53 LDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNI 112
+ + L + L L G++P + L+ L ++ +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 113 PAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQ 172
+ ++ + L + L ++ + + + K
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDS 421
Query: 173 TLSIYTTMISG------EIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQ 226
+S+ T I I I ++L ++ + + E+
Sbjct: 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDY 476
Query: 227 NSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSG------- 279
N L ++ +P + L EL+ I+ N
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536
Query: 280 --SIPANLANATNLVQLQLDTNQISGLIPP-EIGMLSKLTVFFAWQNQLEGSIPSTLASC 336
+ + + + N + + + KL + N++ +
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTN 594
Query: 337 SNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPP--EIGNCSSLVRLRVG 393
L L L +N + +P + L N + IP + + +
Sbjct: 595 VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFS 652
Query: 394 NNRIAGLIPR-----EIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ-- 446
N+I + + + LS N + + + + I LS+N +
Sbjct: 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712
Query: 447 -----GSLPNSLSSLSGLQVLDVSDNRFSGQIPASL--GRLVSLNKIILSKNLFSGPIPS 499
+ + L +D+ N+ + + L L+ + +S N FS P+
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPT 770
Query: 500 SLGLCSSLQLLDL------SSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISAL 553
S L+ + N++ P + +L L + N + + ++
Sbjct: 771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQ-LQIGSNDIRK-VDEKL--T 826
Query: 554 NKLSILDLSHNKL-EGNLNPLAQLDNLVSLNISYNK 588
+L ILD++ N ++ + + Y+K
Sbjct: 827 PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 262 bits (670), Expect = 5e-74
Identities = 70/455 (15%), Positives = 146/455 (32%), Gaps = 42/455 (9%)
Query: 180 MISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGN 239
M + ++ N + L L G +P IG+L +L+ L +S +
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 240 CTSLKMIDFSLNSLSGTIP------LSIGGLSELEEFMISDNNVSGSIPANLANATNLVQ 293
+ M + + + LS+L + I+ N I + + Q
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ 429
Query: 294 LQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASV 353
+ TN+I+ I I L+KL + + + + + + + +
Sbjct: 430 IGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENE 483
Query: 354 PAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGL---------IPRE 404
L++LT + L + +P + + L L + NR + +
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
Query: 405 IGGLKTLNFLDLSSNRLSG-SVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLD 463
+ + N L + +L ++D HN + + + L L
Sbjct: 544 EDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLK 601
Query: 464 VSDNRFSGQIPASLGR-LVSLNKIILSKNLFSG-PIPSSLGLCSSLQLLDLSSNQLTG-- 519
+ N+ +IP + + S N P + + +D S N++
Sbjct: 602 LDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEG 660
Query: 520 ---SVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE--------G 568
S M+ + + LS N + + + +S + LS+N +
Sbjct: 661 RNISCSMDDYKGINAST-VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719
Query: 569 NLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLS 603
L ++++ +NK T L D+ L
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLP 753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-52
Identities = 82/522 (15%), Positives = 150/522 (28%), Gaps = 70/522 (13%)
Query: 117 GRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSI 176
+ L+ M+ +D + +G+A + LPA ++ T S
Sbjct: 168 RVTTELKGMKVTYKED-SKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQ 226
Query: 177 YTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEE 236
S + S F + KL K + + I +
Sbjct: 227 SGIKRSELETQSVRGES-----FTVID----------NKLTKDANVPIQLKETAEYIKDY 271
Query: 237 IGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQL 296
+ +D + F + +L N + L L
Sbjct: 272 KALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSL 330
Query: 297 DTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPS------------------------- 331
G +P IG L++L V + S
Sbjct: 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390
Query: 332 TLASCSNLQALDLSHNSLT-----ASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSS 386
L L DL +++ + T++ ++N I+ I I +
Sbjct: 391 FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTK 449
Query: 387 LVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446
L + N+ + + + + +L ++L +
Sbjct: 450 LQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM 504
Query: 447 GSLPNSLSSLSGLQVLDVSDNRFSG---------QIPASLGRLVSLNKIILSKNLFSG-P 496
LP+ L L LQ L+++ NR ++ + + N P
Sbjct: 505 TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFP 564
Query: 497 IPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISA-LNK 555
+SL L LLD N++ + G L L L N + IP A ++
Sbjct: 565 ASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTD-LKLDYNQIEE-IPEDFCAFTDQ 620
Query: 556 LSILDLSHNKLEG--NLNPLAQLDNLVSLNISYNKFTGYLPD 595
+ L SHNKL+ N+ + + S++ SYNK +
Sbjct: 621 VEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-37
Identities = 50/387 (12%), Positives = 105/387 (27%), Gaps = 88/387 (22%)
Query: 13 QLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGK-L 71
+ P +L L L + + G V L L N + +P
Sbjct: 562 EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFT 618
Query: 72 HNLEELILNSNQLTGKIP--VELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGG 129
+E L + N+L IP + + + N + + + +
Sbjct: 619 DQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK------ 671
Query: 130 NKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMIS------- 182
N + + L+ ++ S + T+ + +++
Sbjct: 672 --------------GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSL 717
Query: 183 GEIPAEIGNCSELVSLFLYENSLSGSIPPEI--GKLKKLEELFLWQNSLVGAIPEEIGNC 240
N L ++ L N L+ S+ + L L + + N + P + N
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNS 775
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
+ LK N + P + +L+QLQ+ +N
Sbjct: 776 SQLKAFGIRHQRD------------------AEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
I + ++ L LD++ N + +
Sbjct: 818 IRK-VDEKL--------------------------TPQLYILDIADNPNISIDVTSVCPY 850
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSL 387
+L+ + +I C +L
Sbjct: 851 IEAGMYVLLYDKT-----QDIRGCDAL 872
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-22
Identities = 29/248 (11%), Positives = 71/248 (28%), Gaps = 38/248 (15%)
Query: 7 IQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL------ 60
I S + + + T+ +S + + + S+N +
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 61 -VGTLPSSLGKLHNLEELILNSNQLTGKIPVEL--SNCKSLRKLLLFDNALAGNIPAELG 117
+ + + L + L N+LT + + + L + + N + P +
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773
Query: 118 RLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIY 177
S L+ +D ++ P + L L I
Sbjct: 774 NSSQLKAFGIRHQRD-------------------AEGNRILRQWPTGITTCPSLIQLQIG 814
Query: 178 TTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEI 237
+ I ++ ++ +L L + +N + + L + ++I
Sbjct: 815 SNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT-----QDI 866
Query: 238 GNCTSLKM 245
C +L +
Sbjct: 867 RGCDALGI 874
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = 2e-91
Identities = 118/565 (20%), Positives = 197/565 (34%), Gaps = 40/565 (7%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
IP L + + L S L + L LD + + + H L+
Sbjct: 27 IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
L+L +N L LS K+L+ L ++ L LE + G N I
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH-ISS 143
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSEL 195
+ + L + + + L + L
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL--------------------- 182
Query: 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCT--SLKMIDFSLNSL 253
SL L N ++ I P + L + I + + N T SL + F
Sbjct: 183 -SLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
Query: 254 SGTIPLSIGGLSE--LEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGM 311
P GL E +E + + + L +L L +S +P +
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVG 299
Query: 312 LSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLIS 370
LS L N+ E + ++ +L L + N+ + G + L+NL +L L
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359
Query: 371 NDI--SGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDE 428
+DI S ++ N S L L + N L L LDL+ RL
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419
Query: 429 I-GDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSG---QIPASLGRLVSLN 484
+ L++++LSH+ L S L LQ L++ N F Q SL L L
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479
Query: 485 KIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTG 544
++LS S + + +DLS N+LT S L ++ + LNL+ N ++
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY--LNLASNHISI 537
Query: 545 PIPAQISALNKLSILDLSHNKLEGN 569
+P+ + L++ ++L N L+
Sbjct: 538 ILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 2e-79
Identities = 105/550 (19%), Positives = 181/550 (32%), Gaps = 61/550 (11%)
Query: 52 VLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGN 111
+ + L +P +L ++ E L + N L S +L L L +
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 112 IPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKL 171
L+ L L + +L L
Sbjct: 73 HEDTFQSQHRLDT-------------------------LVLTANPLIFMAETALSGPKAL 107
Query: 172 QTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVG 231
+ L T IS + N L SL+L N +S P+ +KL+ L N++
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 232 AIPEEIGNCTSLKMIDFSLNSLS-GTIPLSIGGLSELEEFMISDNNVSGSIPANLANAT- 289
E++ + + +LN I + + I L N+T
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227
Query: 290 -NLVQLQLDTNQISGLIPPEIGMLSK--LTVFFAWQNQLEGSIPSTLASCSNLQALDLSH 346
+L + + P L + + ++ +T S LQ LDL+
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287
Query: 347 NSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRV-GNNRIAGLIPREI 405
L+ +P+GL L L KL+L +N N SL L + GN + L +
Sbjct: 288 THLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346
Query: 406 GGLKTLNFLDLSSNRL--SGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLD 463
L+ L LDLS + + S ++ + + LQ ++LS+N + L++LD
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406
Query: 464 VSDNRFSGQIPAS-LGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522
++ R + S L L + LS +L +LQ L+L N
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK--- 463
Query: 523 MELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEG-NLNPLAQLDNLVS 581
+ L +L IL LS L + + L +
Sbjct: 464 -------------------GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504
Query: 582 LNISYNKFTG 591
+++S+N+ T
Sbjct: 505 VDLSHNRLTS 514
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 8e-70
Identities = 91/431 (21%), Positives = 154/431 (35%), Gaps = 18/431 (4%)
Query: 184 EIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSL 243
EIP + + L N L +L L L L + + + + L
Sbjct: 26 EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 244 KMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISG 303
+ + N L ++ G L+ +S L N L L L +N IS
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 304 LIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQ--ALDLSHNSLTASVPAGLFQLQ 361
+ P+ KL V N + ++S +L+L+ N + + G F
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSA 202
Query: 362 NLTKLLLISNDISGSIPPEIGNCS--SLVRLRVGNNRIAGLIPREIGGLKTLN--FLDLS 417
L I + N + SL + + P GL ++ ++L
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 418 SNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL 477
+ + + LQ +DL+ L LP+ L LS L+ L +S N+F S
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 478 GRLVSLNKIILSKNLFSGPIPS-SLGLCSSLQLLDLSSNQLTGS--VPMELGQIEALEIA 534
SL + + N + + L +L+ LDLS + + S ++L + L+
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQS- 380
Query: 535 LNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNL--NPLAQLDNLVSLNISYNKFTGY 592
LNLS N +L +LDL+ +L+ +P L L LN+S++
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD-I 439
Query: 593 LPDNKLFRQLS 603
+ LF L
Sbjct: 440 SSEQ-LFDGLP 449
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 1e-68
Identities = 94/519 (18%), Positives = 165/519 (31%), Gaps = 57/519 (10%)
Query: 11 PLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGK 70
PL T LS K L+ L ++ + + L L SN++
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 71 LHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGN 130
L+ L +N + ++S+ + L L L+ +
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL--------------NLNGND------- 190
Query: 131 KDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLG--KLSKLQTLSIYTTMISGEIPAE 188
+ I D + +L TQ + L + L + PA
Sbjct: 191 ---IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 189 IGNCSE--LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMI 246
E + S+ L ++ L+EL L L +P + ++LK +
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKL 306
Query: 247 DFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPAN-LANATNLVQLQLDTNQISGLI 305
S N +S L I N + L N NL +L L + I
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS- 365
Query: 306 PPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTK 365
L + S+LQ+L+LS+N + + L
Sbjct: 366 ---------------------DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL 404
Query: 366 LLLISNDISGSIPPEI-GNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGS 424
L L + N L L + ++ + + GL L L+L N
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464
Query: 425 VPDEIG---DCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLV 481
+ L+++ LS L ++ +SL + +D+S NR + +L L
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524
Query: 482 SLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGS 520
+ + L+ N S +PS L + S + ++L N L +
Sbjct: 525 GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-56
Identities = 77/417 (18%), Positives = 139/417 (33%), Gaps = 39/417 (9%)
Query: 220 EELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSG 279
+ L IP + N S + ++FS N L + L L ++ +
Sbjct: 15 KTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
+ L L L N + + + L F Q + L + L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 340 QALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISG------------------------ 375
++L L N +++ F + L L +N I
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 376 -SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGG--LKTLNFLDLSSNRLSGSVPDEIGDC 432
I P + + L G + +I + + +++L P
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 433 TE--LQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSK 490
E ++ I+L + N+ SGLQ LD++ S ++P+ L L +L K++LS
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 491 NLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPME-LGQIEALEIALNLSCNGLT--GPIP 547
N F S SL L + N + L +E L L+LS + +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE-LDLSHDDIETSDCCN 369
Query: 548 AQISALNKLSILDLSHNKLEG-NLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLS 603
Q+ L+ L L+LS+N+ + L L++++ + F+ L
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNLH 425
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-42
Identities = 62/314 (19%), Positives = 99/314 (31%), Gaps = 35/314 (11%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSL 387
IP TL + + + L+ S N L +L NLT L L I + L
Sbjct: 26 EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG 447
L + N + + + G K L L +S + + L+ + L N +
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 448 SLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIIL--SKNLFSGPIPSSLGLCS 505
L+VLD +N + L + L + N +G I +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSA 202
Query: 506 SLQLLDLSSNQLTGSVPMELG--QIEALEI-------------------------ALNLS 538
Q L+ Q + L I++L + ++NL
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 539 CNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKL 598
+ + L LDL+ L + L L L L +S NKF L
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFEN-LCQISA 321
Query: 599 --FRQLSPTDLAGN 610
F L+ + GN
Sbjct: 322 SNFPSLTHLSIKGN 335
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-30
Identities = 40/215 (18%), Positives = 80/215 (37%), Gaps = 9/215 (4%)
Query: 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473
+ + L+ +P + + ++ S N L + S L L LD++ +
Sbjct: 17 YNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 474 PASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEI 533
+ L+ ++L+ N ++L +L+ L ++ + L + LE
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 534 ALNLSCNGLTGPIPAQISALNKLSILDLSHNKL----EGNLNPLAQLDNLVSLNISYNKF 589
L L N ++ + KL +LD +N + + +++ L Q NL SLN++ N
Sbjct: 134 -LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL-SLNLNGNDI 191
Query: 590 TGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSCFLS 624
G P + G + L K +
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 44/255 (17%), Positives = 81/255 (31%), Gaps = 9/255 (3%)
Query: 12 LQLPIPTNLSSFKHLQTLVISDANLTGSI-PFDIGDCVGLIVLDFSSNNL--VGTLPSSL 68
+ + S+F L L I + + + L LD S +++ L
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 69 GKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIP-AELGRLSNLEEMRA 127
L +L+ L L+ N+ C L L L L + L L+ +
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 128 GGNKDIVGKIPAELGDCSNMTALGLAD---TQVSGSLPASLGKLSKLQTLSIYTTMISGE 184
+ + + L L + + SL L +L+ L + +S
Sbjct: 433 SHSL-LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 185 IPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLK 244
+ + + L N L+ S + LK + L L N + +P + + +
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQR 550
Query: 245 MIDFSLNSLSGTIPL 259
I+ N L T
Sbjct: 551 TINLRQNPLDCTCSN 565
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 1e-85
Identities = 87/299 (29%), Positives = 138/299 (46%), Gaps = 14/299 (4%)
Query: 328 SIPSTLASCSNLQ----ALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGS--IPPEI 381
I L + + L D + + + Q + L L ++ IP +
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 382 GNCSSLVRLRVGN-NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDL 440
N L L +G N + G IP I L L++L ++ +SG++PD + L +D
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 441 SHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSL-NKIILSKNLFSGPIPS 499
S+N L G+LP S+SSL L + NR SG IP S G L + +S+N +G IP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 500 SLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSIL 559
+ +L +DLS N L G + G + + ++L+ N L + ++ L+ L
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQK-IHLAKNSLAFDLG-KVGLSKNLNGL 249
Query: 560 DLSHNKLEGNLNP--LAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSS 616
DL +N++ G L P L QL L SLN+S+N G +P ++ + A N+ LC S
Sbjct: 250 DLRNNRIYGTL-PQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 4e-77
Identities = 78/267 (29%), Positives = 119/267 (44%), Gaps = 7/267 (2%)
Query: 134 VGKIPAELGDCSNMTALGLADTQVSGS--LPASLGKLSKLQTLSIYTT-MISGEIPAEIG 190
+G + + L L+ + +P+SL L L L I + G IP I
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 191 NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSL 250
++L L++ ++SG+IP + ++K L L N+L G +P I + +L I F
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 251 NSLSGTIPLSIGGLSELEEFM-ISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEI 309
N +SG IP S G S+L M IS N ++G IP AN NL + L N + G
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF 217
Query: 310 GMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLI 369
G +N L + + NL LDL +N + ++P GL QL+ L L +
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 370 SNDISGSIPPEIGNCSSLVRLRVGNNR 396
N++ G I P+ GN NN+
Sbjct: 277 FNNLCGEI-PQGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 3e-76
Identities = 72/297 (24%), Positives = 119/297 (40%), Gaps = 26/297 (8%)
Query: 53 LDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNI 112
D + +G L + + + + L L+ L P I
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP----------------------I 68
Query: 113 PAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQ 172
P+ L L L + GG ++VG IP + + + L + T VSG++P L ++ L
Sbjct: 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128
Query: 173 TLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKL-EELFLWQNSLVG 231
TL +SG +P I + LV + N +SG+IP G KL + + +N L G
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 232 AIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNL 291
IP N +L +D S N L G + G ++ ++ N+++ + + + NL
Sbjct: 189 KIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNL 246
Query: 292 VQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNS 348
L L N+I G +P + L L N L G IP + ++N
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 5e-74
Identities = 78/285 (27%), Positives = 122/285 (42%), Gaps = 11/285 (3%)
Query: 13 QLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGT--LPSSLGK 70
L PT LSS+ T + G + + LD S NL +PSSL
Sbjct: 17 DLGNPTTLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN 74
Query: 71 LHNLEELIL-NSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGG 129
L L L + N L G IP ++ L L + ++G IP L ++ L +
Sbjct: 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134
Query: 130 NKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQT-LSIYTTMISGEIPAE 188
N + G +P + N+ + ++SG++P S G SKL T ++I ++G+IP
Sbjct: 135 NA-LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 189 IGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDF 248
N + L + L N L G G K +++ L +NSL + ++G +L +D
Sbjct: 194 FANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDL 251
Query: 249 SLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPA--NLANATNL 291
N + GT+P + L L +S NN+ G IP NL
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVS 296
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-69
Identities = 67/284 (23%), Positives = 120/284 (42%), Gaps = 30/284 (10%)
Query: 2 VTEITIQSVPL--QLPIPTNLSSFKHLQTLVISDAN-LTGSIPFDIGDCVGLIVLDFSSN 58
V + + + L PIP++L++ +L L I N L G IP I L L +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 59 NLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGR 118
N+ G +P L ++ L L + N L+G +P +S+ +L + N ++G IP G
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 119 LSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYT 178
S L T++ ++ +++G +P + L+ L + +
Sbjct: 172 FSKL------------------------FTSMTISRNRLTGKIPPTFANLN-LAFVDLSR 206
Query: 179 TMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIG 238
M+ G+ G+ + L +NSL+ + ++G K L L L N + G +P+ +
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 239 NCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIP 282
L ++ S N+L G IP G L + ++N P
Sbjct: 266 QLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 5e-78
Identities = 120/581 (20%), Positives = 196/581 (33%), Gaps = 54/581 (9%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+P ++ + + +S L + + L LD S + + LH+L
Sbjct: 26 VPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
LIL N + P S SL L+ + LA +G+L L+++ N
Sbjct: 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSEL 195
K+PA + +N+ + L+ + L L + +
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV--------------------N 183
Query: 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEE-IGNCTSLKMIDFSLNSLS 254
+SL + N + I + + KL EL L N I + + N L + L
Sbjct: 184 LSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242
Query: 255 GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSK 314
L I S +E L + + + +L + L+
Sbjct: 243 DERNLEIFEPSIME---------------GLCD-VTIDEFRLTYTNDFSDDIVKFHCLAN 286
Query: 315 LTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDIS 374
++ + + Q+L + L P L L L L N
Sbjct: 287 VSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKG- 340
Query: 375 GSIPPEIGNCSSLVRLRVGNNRIAGLIPR--EIGGLKTLNFLDLSSNRLSGSVPDEIGDC 432
SI + SL L + N ++ G +L LDLS N +
Sbjct: 341 -SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGL 398
Query: 433 TELQMIDLSHNTLQGSLPNS-LSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491
ELQ +D H+TL+ S SL L LD+S L SLN + ++ N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 492 LFSGPIPSS-LGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQI 550
F S+ ++L LDLS QL + L++ LN+S N L +
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL-LNMSHNNLLFLDSSHY 517
Query: 551 SALNKLSILDLSHNKLEG-NLNPLAQLDNLVSLNISYNKFT 590
+ L LS LD S N++E +L N++ N
Sbjct: 518 NQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 1e-71
Identities = 110/598 (18%), Positives = 194/598 (32%), Gaps = 72/598 (12%)
Query: 28 TLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGK 87
T D L+ +P DI +D S N L S L+ L L+ ++
Sbjct: 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 88 IPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNM 147
L L+L N + P L++LE
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLEN----------------------- 108
Query: 148 TALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISG-EIPAEIGNCSELVSLFLYENSLS 206
L +T+++ +G+L L+ L++ I ++PA N + LV + L N +
Sbjct: 109 --LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 207 GSIPPEIGKLKKL----EELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIP-LSI 261
++ L++ L + N + I ++ L + N S I +
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCL 225
Query: 262 GGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTV--FF 319
L+ L + + P + L +T+ F
Sbjct: 226 QNLAGLHVHRLILGEFKDE------------------RNLEIFEPSIMEGLCDVTIDEFR 267
Query: 320 AWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPP 379
+N+ A+ L+ S+ + + L +I + P
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--VPKHFKWQSLSIIRCQLK-QFPT 324
Query: 380 EIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPD--EIGDCTELQM 437
+ L L + N+ I + L +L++LDLS N LS S L+
Sbjct: 325 --LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380
Query: 438 IDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPAS-LGRLVSLNKIILSKNLFSGP 496
+DLS N + + L LQ LD + S L L + +S
Sbjct: 381 LDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439
Query: 497 IPSSLGLCSSLQLLDLSSNQLTGSVPME-LGQIEALEIALNLSCNGLTGPIPAQISALNK 555
+SL L ++ N + L L+LS L L++
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF-LDLSKCQLEQISWGVFDTLHR 498
Query: 556 LSILDLSHNKLEG-NLNPLAQLDNLVSLNISYNKFTGYLPDN--KLFRQLSPTDLAGN 610
L +L++SHN L + + QL +L +L+ S+N+ + L+ +L N
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 8e-65
Identities = 109/560 (19%), Positives = 188/560 (33%), Gaps = 58/560 (10%)
Query: 62 GTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSN 121
G+L + + N+ +L+ K+P ++ + S + + L N L S
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 122 LEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMI 181
L+ L L+ ++ + L L L + I
Sbjct: 58 LQW-------------------------LDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 182 SGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGA-IPEEIGNC 240
P + L +L E L+ IG+L L++L + N + +P N
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMIS---DNNVSGSIPANLANATNLVQLQLD 297
T+L +D S N + + L E + +S N I L +L L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 298 TNQISGLIPPE-IGMLSKLTV------FFAWQNQLEGSIPSTLASCSNLQA--LDLSHNS 348
N S I + L+ L V F + LE PS + ++ L++ +
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 349 LTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGL 408
+ L N++ + L I ++ L + ++ L
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQF---PTLDL 327
Query: 409 KTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSG--LQVLDVSD 466
L L L+ N+ S + + L +DLS N L S S S L L+ LD+S
Sbjct: 328 PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 467 NRFSGQIPASLGRLVSLNKIILSKNLFSGPIP-SSLGLCSSLQLLDLSSNQLTGSVPMEL 525
N + A+ L L + + S+ L LD+S
Sbjct: 386 NGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
Query: 526 GQIEALEIALNLSCNGLTGPIPAQI-SALNKLSILDLSHNKLEG-NLNPLAQLDNLVSLN 583
+ +L L ++ N + + + L+ LDLS +LE + L L LN
Sbjct: 445 LGLTSLNT-LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503
Query: 584 ISYNKFTGYLPDNKLFRQLS 603
+S+N D+ + QL
Sbjct: 504 MSHNNLLF--LDSSHYNQLY 521
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-51
Identities = 82/513 (15%), Positives = 149/513 (29%), Gaps = 105/513 (20%)
Query: 14 LPIPTNLSSFKHLQTLVISDANLTGSIPFDIGD----CVGLIVLDFSSNNLVGTLPSSLG 69
+P S+ +L + +S + D+ + LD S N + +
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAF 201
Query: 70 KLHNLEELILNSNQLTGKIPVE-LSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAG 128
+ L EL L N + I L N L L E+ S +E
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME----- 256
Query: 129 GNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAE 188
L ++ + + T + +
Sbjct: 257 -----------------------------------GLCDVTIDE-FRLTYTNDFSDDIVK 280
Query: 189 IGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDF 248
+ + ++ L S+ ++ K K + L + + L P + LK +
Sbjct: 281 FHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL-KQFPT--LDLPFLKSLTL 335
Query: 249 SLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLAN--ATNLVQLQLDTNQISGLIP 306
++N S I L L +S N +S S + ++ +L L L N
Sbjct: 336 TMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI---- 389
Query: 307 PEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKL 366
+ + LQ LD H++L F
Sbjct: 390 ---------------------IMSANFMGLEELQHLDFQHSTLKRVTEFSAFL------- 421
Query: 367 LLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVP 426
+ L+ L + GL +LN L ++ N +
Sbjct: 422 ----------------SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
Query: 427 DEI-GDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNK 485
+ + T L +DLS L+ +L LQ+L++S N + +L SL+
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525
Query: 486 IILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518
+ S N SL +L++N +
Sbjct: 526 LDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-47
Identities = 79/422 (18%), Positives = 142/422 (33%), Gaps = 32/422 (7%)
Query: 207 GSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSE 266
GS+ P I + + L +P++I +S K ID S N L S SE
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 267 LEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLE 326
L+ +S + +L L L N I P L+ L A + +L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 327 GSIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEIGN-- 383
+ L+ L+++HN + + F L NL + L N I ++
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 384 --CSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDE-IGDCTELQMIDL 440
+ L + N I I + L+ L L N S ++ + + L + L
Sbjct: 178 ENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 441 SHNTLQGSL------PNSLSSLSGLQV--LDVSDNRFSGQIPASLGRLVSLNKIILSKNL 492
+ P+ + L + + ++ L +++ + L+
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 493 FSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISA 552
+ Q L + QL ++L ++ +L L+ N + A
Sbjct: 297 IKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLK----SLTLTMNKGSISFK--KVA 348
Query: 553 LNKLSILDLSHNKLEGNLNPLA----QLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLA 608
L LS LDLS N L + ++L L++S+N + +L D
Sbjct: 349 LPSLSYLDLSRNALS-FSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQ 407
Query: 609 GN 610
+
Sbjct: 408 HS 409
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-44
Identities = 67/362 (18%), Positives = 124/362 (34%), Gaps = 44/362 (12%)
Query: 273 SDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPST 332
D +S +P ++ ++ + L N + L S+L + ++E
Sbjct: 19 MDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA 75
Query: 333 LASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRV 392
+L L L+ N + S G F +SL L
Sbjct: 76 WHGLHHLSNLILTGNPIQ-SFSPGSFS-----------------------GLTSLENLVA 111
Query: 393 GNNRIAGLIPREIGGLKTLNFLDLSSNRLSG-SVPDEIGDCTELQMIDLSHNTLQGSLPN 451
++A L IG L TL L+++ N + +P + T L +DLS+N +Q N
Sbjct: 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171
Query: 452 SLSSLSGL----QVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGL-CSS 506
L L LD+S N I + + L+++ L N S I + +
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAG 230
Query: 507 LQLLDLSSNQLTGSVPMELGQIEALE-------IALNLSCNGLTGPIPAQISALNKLSIL 559
L + L + +E+ + +E L+ + L +S +
Sbjct: 231 LHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290
Query: 560 DLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKD 619
L+ ++ L + + SL+I + + + L L N+G S +K
Sbjct: 291 SLAGVSIK-YLEDVPKHFKWQSLSIIRCQLKQFPTLD--LPFLKSLTLTMNKGSISFKKV 347
Query: 620 SC 621
+
Sbjct: 348 AL 349
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-12
Identities = 25/143 (17%), Positives = 43/143 (30%), Gaps = 2/143 (1%)
Query: 13 QLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSS-LGKL 71
++ + S + L L IS N L L + N+ S+
Sbjct: 413 RVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT 472
Query: 72 HNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNK 131
NL L L+ QL L+ L + N L + +L +L + N+
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 132 DIVGKIPAELGDCSNMTALGLAD 154
I ++ L +
Sbjct: 533 -IETSKGILQHFPKSLAFFNLTN 554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-09
Identities = 20/97 (20%), Positives = 38/97 (39%)
Query: 12 LQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKL 71
+ ++ +L L +S L L +L+ S NNL+ S +L
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520
Query: 72 HNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNAL 108
++L L + N++ + KSL L +N++
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 3e-73
Identities = 71/319 (22%), Positives = 122/319 (38%), Gaps = 45/319 (14%)
Query: 700 EQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
L V +G G V++A + E +AVK D++S
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ---------DKQS---WQNE 66
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNN----RLLMYDYMPNGSLGSLLHERTGNALEWELR 815
E+ +L ++H+NI++F+G + L+ + GSL L N + W
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNEL 123
Query: 816 YQILLGAAQGLAYLHHDCV-------PPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868
I A+GLAYLH D P I HRDIK+ N+L+ IADFGLA +
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 869 GDFARSSNTVAGSYGYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 923
G A ++ G+ Y+APE + + D+Y+ G+V+ E+ + D +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 924 DGSHV-VDWVRQKKGI---------QVLDPSLLSRPESEIDEMLQALG-VALLCVNASPD 972
+ + + Q + + P L + + L C + +
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK--HAGMAMLCETIEECWDHDAE 301
Query: 973 ERPTMKDVAAMLKEIKHER 991
R + V + +++
Sbjct: 302 ARLSAGCVGERITQMQRLT 320
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-67
Identities = 111/484 (22%), Positives = 199/484 (41%), Gaps = 37/484 (7%)
Query: 18 TNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEEL 77
++ V+ N+T ++ D + L + + L+NL ++
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 78 ILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKI 137
++NQLT P L N L +L+ +N +A P L L+NL + N+ + I
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQ--ITDI 127
Query: 138 PAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVS 197
L + +N+ L L+ +S ++L L+ LQ LS ++ P + N + L
Sbjct: 128 DP-LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ-VTDLKP--LANLTTLER 181
Query: 198 LFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTI 257
L + N +S + KL LE L N + P +G T+L + + N L I
Sbjct: 182 LDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I 236
Query: 258 PLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTV 317
++ L+ L + +++N +S P L+ T L +L+L NQIS + P + L+ LT
Sbjct: 237 G-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 291
Query: 318 FFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSI 377
+NQLE P +++ NL L L N+++ P + L L +L +N +S
Sbjct: 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-- 345
Query: 378 PPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQM 437
+ N +++ L G+N+I+ L P + L + L L+ + + + + +
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 403
Query: 438 IDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPI 497
+ L P ++S D++ N S I FSG +
Sbjct: 404 VKNVTGAL--IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTV 460
Query: 498 PSSL 501
L
Sbjct: 461 TQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 5e-67
Identities = 119/542 (21%), Positives = 197/542 (36%), Gaps = 86/542 (15%)
Query: 50 LIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALA 109
L + + + + + L + +L +T + ++ + L +
Sbjct: 3 LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI- 58
Query: 110 GNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLS 169
+ L+NL + + ++ Q++ P L L+
Sbjct: 59 -KSIDGVEYLNNLTQ-------------------------INFSNNQLTDITP--LKNLT 90
Query: 170 KLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSL 229
KL + + I+ P + N + L L L+ N ++ P + L L L L N++
Sbjct: 91 KLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI 146
Query: 230 VGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANAT 289
+ TSL+ + F N ++ PL L+ LE IS N VS + LA T
Sbjct: 147 SD--ISALSGLTSLQQLSFG-NQVTDLKPL--ANLTTLERLDISSNKVSD--ISVLAKLT 199
Query: 290 NLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSL 349
NL L NQIS + P L +NL L L+ N L
Sbjct: 200 NLESLIATNNQISDITP--------------------------LGILTNLDELSLNGNQL 233
Query: 350 TASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLK 409
L L NLT L L +N IS P + + L L++G N+I+ + P + GL
Sbjct: 234 KD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLT 287
Query: 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469
L L+L+ N+L I + L + L N + P +SSL+ LQ L +N+
Sbjct: 288 ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343
Query: 470 SGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIE 529
S +SL L ++N + N S P L + + L L+ T + +
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399
Query: 530 ALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKF 589
N+ G PA IS + D++ N V++ F
Sbjct: 400 IPNTVKNV--TGALIA-PATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTF 456
Query: 590 TG 591
+G
Sbjct: 457 SG 458
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 6e-60
Identities = 105/428 (24%), Positives = 195/428 (45%), Gaps = 56/428 (13%)
Query: 171 LQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLV 230
L + +I +I +E + L + +++ ++ L ++ L + +
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI- 58
Query: 231 GAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATN 290
+ + +L I+FS N L+ PL L++L + ++++N ++ P LAN TN
Sbjct: 59 -KSIDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANLTN 113
Query: 291 LVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT 350
L L L NQI+ + P L + +NL L+LS N+++
Sbjct: 114 LTGLTLFNNQITDIDP--------------------------LKNLTNLNRLELSSNTIS 147
Query: 351 ASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKT 410
+ L L +L +L N ++ P + N ++L RL + +N+++ + + L
Sbjct: 148 --DISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSDISV--LAKLTN 200
Query: 411 LNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470
L L ++N++S P +G T L + L+ N L+ +L+SL+ L LD+++N+ S
Sbjct: 201 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS 256
Query: 471 GQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEA 530
P L L L ++ L N S P L ++L L+L+ NQL P + ++
Sbjct: 257 NLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKN 310
Query: 531 LEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFT 590
L L L N ++ P +S+L KL L +NK+ +++ LA L N+ L+ +N+ +
Sbjct: 311 LTY-LTLYFNNISDISP--VSSLTKLQRLFFYNNKVS-DVSSLANLTNINWLSAGHNQIS 366
Query: 591 GYLPDNKL 598
P L
Sbjct: 367 DLTPLANL 374
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 63/294 (21%), Positives = 114/294 (38%), Gaps = 20/294 (6%)
Query: 13 QLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLH 72
++ + L+ +L++L+ ++ ++ P +G L L + N L +L L
Sbjct: 188 KVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDIGTLASLT 243
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKD 132
NL +L L +NQ++ P LS L +L L N ++ P L L+ L + N+
Sbjct: 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ- 298
Query: 133 IVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNC 192
+ P + + N+T L L +S P + L+KLQ L Y +S + + N
Sbjct: 299 LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANL 352
Query: 193 SELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNS 252
+ + L N +S P + L ++ +L L + P S+ ++
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTG 409
Query: 253 LSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIP 306
P +I E I+ N S + V + T SG +
Sbjct: 410 AL-IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-29
Identities = 55/247 (22%), Positives = 101/247 (40%), Gaps = 20/247 (8%)
Query: 364 TKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG 423
+ + I+ + ++ +G + + L + L +
Sbjct: 5 SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS 60
Query: 424 SVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSL 483
D + L I+ S+N L P L +L+ L + +++N+ + P L L +L
Sbjct: 61 --IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNL 114
Query: 484 NKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLT 543
+ L N + P L ++L L+LSSN ++ L + +L+ L+ +T
Sbjct: 115 TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQ-LSFGNQ-VT 168
Query: 544 GPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLS 603
P ++ L L LD+S NK+ +++ LA+L NL SL + N+ + P L L
Sbjct: 169 DLKP--LANLTTLERLDISSNKVS-DISVLAKLTNLESLIATNNQISDITPLGIL-TNLD 224
Query: 604 PTDLAGN 610
L GN
Sbjct: 225 ELSLNGN 231
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 3e-61
Identities = 70/292 (23%), Positives = 133/292 (45%), Gaps = 35/292 (11%)
Query: 706 LVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
+ IGKG G+V++ + + V+A+K L E F E+
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG----ETEMIEKFQEFQREVFI 76
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
+ ++ H NIV+ G N ++M +++P G L L ++ + ++W ++ +++L A
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR-MVM-EFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIAL 133
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPY-----IADFGLAKLVDDGDFARSSNTVA 879
G+ Y+ + PPIVHRD+++ NI + E +ADFGL++ S + +
Sbjct: 134 GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLL 187
Query: 880 GSYGYIAPE--YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937
G++ ++APE TEK+D YS+ +++ +LTG+ P D ++ +R++
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG- 246
Query: 938 IQVLDPSLLSRPE--SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
RP + L+ + C + P +RP + L E+
Sbjct: 247 ---------LRPTIPEDCPPRLRNVIEL--CWSGDPKKRPHFSYIVKELSEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 8e-61
Identities = 72/336 (21%), Positives = 118/336 (35%), Gaps = 70/336 (20%)
Query: 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAE- 761
L L +IG+G G VY+ + + +AVK R +F E
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF--------------SFANRQNFINEK 56
Query: 762 -IKTLGSIRHKNIVRFLGCCW-----NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR 815
I + + H NI RF+ R LL+ +Y PNGSL L T +W
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSS 113
Query: 816 YQILLGAAQGLAYLHHD------CVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG 869
++ +GLAYLH + P I HRD+ + N+L+ + I+DFGL+ +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 870 DFAR------SSNTVAGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEVLTGKQ 916
R ++ + G+ Y+APE ++ D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 917 -------------------PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEML 957
PT D +V R+K P + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV--SREK-----QRPKFPEAWKENSLAVR 286
Query: 958 QALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993
C + + R T + + E+ E
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-60
Identities = 81/295 (27%), Positives = 125/295 (42%), Gaps = 45/295 (15%)
Query: 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
L +IG G G VYRA G+ +AVK ++ S ++ E K
Sbjct: 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARH-------DPDEDISQTIENVRQEAKLF 60
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
++H NI+ G C N L+ ++ G L +L + + ++ + A+G
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARG 117
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPY--------IADFGLAKLVDDGDFARSSNT 877
+ YLH + + PI+HRD+K++NILI + E I DFGLA+ + +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMS 173
Query: 878 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP---IDPTIPDGSHVVDWVRQ 934
AG+Y ++APE ++ SDV+SYGV++ E+LTG+ P ID V V
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----LAVAYGVAM 228
Query: 935 KKGIQVLDPSLLSRPE--SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
K S E L C N P RP+ ++ L I
Sbjct: 229 NK----------LALPIPSTCPEPFAKL--MEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-60
Identities = 97/517 (18%), Positives = 175/517 (33%), Gaps = 77/517 (14%)
Query: 50 LIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALA 109
L S+NL +P + + E ++ P + + L D
Sbjct: 13 LQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC--- 68
Query: 110 GNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLS 169
E+ + +P ++ +L + ++ LP L
Sbjct: 69 --------LDRQAHELELNNLG--LSSLPELPP---HLESLVASCNSLT-ELPELPQSLK 114
Query: 170 KLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSL 229
L + +S P L L + N L + PE+ L+ + + NSL
Sbjct: 115 SLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KL-PELQNSSFLKIIDVDNNSL 165
Query: 230 VGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANAT 289
+P+ + L+ I N L +P + L L +N++ +P
Sbjct: 166 K-KLPDLPPS---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLP---L 215
Query: 290 NLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSL 349
+L + N + PE+ L LT +A N L+ ++P +L+AL++ N L
Sbjct: 216 SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLP---PSLEALNVRDNYL 269
Query: 350 TASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLK 409
T +P L L I + +S P +L L +N I L
Sbjct: 270 T-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRSL----CDLPP 317
Query: 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469
+L L++S+N+L +P L+ + S N L +P + L+ L V N
Sbjct: 318 SLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPL 369
Query: 470 SGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIE 529
+ P + L ++ +L P L +L+ L + +N L P +E
Sbjct: 370 R-EFPDIPESVEDLR---MNSHLAEVP-----ELPQNLKQLHVETNPLR-EFPDIPESVE 419
Query: 530 ALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKL 566
L ++ + P +KL H+
Sbjct: 420 ----DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 6e-58
Identities = 109/542 (20%), Positives = 190/542 (35%), Gaps = 109/542 (20%)
Query: 65 PSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEE 124
P ++ L+E + +S+ LT ++PVE N KS + + N P G +
Sbjct: 5 PRNVSNT-FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 125 MRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGE 184
R L DC + + L + +S
Sbjct: 63 SR--------------LRDCLD----------------------RQAHELELNNLGLS-S 85
Query: 185 IPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLK 244
+P + L SL NSL+ +P LK L +L P L+
Sbjct: 86 LPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLE 134
Query: 245 MIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGL 304
+ S N L +P + S L+ + +N++ +P +L + NQ+ L
Sbjct: 135 YLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLEEL 188
Query: 305 IPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLT 364
PE+ L LT +A N L+ +P +L+++ +N L L L LT
Sbjct: 189 --PELQNLPFLTAIYADNNSLK-KLPD---LPLSLESIVAGNNILE--ELPELQNLPFLT 240
Query: 365 KLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGS 424
+ +N + ++P + L L V +N + L P L L+ + + LS
Sbjct: 241 TIYADNNLLK-TLPDLPPS---LEALNVRDNYLTDL-PELPQSLTFLDVSENIFSGLSEL 295
Query: 425 VPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLN 484
P L ++ S N ++ SL + SL + L+VS+N+ ++PA RL L
Sbjct: 296 PP-------NLYYLNASSNEIR-SLCDLPPSL---EELNVSNNKLI-ELPALPPRLERLI 343
Query: 485 KIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEI----------- 533
S N + +P +L+ L + N L P +E L +
Sbjct: 344 ---ASFNHLAE-VPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELP 395
Query: 534 ----ALNLSCNGLTGPIPAQISALNKLSILDLSHNKL-EGNLNPLAQLDNLVSLNISYNK 588
L++ N L P + L ++ ++ + D L ++
Sbjct: 396 QNLKQLHVETNPLRE-FP---DIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451
Query: 589 FT 590
Sbjct: 452 HH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 6e-55
Identities = 105/457 (22%), Positives = 169/457 (36%), Gaps = 82/457 (17%)
Query: 168 LSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKL----------- 216
+ LQ +++ ++ E+P E N + + + PP G+
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 217 --KKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISD 274
++ EL L L ++PE + SL S NSL+ +P L L +
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 275 NNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLA 334
+S P L L + NQ+ L PE+ S L + N L+ +P
Sbjct: 124 KALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK-KLPDLP- 172
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394
+L+ + +N L +P L L LT + +N + +P + L + GN
Sbjct: 173 --PSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGN 224
Query: 395 NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLS 454
N + E+ L L + +N L ++PD L+ +++ N L LP
Sbjct: 225 NILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQ 277
Query: 455 SLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSS 514
S L LDVS+N FS + L LN S N I S L SL+ L++S+
Sbjct: 278 S---LTFLDVSENIFS-GLSELPPNLYYLN---ASSN----EIRSLCDLPPSLEELNVSN 326
Query: 515 NQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE------G 568
N+L +P ++E L S N L +P L L + +N L
Sbjct: 327 NKLI-ELPALPPRLE----RLIASFNHLAE-VPELPQ---NLKQLHVEYNPLREFPDIPE 377
Query: 569 NLNPLAQ----------LDNLVSLNISYNKFTGYLPD 595
++ L NL L++ N PD
Sbjct: 378 SVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD 413
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-54
Identities = 92/503 (18%), Positives = 164/503 (32%), Gaps = 75/503 (14%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+P + K + + + P G+ + V
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC-----------LDRQAH 74
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
EL LN+ L+ +P + L L+ N+L +P L +L +
Sbjct: 75 ELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA--LS 127
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSEL 195
+P L LG+++ Q+ LP L S L+ + + + ++P + L
Sbjct: 128 DLPPLL------EYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPS---L 175
Query: 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSG 255
+ N L PE+ L L ++ NSL +P+ + S+ N L
Sbjct: 176 EFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNIL-- 227
Query: 256 TIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKL 315
+ L L +N + ++P +L L + N ++ L P L+ L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLP---PSLEALNVRDNYLTDL-PELPQSLTFL 282
Query: 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISG 375
V + L P NL L+ S N + S+ +L +L + +N +
Sbjct: 283 DVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLI- 330
Query: 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTEL 435
+P L RL N +A + P LK L + N L PD +L
Sbjct: 331 ELPALPPR---LERLIASFNHLAEV-PELPQNLKQ---LHVEYNPLR-EFPDIPESVEDL 382
Query: 436 QMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495
+M N+ +P + L+ L V N + P + L ++
Sbjct: 383 RM-----NSHLAEVPELPQN---LKQLHVETNPLR-EFPDIPESVEDLR---MNSERVVD 430
Query: 496 PIPSSLGLCSSLQLLDLSSNQLT 518
P + L+ +
Sbjct: 431 PYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-49
Identities = 86/402 (21%), Positives = 142/402 (35%), Gaps = 57/402 (14%)
Query: 209 IPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELE 268
I P L+E ++L +P E N S + + P G E+
Sbjct: 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 269 EFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGS 328
+ D +L+L+ +S L P L L N L
Sbjct: 62 VSRLRDC-----------LDRQAHELELNNLGLSSL-PELPPHLESLVA---SCNSLT-E 105
Query: 329 IPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLV 388
+P S +L + + +L+ P L L + +N + + PE+ N S L
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KL-PELQNSSFLK 156
Query: 389 RLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGS 448
+ V NN + L P L+ + +N+L E+ + L I +N+L+
Sbjct: 157 IIDVDNNSLKKL-PDLPPSLEF---IAAGNNQL--EELPELQNLPFLTAIYADNNSLK-K 209
Query: 449 LPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQ 508
LP+ S L+ + +N L L L I NL +P SL+
Sbjct: 210 LPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPDLPP---SLE 260
Query: 509 LLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEG 568
L++ N LT +P + L++ +GL+ P L L+ S N++
Sbjct: 261 ALNVRDNYLT-DLPELPQSLTFLDV-SENIFSGLSELPP-------NLYYLNASSNEIR- 310
Query: 569 NLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGN 610
+ +L LN+S NK LP L +L + N
Sbjct: 311 --SLCDLPPSLEELNVSNNKLI-ELPA--LPPRLERLIASFN 347
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 67/336 (19%), Positives = 120/336 (35%), Gaps = 57/336 (16%)
Query: 304 LIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL--- 360
I P + L + L +P + + + + + P G +
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 361 ----------QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKT 410
+ +L L + +S S+P + L L N + L P LK+
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLTEL-PELPQSLKS 115
Query: 411 LNFLDLSSNRLSGSVP---------------DEIGDCTELQMIDLSHNTLQGSLPNSLSS 455
L + + LS P E+ + + L++ID+ +N+L+ LP+ S
Sbjct: 116 LLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS 174
Query: 456 LSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSN 515
L+ + +N+ ++P L L L I N +P SL+ + +N
Sbjct: 175 ---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-LPDLPL---SLESIVAGNN 225
Query: 516 QLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQ 575
L +P EL + L + N L +P +L L++ D L
Sbjct: 226 ILE-ELP-ELQNLPFLTT-IYADNNLLKT-LPDLPPSLEALNVRDNYLTDLP------EL 275
Query: 576 LDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNE 611
+L L++S N F+G L + L L + + NE
Sbjct: 276 PQSLTFLDVSENIFSG-LSE--LPPNLYYLNASSNE 308
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-17
Identities = 46/290 (15%), Positives = 82/290 (28%), Gaps = 62/290 (21%)
Query: 13 QLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLH 72
L L + L T+ + L ++P L L+ N L LP L
Sbjct: 226 ILEELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQSLT 280
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKD 132
L+ + L+ P +L L N + ++
Sbjct: 281 FLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDLP---------------- 316
Query: 133 IVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNC 192
++ L +++ ++ LPA +L+ L ++ E+P N
Sbjct: 317 ------------PSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN- 358
Query: 193 SELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNS 252
L L + N L P ++ L NS + +PE N L N
Sbjct: 359 --LKQLHVEYNPLR-EFPDIPESVEDLR-----MNSHLAEVPELPQNLKQL---HVETNP 407
Query: 253 LSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQIS 302
L P + +L ++ V L + +
Sbjct: 408 LR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-60
Identities = 102/525 (19%), Positives = 186/525 (35%), Gaps = 27/525 (5%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
IP NL + L +S L + L VLD S + + L +L
Sbjct: 22 IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
LIL N + S SL+KL+ + LA +G L L+E+ N
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMIS---GEIPAEIGNC 192
K+P + +N+ L L+ ++ L L ++ L++ + I
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 193 SELVSLFLYENSLSGSIPPE-IGKLKKLEELFLW------QNSLVGAIPEEIGNCTSLKM 245
L L L N S ++ I L LE L + +L + +L +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 246 IDFSLNSLSG---TIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQIS 302
+F L L I L+ + F + + + + + L+L +
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGWQHLELVNCKFG 317
Query: 303 GLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTA-SVPAGLF-QL 360
++ L +LT N+ + + +L+ LDLS N L+ +
Sbjct: 318 QFPTLKLKSLKRLTFT---SNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREI-GGLKTLNFLDLSSN 419
+L L L N + ++ L L ++ + + + L+ L +LD+S
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 420 RLSGSVPDEIGDCTELQMIDLSHNTLQGSL-PNSLSSLSGLQVLDVSDNRFSGQIPASLG 478
+ + L+++ ++ N+ Q + P+ + L L LD+S + P +
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 479 RLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPM 523
L SL + ++ N +SLQ + L +N S P
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-47
Identities = 96/483 (19%), Positives = 165/483 (34%), Gaps = 47/483 (9%)
Query: 143 DCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYE 202
C L ++ +LP S + L + + + EL L L
Sbjct: 13 QCME---LNF--YKIPDNLPFST------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 203 NSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIG 262
+ L L L L N + +SL+ + +L+ IG
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 263 GLSELEEFMISDNN-VSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAW 321
L L+E ++ N S +P +N TNL L L +N+I + ++ +L ++ +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 322 ----QNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGS 376
N + I L L L +N + +V Q L L L+ +
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 377 ---IPPEIGNCSSLVRLRVGNNRIAGL------IPREIGGLKTLNFLDLSSNRLSGSVPD 427
+ L L + R+A L I L ++ L S + V D
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKD 299
Query: 428 EIGDC--TELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNK 485
+ L++++ L L+ L + N+ + + L SL
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTL------KLKSLKRLTFTSNKGGN-AFSEVD-LPSLEF 351
Query: 486 IILSKNL--FSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLT 543
+ LS+N F G S +SL+ LDLS N + ++ +E LE L+ + L
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH-LDFQHSNLK 409
Query: 544 G-PIPAQISALNKLSILDLSHNKLEGNLNP--LAQLDNLVSLNISYNKFTGYLPDNKLFR 600
+ +L L LD+SH L +L L ++ N F + +F
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPD-IFT 467
Query: 601 QLS 603
+L
Sbjct: 468 ELR 470
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 63/298 (21%), Positives = 105/298 (35%), Gaps = 17/298 (5%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSL 387
IP L + + LDLS N L F L L L +I + S L
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ- 446
L + N I L GL +L L L+ IG L+ ++++HN +Q
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 447 GSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPI---PSSLGL 503
LP S+L+ L+ LD+S N+ L L + + LS +L P+
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 504 CSSLQLLDLSSNQLTGSVPMELG------QIEALEIALNLSCNGLTGPIPAQISALNKLS 557
L L L +N + +V ++ L + + L + + L L+
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 558 ILDLSHNKLEGNLNPLA----QLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNE 611
I + L+ L+ + L N+ S ++ + D +L +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCK 315
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 6e-09
Identities = 26/119 (21%), Positives = 45/119 (37%), Gaps = 1/119 (0%)
Query: 14 LPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPS-SLGKLH 72
+ + S ++L L IS + + L VL + N+ +L
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNK 131
NL L L+ QL P ++ SL+ L + N L RL++L+++ N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP 529
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 6e-60
Identities = 85/291 (29%), Positives = 136/291 (46%), Gaps = 36/291 (12%)
Query: 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
L IG G G V+RA+ +G +AVK L A + F E+ +
Sbjct: 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAE---------RVNEFLREVAIM 88
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER-TGNALEWELRYQILLGAAQ 824
+RH NIV F+G N ++ +Y+ GSL LLH+ L+ R + A+
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
G+ YLH+ PPIVHR++K+ N+L+ ++ + DFGL++L SS + AG+ +
Sbjct: 149 GMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEW 205
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP---IDPTIPDGSHVVDWVRQKKGIQVL 941
+APE EKSDVYS+GV++ E+ T +QP ++P + VV V K
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-----AQVVAAVGFKC----- 255
Query: 942 DPSLLSRPE--SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
R E ++ + A+ C P +RP+ + +L+ +
Sbjct: 256 -----KRLEIPRNLNPQVAAI--IEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-59
Identities = 77/396 (19%), Positives = 157/396 (39%), Gaps = 51/396 (12%)
Query: 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLS 254
+L ++ P L + L + S+ + S+ + + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 255 GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSK 314
+I I L+ LE ++ N ++ P L+N L L + TN+I+ + L+
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 315 LTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDIS 374
L + ++ + P LA+ + + +L+L N S + L + L L + + +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168
Query: 375 GSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTE 434
P I N + L L + N+I + P + L +L++ N+++ P + + T
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 435 LQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFS 494
L + + +N + + L++LS L L++ N+ S
Sbjct: 223 LNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD----------------------- 257
Query: 495 GPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALN 554
+++ + L++L++ SNQ++ L + L L L+ N L I L
Sbjct: 258 ---INAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNS-LFLNNNQLGNEDMEVIGGLT 311
Query: 555 KLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFT 590
L+ L LS N + ++ PLA L + S + +
Sbjct: 312 NLTTLFLSQNHIT-DIRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-58
Identities = 81/397 (20%), Positives = 167/397 (42%), Gaps = 52/397 (13%)
Query: 171 LQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLV 230
TL+ I+ P + +E + L + S++ + +L+ + +L + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 231 GAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATN 290
+ I T+L+ ++ + N ++ PLS L +L I N ++ + L N TN
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 291 LVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT 350
L +L L+ + IS + P + L+K+ N S S L++ + L L ++ + +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168
Query: 351 ASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKT 410
P + L +L L L N I P + + +SL N+I + P + +
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 411 LNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470
LN L + +N+++ + + ++L +++ N + N++ L+ L++L+V N+ S
Sbjct: 223 LNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 471 GQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEA 530
+ L L LN + L+ N +G ++L L LS N +T P
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-------- 328
Query: 531 LEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE 567
+++L+K+ D ++ ++
Sbjct: 329 -------------------LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 8e-57
Identities = 84/398 (21%), Positives = 155/398 (38%), Gaps = 52/398 (13%)
Query: 49 GLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNAL 108
G L + P L +L +T + +S+ KL++
Sbjct: 1 GAATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE-- 54
Query: 109 AGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKL 168
++++++ + +N+ L L Q++ P L L
Sbjct: 55 ---------KVASIQG----------------IEYLTNLEYLNLNGNQITDISP--LSNL 87
Query: 169 SKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNS 228
KL L I T I+ + + N + L L+L E+++S P + L K+ L L N
Sbjct: 88 VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANH 143
Query: 229 LVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANA 288
+ + N T L + + + + P I L++L ++ N + P LA+
Sbjct: 144 NLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASL 198
Query: 289 TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNS 348
T+L NQI+ + P + +++L N++ P LA+ S L L++ N
Sbjct: 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQ 254
Query: 349 LTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGL 408
++ + L L L + SN IS + N S L L + NN++ IGGL
Sbjct: 255 ISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGL 310
Query: 409 KTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446
L L LS N ++ P + +++ D ++ ++
Sbjct: 311 TNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 4e-55
Identities = 76/351 (21%), Positives = 145/351 (41%), Gaps = 25/351 (7%)
Query: 141 LGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFL 200
D + L V+ + +L + L + ++ I I + L L L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNL 73
Query: 201 YENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLS 260
N ++ P + L KL L++ N + + N T+L+ + + +++S PL
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISPL- 128
Query: 261 IGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFA 320
L+++ + N+ S + L+N T L L + +++ + P I L+ L
Sbjct: 129 -ANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184
Query: 321 WQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPE 380
NQ+E P LAS ++L N +T P + + L L + +N I+ P
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238
Query: 381 IGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDL 440
+ N S L L +G N+I+ + + L L L++ SN++S + + ++L + L
Sbjct: 239 LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 441 SHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491
++N L + L+ L L +S N + P L L ++ +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-53
Identities = 89/369 (24%), Positives = 145/369 (39%), Gaps = 26/369 (7%)
Query: 6 TIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLP 65
T+ ++P + + V+ A++T + + + L + +
Sbjct: 4 TLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQ--EELESITKLVVAGEKV--ASI 59
Query: 66 SSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEM 125
+ L NLE L LN NQ+T P LSN L L + N + + L L+NL E+
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLREL 115
Query: 126 RAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEI 185
+ + I L + + M +L L S + L ++ L L++ + +
Sbjct: 116 YLNEDN--ISDISP-LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVT 171
Query: 186 PAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKM 245
P I N ++L SL L N + P + L L + N + P + N T L
Sbjct: 172 P--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNS 225
Query: 246 IDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLI 305
+ N ++ PL LS+L I N +S I A + + T L L + +NQIS +
Sbjct: 226 LKIGNNKITDLSPL--ANLSQLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISDI- 280
Query: 306 PPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTK 365
+ LS+L F NQL + +NL L LS N +T P L L +
Sbjct: 281 -SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337
Query: 366 LLLISNDIS 374
+ I
Sbjct: 338 ADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-45
Identities = 62/329 (18%), Positives = 133/329 (40%), Gaps = 50/329 (15%)
Query: 263 GLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQ 322
G + L ++ P A+ ++ L ++ ++ L +T
Sbjct: 1 GAATLA---TLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAG 53
Query: 323 NQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIG 382
++ SI + +NL+ L+L+ N +T P L L LT L + +N I+ +
Sbjct: 54 EKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQ 107
Query: 383 NCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442
N ++L L + + I+ + P + L + L+L +N S + + T L + ++
Sbjct: 108 NLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTE 164
Query: 443 NTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLG 502
+ ++ P +++L+ L L ++ N+ P L L SL+ N + P +
Sbjct: 165 SKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VA 218
Query: 503 LCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLS 562
+ L L + +N++T P ++ L++L+ L++
Sbjct: 219 NMTRLNSLKIGNNKITDLSP---------------------------LANLSQLTWLEIG 251
Query: 563 HNKLEGNLNPLAQLDNLVSLNISYNKFTG 591
N++ ++N + L L LN+ N+ +
Sbjct: 252 TNQIS-DINAVKDLTKLKMLNVGSNQISD 279
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 2e-17
Identities = 31/177 (17%), Positives = 66/177 (37%), Gaps = 12/177 (6%)
Query: 435 LQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFS 494
+ + P + L+ + + + L S+ K++++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 495 GPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALN 554
+ ++L+ L+L+ NQ+T P L + L L + N +T + L
Sbjct: 58 SI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTN-LYIGTNKITDISA--LQNLT 110
Query: 555 KLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNE 611
L L L+ + + ++PLA L + SLN+ N L L+ + ++
Sbjct: 111 NLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESK 166
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-58
Identities = 58/298 (19%), Positives = 114/298 (38%), Gaps = 51/298 (17%)
Query: 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
L + + SG +++ G I VK L D + F+ E L
Sbjct: 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKV---------RDWSTRKSRDFNEECPRL 61
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMY--DYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
H N++ LG C + +MP GSL ++LHE T ++ + L A
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
+G+A+LH P I + + +++I + I+ + F+ S +
Sbjct: 122 RGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPA 173
Query: 884 YIAPEYGYMMK------ITEKSDVYSYGVVVLEVLTGKQP---IDPTIPDGSHVVDWVRQ 934
++APE ++ +D++S+ V++ E++T + P + + V
Sbjct: 174 WVAPE---ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----MEIGMKVAL 225
Query: 935 KKGIQVLDPSLLSRPE--SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
+ RP I + L +C+N P +RP + +L++++ +
Sbjct: 226 EG----------LRPTIPPGISPHVSKL--MKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 5e-58
Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 27/288 (9%)
Query: 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+ IG G G VY+ +G+V AVK L T +F E+ L
Sbjct: 26 ITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ---------LQAFKNEVGVL 74
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
RH NI+ F+G ++ + SL LH E + I A+G
Sbjct: 75 RKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARG 132
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
+ YLH I+HRD+K+NNI + + I DFGLA + ++GS ++
Sbjct: 133 MDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 886 APE---YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942
APE + +SDVY++G+V+ E++TG+ P I + +++ V G L
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-SNINNRDQIIEMV----GRGSLS 244
Query: 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
P L + + ++ L C+ DERP+ + A ++E+ E
Sbjct: 245 PDLSKVRSN-CPKRMKRL--MAECLKKKRDERPSFPRILAEIEELARE 289
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 4e-57
Identities = 73/289 (25%), Positives = 127/289 (43%), Gaps = 38/289 (13%)
Query: 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+ V+G+G GVV +A + +A+K++ E R +F E++ L
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI-------------ESESERKAFIVELRQL 55
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLH-ERTGNALEWELRYQILLGAAQ 824
+ H NIV+ G C N L+M +Y GSL ++LH L +Q
Sbjct: 56 SRVNHPNIVKLYGACLN-PVCLVM-EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPY-IADFGLAKLVDDGDFARSSNTVAGSYG 883
G+AYLH ++HRD+K N+L+ I DFG A + GS
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAA 168
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
++APE +EK DV+S+G+++ EV+T ++P D I + + W
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHNG------- 220
Query: 944 SLLSRPE--SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
+RP + + +++L C + P +RP+M+++ ++ +
Sbjct: 221 ---TRPPLIKNLPKPIESL--MTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-56
Identities = 131/607 (21%), Positives = 210/607 (34%), Gaps = 79/607 (13%)
Query: 32 SDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVE 91
NLT +P + L S N + SS L L+ L L S I E
Sbjct: 12 RFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67
Query: 92 -LSNCKSLRKLLLFDNALAGNIPAE-LGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTA 149
N +LR L L + + + + L +L E+R
Sbjct: 68 AFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCG------------------ 108
Query: 150 LGLADTQVSGSLPASLGKLSKLQTLSIYTTMISG-EIPAEIGNCSELVSLFLYENSLSGS 208
L+D + L L L + I + G + L S+ N +
Sbjct: 109 --LSDAVLK---DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-L 162
Query: 209 IPPEIGK---LKKLEELFLWQNSLVGAIPEEIGNC------TSLKMIDFSLNSLSGTIPL 259
+ + K L L NSL + + G C L+++D S N + I
Sbjct: 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITG 222
Query: 260 SIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGML--SKLTV 317
N +S S +L A +++ + I L S +
Sbjct: 223 ------------NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
Query: 318 FFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGS 376
+ + +L+ L+L++N + + F L NL L L N +
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLG-E 328
Query: 377 IPPEI-GNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTEL 435
+ + + + N IA + + L+ L LDL N L+ I +
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSI 383
Query: 436 QMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSG-QIPASLGRLVSLNKIILSKNLFS 494
I LS N L +L+ ++ +S+NR I L R+ L +IL++N FS
Sbjct: 384 PDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439
Query: 495 G-PIPSSLGLCSSLQLLDLSSNQLTGSVPMEL-----GQIEALEIALNLSCNGLTGPIPA 548
+ SL+ L L N L + EL + L++ L L+ N L P
Sbjct: 440 SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV-LYLNHNYLNSLPPG 498
Query: 549 QISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLA 608
S L L L L+ N+L L+ NL L+IS N+ P+ +F LS D+
Sbjct: 499 VFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLA--PNPDVFVSLSVLDIT 555
Query: 609 GNEGLCS 615
N+ +C
Sbjct: 556 HNKFICE 562
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-25
Identities = 62/294 (21%), Positives = 100/294 (34%), Gaps = 47/294 (15%)
Query: 335 SCS-NLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRV 392
SCS + + +LT VP L +LLL N I ++ L L +
Sbjct: 1 SCSFDGRIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIR-TVTASSFPFLEQLQLLEL 55
Query: 393 GNNRIAGLIPREI-GGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSL-- 449
G+ I +E L L LDL S+++ PD L + L L ++
Sbjct: 56 GSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115
Query: 450 PNSLSSLSGLQVLDVSDNRFSG-QIPASLGRLVSLNKIILSKNLFSGPIPSSL-GLCS-S 506
+L L LD+S N+ + S G+L SL I S N L L +
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 507 LQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKL 566
L L++N L V ++ G+ + L ILD+S N
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE-------------------ILDVSGNGW 216
Query: 567 EGNLN-------------PLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDL 607
++ L +++ ++ PD F L+ + +
Sbjct: 217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD--PDQNTFAGLARSSV 268
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-23
Identities = 83/476 (17%), Positives = 145/476 (30%), Gaps = 112/476 (23%)
Query: 12 LQLPIPTNLSSFKHLQTLVISDANLTGSIP---FDIGDCVGLIVLDFSSNNLVGTLPSSL 68
+ +L H+ N+ F + LD S +
Sbjct: 228 ISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286
Query: 69 GKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAG 128
L +L+ L L N++ +L+ L L N L L
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN-----------LLGELY----- 330
Query: 129 GNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAE 188
++ L K+ + + I+
Sbjct: 331 ---------------------------------SSNFYGLPKVAYIDLQKNHIAIIQDQT 357
Query: 189 IGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDF 248
+L +L L +N+L+ I + + ++FL N L +L I+
Sbjct: 358 FKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL-----------VTLPKINL 401
Query: 249 SLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPE 308
+ N + LS L L+ L +L L L+ N+ S +
Sbjct: 402 TANLIH----LSENRLENLDILYF------------LLRVPHLQILILNQNRFSSCSGDQ 445
Query: 309 I-GMLSKLTVFFAWQNQLEGSI-----PSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQ 361
L F +N L+ + S+LQ L L+HN L S+P G+F L
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLT 504
Query: 362 NLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRL 421
L L L SN ++ + ++L L + N++ P +L+ LD++ N+
Sbjct: 505 ALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKF 559
Query: 422 SGSVPDEIGDCTELQMIDL--SHNTLQGSLPNSL-----SSLSGLQVLDVSDNRFS 470
I +C I+ N P + S SG+ + +S
Sbjct: 560 -------ICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCD 608
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-54
Identities = 65/304 (21%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 705 CLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
L+ V+GKGC G + + GEV+ +K+L + +F E+K
Sbjct: 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL-----------IRFDEETQRTFLKEVK 59
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
+ + H N+++F+G + + +Y+ G+L ++ + W R A
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIA 118
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFA----------- 872
G+AYLH I+HRD+ ++N L+ +ADFGLA+L+ D
Sbjct: 119 SGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 873 -RSSNTVAGSYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928
+ TV G+ ++APE M+ EK DV+S+G+V+ E++ +P +
Sbjct: 176 RKKRYTVVGNPYWMAPE---MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP--RTM 230
Query: 929 VDWVRQKKGIQVLDPSLLSRPE--SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
+ + + + + C + P++RP+ + L+
Sbjct: 231 DFGLNVRGFL---------DRYCPPNCPPSFFPI--TVRCCDLDPEKRPSFVKLEHWLET 279
Query: 987 IKHE 990
++
Sbjct: 280 LRMH 283
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-53
Identities = 108/567 (19%), Positives = 198/567 (34%), Gaps = 79/567 (13%)
Query: 32 SDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVE 91
+ T SIP + + LD S N + L NL+ LIL S+++ I +
Sbjct: 13 RSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGD 68
Query: 92 -LSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTAL 150
+ SL L L DN LS+L
Sbjct: 69 AFYSLGSLEHLDLSDN-----------HLSSLS--------------------------- 90
Query: 151 GLADTQVSGSLPASLGKLSKLQTLSIYTTMISG-EIPAEIGNCSELVSLFLYENSLSGSI 209
+ G LS L+ L++ + + N + L +L + I
Sbjct: 91 -----------SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEI 139
Query: 210 PPE-IGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELE 268
L L EL + SL + + + + + L+ + + + LS +
Sbjct: 140 RRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVR 199
Query: 269 EFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGS 328
+ D N++ + L ++ + S L L KL + +++E
Sbjct: 200 YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE-- 257
Query: 329 IPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLV 388
C+ D + + G + + +L + + + +
Sbjct: 258 ----FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313
Query: 389 RLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDE---IGDCTELQMIDLSHNTL 445
R+ V N+++ + LK+L FLDLS N + G LQ + LS N L
Sbjct: 314 RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
Query: 446 Q--GSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGL 503
+ L +L L LD+S N F +P S + + LS + + +
Sbjct: 374 RSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKT--CI 429
Query: 504 CSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSH 563
+L++LD+S+N L S + L +++ L +S N L +P S L ++ +S
Sbjct: 430 PQTLEVLDVSNNNLD-SFSLFLPRLQ----ELYISRNKLKT-LPD-ASLFPVLLVMKISR 482
Query: 564 NKLEG-NLNPLAQLDNLVSLNISYNKF 589
N+L+ +L +L + + N +
Sbjct: 483 NQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-50
Identities = 105/563 (18%), Positives = 199/563 (35%), Gaps = 66/563 (11%)
Query: 47 CVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDN 106
C V D S + ++PS L ++ L L+ N++T +L C +L+ L+L +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 107 ALAGNIPAE-LGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASL 165
+ I + L +LE L L+D +S +
Sbjct: 61 RIN-TIEGDAFYSLGSLEH-------------------------LDLSDNHLSSLSSSWF 94
Query: 166 GKLSKLQTLSIYTTMISG-EIPAEIGNCSELVSLFLYENSLSGSIPPE-IGKLKKLEELF 223
G LS L+ L++ + + N + L +L + I L L EL
Sbjct: 95 GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE 154
Query: 224 LWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPA 283
+ SL + + + + + L+ + + + LS + + D N++ +
Sbjct: 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS 214
Query: 284 NLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALD 343
L ++ + S L L KL + +++E C+ D
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE------FDDCTLNGLGD 268
Query: 344 LSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403
+ + G + + +L + + + + R+ V N+++ +
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 404 EIGGLKTLNFLDLSSNRLSGSVPDE---IGDCTELQMIDLSHNTLQ--GSLPNSLSSLSG 458
LK+L FLDLS N + G LQ + LS N L+ L +L
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
Query: 459 LQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518
L LD+S N F +P S + + LS + + + +L++LD+S+N L
Sbjct: 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKT--CIPQTLEVLDVSNNNLD 444
Query: 519 GSVPMELGQIEALEIA------------------LNLSCNGLTGPIPAQISALNKLSILD 560
S + L +++ L I+ + +S N L L L +
Sbjct: 445 -SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503
Query: 561 LSHNKLEGNLNPLAQLDNLVSLN 583
L N + + + L ++ N
Sbjct: 504 LHTNPWDCSCPRIDYLSRWLNKN 526
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-49
Identities = 92/477 (19%), Positives = 177/477 (37%), Gaps = 38/477 (7%)
Query: 160 SLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEI-GKLKK 218
S+P+ L + +++L + I+ ++ C+ L L L + ++ +I + L
Sbjct: 19 SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGS 75
Query: 219 LEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSG-TIPLSIGGLSELEEFMISDNNV 277
LE L L N L G +SLK ++ N + L+ L+ I +
Sbjct: 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 278 SGSIPAN-LANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASC 336
I A T+L +L++ + + + + ++ +
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADIL 195
Query: 337 SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDIS-------GSIPPEIGNCSSLVR 389
S+++ L+L +L + L + + + ++ S + + L
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255
Query: 390 LRVGNNRIAGL---------IPREIGGLKTLNF--LDLSSNRLSGSVPDEIGDCTELQMI 438
+ + + GL + E+G ++T+ L + L + +++ I
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315
Query: 439 DLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI---PASLGRLVSLNKIILSKNLFS- 494
+ ++ + + L L+ LD+S+N + A G SL ++LS+N
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375
Query: 495 -GPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISAL 553
L +L LD+S N +P E + LNLS G+ + I
Sbjct: 376 MQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF-LNLSSTGIRV-VKTCI--P 430
Query: 554 NKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGN 610
L +LD+S+N L+ + L L L IS NK LPD LF L ++ N
Sbjct: 431 QTLEVLDVSNNNLD---SFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-39
Identities = 87/506 (17%), Positives = 164/506 (32%), Gaps = 74/506 (14%)
Query: 20 LSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVG-TLPSSLGKLHNLEELI 78
S L+ L +SD +L+ G L L+ N + S L NL+ L
Sbjct: 70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129
Query: 79 LNSNQLTGKIPVE-LSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKI 137
+ + + +I + SL +L + +L L + ++
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH------------- 176
Query: 138 PAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVS 197
L L ++ + L LS ++ L + T ++ + +
Sbjct: 177 ------------LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224
Query: 198 LFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTI 257
+ S +L KL L + + E +CT + DF+ +
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVS 278
Query: 258 PLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTV 317
L + I + + + + ++ ++ +++ L+P
Sbjct: 279 ELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVP----------- 326
Query: 318 FFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASV---PAGLFQLQNLTKLLLISNDIS 374
S +L+ LDLS N + A +L L+L N +
Sbjct: 327 ------------CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
Query: 375 GSIPPEIGNCSSLVRLRV---GNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD 431
S+ +L L N +P + + FL+LSS + V I
Sbjct: 375 -SMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCI-- 429
Query: 432 CTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491
L+++D+S+N L S L LQ L +S N+ +P + L + +S+N
Sbjct: 430 PQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPDA-SLFPVLLVMKISRN 483
Query: 492 LFSGPIPSSLGLCSSLQLLDLSSNQL 517
+SLQ + L +N
Sbjct: 484 QLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-36
Identities = 72/364 (19%), Positives = 137/364 (37%), Gaps = 29/364 (7%)
Query: 273 SDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPST 332
+ + SIP+ L + L L N+I+ + ++ + L V +++
Sbjct: 13 RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69
Query: 333 LASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISG-SIPPEIGNCSSLVRL 390
S +L+ LDLS N L+ S+ + F L +L L L+ N + N ++L L
Sbjct: 70 FYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128
Query: 391 RVGNNRIAGLIPRE-IGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSL 449
R+GN I R GL +LN L++ + L + ++ + L + L
Sbjct: 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL 188
Query: 450 PNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGP----------IPS 499
LS ++ L++ D + + L + + S +
Sbjct: 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248
Query: 500 SLGLCSSLQLLDLSSNQLTG------SVPMELGQIEALEIA-LNLSCNGLTGPIPAQISA 552
+ S ++ D + N L V ELG++E + I L++ L + S
Sbjct: 249 YILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308
Query: 553 LNKLSILDLSHNKLEG-NLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPT----DL 607
L K+ + + ++K+ + L +L L++S N N + P+ L
Sbjct: 309 LEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 608 AGNE 611
+ N
Sbjct: 369 SQNH 372
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-36
Identities = 82/463 (17%), Positives = 148/463 (31%), Gaps = 73/463 (15%)
Query: 14 LPIPTNLSSFKHLQTLVISDANLTGSIP-FDIGDCVGLIVLDFSSNNLVGTLPSSLGKLH 72
L + + + +LQTL I + I D L L+ + +L SL +
Sbjct: 113 LGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIR 172
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKD 132
++ L L+ ++ + + S+R L L D LA + L M+ +
Sbjct: 173 DIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR- 231
Query: 133 IVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNC 192
+ L D S L L + +L +
Sbjct: 232 -----GSVLTDESFN------------ELLKLLRYILELSEVEF---------------- 258
Query: 193 SELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNS 252
N L P E + +L ++ +++ +
Sbjct: 259 -----DDCTLNGLGDFNPSESDVVSELGKV----------------ETVTIRRLHIPQFY 297
Query: 253 LSGTIPLSIGGLSELEEFMISDNNVSGSIPAN-LANATNLVQLQLDTNQISGLIPPE--- 308
L + L +++ + ++ V +P + + +L L L N +
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356
Query: 309 IGMLSKLTVFFAWQNQLE--GSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKL 366
G L QN L L + NL +LD+S N+ +P + + L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415
Query: 367 LLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVP 426
L S I + I +L L V NN + L L L +S N+L ++P
Sbjct: 416 NLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFSL----FLPRLQELYISRNKLK-TLP 467
Query: 427 DEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469
D L ++ +S N L+ L+ LQ + + N +
Sbjct: 468 DASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-26
Identities = 47/257 (18%), Positives = 86/257 (33%), Gaps = 31/257 (12%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394
SC D S T S+P+GL +++ L +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGLT--------------------------AAMKSLDLSF 35
Query: 395 NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLS 454
N+I + ++ L L L S+R++ D L+ +DLS N L +
Sbjct: 36 NKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG 95
Query: 455 SLSGLQVLDVSDNRFSG-QIPASLGRLVSLNKIILS-KNLFSGPIPSSLGLCSSLQLLDL 512
LS L+ L++ N + + + L +L + + FS +SL L++
Sbjct: 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI 155
Query: 513 SSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGN-LN 571
+ L L I + L L + + L+ + L+L L +
Sbjct: 156 KALSLRNYQSQSLKSIRDIHH-LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS 214
Query: 572 PLAQLDNLVSLNISYNK 588
PL + + +
Sbjct: 215 PLPVDEVSSPMKKLAFR 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 66/402 (16%), Positives = 122/402 (30%), Gaps = 50/402 (12%)
Query: 3 TEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVG 62
E+ I+++ L+ +L S + + L +
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHH------------------------LTLHLSESAF 186
Query: 63 TLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNL 122
L L ++ L L L L + + + L L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 123 EEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMIS 182
I+ E DC+ ++ + ++ L I +
Sbjct: 247 LRY-------ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 183 GEIPAEIGNCSELVSLFLYENSLSGSIPPEIGK-LKKLEELFLWQNSLVGAIPEE---IG 238
++ ++ + + + + +P + LK LE L L +N +V + G
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358
Query: 239 NCTSLKMIDFSLNSLS--GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQL 296
SL+ + S N L + L L IS N +P + + L L
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNL 417
Query: 297 DTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAG 356
+ I ++ I L V N L+ S L LQ L +S N L ++P
Sbjct: 418 SSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLK-TLPDA 469
Query: 357 LFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRI 397
L + + N + S+P I +SL ++ + N
Sbjct: 470 SL-FPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-53
Identities = 81/321 (25%), Positives = 121/321 (37%), Gaps = 69/321 (21%)
Query: 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+ +GKG G V+R GE +AVK DEKS R+ E+
Sbjct: 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---------DEKSWFRE---TELYNT 56
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMY----DYMPNGSLGSLLHERTGNALEWELRYQILLG 821
+RH+NI+ F+ + Y GSL L T L+ +I+L
Sbjct: 57 VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLS 113
Query: 822 AAQGLAYLHHDCV-----PPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD--FARS 874
A GLA+LH + P I HRD+K+ NIL+ + IAD GLA +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 875 SNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQ------------ 916
+N G+ Y+APE ++ D++++G+V+ EV
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 917 ----PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE----SEIDEMLQALGVALL--C 966
P DP+ D VV ++ RP D L +L L+ C
Sbjct: 234 YDVVPNDPSFEDMRKVV--CVDQQ-----------RPNIPNRWFSDPTLTSLA-KLMKEC 279
Query: 967 VNASPDERPTMKDVAAMLKEI 987
+P R T + L +I
Sbjct: 280 WYQNPSARLTALRIKKTLTKI 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 5e-53
Identities = 59/295 (20%), Positives = 113/295 (38%), Gaps = 40/295 (13%)
Query: 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
L +IGKG G VY +GEV A++ + + +F E+
Sbjct: 35 LEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDI---------ERDNEDQLKAFKREVMAY 83
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
RH+N+V F+G C + + ++ +L S++ + L+ QI +G
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKG 142
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSN---TVAGSY 882
+ YLH I+H+D+K+ N+ + I DFGL + R + G
Sbjct: 143 MGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 883 GYIAPE---------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933
++APE + ++ SDV++ G + E+ + P ++ +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--PAEAIIWQMG 256
Query: 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988
+ + + + + + L C +ERPT + ML+++
Sbjct: 257 TGM--------KPNLSQIGMGKEISDI--LLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-52
Identities = 60/349 (17%), Positives = 118/349 (33%), Gaps = 28/349 (8%)
Query: 207 GSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSE 266
GS E L+ ++ + + + D + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 267 LEEFMISDNNVSGSIPANLANAT--NLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQ 324
+ + + + L +AT V L+L + + P + LS L
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAG 115
Query: 325 LEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNC 384
L +P T+ + L+ L L+ N L ++PA + L L +L + + +P + +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 385 SSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNT 444
+ E GL L L L + S+P I + L+ + + ++
Sbjct: 174 DA---------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 445 LQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLC 504
L +L ++ L L+ LD+ P G L ++IL +P +
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276
Query: 505 SSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISAL 553
+ L+ LDL +P + Q+ A I + + + + A
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQLPANCI-ILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-52
Identities = 53/318 (16%), Positives = 116/318 (36%), Gaps = 21/318 (6%)
Query: 188 EIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMID 247
+ S +L+ ++ + + ++ + N + ++
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIET 62
Query: 248 FSLNSLSGTIPLSIGGLSE--LEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLI 305
+ +L + ++ + + P ++L + +D + L
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMEL- 119
Query: 306 PPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGL-------- 357
P + + L +N L ++P+++AS + L+ L + +P L
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 358 -FQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDL 416
L NL L L I S+P I N +L L++ N+ ++ L I L L LDL
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDL 236
Query: 417 SSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPAS 476
+ P G L+ + L + +LP + L+ L+ LD+ ++P+
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296
Query: 477 LGRLVSLNKIILSKNLFS 494
+ +L + I++ +L +
Sbjct: 297 IAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-50
Identities = 68/346 (19%), Positives = 115/346 (33%), Gaps = 30/346 (8%)
Query: 61 VGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLS 120
+G+ E L + LS + +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSN 56
Query: 121 NLEEMRAGGNKDIVGKIPAELGDCS--NMTALGLADTQVSGSLPASLGKLSKLQTLSIYT 178
N + G + L D + AL L + P +LS LQ ++I
Sbjct: 57 NPQIETRTGRA--LKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 179 TMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIG 238
+ E+P + + L +L L N L ++P I L +L EL + + +PE +
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 239 NCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDT 298
+ + GL L+ + + S+PA++AN NL L++
Sbjct: 172 STDA---------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215
Query: 299 NQISGLIPPEIGMLSKLTVF-FAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGL 357
+ +S L P I L KL L + P + L+ L L S ++P +
Sbjct: 216 SPLSAL-GPAIHHLPKLEELDLRGCTALR-NYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273
Query: 358 FQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403
+L L KL L +P I + + V + A L
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 59/330 (17%), Positives = 108/330 (32%), Gaps = 30/330 (9%)
Query: 24 KHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQ 83
+ L + + D + + +N +
Sbjct: 12 SGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH----SAWRQANSNNPQIETRTGRA 67
Query: 84 LTGKIPVELSNCKS--LRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAEL 141
L L + L L L P + RLS+L+ M + ++P +
Sbjct: 68 LK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG--LMELPDTM 123
Query: 142 GDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLY 201
+ + L LA + +LPAS+ L++L+ LSI E+P + +
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST--------- 173
Query: 202 ENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSI 261
E L L+ L L + ++P I N +LK + + LS + +I
Sbjct: 174 ------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI 225
Query: 262 GGLSELEEFMISDNNVSGSIPANLANATNLVQLQL-DTNQISGLIPPEIGMLSKLTVFFA 320
L +LEE + + P L +L L D + + L P +I L++L
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL-PLDIHRLTQLEKLDL 284
Query: 321 WQNQLEGSIPSTLASCSNLQALDLSHNSLT 350
+PS +A + + +
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-48
Identities = 63/292 (21%), Positives = 111/292 (38%), Gaps = 24/292 (8%)
Query: 17 PTNLSSFKHLQTLVISDANLTGSIPFDIGDC--VGLIVLDFSSNNLVGTLPSSLGKLHNL 74
++ + Q + L + + D G + L+ S L P +L +L
Sbjct: 49 AWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106
Query: 75 EELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIV 134
+ + +++ L ++P + L L L N L +PA + L+ L E+ ++
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164
Query: 135 GKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSE 194
++P L L LQ+L + T I +PA I N
Sbjct: 165 -ELPEPLASTD---------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQN 207
Query: 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLS 254
L SL + + LS ++ P I L KLEEL L + + P G LK + S
Sbjct: 208 LKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
Query: 255 GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIP 306
T+PL I L++LE+ + +P+ +A + + + + L
Sbjct: 267 LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 9e-47
Identities = 58/374 (15%), Positives = 115/374 (30%), Gaps = 56/374 (14%)
Query: 230 VGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANAT 289
+G+ + + + + F ++ + + + +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA------- 53
Query: 290 NLVQLQLDTNQISGL--IPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHN 347
N Q++T L + ++ AL+L
Sbjct: 54 NSNNPQIETRTGRALKATADLLEDATQP----------------------GRVALELRSV 91
Query: 348 SLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGG 407
L P F+L +L + + + + +P + + L L + N + L P I
Sbjct: 92 PLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRAL-PASIAS 148
Query: 408 LKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN 467
L L L + + +P+ + L LQ L +
Sbjct: 149 LNRLRELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWT 193
Query: 468 RFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQ 527
+PAS+ L +L + + + S + ++ L+ LDL + P G
Sbjct: 194 GIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251
Query: 528 IEALEIALNLS-CNGLTGPIPAQISALNKLSILDLSHNKLEGNL-NPLAQLDNLVSLNIS 585
L+ L L C+ L +P I L +L LDL L + +AQL + +
Sbjct: 252 RAPLKR-LILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309
Query: 586 YNKFTGYLPDNKLF 599
+ L ++
Sbjct: 310 PH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-21
Identities = 30/159 (18%), Positives = 60/159 (37%), Gaps = 6/159 (3%)
Query: 13 QLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLH 72
+LQ+L + + S+P I + L L ++ L L ++ L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP 229
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKD 132
LEEL L P L++L+L D + +P ++ RL+ LE++ G +
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289
Query: 133 IVGKIPAELGDCSNMTALGLAD---TQVSGSLPASLGKL 168
+ ++P+ + + + Q+ P +
Sbjct: 290 L-SRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-51
Identities = 63/453 (13%), Positives = 153/453 (33%), Gaps = 21/453 (4%)
Query: 160 SLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKL 219
++ ++ + + + + + + + + L L N LS ++ KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 220 EELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSG 279
E L L N L ++ + ++L+ +D + N + + +E ++NN+S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEG-SIPSTLASCSN 338
+ + + L N+I+ L + G S++ N+++ + AS
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 339 LQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIA 398
L+ L+L +N + V + L L L SN ++ + PE + + + + + NN++
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 399 GLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSG 458
I + + + L DL N ++ ++ T++ + +
Sbjct: 228 L-IEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 459 LQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG----PIPSSLGLCSSLQLLDLSS 514
+ RL++L + + G + + + +D
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 515 NQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLA 574
Q +V ++ + +I L L + A +L +
Sbjct: 346 EQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404
Query: 575 QLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDL 607
+ L L ++ + + + + D
Sbjct: 405 EQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDW 437
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-46
Identities = 61/467 (13%), Positives = 141/467 (30%), Gaps = 22/467 (4%)
Query: 142 GDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLY 201
+ + + D+ + +L + ++ L + +S A++ ++L L L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 202 ENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSI 261
N L ++ L L L L N + +E+ S++ + + N++S +S
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR---VSC 116
Query: 262 GGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPE-IGMLSKLTVFFA 320
+ +++N ++ + + + L L N+I + E L
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 321 WQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPE 380
N + + + L+ LDLS N L + +T + L +N + I
Sbjct: 177 QYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 381 IGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDL 440
+ +L + N R+ K ++ + +CT +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
Query: 441 SHNTLQGSLPNSLSSL-----SGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495
+ L +L + + +I K +
Sbjct: 292 GAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREIDALKEQYRT 350
Query: 496 PIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNK 555
I + L+ L V L+ L + + + + +
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQ 410
Query: 556 LSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQL 602
L + + Q + + ++ +K T +N ++L
Sbjct: 411 LLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKL 457
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 8e-44
Identities = 69/427 (16%), Positives = 129/427 (30%), Gaps = 24/427 (5%)
Query: 50 LIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALA 109
+ + ++L L S N++EL L+ N L+ +L+ L L L N L
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 110 GNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLS 169
+L LS L + N EL ++ L A+ +S + S
Sbjct: 72 E--TLDLESLSTLRTLDLNNNY------VQELLVGPSIETLHAANNNIS-RVSCSR--GQ 120
Query: 170 KLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSG-SIPPEIGKLKKLEELFLWQNS 228
+ + + I+ + G S + L L N + + LE L L N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 229 LVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANA 288
+ + ++ LK +D S N L+ + + + + +N + I L +
Sbjct: 181 IY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236
Query: 289 TNLVQLQLDTNQISGLIPPE-IGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHN 347
NL L N + ++ + ++ C+
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPTLGHYGAY 294
Query: 348 SLTASVPAGLFQLQNLT----KLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403
+L L LL + + E N + + + +I +
Sbjct: 295 CCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQ 354
Query: 404 EIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLD 463
+ L+ L V + EL L ++ S LQ+L
Sbjct: 355 VTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEEQSPLQLLR 413
Query: 464 VSDNRFS 470
R+
Sbjct: 414 AIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-43
Identities = 68/498 (13%), Positives = 143/498 (28%), Gaps = 47/498 (9%)
Query: 64 LPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLE 123
+ + + + + L + + ++++L L N L+ A+L + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 124 EMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISG 183
+ N L + L LS L+TL + +
Sbjct: 62 LLNLSSNV--------------------LYE-------TLDLESLSTLRTLDLNNNYVQ- 93
Query: 184 EIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSL 243
E+ + +L N++S + + + ++L N + + G + +
Sbjct: 94 ----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 244 KMIDFSLNSLSG-TIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQIS 302
+ +D LN + LE + N + + L L L +N+++
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA 204
Query: 303 GLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQN 362
+ PE + +T N+L I L NL+ DL N F +N
Sbjct: 205 F-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKN 261
Query: 363 LTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLS 422
+ + C+ G L L L + +
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQ 321
Query: 423 GSVPDEIG----DCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLG 478
GS + + + + ID + + L+ Q+
Sbjct: 322 GSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381
Query: 479 RLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLS 538
L+ + ++ L + V + Q A+ ++
Sbjct: 382 AHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRD-WDMY 440
Query: 539 CNGLTGPIPAQISALNKL 556
+ T + + + L KL
Sbjct: 441 QHKET-QLAEENARLKKL 457
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 3e-40
Identities = 50/285 (17%), Positives = 108/285 (37%), Gaps = 17/285 (5%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEIGNCSS 386
+I + + + ++ +SL A L Q N+ +L L N +S ++ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 387 LVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446
L L + +N + + + L TL LDL++N + E+ ++ + ++N +
Sbjct: 60 LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 447 GSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG-PIPSSLGLCS 505
+ S G + + +++N+ + G + + L N
Sbjct: 113 -RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 506 SLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNK 565
+L+ L+L N + V ++ L+ L+LS N L + + + ++ + L +NK
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKT-LDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225
Query: 566 LEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGN 610
L L NL ++ N F + + +A
Sbjct: 226 LVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 58/449 (12%), Positives = 130/449 (28%), Gaps = 21/449 (4%)
Query: 17 PTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEE 76
+L+ F L+ L +S L ++ L LD ++N + L ++E
Sbjct: 51 AADLAPFTKLELLNLSSNVLYETLDL--ESLSTLRTLDLNNNYV-----QELLVGPSIET 103
Query: 77 LILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGK 136
L +N ++ V S + + + L +N + + G S ++ + N+
Sbjct: 104 LHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160
Query: 137 IPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELV 196
+ L L + + + +KL+TL + + ++ + E + + +
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 197 SLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGT 256
+ L N L I + + LE L N + ++ + ++
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 257 IPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISG----LIPPEIGML 312
+ + L + + G + E
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQ 335
Query: 313 SKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISND 372
++ A + Q I L+ +L V G L L +
Sbjct: 336 ARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG 395
Query: 373 ISGSIPPEIGNCSSLVRLRVGNNRIA-GLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD 431
+ S L LR R + ++ + D+ ++ + +
Sbjct: 396 -QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARL 454
Query: 432 CTELQMIDLSHNTLQGSLPNSLSSLSGLQ 460
DL+ + +L + L
Sbjct: 455 KKLNGEADLALASANATLQELVVREQNLA 483
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 43/356 (12%), Positives = 98/356 (27%), Gaps = 30/356 (8%)
Query: 14 LPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHN 73
+ +S L+ L + + + + L LD SSN L +
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 74 LEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALA-GNIPAELGRLSNLEEMRAGGNKD 132
+ + L +N+L I L ++L L N G + + ++ + K
Sbjct: 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274
Query: 133 IVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNC 192
+ G+ +C+ T +L L+ G
Sbjct: 275 LTGQNEE---ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER---- 327
Query: 193 SELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNS 252
+ E + E+ + I + + ++ +
Sbjct: 328 ----------------LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKA 371
Query: 253 LSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQIS-GLIPPEIGM 311
L + +EL+ + + + L L+ + + +
Sbjct: 372 LDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQ 430
Query: 312 LSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLL 367
+ + + +Q++ DL+ S A++ + + QNL L
Sbjct: 431 NNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLASQL 486
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-51
Identities = 81/319 (25%), Positives = 124/319 (38%), Gaps = 55/319 (17%)
Query: 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+ IGKG G V+ GE +AVK + T +E S R+ EI
Sbjct: 39 IQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---------EEASWFRE---TEIYQT 85
Query: 766 GSIRHKNIVRFLGCCWNRNNR----LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLG 821
+RH+NI+ F+ L+ DY NGSL L T L+ + ++
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYS 142
Query: 822 AAQGLAYLH-----HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG--DFARS 874
+ GL +LH P I HRD+K+ NIL+ IAD GLA +
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 875 SNTVAGSYGYIAPE--YGYMMKI----TEKSDVYSYGVVVLEVLTGKQP----------- 917
NT G+ Y+ PE + + +D+YS+G+++ EV
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 918 --IDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALL--CVNASPDE 973
+ P+ P + + V KK L PS DE L+ + L+ C +P
Sbjct: 263 HDLVPSDPSYEDMREIVCIKK----LRPSF--PNRWSSDECLRQM-GKLMTECWAHNPAS 315
Query: 974 RPTMKDVAAMLKEIKHERE 992
R T V L ++ ++
Sbjct: 316 RLTALRVKKTLAKMSESQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 3e-51
Identities = 85/330 (25%), Positives = 132/330 (40%), Gaps = 69/330 (20%)
Query: 700 EQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
+ + +V IGKG G V+R GE +AVK +E+S R+
Sbjct: 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---------EERSWFRE--- 84
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNR----LLMYDYMPNGSLGSLLHERTGNALEWELR 815
AEI +RH+NI+ F+ N L+ DY +GSL L+ T + E
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGM 141
Query: 816 YQILLGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG- 869
++ L A GLA+LH + V P I HRD+K+ NIL+ IAD GLA D
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 870 -DFARSSNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQ------ 916
+ N G+ Y+APE + +++D+Y+ G+V E+
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 917 ----------PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE----SEIDEMLQALGV 962
P DP++ + VV QK RP + E L+ +
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVV--CEQKL-----------RPNIPNRWQSCEALRVM-A 307
Query: 963 ALL--CVNASPDERPTMKDVAAMLKEIKHE 990
++ C A+ R T + L ++ +
Sbjct: 308 KIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-48
Identities = 74/386 (19%), Positives = 149/386 (38%), Gaps = 25/386 (6%)
Query: 233 IPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPAN-LANATNL 291
I + + + + L+ + ++ + +PA L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 292 VQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTA 351
L L+ QI + + + N + P + L L L N L+
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 352 SVPAGLFQ-LQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRIAGLIPREIGGLK 409
S+P G+F LT L + +N++ I + +SL L++ +NR+ + ++ +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIP 186
Query: 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469
+L ++S N LS + ++ +D SHN++ + + L +L + N
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL 238
Query: 470 SGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIE 529
+ L L ++ LS N + L+ L +S+N+L ++ + I
Sbjct: 239 T-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 530 ALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKF 589
L++ L+LS N L + ++L L L HN + L L+ L +L +S+N +
Sbjct: 296 TLKV-LDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TL-KLSTHHTLKNLTLSHNDW 351
Query: 590 TGYLPDNKLFRQLSPTDLAGNEGLCS 615
LFR ++ + + C
Sbjct: 352 D-CNSLRALFRNVARPAVDDADQHCK 376
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-38
Identities = 87/455 (19%), Positives = 150/455 (32%), Gaps = 77/455 (16%)
Query: 55 FSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPA 114
+ S+L ++ ++ E + + + ++ + +PA
Sbjct: 4 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPA 62
Query: 115 E-LGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQT 173
L +E + + + +I + +Q
Sbjct: 63 ALLDSFRQVELLNLNDLQ--IEEIDTY-----------------------AFAYAHTIQK 97
Query: 174 LSIYTTMISGEIPAEI-GNCSELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQNSLVG 231
L + I +P + N L L L N LS S+P I KL L + N+L
Sbjct: 98 LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE- 154
Query: 232 AIPEEI-GNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATN 290
I ++ TSL+ + S N L+ + + + L +S N +S LA
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIA 206
Query: 291 LVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT 350
+ +L N I+ + + L L L HN+LT
Sbjct: 207 VEELDASHNSIN-------------------------VVRGPV--NVELTILKLQHNNLT 239
Query: 351 ASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRIAGLIPREIGGLK 409
L L ++ L N++ I L RL + NNR+ + +
Sbjct: 240 -DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP 295
Query: 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469
TL LDLS N L V L+ + L HN++ +L LS+ L+ L +S N +
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351
Query: 470 SGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLC 504
+L R V+ + + GLC
Sbjct: 352 DCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLC 386
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-34
Identities = 63/397 (15%), Positives = 130/397 (32%), Gaps = 73/397 (18%)
Query: 4 EITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDI-GDCVGLIVLDFSSNNLVG 62
++ I + + + + + ++ + +P + + +L+ + +
Sbjct: 25 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE 83
Query: 63 TLPSSLGKLHNLEELILNSNQLTGKIPVE-LSNCKSLRKLLLFDNALAGNIPAELGRLSN 121
+ H +++L + N + +P N L L+L N L+ ++P +
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGI----- 136
Query: 122 LEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMI 181
KL TLS+ +
Sbjct: 137 -------------------------------------------FHNTPKLTTLSMSNNNL 153
Query: 182 SGEIPAEI-GNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
I + + L +L L N L+ + + L + N L +
Sbjct: 154 E-RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIP 204
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
+++ +D S NS++ + EL + NN++ L N LV++ L N+
Sbjct: 205 IAVEELDASHNSINV---VRGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNE 259
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
+ ++ + +L + N+L ++ L+ LDLSHN L V Q
Sbjct: 260 LEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 317
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRI 397
L L L N I ++ +L L + +N
Sbjct: 318 DRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-27
Identities = 50/271 (18%), Positives = 101/271 (37%), Gaps = 29/271 (10%)
Query: 352 SVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTL 411
+ + L + + E ++ + N+ + L + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 412 NFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470
L+L+ ++ + +Q + + N ++ P+ ++ L VL + N S
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 471 GQIPASL-GRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIE 529
+P + L + +S N + +SLQ L LSSN+LT ++L I
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIP 186
Query: 530 ALEIALNLSCNGLTGPIPAQIS-----------------ALNKLSILDLSHNKLEGNLNP 572
+L N+S N L+ + I+ +L+IL L HN L +
Sbjct: 187 SLFH-ANVSYNLLST-LAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT-DTAW 243
Query: 573 LAQLDNLVSLNISYNKFTGYLPDNKLFRQLS 603
L LV +++SYN+ + + F ++
Sbjct: 244 LLNYPGLVEVDLSYNELE-KIMYH-PFVKMQ 272
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 9e-18
Identities = 49/264 (18%), Positives = 95/264 (35%), Gaps = 23/264 (8%)
Query: 25 HLQTLVISDANLTGSIPFDI-GDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQ 83
L TL +S+ NL I D L L SSN L + SL + +L ++ N
Sbjct: 142 KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNL 197
Query: 84 LTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGD 143
L+ L+ ++ +L N++ + + L ++ N + L +
Sbjct: 198 LS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNN--LTDTAW-LLN 246
Query: 144 CSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYEN 203
+ + L+ ++ + K+ +L+ L I + + L L L N
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 305
Query: 204 SLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGG 263
L + + +LE L+L NS+V + + +LK + S N ++
Sbjct: 306 HLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL-- 359
Query: 264 LSELEEFMISDNNVSGSIPANLAN 287
+ + D + I L +
Sbjct: 360 FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 24/92 (26%), Positives = 40/92 (43%), Gaps = 5/92 (5%)
Query: 20 LSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELIL 79
+ L+ L IS+ L ++ L VLD S N+L+ + + + LE L L
Sbjct: 268 FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325
Query: 80 NSNQLTGKIPVELSNCKSLRKLLLFDNALAGN 111
+ N + ++LS +L+ L L N N
Sbjct: 326 DHNSIV---TLKLSTHHTLKNLTLSHNDWDCN 354
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-46
Identities = 87/365 (23%), Positives = 143/365 (39%), Gaps = 46/365 (12%)
Query: 168 LSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQN 227
+ L++ + ++ +P + + +L + +N+L+ S+P +L+ LE + N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLT-SLPALPPELRTLE---VSGN 91
Query: 228 SLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLAN 287
L ++P L + L L P GL +L I N ++ S+P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKLW---IFGNQLT-SLPVLP-- 140
Query: 288 ATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHN 347
L +L + NQ++ L P L KL + NQL S+P S LQ L +S N
Sbjct: 141 -PGLQELSVSDNQLASL-PALPSELCKLWAYN---NQLT-SLPMLP---SGLQELSVSDN 191
Query: 348 SLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGG 407
L S+P +L L +N ++ S+P L L V NR+ L P
Sbjct: 192 QLA-SLPTLPSELYKLWAY---NNRLT-SLPALPSG---LKELIVSGNRLTSL-PVLPSE 242
Query: 408 LKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN 467
LK L +S NRL+ S+P L + N L LP SL LS +++ N
Sbjct: 243 LKELM---VSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 468 RFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQ 527
S + +L + S F S+ +L L +++ L + E
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHL--AAADWLVPAREGEPAP 352
Query: 528 IEALE 532
+
Sbjct: 353 ADRWH 357
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-45
Identities = 91/405 (22%), Positives = 154/405 (38%), Gaps = 73/405 (18%)
Query: 183 GEIPAEIGNC--SELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC 240
+ ++ C + L + E+ L+ ++P + + L + N+L ++P
Sbjct: 28 AAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPEL 83
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
+L + S N L+ ++P+ GL EL F ++ + L +L + NQ
Sbjct: 84 RTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQ 132
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQL 360
++ L P LQ L +S N L S+PA +L
Sbjct: 133 LTSL-PVLPP---------------------------GLQELSVSDNQLA-SLPALPSEL 163
Query: 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
L +N ++ S+P L L V +N++A L P L L +NR
Sbjct: 164 CKLW---AYNNQLT-SLPMLPSG---LQELSVSDNQLASL-PTLPSELYKL---WAYNNR 212
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
L+ S+P EL +S N L SLP S L + L VS NR + +P L
Sbjct: 213 LT-SLPALPSGLKEL---IVSGNRLT-SLPVLPSEL---KELMVSGNRLT-SLPMLPSGL 263
Query: 481 VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALN--LS 538
+SL+ + +N + +P SL SS ++L N L+ L +I + +
Sbjct: 264 LSLS---VYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319
Query: 539 CNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLN 583
+ P + AL+ L+ D EG P + +
Sbjct: 320 FDMAGASAPRETRALH-LAAADWLVPAREGEPAPADRWHMFGQED 363
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-43
Identities = 80/364 (21%), Positives = 139/364 (38%), Gaps = 45/364 (12%)
Query: 240 CTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTN 299
+++ + L+ T+P + + + +I DNN++ S+PA L L++ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALP---PELRTLEVSGN 91
Query: 300 QISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQ 359
Q++ L P L +L++F L S L L + N LT S+P
Sbjct: 92 QLTSL-PVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPV---L 139
Query: 360 LQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSN 419
L +L + N ++ S+P L +L NN++ L P GL+ L+ +S N
Sbjct: 140 PPGLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLTSL-PMLPSGLQELS---VSDN 191
Query: 420 RLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGR 479
+L+ S+P EL + +N L SLP S L + L VS NR + +P
Sbjct: 192 QLA-SLPTLPS---ELYKLWAYNNRLT-SLPALPSGL---KELIVSGNRLT-SLPVLPSE 242
Query: 480 LVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSC 539
L L +S N + +P L L + NQLT +P L + + +NL
Sbjct: 243 LKELM---VSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETT-VNLEG 293
Query: 540 NGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLF 599
N L+ + + + + + + L + +
Sbjct: 294 NPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353
Query: 600 RQLS 603
+
Sbjct: 354 DRWH 357
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-38
Identities = 83/378 (21%), Positives = 140/378 (37%), Gaps = 50/378 (13%)
Query: 33 DANLTGSIPFDIGDCV--GLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPV 90
++ ++ + C+ G VL+ + L TLP L ++ L++ N LT +P
Sbjct: 23 ESRGRAAVVQKMRACLNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-SLPA 78
Query: 91 ELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTAL 150
LR L + N L ++P L L +PA S + L
Sbjct: 79 LPPE---LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT-----HLPALP---SGLCKL 126
Query: 151 GLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIP 210
+ Q++ SLP L +L +PA L L+ Y N L+ S+P
Sbjct: 127 WIFGNQLT-SLPVLPPGLQELSVSDNQLA----SLPALPSE---LCKLWAYNNQLT-SLP 177
Query: 211 PEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEF 270
L+ EL + N L ++P L + L SL P GL EL
Sbjct: 178 MLPSGLQ---ELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSL----PALPSGLKELI-- 227
Query: 271 MISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIP 330
+S N ++ S+P + L +L + N+++ L P L L+V+ NQL +P
Sbjct: 228 -VSGNRLT-SLPVLP---SELKELMVSGNRLTSL-PMLPSGLLSLSVYR---NQLT-RLP 277
Query: 331 STLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKL---LLISNDISGSIPPEIGNCSSL 387
+L S+ ++L N L+ L ++ + ++ + S P E
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337
Query: 388 VRLRVGNNRIAGLIPREI 405
+ R P +
Sbjct: 338 AADWLVPAREGEPAPADR 355
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 8e-38
Identities = 84/458 (18%), Positives = 139/458 (30%), Gaps = 124/458 (27%)
Query: 71 LHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGN 130
+ L + + LT +P L + L++ DN L ++PA L L
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTL-------- 86
Query: 131 KDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIG 190
+ S +L +L P
Sbjct: 87 ------------EVSGN----------------------QLTSL-----------PVLPP 101
Query: 191 NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSL 250
EL L L +L+++ N L ++P L + D L
Sbjct: 102 GLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQL-TSLPVLPPGLQELSVSDNQL 153
Query: 251 NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIG 310
SL P L +L +N ++ S+P + L +L + NQ++ L P
Sbjct: 154 ASL----PALPSELCKLW---AYNNQLT-SLPMLP---SGLQELSVSDNQLASL-PTLPS 201
Query: 311 MLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLIS 370
L KL + N+L S+P A S L+ L +S N LT
Sbjct: 202 ELYKLWAY---NNRLT-SLP---ALPSGLKELIVSGNRLT-------------------- 234
Query: 371 NDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIG 430
S+P L L V NR+ L P GL + L + N+L+ +P+ +
Sbjct: 235 -----SLPVLPSE---LKELMVSGNRLTSL-PMLPSGLLS---LSVYRNQLT-RLPESLI 281
Query: 431 DCTELQMIDLSHN---TLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKII 487
+ ++L N ++S G + + P L
Sbjct: 282 HLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341
Query: 488 LSKNLFSGPIP----SSLGLCSSLQLLDLSSNQLTGSV 521
L P P G + L ++L+ +
Sbjct: 342 LVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETE 379
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-34
Identities = 88/380 (23%), Positives = 134/380 (35%), Gaps = 73/380 (19%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+P L H+ TLVI D NLT S+P L L+ S N L +LP L L
Sbjct: 55 LPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELS 107
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
L + L KL +F N L ++P L L
Sbjct: 108 IFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPVLPPGLQELS------------ 147
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSEL 195
++D Q++ SLPA +L KL + T +P L
Sbjct: 148 ----------------VSDNQLA-SLPALPSELCKLWAYNNQLT----SLPMLPSG---L 183
Query: 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSG 255
L + +N L+ S+P +L KL N L ++P L S N L+
Sbjct: 184 QELSVSDNQLA-SLPTLPSELYKLWAY---NNRLT-SLPALPSGLKEL---IVSGNRLT- 234
Query: 256 TIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKL 315
++P+ L EL +S N ++ S+P + L+ L + NQ++ L P + LS
Sbjct: 235 SLPVLPSELKELM---VSGNRLT-SLPMLP---SGLLSLSVYRNQLTRL-PESLIHLSSE 286
Query: 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISG 375
T N L TL + + + + AG + L L + D
Sbjct: 287 TTVNLEGNPLS---ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW-- 341
Query: 376 SIPPEIGNCSSLVRLRVGNN 395
+P G + R +
Sbjct: 342 LVPAREGEPAPADRWHMFGQ 361
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 65/329 (19%), Positives = 118/329 (35%), Gaps = 16/329 (4%)
Query: 232 AIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNL 291
AI E N K+ + +SL + ++E +S N +S A+LA T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 292 VQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTA 351
L L +N + ++ LS L N + L +++ L ++N+++
Sbjct: 61 ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 352 SVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGL-IPREIGGLKT 410
V Q + L +N I+ + G S + L + N I + T
Sbjct: 113 RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 411 LNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470
L L+L N + V ++ +L+ +DLS N L + S +G+ + + +N+
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 471 GQIPASLGRLVSLNKIILSKN-LFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIE 529
I +L +L L N G + +Q + + + E +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 530 ALEIALNLSCNGLTGPIPAQISALNKLSI 558
L C L P ++ AL
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 55/334 (16%), Positives = 110/334 (32%), Gaps = 21/334 (6%)
Query: 185 IPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLK 244
I N + + ++SL ++ ++EL L N L ++ T L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 245 MIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGL 304
+++ S N L + LS L +++N V L ++ L N IS
Sbjct: 62 LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR- 113
Query: 305 IPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLF-QLQNL 363
+ + N++ S +Q LDL N + A L L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 364 TKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG 423
L L N I + ++ + L L + +N++A + E + ++ L +N+L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV- 227
Query: 424 SVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSL 483
+ + L+ DL N +V V+ ++ ++
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTV 285
Query: 484 NKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQL 517
+ +P+ +L+ L +
Sbjct: 286 PTLGHYGAYCCEDLPAPFA----DRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 49/265 (18%), Positives = 106/265 (40%), Gaps = 17/265 (6%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEIGNCSS 386
+I + + + ++ +SL A L Q N+ +L L N +S ++ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 387 LVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446
L L + +N + + + L TL LDL++N + E+ ++ + ++N +
Sbjct: 60 LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 447 GSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN-LFSGPIPSSLGLCS 505
+ S G + + +++N+ + G + + L N + +
Sbjct: 113 -RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 506 SLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNK 565
+L+ L+L N + V ++ L+ L+LS N L + + + ++ + L +NK
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKT-LDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225
Query: 566 LEGNLNPLAQLDNLVSLNISYNKFT 590
L L NL ++ N F
Sbjct: 226 LVLIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-42
Identities = 56/338 (16%), Positives = 100/338 (29%), Gaps = 41/338 (12%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
+I N ++ + + + + N L + LA + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 340 QALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAG 399
+ L+LS N L ++ + S+L L + NN +
Sbjct: 61 ELLNLSSNVLYE--------------------------TLDLESLSTLRTLDLNNNYV-- 92
Query: 400 LIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGL 459
+E+ ++ L ++N +S V G + I L++N + S +
Sbjct: 93 ---QELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 460 QVLDVSDNRFSG-QIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518
Q LD+ N +L + L N + + + L+ LDLSSN+L
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVF-AKLKTLDLSSNKLA 204
Query: 519 GSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDN 578
+ E + ++L N L I + L DL N N
Sbjct: 205 -FMGPEFQSAAGVTW-ISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
Query: 579 LVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSS 616
++ L PT C
Sbjct: 262 QRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCED 298
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-33
Identities = 61/336 (18%), Positives = 119/336 (35%), Gaps = 27/336 (8%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
I N + + ++D++L ++ + LD S N L + L LE
Sbjct: 5 IKQNGNR---YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
L L+SN L + +L + +LR L L +N + EL ++E + A N +
Sbjct: 62 LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN--IS 112
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISG-EIPAEIGNCSE 194
++ G + LA+ +++ G S++Q L + I +
Sbjct: 113 RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLS 254
L L L N + + ++ KL+ L L N L + E + + I N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 255 GTIPLSIGGLSELEEFMISDNNVS-GSIPANLANATNLVQLQLDTNQISGLIPPEIGMLS 313
I ++ LE F + N G++ + + + T + + +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEEC 283
Query: 314 KLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSL 349
+ + +P+ A + + L H+
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFA----DRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 51/408 (12%), Positives = 109/408 (26%), Gaps = 94/408 (23%)
Query: 64 LPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLE 123
+ + + + + L + + ++++L L N L+ A+L + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 124 EMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISG 183
+ N L
Sbjct: 62 LLNLSSN---------------------------------------VLYETL-------- 74
Query: 184 EIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSL 243
++ + S L +L L N + E+ +E L N++ + G
Sbjct: 75 ----DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSRG--QGK 122
Query: 244 KMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSG-SIPANLANATNLVQLQLDTNQIS 302
K I + N ++ L G S ++ + N + + A++ L L L N I
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 303 GLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQN 362
+ + L+ LDLS N L +
Sbjct: 183 -------------------------DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 363 LTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLS 422
+T + L +N + I + +L + N K ++ +
Sbjct: 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK 273
Query: 423 GSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470
+CT + + L + +++ + +
Sbjct: 274 KLTGQNEEECTVPTLGHYGAYCCE-----DLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 54/302 (17%), Positives = 102/302 (33%), Gaps = 25/302 (8%)
Query: 50 LIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALA 109
+ + ++L L S N++EL L+ N L+ +L+ L L L N L
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 110 GNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLS 169
+L LS L + N EL ++ L A+ +S + S
Sbjct: 72 E--TLDLESLSTLRTLDLNNNY------VQELLVGPSIETLHAANNNIS-RVSCSR--GQ 120
Query: 170 KLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSG-SIPPEIGKLKKLEELFLWQNS 228
+ + + I+ + G S + L L N + + LE L L N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 229 LVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANA 288
+ + ++ LK +D S N L+ + + + + +N + I L +
Sbjct: 181 IY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236
Query: 289 TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNS 348
NL L N + FF+ +++ T+ + + + +
Sbjct: 237 QNLEHFDLRGNGFHCGTLRD---------FFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 349 LT 350
L
Sbjct: 288 LG 289
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 22/131 (16%), Positives = 43/131 (32%), Gaps = 5/131 (3%)
Query: 13 QLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLH 72
+ +S L+ L + + + + L LD SSN L +
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAA 214
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALA-GNIPAELGRLSNLEEMRAGGNK 131
+ + L +N+L I L ++L L N G + + ++ + K
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
Query: 132 DIVGKIPAELG 142
+ G+ E
Sbjct: 274 KLTGQNEEECT 284
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-43
Identities = 77/411 (18%), Positives = 155/411 (37%), Gaps = 49/411 (11%)
Query: 208 SIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSEL 267
I + ++ + + E + K++ F +++ + ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 268 EEFMISDNNVSGSIPAN-LANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLE 326
E ++D + I A A + +L + N I L
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYL---------------------- 114
Query: 327 GSIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEI-GNC 384
P + L L L N L+ S+P G+F LT L + +N++ I +
Sbjct: 115 --PPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 170
Query: 385 SSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNT 444
+SL L++ +NR+ + ++ + +L ++S N LS + ++ +D SHN+
Sbjct: 171 TSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS 222
Query: 445 LQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLC 504
+ + + L +L + N + L L ++ LS N +
Sbjct: 223 IN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKM 277
Query: 505 SSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHN 564
L+ L +S+N+L ++ + I L++ L+LS N L + ++L L L HN
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKV-LDLSHNHLLH-VERNQPQFDRLENLYLDHN 334
Query: 565 KLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCS 615
+ L L+ L +L +S+N + LFR ++ + + C
Sbjct: 335 SIV-TL-KLSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCK 382
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 3e-37
Identities = 104/565 (18%), Positives = 181/565 (32%), Gaps = 91/565 (16%)
Query: 55 FSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPA 114
+ S+L ++ ++ E + + + ++ + +PA
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPA 68
Query: 115 E-LGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQT 173
L +E + + + +I + +Q
Sbjct: 69 ALLDSFRQVELLNLNDLQ--IEEIDTY-----------------------AFAYAHTIQK 103
Query: 174 LSIYTTMISGEIPAEI-GNCSELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQNSLVG 231
L + I +P + N L L L N LS S+P I KL L + N+L
Sbjct: 104 LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE- 160
Query: 232 AIPEEI-GNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATN 290
I ++ TSL+ + S N L+ + + + L +S N +S LA
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIA 212
Query: 291 LVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT 350
+ +L N I+ + + L L L HN+LT
Sbjct: 213 VEELDASHNSINV-VRGPV--------------------------NVELTILKLQHNNLT 245
Query: 351 ASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRIAGLIPREIGGLK 409
L L ++ L N++ I L RL + NNR+ + +
Sbjct: 246 -DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP 301
Query: 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469
TL LDLS N L V L+ + L HN++ +L LS+ L+ L +S N +
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 357
Query: 470 SGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSS--------LQLLDLSSNQLTGSV 521
+L R V+ + + GLC L ++ + V
Sbjct: 358 DCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKV 417
Query: 522 PMELGQIEALEIALNLSCNGLT----GPIPAQISALNKLSILDLSHNK--LEGNLNPLAQ 575
G+ A + ++ G +P Q + + + +L L Q
Sbjct: 418 QRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQ 477
Query: 576 LDNLVSLNISYNKFTGYLPDNKLFR 600
L + I N LP + L R
Sbjct: 478 LLQGLHAEIDTNLRRYRLPKDGLAR 502
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-37
Identities = 98/613 (15%), Positives = 192/613 (31%), Gaps = 75/613 (12%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
I +NL + I F+ ++ F ++ + + L +E
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 76 ELILNSNQLTGKIPVE-LSNCKSLRKLLLFDNALAGNIPAELGR-LSNLEEMRAGGNKDI 133
L LN Q+ +I + +++KL + NA+ +P + + + L + N
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND-- 134
Query: 134 VGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI-GNC 192
+ +P + KL TLS+ + I +
Sbjct: 135 LSSLPRGI-----------------------FHNTPKLTTLSMSNNNLE-RIEDDTFQAT 170
Query: 193 SELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNS 252
+ L +L L N L+ + + L + N L + +++ +D S NS
Sbjct: 171 TSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNS 222
Query: 253 LSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGML 312
++ + EL + NN++ L N LV++ L N++ ++ +
Sbjct: 223 INV---VRGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKM 277
Query: 313 SKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISND 372
+L + N+L ++ L+ LDLSHN L V Q L L L N
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 335
Query: 373 ISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC 432
I ++ +L L + +N + L N +V D C
Sbjct: 336 IV-TLKL--STHHTLKNLTLSHND-----------WDCNSLRALFRNVARPAVDDADQHC 381
Query: 433 TELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSK-- 490
++ + P L + + V + Q S ++ + +
Sbjct: 382 KIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYIT 441
Query: 491 NLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSC-------NGLT 543
P+ + L + + L QLT + ++ L ++ + +GL
Sbjct: 442 QQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLA 501
Query: 544 GPIPAQISALNKLS-----ILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKL 598
L L + + + ++L NI+ K K
Sbjct: 502 RSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQL-DNKRAKQ 560
Query: 599 FRQLSPTDLAGNE 611
T L +
Sbjct: 561 AELRQETSLKRQK 573
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 51/272 (18%), Positives = 100/272 (36%), Gaps = 29/272 (10%)
Query: 351 ASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKT 410
+ + L + + E ++ + N+ + L + +
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 411 LNFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469
+ L+L+ ++ + +Q + + N ++ P+ ++ L VL + N
Sbjct: 77 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135
Query: 470 SGQIPASL-GRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQI 528
S +P + L + +S N + +SLQ L LSSN+LT V L I
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLI 191
Query: 529 EALEIALNLSCNGLTGPIPAQIS-----------------ALNKLSILDLSHNKLEGNLN 571
+L N+S N L+ + I+ +L+IL L HN L +
Sbjct: 192 PSLFH-ANVSYNLLST-LAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT-DTA 248
Query: 572 PLAQLDNLVSLNISYNKFTGYLPDNKLFRQLS 603
L LV +++SYN+ + + F ++
Sbjct: 249 WLLNYPGLVEVDLSYNELE-KIMYH-PFVKMQ 278
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 9e-42
Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 46/281 (16%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG+G VY+ D + +A +L R F E + L ++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCEL---------QDRKLTKSERQRFKEEAEMLKGLQ 83
Query: 770 HKNIVRFLGCC---WNRNNRLLMY-DYMPNGSLGSLLHERTGNALEWELR---YQILLGA 822
H NIVRF +++ + M +G+L + L +R LR QIL
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQIL--- 139
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILI-GLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
+GL +LH PPI+HRD+K +NI I G I D GLA L + V G+
Sbjct: 140 -KGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGT 193
Query: 882 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ--KKGIQ 939
++APE Y K E DVY++G+ +LE+ T + P Q ++
Sbjct: 194 PEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP--------YSECQNAAQIYRRVTS 244
Query: 940 VLDPSLLSRPES-EIDEMLQALGVALLCVNASPDERPTMKD 979
+ P+ + E+ E+++ C+ + DER ++KD
Sbjct: 245 GVKPASFDKVAIPEVKEIIE------GCIRQNKDERYSIKD 279
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-41
Identities = 71/446 (15%), Positives = 162/446 (36%), Gaps = 44/446 (9%)
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKD 132
N + + ++ + +L L ++++ ++ + +L+ L ++ N
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN- 75
Query: 133 IVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNC 192
+ + L +N+T L +++ +L + L+KL L+ T ++ ++ +
Sbjct: 76 -ITTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQN 126
Query: 193 SELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNS 252
L L N+L+ I + +L EL N + + + T L +D S N
Sbjct: 127 PLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 253 LSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGML 312
++ L + L NN++ + L L L +N+++ + ++ L
Sbjct: 182 ITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPL 232
Query: 313 SKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISND 372
++LT F N L + +++ S L L L + L L
Sbjct: 233 TQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQA--EG 284
Query: 373 ISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC 432
++ + + L L I L ++ L +L L++ L+ + +
Sbjct: 285 CRKIKELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHN 338
Query: 433 TELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNL 492
T+L+ + + +Q S+ + L ++ + +P SL + L
Sbjct: 339 TKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLL 395
Query: 493 FSGPIPSSLGLCSSLQLLDLSSNQLT 518
P ++ + D ++N +T
Sbjct: 396 DQFGNPMNI-EPGDGGVYDQATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-41
Identities = 87/422 (20%), Positives = 151/422 (35%), Gaps = 47/422 (11%)
Query: 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLS 254
S + + +L L L +S+ I T L + + N+++
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 255 GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSK 314
L + + L N ++ ++ + T L L DTN+++ L ++
Sbjct: 78 T---LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPL 128
Query: 315 LTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDIS 374
LT +N L I ++ + L LD N + + LT L N I+
Sbjct: 129 LTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 375 GSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTE 434
+ + L RL N I L ++ L FLD SSN+L+ + + T+
Sbjct: 184 -ELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234
Query: 435 LQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFS 494
L D S N L L +S+LS L L +I L L
Sbjct: 235 LTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKI 288
Query: 495 GPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALN 554
+ + + L LLD + +T ++L Q L L L+ LT + +S
Sbjct: 289 KELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVY-LYLNNTELTE-LD--VSHNT 339
Query: 555 KLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFT----GYLPDNKLFRQLSPT--DLA 608
KL L + ++ + + + ++ L + + + L +N L +SP D
Sbjct: 340 KLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398
Query: 609 GN 610
GN
Sbjct: 399 GN 400
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-37
Identities = 73/395 (18%), Positives = 148/395 (37%), Gaps = 40/395 (10%)
Query: 217 KKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNN 276
+ +L +D +S++ + I L+ L + + + NN
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 277 VSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASC 336
++ ++ L+ TNL L D+N+++ L ++ L+KLT N+L + ++
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KLD--VSQN 126
Query: 337 SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNR 396
L L+ + N+LT + LT+L N ++ + L L N+
Sbjct: 127 PLLTYLNCARNTLT-EIDVS--HNTQLTELDCHLNKKITK--LDVTPQTQLTTLDCSFNK 181
Query: 397 IAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSL 456
I L ++ K LN L+ +N ++ + + +L +D S N L + ++ L
Sbjct: 182 ITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPL 232
Query: 457 SGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQ 516
+ L D S N + ++ S L L + + + L + QL+ +
Sbjct: 233 TQLTYFDCSVNPLT-ELDVST--LSKLTTLHCIQTDL-----LEIDLTHNTQLIYFQAEG 284
Query: 517 LTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQL 576
+++ L + L+ G+T + +S KL L L++ +L L ++
Sbjct: 285 CRKIKELDVTHNTQLYL-LDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL-DVSHN 338
Query: 577 DNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNE 611
L SL+ L+ A +
Sbjct: 339 TKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQ 372
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-37
Identities = 69/455 (15%), Positives = 156/455 (34%), Gaps = 46/455 (10%)
Query: 145 SNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENS 204
N + A ++ + S +L+ L +L + + I+ ++ I + L L N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 205 LSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGL 264
++ ++ + + L L N L + + T L ++ N L+ L +
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQN 126
Query: 265 SELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQ 324
L + N ++ I +++ T L +L N+ + ++ ++LT N+
Sbjct: 127 PLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNK 181
Query: 325 LEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNC 384
+ + ++ L L+ N++T + L Q LT L SN ++ I +
Sbjct: 182 IT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPL 232
Query: 385 SSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNT 444
+ L N + L ++ L L L L + + T+L
Sbjct: 233 TQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCR 286
Query: 445 LQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLC 504
L ++ + L +LD + ++ L + L + L+ + + +
Sbjct: 287 KIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-LD--VSHN 338
Query: 505 SSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHN 564
+ L+ L + + +G+I AL + ++ + +
Sbjct: 339 TKLKSLSCVNAHIQ-DFS-SVGKIPALNN-NFEAEGQTITMPKETLTNNSLTIAVSPDLL 395
Query: 565 KLEGNLNPLAQLDN----LVSLNISYNKFTGYLPD 595
GN + D + I++ + P
Sbjct: 396 DQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 73/436 (16%), Positives = 156/436 (35%), Gaps = 73/436 (16%)
Query: 17 PTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEE 76
+ L +L ++++T + I GL L +SNN+ TL L + NL
Sbjct: 35 TISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTY 89
Query: 77 LILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGK 136
L +SN+LT ++++ L L N +L+ L
Sbjct: 90 LACDSNKLTN---LDVTPLTKLTYLNCDTN-----------KLTKL-------------- 121
Query: 137 IPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELV 196
++ +T L A ++ + + ++L L + ++ + ++L
Sbjct: 122 ---DVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLT 173
Query: 197 SLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGT 256
+L N ++ + + + K L L N++ + + L +D S N L+
Sbjct: 174 TLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE- 226
Query: 257 IPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLT 316
+ + L++L F S N ++ + + + L L + + ++ ++L
Sbjct: 227 --IDVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLEI---DLTHNTQLI 278
Query: 317 VFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGS 376
F A + + + + L LD +T + L Q L L L + +++
Sbjct: 279 YFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-E 332
Query: 377 IPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTEL- 435
+ + + + L L N I +G + LN + + ++P E L
Sbjct: 333 LD--VSHNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTI-TMPKETLTNNSLT 387
Query: 436 -----QMIDLSHNTLQ 446
++D N +
Sbjct: 388 IAVSPDLLDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-18
Identities = 57/270 (21%), Positives = 99/270 (36%), Gaps = 30/270 (11%)
Query: 19 NLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELI 78
++S K L L N+T D+ + L LD SSN L + + L L
Sbjct: 186 DVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239
Query: 79 LNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIP 138
+ N LT +++S L L L I L + L +A G + I
Sbjct: 240 CSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKI---KE 290
Query: 139 AELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSL 198
++ + + L ++ L L + KL L + T ++ E+ + + ++L SL
Sbjct: 291 LDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSL 344
Query: 199 FLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGN-----CTSLKMIDFSLNSL 253
+ +GK+ L F + + E + N S ++D N +
Sbjct: 345 SCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM 402
Query: 254 SGTIPLSIGGLSELEEFMISDNNVSGSIPA 283
I GG+ + I+ N+S PA
Sbjct: 403 --NIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-40
Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 33/292 (11%)
Query: 710 NVIGKGCSGVVYRADMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+ +G G G VY + +AVK L TM + F E + I
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME------------VEEFLKEAAVMKEI 273
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
+H N+V+ LG C ++ ++M G+L L E + + + + + Y
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 829 LH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
L + +HR++ A N L+G +ADFGL++L+ + + + AP
Sbjct: 334 LEKKNF----IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAP 388
Query: 888 EYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLL 946
E K + KSDV+++GV++ E+ T G P P I S V + + +K ++ P
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDL-SQVYELL--EKDYRMERPEGC 444
Query: 947 SRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVD 998
E+ M C +P +RP+ ++ + + E +V+
Sbjct: 445 PEKVYEL--MRA-------CWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 487
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-40
Identities = 69/291 (23%), Positives = 115/291 (39%), Gaps = 47/291 (16%)
Query: 711 VIGKGCSGVVYRADMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG+G G V+ + +AVK T + F E + L
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL----------KAKFLQEARILKQYS 170
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H NIVR +G C + ++ + + G + L G L + Q++ AA G+ YL
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYL 229
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI---- 885
+HRD+ A N L+ + I+DFG+++ DG +A S +
Sbjct: 230 ESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL-----RQVPVKW 281
Query: 886 -APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
APE + + +SDV+S+G+++ E + G P P + ++V KG +
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPY-PNLS-NQQTREFVE--KGGR---- 333
Query: 944 SLLSRPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
L PE + M Q C P +RP+ + L+ I+
Sbjct: 334 --LPCPELCPDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 83/299 (27%), Positives = 126/299 (42%), Gaps = 66/299 (22%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+GKG G+VY D+ N IA+K++ + S EI ++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI-----------PERDSRYSQPLHEEIALHKHLK 77
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWEL---RY--QILLGAAQ 824
HKNIV++LG + + +P GSL +LL + G + E Y QIL +
Sbjct: 78 HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL----E 133
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPY-----IADFGLAKLVDDGDFARSSNTVA 879
GL YLH + IVHRDIK +N+LI Y I+DFG +K + + T
Sbjct: 134 GLKYLHDNQ---IVHRDIKGDNVLI----NTYSGVLKISDFGTSKRLA--GINPCTETFT 184
Query: 880 GSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933
G+ Y+APE GY + +D++S G ++E+ TGK P +
Sbjct: 185 GTLQYMAPEIIDKGPRGY----GKAADIWSLGCTIIEMATGKPP-------------FYE 227
Query: 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALL--CVNASPDERPTMKDVAAMLKEIKHE 990
+ + + + EI E + A A + C PD+R A L + E
Sbjct: 228 LGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC----ANDL--LVDE 280
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-39
Identities = 72/314 (22%), Positives = 126/314 (40%), Gaps = 10/314 (3%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
++P + T L L N+I L E L +N + P + NL
Sbjct: 25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 340 QALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRI 397
+ L L N L +P G+F L NLTKL + N I + + + +L L VG+N +
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDL 140
Query: 398 AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLS 457
+ R GL +L L L L+ + + L ++ L H + S L
Sbjct: 141 VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLY 200
Query: 458 GLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQL 517
L+VL++S + + + ++L + ++ + ++ L+ L+LS N +
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI 260
Query: 518 TGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP--LAQ 575
+ L ++ L+ + L L P LN L +L++S N+L L
Sbjct: 261 STIEGSMLHELLRLQ-EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 576 LDNLVSLNISYNKF 589
+ NL +L + N
Sbjct: 319 VGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-36
Identities = 63/332 (18%), Positives = 119/332 (35%), Gaps = 19/332 (5%)
Query: 143 DCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYE 202
C V +P + L + I E + L L L E
Sbjct: 17 LCHR---KRF--VAVPEGIPTET------RLLDLGKNRIKTLNQDEFASFPHLEELELNE 65
Query: 203 NSLSGSIPPEI-GKLKKLEELFLWQNSLVGAIPEEI-GNCTSLKMIDFSLNSLSGTIPLS 260
N +S ++ P L L L L N L IP + ++L +D S N + +
Sbjct: 66 NIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYM 123
Query: 261 IGGLSELEEFMISDNNVSGSIPAN-LANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFF 319
L L+ + DN++ I + +L QL L+ ++ + + L L V
Sbjct: 124 FQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLR 182
Query: 320 AWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPP 379
+ + L+ L++SH ++ NLT L + +++ ++P
Sbjct: 183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY 241
Query: 380 E-IGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMI 438
+ + L L + N I+ + + L L + L +L+ P L+++
Sbjct: 242 LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVL 301
Query: 439 DLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470
++S N L + S+ L+ L + N +
Sbjct: 302 NVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 72/350 (20%), Positives = 137/350 (39%), Gaps = 42/350 (12%)
Query: 32 SDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVE 91
++P I +LD N + +LEEL LN N ++ +
Sbjct: 19 HRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPG 74
Query: 92 -LSNCKSLRKLLLFDNALAGNIPAE-LGRLSNLEEMRAGGNKDIVGKIPAEL-GDCSNMT 148
+N +LR L L N L IP LSNL ++ NK + + + D N+
Sbjct: 75 AFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENK--IVILLDYMFQDLYNLK 131
Query: 149 ALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI-GNCSELVSLFLYENSLSG 207
+L + D + + L+ L+ L++ ++ IP E + L+ L L +++
Sbjct: 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN- 189
Query: 208 SIPPEI-GKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSE 266
+I +L +L+ L + + + +L + + +L+ L++ L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249
Query: 267 LEEFMISDNNVSGSIPAN-LANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQL 325
L +S N +S +I + L L ++QL Q++ + P
Sbjct: 250 LRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAV-VEPY----------------- 290
Query: 326 EGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDIS 374
+ L+ L++S N LT ++ +F + NL L+L SN ++
Sbjct: 291 ------AFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-28
Identities = 70/412 (16%), Positives = 131/412 (31%), Gaps = 109/412 (26%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+P + + + L + + + L L+ + N + P + L NL
Sbjct: 26 VPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLR 83
Query: 76 ELILNSNQLTGKIPVE-LSNCKSLRKLLLFDNALAGNIPAEL-GRLSNLEEMRAGGNKDI 133
L L SN+L IP+ + +L KL + +N + + + L NL+ + G N
Sbjct: 84 TLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDND-- 139
Query: 134 VGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCS 193
+ I + L+ L+ L+
Sbjct: 140 LVYIS-----------------------HRAFSGLNSLEQLT------------------ 158
Query: 194 ELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNS 252
L + +L+ SIP E L L L L ++ I + + F
Sbjct: 159 ------LEKCNLT-SIPTEALSHLHGLIVLRLRHLNI-----NAIRDYS------FK--- 197
Query: 253 LSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGML 312
L L+ IS ++ N NL L + ++ +P
Sbjct: 198 ----------RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYL---- 242
Query: 313 SKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISN 371
+ L+ L+LS+N ++ ++ + L L ++ L+
Sbjct: 243 -------------------AVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGG 282
Query: 372 DISGSIPPEI-GNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLS 422
++ + P + L L V N++ L + L L L SN L+
Sbjct: 283 QLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 63/273 (23%), Positives = 98/273 (35%), Gaps = 36/273 (13%)
Query: 335 SCS-NLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRV 392
CS +A+ +VP G+ L L N I ++ + + L L +
Sbjct: 8 ECSAQDRAVLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIK-TLNQDEFASFPHLEELEL 63
Query: 393 GNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHNTLQGSLPN 451
N ++ + P L L L L SNRL +P + + L +D+S N + L
Sbjct: 64 NENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDY 122
Query: 452 SLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLD 511
L L+ L+V DN +S FSG +SL+ L
Sbjct: 123 MFQDLYNLKSLEVGDNDLV----------------YISHRAFSG--------LNSLEQLT 158
Query: 512 LSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLN 571
L LT L + L + L L + L +L +L++SH +
Sbjct: 159 LEKCNLTSIPTEALSHLHGLIV-LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT 217
Query: 572 PLA-QLDNLVSLNISYNKFTGYLPDNKLFRQLS 603
P NL SL+I++ T +P R L
Sbjct: 218 PNCLYGLNLTSLSITHCNLT-AVPYL-AVRHLV 248
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-15
Identities = 38/228 (16%), Positives = 71/228 (31%), Gaps = 14/228 (6%)
Query: 7 IQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDI-GDCVGLIVLDFSSNNLVGTLP 65
I + +L++L + D +L I L L NL
Sbjct: 116 IVILL-----DYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPT 169
Query: 66 SSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEM 125
+L LH L L L + L+ L + + NL +
Sbjct: 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229
Query: 126 RAGGNKDIVGKIPAE-LGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGE 184
+ +P + + L L+ +S + L +L +LQ + + ++
Sbjct: 230 SITHCN--LTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-V 286
Query: 185 IPAEI-GNCSELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQNSLV 230
+ + L L + N L+ ++ + + LE L L N L
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 42/204 (20%), Positives = 76/204 (37%), Gaps = 40/204 (19%)
Query: 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473
+ R +VP+ I TE +++DL N ++ + +S L+ L++++N S
Sbjct: 16 VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72
Query: 474 PASLGRLVSLNKIILSKNLFSGPIPSSL--GLCSSLQLLDLSSNQLTGSVPMELGQIEAL 531
P + L +L + L N IP + GL S+L LD+S N++
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGL-SNLTKLDISENKIVI------------ 118
Query: 532 EIALNLSCNGLTGPIPAQI-SALNKLSILDLSHNKLEGNLNP--LAQLDNLVSLNISYNK 588
+ + L L L++ N L ++ + L++L L +
Sbjct: 119 --------------LLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCN 163
Query: 589 FTGYLPDNKL--FRQLSPTDLAGN 610
T +P L L L
Sbjct: 164 LT-SIPTEALSHLHGLIVLRLRHL 186
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-39
Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 41/289 (14%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G+GC G V+ + +A+K L P TM+ ++F E + + +R
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------------PEAFLQEAQVMKKLR 237
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H+ +V+ ++ +YM GSL L TG L + A G+AY+
Sbjct: 238 HEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 830 H-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
+ VHRD++A NIL+G +ADFGLA+L++D ++ + APE
Sbjct: 297 ERMNY----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPE 351
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947
+ T KSDV+S+G+++ E+ T G+ P P + + V+D V +G + +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPY-PGMVN-REVLDQVE--RGYR------MP 401
Query: 948 RPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992
P + + M Q C P+ERPT + + A L++ E
Sbjct: 402 CPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTE 443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 70/326 (21%), Positives = 114/326 (34%), Gaps = 71/326 (21%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+G G V+R D G AVKK+ + E+ +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKV----------------RLEVFRVEELVACAGL 107
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQG 825
IV G + + + GSLG L+ ++ G E Y Q L +G
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQAL----EG 162
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLE-FEPYIADFGLAKLVDDGDFARS---SNTVAGS 881
L YLH I+H D+KA+N+L+ + + DFG A + +S + + G+
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 882 YGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937
++APE K D++S ++L +L G P W Q
Sbjct: 220 ETHMAPEVVMGKPC----DAKVDIWSSCCMMLHMLNGCHP-------------WT-QYFR 261
Query: 938 IQVL------DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991
+ P + P S QA+ + P R + A L +
Sbjct: 262 GPLCLKIASEPPPIREIPPSCAPLTAQAI---QEGLRKEPVHRAS----AMEL--RRKVG 312
Query: 992 EEYAKVDMLLKGSPAAANVQENKNSS 1017
+ +V L SP +E + +S
Sbjct: 313 KALQEVGGLK--SPWKGEYKEPRGNS 336
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-38
Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 41/289 (14%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G+GC G V+ + +A+K L P TM+ ++F E + + +R
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------------PEAFLQEAQVMKKLR 320
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H+ +V+ ++ +YM GSL L TG L + A G+AY+
Sbjct: 321 HEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 830 H-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
+ VHRD++A NIL+G +ADFGLA+L++D ++ + APE
Sbjct: 380 ERMNY----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPE 434
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947
+ T KSDV+S+G+++ E+ T G+ P P + + V+D V +G + +
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPY-PGMVN-REVLDQVE--RGYR------MP 484
Query: 948 RPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992
P + + M Q C P+ERPT + + A L++ E
Sbjct: 485 CPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTE 526
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-37
Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 51/295 (17%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G G V+ A + +AVK + P +M+ ++F AE + +++
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS------------VEAFLAEANVMKTLQ 241
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H +V+ ++ ++M GSL L G+ A+G+A++
Sbjct: 242 HDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 830 -HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI--- 885
+ + HRD++A NIL+ IADFGLA++++D ++
Sbjct: 301 EQRNYI----HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG------AKFPIK 350
Query: 886 --APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942
APE T KSDV+S+G++++E++T G+ P P + + V+ + ++G +
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSN-PEVIRAL--ERGYR--- 403
Query: 943 PSLLSRPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993
+ RPE E+ M++ C P+ERPT + + ++L + E
Sbjct: 404 ---MPRPENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDDFYTATES 448
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-37
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 62/305 (20%)
Query: 710 NVIGKGCSGVVYRA----DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
V+G G G VY+ + + ++ +A+K+L T A E
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----------NKEILDEAYV 70
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
+ S+ + ++ R LG C +L+ MP G L + E N L + A+
Sbjct: 71 MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAK 128
Query: 825 GLAYL--HHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVA 879
G+ YL +VHRD+ A N+L+ P I DFGLAKL+ + +
Sbjct: 129 GMNYLEDRR-----LVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA---- 176
Query: 880 GSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVR 933
G + A E T +SDV+SYGV V E++T G +P IP S + +
Sbjct: 177 -EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-DGIP-ASEISSILE 233
Query: 934 QKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989
KG + L +P ++ M + C D RP +++ ++
Sbjct: 234 --KGER------LPQPPICTIDVYMIMRK-------CWMIDADSRPKFRELIIEFSKMAR 278
Query: 990 EREEY 994
+ + Y
Sbjct: 279 DPQRY 283
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 75/300 (25%), Positives = 133/300 (44%), Gaps = 58/300 (19%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G G V+ + +AVK L +M+ D+F AE + ++
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------------PDAFLAEANLMKQLQ 66
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H+ +VR ++ +YM NGSL L +G L + A+G+A++
Sbjct: 67 HQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 830 -HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI--- 885
+ +HRD++A NIL+ IADFGLA+L++D ++
Sbjct: 126 EERNY----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG------AKFPIK 175
Query: 886 --APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQ 939
APE YG T KSDV+S+G+++ E++T G+ P P + + V+ + ++G +
Sbjct: 176 WTAPEAINYG---TFTIKSDVWSFGILLTEIVTHGRIPY-PGMTN-PEVIQNL--ERGYR 228
Query: 940 VLDPSLLSRPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE-EY 994
+ RP+ E+ + M C P++RPT + ++L++ E +Y
Sbjct: 229 ------MVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYLRSVLEDFFTATEGQY 275
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 79/313 (25%), Positives = 127/313 (40%), Gaps = 61/313 (19%)
Query: 704 KCLVDANVIGKGCSGVVYRA---DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
+ VIG+G G VY D D ++ AVK L N +D F
Sbjct: 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--------NRITDIGE--VSQFL 74
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNRLLM-YDYMPNGSLGSLLHERTGNALEWELRYQI 818
E + H N++ LG C L+ YM +G L + + T N +L
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGF 133
Query: 819 LLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSN 876
L A+G+ YL VHRD+ A N ++ +F +ADFGLA+ + D ++ N
Sbjct: 134 GLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 188
Query: 877 TVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSH 927
+ + A E K T KSDV+S+GV++ E++T G P P + +
Sbjct: 189 K---TGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVLLWELMTRGAPPY-PDV-NTFD 240
Query: 928 VVDWVRQKKGIQVLDPSLLSRPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVAAM 983
+ ++ Q + L +PE + E ML+ C + + RP+ ++ +
Sbjct: 241 ITVYLLQGR--------RLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSR 285
Query: 984 LKEI--KHEREEY 994
+ I E Y
Sbjct: 286 ISAIFSTFIGEHY 298
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 1e-36
Identities = 96/489 (19%), Positives = 173/489 (35%), Gaps = 34/489 (6%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+P +LS L IS ++ DI L +L S N + S LE
Sbjct: 15 VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAG-NIPAELGRLSNLEEMRAGGNKDIV 134
L L+ N+L KI +L+ L L NA I E G +S L+ + +
Sbjct: 73 YLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH--L 127
Query: 135 GKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSE 194
K N++ + L + + L T S++ + + I + S
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGE-TYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLS 254
L I + + + + + L + +L I+ + NS
Sbjct: 187 KTVANL--------ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 255 GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATN-----LVQLQLDTNQISGLIPPEI 309
L + + + F IS+ + G + + + L Q+ ++
Sbjct: 239 R--ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 310 GMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLF-QLQNLTKLLL 368
+ S + + + + S LD S+N LT L L L+L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLIL 355
Query: 369 ISNDISGSIPPEIG---NCSSLVRLRVGNNRIAGLIPREI-GGLKTLNFLDLSSNRLSGS 424
N + + SL +L + N ++ + K+L L++SSN L+ +
Sbjct: 356 QMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414
Query: 425 VPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLN 484
+ + ++++DL N ++ S+P + L LQ L+V+ N+ RL SL
Sbjct: 415 IFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQ 471
Query: 485 KIILSKNLF 493
KI L N +
Sbjct: 472 KIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-34
Identities = 87/478 (18%), Positives = 173/478 (36%), Gaps = 35/478 (7%)
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI-GNCSE 194
+P +L T L ++ +S + + LSKL+ L I I + + E
Sbjct: 14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQE 70
Query: 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSL-VGAIPEEIGNCTSLKMIDFSLNSL 253
L L L N L I L+ L L N+ I +E GN + LK + S L
Sbjct: 71 LEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL 127
Query: 254 SGTIPLSIGGLSELEEFMISDNN-VSGSIPANLAN--ATNLVQLQLDTNQISGLIPPEIG 310
+ L I L+ + ++ P L + +L + + ++ +
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVK 187
Query: 311 MLSKLTVF------FAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLT 364
++ L + + SI + L + L L L++ T + + QL T
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247
Query: 365 KLL--------LISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDL 416
+ L + +L +V ++ +N +
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307
Query: 417 SSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPAS 476
+ + + +D S+N L ++ + L+ L+ L + N+ ++
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKI 366
Query: 477 LG---RLVSLNKIILSKN-LFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALE 532
++ SL ++ +S+N + SL L++SSN LT ++ L ++
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIK 424
Query: 533 IALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEG-NLNPLAQLDNLVSLNISYNKF 589
+ L+L N + IP Q+ L L L+++ N+L+ +L +L + + N +
Sbjct: 425 V-LDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 87/439 (19%), Positives = 153/439 (34%), Gaps = 36/439 (8%)
Query: 197 SLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGT 256
+ +N L +P ++ + K L + QN + +I + + L+++ S N +
Sbjct: 4 LVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 257 IPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGL-IPPEIGMLSKL 315
ELE +S N + I + NL L L N L I E G +S+L
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQ---LQNLTKLLLISND 372
LE S +A + + L + + Q ++L + + +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKE 177
Query: 373 ISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNF------LDLSSNRLSGSVP 426
+ + ++L + + L L L L++ + +
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237
Query: 427 DEIGDC---TELQMIDLSHNTLQG-----SLPNSLSSLSGLQVLDVSDNRFSGQIPASLG 478
I T + +S+ LQG S +SL L + V + F
Sbjct: 238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297
Query: 479 RLVSLNKIILSKN---LFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIAL 535
++N + + + PS + S LD S+N LT +V G + LE L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKI---SPFLHLDFSNNLLTDTVFENCGHLTELET-L 353
Query: 536 NLSCNGLT--GPIPAQISALNKLSILDLSHNKLEGNLNPLA--QLDNLVSLNISYNKFTG 591
L N L I + + L LD+S N + + +L+SLN+S N T
Sbjct: 354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413
Query: 592 YLPDNKLFRQLSPTDLAGN 610
+ L ++ DL N
Sbjct: 414 TIFR-CLPPRIKVLDLHSN 431
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 65/395 (16%), Positives = 127/395 (32%), Gaps = 34/395 (8%)
Query: 14 LPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHN 73
LPI + L+ L +S +L + + + L +
Sbjct: 105 LPICKEFGNMSQLKFLGLSTTHLE-KSSVLPIAHLNISKVLLVLGETY-GEKEDPEGLQD 162
Query: 74 LEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDI 133
L+ T K + + L LSN++ +
Sbjct: 163 FNTESLHIVFPTNKEFHFILDVSVKTVANL--------------ELSNIKCVLEDNKCSY 208
Query: 134 VGKIPAELGDCSNMTALGLADTQVSGSLPASLGKL---SKLQTLSIYTTMISGEIPAEIG 190
I A+L ++ L L + + + + + +L + + SI + G++
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF 268
Query: 191 NCS-----ELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKM 245
+ S L + + + + +
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLH 328
Query: 246 IDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPAN---LANATNLVQLQLDTNQIS 302
+DFS N L+ T+ + G L+ELE ++ N + + +L QL + N +S
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVS 387
Query: 303 GLIPPEI-GMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQ 361
L N L +I L ++ LDL N + S+P + +L+
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLE 444
Query: 362 NLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNN 395
L +L + SN + S+P I +SL ++ + N
Sbjct: 445 ALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 7e-16
Identities = 44/227 (19%), Positives = 86/227 (37%), Gaps = 6/227 (2%)
Query: 401 IPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQ 460
+P+++ + L++S N +S +I ++L+++ +SHN +Q + L+
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 461 VLDVSDNRFSGQIPASLGRLVSLNKIILSKNLF-SGPIPSSLGLCSSLQLLDLSSNQLTG 519
LD+S N+ S V+L + LS N F + PI G S L+ L LS+ L
Sbjct: 73 YLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129
Query: 520 SVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNL 579
S + + + ++ L L P + N S+ + E + + +
Sbjct: 130 SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTV 189
Query: 580 VSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSCFLSND 626
+L +S K F + + + + N
Sbjct: 190 ANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 6e-12
Identities = 44/210 (20%), Positives = 81/210 (38%), Gaps = 13/210 (6%)
Query: 2 VTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLV 61
++ + S P F ++ + + + LDFS+N L
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337
Query: 62 GTLPSSLGKLHNLEELILNSNQLT--GKIPVELSNCKSLRKLLLFDNALAGNIPAEL-GR 118
T+ + G L LE LIL NQL KI + KSL++L + N+++ +
Sbjct: 338 DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 119 LSNLEEMRAGGNKDIVGKIPAELGDC--SNMTALGLADTQVSGSLPASLGKLSKLQTLSI 176
+L + N + + C + L L ++ S+P + KL LQ L++
Sbjct: 398 TKSLLSLNMSSN-----ILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNV 451
Query: 177 YTTMISGEIPAEI-GNCSELVSLFLYENSL 205
+ + +P I + L ++L+ N
Sbjct: 452 ASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 68/301 (22%), Positives = 121/301 (40%), Gaps = 51/301 (16%)
Query: 710 NVIGKGCSGVVYRADMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+ +G G G VY + +AVK L TM + F E + I
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME------------VEEFLKEAAVMKEI 66
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
+H N+V+ LG C ++ ++M G+L L E + + + + + Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 829 L-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI-- 885
L + +HRD+ A N L+G +ADFGL++L+ + +
Sbjct: 127 LEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG------AKFPI 176
Query: 886 ---APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941
APE K + KSDV+++GV++ E+ T G P P I S V + + + +
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PGID-LSQVYELLEK--DYR-- 230
Query: 942 DPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKV 997
+ RPE ++ + M C +P +RP+ ++ + + E +V
Sbjct: 231 ----MERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279
Query: 998 D 998
+
Sbjct: 280 E 280
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 74/308 (24%), Positives = 128/308 (41%), Gaps = 64/308 (20%)
Query: 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
+ + +G G GVV +AVK + +M+ D F E +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS------------EDEFFQEAQ 55
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
T+ + H +V+F G C ++ +Y+ NG L + L G LE ++
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVC 114
Query: 824 QGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
+G+A+L H +HRD+ A N L+ + ++DFG+ + V D + S
Sbjct: 115 EGMAFLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG----- 164
Query: 882 YGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWV 932
APE Y K + KSDV+++G+++ EV + GK P S VV V
Sbjct: 165 -TKFPVKWSAPEVFHYF---KYSSKSDVWAFGILMWEVFSLGKMPY-DLYT-NSEVVLKV 218
Query: 933 RQKKGIQVLDPSLLSRPES------EIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
Q G + L RP +I M C + P++RPT + + + ++
Sbjct: 219 SQ--GHR------LYRPHLASDTIYQI--MYS-------CWHELPEKRPTFQQLLSSIEP 261
Query: 987 IKHEREEY 994
+ E++++
Sbjct: 262 L-REKDKH 268
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 67/307 (21%), Positives = 113/307 (36%), Gaps = 50/307 (16%)
Query: 704 KCLVDANVIGKGCSGVVYRADMD-----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSF 758
+ L +G+G G V D GE +AVK L P +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----------IADL 70
Query: 759 SAEIKTLGSIRHKNIVRFLGCCWNRNNRLLM--YDYMPNGSLGSLLHERTGNALEWELRY 816
EI+ L ++ H+NIV++ G C + +++P+GSL L + +
Sbjct: 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 817 QILLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
+ +G+ YL VHRD+ A N+L+ E + I DFGL K ++
Sbjct: 131 -YAVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK----E 181
Query: 876 NTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVV 929
APE K SDV+S+GV + E+LT P +
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 930 DWVRQKKGIQVLDPSL-----LSRPE---SEIDE-MLQALGVALLCVNASPDERPTMKDV 980
Q ++++ +L L P E+ + M + C P R + +++
Sbjct: 242 PTHGQMTVTRLVN-TLKEGKRLPCPPNCPDEVYQLMRK-------CWEFQPSNRTSFQNL 293
Query: 981 AAMLKEI 987
+ +
Sbjct: 294 IEGFEAL 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 83/325 (25%), Positives = 131/325 (40%), Gaps = 75/325 (23%)
Query: 704 KCLVDANVIGKGCSGVVYRADMDNGE------VIAVKKLWPTTMAAANGCSDEKSGVRDS 757
+ +V +G+G G V+ A+ N ++AVK L + +A R
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-----------RQD 89
Query: 758 FSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY- 816
F E + L ++H++IVRF G C L++++YM +G L L +A
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 817 ------------QILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862
+ A G+ YL H VHRD+ N L+G I DFG+
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGM 204
Query: 863 AKLVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT- 913
++ + D+ R G + PE Y K T +SDV+S+GVV+ E+ T
Sbjct: 205 SRDIYSTDYYR-----VGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEIFTY 256
Query: 914 GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNA 969
GKQP + + + +D + Q + L RP E+ M C
Sbjct: 257 GKQPW-YQLSN-TEAIDCITQGR--------ELERPRACPPEVYAIMRG-------CWQR 299
Query: 970 SPDERPTMKDVAAMLKEIKHEREEY 994
P +R ++KDV A L+ + Y
Sbjct: 300 EPQQRHSIKDVHARLQALAQAPPVY 324
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-35
Identities = 82/321 (25%), Positives = 138/321 (42%), Gaps = 76/321 (23%)
Query: 704 KCLVDANVIGKGCSGVVYRADMDNGE------VIAVKKLWPTTMAAANGCSDEKSGVRDS 757
+ +V +G+G G V+ A+ N ++AVK L T+AA R
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-----------RKD 63
Query: 758 FSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY- 816
F E + L +++H++IV+F G C + + +++++YM +G L L +A+
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 817 -------------QILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861
I A G+ YL H VHRD+ N L+G I DFG
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFG 178
Query: 862 LAKLVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT 913
+++ V D+ R G + + PE Y K T +SDV+S+GV++ E+ T
Sbjct: 179 MSRDVYSTDYYR-----VGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFT 230
Query: 914 -GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVN 968
GKQP + + + V++ + Q + +L RP E+ D ML C
Sbjct: 231 YGKQPW-FQLSN-TEVIECITQGR--------VLERPRVCPKEVYDVMLG-------CWQ 273
Query: 969 ASPDERPTMKDVAAMLKEIKH 989
P +R +K++ +L +
Sbjct: 274 REPQQRLNIKEIYKILHALGK 294
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 78/315 (24%), Positives = 119/315 (37%), Gaps = 57/315 (18%)
Query: 704 KCLVDANVIGKGCSGVVYRADMD-----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSF 758
+ L + +GKG G V D G ++AVK+L + + F
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-----------QRDF 71
Query: 759 SAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMY--DYMPNGSLGSLLHERTGNALEWELR- 815
EI+ L ++ IV++ G + + L +Y+P+G L L L
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 816 --YQILLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFA 872
QI +G+ YL C VHRD+ A NIL+ E IADFGLAKL+
Sbjct: 132 YSSQI----CKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK-- 181
Query: 873 RSSNTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGS 926
V G APE + +SDV+S+GVV+ E+ T + P+
Sbjct: 182 --DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239
Query: 927 HVVDWVRQKKGIQVLDPSL-----LSRPE---SEIDE-MLQALGVALLCVNASPDERPTM 977
+ ++L+ L L P +E+ E M C SP +RP+
Sbjct: 240 MMGCERDVPALSRLLE-LLEEGQRLPAPPACPAEVHELMKL-------CWAPSPQDRPSF 291
Query: 978 KDVAAMLKEIKHERE 992
+ L +
Sbjct: 292 SALGPQLDMLWSGSR 306
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 83/311 (26%), Positives = 132/311 (42%), Gaps = 60/311 (19%)
Query: 710 NVIGKGCSGVVYRADMD-----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
+GKG G V D GEV+AVKKL +T F EI+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-----------LRDFEREIEI 95
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLM--YDYMPNGSLGSLLHERTGNALEWELR---YQIL 819
L S++H NIV++ G C++ R L +Y+P GSL L + +L QI
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI- 154
Query: 820 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV-DDGDFARSSNT 877
+G+ YL +HRD+ NIL+ E I DFGL K++ D ++ +
Sbjct: 155 ---CKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK---- 203
Query: 878 VAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932
G APE K + SDV+S+GVV+ E+ T + + ++
Sbjct: 204 -VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
Query: 933 R--QKKGIQVLDPSL-----LSRPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVA 981
+ Q +++ L L RP+ EI M + C N + ++RP+ +D+A
Sbjct: 263 KQGQMIVFHLIE-LLKNNGRLPRPDGCPDEIYMIMTE-------CWNNNVNQRPSFRDLA 314
Query: 982 AMLKEIKHERE 992
+ +I+ +
Sbjct: 315 LRVDQIRDQMA 325
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 69/299 (23%), Positives = 119/299 (39%), Gaps = 59/299 (19%)
Query: 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
L IG G G+V+ N + +A+K + M+ + F E +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------------EEDFIEEAE 55
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
+ + H +V+ G C + L+ ++M +G L L + G L + L
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVC 114
Query: 824 QGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
+G+AYL ++HRD+ A N L+G ++DFG+ + V D + S+
Sbjct: 115 EGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG----- 164
Query: 882 YGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWV 932
+PE + + + KSDV+S+GV++ EV + GK P S VV+ +
Sbjct: 165 -TKFPVKWASPEVFSFS---RYSSKSDVWSFGVLMWEVFSEGKIPY-ENRS-NSEVVEDI 218
Query: 933 RQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
G + L +P + + M C P++RP + L EI
Sbjct: 219 ST--GFR------LYKPRLASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAEI 262
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 84/306 (27%), Positives = 130/306 (42%), Gaps = 60/306 (19%)
Query: 710 NVIGKGCSGVVYRADMD-----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
+GKG G V D GEV+AVKKL +T F EI+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-----------LRDFEREIEI 64
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMY--DYMPNGSLGSLLHERTGNALEWELR---YQIL 819
L S++H NIV++ G C++ R L +Y+P GSL L + +L QI
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI- 123
Query: 820 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV-DDGDFARSSNT 877
+G+ YL +HRD+ NIL+ E I DFGL K++ D +F +
Sbjct: 124 ---CKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 878 VAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932
G APE K + SDV+S+GVV+ E+ T + + ++
Sbjct: 177 -----GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 933 R--QKKGIQVLDPSL-----LSRPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVA 981
+ Q +++ L L RP+ EI M + C N + ++RP+ +D+A
Sbjct: 232 KQGQMIVFHLIE-LLKNNGRLPRPDGCPDEIYMIMTE-------CWNNNVNQRPSFRDLA 283
Query: 982 AMLKEI 987
+ +I
Sbjct: 284 LRVDQI 289
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 79/318 (24%), Positives = 128/318 (40%), Gaps = 61/318 (19%)
Query: 704 KCLVDANVIGKGCSGVVYRA---DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
+ VIG+G G VY D D ++ AVK L N +D F
Sbjct: 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--------NRITDIGE--VSQFL 138
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNRLLM-YDYMPNGSLGSLLHERTGNALEWELRYQI 818
E + H N++ LG C L+ YM +G L + + T N +L
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGF 197
Query: 819 LLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSN 876
L A+G+ +L VHRD+ A N ++ +F +ADFGLA+ + D +F
Sbjct: 198 GLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS--- 249
Query: 877 TVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSH 927
+ + A E K T KSDV+S+GV++ E++T G P P + +
Sbjct: 250 VHNKTGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVLLWELMTRGAPPY-PDV-NTFD 304
Query: 928 VVDWVRQKKGIQVLDPSLLSRPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVAAM 983
+ ++ Q + L +PE + E ML+ C + + RP+ ++ +
Sbjct: 305 ITVYLLQGR--------RLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSR 349
Query: 984 LKEI--KHEREEYAKVDM 999
+ I E Y V+
Sbjct: 350 ISAIFSTFIGEHYVHVNA 367
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 74/293 (25%), Positives = 116/293 (39%), Gaps = 57/293 (19%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IGKG G V D +V AVK + +F AE + +R
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKV-AVKCIKNDAT-------------AQAFLAEASVMTQLR 244
Query: 770 HKNIVRFLGCCWNRNNRLLM-YDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
H N+V+ LG L + +YM GSL L R + L + + L + + Y
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 829 L-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI-- 885
L ++ V HRD+ A N+L+ + ++DFGL K G +
Sbjct: 305 LEGNNFV----HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----------DTGKLPV 350
Query: 886 ---APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941
APE K + KSDV+S+G+++ E+ + G+ P P IP VV V +KG +
Sbjct: 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPL-KDVVPRV--EKGYK-- 404
Query: 942 DPSLLSRPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
+ P+ + + M C + RPT + L+ I+
Sbjct: 405 ----MDAPDGCPPAVYDVMKN-------CWHLDAATRPTFLQLREQLEHIRTH 446
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 69/302 (22%), Positives = 122/302 (40%), Gaps = 59/302 (19%)
Query: 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
K L +G G GVV +A+K + +M+ D F E K
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------------EDEFIEEAK 71
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
+ ++ H+ +V+ G C + ++ +YM NG L + L E +L ++
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVC 130
Query: 824 QGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGS 881
+ + YL +HRD+ A N L+ + ++DFGL++ V D ++ S
Sbjct: 131 EAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG----- 180
Query: 882 YGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWV 932
PE Y K + KSD++++GV++ E+ + GK P S + +
Sbjct: 181 -SKFPVRWSPPEVLMYS---KFSSKSDIWAFGVLMWEIYSLGKMPY-ERFT-NSETAEHI 234
Query: 933 RQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988
Q G++ L RP ++ M C + DERPT K + + + ++
Sbjct: 235 AQ--GLR------LYRPHLASEKVYTIMYS-------CWHEKADERPTFKILLSNILDVM 279
Query: 989 HE 990
E
Sbjct: 280 DE 281
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 74/309 (23%), Positives = 120/309 (38%), Gaps = 55/309 (17%)
Query: 705 CLVDANVIGKGCSGVVYRA---DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSA 760
VIGKG GVVY D + A+K L + ++ + ++F
Sbjct: 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--------SRITEMQQ--VEAFLR 71
Query: 761 EIKTLGSIRHKNIVRFLGCCWNRNNRLLM-YDYMPNGSLGSLLHERTGNALEWELRYQIL 819
E + + H N++ +G + YM +G L + N +L
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFG 130
Query: 820 LGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT 877
L A+G+ YL VHRD+ A N ++ F +ADFGLA+ + D ++
Sbjct: 131 LQVARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185
Query: 878 VAGSY--GYIAPE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDW 931
+ A E + T KSDV+S+GV++ E+LT G P I D + +
Sbjct: 186 RHARLPVKWTALESLQTY---RFTTKSDVWSFGVLLWELLTRGAPPY-RHI-DPFDLTHF 240
Query: 932 VRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+ Q + L +PE + M Q C A P RPT + + +++I
Sbjct: 241 LAQGR--------RLPQPEYCPDSLYQVMQQ-------CWEADPAVRPTFRVLVGEVEQI 285
Query: 988 KH--EREEY 994
+ Y
Sbjct: 286 VSALLGDHY 294
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 69/321 (21%), Positives = 121/321 (37%), Gaps = 75/321 (23%)
Query: 704 KCLVDANVIGKGCSGVVYRADMDNGE------VIAVKKLWPTTMAAANGCSDEKSGVRDS 757
+ +G+ G VY+ + +A+K L R+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL----------REE 58
Query: 758 FSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY- 816
F E ++H N+V LG +++ Y +G L L R+ ++
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 817 -------------QILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861
++ A G+ YL HH +VH+D+ N+L+ + I+D G
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLG 173
Query: 862 LAKLVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT 913
L + V D+ + + APE YG K + SD++SYGVV+ EV +
Sbjct: 174 LFREVYAADYYK-----LLGNSLLPIRWMAPEAIMYG---KFSIDSDIWSYGVVLWEVFS 225
Query: 914 -GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVN 968
G QP + VV+ +R ++ +L P+ + + M++ C N
Sbjct: 226 YGLQPY-CGYSN-QDVVEMIRNRQ--------VLPCPDDCPAWVYALMIE-------CWN 268
Query: 969 ASPDERPTMKDVAAMLKEIKH 989
P RP KD+ + L+ +
Sbjct: 269 EFPSRRPRFKDIHSRLRAWGN 289
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 78/311 (25%), Positives = 124/311 (39%), Gaps = 56/311 (18%)
Query: 710 NVIGKGCSGVVYRADMDN-----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
+G+G G V D GE++AVK L R + EI
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH----------RSGWKQEIDI 86
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLM--YDYMPNGSLGSLLHERTGNALE-WELRYQILLG 821
L ++ H++I+++ GCC + L +Y+P GSL L + + QI
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI--- 143
Query: 822 AAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV-DDGDFARSSNTVA 879
+G+AYLH +HRD+ A N+L+ + I DFGLAK V + ++ R
Sbjct: 144 -CEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-----V 193
Query: 880 GSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVR 933
G APE K SDV+S+GV + E+LT P +
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253
Query: 934 QKKGIQVLDPSL-----LSRPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVAAML 984
Q +++ + L L RP+ +E+ M C RPT +++ +L
Sbjct: 254 QMTVLRLTE-LLERGERLPRPDKCPAEVYHLMKN-------CWETEASFRPTFENLIPIL 305
Query: 985 KEIKHEREEYA 995
K + + + A
Sbjct: 306 KTVHEKYQGQA 316
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-35
Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 41/281 (14%)
Query: 711 VIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL-GSIR 769
V+G G G + M + +AVK++ P + A E++ L S
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA--------------DREVQLLRESDE 76
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H N++R+ +R + + + +L + ++ L E +L GLA+L
Sbjct: 77 HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHL 134
Query: 830 H-HDCVPPIVHRDIKANNILIGLEFEPY-----IADFGLAKLVDDGDFARSS-NTVAGSY 882
H + IVHRD+K +NILI + I+DFGL K + G + S + V G+
Sbjct: 135 HSLN----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 883 GYIAPEY---GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939
G+IAPE T D++S G V V++ P G + G
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSLQRQANILLGAC 245
Query: 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
LD PE D + + L ++ ++ P +RP+ K V
Sbjct: 246 SLDC---LHPEKHEDVIARELIEKMIAMD--PQKRPSAKHV 281
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-35
Identities = 63/309 (20%), Positives = 120/309 (38%), Gaps = 24/309 (7%)
Query: 219 LEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVS 278
L + L +P+++ ++D N ++ L L ++ +N +S
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 279 GSIPAN-LANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPS-TLASC 336
I A L +L L NQ+ +P M L +N++ +
Sbjct: 90 -KISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 337 SNLQALDLSHNSLTAS-VPAGLFQ-LQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394
+ + ++L N L +S + G FQ ++ L+ + + +I+ +IP G SL L +
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDG 201
Query: 395 NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLS 454
N+I + + GL L L LS N +S + + L+ + L++N L +P L+
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260
Query: 455 SLSGLQVLDVSDNRFSG------QIPASLGRLVSLNKIILSKN-LFSGPIPSSLGLC-SS 506
+QV+ + +N S P + S + + L N + I S C
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320
Query: 507 LQLLDLSSN 515
+ L +
Sbjct: 321 RAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 60/315 (19%), Positives = 120/315 (38%), Gaps = 35/315 (11%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
+P +L + L L N+I+ + + L L N++ P A L
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 340 QALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRI- 397
+ L LS N L +P + + L +L + N+I+ + + + ++ + +G N +
Sbjct: 103 ERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
Query: 398 -AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSL 456
+G+ G+K L+++ ++ ++ ++P G L + L N + SL L
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGL 215
Query: 457 SGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQ 516
+ L L +S N S SL L ++ L+ N +P L +Q++ L +N
Sbjct: 216 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNN 274
Query: 517 LTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE-GNLNPLA- 574
++ I N C P + S + L N ++ + P
Sbjct: 275 IS-------------AIGSNDFCP------PGYNTKKASYSGVSLFSNPVQYWEIQPSTF 315
Query: 575 -QLDNLVSLNISYNK 588
+ ++ + K
Sbjct: 316 RCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 58/360 (16%), Positives = 115/360 (31%), Gaps = 80/360 (22%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+P +L L + + +T D + L L +N + P + L LE
Sbjct: 46 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAE-LGRLSNLEEMRAGGNKDIV 134
L L+ NQL ++P ++ K+L++L + +N + + L+ + + G N
Sbjct: 104 RLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKS 159
Query: 135 GKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSE 194
I + + KL +
Sbjct: 160 SGIE-----------------------NGAFQGMKKLSYIR------------------- 177
Query: 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEI-GNCTSLKMIDFSLNSL 253
+ + +++ +IP G L EL L N + + +L + S NS+
Sbjct: 178 -----IADTNIT-TIPQ--GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSI 228
Query: 254 SGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLS 313
S S+ L E +++N + +P LA+ + + L N IS +
Sbjct: 229 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS------- 280
Query: 314 KLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTA-SVPAGLFQ-LQNLTKLLLISN 371
F P ++ + L N + + F+ + + L +
Sbjct: 281 --NDF---------CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 29/111 (26%), Positives = 46/111 (41%), Gaps = 10/111 (9%)
Query: 504 CS-SLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLS 562
C L+++ S L VP +L + L+L N +T L L L L
Sbjct: 29 CQCHLRVVQCSDLGLE-KVPKDLP--PDTAL-LDLQNNKITEIKDGDFKNLKNLHTLILI 84
Query: 563 HNKLEGNLNP--LAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNE 611
+NK+ ++P A L L L +S N+ LP+ + + L + NE
Sbjct: 85 NNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEK-MPKTLQELRVHENE 132
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 76/300 (25%), Positives = 122/300 (40%), Gaps = 65/300 (21%)
Query: 710 NVIGKGCSGVVYRA---DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+IG G SG V +V +A+K L R F +E +
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ----------RRDFLSEASIM 104
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
G H NI+R G +++ +YM NGSL + L G +L +L G G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-VGMLRGVGAG 163
Query: 826 LAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV-DDGDFARSSNTVAGSY 882
+ YL VHRD+ A N+L+ ++DFGL++++ DD D A ++ +
Sbjct: 164 MRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT-----TG 213
Query: 883 GYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVR 933
G I APE + + SDV+S+GVV+ EVL G++P + V+ V
Sbjct: 214 GKIPIRWTAPEAIAFR---TFSSASDVWSFGVVMWEVLAYGERPY-WNM-TNRDVISSVE 268
Query: 934 QKKGIQVLDPSLLSRPES------EIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+ G + L P ++ ML C + +RP + ++L +
Sbjct: 269 E--GYR------LPAPMGCPHALHQL--MLD-------CWHKDRAQRPRFSQIVSVLDAL 311
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 75/297 (25%), Positives = 118/297 (39%), Gaps = 58/297 (19%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IGKG G V D +V AVK + +F AE + +R
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKV-AVKCIKNDAT-------------AQAFLAEASVMTQLR 72
Query: 770 HKNIVRFLGCCWNRNNRLLM-YDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
H N+V+ LG L + +YM GSL L R + L + + L + + Y
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 829 L-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI-- 885
L ++ VHRD+ A N+L+ + ++DFGL K G +
Sbjct: 133 LEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----------DTGKLPV 178
Query: 886 ---APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941
APE K + KSDV+S+G+++ E+ + G+ P P IP VV V +KG +
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIP-LKDVVPRV--EKGYK-- 232
Query: 942 DPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEY 994
+ P+ + + M C + RP+ + L+ IK E +
Sbjct: 233 ----MDAPDGCPPAVYEVMKN-------CWHLDAAMRPSFLQLREQLEHIKTH-ELH 277
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 75/330 (22%), Positives = 125/330 (37%), Gaps = 76/330 (23%)
Query: 710 NVIGKGCSGVVYRADMDNGEV---IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
+VIG+G G V +A + + A+K++ F+ E++ L
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----------HRDFAGELEVLC 80
Query: 767 SI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY--------- 816
+ H NI+ LG C +R L +Y P+G+L L + +
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 817 -----QILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG 869
A+G+ YL +HRD+ A NIL+G + IADFGL++
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR---GQ 192
Query: 870 DFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDP 920
+ + G + A E Y T SDV+SYGV++ E+++ G P
Sbjct: 193 EVYV-----KKTMGRLPVRWMAIESLNYS---VYTTNSDVWSYGVLLWEIVSLGGTPY-C 243
Query: 921 TIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEIDE-MLQALGVALLCVNASPDERPT 976
+ + + + + Q L +P E+ + M Q C P ERP+
Sbjct: 244 GMT-CAELYEKLPQGY--------RLEKPLNCDDEVYDLMRQ-------CWREKPYERPS 287
Query: 977 MKDVAAMLKEIKHEREEYAKVDMLLKGSPA 1006
+ L + ER+ Y + K + A
Sbjct: 288 FAQILVSLNRMLEERKTYVNTTLYEKFTYA 317
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 61/307 (19%), Positives = 114/307 (37%), Gaps = 68/307 (22%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+IG G G V++A +G+ +K++ A E+K L +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER---------------EVKALAKL 61
Query: 769 RHKNIVRFLGC---------------CWNRNNRL--LMYDYMPNGSLGSLLHERTGNALE 811
H NIV + GC ++ L M ++ G+L + +R G L+
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM-EFCDKGTLEQWIEKRRGEKLD 120
Query: 812 ----WELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867
EL QI G + Y+H +++RD+K +NI + + I DFGL +
Sbjct: 121 KVLALELFEQITKG----VDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173
Query: 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSH 927
+ G+ Y++PE ++ D+Y+ G+++ E+L + S
Sbjct: 174 NDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----AFETSK 226
Query: 928 VVDWVRQKKGIQVLDPSLLSRPESE-IDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
+R + + E + ++L P++RP ++ L
Sbjct: 227 FFTDLRDGI-----ISDIFDKKEKTLLQKLLS----------KKPEDRPNTSEILRTLTV 271
Query: 987 IKHEREE 993
K E+
Sbjct: 272 WKKSPEK 278
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 72/302 (23%), Positives = 123/302 (40%), Gaps = 56/302 (18%)
Query: 710 NVIGKGCSGVVYRA----DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
V+G G G VY+ + + ++ +A+K+L T A E
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----------NKEILDEAYV 70
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
+ S+ + ++ R LG C +L+ MP G L + E N + + + A+
Sbjct: 71 MASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAK 128
Query: 825 GLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
G+ YL +VHRD+ A N+L+ I DFGLAKL+ + +
Sbjct: 129 GMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-----EG 178
Query: 883 GYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKK 936
G + A E T +SDV+SYGV V E++T G +P IP S + + +K
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-DGIP-ASEISSIL--EK 234
Query: 937 GIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992
G + L +P ++ M++ C D RP +++ ++ + +
Sbjct: 235 GER------LPQPPICTIDVYMIMVK-------CWMIDADSRPKFRELIIEFSKMARDPQ 281
Query: 993 EY 994
Y
Sbjct: 282 RY 283
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-34
Identities = 55/300 (18%), Positives = 101/300 (33%), Gaps = 30/300 (10%)
Query: 323 NQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIG 382
+ S + N + + L + ++L L ++S S+P +
Sbjct: 23 SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLP 79
Query: 383 NCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442
+ L + N + L P L+ L D NRLS ++P+ L D+ +
Sbjct: 80 --PQITVLEITQNALISL-PELPASLEYL---DACDNRLS-TLPELPASLKHL---DVDN 129
Query: 443 NTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLG 502
N L LP + L + ++ +N+ + +P L L+ + N + +P
Sbjct: 130 NQLT-MLPELPALL---EYINADNNQLT-MLPELPTSLEVLS---VRNNQLTF-LPELPE 180
Query: 503 LCSSLQLLDLSSNQLTGSVPMELGQIEALE---IALNLSCNGLTGPIPAQISALNKLSIL 559
SL+ LD+S+N L S+P + E I N +T IP I +L+ +
Sbjct: 181 ---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTI 235
Query: 560 DLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKD 619
L N L + + + D + + D
Sbjct: 236 ILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSD 295
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 4e-32
Identities = 70/384 (18%), Positives = 132/384 (34%), Gaps = 49/384 (12%)
Query: 208 SIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC----TSLKMIDFSLNSLSGTIPLSIGG 263
SI I L + + N++ + + + + N + +
Sbjct: 2 SIMLPINNNFSLSQN-SFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECL-- 57
Query: 264 LSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQN 323
+++ E ++ N+S S+P NL + L++ N + L P L L N
Sbjct: 58 INQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALISL-PELPASLEYLDACD---N 110
Query: 324 QLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGN 383
+L ++P ++L+ LD+ +N LT +P L + +N ++ +P +
Sbjct: 111 RLS-TLPELP---ASLKHLDVDNNQLT-MLPE---LPALLEYINADNNQLT-MLPELPTS 161
Query: 384 CSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQ----MID 439
L L V NN++ L P L+ L D+S+N L S+P +
Sbjct: 162 ---LEVLSVRNNQLTFL-PELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFR 213
Query: 440 LSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPS 499
N + +P ++ SL + + DN S +I SL + + + FS
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
Query: 500 SLGLCSSLQLLDLSSNQLTGSVPMELGQ----IEALEIALNLSCNGLTGPIPAQISALNK 555
L D + + ++ Q E E A S ++S
Sbjct: 273 Q--NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAF------LDRLSDTVS 324
Query: 556 LSILDLSHNKLEGNLNPLAQLDNL 579
++ L L+ L
Sbjct: 325 ARNTSGFREQVAAWLEKLSASAEL 348
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 69/438 (15%), Positives = 140/438 (31%), Gaps = 45/438 (10%)
Query: 10 VPLQLPI--PTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSS 67
+ + LPI +LS T+ + + + N V L
Sbjct: 1 MSIMLPINNNFSLSQNSFYNTI----SGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC 56
Query: 68 LGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRA 127
L ++ EL LN L+ +P L + L + NAL ++P L L+ A
Sbjct: 57 L--INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNAL-ISLPELPASLEYLD---A 107
Query: 128 GGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPA 187
N+ + +P ++ L + + Q++ LP L+ ++ ++ +P
Sbjct: 108 CDNR--LSTLPELPA---SLKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPE 157
Query: 188 EIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMID 247
+ L L + N L+ +P LE L + N L ++P + +
Sbjct: 158 LPTS---LEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETE 209
Query: 248 FSL----NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISG 303
N ++ IP +I L ++ DN +S I +L+ T S
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268
Query: 304 LIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNL 363
+ + A + S ++ + + N+ + + L +
Sbjct: 269 SDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSA 325
Query: 364 TKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG 423
++ + S+ LR + +A L + +L L
Sbjct: 326 RNTSGFREQVAAWLE----KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVH 381
Query: 424 SVPDEIGDCTELQMIDLS 441
+ + D ++ L
Sbjct: 382 QASEGLFDNDTGALLSLG 399
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 8e-21
Identities = 59/369 (15%), Positives = 124/369 (33%), Gaps = 46/369 (12%)
Query: 23 FKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSN 82
L ++ NL+ S+P ++ + VL+ + N L+ +LP +LE L N
Sbjct: 58 INQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPA---SLEYLDACDN 110
Query: 83 QLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRL-----------------SNLEEM 125
+L+ +P ++ K L + +N L +P L ++LE +
Sbjct: 111 RLS-TLPELPASLKHLD---VDNNQLT-MLPELPALLEYINADNNQLTMLPELPTSLEVL 165
Query: 126 RAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMIS--- 182
N+ + +P ++ AL ++ + SLPA + + I+
Sbjct: 166 SVRNNQ--LTFLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI 219
Query: 183 GEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTS 242
IP I + ++ L +N LS I + + + + ++ + N
Sbjct: 220 THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLH 277
Query: 243 LKMIDFSLNSLSGTIPLSIGGL-SELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQI 301
+ D + + E N + L++ + Q+
Sbjct: 278 RPLADAVTAWFPENKQSDVSQIWHAFEH--EEHANTFSAFLDRLSDTVSARNTSGFREQV 335
Query: 302 SGLIPPEIGMLSKL-TVFFAWQNQLEGSIPSTLASC-SNLQALDLSHNSLTASVPAGLFQ 359
+ ++ ++L FA S +A +NL+ L H +
Sbjct: 336 AAW-LEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGA 394
Query: 360 LQNLTKLLL 368
L +L + +
Sbjct: 395 LLSLGREMF 403
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 73/318 (22%), Positives = 132/318 (41%), Gaps = 66/318 (20%)
Query: 704 KCLVDANVIGKGCSGVVYRA----DMDNGEV-IAVK--KLWPTTMAAANGCSDEKSGVRD 756
L V+G G G V++ + ++ ++ + +K + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS------------FQ 60
Query: 757 SFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY 816
+ + + +GS+ H +IVR LG C + +L+ Y+P GSL + + G L
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 817 QILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDF 871
+ A+G+ YL H +VHR++ A N+L+ P +ADFG+A L+ D
Sbjct: 120 -WGVQIAKGMYYLEEHG-----MVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDK 170
Query: 872 ARSSNTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDG 925
S A E + K T +SDV+SYGV V E++T G +P +
Sbjct: 171 QLLY-----SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY-AGLR-L 223
Query: 926 SHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERPTMKDVA 981
+ V D + + G + L++P+ ++ M++ C + RPT K++A
Sbjct: 224 AEVPDLLEK--GER------LAQPQICTIDVYMVMVK-------CWMIDENIRPTFKELA 268
Query: 982 AMLKEIKHEREEYAKVDM 999
+ + Y +
Sbjct: 269 NEFTRMARDPPRYLVIKR 286
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 68/324 (20%), Positives = 123/324 (37%), Gaps = 68/324 (20%)
Query: 704 KCLVDANVIGKGCSGVVYRA---DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
+ ++GKG G V A D V +AVK L +A+++ + F
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD---------IEEFL 73
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYD------YMPNGSLGSLLHERTGNALEWE 813
E + H ++ + +G + + +M +G L + L +
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 814 LRYQILLG----AAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867
L Q L+ A G+ YL + +HRD+ A N ++ + +ADFGL++ +
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188
Query: 868 DGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 918
GD+ R G + A E T SDV+++GV + E++T G+ P
Sbjct: 189 SGDYYR-----QGCASKLPVKWLALESLADN---LYTVHSDVWAFGVTMWEIMTRGQTPY 240
Query: 919 DPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDER 974
I + + + +++ L +P E+ D M Q C +A P +R
Sbjct: 241 -AGI-ENAEIYNYLIGGN--------RLKQPPECMEEVYDLMYQ-------CWSADPKQR 283
Query: 975 PTMKDVAAMLKEIKHEREEYAKVD 998
P+ + L+ I +
Sbjct: 284 PSFTCLRMELENILGHLSVLSTSQ 307
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 69/358 (19%), Positives = 129/358 (36%), Gaps = 62/358 (17%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG G S V++ + ++ A+K + + + DS+ EI L ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYV---------NLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 770 HKN--IVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQ 824
+ I+R + M N L S L ++ + WE + +L +
Sbjct: 66 QHSDKIIRLYDYEITDQY-IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNML----E 119
Query: 825 GLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
+ +H H IVH D+K N LI + + DFG+A + + ++ G+
Sbjct: 120 AVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 884 YIAPE-----------YGYMMKITEKSDVYSYGVVVLEVLTGKQP---IDPTIPDGSHVV 929
Y+ PE KI+ KSDV+S G ++ + GK P I I ++
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234
Query: 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989
++ P + + D + L + P +R ++ ++ + H
Sbjct: 235 -----DPNHEIEFPDIPE--KDLQDVLKC-----CLKRD--PKQRISIPEL------LAH 274
Query: 990 E--REEYAKVDMLLKGSPAAANVQENKNSSGVLATSSSKPAVTLHPKSNNTSFSASSL 1045
+ + V+ + KG+ + S K A TL+ + SS
Sbjct: 275 PYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 332
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 71/337 (21%), Positives = 116/337 (34%), Gaps = 70/337 (20%)
Query: 705 CLVDANVIGKGCSGVVYRA---DMDNGE---VIAVKKLWPTTMAAANGCSDEKSGVRDSF 758
+ +G G G VY M N +AVK L F
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD----------ELDF 80
Query: 759 SAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE-LRYQ 817
E + H+NIVR +G R ++ + M G L S L E + L
Sbjct: 81 LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 818 ILLG----AAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDD 868
LL A G YL +H +HRDI A N L+ I DFG+A+ +
Sbjct: 141 DLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
Query: 869 GDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 919
+ R G + PE G T K+D +S+GV++ E+ + G P
Sbjct: 196 ASYYRK-----GGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLGYMPY- 246
Query: 920 PTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERP 975
P+ + V+++V + P+ + M Q C P++RP
Sbjct: 247 PSKSN-QEVLEFVTSGG--------RMDPPKNCPGPVYRIMTQ-------CWQHQPEDRP 290
Query: 976 TMKDVAAMLKEIKHEREEYAKVDMLLKGSPAAANVQE 1012
+ ++ + + + ++ P ++
Sbjct: 291 NFAIILERIEYCTQD-PDVINTALPIEYGPLVEEEEK 326
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 69/310 (22%), Positives = 117/310 (37%), Gaps = 64/310 (20%)
Query: 704 KCLVDANVIGKGCSGVVYRA---DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
+ + IG+G G V++ +N + +A+K T VR+ F
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS----------DSVREKFL 64
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQIL 819
E T+ H +IV+ +G N ++ + G L S L R + L
Sbjct: 65 QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASL-ILYA 122
Query: 820 LGAAQGLAYL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTV 878
+ LAYL V HRDI A N+L+ + DFGL++ ++D + ++S
Sbjct: 123 YQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-- 176
Query: 879 AGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVV 929
G + APE + + T SDV+ +GV + E+L G +P + + V+
Sbjct: 177 ----GKLPIKWMAPESINFR---RFTSASDVWMFGVCMWEILMHGVKPF-QGVK-NNDVI 227
Query: 930 DWVRQKKGIQVLDPSLLSRPES------EIDEMLQALGVALLCVNASPDERPTMKDVAAM 983
+ + L P + + M + C P RP ++ A
Sbjct: 228 GRIENGE--------RLPMPPNCPPTLYSL--MTK-------CWAYDPSRRPRFTELKAQ 270
Query: 984 LKEIKHEREE 993
L I E +
Sbjct: 271 LSTILEEEKA 280
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 61/301 (20%), Positives = 113/301 (37%), Gaps = 48/301 (15%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G+G V + +G A+K++ C +++ R+ E
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRI---------LCHEQQD--REEAQREADMHRLFN 84
Query: 770 HKNIVRFLGCCWNRNNR-----LLMYDYMPNGSLGSLLHERTGNAL---EWELRYQILLG 821
H NI+R + C LL+ + G+L + + E ++ +LLG
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLL-PFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLG 142
Query: 822 AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSN----- 876
+GL +H HRD+K NIL+G E +P + D G
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 877 --TVAGSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930
+ Y APE + + I E++DV+S G V+ ++ G+ P D G V
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA- 257
Query: 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
+ + + + S L L +++ V+ P +RP + + + L+ ++
Sbjct: 258 -LAVQNQLSIPQSPRHSSA-------LWQLLNSMMTVD--PHQRPHIPLLLSQLEALQPP 307
Query: 991 R 991
Sbjct: 308 A 308
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 70/316 (22%), Positives = 121/316 (38%), Gaps = 69/316 (21%)
Query: 704 KCLVDANVIGKGCSGVVYRA-----DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDS 757
+ + + +G+G G+VY D E +A+K + R
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE----------RIE 74
Query: 758 FSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER----TGNALEWE 813
F E + ++VR LG L++ + M G L S L N +
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 814 LRYQILLG----AAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867
++ A G+AYL + VHRD+ A N ++ +F I DFG+ + +
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 868 DGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 918
+ D+ R G G + +PE G T SDV+S+GVV+ E+ T +QP
Sbjct: 190 ETDYYR-----KGGKGLLPVRWMSPESLKDG---VFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 919 DPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDER 974
+ + V+ +V + LL +P+ + + M C +P R
Sbjct: 242 -QGLSN-EQVLRFVMEGG--------LLDKPDNCPDMLFELMRM-------CWQYNPKMR 284
Query: 975 PTMKDVAAMLKEIKHE 990
P+ ++ + +KE
Sbjct: 285 PSFLEIISSIKEEMEP 300
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 78/331 (23%), Positives = 123/331 (37%), Gaps = 83/331 (25%)
Query: 710 NVIGKGCSGVVYRA---DMDNGE---VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
IG+G G V++A + E ++AVK L A + F E
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM----------QADFQREAA 102
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY------- 816
+ + NIV+ LG C L+++YM G L L + + +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 817 ---------------QILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIAD 859
I A G+AYL VHRD+ N L+G IAD
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIAD 217
Query: 860 FGLAKLVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEV 911
FGL++ + D+ + A I PE Y + T +SDV++YGVV+ E+
Sbjct: 218 FGLSRNIYSADYYK-----ADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEI 269
Query: 912 LT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLC 966
+ G QP + V+ +VR +L+ PE E+ + M C
Sbjct: 270 FSYGLQPY-YGMAH-EEVIYYVRDGN--------ILACPENCPLELYNLMRL-------C 312
Query: 967 VNASPDERPTMKDVAAMLKEIKHEREEYAKV 997
+ P +RP+ + +L+ + E V
Sbjct: 313 WSKLPADRPSFCSIHRILQRMCERAEGTVGV 343
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 67/314 (21%), Positives = 123/314 (39%), Gaps = 66/314 (21%)
Query: 704 KCLVDANVIGKGCSGVVYRA--DMDNGEVI--AVKKLWPTTMAAANGCSDEKSGVRDSFS 759
+ +V ++G+G G VY GE I AVK ++ F
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN----------KEKFM 61
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQIL 819
+E + ++ H +IV+ +G ++ + P G LG L + L
Sbjct: 62 SEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYS 119
Query: 820 LGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT 877
L + +AYL + VHRDI NIL+ + DFGL++ ++D D+ ++S
Sbjct: 120 LQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV- 173
Query: 878 VAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHV 928
+ +PE + + T SDV+ + V + E+L+ GKQP + + V
Sbjct: 174 -----TRLPIKWMSPESINFR---RFTTASDVWMFAVCMWEILSFGKQPF-FWL-ENKDV 223
Query: 929 VDWVRQKKGIQVLDPSLLSRPES------EIDEMLQALGVALLCVNASPDERPTMKDVAA 982
+ + + G L +P+ + M + C + P +RP ++
Sbjct: 224 IGVLEK--GD------RLPKPDLCPPVLYTL--MTR-------CWDYDPSDRPRFTELVC 266
Query: 983 MLKEIKHEREEYAK 996
L ++ ++ A
Sbjct: 267 SLSDVYQMEKDIAM 280
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 72/323 (22%), Positives = 124/323 (38%), Gaps = 77/323 (23%)
Query: 710 NVIGKGCSGVVYRA---DMDNGE---VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
+G G G V A + + +AVK L P+ R++ +E+K
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE----------REALMSELK 78
Query: 764 TLGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGA 822
L + H NIV LG C L++ +Y G L + L + + + + I+
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 823 ----------------AQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
A+G+A+L + +HRD+ A NIL+ I DFGLA+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 865 LVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GK 915
+ + + APE T +SDV+SYG+ + E+ + G
Sbjct: 194 DIKNDSNYV-----VKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGS 245
Query: 916 QPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEIDE-MLQALGVALLCVNASP 971
P P +P S +++ + PE +E+ + M C +A P
Sbjct: 246 SPY-PGMPVDSKFYKMIKEGF--------RMLSPEHAPAEMYDIMKT-------CWDADP 289
Query: 972 DERPTMKDVAAMLKEIKHEREEY 994
+RPT K + ++++ E +
Sbjct: 290 LKRPTFKQIVQLIEKQISESTNH 312
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 51/281 (18%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+GKG VYRA + G +A+K + M K+G+ E+K ++H
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--------YKAGMVQRVQNEVKIHCQLKH 70
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGLA 827
+I+ + N L+ + NG + L R E E R+ QI G+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI----ITGML 126
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
YLH + +HRD+ +N+L+ IADFGLA + T+ G+ YI+P
Sbjct: 127 YLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTPNYISP 181
Query: 888 E------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941
E +G +SDV+S G + +L G+ P D + + +
Sbjct: 182 EIATRSAHGL------ESDVWSLGCMFYTLLIGRPPFD----TDTVKNTLNKVVLADYEM 231
Query: 942 DPSLLSRPESE--IDEMLQALGVALLCVNASPDERPTMKDV 980
PS LS E++ I ++L+ N P +R ++ V
Sbjct: 232 -PSFLS-IEAKDLIHQLLR--------RN--PADRLSLSSV 260
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 80/308 (25%), Positives = 123/308 (39%), Gaps = 68/308 (22%)
Query: 711 VIGKGCSGVVYRA----DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
VIG G G VY+ EV +A+K L R F E +
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ----------RVDFLGEAGIM 100
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
G H NI+R G +++ +YM NG+L L E+ G +L +L G A G
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-VGMLRGIAAG 159
Query: 826 LAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
+ YL + VHRD+ A NIL+ ++DFGL+++++D T S G
Sbjct: 160 MKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLED----DPEATYTTSGG 210
Query: 884 YI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPD--GSHVVDWV 932
I APE Y K T SDV+S+G+V+ EV+T G++P + V+ +
Sbjct: 211 KIPIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGERP----YWELSNHEVMKAI 263
Query: 933 RQKKGIQVLDPSLLSRPES------EIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
L P ++ M+Q C RP D+ ++L +
Sbjct: 264 NDGF--------RLPTPMDCPSAIYQL--MMQ-------CWQQERARRPKFADIVSILDK 306
Query: 987 IKHEREEY 994
+ +
Sbjct: 307 LIRAPDSL 314
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 69/318 (21%), Positives = 119/318 (37%), Gaps = 67/318 (21%)
Query: 704 KCLVDANVIGKGCSGVVYRA---DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
L+ ++G+G G V D + +AVK + + + F
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE---------IEEFL 84
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYD-----YMPNGSLGSLLHERTGNALEWEL 814
+E + H N++R LG C +++ + +M G L + L +
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 815 RYQILLG----AAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868
Q LL A G+ YL + +HRD+ A N ++ + +ADFGL+K +
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199
Query: 869 GDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 919
GD+ R G + A E T KSDV+++GV + E+ T G P
Sbjct: 200 GDYYR-----QGRIAKMPVKWIAIESLADR---VYTSKSDVWAFGVTMWEIATRGMTPY- 250
Query: 920 PTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERP 975
P + + D++ L +PE E+ + M C P +RP
Sbjct: 251 PGV-QNHEMYDYLLHGH--------RLKQPEDCLDELYEIMYS-------CWRTDPLDRP 294
Query: 976 TMKDVAAMLKEIKHEREE 993
T + L+++ +
Sbjct: 295 TFSVLRLQLEKLLESLPD 312
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 68/341 (19%), Positives = 129/341 (37%), Gaps = 48/341 (14%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG+G G ++G +K++ + M K R+ E+ L +++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRM-------SSKE--REESRREVAVLANMK 81
Query: 770 HKNIVRFLGCCWNRNNRLLMY-DYMPNGSLGSLLHERTGNALE----WELRYQILLGAAQ 824
H NIV++ + N L + DY G L ++ + G + + QI L
Sbjct: 82 HPNIVQYRES-FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA--- 137
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFARSSNTVAGSYG 883
L ++H I+HRDIK+ NI + + + DFG+A+ L + A G+
Sbjct: 138 -LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA---RACIGTPY 190
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ-KKGIQVLD 942
Y++PE KSD+++ G V+ E+ T K + + + V + G
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF-----EAGSMKNLVLKIISGSFPPV 245
Query: 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKD------VAAMLKEIKHEREEYAK 996
S L++L L N P +RP++ +A +++ + +
Sbjct: 246 SLHYSYD-------LRSLVSQLFKRN--PRDRPSVNSILEKGFIAKRIEKFLSPQLIAEE 296
Query: 997 VDMLLKGSPAAANVQENKNSSGVLATSSSKPAVTLHPKSNN 1037
+ + + + +SG + S P +
Sbjct: 297 FCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKY 337
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 71/318 (22%), Positives = 111/318 (34%), Gaps = 69/318 (21%)
Query: 704 KCLVDANVIGKGCSGVVYRA---DMDNGE---VIAVKKLWPTTMAAANGCSDEKSGVRDS 757
K + +G G G VY M N +AVK L
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD----------ELD 120
Query: 758 FSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEW-ELRY 816
F E + H+NIVR +G R ++ + M G L S L E + L
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 817 QILLG----AAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVD 867
LL A G YL +H +HRDI A N L+ I DFG+A+ +
Sbjct: 181 LDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235
Query: 868 DGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 918
+ R G + PE G T K+D +S+GV++ E+ + G P
Sbjct: 236 RAGYYRK-----GGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLGYMPY 287
Query: 919 DPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDER 974
P+ + V+++V + P+ + M Q C P++R
Sbjct: 288 -PSKSN-QEVLEFVTSGG--------RMDPPKNCPGPVYRIMTQ-------CWQHQPEDR 330
Query: 975 PTMKDVAAMLKEIKHERE 992
P + ++ + +
Sbjct: 331 PNFAIILERIEYCTQDPD 348
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-33
Identities = 70/358 (19%), Positives = 130/358 (36%), Gaps = 62/358 (17%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG G S V++ + ++ A+K + + + DS+ EI L ++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYV---------NLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 770 HKN--IVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQ 824
+ I+R + M N L S L ++ + WE + +L +
Sbjct: 113 QHSDKIIRLYDYEITDQY-IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNML----E 166
Query: 825 GLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
+ +H H IVH D+K N LI + + DFG+A + + ++ G+
Sbjct: 167 AVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 884 YIAPE-----------YGYMMKITEKSDVYSYGVVVLEVLTGKQP---IDPTIPDGSHVV 929
Y+ PE KI+ KSDV+S G ++ + GK P I I ++
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989
D ++ P + + D + L + P +R ++ ++ + H
Sbjct: 282 D-----PNHEIEFPDIPE--KDLQDVLKC-----CLKRD--PKQRISIPEL------LAH 321
Query: 990 E--REEYAKVDMLLKGSPAAANVQENKNSSGVLATSSSKPAVTLHPKSNNTSFSASSL 1045
+ + V+ + KG+ + S K A TL+ + SS
Sbjct: 322 PYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 379
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 79/312 (25%), Positives = 131/312 (41%), Gaps = 57/312 (18%)
Query: 701 QVLKCLVDAN------VIGKGCSGVVYRA--DMDNGEVI--AVKKLWPTTMAAANGCSDE 750
Q L CL+ +G G GVV R D +G+ + AVK L P ++
Sbjct: 9 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE----- 63
Query: 751 KSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNAL 810
D F E+ + S+ H+N++R G +++ + P GSL L + G+ L
Sbjct: 64 ---AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFL 119
Query: 811 EWELRYQILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868
L + + A+G+ YL +HRD+ A N+L+ I DFGL + +
Sbjct: 120 LGTL-SRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173
Query: 869 GDFARSSNTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 922
D + V + + APE + SD + +GV + E+ T G++P +
Sbjct: 174 ND----DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW-IGL 228
Query: 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERPTMK 978
GS ++ + K+G + L RPE +I + M+Q C P++RPT
Sbjct: 229 N-GSQILHKI-DKEGER------LPRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFV 273
Query: 979 DVAAMLKEIKHE 990
+ L E +
Sbjct: 274 ALRDFLLEAQPT 285
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 73/337 (21%), Positives = 120/337 (35%), Gaps = 90/337 (26%)
Query: 710 NVIGKGCSGVVYRA-----DMDNGEVI-AVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
V+G G G V A + AVK L ++ R++ +E+K
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE----------REALMSELK 100
Query: 764 TLGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR------- 815
+ + H+NIV LG C L+++Y G L + L + E E+
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 816 ------------------YQILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEP 855
YQ+ A+G+ +L VHRD+ A N+L+
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQV----AKGMEFLEFKS-----CVHRDLAARNVLVTHGKVV 211
Query: 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVV 907
I DFGLA+ + + APE G T KSDV+SYG++
Sbjct: 212 KICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEG---IYTIKSDVWSYGIL 263
Query: 908 VLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEIDE-MLQALGV 962
+ E+ + G P P IP ++ ++ + +P EI M
Sbjct: 264 LWEIFSLGVNPY-PGIPVDANFYKLIQNGF--------KMDQPFYATEEIYIIMQS---- 310
Query: 963 ALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVDM 999
C +RP+ ++ + L + EE ++
Sbjct: 311 ---CWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNV 344
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 76/303 (25%), Positives = 120/303 (39%), Gaps = 59/303 (19%)
Query: 704 KCLVDANVIGKGCSGVVYRA---DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
+ V+G G G V E+ +A+K L R F
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ----------RRDFL 94
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQIL 819
E +G H NI+R G +++ +YM NGSL S L + +L +L
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-VGML 153
Query: 820 LGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV-DDGDFARSSN 876
G A G+ YL VHRD+ A NILI ++DFGL +++ DD + A ++
Sbjct: 154 RGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT- 207
Query: 877 TVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVD 930
G I +PE K T SDV+SYG+V+ EV++ G++P + V+
Sbjct: 208 ----RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-WEM-SNQDVIK 261
Query: 931 WVRQKKGIQVLDPSLLSRPES------EIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
V + L P ++ ML C + RP + + ++L
Sbjct: 262 AVDEGY--------RLPPPMDCPAALYQL--MLD-------CWQKDRNNRPKFEQIVSIL 304
Query: 985 KEI 987
++
Sbjct: 305 DKL 307
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 69/303 (22%), Positives = 109/303 (35%), Gaps = 62/303 (20%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG-SI 768
++G G SG V G +AVK++ D EIK L S
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--------------DIALMEIKLLTESD 66
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSL------GSLLHERTGNALEWELR---YQIL 819
H N++R+ + + N +L ++ E E+ QI
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY-------------IADFGLAKLV 866
G+A+LH I+HRD+K NIL+ I+DFGL K +
Sbjct: 126 ----SGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 867 DDGD--FARSSNTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
D G F + N +G+ G+ APE ++T D++S G V +L+ +
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 918 IDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM 977
P G +GI LD + + + L ++ + P +RPT
Sbjct: 239 -----PFGDKYSRESNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHD--PLKRPTA 290
Query: 978 KDV 980
V
Sbjct: 291 MKV 293
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 60/303 (19%), Positives = 109/303 (35%), Gaps = 78/303 (25%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGV----RDSFSAEIKTL 765
IG G S V++ + ++ A+K + DS+ EI L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYV-------------NLEEADNQTLDSYRNEIAYL 80
Query: 766 GSIRHKN--IVRFLGCCWNRNNRLLMYDYM--PNGSLGSLLHERTGNALEWELRY---QI 818
++ + I+R +Y M N L S L ++ + WE + +
Sbjct: 81 NKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNM 136
Query: 819 LLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT 877
L + + +H H IVH D+K N LI + + DFG+A + + ++
Sbjct: 137 L----EAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS 187
Query: 878 VAGSYGYIAPE-----------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT----- 921
G+ Y+ PE KI+ KSDV+S G ++ + GK P
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247
Query: 922 ----IPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM 977
I D +H +++ P + + D + L + P +R ++
Sbjct: 248 KLHAIIDPNHEIEF-----------PDIPE--KDLQDVLKC-----CLKRD--PKQRISI 287
Query: 978 KDV 980
++
Sbjct: 288 PEL 290
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 67/295 (22%), Positives = 117/295 (39%), Gaps = 53/295 (17%)
Query: 711 VIGKGCSGVVYRA--DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGS 767
+G G G V + M +AVK L A +D AE +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL---------KDELLAEANVMQQ 74
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLA 827
+ + IVR +G C + L+M + G L L + ++ + +++ + G+
Sbjct: 75 LDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMK 131
Query: 828 YL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
YL + VHRD+ A N+L+ + I+DFGL+K + + + A ++G
Sbjct: 132 YLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE----NYYKAQTHGKW 182
Query: 886 -----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQ 939
APE K + KSDV+S+GV++ E + G++P + GS V + + +
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMK-GSEVTAMLEKGE--- 237
Query: 940 VLDPSLLSRPE---SEI-DEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
+ P E+ D M C + RP V L+ ++
Sbjct: 238 -----RMGCPAGCPREMYDLMNL-------CWTYDVENRPGFAAVELRLRNYYYD 280
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-32
Identities = 65/325 (20%), Positives = 118/325 (36%), Gaps = 84/325 (25%)
Query: 710 NVIGKGCSGVVYRA---DMDNGE---VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
+G+G G V A +D +AVK L + + +E+K
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE----------HRALMSELK 82
Query: 764 TLGSI-RHKNIVRFLGCCWNRNNRLLM-YDYMPNGSLGSLLHERTGNALEWELR------ 815
L I H N+V LG C L++ ++ G+L + L + + +++
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 816 ------------YQILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861
+Q+ A+G+ +L +HRD+ A NIL+ + I DFG
Sbjct: 143 DFLTLEHLICYSFQV----AKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFG 193
Query: 862 LAKLVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT 913
LA+ + + APE T +SDV+S+GV++ E+ +
Sbjct: 194 LARDIYKDPDYV-----RKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVLLWEIFS 245
Query: 914 -GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEIDE-MLQALGVALLCVN 968
G P P + +++ + P+ E+ + ML C +
Sbjct: 246 LGASPY-PGVKIDEEFCRRLKEGT--------RMRAPDYTTPEMYQTMLD-------CWH 289
Query: 969 ASPDERPTMKDVAAMLKEIKHEREE 993
P +RPT ++ L + +
Sbjct: 290 GEPSQRPTFSELVEHLGNLLQANAQ 314
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 73/280 (26%), Positives = 118/280 (42%), Gaps = 50/280 (17%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+GKG + D D EV A K + + + K R+ S EI S+ H
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLL--------LKPHQREKMSMEISIHRSLAH 74
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGLA 827
+++V F G + + ++ + SL L R E E RY QI G
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQI----VLGCQ 129
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD-DGDFARSSNTVAGSYGYIA 886
YLH + V +HRD+K N+ + + E I DFGLA V+ DG+ + + G+ YIA
Sbjct: 130 YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIA 183
Query: 887 PE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940
PE + + + DV+S G ++ +L GK P + ++R KK
Sbjct: 184 PEVLSKKGHSF------EVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIKKNEYS 233
Query: 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ P ++ +L +L + P RPT+ ++
Sbjct: 234 I-PKHINPV-------AASLIQKMLQTD--PTARPTINEL 263
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-32
Identities = 97/471 (20%), Positives = 157/471 (33%), Gaps = 42/471 (8%)
Query: 137 IPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI-GNCSEL 195
+P +L AL L+ +S + LS+L+ L + I + + +L
Sbjct: 46 VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102
Query: 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPE--EIGNCTSLKMIDFSLNSL 253
L + N L +I + L L L N +P E GN T L + S
Sbjct: 103 EYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 254 SGTIPLSIGGLSELEEFMISDNNVSGSIPANLANA---TNLVQLQLDTNQISGLIPPEIG 310
L + ++ L I + VS I + N L L + S
Sbjct: 159 RQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNM 215
Query: 311 MLSKLTVFFAWQNQLEG-------SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQN- 362
++ L +L + S L L + L H T LFQ
Sbjct: 216 SVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP 275
Query: 363 --LTKLLLISNDISGSIPPEIGNCS-----SLVRLRVGNNRIAGLIPREIGGLKTLNFLD 415
+ L + + I+ I E S SL+ V N +N
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 416 LSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPA 475
LS + + ++ + N S+ S+L LQ L + N
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 476 SLGRLVSLNKIILSKN----LFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEAL 531
+++ + L S + S+ +L+LSSN LTGSV L +
Sbjct: 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KV 452
Query: 532 EIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSL 582
++ L+L N + IP ++ L L L+++ N+L P D L SL
Sbjct: 453 KV-LDLHNNRIMS-IPKDVTHLQALQELNVASNQL--KSVPDGVFDRLTSL 499
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-32
Identities = 87/504 (17%), Positives = 168/504 (33%), Gaps = 55/504 (10%)
Query: 32 SDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVE 91
S+ NLT +P D+ L S N++ + L L L L+ N++ +
Sbjct: 39 SNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFH 94
Query: 92 L-SNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTAL 150
+ + L L + N L NI +++L + N V + E G+ + +T L
Sbjct: 95 VFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFL 151
Query: 151 GLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIP 210
GL+ + + L L + E L L + S
Sbjct: 152 GLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSV 211
Query: 211 PEIGKLKKLEELFLWQNSLVGAIPEEIGN-----CTSLKMIDFSLNSLSGTIP-----LS 260
+ L L L L + + +++ +L + T
Sbjct: 212 QVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQ 271
Query: 261 IGGLSELEEFMISDNNVSGSIPANLANATN-----LVQLQLDTNQISGLIPPEIGMLSKL 315
+E I + ++ I + L+ + + +++
Sbjct: 272 FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331
Query: 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISG 375
+ + S S+ L+ + N T SV G L+ L L+L N +
Sbjct: 332 NIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK- 390
Query: 376 SIPPEIGNCSSLVRLRVGNNRI----AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD 431
+ ++ L + + + R +++ L+LSSN L+GSV +
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP- 449
Query: 432 CTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491
+++++DL +N + S+P ++ L LQ L+V+ N+ L S+
Sbjct: 450 -PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ-----------LKSVPD------ 490
Query: 492 LFSGPIPSSLGLCSSLQLLDLSSN 515
+SLQ + L N
Sbjct: 491 -------GVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-28
Identities = 88/477 (18%), Positives = 163/477 (34%), Gaps = 36/477 (7%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSL-GKLHNL 74
+P +L + L +S +++ DI L VL S N + +L + +L
Sbjct: 46 VPKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDL 102
Query: 75 EELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAG-NIPAELGRLSNLEEMRAGGNKDI 133
E L ++ N+L I SLR L L N + E G L+ L + K
Sbjct: 103 EYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159
Query: 134 VGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCS 193
+ + L L + G SL L + S + +
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVN 218
Query: 194 ELVSLFLYENSLSG-------SIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNC------ 240
L L L L+ + E+ + L + L ++
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISD--NNVSGSIPANLANA-TNLVQLQLD 297
L + + ++ + + L+ MI N V L + + L
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETA-LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 298 TNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGL 357
+ + S T QN S+ ++ LQ L L N L +
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVA 396
Query: 358 FQLQNLTKLLLISNDI----SGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNF 413
+N++ L + + S + S++ L + +N + G + R + +
Sbjct: 397 LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKV 454
Query: 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPN-SLSSLSGLQVLDVSDNRF 469
LDL +NR+ S+P ++ LQ ++++ N L+ S+P+ L+ LQ + + DN +
Sbjct: 455 LDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 66/329 (20%), Positives = 119/329 (36%), Gaps = 25/329 (7%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIP-STLASCSN 338
+P +L L L N IS L P+I LS+L V N++ S+ +
Sbjct: 45 HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 339 LQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPP--EIGNCSSLVRLRVGNNR 396
L+ LD+SHN L ++ + +L L L ND +P E GN + L L + +
Sbjct: 102 LEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAK 157
Query: 397 IAGLIPREIGGLKT-LNFLDLSSNRLSGSVPDEIGD-CTELQMIDLSHNTLQGSLPN-SL 453
L + L LDL S + G + + T + + N+L N S+
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 454 SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPS-------SLGLCSS 506
++L LQ+ ++ N + Q + ++ +L+ L
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 507 LQLLDLSSNQLTGSVPMELGQIEALEIA----LNLSCNGLTGPIPAQISALNKLSILDLS 562
++ L++ + +T + E + ++ A S +++I LS
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 563 HNKLEGNLN-PLAQLDNLVSLNISYNKFT 590
+ + LN + N FT
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFT 366
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-21
Identities = 81/441 (18%), Positives = 161/441 (36%), Gaps = 32/441 (7%)
Query: 192 CSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLN 251
+ +L+ +P ++ + + L L QNS+ +I + L+++ S N
Sbjct: 30 NELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHN 86
Query: 252 SLSGTIPLSI-GGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGL-IPPEI 309
+ ++ + +LE +S N + +I +L L L N L + E
Sbjct: 87 RIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEF 142
Query: 310 GMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT-ASVPAGLFQLQNLTKLLL 368
G L+KLT + + + +L + L S Q+ N T L L
Sbjct: 143 GNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL 201
Query: 369 ISNDISGSIPPEIGNCSSLVRLRVGNNRI-----AGLIPREIGGLKTLNFLDLSSNRLSG 423
+ + S + ++L L++ N ++ L+ + L+++ +
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261
Query: 424 SVPDEIGD-----CTELQMIDLSHNTLQG-----SLPNSLSSLSGLQVLDVSDNRFSGQI 473
+ + ++ +++ + T+ S ++L L + V + F
Sbjct: 262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSK 321
Query: 474 PASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEI 533
A +N +LS + SS L+ + N T SV ++ L+
Sbjct: 322 EALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT 381
Query: 534 ALNLSCNGLT--GPIPAQISALNKLSILDLSHNKLEGNLNPL--AQLDNLVSLNISYNKF 589
L L NGL + ++ L LD+S N L + A ++++ LN+S N
Sbjct: 382 -LILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML 440
Query: 590 TGYLPDNKLFRQLSPTDLAGN 610
TG + L ++ DL N
Sbjct: 441 TGSVFR-CLPPKVKVLDLHNN 460
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 61/278 (21%), Positives = 104/278 (37%), Gaps = 23/278 (8%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPP-EIGNCSSLVRLRVG 393
S +D S+ +LT VP L L L N IS + +I S L LR+
Sbjct: 29 SNELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLS 84
Query: 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNS- 452
+NRI L + L +LD+S NRL ++ L+ +DLS N LP
Sbjct: 85 HNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCK 140
Query: 453 -LSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIIL---SKNLFSGPIPSSLGLCSSLQ 508
+L+ L L +S +F Q+ + L+ I+L S ++ G S +++
Sbjct: 141 EFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL 199
Query: 509 LLDLSSNQLTGS-VPMELGQIEALEI-ALNLSCNGLTGPIPAQISALNKLSILDLSHNKL 566
L N L V M + + L++ + L+ + ++L+++ +
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259
Query: 567 EGNLNPL------AQLDNLVSLNISYNKFTGYLPDNKL 598
E + LNI T + +
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 43/263 (16%), Positives = 96/263 (36%), Gaps = 19/263 (7%)
Query: 2 VTEITIQSVPLQLPIPTNLSSF---KHLQTLVISDANLTGSIPFDIGDCVG-----LIVL 53
+ +T+Q + L F + ++ L I + +T I + L++
Sbjct: 251 LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE 310
Query: 54 DFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIP 113
+ + + + + +L+ + V + S L N ++
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370
Query: 114 AELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQV----SGSLPASLGKLS 169
L L+ + N + NM++L D + S + +
Sbjct: 371 QGCSTLKRLQTLILQRNG--LKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 170 KLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSL 229
+ L++ + M++G + + ++ L L+ N + SIP ++ L+ L+EL + N L
Sbjct: 429 SILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
Query: 230 VGAIPEEI-GNCTSLKMIDFSLN 251
++P+ + TSL+ I N
Sbjct: 486 K-SVPDGVFDRLTSLQYIWLHDN 507
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 65/296 (21%), Positives = 117/296 (39%), Gaps = 46/296 (15%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG+G VYRA + +G +A+KK+ D K+ R EI L +
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKV------QIFDLMDAKA--RADCIKEIDLLKQLN 90
Query: 770 HKNIVRFLGCCWNRNNRLLMY-DYMPNGSLGSLL--HERTGNALE----WELRYQILLGA 822
H N++++ + +N L + + G L ++ ++ + W+ Q+
Sbjct: 91 HPNVIKYYAS-FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA- 148
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFARSSNTVAGS 881
L ++H ++HRDIK N+ I + D GL + A +++ G+
Sbjct: 149 ---LEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGT 199
Query: 882 YGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937
Y++PE GY KSD++S G ++ E+ + P + + KK
Sbjct: 200 PYYMSPERIHENGY----NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-----KKI 250
Query: 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993
Q P L P E L+ L + + P++RP + V + K +
Sbjct: 251 EQCDYPPL---PSDHYSEELRQLVNMCINPD--PEKRPDVTYVYDVAKRMHACTAS 301
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-32
Identities = 68/304 (22%), Positives = 115/304 (37%), Gaps = 54/304 (17%)
Query: 704 KCLVDANVIGKGCSGVVYRA---DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
+ + IG+G G V++ +N + +A+K T + R+ F
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV----------REKFL 439
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQIL 819
E T+ H +IV+ +G N ++ + G L S L R + L
Sbjct: 440 QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASL-ILYA 497
Query: 820 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTV 878
+ LAYL V HRDI A N+L+ + DFGL++ ++D + ++S
Sbjct: 498 YQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-- 551
Query: 879 AGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWV 932
G + APE + T SDV+ +GV + E+L G +P + + V+ +
Sbjct: 552 ----GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-QGVK-NNDVIGRI 605
Query: 933 RQKKGIQVLDPSLLSRPE---SEIDE-MLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988
+ L P + M + C P RP ++ A L I
Sbjct: 606 ENGE--------RLPMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLSTIL 650
Query: 989 HERE 992
E +
Sbjct: 651 EEEK 654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 74/328 (22%), Positives = 125/328 (38%), Gaps = 78/328 (23%)
Query: 710 NVIGKGCSGVVYRA--------DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAE 761
+G+G G V A +AVK L +E
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD----------LSDLVSE 90
Query: 762 IKTLGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER----------TGNAL 810
++ + I +HKNI+ LG C ++ +Y G+L L R
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 811 EWELRYQILLG----AAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
E ++ ++ L+ A+G+ YL +HRD+ A N+L+ IADFGLA+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 865 LVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GK 915
+++ D+ + + G + APE T +SDV+S+GV++ E+ T G
Sbjct: 206 DINNIDYYK-----KTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGG 257
Query: 916 QPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDE----MLQALGVALLCVNASP 971
P P IP + +++ + +P + +E M C +A P
Sbjct: 258 SPY-PGIP-VEELFKLLKEGH--------RMDKPANCTNELYMMMRD-------CWHAVP 300
Query: 972 DERPTMKDVAAMLKEIKHEREEYAKVDM 999
+RPT K + L I +D+
Sbjct: 301 SQRPTFKQLVEDLDRILTLTTNEEYLDL 328
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 1e-31
Identities = 32/304 (10%), Positives = 70/304 (23%), Gaps = 56/304 (18%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+ G VV+ D++ E A+K ++ + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMG--------AENSRSELERLHEATFAAARLL 120
Query: 770 HKNIVRFLGCC--------------------------WNRNNRLLMYDYMPNGSLGSLLH 803
++ + N LL+ + L L
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFS 179
Query: 804 E-----RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858
+ + + A L +VH +N+ I + +
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLG 236
Query: 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQ 916
D V + Y E+ T + + G+ + V
Sbjct: 237 DVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
Query: 917 PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT 976
P P + ++ SL + + + ++ L L + R
Sbjct: 292 PFGLVTP---GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD--RRRRLL 346
Query: 977 MKDV 980
+
Sbjct: 347 PLEA 350
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 71/323 (21%), Positives = 119/323 (36%), Gaps = 81/323 (25%)
Query: 710 NVIGKGCSGVVYRA-----DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
+G G G V A ++ + +AVK L T A +++ +E+K
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE----------KEALMSELK 101
Query: 764 TLGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR------- 815
+ + +H+NIV LG C + L++ +Y G L + L ++
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 816 ---------YQILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
Q+ AQG+A+L + +HRD+ A N+L+ I DFGLA+
Sbjct: 162 STRDLLHFSSQV----AQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 865 LVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GK 915
+ + + APE T +SDV+SYG+++ E+ + G
Sbjct: 213 DIMNDSNYI-----VKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIFSLGL 264
Query: 916 QPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGVALLCVNASP 971
P P I S V+ +++P I M C P
Sbjct: 265 NPY-PGILVNSKFYKLVKDGY--------QMAQPAFAPKNIYSIMQA-------CWALEP 308
Query: 972 DERPTMKDVAAMLKEIKHEREEY 994
RPT + + + L+E E
Sbjct: 309 THRPTFQQICSFLQEQAQEDRRE 331
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 68/305 (22%), Positives = 115/305 (37%), Gaps = 63/305 (20%)
Query: 712 IGKGCSGVVYRA--DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G G G V + M ++ +A+K L T A + E + + +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD----------TEEMMREAQIMHQL 67
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
+ IVR +G C L+M + G L L + + ++L + G+ Y
Sbjct: 68 DNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKY 125
Query: 829 L--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI- 885
L + VHRD+ A N+L+ I+DFGL+K + D S A S G
Sbjct: 126 LEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD----SYYTARSAGKWP 176
Query: 886 ----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937
APE + K + +SDV+SYGV + E L+ G++P + G V+ ++ Q K
Sbjct: 177 LKWYAPECINFR---KFSSRSDVWSYGVTMWEALSYGQKPY-KKMK-GPEVMAFIEQGK- 230
Query: 938 IQVLDPSLLSRPES------EIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991
+ P + M C ++RP V ++ +
Sbjct: 231 -------RMECPPECPPELYAL--MSD-------CWIYKWEDRPDFLTVEQRMRACYYSL 274
Query: 992 EEYAK 996
+
Sbjct: 275 ASKVE 279
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 73/280 (26%), Positives = 118/280 (42%), Gaps = 50/280 (17%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+GKG + D D EV A K + + + K R+ S EI S+ H
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLL--------LKPHQREKMSMEISIHRSLAH 100
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGLA 827
+++V F G + + ++ + SL L R E E RY QI G
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQI----VLGCQ 155
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD-DGDFARSSNTVAGSYGYIA 886
YLH + V +HRD+K N+ + + E I DFGLA V+ DG+ + + G+ YIA
Sbjct: 156 YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIA 209
Query: 887 PE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940
PE + + + DV+S G ++ +L GK P + ++R KK
Sbjct: 210 PEVLSKKGHSF------EVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIKKNEYS 259
Query: 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ P ++ +L +L + P RPT+ ++
Sbjct: 260 I-PKHINPV-------AASLIQKMLQTD--PTARPTINEL 289
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 49/307 (15%), Positives = 109/307 (35%), Gaps = 72/307 (23%)
Query: 711 VIGKGCSGVVYRA-------DMDNGEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI 762
+G+G +++ E + +K L +SF
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY-----------SESFFEAA 63
Query: 763 KTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGA 822
+ + HK++V G C + +L+ +++ GSL + L + N + + ++
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQL 122
Query: 823 AQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPY--------IADFGLAKLVDDGDFA 872
A + +L + ++H ++ A NIL+ E + ++D G++ V D
Sbjct: 123 AAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-- 175
Query: 873 RSSNTVAGSYGYI-----APE-YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDG 925
PE + +D +S+G + E+ + G +P+ + D
Sbjct: 176 ---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL-SAL-DS 224
Query: 926 SHVVDWVRQKKGIQVLDPSLLSRPES-EI-DEMLQALGVALLCVNASPDERPTMKDVAAM 983
+ + Q L P++ E+ + + C++ PD RP+ + +
Sbjct: 225 QRKLQFYED--RHQ------LPAPKAAELANLINN-------CMDYEPDHRPSFRAIIRD 269
Query: 984 LKEIKHE 990
L +
Sbjct: 270 LNSLFTP 276
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 64/284 (22%), Positives = 116/284 (40%), Gaps = 45/284 (15%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG G G + +G+++ K+L +M E + +E+ L ++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-------TEAE--KQMLVSEVNLLRELK 63
Query: 770 HKNIVRFLGCCWNRNNRLL---MYDYMPNGSLGSLL--HERTGNALE----WELRYQILL 820
H NIVR+ +R N L M +Y G L S++ + L+ + Q+ L
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVM-EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 821 GAAQGLAYLH--HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD-DGDFARSSNT 877
L H D ++HRD+K N+ + + + DFGLA++++ D FA T
Sbjct: 123 A----LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KT 175
Query: 878 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ-KK 936
G+ Y++PE M EKSD++S G ++ E+ P + + ++
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGKIRE 230
Query: 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
G P S L + +L + RP+++++
Sbjct: 231 GKFRRIPYRYSDE-------LNEIITRMLNLK--DYHRPSVEEI 265
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 57/294 (19%), Positives = 107/294 (36%), Gaps = 36/294 (12%)
Query: 310 GMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLL-- 367
G S + + + + + +L+ L + + + + G ++ ++ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 368 -LISNDISGSIPPEIGNCS--SLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGS 424
L + +++G+ PP + + L L + N A +L L
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR----------DAWLAELQQWLKPG 150
Query: 425 VPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIP----ASLGRL 480
L+++ ++ + L LD+SDN G+ +
Sbjct: 151 ----------LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKF 200
Query: 481 VSLNKIILSKNLF---SGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNL 537
+L + L SG + LQ LDLS N L + + +LNL
Sbjct: 201 PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260
Query: 538 SCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTG 591
S GL +P + A KLS+LDLS+N+L+ +L + +L++ N F
Sbjct: 261 SFTGLKQ-VPKGLPA--KLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 61/307 (19%), Positives = 98/307 (31%), Gaps = 47/307 (15%)
Query: 256 TIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKL 315
+ L GG S D ++ + +L +L + +I I
Sbjct: 35 DVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA------ 88
Query: 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDIS- 374
+ S LQ L L + +T + P L + +L ++S
Sbjct: 89 ---------------LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 375 ---GSIPPEIGNCS--SLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI 429
+ E+ L L + ++ L+ LDLS N G
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 430 GDC----TELQMIDLSHN---TLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPAS----LG 478
C LQ++ L + T G ++ LQ LD+S N A
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
Query: 479 RLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLS 538
+L SLN LS +P L + L +LDLS N+L P ++ + L+L
Sbjct: 254 QLNSLN---LSFTGLKQ-VPKGLP--AKLSVLDLSYNRLD-RNP-SPDELPQVGN-LSLK 304
Query: 539 CNGLTGP 545
N
Sbjct: 305 GNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 36/224 (16%), Positives = 77/224 (34%), Gaps = 28/224 (12%)
Query: 382 GNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPD---EIGDCTELQMI 438
G S L+ + +I +L L + + R+ + + + LQ +
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 439 DLSHNTLQGSLPNSLSSLSG--LQVLDVSDNRFSG--QIPASLGRLV--SLNKIILSKNL 492
L + + G+ P L +G L +L++ + ++ A L + + L + +++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 493 FSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISA 552
+ + +L LDLS N G + ++ P +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGL------------------ISALCPLKFPT 202
Query: 553 LNKLSILDLSHNKLEGNLNPL-AQLDNLVSLNISYNKFTGYLPD 595
L L++ + G + L A L L++S+N
Sbjct: 203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 52/301 (17%), Positives = 92/301 (30%), Gaps = 23/301 (7%)
Query: 21 SSFKHLQTLVISDANLTGSIPFDI-GDCVGLIVLDFSSNNLVGTLP-SSLGKLHNLEELI 78
+F + S N G+ ++ G L L + + + K +L+ L
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLT 74
Query: 79 LNSNQLTGKIPVELS---NCKSLRKLLLFDNALAGNIPAELGRLS--NLEEMRAGGNK-D 132
+ + ++ +I L++L L + + G P L + +L +
Sbjct: 75 VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
Query: 133 IVGKIPAELGDCS--NMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIG 190
AEL + L +A + L TL + GE
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 191 NC----SELVSLFLYEN---SLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEI-GNCTS 242
C L L L + SG +L+ L L NSL A +
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
Query: 243 LKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQIS 302
L ++ S L +P + ++L +S N + P+ + L L N
Sbjct: 255 LNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFL 309
Query: 303 G 303
Sbjct: 310 D 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 42/247 (17%), Positives = 87/247 (35%), Gaps = 21/247 (8%)
Query: 2 VTEITIQSVPLQLPIPTNLS---SFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFS-S 57
+ +T+++ + I LQ L + + +TG+ P + + G + +
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 58 NNLVGTLPSSLGKLHN-----LEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNI 112
N T + L +L L+ L + ++ +L L L DN G
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 113 P----AELGRLSNLEEMRAGGN--KDIVGKIPAELGDCSNMTALGLADTQVSGSLPASL- 165
+ L+ + + G A + L L+ + + A
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 166 GKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLW 225
S+L +L++ T + ++P + ++L L L N L + P +L ++ L L
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLK 304
Query: 226 QNSLVGA 232
N + +
Sbjct: 305 GNPFLDS 311
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 74/315 (23%), Positives = 126/315 (40%), Gaps = 70/315 (22%)
Query: 710 NVIGKGCSGVVYRA---DMDNGE-----VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAE 761
+G+GC G V A +D + +AVK L +E
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD----------LSDLVSE 136
Query: 762 IKTLGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER----------TGNAL 810
++ + I +HKNI+ LG C ++ +Y G+L L R
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 811 EWELRYQILLG-AAQ---GLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
E ++ ++ L+ Q G+ YL +HRD+ A N+L+ IADFGLA+
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 865 LVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GK 915
+++ D+ + + G + APE T +SDV+S+GV++ E+ T G
Sbjct: 252 DINNIDYYK-----KTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGG 303
Query: 916 QPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERP 975
P P IP + +++ + +P + +E+ + C +A P +RP
Sbjct: 304 SPY-PGIP-VEELFKLLKEGH--------RMDKPANCTNELYM---MMRDCWHAVPSQRP 350
Query: 976 TMKDVAAMLKEIKHE 990
T K + L I
Sbjct: 351 TFKQLVEDLDRILTL 365
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 77/329 (23%), Positives = 122/329 (37%), Gaps = 91/329 (27%)
Query: 710 NVIGKGCSGVVYRA-----DMDNGEVI-AVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
+G+G G V +A G AVK L + +E
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE----------LRDLLSEFN 78
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR-------- 815
L + H ++++ G C LL+ +Y GSL L E +
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 816 ------------------YQILLGAAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEP 855
+QI +QG+ YL +VHRD+ A NIL+ +
Sbjct: 139 LDHPDERALTMGDLISFAWQI----SQGMQYLAEMK-----LVHRDLAARNILVAEGRKM 189
Query: 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVV 907
I+DFGL++ V + D S G I A E T +SDV+S+GV+
Sbjct: 190 KISDFGLSRDVYEEDSYV-----KRSQGRIPVKWMAIESLFDH---IYTTQSDVWSFGVL 241
Query: 908 VLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-DEMLQALGV 962
+ E++T G P P IP + + ++ + RP+ E+ MLQ
Sbjct: 242 LWEIVTLGGNPY-PGIP-PERLFNLLKTGH--------RMERPDNCSEEMYRLMLQ---- 287
Query: 963 ALLCVNASPDERPTMKDVAAMLKEIKHER 991
C PD+RP D++ L+++ +R
Sbjct: 288 ---CWKQEPDKRPVFADISKDLEKMMVKR 313
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 73/316 (23%), Positives = 122/316 (38%), Gaps = 78/316 (24%)
Query: 710 NVIGKGCSGVVYRA--------DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAE 761
+G+G G V A + +AVK L +E
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD----------LSDLISE 124
Query: 762 IKTLGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER----------TGNAL 810
++ + I +HKNI+ LG C ++ +Y G+L L R +
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 811 EWELRYQILLG----AAQGLAYL--HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
E +L + L+ A+G+ YL +HRD+ A N+L+ + IADFGLA+
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 865 LVDDGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GK 915
+ D+ + + G + APE T +SDV+S+GV++ E+ T G
Sbjct: 240 DIHHIDYYK-----KTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVLLWEIFTLGG 291
Query: 916 QPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDE----MLQALGVALLCVNASP 971
P P +P + +++ + +P + +E M C +A P
Sbjct: 292 SPY-PGVP-VEELFKLLKEGH--------RMDKPSNCTNELYMMMRD-------CWHAVP 334
Query: 972 DERPTMKDVAAMLKEI 987
+RPT K + L I
Sbjct: 335 SQRPTFKQLVEDLDRI 350
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 78/352 (22%), Positives = 124/352 (35%), Gaps = 47/352 (13%)
Query: 289 TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPS-TLASCSNLQALDLSHN 347
++ + L N I+ L L L Q I + T S+L L L +N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 348 SLTASVPAGLFQ-LQNLTKLLLISNDI-SGSIPPEI-GNCSSLVRLRVGNNRIAGLIPRE 404
+ G F L NL L L ++ + +SL L + +N I + P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 405 I-GGLKTLNFLDLSSNRLSGSVPDEIGD---CTELQMIDLSHNTLQGSLPNSLSS----- 455
++ + LDL+ N++ S+ +E ++ LS TLQ L
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 456 ---LSGLQVLDVSDNRFSGQIPASLGRLVSLNKII-------------LSKNLFSGPIPS 499
+ + LD+S N F + ++ KI F P
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 500 SLG--LCSSLQLLDLSSNQLT---GSVPMELGQIEALEIALNLSCNGLTGPIPAQI-SAL 553
+ S ++ DLS +++ SV +E L L+ N + I L
Sbjct: 268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQL----TLAQNEIN-KIDDNAFWGL 322
Query: 554 NKLSILDLSHNKLEGNLNP--LAQLDNLVSLNISYNKFTGYLPDNKLFRQLS 603
L L+LS N L G+++ LD L L++SYN L D F L
Sbjct: 323 THLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQ-SFLGLP 371
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 75/442 (16%), Positives = 144/442 (32%), Gaps = 92/442 (20%)
Query: 52 VLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGN 111
+D S N++ +S +L +L+ L + I F
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN-----------TFRG----- 77
Query: 112 IPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPAS-LGKLSK 170
LS+L L L Q L L+
Sbjct: 78 -------LSSLII-------------------------LKLDYNQFL-QLETGAFNGLAN 104
Query: 171 LQTLSIYTTMI-SGEIPAEI-GNCSELVSLFLYENSLSGSIPPEI--GKLKKLEELFLWQ 226
L+ L++ + + + L L L +N++ I P +++ L L
Sbjct: 105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTF 163
Query: 227 NSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLA 286
N + +I EE L + G ++ LS + +++ + N
Sbjct: 164 NKVK-SICEED------------LLNFQGK-HFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 287 NATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLAS----------- 335
T++ L L N + T + ++ S+
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 336 ----CSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEI-GNCSSLVR 389
S ++ DLS + + ++ +F +L +L L N+I+ I + L++
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK 327
Query: 390 LRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-CTELQMIDLSHNTLQGS 448
L + N + + R L L LDLS N + ++ D+ L+ + L N L+ S
Sbjct: 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-S 385
Query: 449 LPNS-LSSLSGLQVLDVSDNRF 469
+P+ L+ LQ + + N +
Sbjct: 386 VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-30
Identities = 80/403 (19%), Positives = 130/403 (32%), Gaps = 70/403 (17%)
Query: 145 SNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI-GNCSELVSLFLYEN 203
+++ + L+ ++ S +L LQ L + I S L+ L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 204 SLSGSIPPEI-GKLKKLEELFLWQNSLVGA-IPEEI-GNCTSLKMIDFSLNSLSGTIPLS 260
+ L LE L L Q +L GA + TSL+M+ N++ P S
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 261 I-GGLSELEEFMISDNNVSGSIPANL---ANATNLVQLQLDTNQISGLIPPEIGMLSKLT 316
+ ++ N V SI + L+L + + +
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNE---------- 197
Query: 317 VFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLL-LISNDISG 375
L +++ LDLS N S+ F TK+ LI ++
Sbjct: 198 ------YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251
Query: 376 SIPPEIGNC--------------SSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRL 421
S + + ++I L+ L L L+ N +
Sbjct: 252 MGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI 311
Query: 422 SGSVPDEIGD-CTELQMIDLSHNTLQGSLP-NSLSSLSGLQVLDVSDNRFSGQIPASLGR 479
+ + D T L ++LS N L S+ +L L+VLD+S N
Sbjct: 312 N-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR--------- 360
Query: 480 LVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522
L F G +L+ L L +NQL SVP
Sbjct: 361 -------ALGDQSFLG--------LPNLKELALDTNQLK-SVP 387
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-31
Identities = 75/333 (22%), Positives = 123/333 (36%), Gaps = 57/333 (17%)
Query: 670 RRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRA--DMDN 727
R D E S P + K + L+ +G G G V + M
Sbjct: 306 RPMPMDTSVFESPFSDPEEL----KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRK 361
Query: 728 GEV-IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR 786
++ +A+K L T A + E + + + + IVR +G C
Sbjct: 362 KQIDVAIKVLKQGTEKAD----------TEEMMREAQIMHQLDNPYIVRLIGVCQAEALM 411
Query: 787 LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL--HHDCVPPIVHRDIKA 844
L+M + G L L + + ++L + G+ YL + VHR++ A
Sbjct: 412 LVM-EMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEKN-----FVHRNLAA 464
Query: 845 NNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI-----APEYGYMMKITEKS 899
N+L+ I+DFGL+K + D S A S G APE K + +S
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADD----SYYTARSAGKWPLKWYAPECINFRKFSSRS 520
Query: 900 DVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPE---SEI-D 954
DV+SYGV + E L+ G++P + G V+ ++ Q K + P E+
Sbjct: 521 DVWSYGVTMWEALSYGQKPY-KKMK-GPEVMAFIEQGK--------RMECPPECPPELYA 570
Query: 955 EMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
M C ++RP V ++
Sbjct: 571 LMSD-------CWIYKWEDRPDFLTVEQRMRAC 596
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 61/303 (20%), Positives = 115/303 (37%), Gaps = 76/303 (25%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI- 768
IG G G V++ +G + A+K+ G DE++ +R E+ +
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA----GSVDEQNALR-----EVYAHAVLG 68
Query: 769 RHKNIVRFLGCCWNRNNRLLMY-DYMPNGSLGSLL--HERTGNALE----WELRYQILLG 821
+H ++VR+ W ++ +L+ +Y GSL + + R + + +L Q+ G
Sbjct: 69 QHSHVVRYFSA-WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 822 AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY-------------------IADFGL 862
L Y+H +VH DIK +NI I P I D G
Sbjct: 128 ----LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 863 AKLVDDGDFARSSNTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ S G ++A E Y + K+D+++ + V+ +
Sbjct: 181 VTRIS------SPQVEEGDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPL 230
Query: 918 IDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM 977
P +RQ + ++ P +LS+ E E+L+ + ++ P+ RP+
Sbjct: 231 -----PRNGDQWHEIRQGRLPRI--PQVLSQ---EFTELLK------VMIHPDPERRPSA 274
Query: 978 KDV 980
+
Sbjct: 275 MAL 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 66/297 (22%), Positives = 116/297 (39%), Gaps = 23/297 (7%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
++P ++ + L L N IS L + L L N++ + L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 340 QALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRI- 397
Q L +S N L +P L +L +L + N I +P + ++ + +G N +
Sbjct: 105 QKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 398 -AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSL 456
+G P GLK LN+L +S +L+ +P ++ L + L HN +Q L
Sbjct: 161 NSGFEPGAFDGLK-LNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRY 216
Query: 457 SGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQ 516
S L L + N+ SL L +L ++ L N S +P+ L LQ++ L +N
Sbjct: 217 SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNN 275
Query: 517 LTGSVP------MELGQIEALEIALNLSCNGLT-GPIPAQI-SALNKLSILDLSHNK 565
+T V + G A ++L N + + + + + K
Sbjct: 276 IT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 68/352 (19%), Positives = 128/352 (36%), Gaps = 60/352 (17%)
Query: 25 HLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQL 84
HL+ + SD L ++P +I +LD +N++ L +L L+L +N++
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 85 TGKIPVE-LSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGD 143
+ KI + S + L+KL + N L IP L S+L E+R N+ + K+P
Sbjct: 91 S-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNR--IRKVP----- 139
Query: 144 CSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMI-SGEIPAEIGNCSELVSLFLYE 202
L + + + + + + +L L + E
Sbjct: 140 ------------------KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181
Query: 203 NSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEI-GNCTSLKMIDFSLNSLSGTIPLSI 261
L+ IP ++ + L EL L N + AI E + L + N + S+
Sbjct: 182 AKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSL 237
Query: 262 GGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAW 321
L L E + +N +S +PA L + L + L TN I+ + + +
Sbjct: 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV---GVNDFCPVGFGVKR 293
Query: 322 QNQLEGSIPSTLASCSNLQALDLSHNSLT-ASVPAGLFQ-LQNLTKLLLISN 371
+ + L +N + V F+ + + + +
Sbjct: 294 ---------------AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 401 IPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQ 460
+P+EI LDL +N +S D+ L + L +N + + S L LQ
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105
Query: 461 VLDVSDNRFS---GQIPASLGRL-VSLNKI-ILSKNLFSGPIPSSLGLCSSLQLLDLSSN 515
L +S N +P+SL L + N+I + K +FSG ++ +++ N
Sbjct: 106 KLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSG--------LRNMNCIEMGGN 157
Query: 516 QLTGSVPMELGQIEALEIA-LNLSCNGLTGPIPAQISALNKLSILDLSHNKLEG-NLNPL 573
L + E G + L++ L +S LTG IP L+ L L HNK++ L L
Sbjct: 158 PLE-NSGFEPGAFDGLKLNYLRISEAKLTG-IPKD--LPETLNELHLDHNKIQAIELEDL 213
Query: 574 AQLDNLVSLNISYNKFTGYLPDNKLFRQLS 603
+ L L + +N+ + + L
Sbjct: 214 LRYSKLYRLGLGHNQIR-MIENG-SLSFLP 241
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 60/322 (18%), Positives = 111/322 (34%), Gaps = 67/322 (20%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGV---RDSFSAEIKTLG 766
++G+G + V+R G++ A+K D E + L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVF-------------NNISFLRPVDVQMREFEVLK 62
Query: 767 SIRHKNIVRFLGCCWNRNNR---LLMYDYMPNGSLGSLL--HERTGNALEWELRY---QI 818
+ HKNIV+ R L+M ++ P GSL ++L E E +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIM-EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY----IADFGLAKLVDDGDFARS 874
+ G+ +L + IVHR+IK NI+ + + + DFG A+ ++D +
Sbjct: 122 V----GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV- 173
Query: 875 SNTVAGSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS 926
++ G+ Y+ P+ + K D++S GV TG P P
Sbjct: 174 --SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
Query: 927 HVVDWVRQKKGIQVLDPSLLSRPES-----------------EIDEMLQALGVALLCVNA 969
+ + G S + + E+ + +L + +L +
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD- 290
Query: 970 SPDERPTMKDVAAMLKEIKHER 991
++ A +I H
Sbjct: 291 -QEKCWGFDQFFAETSDILHRG 311
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 61/279 (21%), Positives = 95/279 (34%), Gaps = 33/279 (11%)
Query: 197 SLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLS-- 254
+ L+ S+P I L L N L T L + S N LS
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 255 GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSK 314
G S G + L+ +S N V ++ +N L L + + + E +
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM--SEFSVFLS 124
Query: 315 LTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDI 373
L NL LD+SH G+F L +L L + N
Sbjct: 125 LR---------------------NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSF 162
Query: 374 SGSIPPEI-GNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC 432
+ P+I +L L + ++ L P L +L L++S N
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222
Query: 433 TELQMIDLSHNTLQGSLPNSLSSL-SGLQVLDVSDNRFS 470
LQ++D S N + S L S L L+++ N F+
Sbjct: 223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 67/271 (24%), Positives = 107/271 (39%), Gaps = 40/271 (14%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDIS-GSIPPEI-GNC 384
S+P+ + S + L+L N L S+P G+F L LTKL L SN +S +
Sbjct: 21 SVPTGIPS--SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 385 SSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHN 443
+SL L + N + + GL+ L LD + L + L +D+SH
Sbjct: 78 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 444 TLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGL 503
+ + + LS L+VL ++ N F ++F+
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP---------------DIFTE-------- 173
Query: 504 CSSLQLLDLSSNQLTGSVPME-LGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLS 562
+L LDLS QL + + +L++ LN+S N LN L +LD S
Sbjct: 174 LRNLTFLDLSQCQLE-QLSPTAFNSLSSLQV-LNMSHNNFFSLDTFPYKCLNSLQVLDYS 231
Query: 563 HNKL----EGNLNPLAQLDNLVSLNISYNKF 589
N + + L +L LN++ N F
Sbjct: 232 LNHIMTSKKQELQHF--PSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 53/257 (20%), Positives = 88/257 (34%), Gaps = 16/257 (6%)
Query: 27 QTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTG 86
+ + LT S+P I L+ SN L KL L +L L+SN L+
Sbjct: 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 87 K--IPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAE--LG 142
K SL+ L L N + + + L LE + + + ++
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN--LKQMSEFSVFL 123
Query: 143 DCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI-GNCSELVSLFLY 201
N+ L ++ T + LS L+ L + +I L L L
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 202 ENSLSGSIPPEI-GKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLS 260
+ L + P L L+ L + N+ SL+++D+SLN + T
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
Query: 261 I--GGLSELEEFMISDN 275
S L ++ N
Sbjct: 242 ELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 42/195 (21%), Positives = 68/195 (34%), Gaps = 32/195 (16%)
Query: 412 NFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSG 471
+ +S L+ SVP I + ++L N LQ L+ L L +S N
Sbjct: 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG--- 63
Query: 472 QIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEAL 531
L+ G +SL+ LDLS N + ++ +E L
Sbjct: 64 -----------LSFKGCCSQSDFG--------TTSLKYLDLSFNGVI-TMSSNFLGLEQL 103
Query: 532 EIALNLSCNGLTGPIPAQI-SALNKLSILDLSHNKLEGNLNP--LAQLDNLVSLNISYNK 588
E L+ + L + +L L LD+SH L +L L ++ N
Sbjct: 104 EH-LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNS 161
Query: 589 FTGYLPDNKLFRQLS 603
F + +F +L
Sbjct: 162 FQENFLPD-IFTELR 175
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 28/168 (16%), Positives = 54/168 (32%), Gaps = 10/168 (5%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDI-GDCVGLIVLDFSSNNLVGTLPSSLGKLHNL 74
+ +N + L+ L +NL F + LI LD S + L +L
Sbjct: 93 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 152
Query: 75 EELILNSNQLTGKIPVE-LSNCKSLRKLLLFDNALAGNIPAE-LGRLSNLEEMRAGGNKD 132
E L + N + + ++L L L L + LS+L+ + N
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNN- 210
Query: 133 IVGKIPAE-LGDCSNMTALGLADTQVSGSLPASL--GKLSKLQTLSIY 177
+ +++ L + + + S L L++
Sbjct: 211 -FFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLT 256
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 65/280 (23%), Positives = 103/280 (36%), Gaps = 51/280 (18%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI- 768
+G G G V++ ++G + AVK+ M+ G D + E+ + +
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRS----MSPFRGPKDRARKLA-----EVGSHEKVG 114
Query: 769 RHKNIVRFLGCCWNRNNRLLMY-DYMPNGSLGSLLHERTGNALE----WELRYQILLGAA 823
+H VR W L + + SL E G +L W LL
Sbjct: 115 QHPCCVRLEQA-WEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLA-- 169
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
LA+LH +VH D+K NI +G + DFGL + G
Sbjct: 170 --LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG---EVQEGDPR 221
Query: 884 YIAPEY---GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940
Y+APE Y +DV+S G+ +LEV + P G +RQ +
Sbjct: 222 YMAPELLQGSY----GTAADVFSLGLTILEVACNMEL-----PHGGEGWQQLRQGY-LPP 271
Query: 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ LS L+++ V +L + P R T + +
Sbjct: 272 EFTAGLSSE-------LRSVLVMMLEPD--PKLRATAEAL 302
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 67/306 (21%), Positives = 115/306 (37%), Gaps = 73/306 (23%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+G+G G V +A + + A+KK+ + +E+ L S+
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKI------------RHTEEKLSTILSEVMLLASLN 60
Query: 770 HKNIVRFLGCCWNRNNRLLMY-------------DYMPNGSLGSLLHERTGNALE---WE 813
H+ +VR+ R N + +Y NG+L L+H N W
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 814 LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFAR 873
L QIL L+Y+H I+HRD+K NI I I DFGLAK V
Sbjct: 121 LFRQILEA----LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 874 SS------------NTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTG 914
+ G+ Y+A E Y EK D+YS G++ E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN------EKIDMYSLGIIFFEMIYP 227
Query: 915 KQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDER 974
G V+ +++ + + + P + ++ + + L+ + P++R
Sbjct: 228 -------FSTGMERVNILKKLRSVSIEFPPDFDDNKM---KVEKKIIRLLIDHD--PNKR 275
Query: 975 PTMKDV 980
P + +
Sbjct: 276 PGARTL 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 57/300 (19%), Positives = 105/300 (35%), Gaps = 64/300 (21%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G+G GVV+ A + + A+K++ A R+ E+K L +
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA----------REKVMREVKALAKLE 61
Query: 770 HKNIVRFLGCCWNRNNR-------------LLMYDYMPNGSLGSLLHERTGNALE----- 811
H IVR+ +N + M +L ++ R
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQM-QLCRKENLKDWMNGRCTIEERERSVC 120
Query: 812 WELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF 871
+ QI + +LH ++HRD+K +NI ++ + DFGL +D +
Sbjct: 121 LHIFLQIAE----AVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 872 ARSSNTVAGSYG----------YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921
++ T +Y Y++PE + + K D++S G+++ E+L P
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PF 227
Query: 922 IPDGSHVVDWVRQKKGIQVLDPSLLSRPESE-IDEMLQALGVALLCVNASPDERPTMKDV 980
V + + E + +ML SP ERP ++
Sbjct: 228 STQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLS----------PSPMERPEAINI 277
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 60/322 (18%), Positives = 111/322 (34%), Gaps = 67/322 (20%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGV---RDSFSAEIKTLG 766
++G+G + V+R G++ A+K D E + L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVF-------------NNISFLRPVDVQMREFEVLK 62
Query: 767 SIRHKNIVRFLGCCWNRNNR---LLMYDYMPNGSLGSLL--HERTGNALEWELRY---QI 818
+ HKNIV+ R L+M ++ P GSL ++L E E +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIM-EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY----IADFGLAKLVDDGDFARS 874
+ G+ +L + IVHR+IK NI+ + + + DFG A+ ++D +
Sbjct: 122 V----GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-- 172
Query: 875 SNTVAGSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS 926
++ G+ Y+ P+ + K D++S GV TG P P
Sbjct: 173 -VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
Query: 927 HVVDWVRQKKGIQVLDPSLLSRPESE-----------------IDEMLQALGVALLCVNA 969
+ + G S + + E+ + +L + +L +
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD- 290
Query: 970 SPDERPTMKDVAAMLKEIKHER 991
++ A +I H
Sbjct: 291 -QEKCWGFDQFFAETSDILHRM 311
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 72/322 (22%), Positives = 130/322 (40%), Gaps = 57/322 (17%)
Query: 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
+ +G G GVV++ +G V+A K + + K +R+ E++
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----------LEIKPAIRNQIIRELQV 84
Query: 765 LGSIRHKNIVRFLGC------CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQI 818
L IV F G + M ++M GSL +L + G E L +
Sbjct: 85 LHECNSPYIVGFYGAFYSDGEIS-----ICM-EHMDGGSLDQVLK-KAGRIPEQILGK-V 136
Query: 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA-KLVDDGDFARSSNT 877
+ +GL YL I+HRD+K +NIL+ E + DFG++ +L+D +N+
Sbjct: 137 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANS 189
Query: 878 VAGSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933
G+ Y++PE Y + +SD++S G+ ++E+ G+ PI P ++ +
Sbjct: 190 FVGTRSYMSPERLQGTHY----SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245
Query: 934 QKKGIQVLDPSL------LSRPESEIDEMLQALGVALLCVNASPDERPT------MKD-V 980
+ P L++ + + + VN P + P+ +D V
Sbjct: 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305
Query: 981 AAMLKEIKHEREEYAKVDMLLK 1002
L + ER A + L+
Sbjct: 306 NKCLIKNPAER---ADLKQLMV 324
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 53/304 (17%), Positives = 104/304 (34%), Gaps = 55/304 (18%)
Query: 711 VIGKGCSGVVYRADMDNGEVIAVKKL------WPTTMAAANGCSDEKSGVRDSFSAEIKT 764
+ +G + + + + A+KK +N D F E++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSL-------GSLLHERTGNALEWELR-- 815
+ I+++ + G N + ++Y+YM N S+ L T ++
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 816 -YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARS 874
+L +Y+H++ I HRD+K +NIL+ ++DFG ++ + D
Sbjct: 157 IKSVLNS----FSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--- 207
Query: 875 SNTVAGSYGYIAPE--YGYMMKITEKSDVYSYGVVVLEVLTGKQP-------------I- 918
G+Y ++ PE K D++S G+ + + P I
Sbjct: 208 -KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 919 --DPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT 976
+ P + + K + L + + L+ N P ER T
Sbjct: 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR--------KN--PAERIT 316
Query: 977 MKDV 980
+D
Sbjct: 317 SEDA 320
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 8e-29
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 32/223 (14%)
Query: 710 NVIGKGCS--GVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
VIGKG V A GE + V+++ CS+E E+
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA------CSNEM---VTFLQGELHVSK 81
Query: 767 SIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
H NIV + + +N L ++ +M GS L+ + + IL G +
Sbjct: 82 LFNHPNIVPYRAT-FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG-LAKLVDDGDFARSSNTVAGSY-G 883
L Y+HH VHR +KA++ILI ++ + Y++ ++ G R +
Sbjct: 141 LDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 884 ---YIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+++PE GY KSD+YS G+ E+ G P
Sbjct: 198 VLPWLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHVP 236
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 66/308 (21%), Positives = 122/308 (39%), Gaps = 21/308 (6%)
Query: 284 NLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALD 343
N +++ + ++ + L +T A+ + +I + +NL L+
Sbjct: 14 PDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLE 69
Query: 344 LSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403
L N +T P L L +T+L L N + ++ I S+ L + + +I + P
Sbjct: 70 LKDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP- 124
Query: 404 EIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLD 463
+ GL L L L N+++ P + T LQ + + + + L L++LS L L
Sbjct: 125 -LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLK 179
Query: 464 VSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPM 523
DN+ S I L L +L ++ L N S S L S+L ++ L++ +T
Sbjct: 180 ADDNKIS-DISP-LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTITNQPVF 235
Query: 524 ELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLN 583
+ + S + PA IS + +L+ N N + V+
Sbjct: 236 YNNNLVVPNVVKGPSGAPIA---PATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFK 292
Query: 584 ISYNKFTG 591
+ F+G
Sbjct: 293 NTTVPFSG 300
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 65/290 (22%), Positives = 120/290 (41%), Gaps = 25/290 (8%)
Query: 239 NCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDT 298
+ I ++++ T+ + L + V+ +I + NL+ L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 299 NQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLF 358
NQI+ L P + L+K+T N L S +A +++ LDL+ +T P L
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 359 QLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSS 418
L NL L L N I+ +I P + ++L L +GN +++ L P + L L L
Sbjct: 127 GLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182
Query: 419 NRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLG 478
N++S P + L + L +N + P L++ S L ++ +++ + Q
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 479 RLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQI 528
LV N + K PI + + +S LT ++ + +
Sbjct: 239 NLVVPNVV---KGPSGAPIAPA----TISDNGTYASPNLTWNLTSFINNV 281
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 59/293 (20%), Positives = 115/293 (39%), Gaps = 25/293 (8%)
Query: 165 LGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFL 224
L+ ++ + ++ + + + +L + ++ +I + L L L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 225 WQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPAN 284
N + + N T + ++ S N L ++ GL ++ ++ ++ P
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITDVTP-- 124
Query: 285 LANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDL 344
LA +NL L LD NQI+ + P + L+ L Q+ + + LA+ S L L
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKA 180
Query: 345 SHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPRE 404
N ++ + L L NL ++ L +N IS + P + N S+L + + N I
Sbjct: 181 DDNKIS-DIS-PLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFY 236
Query: 405 IGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLS 457
L N + S P I D + L +L + ++++S
Sbjct: 237 NNNLVVPNVVKGPSGAP--IAPATISD-----NGTYASPNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 47/228 (20%), Positives = 97/228 (42%), Gaps = 17/228 (7%)
Query: 383 NCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442
++ +++ G + + + L + L ++ + + L ++L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 443 NTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLG 502
N + L L +L+ + L++S N + A + L S+ + L+ + P L
Sbjct: 73 NQIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 503 LCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLS 562
S+LQ+L L NQ+T P L + L+ L++ ++ P ++ L+KL+ L
Sbjct: 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQY-LSIGNAQVSDLTP--LANLSKLTTLKAD 181
Query: 563 HNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGN 610
NK+ +++PLA L NL+ +++ N+ + P L L
Sbjct: 182 DNKIS-DISPLASLPNLIEVHLKNNQISDVSPLANT-SNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 62/315 (19%), Positives = 112/315 (35%), Gaps = 70/315 (22%)
Query: 66 SSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEM 125
L N ++ + +T V ++ + L F ++ +E
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGT-----------GVTTIE-- 57
Query: 126 RAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEI 185
+ +N+ L L D Q++ L L L+K+ L + + +
Sbjct: 58 --------------GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NV 100
Query: 186 PAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKM 245
A I + +L L ++ + P + L L+ L+L N + P + T+L+
Sbjct: 101 SA-IAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQY 155
Query: 246 IDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLI 305
+ +S PL+ LS+L DN +S I LA+ NL+++ L NQIS +
Sbjct: 156 LSIGNAQVSDLTPLA--NLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVS 211
Query: 306 PPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTK 365
P LA+ SNL + L++ ++T F NL
Sbjct: 212 P--------------------------LANTSNLFIVTLTNQTITNQPV---FYNNNLVV 242
Query: 366 LLLISNDISGSIPPE 380
++ I P
Sbjct: 243 PNVVKGPSGAPIAPA 257
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 54/259 (20%), Positives = 97/259 (37%), Gaps = 22/259 (8%)
Query: 50 LIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALA 109
I + +N+ T + L + L +T I + +L L L DN +
Sbjct: 21 AIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT 76
Query: 110 GNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLS 169
++ L L+ + E+ GN + + A + ++ L L TQ++ P L LS
Sbjct: 77 -DLA-PLKNLTKITELELSGNP--LKNVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLS 129
Query: 170 KLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSL 229
LQ L + I+ I + + L L + +S + P + L KL L N +
Sbjct: 130 NLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKI 185
Query: 230 VGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANAT 289
+ + +L + N +S PL+ S L +++ ++ + P N
Sbjct: 186 SDI--SPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTIT-NQPVFYNN-- 238
Query: 290 NLVQLQLDTNQISGLIPPE 308
NLV + I P
Sbjct: 239 NLVVPNVVKGPSGAPIAPA 257
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 47/218 (21%), Positives = 88/218 (40%), Gaps = 17/218 (7%)
Query: 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSL 453
I + P L + + ++ +V D + + + ++ +
Sbjct: 6 PTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-V 59
Query: 454 SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLS 513
L+ L L++ DN+ + P L L + ++ LS N S++ S++ LDL+
Sbjct: 60 QYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLT 115
Query: 514 SNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPL 573
S Q+T P L + L++ L L N +T P ++ L L L + + ++ +L PL
Sbjct: 116 STQITDVTP--LAGLSNLQV-LYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTPL 169
Query: 574 AQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNE 611
A L L +L NK + + L L N+
Sbjct: 170 ANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQ 206
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 51/239 (21%), Positives = 95/239 (39%), Gaps = 17/239 (7%)
Query: 18 TNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEEL 77
+ +L L + D +T + + + + L+ S N L S++ L +++ L
Sbjct: 57 EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTL 112
Query: 78 ILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKI 137
L S Q+T P L+ +L+ L L N + NI L L+NL+ + G + V +
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQ--VSDL 166
Query: 138 PAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVS 197
L + S +T L D ++S + L L L + + IS P + N S L
Sbjct: 167 TP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 198 LFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGT 256
+ L +++ + P + + + A P I + + + + N S
Sbjct: 222 VTLTNQTIT-NQPVFYNNNLVVPNVVKGPSGAPIA-PATISDNGTYASPNLTWNLTSFI 278
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 71/303 (23%), Positives = 121/303 (39%), Gaps = 75/303 (24%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI- 768
++G G G VY+ + G++ A+K + + DE+ + EI L
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVM--------DVTGDEE----EEIKQEINMLKKYS 78
Query: 769 RHKNIVRFLGC-----CWNRNNRL--LMYDYMPNGSLGSLLHERTGNAL-EWELRYQILL 820
H+NI + G +++L +M ++ GS+ L+ GN L E + Y I
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVM-EFCGAGSVTDLIKNTKGNTLKEEWIAY-ICR 136
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
+GL++LH V +HRDIK N+L+ E + DFG++ +D R NT G
Sbjct: 137 EILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIG 191
Query: 881 SYGYIAPE---------YGYMMKITEKSDVYSYGVVVLEVLTGKQP---IDPT-----IP 923
+ ++APE Y KSD++S G+ +E+ G P + P IP
Sbjct: 192 TPYWMAPEVIACDENPDATY----DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247
Query: 924 DGSHVVDWVRQKKGIQVLDPSLLSRPESE-IDEMLQALGVALLCVNASPDERPTMKDVAA 982
+ L S+ I+ C+ + +RP +
Sbjct: 248 -----------RNPAPRLKSKKWSKKFQSFIE----------SCLVKNHSQRPATEQ--- 283
Query: 983 MLK 985
++K
Sbjct: 284 LMK 286
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+GKG G VY A + + ++A+K L+ + EK+GV E++ +
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--------EKAGVEHQLRREVEIQSHL 66
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQG 825
RH NI+R G + L+ +Y P G++ L ++ E ++ A
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITEL----ANA 121
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
L+Y H V +HRDIK N+L+G E IADFG + + G+ Y+
Sbjct: 122 LSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYL 174
Query: 886 APE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 919
PE + EK D++S GV+ E L GK P +
Sbjct: 175 PPEMIEGRMHD------EKVDLWSLGVLCYEFLVGKPPFE 208
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 7/215 (3%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
++P + ++ L N+IS + LT+ + N L + + L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 340 QALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRI 397
+ LDLS N+ SV F L L L L + + P + ++L L + +N +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 398 AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHNTLQGSLPNSLSSL 456
L L L L L NR+S SVP+ L + L N + P++ L
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 457 SGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491
L L + N S +L L +L + L+ N
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 63/261 (24%), Positives = 87/261 (33%), Gaps = 40/261 (15%)
Query: 335 SCSNLQAL--DLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLR 391
C N + L +VP G+ ++ L N IS +P C +L L
Sbjct: 7 VCYNEPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRIS-HVPAASFRACRNLTILW 62
Query: 392 VGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHNTLQGSLP 450
+ +N +A + GL L LDLS N SV L + L LQ L
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG 121
Query: 451 -NSLSSLSGLQVLDVSDNRFSGQIPA-SLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQ 508
L+ LQ L + DN +P + L +L + L N S + SL
Sbjct: 122 PGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 509 LLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEG 568
L L N++ V P L +L L L N L
Sbjct: 181 RLLLHQNRVA-HVH------------------------PHAFRDLGRLMTLYLFANNLS- 214
Query: 569 NLNP--LAQLDNLVSLNISYN 587
L LA L L L ++ N
Sbjct: 215 ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 47/228 (20%), Positives = 83/228 (36%), Gaps = 15/228 (6%)
Query: 32 SDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVE 91
L ++P I + N + +S NL L L+SN L
Sbjct: 19 PQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 92 LSNCKSLRKLLLFDNALAGNIPAE-LGRLSNLEEMRAGGNKDIVGKIPAE-LGDCSNMTA 149
+ L +L L DNA ++ L L + + ++ + +
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG--LQELGPGLFRGLAALQY 133
Query: 150 LGLADTQVSGSLPA-SLGKLSKLQTLSIYTTMISGEIPAEI-GNCSELVSLFLYENSLSG 207
L L D + +LP + L L L ++ IS +P L L L++N ++
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA- 190
Query: 208 SIPPEI-GKLKKLEELFLWQNSLVGAIPEEI-GNCTSLKMIDFSLNSL 253
+ P L +L L+L+ N+L A+P E +L+ + + N
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 43/201 (21%), Positives = 70/201 (34%), Gaps = 16/201 (7%)
Query: 409 KTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNR 468
+ L +VP I Q I L N + S + L +L + N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 469 FSGQIPASLGRLVSLNKIILSKNLFSGPIPSSL--GLCSSLQLLDLSSNQLTGSVPME-L 525
+ A+ L L ++ LS N + + GL L L L L +
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGL-GRLHTLHLDRCGLQ-ELGPGLF 125
Query: 526 GQIEALEIALNLSCNGLTGPIPAQI-SALNKLSILDLSHNKLEGNLNP--LAQLDNLVSL 582
+ AL+ L L N L +P L L+ L L N++ ++ L +L L
Sbjct: 126 RGLAALQY-LYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRL 182
Query: 583 NISYNKFTGYLPDNKLFRQLS 603
+ N+ ++ + FR L
Sbjct: 183 LLHQNRVA-HVHPH-AFRDLG 201
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 49/274 (17%), Positives = 90/274 (32%), Gaps = 59/274 (21%)
Query: 80 NSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPA 139
L +PV + + +++ L N ++ A NL + N + +I
Sbjct: 19 PQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV--LARID- 72
Query: 140 ELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI-GNCSELVSL 198
A+ L+ L+ L + + L +L
Sbjct: 73 ----------------------AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110
Query: 199 FLYENSLSGSIPPEI-GKLKKLEELFLWQNSLVGAIPEEI-GNCTSLKMIDFSLNSLSGT 256
L L + P + L L+ L+L N+L A+P++ + +L + N +S
Sbjct: 111 HLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSV 168
Query: 257 IPLSIGGLSELEEFMISDNNVSGSIPAN-LANATNLVQLQLDTNQISGLIPPEIGMLSKL 315
+ GL L+ ++ N V+ + + + L+ L L N +S +P E
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEA------ 220
Query: 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSL 349
LA LQ L L+ N
Sbjct: 221 -----------------LAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 32/127 (25%), Positives = 51/127 (40%), Gaps = 11/127 (8%)
Query: 7 IQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDI-GDCVGLIVLDFSSNNLVGTLP 65
+Q + P LQ L + D L ++P D D L L N +
Sbjct: 117 LQELG-----PGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPE 170
Query: 66 SSLGKLHNLEELILNSNQLTGKIPVE-LSNCKSLRKLLLFDNALAGNIPAE-LGRLSNLE 123
+ LH+L+ L+L+ N++ + + L L LF N L+ +P E L L L+
Sbjct: 171 RAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQ 228
Query: 124 EMRAGGN 130
+R N
Sbjct: 229 YLRLNDN 235
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIG G + VV A E +A+K++ C + EI+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRI------NLEKCQTSMDELL----KEIQAMSQCH 71
Query: 770 HKNIVRFLGCCWNRNNRL--LMYDYMPNGSLGSLLHERTGNALEWELRYQ------ILLG 821
H NIV + + + L +M + GS+ ++ IL
Sbjct: 72 HPNIVSYY-TSFVVKDELWLVM-KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 822 AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL-AKLVDDGDFARSS--NTV 878
+GL YLH + +HRD+KA NIL+G + IADFG+ A L GD R+ T
Sbjct: 130 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 879 AGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G+ ++APE GY K+D++S+G+ +E+ TG P
Sbjct: 187 VGTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAP 226
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 59/260 (22%), Positives = 109/260 (41%), Gaps = 17/260 (6%)
Query: 335 SCSN-LQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRV 392
SCSN + + L+ VP G+ N L L+ N+I I + + L L++
Sbjct: 51 SCSNQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQL 106
Query: 393 GNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHNTLQGSLPN 451
G N I + GL +LN L+L N L+ +P ++L+ + L +N ++
Sbjct: 107 GRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSY 165
Query: 452 SLSSLSGLQVLDVSDNRFSGQIPA-SLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLL 510
+ + + L LD+ + + I + L +L + L +P+ L L+ L
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPL-VGLEEL 223
Query: 511 DLSSNQLTGSVPME-LGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGN 569
++S N + + +L+ L + + ++ L L L+L+HN L +
Sbjct: 224 EMSGNHFP-EIRPGSFHGLSSLKK-LWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-S 280
Query: 570 LNP--LAQLDNLVSLNISYN 587
L L LV L++ +N
Sbjct: 281 LPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 65/269 (24%), Positives = 111/269 (41%), Gaps = 39/269 (14%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
+P + +N L L N I + L L V +N + ++L
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 340 QALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGN-NR 396
L+L N LT +P+G F+ L L +L L +N I SIP SL+RL +G +
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183
Query: 397 IAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSL 456
+ + GL L +L+L + +P+ + L+ +++S N P S L
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGL 241
Query: 457 SGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQ 516
S L+ L V +++ S ++ +N F G +SL L+L+ N
Sbjct: 242 SSLKKLWVMNSQVS----------------LIERNAFDG--------LASLVELNLAHNN 277
Query: 517 LTGSVPME----LGQIEALEIALN-LSCN 540
L+ S+P + L + L + N +C+
Sbjct: 278 LS-SLPHDLFTPLRYLVELHLHHNPWNCD 305
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-27
Identities = 58/255 (22%), Positives = 103/255 (40%), Gaps = 14/255 (5%)
Query: 218 KLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNV 277
+ ++ + L +P+ I ++ + ++ N++ + L LE + N++
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 278 SGSIPAN-LANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPS-TLAS 335
I +L L+L N ++ + LSKL + N +E SIPS
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169
Query: 336 CSNLQALDLSH-NSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVG 393
+L LDL L + G F+ L NL L L +I +P + L L +
Sbjct: 170 VPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226
Query: 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLP-NS 452
N + P GL +L L + ++++S + L ++L+HN L SLP +
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
Query: 453 LSSLSGLQVLDVSDN 467
+ L L L + N
Sbjct: 286 FTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 58/257 (22%), Positives = 100/257 (38%), Gaps = 17/257 (6%)
Query: 25 HLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQL 84
+V + L+ +P I L+ NN+ + LH+LE L L N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 85 TGKIPVE-LSNCKSLRKLLLFDNALAGNIPAE-LGRLSNLEEMRAGGNKDIVGKIPAE-L 141
+I V + SL L LFDN L IP+ LS L E+ N + IP+
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNP--IESIPSYAF 167
Query: 142 GDCSNMTALGLADTQVSGSLPA-SLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFL 200
++ L L + + + + L L+ L++ I ++P + L L +
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEM 225
Query: 201 YENSLSGSIPPE-IGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPL 259
N I P L L++L++ + + SL ++ + N+LS ++P
Sbjct: 226 SGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPH 283
Query: 260 SI-GGLSELEEFMISDN 275
+ L L E + N
Sbjct: 284 DLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-15
Identities = 53/229 (23%), Positives = 82/229 (35%), Gaps = 17/229 (7%)
Query: 7 IQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDI-GDCVGLIVLDFSSNNLVGTLP 65
IQ + HL+ L + ++ I L L+ N L
Sbjct: 87 IQMIQ-----ADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPS 140
Query: 66 SSLGKLHNLEELILNSNQLTGKIPVE-LSNCKSLRKLLLFDNALAGNIPAE-LGRLSNLE 123
+ L L EL L +N + IP + SL +L L + I L NL+
Sbjct: 141 GAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLK 199
Query: 124 EMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISG 183
+ G + +P L + L ++ P S LS L+ L + + +S
Sbjct: 200 YLNLGMCN--IKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS- 255
Query: 184 EIPAE-IGNCSELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQNSLV 230
I + LV L L N+LS S+P ++ L+ L EL L N
Sbjct: 256 LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IGKG G V++ D +V+A+K + DE ++ EI L
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKII------DLEEAEDEIEDIQ----QEITVLSQCD 78
Query: 770 HKNIVRFLGCCWNRNNRL--LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLA 827
+ ++ G + ++ +L +M +Y+ GS LL + E ++ IL +GL
Sbjct: 79 SPYVTKYYGS-YLKDTKLWIIM-EYLGGGSALDLLEPGPLD--ETQIAT-ILREILKGLD 133
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
YLH + +HRDIKA N+L+ E +ADFG+A + D R NT G+ ++AP
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAP 188
Query: 888 E----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
E Y K+D++S G+ +E+ G+ P
Sbjct: 189 EVIKQSAY----DSKADIWSLGITAIELARGEPP 218
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 55/293 (18%), Positives = 110/293 (37%), Gaps = 24/293 (8%)
Query: 192 CSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLN 251
C SL+ SIP + + ++ L L N + ++ C +L+ + + N
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 252 SLSGTIPLSI-GGLSELEEFMISDNNVSGSIPANL-ANATNLVQLQLDTNQISGLIPPEI 309
++ TI L LE +S N +S ++ ++ ++L L L N L +
Sbjct: 87 GIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSL 144
Query: 310 -GMLSKLTVFFAWQNQLEGSIPS-TLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKL 366
L+KL + I A + L+ L++ + L S + +QN++ L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHL 203
Query: 367 LLISNDISGSIPPEI-GNCSSLVRLRVGNNRIAGLIPREI--------GGLKTLNFLDLS 417
+L + SS+ L + + + E+ T + ++
Sbjct: 204 ILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT 262
Query: 418 SNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNS-LSSLSGLQVLDVSDNRF 469
L V + + L ++ S N L+ S+P+ L+ LQ + + N +
Sbjct: 263 DESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 61/281 (21%), Positives = 114/281 (40%), Gaps = 29/281 (10%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEI-GNCS 385
SIPS L +++LDLS+N +T + Q NL L+L SN I+ +I + +
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100
Query: 386 SLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI--GDCTELQMIDLSHN 443
SL L + N ++ L L +L FL+L N ++ + T+LQ++ + +
Sbjct: 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNM 159
Query: 444 TLQGSLP-NSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLG 502
+ + L+ L+ L++ + P SL + +++ +IL + +
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219
Query: 503 LCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLS 562
+ SS++ L+L L L N L + ++
Sbjct: 220 VTSSVECLELRDTDLDTF------HFSELS---TGETNSLIK--------KFTFRNVKIT 262
Query: 563 HNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLS 603
L + L Q+ L+ L S N+ +PD +F +L+
Sbjct: 263 DESLFQVMKLLNQISGLLELEFSRNQLKS-VPDG-IFDRLT 301
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 59/324 (18%), Positives = 106/324 (32%), Gaps = 53/324 (16%)
Query: 32 SDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVE 91
S +L SIP + + LD S+N + S L + NL+ L+L SN + I +
Sbjct: 39 SSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEED 94
Query: 92 L-SNCKSLRKLLLFDNALAGNIPAEL-GRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTA 149
S+ SL L L N L+ N+ + LS+L + GN + + +
Sbjct: 95 SFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQI 153
Query: 150 LGLADTQVSGSLPA-SLGKLSKLQTLSIYTTMISGEIPAEI-GNCSELVSLFLYENSLSG 207
L + + + L+ L+ L I + + + + + L L+
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI- 211
Query: 208 SIPPEI-GKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSE 266
+ +E L L L F + LS S+
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDT----------------FHFSELSTGETNSLIKKFT 255
Query: 267 LEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLE 326
I+D ++ + L + L++L+ NQ+ +P I
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGI----------------- 296
Query: 327 GSIPSTLASCSNLQALDLSHNSLT 350
++LQ + L N
Sbjct: 297 ------FDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 52/281 (18%), Positives = 98/281 (34%), Gaps = 41/281 (14%)
Query: 366 LLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSV 425
++IS S +C + + + IP + + + LDLS+NR++
Sbjct: 12 GVIISLSKEESSNQASLSCDRNGICKGSSGSLNS-IPSGL--TEAVKSLDLSNNRITYIS 68
Query: 426 PDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL-GRLVSLN 484
++ C LQ + L+ N + +S SSL L+ LD+S N S + +S L SL
Sbjct: 69 NSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLT 127
Query: 485 KIILSKNLFSGPIPSSL--GL------------------------CSSLQLLDLSSNQLT 518
+ L N + +SL L + L+ L++ ++ L
Sbjct: 128 FLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187
Query: 519 GSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGN--------- 569
P L I+ + L L + + + + L+L L+
Sbjct: 188 SYEPKSLKSIQNVSH-LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE 246
Query: 570 LNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGN 610
N L + ++ I+ + L + + N
Sbjct: 247 TNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 33/174 (18%), Positives = 64/174 (36%), Gaps = 13/174 (7%)
Query: 14 LPIPTNLSSFKHLQTLVISDANLTGSIPFDI-GDCVGLIVLDFSSNNLVGTLPSSLGKLH 72
L + S LQ L + + + I L L+ +++L P SL +
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQ 198
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAEL--------GRLSNLEE 124
N+ LIL+ Q + + + S+ L L D L +EL +
Sbjct: 199 NVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258
Query: 125 MRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPAS-LGKLSKLQTLSIY 177
++ + ++ L S + L + Q+ S+P +L+ LQ + ++
Sbjct: 259 VKITDES--LFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLH 309
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 68/299 (22%), Positives = 106/299 (35%), Gaps = 58/299 (19%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G G VY A D +A+K ++ E++ R F E+ + H
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPR------EKEETLKR--FEREVHNSSQLSH 70
Query: 771 KNIVRFLGCCWNRNNRLLMYD-------------YMPNGSLGSLLHERTGNALEWELRYQ 817
+NIV M D Y+ +L + L +
Sbjct: 71 QNIVS-------------MIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAIN 115
Query: 818 ILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT 877
G+ + H IVHRDIK NILI I DFG+AK + + +N
Sbjct: 116 FTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNH 171
Query: 878 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG---SHVVDWVRQ 934
V G+ Y +PE E +D+YS G+V+ E+L G+ P + H+ D V
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-- 229
Query: 935 KKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993
P++ + +I + L V L R K + M ++ E
Sbjct: 230 --------PNVTTDVRKDIPQSLSN--VILRATEKDKANRY--KTIQEMKDDLSSVLHE 276
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 41/221 (18%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++G+G G VY A D ++A+K + T+++ D R E +T G ++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSS-----DPVFRTR--MQREARTAGRLQ 92
Query: 770 HKNIVRFLGCCWNRNNRLLMYD-------------YMPNGSLGSLLHERTGNALEWELRY 816
++V ++D + L ++L + L
Sbjct: 93 EPHVVP-------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAV 137
Query: 817 QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSN 876
I+ L H HRD+K NIL+ + Y+ DFG+A D +
Sbjct: 138 AIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LG 193
Query: 877 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G+ Y+APE T ++D+Y+ V+ E LTG P
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-27
Identities = 63/263 (23%), Positives = 95/263 (36%), Gaps = 41/263 (15%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G G V R D GE +A+K+ K+ R+ + EI+ + +
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQC--------RQELSPKN--RERWCLEIQIMKKLN 70
Query: 770 HKNIVRFL-------GCCWNRNNRLLMYDYMPNGSLGSLL--HERTGNALEWELRY---Q 817
H N+V N L M +Y G L L E E +R
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAM-EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 818 ILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARS 874
I L YLH + I+HRD+K NI++ + I D G AK +D G+
Sbjct: 130 IS----SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT- 181
Query: 875 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ 934
G+ Y+APE K T D +S+G + E +TG +P P V W +
Sbjct: 182 --EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP----NWQPVQWHGK 235
Query: 935 KKGIQVLDPSLLSRPESEIDEML 957
+ + +
Sbjct: 236 VREKSNEHIVVYDDLTGAVKFSS 258
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+GKG G VY A + N ++A+K L+ + + EK GV EI+ +R
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--------EKEGVEHQLRREIEIQSHLR 72
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQGL 826
H NI+R +R LM ++ P G L L ++ G E ++ A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEEL----ADAL 127
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIA 886
Y H V +HRDIK N+L+G + E IADFG + T+ G+ Y+
Sbjct: 128 HYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLP 180
Query: 887 PE----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
PE + EK D++ GV+ E L G P
Sbjct: 181 PEMIEGKTH----DEKVDLWCAGVLCYEFLVGMPP 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 72/284 (25%), Positives = 121/284 (42%), Gaps = 57/284 (20%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+G G VY+A + G+++A+K++ +S +++ EI +
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV------------PVESDLQE-IIKEISIMQQC 81
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
++V++ G + + ++ +Y GS+ ++ R E E+ IL +GL Y
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-ILQSTLKGLEY 140
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
LH +HRDIKA NIL+ E +ADFG+A + D R NTV G+ ++APE
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--NTVIGTPFWMAPE 195
Query: 889 ----YGYMMKITEKSDVYSYGVVVLEVLTGKQP---IDP-----TIPDGSHVVDWVRQKK 936
GY +D++S G+ +E+ GK P I P IP
Sbjct: 196 VIQEIGY----NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-----------TN 240
Query: 937 GIQVL-DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKD 979
P L S + ++ C+ SP++R T
Sbjct: 241 PPPTFRKPELWSD---NFTDFVK------QCLVKSPEQRATATQ 275
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 64/308 (20%), Positives = 116/308 (37%), Gaps = 57/308 (18%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+ +G VY A D+ +G A+K+L ++E+ + E+ + +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRL---------LSNEEEK--NRAIIQEVCFMKKLS 83
Query: 770 -HKNIVRFLGCCWNRNNR---------LLMYDYMPNGSLGSLLHERTGNAL-EWELRYQI 818
H NIV+F LL + L + L + +I
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESRGPLSCDTVL-KI 141
Query: 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS--- 875
+ + ++H PPI+HRD+K N+L+ + + DFG A + S
Sbjct: 142 FYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 876 -------NTVAGSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD 924
T + Y PE Y I EK D+++ G ++ + + P + D
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHPFE----D 255
Query: 925 GSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
G+ + ++++ P + +L A+L VN P+ER ++ +V L
Sbjct: 256 GAKL----------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEERLSIAEVVHQL 303
Query: 985 KEIKHERE 992
+EI R
Sbjct: 304 QEIAAARN 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 52/218 (23%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G G G VY+A + + G + A K + S+E+ + + EI+ L +
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVI--------ETKSEEE---LEDYIVEIEILATC 73
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
H IV+ LG ++ +M ++ P G++ +++ E E +++ + + L +
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNF 132
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
LH + +HRD+KA N+L+ LE + +ADFG++ R ++ G+ ++APE
Sbjct: 133 LHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMAPE 187
Query: 889 ---------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
Y K+D++S G+ ++E+ + P
Sbjct: 188 VVMCETMKDTPY----DYKADIWSLGITLIEMAQIEPP 221
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 55/282 (19%), Positives = 106/282 (37%), Gaps = 42/282 (14%)
Query: 219 LEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVS 278
+ E + P++ + S++ + + L+ +++ + +++++
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56
Query: 279 GSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSN 338
S+ + N+ +L L+ N+++ +I L+ L N
Sbjct: 57 -SVQ-GIQYLPNVTKLFLNGNKLT-----DIKPLTNLK---------------------N 88
Query: 339 LQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIA 398
L L L N + L L+ L L L N IS I + + L L +GNN+I
Sbjct: 89 LGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT 144
Query: 399 GLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSG 458
+ + L L+ L L N++S + + T+LQ + LS N + L L+ L
Sbjct: 145 DITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKN 198
Query: 459 LQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSS 500
L VL++ + LV N + + P S
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-25
Identities = 62/345 (17%), Positives = 117/345 (33%), Gaps = 45/345 (13%)
Query: 267 LEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLE 326
+ E + + I ++ L ++ +
Sbjct: 1 MGETITVSTPIK-QIF-PDDAFAETIKDNLKKKSVTDAVT-------------------- 38
Query: 327 GSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSS 386
+++ + +++ + SV G+ L N+TKL L N ++ I P + N +
Sbjct: 39 ------QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DIKP-LTNLKN 88
Query: 387 LVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446
L L + N+I L + LK L L L N +S + + +L+ + L +N +
Sbjct: 89 LGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKI- 143
Query: 447 GSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSS 506
+ LS L+ L L + DN+ S I L L L + LSKN S +L +
Sbjct: 144 -TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKN 198
Query: 507 LQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKL 566
L +L+L S + + + + P IS ++ +
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPN---TVKNTDGSLVTPEIISDDGDYEKPNVKWHLP 255
Query: 567 EGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNE 611
E V++ + +F G + D+ G
Sbjct: 256 EFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTV 300
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 97.9 bits (243), Expect = 5e-21
Identities = 52/257 (20%), Positives = 92/257 (35%), Gaps = 18/257 (7%)
Query: 141 LGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFL 200
+ L V+ ++ +L+ + + + I + I + LFL
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 72
Query: 201 YENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLS 260
N L+ I P + LK L LFL +N + + + + LK + N +S L
Sbjct: 73 NGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGISDINGLV 128
Query: 261 IGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFA 320
L +LE + +N ++ I L+ T L L L+ NQIS + + L+KL +
Sbjct: 129 --HLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYL 182
Query: 321 WQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPE 380
+N + + LA NL L+L L + + P
Sbjct: 183 SKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEI 238
Query: 381 IGNCSSLVRLRVGNNRI 397
I + + V +
Sbjct: 239 ISDDGDYEKPNVKWHLP 255
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 86.7 bits (214), Expect = 2e-17
Identities = 47/238 (19%), Positives = 95/238 (39%), Gaps = 21/238 (8%)
Query: 66 SSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEM 125
+ L +T + + S+ +++ ++ + ++ + L N+ ++
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 70
Query: 126 RAGGNK--DIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISG 183
GNK DI L + N+ L L + ++ L SL L KL++LS+ IS
Sbjct: 71 FLNGNKLTDIKP-----LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS- 122
Query: 184 EIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSL 243
+I + + +L SL+L N ++ I + +L KL+ L L N + + T L
Sbjct: 123 DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKL 177
Query: 244 KMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQI 301
+ + S N +S L+ GL L+ + + +N ++ +
Sbjct: 178 QNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 9e-17
Identities = 48/259 (18%), Positives = 97/259 (37%), Gaps = 41/259 (15%)
Query: 18 TNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEEL 77
+ + ++ +++++ S+ I + L + N L L L NL L
Sbjct: 37 VTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWL 92
Query: 78 ILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKI 137
L+ N++ + L + K L+ L L N +S++
Sbjct: 93 FLDENKIK-DLS-SLKDLKKLKSLSLEHN-----------GISDIN-------------- 125
Query: 138 PAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVS 197
L + +L L + +++ L +L+KL TLS+ IS +I + ++L +
Sbjct: 126 --GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQN 179
Query: 198 LFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTI 257
L+L +N +S + + LK L+ L L+ + N + + SL
Sbjct: 180 LYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VT 235
Query: 258 PLSIGGLSELEEFMISDNN 276
P I + E+ + +
Sbjct: 236 PEIISDDGDYEKPNVKWHL 254
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 60/312 (19%), Positives = 121/312 (38%), Gaps = 58/312 (18%)
Query: 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK- 763
L +G+G GVV + + +G+++AVK++ + S + ++
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI----------RATVNSQEQKRLLMDLDI 58
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLL---HERTGNALEWELRYQILL 820
++ ++ V F G + + + + M + SL ++ E L I +
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK-IAV 116
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL-AKLVDDGDFARSSNTVA 879
+ L +LH ++HRD+K +N+LI + + DFG+ LVD + + A
Sbjct: 117 SIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDIDA 170
Query: 880 GSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931
G Y+APE GY + KSD++S G+ ++E+ + P
Sbjct: 171 GCKPYMAPERINPELNQKGY----SVKSDIWSLGITMIELAILRFP----YDSWGTPFQQ 222
Query: 932 VRQKKGIQVLDPSLLSRPE--SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK--EI 987
++Q + L + +E + C+ + ERPT + +++
Sbjct: 223 LKQ---VVEEPSPQLPADKFSAEFVDFTSQ------CLKKNSKERPTYPE---LMQHPFF 270
Query: 988 KHEREEYAKVDM 999
+ D+
Sbjct: 271 TLHESK--GTDV 280
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/215 (26%), Positives = 107/215 (49%), Gaps = 36/215 (16%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G SG VY A D+ G+ +A+++ + ++ ++ EI + ++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQ-----------MNLQQQPKKELIINEILVMRENKN 76
Query: 771 KNIVRFLGCCWNRNNRL--LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
NIV +L + + L +M +Y+ GSL ++ E + E ++ + Q L +
Sbjct: 77 PNIVNYLDS-YLVGDELWVVM-EYLAGGSLTDVVTETCMD--EGQIAA-VCRECLQALEF 131
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
LH + ++HRDIK++NIL+G++ + DFG + R +T+ G+ ++APE
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPE 186
Query: 889 ------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
YG K D++S G++ +E++ G+ P
Sbjct: 187 VVTRKAYGP------KVDIWSLGIMAIEMIEGEPP 215
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 47/295 (15%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G G V+ A D+ + +AVK L D +R F E + ++ H
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADL------ARDPSFYLR--FRREAQNAAALNH 71
Query: 771 KNIVRFLGCCWNRNNRLLMY----DYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGL 826
IV + +Y+ +L ++H + + +++ A Q L
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQAL 129
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFAR-SSNTVAGSYGYI 885
+ H + I+HRD+K NI+I + DFG+A+ + D + + V G+ Y+
Sbjct: 130 NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 886 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG--------SHVVDWVRQKKG 937
+PE + +SDVYS G V+ EVLTG+ P G HV +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSVAYQHVRE------- 234
Query: 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992
DP S + L A V L + +P+ R + A M ++
Sbjct: 235 ----DPIPPSARHEGLSADLDA--VVLKALAKNPENRY--QTAAEMRADLVRVHN 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 47/307 (15%), Positives = 85/307 (27%), Gaps = 66/307 (21%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVK---KLWPTTMAAANGCSDEKSGVR----------- 755
V+G+ A D + GE V A +E +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 756 ---DSFSAEIKTLGSIRHKNIVRFLGC---CWNRNNRLLMYDYMPNGSLGSLLHE----- 804
F + + K ++R W + L +L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP--RMQSNLQTFGEVLLSHS 197
Query: 805 RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
T +L R Q+ L + LA LHH +VH ++ +I++ ++ F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 865 LVDDGDFARSSNTVAGSYGYIAPEY-----------GYMMKITEKSDVYSYGVVVLEVLT 913
+ + S G+ PE +T D ++ G+V+ +
Sbjct: 255 RDG------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 914 GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDE 973
PI G + R I + ++AL L ++
Sbjct: 309 ADLPITKDAALGGS----------------EWIFRSCKNIPQPVRALLEGFLRYP--KED 350
Query: 974 RPTMKDV 980
R
Sbjct: 351 RLLPLQA 357
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 62/249 (24%), Positives = 98/249 (39%), Gaps = 41/249 (16%)
Query: 694 KLNFSVEQVLKC----LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCS 748
KL S EQ L D IG+G G V + +G+++AVK++ S
Sbjct: 8 KLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI----------RS 57
Query: 749 DEKSGVRDSFSAEIKT-LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHE--- 804
+ ++ + S IV+F G + + + + M + S
Sbjct: 58 TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYS 116
Query: 805 -RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL- 862
E L I L + L +L + I+HRDIK +NIL+ + DFG+
Sbjct: 117 VLDDVIPEEILGK-ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS 173
Query: 863 AKLVDDGDFARSSNTVAGSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLEVLTG 914
+LVD + + AG Y+APE GY +SDV+S G+ + E+ TG
Sbjct: 174 GQLVD----SIAKTRDAGCRPYMAPERIDPSASRQGY----DVRSDVWSLGITLYELATG 225
Query: 915 KQPIDPTIP 923
+ P
Sbjct: 226 RFPYPKWNS 234
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 59/264 (22%), Positives = 102/264 (38%), Gaps = 35/264 (13%)
Query: 232 AIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPAN-LANATN 290
+P+ I T+ ++++ N + S L LE +S N++ +I N
Sbjct: 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113
Query: 291 LVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT 350
L L+L N+++ IP G L+ L+ L L +N +
Sbjct: 114 LNTLELFDNRLTT-IPN--GAFVYLS---------------------KLKELWLRNNPIE 149
Query: 351 ASVPAGLFQ-LQNLTKLLLIS-NDISGSIPPEI-GNCSSLVRLRVGNNRIAGLIPREIGG 407
S+P+ F + +L +L L +S I S+L L + + IP +
Sbjct: 150 -SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTP 205
Query: 408 LKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN 467
L L+ LDLS N LS P LQ + + + +Q N+ +L L ++++ N
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 468 RFSGQIPASLGRLVSLNKIILSKN 491
+ L L +I L N
Sbjct: 266 NLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-25
Identities = 72/314 (22%), Positives = 127/314 (40%), Gaps = 44/314 (14%)
Query: 307 PEIGMLSKLTVFFAWQNQLEGSIPSTLASCS---NLQALDLSHNSLTASVPAGLFQLQNL 363
P + ++S L+V GS + + CS + +L VP G+ N
Sbjct: 10 PALLLVSLLSVLLMGCVAETGSAQTCPSVCSCSNQFSKVICVRKNLR-EVPDGIST--NT 66
Query: 364 TKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLS 422
L L N I I + L L++ N I + GL LN L+L NRL+
Sbjct: 67 RLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125
Query: 423 GSVPDEI-GDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLV 481
++P+ ++L+ + L +N ++ + + + L+ LD+ +
Sbjct: 126 -TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL-------------- 170
Query: 482 SLNKI-ILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN 540
++ +S+ F G S+L+ L+L+ L +P L + L+ L+LS N
Sbjct: 171 --KRLSYISEGAFEG--------LSNLRYLNLAMCNLR-EIP-NLTPLIKLD-ELDLSGN 217
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEG-NLNPLAQLDNLVSLNISYNKFTGYLPDNKLF 599
L+ P L L L + ++++ N L +LV +N+++N T LP + LF
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHD-LF 275
Query: 600 RQLSPT---DLAGN 610
L L N
Sbjct: 276 TPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 59/279 (21%), Positives = 97/279 (34%), Gaps = 37/279 (13%)
Query: 25 HLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQL 84
++ NL +P I +L+ N + +S L +LE L L+ N +
Sbjct: 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 85 TGKIPVE-LSNCKSLRKLLLFDNALAGNIPAE-LGRLSNLEEMRAGGNKDIVGKIPAELG 142
I + + +L L LFDN L IP LS L+E+ N + IP
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNP--IESIP---- 152
Query: 143 DCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI-GNCSELVSLFLY 201
+ ++ L+ L + I S L L L
Sbjct: 153 -------------------SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193
Query: 202 ENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSI 261
+L IP + L KL+EL L N L P L+ + + + +
Sbjct: 194 MCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251
Query: 262 GGLSELEEFMISDNNVSGSIPAN-LANATNLVQLQLDTN 299
L L E ++ NN++ +P + +L ++ L N
Sbjct: 252 DNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 65/319 (20%), Positives = 116/319 (36%), Gaps = 66/319 (20%)
Query: 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
L + +G G G V++ G VIAVK++ +G +E + ++
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM------RRSGNKEENKRIL----MDLDV 76
Query: 765 L-GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
+ S IV+ G + + + M L G E L + +
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK-MTVAIV 134
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL-AKLVDDGDFARSSNTVAGSY 882
+ L YL ++HRD+K +NIL+ + + DFG+ +LVD ++ + AG
Sbjct: 135 KALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCA 188
Query: 883 GYIAPE---------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933
Y+APE Y ++DV+S G+ ++E+ TG+ P D
Sbjct: 189 AYMAPERIDPPDPTKPDY----DIRADVWSLGISLVELATGQFPYKNCKTD-------FE 237
Query: 934 QKKGIQVLDPSLLSRPES---EIDEMLQALGVALLCVNASPDERPTMK------------ 978
+ +P LL + ++ C+ +RP
Sbjct: 238 VLTKVLQEEPPLLPGHMGFSGDFQSFVKD------CLTKDHRKRPKYNKLLEHSFIKRYE 291
Query: 979 ----DVAAMLKEIKHEREE 993
DVA+ K++ + E
Sbjct: 292 TLEVDVASWFKDVMAKTES 310
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-26
Identities = 46/304 (15%), Positives = 84/304 (27%), Gaps = 51/304 (16%)
Query: 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEK------------- 751
LV V+G+ A D + GE V + T +N K
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 752 ----SGVRDSFSAEIKTLGSIRHKNIVRFLGC---CWNRNNRLLM-YDYMPNGSLGSLLH 803
+ V F + + K ++R W + L + G +L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 804 E--RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861
T +L R Q+ L + LA LHH +VH ++ +I++ ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK-----ITEKSDVYSYGVVVLEVLTGKQ 916
+ A + +T D ++ G+ + +
Sbjct: 257 HLVRDGASAVSP-IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 917 PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT 976
P G + R I + ++AL L ++R
Sbjct: 316 PNTDDAALGG----------------SEWIFRSCKNIPQPVRALLEGFLRYP--KEDRLL 357
Query: 977 MKDV 980
Sbjct: 358 PLQA 361
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 9e-26
Identities = 59/290 (20%), Positives = 105/290 (36%), Gaps = 54/290 (18%)
Query: 711 VIGKGCSGVVYRA-DMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
I G G +Y A D + NG + +K L + A A + AE + L +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEA----------QAMAMAERQFLAEV 136
Query: 769 RHKNIVRFL--GCCWNRNNRLLMY---DYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
H +IV+ +R+ + Y +Y+ SL ++ L LL
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEIL 192
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
L+YLH +V+ D+K NI++ E + + D G ++ + G+ G
Sbjct: 193 PALSYLHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINS------FGYLYGTPG 242
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
+ APE T +D+Y+ G + + +G +V G+ D
Sbjct: 243 FQAPEI-VRTGPTVATDIYTVGRTLAALTLDLPT-----RNGRYV-------DGLPE-DD 288
Query: 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993
+L +S +L ++ P +R T M ++ E
Sbjct: 289 PVLKTYDS-YGRLL------RRAIDPDPRQRFT--TAEEMSAQLTGVLRE 329
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 74/292 (25%), Positives = 116/292 (39%), Gaps = 62/292 (21%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG G G VY A D+ N EV+A+KK+ + + + E++ L +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKM--------SYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
RH N +++ GC + L+ +Y GS LL E E+ + GA QGLAY
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
LH ++HRD+KA NIL+ + DFG A ++ +N+ G+ ++APE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPE 220
Query: 889 -------YGYMMKITEKSDVYSYGVVVLEVLTGKQP---IDP-----TIPDGSHVVDWVR 933
Y K DV+S G+ +E+ K P ++ I
Sbjct: 221 VILAMDEGQY----DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------- 266
Query: 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
+ L S + C+ P +RPT + +LK
Sbjct: 267 -QNESPALQSGHWSE---YFRNFVD------SCLQKIPQDRPTSEV---LLK 305
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG+G +G+V A + +G +AVK K R+ E+ + +H
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKM-----------MDLRKQQRRELLFNEVVIMRDYQH 101
Query: 771 KNIVRFLGCCWNRNNRL--LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
N+V + L LM +++ G+L ++ + N E ++ + Q LAY
Sbjct: 102 FNVVEMYKS-YLVGEELWVLM-EFLQGGALTDIVSQVRLN--EEQIAT-VCEAVLQALAY 156
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
LH ++HRDIK+++IL+ L+ ++DFG + R ++ G+ ++APE
Sbjct: 157 LHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPE 211
Query: 889 ------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
Y + D++S G++V+E++ G+ P
Sbjct: 212 VISRSLYAT------EVDIWSLGIMVIEMVDGEPP 240
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 66/289 (22%), Positives = 104/289 (35%), Gaps = 49/289 (16%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRD--SFSAEIKTLG 766
+G G G V + + A+K + + D K+ + EI L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAA 823
S+ H NI++ ++ L+ ++ G L + R E + + QIL
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQIL---- 156
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILI---GLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
G+ YLH IVHRDIK NIL+ I DFGL+ G
Sbjct: 157 SGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLG 210
Query: 881 SYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935
+ YIAPE Y EK DV+S GV++ +L G P +
Sbjct: 211 TAYYIAPEVLKKKYN------EKCDVWSCGVIMYILLCGYPPF------------GGQND 252
Query: 936 KGI--QVL--DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ I +V I + + L +L + ++R T ++
Sbjct: 253 QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYD--YNKRCTAEEA 299
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 74/335 (22%), Positives = 126/335 (37%), Gaps = 58/335 (17%)
Query: 670 RRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDAN-----VIGKGCSGVVYRA- 723
RR + ++ + L S F F L + V + +G G G V A
Sbjct: 97 RRPLNNNSEIALSLSRNKVFV-FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF 155
Query: 724 DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783
+ + +A++ + A S ++ + EI+ L + H I++
Sbjct: 156 ERKTCKKVAIRIISKRKFAIG---SAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212
Query: 784 NNRLLMYDYMPNGSL-------GSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPP 836
+ +++ + M G L L E T YQ+L + YLH +
Sbjct: 213 DYYIVL-ELMEGGELFDKVVGNKRL-KEATCK----LYFYQML----LAVQYLHENG--- 259
Query: 837 IVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVAGSYGYIAPE----- 888
I+HRD+K N+L+ + E I DFG +K++ + R T+ G+ Y+APE
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---TLCGTPTYLAPEVLVSV 316
Query: 889 --YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ-KKGIQVLDPSL 945
GY D +S GV++ L+G P + V Q G +
Sbjct: 317 GTAGY----NRAVDCWSLGVILFICLSGYPPFS----EHRTQVSLKDQITSG----KYNF 364
Query: 946 LSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ +E+ E L LL V+ P R T ++
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVD--PKARFTTEEA 397
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-24
Identities = 62/287 (21%), Positives = 106/287 (36%), Gaps = 56/287 (19%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G G G V D A+K + + + S + + E+ L +
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIK-----IIRKTSVSTSSNSKLLE----EVAVLKLL 93
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQG 825
H NI++ ++ N L+ + G L + R E + + Q+L G
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVL----SG 148
Query: 826 LAYLHHDCVPPIVHRDIKANNILI---GLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
+ YLH IVHRD+K N+L+ + I DFGL+ + ++ + G+
Sbjct: 149 VTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTA 202
Query: 883 GYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937
YIAPE Y EK DV+S GV++ +L G P + +
Sbjct: 203 YYIAPEVLRKKYD------EKCDVWSIGVILFILLAGYPPF------------GGQTDQE 244
Query: 938 I--QVL--DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
I +V + S + E + L +L + R + +
Sbjct: 245 ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFD--SQRRISAQQA 289
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/250 (22%), Positives = 95/250 (38%), Gaps = 18/250 (7%)
Query: 251 NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIG 310
+ +E + + +V+ ++ ++ Q+ + + I + I
Sbjct: 12 TPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQ 65
Query: 311 MLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLIS 370
L +T F N+L I LA+ NL L L N + L L+ L L L
Sbjct: 66 YLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEH 121
Query: 371 NDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIG 430
N IS I + + L L +GNN+I + + L L+ L L N++S + +
Sbjct: 122 NGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LA 175
Query: 431 DCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSK 490
T+LQ + LS N S +L+ L L VL++ + LV N + +
Sbjct: 176 GLTKLQNLYLSKN--HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 233
Query: 491 NLFSGPIPSS 500
P S
Sbjct: 234 GSLVTPEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 60/308 (19%), Positives = 111/308 (36%), Gaps = 43/308 (13%)
Query: 284 NLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALD 343
+ ++ L ++ T +++ +
Sbjct: 19 SDDAFAETIKDNLKKKSVTDA--------------------------VTQNELNSIDQII 52
Query: 344 LSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403
+++ + SV G+ L N+TKL L N ++ I P + N +L L + N++ L
Sbjct: 53 ANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDLSS- 107
Query: 404 EIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLD 463
+ LK L L L N + S + + +L+ + L +N + + LS L+ L L
Sbjct: 108 -LKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLS 162
Query: 464 VSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPM 523
+ DN+ S I L L L + LSKN S +L +L +L+L S +
Sbjct: 163 LEDNQIS-DIV-PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPIN 218
Query: 524 ELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLN 583
+ N + +T P IS ++ + E V++
Sbjct: 219 HQSNLVVPNTVKNTDGSLVT---PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIG 275
Query: 584 ISYNKFTG 591
+ +F G
Sbjct: 276 KAKARFHG 283
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 51/257 (19%), Positives = 107/257 (41%), Gaps = 18/257 (7%)
Query: 331 STLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRL 390
+ + + +L S+T +V +L ++ +++ ++DI S+ I ++ +L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 391 RVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLP 450
+ N++ + P + LK L +L L N++ + D +L+ + L HN + +
Sbjct: 74 FLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DIN 128
Query: 451 NSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLL 510
L L L+ L + +N+ + I L RL L+ + L N S L + LQ L
Sbjct: 129 G-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNL 183
Query: 511 DLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNL 570
LS N ++ + L ++ L++ L L S L + + + L
Sbjct: 184 YLSKNHIS-DLR-ALAGLKNLDV-LELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TP 239
Query: 571 NPLAQLDNLVSLNISYN 587
++ + N+ ++
Sbjct: 240 EIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 50/233 (21%), Positives = 87/233 (37%), Gaps = 16/233 (6%)
Query: 141 LGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFL 200
+ L V+ ++ +L+ + + + I + I + LFL
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75
Query: 201 YENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLS 260
N L+ I P + LK L LFL +N + + + LK + N +S L
Sbjct: 76 NGNKLT-DIKP-LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 261 IGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFA 320
L +LE + +N ++ I L+ T L L L+ NQIS ++P + L+KL +
Sbjct: 132 --HLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185
Query: 321 WQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDI 373
+N + + LA NL L+L L + +
Sbjct: 186 SKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 51/267 (19%), Positives = 105/267 (39%), Gaps = 25/267 (9%)
Query: 42 FDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKL 101
F I + ++ T + +L++++++I N++ + + + ++ KL
Sbjct: 18 FSDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 73
Query: 102 LLFDNALAGNIPAELGRLSNLEEMRAGGNK--DIVGKIPAELGDCSNMTALGLADTQVSG 159
L N L +I L L NL + NK D+ L D + +L L +S
Sbjct: 74 FLNGNKLT-DIK-PLANLKNLGWLFLDENKVKDLSS-----LKDLKKLKSLSLEHNGIS- 125
Query: 160 SLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKL 219
+ L L +L++L + I+ +I + ++L +L L +N +S I P + L KL
Sbjct: 126 DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKL 180
Query: 220 EELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSG 279
+ L+L +N + + + +L +++ L +D ++
Sbjct: 181 QNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 238
Query: 280 ----SIPANLANATNLVQLQLDTNQIS 302
S + L TN++S
Sbjct: 239 PEIISDDGDYEKPNVKWHLPEFTNEVS 265
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 43/190 (22%), Positives = 73/190 (38%), Gaps = 17/190 (8%)
Query: 18 TNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEEL 77
+ ++ L ++ LT I + + L L N + SSL L L+ L
Sbjct: 62 QGIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSL 117
Query: 78 ILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNK--DIVG 135
L N ++ I L + L L L +N + +I L RL+ L+ + N+ DIV
Sbjct: 118 SLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVP 173
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSEL 195
L + + L L+ +S L A L L L L +++ + N
Sbjct: 174 -----LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVP 226
Query: 196 VSLFLYENSL 205
++ + SL
Sbjct: 227 NTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 18/84 (21%), Positives = 38/84 (45%), Gaps = 8/84 (9%)
Query: 520 SVPMELGQIEALE-----IALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLA 574
+VP + QI + + I NL +T + + LN + + +++ ++ ++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQ 65
Query: 575 QLDNLVSLNISYNKFTGYLPDNKL 598
L N+ L ++ NK T P L
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANL 89
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 65/287 (22%), Positives = 109/287 (37%), Gaps = 55/287 (19%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
V+GKG G V D G+ AVK + + ++S E++ L +
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--------KESLLREVQLLKQL 83
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQG 825
H NI++ ++ L+ + G L + R E + + Q+L G
Sbjct: 84 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVL----SG 138
Query: 826 LAYLHHDCVPPIVHRDIKANNILI---GLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
+ Y+H + IVHRD+K N+L+ + I DFGL+ + + G+
Sbjct: 139 ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGTA 192
Query: 883 GYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937
YIAPE Y EK DV+S GV++ +L+G P +
Sbjct: 193 YYIAPEVLHGTYD------EKCDVWSTGVILYILLSGCPPF------------NGANEYD 234
Query: 938 I--QVL--DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
I +V + ++ E + L +L P R + +D
Sbjct: 235 ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV--PSMRISARDA 279
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 63/244 (25%), Positives = 97/244 (39%), Gaps = 38/244 (15%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
IP NL + L L N + L F S L
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGS---------YSF---------------FSFPEL 54
Query: 340 QALDLSHNSLTASVPAGLF-QLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRI 397
Q LDLS + ++ G + L +L+ L+L N I S+ SSL +L +
Sbjct: 55 QVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL 112
Query: 398 AGLIPREIGGLKTLNFLDLSSNRL-SGSVPDEIGDCTELQMIDLSHNTLQGSLP-NSLSS 455
A L IG LKTL L+++ N + S +P+ + T L+ +DLS N +Q S+ L
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
Query: 456 LSGLQV----LDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLD 511
L + + LD+S N + I + + L ++ L N +SLQ +
Sbjct: 172 LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIW 230
Query: 512 LSSN 515
L +N
Sbjct: 231 LHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 52/262 (19%), Positives = 90/262 (34%), Gaps = 42/262 (16%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVG 393
N + +P L + L L N + + + L L +
Sbjct: 6 VVPN-ITYQCMELNFY-KIPDNLPF--STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLS 60
Query: 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHNTLQGSLPNS 452
I + L L+ L L+ N + S+ + LQ + L SL N
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENF 118
Query: 453 L-SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLD 511
L L+ L+V+ N + FS ++L+ LD
Sbjct: 119 PIGHLKTLKELNVAHNL--------------IQSFK-LPEYFSN--------LTNLEHLD 155
Query: 512 LSSNQLTGSVPME----LGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE 567
LSSN++ S+ L Q+ L ++L+LS N + I +L L L N+L+
Sbjct: 156 LSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK 213
Query: 568 GNLNP--LAQLDNLVSLNISYN 587
++ +L +L + + N
Sbjct: 214 -SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 46/221 (20%), Positives = 83/221 (37%), Gaps = 16/221 (7%)
Query: 208 SIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSI-GGLSE 266
IP + + L L N L + L+++D S + TI LS
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 267 LEEFMISDNNVSGSIPANL-ANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQL 325
L +++ N + S+ + ++L +L ++ L IG L L N +
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 326 EGSIPS--TLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLT----KLLLISNDISGSIP 378
+ S ++ +NL+ LDLS N + S+ + L + L L N ++ I
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193
Query: 379 PEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSN 419
P L L + N++ + L +L + L +N
Sbjct: 194 PGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 51/253 (20%), Positives = 87/253 (34%), Gaps = 42/253 (16%)
Query: 32 SDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVE 91
+ N IP ++ LD S N L S L+ L L+ ++ I
Sbjct: 15 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70
Query: 92 LSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAEL-GDCSNMTAL 150
+ + LS+L + GN + + S++ L
Sbjct: 71 -----------AYQS------------LSHLSTLILTGNP--IQSLALGAFSGLSSLQKL 105
Query: 151 GLADTQVSGSLPASL-GKLSKLQTLSIYTTMI-SGEIPAEIGNCSELVSLFLYENSLSGS 208
+T ++ SL G L L+ L++ +I S ++P N + L L L N + S
Sbjct: 106 VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-S 163
Query: 209 IPPEI-GKLKKLE----ELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSI-G 262
I L ++ L L N + I LK + N L ++P I
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFD 221
Query: 263 GLSELEEFMISDN 275
L+ L++ + N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 44/190 (23%), Positives = 64/190 (33%), Gaps = 34/190 (17%)
Query: 417 SSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPAS 476
+PD + + +DLS N L+ S S LQVLD+S I
Sbjct: 15 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70
Query: 477 L-GRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIAL 535
L L+ +IL+ N + SSLQ L L S+
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLE------------- 116
Query: 536 NLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP--LAQLDNLVSLNISYNKFTGYL 593
P L L L+++HN ++ P + L NL L++S NK +
Sbjct: 117 ---------NFPIGH--LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SI 164
Query: 594 PDNKLFRQLS 603
R L
Sbjct: 165 YCT-DLRVLH 173
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 16/204 (7%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEI-GNCS 385
IPS + Q L L L ++P+ F L N++++ + + + N S
Sbjct: 25 RIPSLPP---STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80
Query: 386 SLVRLRVGNNRIAGLIPREI-GGLKTLNFLDLSSNRLSGSVPDE--IGDCTELQMIDLSH 442
+ + + N R I + L L FL + + L PD + +++++
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITD 139
Query: 443 NTLQGSLP-NSLSSLSG-LQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSS 500
N S+P N+ L L + +N F+ + L+ + L+KN + I
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKD 198
Query: 501 L--GLCSSLQLLDLSSNQLTGSVP 522
G+ S LLD+S +T ++P
Sbjct: 199 AFGGVYSGPSLLDVSQTSVT-ALP 221
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 33/231 (14%), Positives = 74/231 (32%), Gaps = 34/231 (14%)
Query: 241 TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANL-ANATNLVQLQLDTN 299
S + + L + L + +S + + ++ N + + +++
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 300 QISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAG--L 357
+ I P+ L L+ L + + L P +
Sbjct: 91 RNLTYIDPD-----------------------ALKELPLLKFLGIFNTGLK-MFPDLTKV 126
Query: 358 FQLQNLTKLLLISNDISGSIPPEI--GNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLD 415
+ L + N SIP G C+ + L++ NN + L+ +
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVY 185
Query: 416 LSSNRLSGSVPDEI--GDCTELQMIDLSHNTLQGSLP-NSLSSLSGLQVLD 463
L+ N+ + + G + ++D+S ++ +LP L L L +
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 43/234 (18%), Positives = 89/234 (38%), Gaps = 23/234 (9%)
Query: 46 DCVGLIVLDFSSNNL--VGTLPSSLGKLHNLEELILNSNQLTGKIPVE-LSNCKSLRKLL 102
+C + ++ + +LP + + L L L IP SN ++ ++
Sbjct: 9 ECHQEEDFRVTCKDIQRIPSLPP------STQTLKLIETHLR-TIPSHAFSNLPNISRIY 61
Query: 103 LFDNALAGNIPAEL-GRLSNLEEMRAGGNKDIVGKIPAE-LGDCSNMTALGLADTQVSGS 160
+ + + + LS + + +++ I + L + + LG+ +T +
Sbjct: 62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDALKELPLLKFLGIFNTGLK-M 119
Query: 161 LPA--SLGKLSKLQTLSIYTTMISGEIPAEI--GNCSELVSLFLYENSLSGSIPPEIGKL 216
P + L I IP G C+E ++L LY N + S+
Sbjct: 120 FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG 178
Query: 217 KKLEELFLWQNSLVGAIPEEI--GNCTSLKMIDFSLNSLSGTIPLSI-GGLSEL 267
KL+ ++L +N + I ++ G + ++D S S++ +P L EL
Sbjct: 179 TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 34/208 (16%), Positives = 75/208 (36%), Gaps = 19/208 (9%)
Query: 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473
++ + +P Q + L L+ ++ S+L + + VS + Q+
Sbjct: 16 FRVTCKDIQ-RIPSLP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQL 71
Query: 474 PA-SLGRLVSLNKIILSKNLFSGPIPSSL--GLCSSLQLLDLSSNQLTGSVPMELGQIEA 530
+ S L + I + I L L+ L + + L P +L ++ +
Sbjct: 72 ESHSFYNLSKVTHIEIRNTRNLTYIDPDALKEL-PLLKFLGIFNTGLK-MFP-DLTKVYS 128
Query: 531 LEI--ALNLSCNGLTGPIPAQI--SALNKLSILDLSHNKLEGNLNPLA-QLDNLVSLNIS 585
+I L ++ N IP N+ L L +N ++ A L ++ ++
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187
Query: 586 YNKFTGYLPDN---KLFRQLSPTDLAGN 610
NK+ + + ++ S D++
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQT 215
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 32/219 (14%), Positives = 72/219 (32%), Gaps = 34/219 (15%)
Query: 16 IPTN-LSSFKHLQTLVISDANLTGSIPFDI-GDCVGLIVLDFSSNNLVGTLPSS-LGKLH 72
IP++ S+ ++ + +S + + + ++ + + + L +L
Sbjct: 46 IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP 105
Query: 73 NLEELILNSNQLTGKIP--VELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGN 130
L+ L + + L P ++ + L + DN +IP L
Sbjct: 106 LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV--NAFQGL-------- 154
Query: 131 KDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI- 189
C+ L L + + S+ +KL + + I +
Sbjct: 155 -------------CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAF 200
Query: 190 -GNCSELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQ 226
G S L + + S++ ++P + LK+L W
Sbjct: 201 GGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 41/215 (19%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G G V A + + +A+K + A S ++ + EI+ L +
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFA---IGSAREADPALNVETEIEILKKLN 73
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSL-------GSLLHERTGNALEWELRYQILLGA 822
H I++ + +++ + M G L L E T YQ+L
Sbjct: 74 HPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRL-KEATCK----LYFYQML--- 124
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVA 879
+ YLH + I+HRD+K N+L+ + E I DFG +K++ + R T+
Sbjct: 125 -LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---TLC 177
Query: 880 GSYGYIAPE-------YGYMMKITEKSDVYSYGVV 907
G+ Y+APE GY D +S GV+
Sbjct: 178 GTPTYLAPEVLVSVGTAGY----NRAVDCWSLGVI 208
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 63/287 (21%), Positives = 110/287 (38%), Gaps = 56/287 (19%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
++GKG G V + D + AVK + A+ + + S + E++ L +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVK-----VINKASAKNKDTSTILR----EVELLKKL 78
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQG 825
H NI++ + ++ ++ + G L + +R E + + Q+ G
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVF----SG 133
Query: 826 LAYLHHDCVPPIVHRDIKANNILI---GLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
+ Y+H IVHRD+K NIL+ + + I DFGL+ G+
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTA 187
Query: 883 GYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937
YIAPE Y EK DV+S GV++ +L+G P + + +
Sbjct: 188 YYIAPEVLRGTYD------EKCDVWSAGVILYILLSGTPPF------------YGKNEYD 229
Query: 938 I--QVL--DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
I +V + I + + L +L + P R T
Sbjct: 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH--PSLRITATQC 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-21
Identities = 54/297 (18%), Positives = 105/297 (35%), Gaps = 46/297 (15%)
Query: 701 QVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA 760
+ L L ++ + + E + + D+ S
Sbjct: 56 KALAKLEHPGIVRYFNAWL-----ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSV 110
Query: 761 EIKTLGSIRHKNIVRFLGCCWNRNNRL--LMYDYMPNGSLGSLLHERTGN-----ALEWE 813
+I+ + KN V L + L M +L ++ R +
Sbjct: 111 KIRRMDPFSTKNTVGQL-QPSSPKVYLYIQM-QLCRKENLKDWMNRRCSLEDREHGVCLH 168
Query: 814 LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFAR 873
+ QI + +LH ++HRD+K +NI ++ + DFGL +D + +
Sbjct: 169 IFIQIAEA----VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 874 SSNTVA----------GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 923
+ T G+ Y++PE + + K D++S G+++ E+L T
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF----STQM 277
Query: 924 DGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ ++ VR K P L ++ + M+Q +L + P ERP D+
Sbjct: 278 ERVRIITDVRNLK-----FPLLFTQKYPQEHMMVQ----DMLSPS--PTERPEATDI 323
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 34/228 (14%), Positives = 68/228 (29%), Gaps = 34/228 (14%)
Query: 710 NVIGKGCSGVVYRA------DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
+++G+G VY A D N + +K P E ++
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-------WEFYIGTQ----LME 119
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER---TGNALEWELRYQILL 820
L ++F +N +L+ + G+L + ++ + L +
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY-----------IADFGLAKLVDDG 869
+ +H I+H DIK +N ++G F + D G + +
Sbjct: 180 RMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 870 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ G+ E + D + V +L G
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 62/319 (19%), Positives = 95/319 (29%), Gaps = 72/319 (22%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG+G GVV A + + A+K + D + E++ + +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIM-NKNKIRQINPKDVERIKT-----EVRLMKKLH 86
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA------ 823
H NI R + L+ + G L L+ ++ +
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 824 --------------------------------QGLAYLHHDCVPPIVHRDIKANNILIGL 851
L YLH+ I HRDIK N L
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFST 203
Query: 852 --EFEPYIADFGLAKLVDDGDFARSS--NTVAGSYGYIAPE--YGYMMKITEKSDVYSYG 905
FE + DFGL+K + T AG+ ++APE K D +S G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 906 VVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI--QVL--DPSLLSRPESEIDEMLQALG 961
V++ +L G P QVL + + + + + L
Sbjct: 264 VLLHLLLMGAVPF------------PGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL 311
Query: 962 VALLCVNASPDERPTMKDV 980
LL N DER
Sbjct: 312 SNLLNRN--VDERFDAMRA 328
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI- 768
++G+G S VV R + AVK + + ++E +R++ E+ L +
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKII--DVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQG 825
H NI++ L++D M G L L E+ E E R +L +
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALL----EV 136
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
+ LH IVHRD+K NIL+ + + DFG + +D G+ R V G+ Y+
Sbjct: 137 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYL 190
Query: 886 APE------YGYMMKITEKSDVYSYGVV 907
APE ++ D++S GV+
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 63/286 (22%), Positives = 110/286 (38%), Gaps = 56/286 (19%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++GKG G V + D + AVK + A+ + + S + E++ L +
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVK-----VINKASAKNKDTSTILR----EVELLKKLD 79
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQGL 826
H NI++ + ++ ++ + G L + +R E + + Q+ G+
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVF----SGI 134
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVAGSYG 883
Y+H IVHRD+K NIL+ + + I DFGL+ G+
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAY 188
Query: 884 YIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938
YIAPE Y EK DV+S GV++ +L+G P + + + I
Sbjct: 189 YIAPEVLRGTYD------EKCDVWSAGVILYILLSGTPPF------------YGKNEYDI 230
Query: 939 --QVL--DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+V + I + + L +L + P R T
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH--PSLRITATQC 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 41/211 (19%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+GKG VV R G A K + + + + E + ++
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAK-----IINTKKLSARDFQKLER----EARICRKLQ 63
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQGL 826
H NIVR + L++D + G L + R E + QIL + +
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQIL----ESI 118
Query: 827 AYLH-HDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVAGSY 882
AY H + IVHR++K N+L+ + + +ADFGLA V+D + AG+
Sbjct: 119 AYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTP 171
Query: 883 GYIAPE------YGYMMKITEKSDVYSYGVV 907
GY++PE Y + D+++ GV+
Sbjct: 172 GYLSPEVLKKDPYS------KPVDIWACGVI 196
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 59/289 (20%), Positives = 99/289 (34%), Gaps = 64/289 (22%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRD--SFSAEIKTLGS 767
IG+G G V A A KK+ K V D F EI+ + S
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKI-------------PKYFVEDVDRFKQEIEIMKS 62
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQ 824
+ H NI+R + + L+ + G L + + E + + +L
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVL----S 117
Query: 825 GLAYLH-HDCVPPIVHRDIKANNILI---GLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
+AY H + + HRD+K N L + + DFGLA G T G
Sbjct: 118 AVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVG 170
Query: 881 SYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935
+ Y++P+ YG + D +S GV++ +L G P
Sbjct: 171 TPYYVSPQVLEGLYG------PECDEWSAGVMMYVLLCGYPPF------------SAPTD 212
Query: 936 KGI--QVL--DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ ++ + + + ++L LL + P +R T
Sbjct: 213 SEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKS--PKQRITSLQA 259
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 44/217 (20%), Positives = 89/217 (41%), Gaps = 15/217 (6%)
Query: 284 NLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALD 343
N V+ L ++ L+ LS + F + ++ S+ + + +NL+ L
Sbjct: 14 PDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELH 69
Query: 344 LSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403
LSHN ++ + L L L +L + N + ++ + L RL + NN +
Sbjct: 70 LSHNQIS--DLSPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRDTDS- 123
Query: 404 EIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLD 463
+ LK L L + +N+L V +G ++L+++DL N + + L+ L + +D
Sbjct: 124 -LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWID 178
Query: 464 VSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSS 500
++ + + L N + + P S
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 45/261 (17%), Positives = 90/261 (34%), Gaps = 18/261 (6%)
Query: 331 STLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRL 390
+N +L S+T V +L + +++I S+ + ++L L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 391 RVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLP 450
+ +N+I+ L P + L L L ++ NRL L + L +N L+
Sbjct: 69 HLSHNQISDLSP--LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--T 121
Query: 451 NSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLL 510
+SL L L++L + +N+ I LG L L + L N + L + +
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWI 177
Query: 511 DLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNL 570
DL+ + ++ + ++ P IS +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWELPVYTD 234
Query: 571 NPLAQLDNLVSLNISYNKFTG 591
+ +++ + F G
Sbjct: 235 EVSYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 37/236 (15%), Positives = 78/236 (33%), Gaps = 17/236 (7%)
Query: 165 LGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFL 224
L+ ++ ++ + S + + +++ S+ + L+EL L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 225 WQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPAN 284
N + P + + T L+ + + N L + + L + +N + +
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIP---SACLSRLFLDNNELRD--TDS 123
Query: 285 LANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDL 344
L + NL L + N++ ++ +G LSKL V N++ + L + +DL
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDL 179
Query: 345 SHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGL 400
+ +L + P I N S V V
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 34/197 (17%), Positives = 65/197 (32%), Gaps = 61/197 (30%)
Query: 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSL 453
I + P GL +L ++ V + + +Q + ++ +Q SL +
Sbjct: 6 PTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-M 59
Query: 454 SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLS 513
+ L+ L +S N+ ++ + S L + L+ L ++
Sbjct: 60 QFFTNLKELHLSHNQ--------------ISDL------------SPLKDLTKLEELSVN 93
Query: 514 SNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPL 573
N+L + + LS L L +N+L + + L
Sbjct: 94 RNRLK--------NLNGIP--------------------SACLSRLFLDNNELR-DTDSL 124
Query: 574 AQLDNLVSLNISYNKFT 590
L NL L+I NK
Sbjct: 125 IHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 31/191 (16%), Positives = 63/191 (32%), Gaps = 20/191 (10%)
Query: 66 SSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEM 125
L N + L +T V ++ ++ + ++ + +NL+E+
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 126 RAGGNK--DIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISG 183
N+ D+ L D + + L + ++ + + L L + +
Sbjct: 69 HLSHNQISDLSP-----LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD 120
Query: 184 EIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSL 243
+ + L L + N L SI +G L KLE L L N + + +
Sbjct: 121 TDS--LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT--GGLTRLKKV 174
Query: 244 KMIDFSLNSLS 254
ID +
Sbjct: 175 NWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 39/167 (23%), Positives = 63/167 (37%), Gaps = 18/167 (10%)
Query: 18 TNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEEL 77
+ +Q ++N+ S+ + L L S N + + S L L LEEL
Sbjct: 35 VSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQI--SDLSPLKDLTKLEEL 90
Query: 78 ILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNK--DIVG 135
+N N+L + L +L L +N L L L NLE + NK IV
Sbjct: 91 SVNRNRLKN---LNGIPSACLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLKSIVM 145
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMIS 182
LG S + L L +++ + L +L K+ + +
Sbjct: 146 -----LGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 20/96 (20%), Positives = 33/96 (34%), Gaps = 4/96 (4%)
Query: 13 QLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLH 72
+L +L K+L+ L I + L SI +G L VLD N + T L +L
Sbjct: 117 ELRDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEI--TNTGGLTRLK 172
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNAL 108
+ + L + + + D
Sbjct: 173 KVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 5e-21
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 25/161 (15%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLG 766
IG+G G V++A + + E++A+K++ + D+ GV SA EI L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV---RL------DDDDEGV--PSSALREICLLK 56
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAA 823
++HKNIVR + L++++ L G+ ++ +Q+L
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---- 111
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
+GL + H ++HRD+K N+LI E +A+FGLA+
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-21
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 22/161 (13%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLG 766
+ +G+G VY+A D + +++A+KK+ S+ K G+ +A EIK L
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKI------KLGHRSEAKDGIN--RTALREIKLLQ 67
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAA 823
+ H NI+ L +++N L++D+M L ++ + + ++ L
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL---- 122
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
QGL YLH I+HRD+K NN+L+ +ADFGLAK
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 5e-21
Identities = 49/289 (16%), Positives = 96/289 (33%), Gaps = 43/289 (14%)
Query: 330 PSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLV 388
+ CSN + + +T +P+ L + N +L + + I L
Sbjct: 3 HHRICHCSN-RVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDLE 57
Query: 389 RLRVGNNRIAGLIPREI-GGLKTLNFLDLS-SNRLSGSVPDEI-GDCTELQMIDLSHNTL 445
++ + N + +I ++ L L+ + + +N L + E + LQ + +S+ +
Sbjct: 58 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI 116
Query: 446 QGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKI-ILSKNLFSGPIPSSLGLC 504
+ +LD+ DN I + +N F G L
Sbjct: 117 KHLPDVHKIHSLQKVLLDIQDN----------------INIHTIERNSFVG-------LS 153
Query: 505 SSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQI-SALNKLSILDLSH 563
+L L+ N + + L+ N L +P + + ILD+S
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISR 211
Query: 564 NKLEGNLNP--LAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGN 610
++ +L L L L + + K LP + L L
Sbjct: 212 TRIH-SLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 47/261 (18%), Positives = 91/261 (34%), Gaps = 20/261 (7%)
Query: 238 GNCT-SLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPAN-LANATNLVQLQ 295
C S ++ + ++ IP + E + I + +L +++
Sbjct: 5 RICHCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIE 60
Query: 296 LDTNQISGLIPPEI-GMLSKLTV-FFAWQNQLEGSIPS-TLASCSNLQALDLSHNSLTAS 352
+ N + +I ++ L KL N L I + NLQ L +S+ +
Sbjct: 61 ISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-H 118
Query: 353 VPAGLFQ-LQNLTKLLLISNDISGSIPPEI--GNCSSLVRLRVGNNRIAGLIPREIGGLK 409
+P L + N +I G V L + N I + G +
Sbjct: 119 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQ 178
Query: 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLP-NSLSSLSGLQVLDVSDNR 468
+N L D + ++D+S + SLP L +L L+ + +
Sbjct: 179 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK 237
Query: 469 FSGQIPASLGRLVSLNKIILS 489
++P +L +LV+L + L+
Sbjct: 238 ---KLP-TLEKLVALMEASLT 254
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 44/257 (17%), Positives = 79/257 (30%), Gaps = 34/257 (13%)
Query: 145 SNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI-GNCSELVSLFLYE- 202
N L T++ + L+ + I + I A++ N +L + + +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 203 NSLSGSIPPEI-GKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSI 261
N+L I PE L L+ L + + +P +
Sbjct: 90 NNLL-YINPEAFQNLPNLQYLLISNTGIK-HLP-----------------------DVHK 124
Query: 262 GGLSELEEFMISDNNVSGSIPANL--ANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFF 319
+ I DN +I N + V L L+ N I + +
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNL 184
Query: 320 AWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPP 379
+ N LE S LD+S + S+P+ +NL KL S +P
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGL--ENLKKLRARSTYNLKKLPT 241
Query: 380 EIGNCSSLVRLRVGNNR 396
+ +L+ +
Sbjct: 242 -LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 57/301 (18%), Positives = 95/301 (31%), Gaps = 62/301 (20%)
Query: 53 LDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNI 112
+ + +PS L N EL +L S L K+ + N + I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 113 PAE-LGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKL 171
A+ L L E+R +++ I E L L
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLL-YINPEA-----------------------FQNLPNL 106
Query: 172 QTLSIYTTMISGEIPAEI-GNCSELVSLFLYENSLSGSIPPEI--GKLKKLEELFLWQNS 228
Q L I T I +P + + V L + +N +I G + L+L +N
Sbjct: 107 QYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165
Query: 229 LVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPAN-LAN 287
+ I S ++L+E +SDNN +P +
Sbjct: 166 IQ-------------------------EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG 200
Query: 288 ATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHN 347
A+ V L + +I L + L KL + + +P+ L L L++
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256
Query: 348 S 348
S
Sbjct: 257 S 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 37/241 (15%), Positives = 72/241 (29%), Gaps = 35/241 (14%)
Query: 17 PTNLSSFKHLQTLVISDANLTGSIPFDI-GDCVGLIVLDFSSNNLVGTLPSS-LGKLHNL 74
S F L+ + IS ++ I D+ + L + N + + L NL
Sbjct: 47 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 106
Query: 75 EELILNSNQLTGKIPVEL-SNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDI 133
+ L++++ + +P + L + DN I L
Sbjct: 107 QYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER--NSFVGL----------- 152
Query: 134 VGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI-GNC 192
L L + + S ++L L++ E+P ++
Sbjct: 153 ----------SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGA 201
Query: 193 SELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLN 251
S V L + + S+P LKKL + + + +L +
Sbjct: 202 SGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPT----LEKLVALMEASLTYP 256
Query: 252 S 252
S
Sbjct: 257 S 257
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 6e-21
Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 26/162 (16%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLG 766
IG+G GVVY+A + GEV+A+KK+ + E GV +A EI L
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKI---RL------DTETEGV--PSTAIREISLLK 57
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR----YQILLGA 822
+ H NIV+ L N L+++++ L + + L +Q+L
Sbjct: 58 ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
QGLA+ H ++HRD+K N+LI E +ADFGLA+
Sbjct: 114 -QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-21
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 25/160 (15%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLG 766
++G+G G+V + + D G ++A+KK SD+ V+ A EIK L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLE---------SDDDKMVK--KIAMREIKLLK 79
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAA 823
+RH+N+V L C + L+++++ + ++ L ++ +QI+
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---- 134
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863
G+ + H I+HRDIK NIL+ + DFG A
Sbjct: 135 NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 21/158 (13%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG+G GVV++ + D G+++A+KK S++ ++ EI+ L +
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF---------LESEDDPVIKKIALREIRMLKQL 59
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQG 825
+H N+V L + L+++Y + ++ L E ++ +Q L Q
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL----QA 114
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863
+ + H +HRD+K NILI + DFG A
Sbjct: 115 VNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-21
Identities = 35/164 (21%), Positives = 68/164 (41%), Gaps = 7/164 (4%)
Query: 332 TLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLR 391
T A ++L + L++ ++T G+ N+ L + + + P I S+L RLR
Sbjct: 39 TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 392 VGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPN 451
+ + + GL +L LD+S + S+ +I ++ IDLS+N +
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 452 SLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495
L +L L+ L++ + + LN++ G
Sbjct: 155 -LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 32/185 (17%), Positives = 76/185 (41%), Gaps = 10/185 (5%)
Query: 216 LKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDN 275
K L Q+S ++ + T + + + ++ L+G I +++ I++
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNI 76
Query: 276 NVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLAS 335
+ + P ++ +NL +L++ ++ P + L+ LT+ + + SI + + +
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 336 CSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNN 395
+ ++DLS+N + L L L L + + + I + L +L +
Sbjct: 135 LPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQ 191
Query: 396 RIAGL 400
I G
Sbjct: 192 TIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-19
Identities = 29/206 (14%), Positives = 69/206 (33%), Gaps = 34/206 (16%)
Query: 386 SLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTL 445
+ + +G + A + + + +L ++ L++ ++ I ++ + +++
Sbjct: 24 AYLNGLLGQSSTANITEAQ---MNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHA 78
Query: 446 QGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCS 505
P +S LS L+ L + + +L L SL + +S + I + +
Sbjct: 79 TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 506 SLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNK 565
+ +DLS N + I L L +L L++ +
Sbjct: 137 KVNSIDLSYNGA-------ITDIMPL-------------------KTLPELKSLNIQFDG 170
Query: 566 LEGNLNPLAQLDNLVSLNISYNKFTG 591
+ + + L L G
Sbjct: 171 VH-DYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 29/180 (16%), Positives = 61/180 (33%), Gaps = 9/180 (5%)
Query: 265 SELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQ 324
S + ++ S + A +L + L ++ L I +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH 77
Query: 325 LEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNC 384
+ ++ SNL+ L + +T+ L L +LT L + + SI +I
Sbjct: 78 ATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 385 SSLVRLRV-GNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHN 443
+ + + N I ++P + L L L++ + + I D +L +
Sbjct: 136 PKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 27/162 (16%), Positives = 56/162 (34%), Gaps = 7/162 (4%)
Query: 164 SLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELF 223
+ +++ L +++ ++ I + L + + P I L LE L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 224 LWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPA 283
+ + + TSL ++D S ++ +I I L ++ +S N I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM- 153
Query: 284 NLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQL 325
L L L + + + I KL +A+ +
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-18
Identities = 33/209 (15%), Positives = 62/209 (29%), Gaps = 32/209 (15%)
Query: 358 FQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLS 417
L S + +SL + + N + L I + L ++
Sbjct: 17 IPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTIN 74
Query: 418 SNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL 477
+ + P I + L+ + + + +LS L+ L +LD+S + I +
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 478 GRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNL 537
L +N I LS N I L L+ L++ + +
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--------------- 176
Query: 538 SCNGLTGPIPAQISALNKLSILDLSHNKL 566
I KL+ L +
Sbjct: 177 ------------IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 30/164 (18%), Positives = 59/164 (35%), Gaps = 8/164 (4%)
Query: 21 SSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILN 80
+ L + +++ N+T + I + L ++ + T + + L NLE L +
Sbjct: 41 AQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIM 96
Query: 81 SNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAE 140
+T LS SL L + +A +I ++ L + + N I
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI--TDIMP 154
Query: 141 LGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGE 184
L + +L + V + KL L ++ I G+
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 27/209 (12%), Positives = 64/209 (30%), Gaps = 35/209 (16%)
Query: 71 LHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGN 130
+L + + + SL + L + +++L
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANI-----------NVTDLT------- 60
Query: 131 KDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIG 190
+ N+ L + + + P + LS L+ L I ++ + +
Sbjct: 61 ---------GIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLS 109
Query: 191 NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSL 250
+ L L + ++ SI +I L K+ + L N + I + LK ++
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQF 168
Query: 251 NSLSGTIPLSIGGLSELEEFMISDNNVSG 279
+ + + +L + + G
Sbjct: 169 DGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 26/185 (14%), Positives = 63/185 (34%), Gaps = 12/185 (6%)
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNK- 131
+ + + + + SL + L + + ++ + N++++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHA 78
Query: 132 -DIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIG 190
+ + SN+ L + V+ +L L+ L L I + I +I
Sbjct: 79 TNY-----NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 191 NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSL 250
++ S+ L N I P + L +L+ L + + + I + L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 251 NSLSG 255
++ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 23/142 (16%), Positives = 49/142 (34%), Gaps = 6/142 (4%)
Query: 18 TNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEEL 77
T + +++ L I++ + T P I L L ++ +L L +L L
Sbjct: 60 TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 78 ILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKI 137
++ + I +++ + + L N +I L L L+ + + V
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDG--VHDY 174
Query: 138 PAELGDCSNMTALGLADTQVSG 159
+ D + L + G
Sbjct: 175 RG-IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 21/104 (20%), Positives = 35/104 (33%), Gaps = 3/104 (2%)
Query: 3 TEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVG 62
+ I + NLS L L IS + SI I + +D S N +
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 63 TLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDN 106
+ L L L+ L + + + + + L +L F
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 20/118 (16%), Positives = 48/118 (40%), Gaps = 9/118 (7%)
Query: 480 LVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSC 539
+ +L ++ + + + +SL + L++ +T +E ++ L ++
Sbjct: 22 FKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDLTGIE--YAHNIKD-LTINN 75
Query: 540 NGLTGPIPAQISALNKLSILDLSHNKLEGN-LNPLAQLDNLVSLNISYNKFTGYLPDN 596
T P IS L+ L L + + + + L+ L +L L+IS++ +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 24/160 (15%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLGS 767
IG+G GVVY+A + GE A+KK+ + E G+ + EI L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKI---RL------EKEDEGI--PSTTIREISILKE 56
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQ 824
++H NIV+ + +L+++++ L LL G + Q+L
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL----N 111
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
G+AY H ++HRD+K N+LI E E IADFGLA+
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 44/221 (19%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+G G V+ G++ A+K + + S EI L I+
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCI-----------KKSPAFRDSSLENEIAVLKKIK 64
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQGL 826
H+NIV + + L+ + G L + ER G E + + Q+L +
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVL----SAV 119
Query: 827 AYLH-HDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVAGSY 882
YLH + IVHRD+K N+L E I DFGL+K+ +G +T G+
Sbjct: 120 KYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTP 171
Query: 883 GYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
GY+APE Y + D +S GV+ +L G P
Sbjct: 172 GYVAPEVLAQKPYS------KAVDCWSIGVITYILLCGYPP 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 24/160 (15%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLGS 767
+G+G GVVY+A G ++A+K++ + E G+ +A EI L
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI---RL------DAEDEGI--PSTAIREISLLKE 75
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQ 824
+ H NIV + + L++++M L +L E + +++ YQ+L +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL----R 130
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
G+A+ H I+HRD+K N+LI + +ADFGLA+
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 65/279 (23%), Positives = 107/279 (38%), Gaps = 49/279 (17%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IGKG V A + G +A+K + T + + E++ + + H
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---------LQKLFREVRIMKILNH 73
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGLA 827
NIV+ L+ +Y G + L G E E R QI+ +
Sbjct: 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIV----SAVQ 128
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
Y H IVHRD+KA N+L+ + IADFG + G G+ Y AP
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD---AFCGAPPYAAP 182
Query: 888 EY----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
E Y + DV+S GV++ +++G P DG ++ + + + P
Sbjct: 183 ELFQGKKY---DGPEVDVWSLGVILYTLVSGSLPF-----DGQNLKELRERVLRGKYRIP 234
Query: 944 SLLSRPESE--IDEMLQALGVALLCVNASPDERPTMKDV 980
+S + E + L +N P +R T++ +
Sbjct: 235 FYMS-TDCENLLKRFLV--------LN--PIKRGTLEQI 262
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 59/237 (24%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLG 766
IG+G G V++A G+ +A+KK+ M +EK G +A EIK L
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV---LM------ENEKEGFP--ITALREIKILQ 71
Query: 767 SIRHKNIVRFLGCCWNRNNRL--------LMYDYMPNGSLGSLLHERTGNALEWELR--- 815
++H+N+V + C + + L++D+ + L LL E++
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 130
Query: 816 YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
+L GL Y+H + I+HRD+KA N+LI + +ADFGLA+ F+ +
Sbjct: 131 QMLL----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA-----FSLAK 178
Query: 876 NTVAGSYG-------YIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918
N+ Y Y PE YG D++ G ++ E+ T PI
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYG------PPIDLWGAGCIMAEMWTRS-PI 228
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 41/211 (19%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+GKG VV R G A K + + + + E + ++
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAK-----IINTKKLSARDFQKLER----EARICRKLQ 86
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQGL 826
H NIVR + L++D + G L + R E + QIL + +
Sbjct: 87 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQIL----ESI 141
Query: 827 AYLH-HDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVAGSY 882
AY H + IVHR++K N+L+ + + +ADFGLA V+D + AG+
Sbjct: 142 AYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTP 194
Query: 883 GYIAPE------YGYMMKITEKSDVYSYGVV 907
GY++PE Y + D+++ GV+
Sbjct: 195 GYLSPEVLKKDPYS------KPVDIWACGVI 219
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 191 NCS-ELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFS 249
+ + + + +L+ ++PP++ K L L +N L + T L ++
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 250 LNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEI 309
L+ + + G L L +S N + S+P L L + N+++ L P
Sbjct: 64 RAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSL-PLGA 119
Query: 310 -GMLSKLTVFFAWQNQLEGSIPS-TLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKL 366
L +L + N+L+ ++P L L+ L L++N+LT +PAGL L+NL L
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL 177
Query: 367 LLISNDISGSIPPEIGNCSSLVRLRVGNN 395
LL N + +IP L + N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 56/242 (23%), Positives = 85/242 (35%), Gaps = 45/242 (18%)
Query: 330 PSTLASCS-NLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSL 387
P S + ++ +LT ++P L + + T L L N + + + L
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLY-TFSLATLMPYTRL 57
Query: 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG 447
+L + + L + G L L LDLS N+L S+P L ++D+S N L
Sbjct: 58 TQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT- 113
Query: 448 SLPNSL-SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSS 506
SLP L LQ L + N L L +
Sbjct: 114 SLPLGALRGLGELQELYLKGNELK----------------TLPPGLLTP-------T-PK 149
Query: 507 LQLLDLSSNQLTGSVPME----LGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLS 562
L+ L L++N LT +P L ++ L L N L IP + L L
Sbjct: 150 LEKLSLANNNLT-ELPAGLLNGLENLD----TLLLQENSLYT-IPKGFFGSHLLPFAFLH 203
Query: 563 HN 564
N
Sbjct: 204 GN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 50/207 (24%), Positives = 81/207 (39%), Gaps = 11/207 (5%)
Query: 287 NATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSH 346
+ +++ D ++ +PP++ T+ +N L +TL + L L+L
Sbjct: 8 KVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 347 NSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIG 406
LT + L L L L N + S+P +L L V NR+ L +
Sbjct: 65 AELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 407 GLKTLNFLDLSSNRLSGSVPDEIGDC-TELQMIDLSHNTLQGSLP-NSLSSLSGLQVLDV 464
GL L L L N L ++P + +L+ + L++N L LP L+ L L L +
Sbjct: 122 GLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLL 179
Query: 465 SDNRFSGQIPASLGRLVSLNKIILSKN 491
+N IP L L N
Sbjct: 180 QENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 14/205 (6%)
Query: 26 LQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLT 85
+ NLT ++P D+ +L S N L ++L L +L L+ +LT
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 86 GKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGD-C 144
K+ V+ L L L N L ++P L L + N+ + +P
Sbjct: 69 -KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR--LTSLPLGALRGL 123
Query: 145 SNMTALGLADTQVSGSLPASL-GKLSKLQTLSIYTTMISGEIPAEI-GNCSELVSLFLYE 202
+ L L ++ +LP L KL+ LS+ ++ E+PA + L +L L E
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQE 181
Query: 203 NSLSGSIPPEIGKLKKLEELFLWQN 227
NSL +IP L FL N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 43/174 (24%), Positives = 73/174 (41%), Gaps = 13/174 (7%)
Query: 411 LNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470
++ L+ ++P ++ + ++ LS N L +L + L L++ +
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 471 GQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEA 530
++ G L L + LS N +P +L +LD+S N+LT L +
Sbjct: 69 -KLQVD-GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 531 LEIALNLSCNGLTGPIPAQI-SALNKLSILDLSHNKL----EGNLNPLAQLDNL 579
L+ L L N L +P + + KL L L++N L G LN L LD L
Sbjct: 126 LQE-LYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 36/133 (27%), Positives = 54/133 (40%), Gaps = 15/133 (11%)
Query: 473 IPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALE 532
+P L LS+NL ++L + L L+L +LT + G + L
Sbjct: 29 LPKDTTILH------LSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLG 80
Query: 533 IALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP--LAQLDNLVSLNISYNKFT 590
L+LS N L +P L L++LD+S N+L +L L L L L + N+
Sbjct: 81 T-LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137
Query: 591 GYLPDNKLFRQLS 603
LP L
Sbjct: 138 -TLPPG-LLTPTP 148
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 22/95 (23%), Positives = 40/95 (42%), Gaps = 6/95 (6%)
Query: 496 PIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNK 555
PI + S ++ LT ++P + + L+LS N L A + +
Sbjct: 2 PICEVSKVAS-HLEVNCDKRNLT-ALPPD---LPKDTTILHLSENLLYTFSLATLMPYTR 56
Query: 556 LSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFT 590
L+ L+L +L L L L +L++S+N+
Sbjct: 57 LTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQ 90
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 31/166 (18%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLG 766
+G+G G VY+A D E +A+K++ + E+ GV +A E+ L
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI---RL------EHEEEGV--PGTAIREVSLLK 88
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAA 823
++H+NI+ + + L+++Y N L + ++ + ++ YQ++
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLI---- 142
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY-----IADFGLAK 864
G+ + H +HRD+K N+L+ + I DFGLA+
Sbjct: 143 NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 56/224 (25%), Positives = 88/224 (39%), Gaps = 45/224 (20%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVR---DSFSAEIKTLG 766
+G G G V+ + +G +K + K + + AEI+ L
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTI-------------NKDRSQVPMEQIEAEIEVLK 75
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT---GNALEWE---LRYQILL 820
S+ H NI++ + +N ++ + G L + E L Q++
Sbjct: 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM- 134
Query: 821 GAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFE---PYIADFGLAKLVDDGDFARSSN 876
LAY H +VH+D+K NIL I DFGLA+L + +
Sbjct: 135 ---NALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---T 184
Query: 877 TVAGSYGYIAPE---YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
AG+ Y+APE T K D++S GVV+ +LTG P
Sbjct: 185 NAAGTALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTGCLP 224
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 7e-20
Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLG 766
+ +G+G VY+ ++A+K++ + + G +A E+ L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI----------RLEHEEGA--PCTAIREVSLLK 55
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAA 823
++H NIV + L+++Y+ L L + ++ +Q+L
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---- 110
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
+GLAY H ++HRD+K N+LI E +ADFGLA+
Sbjct: 111 RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-20
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIG+G S VV R G AVK + + A ++ VR++ E L +
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIM---EVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 770 -HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQG 825
H +I+ + + + L++D M G L L E+ E E R +L +
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLL----EA 212
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
+++LH + IVHRD+K NIL+ + ++DFG + ++ G+ R + G+ GY+
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYL 266
Query: 886 APE------YGYMMKITEKSDVYSYGVV 907
APE ++ D+++ GV+
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 72/280 (25%), Positives = 109/280 (38%), Gaps = 46/280 (16%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA---EIKTLGS 767
+G+G G V A + E +AVK + + D EI
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-------------DMKRAVDCPENIKKEICINKM 61
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQ 824
+ H+N+V+F G N + L +Y G L + E + + Q++
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLM----A 116
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
G+ YLH I HRDIK N+L+ I+DFGLA + + R N + G+ Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 885 IAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940
+APE + E DV+S G+V+ +L G+ P D S K +
Sbjct: 174 VAPELLKRREF---HAEPVDVWSCGIVLTAMLAGELPWD----QPSDSCQEYSDWKEKKT 226
Query: 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
P +ID AL +L N P R T+ D+
Sbjct: 227 YLN-----PWKKIDSAPLALLHKILVEN--PSARITIPDI 259
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 72/242 (29%), Positives = 106/242 (43%), Gaps = 60/242 (24%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIG G GVVY+A D+GE++A+KK+ D++ R E++ + +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQ----------DKRFKNR-----ELQIMRKLD 105
Query: 770 HKNIVRFLGCCWNRNNRL------LMYDYMPNGSLGSLL--HERTGNALEWEL----RYQ 817
H NIVR ++ + L+ DY+P ++ + + R L YQ
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 818 ILLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPY-IADFGLAKLVDDGDFARSS 875
+ + LAY+H I HRDIK N+L+ + + DFG AK + G+
Sbjct: 165 LF----RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---- 212
Query: 876 NT--VAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928
N + Y Y APE Y I DV+S G V+ E+L G QPI P G
Sbjct: 213 NVSYICSRY-YRAPELIFGATDYTSSI----DVWSAGCVLAELLLG-QPIFP----GDSG 262
Query: 929 VD 930
VD
Sbjct: 263 VD 264
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 62/282 (21%), Positives = 107/282 (37%), Gaps = 50/282 (17%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G G G V+ A D + + + VK + + D K G + EI L + H
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG---KVTLEIAILSRVEH 88
Query: 771 KNIVRFLGCCWNRNN-RLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGL 826
NI++ L N+ +L+M + L + + E Y Q++ +
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLV----SAV 143
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIA 886
YL I+HRDIK NI+I +F + DFG A ++ G T G+ Y A
Sbjct: 144 GYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF---YTFCGTIEYCA 197
Query: 887 PEY----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942
PE Y + +++S GV + ++ + P + + +
Sbjct: 198 PEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFC----------ELEETVEA-AIHP 243
Query: 943 PSLLSRPESE--IDEMLQALGVALLCVNASPDERPTMKDVAA 982
P L+S E + +LQ P+ R T++ +
Sbjct: 244 PYLVS-KELMSLVSGLLQ--------PV--PERRTTLEKLVT 274
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 48/214 (22%), Positives = 88/214 (41%), Gaps = 39/214 (18%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIGKG VV R + + G+ AVK + ++ G S E ++ E ++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED--LKR----EASICHMLK 84
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEW------ELRYQILLGAA 823
H +IV L + +++++M L + +R + QIL
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---- 140
Query: 824 QGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVA 879
+ L Y H ++ I+HRD+K + +L+ + + FG+A + + +
Sbjct: 141 EALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRV 194
Query: 880 GSYGYIAPE------YGYMMKITEKSDVYSYGVV 907
G+ ++APE YG + DV+ GV+
Sbjct: 195 GTPHFMAPEVVKREPYG------KPVDVWGCGVI 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 37/279 (13%)
Query: 693 QKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEK 751
++ S VLK + IG G G+V A D +A+KKL + K
Sbjct: 14 VEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL----SRPFQNQTHAK 69
Query: 752 SGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYD-YMPNGSLGSLLHERTGNAL 810
R E+ + + HKNI+ L + + D Y+ + + L + L
Sbjct: 70 RAYR-----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124
Query: 811 EWE----LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV 866
+ E L YQ+L G+ +LH + +HRD+K +NI++ + I DFGLA+
Sbjct: 125 DHERMSYLLYQML----CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 867 DDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS 926
+ V Y Y APE M E D++S G ++ E++ G + P G+
Sbjct: 178 GTSFM--MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-VLFP----GT 229
Query: 927 HVVDWVRQ-KKGIQVL---DPSLLSRPESEIDEMLQALG 961
+D Q K I+ L P + + + + ++
Sbjct: 230 DHID---QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP 265
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 52/248 (20%), Positives = 91/248 (36%), Gaps = 66/248 (26%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFS------AEIK 763
+ G+G G V + G +A+KK V ++
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKK------------------VIQDPRFRNRELQIMQ 71
Query: 764 TLGSIRHKNIVRFLGCCWNRNNR-------LLMYDYMPNGSLGSLL--HERTGNALEWEL 814
L + H NIV+ + R ++ +Y+P+ +L + R A L
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 815 ----RYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI-GLEFEPYIADFGLAKLVDDG 869
+Q++ + + LH V + HRDIK +N+L+ + + DFG AK +
Sbjct: 131 IKVFLFQLI----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185
Query: 870 DFARSSNT--VAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI 922
+ N + Y Y APE Y + D++S G + E++ G +PI
Sbjct: 186 EP----NVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLG-EPIFR-- 233
Query: 923 PDGSHVVD 930
G +
Sbjct: 234 --GDNSAG 239
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 28/217 (12%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G +V + + G A K + + + R+ E+ L +
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAK-----FIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGL 826
H N++ NR + +L+ + + G L L ++ + E E QIL G+
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQIL----DGV 128
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPY----IADFGLAKLVDDGDFARSSNTVAGSY 882
YLH I H D+K NI++ + P + DFGLA ++DG + + G+
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTP 182
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVV--VLEVLTGKQP 917
++APE + ++D++S GV+ +L L+G P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYIL--LSGASP 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 31/165 (18%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTLG 766
+G G VY+ + G +A+K++ + D + G +A EI +
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV---KL-------DSEEGT--PSTAIREISLMK 58
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR--------YQI 818
++H+NIVR N L++++M N L + RT L +Q+
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863
L QGLA+ H + I+HRD+K N+LI + + DFGLA
Sbjct: 118 L----QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 28/217 (12%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G +V + + G A K + + + R+ E+ L +
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAK-----FIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGL 826
H NI+ NR + +L+ + + G L L ++ + E E QIL G+
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQIL----DGV 128
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPY----IADFGLAKLVDDGDFARSSNTVAGSY 882
YLH I H D+K NI++ + P + DFGLA ++DG + + G+
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTP 182
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVV--VLEVLTGKQP 917
++APE + ++D++S GV+ +L L+G P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYIL--LSGASP 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 41/209 (19%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G+G + +VYR + A+K L +K+ + EI L +
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL-------------KKTVDKKIVRTEIGVLLRLS 106
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQGL 826
H NI++ L+ + + G L + E+ G E + QIL + +
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQIL----EAV 161
Query: 827 AYLH-HDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVAGSY 882
AYLH + IVHRD+K N+L IADFGL+K+V+ + TV G+
Sbjct: 162 AYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---TVCGTP 214
Query: 883 GYIAPE----YGYMMKITEKSDVYSYGVV 907
GY APE Y + D++S G++
Sbjct: 215 GYCAPEILRGCAY----GPEVDMWSVGII 239
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 34/216 (15%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTL-ASCSN 338
+IP+N+ + +L L +N++S L L+KL + + N+L+ ++P+ + N
Sbjct: 30 AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 339 LQALDLSHNSLTASVPAGLF-QLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRI 397
L+ L ++ N L ++P G+F QL NL +L L N + S+PP + +
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD-------------- 130
Query: 398 AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC-TELQMIDLSHNTLQGSLPNSL-SS 455
L L +L L N L S+P + D T L+ + L +N L+ +P
Sbjct: 131 ---------SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDK 179
Query: 456 LSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491
L+ L+ L + +N+ + L L + L +N
Sbjct: 180 LTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 13/182 (7%)
Query: 52 VLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNC-KSLRKLLLFDNALAG 110
LD SN L + +L L L LN N+L +P + K+L L + DN L
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ- 98
Query: 111 NIPAEL-GRLSNLEEMRAGGNKDIVGKIPAELGDC-SNMTALGLADTQVSGSLPASL-GK 167
+P + +L NL E+R N+ + +P + D + +T L L ++ SLP + K
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQ--LKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 168 LSKLQTLSIYTTMISGEIPAEI-GNCSELVSLFLYENSLSGSIPPEI-GKLKKLEELFLW 225
L+ L+ L +Y + +P +EL +L L N L +P L+KL+ L L
Sbjct: 156 LTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQ 213
Query: 226 QN 227
+N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 21/190 (11%)
Query: 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469
N +D SS +L+ ++P I + + +DL N L + L+ L++L ++DN+
Sbjct: 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73
Query: 470 SGQIPASL-GRLVSLNKIILSKNLFSGPIPSSL--GLCSSLQLLDLSSNQLTGSVP---- 522
+PA + L +L + ++ N +P + L +L L L NQL S+P
Sbjct: 74 Q-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQL-VNLAELRLDRNQLK-SLPPRVF 129
Query: 523 MELGQIEALEIALNLSCNGLTGPIPAQI-SALNKLSILDLSHNKLEG-NLNPLAQLDNLV 580
L ++ L+L N L +P + L L L L +N+L+ +L L
Sbjct: 130 DSLTKLT----YLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELK 184
Query: 581 SLNISYNKFT 590
+L + N+
Sbjct: 185 TLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 53/232 (22%), Positives = 77/232 (33%), Gaps = 82/232 (35%)
Query: 145 SNMTALGLADTQVSGSLPASL-GKLSKLQTLSIYTTMISGEIPAEI-GNCSELVSLFLYE 202
+ + L L D ++ +LPA + +L L+TL + + +P + L L L
Sbjct: 61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDR 118
Query: 203 NSLSGSIPPEI-GKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSI 261
N L S+PP + L KL L L N L
Sbjct: 119 NQLK-SLPPRVFDSLTKLTYLSLGYNELQ------------------------------- 146
Query: 262 GGLSELEEFMISDNNVSGSIPANL-ANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFA 320
S+P + T+L +L+L NQ+ +P G KLT
Sbjct: 147 ------------------SLPKGVFDKLTSLKELRLYNNQLKR-VPE--GAFDKLT---- 181
Query: 321 WQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLF-QLQNLTKLLLISN 371
L+ L L +N L VP G F L+ L L L N
Sbjct: 182 -----------------ELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 72/280 (25%), Positives = 109/280 (38%), Gaps = 46/280 (16%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA---EIKTLGS 767
+G+G G V A + E +AVK + + D EI
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-------------DMKRAVDCPENIKKEICINKM 61
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQ 824
+ H+N+V+F G N + L +Y G L + E + + Q++
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLM----A 116
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
G+ YLH I HRDIK N+L+ I+DFGLA + + R N + G+ Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 885 IAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940
+APE + E DV+S G+V+ +L G+ P D S K +
Sbjct: 174 VAPELLKRREF---HAEPVDVWSCGIVLTAMLAGELPWD----QPSDSCQEYSDWKEKKT 226
Query: 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
P +ID AL +L N P R T+ D+
Sbjct: 227 YLN-----PWKKIDSAPLALLHKILVEN--PSARITIPDI 259
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-19
Identities = 68/284 (23%), Positives = 112/284 (39%), Gaps = 38/284 (13%)
Query: 688 QFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANG 746
QF + + S VLK + IG G G+V A D +A+KKL
Sbjct: 47 QFYSVE-VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL----SRPFQN 101
Query: 747 CSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYD-YMPNGSLGSLLHER 805
+ K R E+ + + HKNI+ L + D Y+ + + L +
Sbjct: 102 QTHAKRAYR-----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV 156
Query: 806 TGNALEWE----LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861
L+ E L YQ+L G + +LH + +HRD+K +NI++ + I DFG
Sbjct: 157 IQMELDHERMSYLLYQMLCG----IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFG 209
Query: 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921
LA+ + V Y Y APE M E D++S G ++ E++ K
Sbjct: 210 LARTAGTSFM--MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----IL 262
Query: 922 IPDGSHVVDWVRQKKGI-QVL---DPSLLSRPESEIDEMLQALG 961
P G +D Q + + L P + + + + ++
Sbjct: 263 FP-GRDYID---QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 302
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 29/284 (10%), Positives = 66/284 (23%), Gaps = 68/284 (23%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
G ++A D +A+ + P + V + L I
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD--------DVLQETLSRTLRLSRID 89
Query: 770 HKNIVRFL------GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
+ R L ++ +++ GSL + + + A
Sbjct: 90 KPGVARVLDVVHTRAGGL-----VVA-EWIRGGSLQEVADTS----PSPVGAIRAMQSLA 139
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
H + + + ++ G L
Sbjct: 140 AAADAAHRA---GVALSIDHPSRVR--------VSIDGDVVL---AYP-----------A 174
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
+ + D+ G + +L + P+ + Q ++P
Sbjct: 175 TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AERDTAGQPIEP 225
Query: 944 SLLSRPE--SEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985
+ + + +I VA V R + M +
Sbjct: 226 ADI-DRDIPFQISA------VAARSVQGDGGIRSASTLLNLMQQ 262
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 7e-19
Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 20/179 (11%)
Query: 816 YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
+Q+ A+G+ +L +HRD+ A NIL+ + I DFGLA+ +
Sbjct: 200 FQV----AKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 876 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQ 934
++APE + T +SDV+S+GV++ E+ + G P P + +
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDEEFCRRL-- 309
Query: 935 KKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993
K+G + + P+ EM Q L C + P +RPT ++ L + +
Sbjct: 310 KEGTR------MRAPDYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 24/104 (23%), Positives = 39/104 (37%), Gaps = 18/104 (17%)
Query: 710 NVIGKGCSGVVYRAD------MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
+G+G G V AD +AVK L + + +E+K
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE----------HRALMSELK 77
Query: 764 TLGSI-RHKNIVRFLGCCWNRNNRLLM-YDYMPNGSLGSLLHER 805
L I H N+V LG C L++ ++ G+L + L +
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G +V + G+ A K + S + R+ E+ L IR
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAK-----FIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQGL 826
H NI+ N+ + +L+ + + G L L E+ + E E QIL G+
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQIL----DGV 121
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPY----IADFGLAKLVDDGDFARSSNTVAGSY 882
YLH I H D+K NI++ + P + DFG+A ++ G+ + + G+
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---NIFGTP 175
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVV 907
++APE + ++D++S GV+
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 40/211 (18%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+GKG VV R + G+ A + + + + E + ++
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAM-----IINTKKLSARDHQKLER----EARICRLLK 68
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQGL 826
H NIVR + L++D + G L + R E + QIL + +
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQIL----EAV 123
Query: 827 AYLH-HDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVAGSY 882
+ H +VHR++K N+L+ + + +ADFGLA V+ ++ AG+
Sbjct: 124 LHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTP 177
Query: 883 GYIAPE------YGYMMKITEKSDVYSYGVV 907
GY++PE YG + D+++ GV+
Sbjct: 178 GYLSPEVLRKDPYG------KPVDLWACGVI 202
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 43/174 (24%), Positives = 73/174 (41%), Gaps = 41/174 (23%)
Query: 712 IGKGCSGVVYRA---DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+G G VY+A D + + A+K++ E +G+ S EI L +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI-------------EGTGISMSACREIALLREL 75
Query: 769 RHKNIVRFLGCCWNRNNRLLM--YDYMPNGSLGSLLHERTGNALEWELR----------- 815
+H N++ + +R + +DY + L ++ + +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 816 YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY----IADFGLAKL 865
YQIL G+ YLH + ++HRD+K NIL+ E IAD G A+L
Sbjct: 135 YQIL----DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 42/222 (18%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVR-----DSFSAEIKT 764
++G+G V A ++ A+K L EK + + E
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKIL-------------EKRHIIKENKVPYVTRERDV 83
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLG 821
+ + H V+ + Y NG L + + G+ E R+ +I+
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSA 142
Query: 822 AAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
L YLH I+HRD+K NIL+ + I DFG AK++ +N+ G
Sbjct: 143 ----LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 881 SYGYIAPEYGYMMKITEK-----SDVYSYGVVVLEVLTGKQP 917
+ Y++PE +TEK SD+++ G ++ +++ G P
Sbjct: 195 TAQYVSPEL-----LTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 75/279 (26%), Positives = 113/279 (40%), Gaps = 48/279 (17%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G G G V G +AVK L + V EI+ L RH
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--------RSLDVVGKIKREIQNLKLFRH 70
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQGLA 827
+I++ + ++ +Y+ G L + + G E E R QIL +
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQIL----SAVD 125
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
Y H +VHRD+K N+L+ IADFGL+ ++ DG+F R T GS Y AP
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSCGSPNYAAP 179
Query: 888 E----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
E Y + D++S GV++ +L G P D HV ++ +G P
Sbjct: 180 EVISGRLY---AGPEVDIWSCGVILYALLCGTLPF-----DDEHVPTLFKKIRGGVFYIP 231
Query: 944 SLLSRPESE--IDEMLQALGVALLCVNASPDERPTMKDV 980
L+ + MLQ V+ P +R T+KD+
Sbjct: 232 EYLN-RSVATLLMHMLQ--------VD--PLKRATIKDI 259
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-18
Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 61/242 (25%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIG G GVV++A +++ EV A+KK+ D++ R E++ + ++
Sbjct: 47 VIGNGSFGVVFQAKLVESDEV-AIKKV----------LQDKRFKNR-----ELQIMRIVK 90
Query: 770 HKNIVRFLGCCWNRNNRL------LMYDYMPNGSLGSLL--HERTGNALEWEL----RYQ 817
H N+V ++ ++ L+ +Y+P ++ + + + L YQ
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 818 ILLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPY-IADFGLAKLVDDGDFARSS 875
+L + LAY+H I HRDIK N+L+ + DFG AK++ G+
Sbjct: 150 LL----RSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---- 197
Query: 876 NT--VAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928
N + Y Y APE Y I D++S G V+ E++ G QP+ P G
Sbjct: 198 NVSYICSRY-YRAPELIFGATNYTTNI----DIWSTGCVMAELMQG-QPLFP----GESG 247
Query: 929 VD 930
+D
Sbjct: 248 ID 249
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 63/223 (28%), Positives = 92/223 (41%), Gaps = 37/223 (16%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IG G GV D E++AVK + + + + ++ EI S+RH
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI------------ERGAAIDENVQREIINHRSLRH 75
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGLA 827
NIVRF + ++ +Y G L + G E E R+ Q+L G++
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLL----SGVS 130
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPY--IADFGLAKLVDDGDFARSSNTVAGSYGYI 885
Y H + HRD+K N L+ P I DFG +K + + G+ YI
Sbjct: 131 YCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYI 184
Query: 886 APE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPI-DPTIP 923
APE Y K +DV+S GV + +L G P DP P
Sbjct: 185 APEVLLRQEYDGK---IADVWSCGVTLYVMLVGAYPFEDPEEP 224
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-18
Identities = 87/474 (18%), Positives = 163/474 (34%), Gaps = 91/474 (19%)
Query: 145 SNMTALGLADTQVSGSLPASLGK-LSKLQTLSIYTTMISGE----IPAEIGNCSELVSLF 199
++ +L + ++S + A L L + Q + + ++ I + + L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 200 LYENSLSGSIPPEIGK-LK----KLEELFLWQNSL----VGAIPEEIGNCTSLKMIDFSL 250
L N L + + L+ K+++L L L G + + +L+ + S
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 251 NSL--SGTIPLSIGGLSE---LEEFMISDNNVSGSIPANLANA----TNLVQLQLDTNQI 301
N L +G L G L LE+ + ++S + LA+ + +L + N I
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 302 S---------GLIPPEIGMLSKLTVFFAWQNQL--EG--SIPSTLASCSNLQALDLSHNS 348
+ GL +L + + + +AS ++L+ L L N
Sbjct: 183 NEAGVRVLCQGLKDSP----CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238
Query: 349 LTAS-----VPAGLFQLQNLTKLLLISNDIS----GSIPPEIGNCSSLVRLRVGNNRI-- 397
L P L L L + I+ G + + SL L + N +
Sbjct: 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 298
Query: 398 ---AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD----CTELQMIDLSHNTLQGS-- 448
L + L L + S + + L + +S+N L+ +
Sbjct: 299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358
Query: 449 --LPNSL-SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCS 505
L L S L+VL ++D S +SL ++L
Sbjct: 359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA--------------------ATLLANH 398
Query: 506 SLQLLDLSSNQLTGSVPMELGQIEALEI------ALNLSCNGLTGPIPAQISAL 553
SL+ LDLS+N L + ++L E++ L L + + ++ AL
Sbjct: 399 SLRELDLSNNCLGDAGILQLV--ESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 450
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-16
Identities = 70/448 (15%), Positives = 148/448 (33%), Gaps = 89/448 (19%)
Query: 193 SELVSLFLYENSLSGSIPPEIGK-LKKLEELFLWQNSL----VGAIPEEIGNCTSLKMID 247
++ SL + LS + E+ L++ + + L L I + +L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 248 FSLNSL--SGTIPLSIGGLSE---LEEFMISDNNVS----GSIPANLANATNLVQLQLDT 298
N L G + G + +++ + + ++ G + + L L +L L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 299 NQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTA----SVP 354
N + + +L + L L+ L L + SL+A +
Sbjct: 123 NLLG---DAGLQLLCEGL----------------LDPQCRLEKLQLEYCSLSAASCEPLA 163
Query: 355 AGLFQLQNLTKLLLISNDISGSIPPEIG-----NCSSLVRLRVGNNRI----AGLIPREI 405
+ L + +L + +NDI+ + + + L L++ + + + +
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223
Query: 406 GGLKTLNFLDLSSNRLSGSVPDEIGD-----CTELQMIDLSHNTLQ----GSLPNSLSSL 456
+L L L SN+L E+ + L+ + + + G L L +
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283
Query: 457 SGLQVLDVSDNRFSGQIPASLGRLV-----SLNKIILSKNLFSG----PIPSSLGLCSSL 507
L+ L ++ N + L + L + + F+ S L L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 508 QLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE 567
L +S+N+L + EL + L + L +L L+ +
Sbjct: 344 LELQISNNRLEDAGVRELC--QGLG------------------QPGSVLRVLWLADCDVS 383
Query: 568 GN-----LNPLAQLDNLVSLNISYNKFT 590
+ L +L L++S N
Sbjct: 384 DSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 7e-15
Identities = 83/425 (19%), Positives = 156/425 (36%), Gaps = 78/425 (18%)
Query: 20 LSSFKHLQTLVISDANLT----GSIPFDIGDCVGLIVLDFSSNNL----VGTLPSSLGKL 71
L + Q + + D LT I + L L+ SN L V + L
Sbjct: 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83
Query: 72 H-NLEELILNSNQLTGK----IPVELSNCKSLRKLLLFDNALAGNIPAE------LGRLS 120
+++L L + LTG + L +L++L L DN L G+ + L
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL-GDAGLQLLCEGLLDPQC 142
Query: 121 NLEEMRAGGNK---DIVGKIPAELGDCSNMTALGLADTQVSGS----LPASLGK-LSKLQ 172
LE+++ + + L + L +++ ++ + L L +L+
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202
Query: 173 TLSIYTTMISGE----IPAEIGNCSELVSLFLYENSLSGSIPPEIGK-----LKKLEELF 223
L + + ++ + + + + + L L L N L E+ +L L+
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262
Query: 224 LWQNSL----VGAIPEEIGNCTSLKMIDFSLNSL--SGTIPLSIGGLSE---LEEFMISD 274
+W+ + G + + SLK + + N L G L L LE +
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322
Query: 275 NNVSGSIPANLANA----TNLVQLQLDTNQIS---------GLIPPEIGMLSKLTVFFAW 321
+ + + ++ ++ L++LQ+ N++ GL P S L V +
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP----GSVLRVLWLA 378
Query: 322 QNQL--EG--SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQ--------NLTKLLLI 369
+ S+ +TL + +L+ LDLS+N L AG+ QL L +L+L
Sbjct: 379 DCDVSDSSCSSLAATLLANHSLRELDLSNNCLG---DAGILQLVESVRQPGCLLEQLVLY 435
Query: 370 SNDIS 374
S
Sbjct: 436 DIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 72/410 (17%), Positives = 127/410 (30%), Gaps = 58/410 (14%)
Query: 20 LSSFKHLQTLVISDANLTGSIPFDIGDCVG-----LIVLDFSSNNL----VGTLPSSLGK 70
L L L + L + + + L + L G L S+L
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 71 LHNLEELILNSNQLTGK-----IPVELSNCKSLRKLLLFDNAL----AGNIPAELGRLSN 121
L L+EL L+ N L L L KL L +L + + L +
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171
Query: 122 LEEMRAGGNK---DIVGKIPAELGDC-SNMTALGLADTQVS----GSLPASLGKLSKLQT 173
+E+ N V + L D + AL L V+ L + + L+
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231
Query: 174 LSIYTTMISGE-----IPAEIGNCSELVSLFLYENSLS----GSIPPEIGKLKKLEELFL 224
L++ + + P + S L +L+++E ++ G + + + L+EL L
Sbjct: 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291
Query: 225 WQNSL----VGAIPEEIGNC-TSLKMIDFSLNSLS--GTIPLS--IGGLSELEEFMISDN 275
N L + E + L+ + S + S + L E IS+N
Sbjct: 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNN 351
Query: 276 NVSGSIPANLANA-----TNLVQLQLDTNQIS----GLIPPEIGMLSKLTVFFAWQNQLE 326
+ + L + L L L +S + + L N L
Sbjct: 352 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
Query: 327 GSIPSTLA-----SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISN 371
+ L L+ L L + + L L+ L + +
Sbjct: 412 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 69/295 (23%), Positives = 119/295 (40%), Gaps = 51/295 (17%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVK---------------KLWPTTMAAANGCSDEKSGVR 755
IGKG GVV A + ++ A+K + P A G + G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 756 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMY---DYMPNGSLGSLLHERTGNALEW 812
+ EI L + H N+V+ L + N +Y + + G + + E
Sbjct: 81 EQVYQEIAILKKLDHPNVVK-LVEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKPLSED 137
Query: 813 ELRY---QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG 869
+ R+ ++ G + YLH+ I+HRDIK +N+L+G + IADFG++
Sbjct: 138 QARFYFQDLIKG----IEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 870 DFARSSNTVAGSYGYIAPE--YGYMMKIT-EKSDVYSYGVVVLEVLTGKQP-IDPTIPDG 925
D S G+ ++APE + + DV++ GV + + G+ P +D I
Sbjct: 191 DALLS--NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC- 247
Query: 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ K I+ +P +I E L+ L +L N P+ R + ++
Sbjct: 248 ------LHSK--IKSQALEFPDQP--DIAEDLKDLITRMLDKN--PESRIVVPEI 290
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 45/220 (20%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR- 769
+G+G V+ A ++ N E + VK L P +K R EIK L ++R
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPV---------KKKKIKR-----EIKILENLRG 89
Query: 770 HKNIVRFLGCCWNRNNR--LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLA 827
NI+ + +R L+++++ N L T + + + Y+IL + L
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-YEIL----KALD 144
Query: 828 YLH-HDCVPPIVHRDIKANNILIGLEF-EPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
Y H I+HRD+K +N++I E + + D+GLA+ G + VA Y +
Sbjct: 145 YCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRY-FK 197
Query: 886 APE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918
PE Y Y + D++S G ++ ++ K+P
Sbjct: 198 GPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEPF 231
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 33/171 (19%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRD-SFSA--EI--- 762
IG G G VY+A D +G +A+K + + G S E+
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVR---------VPNGGGGGGGLPISTVREVALL 65
Query: 763 KTLGSIRHKNIVR----FLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWE---- 813
+ L + H N+VR +R ++ L+++++ L + L + L E
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 814 LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
L Q L +GL +LH +C IVHRD+K NIL+ +ADFGLA+
Sbjct: 125 LMRQFL----RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 67/257 (26%), Positives = 107/257 (41%), Gaps = 43/257 (16%)
Query: 690 TPFQKLNFSVEQVLKCL-------VDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTM 741
P + F ++V K D +G G G V A D G +A+KKL
Sbjct: 4 PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL----Y 59
Query: 742 AAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYD-YMPNGSLGS 800
K R E++ L +RH+N++ L D Y+ +G+
Sbjct: 60 RPFQSELFAKRAYR-----ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT 114
Query: 801 LLHE--RTGNALEWE----LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE 854
L + + L + L YQ+L +GL Y+H + +HRD+K N+ + + E
Sbjct: 115 DLGKLMKH-EKLGEDRIQFLVYQML----KGLRYIHAAGI---IHRDLKPGNLAVNEDCE 166
Query: 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY-GYMMKITEKSDVYSYGVVVLEVLT 913
I DFGLA+ D + V + Y APE M+ T+ D++S G ++ E++T
Sbjct: 167 LKILDFGLARQADS----EMTGYVVTRW-YRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221
Query: 914 GKQPIDPTIPDGSHVVD 930
GK + GS +D
Sbjct: 222 GK-TLFK----GSDHLD 233
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 46/173 (26%), Positives = 70/173 (40%), Gaps = 14/173 (8%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEI-GMLSKLTVFFAWQNQLEGSIPS-TLASCS 337
++P +L + L L N +S L L+ L N L I S
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 338 NLQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNN 395
NL+ LDLS N L ++ LF LQ L LLL +N I + + + L +L + N
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 396 RIAGLIP---REIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQM--IDLSHN 443
+I+ ++ L L LDLSSN+L ++ + L +N
Sbjct: 147 QISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 52/242 (21%), Positives = 79/242 (32%), Gaps = 66/242 (27%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394
C++ L S L +VP +P L + +
Sbjct: 17 LCAS-NILSCSKQQLP-NVPQS--------------------LPSYT------ALLDLSH 48
Query: 395 NRIAGLIPREI-GGLKTLNFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHNTLQGSLP-N 451
N ++ L L L+ L LS N L+ + E L+ +DLS N L +L
Sbjct: 49 NNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEF 106
Query: 452 SLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLD 511
S L L+VL + +N + N F + LQ L
Sbjct: 107 LFSDLQALEVLLLYNNHIV-VVDR---------------NAFED--------MAQLQKLY 142
Query: 512 LSSNQLTGSVPME----LGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE 567
LS NQ++ P+E ++ L + L+LS N L + L L L
Sbjct: 143 LSQNQIS-RFPVELIKDGNKLPKLML-LDLSSNKLKKLPLTDLQKLPAWVKNGLY---LH 197
Query: 568 GN 569
N
Sbjct: 198 NN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 43/179 (24%), Positives = 66/179 (36%), Gaps = 18/179 (10%)
Query: 32 SDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPS--SLGKLHNLEELILNSNQLTGKIP 89
S L ++P + +LD S NNL L + + +L NL L+L+ N L I
Sbjct: 26 SKQQLP-NVPQSLP--SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FIS 80
Query: 90 VE-LSNCKSLRKLLLFDNALAGNIPAE-LGRLSNLEEMRAGGNKDIVGKIPAE-LGDCSN 146
E +LR L L N L + L LE + N + + D +
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNH--IVVVDRNAFEDMAQ 137
Query: 147 MTALGLADTQVSGSLPA----SLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLY 201
+ L L+ Q+S P KL KL L + + + ++ V LY
Sbjct: 138 LQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 26/108 (24%), Positives = 48/108 (44%), Gaps = 11/108 (10%)
Query: 24 KHLQTLVISDANLTGSIP---FDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILN 80
+L+ L +S +L ++ F D L VL +N++V ++ + L++L L+
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFS--DLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLS 144
Query: 81 SNQLTGKIPVE----LSNCKSLRKLLLFDNALAGNIPAELGRLSNLEE 124
NQ++ + PVE + L L L N L +L +L +
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 49/221 (22%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+G+G V ++ + AVK + + +R E++ L +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKII-----------EKQPGHIRSRVFREVEMLYQCQ 68
Query: 770 -HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQG 825
H+N++ + + L+++ M GS+ S +H+R + E E + +
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVA----SA 123
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSN-----T 877
L +LH+ I HRD+K NIL + I DF L + + T
Sbjct: 124 LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 878 VAGSYGYIAPE-----------YGYMMKITEKSDVYSYGVV 907
GS Y+APE Y ++ D++S GV+
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYD------KRCDLWSLGVI 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 65/292 (22%), Positives = 107/292 (36%), Gaps = 56/292 (19%)
Query: 707 VDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+ V+G G +G V G+ A+K L + R E+
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLL------------YDSPKARQ----EVDHH 75
Query: 766 GSI-RHKNIVRFLGCCWNRNNR-----LLMYDYMPNGSLGSLLHERTGNAL-EWE---LR 815
+IV L N ++ ++M + M G L S + ER A E E +
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIM-ECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 816 YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFA 872
I + +LH I HRD+K N+L + + + DFG AK
Sbjct: 135 RDIG----TAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL- 186
Query: 873 RSSNTVAGSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928
T + Y+APE Y + D++S GV++ +L G P G +
Sbjct: 187 ---QTPCYTPYYVAPEVLGPEKY----DKSCDMWSLGVIMYILLCGFPPFYS--NTGQAI 237
Query: 929 VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
++++ I++ + SE+ E + L LL + P ER T+
Sbjct: 238 SPGMKRR--IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTD--PTERLTITQF 285
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 46/225 (20%), Positives = 87/225 (38%), Gaps = 52/225 (23%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGV-RDSFSAEIKTLGSI 768
+G+G G+V+R + + + K + + G + EI L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-------------KVKGTDQVLVKKEISILNIA 58
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSL-------GSLLHERTGNALEWELRYQILLG 821
RH+NI+ + +++++++ + L+ER + + Q+
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY---VH-QVC-- 112
Query: 822 AAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPY--IADFGLAKLVDDGDFARSSNTV 878
+ L +LH H+ I H DI+ NI+ I +FG A+ + GD R +
Sbjct: 113 --EALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR---LL 163
Query: 879 AGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ Y APE +D++S G +V +L+G P
Sbjct: 164 FTAPEYYAPEVHQHDVVST------ATDMWSLGTLVYVLLSGINP 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 50/228 (21%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G VV + + G A K + S + R+ E+ L I+
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAK-----FIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSL-------GSLLHERTGNALEWELRYQILLGA 822
H N++ N+ + +L+ + + G L SL E L+ QIL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEATEF---LK-QIL--- 124
Query: 823 AQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPY----IADFGLAKLVDDGDFARSSNT 877
G+ YLH I H D+K NI++ P I DFGLA +D G+ +
Sbjct: 125 -NGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---N 176
Query: 878 VAGSYGYIAPE------YGYMMKITEKSDVYSYGVV--VLEVLTGKQP 917
+ G+ ++APE G ++D++S GV+ +L L+G P
Sbjct: 177 IFGTPEFVAPEIVNYEPLG------LEADMWSIGVITYIL--LSGASP 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 63/287 (21%), Positives = 99/287 (34%), Gaps = 55/287 (19%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG-S 767
IG G V R AVK + K + EI+ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKII-----------DKSKRDPTE----EIEILLRY 72
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQ 824
+H NI+ + ++ + M G L + + E E + + I +
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTIT----K 127
Query: 825 GLAYLH-HDCVPPIVHRDIKANNILIGLEFEPY----IADFGLAKLVDDGDFARSSNTVA 879
+ YLH +VHRD+K +NIL E I DFG AK + + T
Sbjct: 128 TVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPC 181
Query: 880 GSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933
+ ++APE Y D++S GV++ +LTG P D +
Sbjct: 182 YTANFVAPEVLERQGYD------AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---- 231
Query: 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
I SL + + + + L +L V+ P +R T V
Sbjct: 232 -LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVD--PHQRLTAALV 275
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 45/218 (20%), Positives = 84/218 (38%), Gaps = 37/218 (16%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G GVV+R + G V K + + + + EI + +
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFI-----------NTPYPLDKYTVKNEISIMNQLH 106
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSL-------GSLLHERTGNALEWELRYQILLGA 822
H ++ ++ +L+ +++ G L + E +R Q
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY---MR-QAC--- 159
Query: 823 AQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPY--IADFGLAKLVDDGDFARSSNTVA 879
+GL ++H H IVH DIK NI+ + I DFGLA ++ + +
Sbjct: 160 -EGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTT 211
Query: 880 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ + APE + +D+++ GV+ +L+G P
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 68/253 (26%), Positives = 110/253 (43%), Gaps = 44/253 (17%)
Query: 693 QKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEK 751
+ + V V + + IG+G G+V A D N +A+KK+ + + +
Sbjct: 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-----SPFEHQTYCQ 70
Query: 752 SGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL-----LMYDYMPNGSLGSLLHE-- 804
+R EIK L RH+NI+ ++ D M + L++
Sbjct: 71 RTLR-----EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLL 120
Query: 805 RTGNALEWE----LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860
+T L + YQIL +GL Y+H V +HRD+K +N+L+ + I DF
Sbjct: 121 KT-QHLSNDHICYFLYQIL----RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDF 172
Query: 861 GLAKLVDDGDFARSSNT--VAGSYGYIAPEY-GYMMKITEKSDVYSYGVVVLEVLTGKQP 917
GLA++ D T VA + Y APE T+ D++S G ++ E+L+ + P
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRW-YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-P 230
Query: 918 IDPTIPDGSHVVD 930
I P G H +D
Sbjct: 231 IFP----GKHYLD 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 66/242 (27%), Positives = 101/242 (41%), Gaps = 43/242 (17%)
Query: 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
++ K V +G G G V A D +GE +A+KKL K R
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL----SRPFQSEIFAKRAYR---- 72
Query: 760 AEIKTLGSIRHKNIVRFL------GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE 813
E+ L ++H+N++ L N + L+ +M + L + G E
Sbjct: 73 -ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEE 126
Query: 814 ----LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG 869
L YQ+L +GL Y+H V VHRD+K N+ + + E I DFGLA+ D
Sbjct: 127 KIQYLVYQML----KGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARHADA- 178
Query: 870 DFARSSNTVAGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928
+ V + Y APE M + D++S G ++ E+LTGK + G
Sbjct: 179 ---EMTGYVVTRW-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFK----GKDY 229
Query: 929 VD 930
+D
Sbjct: 230 LD 231
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 50/224 (22%), Positives = 95/224 (42%), Gaps = 49/224 (21%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRD--SFSAEIKTLGS 767
++G G G V++ + G +A K + + G++D EI +
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKII-------------KTRGMKDKEEVKNEISVMNQ 142
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSL-------GSLLHERTGNALEWELRYQILL 820
+ H N+++ ++N+ +L+ +Y+ G L L E ++ QI
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF---MK-QIC- 197
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI--ADFGLAKLVDDGDFARSSNTV 878
+G+ ++H I+H D+K NIL I DFGLA+ + +
Sbjct: 198 ---EGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK---VN 248
Query: 879 AGSYGYIAPE---YGYMMKITEKSDVYSYGVV--VLEVLTGKQP 917
G+ ++APE Y + ++ +D++S GV+ +L L+G P
Sbjct: 249 FGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAYML--LSGLSP 287
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 35/171 (20%)
Query: 710 NVIGKGCSGVVYRA--DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA--EIKTL 765
IG+G G V++A + G +A+K++ + G+ S E+ L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVR---------VQTGEEGM--PLSTIREVAVL 65
Query: 766 GSIR---HKNIVR----FLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELR-- 815
+ H N+VR +R +L L+++++ L + L + + E
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 816 --YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864
+Q+L +GL +LH +VHRD+K NIL+ + +ADFGLA+
Sbjct: 125 MMFQLL----RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 59/284 (20%), Positives = 109/284 (38%), Gaps = 56/284 (19%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++G G G VY + + +A+K + ++ + E+ L +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-----EVVLLKKVS 104
Query: 770 HK--NIVRFLGCCWNRNNRLLMYDY-MPNGSLGSLLHERTGNALEWELRY---QILLGAA 823
++R L ++ +L+ + P L + ER G E R Q+L
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVL---- 159
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLE-FEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
+ + + H+ V +HRDIK NILI L E + DFG L+ D + G+
Sbjct: 160 EAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTR 212
Query: 883 GYIAPEY----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938
Y PE+ Y + + V+S G+++ +++ G P + ++
Sbjct: 213 VYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFE----HDEEIIRG------- 258
Query: 939 QVLDPSLLSRPESE--IDEMLQALGVALLCVNASPDERPTMKDV 980
QV +S E + I L + P +RPT +++
Sbjct: 259 QVFFRQRVS-SECQHLIRWCLA--------LR--PSDRPTFEEI 291
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 1e-16
Identities = 43/249 (17%), Positives = 82/249 (32%), Gaps = 36/249 (14%)
Query: 344 LSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403
+ + L + L S + S + E+ +C L L N +
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCEL-SVEKSTVLQSELESCKELQELEPENKWC---LLT 387
Query: 404 EIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLD 463
I ++ L+ L L + D +D + + ++VL
Sbjct: 388 IILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH 447
Query: 464 VSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPM 523
++ + + L +L+ + + LS N +P +L L++L S N L
Sbjct: 448 LAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE----- 499
Query: 524 ELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEG--NLNPLAQLDNLVS 581
+ +G+ + L +L L L +N+L+ + PL LV
Sbjct: 500 --------------NVDGV--------ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 537
Query: 582 LNISYNKFT 590
LN+ N
Sbjct: 538 LNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 77.9 bits (191), Expect = 8e-15
Identities = 53/340 (15%), Positives = 106/340 (31%), Gaps = 22/340 (6%)
Query: 17 PTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEE 76
P + S++ + + L+ + + + FS VG+ +L + +
Sbjct: 223 PNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAP 282
Query: 77 LILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGK 136
L + G+ L L D + +E + +
Sbjct: 283 LSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKEC-----VLLKDR 337
Query: 137 IPAELGDCSNMTALGLADT-----QVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGN 191
D + L + V S S +L +L+ + + + + +
Sbjct: 338 PECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDP 397
Query: 192 CSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLN 251
Y ++L P L L FL +N ++++ +
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN------SVLKMEYADVRVLHLAHK 451
Query: 252 SLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGM 311
L+ + + L + +S N + ++P LA L LQ N + + +
Sbjct: 452 DLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVAN 506
Query: 312 LSKLTVFFAWQNQLEG-SIPSTLASCSNLQALDLSHNSLT 350
L +L N+L+ + L SC L L+L NSL
Sbjct: 507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 27/202 (13%), Positives = 57/202 (28%), Gaps = 9/202 (4%)
Query: 411 LNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470
L L+ + + L + + ++ L ++S + S
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEK-S 361
Query: 471 GQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEA 530
+ + L L ++ I + L + + L ++
Sbjct: 362 TVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS-----TLKAVDP 416
Query: 531 LEIALNLSC-NGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKF 589
+ A + + +L L+H L L L QL + L++S+N+
Sbjct: 417 MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRL 475
Query: 590 TGYLPDNKLFRQLSPTDLAGNE 611
P R L + N
Sbjct: 476 RALPPALAALRCLEVLQASDNA 497
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 8e-06
Identities = 22/108 (20%), Positives = 39/108 (36%), Gaps = 28/108 (25%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+P L++ + L+ L S+N + + + L L+
Sbjct: 478 LPPALAALRCLEVL-----QA--------------------SDNALENVD-GVANLPRLQ 511
Query: 76 ELILNSNQLTG-KIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNL 122
EL+L +N+L L +C L L L N+L RL+ +
Sbjct: 512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 47/221 (21%), Positives = 90/221 (40%), Gaps = 44/221 (19%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G+G + + + + AVK + K ++ EI L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII-------------SKRMEANTQK-EITALKLCE 63
Query: 770 -HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQG 825
H NIV+ ++ + L+ + + G L + ++ + E E + +++
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLV----SA 118
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVAGSY 882
++++H +VHRD+K N+L E + I DFG A+L + + T +
Sbjct: 119 VSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTL 173
Query: 883 GYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
Y APE Y E D++S GV++ +L+G+ P
Sbjct: 174 HYAAPELLNQNGYD------ESCDLWSLGVILYTMLSGQVP 208
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 49/228 (21%), Positives = 90/228 (39%), Gaps = 44/228 (19%)
Query: 707 VDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
+ + +G+G VV + G+ A K + D ++ + EI L
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAK-----FLKKRRRGQDCRAEILH----EIAVL 82
Query: 766 GSIRH-KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNAL-EWELRY---QILL 820
+ ++ N + +L+ +Y G + SL + E ++ QIL
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL- 141
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNT 877
+G+ YLH + IVH D+K NIL+ + I DFG+++ + R
Sbjct: 142 ---EGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---E 192
Query: 878 VAGSYGYIAPE------YGYMMKITEKSDVYSYGVV--VLEVLTGKQP 917
+ G+ Y+APE +D+++ G++ +L LT P
Sbjct: 193 IMGTPEYLAPEILNYDPIT------TATDMWNIGIIAYML--LTHTSP 232
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 54/234 (23%), Positives = 85/234 (36%), Gaps = 35/234 (14%)
Query: 711 VIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANG-----CSDEKSGVRDSFSAEIKTL 765
I G G V G +A+K+++ T K +R EI+ L
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-----EIRLL 83
Query: 766 GSIRHKNIVRFLGCCWNRNNRL-----LMYDYMPNGSLGSLLHERTGNALEWELR---YQ 817
H NI+ + L+ + M L ++H++ ++ Y
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYH 142
Query: 818 ILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT 877
IL GL LH V VHRD+ NIL+ + I DF LA+ ++
Sbjct: 143 IL----LGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTHY 193
Query: 878 VAGSYGYIAPEY-GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930
V + Y APE T+ D++S G V+ E+ K + GS +
Sbjct: 194 VTHRW-YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFR----GSTFYN 241
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 27/213 (12%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G GVV+R + G A K + +++ EI+T+ +R
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFV-----------MTPHESDKETVRKEIQTMSVLR 212
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWE---LRYQILLGAAQGL 826
H +V + N +++Y++M G L + + E E Q+ +GL
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC----KGL 268
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYI--ADFGLAKLVDDGDFARSSNTVAGSYGY 884
++H + VH D+K NI+ + + DFGL +D + G+ +
Sbjct: 269 CHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEF 322
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
APE + +D++S GV+ +L+G P
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-16
Identities = 62/258 (24%), Positives = 100/258 (38%), Gaps = 47/258 (18%)
Query: 674 KDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRADM-DNGEVIA 732
D W++ Q + + + + V+GKG G V + G++ A
Sbjct: 160 DYLDSIYFNRFLQWKWLERQPVTKNTFRQYR------VLGKGGFGEVCACQVRATGKMYA 213
Query: 733 VKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRL-LMYD 791
KKL + ++ G E + L + + +V L + + L L+
Sbjct: 214 CKKLEKKRIK-------KRKGE-AMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVLT 264
Query: 792 YMPNGSLGSLLH-ERTGNALEWELR---Y--QILLGAAQGLAYLHHDCVPPIVHRDIKAN 845
M G L H G A E R Y +I G L LH + IV+RD+K
Sbjct: 265 LMNGGDL--KFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHRER---IVYRDLKPE 315
Query: 846 NILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE------YGYMMKITEKS 899
NIL+ I+D GLA V +G + G+ GY+APE Y +
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSP------ 366
Query: 900 DVYSYGVVVLEVLTGKQP 917
D ++ G ++ E++ G+ P
Sbjct: 367 DWWALGCLLYEMIAGQSP 384
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 58/254 (22%)
Query: 684 SWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMA 742
S P F + +NF ++L+ IGKG G V D ++ A+K +
Sbjct: 1 SMPPVFDENEDVNFDHFEILR------AIGKGSFGKVCIVQKNDTKKMYAMKYM------ 48
Query: 743 AANGCSDEKSGV--RDSFS---AEIKTLGSIRHKNIVRFLGCCWNRNNRLLM-YDYMPNG 796
K R+ E++ + + H +V L + + M D + G
Sbjct: 49 -------NKQKCVERNEVRNVFKELQIMQGLEHPFLVN-LWYSFQDEEDMFMVVDLLLGG 100
Query: 797 SLGSLLHERTGNALEWELRY---QILLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLE 852
L L ++ + E ++ ++++ L YL I+HRD+K +NIL+
Sbjct: 101 DLRYHL-QQNVHFKEETVKLFICELVMA----LDYLQNQR----IIHRDMKPDNILLDEH 151
Query: 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE---------YGYMMKITEKSDVYS 903
+I DF +A ++ T+AG+ Y+APE Y + + D +S
Sbjct: 152 GHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAV------DWWS 202
Query: 904 YGVVVLEVLTGKQP 917
GV E+L G++P
Sbjct: 203 LGVTAYELLRGRRP 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 49/279 (17%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G+G G V A + +A+K + + +KS + EI L +RH
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLL--------KKSDMHMRVEREISYLKLLRH 68
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQGLA 827
+I++ + +++ +Y G L + E+ E E R QI+ +
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQII----CAIE 122
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
Y H IVHRD+K N+L+ IADFGL+ ++ DG+F + T GS Y AP
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK---TSCGSPNYAAP 176
Query: 888 E----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
E Y + DV+S G+V+ +L G+ P D + + ++ + P
Sbjct: 177 EVINGKLY---AGPEVDVWSCGIVLYVMLVGRLPF-----DDEFIPNLFKKVNSCVYVMP 228
Query: 944 SLLSRPESE--IDEMLQALGVALLCVNASPDERPTMKDV 980
LS P ++ I M+ + P +R T++++
Sbjct: 229 DFLS-PGAQSLIRRMIV--------AD--PMQRITIQEI 256
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 77/279 (27%), Positives = 114/279 (40%), Gaps = 48/279 (17%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
+G G G V G +AVK L + V EI+ L RH
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKI--------RSLDVVGKIRREIQNLKLFRH 75
Query: 771 KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR---YQILLGAAQGLA 827
+I++ ++ ++ +Y+ G L + + G E E R QIL G+
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQIL----SGVD 130
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
Y H V VHRD+K N+L+ IADFGL+ ++ DG+F R T GS Y AP
Sbjct: 131 YCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSCGSPNYAAP 184
Query: 888 E----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
E Y + D++S GV++ +L G P D HV ++ P
Sbjct: 185 EVISGRLY---AGPEVDIWSSGVILYALLCGTLPF-----DDDHVPTLFKKICDGIFYTP 236
Query: 944 SLLSRPESE--IDEMLQALGVALLCVNASPDERPTMKDV 980
L+ P + MLQ V+ P +R T+KD+
Sbjct: 237 QYLN-PSVISLLKHMLQ--------VD--PMKRATIKDI 264
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 52/234 (22%), Positives = 87/234 (37%), Gaps = 56/234 (23%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSA------EIK 763
++G+G G V D + AVK L +K +R + EI+
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKIL-------------KKKKLRRIPNGEANVKKEIQ 58
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLL-------------MYDYMPNGSLGSLLHERTGNAL 810
L +RHKN+++ + +N + + M D +P
Sbjct: 59 LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP----------- 107
Query: 811 EWELRY---QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867
+ Q++ GL YLH IVH+DIK N+L+ I+ G+A+ +
Sbjct: 108 VCQAHGYFCQLI----DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITE--KSDVYSYGVVVLEVLTGKQPID 919
+ T GS + PE + K D++S GV + + TG P +
Sbjct: 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-15
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 38/221 (17%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
V+G+G G V+ M G++ A KKL + ++ G E K L +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-------KRKGY-QGAMVEKKILAKVH 243
Query: 770 HKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLH---ERTGNALEWELRY---QILLGA 822
+ IV L + L L+ M G + ++ E E + QI+ G
Sbjct: 244 SRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG- 301
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
L +LH I++RD+K N+L+ + I+D GLA + G + AG+
Sbjct: 302 ---LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTP 353
Query: 883 GYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G++APE Y + + D ++ GV + E++ + P
Sbjct: 354 GFMAPELLLGEEYDFSV------DYFALGVTLYEMIAARGP 388
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-15
Identities = 65/264 (24%), Positives = 106/264 (40%), Gaps = 54/264 (20%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++G+G GVV A GE++A+KK+ + +R EIK L +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKI-----EPFDKPLFALRTLR-----EIKILKHFK 67
Query: 770 HKNIVRFL-----GCCWNRNNRLLMYDYMPNGSLGSLLHER-TGNALEWE----LRYQIL 819
H+NI+ N N ++ + M + LH + L + YQ L
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVA 879
+ + LH V +HRD+K +N+LI + + DFGLA+++D+ S T
Sbjct: 123 ----RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 880 GSY--GYI------APEY-GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930
S ++ APE K + DV+S G ++ E+ + PI P G
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFP----GRDYRH 230
Query: 931 WVRQKKGIQVLDPSLLSRPESEID 954
Q I ++ P S+ D
Sbjct: 231 ---QLLLIF----GIIGTPHSDND 247
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 56/287 (19%), Positives = 106/287 (36%), Gaps = 60/287 (20%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++GKG G V+ + + +A+K + + + SD + E+ L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-----EVALLWKVG 92
Query: 770 ----HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLH--ERTGNALEWELRY---QILL 820
H ++R L + +L+ + L G E R Q++
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGPSRCFFGQVV- 149
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLE-FEPYIADFGLAKLVDDGDFARSSNTVA 879
+ + H V VHRDIK NILI L + DFG L+ D +
Sbjct: 150 ---AAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFD 199
Query: 880 GSYGYIAPEY----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935
G+ Y PE+ Y + V+S G+++ +++ G P + +++
Sbjct: 200 GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFE----RDQEILEA---- 248
Query: 936 KGIQVLDPSLLSRPESE--IDEMLQALGVALLCVNASPDERPTMKDV 980
++ P+ +S P+ I L P RP+++++
Sbjct: 249 ---ELHFPAHVS-PDCCALIRRCLA--------PK--PSSRPSLEEI 281
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 53/244 (21%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G +G+V+ A D D + +A+KK+ K +R EIK + +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKI------VLTDPQSVKHALR-----EIKIIRRLD 66
Query: 770 HKNIVRFLGCCWNRNNRL--------------LMYDYMPNGSLGSLLHE--RTGNALEWE 813
H NIV+ ++L ++ +YM + L G LE
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEH 121
Query: 814 LR---YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-EPYIADFGLAKLVDDG 869
R YQ+L +GL Y+H V +HRD+K N+ I E I DFGLA+++D
Sbjct: 122 ARLFMYQLL----RGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 870 DFARSSNT--VAGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS 926
+ + + + Y +P T+ D+++ G + E+LTGK + G+
Sbjct: 175 YSHKGHLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFA----GA 228
Query: 927 HVVD 930
H ++
Sbjct: 229 HELE 232
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 53/271 (19%), Positives = 102/271 (37%), Gaps = 86/271 (31%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G G+V D+++G+ A+KK+ D + R E+ + +
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQ----------DPRYKNR-----ELDIMKVLD 58
Query: 770 HKNIVRFLGCCWNRNNRL--------------------------------------LMYD 791
H NI++ + + + ++ +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 792 YMPNGSLGSLL--HERTGNALEWEL----RYQILLGAAQGLAYLH-HDCVPPIVHRDIKA 844
Y+P+ +L +L R+G ++ L YQ+ + + ++H I HRDIK
Sbjct: 119 YVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSLG----ICHRDIKP 169
Query: 845 NNILIGLE-FEPYIADFGLAKLVDDGDFARSSNT--VAGSYGYIAPE--YGYMMKITEKS 899
N+L+ + + DFG AK + + + + + Y APE G + T
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRF-YRAPELMLGA-TEYTPSI 223
Query: 900 DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930
D++S G V E++ G +P+ G +D
Sbjct: 224 DLWSIGCVFGELILG-KPLFS----GETSID 249
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 41/199 (20%), Positives = 75/199 (37%), Gaps = 33/199 (16%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+IG+G G VY A D + + +A+KK+ D K +R EI L ++
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKV----NRMFEDLIDCKRILR-----EITILNRLK 83
Query: 770 HKNIVRFLGCCWNRNNRL-----LMYDYMPNGSLGSLLHE--RTGNALEWE----LRYQI 818
I+R + ++ + S L + +T L E + Y +
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTV 878
L G ++H + +HRD+K N L+ + + DFGLA+ ++ N +
Sbjct: 139 L----LGENFIHESGI---IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 879 AGSYGYIAPEYGYMMKITE 897
+ ++T
Sbjct: 192 EENEEPGPHNKNLKKQLTS 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 29/218 (13%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIG+G G V + + +V A+K L M K F E L +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEML--------KRAETACFREERDVLVNGD 132
Query: 770 HKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQG 825
K I L + +N L L+ DY G L +LL + E R+ ++++
Sbjct: 133 SKWITT-LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA---- 187
Query: 826 LAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
+ +H VHRDIK +NIL+ + +ADFG + + + S+ G+ Y
Sbjct: 188 IDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDY 242
Query: 885 IAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
I+PE G + + D +S GV + E+L G+ P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 10/162 (6%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVG 393
+CSN +D LT +P L + +T++ L N I IPP L R+ +
Sbjct: 10 TCSN-NIVDCRGKGLT-EIPTNLPE--TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLS 64
Query: 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC-TELQMIDLSHNTLQGSLPN- 451
NN+I+ L P GL++LN L L N+++ +P + + LQ++ L+ N + L
Sbjct: 65 NNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVD 122
Query: 452 SLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLF 493
+ L L +L + DN+ + L ++ + L++N F
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 32/167 (19%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
IP NL + +++L+ N I + PP F + L
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVI-PP--------GAF---------------SPYKKL 58
Query: 340 QALDLSHNSLTASVPAGLF-QLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRI 397
+ +DLS+N ++ + F L++L L+L N I+ +P + SL L + N+I
Sbjct: 59 RRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKI 116
Query: 398 AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-CTELQMIDLSHN 443
L L LN L L N+L ++ +Q + L+ N
Sbjct: 117 NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 417 SSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPA- 475
L+ +P + + I L NT++ P + S L+ +D+S+N+ S ++
Sbjct: 19 RGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74
Query: 476 SLGRLVSLNKIILSKNLFSGPIPSSL--GLCSSLQLLDLSSNQLTGSVPMELGQ-IEALE 532
+ L SLN ++L N + +P SL GL SLQLL L++N++ + ++ Q + L
Sbjct: 75 AFQGLRSLNSLVLYGNKITE-LPKSLFEGL-FSLQLLLLNANKIN-CLRVDAFQDLHNLN 131
Query: 533 IALNLSCNGLTGPIPAQISALNKLSILDLSHN 564
+ L+L N L S L + + L+ N
Sbjct: 132 L-LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/110 (18%), Positives = 44/110 (40%), Gaps = 6/110 (5%)
Query: 193 SELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQNSLVGAIPEEI-GNCTSLKMIDFSL 250
+L + L N +S + P+ L+ L L L+ N + +P+ + SL+++ +
Sbjct: 56 KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNA 113
Query: 251 NSLSGTIPLSI-GGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTN 299
N ++ + + L L + DN + + + + L N
Sbjct: 114 NKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 34/159 (21%), Positives = 59/159 (37%), Gaps = 33/159 (20%)
Query: 73 NLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAEL-GRLSNLEEMRAGGNK 131
+ E+ L N + P S K LR++ L +N ++ + + L +L
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNS------- 84
Query: 132 DIVGKIPAELGDCSNMTALGLADTQVSGSLPASL-GKLSKLQTLSIYTTMISGEIPAEI- 189
L L +++ LP SL L LQ L + I+ + +
Sbjct: 85 ------------------LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF 124
Query: 190 GNCSELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQN 227
+ L L LY+N L +I L+ ++ + L QN
Sbjct: 125 QDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 20/86 (23%), Positives = 37/86 (43%), Gaps = 6/86 (6%)
Query: 24 KHLQTLVISDANLTGSIP---FDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILN 80
+ L +LV+ +T +P F+ L +L ++N + + LHNL L L
Sbjct: 80 RSLNSLVLYGNKIT-ELPKSLFE--GLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLY 136
Query: 81 SNQLTGKIPVELSNCKSLRKLLLFDN 106
N+L S ++++ + L N
Sbjct: 137 DNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 24/130 (18%), Positives = 53/130 (40%), Gaps = 7/130 (5%)
Query: 52 VLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVEL-SNCKSLRKLLLFDNALAG 110
+ N + P + L + L++NQ++ ++ + +SL L+L+ N +
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 111 NIPAEL-GRLSNLEEMRAGGNKDIVGKIPAELGDC-SNMTALGLADTQVSGSLPASLGKL 168
+P L L +L+ + NK + + + N+ L L D ++ + L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANK--INCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 169 SKLQTLSIYT 178
+QT+ +
Sbjct: 152 RAIQTMHLAQ 161
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-15
Identities = 48/216 (22%), Positives = 81/216 (37%), Gaps = 35/216 (16%)
Query: 688 QFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANG 746
+ T S Q+ ++IG G G V A D V+A+KK+ +
Sbjct: 37 KPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI----LRVFED 92
Query: 747 CSDEKSGVRDSFSAEIKTLGSIRHKNIVR----FLGCCWNRNNRL-LMYDYMPNGSLGSL 801
D K +R EI L + H ++V+ + + + L ++ + S
Sbjct: 93 LIDCKRILR-----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSD 142
Query: 802 LHE--RTGNALEWE----LRYQILLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFE 854
+ RT L L Y +L G+ Y+H I+HRD+K N L+ +
Sbjct: 143 FKKLFRTPVYLTELHIKTLLYNLL----VGVKYVHSAG----ILHRDLKPANCLVNQDCS 194
Query: 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG 890
+ DFGLA+ VD + S ++ +
Sbjct: 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-15
Identities = 54/222 (24%), Positives = 86/222 (38%), Gaps = 35/222 (15%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIG+G V M G+V A+K + M ++ V F E L +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-------KRGEV-SCFREERDVLVNGD 119
Query: 770 HKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELR---Y--QILLGAA 823
+ I + L + N L L+ +Y G L +LL + G + Y +I++
Sbjct: 120 RRWITQ-LHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIP-AEMARFYLAEIVMA-- 174
Query: 824 QGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
+ +H VHRDIK +NIL+ +ADFG + R S G+
Sbjct: 175 --IDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTP 227
Query: 883 GYIAPEYGYMMKITEKSDVY-------SYGVVVLEVLTGKQP 917
Y++PE + + Y + GV E+ G+ P
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 8e-15
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+IG+G G VY D G++ A+K L + K G + E L +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-------MKQGETLAL-NERIMLSLVS 247
Query: 770 HKN---IVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGA 822
+ IV + ++ ++L + D M G L L + G E ++R+ +I+LG
Sbjct: 248 TGDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILG- 304
Query: 823 AQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
L ++H+ +V+RD+K NIL+ I+D GLA + G++
Sbjct: 305 ---LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTH 354
Query: 883 GYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
GY+APE Y +D +S G ++ ++L G P
Sbjct: 355 GYMAPEVLQKGVAY----DSSADWFSLGCMLFKLLRGHSP 390
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 30/217 (13%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIG+G G V +V A+K L M ++S F E +
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-------KRSDS-AFFWEERDIMAFAN 127
Query: 770 HKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGAAQG 825
+V+ L + + L ++ +YMP G L +L+ + E R+ +++L
Sbjct: 128 SPWVVQ-LFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLA---- 180
Query: 826 LAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
L +H +HRD+K +N+L+ +ADFG ++ R +T G+ Y
Sbjct: 181 LDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDY 235
Query: 885 IAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
I+PE G + D +S GV + E+L G P
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 42/250 (16%)
Query: 693 QKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEK 751
Q+LN ++ +V + + + +G G G V A D G +AVKKL K
Sbjct: 18 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAK 73
Query: 752 SGVRDSFSAEIKTLGSIRHKNIVRFL------GCCWNRNNRLLMYDYMPNGSLGSLLHER 805
R E++ L ++H+N++ L N+ L+ M L +++
Sbjct: 74 RTYR-----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK-- 125
Query: 806 TGNALEWE----LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861
L + L YQIL +GL Y+H I+HRD+K +N+ + + E I DFG
Sbjct: 126 -CQKLTDDHVQFLIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 177
Query: 862 LAKLVDDGDFARSSNTVAGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920
LA+ D + VA + Y APE M + D++S G ++ E+LTG+ + P
Sbjct: 178 LARHTAD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFP 231
Query: 921 TIPDGSHVVD 930
G+ +D
Sbjct: 232 ----GTDHID 237
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 53/226 (23%), Positives = 85/226 (37%), Gaps = 51/226 (22%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI- 768
V+G G +G V + + E A+K L D R E++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-----------QDCPKARR-----EVELHWRAS 112
Query: 769 RHKNIVRFLG----CCWNRNNRLLMYDYMPNGSLGSLLHERTGNAL-EWE---LRYQILL 820
+ +IVR + R L++ + + G L S + +R A E E + I
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG- 171
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNT 877
+ + YLH I HRD+K N+L + + DFG AK + T
Sbjct: 172 ---EAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---T 222
Query: 878 VAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ Y+APE Y + D++S GV++ +L G P
Sbjct: 223 PCYTPYYVAPEVLGPEKYD------KSCDMWSLGVIMYILLCGYPP 262
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 51/224 (22%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGV-----RDSFSAEIKT 764
+G G G V+ NG A+K L +K V + + E
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVL-------------KKEIVVRLKQVEHTNDERLM 59
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLG 821
L + H I+R G + ++ DY+ G L SLL ++ ++ ++ L
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCLA 118
Query: 822 AAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
L YLH D I++RD+K NIL+ I DFG AK V D + T+ G
Sbjct: 119 ----LEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCG 165
Query: 881 SYGYIAPE------YGYMMKITEKS-DVYSYGVVVLEVLTGKQP 917
+ YIAPE Y KS D +S+G+++ E+L G P
Sbjct: 166 TPDYIAPEVVSTKPYN-------KSIDWWSFGILIYEMLAGYTP 202
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 51/224 (22%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDS-----FSAEIKT 764
+G G G V ++G A+K L +K V E +
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKIL-------------DKQKVVKLKQIEHTLNEKRI 94
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRY---QILLG 821
L ++ +V+ + +N ++ +Y+ G + S L R G E R+ QI+L
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLT 153
Query: 822 AAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
YLH D +++RD+K N+LI + + DFG AK V + T+ G
Sbjct: 154 ----FEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCG 200
Query: 881 SYGYIAPE------YGYMMKITEKS-DVYSYGVVVLEVLTGKQP 917
+ +APE Y K+ D ++ GV++ E+ G P
Sbjct: 201 TPEALAPEIILSKGYN-------KAVDWWALGVLIYEMAAGYPP 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 56/229 (24%)
Query: 711 VIGKGCSGVVY----RADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT-- 764
V+G+G G V+ + D ++ A+K L +K+ ++ K
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVL-------------KKATLKVRDRVRTKMER 77
Query: 765 --LGSIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QI 818
L + H IV+ L + +L L+ D++ G L + L + E ++++ ++
Sbjct: 78 DILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAEL 135
Query: 819 LLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYI--ADFGLAKL-VDDGDFARS 874
L L +LH I++RD+K NIL L+ E +I DFGL+K +D A
Sbjct: 136 ALA----LDHLHSLG----IIYRDLKPENIL--LDEEGHIKLTDFGLSKESIDHEKKA-- 183
Query: 875 SNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+ G+ Y+APE + D +S+GV++ E+LTG P
Sbjct: 184 -YSFCGTVEYMAPEVVNRRGHTQSA------DWWSFGVLMFEMLTGTLP 225
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 10/168 (5%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPS-TLASCSN 338
S+P+ + T +L L + ++ L L+KLT NQL+ ++ + +
Sbjct: 28 SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 339 LQALDLSHNSLTASVPAGLF-QLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNR 396
L L L++N L S+P G+F L L KL L N + S+P + + L LR+ N+
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142
Query: 397 IAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-CTELQMIDLSHN 443
+ + L L L LS+N+L SVP D +LQ I L N
Sbjct: 143 LQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 335 SCSN-LQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVG 393
+C+ + +D SL SVP+G+ + KL L S ++ + L L +
Sbjct: 11 TCNEGKKEVDCQGKSLD-SVPSGIPA--DTEKLDLQSTGLATLSDATFRGLTKLTWLNLD 67
Query: 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC-TELQMIDLSHNTLQGSLPNS 452
N++ L L L L L++N+L+ S+P + D T+L + L N L+ SLP+
Sbjct: 68 YNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSG 125
Query: 453 L-SSLSGLQVLDVSDNRFSGQIPASL-GRLVSLNKIILSKN-LFSGPIPSSLGLCSSLQL 509
+ L+ L+ L ++ N+ IPA +L +L + LS N L S P + L LQ
Sbjct: 126 VFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRL-GKLQT 183
Query: 510 LDLSSNQ 516
+ L NQ
Sbjct: 184 ITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 47/202 (23%), Positives = 73/202 (36%), Gaps = 54/202 (26%)
Query: 197 SLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGT 256
L L L+ L KL L L N L + + +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFD----------------- 80
Query: 257 IPLSIGGLSELEEFMISDNNVSGSIPANL-ANATNLVQLQLDTNQISGLIPPEIGMLSKL 315
L+EL +++N ++ S+P + + T L +L L NQ+ L P G+ +L
Sbjct: 81 ------DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSL-PS--GVFDRL 130
Query: 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLF-QLQNLTKLLLISNDIS 374
T L+ L L+ N L S+PAG F +L NL L L +N +
Sbjct: 131 T---------------------KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ 168
Query: 375 GSIPPEI-GNCSSLVRLRVGNN 395
S+P L + + N
Sbjct: 169 -SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 50/177 (28%), Positives = 70/177 (39%), Gaps = 24/177 (13%)
Query: 415 DLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIP 474
D L SVP I T + +DL L + L+ L L++ N+ +
Sbjct: 20 DCQGKSLD-SVPSGIPADT--EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLS 75
Query: 475 ASL-GRLVSLNKIILSKN-LFSGP--IPSSLGLCSSLQLLDLSSNQLTGSVPM----ELG 526
A + L L + L+ N L S P + L + L L L NQL S+P L
Sbjct: 76 AGVFDDLTELGTLGLANNQLASLPLGVFDHL---TQLDKLYLGGNQLK-SLPSGVFDRLT 131
Query: 527 QIEALEIALNLSCNGLTGPIPAQI-SALNKLSILDLSHNKLEGNLNPLAQLDNLVSL 582
+++ L L+ N L IPA L L L LS N+L+ P D L L
Sbjct: 132 KLK----ELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQS--VPHGAFDRLGKL 181
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 11/158 (6%)
Query: 75 EELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAEL-GRLSNLEEMRAGGNKDI 133
E+L L S L L L L N L + A + L+ L + N+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQ-- 94
Query: 134 VGKIPAELGDC-SNMTALGLADTQVSGSLPASL-GKLSKLQTLSIYTTMISGEIPAEI-G 190
+ +P + D + + L L Q+ SLP+ + +L+KL+ L + T + IPA
Sbjct: 95 LASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152
Query: 191 NCSELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQN 227
+ L +L L N L S+P +L KL+ + L+ N
Sbjct: 153 KLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 47/224 (20%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGV--RD---SFSAEIKT 764
++GKG G V G A+K L +K + +D E +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKIL-------------KKEVIVAKDEVAHTLTENRV 201
Query: 765 LGSIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QILL 820
L + RH + L + ++RL + +Y G L L R E R+ +I+
Sbjct: 202 LQNSRHPFLTA-LKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVS 259
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSNTVA 879
L YLH + +V+RD+K N+++ + I DFGL K + DG + T
Sbjct: 260 A----LDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFC 310
Query: 880 GSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G+ Y+APE YG + D + GVV+ E++ G+ P
Sbjct: 311 GTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 348
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 70/272 (25%)
Query: 694 KLNFSVE---QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSD 749
+++ V +++K +GKG G+V+++ D GEV+AVKK+ A +D
Sbjct: 2 RVDRHVLRKYELVK------KLGKGAYGIVWKSIDRRTGEVVAVKKI----FDAFQNSTD 51
Query: 750 EKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNRNNR--LLMYDYMPNGSLGSLLHERT 806
+ R EI L + H+NIV L N+R L++DYM L +++
Sbjct: 52 AQRTFR-----EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIR--- 102
Query: 807 GNALEWE----LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862
N LE + YQ++ + + YLH + +HRD+K +NIL+ E +ADFGL
Sbjct: 103 ANILEPVHKQYVVYQLI----KVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGL 155
Query: 863 AKLVDDGDFARSSNTVAGSYG-------------------YIAPE-----YGYMMKITEK 898
++ + ++ ++ + Y APE Y T+
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY----TKG 211
Query: 899 SDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930
D++S G ++ E+L GK PI P GS ++
Sbjct: 212 IDMWSLGCILGEILCGK-PIFP----GSSTMN 238
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 38/163 (23%), Positives = 69/163 (42%), Gaps = 11/163 (6%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIG--NCSSLVRLRV 392
C D S+ L +P + Q +L L +N+ + + L ++
Sbjct: 10 RCEGTTV-DCSNQKLN-KIPEHIPQ--YTAELRLNNNEFT-VLEATGIFKKLPQLRKINF 64
Query: 393 GNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-CTELQMIDLSHNTLQGSLPN 451
NN+I + G +N + L+SNRL +V ++ L+ + L N + + N
Sbjct: 65 SNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGN 122
Query: 452 -SLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLF 493
S LS +++L + DN+ + P + L SL+ + L N F
Sbjct: 123 DSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 34/143 (23%), Positives = 65/143 (45%), Gaps = 7/143 (4%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEI-GMLSKLTVFFAWQNQLEGSIPSTLASCSN 338
IP ++ +L+L+ N+ + L I L +L N++ S
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 339 LQALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNR 396
+ + L+ N L +V +F+ L++L L+L SN I+ + + SS+ L + +N+
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 397 IAGLIPREIGGLKTLNFLDLSSN 419
I + P L +L+ L+L +N
Sbjct: 141 ITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 36/158 (22%), Positives = 68/158 (43%), Gaps = 19/158 (12%)
Query: 415 DLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSL-SSLSGLQVLDVSDNRFSGQI 473
D S+ +L+ +P+ I + L++N + L L+ ++ S+N+ +
Sbjct: 17 DCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIE 73
Query: 474 PASLGRLVSLNKIILSKNLFSGPIPSSL--GLCSSLQLLDLSSNQLTGSVPME----LGQ 527
+ +N+I+L+ N + + GL SL+ L L SN++T V + L
Sbjct: 74 EGAFEGASGVNEILLTSNRLEN-VQHKMFKGL-ESLKTLMLRSNRIT-CVGNDSFIGLSS 130
Query: 528 IEALEIALNLSCNGLTGPIPAQI-SALNKLSILDLSHN 564
+ L+L N +T + L+ LS L+L N
Sbjct: 131 VR----LLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 18/88 (20%), Positives = 30/88 (34%), Gaps = 8/88 (9%)
Query: 25 HLQTLVISDANLTGSIP---FDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNS 81
+ ++++ L ++ F L L SN + S L ++ L L
Sbjct: 82 GVNEILLTSNRLE-NVQHKMFK--GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYD 138
Query: 82 NQLTGKIPVE-LSNCKSLRKLLLFDNAL 108
NQ+T + SL L L N
Sbjct: 139 NQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 5e-13
Identities = 78/422 (18%), Positives = 151/422 (35%), Gaps = 47/422 (11%)
Query: 20 LSSFKHLQTLVISD-ANLTGSIPFDIG-DCVGLIVLDFSSNNLVGTLPSSLGKL----HN 73
SFK+ + LV+S + I C L LD +++ L +
Sbjct: 126 AKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185
Query: 74 LEELILN--SNQLTGK-IPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGG- 129
L L ++ +++++ + ++ C +L+ L L + L R LEE+ GG
Sbjct: 186 LVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY 245
Query: 130 ----NKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSI-YTTMISGE 184
D+ + L C + L V LPA S+L TL++ Y T+ S +
Sbjct: 246 TAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYD 305
Query: 185 IPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLK 244
+ + C +L L++ + + K L EL + + P + +L
Sbjct: 306 LVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLREL-----RVFPSEPFVMEPNVALT 360
Query: 245 MIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLA-NATNLVQLQLDTNQISG 303
+ L S+S G +LE + ++ + +A N N+ + +L
Sbjct: 361 --EQGLVSVS-------MGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRL------- 404
Query: 304 LIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNL 363
++ + L+ + + C +L+ L LS + +
Sbjct: 405 ------CIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKM 458
Query: 364 TKLLLISNDISG-SIPPEIGNCSSLVRLRVGNNRI--AGLIPREIGGLKTLNFLDLSSNR 420
L + S + + C SL +L + + L+ L+T+ L +SS
Sbjct: 459 EMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALL-ANASKLETMRSLWMSSCS 517
Query: 421 LS 422
+S
Sbjct: 518 VS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 3e-10
Identities = 70/479 (14%), Positives = 153/479 (31%), Gaps = 73/479 (15%)
Query: 141 LGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGE----IPAEIGNCSELV 196
L C + GLA A L+ L + + + + + LV
Sbjct: 137 LSSCEGFSTDGLA---------AIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187
Query: 197 SLFL--YENSLSGSIPPEIGK-LKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSL 253
SL + + +S S + L+ L L + + + + L+ + +
Sbjct: 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA 247
Query: 254 SGT------IPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQIS--GLI 305
+ +++ G EL + V +PA + + L L L + L+
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLV 307
Query: 306 PPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSH---------NSLT-ASVPA 355
+ KL + + + ++C +L+ L + +LT + +
Sbjct: 308 KL-LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366
Query: 356 GLFQLQNLTKLLLISNDISGSIPPEIG-NCSSLVRLRVGNNRIAGLIPREIGGLKTLNFL 414
L +L ++ + I N ++ R R+ +I + TL L
Sbjct: 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC------IIEPKAPDYLTLEPL 420
Query: 415 DLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQ-I 473
D+ + C +L+ + LS + +++L V+ S +
Sbjct: 421 DIGFGAIVEH-------CKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGM 473
Query: 474 PASLGRLVSLNKIILSK-NLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQ----- 527
L SL K+ + + ++ +++ L +SS ++ LGQ
Sbjct: 474 HHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKL 533
Query: 528 -IEALEIALN-------------LSCNGLTGP---IPAQISALNKLSILDLSHNKLEGN 569
+E ++ + GP +P + +++ S + S + N
Sbjct: 534 NVEVIDERGAPDSRPESCPVERVFIYRTVAGPRFDMPGFVWNMDQDSTMRFSRQIITTN 592
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 5e-10
Identities = 71/465 (15%), Positives = 139/465 (29%), Gaps = 58/465 (12%)
Query: 141 LGDCSNMTALGLADTQVSGSLPASLGKLS----KLQTLSIYTTMISGEIPAEIG-NCSEL 195
L + L G + + +S L+ + + +++ + I +
Sbjct: 73 LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNF 132
Query: 196 VSLFLYE-NSLSGSIPPEIGK-LKKLEELFLWQNSLVGAIPEEIG----NCTSLKMIDFS 249
L L S I + L+EL L ++ + + TSL S
Sbjct: 133 KVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV----S 188
Query: 250 LNSLSGTIPLSIGGLSE-------LEEFMISDNNVSGSIPANLANATNLVQLQL------ 296
LN +S L L+ ++ + L A L +L
Sbjct: 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAE 248
Query: 297 -DTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT-ASVP 354
+ SGL G + W + + +P+ + CS L L+LS+ ++ +
Sbjct: 249 VRPDVYSGLSVALSGCKELRCLSGFW-DAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLV 307
Query: 355 AGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPRE---------- 404
L Q L +L ++ + C L LRV + + P
Sbjct: 308 KLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367
Query: 405 IGGLKTLNFLDLSSNRLSGSVPDEIGD-CTELQMIDLSHNTLQGSLPNSLSSLSGLQVLD 463
G L + +++ + I + L + L+ LD
Sbjct: 368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCI------IEPKAPDYLTLEPLD 421
Query: 464 VSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG-SVP 522
+ A + L ++ LS L +++L ++ + +
Sbjct: 422 IG-------FGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH 474
Query: 523 MELGQIEALEIALNLS-CNGLTGPIPAQISALNKLSILDLSHNKL 566
L ++L L + C + A S L + L +S +
Sbjct: 475 HVLSGCDSLRK-LEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 5e-08
Identities = 45/271 (16%), Positives = 90/271 (33%), Gaps = 21/271 (7%)
Query: 321 WQNQLEGSIPSTLASCSNLQALDLSHNSLT-ASVPAGLFQLQNLTKLLLIS-NDISGSIP 378
W + I + +S + L+ + L +T + +N L+L S S
Sbjct: 89 WGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGL 148
Query: 379 PEIG-NCSSLVRLRVGNNRIAGL-------IPREIGGLKTLNFLDLSSNRLSGSVPDEIG 430
I C +L L + + + + P L +LN L+S ++ +
Sbjct: 149 AAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVT 208
Query: 431 DCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVS------DNRFSGQIPASLGRLVSLN 484
C L+ + L+ L L L+ L + +L L
Sbjct: 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELR 268
Query: 485 KIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQ----IEALEIALNLSCN 540
+ + +P+ +CS L L+LS + ++L ++ L + +
Sbjct: 269 CLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDA 328
Query: 541 GLTGPIPAQISALNKLSILDLSHNKLEGNLN 571
GL + + L +L + +E N+
Sbjct: 329 GLE-VLASTCKDLRELRVFPSEPFVMEPNVA 358
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 46/350 (13%), Positives = 106/350 (30%), Gaps = 56/350 (16%)
Query: 5 ITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTL 64
+ ++ + L L ++ + + C L L + + L
Sbjct: 222 VPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYL 281
Query: 65 PSSLGKLHNLEELILNSNQLTGKIPVEL-SNCKSLRKLLLFDNALAGNIPAELGRLSNLE 123
P+ L L L+ + V+L C L++L + D + +L
Sbjct: 282 PAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLR 341
Query: 124 EMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISG 183
E+ + P + +T GL VS P KL+++ + ++
Sbjct: 342 EL------RVFPSEPFVMEPNVALTEQGLV--SVSMGCP-------KLESVLYFCRQMTN 386
Query: 184 EIPAEIG-NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTS 242
I N + L ++ +L L + +C
Sbjct: 387 AALITIARNRPNMTRFRL-------------CIIEPKAPDYLTLEPLDIGFGAIVEHCKD 433
Query: 243 LKMIDFSLNSLSGTIPLSIG-GLSELEEFMISDNNVSG-SIPANLANATNLVQLQLDTNQ 300
L+ + S L+ + IG ++E ++ S + L+ +L +L++
Sbjct: 434 LRRLSLS-GLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP 492
Query: 301 ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT 350
+ ++ + + +++L +S S++
Sbjct: 493 FG-----------------------DKALLANASKLETMRSLWMSSCSVS 519
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 53/313 (16%), Positives = 109/313 (34%), Gaps = 63/313 (20%)
Query: 339 LQALDLSHNSLTA----SVPAGLFQLQNLTKLLLISNDISG----SIPPEIGNCSSLVRL 390
++ L +++T SV A L + ++ +++L N I + I + L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 391 RVGNNRI----------AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD----CTELQ 436
+ L+ + + L+ + LS N + + + D T L+
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 437 MIDLSHNTL-------------QGSLPNSLSSLSGLQVLDVSDNRFSGQ----IPASLGR 479
+ L +N L + ++ + L+ + NR +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 480 LVSLNKIILSKNLF-----SGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALE-- 532
L+ + + +N + L C L++LDL N T L AL+
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA--IALKSW 243
Query: 533 ---IALNLSCNGLTGP-IPAQISALN-----KLSILDLSHNKLEGN-LNPLAQ-----LD 577
L L+ L+ A + A + L L L +N++E + + L +
Sbjct: 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303
Query: 578 NLVSLNISYNKFT 590
+L+ L ++ N+F+
Sbjct: 304 DLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 60/412 (14%), Positives = 124/412 (30%), Gaps = 95/412 (23%)
Query: 53 LDFSSNNL----VGTLPSSLGKLHNLEELILNSNQLTGK----IPVELSNCKSLRKLLLF 104
+ + ++ + L + +++E++L+ N + + + +++ K L
Sbjct: 9 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 68
Query: 105 DNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSG----S 160
D GR+ + + + + L C + + L+D
Sbjct: 69 DI--------FTGRVKDEIP-------EALRLLLQALLKCPKLHTVRLSDNAFGPTAQEP 113
Query: 161 LPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLE 220
L L K + L+ L ++ + + ++ L E +++ + L
Sbjct: 114 LIDFLSKHTPLEHLYLHNNGLGPQ-------AGAKIARALQELAVNK----KAKNAPPLR 162
Query: 221 ELFLWQNSL----VGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNN 276
+ +N L + + + L + N I
Sbjct: 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG-------------------IRPEG 203
Query: 277 VSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASC 336
+ + LA L L L N + +G ++ L S
Sbjct: 204 IEHLLLEGLAYCQELKVLDLQDNTFT-----HLGSS---------------ALAIALKSW 243
Query: 337 SNLQALDLSHNSLTA----SVPAGLFQLQN--LTKLLLISNDISGSIPPEIG-----NCS 385
NL+ L L+ L+A +V +L+N L L L N+I +
Sbjct: 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303
Query: 386 SLVRLRVGNNRI--AGLIPREIG-GLKTLNFLDLSSNRLSGSVPDEIGDCTE 434
L+ L + NR + EI T +L + DE + E
Sbjct: 304 DLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTDEEEEDEE 355
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 56/317 (17%), Positives = 100/317 (31%), Gaps = 60/317 (18%)
Query: 165 LGKLSKLQTLSIYTTMISGE----IPAEIGNCSELVSLFLYENSLSG----SIPPEIGKL 216
+ + S ++ S+ I+ E + A + + + L N++ + I
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 217 KKLEELFLWQNSL----------VGAIPEEIGNCTSLKMIDFSLNSLS--GTIPLS--IG 262
K LE + + + + C L + S N+ PL +
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 263 GLSELEEFMISDNNVS-------------GSIPANLANATNLVQLQLDTNQISG----LI 305
+ LE + +N + ++ NA L + N++
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 306 PPEIGMLSKLTVFFAWQNQL-----EGSIPSTLASCSNLQALDLSHNSLTA----SVPAG 356
L QN + E + LA C L+ LDL N+ T ++
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239
Query: 357 LFQLQNLTKLLLISNDISGSIPPEIGNC------SSLVRLRVGNNRI----AGLIPREIG 406
L NL +L L +S + + L LR+ N I + I
Sbjct: 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299
Query: 407 G-LKTLNFLDLSSNRLS 422
+ L FL+L+ NR S
Sbjct: 300 EKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 50/272 (18%), Positives = 86/272 (31%), Gaps = 56/272 (20%)
Query: 20 LSSFKHLQTLVISDANLTGSIPFDIGDCVG-----------LIVLDFSSNNL----VGTL 64
++S K L+ SD TG + +I + + L + S N L
Sbjct: 56 IASKKDLEIAEFSD-IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPL 114
Query: 65 PSSLGKLHNLEELILNSNQLT-------------GKIPVELSNCKSLRKLLLFDNAL--- 108
L K LE L L++N L + + N LR ++ N L
Sbjct: 115 IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 174
Query: 109 -AGNIPAELGRLSNLEEMRAGGN----KDIVGKIPAELGDCSNMTALGLADTQVSG---- 159
L ++ N + I + L C + L L D +
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 234
Query: 160 SLPASLGKLSKLQTLSIYTTMIS-------GEIPAEIGNCSELVSLFLYENSLSGSIPPE 212
+L +L L+ L + ++S + +++ N L +L L N +
Sbjct: 235 ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG-LQTLRLQYNEIELDAVRT 293
Query: 213 IG-----KLKKLEELFLWQNSL--VGAIPEEI 237
+ K+ L L L N + +EI
Sbjct: 294 LKTVIDEKMPDLLFLELNGNRFSEEDDVVDEI 325
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 44/226 (19%)
Query: 711 VIGKGCSGVVY----RADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
V+G G G V+ + D G++ A+K L T+ +K+ + E + L
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-------QKAKTTEHTRTERQVLE 113
Query: 767 SIRHKN-IVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QILLG 821
IR +V L + +L L+ DY+ G L + L + E E++ +I+L
Sbjct: 114 HIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHL-SQRERFTEHEVQIYVGEIVLA 171
Query: 822 AAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK--LVDDGDFARSSNTV 878
L +LH I++RDIK NIL+ + DFGL+K + D+ + A
Sbjct: 172 ----LEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA---YDF 220
Query: 879 AGSYGYIAPE------YGYMMKITEKS-DVYSYGVVVLEVLTGKQP 917
G+ Y+AP+ G+ +K+ D +S GV++ E+LTG P
Sbjct: 221 CGTIEYMAPDIVRGGDSGH-----DKAVDWWSLGVLMYELLTGASP 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-12
Identities = 60/226 (26%), Positives = 92/226 (40%), Gaps = 52/226 (23%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGV--RDSFS---AEIKT 764
++GKG G V G A+K L K + +D + E +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKIL-------------RKEVIIAKDEVAHTVTESRV 58
Query: 765 LGSIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLH-ERTGNALEWELRY---QIL 819
L + RH + L + ++RL + +Y G L H R E R+ +I+
Sbjct: 59 LQNTRHPFLTA-LKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIV 115
Query: 820 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSNT 877
L YLH D +V+RDIK N+++ + I DFGL K + DG T
Sbjct: 116 SA----LEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KT 164
Query: 878 VAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G+ Y+APE YG + D + GVV+ E++ G+ P
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 204
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 6e-12
Identities = 31/196 (15%), Positives = 48/196 (24%), Gaps = 42/196 (21%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL------ 765
IG+G G V++ D+ V A+K + NG + + EI
Sbjct: 28 IGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTF---EEILPEIIISKELSLL 83
Query: 766 ---GSIRHKNIVRFLG--CCWNRNNRLLMYDYM----PNGSL------------------ 798
R + + C LL+ + GS
Sbjct: 84 SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143
Query: 799 ---GSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855
G L + IL LA HRD+ N+L+
Sbjct: 144 EFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLK 201
Query: 856 YIADFGLAKLVDDGDF 871
+ K
Sbjct: 202 KLHYTLNGKSSTIPSC 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 46/225 (20%)
Query: 711 VIGKGCSGVVY----RADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
V+GKG G V+ + G++ A+K L + + AE L
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-------RNAKDTAHTKAERNILE 76
Query: 767 SIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QILLGA 822
++H IV L + +L L+ +Y+ G L L R G +E + +I +
Sbjct: 77 EVKHPFIVD-LIYAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLAEISMA- 133
Query: 823 AQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYI--ADFGLAKL-VDDGDFARSSNTV 878
L +LH I++RD+K NI+ L + ++ DFGL K + DG +T
Sbjct: 134 ---LGHLHQKG----IIYRDLKPENIM--LNHQGHVKLTDFGLCKESIHDGTVT---HTF 181
Query: 879 AGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G+ Y+APE + + D +S G ++ ++LTG P
Sbjct: 182 CGTIEYMAPEILMRSGHNRAV------DWWSLGALMYDMLTGAPP 220
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 29/205 (14%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSL 387
P +L S+T +L ++ +++ ++DI S+ I ++
Sbjct: 12 IFPDDA-FAE-TIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIK-SVQG-IQYLPNV 65
Query: 388 VRLRVGNNRIAGLIPREIG---GLKTLNFLDLSSNRLSGSVPDEIGDC-TELQMIDLSHN 443
L +G N++ + L L +L L+ N+L S+P+ + D T L+ + L N
Sbjct: 66 RYLALGGNKLHDI-----SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119
Query: 444 TLQGSLPNSL-SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN-LFSGPIPS-- 499
LQ SLP+ + L+ L L+++ N+ +L +L ++ LS N L S +P
Sbjct: 120 QLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS--LPEGV 176
Query: 500 --SLGLCSSLQLLDLSSNQLTGSVP 522
L L+ L L NQL SVP
Sbjct: 177 FDKLT---QLKDLRLYQNQLK-SVP 197
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 27/198 (13%)
Query: 185 IPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIG---NCT 241
+ + + + + + S+ I L + L L N L +I T
Sbjct: 34 AVTQNE-LNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKL-----HDISALKELT 85
Query: 242 SLKMIDFSLNSLSGTIPLSI-GGLSELEEFMISDNNVSGSIPANLANA-TNLVQLQLDTN 299
+L + + N L ++P + L+ L+E ++ +N + S+P + + TNL L L N
Sbjct: 86 NLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHN 143
Query: 300 QISGLIPPEI-GMLSKLTVFFAWQNQLEGSIPS----TLASCSNLQALDLSHNSLTASVP 354
Q+ L P + L+ LT NQL+ S+P L L+ L L N L SVP
Sbjct: 144 QLQSL-PKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLT---QLKDLRLYQNQLK-SVP 197
Query: 355 AGLF-QLQNLTKLLLISN 371
G+F +L +L + L N
Sbjct: 198 DGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 59/246 (23%), Positives = 98/246 (39%), Gaps = 50/246 (20%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
P + ++ L ++ + L+ + A + ++ S+ + N+
Sbjct: 12 IFPDDAF--AETIKANLKKKSVTDA-VTQNE-LNSIDQIIANNSDIK-SVQG-IQYLPNV 65
Query: 340 QALDLSHNSLTASVPAGLF-QLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIA 398
+ L L N L +L NLT L+L N + S+P + +
Sbjct: 66 RYLALGGNKLHD---ISALKELTNLTYLILTGNQLQ-SLPNGVFD--------------- 106
Query: 399 GLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC-TELQMIDLSHNTLQGSLPNSL-SSL 456
L L L L N+L S+PD + D T L ++L+HN LQ SLP + L
Sbjct: 107 --------KLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKL 156
Query: 457 SGLQVLDVSDNRFSGQIPASL-GRLVSLNKIILSKN-LFSGPIPS----SLGLCSSLQLL 510
+ L LD+S N+ +P + +L L + L +N L S +P L +SLQ +
Sbjct: 157 TNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS--VPDGVFDRL---TSLQYI 210
Query: 511 DLSSNQ 516
L N
Sbjct: 211 WLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 39/197 (19%)
Query: 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473
+L ++ + + I +++ ++ S+ + L ++ L + N+
Sbjct: 24 ANLKKKSVT-DAVTQNEL-NSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLH--- 76
Query: 474 PASLG---RLVSLNKIILSKN-LFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPM----EL 525
+ L +L +IL+ N L S P L ++L+ L L NQL S+P +L
Sbjct: 77 --DISALKELTNLTYLILTGNQLQSLPNGVFDKL-TNLKELVLVENQLQ-SLPDGVFDKL 132
Query: 526 GQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKL----EGNLNPLAQLDNLVS 581
+ L NL+ N L L L+ LDLS+N+L EG + L QL +L
Sbjct: 133 TNLTYL----NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL-- 186
Query: 582 LNISYNKFTGYLPDNKL 598
L N+L
Sbjct: 187 ----------RLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 41/191 (21%), Positives = 76/191 (39%), Gaps = 31/191 (16%)
Query: 8 QSVPLQLPIPT-----------NLSSFKHL---QTLVISDANLTGSIPFDIGDCVGLIVL 53
Q P T + + L ++ +++++ + L
Sbjct: 11 QIFPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQY--LPNVRYL 68
Query: 54 DFSSNNLVGTLPSSLG---KLHNLEELILNSNQLTGKIPVEL-SNCKSLRKLLLFDNALA 109
N L + +L NL LIL NQL +P + +L++L+L +N L
Sbjct: 69 ALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ 122
Query: 110 GNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDC-SNMTALGLADTQVSGSLPASL-GK 167
+L+NL + N+ + +P + D +N+T L L+ Q+ SLP + K
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQ--LQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDK 179
Query: 168 LSKLQTLSIYT 178
L++L+ L +Y
Sbjct: 180 LTQLKDLRLYQ 190
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 6e-11
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 53/227 (23%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGV--RD---SFSAEIKT 764
V+GKG G V ++ E+ AVK L +K V D E +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKIL-------------KKDVVIQDDDVECTMVEKRV 394
Query: 765 LGSI-RHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QIL 819
L + + + L C+ +RL + +Y+ G L + + G E + +I
Sbjct: 395 LALPGKPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIA 452
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI--ADFGLAKL-VDDGDFARSSN 876
+G L +L I++RD+K +N++ L+ E +I ADFG+ K + DG ++
Sbjct: 453 IG----LFFLQSK---GIIYRDLKLDNVM--LDSEGHIKIADFGMCKENIWDGV---TTK 500
Query: 877 TVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
T G+ YIAPE YG + D +++GV++ E+L G+ P
Sbjct: 501 TFCGTPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAP 541
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 54/300 (18%), Positives = 103/300 (34%), Gaps = 64/300 (21%)
Query: 333 LASCSNLQALDLSHNSLTASVPAGLFQL-----QNLTKLLLISNDISGSIPPEIGNCSSL 387
+ + +LDLS N+L + L Q ++T L L N + N L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK------NSDEL 71
Query: 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-----CTELQMIDLSH 442
V++ + L+LS N LS DE+ + ++DL
Sbjct: 72 VQILAAIPA-------------NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118
Query: 443 NTLQGS----LPNSLSSL-SGLQVLDVSDNRFSGQIPASLGRL-----VSLNKIILSKNL 492
N + S+L + + L++ N + L ++ ++N + L N
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178
Query: 493 FSGP----IPSSL-GLCSSLQLLDLSSNQLTGSVPMELGQIEALE------IALNLSCNG 541
+ + L + +S+ LDLS+N L EL ++LNL N
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELA--YIFSSIPNHVVSLNLCLNC 236
Query: 542 LTGPIPAQISAL----NKLSILDLSHNKL--------EGNLNPLAQLDNLVSLNISYNKF 589
L GP + L L + L ++ + + + ++ ++ + +
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 53/397 (13%), Positives = 116/397 (29%), Gaps = 96/397 (24%)
Query: 232 AIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGL-----SELEEFMISDNNVSGSIPANLA 286
+ E + +D SLN+L + + + + +S N++ L
Sbjct: 13 PVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELV 72
Query: 287 NA-----TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASC-SNLQ 340
N+ L L N +S + TLA+ +
Sbjct: 73 QILAAIPANVTSLNLSGNFLS-----YKSSDE---------------LVKTLAAIPFTIT 112
Query: 341 ALDLSHNSLTASVPAGLFQL-----QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNN 395
LDL N ++ + Q ++T L L ND+ ++
Sbjct: 113 VLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK----------------SSD 156
Query: 396 RIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-----CTELQMIDLSHNTLQGSLP 450
+ ++ + +L +L N L+ E+ + +DLS N L
Sbjct: 157 ELIQILAAIPANVNSL---NLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSY 213
Query: 451 NSLSSL-----SGLQVLDVSDNRFSGQ----IPASLGRLVSLNKIILSKNLFSGP----- 496
L+ + + + L++ N G + L L + L ++
Sbjct: 214 AELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQC 273
Query: 497 --IPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALN 554
+ ++ + L+D + ++ S + + + LS +
Sbjct: 274 KALGAAFPNIQKIILVDKNGKEIHPSHSIPI--SNLIR---ELSGK------------AD 316
Query: 555 KLSILDLSHNKLEGNLNPLAQLDN---LVSLNISYNK 588
S+L+ + + + L+ L +
Sbjct: 317 VPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKP 353
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 47/219 (21%), Positives = 83/219 (37%), Gaps = 39/219 (17%)
Query: 409 KTLNFLDLSSNRLSGSVPDEIGDC-----TELQMIDLSHNTLQGSLPNSLSSL-----SG 458
+ LDLS N L E+ + ++LS N+L + L + +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 459 LQVLDVSDNRFSGQIPASLGRLV-----SLNKIILSKNLFSG----PIPSSLGLC-SSLQ 508
+ L++S N S + L + + ++ + L N FS + +S+
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 509 LLDLSSNQLTGSVPMELGQIEALE------IALNLSCNGLTGP----IPAQISALNK-LS 557
L+L N L EL + L +LNL N L + ++++ ++
Sbjct: 142 SLNLRGNDLGIKSSDELI--QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT 199
Query: 558 ILDLSHNKLEGN-LNPLAQL-----DNLVSLNISYNKFT 590
LDLS N L LA + +++VSLN+ N
Sbjct: 200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 9e-04
Identities = 60/404 (14%), Positives = 113/404 (27%), Gaps = 99/404 (24%)
Query: 47 CVGLIVLDFSSNNL----VGTLPSSLGKLH-NLEELILNSNQLTGKIPVEL-----SNCK 96
G+ LD S NNL L + ++ L L+ N L K EL +
Sbjct: 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80
Query: 97 SLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQ 156
++ L L N L K + +T L L
Sbjct: 81 NVTSLNLSGNFL--------------------SYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 157 VSGSLPASLGKL-----SKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPP 211
S + + + + +L++ + + + EL+ +
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK------SSDELIQILAAIP-------- 166
Query: 212 EIGKLKKLEELFLWQNSL----VGAIPEEI-GNCTSLKMIDFSLNSL--SGTIPLSIGGL 264
+ L L N+L + + + S+ +D S N L L+
Sbjct: 167 -----ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221
Query: 265 S---ELEEFMISDNNVSGSIPANLANA----TNLVQLQLDTNQISGLIPPEIGMLSKLTV 317
S + + N + G NL +L + LD + + + + L
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALG---- 277
Query: 318 FFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSI 377
+ + + +D + + P+ + NL + L D+
Sbjct: 278 -------------AAFPNIQKIILVDKNGKEIH---PSHSIPISNLIRELSGKADV---- 317
Query: 378 PPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRL 421
P + N + + N IP E L + L
Sbjct: 318 -PSLLNQCLIFAQKHQTNIEDLNIPDE------LRESIQTCKPL 354
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 36/147 (24%), Positives = 64/147 (43%), Gaps = 18/147 (12%)
Query: 329 IPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLV 388
+ +TL++ + L LS N++ + L ++NL L L N I I +L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 389 RLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLS--GSVPDEIGDCTELQMIDLSHNTLQ 446
L + N+IA L I L L L +S+N+++ G + D++ +L+ + L+ N L
Sbjct: 97 ELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLY 153
Query: 447 GSLPNS----------LSSLSGLQVLD 463
+ + L L+ LD
Sbjct: 154 NDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 30/124 (24%), Positives = 52/124 (41%), Gaps = 23/124 (18%)
Query: 497 IPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEI-----ALNLSCNGLTGPIPAQIS 551
+ ++L + + L LS+N + +I +L L+L N + I +
Sbjct: 40 MDATLSTLKACKHLALSTNNIE--------KISSLSGMENLRILSLGRNLIKK-IENLDA 90
Query: 552 ALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFT-----GYLPDNKLFRQLSPTD 606
+ L L +S+N++ +L+ + +L NL L +S NK T L L
Sbjct: 91 VADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL--- 146
Query: 607 LAGN 610
LAGN
Sbjct: 147 LAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 35/154 (22%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 428 EIGDCTELQMIDL--SHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNK 485
+ TE + ++L ++ + +LS+L + L +S N +I +SL + +L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRI 74
Query: 486 IILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGP 545
+ L +NL I + + +L+ L +S NQ+ + + ++ L + L +S N +T
Sbjct: 75 LSLGRNLIKK-IENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRV-LYMSNNKITNW 130
Query: 546 IP-AQISALNKLSILDLSHNKLEGNLNPLAQLDN 578
+++AL+KL L L+ N L +
Sbjct: 131 GEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 25/127 (19%), Positives = 46/127 (36%), Gaps = 8/127 (6%)
Query: 184 EIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSL 243
++ A + L L N++ I + ++ L L L +N + I +L
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 244 KMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVS--GSIPANLANATNLVQLQLDTNQI 301
+ + S N ++ + L L +S+N ++ G I LA L L L N +
Sbjct: 96 EELWISYNQIASLSGIE--KLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPL 152
Query: 302 SGLIPPE 308
Sbjct: 153 YNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 37/185 (20%), Positives = 70/185 (37%), Gaps = 44/185 (23%)
Query: 50 LIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALA 109
+ L + + ++L L + L L++N + KI LS ++LR L L N +
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK 83
Query: 110 GNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLS 169
++ NL+ + + L ++ Q++ SL + + KL
Sbjct: 84 --------KIENLDAV------------------ADTLEELWISYNQIA-SL-SGIEKLV 115
Query: 170 KLQTLSIYTTMIS--GEIPAEIGNCSELVSLFLYENSLSGSIPPE----------IGKLK 217
L+ L + I+ GEI ++ +L L L N L + +L
Sbjct: 116 NLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174
Query: 218 KLEEL 222
L++L
Sbjct: 175 NLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 24/98 (24%), Positives = 41/98 (41%), Gaps = 4/98 (4%)
Query: 19 NLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELI 78
+LS ++L+ L + + I L L S N + S + KL NL L
Sbjct: 65 SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLY 121
Query: 79 LNSNQLTGKIPVE-LSNCKSLRKLLLFDNALAGNIPAE 115
+++N++T ++ L+ L LLL N L +
Sbjct: 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 7/142 (4%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTL-ASCSN 338
S+PA + L L NQI+ L P L L + NQL ++P + S +
Sbjct: 33 SVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 339 LQALDLSHNSLTASVPAGLF-QLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRI 397
L LDL N LT +P+ +F +L +L +L + N ++ +P I + L L + N++
Sbjct: 90 LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
Query: 398 AGLIPREIGGLKTLNFLDLSSN 419
+ L +L L N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 9/144 (6%)
Query: 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC-TE 434
S+P I ++ L + +N+I L P L L L L SN+L ++P + D T+
Sbjct: 33 SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 435 LQMIDLSHNTLQGSLPNSL-SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN-L 492
L ++DL N L LP+++ L L+ L + N+ + +P + RL L + L +N L
Sbjct: 90 LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
Query: 493 FSGPIPSSLGLCSSLQLLDLSSNQ 516
S P + L SSL L N
Sbjct: 148 KSIPHGAFDRL-SSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 48/172 (27%), Positives = 68/172 (39%), Gaps = 39/172 (22%)
Query: 415 DLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIP 474
D S R + SVP I T Q++ L N + P SL L+ L + N+ +P
Sbjct: 25 DCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALP 80
Query: 475 ASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPM----ELGQIEA 530
+ SL + L +LDL +NQLT +P L ++
Sbjct: 81 VG--------------------VFDSL---TQLTVLDLGTNQLT-VLPSAVFDRLVHLKE 116
Query: 531 LEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSL 582
L + CN LT +P I L L+ L L N+L+ P D L SL
Sbjct: 117 L----FMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS--IPHGAFDRLSSL 161
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 57/229 (24%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGV-----RDSFSAEIKT 764
VIGKG G V A AVK L +K + +E
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVL-------------QKKAILKKKEEKHIMSERNV 91
Query: 765 LG-SIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLH-ERTGNALEWELRY---QI 818
L +++H +V L + ++L + DY+ G L H +R LE R+ +I
Sbjct: 92 LLKNVKHPFLVG-LHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEI 148
Query: 819 LLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYI--ADFGLAKL-VDDGDFARS 874
L YLH + IV+RD+K NIL L+ + +I DFGL K ++
Sbjct: 149 ASA----LGYLHSLN----IVYRDLKPENIL--LDSQGHIVLTDFGLCKENIEHNSTT-- 196
Query: 875 SNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
+T G+ Y+APE Y + D + G V+ E+L G P
Sbjct: 197 -STFCGTPEYLAPEVLHKQPYDRTV------DWWCLGAVLYEMLYGLPP 238
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 57/229 (24%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVR-----DSFSAEIKT 764
V+GKG G V ++ E+ AVK L +K V + E +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKIL-------------KKDVVIQDDDVECTMVEKRV 73
Query: 765 LGSI-RHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLH-ERTGNALEWELRY---QI 818
L + + + L C+ +RL + +Y+ G L + H ++ G E + +I
Sbjct: 74 LALPGKPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEI 130
Query: 819 LLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYI--ADFGLAKL-VDDGDFARS 874
+G L +L I++RD+K +N++ L+ E +I ADFG+ K + DG
Sbjct: 131 AIG----LFFLQSKG----IIYRDLKLDNVM--LDSEGHIKIADFGMCKENIWDGVTT-- 178
Query: 875 SNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
T G+ YIAPE YG + D +++GV++ E+L G+ P
Sbjct: 179 -KTFCGTPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 53/227 (23%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGV-----RDSFSAEIKT 764
V+GKG G V A + + G++ AVK L +K + + E +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVL-------------KKDVILQDDDVECTMTEKRI 76
Query: 765 LGSI-RHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLH-ERTGNALEWELRY---QI 818
L H + + L CC+ +RL + +++ G L + H +++ E R+ +I
Sbjct: 77 LSLARNHPFLTQ-LFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEI 133
Query: 819 LLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSN 876
+ L +LH I++RD+K +N+L+ E +ADFG+ K + +G
Sbjct: 134 ISA----LMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT---A 182
Query: 877 TVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
T G+ YIAPE YG + D ++ GV++ E+L G P
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAV------DWWAMGVLLYEMLCGHAP 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 51/226 (22%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGV--RDSFS---AEIKT 764
++GKG G V+ A+ + A+K L +K V D E +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKAL-------------KKDVVLMDDDVECTMVEKRV 70
Query: 765 LG-SIRHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRY---QIL 819
L + H + + C + L + +Y+ G L + + +I+
Sbjct: 71 LSLAWEHPFLTH-MFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEII 128
Query: 820 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSNT 877
LG L +LH IV+RD+K +NIL+ + IADFG+ K + NT
Sbjct: 129 LG----LQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NT 177
Query: 878 VAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
G+ YIAPE Y + + D +S+GV++ E+L G+ P
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSV------DWWSFGVLLYEMLIGQSP 217
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 51/349 (14%), Positives = 110/349 (31%), Gaps = 34/349 (9%)
Query: 47 CVGLIVLDFSSNNLVGTLPSSLGKL----HNLEELILNSNQLTGKIPVELSNCKSLRKLL 102
L VL+F P L + +L + + ++ + +L +
Sbjct: 191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGF-FKAAANLEEFC 249
Query: 103 LFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGK-IPAELGDCSNMTALGLAD-TQVSGS 160
+P + L ++ G + +P + + L L +
Sbjct: 250 GGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETED 309
Query: 161 LPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLE 220
+ K L+ L + + C +L L + + + E G
Sbjct: 310 HCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEG------ 363
Query: 221 ELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIG-GLSELEEF--------- 270
+ Q L+ A+ + C L+ + ++ ++ SIG L L +F
Sbjct: 364 --LVSQRGLI-ALAQ---GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREE 417
Query: 271 MISDNNVSGSIPANLANATNLVQLQLDTN--QISGLIPPEIGMLSKL--TVFFAWQNQLE 326
I+D + + + L L + ++ L IG S + + + +
Sbjct: 418 RITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESD 477
Query: 327 GSIPSTLASCSNLQALDLSHNSLT-ASVPAGLFQLQNLTKLLLISNDIS 374
+ C NLQ L++ + ++ A + +L +L L + S
Sbjct: 478 EGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 68/521 (13%), Positives = 152/521 (29%), Gaps = 75/521 (14%)
Query: 97 SLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQ 156
R+ + R NL + +L L
Sbjct: 50 ETREHVTMALCYTATPDRLSRRFPNLRSL--------------KLKGKPRAAMFNLIPEN 95
Query: 157 VSGSLPASLGKLSK----LQTLSIYTTMISGEIPAEI--GNCSELVSLFLYENSL--SGS 208
G + + ++S L+++ ++S + +L +L L + S +
Sbjct: 96 WGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDG 155
Query: 209 IPPEIGKLKKLEELFLWQNSLVGAIPEEIG----NCTSLKMIDFSLNSLSGTIPLSIGGL 264
+ + +K++ L + ++S + + + TSL++++F + + P + +
Sbjct: 156 LLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETI 215
Query: 265 SE----LEEFMISDNNVS--GSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVF 318
+ L + D + AN L+ + + KL
Sbjct: 216 ARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRL 275
Query: 319 FAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKL--LLISNDIS-G 375
+P + ++ LDL + L +Q L L N I
Sbjct: 276 GLSYMGPNE-MPILFPFAAQIRKLDLLYALLET--EDHCTLIQKCPNLEVLETRNVIGDR 332
Query: 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIG------------GLKTLNFLDLSSNRLSG 423
+ C L RLR+ + E G G + L ++ + + ++
Sbjct: 333 GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITN 392
Query: 424 SVPDEIG----DCTELQMIDLSHNTLQGSLPNS------LSSLSGLQVLDVSDNRFSGQI 473
+ IG + + +++ L LP L L+ G +
Sbjct: 393 ESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR--QGGL 450
Query: 474 P-ASLGRLVSLNKIILSKNLFSGPIPSSLGL------CSSLQLLDLSSNQLT-GSVPMEL 525
L + + + L S GL C +LQ L++ + ++ +
Sbjct: 451 TDLGLSYIGQYSPNVRWMLLGYVGE-SDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAV 509
Query: 526 GQIEALEIALNLS-CNGLTGPIPAQISALN--KLSILDLSH 563
++ +L L + A + ++
Sbjct: 510 TKLPSLRY-LWVQGYRASMTGQDLMQMARPYWNIELIPSRR 549
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 42/301 (13%), Positives = 87/301 (28%), Gaps = 36/301 (11%)
Query: 321 WQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQ--NLTKLLLIS-NDISGSI 377
W + + + L+++ ++ L + + +L L L + +
Sbjct: 96 WGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDG 155
Query: 378 PPEIG-NCSSLVRLRVGNNRIAGL-------IPREIGGLKTLNFLDLSSNRLSGSVPDEI 429
I +C + L + + + + + L+ LNF ++S + I
Sbjct: 156 LLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETI 215
Query: 430 GD-CTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIIL 488
C L + + + L + + L+ +P LV K+
Sbjct: 216 ARNCRSLVSVKVGDFEI-LELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR 274
Query: 489 SKNLFSGP--IPSSLGLCSSLQLLDLSSNQLTGSVPMEL----GQIEALEIALNLSCNGL 542
+ GP +P + ++ LDL L L +E LE + GL
Sbjct: 275 LGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGL 334
Query: 543 TGPIPAQISALNKLSILDLSHNKLEGNLNPLAQL-------------DNLVSLNISYNKF 589
+L L + E + L L + + +
Sbjct: 335 E----VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDI 390
Query: 590 T 590
T
Sbjct: 391 T 391
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 53/227 (23%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGV-----RDSFSAEIKT 764
VIG+G V + + A+K + +K V D E
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVV-------------KKELVNDDEDIDWVQTEKHV 62
Query: 765 LGSI-RHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLH-ERTGNALEWELRY---QI 818
H +V L C+ +RL + +Y+ G L + H +R E R+ +I
Sbjct: 63 FEQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEI 119
Query: 819 LLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSN 876
L L YLH I++RD+K +N+L+ E + D+G+ K + GD +
Sbjct: 120 SLA----LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---S 168
Query: 877 TVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
T G+ YIAPE YG+ + D ++ GV++ E++ G+ P
Sbjct: 169 TFCGTPNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSP 209
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 60.0 bits (144), Expect = 2e-09
Identities = 28/180 (15%), Positives = 63/180 (35%), Gaps = 25/180 (13%)
Query: 327 GSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIG--NC 384
+ L + L L + T ++ G NL L +IS + S+ +I +
Sbjct: 162 VDLSPVLDAMPLLNNLKIK---GTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 385 SSLVRLRV--------GNNRIAGLIPR-EIGGLKTLNFLDLSSNRLSGSVPDEIGDC--- 432
+L +L + + + P L +L + V + +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 433 TELQMIDLSHNTLQGS----LPNSLSSLSGLQVLDVSDNRFSG----QIPASLGRLVSLN 484
+L+ +D+S L L + + + L+ +++ N S ++ SL + ++
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 6e-05
Identities = 20/163 (12%), Positives = 50/163 (30%), Gaps = 21/163 (12%)
Query: 446 QGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLG--L 503
Q L L ++ L L + + + + +L + + + +
Sbjct: 161 QVDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 504 CSSLQLLDL---SSNQLTGSVPMELGQIEALE-----IALNLSCNGLTGPIPAQISA--- 552
+L+ L L + + + + L + +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 553 LNKLSILDLSHNKLEGN-----LNPLAQLDNLVSLNISYNKFT 590
L +L +D+S L L+ + ++ +L +N+ YN +
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 5e-04
Identities = 32/222 (14%), Positives = 59/222 (26%), Gaps = 50/222 (22%)
Query: 159 GSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIG--KL 216
L L + L L I T L SL + L S+ +I L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKP---RPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 217 KKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNN 276
LE+L L+ D +N S L+ I D
Sbjct: 219 PNLEKLVLYVGV-------------EDYGFDGDMNVFRPL--FSKDRFPNLKWLGIVDAE 263
Query: 277 VSGSIPANLANA---TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEG--SIPS 331
+ + L + + ++ EG +
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTD----------------------EGARLLLD 301
Query: 332 TLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDI 373
+ +L+ +++ +N L+ +LQ + + +D
Sbjct: 302 HVDKIKHLKFINMKYNYLS---DEMKKELQKSLPMKIDVSDS 340
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 53/227 (23%)
Query: 711 VIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVR-----DSFSAEIKT 764
VIG+G V + + A++ + +K V D E
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVV-------------KKELVNDDEDIDWVQTEKHV 105
Query: 765 LGSI-RHKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLH-ERTGNALEWELRY---QI 818
H +V L C+ +RL + +Y+ G L + H +R E R+ +I
Sbjct: 106 FEQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEI 162
Query: 819 LLGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL-VDDGDFARSSN 876
L L YLH I++RD+K +N+L+ E + D+G+ K + GD +
Sbjct: 163 SLA----LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---S 211
Query: 877 TVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 917
T G+ YIAPE YG+ + D ++ GV++ E++ G+ P
Sbjct: 212 TFCGTPNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSP 252
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 25/127 (19%), Positives = 44/127 (34%), Gaps = 6/127 (4%)
Query: 294 LQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASV 353
++L I + + ++ I + A+ A+D S N +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--K 56
Query: 354 PAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGL-IPREIGGLKTLN 412
G L+ L LL+ +N I L L + NN + L + LK+L
Sbjct: 57 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 413 FLDLSSN 419
+L + N
Sbjct: 117 YLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 26/128 (20%), Positives = 46/128 (35%), Gaps = 8/128 (6%)
Query: 342 LDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLI 401
+ L+ + + A +L L I I + +N I L
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL- 57
Query: 402 PREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ--GSLPNSLSSLSGL 459
L+ L L +++NR+ +L + L++N+L G L + L+SL L
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSL 115
Query: 460 QVLDVSDN 467
L + N
Sbjct: 116 TYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 32/158 (20%), Positives = 58/158 (36%), Gaps = 36/158 (22%)
Query: 437 MIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGP 496
M+ L+ ++ + ++ + LD+ + + I +NL +
Sbjct: 1 MVKLTAELIEQAA--QYTNAVRDRELDLRGYK--------------IPVI---ENLGA-- 39
Query: 497 IPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALE--IALNLSCNGLTGPIPAQISALN 554
+D S N++ +L L L ++ N + AL
Sbjct: 40 ------TLDQFDAIDFSDNEIR-----KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88
Query: 555 KLSILDLSHNKLE--GNLNPLAQLDNLVSLNISYNKFT 590
L+ L L++N L G+L+PLA L +L L I N T
Sbjct: 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 27/167 (16%), Positives = 56/167 (33%), Gaps = 40/167 (23%)
Query: 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473
+ L++ + + + + + +DL + + N ++L +D SDN +I
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EI 54
Query: 474 P--ASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEAL 531
L L ++++ N L L L++N L ELG ++ L
Sbjct: 55 RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPL 109
Query: 532 EIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDN 578
++L L+ L + NP+ +
Sbjct: 110 -------------------ASLKSLTYLCILR-------NPVTNKKH 130
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 28/142 (19%), Positives = 41/142 (28%), Gaps = 30/142 (21%)
Query: 211 PEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEF 270
+ + EL L + I IDFS N + + G L
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-----KLDGFPLL--- 63
Query: 271 MISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLE--GS 328
L L ++ N+I + L LT N L G
Sbjct: 64 ------------------RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 105
Query: 329 IPSTLASCSNLQALDLSHNSLT 350
+ LAS +L L + N +T
Sbjct: 106 L-DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 20/114 (17%), Positives = 39/114 (34%), Gaps = 4/114 (3%)
Query: 18 TNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEEL 77
++ + L + + I +DFS N + L L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 69
Query: 78 ILNSNQLTGKIPVELSNCKSLRKLLLFDNALAG-NIPAELGRLSNLEEMRAGGN 130
++N+N++ L +L+L +N+L L L +L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 60/285 (21%), Positives = 100/285 (35%), Gaps = 70/285 (24%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI- 768
V+G G +G V + + E A+K L D R E++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-----------QDCPKARR-----EVELHWRAS 68
Query: 769 RHKNIVRFLGCC----WNRNNRLLMYDYMPNGSLGSLLHERTGNAL-EWE---LRYQILL 820
+ +IVR + R L++ + + G L S + +R A E E + I
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG- 127
Query: 821 GAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEP---YIADFGLAKLVDDGDFARSSN 876
+ + YLH + I HRD+K N+L + + DFG AK
Sbjct: 128 ---EAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---------- 170
Query: 877 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPDGSHVVDWVRQK 935
Y + D++S GV++ +L G P S + K
Sbjct: 171 -TGEKYD-------------KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-----K 211
Query: 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
I++ + SE+ E ++ L LL P +R T+ +
Sbjct: 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE--PTQRMTITEF 254
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 35/124 (28%), Positives = 49/124 (39%), Gaps = 28/124 (22%)
Query: 274 DNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTL 333
D N +P L+N +L + L N+IS L S +T
Sbjct: 39 DGNQFTLVPKELSNYKHLTLIDLSNNRISTL-SN--QSFSNMT----------------- 78
Query: 334 ASCSNLQALDLSHNSLTASVPAGLF-QLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLR 391
L L LS+N L +P F L++L L L NDIS +P + S+L L
Sbjct: 79 ----QLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLA 132
Query: 392 VGNN 395
+G N
Sbjct: 133 IGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 36/128 (28%), Positives = 61/128 (47%), Gaps = 12/128 (9%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394
+C + + S+ L +P G+ + ++T+L L N + +P E+ N L + + N
Sbjct: 9 TCLD-TVVRCSNKGLK-VLPKGIPR--DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSN 63
Query: 395 NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-CTELQMIDLSHNTLQGSLP--- 450
NRI+ L + + L L LS NRL +P D L+++ L N + +P
Sbjct: 64 NRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGA 121
Query: 451 -NSLSSLS 457
N LS+LS
Sbjct: 122 FNDLSALS 129
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSL-SSLSGLQVLDVSDNRFSGQ 472
L L N+ + VP E+ + L +IDLS+N + +L N S+++ L L +S NR
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 473 IPASLGRLVSLNKIILSKN-LFSGPIP----SSLGLCSSLQLLDLSSNQL 517
P + L SL + L N + +P + L S+L L + +N L
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISV--VPEGAFNDL---SALSHLAIGANPL 138
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 48/166 (28%), Positives = 70/166 (42%), Gaps = 30/166 (18%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
S+P + T L L+TN + L L+ LT + N+L+ ++L
Sbjct: 21 SVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 340 QALDLSHNSLTASVPAGLF-QLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIA 398
L+LS N L S+P G+F +L L +L L +N + S+P
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLP-------------------D 117
Query: 399 GLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-CTELQMIDLSHN 443
G+ + L L L L N+L SVPD + D T LQ I L N
Sbjct: 118 GVFDK----LTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC-TE 434
S+P I + L + N + L L +L L L N+L S+P+ + + T
Sbjct: 21 SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 435 LQMIDLSHNTLQGSLPNSL-SSLSGLQVLDVSDNRFSGQIPASL-GRLVSLNKIILSKN- 491
L ++LS N LQ SLPN + L+ L+ L ++ N+ +P + +L L + L +N
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135
Query: 492 LFSGP--IPSSLGLCSSLQLLDLSSNQ 516
L S P + L +SLQ + L N
Sbjct: 136 LKSVPDGVFDRL---TSLQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 45/190 (23%), Positives = 64/190 (33%), Gaps = 56/190 (29%)
Query: 185 IPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLK 244
+P I + L L NSL +L L +L+L N L SL
Sbjct: 22 VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-----------QSL- 67
Query: 245 MIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGL 304
+ L + L L L TNQ+ L
Sbjct: 68 ---------------------------------PNGVFNKLTS---LTYLNLSTNQLQSL 91
Query: 305 IPPEI-GMLSKLTVFFAWQNQLEGSIPS-TLASCSNLQALDLSHNSLTASVPAGLF-QLQ 361
P + L++L NQL+ S+P + L+ L L N L SVP G+F +L
Sbjct: 92 -PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 148
Query: 362 NLTKLLLISN 371
+L + L N
Sbjct: 149 SLQYIWLHDN 158
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-09
Identities = 31/134 (23%), Positives = 51/134 (38%), Gaps = 26/134 (19%)
Query: 287 NATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSH 346
+++ +L LD ++ + EG + L+ L +
Sbjct: 15 TPSDVKELVLDNSRSN-----------------------EGKLEGLTDEFEELEFLSTIN 51
Query: 347 NSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGL-IPREI 405
LT S+ A L +L L KL L N +SG + C +L L + N+I L +
Sbjct: 52 VGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPL 109
Query: 406 GGLKTLNFLDLSSN 419
L+ L LDL +
Sbjct: 110 KKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-08
Identities = 25/111 (22%), Positives = 48/111 (43%), Gaps = 10/111 (9%)
Query: 482 SLNKIILSKNLFS-GPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALE--IALNLS 538
+ +++L + + G + L+ L + LT + + L L LS
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELS 72
Query: 539 CNGLTGPIPAQISALNKLSILDLSHNKLE--GNLNPLAQLDNLVSLNISYN 587
N ++G + L+ L+LS NK++ + PL +L+NL SL++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 28/135 (20%), Positives = 52/135 (38%), Gaps = 28/135 (20%)
Query: 335 SCSNLQALDLSHNSLTA-SVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVG 393
+ S+++ L L ++ + + + L L I+ ++ I N L +L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKK- 68
Query: 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG-SLPNS 452
L+LS NR+SG + C L ++LS N ++ S
Sbjct: 69 --------------------LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108
Query: 453 LSSLSGLQVLDVSDN 467
L L L+ LD+ +
Sbjct: 109 LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 23/114 (20%), Positives = 42/114 (36%), Gaps = 4/114 (3%)
Query: 191 NCSELVSLFLYENSLS-GSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFS 249
S++ L L + + G + + ++LE L L + LK ++ S
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 250 LNSLSGTIPLSIGGLSELEEFMISDNNVSG-SIPANLANATNLVQLQLDTNQIS 302
N +SG + + L +S N + S L NL L L +++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 24/111 (21%), Positives = 49/111 (44%), Gaps = 4/111 (3%)
Query: 22 SFKHLQTLVISDANLT-GSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILN 80
+ ++ LV+ ++ G + + L L + L ++L KL+ L++L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 81 SNQLTGKIPVELSNCKSLRKLLLFDNALAG-NIPAELGRLSNLEEMRAGGN 130
N+++G + V C +L L L N + + L +L NL+ +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 27/140 (19%), Positives = 49/140 (35%), Gaps = 19/140 (13%)
Query: 383 NCSSLVRLRVGNNRIAGLIPREIGGLKTLN---FLDLSSNRLSGSVPDEIGDCTELQMID 439
S + L + N+R + G FL + L+ S+ + + +L+ ++
Sbjct: 15 TPSDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLE 70
Query: 440 LSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSG-QIPASLGRLVSLNKIILSKNLFSGPI- 497
LS N + G L L L++S N+ L +L +L + L +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC----EVT 126
Query: 498 ------PSSLGLCSSLQLLD 511
+ L L LD
Sbjct: 127 NLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 31/140 (22%), Positives = 50/140 (35%), Gaps = 32/140 (22%)
Query: 215 KLKKLEELFLWQNSL-VGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSE---LEEF 270
++EL L + G + L+ + L+ SI L + L++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69
Query: 271 MISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIP 330
+SDN VSG + NL L L N+I L + +E
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL------------------STIE---- 107
Query: 331 STLASCSNLQALDLSHNSLT 350
L NL++LDL + +T
Sbjct: 108 -PLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 30/104 (28%), Positives = 43/104 (41%), Gaps = 3/104 (2%)
Query: 51 IVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAG 110
+VLD S +N G L + LE L + LT I L L+KL L DN ++G
Sbjct: 22 LVLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSG 78
Query: 111 NIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLAD 154
+ + NL + GNK L N+ +L L +
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 31/135 (22%), Positives = 51/135 (37%), Gaps = 27/135 (20%)
Query: 431 DCTELQMIDLSHNTLQ-GSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILS 489
++++ + L ++ G L L+ L + + I A+L +L L K+ LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 490 KNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQ 549
N SG + C +L L+LS N++ +L IE L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK-----DLSTIEPL------------------ 109
Query: 550 ISALNKLSILDLSHN 564
L L LDL +
Sbjct: 110 -KKLENLKSLDLFNC 123
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 19/109 (17%), Positives = 41/109 (37%), Gaps = 3/109 (2%)
Query: 384 CSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDE-IGDCTELQMIDLSH 442
LR A + G + L L + + + + + EL+ + +
Sbjct: 7 PHGSSGLRC-TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 443 NTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491
+ L+ P++ L L++S N + + +SL +++LS N
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 20/133 (15%), Positives = 37/133 (27%), Gaps = 27/133 (20%)
Query: 240 CTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPAN-LANATNLVQLQLDT 298
+ + + + G L E I + + L L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 299 NQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLF 358
+ + + P+ L L+LS N+L S+
Sbjct: 66 SGLR-FVAPD-----------------------AFHFTPRLSRLNLSFNALE-SLSWKTV 100
Query: 359 QLQNLTKLLLISN 371
Q +L +L+L N
Sbjct: 101 QGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 9e-08
Identities = 25/135 (18%), Positives = 41/135 (30%), Gaps = 25/135 (18%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394
L + + L +NLT+L + + +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRD------------- 51
Query: 395 NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLS 454
+ GL L L + + L PD L ++LS N L+ ++
Sbjct: 52 ----------LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQ 101
Query: 455 SLSGLQVLDVSDNRF 469
LS LQ L +S N
Sbjct: 102 GLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 21/119 (17%), Positives = 36/119 (30%), Gaps = 26/119 (21%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
+L A NL +L ++ Q + L L
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELR-----------------------DLRGLGEL 58
Query: 340 QALDLSHNSLTASVPAGLFQ-LQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRI 397
+ L + + L V F L++L L N + S+ + SL L + N +
Sbjct: 59 RNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 2/94 (2%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIP-FDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNL 74
+L ++L L I + + D+ L L + L P + L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 75 EELILNSNQLTGKIPVELSNCKSLRKLLLFDNAL 108
L L+ N L + + SL++L+L N L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 14/88 (15%), Positives = 27/88 (30%), Gaps = 2/88 (2%)
Query: 432 CTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPA-SLGRLVSLNKIILSK 490
+ + + + L L L + + + + L L L + + K
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 491 NLFSGPIPSSLGLCSSLQLLDLSSNQLT 518
+ P + L L+LS N L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 19/106 (17%), Positives = 35/106 (33%), Gaps = 5/106 (4%)
Query: 27 QTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPS-SLGKLHNLEELILNSNQLT 85
L + + L L + + L L L L L + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 86 GKIPVE-LSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGN 130
+ + L +L L NAL ++ + + +L+E+ GN
Sbjct: 70 -FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 15/109 (13%), Positives = 32/109 (29%), Gaps = 3/109 (2%)
Query: 192 CSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEE-IGNCTSLKMIDFSL 250
L + + + L EL++ + + + L+ +
Sbjct: 7 PHGSSGL-RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 251 NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTN 299
+ L P + L +S N + S+ +L +L L N
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 7e-05
Identities = 15/87 (17%), Positives = 27/87 (31%), Gaps = 4/87 (4%)
Query: 47 CVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVE-LSNCKSLRKLLLFD 105
G L + + + L NL EL + + Q + + L LR L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 106 NALAGNIPAE-LGRLSNLEEMRAGGNK 131
+ L + + L + N
Sbjct: 66 SGLR-FVAPDAFHFTPRLSRLNLSFNA 91
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 27/94 (28%), Positives = 40/94 (42%), Gaps = 3/94 (3%)
Query: 327 GSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSS 386
G I A NL+ L L + L SV + L +L L KL L N I G + +
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 387 LVRLRVGNNRIAGL-IPREIGGLKTLNFLDLSSN 419
L L + N++ + + L+ L LDL +
Sbjct: 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 27/98 (27%), Positives = 42/98 (42%), Gaps = 9/98 (9%)
Query: 497 IPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALE--IALNLSCNGLTGPIPAQISALN 554
I +L+ L L + L + + L L LS N + G + L
Sbjct: 41 IEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLP 95
Query: 555 KLSILDLSHNKLE--GNLNPLAQLDNLVSLNISYNKFT 590
L+ L+LS NKL+ L PL +L+ L SL++ + T
Sbjct: 96 NLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 28/135 (20%), Positives = 49/135 (36%), Gaps = 7/135 (5%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394
S +D+ ++ L L ++ G I +L L + N
Sbjct: 1 GSSGSSGMDMKRRIHLELRNRTPAAVRELV-LDNCKSND-GKIEGLTAEFVNLEFLSLIN 58
Query: 395 NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ--GSLPNS 452
+ + + L L L+LS NR+ G + L ++LS N L+ +L
Sbjct: 59 VGLISVSN--LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EP 115
Query: 453 LSSLSGLQVLDVSDN 467
L L L+ LD+ +
Sbjct: 116 LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 33/181 (18%), Positives = 55/181 (30%), Gaps = 52/181 (28%)
Query: 384 CSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHN 443
S + + L R ++ L LD + G + + L+ + L +
Sbjct: 2 SSGSSGMDMKRRIHLELRNRTPAAVRELV-LDNCKSND-GKIEGLTAEFVNLEFLSLINV 59
Query: 444 TLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGL 503
L S+S L +L L K+ LS+N G +
Sbjct: 60 --------GLISVSNLP------------------KLPKLKKLELSENRIFGGLDMLAEK 93
Query: 504 CSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSH 563
+L L+LS N+L ++ +E L L L LDL +
Sbjct: 94 LPNLTHLNLSGNKLK-----DISTLEPL-------------------KKLECLKSLDLFN 129
Query: 564 N 564
Sbjct: 130 C 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 25/111 (22%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 22 SFKHLQTLVISDANLT-GSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILN 80
+ ++ LV+ + G I + V L L + L+ S+L KL L++L L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 81 SNQLTGKIPVELSNCKSLRKLLLFDNALAG-NIPAELGRLSNLEEMRAGGN 130
N++ G + + +L L L N L + L +L L+ +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 31/136 (22%), Positives = 51/136 (37%), Gaps = 13/136 (9%)
Query: 239 NCTSLKMIDFSLNSLS-GTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLD 297
+++ + + G I LE + + + S+ +NL L +L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 298 TNQISGLIPPEIGMLSKLTVFFAWQNQLEG-SIPSTLASCSNLQALDLSHNSLT------ 350
N+I G + L LT N+L+ S L L++LDL + +T
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYR 139
Query: 351 ASVPAGLFQLQNLTKL 366
SV L LT L
Sbjct: 140 ESV---FKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 24/81 (29%), Positives = 36/81 (44%), Gaps = 3/81 (3%)
Query: 51 IVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAG 110
+VLD +N G + + NLE L L + L + L L+KL L +N + G
Sbjct: 29 LVLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFG 85
Query: 111 NIPAELGRLSNLEEMRAGGNK 131
+ +L NL + GNK
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNK 106
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 43/257 (16%), Positives = 85/257 (33%), Gaps = 19/257 (7%)
Query: 290 NLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSL 349
++ + + + + + + ++ L+ CS LQ L L L
Sbjct: 71 GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 130
Query: 350 TASVPAGLFQLQNLTKLLL-----ISNDISGSIPPEIGNCSSLVRL------RVGNNRIA 398
+ + L + NL +L L S ++ + +CS L L +
Sbjct: 131 SDPIVNTLAKNSNLVRLNLSGCSGFSEF---ALQTLLSSCSRLDELNLSWCFDFTEKHVQ 187
Query: 399 GLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNT-LQGSLPNSLSSLS 457
+ + LN N + + C L +DLS + L+ L+
Sbjct: 188 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 247
Query: 458 GLQVLDVSD-NRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQ 516
LQ L +S + LG + +L + + + G + L +L L ++ +
Sbjct: 248 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL---LKEALPHLQINCSH 304
Query: 517 LTGSVPMELGQIEALEI 533
T +G + EI
Sbjct: 305 FTTIARPTIGNKKNQEI 321
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 44/242 (18%), Positives = 81/242 (33%), Gaps = 30/242 (12%)
Query: 35 NLTGSIPFDIGDCVGLIVLDFSSNNL-VGTLPSSLGKLHNLEELILNSNQLTGKIPVELS 93
+ + + +D S++ + V TL L + L+ L L +L+ I L+
Sbjct: 80 SFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA 139
Query: 94 NCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPA----ELGDCSNMTA 149
+L +L LS + ++ L C + T
Sbjct: 140 KNSNLVRL----------------NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT- 182
Query: 150 LGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGE-IPAEIGNCSELVSLFLYE-NSLSG 207
+ V ++ +++L LS Y + + + C LV L L + L
Sbjct: 183 ----EKHVQVAVAHVSETITQL-NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN 237
Query: 208 SIPPEIGKLKKLEELFLWQNSLVG-AIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSE 266
E +L L+ L L + + E+G +LK + GT+ L L
Sbjct: 238 DCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH 297
Query: 267 LE 268
L+
Sbjct: 298 LQ 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 34/189 (17%), Positives = 64/189 (33%), Gaps = 17/189 (8%)
Query: 20 LSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLV--GTLPSSLGKLHNLEEL 77
LS LQ L + L+ I + L+ L+ S + L + L L+EL
Sbjct: 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 173
Query: 78 ILNS-NQLTGKIPVEL--SNCKSLRKLLLF-------DNALAGNIPAELGRLSNLEEMRA 127
L+ T K +++ +L L + L+ + R NL +
Sbjct: 174 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLS----TLVRRCPNLVHLDL 229
Query: 128 GGNKDIVGKIPAELGDCSNMTALGLAD-TQVSGSLPASLGKLSKLQTLSIYTTMISGEIP 186
+ + E + + L L+ + LG++ L+TL ++ + G +
Sbjct: 230 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 289
Query: 187 AEIGNCSEL 195
L
Sbjct: 290 LLKEALPHL 298
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 49/198 (24%), Positives = 76/198 (38%), Gaps = 11/198 (5%)
Query: 400 LIPREIGGLKTLNFLDLSSNRLSGSVP-DEIGDCTELQMIDLSHNTL-QGSLPNSLSSLS 457
L P G L + + R P E +Q +DLS++ + +L LS S
Sbjct: 59 LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCS 118
Query: 458 GLQVLDVSDNRFSGQIPASLGRLVSLNKIILS--KNLFSGPIPSSLGLCSSLQLLDLSS- 514
LQ L + R S I +L + +L ++ LS + + L CS L L+LS
Sbjct: 119 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 178
Query: 515 NQLT-GSVPMELGQIEALEIALNLS--CNGLT-GPIPAQISALNKLSILDLSHNKL--EG 568
T V + + + LNLS L + + L LDLS + +
Sbjct: 179 FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND 238
Query: 569 NLNPLAQLDNLVSLNISY 586
QL+ L L++S
Sbjct: 239 CFQEFFQLNYLQHLSLSR 256
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 53/236 (22%), Positives = 85/236 (36%), Gaps = 60/236 (25%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G V+ A DM N +A+K + ++ EIK L +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-------RGDKVYTEAAED-----EIKLLQRVN 73
Query: 770 HKNIVRFLGCCWNRNNRLLMYDY-MPNGSLGS---LLHERTG-NALEWELRY-------- 816
+ + N+ L + D+ G G ++ E G N L +Y
Sbjct: 74 DADNTKE--DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 131
Query: 817 -------QILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY------IADFGLA 863
Q+LLG L Y+H C I+H DIK N+L+ + P IAD G A
Sbjct: 132 YVKQISKQLLLG----LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
Query: 864 KLVDDGDFARSSNTVAGSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGK 915
D+ + Y +PE + D++S ++ E++TG
Sbjct: 186 CWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGA----DIWSTACLIFELITGD 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 2e-08
Identities = 88/646 (13%), Positives = 176/646 (27%), Gaps = 236/646 (36%)
Query: 65 PSSLGKLHNLE-ELILNSNQLTGKIPVE-LSNCKSLRKLLLFDNALAGNIPAELGRLSN- 121
PS + +++ + + + N NQ+ K V L LR+ LL EL N
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL-----------ELRPAKNV 153
Query: 122 -LEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTM 180
++ + G GK + + +V + I+
Sbjct: 154 LIDGV--LG----SGK--------TWVALDVCLSYKVQCKMD-----------FKIF--W 186
Query: 181 ISGEIPAEIGNCSELVSLFLYENSL--------------SGSIPPEIGKLK-KLEELFLW 225
++ + NC+ ++ L S +I I ++ +L L
Sbjct: 187 LN------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240
Query: 226 Q---NSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIP 282
+ N L+ + + N + + S L T V
Sbjct: 241 KPYENCLL--VLLNVQNAKAWNAFNLSCKILLTT----------------RFKQV----- 277
Query: 283 ANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQAL 342
+ +A + LD + L P E ++ + + +P + L
Sbjct: 278 TDFLSAATTTHISLDHHS-MTLTPDE-----VKSLLLKYLDCRPQDLPR--------EVL 323
Query: 343 DLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIP 402
+ P +S I +R G
Sbjct: 324 TTN--------P------------RRLS---------IIAE-----SIRDGLATWD---- 345
Query: 403 REIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSL-SGLQV 461
N+ ++ ++L+ +I+ S N L+ P + L V
Sbjct: 346 ---------NWKHVNCDKLT-------------TIIESSLNVLE---PAEYRKMFDRLSV 380
Query: 462 L--DVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519
IP L L ++ ++ + + L++ + T
Sbjct: 381 FPPSA-------HIPTIL--LS-----LIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 520 SVP---MELGQ------------IEALEIALNLSCNGLTGPI-----------------P 547
S+P +EL ++ I + L P
Sbjct: 427 SIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEH 486
Query: 548 AQISALNKLSILDLS--HNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPT 605
+ L ++ LD K+ + ++++ + Y+ DN P
Sbjct: 487 PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN------DPK 540
Query: 606 DLAGNEGLCSSRKDSCFLSNDGKAGLASNENDVRRSRKLKVAIALL 651
E L ++ D FL + + S D+ + IAL+
Sbjct: 541 ----YERLVNAILD--FLPKIEENLICSKYTDL-------LRIALM 573
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 3e-06
Identities = 84/610 (13%), Positives = 164/610 (26%), Gaps = 187/610 (30%)
Query: 247 DFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGS---IPANLANATNLVQ------LQLD 297
+F + +P SI E++ ++S + VSG+ L+ +VQ L+++
Sbjct: 32 NFDCKDVQ-DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN 90
Query: 298 TNQISGLIPPEIGMLSKLTVFFAWQ-NQLEGSIPSTLASCSNLQALDLSHNSLTASVPAG 356
+ I E S +T + Q ++L ++S +
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV-------FAKYNVSRLQPYLKLRQA 143
Query: 357 LFQLQN----------------LTKLLLISNDISGSIPPEI-----GNCSSLVRLRVGNN 395
L +L+ + + +S + + +I NC+S
Sbjct: 144 LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS--------- 194
Query: 396 RIAGLIPREIGGLKTLNFL--DLSSNRLSG-----SVPDEIGDCTELQMIDLSHNTLQGS 448
P + L+ L L + N S ++ I +L
Sbjct: 195 ------PETV--LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA----ELRRLLKSKP 242
Query: 449 LPNSLSSLSGLQVLD-VSDNR----FSGQIP-------ASLGRLVSLNKIILSKNLFSGP 496
N L L VL V + + F+ + +S + ++
Sbjct: 243 YENCL-----L-VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAAT---TTHISLDH 293
Query: 497 IPSSLGLCSSLQLL---------DLSSNQLTGSVPMELGQI------------------- 528
+L LL DL LT + P L I
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN-PRRLSIIAESIRDGLATWDNWKHVNC 352
Query: 529 EALEIALNLSCNGLTG-----------------PIPAQISALNKLSIL--DLSHNKLEGN 569
+ L + S N L IP + LS++ D+ + +
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL-----LSLIWFDVIKSDVMVV 407
Query: 570 LNPLAQLDNLVSLNISYNKFTGYLPD----------------NKLFRQLSPTDLAGNEGL 613
+N +L + + T +P + + ++ L
Sbjct: 408 VN---KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 614 CSSRKDSCFLSNDG----KAGLASNENDVRR--------SRKLKVAIALLITLTVAMAIM 661
D F S+ G R +K++ + +
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 662 GTFALIRARRAMKDDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVY 721
+ D L ++ L+F + K + N+I + ++
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAI---------LDF----LPKI--EENLICSKYTDLLR 569
Query: 722 RADMDNGEVI 731
A M E I
Sbjct: 570 IALMAEDEAI 579
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 34/119 (28%), Positives = 62/119 (52%), Gaps = 8/119 (6%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTL-ASCSN 338
S+P + ++ +L+L++N++ L L++LT QNQ++ S+P + +
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 339 LQALDLSHNSLTASVPAGLF-QLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNN 395
L L L N L S+P G+F +L L +L L +N + S+P I +SL ++ + N
Sbjct: 78 LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 32/159 (20%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394
SCS + + LT SVP G IP SS RL + +
Sbjct: 6 SCSG-TEIRCNSKGLT-SVPTG--------------------IP------SSATRLELES 37
Query: 395 NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC-TELQMIDLSHNTLQGSLPNSL 453
N++ L L L L LS N++ S+PD + D T+L ++ L N LQ SLPN +
Sbjct: 38 NKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGV 95
Query: 454 -SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491
L+ L+ L + N+ RL SL KI L N
Sbjct: 96 FDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 28/136 (20%), Positives = 58/136 (42%), Gaps = 14/136 (10%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPE--IGNCSSLVRLRV 392
C +D + L +P + + T+LLL N++ I + G LV+L +
Sbjct: 7 HCEG-TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELG-RISSDGLFGRLPHLVKLEL 61
Query: 393 GNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-CTELQMIDLSHNTLQGSLP- 450
N++ G+ P G + L L N++ + +++ +L+ ++L N + +
Sbjct: 62 KRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMP 119
Query: 451 ---NSLSSLSGLQVLD 463
L+SL+ L +
Sbjct: 120 GSFEHLNSLTSLNLAS 135
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 33/143 (23%), Positives = 52/143 (36%), Gaps = 31/143 (21%)
Query: 232 AIPEEIGNCTSLKMIDFSLNSLSGTIPLSI-GGLSELEEFMISDNNVSGSIPANL-ANAT 289
IP +I + + N L + G L L + + N ++ I N A+
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 290 NLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSL 349
++ +LQL N+I + M L L+ L+L N +
Sbjct: 79 HIQELQLGENKIKEI-SN--KMFLGLH---------------------QLKTLNLYDNQI 114
Query: 350 TASVPAGLF-QLQNLTKLLLISN 371
+ V G F L +LT L L SN
Sbjct: 115 S-CVMPGSFEHLNSLTSLNLASN 136
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 33/171 (19%), Positives = 63/171 (36%), Gaps = 29/171 (16%)
Query: 712 IGKGCSGVVYRA---------DMDNGEVIAVKKLWPTTMAAANG--CSDEKSGVRDSFSA 760
+ G++Y A + ++K + A +G +++ R +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGRLFNEQNFFQRAAKPL 103
Query: 761 EI---KTLGSIRHKNIVRFLGCCWNRNN-RLLMYDYMPNG-SLGSLLHERTGNALEWELR 815
++ K L S I +G +++ R L+ + G SL S L + L
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSV 161
Query: 816 YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP--YIADFGLAK 864
Q+ L +LH + VH ++ A NI + E + +A +G A
Sbjct: 162 LQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 34/172 (19%), Positives = 67/172 (38%), Gaps = 31/172 (18%)
Query: 712 IGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAAN--GCSDE----KSGVRDSFSAEIKTL 765
IG+G G +Y ADM++ E + + ++ E + + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQ-------- 817
+++ + ++ G + N Y +M + +R G+ L+
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGK-SYRFM--------IMDRFGSDLQKIYEANAKRFSRKT 153
Query: 818 ILLGAAQGLA---YLHHDCVPPIVHRDIKANNILIGLEFEP--YIADFGLAK 864
+L + + L Y+H VH DIKA+N+L+ + Y+ D+GLA
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 55/241 (22%), Positives = 87/241 (36%), Gaps = 69/241 (28%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVK--KLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
++IGKG G V +A D E +A+K K + A E++ L
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ--------------IEVRLLE 105
Query: 767 SIRH------KNIVRFLGCCWNRNNR-----LL---MYDYM-PNGSLG-SLLHERTGNAL 810
+ IV RN+ +L +YD + G SL R
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK---- 161
Query: 811 EWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870
Q+ L +L + I+H D+K NIL+ I K+VD G
Sbjct: 162 ---FAQQMC----TALLFLATPELS-IIHCDLKPENILLCNPKRSAI------KIVDFGS 207
Query: 871 FARSSNTVAGSYGYI------APE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920
+ + Y YI +PE Y + I D++S G +++E+ TG+ P+
Sbjct: 208 SCQLGQRI---YQYIQSRFYRSPEVLLGMPYDLAI----DMWSLGCILVEMHTGE-PLFS 259
Query: 921 T 921
Sbjct: 260 G 260
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTL-ASCSN 338
S+P + T L L NQI+ L P L++LT NQL +P+ + +
Sbjct: 23 SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 339 LQALDLSHNSLTASVPAGLF-QLQNLTKLLLISN 371
L L L+ N L S+P G F L++LT + L++N
Sbjct: 80 LTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 37/127 (29%), Positives = 54/127 (42%), Gaps = 35/127 (27%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394
SCS +D S SL SVP G IP ++ L + +
Sbjct: 8 SCSG-TTVDCSGKSLA-SVPTG--------------------IP------TTTQVLYLYD 39
Query: 395 NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-CTELQMIDLSHNTLQGSLPN-- 451
N+I L P L L LDL +N+L+ +P + D T+L + L+ N L+ S+P
Sbjct: 40 NQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK-SIPRGA 97
Query: 452 --SLSSL 456
+L SL
Sbjct: 98 FDNLKSL 104
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 62/238 (26%), Positives = 90/238 (37%), Gaps = 67/238 (28%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
VIGKG G V +A D + +A+K + N + EI+ L +R
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-------RNEKRFHRQAAE-----EIRILEHLR 151
Query: 770 HK------NIVRFLGCCWNRNN-----RLL---MYDYMPNGSLG--SLLHERTGNALEWE 813
+ N++ L RN+ LL +Y+ + SL R
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK------- 204
Query: 814 LRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFAR 873
+ IL Q L LH I+H D+K NIL+ + I K++D G
Sbjct: 205 FAHSIL----QCLDALHK---NRIIHCDLKPENILLKQQGRSGI------KVIDFGSSCY 251
Query: 874 SSNTVAGSYGYI------APE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921
V Y YI APE Y M I D++S G ++ E+LTG P+ P
Sbjct: 252 EHQRV---YTYIQSRFYRAPEVILGARYGMPI----DMWSLGCILAELLTGY-PLLPG 301
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 37/168 (22%), Positives = 60/168 (35%), Gaps = 41/168 (24%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDS-FSAEIKTLGSIR 769
IG+G GV++ ++ N + +A+K E E +T +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIK--------------FEPRRSDAPQLRDEYRTYKLLA 63
Query: 770 H-KNIVRFLGCCWNRNNRLLMYDYMPNGSLG-SL--LHERTGNALEWE----LRYQILLG 821
I + +L+ D LG SL L + G + Q+L
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDL-----LGPSLEDLLDLCGRKFSVKTVAMAAKQML-- 116
Query: 822 AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP-----YIADFGLAK 864
+ +H +V+RDIK +N LIG Y+ DFG+ K
Sbjct: 117 --ARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 32/168 (19%), Positives = 55/168 (32%), Gaps = 41/168 (24%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVR-DSFSAEIKTLGSIR 769
IG G G + ++ E +A+K E R E + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--------------EPMKSRAPQLHLEYRFYKQLG 62
Query: 770 H-KNIVRFLGCCWNRNNRLLMYDYMPNGSLG-SL--LHERTGNALEWE----LRYQILLG 821
I + ++ + LG SL L + + + Q++
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLEL-----LGPSLEDLFDLCDRTFSLKTVLMIAIQLI-- 115
Query: 822 AAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP-----YIADFGLAK 864
+ Y+H +++RD+K N LIG +I DF LAK
Sbjct: 116 --SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPS-TLASCSN 338
S+PA + T+ +L L+ NQI+ L P L L + N+L +IP+ +
Sbjct: 26 SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 339 LQALDLSHNSLTASVPAGLF-QLQNLTKLLLISN 371
L LDL+ N L S+P G F L++LT + L +N
Sbjct: 83 LTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 36/127 (28%), Positives = 54/127 (42%), Gaps = 35/127 (27%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394
SC ++ + L SVPAG IP + RL + N
Sbjct: 11 SCDQ-TLVNCQNIRLA-SVPAG--------------------IP------TDKQRLWLNN 42
Query: 395 NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-CTELQMIDLSHNTLQGSLPN-- 451
N+I L P L L L +SN+L+ ++P + D T+L +DL+ N L+ S+P
Sbjct: 43 NQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK-SIPRGA 100
Query: 452 --SLSSL 456
+L SL
Sbjct: 101 FDNLKSL 107
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 17/41 (41%), Positives = 25/41 (60%), Gaps = 5/41 (12%)
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEP--YIADFGLAK 864
L Y+H + VH DIKA N+L+G + Y+AD+GL+
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 41/174 (23%), Positives = 65/174 (37%), Gaps = 47/174 (27%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDS-FSAEIKTLGSIR 769
IG G G +Y D+ GE +A+K E + E K ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL--------------ECVKTKHPQLHIESKIYKMMQ 62
Query: 770 H-KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQ--------ILL 820
I C + +++ + + G +LE + +LL
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELL-------------GPSLEDLFNFCSRKFSLKTVLL 109
Query: 821 GAAQGLA---YLHHDCVPPIVHRDIKANNILIGLEFEP---YIADFGLAKLVDD 868
A Q ++ Y+H +HRD+K +N L+GL + YI DFGLAK D
Sbjct: 110 LADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 32/178 (17%), Positives = 52/178 (29%), Gaps = 46/178 (25%)
Query: 797 SLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE---- 852
L + + L +I+ QGL YLH C I+H DIK NIL+ +
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187
Query: 853 -------------------------------------FEPYIADFGLAKLVDDGDFARSS 875
EP A+ K+ D G+
Sbjct: 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247
Query: 876 NTVAG---SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930
+ Y + E +D++S + E+ TG +P + +
Sbjct: 248 KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDE 305
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 39/174 (22%), Positives = 61/174 (35%), Gaps = 47/174 (27%)
Query: 712 IGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDS-FSAEIKTLGSIR 769
IG G G +Y ++ E +A+K E + E K ++
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--------------ENVKTKHPQLLYESKIYRILQ 60
Query: 770 -HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQ--------ILL 820
I + +L+ D + G +LE + +L+
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLL-------------GPSLEDLFNFCSRKLSLKTVLM 107
Query: 821 GAAQGLA---YLHHDCVPPIVHRDIKANNILIGLEFEP---YIADFGLAKLVDD 868
A Q + ++H +HRDIK +N L+GL YI DFGLAK D
Sbjct: 108 LADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 20/134 (14%), Positives = 47/134 (35%), Gaps = 23/134 (17%)
Query: 326 EGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLL-----ISNDISGSIPPE 380
+P+ +QA+D + + + + + LQ + K+ L I + +
Sbjct: 50 YNHLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQL 109
Query: 381 IGNCSSLVRLRV-GNNRI--AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQM 437
S++ + + + G+I + + L +L LS D ++
Sbjct: 110 ENLQKSMLEMEIISCGNVTDKGII--ALHHFRNLKYLFLS-------------DLPGVKE 154
Query: 438 IDLSHNTLQGSLPN 451
+ + SLP+
Sbjct: 155 KEKIVQAFKTSLPS 168
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 46/247 (18%), Positives = 78/247 (31%), Gaps = 74/247 (29%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVK--KLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGS 767
+G G G V +DN + AVK + + +K S E L
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR------------NIKK--YTRSAKIEADILKK 87
Query: 768 IRH-----KNIVRFLGCCWNRNN-----RLL---MYDYM-PNGSLG-SLLHERTGNALEW 812
I++ NIV++ G ++ L +Y+ + N G + +
Sbjct: 88 IQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK------- 140
Query: 813 ELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFA 872
+IL + L YL + H D+K NIL+ +
Sbjct: 141 LYCIEIL----KALNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 873 RSSNTVA------GS--------YGYI------APE----YGYMMKITEKSDVYSYGVVV 908
+ + G I APE G+ + D++S+G V+
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSS----DMWSFGCVL 249
Query: 909 LEVLTGK 915
E+ TG
Sbjct: 250 AELYTGS 256
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 37/257 (14%), Positives = 81/257 (31%), Gaps = 36/257 (14%)
Query: 267 LEEFMISDNNVSGSIPANLANA-TNLVQLQLDTNQI---------SGLIPPEIGMLSKLT 316
L+E ++ + + L +L L N + L+ + ++T
Sbjct: 103 LDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQ----CQIT 158
Query: 317 VFFAWQNQLEGS----IPSTLASCSNLQALDLSHNSLT-ASVPA---GLFQLQNLTKLLL 368
N L + + LA +++ L L H L + L + + L +L +
Sbjct: 159 TLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNV 218
Query: 369 ISNDISGS----IPPEIGNCSSLVRLRVGNNRI----AGLIPREIGGLKTLNFLDLSSNR 420
N + + SL L + N + ++ G + + +S
Sbjct: 219 AYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSL-- 276
Query: 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRL 480
G+ E L + + N+ + L + D+ D+R + P +L
Sbjct: 277 TEGTAVSEYW-SVILSEVQRNLNSWDRARVQRHLELL---LRDLEDSRGATLNPWRKAQL 332
Query: 481 VSLNKIILSKNLFSGPI 497
+ + + + G
Sbjct: 333 LRVEGEVRALLEQLGSS 349
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 36/241 (14%), Positives = 72/241 (29%), Gaps = 72/241 (29%)
Query: 337 SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNR 396
S+L+ L+L+ +T + + +L +L + + + +
Sbjct: 72 SSLRQLNLAGVRMTPV------KCTVVAAVLGSGR-------------HALDEVNLASCQ 112
Query: 397 I--AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-----CTELQMIDLSHNTLQGS- 448
+ AGL + L L N L ++ D ++ + LS+N L +
Sbjct: 113 LDPAGLR-TLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAG 171
Query: 449 ---LPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCS 505
L L+ + + L + + L + N
Sbjct: 172 VAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN--------------------R 211
Query: 506 SLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNK 565
LQ L+++ N + AL +A + L +L L N+
Sbjct: 212 QLQELNVAYNGAGDTA--------ALALARAAREH-------------PSLELLHLYFNE 250
Query: 566 L 566
L
Sbjct: 251 L 251
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1058 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.86 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.8 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.68 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.59 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.58 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.58 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.57 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.56 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.48 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.39 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.38 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.38 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.36 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.36 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.19 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.17 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.11 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.82 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.77 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.23 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.22 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.16 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.08 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.05 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.93 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.51 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.29 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.25 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.19 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.05 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.85 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.77 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.76 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.53 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.33 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.31 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.14 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.92 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.69 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.56 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.05 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.06 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 87.27 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.64 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 84.14 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-76 Score=739.64 Aligned_cols=616 Identities=35% Similarity=0.528 Sum_probs=468.3
Q ss_pred eeeEeecCCCCCCC---CCccccCCCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCCh--hhcCcccCCE
Q 043053 2 VTEITIQSVPLQLP---IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPS--SLGKLHNLEE 76 (1058)
Q Consensus 2 ~~~~~~~~~~~~~~---~p~~~~~~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~--~l~~l~~L~~ 76 (1058)
||++.+...++.-. +|+.+.++++|+.++++.+.+. .+|..++.+++|++|+|++|.+++.+|. .+++|++|++
T Consensus 52 v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~ 130 (768)
T 3rgz_A 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKF 130 (768)
T ss_dssp EEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCE
T ss_pred EEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCE
Confidence 67788887777555 7777788888888888877765 4667788888888888888888777777 7888888888
Q ss_pred EeccccCCCCcccccc-ccchhhhHHhhhhccccCCChhh---hcccccchhhhcCCCccccCCCCccccCCCCCceecc
Q 043053 77 LILNSNQLTGKIPVEL-SNCKSLRKLLLFDNALAGNIPAE---LGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGL 152 (1058)
Q Consensus 77 L~L~~n~~~~~~p~~l-~~l~~L~~L~L~~n~~~~~~p~~---l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l 152 (1058)
|+|++|++.+.+|..+ .++++|++|+|++|.+.+..|.. ++++++|++|++++|. +.+..+ ++.+++|++|++
T Consensus 131 L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~--~~~l~~L~~L~L 207 (768)
T 3rgz_A 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK-ISGDVD--VSRCVNLEFLDV 207 (768)
T ss_dssp EECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSE-EESCCB--CTTCTTCCEEEC
T ss_pred EECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCc-ccccCC--cccCCcCCEEEC
Confidence 8888887777777665 77888888888888877666665 6777777777777775 222222 366777777777
Q ss_pred cCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCC
Q 043053 153 ADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGA 232 (1058)
Q Consensus 153 ~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 232 (1058)
++|.+.+..|. ++++++|++|++++|.+++.+|..++++++|++|+|++|.+.+.+|.. .+++|++|+|++|.+.+.
T Consensus 208 s~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ 284 (768)
T 3rgz_A 208 SSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGE 284 (768)
T ss_dssp CSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEES
T ss_pred cCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCc
Confidence 77777765555 777777777777777777777777777777777777777776655544 667777777777777766
Q ss_pred CCccccCc-CCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCcccc-ccccccchhhhhcCCcccCcCCCccc
Q 043053 233 IPEEIGNC-TSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPAN-LANATNLVQLQLDTNQISGLIPPEIG 310 (1058)
Q Consensus 233 ~~~~l~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~L~~N~i~~~~~~~~~ 310 (1058)
+|..+..+ ++|++|+|++|.+++.+|..|+.+++|++|++++|.+.+.+|.. +..+++|++|+|++|++++..|..+.
T Consensus 285 ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~ 364 (768)
T 3rgz_A 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364 (768)
T ss_dssp CCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHH
T ss_pred cCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHH
Confidence 66666554 77777777777777777777777777777777777776555543 67777777777777777766777777
Q ss_pred ccc-hhhhhhccCcccCCCCChhhhc--cCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCC
Q 043053 311 MLS-KLTVFFAWQNQLEGSIPSTLAS--CSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSL 387 (1058)
Q Consensus 311 ~l~-~L~~L~l~~N~l~~~~~~~~~~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 387 (1058)
.++ +|++|++++|++++.++..+.. +++|++|++++|++++.+|..+..+++|++|+|++|.+++..|..|+++++|
T Consensus 365 ~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 444 (768)
T 3rgz_A 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKL 444 (768)
T ss_dssp HHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC
T ss_pred hhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCC
Confidence 665 6777777777776666666655 6667777777777776666667777777777777777766667677777777
Q ss_pred cEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCC
Q 043053 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN 467 (1058)
Q Consensus 388 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 467 (1058)
+.|++++|++++..|..|..+++|++|+|++|++++..|..+..+++|+.|+|++|++++.+|.+|+.+++|++|+|++|
T Consensus 445 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 524 (768)
T 3rgz_A 445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524 (768)
T ss_dssp CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred CEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCC
Confidence 77777777777666667777777777777777777666777777777777777777777667777777777777777777
Q ss_pred ccccCCcccccccccccccccccccCCCCCCC------------------------------------------------
Q 043053 468 RFSGQIPASLGRLVSLNKIILSKNLFSGPIPS------------------------------------------------ 499 (1058)
Q Consensus 468 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~------------------------------------------------ 499 (1058)
++++.+|..+..+++|+.|+|++|++++.+|.
T Consensus 525 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (768)
T 3rgz_A 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL 604 (768)
T ss_dssp CCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGG
T ss_pred cccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhh
Confidence 77766777777777777777777766655553
Q ss_pred ----------------------cccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCcccccccccc
Q 043053 500 ----------------------SLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLS 557 (1058)
Q Consensus 500 ----------------------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~ 557 (1058)
.+..+++|+.|||++|+++|.+|..++.+..++ .|+|++|+++|.+|..|+++++|+
T Consensus 605 ~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~-~L~Ls~N~l~g~ip~~l~~L~~L~ 683 (768)
T 3rgz_A 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLF-ILNLGHNDISGSIPDEVGDLRGLN 683 (768)
T ss_dssp GGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCC-EEECCSSCCCSCCCGGGGGCTTCC
T ss_pred hccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCC-EEeCcCCccCCCCChHHhCCCCCC
Confidence 455568899999999999999999999999887 599999999999999999999999
Q ss_pred EEecCCCcccCCC-CcccccCcceeEEEecccccccCCCccccccCCCccccCCcccccCCCCCCcccC
Q 043053 558 ILDLSHNKLEGNL-NPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSCFLSN 625 (1058)
Q Consensus 558 ~L~L~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~~ 625 (1058)
.|||++|+++|.+ ..+..+++|++||+++|+++|.+|...+|+.+...++.|||++||.|...|...+
T Consensus 684 ~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~~ 752 (768)
T 3rgz_A 684 ILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSN 752 (768)
T ss_dssp EEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSCC
T ss_pred EEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCCc
Confidence 9999999999865 6789999999999999999999999999999999999999999999988887543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-70 Score=682.67 Aligned_cols=568 Identities=33% Similarity=0.522 Sum_probs=526.4
Q ss_pred CCCccccCCCCCcEEEccCCcCCCCCCC--CCCCCCcccEEecCCCCCCCCCChhh-cCcccCCEEeccccCCCCccccc
Q 043053 15 PIPTNLSSFKHLQTLVISDANLTGSIPF--DIGDCVGLIVLDFSSNNLVGTLPSSL-GKLHNLEELILNSNQLTGKIPVE 91 (1058)
Q Consensus 15 ~~p~~~~~~~~L~~L~l~~~~~~~~~p~--~l~~l~~L~~L~l~~~~i~~~lp~~l-~~l~~L~~L~L~~n~~~~~~p~~ 91 (1058)
++|..++++++|++|+|++|.+.|.+|. .++.|++|++|+|++|.+++.+|..+ .++++|++|+|++|++.+..|..
T Consensus 91 ~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 170 (768)
T 3rgz_A 91 GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170 (768)
T ss_dssp ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHH
T ss_pred CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChh
Confidence 4668899999999999999999988998 89999999999999999998888877 89999999999999999878877
Q ss_pred ---cccchhhhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCC
Q 043053 92 ---LSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKL 168 (1058)
Q Consensus 92 ---l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l 168 (1058)
+.++++|++|++++|.+.+..|. +++++|++|++++|. +.+.+|. ++.+++|++|++++|.+.+..|..++++
T Consensus 171 ~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~-l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l 246 (768)
T 3rgz_A 171 WVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNN-FSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTC 246 (768)
T ss_dssp HHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSC-CCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTC
T ss_pred hhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCc-CCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcC
Confidence 88999999999999999876654 889999999999997 3344555 9999999999999999999999999999
Q ss_pred CccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCC-CCcceeecccccccCCCCccccCcCCccEEE
Q 043053 169 SKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKL-KKLEELFLWQNSLVGAIPEEIGNCTSLKMID 247 (1058)
Q Consensus 169 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 247 (1058)
++|++|++++|.+.+.+|.. .+++|++|+|++|.+++.+|..+..+ ++|++|+|++|.+.+..|..|+++++|++|+
T Consensus 247 ~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 324 (768)
T 3rgz_A 247 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLA 324 (768)
T ss_dssp SSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEE
T ss_pred CCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEE
Confidence 99999999999999887765 89999999999999998899888775 9999999999999999999999999999999
Q ss_pred eecCCCcCcCCcc-ccccCCcceeecccCccCCCccccccccc-cchhhhhcCCcccCcCCCcccc--cchhhhhhccCc
Q 043053 248 FSLNSLSGTIPLS-IGGLSELEEFMISDNNVSGSIPANLANAT-NLVQLQLDTNQISGLIPPEIGM--LSKLTVFFAWQN 323 (1058)
Q Consensus 248 L~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~--l~~L~~L~l~~N 323 (1058)
+++|.+.+.+|.. ++.+++|++|++++|.+.+..|..+..++ +|+.|++++|++++..|..+.. +++|++|++++|
T Consensus 325 L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n 404 (768)
T 3rgz_A 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404 (768)
T ss_dssp CCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSS
T ss_pred CCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCC
Confidence 9999999888865 89999999999999999988999999987 9999999999999988888877 889999999999
Q ss_pred ccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccc
Q 043053 324 QLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403 (1058)
Q Consensus 324 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 403 (1058)
++++.+|..|..+++|+.|++++|++++..|..+..+++|++|++++|.+++.+|..+..+++|++|+|++|++++..|.
T Consensus 405 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 484 (768)
T 3rgz_A 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484 (768)
T ss_dssp EEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred ccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccc------
Q 043053 404 EIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL------ 477 (1058)
Q Consensus 404 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------ 477 (1058)
.|..+++|++|+|++|++++.+|..++.+++|+.|+|++|++++.+|..++.+++|++|++++|+++|.+|..+
T Consensus 485 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~ 564 (768)
T 3rgz_A 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK 564 (768)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTC
T ss_pred HHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccch
Confidence 99999999999999999999999999999999999999999999999999999999999999999988777543
Q ss_pred ----------------------------------------------------------------cccccccccccccccC
Q 043053 478 ----------------------------------------------------------------GRLVSLNKIILSKNLF 493 (1058)
Q Consensus 478 ----------------------------------------------------------------~~l~~L~~L~Ls~N~l 493 (1058)
..+.+|+.|+|++|++
T Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l 644 (768)
T 3rgz_A 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644 (768)
T ss_dssp BCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCC
T ss_pred hhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcc
Confidence 3356789999999999
Q ss_pred CCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCCcc
Q 043053 494 SGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPL 573 (1058)
Q Consensus 494 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 573 (1058)
+|.+|..|+.+++|+.|+|++|+++|.+|..++.+..++ .|+|++|+++|.+|..|..+++|++|||++|+|+|.++..
T Consensus 645 ~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~-~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~ 723 (768)
T 3rgz_A 645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN-ILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723 (768)
T ss_dssp BSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC-EEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS
T ss_pred cccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCC-EEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc
Confidence 999999999999999999999999999999999999987 5999999999999999999999999999999999988766
Q ss_pred cccCcceeEEEecccc
Q 043053 574 AQLDNLVSLNISYNKF 589 (1058)
Q Consensus 574 ~~l~~L~~L~l~~N~l 589 (1058)
..+..+....+.+|+.
T Consensus 724 ~~~~~~~~~~~~gN~~ 739 (768)
T 3rgz_A 724 GQFETFPPAKFLNNPG 739 (768)
T ss_dssp SSGGGSCGGGGCSCTE
T ss_pred hhhccCCHHHhcCCch
Confidence 6666666666778864
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-62 Score=604.56 Aligned_cols=585 Identities=23% Similarity=0.217 Sum_probs=398.8
Q ss_pred cEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhc
Q 043053 27 QTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDN 106 (1058)
Q Consensus 27 ~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n 106 (1058)
+.+++++++++ .+|..+. .+|++|+|++|++++..+..++++++|++|+|++|++.+..|..|+++++|++|+|++|
T Consensus 7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 45667777666 5666554 56777777777776444456777777777777777776666666777777777777777
Q ss_pred cccCCCh-hhhcccccchhhhcCCCccccCCCC-ccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccc
Q 043053 107 ALAGNIP-AELGRLSNLEEMRAGGNKDIVGKIP-AELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGE 184 (1058)
Q Consensus 107 ~~~~~~p-~~l~~l~~L~~L~l~~~~~~~~~l~-~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~ 184 (1058)
.+. .+| ..++++++|++|++++|. +..++ ..++.+++|++|++++|.+.+..|..++++++|++|++++|.+++.
T Consensus 84 ~l~-~l~~~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 84 ELS-QLSDKTFAFCTNLTELHLMSNS--IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160 (680)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSC--CCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred ccC-ccChhhhccCCCCCEEECCCCc--cCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccccc
Confidence 766 444 357777777777777765 33333 4566777777777777777766666777777777777777777655
Q ss_pred cCcccc--CCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCcccc---CcCCccEEEeecCCCcCcCCc
Q 043053 185 IPAEIG--NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIG---NCTSLKMIDFSLNSLSGTIPL 259 (1058)
Q Consensus 185 ~~~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~---~l~~L~~L~L~~n~l~~~~~~ 259 (1058)
.+..+. .+++|++|++++|.+++..|..|..+++|+.|++++|.+.......+. ..++|+.|++++|.+.+..+.
T Consensus 161 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~ 240 (680)
T 1ziw_A 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240 (680)
T ss_dssp CHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT
T ss_pred CHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh
Confidence 554443 456777777777777766666777777777777776665422111111 235677777777777766666
Q ss_pred cccccCC--cceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCC-----CCC--
Q 043053 260 SIGGLSE--LEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEG-----SIP-- 330 (1058)
Q Consensus 260 ~~~~l~~--L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~-----~~~-- 330 (1058)
.|.+++. |++|++++|.+.+..+..|..+++|++|+|++|++.+..+..|..+++|+.|++.+|...+ .+|
T Consensus 241 ~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i 320 (680)
T 1ziw_A 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320 (680)
T ss_dssp TTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEE
T ss_pred HhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccccc
Confidence 6666644 7777777777776666667777777777777777777777777777777777776654432 112
Q ss_pred --hhhhccCcccccccccccccccCcccccccccchhhhccccCCCC--CCCCCccCC--CCCcEEEccCccccCCcccc
Q 043053 331 --STLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISG--SIPPEIGNC--SSLVRLRVGNNRIAGLIPRE 404 (1058)
Q Consensus 331 --~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~ 404 (1058)
..|..+++|++|++++|++.+..+..|..+++|++|++++|.+.. .....|..+ ++|+.|++++|+++++.|..
T Consensus 321 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~ 400 (680)
T 1ziw_A 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTT
T ss_pred ChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhh
Confidence 256677777777777777777666667777777777777776432 222233332 46777777777777777777
Q ss_pred ccCccccceeeccCccCCCCCC-CcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccc--cCCcccccccc
Q 043053 405 IGGLKTLNFLDLSSNRLSGSVP-DEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS--GQIPASLGRLV 481 (1058)
Q Consensus 405 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~ 481 (1058)
|..+++|++|+|++|.+++.+| ..|..+++|+.|++++|++++..+..|..+++|+.|++++|.++ +..|..|..++
T Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~ 480 (680)
T 1ziw_A 401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480 (680)
T ss_dssp TTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCT
T ss_pred hhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCC
Confidence 7777777777777777765444 56777777777777777777777777777777777777777765 45667777777
Q ss_pred cccccccccccCCCCCCCcccCCcccccccccCCcccCCCC--------hhhhhhHHHHHHHhhccCCCCCCCCcccccc
Q 043053 482 SLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP--------MELGQIEALEIALNLSCNGLTGPIPAQISAL 553 (1058)
Q Consensus 482 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--------~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l 553 (1058)
+|+.|+|++|++++..+..|..+++|++|++++|++++..+ ..+..+..++ .|++++|+++.+.+..|.++
T Consensus 481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~-~L~L~~N~l~~i~~~~~~~l 559 (680)
T 1ziw_A 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH-ILNLESNGFDEIPVEVFKDL 559 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCC-EEECCSSCCCCCCTTTTTTC
T ss_pred CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCC-EEECCCCCCCCCCHHHcccc
Confidence 77777777777777666777777777777777777764321 1245555554 37777777776666677888
Q ss_pred ccccEEecCCCcccCCCC-cccccCcceeEEEecccccccCCCcc--ccccCCCccccCCcccccCCC
Q 043053 554 NKLSILDLSHNKLEGNLN-PLAQLDNLVSLNISYNKFTGYLPDNK--LFRQLSPTDLAGNEGLCSSRK 618 (1058)
Q Consensus 554 ~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~~~~~~~~~~n~~~c~~~~ 618 (1058)
++|+.|||++|+|++.++ .+..+++|+.|++++|++++..|... .+..+...++.+|||.|+|+.
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 888888888888887664 35678888888888888887666532 467777888888888888763
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-62 Score=606.16 Aligned_cols=590 Identities=21% Similarity=0.215 Sum_probs=504.3
Q ss_pred eeEeecCCCCCCCCCccccCCCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEecccc
Q 043053 3 TEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSN 82 (1058)
Q Consensus 3 ~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n 82 (1058)
+...+..||. .+| +++++|+|++|++++..+..++++++|++|+|++|.+++..|..++++++|++|+|++|
T Consensus 12 s~~~L~~ip~--~~~------~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 12 SHLKLTQVPD--DLP------TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CSSCCSSCCS--CSC------TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CCCCcccccc--ccC------CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 3445555655 333 68999999999999656667999999999999999999888999999999999999999
Q ss_pred CCCCccccccccchhhhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCC
Q 043053 83 QLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLP 162 (1058)
Q Consensus 83 ~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~ 162 (1058)
++.+..+..|+++++|++|++++|.+.+..|..++++++|++|++++|. +.+..|..++.+++|++|++++|.+.+..+
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG-LSSTKLGTQVQLENLQELLLSNNKIQALKS 162 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSC-CSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCc-ccccCchhhcccccCCEEEccCCcccccCH
Confidence 9985444579999999999999999986556889999999999999997 345567778999999999999999987777
Q ss_pred cccc--CCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcC---CCCCcceeecccccccCCCCccc
Q 043053 163 ASLG--KLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIG---KLKKLEELFLWQNSLVGAIPEEI 237 (1058)
Q Consensus 163 ~~l~--~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~L~~n~l~~~~~~~l 237 (1058)
..++ .+++|+.|++++|.+.+..|..+..+.+|+.|++.+|.+.+.....+. ..++|+.|++++|.+.+..+..|
T Consensus 163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~ 242 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242 (680)
T ss_dssp HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence 6654 568999999999999998999999999999999999887532221111 34789999999999998888888
Q ss_pred cCcCC--ccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccC---------cCC
Q 043053 238 GNCTS--LKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISG---------LIP 306 (1058)
Q Consensus 238 ~~l~~--L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~---------~~~ 306 (1058)
..++. |++|+|++|++++..+..|+.+++|++|++++|.+.+..+..|..+++|+.|++++|...+ +..
T Consensus 243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~ 322 (680)
T 1ziw_A 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322 (680)
T ss_dssp GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence 88865 9999999999998888889999999999999999998888999999999999999875542 233
Q ss_pred CcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccc--cCccccccc--ccchhhhccccCCCCCCCCCcc
Q 043053 307 PEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTA--SVPAGLFQL--QNLTKLLLISNDISGSIPPEIG 382 (1058)
Q Consensus 307 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~ 382 (1058)
..|..+++|++|++++|++++..+..|..+++|++|++++|.+.. .....|..+ ++|+.|++++|++++..|..|.
T Consensus 323 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~ 402 (680)
T 1ziw_A 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402 (680)
T ss_dssp TTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTT
T ss_pred hhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhh
Confidence 478899999999999999999989999999999999999998542 222233333 5899999999999998899999
Q ss_pred CCCCCcEEEccCccccCCc-cccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccC--CCCccccccCCCC
Q 043053 383 NCSSLVRLRVGNNRIAGLI-PREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ--GSLPNSLSSLSGL 459 (1058)
Q Consensus 383 ~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L 459 (1058)
.+++|+.|+|++|.+++.. +..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++ +..|..|.++++|
T Consensus 403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L 482 (680)
T 1ziw_A 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482 (680)
T ss_dssp TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence 9999999999999998644 478999999999999999999888999999999999999999987 5688899999999
Q ss_pred CeeecCCCccccCCcccccccccccccccccccCCCCCC--------CcccCCcccccccccCCcccCCCChhhhhhHHH
Q 043053 460 QVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIP--------SSLGLCSSLQLLDLSSNQLTGSVPMELGQIEAL 531 (1058)
Q Consensus 460 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l 531 (1058)
++|++++|++++..+..|..+++|+.|+|++|++++..+ ..|..+++|+.|++++|+++...+..|..+..+
T Consensus 483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 562 (680)
T 1ziw_A 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence 999999999998888889999999999999999986422 347889999999999999995444568888887
Q ss_pred HHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCCc-cc-ccCcceeEEEecccccccCCC-ccccccC
Q 043053 532 EIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP-LA-QLDNLVSLNISYNKFTGYLPD-NKLFRQL 602 (1058)
Q Consensus 532 ~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~-~l~~L~~L~l~~N~l~~~~~~-~~~~~~~ 602 (1058)
+ .|++++|++++..+..|.++++|+.|+|++|+|++.++. +. .+++|+.|++++|+|.|.|+. .+...++
T Consensus 563 ~-~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~ 635 (680)
T 1ziw_A 563 K-IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWI 635 (680)
T ss_dssp C-EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECCS
T ss_pred c-eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHHH
Confidence 6 499999999998889999999999999999999998754 44 689999999999999999985 4433343
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=557.62 Aligned_cols=530 Identities=22% Similarity=0.190 Sum_probs=295.8
Q ss_pred EEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCcc-ccccccchhhhHHhhhhc
Q 043053 28 TLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKI-PVELSNCKSLRKLLLFDN 106 (1058)
Q Consensus 28 ~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~-p~~l~~l~~L~~L~L~~n 106 (1058)
..+.++++++ .+|. -.++|++|+|++|.|++..|.++.++++|++|+|++|...+.+ |..|+++++|++|+|++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 3444444444 3443 2344555555555555444445555555555555555333333 444555555555555555
Q ss_pred cccCCChhhhcccccchhhhcCCCccccCCCCcc--ccCCCCCceecccCccccccCC-ccccCCCccceeeeecccccc
Q 043053 107 ALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAE--LGDCSNMTALGLADTQVSGSLP-ASLGKLSKLQTLSIYTTMISG 183 (1058)
Q Consensus 107 ~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~--l~~l~~L~~L~l~~~~~~~~~~-~~l~~l~~L~~L~l~~n~i~~ 183 (1058)
.+.+..|..++++++|++|++++|. +.+.+|.. ++.+++|++|++++|.+.+..+ ..|+++++|++|++++|.+.+
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCG-LSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCC-CSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCC-CCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 5544344455555555555555443 12223332 5555555555555555554333 345566666666666666655
Q ss_pred ccCccccCC--CCccEEEccCCcCCCCCCCCcCCCCC------cceeecccccccCCCCccccCc---CCccEEEeecC-
Q 043053 184 EIPAEIGNC--SELVSLFLYENSLSGSIPPEIGKLKK------LEELFLWQNSLVGAIPEEIGNC---TSLKMIDFSLN- 251 (1058)
Q Consensus 184 ~~~~~l~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~------L~~L~L~~n~l~~~~~~~l~~l---~~L~~L~L~~n- 251 (1058)
..+..+..+ ++|+.|+|++|.+.+..|..++.+.+ |+.|++++|.+.+..+..+... ++++.|+++.+
T Consensus 163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~ 242 (844)
T 3j0a_A 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242 (844)
T ss_dssp CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred eCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence 555555555 55666666666665555555544443 6666666665555555444322 34555555422
Q ss_pred --------CCcCcCCcccccc--CCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhcc
Q 043053 252 --------SLSGTIPLSIGGL--SELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAW 321 (1058)
Q Consensus 252 --------~l~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~ 321 (1058)
.+.+.....|.++ ++|+.|++++|.+.+..+..|..+++|+.|+|++|+|+++.+..|..+++|++|+++
T Consensus 243 ~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls 322 (844)
T 3j0a_A 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS 322 (844)
T ss_dssp CBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEE
T ss_pred ccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECC
Confidence 2222222333332 456666666666655555555666666666666666665555556666666666666
Q ss_pred CcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCc
Q 043053 322 QNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLI 401 (1058)
Q Consensus 322 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 401 (1058)
+|++++..+..|..+++|+.|++++|++....+..|..+++|++|+|++|.+++. ..+++|+.|++++|+++.+
T Consensus 323 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~~l- 396 (844)
T 3j0a_A 323 YNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLVTL- 396 (844)
T ss_dssp SCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCCCC-
T ss_pred CCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcccc-
Confidence 6666555555666666666666666666554455555566666666666665532 2255566666666666543
Q ss_pred cccccCccccceeeccCccCCCCCC-CcccCCcccchhhccCCccCCCCcc-ccccCCCCCeeecCCCccc-----cCCc
Q 043053 402 PREIGGLKTLNFLDLSSNRLSGSVP-DEIGDCTELQMIDLSHNTLQGSLPN-SLSSLSGLQVLDVSDNRFS-----GQIP 474 (1058)
Q Consensus 402 ~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~~ 474 (1058)
|.. ..+++.|++++|++++... ..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..+
T Consensus 397 ~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~ 473 (844)
T 3j0a_A 397 PKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW 473 (844)
T ss_dssp CCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCS
T ss_pred ccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccch
Confidence 211 3456666666666654321 1233556666666666666543322 3444566666666666665 2333
Q ss_pred ccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccc
Q 043053 475 ASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALN 554 (1058)
Q Consensus 475 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~ 554 (1058)
..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++ ..+..+. +
T Consensus 474 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-------------------------l~~~~~~--~ 526 (844)
T 3j0a_A 474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-------------------------LSHNDLP--A 526 (844)
T ss_dssp SCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSS-------------------------CCCCCCC--S
T ss_pred hhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCc-------------------------cChhhhh--c
Confidence 456666666666666666666666666666666666666666664 3333333 7
Q ss_pred cccEEecCCCcccCCCCcccccCcceeEEEecccccccCCCccccc
Q 043053 555 KLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFR 600 (1058)
Q Consensus 555 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~ 600 (1058)
+|+.|||++|+|++.++.. +.+|+.|++++|+|.|.|+..+...
T Consensus 527 ~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~~~f~~ 570 (844)
T 3j0a_A 527 NLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECELSTFIN 570 (844)
T ss_dssp CCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSCCSHHH
T ss_pred cccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccccHHHHH
Confidence 8999999999999876543 4588999999999999998654333
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=546.72 Aligned_cols=541 Identities=21% Similarity=0.199 Sum_probs=386.1
Q ss_pred CcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhh
Q 043053 26 LQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFD 105 (1058)
Q Consensus 26 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~ 105 (1058)
-++++.++..++ .+|..+.. ++++|+|++|.|++..|.+++++++|++|+|++|++.+..|..|+++++|++|+|++
T Consensus 14 ~~~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~ 90 (606)
T 3t6q_A 14 NKTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTA 90 (606)
T ss_dssp TTEEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CceEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCC
Confidence 346677777766 67766644 577777777777755566777777777777777777766677777777777777777
Q ss_pred ccccCCChhhhcccccchhhhcCCCccccCCC-CccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccc
Q 043053 106 NALAGNIPAELGRLSNLEEMRAGGNKDIVGKI-PAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGE 184 (1058)
Q Consensus 106 n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l-~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~ 184 (1058)
|.+.+..|..++++++|++|++++|. +..+ +..++.+++|++|++++|++.+..+..+..+++|++|++++|.+++.
T Consensus 91 n~l~~~~~~~~~~l~~L~~L~L~~n~--i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 168 (606)
T 3t6q_A 91 NPLIFMAETALSGPKALKHLFFIQTG--ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168 (606)
T ss_dssp CCCSEECTTTTSSCTTCCEEECTTSC--CSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEE
T ss_pred CcccccChhhhcccccccEeeccccC--cccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccccc
Confidence 77775566777777777777777776 3333 45677778888888888877754444455588888888888888777
Q ss_pred cCccccCCCCcc--EEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCc-----CcC
Q 043053 185 IPAEIGNCSELV--SLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLS-----GTI 257 (1058)
Q Consensus 185 ~~~~l~~l~~L~--~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~-----~~~ 257 (1058)
.+..++.+++|+ .|++++|.+.+..|..+.. .+|+.|++++|. ..+..+..+.+++...+..+.+. ...
T Consensus 169 ~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~ 244 (606)
T 3t6q_A 169 SKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244 (606)
T ss_dssp CHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCC
T ss_pred ChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccC
Confidence 677778888887 7888888887666655544 578888888775 23344555555544444333322 122
Q ss_pred CccccccC--CcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhc
Q 043053 258 PLSIGGLS--ELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLAS 335 (1058)
Q Consensus 258 ~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 335 (1058)
+..+.++. +|+.|++++|.+.+..+..|..+++|++|++++|+++ ..|..+..+++|++|++++|++++..+..+..
T Consensus 245 ~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 323 (606)
T 3t6q_A 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323 (606)
T ss_dssp GGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGG
T ss_pred hhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhc
Confidence 23333333 6777777777777766677777777777777777777 44666777777777777777777776777777
Q ss_pred cCcccccccccccccccCcc-cccccccchhhhccccCCCCCC--CCCccCCCCCcEEEccCccccCCccccccCccccc
Q 043053 336 CSNLQALDLSHNSLTASVPA-GLFQLQNLTKLLLISNDISGSI--PPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLN 412 (1058)
Q Consensus 336 l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 412 (1058)
+++|+.|++++|.+.+.++. .+..+++|++|++++|.+++.. +..+..+++|++|++++|++.+..|..|..+++|+
T Consensus 324 l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 403 (606)
T 3t6q_A 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403 (606)
T ss_dssp CTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCS
T ss_pred cCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCC
Confidence 77777777777777654544 3667777777777777777554 66777777888888888887777777777778888
Q ss_pred eeeccCccCCCCCCC-cccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccC---Cccccccccccccccc
Q 043053 413 FLDLSSNRLSGSVPD-EIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQ---IPASLGRLVSLNKIIL 488 (1058)
Q Consensus 413 ~L~Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~L 488 (1058)
+|++++|++++..+. .+..+++|+.|++++|.+++..|..|..+++|++|++++|++++. .+..+..+++|+.|+|
T Consensus 404 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~L 483 (606)
T 3t6q_A 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483 (606)
T ss_dssp EEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEEC
T ss_pred eEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEEC
Confidence 888888877765543 377777888888888888777777777788888888888877652 2355777777888888
Q ss_pred ccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccC
Q 043053 489 SKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEG 568 (1058)
Q Consensus 489 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 568 (1058)
++|++++..|..|..+++|+.|++++|++++.+ |..|..+++| .|||++|++++
T Consensus 484 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-------------------------~~~l~~l~~L-~L~L~~N~l~~ 537 (606)
T 3t6q_A 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS-------------------------IEALSHLKGI-YLNLASNHISI 537 (606)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCGGG-------------------------GGGGTTCCSC-EEECCSSCCCC
T ss_pred CCCccCccChhhhccccCCCEEECCCCccCcCC-------------------------hhHhCccccc-EEECcCCcccc
Confidence 888887777777777788888887777777544 4455677888 89999999988
Q ss_pred CCC-cccccCcceeEEEecccccccCCCccccccC
Q 043053 569 NLN-PLAQLDNLVSLNISYNKFTGYLPDNKLFRQL 602 (1058)
Q Consensus 569 ~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~ 602 (1058)
.++ .+..+++|+.|++++|+|+|.++..+...++
T Consensus 538 ~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~w~ 572 (606)
T 3t6q_A 538 ILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWY 572 (606)
T ss_dssp CCGGGHHHHHTSSEEECTTCCEECSGGGHHHHHHH
T ss_pred cCHhhcccCCCCCEEeCCCCCccccCCcHHHHHHH
Confidence 664 4678888999999999999888765444443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=538.46 Aligned_cols=505 Identities=19% Similarity=0.224 Sum_probs=346.1
Q ss_pred eeEeecCCCCCCCCCccccCCCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEecccc
Q 043053 3 TEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSN 82 (1058)
Q Consensus 3 ~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n 82 (1058)
+...+..||. .+|. .+++|+|++|++++..|..++++++|++|+|++|++++..|.+|+++++|++|+|++|
T Consensus 20 ~~~~l~~iP~--~l~~------~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 20 ENLGLNEIPG--TLPN------STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91 (606)
T ss_dssp TTSCCSSCCT--TSCT------TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CCCCcccCcC--CCCC------cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence 3445556665 4443 6899999999999766889999999999999999999777999999999999999999
Q ss_pred CCCCccccccccchhhhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCC-CccccCCCCCceecccCccccccC
Q 043053 83 QLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKI-PAELGDCSNMTALGLADTQVSGSL 161 (1058)
Q Consensus 83 ~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l-~~~l~~l~~L~~L~l~~~~~~~~~ 161 (1058)
++.+..|..|+++++|++|++++|.+.+..|..++++++|++|++++|. +..+ +..+..+++|++|++++|.+.+..
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 169 (606)
T 3t6q_A 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH--ISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169 (606)
T ss_dssp CCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSC--CCCCCCCTTCCCTTCCEEECCSSCCCEEC
T ss_pred cccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCc--ccccCcccccCCcccCEEEcccCcccccC
Confidence 9998889999999999999999999995557889999999999999998 4443 233444999999999999999888
Q ss_pred CccccCCCccc--eeeeeccccccccCccccCCCCccEEEccCCcCC--------------------------CCCCCCc
Q 043053 162 PASLGKLSKLQ--TLSIYTTMISGEIPAEIGNCSELVSLFLYENSLS--------------------------GSIPPEI 213 (1058)
Q Consensus 162 ~~~l~~l~~L~--~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~--------------------------~~~~~~~ 213 (1058)
+..++.+++|+ .|++++|.+.+..|..+.. .+|+.|++++|... ...+..+
T Consensus 170 ~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~ 248 (606)
T 3t6q_A 170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248 (606)
T ss_dssp HHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGG
T ss_pred hhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHh
Confidence 89999999999 8899999999777766554 68999999988511 0011112
Q ss_pred CCCC--CcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccc
Q 043053 214 GKLK--KLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNL 291 (1058)
Q Consensus 214 ~~l~--~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 291 (1058)
..+. +|+.|++++|.+.+..+..|..+++|++|++++|+++ .+|..++++++|++|++++|.+.+..+..+..+++|
T Consensus 249 ~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 327 (606)
T 3t6q_A 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327 (606)
T ss_dssp GGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTC
T ss_pred chhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcC
Confidence 2222 4566666666666555555666666666666666665 445555666666666666666665555566666666
Q ss_pred hhhhhcCCcccCcCC-CcccccchhhhhhccCcccCCCC--ChhhhccCcccccccccccccccCcccccccccchhhhc
Q 043053 292 VQLQLDTNQISGLIP-PEIGMLSKLTVFFAWQNQLEGSI--PSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLL 368 (1058)
Q Consensus 292 ~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 368 (1058)
++|++++|.+.+..+ ..|..+++|++|++++|++++.. +..+..+++|++|++++|++.+..|..+..+++|++|++
T Consensus 328 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 407 (606)
T 3t6q_A 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407 (606)
T ss_dssp SEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred CEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence 666666666553333 33556666666666666665544 455566666666666666666555555556666666666
Q ss_pred cccCCCCCCCC-CccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCC---CCCCcccCCcccchhhccCCc
Q 043053 369 ISNDISGSIPP-EIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG---SVPDEIGDCTELQMIDLSHNT 444 (1058)
Q Consensus 369 ~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L~l~~N~ 444 (1058)
++|.+.+..+. .|..+++|++|++++|.+++..|..|..+++|++|+|++|++++ ..+..+..+++|+.|++++|+
T Consensus 408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~ 487 (606)
T 3t6q_A 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487 (606)
T ss_dssp TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence 66666554433 25566666666666666665555566666666666666666554 122445556666666666666
Q ss_pred cCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCC
Q 043053 445 LQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGS 520 (1058)
Q Consensus 445 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 520 (1058)
+++..|..|.++++|++|+|++|++++..|..+..++.| .|+|++|++++..|..+..+++|+.|++++|++.+.
T Consensus 488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred cCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 665555666666666666666666665556666666666 666666666655555556666666666666666543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=541.12 Aligned_cols=539 Identities=22% Similarity=0.224 Sum_probs=348.8
Q ss_pred CcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhh
Q 043053 26 LQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFD 105 (1058)
Q Consensus 26 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~ 105 (1058)
-++++.++++++ .+|..+. .+|++|+|++|++++..|..+.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~ 89 (606)
T 3vq2_A 13 NITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTG 89 (606)
T ss_dssp TTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCC
Confidence 467888888887 7887665 6888999999988866666888889999999999888866677888888888888888
Q ss_pred ccccCCChhhhcccccchhhhcCCCccccCCCC-ccccCCCCCceecccCccccc-cCCccccCCCccceeeeecccccc
Q 043053 106 NALAGNIPAELGRLSNLEEMRAGGNKDIVGKIP-AELGDCSNMTALGLADTQVSG-SLPASLGKLSKLQTLSIYTTMISG 183 (1058)
Q Consensus 106 n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~-~~l~~l~~L~~L~l~~~~~~~-~~~~~l~~l~~L~~L~l~~n~i~~ 183 (1058)
|.+.+..|..++++++|++|++++|. +..++ ..++.+++|++|++++|.+.+ .+|..|+++++|++|++++|.+++
T Consensus 90 n~l~~~~p~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~ 167 (606)
T 3vq2_A 90 NPIQSFSPGSFSGLTSLENLVAVETK--LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167 (606)
T ss_dssp CCCCCCCTTSSTTCTTCCEEECTTSC--CCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred CcccccChhhcCCcccCCEEEccCCc--cccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence 88886667788888888888888776 33443 567777788888888777764 457777778888888888777777
Q ss_pred ccCccccCCCCcc----EEEccCCcCCCCCCCCcCCCCCcceeeccccccc-CCCCccccCcCCccEEEeecCCCcCcC-
Q 043053 184 EIPAEIGNCSELV----SLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLV-GAIPEEIGNCTSLKMIDFSLNSLSGTI- 257 (1058)
Q Consensus 184 ~~~~~l~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~~- 257 (1058)
..+..++.+++|+ +|++++|.+++..+..+... +|+.|++++|.+. +..+..+.++++|+.+++..+.+.+..
T Consensus 168 ~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~ 246 (606)
T 3vq2_A 168 ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN 246 (606)
T ss_dssp ECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCC
T ss_pred cChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCc
Confidence 6666666665554 67888887775444444443 7778888777765 344556777777777777655443211
Q ss_pred -----CccccccC--Ccceeec-ccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCC
Q 043053 258 -----PLSIGGLS--ELEEFMI-SDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSI 329 (1058)
Q Consensus 258 -----~~~~~~l~--~L~~L~l-~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 329 (1058)
+..+.++. .++.+++ ..|.+.+..+. +..+++|+.|++++|.+..+ | .+..+++|++|++++|++ +.+
T Consensus 247 l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l-~-~l~~~~~L~~L~l~~n~l-~~l 322 (606)
T 3vq2_A 247 LEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYL-E-DVPKHFKWQSLSIIRCQL-KQF 322 (606)
T ss_dssp CSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCC-C-CCCTTCCCSEEEEESCCC-SSC
T ss_pred ccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhh-h-hccccccCCEEEcccccC-ccc
Confidence 11111111 2344444 44455544444 55566666666666665443 2 455555555555555555 233
Q ss_pred ChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCC--CCCCccCCCCCcEEEccCccccCCccccccC
Q 043053 330 PSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGS--IPPEIGNCSSLVRLRVGNNRIAGLIPREIGG 407 (1058)
Q Consensus 330 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 407 (1058)
| .+ .+++|+.|++++|+..+.. .+..+++|++|++++|.+++. .+..+..+++|++|++++|.++++ |..|..
T Consensus 323 p-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~ 397 (606)
T 3vq2_A 323 P-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMG 397 (606)
T ss_dssp C-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEE-CCCCTT
T ss_pred c-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccc-hhhccC
Confidence 4 23 5555555555555433222 344555555555555555533 244555555555555555555543 345555
Q ss_pred ccccceeeccCccCCCCCC-CcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCcccc-CCcccccccccccc
Q 043053 408 LKTLNFLDLSSNRLSGSVP-DEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSG-QIPASLGRLVSLNK 485 (1058)
Q Consensus 408 l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~ 485 (1058)
+++|++|++++|++.+..| ..+..+++|+.|++++|.+++..|..|.++++|++|++++|++++ .+|..|..+++|+.
T Consensus 398 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 477 (606)
T 3vq2_A 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477 (606)
T ss_dssp CTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCE
Confidence 5555555555555554444 445555555555555555555555555555555555555555554 24555555555555
Q ss_pred cccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCc
Q 043053 486 IILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNK 565 (1058)
Q Consensus 486 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 565 (1058)
|+|++|++++..|..|..+++|+.|++++|+++ +..|..|.++++|+.|||++|+
T Consensus 478 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~l~~N~ 532 (606)
T 3vq2_A 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL-------------------------FLDSSHYNQLYSLSTLDCSFNR 532 (606)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-------------------------CEEGGGTTTCTTCCEEECTTSC
T ss_pred EECCCCcCCccChhhhcccccCCEEECCCCcCC-------------------------CcCHHHccCCCcCCEEECCCCc
Confidence 555555555555555555555555555555554 4556667889999999999999
Q ss_pred ccCCCCcccccC-cceeEEEecccccccCCCccccccCCC
Q 043053 566 LEGNLNPLAQLD-NLVSLNISYNKFTGYLPDNKLFRQLSP 604 (1058)
Q Consensus 566 l~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~~~~~~ 604 (1058)
|++.+..+..++ +|+.|++++|+|.|.++..+.++++..
T Consensus 533 l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~l~~ 572 (606)
T 3vq2_A 533 IETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKE 572 (606)
T ss_dssp CCCEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTTTTT
T ss_pred CcccCHhHhhhcccCcEEEccCCCcccCCccHHHHHHHHc
Confidence 998777788887 599999999999999998766666543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=544.35 Aligned_cols=526 Identities=23% Similarity=0.234 Sum_probs=383.9
Q ss_pred cEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhccccCCC-hhhhcccccchhhhcCC
Q 043053 51 IVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNI-PAELGRLSNLEEMRAGG 129 (1058)
Q Consensus 51 ~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~-p~~l~~l~~L~~L~l~~ 129 (1058)
+..+.++++++ .+|. -.++|++|||++|++.+..|..|.++++|++|+|++|...+.+ |..+++|++|++|++++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 57889999999 8897 4689999999999999778899999999999999999666566 67889999999999998
Q ss_pred CccccCCCCccccCCCCCceecccCccccccCCcc--ccCCCccceeeeeccccccccC-ccccCCCCccEEEccCCcCC
Q 043053 130 NKDIVGKIPAELGDCSNMTALGLADTQVSGSLPAS--LGKLSKLQTLSIYTTMISGEIP-AEIGNCSELVSLFLYENSLS 206 (1058)
Q Consensus 130 ~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~--l~~l~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L~L~~n~l~ 206 (1058)
|. +....|..++.+++|++|++++|.+.+..|.. |+++++|++|++++|.+.+..+ ..++++++|++|+|++|.++
T Consensus 83 N~-l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~ 161 (844)
T 3j0a_A 83 SK-IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161 (844)
T ss_dssp CC-CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred Cc-CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence 87 33445778888999999999999888766655 8888899999999888876654 57888889999999998888
Q ss_pred CCCCCCcCCC--CCcceeecccccccCCCCccccCcCC------ccEEEeecCCCcCcCCcccccc---CCcceeecccC
Q 043053 207 GSIPPEIGKL--KKLEELFLWQNSLVGAIPEEIGNCTS------LKMIDFSLNSLSGTIPLSIGGL---SELEEFMISDN 275 (1058)
Q Consensus 207 ~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~l~~l~~------L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~l~~n 275 (1058)
+..+..+..+ ++|+.|++++|.+.+..+..++.+++ |+.|++++|.+.+..+..+... .+++.|.++.+
T Consensus 162 ~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~ 241 (844)
T 3j0a_A 162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241 (844)
T ss_dssp CCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSS
T ss_pred eeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccc
Confidence 7778888777 78889999988888877777766665 8888888888887777666543 56777777633
Q ss_pred ---------ccCCCcccccccc--ccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCccccccc
Q 043053 276 ---------NVSGSIPANLANA--TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDL 344 (1058)
Q Consensus 276 ---------~l~~~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 344 (1058)
.+.......|..+ ++|+.|+|++|.+.+..+..|..+++|+.|++++|++++..+..|.++++|++|+|
T Consensus 242 ~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 321 (844)
T 3j0a_A 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321 (844)
T ss_dssp CCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEE
T ss_pred cccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEEC
Confidence 2333333344443 56677777777776666666666667777777777666666666666666777777
Q ss_pred ccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCC
Q 043053 345 SHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGS 424 (1058)
Q Consensus 345 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 424 (1058)
++|++++..|..|..+++|++|++++|.+.+..+..|.++++|+.|+|++|.++++. .+++|+.|++++|+++ .
T Consensus 322 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~-~ 395 (844)
T 3j0a_A 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH-----FIPSIPDIFLSGNKLV-T 395 (844)
T ss_dssp ESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS-----SCCSCSEEEEESCCCC-C
T ss_pred CCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc-----CCCCcchhccCCCCcc-c
Confidence 776666655666666666666666666666666666666666666666666666432 2566666666666666 3
Q ss_pred CCCcccCCcccchhhccCCccCCCCc-cccccCCCCCeeecCCCccccCCcc-cccccccccccccccccCC-----CCC
Q 043053 425 VPDEIGDCTELQMIDLSHNTLQGSLP-NSLSSLSGLQVLDVSDNRFSGQIPA-SLGRLVSLNKIILSKNLFS-----GPI 497 (1058)
Q Consensus 425 ~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~ 497 (1058)
+|.. ..+++.|++++|++++... ..+.++++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..
T Consensus 396 l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~ 472 (844)
T 3j0a_A 396 LPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC 472 (844)
T ss_dssp CCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCC
T ss_pred cccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccc
Confidence 3332 3456666666666665321 2244666666666666666643332 3444566666666666665 333
Q ss_pred CCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCCcccccC
Q 043053 498 PSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLD 577 (1058)
Q Consensus 498 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~ 577 (1058)
+..|..+++|+.|+|++|+|+ +..+..|.++++|+.|||++|+|++.++.... +
T Consensus 473 ~~~~~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~ 526 (844)
T 3j0a_A 473 WDVFEGLSHLQVLYLNHNYLN-------------------------SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-A 526 (844)
T ss_dssp SSCSSCBCCEECCCCCHHHHT-------------------------TCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-S
T ss_pred hhhhcCcccccEEECCCCccc-------------------------ccChhHccchhhhheeECCCCCCCccChhhhh-c
Confidence 445666666666666666665 45556678899999999999999987754443 8
Q ss_pred cceeEEEecccccccCCCccccccCCCccccCCcccccCCC
Q 043053 578 NLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRK 618 (1058)
Q Consensus 578 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~ 618 (1058)
+|+.|++++|++++.+|.. |..+...++.+|||.|+|+.
T Consensus 527 ~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 527 NLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp CCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSC
T ss_pred cccEEECCCCcCCCCChhH--hCCcCEEEecCCCccccccc
Confidence 9999999999999998864 67888899999999998864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=526.38 Aligned_cols=499 Identities=20% Similarity=0.192 Sum_probs=318.9
Q ss_pred eeeEeecCCCCCCCCCccccCCCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccc
Q 043053 2 VTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNS 81 (1058)
Q Consensus 2 ~~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~ 81 (1058)
|++..+..||. .+| +++++|+|++|++++..+..++++++|++|+|++|++++..|.+++++++|++|+|++
T Consensus 18 c~~~~l~~ip~--~~~------~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~ 89 (606)
T 3vq2_A 18 CMDQKLSKVPD--DIP------SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTG 89 (606)
T ss_dssp CTTSCCSSCCT--TSC------TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccCCCcccCCC--CCC------CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCC
Confidence 33444555665 333 6899999999999976677899999999999999999977788999999999999999
Q ss_pred cCCCCccccccccchhhhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccC
Q 043053 82 NQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSL 161 (1058)
Q Consensus 82 n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~ 161 (1058)
|++.+..|..|+++++|++|++++|.+.+..|..++++++|++|++++|......+|..++++++|++|++++|++.+..
T Consensus 90 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~ 169 (606)
T 3vq2_A 90 NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169 (606)
T ss_dssp CCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred CcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence 99997779999999999999999999985555889999999999999998322368999999999999999999999888
Q ss_pred CccccCCCccc----eeeeeccccccccCccccCCCCccEEEccCCcCC-CCCCCCcCCCCCcceeecccc---------
Q 043053 162 PASLGKLSKLQ----TLSIYTTMISGEIPAEIGNCSELVSLFLYENSLS-GSIPPEIGKLKKLEELFLWQN--------- 227 (1058)
Q Consensus 162 ~~~l~~l~~L~----~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n--------- 227 (1058)
+..++.+++|+ .|++++|.+++..+..+... +|+.|++++|.+. +..|..+.+++.|+.+++..+
T Consensus 170 ~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~ 248 (606)
T 3vq2_A 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248 (606)
T ss_dssp TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred hhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccc
Confidence 88888887776 79999999986555555544 8999999999886 345666777777777776433
Q ss_pred ------------------------cccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccc
Q 043053 228 ------------------------SLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPA 283 (1058)
Q Consensus 228 ------------------------~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 283 (1058)
.+.+..|. +..+++|+.|++++|.+.. +| .+..+++|++|++++|.+. .+|
T Consensus 249 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l~-~lp- 323 (606)
T 3vq2_A 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQLK-QFP- 323 (606)
T ss_dssp CCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCCS-SCC-
T ss_pred ccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccCc-ccc-
Confidence 33333333 4444555555555555542 22 4444555555555555552 333
Q ss_pred cccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCC--CChhhhccCcccccccccccccccCcccccccc
Q 043053 284 NLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGS--IPSTLASCSNLQALDLSHNSLTASVPAGLFQLQ 361 (1058)
Q Consensus 284 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 361 (1058)
.+ .+++|++|++++|+..+. ..+..+++|++|++++|++++. .+..+..+++|++|++++|.+.+ +|..+..++
T Consensus 324 ~~-~l~~L~~L~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~ 399 (606)
T 3vq2_A 324 TL-DLPFLKSLTLTMNKGSIS--FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLE 399 (606)
T ss_dssp CC-CCSSCCEEEEESCSSCEE--CCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCT
T ss_pred cC-CCCccceeeccCCcCccc--hhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCC
Confidence 22 455555555555533221 1344455555555555555443 24445555555555555555542 334444455
Q ss_pred cchhhhccccCCCCCCC-CCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCC-CCCCcccCCcccchhh
Q 043053 362 NLTKLLLISNDISGSIP-PEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG-SVPDEIGDCTELQMID 439 (1058)
Q Consensus 362 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~ 439 (1058)
+|++|++++|.+.+..+ ..|.++++|++|++++|++++..|..|.++++|++|++++|++++ ..|..|..+++|+.|+
T Consensus 400 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 479 (606)
T 3vq2_A 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479 (606)
T ss_dssp TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEE
Confidence 55555555555554444 344555555555555555554445555555555555555555544 2444455555555555
Q ss_pred ccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCc-ccccccccCCccc
Q 043053 440 LSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCS-SLQLLDLSSNQLT 518 (1058)
Q Consensus 440 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~ 518 (1058)
+++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|+|+ .+|..+..++ +|+.|++++|++.
T Consensus 480 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~ 558 (606)
T 3vq2_A 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVA 558 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCC
T ss_pred CCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcc
Confidence 5555555444445555555555555555555444555555555555555555554 3333344443 3555555555554
Q ss_pred C
Q 043053 519 G 519 (1058)
Q Consensus 519 ~ 519 (1058)
+
T Consensus 559 c 559 (606)
T 3vq2_A 559 C 559 (606)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=452.81 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=211.4
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
..+.+.+.||+|+||+||+|.+ .+++.||||++... ......++|.+|+.++++++|||||+++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~----------~~~~~~~~f~~E~~il~~l~HpNIV~l~ 95 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK----------AEGPLREEFRHEAMLRARLQHPNVVCLL 95 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-----------CCC-CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc----------cChHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 4567788999999999999965 35688999998533 2234468899999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIK 843 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik 843 (1058)
|++.+++..++|||||++|+|.++++.+. ...++|..+.+|+.|||+||+|||+. +|||||||
T Consensus 96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK 172 (308)
T 4gt4_A 96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLA 172 (308)
T ss_dssp EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCcc
Confidence 99999999999999999999999996532 24689999999999999999999999 99999999
Q ss_pred CCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 043053 844 ANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 922 (1058)
Q Consensus 844 p~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 922 (1058)
|+|||+++++.+||+|||+|+.....+........+||++|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 173 ~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp GGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred ccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987765544445566789999999999999999999999999999999998 899997542
Q ss_pred CCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
...+...+..... +. .++.+..+ +.+++.+||+.||++||||+||++.|+.+
T Consensus 253 --~~~~~~~i~~~~~-----~~---~p~~~~~~---~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 253 --NQDVVEMIRNRQV-----LP---CPDDCPAW---VYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HHHHHHHHHTTCC-----CC---CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHHHHHHHHcCCC-----CC---CcccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2334443333211 11 12222222 34478889999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=445.83 Aligned_cols=263 Identities=28% Similarity=0.395 Sum_probs=203.1
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+++.+.+.||+|+||+||+|.+. ..||||++... .......++|.+|++++++++|||||+++|++.+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~---------~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 103 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVV---------DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK- 103 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCS---------SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEec---------CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence 45678899999999999999765 36999998532 1234456889999999999999999999998864
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..|+|||||+||+|.++++.. ...++|..+.+|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred CeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCc
Confidence 5689999999999999999764 46799999999999999999999998 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
+..............+||+.|||||++.+ ..|+.++|||||||++|||+||+.||....+ ...+...+... .
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-~~~~~~~~~~~----~ 254 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-RDQIIFMVGRG----Y 254 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHTT----C
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcC----C
Confidence 87655443344556789999999999864 4589999999999999999999999975432 11222222221 1
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
..|.....+.....+ +.+++.+||+.||++||||+||++.|+.++..
T Consensus 255 ~~p~~~~~~~~~~~~---l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 255 ASPDLSKLYKNCPKA---MKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCCSTTSCTTSCHH---HHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCCCcccccccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 122222222222222 33478889999999999999999999887653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=450.03 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=212.9
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|.+.+.||+|+||+||+|.+. ++..||||++... .....++|.+|++++++++|||||+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----------~~~~~~~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----------SDNARKDFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----------ChHHHHHHHHHHHHHHhCCCCCCccEE
Confidence 46888999999999999999653 4788999998522 334568899999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhc-----------CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCc
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHER-----------TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANN 846 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~N 846 (1058)
|++.+++..|+|||||++|+|.++++.. ....++|..+.+|+.|||+||+|||++ +||||||||+|
T Consensus 82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~N 158 (299)
T 4asz_A 82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRN 158 (299)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhh
Confidence 9999999999999999999999999753 235799999999999999999999999 99999999999
Q ss_pred EEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 043053 847 ILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDG 925 (1058)
Q Consensus 847 ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~ 925 (1058)
||+++++.+||+|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||.... .
T Consensus 159 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--~ 236 (299)
T 4asz_A 159 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--N 236 (299)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--H
T ss_pred EEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--H
Confidence 9999999999999999987665544444455679999999999999999999999999999999999 899997542 2
Q ss_pred hhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
..+...+..... +..+...+ .+ +.+++.+||+.||++|||+++|.+.|+++...
T Consensus 237 ~~~~~~i~~~~~-----~~~p~~~~---~~---~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 237 NEVIECITQGRV-----LQRPRTCP---QE---VYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHHHHTCC-----CCCCTTCC---HH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCC-----CCCCccch---HH---HHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 333333333221 11112222 22 34578889999999999999999999887654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=452.15 Aligned_cols=261 Identities=28% Similarity=0.457 Sum_probs=205.9
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|...++||+|+||+||+|.+. +++.||||++.. ......++|.+|++++++++|||||+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-----------~~~~~~~~f~~E~~il~~l~HpnIV~l~ 109 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----------ASESARQDFQREAELLTMLQHQHIVRFF 109 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-----------CSHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-----------CCHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 46778899999999999999653 578999999852 2334568899999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC-------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT-------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKA 844 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp 844 (1058)
|++.+++..|+|||||++|+|.++++... ..+++|.++++|+.|||+||+|||+. +||||||||
T Consensus 110 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp 186 (329)
T 4aoj_A 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLAT 186 (329)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred EEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccH
Confidence 99999999999999999999999997532 34699999999999999999999998 999999999
Q ss_pred CcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043053 845 NNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 923 (1058)
Q Consensus 845 ~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~ 923 (1058)
+|||+++++.+||+|||+|+.....+........+||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 187 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~- 265 (329)
T 4aoj_A 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS- 265 (329)
T ss_dssp GGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-
T ss_pred hhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC-
Confidence 999999999999999999997765554445556789999999999999999999999999999999999 899997542
Q ss_pred CChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 924 DGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.......+.... .+..+...+. + +.+++.+||+.||++|||++||+++|+.+.+..
T Consensus 266 -~~~~~~~i~~g~-----~~~~p~~~~~---~---~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 266 -NTEAIDCITQGR-----ELERPRACPP---E---VYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp -HHHHHHHHHHTC-----CCCCCTTCCH---H---HHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred -HHHHHHHHHcCC-----CCCCcccccH---H---HHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 233333333322 1112222222 2 344788899999999999999999999886543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=455.67 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=204.5
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++.... ......+.+.+|++++++++|||||++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR---------MSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT---------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH---------CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 68999999999999999999 56789999999985432 223346789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+|||||+||+|.++++.+....+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence 99999999999999999999876667789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+...... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+.... .
T Consensus 172 a~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~-----~ 242 (350)
T 4b9d_A 172 ARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--MKNLVLKIISGS-----F 242 (350)
T ss_dssp ESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTC-----C
T ss_pred ceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCC-----C
Confidence 98764321 22345689999999999999999999999999999999999999997542 222222222211 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+......+.+ +.+++.+||++||++|||++|++++-
T Consensus 243 ~~~~~~~s~~------~~~li~~~L~~dP~~R~s~~e~l~hp 278 (350)
T 4b9d_A 243 PPVSLHYSYD------LRSLVSQLFKRNPRDRPSVNSILEKG 278 (350)
T ss_dssp CCCCTTSCHH------HHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred CCCCccCCHH------HHHHHHHHccCChhHCcCHHHHhcCH
Confidence 1122222222 34477889999999999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=437.13 Aligned_cols=253 Identities=18% Similarity=0.267 Sum_probs=210.7
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++.+.... .....+.+.+|++++++++|||||++++++.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~--------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII--------KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--------HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC--------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 57999999999999999999 5678999999999654321 22346789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+|||||+||+|.++++.. +.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 104 ~~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 104 DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 99999999999999999999864 6799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+..............+||+.|||||++.+..|+.++||||+||++|||++|+.||... +.......+... .
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~------~ 250 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--NEGLIFAKIIKL------E 250 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHT------C
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcC------C
Confidence 99876544444556778999999999999999999999999999999999999999753 222222222221 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..+....+. ++.+++.+||++||++|||++|+..+
T Consensus 251 ~~~p~~~s~------~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 251 YDFPEKFFP------KARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp CCCCTTCCH------HHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred CCCCcccCH------HHHHHHHHHccCCHhHCcChHHHcCC
Confidence 112222222 23457888999999999999987543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=441.57 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=205.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|+..+.||+|+||+||+| +..+|+.||||++... .....+.+.+|++++++++|||||++++++.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-----------~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~ 142 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-----------KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 142 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG-----------GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecC-----------chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 46888999999999999999 5568999999998533 12234668899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+|||||+||+|.++++. ..+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+
T Consensus 143 ~~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 216 (346)
T 4fih_A 143 GDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGF 216 (346)
T ss_dssp TTEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcC
Confidence 9999999999999999999975 4689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+...... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+..... ..
T Consensus 217 a~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~---~~ 289 (346)
T 4fih_A 217 CAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLP---PR 289 (346)
T ss_dssp CEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSC---CC
T ss_pred ceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCC---CC
Confidence 99775433 23456789999999999999999999999999999999999999997542 2222222222111 01
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.......+. .+.+++.+||++||++|||++|++++
T Consensus 290 ~~~~~~~s~------~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 290 LKNLHKVSP------SLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CSCGGGSCH------HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCH------HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111122 23457888999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=439.37 Aligned_cols=256 Identities=21% Similarity=0.268 Sum_probs=204.7
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.+.|...++||+|+||+||+| +..+|+.||||++.... ...+|+.++++++|||||++++++.
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----------------~~~~E~~il~~l~HpnIV~l~~~~~ 120 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----------------FRVEELVACAGLSSPRIVPLYGAVR 120 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----------------CCTHHHHTTTTCCCTTBCCEEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----------------hHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 357888999999999999999 55689999999985321 1247999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-Ceeeecc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-EPYIADF 860 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~Df 860 (1058)
+++..|+|||||+||+|.++++.. +.+++..+..++.||+.||+|||++ +||||||||+|||++.+| .+||+||
T Consensus 121 ~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DF 195 (336)
T 4g3f_A 121 EGPWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDF 195 (336)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCC
T ss_pred ECCEEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeC
Confidence 999999999999999999999864 5799999999999999999999999 999999999999999998 6999999
Q ss_pred ccceeccCCCccc---ccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 861 GLAKLVDDGDFAR---SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 861 Gl~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|+|+......... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||........ . ..+.....
T Consensus 196 Gla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~-~~i~~~~~ 273 (336)
T 4g3f_A 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-C-LKIASEPP 273 (336)
T ss_dssp TTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-H-HHHHHSCC
T ss_pred CCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-H-HHHHcCCC
Confidence 9999876533211 23456899999999999999999999999999999999999999976543321 1 11222110
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.........+.. +.+++.+||++||++|||++|+++++.....+
T Consensus 274 ---~~~~~~~~~s~~------~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 274 ---PIREIPPSCAPL------TAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp ---GGGGSCTTSCHH------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CchhcCccCCHH------HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 001122222222 23467789999999999999999988776543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=484.92 Aligned_cols=534 Identities=20% Similarity=0.236 Sum_probs=320.4
Q ss_pred CcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhh
Q 043053 26 LQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFD 105 (1058)
Q Consensus 26 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~ 105 (1058)
.++.+.++.+++ .+|..+. .++++|+|++|++++..+.++.++++|++|+|++|++.+..|..|+++++|++|+|++
T Consensus 9 ~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 85 (570)
T 2z63_A 9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (570)
T ss_dssp TTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcC
Confidence 355666776666 5776553 4677788888877755566777788888888888877755566677777777777777
Q ss_pred ccccCCChhhhcccccchhhhcCCCccccCCCCc-cccCCCCCceecccCccccc-cCCccccCCCccceeeeecccccc
Q 043053 106 NALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPA-ELGDCSNMTALGLADTQVSG-SLPASLGKLSKLQTLSIYTTMISG 183 (1058)
Q Consensus 106 n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~-~l~~l~~L~~L~l~~~~~~~-~~~~~l~~l~~L~~L~l~~n~i~~ 183 (1058)
|.+.+..|..++++++|++|++++|. +..++. .++.+++|++|++++|.+.+ .+|..|+++++|++|++++|.+.+
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~n~--l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~ 163 (570)
T 2z63_A 86 NPIQSLALGAFSGLSSLQKLVAVETN--LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163 (570)
T ss_dssp CCCCEECTTTTTTCTTCCEEECTTSC--CCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCE
T ss_pred CcCCccCHhhhcCccccccccccccc--cccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccce
Confidence 77764444566666666666666665 333333 46667777777777776664 356666667777777776666665
Q ss_pred ccCccccCCCCc----cEEEccCCcCCCCCCCCcCCCCCcceeecccccccC-CCCccccCcCCccEEEeecCCCcCcCC
Q 043053 184 EIPAEIGNCSEL----VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVG-AIPEEIGNCTSLKMIDFSLNSLSGTIP 258 (1058)
Q Consensus 184 ~~~~~l~~l~~L----~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~ 258 (1058)
..+..++.+++| +.|++++|.+++..+..|..+ +|+.|++++|.... ..+..+..+++++.+++....+..
T Consensus 164 ~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~--- 239 (570)
T 2z63_A 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN--- 239 (570)
T ss_dssp ECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCC---
T ss_pred ecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccC---
Confidence 555666666666 666666666665555555544 56666666653321 122334455555554443322211
Q ss_pred ccccccCCcceeecccCccCCCccccccccc--cchhhhhcCC-cccCcCCCcccccchhhhhhccCcccCCCCChhhhc
Q 043053 259 LSIGGLSELEEFMISDNNVSGSIPANLANAT--NLVQLQLDTN-QISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLAS 335 (1058)
Q Consensus 259 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 335 (1058)
..+++. .....+..+. .++.+++++| .+.+..+..|..+++|+.|++++|.++ .+|..+..
T Consensus 240 -----~~~l~~----------~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~ 303 (570)
T 2z63_A 240 -----EGNLEK----------FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYN 303 (570)
T ss_dssp -----CSSCEE----------CCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSC
T ss_pred -----chhhhh----------cchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhcc
Confidence 000110 1111111111 2344444444 444445555555555555555555555 24444555
Q ss_pred cCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCc--cccccCccccce
Q 043053 336 CSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLI--PREIGGLKTLNF 413 (1058)
Q Consensus 336 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~ 413 (1058)
+ +|+.|++++|.+. .+|. ..+++|++|++++|.+.+..+. ..+++|++|++++|++++.. +..+..+++|++
T Consensus 304 ~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~ 377 (570)
T 2z63_A 304 F-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377 (570)
T ss_dssp C-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCE
T ss_pred C-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCE
Confidence 5 6666666666655 3333 3455566666666655544333 45566666666666665443 445556666666
Q ss_pred eeccCccCCCCCCCcccCCcccchhhccCCccCCCCc-cccccCCCCCeeecCCCccccCCccccccccccccccccccc
Q 043053 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLP-NSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNL 492 (1058)
Q Consensus 414 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 492 (1058)
|++++|.+.+..+. +..+++|+.|++++|.+++..+ ..|.++++|++|++++|.+++..|..|..+++|+.|+|++|+
T Consensus 378 L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 456 (570)
T 2z63_A 378 LDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456 (570)
T ss_dssp EECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCE
T ss_pred EECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCc
Confidence 66666666543333 5566666666666666655433 345666666666666666665555666666666666666666
Q ss_pred CC-CCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCC
Q 043053 493 FS-GPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLN 571 (1058)
Q Consensus 493 l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 571 (1058)
+. +.+|..+..+++|+.|++++|+++ +..|.+|..+++|+.|+|++|++++.++
T Consensus 457 l~~~~~p~~~~~l~~L~~L~l~~n~l~-------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 511 (570)
T 2z63_A 457 FQENFLPDIFTELRNLTFLDLSQCQLE-------------------------QLSPTAFNSLSSLQVLNMASNQLKSVPD 511 (570)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCC-------------------------EECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CccccchhhhhcccCCCEEECCCCccc-------------------------cCChhhhhcccCCCEEeCCCCcCCCCCH
Confidence 65 345566666666666666666555 3445566788999999999999998764
Q ss_pred -cccccCcceeEEEecccccccCCCcccc-ccCC--CccccCCcccccCC
Q 043053 572 -PLAQLDNLVSLNISYNKFTGYLPDNKLF-RQLS--PTDLAGNEGLCSSR 617 (1058)
Q Consensus 572 -~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~~~~--~~~~~~n~~~c~~~ 617 (1058)
.+..+++|+.|++++|+|+|.+|....+ .|+. ...+.+.+ .|..+
T Consensus 512 ~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~ 560 (570)
T 2z63_A 512 GIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGS 560 (570)
T ss_dssp TTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTT
T ss_pred HHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCC
Confidence 5788999999999999999999986544 3332 23344554 66554
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=428.50 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=196.9
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc--
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN-- 782 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 782 (1058)
|.+.++||+|+||+||+| +..+++.||||++.... ......+.|.+|++++++++|||||++++++.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 356778999999999999 56679999999985432 223346789999999999999999999999865
Q ss_pred --CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC-CCCeeeec
Q 043053 783 --RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-EFEPYIAD 859 (1058)
Q Consensus 783 --~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~D 859 (1058)
+...|+|||||+||+|.+++++. ..+++..+..|+.||++||+|||+++. +||||||||+|||++. ++.+||+|
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~D 175 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECC
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEe
Confidence 34579999999999999999864 679999999999999999999999811 3999999999999984 78999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
||+|+.... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ...+...+...
T Consensus 176 FGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-~~~~~~~i~~~---- 245 (290)
T 3fpq_A 176 LGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSG---- 245 (290)
T ss_dssp TTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTT----
T ss_pred CcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-HHHHHHHHHcC----
Confidence 999985433 23346789999999998865 699999999999999999999999974322 11121111111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...+......+. ++.+++.+||++||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~------~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 246 VKPASFDKVAIP------EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCCGGGGGCCCH------HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCccCCH------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111222 23457888999999999999999875
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=484.30 Aligned_cols=506 Identities=19% Similarity=0.190 Sum_probs=429.8
Q ss_pred eeeEeecCCCCCCCCCccccCCCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccc
Q 043053 2 VTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNS 81 (1058)
Q Consensus 2 ~~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~ 81 (1058)
|+...+..||. .+| +++++|+|++|++++..+..+.++++|++|+|++|++++..|..++++++|++|+|++
T Consensus 14 c~~~~l~~ip~--~l~------~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 85 (570)
T 2z63_A 14 CMELNFYKIPD--NLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (570)
T ss_dssp CCSSCCSSCCS--SSC------SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred eCCCCccccCC--Ccc------ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcC
Confidence 44445666665 444 4799999999999866677899999999999999999966678899999999999999
Q ss_pred cCCCCccccccccchhhhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccC
Q 043053 82 NQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSL 161 (1058)
Q Consensus 82 n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~ 161 (1058)
|++++..|..|+++++|++|++++|.+.+..+..++++++|++|++++|......+|..++++++|++|++++|++.+..
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~ 165 (570)
T 2z63_A 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165 (570)
T ss_dssp CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEEC
T ss_pred CcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceec
Confidence 99997777899999999999999999984333479999999999999997222257999999999999999999999888
Q ss_pred CccccCCCcc----ceeeeeccccccccCccccCCCCccEEEccCCcCCC-CCCCCcCCCCCcceeeccccccc------
Q 043053 162 PASLGKLSKL----QTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSG-SIPPEIGKLKKLEELFLWQNSLV------ 230 (1058)
Q Consensus 162 ~~~l~~l~~L----~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~------ 230 (1058)
+..++.+++| +.|++++|.+.+..+..+..+ +|+.|++++|.... .++..+..+++++.+.+....+.
T Consensus 166 ~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~ 244 (570)
T 2z63_A 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244 (570)
T ss_dssp GGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCE
T ss_pred HHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhh
Confidence 8899999888 899999999998888777766 89999999986542 24455667777777666543322
Q ss_pred CCCCccccCcC--CccEEEeecC-CCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCC
Q 043053 231 GAIPEEIGNCT--SLKMIDFSLN-SLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPP 307 (1058)
Q Consensus 231 ~~~~~~l~~l~--~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~ 307 (1058)
......+..+. .++.+++++| .+.+..+..+..+++|++|++++|.+. .+|..+..+ +|++|++++|.+..+..
T Consensus 245 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~- 321 (570)
T 2z63_A 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPT- 321 (570)
T ss_dssp ECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCB-
T ss_pred hcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccCc-
Confidence 11222333333 3677888888 777788888999999999999999988 577778888 99999999999985433
Q ss_pred cccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccC--cccccccccchhhhccccCCCCCCCCCccCCC
Q 043053 308 EIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASV--PAGLFQLQNLTKLLLISNDISGSIPPEIGNCS 385 (1058)
Q Consensus 308 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 385 (1058)
..+++|+.|++.+|.+.+..+. ..+++|+.|++++|++++.. +..+..+++|++|++++|.+.+..+. +..++
T Consensus 322 --~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~ 396 (570)
T 2z63_A 322 --LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLE 396 (570)
T ss_dssp --CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCT
T ss_pred --ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccC
Confidence 4778899999999998876655 78899999999999998654 67788999999999999999865554 99999
Q ss_pred CCcEEEccCccccCCcc-ccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccC-CCCccccccCCCCCeee
Q 043053 386 SLVRLRVGNNRIAGLIP-REIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ-GSLPNSLSSLSGLQVLD 463 (1058)
Q Consensus 386 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~ 463 (1058)
+|++|++++|.+.+..+ ..|..+++|++|++++|.+.+..|..|..+++|+.|++++|.++ +.+|..|..+++|++|+
T Consensus 397 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~ 476 (570)
T 2z63_A 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476 (570)
T ss_dssp TCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEE
Confidence 99999999999998766 57899999999999999999999999999999999999999997 57889999999999999
Q ss_pred cCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChh
Q 043053 464 VSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPME 524 (1058)
Q Consensus 464 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~ 524 (1058)
+++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++++..|..
T Consensus 477 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 9999999888999999999999999999999988889999999999999999999887753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=440.04 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=211.9
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC-Ccccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH-KNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~ 776 (1058)
++|++.+.||+|+||+||+|.+. .++.||||++... ......+.|.+|++++.+++| ||||++
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~----------~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----------ATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc----------cChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 68999999999999999999543 2367999998533 223346789999999999975 999999
Q ss_pred eeEEEcC-CCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCC
Q 043053 777 LGCCWNR-NNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRD 841 (1058)
Q Consensus 777 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrD 841 (1058)
+|+|.++ +..++|||||++|+|.++++... ...+++..+..++.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 56899999999999999997532 24589999999999999999999999 999999
Q ss_pred CCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 043053 842 IKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDP 920 (1058)
Q Consensus 842 ikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 920 (1058)
|||+|||+++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997765444344556789999999999999999999999999999999998 9999976
Q ss_pred CCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 921 TIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
... ...+...+..... +..+...+ .+ +.+++..||+.||++|||++||+++|+.+.+.
T Consensus 291 ~~~-~~~~~~~i~~g~~-----~~~p~~~~---~~---~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKI-DEEFCRRLKEGTR-----MRAPDYTT---PE---MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCC-SHHHHHHHHHTCC-----CCCCTTCC---HH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCH-HHHHHHHHHcCCC-----CCCCccCC---HH---HHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 532 2233333333221 11222222 22 34578889999999999999999999887543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=421.20 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=191.0
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
.+.+|++.+.||+|+||+||+| +..+|+.||||++.+... ......+.+.+|++++++++|||||++++++
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~ 82 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL--------AKSDMQGRIEREISYLRLLRHPHIIKLYDVI 82 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc--------CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 3578999999999999999999 556899999999864422 2233467899999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+++..|+||||+ +|+|.+++.. .+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 83 KSKDEIIMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp ECSSEEEEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred EECCEEEEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence 9999999999999 6799999986 36799999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
|+|+...... .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||... ........+...
T Consensus 157 Gla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--~~~~~~~~i~~~---- 227 (275)
T 3hyh_A 157 GLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--SIPVLFKNISNG---- 227 (275)
T ss_dssp SCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHT----
T ss_pred CCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcC----
Confidence 9998765432 3345789999999999998876 57999999999999999999999753 112222222211
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
...+....+.+ +.+++.+||++||++|||++|++++-
T Consensus 228 --~~~~p~~~s~~------~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 228 --VYTLPKFLSPG------AAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp --CCCCCTTSCHH------HHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred --CCCCCCCCCHH------HHHHHHHHccCChhHCcCHHHHHcCc
Confidence 11122222222 34577889999999999999998854
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=442.90 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=206.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|+..+.||+|+||+||+| +..+|+.||||++... .....+.+.+|+.+|++++|||||+++++|.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-----------~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~ 219 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-----------KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 219 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST-----------TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc-----------chhHHHHHHHHHHHHHhCCCCCCCceEEEEEE
Confidence 46899999999999999999 5568999999998532 12235678999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+|||||+||+|.++++. ..+++..+..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+
T Consensus 220 ~~~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGl 293 (423)
T 4fie_A 220 GDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGF 293 (423)
T ss_dssp TTEEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCcc
Confidence 9999999999999999999975 4589999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+.+.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+..... ..
T Consensus 294 a~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~---~~ 366 (423)
T 4fie_A 294 CAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLP---PR 366 (423)
T ss_dssp CEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCC---CC
T ss_pred ceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCC---CC
Confidence 99775433 23456789999999999999999999999999999999999999997542 2222222222111 11
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.......+. .+.+++.+||..||++|||++|++++
T Consensus 367 ~~~~~~~s~------~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 367 LKNLHKVSP------SLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CSCTTSSCH------HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CcccccCCH------HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111112222 23457788999999999999999875
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=478.79 Aligned_cols=452 Identities=18% Similarity=0.259 Sum_probs=375.7
Q ss_pred CcccEEecCCCCCCCCCChhhcCcccCCEEeccccCC------CC------ccccccccchhhhHHhhhhccccCCChhh
Q 043053 48 VGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQL------TG------KIPVELSNCKSLRKLLLFDNALAGNIPAE 115 (1058)
Q Consensus 48 ~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~------~~------~~p~~l~~l~~L~~L~L~~n~~~~~~p~~ 115 (1058)
.+++.|+|++|+++|.+|.++++|++|++|+|++|.+ .+ .+|... +.+|+ +++++|.+.+..|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4789999999999999999999999999999999976 22 345444 78888 999999999888888
Q ss_pred hcc-cccchhhhcCCCccccCCCCccccCCCCCceeccc--CccccccCCccccCCCccceeeeeccccccc--------
Q 043053 116 LGR-LSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLA--DTQVSGSLPASLGKLSKLQTLSIYTTMISGE-------- 184 (1058)
Q Consensus 116 l~~-l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~--~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~-------- 184 (1058)
++. +..+..+++.... ........++.+.+. +|++++ +|..|+++++|++|++++|.+++.
T Consensus 158 ~~~~~~~l~~~~l~~~~-------~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 229 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKS-------IKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229 (636)
T ss_dssp SCHHHHHHHHHCTTSCC-------CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC
T ss_pred HHHHHHHHhhcCccccc-------cccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc
Confidence 775 5566666555432 111223344444444 578887 899999999999999999999875
Q ss_pred ---------cCcccc--CCCCccEEEccCCcCCCCCCCCcCCCCCcceeeccccc-ccC-CCCccccCc------CCccE
Q 043053 185 ---------IPAEIG--NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNS-LVG-AIPEEIGNC------TSLKM 245 (1058)
Q Consensus 185 ---------~~~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~l~~l------~~L~~ 245 (1058)
+|..++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..++.+ ++|++
T Consensus 230 ~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~ 309 (636)
T 4eco_A 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309 (636)
T ss_dssp TTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCE
T ss_pred cccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCE
Confidence 899998 99999999999999998999999999999999999998 887 788888776 89999
Q ss_pred EEeecCCCcCcCCc--cccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccch-hhhhhccC
Q 043053 246 IDFSLNSLSGTIPL--SIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSK-LTVFFAWQ 322 (1058)
Q Consensus 246 L~L~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~l~~ 322 (1058)
|++++|+++ .+|. .++.+++|++|++++|.+.+.+| .|..+++|++|+|++|+++ ..|..|..+++ |++|++++
T Consensus 310 L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~ 386 (636)
T 4eco_A 310 IYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAH 386 (636)
T ss_dssp EECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCS
T ss_pred EECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccC
Confidence 999999998 7787 89999999999999999997778 8899999999999999998 66778899988 99999999
Q ss_pred cccCCCCChhhhccC--cccccccccccccccCccccc-------ccccchhhhccccCCCCCCCCCccCCCCCcEEEcc
Q 043053 323 NQLEGSIPSTLASCS--NLQALDLSHNSLTASVPAGLF-------QLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVG 393 (1058)
Q Consensus 323 N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 393 (1058)
|+++ .+|..+..++ +|+.|++++|++.+..|..+. .+++|++|+|++|++++..+..+..+++|+.|+|+
T Consensus 387 N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls 465 (636)
T 4eco_A 387 NKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465 (636)
T ss_dssp SCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECC
T ss_pred CcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECC
Confidence 9998 6677776654 899999999999988888877 77889999999999985544456678899999999
Q ss_pred CccccCCccccccCcc-------ccceeeccCccCCCCCCCccc--CCcccchhhccCCccCCCCccccccCCCCCeeec
Q 043053 394 NNRIAGLIPREIGGLK-------TLNFLDLSSNRLSGSVPDEIG--DCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDV 464 (1058)
Q Consensus 394 ~N~l~~~~~~~~~~l~-------~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 464 (1058)
+|+|+.+.+..+..+. +|++|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|
T Consensus 466 ~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~L 543 (636)
T 4eco_A 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543 (636)
T ss_dssp SSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEEC
T ss_pred CCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEEC
Confidence 9999866555555443 8999999999998 6777776 88999999999999987 7888889999999999
Q ss_pred ------CCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccC
Q 043053 465 ------SDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 465 ------~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
++|++.+.+|..+..+++|+.|+|++|+| +.+|..+. ++|+.|++++|++..
T Consensus 544 s~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp CSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred CCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence 56778888888888899999999999999 46777665 789999999998873
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=429.52 Aligned_cols=269 Identities=29% Similarity=0.338 Sum_probs=202.0
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|...+.||+|+||+||+|.+. |+.||||++... ......+.+|+..+.+++|||||++++++.++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~------------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~ 69 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR------------EERSWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG------------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc------------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEec
Confidence 57888999999999999999874 899999998432 11123344567777889999999999999865
Q ss_pred C----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccC-----CCCeEeCCCCCCcEEEcCCCC
Q 043053 784 N----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDC-----VPPIVHRDIKANNILIGLEFE 854 (1058)
Q Consensus 784 ~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrDikp~Nill~~~~~ 854 (1058)
+ ..|+|||||++|+|.++++. ..++|..+.+++.|+|+||+|||+++ .++||||||||+|||++.++.
T Consensus 70 ~~~~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~ 146 (303)
T 3hmm_A 70 NGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence 4 46899999999999999986 46899999999999999999999762 358999999999999999999
Q ss_pred eeeeccccceeccCCCcc--cccccccCcCCccCccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCC----
Q 043053 855 PYIADFGLAKLVDDGDFA--RSSNTVAGSYGYIAPEYGYMM------KITEKSDVYSYGVVVLEVLTGKQPIDPTI---- 922 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg~~P~~~~~---- 922 (1058)
+||+|||+|+........ ......+||+.|||||++.+. .++.++|||||||++|||+||+.||....
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 999999999877654321 123356799999999998654 46779999999999999999987764321
Q ss_pred ------CCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 923 ------PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 923 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
+....... +.........+|.+...... .+....+.+++.+||+.||++||||+||++.|+++.++
T Consensus 227 p~~~~~~~~~~~~~-~~~~~~~~~~rp~~p~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 227 PYYDLVPSDPSVEE-MRKVVCEQKLRPNIPNRWQS-CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTTSCSSCCHHH-HHHHHTTSCCCCCCCGGGGS-SHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchhcccccchHHH-HHHHHhcccCCCCCCccccc-hHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11111112 22222222333333322211 12223345689999999999999999999999988654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=425.17 Aligned_cols=250 Identities=24% Similarity=0.288 Sum_probs=196.2
Q ss_pred hhccccceeccccceEEEEEEe----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|++.+.||+|+||+||+|.. .+++.||||++.+.... .....++.+|++++++++|||||+++++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~---------~~~~~~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK---------VRDRVRTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE---------EEECC------CCCCCCCCTTEECEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC---------hHHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 5799999999999999999954 35789999999654321 1223468899999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+.+++..|+|||||+||+|.++++.. +.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D 169 (304)
T 3ubd_A 95 FQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD 169 (304)
T ss_dssp EEETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence 99999999999999999999999864 5799999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
||+|+...... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+...
T Consensus 170 FGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~---- 241 (304)
T 3ubd_A 170 FGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--RKETMTMILKA---- 241 (304)
T ss_dssp SEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC----
T ss_pred cccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--HHHHHHHHHcC----
Confidence 99998654432 33456789999999999999999999999999999999999999997542 22222222221
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM-----KDVAAM 983 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~-----~~v~~~ 983 (1058)
....+...+. ++.+++.+||++||++|||+ +|++++
T Consensus 242 --~~~~p~~~s~------~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 242 --KLGMPQFLSP------EAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp --CCCCCTTSCH------HHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred --CCCCCCcCCH------HHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1112222222 23457888999999999985 466543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=480.35 Aligned_cols=454 Identities=17% Similarity=0.244 Sum_probs=354.7
Q ss_pred CCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCC------CC------CCChhhcCcccCCEEeccccCCCCccccc
Q 043053 24 KHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL------VG------TLPSSLGKLHNLEELILNSNQLTGKIPVE 91 (1058)
Q Consensus 24 ~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i------~~------~lp~~l~~l~~L~~L~L~~n~~~~~~p~~ 91 (1058)
.+++.|+|+++.+.|.+|.++++|++|++|+|++|.+ .+ .+|..+ +..|+ ++++.|.+.+..|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 5799999999999999999999999999999999976 23 567666 67888 999999998888888
Q ss_pred cc-cchhhhHHhhhhccccCCChhhhcccccchhhhcCC-CccccCCCCccccCCCCCceecccCcccccc---------
Q 043053 92 LS-NCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGG-NKDIVGKIPAELGDCSNMTALGLADTQVSGS--------- 160 (1058)
Q Consensus 92 l~-~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~-~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~--------- 160 (1058)
+. .+..+..+++....+. ......++.+.+.. ++.+.+ +|..++++++|++|++++|++++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~------~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 230 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIK------KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCC------CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred HHHHHHHHhhcCccccccc------cccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence 77 4556666666543322 12233455555554 223334 788888888888888888888764
Q ss_pred --------CCcccc--CCCccceeeeeccccccccCccccCCCCccEEEccCCc-CCC-CCCCCcCCC------CCccee
Q 043053 161 --------LPASLG--KLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENS-LSG-SIPPEIGKL------KKLEEL 222 (1058)
Q Consensus 161 --------~~~~l~--~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L 222 (1058)
+|..++ ++++|++|++++|.+.+.+|..++++++|++|+|++|. +++ .+|..++.+ ++|++|
T Consensus 231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L 310 (636)
T 4eco_A 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310 (636)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEE
T ss_pred ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEE
Confidence 788877 88888888888888888888888888888888888887 776 677777665 788888
Q ss_pred ecccccccCCCCc--cccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCcccccccccc-chhhhhcCC
Q 043053 223 FLWQNSLVGAIPE--EIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATN-LVQLQLDTN 299 (1058)
Q Consensus 223 ~L~~n~l~~~~~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~N 299 (1058)
+|++|.++ .+|. .|+++++|++|++++|+++|.+| .++.+++|++|++++|.+. .+|..+..+++ |++|++++|
T Consensus 311 ~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N 387 (636)
T 4eco_A 311 YIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHN 387 (636)
T ss_dssp ECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSS
T ss_pred ECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCC
Confidence 88888887 6676 78888888888888888887777 7788888888888888887 66777888887 888888888
Q ss_pred cccCcCCCcccccc--hhhhhhccCcccCCCCChhhh-------ccCcccccccccccccccCcccc-cccccchhhhcc
Q 043053 300 QISGLIPPEIGMLS--KLTVFFAWQNQLEGSIPSTLA-------SCSNLQALDLSHNSLTASVPAGL-FQLQNLTKLLLI 369 (1058)
Q Consensus 300 ~i~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~ 369 (1058)
+++ ..|..+..++ +|++|++++|++++..|..|. .+++|+.|+|++|+++. +|..+ ..+++|++|+|+
T Consensus 388 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~~~l~~L~~L~Ls 465 (636)
T 4eco_A 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK-FPKELFSTGSPLSSINLM 465 (636)
T ss_dssp CCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCS-CCTHHHHTTCCCSEEECC
T ss_pred cCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCc-CCHHHHccCCCCCEEECC
Confidence 887 5566666654 788888888888887777777 77788888888888884 55444 457888888888
Q ss_pred ccCCCCCCCCCccCC-------CCCcEEEccCccccCCcccccc--CccccceeeccCccCCCCCCCcccCCcccchhhc
Q 043053 370 SNDISGSIPPEIGNC-------SSLVRLRVGNNRIAGLIPREIG--GLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDL 440 (1058)
Q Consensus 370 ~N~l~~~~~~~~~~l-------~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 440 (1058)
+|+++.+.+..+... ++|+.|+|++|+|+. +|..+. .+++|++|+|++|++++ +|..+..+++|+.|+|
T Consensus 466 ~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~L 543 (636)
T 4eco_A 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543 (636)
T ss_dssp SSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCB-CCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEEC
T ss_pred CCCCCCcCHHHhccccccccccCCccEEECcCCcCCc-cChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEEC
Confidence 888884433344333 288999999999884 455665 88899999999999986 7888888899999988
Q ss_pred ------cCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCC
Q 043053 441 ------SHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPI 497 (1058)
Q Consensus 441 ------~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 497 (1058)
++|++.+.+|..+..+++|++|+|++|++ +.+|..+. ++|+.|+|++|++....
T Consensus 544 s~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISID 603 (636)
T ss_dssp CSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEEE
T ss_pred CCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcccc
Confidence 56778888999999999999999999999 57787766 79999999999887543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=468.58 Aligned_cols=482 Identities=20% Similarity=0.195 Sum_probs=359.5
Q ss_pred CcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhh
Q 043053 26 LQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFD 105 (1058)
Q Consensus 26 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~ 105 (1058)
..+.+.+++.++ .+|..+. .+|++|+|++|++++..|.+++++++|++|+|++|++.+..|..|+++++|++|+|++
T Consensus 7 ~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~ 83 (549)
T 2z81_A 7 SGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83 (549)
T ss_dssp TSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred CceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence 334566677776 6776554 5777777777777755566777777777777777777765666777777777777777
Q ss_pred ccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCC-ccccCCCccceeeeeccccccc
Q 043053 106 NALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLP-ASLGKLSKLQTLSIYTTMISGE 184 (1058)
Q Consensus 106 n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~-~~l~~l~~L~~L~l~~n~i~~~ 184 (1058)
|.+.+..|..++++++|++|++++|.......|..++.+++|++|++++|.+.+.+| ..|+++++|++|++++|.+.+.
T Consensus 84 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 163 (549)
T 2z81_A 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163 (549)
T ss_dssp SCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccccc
Confidence 777755556677777777777777762111345667778888888888777433443 5677888888888888888777
Q ss_pred cCccccCCCCccEEEccCCcCCCCCCCC-cCCCCCcceeecccccccCCC--C-ccccCcCCccEEEeecCCCcCcCCc-
Q 043053 185 IPAEIGNCSELVSLFLYENSLSGSIPPE-IGKLKKLEELFLWQNSLVGAI--P-EEIGNCTSLKMIDFSLNSLSGTIPL- 259 (1058)
Q Consensus 185 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~--~-~~l~~l~~L~~L~L~~n~l~~~~~~- 259 (1058)
.|..++.+++|++|++++|.+. .+|.. +..+++|++|++++|.+.+.. + .....+++|+.|++++|.+++..+.
T Consensus 164 ~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 242 (549)
T 2z81_A 164 QSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242 (549)
T ss_dssp CTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHH
T ss_pred ChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHH
Confidence 7778888888888888888776 33333 345778888888888777542 1 2234567788888888877654333
Q ss_pred ---cccccCCcceeecccCccCCCc------cccccccccchhhhhcCCcccCcC-----CCcccccchhhhhhccCccc
Q 043053 260 ---SIGGLSELEEFMISDNNVSGSI------PANLANATNLVQLQLDTNQISGLI-----PPEIGMLSKLTVFFAWQNQL 325 (1058)
Q Consensus 260 ---~~~~l~~L~~L~l~~n~l~~~~------~~~~~~l~~L~~L~L~~N~i~~~~-----~~~~~~l~~L~~L~l~~N~l 325 (1058)
.+..+++|+.+++++|.+.+.. ...+..+.+|+.|++.++.+.... +..+....+|+.|++++|++
T Consensus 243 l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l 322 (549)
T 2z81_A 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322 (549)
T ss_dssp HHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCC
T ss_pred HHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCcc
Confidence 3355677888888888766431 123456677888888887765431 11234456788899999998
Q ss_pred CCCCChhh-hccCcccccccccccccccCc---ccccccccchhhhccccCCCCCCC--CCccCCCCCcEEEccCccccC
Q 043053 326 EGSIPSTL-ASCSNLQALDLSHNSLTASVP---AGLFQLQNLTKLLLISNDISGSIP--PEIGNCSSLVRLRVGNNRIAG 399 (1058)
Q Consensus 326 ~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~ 399 (1058)
+. +|..+ ..+++|++|++++|++.+..| ..+..+++|++|+|++|++++..+ ..+..+++|++|++++|+|+.
T Consensus 323 ~~-ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 401 (549)
T 2z81_A 323 FL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP 401 (549)
T ss_dssp CC-CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC
T ss_pred cc-CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCcc
Confidence 84 45544 689999999999999987664 346788999999999999986432 458889999999999999995
Q ss_pred CccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccc
Q 043053 400 LIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGR 479 (1058)
Q Consensus 400 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 479 (1058)
.|..+..+++|++|+|++|++++ +|..+ .++|+.|++++|+|++.+ ..+++|++|+|++|+|+ .+|. ...
T Consensus 402 -lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~ 471 (549)
T 2z81_A 402 -MPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASL 471 (549)
T ss_dssp -CCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGG
T ss_pred -CChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-ccc
Confidence 57788899999999999999984 44433 268999999999999743 57899999999999998 6665 567
Q ss_pred cccccccccccccCCCCCCCcccCCcccccccccCCcccCCCC
Q 043053 480 LVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 480 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
+++|+.|+|++|++++.+|..|..+++|+.|++++|++.+..|
T Consensus 472 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 472 FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 8999999999999999889999999999999999999987766
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=418.36 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=189.6
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
..++|++.+.||+|+||+||+| +..+|+.||||++... ..+...+.+.+|++++++++|||||++++++
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~ 72 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP----------NRELAREKVMREVKALAKLEHPGIVRYFNAW 72 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC----------SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc----------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3567999999999999999999 5568999999998532 2334567899999999999999999999998
Q ss_pred EcCCC------------ceEEEEecCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcE
Q 043053 781 WNRNN------------RLLMYDYMPNGSLGSLLHERTG-NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNI 847 (1058)
Q Consensus 781 ~~~~~------------~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Ni 847 (1058)
.+.+. .|+|||||+||+|.++++.+.. ...++..++.|+.||++||+|||++ +||||||||+||
T Consensus 73 ~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NI 149 (299)
T 4g31_A 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNI 149 (299)
T ss_dssp EEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred EecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHe
Confidence 75443 5899999999999999986432 2356677889999999999999999 999999999999
Q ss_pred EEcCCCCeeeeccccceeccCCCcc----------cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 043053 848 LIGLEFEPYIADFGLAKLVDDGDFA----------RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917 (1058)
Q Consensus 848 ll~~~~~~kl~DfGl~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P 917 (1058)
|++.++.+||+|||+|+........ ...+..+||+.|||||++.+..|+.++||||+||++|||++ |
T Consensus 150 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---P 226 (299)
T 4g31_A 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P 226 (299)
T ss_dssp EECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---C
T ss_pred EECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---C
Confidence 9999999999999999876543211 12345679999999999999999999999999999999996 7
Q ss_pred CCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 918 IDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
|... ......+...... ..++..........+++.+||++||++|||+.|++++
T Consensus 227 f~~~----~~~~~~~~~~~~~--------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 227 FSTQ----MERVRTLTDVRNL--------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp CSSH----HHHHHHHHHHHTT--------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCc----cHHHHHHHHHhcC--------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 7532 1111111111110 0111111222234458899999999999999999874
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=464.92 Aligned_cols=491 Identities=18% Similarity=0.207 Sum_probs=359.4
Q ss_pred CCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhccccCCChhhhcccccchhhh
Q 043053 47 CVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMR 126 (1058)
Q Consensus 47 l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~ 126 (1058)
|....+.|.++++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|++++|.+.+..|..++++++|++|+
T Consensus 4 C~~~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 80 (549)
T 2z81_A 4 CDASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD 80 (549)
T ss_dssp ECTTSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence 344455789999998 9998775 7999999999999977788999999999999999999976778899999999999
Q ss_pred cCCCccccCCCCc-cccCCCCCceecccCccccc-cCCccccCCCccceeeeeccccccccC-ccccCCCCccEEEccCC
Q 043053 127 AGGNKDIVGKIPA-ELGDCSNMTALGLADTQVSG-SLPASLGKLSKLQTLSIYTTMISGEIP-AEIGNCSELVSLFLYEN 203 (1058)
Q Consensus 127 l~~~~~~~~~l~~-~l~~l~~L~~L~l~~~~~~~-~~~~~l~~l~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L~L~~n 203 (1058)
+++|. ...++. .++.+++|++|++++|++.+ ..|..++++++|++|++++|.+.+.+| ..+.++++|++|++++|
T Consensus 81 Ls~n~--l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n 158 (549)
T 2z81_A 81 LSDNH--LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158 (549)
T ss_dssp CTTSC--CCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred CCCCc--cCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCC
Confidence 99997 445554 48899999999999999885 356788999999999999998544554 68899999999999999
Q ss_pred cCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcC--C-ccccccCCcceeecccCccCCC
Q 043053 204 SLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTI--P-LSIGGLSELEEFMISDNNVSGS 280 (1058)
Q Consensus 204 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~--~-~~~~~l~~L~~L~l~~n~l~~~ 280 (1058)
.+++..|..++.+++|+.|++++|.+.......+..+++|++|++++|++++.. + .....+++|+.|++++|.+.+.
T Consensus 159 ~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 238 (549)
T 2z81_A 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238 (549)
T ss_dssp TCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHH
T ss_pred cccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchh
Confidence 999888899999999999999999886332233457899999999999988642 2 2234578889999998887754
Q ss_pred ccc----cccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCccccccccccccccc----
Q 043053 281 IPA----NLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTAS---- 352 (1058)
Q Consensus 281 ~~~----~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---- 352 (1058)
.+. .+..+++|+.|++++|.+.+...-. ......+..+.+|+.|+++++.+...
T Consensus 239 ~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~------------------~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~ 300 (549)
T 2z81_A 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFN------------------PSESDVVSELGKVETVTIRRLHIPQFYLFY 300 (549)
T ss_dssp HHHHHHGGGGGCTTCCEEEEESCEEECCSCCC------------------CCTTTCCCCCTTCCEEEEESCBCSCGGGSC
T ss_pred HHHHHHHHhhhhcccccccccccccccccccc------------------ccchhhhhhhcccccccccccccchhhhcc
Confidence 433 3355677888888888776542110 00112234455666666666655421
Q ss_pred -CcccccccccchhhhccccCCCCCCCCCc-cCCCCCcEEEccCccccCCcc---ccccCccccceeeccCccCCCCCC-
Q 043053 353 -VPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRIAGLIP---REIGGLKTLNFLDLSSNRLSGSVP- 426 (1058)
Q Consensus 353 -~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~- 426 (1058)
.+..+...++|++|++++|.+. .+|..+ .++++|++|+|++|++++..| ..++.+++|++|+|++|++++..+
T Consensus 301 ~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 379 (549)
T 2z81_A 301 DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT 379 (549)
T ss_dssp CCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHH
T ss_pred cchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccc
Confidence 1111223456677777777766 344443 457777777777777766543 236667777777777777765432
Q ss_pred -CcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCc
Q 043053 427 -DEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCS 505 (1058)
Q Consensus 427 -~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 505 (1058)
..+..+++|+.|++++|++++ +|..+..+++|++|++++|+++ .+|..+. ++|+.|+|++|+|++.+ ..++
T Consensus 380 ~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~ 451 (549)
T 2z81_A 380 GEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLP 451 (549)
T ss_dssp HHHGGGCTTCCEEECTTCCCCC-CCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCT
T ss_pred hhhhhcCCCCCEEECCCCCCcc-CChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCC
Confidence 346677777777777777773 5666777777777777777776 3343332 46777777777777542 4567
Q ss_pred ccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCC-cccccCcceeEEE
Q 043053 506 SLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLN-PLAQLDNLVSLNI 584 (1058)
Q Consensus 506 ~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l 584 (1058)
+|++|+|++|+|+ .+|. ...+++|+.|||++|++++.++ .+..+++|+.|++
T Consensus 452 ~L~~L~Ls~N~l~-~ip~--------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 504 (549)
T 2z81_A 452 RLQELYISRNKLK-TLPD--------------------------ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504 (549)
T ss_dssp TCCEEECCSSCCS-SCCC--------------------------GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEEC
T ss_pred hhcEEECCCCccC-cCCC--------------------------cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEe
Confidence 7888888888776 3442 2346789999999999998765 4888999999999
Q ss_pred ecccccccCCCc
Q 043053 585 SYNKFTGYLPDN 596 (1058)
Q Consensus 585 ~~N~l~~~~~~~ 596 (1058)
++|+|+|.+|..
T Consensus 505 ~~N~~~~~~~~~ 516 (549)
T 2z81_A 505 HTNPWDCSCPRI 516 (549)
T ss_dssp CSSCBCCCHHHH
T ss_pred cCCCccCCCccH
Confidence 999999988853
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=467.76 Aligned_cols=435 Identities=19% Similarity=0.242 Sum_probs=241.9
Q ss_pred CcccEEecCCCCCCCCCChhhcCcccCCEEec-cccCCCCccccccc---------cchhhhHHhhhhccccCCChhhhc
Q 043053 48 VGLIVLDFSSNNLVGTLPSSLGKLHNLEELIL-NSNQLTGKIPVELS---------NCKSLRKLLLFDNALAGNIPAELG 117 (1058)
Q Consensus 48 ~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L-~~n~~~~~~p~~l~---------~l~~L~~L~L~~n~~~~~~p~~l~ 117 (1058)
.+++.|+|++|++.|.+|.+|++|++|++|+| ++|.+.+..|-... .+..++..... .+....|. .
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~--~~l~~~~~--~ 398 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK--MFLDYDQR--L 398 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHH--HHTCCCGG--G
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhh--hhhccCcc--h
Confidence 46899999999999999999999999999999 88877655332211 11222222221 11111111 0
Q ss_pred ccccchhhhcCCCccccCCCCccccCCCCCceecccC--ccccccCCccccCCCccceeeeeccccccc-----------
Q 043053 118 RLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLAD--TQVSGSLPASLGKLSKLQTLSIYTTMISGE----------- 184 (1058)
Q Consensus 118 ~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~--~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~----------- 184 (1058)
++..+-...+..+. ...+........++.+.+.. |++++ +|..|+++++|+.|+|++|.+++.
T Consensus 399 ~~s~l~~~~l~~~~---~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~ 474 (876)
T 4ecn_A 399 NLSDLLQDAINRNP---EMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS 474 (876)
T ss_dssp GSCHHHHHHHHTCT---TSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTS
T ss_pred hhhHHHHHHhhhCc---cccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccccccc
Confidence 11111111111111 01111112233444444443 66665 677777777777777777777652
Q ss_pred ------cCcccc--CCCCccEEEccCCcCCCCCCCCcCCCCCcceeeccccc-ccC-CCCccccCcC-------CccEEE
Q 043053 185 ------IPAEIG--NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNS-LVG-AIPEEIGNCT-------SLKMID 247 (1058)
Q Consensus 185 ------~~~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~l~~l~-------~L~~L~ 247 (1058)
+|..++ ++++|+.|+|++|.+.+.+|..|+++++|+.|+|++|+ +++ .+|..++.++ +|++|+
T Consensus 475 n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~ 554 (876)
T 4ecn_A 475 DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554 (876)
T ss_dssp HHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEE
T ss_pred ccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEE
Confidence 555554 55555555555555555555555555555555555554 444 3444443333 555555
Q ss_pred eecCCCcCcCCc--cccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCccc
Q 043053 248 FSLNSLSGTIPL--SIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQL 325 (1058)
Q Consensus 248 L~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l 325 (1058)
|++|+++ .+|. .++++++|+.|++++|.+. .+| .|..+++|+.|+|++|+ +
T Consensus 555 Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~------------------------l 607 (876)
T 4ecn_A 555 MGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQ------------------------I 607 (876)
T ss_dssp CCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSC------------------------C
T ss_pred eeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCc------------------------c
Confidence 5555555 4444 4555555555555555544 333 44444445555554444 4
Q ss_pred CCCCChhhhccCc-ccccccccccccccCcccccccc--cchhhhccccCCCCCCCCCc---c--CCCCCcEEEccCccc
Q 043053 326 EGSIPSTLASCSN-LQALDLSHNSLTASVPAGLFQLQ--NLTKLLLISNDISGSIPPEI---G--NCSSLVRLRVGNNRI 397 (1058)
Q Consensus 326 ~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l 397 (1058)
+ .+|..+..+++ |+.|+|++|+++ .+|..+..+. +|+.|+|++|++.+.+|... . .+++|+.|+|++|+|
T Consensus 608 ~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L 685 (876)
T 4ecn_A 608 E-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEI 685 (876)
T ss_dssp S-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCC
T ss_pred c-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcC
Confidence 4 34444555555 666666666655 4555544433 26666666666655443221 1 234677777777777
Q ss_pred cCCccccccCccccceeeccCccCCCCCCCcccC-------CcccchhhccCCccCCCCccccc--cCCCCCeeecCCCc
Q 043053 398 AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD-------CTELQMIDLSHNTLQGSLPNSLS--SLSGLQVLDVSDNR 468 (1058)
Q Consensus 398 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-------l~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~L~~N~ 468 (1058)
+.+.+..+..+++|++|+|++|+|+.+.+..+.. +++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+
T Consensus 686 ~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~ 764 (876)
T 4ecn_A 686 QKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNC 764 (876)
T ss_dssp CSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSC
T ss_pred CccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCC
Confidence 7655555556777777777777777333333322 237777777777777 4566665 77777777777777
Q ss_pred cccCCccccccccccccccccc------ccCCCCCCCcccCCcccccccccCCcccCCCC
Q 043053 469 FSGQIPASLGRLVSLNKIILSK------NLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 469 l~~~~~~~~~~l~~L~~L~Ls~------N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
|++ +|..+..+++|+.|+|++ |++.+.+|..|..+++|+.|+|++|++ +.+|
T Consensus 765 L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip 822 (876)
T 4ecn_A 765 FSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVD 822 (876)
T ss_dssp CSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCC
T ss_pred CCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccC
Confidence 775 566666666777776655 555555565666666666666666655 3444
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=454.41 Aligned_cols=455 Identities=17% Similarity=0.202 Sum_probs=326.2
Q ss_pred cEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhc
Q 043053 27 QTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDN 106 (1058)
Q Consensus 27 ~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n 106 (1058)
++|++++|+++ .+|..+. ++|++|+|++|++++..|..+.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57899999998 6888776 79999999999998666688999999999999999998777888888888888888888
Q ss_pred cccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccc-cCCccccCCCccceeeeecccccccc
Q 043053 107 ALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSG-SLPASLGKLSKLQTLSIYTTMISGEI 185 (1058)
Q Consensus 107 ~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~-~~~~~l~~l~~L~~L~l~~n~i~~~~ 185 (1058)
.+. .+|.. .+++|++|++++|. +.+ ..|..|+++++|++|++++|.+.+
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~-------------------------l~~~~~p~~~~~l~~L~~L~L~~n~l~~-- 129 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNA-------------------------FDALPICKEFGNMSQLKFLGLSTTHLEK-- 129 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSC-------------------------CSSCCCCGGGGGCTTCCEEEEEESSCCG--
T ss_pred cee-ecCcc--ccCCccEEeccCCc-------------------------cccccchhhhccCCcceEEEecCcccch--
Confidence 877 56654 55555555555554 433 234445555555555555554443
Q ss_pred CccccCCCCc--cEEEccCCcC--CCCCCCCcCCCC-CcceeecccccccCCCCc-cccCcCCccEEEeecCC-------
Q 043053 186 PAEIGNCSEL--VSLFLYENSL--SGSIPPEIGKLK-KLEELFLWQNSLVGAIPE-EIGNCTSLKMIDFSLNS------- 252 (1058)
Q Consensus 186 ~~~l~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~L~~n~------- 252 (1058)
..+..+++| +.|++++|.+ .+..|..+..+. +...+++++|.+.+..+. .+..+++|+.|++++|.
T Consensus 130 -~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 208 (520)
T 2z7x_B 130 -SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208 (520)
T ss_dssp -GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHH
T ss_pred -hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccce
Confidence 223334444 5555555555 444444444443 223344455544433332 34455555555555554
Q ss_pred CcCcCCccccccCCcceeecccCccCCCcccccc---ccccchhhhhcCCcccCcCCCcc-----cccchhhhhhccCcc
Q 043053 253 LSGTIPLSIGGLSELEEFMISDNNVSGSIPANLA---NATNLVQLQLDTNQISGLIPPEI-----GMLSKLTVFFAWQNQ 324 (1058)
Q Consensus 253 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~---~l~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~l~~N~ 324 (1058)
+.+.++ .++.+++|+.|++++|.+.+..+..+. ..++|++|++++|++++..|..+ +.+++|+.+++++|.
T Consensus 209 ~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~ 287 (520)
T 2z7x_B 209 FLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287 (520)
T ss_dssp HHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECC
T ss_pred eecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccc
Confidence 333333 455556666666665555432221111 13466666666666666666666 667777777777777
Q ss_pred cCCCCChhhhcc---CcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccC--
Q 043053 325 LEGSIPSTLASC---SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAG-- 399 (1058)
Q Consensus 325 l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-- 399 (1058)
+ ......+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++..|..++++++|++|+|++|+|++
T Consensus 288 ~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 364 (520)
T 2z7x_B 288 F-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364 (520)
T ss_dssp C-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHH
T ss_pred e-ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccc
Confidence 7 2322455554 67999999999987432 12578999999999999998899999999999999999999997
Q ss_pred CccccccCccccceeeccCccCCCCCC-CcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCccccc
Q 043053 400 LIPREIGGLKTLNFLDLSSNRLSGSVP-DEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLG 478 (1058)
Q Consensus 400 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 478 (1058)
..|..|..+++|++|+|++|++++.+| ..+..+++|+.|++++|++++..|..+. ++|++|++++|+|+ .+|..+.
T Consensus 365 ~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~ 441 (520)
T 2z7x_B 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV 441 (520)
T ss_dssp HHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG
T ss_pred cchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh
Confidence 445779999999999999999998444 4588999999999999999887776665 79999999999998 7888888
Q ss_pred ccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCC
Q 043053 479 RLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 479 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
.+++|+.|+|++|+|++..+..|..+++|+.|++++|++++..+
T Consensus 442 ~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 442 KLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp GCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 99999999999999996444459999999999999999987654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=462.78 Aligned_cols=444 Identities=18% Similarity=0.207 Sum_probs=302.3
Q ss_pred CCCceecccCccccccCCccccCCCccceeee-eccccccccCccc----------------------------------
Q 043053 145 SNMTALGLADTQVSGSLPASLGKLSKLQTLSI-YTTMISGEIPAEI---------------------------------- 189 (1058)
Q Consensus 145 ~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l-~~n~i~~~~~~~l---------------------------------- 189 (1058)
..++.|+|+++.+.|.+|.+|++|++|+.|+| ++|.+.+..|...
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57888899999988888989999999999999 7777665533111
Q ss_pred -----------------cCCCCccEEEccC--CcCCCCCCCCcCCCCCcceeecccccccC-----------------CC
Q 043053 190 -----------------GNCSELVSLFLYE--NSLSGSIPPEIGKLKKLEELFLWQNSLVG-----------------AI 233 (1058)
Q Consensus 190 -----------------~~l~~L~~L~L~~--n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~~ 233 (1058)
.....++.+.+.. |.+++ +|..|+++++|+.|+|++|.+++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 1112233333332 56665 66677777777777777777776 26
Q ss_pred Ccccc--CcCCccEEEeecCCCcCcCCccccccCCcceeecccCc-cCC-Cccccccccc-------cchhhhhcCCccc
Q 043053 234 PEEIG--NCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNN-VSG-SIPANLANAT-------NLVQLQLDTNQIS 302 (1058)
Q Consensus 234 ~~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~-~~~~~~~~l~-------~L~~L~L~~N~i~ 302 (1058)
|..++ ++++|++|+|++|.+.+.+|..|+++++|+.|+|++|+ +++ .+|..+..++ +|++|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 66655 77777777777777777777777777777777777776 665 5666555554 7777777777777
Q ss_pred CcCCC--cccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCccccccccc-chhhhccccCCCCCCCC
Q 043053 303 GLIPP--EIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQN-LTKLLLISNDISGSIPP 379 (1058)
Q Consensus 303 ~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~ 379 (1058)
.+|. .|+.+++|+.|++++|+++ .+| .|..+++|+.|+|++|++. .+|..+..+++ |++|+|++|.++ .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 5555 6777777777777777777 555 6777777777777777777 56666777776 777777777776 5566
Q ss_pred CccCCCC--CcEEEccCccccCCccccc---c--CccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccc
Q 043053 380 EIGNCSS--LVRLRVGNNRIAGLIPREI---G--GLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNS 452 (1058)
Q Consensus 380 ~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 452 (1058)
.+..++. |+.|+|++|++.+.+|... . .+++|++|+|++|+++.+.+..+..+++|+.|+|++|+|+.+.+..
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~ 716 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTS
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHH
Confidence 6665543 7777777777766544322 1 2346777777777777333333346677777777777777433333
Q ss_pred ccc-------CCCCCeeecCCCccccCCccccc--ccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCCh
Q 043053 453 LSS-------LSGLQVLDVSDNRFSGQIPASLG--RLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPM 523 (1058)
Q Consensus 453 ~~~-------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 523 (1058)
+.. +++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+
T Consensus 717 ~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------- 787 (876)
T 4ecn_A 717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------- 787 (876)
T ss_dssp SSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB-------
T ss_pred hccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC-------
Confidence 332 226777777777776 5666665 67777777777777775 56667777777777777765
Q ss_pred hhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCCcccccCcceeEEEecccccccCCCcc-ccccC
Q 043053 524 ELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNK-LFRQL 602 (1058)
Q Consensus 524 ~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~~~~ 602 (1058)
++++|++.+.+|..|.++++|+.|+|++|+|...+..+. ++|+.|+|++|++....+... .....
T Consensus 788 ------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~ 853 (876)
T 4ecn_A 788 ------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEA 853 (876)
T ss_dssp ------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHT
T ss_pred ------------CcccccccccChHHHhcCCCCCEEECCCCCCCccCHhhc--CCCCEEECCCCCCCccChHHccccccc
Confidence 356799999999999999999999999999965655554 699999999999986554321 22234
Q ss_pred CCccccCCcccc--cCC
Q 043053 603 SPTDLAGNEGLC--SSR 617 (1058)
Q Consensus 603 ~~~~~~~n~~~c--~~~ 617 (1058)
....+.+|++.| +|+
T Consensus 854 ~~~~L~~n~~~~I~gC~ 870 (876)
T 4ecn_A 854 GMYVLLYDKTQDIRGCD 870 (876)
T ss_dssp TCCEEECCTTSEEESCG
T ss_pred hheeecCCCccccCCCC
Confidence 455666666544 554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=451.09 Aligned_cols=450 Identities=22% Similarity=0.218 Sum_probs=283.0
Q ss_pred EeecCCCCCCCCCccccCCCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCC
Q 043053 5 ITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQL 84 (1058)
Q Consensus 5 ~~~~~~~~~~~~p~~~~~~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~ 84 (1058)
+.+..-.++ .+|..+. ++|++|+|++|++++..|..++++++|++|+|++|++++..|..++++++|++|+|++|++
T Consensus 5 l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 81 (520)
T 2z7x_B 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81 (520)
T ss_dssp EECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCC
T ss_pred EecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCce
Confidence 344444443 5666555 8999999999999966667899999999999999999977789999999999999999999
Q ss_pred CCccccccccchhhhHHhhhhccccC-CChhhhcccccchhhhcCCCccccCCCCccccCCCCC--ceecccCccc--cc
Q 043053 85 TGKIPVELSNCKSLRKLLLFDNALAG-NIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNM--TALGLADTQV--SG 159 (1058)
Q Consensus 85 ~~~~p~~l~~l~~L~~L~L~~n~~~~-~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L--~~L~l~~~~~--~~ 159 (1058)
+ .+|.. .+++|++|+|++|.+.+ .+|..++++++|++|++++|. +.. ..++.+++| ++|++++|.+ .+
T Consensus 82 ~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~--l~~--~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 82 V-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH--LEK--SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp C-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESS--CCG--GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred e-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcc--cch--hhccccccceeeEEEeecccccccc
Confidence 8 78877 89999999999999986 467888888888888888775 211 234445555 5555555555 44
Q ss_pred cCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCC-CCcCCCCCcceeeccccc-------ccC
Q 043053 160 SLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIP-PEIGKLKKLEELFLWQNS-------LVG 231 (1058)
Q Consensus 160 ~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~-------l~~ 231 (1058)
..|..+..+.. +...+++++|.+.+.++ ..+..+++|+.|++++|. +.+
T Consensus 155 ~~~~~l~~l~~-----------------------~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 211 (520)
T 2z7x_B 155 EDPEGLQDFNT-----------------------ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211 (520)
T ss_dssp CCTTTTTTCCE-----------------------EEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHH
T ss_pred ccccccccccc-----------------------ceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeec
Confidence 44555444431 12233444444433322 233344444444444443 322
Q ss_pred CCCccccCcCCccEEEeecCCCcCcCCcccc---ccCCcceeecccCccCCCccccc-----cccccchhhhhcCCcccC
Q 043053 232 AIPEEIGNCTSLKMIDFSLNSLSGTIPLSIG---GLSELEEFMISDNNVSGSIPANL-----ANATNLVQLQLDTNQISG 303 (1058)
Q Consensus 232 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~i~~ 303 (1058)
.++ .+..+++|+.|++++|.+.+..+..+. .+++|++|++++|++.+..|..+ ..+++|+.+++++|.+ .
T Consensus 212 ~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~ 289 (520)
T 2z7x_B 212 ILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-G 289 (520)
T ss_dssp HHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-C
T ss_pred chh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-e
Confidence 222 344444555555544444432111111 12345555555555544444444 4455555555555554 2
Q ss_pred cCCCccccc---chhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCC--CCC
Q 043053 304 LIPPEIGML---SKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISG--SIP 378 (1058)
Q Consensus 304 ~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~ 378 (1058)
+....+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++..|..+..+++|++|++++|++++ ..|
T Consensus 290 ~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~ 367 (520)
T 2z7x_B 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA 367 (520)
T ss_dssp SCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHH
T ss_pred cchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccch
Confidence 211233332 33555555555544321 12456666677777777666666666666677777777776664 334
Q ss_pred CCccCCCCCcEEEccCccccC-CccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCC
Q 043053 379 PEIGNCSSLVRLRVGNNRIAG-LIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLS 457 (1058)
Q Consensus 379 ~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 457 (1058)
..+..+++|++|++++|++++ +.+..|..+++|++|+|++|++++..|..+. ++|+.|++++|+|+ .+|..+..++
T Consensus 368 ~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~ 444 (520)
T 2z7x_B 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLE 444 (520)
T ss_dssp HHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred HHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCC
Confidence 556777777777777777776 4334567777777777777777665555543 67777777777777 4566666777
Q ss_pred CCCeeecCCCccccCCcc-cccccccccccccccccCCC
Q 043053 458 GLQVLDVSDNRFSGQIPA-SLGRLVSLNKIILSKNLFSG 495 (1058)
Q Consensus 458 ~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~ 495 (1058)
+|++|++++|+|++ +|. .|..+++|+.|+|++|++.+
T Consensus 445 ~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c 482 (520)
T 2z7x_B 445 ALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDC 482 (520)
T ss_dssp TCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcc
Confidence 77777777777773 444 37777777777787777764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=450.54 Aligned_cols=536 Identities=20% Similarity=0.193 Sum_probs=378.4
Q ss_pred EEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhcc
Q 043053 28 TLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNA 107 (1058)
Q Consensus 28 ~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n~ 107 (1058)
+.+-++.+++ .+|..+- .++++|||++|+|++..|.+|.++++|++|+|++|++.+..|..|.+|++|++|+|++|+
T Consensus 35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 4456666665 5666553 367777777777773334567777777777777777775555567777777777777777
Q ss_pred ccCCChhhhcccccchhhhcCCCccccCCCCc-cccCCCCCceecccCccccc-cCCccccCCCccceeeeecccccccc
Q 043053 108 LAGNIPAELGRLSNLEEMRAGGNKDIVGKIPA-ELGDCSNMTALGLADTQVSG-SLPASLGKLSKLQTLSIYTTMISGEI 185 (1058)
Q Consensus 108 ~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~-~l~~l~~L~~L~l~~~~~~~-~~~~~l~~l~~L~~L~l~~n~i~~~~ 185 (1058)
+.+..+..|++|++|++|++++|. +..++. .++++++|++|++++|++.+ ..|..++.+++|++|++++|++.+..
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N~--l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 189 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVETN--LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 189 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTSC--CCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred CCCCCHHHhcCCCCCCEEECCCCc--CCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccc
Confidence 763333557777777777777775 444544 46777777888887777764 35667777788888888888777666
Q ss_pred CccccCCCCc----cEEEccCCcCCCCCCCCcCCCCCcceeecccccccCC-CCccccCcCCccEEEeecCCCc------
Q 043053 186 PAEIGNCSEL----VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGA-IPEEIGNCTSLKMIDFSLNSLS------ 254 (1058)
Q Consensus 186 ~~~l~~l~~L----~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~------ 254 (1058)
+..+..+.++ ..++++.|.+....+. ......++.|++.+|..... .+..+..+..++...+..+...
T Consensus 190 ~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~-~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~ 268 (635)
T 4g8a_A 190 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 268 (635)
T ss_dssp GGGGHHHHTCTTCCCEEECTTCCCCEECTT-TTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred cccccchhhhhhhhhhhhcccCcccccCcc-cccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccc
Confidence 6666654443 3677777777743333 33444567777777654321 2234556666666665443322
Q ss_pred CcCCccccccCCcceeecccCccCCC---ccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCCh
Q 043053 255 GTIPLSIGGLSELEEFMISDNNVSGS---IPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPS 331 (1058)
Q Consensus 255 ~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 331 (1058)
......+..+..+....+..+..... ....+..+.+++.+++.+|.+... ..+.....++.|++.+|.+....+
T Consensus 269 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~- 345 (635)
T 4g8a_A 269 KFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPT- 345 (635)
T ss_dssp CCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCC-
T ss_pred cccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCc-
Confidence 22233444555555555554433321 233455566777777777776654 235556677777888877765543
Q ss_pred hhhccCcccccccccccccccCcccccccccchhhhccccCCCC--CCCCCccCCCCCcEEEccCccccCCccccccCcc
Q 043053 332 TLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISG--SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLK 409 (1058)
Q Consensus 332 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 409 (1058)
..+..|+.++++.|.+.. +.....+++|+.|++++|.+.. ..+..+..+.+|+.|++..|.+... +..+..++
T Consensus 346 --~~l~~L~~l~l~~n~~~~--~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~-~~~~~~l~ 420 (635)
T 4g8a_A 346 --LKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITM-SSNFLGLE 420 (635)
T ss_dssp --CBCTTCCEEEEESCCSCC--BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEE-CSCCTTCT
T ss_pred --ccchhhhhcccccccCCC--Ccccccccccccchhhccccccccccccchhhhhhhhhhhccccccccc-cccccccc
Confidence 345677788888887763 2334567888888888888753 3455566778899999999988754 55688899
Q ss_pred ccceeeccCccCCCCC-CCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccc-cCCcccccccccccccc
Q 043053 410 TLNFLDLSSNRLSGSV-PDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS-GQIPASLGRLVSLNKII 487 (1058)
Q Consensus 410 ~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~ 487 (1058)
+|+.+++++|...... +..|..+++++.+++++|.+.+..+..+..++.|+.|+|++|.+. +..|..|..+++|+.|+
T Consensus 421 ~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~ 500 (635)
T 4g8a_A 421 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 500 (635)
T ss_dssp TCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred cccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEE
Confidence 9999999888776544 356788899999999999999888889999999999999999754 45778899999999999
Q ss_pred cccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCccc
Q 043053 488 LSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE 567 (1058)
Q Consensus 488 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 567 (1058)
|++|+|++..|..|..+++|++|+|++|+|++..| ..|.++++|+.|||++|+|+
T Consensus 501 Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~-------------------------~~~~~l~~L~~L~Ls~N~l~ 555 (635)
T 4g8a_A 501 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT-------------------------FPYKCLNSLQVLDYSLNHIM 555 (635)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCC-------------------------GGGTTCTTCCEEECTTSCCC
T ss_pred CCCCccCCcChHHHcCCCCCCEEECCCCcCCCCCh-------------------------hHHhCCCCCCEEECCCCcCC
Confidence 99999999889999999999999999999885433 44577889999999999999
Q ss_pred CCC-Cccccc-CcceeEEEecccccccCCCccccccC
Q 043053 568 GNL-NPLAQL-DNLVSLNISYNKFTGYLPDNKLFRQL 602 (1058)
Q Consensus 568 ~~~-~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~~~~ 602 (1058)
+.+ ..+..+ ++|+.|++++|+|+|.|...+..+|+
T Consensus 556 ~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl 592 (635)
T 4g8a_A 556 TSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWI 592 (635)
T ss_dssp BCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHH
T ss_pred CCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHH
Confidence 876 456777 68999999999999999765544444
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=410.84 Aligned_cols=264 Identities=23% Similarity=0.288 Sum_probs=201.0
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+| +..+|+.||||++.... ......+.+.+|+++|++++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~---------~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 124 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF---------DVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 124 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT---------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc---------cchHHHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence 57999999999999999999 56789999999985331 233345788999999999999999999998764
Q ss_pred C------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 783 R------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 783 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
. +..|+|||||+ |+|.+++.. ...+++..+..++.||+.||+|||++ +||||||||+|||++.++.+|
T Consensus 125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 125 TVPYGEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp SSCTTTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEE
T ss_pred ccccccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEE
Confidence 3 56799999996 689999976 46799999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCC--cccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 857 IADFGLAKLVDDGD--FARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 857 l~DfGl~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
|+|||+|+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.. .......+.
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~~~~l~~I~ 276 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--YVHQLQLIM 276 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHH
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--HHHHHHHHH
Confidence 99999998764432 12234567899999999998775 56899999999999999999999997542 112111111
Q ss_pred hhcCc-c--ccC-----------CCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 934 QKKGI-Q--VLD-----------PSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 934 ~~~~~-~--~~~-----------~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
..... . ... .......+..... ...+.+++.+||..||++|||++|++++-
T Consensus 277 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 277 MVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp HHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 11100 0 000 0000000100111 12345688999999999999999998864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=403.92 Aligned_cols=200 Identities=27% Similarity=0.385 Sum_probs=170.5
Q ss_pred HHhhccccceeccccceEEEEEEe----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 702 VLKCLVDANVIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
+.++|++.+.||+|+||+||+|.. .+++.||||++.+. ....++.+|+++++.+ +|||||++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-------------~~~~~~~~E~~~l~~~~~h~nIv~l 85 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-------------SHPIRIAAELQCLTVAGGQDNVMGV 85 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-------------SCHHHHHHHHHHHHHTCSBTTBCCC
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-------------cCHHHHHHHHHHHHHhcCCCCCceE
Confidence 446799999999999999999943 25788999988432 2245788999999998 59999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC-CCe
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE-FEP 855 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~-~~~ 855 (1058)
++++.+++..|+||||++||+|.++++ .+++..+..++.|++.||+|||++ |||||||||+|||++.+ +.+
T Consensus 86 ~~~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~ 157 (361)
T 4f9c_A 86 KYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKY 157 (361)
T ss_dssp SEEEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEE
T ss_pred EEEEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeE
Confidence 999999999999999999999999984 388999999999999999999999 99999999999999877 799
Q ss_pred eeeccccceeccCCCcc--------------------------cccccccCcCCccCccccccC-CCCcccchhhHHHHH
Q 043053 856 YIADFGLAKLVDDGDFA--------------------------RSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVV 908 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl 908 (1058)
||+|||+|+........ ......+||+.|||||++.+. .++.++||||+||++
T Consensus 158 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il 237 (361)
T 4f9c_A 158 ALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237 (361)
T ss_dssp EECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred EECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHH
Confidence 99999999865432210 112346799999999998775 589999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 043053 909 LEVLTGKQPIDPTI 922 (1058)
Q Consensus 909 ~elltg~~P~~~~~ 922 (1058)
|||++|+.||....
T Consensus 238 ~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 238 LSLLSGRYPFYKAS 251 (361)
T ss_dssp HHHHHTCSSSSCCS
T ss_pred HHHHHCCCCCCCCC
Confidence 99999999997543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=419.00 Aligned_cols=256 Identities=20% Similarity=0.218 Sum_probs=202.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.++||+|+||+||+| +..+|+.||||++.+...... ...........++.+++.++|||||+++++|.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~-----~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchh-----hhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 67999999999999999999 566899999999965433211 112222333455778888899999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+|||||+||+|.+++... +.+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccce
Confidence 99999999999999999999864 6799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
|+..... ...+.+||+.|||||++. +..|+.++||||+||++|||++|+.||......... ...+.... .
T Consensus 339 A~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~~~i~~---~ 409 (689)
T 3v5w_A 339 ACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT---M 409 (689)
T ss_dssp CEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHHHHHHH---C
T ss_pred eeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhhcC---C
Confidence 9877543 234678999999999986 457999999999999999999999999754332221 11111111 1
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAML 984 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~l 984 (1058)
....+...+. .+.+++..||++||++|++ ++||.++-
T Consensus 410 ~~~~p~~~S~------~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 410 AVELPDSFSP------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp CCCCCTTSCH------HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred CCCCCccCCH------HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 1122222232 2345778899999999998 68887654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=436.35 Aligned_cols=540 Identities=21% Similarity=0.223 Sum_probs=391.6
Q ss_pred CCCCCCCCCCcc---cEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhccccCCChhh
Q 043053 39 SIPFDIGDCVGL---IVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAE 115 (1058)
Q Consensus 39 ~~p~~l~~l~~L---~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~ 115 (1058)
.+|.....|... +..+=++.+++ .+|..+- .++++|||++|+|++..|..|.++++|++|+|++|.+.+..|..
T Consensus 19 ~~p~~~~~c~~~~~~~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~ 95 (635)
T 4g8a_A 19 SIPESWEPCVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 95 (635)
T ss_dssp ------CCSEEEETTTEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTT
T ss_pred CCCCCCCCccccCCCCEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhH
Confidence 456655555433 24455566787 8897653 48999999999999656678999999999999999998545567
Q ss_pred hcccccchhhhcCCCccccCCCCc-cccCCCCCceecccCccccccCCccccCCCccceeeeecccccc-ccCccccCCC
Q 043053 116 LGRLSNLEEMRAGGNKDIVGKIPA-ELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISG-EIPAEIGNCS 193 (1058)
Q Consensus 116 l~~l~~L~~L~l~~~~~~~~~l~~-~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~-~~~~~l~~l~ 193 (1058)
|++|++|++|++++|. +..+|. .|+.+++|++|++++|++++..+..|+++++|++|++++|.+.+ ..|..++.++
T Consensus 96 f~~L~~L~~L~Ls~N~--l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~ 173 (635)
T 4g8a_A 96 YQSLSHLSTLILTGNP--IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 173 (635)
T ss_dssp TTTCTTCCEEECTTCC--CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred hcCCCCCCEEEccCCc--CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccch
Confidence 9999999999999997 566665 58899999999999999997777789999999999999999976 4678899999
Q ss_pred CccEEEccCCcCCCCCCCCcCCCCCcc----eeecccccccCCCCccccCcCCccEEEeecCCCcC-cCCccccccCCcc
Q 043053 194 ELVSLFLYENSLSGSIPPEIGKLKKLE----ELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSG-TIPLSIGGLSELE 268 (1058)
Q Consensus 194 ~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~ 268 (1058)
+|++|+|++|.+++..+..|..+.+++ .++++.|.+....+..+ ....+..+++++|.... ..+..+.++..++
T Consensus 174 ~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~ 252 (635)
T 4g8a_A 174 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE 252 (635)
T ss_dssp TCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCE
T ss_pred hhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccc
Confidence 999999999999987787777665544 68899999985555444 44567889999987653 3345567778777
Q ss_pred eeecccCc------cCCCccccccccccchhhhhcCCcccC---cCCCcccccchhhhhhccCcccCCCCChhhhccCcc
Q 043053 269 EFMISDNN------VSGSIPANLANATNLVQLQLDTNQISG---LIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339 (1058)
Q Consensus 269 ~L~l~~n~------l~~~~~~~~~~l~~L~~L~L~~N~i~~---~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 339 (1058)
...+..+. +.......+..+..+..+++..+.... .....+..+.+++.+.+.++.+.... .+....+|
T Consensus 253 ~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L 330 (635)
T 4g8a_A 253 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGW 330 (635)
T ss_dssp EEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCC
T ss_pred cccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhh
Confidence 76665443 222333445555555555555443322 23344556666777777777665432 35556677
Q ss_pred cccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccC--CccccccCccccceeecc
Q 043053 340 QALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAG--LIPREIGGLKTLNFLDLS 417 (1058)
Q Consensus 340 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls 417 (1058)
+.|++++|.+....+ ..+..|+.+++..|.+... ..+..+++|+.|++++|.+.. ..+..+..+.+|++|+++
T Consensus 331 ~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~ 405 (635)
T 4g8a_A 331 QHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLS 405 (635)
T ss_dssp SEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECC
T ss_pred hhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcc
Confidence 777777777764332 2345666777777766532 234567777777777777753 234455566777777777
Q ss_pred CccCCCCCCCcccCCcccchhhccCCccCCCC-ccccccCCCCCeeecCCCccccCCcccccccccccccccccccCC-C
Q 043053 418 SNRLSGSVPDEIGDCTELQMIDLSHNTLQGSL-PNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFS-G 495 (1058)
Q Consensus 418 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~ 495 (1058)
.|.+. ..+..+..+++|+.+++++|.+.... +..|..+.+++.+++++|.+.+..+..+..++.|+.|+|++|.+. +
T Consensus 406 ~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~ 484 (635)
T 4g8a_A 406 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 484 (635)
T ss_dssp SCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGG
T ss_pred ccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccc
Confidence 77766 34455667777777777777655433 345677777777777777777777777777777777777777643 3
Q ss_pred CCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCC-Cccc
Q 043053 496 PIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNL-NPLA 574 (1058)
Q Consensus 496 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~ 574 (1058)
..|..|..+++|+.|+|++|+|++ ..|.+|.++++|++|+|++|+|++.+ ..+.
T Consensus 485 ~~~~~~~~l~~L~~L~Ls~N~L~~-------------------------l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~ 539 (635)
T 4g8a_A 485 FLPDIFTELRNLTFLDLSQCQLEQ-------------------------LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 539 (635)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCE-------------------------ECTTTTTTCTTCCEEECTTSCCCBCCCGGGT
T ss_pred cCchhhhhccccCEEECCCCccCC-------------------------cChHHHcCCCCCCEEECCCCcCCCCChhHHh
Confidence 466777777777777777777764 44556688999999999999999976 4688
Q ss_pred ccCcceeEEEecccccccCCCcc--ccccCCCccccCCcccccCC
Q 043053 575 QLDNLVSLNISYNKFTGYLPDNK--LFRQLSPTDLAGNEGLCSSR 617 (1058)
Q Consensus 575 ~l~~L~~L~l~~N~l~~~~~~~~--~~~~~~~~~~~~n~~~c~~~ 617 (1058)
.+++|+.|++++|++++..|..- ....++..++.+|||.|+|.
T Consensus 540 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 540 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99999999999999999988742 23678889999999999885
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=429.94 Aligned_cols=458 Identities=19% Similarity=0.193 Sum_probs=316.7
Q ss_pred CCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhh
Q 043053 24 KHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLL 103 (1058)
Q Consensus 24 ~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L 103 (1058)
...+++++++++++ .+|..+. ++|++|+|++|+|++..|.+++++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 31 ~~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 107 (562)
T 3a79_B 31 ELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV 107 (562)
T ss_dssp --CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEEC
Confidence 34466777777766 4666553 56777777777776444466777777777777777766555666666666666666
Q ss_pred hhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccc-cCCccccCCCccceeeeeccccc
Q 043053 104 FDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSG-SLPASLGKLSKLQTLSIYTTMIS 182 (1058)
Q Consensus 104 ~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~-~~~~~l~~l~~L~~L~l~~n~i~ 182 (1058)
++|.+. .+|.. .+++|++|++++|++.+ ..|..|+++++|++|++++|.+.
T Consensus 108 s~N~l~-~lp~~---------------------------~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~ 159 (562)
T 3a79_B 108 SHNRLQ-NISCC---------------------------PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159 (562)
T ss_dssp TTSCCC-EECSC---------------------------CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCC
T ss_pred CCCcCC-ccCcc---------------------------ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccc
Confidence 666655 44433 34555555555555553 23456666666666666666665
Q ss_pred cccCccccCCCCc--cEEEccCCcC--CCCCCCCcCCCC-CcceeecccccccCCCCc-cccCcCCccEEEeecCCCc--
Q 043053 183 GEIPAEIGNCSEL--VSLFLYENSL--SGSIPPEIGKLK-KLEELFLWQNSLVGAIPE-EIGNCTSLKMIDFSLNSLS-- 254 (1058)
Q Consensus 183 ~~~~~~l~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~L~~n~l~-- 254 (1058)
+. .+..+++| +.|++++|.+ ++..|..|..+. ..-.+++++|.+.+..+. .+..+++|+.|++++|...
T Consensus 160 ~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 236 (562)
T 3a79_B 160 QL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ 236 (562)
T ss_dssp TT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH
T ss_pred cC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccc
Confidence 42 23333333 6666666666 555555555543 111445666665544433 3456667777777766411
Q ss_pred --CcCCccccccCCcceeecccCccCCCcccc---ccccccchhhhhcCCcccCcCCCcc-----cccchhhhhhccCcc
Q 043053 255 --GTIPLSIGGLSELEEFMISDNNVSGSIPAN---LANATNLVQLQLDTNQISGLIPPEI-----GMLSKLTVFFAWQNQ 324 (1058)
Q Consensus 255 --~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---~~~l~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~l~~N~ 324 (1058)
......+.++++|+.|+++++.+.+..... ....++|++|++++|++++..|..+ ..++.|+.+++..|.
T Consensus 237 ~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~ 316 (562)
T 3a79_B 237 RLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQV 316 (562)
T ss_dssp HHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECC
T ss_pred hHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccce
Confidence 011223556667777776666654321111 1123477778888887777667666 667777777777776
Q ss_pred cCCCCC-hhhhcc---CcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCC
Q 043053 325 LEGSIP-STLASC---SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGL 400 (1058)
Q Consensus 325 l~~~~~-~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 400 (1058)
+ .+| ..+..+ .+|+.|++++|.+.... ....+++|++|++++|.+++..|..+.++++|+.|+|++|+++++
T Consensus 317 ~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 392 (562)
T 3a79_B 317 F--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNF 392 (562)
T ss_dssp C--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBT
T ss_pred e--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCc
Confidence 6 233 333332 67999999999987422 126789999999999999998999999999999999999999975
Q ss_pred c--cccccCccccceeeccCccCCC-CCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccc
Q 043053 401 I--PREIGGLKTLNFLDLSSNRLSG-SVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL 477 (1058)
Q Consensus 401 ~--~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 477 (1058)
. |..|..+++|++|+|++|++++ ..+..+..+++|+.|++++|++++..|..+. ++|++|+|++|+|+ .+|..+
T Consensus 393 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~ 469 (562)
T 3a79_B 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDV 469 (562)
T ss_dssp THHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTT
T ss_pred ccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhh
Confidence 4 4679999999999999999998 4445688999999999999999876666554 79999999999998 677777
Q ss_pred cccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCC
Q 043053 478 GRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 478 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+..|
T Consensus 470 ~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 470 THLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp TSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred cCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 799999999999999996444459999999999999999997655
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=430.37 Aligned_cols=458 Identities=20% Similarity=0.208 Sum_probs=296.3
Q ss_pred hhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccC
Q 043053 123 EEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYE 202 (1058)
Q Consensus 123 ~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~ 202 (1058)
+++++++|. ...+|..+. ++|++|++++|.+.+..+..|+++++|++|++++|.+++..|..|.++++|++|+|++
T Consensus 34 ~~l~ls~~~--L~~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRN--LTHVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSC--CCSCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred cEEEcCCCC--CccCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 444555544 334554443 5566666666666655555666666666666666666655566666666666666666
Q ss_pred CcCCCCCCCCcCCCCCcceeecccccccCC-CCccccCcCCccEEEeecCCCcCcCCccccccCCc--ceeecccCcc--
Q 043053 203 NSLSGSIPPEIGKLKKLEELFLWQNSLVGA-IPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSEL--EEFMISDNNV-- 277 (1058)
Q Consensus 203 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~l~~n~l-- 277 (1058)
|.++ .+|.. .+++|++|+|++|++.+. .|..|+++++|++|++++|.+++. .+..+++| ++|++++|.+
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 6666 44444 566666666666666542 245666666666666666666542 23344444 6666666666
Q ss_pred CCCccccccccc-cchhhhhcCCcccCcCCC-cccccchhhhhhccCcc-----cCCCCChhhhccCccccccccccccc
Q 043053 278 SGSIPANLANAT-NLVQLQLDTNQISGLIPP-EIGMLSKLTVFFAWQNQ-----LEGSIPSTLASCSNLQALDLSHNSLT 350 (1058)
Q Consensus 278 ~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~-~~~~l~~L~~L~l~~N~-----l~~~~~~~~~~l~~L~~L~Ls~N~l~ 350 (1058)
.+..|..+..+. ....+++++|.+.+..+. .+..+++|+.+++++|+ +.+ ....|..+++|+.|+++++.+.
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEEC
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCc
Confidence 555555555543 111345666665543332 34556666666666663 111 1234666777777777777665
Q ss_pred ccCccc---ccccccchhhhccccCCCCCCCCCc-----cCCCCCcEEEccCccccCCccccccCc---cccceeeccCc
Q 043053 351 ASVPAG---LFQLQNLTKLLLISNDISGSIPPEI-----GNCSSLVRLRVGNNRIAGLIPREIGGL---KTLNFLDLSSN 419 (1058)
Q Consensus 351 ~~~~~~---~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~N 419 (1058)
+..... ....++|++|++++|.+++.+|..+ .+++.|+.++++.|.+ .+....+..+ .+|++|++++|
T Consensus 263 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~~~~~~~~~~~~L~~L~l~~n 341 (562)
T 3a79_B 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSKEALYSVFAEMNIKMLSISDT 341 (562)
T ss_dssp HHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCHHHHHHHHHTCCCSEEEEESS
T ss_pred HHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecChhhhhhhhccCcceEEEccCC
Confidence 321111 1123478888888888877777766 6666677777777766 2322333332 56888888888
Q ss_pred cCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccC--CcccccccccccccccccccCCCCC
Q 043053 420 RLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQ--IPASLGRLVSLNKIILSKNLFSGPI 497 (1058)
Q Consensus 420 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~ 497 (1058)
.+.... ....+++|+.|++++|++++..|..+.++++|++|+|++|++++. +|..|..+++|+.|+|++|++.+.+
T Consensus 342 ~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 419 (562)
T 3a79_B 342 PFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHA 419 (562)
T ss_dssp CCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCC
T ss_pred Cccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCcc
Confidence 775322 125677888888888888877777788888888888888888753 2456777888888888888887734
Q ss_pred C-CcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCCc-ccc
Q 043053 498 P-SSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP-LAQ 575 (1058)
Q Consensus 498 ~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~ 575 (1058)
| ..+..+++|+.|++++|++++.+|..+. ..++ .|++++|+++. +|..+.++++|+.|||++|+|++.+.. +..
T Consensus 420 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~-~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~ 495 (562)
T 3a79_B 420 YDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVK-VLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDR 495 (562)
T ss_dssp SSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCS-EEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCCCCCTTSTTT
T ss_pred ChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCC-EEECCCCcCcc-cChhhcCCCCCCEEECCCCCCCCCCHHHHhc
Confidence 4 4577778888888888888776666553 2222 47788888874 555556999999999999999987766 889
Q ss_pred cCcceeEEEecccccccCCCccc
Q 043053 576 LDNLVSLNISYNKFTGYLPDNKL 598 (1058)
Q Consensus 576 l~~L~~L~l~~N~l~~~~~~~~~ 598 (1058)
+++|+.|++++|+|+|.||..+.
T Consensus 496 l~~L~~L~l~~N~~~c~c~~~~~ 518 (562)
T 3a79_B 496 LTSLQYIWLHDNPWDCTCPGIRY 518 (562)
T ss_dssp CTTCCCEECCSCCBCCCHHHHHH
T ss_pred CCCCCEEEecCCCcCCCcchHHH
Confidence 99999999999999999986544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=416.37 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=209.5
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.++++|.+.+.||+|+||+||+| +..+|+.||||++... .....+.+.+|+++|+.++|||||+++++
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-----------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 222 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----------HESDKETVRKEIQTMSVLRHPTLVNLHDA 222 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------SHHHHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-----------chhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34678999999999999999999 6678999999998432 22345788999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC--CCeee
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE--FEPYI 857 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~--~~~kl 857 (1058)
|.+++..|+|||||+||+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 223 ~~~~~~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl 298 (573)
T 3uto_A 223 FEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298 (573)
T ss_dssp EECSSEEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEECCEEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEE
Confidence 99999999999999999999999753 46799999999999999999999999 99999999999999864 89999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+|||+|+...... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+...
T Consensus 299 ~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--~~~~~~~i~~~-- 371 (573)
T 3uto_A 299 IDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSC-- 371 (573)
T ss_dssp CCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTT--
T ss_pred eeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHhC--
Confidence 9999999876543 3345689999999999999999999999999999999999999997542 12222222211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
...+.+......+. .+.+++.+||+.||++|||++|++++-
T Consensus 372 ~~~~~~~~~~~~s~------~~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 372 DWNMDDSAFSGISE------DGKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp CCCCCSGGGTTSCH------HHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CCCCCcccccCCCH------HHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 11111222222222 234578899999999999999999853
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=375.68 Aligned_cols=274 Identities=36% Similarity=0.605 Sum_probs=221.4
Q ss_pred HHHhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
...++|...+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++||||+++++++
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-----------SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-----------CSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-----------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345789999999999999999998888999999987432 233467899999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
.+++..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999997643 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC-hhHHHHHHhhc-
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG-SHVVDWVRQKK- 936 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~-~~~~~~~~~~~- 936 (1058)
|||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||....+.. .....|.....
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 9999987654333333445668999999999988899999999999999999999999997654432 23333332211
Q ss_pred ---CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 937 ---GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 937 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.....++........ .....+.+++.+||+.||++|||++|++++|+.+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTCCCSSSSSSCTTCSCH--HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cccHHHhcChhhccccCH--HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 112223333222222 2333455689999999999999999999999887543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=379.59 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=212.9
Q ss_pred hhccccceeccccceEEEEEEe--------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCccc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM--------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIV 774 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 774 (1058)
++|.+.+.||+|+||.||+|.. .++..||||++... ......+.+.+|+++++++ +||||+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hpnIv 150 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----------ATEKDLSDLVSEMEMMKMIGKHKNII 150 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----------CBHHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----------cCHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 6899999999999999999954 24567999998533 2334467899999999999 899999
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeC
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 840 (1058)
++++++.+++..|+||||+++|+|.++++... ...+++..++.++.||++||+|||+. +|+||
T Consensus 151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHr 227 (370)
T 2psq_A 151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHR 227 (370)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred eEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceecc
Confidence 99999999999999999999999999998643 23588999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 043053 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 919 (1058)
Q Consensus 841 Dikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 919 (1058)
||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999997765544344455668899999999999999999999999999999999 999997
Q ss_pred CCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 920 PTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
... .......+.... .+......+. + +..++..||+.||++|||+.|+++.|+++...
T Consensus 308 ~~~--~~~~~~~~~~~~-----~~~~~~~~~~---~---l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 308 GIP--VEELFKLLKEGH-----RMDKPANCTN---E---LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp TCC--GGGHHHHHHTTC-----CCCCCTTSCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC--HHHHHHHHhcCC-----CCCCCCCCCH---H---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 542 223333222221 1111112222 2 33477889999999999999999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=369.30 Aligned_cols=260 Identities=30% Similarity=0.437 Sum_probs=200.9
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.+|.+.+.||+|+||+||+|.. +|+.||||++.... ......+++.+|++++++++||||+++++++.+.
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQD---------FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCC---------CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCC---------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 6889999999999999999976 48999999985331 2334457899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCC--eEeCCCCCCcEEEcCCCCeeeecc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERT-GNALEWELRYQILLGAAQGLAYLHHDCVPP--IVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
+..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999997632 12489999999999999999999999 7 999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+ ......+.....
T Consensus 184 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--~~~~~~~~~~~~--- 256 (309)
T 3p86_A 184 GLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--AQVVAAVGFKCK--- 256 (309)
T ss_dssp C-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--HHHHHHHHHSCC---
T ss_pred CCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCC---
Confidence 9998654322 223456799999999999999999999999999999999999999975422 222222211111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
........+.. +..++.+||+.||++|||++++++.|+.+...
T Consensus 257 -~~~~~~~~~~~------l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 257 -RLEIPRNLNPQ------VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -CCCCCTTSCHH------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -CCCCCccCCHH------HHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11112222222 33477889999999999999999999887654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=374.11 Aligned_cols=269 Identities=26% Similarity=0.331 Sum_probs=208.2
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.++||+|+||+||+|... ++.||||++... ......+.+|+.++++++||||+++++++...
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ------------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG------------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC------------chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 57899999999999999999776 899999998432 22345667799999999999999999999875
Q ss_pred CC----ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhccccc-------CCCCeEeCCCCCCcEEEcCC
Q 043053 784 NN----RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHD-------CVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 784 ~~----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~~ivHrDikp~Nill~~~ 852 (1058)
.. .++||||+++|+|.++++. ..+++..++.++.|+++||+|||+. +.++|+||||||+||+++.+
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 54 5999999999999999976 3589999999999999999999985 12389999999999999999
Q ss_pred CCeeeeccccceeccCCCcccccccccCcCCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh-
Q 043053 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS- 926 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~- 926 (1058)
+.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 9999999999988765544344455679999999999876 3456788999999999999999999976433211
Q ss_pred ----------hHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 927 ----------HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 927 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
....+.... ......+...... ........+.+++.+||+.||++|||++++++.|+++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVV-VHKKKRPVLRDYW-QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHH-TTSCCCCCCCGGG-GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhccCCchhhhhhhh-hcccCCCCccccc-cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111111 1111111111111 1112223355689999999999999999999999988753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=368.44 Aligned_cols=251 Identities=22% Similarity=0.377 Sum_probs=204.4
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||+||+| +..+++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 87 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-----------QQPKKELIINEILVMRENKNPNIVNYLDSYL 87 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGG-----------GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecc-----------cccHHHHHHHHHHHHhcCCCCCCCeEeEEEE
Confidence 468999999999999999999 4578999999998533 2223577899999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
.++..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 161 (297)
T 3fxz_A 88 VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG 161 (297)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred ECCEEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCC
Confidence 99999999999999999999986 3589999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....+ ......+.......
T Consensus 162 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~-- 235 (297)
T 3fxz_A 162 FCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGTPE-- 235 (297)
T ss_dssp TCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHHCSCC--
T ss_pred CceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCC--
Confidence 998765433 233456799999999999999999999999999999999999999975422 11111111111111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.......+. .+.+++.+||+.||++|||++|++++
T Consensus 236 -~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 -LQNPEKLSA------IFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -CSCGGGSCH------HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCccccCH------HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111111 23347888999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=374.06 Aligned_cols=256 Identities=26% Similarity=0.361 Sum_probs=205.6
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||+||+| +..+++.||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 75 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----------AVDCPENIKKEICINKMLNHENVVKFYGHRR 75 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc----------ccchHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 468999999999999999999 45589999999984331 1223467889999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++..|+||||+++|+|.+++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg 150 (323)
T 3tki_A 76 EGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG 150 (323)
T ss_dssp CSSEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEee
Confidence 99999999999999999999975 35699999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
+++...............||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+......
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--- 227 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--- 227 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT---
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc---
Confidence 9987654433334456789999999999887765 778999999999999999999998664444444333322111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
..+ ....+. .+.+++.+||+.||++|||++|++++-
T Consensus 228 ~~~--~~~~~~------~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 228 LNP--WKKIDS------APLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp STT--GGGSCH------HHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CCc--cccCCH------HHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 110 111111 223578889999999999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=374.12 Aligned_cols=273 Identities=41% Similarity=0.692 Sum_probs=218.3
Q ss_pred HHhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
..++|...+.||+|+||.||+|...+|+.||||++.... .......+.+|++++++++||||+++++++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER----------TQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred HhhccccceeEecCCCcEEEEEEecCCCEEEEEEecccc----------CchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 347899999999999999999987789999999985432 1122346899999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
.++..++||||+++|+|.++++... ...+++..+..|+.|++.||+|||+.+.++|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999998643 34599999999999999999999998777999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC---CCCChhHHHHHHhhc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT---IPDGSHVVDWVRQKK 936 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~---~~~~~~~~~~~~~~~ 936 (1058)
||+++....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||+.. .........|.....
T Consensus 178 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 178 FGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred CccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999987654332 2334556999999999998888999999999999999999999999621 122334444544332
Q ss_pred Cccc----cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 937 GIQV----LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 937 ~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
.... .+....... .......+.+++..||+.||++|||+++++++|+..
T Consensus 257 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNY--KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SSCCSTTSSCTTCTTSC--CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hchhhhhhcChhhcccc--CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 2211 122222111 223344556689999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=369.64 Aligned_cols=259 Identities=25% Similarity=0.476 Sum_probs=210.7
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||+||+| +..+++.||+|++.. ......+.+.+|++++++++||||+++++++.+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----------FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----------CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 57899999999999999999 556799999998742 234456889999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGL 154 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred CCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeeccc
Confidence 99999999999999999999874 46799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCccc------------ccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh----
Q 043053 863 AKLVDDGDFAR------------SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS---- 926 (1058)
Q Consensus 863 ~~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~---- 926 (1058)
++......... ......||+.|+|||++.+..++.++||||||+++|||++|..||....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~ 234 (310)
T 3s95_A 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234 (310)
T ss_dssp CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB
T ss_pred ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh
Confidence 98765432111 11245799999999999999999999999999999999999999875433211
Q ss_pred hHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 927 HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
........ ......+.. +..++.+||+.||++|||++++++.|+.+.....
T Consensus 235 ~~~~~~~~---------~~~~~~~~~------l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 235 NVRGFLDR---------YCPPNCPPS------FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp CHHHHHHH---------TCCTTCCTT------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhhccccc---------cCCCCCCHH------HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11111111 111122222 3347778999999999999999999998876543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=391.37 Aligned_cols=373 Identities=21% Similarity=0.196 Sum_probs=292.1
Q ss_pred cCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeecccccccc-CccccCCCCccEEEccCCcCCCCCCCC
Q 043053 134 VGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEI-PAEIGNCSELVSLFLYENSLSGSIPPE 212 (1058)
Q Consensus 134 ~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~ 212 (1058)
...+|. + .++|++|++++|.+.+..|..|+++++|++|++++|.+.+.+ +..|.++++|++|+|++|.+++..|..
T Consensus 22 l~~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 98 (455)
T 3v47_A 22 LHQVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGA 98 (455)
T ss_dssp CSSCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTT
T ss_pred cccCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhh
Confidence 445555 2 267888888888888777888888888888888888876554 566888888888888888888777888
Q ss_pred cCCCCCcceeecccccccCCCCcc--ccCcCCccEEEeecCCCcCcCCcc-ccccCCcceeecccCccCCCcccccccc-
Q 043053 213 IGKLKKLEELFLWQNSLVGAIPEE--IGNCTSLKMIDFSLNSLSGTIPLS-IGGLSELEEFMISDNNVSGSIPANLANA- 288 (1058)
Q Consensus 213 ~~~l~~L~~L~L~~n~l~~~~~~~--l~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l- 288 (1058)
|+++++|++|+|++|.+.+..+.. |..+++|++|+|++|.+++..|.. +.++++|++|++++|.+.+..+..+..+
T Consensus 99 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 178 (455)
T 3v47_A 99 FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ 178 (455)
T ss_dssp TTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGT
T ss_pred ccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccc
Confidence 888888888888888887644443 788888888888888888776765 7788888888888888887777777766
Q ss_pred -ccchhhhhcCCcccCcCCCccc--------ccchhhhhhccCcccCCCCChhhhcc---CcccccccccccccccCccc
Q 043053 289 -TNLVQLQLDTNQISGLIPPEIG--------MLSKLTVFFAWQNQLEGSIPSTLASC---SNLQALDLSHNSLTASVPAG 356 (1058)
Q Consensus 289 -~~L~~L~L~~N~i~~~~~~~~~--------~l~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~ 356 (1058)
.+|+.|++++|.+.+..+..++ .+++|++|++++|++++..+..+..+ .+|+.|++++|.+.+..
T Consensus 179 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--- 255 (455)
T 3v47_A 179 GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--- 255 (455)
T ss_dssp TCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC---
T ss_pred cccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc---
Confidence 6788888888888766554432 33455555555555554444444333 45555555555443211
Q ss_pred ccccccchhhhccccCCCCCCCCCccC--CCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcc
Q 043053 357 LFQLQNLTKLLLISNDISGSIPPEIGN--CSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTE 434 (1058)
Q Consensus 357 ~~~l~~L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 434 (1058)
+..+.+....+..+.. .++|+.|++++|++++..|..|..+++|++|+|++|++++..|..|..+++
T Consensus 256 -----------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 324 (455)
T 3v47_A 256 -----------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324 (455)
T ss_dssp -----------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred -----------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCccc
Confidence 1112222233333433 368999999999999999999999999999999999999999999999999
Q ss_pred cchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccC
Q 043053 435 LQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSS 514 (1058)
Q Consensus 435 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 514 (1058)
|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|++++
T Consensus 325 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 404 (455)
T 3v47_A 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 404 (455)
T ss_dssp CCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccC
Confidence 99999999999988899999999999999999999988899999999999999999999988888889999999999999
Q ss_pred CcccCCCCh
Q 043053 515 NQLTGSVPM 523 (1058)
Q Consensus 515 N~l~~~~p~ 523 (1058)
|++++..|.
T Consensus 405 N~l~~~~~~ 413 (455)
T 3v47_A 405 NPWDCSCPR 413 (455)
T ss_dssp SCBCCCTTT
T ss_pred CCcccCCCc
Confidence 999988873
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=388.74 Aligned_cols=362 Identities=22% Similarity=0.236 Sum_probs=167.0
Q ss_pred CCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhccccCCChhhhcccccchhh
Q 043053 46 DCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEM 125 (1058)
Q Consensus 46 ~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L 125 (1058)
..++|++|++++|.+ +.+|.++++|++|++|+|++|++.+.+|..++++++|+.+++.+|.. .++++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 346667777777776 46777777777777777777766666777777777777776666642 345566
Q ss_pred hcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcC
Q 043053 126 RAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSL 205 (1058)
Q Consensus 126 ~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l 205 (1058)
++++|. ...+|.. .++|++|++++|.+.+ +|.. +++|+.|++++|.+++ ++.. .++|++|++++|.+
T Consensus 77 ~l~~~~--l~~lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l 143 (454)
T 1jl5_A 77 ELNNLG--LSSLPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQL 143 (454)
T ss_dssp ECTTSC--CSCCCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCC
T ss_pred EecCCc--cccCCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCC
Confidence 666665 3444432 2456666666666553 4432 2455566666655542 2211 14556666666655
Q ss_pred CCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccc
Q 043053 206 SGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANL 285 (1058)
Q Consensus 206 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 285 (1058)
++ +| .|+.+++|++|++++|++.+ +|..+ ++|++|++++|++++ +| .++++++|++|++++|.+++ +|..
T Consensus 144 ~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~- 213 (454)
T 1jl5_A 144 EK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL- 213 (454)
T ss_dssp SS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC-
T ss_pred CC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC-
Confidence 53 44 35555666666666665553 33322 355555555555554 33 35555555555555555553 2221
Q ss_pred cccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchh
Q 043053 286 ANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTK 365 (1058)
Q Consensus 286 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 365 (1058)
.++|++|++++|+++.+ | .|+.+++|++|++++|++++ +|.. .++|++
T Consensus 214 --~~~L~~L~l~~n~l~~l-p-~~~~l~~L~~L~l~~N~l~~-------------------------l~~~---~~~L~~ 261 (454)
T 1jl5_A 214 --PLSLESIVAGNNILEEL-P-ELQNLPFLTTIYADNNLLKT-------------------------LPDL---PPSLEA 261 (454)
T ss_dssp --CTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSS-------------------------CCSC---CTTCCE
T ss_pred --cCcccEEECcCCcCCcc-c-ccCCCCCCCEEECCCCcCCc-------------------------cccc---ccccCE
Confidence 13455555555555422 2 24444444444444444443 2221 134444
Q ss_pred hhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCC-cccchhhccCCc
Q 043053 366 LLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC-TELQMIDLSHNT 444 (1058)
Q Consensus 366 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~l~~N~ 444 (1058)
|++++|++++ +|.. +++|+.|++++|+++++. . -.++|++|++++|++++. + .+ ++|+.|++++|+
T Consensus 262 L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~-~---~~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~ 328 (454)
T 1jl5_A 262 LNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLS-E---LPPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNK 328 (454)
T ss_dssp EECCSSCCSC-CCCC---CTTCCEEECCSSCCSEES-C---CCTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSC
T ss_pred EECCCCcccc-cCcc---cCcCCEEECcCCccCccc-C---cCCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCc
Confidence 4444444443 2221 244555555555554321 0 013455555555555421 1 11 245555555555
Q ss_pred cCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCC
Q 043053 445 LQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495 (1058)
Q Consensus 445 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 495 (1058)
+++ +|.. +++|++|++++|+++ .+|. .+++|+.|+|++|++++
T Consensus 329 l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 329 LIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp CSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSS
T ss_pred ccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCc
Confidence 553 2322 344555555555554 2333 23455555555555554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=389.38 Aligned_cols=283 Identities=23% Similarity=0.254 Sum_probs=201.4
Q ss_pred CCCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHH
Q 043053 22 SFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKL 101 (1058)
Q Consensus 22 ~~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L 101 (1058)
+..+|++|++++|.+ |.+|.+++++++|++|++++|++++.+|.+++++.+|+.+++++|.. .+|++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 468999999999999 69999999999999999999999999999999999997777777742 456777
Q ss_pred hhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeecccc
Q 043053 102 LLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMI 181 (1058)
Q Consensus 102 ~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i 181 (1058)
++++|.+. .+|.. .++|++|++++|. ...+|.. +++|++|++++|++.+ ++.. .++|++|++++|.+
T Consensus 77 ~l~~~~l~-~lp~~---~~~L~~L~l~~n~--l~~lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l 143 (454)
T 1jl5_A 77 ELNNLGLS-SLPEL---PPHLESLVASCNS--LTELPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQL 143 (454)
T ss_dssp ECTTSCCS-CCCSC---CTTCSEEECCSSC--CSSCCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCC
T ss_pred EecCCccc-cCCCC---cCCCCEEEccCCc--CCccccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCC
Confidence 77777776 45542 3577888888776 4456653 3789999999998873 3322 16899999999999
Q ss_pred ccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccc
Q 043053 182 SGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSI 261 (1058)
Q Consensus 182 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~ 261 (1058)
++ +| .++++++|++|++++|.+++ +|..+ .+|++|++++|.+.+ +| .++.+++|++|++++|++++ +|..
T Consensus 144 ~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~- 213 (454)
T 1jl5_A 144 EK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL- 213 (454)
T ss_dssp SS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC-
T ss_pred CC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC-
Confidence 85 77 69999999999999999985 66544 589999999999996 55 69999999999999999986 4432
Q ss_pred cccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccc
Q 043053 262 GGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQA 341 (1058)
Q Consensus 262 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 341 (1058)
.++|++|++++|.+. .+| .+..+++|++|++++|+++++ |.. +++|+.|++++|++++. |.. .++|+.
T Consensus 214 --~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~N~l~~l-~~~---~~~L~~ 281 (454)
T 1jl5_A 214 --PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTL-PDL---PPSLEALNVRDNYLTDL-PEL---PQSLTF 281 (454)
T ss_dssp --CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSC-CSC---CTTCCEEECCSSCCSCC-CCC---CTTCCE
T ss_pred --cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCcc-ccc---ccccCEEECCCCccccc-Ccc---cCcCCE
Confidence 258999999999998 556 489999999999999999874 322 35666666666666652 222 255666
Q ss_pred cccccccccc
Q 043053 342 LDLSHNSLTA 351 (1058)
Q Consensus 342 L~Ls~N~l~~ 351 (1058)
|++++|++++
T Consensus 282 L~ls~N~l~~ 291 (454)
T 1jl5_A 282 LDVSENIFSG 291 (454)
T ss_dssp EECCSSCCSE
T ss_pred EECcCCccCc
Confidence 6666666654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=381.15 Aligned_cols=260 Identities=24% Similarity=0.398 Sum_probs=210.2
Q ss_pred hhccccceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+|... +++.||||++... ......++|.+|++++++++||||+++++++..
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET----------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT----------SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc----------CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 57899999999999999999654 7999999998532 123345678899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++|+|.++++.. +..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred CCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 99999999999999999999864 35689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.... .......+.....
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~--~~~~~~~~~~~~~---- 333 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS--NQQTREFVEKGGR---- 333 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC--HHHHHHHHHTTCC----
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC----
Confidence 987554332222223346788999999988889999999999999999998 999997542 2233333322211
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.......+. + +.+++..||+.||++|||++++++.|+++..+
T Consensus 334 -~~~~~~~~~---~---l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 334 -LPCPELCPD---A---VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -CCCCTTCCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCH---H---HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 111111222 2 33478889999999999999999999988653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=375.35 Aligned_cols=262 Identities=16% Similarity=0.164 Sum_probs=208.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 781 (1058)
++|.+.+.||+|+||+||+| +..+|+.||||++... ...+.+.+|+++++++ +||||+++++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 75 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-------------SRAPQLHLEYRFYKQLGSGDGIPQVYYFGP 75 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT-------------CSSCCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc-------------cchHHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence 57899999999999999999 4578999999987422 1124578999999999 8999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC-----ee
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE-----PY 856 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~-----~k 856 (1058)
.++..++||||+ +|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +|
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~k 150 (330)
T 2izr_A 76 CGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIH 150 (330)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred cCCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEE
Confidence 999999999999 99999999864 46799999999999999999999999 9999999999999998887 99
Q ss_pred eeccccceeccCCCcc-----cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh-hHHH
Q 043053 857 IADFGLAKLVDDGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS-HVVD 930 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~ 930 (1058)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~ 230 (330)
T 2izr_A 151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230 (330)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH
Confidence 9999999876543321 123466799999999999999999999999999999999999999986543322 1111
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.+..... ........... . .+..++..||+.||.+||+++++.+.++++....
T Consensus 231 ~i~~~~~-~~~~~~~~~~~----p---~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 231 KIGDTKR-ATPIEVLCENF----P---EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHH-HSCHHHHTTTC----H---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHhhhc-cCCHHHHhccC----h---HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1111110 00000001111 1 3445788899999999999999999998876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=359.01 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=210.3
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||.||+|...++..||||++... ....+++.+|++++++++||||+++++++.++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG------------SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT------------TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccC------------CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 678999999999999999998888889999998532 22346789999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred CceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence 9999999999999999999864 35689999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... ......+.. ......
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~--~~~~~~ 226 (268)
T 3sxs_A 152 RYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEVVLKVSQ--GHRLYR 226 (268)
T ss_dssp EECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHT--TCCCCC
T ss_pred eecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--HHHHHHHHc--CCCCCC
Confidence 87655432 22334557788999999998889999999999999999999 9999975421 122111111 111111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
+ ...+. .+..++..||+.||++|||++++++.|+.+..+.
T Consensus 227 ~---~~~~~------~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 227 P---HLASD------TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp C---TTSCH------HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred C---CcChH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1 11122 2344788899999999999999999999887653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=369.93 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=204.7
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+|.+.+.||+|+||.||+|. ..+|+.||||++.... ......+.+.+|+++++.++||||+++++++..
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ---------LNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc---------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 579999999999999999994 4789999999985432 223446788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred CCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccC
Confidence 99999999999999999999764 5689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++...... .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||.... .......+....
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~----- 230 (328)
T 3fe3_A 161 SNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--LKELRERVLRGK----- 230 (328)
T ss_dssp CGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCC-----
T ss_pred ceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCC-----
Confidence 98665432 33466799999999999887765 78999999999999999999997542 122222222111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.......+. .+.+++.+||+.||.+|||++|++++
T Consensus 231 -~~~p~~~s~------~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 -YRIPFYMST------DCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCCCTTSCH------HHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCCH------HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111111222 23347788999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=367.53 Aligned_cols=262 Identities=25% Similarity=0.373 Sum_probs=208.2
Q ss_pred hhccccceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||+||+|... .+..||||++... ......+.+.+|+.++++++||||++++++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG----------YTERQRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT----------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC----------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 67899999999999999999553 4556999998532 233456789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+.+++..++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 194 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD 194 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECC
Confidence 99999999999999999999999764 45799999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||+++....... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||.... .......+....
T Consensus 195 fg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~~~~~~- 271 (325)
T 3kul_A 195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--NRDVISSVEEGY- 271 (325)
T ss_dssp CSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--HHHHHHHHHTTC-
T ss_pred CCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcCC-
Confidence 999987654321 122334456788999999998889999999999999999999 999997542 222222222211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
........+. .+..++..||+.||++|||++++++.|+.+....+
T Consensus 272 ----~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 272 ----RLPAPMGCPH------ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ----CCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ----CCCCCCCcCH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 1111112222 23347788999999999999999999998875433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=364.31 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=205.5
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+| +..+++.||+|++.... .......+.+.+|+.++++++||||+++++++.+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP--------REKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS--------SCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc--------cccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence 57999999999999999999 55679999999985331 2334456889999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||++||+|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGI 157 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCC
Confidence 99999999999999999999864 5789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc-Ccccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK-GIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~ 941 (1058)
++....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... . ....... .....
T Consensus 158 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~--~~~~~~~~~~~~~ 232 (294)
T 4eqm_A 158 AKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--S--IAIKHIQDSVPNV 232 (294)
T ss_dssp STTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--H--HHHHHHSSCCCCH
T ss_pred ccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--H--HHHHHhhccCCCc
Confidence 986644321 2234567999999999999999999999999999999999999999754221 1 1111111 11111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHhhhhhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERP-TMKDVAAMLKEIKHER 991 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-t~~~v~~~l~~~~~~~ 991 (1058)
........+. .+..++.+||++||++|| +++++.+.++.+..+.
T Consensus 233 ~~~~~~~~~~------~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 233 TTDVRKDIPQ------SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHHSCTTSCH------HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred chhcccCCCH------HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 1111112222 233477889999999999 8999999888765443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=357.86 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=210.2
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|...+.||+|+||.||+|...+++.||||++... ....+++.+|++++++++||||+++++++.++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG------------AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT------------SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc------------ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 578999999999999999998878999999998532 22346799999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++|+|.++++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred CceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccc
Confidence 9999999999999999999764 45789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+...... ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... .......+... ..
T Consensus 154 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--~~~~~~~~~~~--~~--- 225 (269)
T 4hcu_A 154 RFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTG--FR--- 225 (269)
T ss_dssp GGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTT--CC---
T ss_pred ccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHHhcC--cc---
Confidence 8654432 123334557889999999998999999999999999999999 999997542 22222222211 11
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
+......+. .+.+++..||+.||++|||+++++++|+++...
T Consensus 226 ~~~~~~~~~------~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 LYKPRLAST------HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCcCCH------HHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111111122 234477889999999999999999999988653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=370.46 Aligned_cols=260 Identities=21% Similarity=0.292 Sum_probs=207.8
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.+.|.+.+.||+|+||.||+| +..+|+.||||++....... .......+.+.+|+.++++++||||+++++++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA-----SRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTT-----CSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccc-----ccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 4468999999999999999999 55579999999986442211 11223467899999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC----Cee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF----EPY 856 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~----~~k 856 (1058)
.++...|+||||++||+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+|
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEE
Confidence 999999999999999999999976 36799999999999999999999999 999999999999998877 799
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|+|||+++...... .....+||+.|+|||++.+..++.++||||+||++|+|++|..||.... .......+...
T Consensus 160 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~- 233 (361)
T 2yab_A 160 LIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANITAV- 233 (361)
T ss_dssp ECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTT-
T ss_pred EEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhc-
Confidence 99999998765532 2345679999999999999899999999999999999999999997542 11222111111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
....++......+. .+.+++..||.+||++|||++|++++-
T Consensus 234 -~~~~~~~~~~~~s~------~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 234 -SYDFDEEFFSQTSE------LAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp -CCCCCHHHHTTSCH------HHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred -CCCCCchhccCCCH------HHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 11111111112222 234578889999999999999998754
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=389.51 Aligned_cols=382 Identities=18% Similarity=0.193 Sum_probs=193.5
Q ss_pred cEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCcc-ccccccchhhhHHhhhh
Q 043053 27 QTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKI-PVELSNCKSLRKLLLFD 105 (1058)
Q Consensus 27 ~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~-p~~l~~l~~L~~L~L~~ 105 (1058)
+.++.++++++ .+|. +. ++|++|+|++|++++..|..++++++|++|+|++|.+.+.+ |..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 34566666665 5555 22 56666666666666555666666666666666666654333 23344444444444433
Q ss_pred ccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeecccccccc
Q 043053 106 NALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEI 185 (1058)
Q Consensus 106 n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~ 185 (1058)
|.+. ...|..++.+++|++|++++|++.+..+..
T Consensus 89 n~l~-------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--------------------- 122 (455)
T 3v47_A 89 NQFL-------------------------QLETGAFNGLANLEVLTLTQCNLDGAVLSG--------------------- 122 (455)
T ss_dssp CTTC-------------------------EECTTTTTTCTTCCEEECTTSCCBTHHHHS---------------------
T ss_pred CccC-------------------------ccChhhccCcccCCEEeCCCCCCCccccCc---------------------
Confidence 3332 112333444445555555555554333322
Q ss_pred CccccCCCCccEEEccCCcCCCCCCCC-cCCCCCcceeecccccccCCCCccccCc--CCccEEEeecCCCcCcCCcc--
Q 043053 186 PAEIGNCSELVSLFLYENSLSGSIPPE-IGKLKKLEELFLWQNSLVGAIPEEIGNC--TSLKMIDFSLNSLSGTIPLS-- 260 (1058)
Q Consensus 186 ~~~l~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~~~~-- 260 (1058)
..++.+++|++|+|++|.+++..|.. +.++++|++|++++|.+.+..+..+..+ .+|+.|++++|.+.+..+..
T Consensus 123 -~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~ 201 (455)
T 3v47_A 123 -NFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG 201 (455)
T ss_dssp -STTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTT
T ss_pred -ccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcc
Confidence 11444455555555555554443433 4445555555555555544444444433 44555555555554333222
Q ss_pred ------ccccCCcceeecccCccCCCcccccccc---ccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCCh
Q 043053 261 ------IGGLSELEEFMISDNNVSGSIPANLANA---TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPS 331 (1058)
Q Consensus 261 ------~~~l~~L~~L~l~~n~l~~~~~~~~~~l---~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 331 (1058)
+..+++|++|++++|.+.+..+..+..+ ++|+.|++++|.+.+.. +..+.+....+.
T Consensus 202 ~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~ 267 (455)
T 3v47_A 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNF 267 (455)
T ss_dssp HHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTT
T ss_pred ccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCccc
Confidence 2234555666666665555555444433 55666666666544321 111222222222
Q ss_pred hhhcc--CcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCcc
Q 043053 332 TLASC--SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLK 409 (1058)
Q Consensus 332 ~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 409 (1058)
.+..+ ++|+.|++++|++.+..|..+..+++|++|+|++|.+++..|..|.++++|++|+|++|+++++.+..|..++
T Consensus 268 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 347 (455)
T 3v47_A 268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD 347 (455)
T ss_dssp TTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCT
T ss_pred ccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcc
Confidence 23222 4566666666666655555555555555555555555555555555555555555555555555555555555
Q ss_pred ccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCC
Q 043053 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473 (1058)
Q Consensus 410 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 473 (1058)
+|++|+|++|++++..|..|..+++|++|+|++|+|+++.+..|..+++|++|++++|++++..
T Consensus 348 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 348 KLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred cCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 5555555555555555555555555555555555555544444555555555555555555433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=364.81 Aligned_cols=253 Identities=21% Similarity=0.231 Sum_probs=205.5
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||+||+| +..+|+.||||++.+.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII--------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--------HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh--------hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 67999999999999999999 4557999999998644211 22345778999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..|+||||++||+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999999763 5789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+... .
T Consensus 152 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~------~ 221 (337)
T 1o6l_A 152 CKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILME------E 221 (337)
T ss_dssp CBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC------C
T ss_pred hhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--HHHHHHHHHcC------C
Confidence 98643322 23446679999999999999999999999999999999999999997532 12222222111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAMLK 985 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l~ 985 (1058)
.......+. .+.+++..||+.||++|| +++|++++-.
T Consensus 222 ~~~p~~~s~------~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 222 IRFPRTLSP------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp CCCCTTSCH------HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CCCCCCCCH------HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 111112222 234477889999999999 8999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=374.74 Aligned_cols=263 Identities=23% Similarity=0.344 Sum_probs=210.6
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|.+.+.||+|+||+||+|.. .+++.||||++... .......++.+|+.++++++||||++++
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 140 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----------CSEQDELDFLMEALIISKFNHQNIVRCI 140 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS----------CCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc----------cChhhHHHHHHHHHHHHhCCCCCCCeEE
Confidence 6789999999999999999963 25678999998432 2334456789999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC-----CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT-----GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
+++.+....++||||+++|+|.++++... ...+++..++.++.||++||+|||+. +|+||||||+|||++.+
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 217 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 217 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCS
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecC
Confidence 99999999999999999999999998643 24589999999999999999999999 99999999999999965
Q ss_pred C---CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhH
Q 043053 853 F---EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHV 928 (1058)
Q Consensus 853 ~---~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 928 (1058)
+ .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||... .....
T Consensus 218 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~--~~~~~ 295 (367)
T 3l9p_A 218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEV 295 (367)
T ss_dssp STTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHH
T ss_pred CCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHH
Confidence 5 599999999986544333334445678999999999999999999999999999999998 99999754 22233
Q ss_pred HHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 929 VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
...+..... .......+. + +..++..||+.||++|||+++++++++.+.....
T Consensus 296 ~~~i~~~~~-----~~~~~~~~~---~---l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 296 LEFVTSGGR-----MDPPKNCPG---P---VYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHHHHTTCC-----CCCCTTCCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHHHcCCC-----CCCCccCCH---H---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 332222211 111112222 2 3347888999999999999999999998876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=363.04 Aligned_cols=269 Identities=22% Similarity=0.284 Sum_probs=207.6
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.++||+|+||+||+| +..+++.||||++.... .....+.+.+|++++++++||||+++++++..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----------FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----------GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc----------ccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 57899999999999999999 45569999999985432 22335778899999999999999999999987
Q ss_pred CC--CceEEEEecCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE----cCCCCe
Q 043053 783 RN--NRLLMYDYMPNGSLGSLLHERT-GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI----GLEFEP 855 (1058)
Q Consensus 783 ~~--~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill----~~~~~~ 855 (1058)
.. ..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+||++ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceE
Confidence 65 6699999999999999998643 23489999999999999999999999 99999999999999 778889
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh-
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY--------MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS- 926 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~- 926 (1058)
||+|||+++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........
T Consensus 156 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 232 (319)
T 4euu_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (319)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred EEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence 999999998765543 233457999999999876 56789999999999999999999999975432221
Q ss_pred -hHHHHHHhhcCcc-------------ccCCCCCC--CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 927 -HVVDWVRQKKGIQ-------------VLDPSLLS--RPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 927 -~~~~~~~~~~~~~-------------~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.....+....... ...+.... ........ .+.+++..||+.||++|||++|++++..+....
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQV--LLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHH--HHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHH--HhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 1111111111100 00001111 11122222 234588999999999999999999988765543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=374.72 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=209.8
Q ss_pred HhhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVR 775 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 775 (1058)
.++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+.+|+++++++ +||||++
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----------ATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc----------CCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 37899999999999999999952 35688999998532 2233457899999999999 7999999
Q ss_pred eeeEEEcCCC-ceEEEEecCCCChhhhhhhcCC-----------------------------------------------
Q 043053 776 FLGCCWNRNN-RLLMYDYMPNGSLGSLLHERTG----------------------------------------------- 807 (1058)
Q Consensus 776 ~~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------- 807 (1058)
+++++.+.+. .++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987655 8999999999999999986432
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCC
Q 043053 808 -----------------NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD 870 (1058)
Q Consensus 808 -----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~ 870 (1058)
..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1289999999999999999999999 99999999999999999999999999998765444
Q ss_pred cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCC
Q 043053 871 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRP 949 (1058)
Q Consensus 871 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (1058)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... ......+..... .......
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~-----~~~~~~~ 321 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTR-----MRAPDYT 321 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHHTCC-----CCCCTTC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-HHHHHHHHcCCC-----CCCCCCC
Confidence 3334456678999999999999999999999999999999998 99999765332 222222222111 1111112
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 950 ESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 950 ~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
+. .+.+++..||+.||++|||+++++++|+++...
T Consensus 322 ~~------~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 322 TP------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CH------HHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 22 234477889999999999999999999988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=363.21 Aligned_cols=261 Identities=26% Similarity=0.382 Sum_probs=212.7
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+.+|++++++++||||++++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN----------ASPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT----------CCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC----------CCHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 6899999999999999999954 34588999998532 2334467899999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHhhcccccCCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTG----------------------NALEWELRYQILLGAAQGLAYLHHDCVP 835 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 835 (1058)
+++.+.+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--- 169 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--- 169 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---
Confidence 999999999999999999999999986432 3489999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-C
Q 043053 836 PIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-G 914 (1058)
Q Consensus 836 ~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g 914 (1058)
+|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |
T Consensus 170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987765443333445567889999999998889999999999999999999 9
Q ss_pred CCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 915 KQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 915 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
+.||..... ......+..... +......+. .+..++..||+.||++|||++++++.|+++..+
T Consensus 250 ~~p~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 250 GNPYPGIPP--ERLFNLLKTGHR-----MERPDNCSE------EMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCSSTTCCG--GGHHHHHHTTCC-----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCH--HHHHHHhhcCCc-----CCCCccCCH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 999975532 233333322211 111122222 233477889999999999999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=377.50 Aligned_cols=259 Identities=19% Similarity=0.238 Sum_probs=207.4
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
..+.++|.+.+.||+|+||+||+| +..+|+.||+|++.... ......+.+.+|++++++++||||+++++
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~---------~~~~~~~~~~~E~~il~~l~hpnIv~l~~ 77 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK---------LSARDHQKLEREARICRLLKHPNIVRLHD 77 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS---------CHHHHHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc---------CCHHHHHHHHHHHHHHHhCCCcCCCeEEE
Confidence 456789999999999999999999 56789999999985432 12234577899999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc---CCCCe
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG---LEFEP 855 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~---~~~~~ 855 (1058)
++.+++..|+||||++||+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||++ .++.+
T Consensus 78 ~~~~~~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 78 SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp EEECSSEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCE
T ss_pred EEEECCEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcE
Confidence 999999999999999999999999874 5699999999999999999999999 999999999999998 45789
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||... ........+...
T Consensus 153 kL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~ 228 (444)
T 3soa_A 153 KLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE--DQHRLYQQIKAG 228 (444)
T ss_dssp EECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHT
T ss_pred EEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHhC
Confidence 999999998765432 2334567999999999999989999999999999999999999999753 222222222221
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
. ...........+. .+.+++..||+.||++|||++|++++-
T Consensus 229 ~--~~~~~~~~~~~s~------~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 229 A--YDFPSPEWDTVTP------EAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp C--CCCCTTTTTTSCH------HHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred C--CCCCccccccCCH------HHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 1 1111111112222 234577889999999999999999853
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=361.18 Aligned_cols=262 Identities=27% Similarity=0.369 Sum_probs=200.7
Q ss_pred HhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcc--cCCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGS--IRHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~ 780 (1058)
.++|.+.+.||+|+||+||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--------------~~~~~~~e~~~~~~~~l~h~niv~~~~~~ 71 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--------------DEKSWFRETELYNTVMLRHENILGFIASD 71 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--------------GHHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--------------cchhhHHHHHHHHHhhccCcCeeeEEEee
Confidence 36899999999999999999977 5899999998432 23455666666665 7899999999987
Q ss_pred EcC----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhccc--------ccCCCCeEeCCCCCCcEE
Q 043053 781 WNR----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH--------HDCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 781 ~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivHrDikp~Nil 848 (1058)
... ...++||||+++|+|.++++. ..+++..+++++.|+++||+||| +. +|+||||||+|||
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nil 145 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNIL 145 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEE
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEE
Confidence 643 447899999999999999964 56999999999999999999999 77 9999999999999
Q ss_pred EcCCCCeeeeccccceeccCCCcc--cccccccCcCCccCccccccC------CCCcccchhhHHHHHHHHHhC------
Q 043053 849 IGLEFEPYIADFGLAKLVDDGDFA--RSSNTVAGSYGYIAPEYGYMM------KITEKSDVYSYGVVVLEVLTG------ 914 (1058)
Q Consensus 849 l~~~~~~kl~DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg------ 914 (1058)
++.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 999999999999999876543321 112345799999999998776 455789999999999999999
Q ss_pred ----CCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 915 ----KQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 915 ----~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
+.||....+............. .....+...... ........+.+++..||+.||++|||++++++.|+++
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVC-VDQQRPNIPNRW-FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHT-TSCCCCCCCGGG-GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCcchhhhhHHHh-ccCCCCCCChhh-ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 8888765444333332222111 111112111110 0111223345689999999999999999999999876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=367.16 Aligned_cols=261 Identities=25% Similarity=0.405 Sum_probs=202.5
Q ss_pred hhccccceeccccceEEEEEE-ecCCcE----EEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEV----IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|...+.||+|+||+||+|. ..+++. ||+|.+... ......+++.+|+.++++++||||+++++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 84 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------TSPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------------CHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc----------cCHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 578999999999999999995 445554 577776422 22344678999999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++.++ ..++||||+++|+|.+++... ...+++..++.|+.|+++||+|||+. +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~-~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~ 159 (327)
T 3poz_A 85 ICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp EEESS-SEEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred EEecC-CeEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEc
Confidence 99875 478999999999999999875 46799999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+.....
T Consensus 160 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~~ 237 (327)
T 3poz_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGER 237 (327)
T ss_dssp CTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCC
T ss_pred cCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC--HHHHHHHHHcCCC
Confidence 9999987765443334445567889999999999999999999999999999999 999997543 2233333332211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
. . .+..... .+..++.+||+.||++|||+.++++.|+.+.....
T Consensus 238 ~-----~---~~~~~~~---~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 281 (327)
T 3poz_A 238 L-----P---QPPICTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp C-----C---CCTTBCH---HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred C-----C---CCccCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence 1 1 1111112 23447888999999999999999999998876544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=364.89 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=208.0
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+.++|.+.+.||+|+||.||+| +..+|+.||||++...... ........+.+.+|+.++++++||||++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 82 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTK-----SSRRGVSREDIEREVSILKEIQHPNVITLHEV 82 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCST-----TCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccc-----cccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 45678999999999999999999 4557999999998544221 11122346789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC----Ce
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF----EP 855 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~----~~ 855 (1058)
+.++...++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 157 (326)
T 2y0a_A 83 YENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRI 157 (326)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCE
T ss_pred EEeCCEEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCE
Confidence 9999999999999999999999976 36789999999999999999999999 999999999999999887 79
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... .......+...
T Consensus 158 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~ 232 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANVSAV 232 (326)
T ss_dssp EECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHT
T ss_pred EEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHHhc
Confidence 999999998775432 2335679999999999998899999999999999999999999997542 11111111111
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
. ...........+. .+.+++..||+.||++|||+++++++-
T Consensus 233 ~--~~~~~~~~~~~~~------~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 233 N--YEFEDEYFSNTSA------LAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp C--CCCCHHHHTTSCH------HHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred C--CCcCccccccCCH------HHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 1 0111111111122 234578889999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.07 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=207.4
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||+||+|...++..||||++... ....+++.+|++++++++||||+++++++.++
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------------SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT------------SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC------------CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 689999999999999999998888899999998532 22346789999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred CCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccc
Confidence 9999999999999999999764 35689999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... .......+... . .
T Consensus 168 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~--~---~ 239 (283)
T 3gen_A 168 RYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHIAQG--L---R 239 (283)
T ss_dssp GGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHTT--C---C
T ss_pred cccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--hhHHHHHHhcc--c---C
Confidence 86644321 22334457888999999998899999999999999999998 999997542 12222222211 1 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.......+. .+..++..||+.||++|||+++++++|+++..+
T Consensus 240 ~~~~~~~~~------~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 LYRPHLASE------KVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCTTCCH------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcCCH------HHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 111111222 234478889999999999999999999988654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=369.43 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=209.9
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|.+.+.||+|+||.||+|... +++.||||++... ......+.+.+|+.++++++||||++++
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 116 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----------ASADMQADFQREAALMAEFDNPNIVKLL 116 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----------CCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc----------cCHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 68899999999999999999553 4589999998533 2334567899999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHhhcccccCCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT----------------------GNALEWELRYQILLGAAQGLAYLHHDCVP 835 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 835 (1058)
+++.+++..++||||+++|+|.++++... ...+++..++.++.||++||+|||+.
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--- 193 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--- 193 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 99999999999999999999999998642 15789999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-C
Q 043053 836 PIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-G 914 (1058)
Q Consensus 836 ~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g 914 (1058)
+|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 999999999999999999999999999987654333333445668999999999998899999999999999999999 9
Q ss_pred CCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 915 KQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 915 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
..||.... .......+..... +......+. .+..++..||+.||++|||+.++++.|+++....+
T Consensus 274 ~~p~~~~~--~~~~~~~~~~~~~-----~~~~~~~~~------~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 274 LQPYYGMA--HEEVIYYVRDGNI-----LACPENCPL------ELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp CCTTTTSC--HHHHHHHHHTTCC-----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCcCCCCC--hHHHHHHHhCCCc-----CCCCCCCCH------HHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 99997542 2222222222111 111112222 23447788999999999999999999998876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=371.88 Aligned_cols=262 Identities=26% Similarity=0.381 Sum_probs=213.2
Q ss_pred hhccccceeccccceEEEEEEe--------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCccc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM--------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIV 774 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 774 (1058)
++|.+.+.||+|+||+||+|.. ..+..||||++... ......+++.+|+++++++ +||||+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----------ATEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----------cCHHHHHHHHHHHHHHHHhcCCchhh
Confidence 6899999999999999999954 23367999998533 2334467899999999999 899999
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeC
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 840 (1058)
++++++..++..++||||+++|+|.+++.... ...+++..++.|+.|+++||+|||+. +|+||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 215 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 215 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecC
Confidence 99999999999999999999999999998753 24589999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 043053 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 919 (1058)
Q Consensus 841 Dikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 919 (1058)
||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987765444344455668899999999999999999999999999999999 999997
Q ss_pred CCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 920 PTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.. ........+..... .......+. + +..++..||+.||++|||++++++.|+++....
T Consensus 296 ~~--~~~~~~~~~~~~~~-----~~~~~~~~~---~---l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 296 GV--PVEELFKLLKEGHR-----MDKPSNCTN---E---LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp TC--CHHHHHHHHHTTCC-----CCCCSSCCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CC--CHHHHHHHHHcCCC-----CCCCccCCH---H---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 54 22233332222211 111112222 2 334778899999999999999999999886543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=365.02 Aligned_cols=255 Identities=18% Similarity=0.234 Sum_probs=206.7
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| +..+++.||+|.+... ....+.+.+|+++++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 71 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------------GTDQVLVKKEISILNIARHRNILHLHESFE 71 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------------THHHHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------------cccHHHHHHHHHHHHhCCCCCCCeEeEEEe
Confidence 468999999999999999999 5567899999988422 223567899999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC--CCCeeeec
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL--EFEPYIAD 859 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~--~~~~kl~D 859 (1058)
+.+..++||||++||+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~D 147 (321)
T 1tki_A 72 SMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp ETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred cCCEEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEE
Confidence 999999999999999999999763 35789999999999999999999999 9999999999999987 78999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.... .......+.... .
T Consensus 148 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~--~ 220 (321)
T 1tki_A 148 FGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAE--Y 220 (321)
T ss_dssp CTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTC--C
T ss_pred CCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHcCC--C
Confidence 99998876543 2345679999999999998888999999999999999999999997542 222222222111 1
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
..+.......+. .+.+++.+||..||++|||+.|++++-.-
T Consensus 221 ~~~~~~~~~~s~------~~~~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 221 TFDEEAFKEISI------EAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp CCCHHHHTTSCH------HHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred CCChhhhccCCH------HHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence 111111111121 34458889999999999999999986553
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=358.43 Aligned_cols=274 Identities=32% Similarity=0.531 Sum_probs=212.2
Q ss_pred HHHhhcccc------ceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccc
Q 043053 701 QVLKCLVDA------NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIV 774 (1058)
Q Consensus 701 ~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 774 (1058)
.+.+.|... +.||+|+||.||+|.. +++.||||++..... ...+...+.+.+|+.++++++||||+
T Consensus 22 ~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 22 NVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD-------ITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp HHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTT-------SCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccC-------cchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 344455544 8999999999999976 488999999853311 12344568899999999999999999
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT-GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
++++++.+.+..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~ 170 (307)
T 2nru_A 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAF 170 (307)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTC
T ss_pred EEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCC
Confidence 99999999999999999999999999997532 45689999999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh--hHHHH
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS--HVVDW 931 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~ 931 (1058)
.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|+|++|..||........ .....
T Consensus 171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (307)
T 2nru_A 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249 (307)
T ss_dssp CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHH
T ss_pred cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHH
Confidence 999999999987655433333445679999999998765 478899999999999999999999976533221 11111
Q ss_pred HHhhc-C-ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 932 VRQKK-G-IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 932 ~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
..... . ....++.....+... ...+..++..||+.||.+|||+++++++|+++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 250 IEDEEKTIEDYIDKKMNDADSTS---VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHTTSCCHHHHSCSSCSCCCHHH---HHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhhhhhhhccccccccchHH---HHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11111 0 011222222222222 2334458999999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=366.87 Aligned_cols=261 Identities=27% Similarity=0.394 Sum_probs=204.4
Q ss_pred hhccccceeccccceEEEEEE-ecCCcE----EEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEV----IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|...+.||+|+||+||+|. ..+++. ||+|.+... ......+.+.+|+.++++++||||+++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 82 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK----------SGRQSFQAVTDHMLAIGSLDHAHIVRLLG 82 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT----------TSCSCBCSCCHHHHHHHTCCCTTBCCEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc----------ccHHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 578899999999999999995 445554 777766322 12223456788999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++. ++..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+
T Consensus 83 ~~~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~ 157 (325)
T 3kex_A 83 LCP-GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVA 157 (325)
T ss_dssp EEC-BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEEC
T ss_pred EEc-CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEEC
Confidence 886 56689999999999999999764 35789999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++...............||..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+.....
T Consensus 158 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~ 235 (325)
T 3kex_A 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKGER 235 (325)
T ss_dssp SCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHHHTTCB
T ss_pred CCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHHHcCCC
Confidence 9999987765443344456678889999999998999999999999999999999 9999976532 233333332211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
. ..+. ..+.. +..++..||+.||++|||+++++++|+.+.....
T Consensus 236 ~--~~~~---~~~~~------~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~ 279 (325)
T 3kex_A 236 L--AQPQ---ICTID------VYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279 (325)
T ss_dssp C--CCCT---TBCTT------TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred C--CCCC---cCcHH------HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 1 1111 11111 2347778999999999999999999998866543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=370.20 Aligned_cols=261 Identities=26% Similarity=0.385 Sum_probs=198.2
Q ss_pred hhccccceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||.||+|... ++..||||++... ......++|.+|+.++++++||||++++++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG----------YTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT----------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc----------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 57899999999999999999654 5778999998532 233456789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+.+.+..++||||+++|+|.++++.. ...+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 190 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECc
Confidence 99999999999999999999999864 45789999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+....
T Consensus 191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--~~~~~~~i~~~~- 267 (373)
T 2qol_A 191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--NQDVIKAVDEGY- 267 (373)
T ss_dssp C----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--HHHHHHHHHTTE-
T ss_pred CccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-
Confidence 999987654321 112223346788999999999999999999999999999998 999997542 222222222211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
........+. .+..++..||+.||++||++.++++.|+.+....
T Consensus 268 ----~~~~~~~~~~------~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 268 ----RLPPPMDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ----ECCCCTTCBH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ----CCCCCccccH------HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 1111111222 2344788899999999999999999999886543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=367.12 Aligned_cols=262 Identities=20% Similarity=0.277 Sum_probs=206.8
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.++|.+.+.||+|+||+||+| +..+|+.||||++....... ......+.+.+|++++++++||||+++++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 95 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTS------SPGLSTEDLKREASICHMLKHPHIVELLETY 95 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHT------SSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccc------cccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3478999999999999999999 55679999999985432211 1122357899999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC---e
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE---P 855 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~---~ 855 (1058)
.+++..|+||||++||+|.+++... ....+++..+..++.||++||+|||+. +|+||||||+||+++.++. +
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence 9999999999999999999888653 234689999999999999999999999 9999999999999987654 9
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||... .......+...
T Consensus 173 kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~i~~~ 247 (351)
T 3c0i_A 173 KLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT---KERLFEGIIKG 247 (351)
T ss_dssp EECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---HHHHHHHHHHT
T ss_pred EEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc---HHHHHHHHHcC
Confidence 999999998775533 2234567999999999999999999999999999999999999999753 11221111111
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
. ....+......+. .+.+++.+||+.||++|||+.+++++-.
T Consensus 248 ~--~~~~~~~~~~~s~------~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 248 K--YKMNPRQWSHISE------SAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp C--CCCCHHHHTTSCH------HHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred C--CCCCccccccCCH------HHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 1 1111111111122 2345788899999999999999998543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=368.09 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=206.6
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+.++|.+.+.||+|+||.||+| +..+|+.||||++.... ......+.+.+|++++++++||||++++++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~ 96 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---------LSARDFQKLEREARICRKLQHPNIVRLHDS 96 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc---------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 45688999999999999999999 55679999999985331 122345788999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC---Cee
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF---EPY 856 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~---~~k 856 (1058)
+.+++..|+||||+++|+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++ .+|
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~k 171 (362)
T 2bdw_A 97 IQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVK 171 (362)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEE
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence 99999999999999999999999763 5689999999999999999999999 999999999999998654 599
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|+|||++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||... +.......+....
T Consensus 172 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~--~~~~~~~~i~~~~ 246 (362)
T 2bdw_A 172 LADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGA 246 (362)
T ss_dssp ECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTC
T ss_pred EeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCC
Confidence 99999998765432 234567999999999999989999999999999999999999999753 2222222222211
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
. ..........+. .+.+++.+||+.||++|||+++++++-.
T Consensus 247 -~-~~~~~~~~~~~~------~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 247 -Y-DYPSPEWDTVTP------EAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp -C-CCCTTGGGGSCH------HHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred -C-CCCcccccCCCH------HHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 1 111111111121 2345788899999999999999987643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=366.80 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=203.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+|.+.+.||+|+||+||+| +..+++.||||++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--------KKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc--------cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 57999999999999999999 457899999999854322 122234678999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+ +|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~ 154 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGL 154 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred CCEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEecc
Confidence 99999999999 78999998764 5699999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+.....+. .....+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||........ .......
T Consensus 155 s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------~~~i~~~ 223 (336)
T 3h4j_B 155 SNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------FKKVNSC 223 (336)
T ss_dssp TBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--------BCCCCSS
T ss_pred ceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--------HHHHHcC
Confidence 98765433 2345679999999999988776 6899999999999999999999975422110 0000000
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
........+. .+.+++.+||+.||.+|||++|++++-..
T Consensus 224 ~~~~p~~~s~------~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 224 VYVMPDFLSP------GAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp CCCCCTTSCH------HHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred CCCCcccCCH------HHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 1111111122 23457889999999999999999986543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=358.73 Aligned_cols=263 Identities=19% Similarity=0.218 Sum_probs=208.9
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 781 (1058)
++|.+.+.||+|+||.||+|. ..+|+.||||++... ...+.+.+|+.+++++ +|++++++++++.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-------------SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-------------TTSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-------------CccHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 579999999999999999994 578999999987422 1234578999999999 7999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC-----ee
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE-----PY 856 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~-----~k 856 (1058)
+....++||||+ +|+|.++++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++. +|
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~k 151 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIY 151 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CCceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEE
Confidence 999999999999 99999999864 45699999999999999999999999 9999999999999988776 99
Q ss_pred eeccccceeccCCCcc-----cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh-hHHH
Q 043053 857 IADFGLAKLVDDGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS-HVVD 930 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~ 930 (1058)
|+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ....
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (298)
T 1csn_A 152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231 (298)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence 9999999877654321 123456799999999999999999999999999999999999999986543222 1111
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.+..... ....+......+. .+..++..||+.||++|||++++++.|+++..+.
T Consensus 232 ~~~~~~~-~~~~~~~~~~~~~------~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 232 RIGEKKQ-STPLRELCAGFPE------EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHHHHH-HSCHHHHTTTSCH------HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHhhcc-CccHHHHHhhCcH------HHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 1111110 0000111112222 2334777899999999999999999999886543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=371.49 Aligned_cols=257 Identities=20% Similarity=0.247 Sum_probs=200.8
Q ss_pred HhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
.++|.+.++||+|+||+||+|. ..+++.||||++.+... ......+.+.+|..++.++ +||||+++++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~--------~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV--------NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT--------C----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--------cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 3689999999999999999994 55788999999865422 1223346788999999887 799999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+++..|+||||++||+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 123 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 123 QTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999999864 5799999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC----hhHHHHHHhhc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG----SHVVDWVRQKK 936 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~----~~~~~~~~~~~ 936 (1058)
|+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...........
T Consensus 198 Gla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~ 275 (396)
T 4dc2_A 198 GMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275 (396)
T ss_dssp TTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred ceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence 9998533222 33456789999999999999999999999999999999999999996432111 00111111111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM------KDVAAM 983 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~------~~v~~~ 983 (1058)
.. ........+. .+.+++..||+.||++||++ +|++++
T Consensus 276 ~~---~~~~p~~~s~------~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 276 EK---QIRIPRSLSV------KAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HC---CCCCCTTSCH------HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred cc---ccCCCCcCCH------HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 00 1111112222 23457788999999999996 566554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=357.22 Aligned_cols=266 Identities=23% Similarity=0.320 Sum_probs=203.3
Q ss_pred HHHhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
.+.++|.+.+.||+|+||+||+|...+|+.||||++.... ......+.+.+|++++++++||||+++++++
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 88 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---------EDEGIPSTAIREISLLKELHHPNIVSLIDVI 88 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc---------ccchhhHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 3457899999999999999999987889999999985431 2334467889999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.++...++||||+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df 163 (311)
T 3niz_A 89 HSERCLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADF 163 (311)
T ss_dssp CCSSCEEEEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCEEEEEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccC
Confidence 999999999999985 888888764 45689999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
|+++...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .............
T Consensus 164 g~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~ 240 (311)
T 3niz_A 164 GLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPN 240 (311)
T ss_dssp TTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCC
T ss_pred cCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCC
Confidence 9998765432 23345678999999999876 568999999999999999999999997654332 2222221111000
Q ss_pred cc-CC-----------CCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 VL-DP-----------SLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~~-~~-----------~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. .+ ............ ..++.+++.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 00 000000000000 0134568889999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=376.19 Aligned_cols=260 Identities=23% Similarity=0.252 Sum_probs=203.9
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...++||+|+||+||+|.. .+++.||||++.+.... .....+.+.+|+.++..++||||+++++++.+
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML--------KRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH--------HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh--------hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 6899999999999999999954 56899999998543221 11223458899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||++||+|.+++... ...+++..++.++.|++.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999999863 46799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
++....... ......+||+.|+|||++. ...++.++||||+||++|||++|+.||..... ......+.....
T Consensus 222 a~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~ 298 (437)
T 4aw2_A 222 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKE 298 (437)
T ss_dssp CEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTHHH
T ss_pred hhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--hHHHHhhhhccc
Confidence 987654332 2334567999999999986 45689999999999999999999999975421 111111111110
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDE--RPTMKDVAAMLK 985 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~~v~~~l~ 985 (1058)
....|......+. .+.+++.+|+..+|++ ||+++|++++-.
T Consensus 299 -~~~~p~~~~~~s~------~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 299 -RFQFPTQVTDVSE------NAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp -HCCCCSSCCCSCH------HHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred -cccCCcccccCCH------HHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 0111111112222 2344777889888888 999999988643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=366.40 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=211.4
Q ss_pred HhhccccceeccccceEEEEEEec-CC-----cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMD-NG-----EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVR 775 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 775 (1058)
.++|...+.||+|+||.||+|... ++ ..||||++... ......+.+.+|+.+++++ +||||++
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~iv~ 114 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST----------AHADEKEALMSELKIMSHLGQHENIVN 114 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc----------cChHHHHHHHHHHHHHHhhcCCCCeee
Confidence 367899999999999999999543 33 47999998533 2233467899999999999 8999999
Q ss_pred eeeEEEcCCCceEEEEecCCCChhhhhhhcC------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCC
Q 043053 776 FLGCCWNRNNRLLMYDYMPNGSLGSLLHERT------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIK 843 (1058)
Q Consensus 776 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDik 843 (1058)
+++++..++..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+|||||
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 191 (333)
T 2i1m_A 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVA 191 (333)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcc
Confidence 9999999999999999999999999997532 34679999999999999999999999 99999999
Q ss_pred CCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 043053 844 ANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 922 (1058)
Q Consensus 844 p~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~ 922 (1058)
|+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999999999987654433233345567889999999998899999999999999999999 999997543
Q ss_pred CCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
.. ............ .......+. .+..++..||+.||++|||++++++.|+++..+..
T Consensus 272 ~~-~~~~~~~~~~~~-----~~~~~~~~~------~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 272 VN-SKFYKLVKDGYQ-----MAQPAFAPK------NIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp SS-HHHHHHHHHTCC-----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hh-HHHHHHHhcCCC-----CCCCCCCCH------HHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 22 222222222211 111111222 23447888999999999999999999998866543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=366.41 Aligned_cols=264 Identities=24% Similarity=0.338 Sum_probs=209.1
Q ss_pred HhhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVR 775 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 775 (1058)
.++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+.+|+.+++++ +||||++
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~iv~ 113 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK----------ADSSEREALMSELKMMTQLGSHENIVN 113 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc----------cCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 37899999999999999999964 34678999998533 1233457899999999999 8999999
Q ss_pred eeeEEEcCCCceEEEEecCCCChhhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHhhcccccCC
Q 043053 776 FLGCCWNRNNRLLMYDYMPNGSLGSLLHERTG---------------------NALEWELRYQILLGAAQGLAYLHHDCV 834 (1058)
Q Consensus 776 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~ 834 (1058)
+++++...+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.
T Consensus 114 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 191 (344)
T 1rjb_A 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-- 191 (344)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred EEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 99999999999999999999999999986432 2479999999999999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-
Q 043053 835 PPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT- 913 (1058)
Q Consensus 835 ~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt- 913 (1058)
+|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++
T Consensus 192 -~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 192 -SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp -TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred -CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 999999999999999999999999999987655433333445567889999999998899999999999999999998
Q ss_pred CCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 914 GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 914 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
|..||..... .......+.... .+......+. .+..++..||+.||++|||+.+++++|+.+....
T Consensus 271 g~~p~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 271 GVNPYPGIPV-DANFYKLIQNGF-----KMDQPFYATE------EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp SCCSSTTCCC-SHHHHHHHHTTC-----CCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCCCcccCCc-HHHHHHHHhcCC-----CCCCCCCCCH------HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 9999976532 223333222221 1111111222 2334778899999999999999999999876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.71 Aligned_cols=265 Identities=28% Similarity=0.403 Sum_probs=202.3
Q ss_pred hhccccceeccccceEEEEEEe-----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|++.+.||+|+||+||+|.+ .+++.||||++... .....+.+.+|++++++++||||+++++
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----------TEEHLRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 6899999999999999999963 46899999998522 3344578999999999999999999999
Q ss_pred EEEc--CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 779 CCWN--RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 779 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
++.. ....++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~k 154 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVK 154 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEE
Confidence 9865 35589999999999999999864 34689999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC----------CCC
Q 043053 857 IADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI----------PDG 925 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~----------~~~ 925 (1058)
|+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++|..||.... +..
T Consensus 155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T 3ugc_A 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234 (295)
T ss_dssp ECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCT
T ss_pred EccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcccc
Confidence 999999987654321 122334457788999999999999999999999999999999999986421 011
Q ss_pred hhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
............ ...........+ .+ +..++..||+.||++|||++|+++.|+++...
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~---~~---l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 235 QMIVFHLIELLK-NNGRLPRPDGCP---DE---IYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHH-TTCCCCCCTTCC---HH---HHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHHHHHh-ccCcCCCCcCcC---HH---HHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 111101111000 000111111222 22 33478889999999999999999999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=374.57 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=206.3
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|...+.||+|+||.||+|... |+.||||++... ...+.|.+|++++++++||||+++++++...
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC-------------TTSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc-------------hHHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 57888999999999999999876 789999998422 2357899999999999999999999998776
Q ss_pred C-CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 784 N-NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 784 ~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
. ..++||||+++|+|.++++......+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 5 689999999999999999876555689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+....
T Consensus 336 a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~----- 403 (450)
T 1k9a_A 336 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY----- 403 (450)
T ss_dssp CEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTTC-----
T ss_pred ccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-----
Confidence 9864332 123357889999999999999999999999999999998 99999765332 2333332221
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
........+. + +.+++..||+.||++|||+.++++.|+++...
T Consensus 404 ~~~~p~~~~~---~---l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 KMDAPDGCPP---A---VYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCCTTCCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCcCCH---H---HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1111122222 2 33477889999999999999999999988654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=356.58 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=200.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||+||+| +..+++.||||++.... ......+.+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------DDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---------SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC---------CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 57899999999999999999 55679999999985331 233456788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++ ++.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 9999999999976 666666543 46799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc--
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ-- 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 939 (1058)
++...... .......||+.|+|||++.+.. ++.++||||+||++|||++|..||..............+......
T Consensus 148 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 148 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp CEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 98765432 3334567899999999987765 799999999999999999999887543222222222222111000
Q ss_pred c---------cCC--------CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 V---------LDP--------SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~---------~~~--------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. ..+ ......+.... .+.+++..||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA---TGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccccccccccccCCcchhhcccccCh---HHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000 00000001111 23457888999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=352.64 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=197.1
Q ss_pred hhccccceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||.||+|... .+..||||++... ......+.+.+|+.++++++||||++++++
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----------TSDSVREKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----------TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----------CCHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence 68999999999999999999543 3557999987532 233456789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+. ++..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECc
Confidence 84 56789999999999999999864 45789999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |..||..... ......+.....
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--~~~~~~i~~~~~- 235 (281)
T 1mp8_A 160 FGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGER- 235 (281)
T ss_dssp --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCC-
T ss_pred cccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--HHHHHHHHcCCC-
Confidence 999987654332 22234457889999999998899999999999999999997 9999975432 233333322211
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.......+.. +..++..||+.||++|||+.++++.|+++..+.
T Consensus 236 ----~~~~~~~~~~------l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 236 ----LPMPPNCPPT------LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ----CCCCTTCCHH------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCHH------HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111222222 334778899999999999999999999886543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=382.55 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=212.7
Q ss_pred hhccccceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+|... ++..||||++... ....++|.+|++++++++||||+++++++.+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc------------ccchHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 56888999999999999999554 5899999998532 2236789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||+++|+|.++++......+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccc
Confidence 99999999999999999999876567799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.... .......+.....
T Consensus 365 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~---- 437 (495)
T 1opk_A 365 SRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYR---- 437 (495)
T ss_dssp EECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTTCC----
T ss_pred ceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC----
Confidence 987654332 22334557789999999998889999999999999999999 999997543 2333333332211
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.......+. + +..++.+||+.||++|||++++++.|+.+....
T Consensus 438 -~~~~~~~~~---~---l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 438 -MERPEGCPE---K---VYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp -CCCCTTCCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred -CCCCCCCCH---H---HHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 111112222 2 334778899999999999999999999876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=359.20 Aligned_cols=262 Identities=27% Similarity=0.392 Sum_probs=212.4
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
++|...+.||+|+||.||+|.. .+++.||||++... ......+.+.+|+.+++++ +||||+++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----------AHLTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc----------hhHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 6899999999999999999953 35788999998533 2223467899999999999 89999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcCC----------------CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeC
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERTG----------------NALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 840 (1058)
++++.+++..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+. +|+||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~ 169 (313)
T 1t46_A 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHR 169 (313)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecC
Confidence 9999999999999999999999999986432 2589999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 043053 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 919 (1058)
Q Consensus 841 Dikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 919 (1058)
||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 170 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987765443333445567889999999999999999999999999999999 999997
Q ss_pred CCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 920 PTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.... ............ ........+. .+..++.+||+.||++|||++++++.|+++..+
T Consensus 250 ~~~~-~~~~~~~~~~~~-----~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 250 GMPV-DSKFYKMIKEGF-----RMLSPEHAPA------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp TCCS-SHHHHHHHHHTC-----CCCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccc-hhHHHHHhccCC-----CCCCcccCCH------HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 6532 222222222211 1111112222 234477889999999999999999999887654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=356.68 Aligned_cols=260 Identities=20% Similarity=0.296 Sum_probs=195.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCC---------------CCcccchHHHHHHHHHHHcc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGC---------------SDEKSGVRDSFSAEIKTLGS 767 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~---------------~~~~~~~~~~~~~E~~~l~~ 767 (1058)
++|.+.+.||+|+||.||+| +..+++.||||++........... ........+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 67999999999999999999 556789999999854432111000 00112234678999999999
Q ss_pred cCCCcccceeeEEEc--CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCC
Q 043053 768 IRHKNIVRFLGCCWN--RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKAN 845 (1058)
Q Consensus 768 l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~ 845 (1058)
++||||+++++++.+ ....++||||+++|+|.+++.. ..+++..++.++.|+++||+|||+. +|+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 999999999999986 4567999999999999997653 5789999999999999999999999 9999999999
Q ss_pred cEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCC
Q 043053 846 NILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTI 922 (1058)
Q Consensus 846 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~P~~~~~ 922 (1058)
||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999998765433 2234567999999999987665 3778999999999999999999997431
Q ss_pred CCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.......+.... .........+. .+.+++.+||+.||++|||++|++++
T Consensus 245 --~~~~~~~~~~~~----~~~~~~~~~~~------~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 --IMCLHSKIKSQA----LEFPDQPDIAE------DLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp --HHHHHHHHHHCC----CCCCSSSCCCH------HHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred --HHHHHHHHhccc----CCCCCccccCH------HHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 111111111111 11111111222 23447788999999999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=368.09 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=199.8
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
.++|.+.++||+|+||+||+| +..+|+.||||++.+... ......+.+.+|+.+++.+ +||||+++++++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~--------~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--------LQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--------HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh--------cchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 478999999999999999999 456799999999864422 1223456788999999988 699999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+++..|+||||++||+|.++++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 94 QTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccc
Confidence 9999999999999999999999864 5699999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 169 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~~---- 240 (353)
T 3txo_A 169 GMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAILNDE---- 240 (353)
T ss_dssp TTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCC----
T ss_pred cceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--HHHHHHHHHcCC----
Confidence 9998543322 23446689999999999999899999999999999999999999997542 222222222211
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM------KDVAAML 984 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~------~~v~~~l 984 (1058)
.......+. .+.+++..||++||++||++ ++++++-
T Consensus 241 --~~~p~~~~~------~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 241 --VVYPTWLHE------DATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp --CCCCTTSCH------HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred --CCCCCCCCH------HHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 111111222 23457788999999999998 6777643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=358.67 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=203.2
Q ss_pred hccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-----------KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG 114 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-----------TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc-----------chhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC
Confidence 367778999999999999955 47999999998432 223457889999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 115 ~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~ 188 (321)
T 2c30_A 115 EELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC 188 (321)
T ss_dssp TEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeee
Confidence 999999999999999999874 4689999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.... .+
T Consensus 189 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~--~~~~~~~~~~~~-----~~ 259 (321)
T 2c30_A 189 AQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS--PVQAMKRLRDSP-----PP 259 (321)
T ss_dssp EECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSS-----CC
T ss_pred eecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCC-----CC
Confidence 8765432 22345679999999999999999999999999999999999999997542 222222222211 11
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
... ....... .+.+++.+||+.||++|||+++++++...
T Consensus 260 ~~~-~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 260 KLK-NSHKVSP---VLRDFLERMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp CCT-TGGGSCH---HHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CcC-ccccCCH---HHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 111 0011111 23447788999999999999999886443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=364.92 Aligned_cols=253 Identities=22% Similarity=0.288 Sum_probs=203.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+| +..+++.||||++..... ......+.+.+|++++++++|||||++++++.+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~--------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--------VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc--------ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 68999999999999999999 556789999999854422 122345788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccce
Confidence 9999999999999999999986 46799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
++..... ......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... .........
T Consensus 162 a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~~~~~~~~- 235 (384)
T 4fr4_A 162 AAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK--EIVHTFETT- 235 (384)
T ss_dssp CEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH--HHHHHHHHC-
T ss_pred eeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH--HHHHHHhhc-
Confidence 9876543 23446779999999999863 45889999999999999999999999754332221 111111100
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT-MKDVAAM 983 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~~v~~~ 983 (1058)
........+. .+..++..||+.||++||+ ++++.++
T Consensus 236 --~~~~p~~~s~------~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 236 --VVTYPSAWSQ------EMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp --CCCCCTTSCH------HHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred --ccCCCCcCCH------HHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 1111112222 2345778899999999998 6766653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=360.45 Aligned_cols=262 Identities=25% Similarity=0.379 Sum_probs=211.0
Q ss_pred hhccccceeccccceEEEEEEe--------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCccc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM--------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIV 774 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 774 (1058)
++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+.+|+++++++ +||||+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----------ATEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT----------CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC----------CcHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 6899999999999999999965 35778999998532 2334467899999999999 899999
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeC
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTG--------------NALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 840 (1058)
++++++.+.+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+. +|+||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 181 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHR 181 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCC
Confidence 999999999999999999999999999986431 3489999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 043053 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 919 (1058)
Q Consensus 841 Dikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 919 (1058)
||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 182 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 9999999999999999999999987765543334445567889999999988889999999999999999999 999997
Q ss_pred CCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 920 PTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
... .......+..... .......+. .+..++..||+.||++|||+.++++.|+++....
T Consensus 262 ~~~--~~~~~~~~~~~~~-----~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 262 GIP--VEELFKLLKEGHR-----MDKPANCTN------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp TCC--HHHHHHHHHHTCC-----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCC--HHHHHHHHhcCCC-----CCCCccCCH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 542 2222222222211 111122222 2334778899999999999999999999886543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=353.75 Aligned_cols=262 Identities=26% Similarity=0.377 Sum_probs=194.5
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||+||+|... ..||||++.... ......+.+.+|++++++++||||+++++++ ..
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA---------PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSS---------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred cceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccC---------CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 57899999999999999999764 359999885331 2344567899999999999999999999965 45
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred CccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceec
Confidence 6689999999999999999754 46789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
+...............||+.|+|||++. +..++.++||||+|+++|||++|+.||..... .......+........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIEMVGRGSLSPD 246 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-HHHHHHHHHHTSCCCC
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-HHHHHHHhcccccCcc
Confidence 8655433223344567999999999876 56788899999999999999999999975432 2222222222211111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
........+. + +..++..||+.||++|||++++++.|+++..
T Consensus 247 -~~~~~~~~~~---~---l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 -LSKVRSNCPK---R---MKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -TTSSCTTSCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -hhhccccCCH---H---HHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111112222 2 3347788999999999999999999988754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=362.99 Aligned_cols=255 Identities=21% Similarity=0.328 Sum_probs=198.6
Q ss_pred HHHhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
...++|.+.+.||+|+||.||+|.. .+|+.||||++... ..+...+.+.+|++++++++||||++++++
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 72 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP----------NRELAREKVMREVKALAKLEHPGIVRYFNA 72 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECC----------STTTHHHHHHHHHHHHTSCCCTTBCCEEEE
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecC----------CchhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3568899999999999999999955 58999999998532 233456889999999999999999999999
Q ss_pred EEcCCC---------------------------------------------------------ceEEEEecCCCChhhhh
Q 043053 780 CWNRNN---------------------------------------------------------RLLMYDYMPNGSLGSLL 802 (1058)
Q Consensus 780 ~~~~~~---------------------------------------------------------~~lv~e~~~~gsL~~~l 802 (1058)
+.+... .++||||+++|+|.+++
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 152 (332)
T 3qd2_B 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152 (332)
T ss_dssp EEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHH
T ss_pred EEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHH
Confidence 865432 68999999999999999
Q ss_pred hhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCc----------
Q 043053 803 HERT-GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF---------- 871 (1058)
Q Consensus 803 ~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~---------- 871 (1058)
+... ....++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 153 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~ 229 (332)
T 3qd2_B 153 NRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229 (332)
T ss_dssp HTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------
T ss_pred hcccCccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccc
Confidence 8643 23456777899999999999999999 999999999999999999999999999987765421
Q ss_pred ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCch
Q 043053 872 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPES 951 (1058)
Q Consensus 872 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 951 (1058)
........||+.|+|||++.+..++.++||||+||++|||++|..|+.. ........... ..+..
T Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~~~~~~~--------~~~~~ 294 (332)
T 3qd2_B 230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRIITDVRNL--------KFPLL 294 (332)
T ss_dssp --CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHHHHHHTT--------CCCHH
T ss_pred cccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHHHHhhcc--------CCCcc
Confidence 1223456799999999999999999999999999999999998766421 11111111110 01111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 952 EIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 952 ~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.........+++..||+.||++|||++|++++
T Consensus 295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 11122234568899999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=355.93 Aligned_cols=260 Identities=26% Similarity=0.355 Sum_probs=198.3
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||+||+|...+|+.||||++.... ......+.+.+|++++++++||||+++++++.++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---------EDEGIPSTTIREISILKELKHSNIVKLYDVIHTK 72 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS---------GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccc---------cccccchhHHHHHHHHHhcCCCCEeeeeeEEccC
Confidence 4789999999999999999977889999999985432 2233457788999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 73 KRLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp SCEEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CeEEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccc
Confidence 999999999976 999998764 36789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc----
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI---- 938 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---- 938 (1058)
+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ........+.....
T Consensus 148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 148 RAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTT
T ss_pred cccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHHCCCChhh
Confidence 8664322 223355789999999998764 589999999999999999999999975421 11111111110000
Q ss_pred -------cccCCCCCCC--------CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 -------QVLDPSLLSR--------PESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 -------~~~~~~~~~~--------~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...++..... ...... .+.+++.+||+.||++|||++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDE---SGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhcccccccccccccCccHHHHhhhcCH---HHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0001110000 000111 23457888999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=353.62 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=215.7
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+|. ..++..||||++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS------------CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc------------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 678999999999999999994 45689999999842 22346789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999999999876667799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+........ .......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.... .......+.....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~--~~~~~~~~~~~~~---- 230 (288)
T 3kfa_A 158 SRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYR---- 230 (288)
T ss_dssp GGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTTCC----
T ss_pred ceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhccCC----
Confidence 987654332 23344567889999999998899999999999999999999 999997542 2233333322211
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYA 995 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~~~ 995 (1058)
.......+. .+.+++..||+.||++|||++++++.|+.+..+.....
T Consensus 231 -~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~~ 277 (288)
T 3kfa_A 231 -MERPEGCPE------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277 (288)
T ss_dssp -CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCH------HHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 111122222 23447788999999999999999999998876654433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=358.60 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=203.6
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+| +..+|+.||+|++...... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV--------RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--------HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--------hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 67999999999999999999 4557999999998644221 12335778899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....|+||||++||+|.++++. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 78 AQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCc
Confidence 9999999999999999999986 35789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
++..... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+... .
T Consensus 153 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~------~ 219 (318)
T 1fot_A 153 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TMKTYEKILNA------E 219 (318)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHC------C
T ss_pred ceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC------C
Confidence 9876432 235679999999999999999999999999999999999999997532 11111111111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l 984 (1058)
.......+. .+.+++.+||..||++|| ++++++++-
T Consensus 220 ~~~p~~~~~------~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 220 LRFPPFFNE------DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp CCCCTTSCH------HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCCCCCCCH------HHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 111112222 234477789999999999 888888753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=379.65 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=209.3
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|...+.||+|+||+||+|...++..||||++... ....+.|.+|++++++++||||+++++++. .
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------------SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT------------SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC------------CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 678899999999999999998888899999998532 123678999999999999999999999986 6
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.++++......+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 6789999999999999999865445688999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......+|+.|+|||++....++.++|||||||++|||++ |+.||.... .......+.....
T Consensus 332 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~~~~~----- 403 (454)
T 1qcf_A 332 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYR----- 403 (454)
T ss_dssp GGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHHTCC-----
T ss_pred eEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC-----
Confidence 87644221 22234457789999999998899999999999999999999 999997542 2233333322211
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.......+ .+ +..++.+||+.||++|||++++++.|+++...
T Consensus 404 ~~~~~~~~---~~---l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 404 MPRPENCP---EE---LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCCCTTSC---HH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCC---HH---HHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11111122 22 34478889999999999999999999887543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=362.52 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=194.5
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| +..+++.||||++.... .........+.+|++++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 82 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--------ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 82 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT--------TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc--------cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeee
Confidence 468999999999999999999 45789999999985431 123345678999999999999999999999998
Q ss_pred cCCCc----eEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeee
Q 043053 782 NRNNR----LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857 (1058)
Q Consensus 782 ~~~~~----~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl 857 (1058)
..... |+||||++||+|.++++.. ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEE
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEE
Confidence 76554 9999999999999999864 5789999999999999999999999 9999999999999999999999
Q ss_pred eccccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 858 ADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
+|||+++....... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||....+ ..........
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~~~~~~~~~~- 234 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVRE- 234 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHC-
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcC-
Confidence 99999986654321 1223345699999999999999999999999999999999999999975422 1111111111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
............+. .+..++.+||+.||++||++.+++.+
T Consensus 235 -~~~~~~~~~~~~~~------~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 235 -DPIPPSARHEGLSA------DLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp -CCCCHHHHSTTCCH------HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -CCCCcccccCCCCH------HHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 00000011111222 23347788999999999987766653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=350.50 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=204.3
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|...+.||+|+||.||+|... ++.||||++.... ......+.+.+|+.++++++||||+++++++.++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRD---------WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTT---------CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccc---------cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 57899999999999999999876 8999999985431 2334467899999999999999999999999877
Q ss_pred --CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCC--eEeCCCCCCcEEEcCCCCeeeec
Q 043053 784 --NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPP--IVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 784 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDikp~Nill~~~~~~kl~D 859 (1058)
...++||||+++|+|.++++......+++..++.++.|+++||+|||+. + |+||||||+||+++.++.++++|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence 6779999999999999999876555799999999999999999999998 7 99999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCc---ccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITE---KSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
||++..... ....||+.|+|||++.+..++. ++||||||+++|||++|+.||..... ..........
T Consensus 157 ~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~- 226 (271)
T 3kmu_A 157 ADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--MEIGMKVALE- 226 (271)
T ss_dssp GGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--HHHHHHHHHS-
T ss_pred ccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--HHHHHHHHhc-
Confidence 988654322 2456899999999988765544 79999999999999999999975421 1111111111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
...+......+.. +.+++..||+.||++|||++++++.|+++..
T Consensus 227 ---~~~~~~~~~~~~~------~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 ---GLRPTIPPGISPH------VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---CCCCCCCTTCCHH------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---CCCCCCCCCCCHH------HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1122222222322 3347778999999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=367.36 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=206.1
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+.++|.+.+.||+|+||.||+| +..+|+.||+|++... .......+.+|++++++++||||++++++
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----------~~~~~~~~~~E~~il~~l~hpnIv~~~~~ 116 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----------YPLDKYTVKNEISIMNQLHHPKLINLHDA 116 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------SHHHHHHHHHHHHHHTTCCSTTBCCEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-----------chhhHHHHHHHHHHHHhCCCcCCCeEEEE
Confidence 34578999999999999999999 5567999999988432 12235678999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC--CCCeee
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL--EFEPYI 857 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~--~~~~kl 857 (1058)
+.+....++||||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+||
T Consensus 117 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL 192 (387)
T 1kob_A 117 FEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKI 192 (387)
T ss_dssp EECSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEeCCEEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEE
Confidence 99999999999999999999999754 35789999999999999999999999 9999999999999974 468999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+...
T Consensus 193 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~i~~~-- 265 (387)
T 1kob_A 193 IDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DLETLQNVKRC-- 265 (387)
T ss_dssp CCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHC--
T ss_pred EecccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--HHHHHHHHHhC--
Confidence 9999998775532 2234579999999999999999999999999999999999999997542 12222222211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
....++......+. .+.+++..||+.||++|||++|++++-
T Consensus 266 ~~~~~~~~~~~~s~------~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 266 DWEFDEDAFSSVSP------EAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp CCCCCSSTTTTSCH------HHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CCCCCccccccCCH------HHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 11112222222222 234578889999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=360.71 Aligned_cols=263 Identities=24% Similarity=0.388 Sum_probs=201.6
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEE----EEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVI----AVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~v----avK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|.+.+.||+|+||+||+|. ..+++.| |+|.+... ......+.+.+|+.++++++||||+++++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 84 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------TSPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC----------SSCCCHHHHHHHHHHHTTCCBTTBCCCCE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc----------cCHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence 578999999999999999995 4556554 66655322 23345688999999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++..+. .++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~~~~~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~ 159 (327)
T 3lzb_A 85 ICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp EEESSS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred EEecCC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEc
Confidence 998654 78999999999999999875 46789999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+.....
T Consensus 160 DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~~~~~~~ 237 (327)
T 3lzb_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGER 237 (327)
T ss_dssp CTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTTCC
T ss_pred cCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCC
Confidence 9999987655443333445567889999999999999999999999999999999 999997653 2233333332211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEY 994 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~~ 994 (1058)
.......+. .+..++..||+.||++|||++|+++.|+++......+
T Consensus 238 -----~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 283 (327)
T 3lzb_A 238 -----LPQPPICTI------DVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRY 283 (327)
T ss_dssp -----CCCCTTBCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHH
T ss_pred -----CCCCccCCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCce
Confidence 111111122 2344788899999999999999999999987665443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=358.60 Aligned_cols=263 Identities=23% Similarity=0.350 Sum_probs=188.5
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||+||+| +..+|+.||||++... ......+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 73 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD----------SEEGTPSTAIREISLMKELKHENIVRLYDVIH 73 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECC----------STTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecc----------cccccHHHHHHHHHHHHhcCCCCcceEEEEEE
Confidence 357889999999999999999 4557999999998533 12233567889999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeee
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERT----GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl 857 (1058)
+++..++||||++ |+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 74 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 149 (317)
T 2pmi_A 74 TENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKL 149 (317)
T ss_dssp CTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred ECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEE
Confidence 9999999999998 59999987542 24589999999999999999999999 9999999999999999999999
Q ss_pred eccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
+|||+++...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+....
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~ 225 (317)
T 2pmi_A 150 GDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND--EEQLKLIFDIM 225 (317)
T ss_dssp CCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHH
T ss_pred CcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHh
Confidence 9999998765332 22345578999999999876 4689999999999999999999999975422 11111111110
Q ss_pred Cc------------cccCCCCCCCCchhHHH----------HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 GI------------QVLDPSLLSRPESEIDE----------MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ~~------------~~~~~~~~~~~~~~~~~----------~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. ....+............ ...+.+++..||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 00011111111100000 0134568889999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=370.60 Aligned_cols=207 Identities=23% Similarity=0.294 Sum_probs=180.2
Q ss_pred hhccccceeccc--cceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 704 KCLVDANVIGKG--CSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 704 ~~~~~~~~lG~G--~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
.+|.+.+.||+| +||+||+|. ..+|+.||||++.... ......+.+.+|+.++++++|||||++++++
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA---------CSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG---------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc---------cChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 689999999999 999999994 4589999999985432 2234567889999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+++..|+||||+++|+|.+++.......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCG
T ss_pred EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccc
Confidence 9999999999999999999999876567799999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCc-----ccccccccCcCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 043053 861 GLAKLVDDGDF-----ARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTI 922 (1058)
Q Consensus 861 Gl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 922 (1058)
|.+........ ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99865432211 112234578999999999887 678999999999999999999999997643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=354.69 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=198.1
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||+||+|... ++.||||++.. ....+.+.+|++++++++||||+++++++.
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 71 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES-------------ESERKAFIVELRQLSRVNHPNIVKLYGACL-- 71 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS-------------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC-------------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--
Confidence 57889999999999999999775 78999999842 234678999999999999999999999886
Q ss_pred CCceEEEEecCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC-eeeeccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTG-NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE-PYIADFG 861 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~-~kl~DfG 861 (1058)
+..++||||+++|+|.++++.... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg 151 (307)
T 2eva_A 72 NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151 (307)
T ss_dssp TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence 458999999999999999986432 24788999999999999999999932229999999999999998886 7999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||................. .
T Consensus 152 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----~ 221 (307)
T 2eva_A 152 TACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-----T 221 (307)
T ss_dssp C-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-----C
T ss_pred cccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC-----C
Confidence 99765432 2344699999999999999999999999999999999999999975433222221111111 1
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.+......+.. +.+++.+||+.||++|||++++++.|+.+....
T Consensus 222 ~~~~~~~~~~~------l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 222 RPPLIKNLPKP------IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CCCCBTTCCHH------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CCCcccccCHH------HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 12222222222 334778899999999999999999999886543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=359.03 Aligned_cols=262 Identities=21% Similarity=0.359 Sum_probs=193.9
Q ss_pred hhccccceeccccceEEEEEEecC-Cc---EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDN-GE---VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||+||+|.... ++ .||||++.... ......+.+.+|++++++++||||++++++
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI---------IASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc---------cCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 579999999999999999995543 32 79999985431 123446889999999999999999999999
Q ss_pred EEcCCCc------eEEEEecCCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE
Q 043053 780 CWNRNNR------LLMYDYMPNGSLGSLLHERT----GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI 849 (1058)
Q Consensus 780 ~~~~~~~------~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill 849 (1058)
+...... ++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli 170 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCML 170 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEE
Confidence 9877655 99999999999999997532 22589999999999999999999999 99999999999999
Q ss_pred cCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhH
Q 043053 850 GLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHV 928 (1058)
Q Consensus 850 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 928 (1058)
+.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ...
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~ 248 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEI 248 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGH
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--HHH
Confidence 9999999999999987765544344445567889999999999999999999999999999999 9999975432 223
Q ss_pred HHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 929 VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
...+..... .......+ . .+.+++.+||+.||++|||+.++++.++++...
T Consensus 249 ~~~~~~~~~-----~~~~~~~~---~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 249 YNYLIGGNR-----LKQPPECM---E---EVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHHHHTTCC-----CCCCTTCC---H---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcCCC-----CCCCCccC---H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 222222111 11111122 2 234578889999999999999999999988654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=351.53 Aligned_cols=259 Identities=26% Similarity=0.470 Sum_probs=202.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||+||+| +..+++.||||++....... ........+.+.+|++++++++||||+++++++.+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG----ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC----CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc----chhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 67899999999999999999 45689999999985432110 00011122789999999999999999999999865
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCC--eEeCCCCCCcEEEcCCCC-----e
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPP--IVHRDIKANNILIGLEFE-----P 855 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDikp~Nill~~~~~-----~ 855 (1058)
.. ++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. + |+||||||+||+++.++. +
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred CC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence 43 7999999999999998764 46799999999999999999999999 7 999999999999988776 9
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY--MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
||+|||+++.... ......||+.|+|||++. ...++.++||||+||++|||++|+.||...............
T Consensus 169 kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 243 (287)
T 4f0f_A 169 KVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243 (287)
T ss_dssp EECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred EeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence 9999999975433 233567999999999983 455788999999999999999999999865443332232222
Q ss_pred hhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
... ..+......+.. +.+++..||+.||++|||++++++.|+++
T Consensus 244 ~~~----~~~~~~~~~~~~------l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEG----LRPTIPEDCPPR------LRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSC----CCCCCCTTSCHH------HHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccC----CCCCCCcccCHH------HHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 211 122222222322 33477789999999999999999998763
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=350.41 Aligned_cols=257 Identities=30% Similarity=0.441 Sum_probs=193.3
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|...+.||+|+||.||+|... ++.||||++..... .......+.+.+|+++++.++||||+++++++.++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPD-------EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE 78 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC-----------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCc-------ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 57889999999999999999765 89999999854321 12234467899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC--------CCCe
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL--------EFEP 855 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~--------~~~~ 855 (1058)
+..++||||+++|+|.+++.. ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++. ++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred CceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 999999999999999999964 56899999999999999999999993223999999999999986 6789
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||+++...... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... ...........
T Consensus 156 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~ 229 (271)
T 3dtc_A 156 KITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--GLAVAYGVAMN 229 (271)
T ss_dssp EECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--HHHHHHHHHTS
T ss_pred EEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHhhhcC
Confidence 999999998655422 224569999999999999899999999999999999999999997542 11111111111
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
..........+. .+.+++.+||+.||++|||++|++++|+++
T Consensus 230 ----~~~~~~~~~~~~------~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 ----KLALPIPSTCPE------PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----CCCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----CCCCCCCcccCH------HHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111111222222 233477889999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.81 Aligned_cols=257 Identities=26% Similarity=0.343 Sum_probs=208.5
Q ss_pred HHHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
...++|.+.+.||+|+||.||+|. ..+++.||||++... ......+.+.+|+.++++++||||++++++
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----------RAVDCPENIKKEICINKMLNHENVVKFYGH 73 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGG----------GCTTHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeec----------cchhhhHHHHHHHHHHHhcCCCCceeeeeE
Confidence 356899999999999999999995 457999999998533 122346789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+.+++..++||||+++|+|.+++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 148 (276)
T 2yex_A 74 RREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISD 148 (276)
T ss_dssp EEETTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred EEcCCEEEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEee
Confidence 9999999999999999999999975 35789999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
||.+................||+.|+|||++.+..+ +.++||||+|+++|||++|+.||............+......
T Consensus 149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 227 (276)
T 2yex_A 149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY- 227 (276)
T ss_dssp CTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-
T ss_pred CCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-
Confidence 999987654332233445679999999999887765 778999999999999999999998664444444333322111
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. +. ....+. .+.+++..||+.||++|||++|++++
T Consensus 228 --~-~~-~~~~~~------~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 --L-NP-WKKIDS------APLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --S-TT-GGGSCH------HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --c-Cc-hhhcCH------HHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0 00 111111 23347888999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=347.73 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=209.5
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|...+.||+|+||.||+|...+++.||||++... ....+.+.+|++++++++||||+++++++.++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG------------AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT------------TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc------------CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 578999999999999999998888999999998533 12246899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.++++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred CCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence 9999999999999999999864 45689999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+...... ........++..|+|||+..+..++.++||||+|+++|||++ |+.||.... .......+... ..
T Consensus 152 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~i~~~--~~--- 223 (267)
T 3t9t_A 152 RFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTG--FR--- 223 (267)
T ss_dssp GGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTT--CC---
T ss_pred ccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--HHHHHHHHhcC--Cc---
Confidence 8654322 122334557889999999998889999999999999999999 899997542 22222222211 11
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.......+. .+..++.+||+.||++|||++++++.|+++..+
T Consensus 224 ~~~~~~~~~------~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 LYKPRLAST------HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCccCcH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111122 233478889999999999999999999988653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=363.81 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=203.6
Q ss_pred HhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
.++|.+.+.||+|+||.||+|. ..+|+.||||++...... .....+.+..|..++..+ +||||+++++++
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL--------MDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH--------HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh--------hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 4789999999999999999995 457899999998644221 122356788899999887 899999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+++..|+||||++||+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEC
Confidence 9999999999999999999999864 5689999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+...
T Consensus 163 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~----- 233 (345)
T 1xjd_A 163 GMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMD----- 233 (345)
T ss_dssp TTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC-----
T ss_pred hhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHhC-----
Confidence 9998643322 23456789999999999999999999999999999999999999997542 22222222211
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMK-DVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~-~v~~~ 983 (1058)
.+......+. .+.+++.+||+.||++||++. ++.++
T Consensus 234 -~~~~p~~~s~------~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 234 -NPFYPRWLEK------EAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -CCCCCTTSCH------HHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -CCCCCcccCH------HHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1111122222 234577889999999999997 77654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.01 Aligned_cols=270 Identities=20% Similarity=0.295 Sum_probs=202.3
Q ss_pred HHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
...+|.+.+.||+|+||.||+|. ..+|+.||||++.... .......+.+.+|+.++++++||||+++++++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD--------LMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTS--------SCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhh--------ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34689999999999999999994 5689999999985421 12334567899999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
...+..++||||+++|+|.+++... ....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~ 178 (310)
T 2wqm_A 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLG 178 (310)
T ss_dssp EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEE
Confidence 9999999999999999999999752 246789999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
|||+++...... .......|++.|+|||++.+..++.++||||||+++|||++|+.||.............+....
T Consensus 179 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-- 254 (310)
T 2wqm_A 179 DLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-- 254 (310)
T ss_dssp CC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--
T ss_pred eccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--
Confidence 999998665432 2233456899999999999989999999999999999999999999754332222222222211
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEY 994 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~~ 994 (1058)
..+......+. .+..++..||+.||++|||++++++.++++.....+.
T Consensus 255 --~~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 255 --YPPLPSDHYSE------ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp --SCCCCTTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred --CCCCcccccCH------HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 11111112222 2334778899999999999999999999998765543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=364.26 Aligned_cols=256 Identities=22% Similarity=0.303 Sum_probs=196.7
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC--CcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH--KNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~ 781 (1058)
++|.+.+.||+|+||.||+|...+++.||||++.... ......+.+.+|+.++++++| |||+++++++.
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT---------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc---------cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 5689999999999999999987889999999985331 233446789999999999986 99999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
++...++||| +.+|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 80 ~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG 152 (343)
T 3dbq_A 80 TDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG 152 (343)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred eCCEEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecc
Confidence 9999999999 5578999999873 6789999999999999999999999 999999999999997 6789999999
Q ss_pred cceeccCCCcccccccccCcCCccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-----------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 930 (1058)
+++..............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 232 (343)
T 3dbq_A 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232 (343)
T ss_dssp SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH
Confidence 9987655433333446679999999999764 67888999999999999999999999754221111111
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
..... .........+. .+.+++..||+.||++|||++|++++...
T Consensus 233 ~~~~~-----~~~~~~~~~~~------~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 233 IIDPN-----HEIEFPDIPEK------DLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp HHCTT-----SCCCCCCCSCH------HHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HhcCC-----cccCCcccCCH------HHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 11100 11111122222 23347788999999999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=361.38 Aligned_cols=256 Identities=20% Similarity=0.243 Sum_probs=201.6
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 781 (1058)
++|...+.||+|+||.||+|. ..+++.||||++..... ......+.+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 80 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV--------NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 80 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS--------CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh--------cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence 578999999999999999995 45789999999864421 2233457788999999988 7999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++..|+||||++||+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecc
Confidence 999999999999999999999864 5689999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC----hhHHHHHHhhcC
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG----SHVVDWVRQKKG 937 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~----~~~~~~~~~~~~ 937 (1058)
+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ............
T Consensus 156 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 156 MCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp GCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred ccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 998643222 23446689999999999999999999999999999999999999997532110 111111111100
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM------KDVAAM 983 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~------~~v~~~ 983 (1058)
. ........+. .+.+++..||+.||++||++ ++++++
T Consensus 234 ~---~~~~p~~~s~------~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 234 K---QIRIPRSLSV------KAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp C---CCCCCTTSCH------HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred C---CCCCCCCCCH------HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0 1111112222 23457788999999999996 566554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=362.30 Aligned_cols=256 Identities=22% Similarity=0.230 Sum_probs=201.8
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceee
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLG 778 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 778 (1058)
.+.++|.+.+.||+|+||.||+| +..+|+.||||++.... ....+|++++.++ +||||+++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------------~~~~~E~~~l~~~~~hp~iv~~~~ 83 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---------------RDPTEEIEILLRYGQHPNIITLKD 83 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT---------------CCCHHHHHHHHHHTTSTTBCCEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc---------------CChHHHHHHHHHhcCCCCcCeEEE
Confidence 45688999999999999999999 55679999999984321 1235788888888 6999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC----CC
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE----FE 854 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~----~~ 854 (1058)
++.+++..|+||||++||+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||++..+ +.
T Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~ 158 (342)
T 2qr7_A 84 VYDDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPES 158 (342)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGG
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCe
Confidence 99999999999999999999999976 35789999999999999999999999 99999999999998543 35
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC-hhHHHHHH
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG-SHVVDWVR 933 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~-~~~~~~~~ 933 (1058)
+||+|||+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......+.
T Consensus 159 ~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 236 (342)
T 2qr7_A 159 IRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236 (342)
T ss_dssp EEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH
T ss_pred EEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc
Confidence 9999999998765432 22345679999999999988888999999999999999999999997542222 12222222
Q ss_pred hhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
... ...........+. .+.+++..||+.||++|||+++++++-..
T Consensus 237 ~~~--~~~~~~~~~~~s~------~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 237 SGK--FSLSGGYWNSVSD------TAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp HCC--CCCCSTTTTTSCH------HHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred cCC--cccCccccccCCH------HHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 211 1111111122222 23447788999999999999999986554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=367.87 Aligned_cols=269 Identities=22% Similarity=0.287 Sum_probs=207.8
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.++||+|+||+||+| +..+|+.||||++.... .....+.+.+|++++++++||||+++++++..
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----------FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----------GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc----------ccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 57899999999999999999 55569999999985432 22335778899999999999999999999987
Q ss_pred CC--CceEEEEecCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE----cCCCCe
Q 043053 783 RN--NRLLMYDYMPNGSLGSLLHERT-GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI----GLEFEP 855 (1058)
Q Consensus 783 ~~--~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill----~~~~~~ 855 (1058)
.. ..++||||+++|+|.++++... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeE
Confidence 65 5699999999999999998643 23489999999999999999999999 99999999999999 777889
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCcccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh-
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM--------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS- 926 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~- 926 (1058)
||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 999999998765432 2345679999999998765 5677899999999999999999999975433222
Q ss_pred -hHHHHHHhhcCccc-------------cCCCCCC--CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 927 -HVVDWVRQKKGIQV-------------LDPSLLS--RPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 927 -~~~~~~~~~~~~~~-------------~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.....+........ ....... ........ .+..++..||+.||++||+++++++.++++...
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQV--LLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHH--HHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHh--hchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 22111111111000 0001111 11122222 234588999999999999999999999887554
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=364.45 Aligned_cols=255 Identities=23% Similarity=0.265 Sum_probs=193.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+| +..+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG------------AAIDENVQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS------------TTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC------------ccccHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 68999999999999999999 4558999999998422 1224678899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC--eeeecc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE--PYIADF 860 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~--~kl~Df 860 (1058)
++..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 88 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Df 162 (361)
T 3uc3_A 88 PTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDF 162 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred CCEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeec
Confidence 99999999999999999999764 5689999999999999999999999 9999999999999987765 999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEK-SDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
|+++..... .......||+.|+|||++.+..+..+ +||||+||++|+|++|+.||....... .....+.......
T Consensus 163 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~ 238 (361)
T 3uc3_A 163 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVK 238 (361)
T ss_dssp CCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTC
T ss_pred Ccccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCC
Confidence 998743322 22345579999999999888877655 899999999999999999997653322 2222222221111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
...+.. ...+. .+.+++.+||+.||++|||+.|++++-..
T Consensus 239 ~~~~~~-~~~s~------~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 239 YSIPDD-IRISP------ECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp CCCCTT-SCCCH------HHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred CCCCCc-CCCCH------HHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 111110 11122 23457888999999999999999987554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.05 Aligned_cols=249 Identities=19% Similarity=0.207 Sum_probs=204.4
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+|. ..+|+.||||++..... ......+.+.+|++++++++||||+++++++.+
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--------VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--------ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 689999999999999999994 45799999999854422 122345788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...|+||||++||+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccccc
Confidence 99999999999999999999864 5689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
++..... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 188 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~------ 254 (350)
T 1rdq_E 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGK------ 254 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCC------
T ss_pred ceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--HHHHHHHHHcCC------
Confidence 9876542 235679999999999999999999999999999999999999997542 222222222111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~l 984 (1058)
.......+. .+.+++..||+.||++||+ +++++++-
T Consensus 255 ~~~p~~~~~------~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 255 VRFPSHFSS------DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp CCCCTTCCH------HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCCCCCCCH------HHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 111122222 2344778899999999998 88887654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=375.59 Aligned_cols=261 Identities=23% Similarity=0.250 Sum_probs=195.2
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||+||+| +..+|+.||||++.... ......+++.+|+.+++.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG---------GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc---------cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 478999999999999999999 66789999999985431 23344678899999999999999999999997
Q ss_pred cCC------CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 782 NRN------NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 782 ~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
... ..|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~ 203 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 203 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCE
Confidence 654 35999999976 57666643 489999999999999999999999 99999999999999999999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||+++..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ...+...++..
T Consensus 204 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i~~~l 279 (464)
T 3ttj_A 204 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQL 279 (464)
T ss_dssp EECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHH
T ss_pred EEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhc
Confidence 99999999876543 233456899999999999999999999999999999999999999975421 11111111100
Q ss_pred cCc--c-----------c--cCCCCC------------CCCchhH--HHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 936 KGI--Q-----------V--LDPSLL------------SRPESEI--DEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 936 ~~~--~-----------~--~~~~~~------------~~~~~~~--~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
... . . ..+... ....... .....+.+++.+||..||++|||++|++++-
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000 0 0 000000 0000011 1123456789999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=368.54 Aligned_cols=257 Identities=22% Similarity=0.262 Sum_probs=193.9
Q ss_pred HHHhhcccc-ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcc-cCCCccccee
Q 043053 701 QVLKCLVDA-NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGS-IRHKNIVRFL 777 (1058)
Q Consensus 701 ~~~~~~~~~-~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~ 777 (1058)
.+.+.|.+. ++||+|+||+||+| +..+|+.||||++.. ...+.+|++++.+ .+||||++++
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----------------~~~~~~E~~~~~~~~~hp~iv~l~ 121 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------------CPKARREVELHWRASQCPHIVRIV 121 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------------SHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----------------chhHHHHHHHHHHhcCCCCcceEe
Confidence 345667766 78999999999999 556799999998831 2456788888744 4799999999
Q ss_pred eEEEc----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC--
Q 043053 778 GCCWN----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-- 851 (1058)
Q Consensus 778 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-- 851 (1058)
+++.. ....|+||||++||+|.+++.......+++..+..|+.||+.||+|||+. +|+||||||+|||++.
T Consensus 122 ~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~ 198 (400)
T 1nxk_A 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKR 198 (400)
T ss_dssp EEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSS
T ss_pred EEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCC
Confidence 99875 55679999999999999999876556799999999999999999999999 9999999999999998
Q ss_pred -CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC--hhH
Q 043053 852 -EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG--SHV 928 (1058)
Q Consensus 852 -~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~--~~~ 928 (1058)
++.+||+|||+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 199 ~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 275 (400)
T 1nxk_A 199 PNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275 (400)
T ss_dssp TTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH
T ss_pred CCccEEEEecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH
Confidence 789999999999876542 22345679999999999999999999999999999999999999997653322 112
Q ss_pred HHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 929 VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
...+.... .....+ .....+. .+.+++..||+.||++|||++|++++-...
T Consensus 276 ~~~i~~~~-~~~~~~-~~~~~s~------~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 276 KTRIRMGQ-YEFPNP-EWSEVSE------EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp HHHHHHTC-CCCCTT-TTTTSCH------HHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHHHcCc-ccCCCc-ccccCCH------HHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 22222111 111111 1111222 234578899999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=379.29 Aligned_cols=255 Identities=23% Similarity=0.270 Sum_probs=207.2
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...++||+|+||.||+|. ..+|+.||||++...... .....+.+.+|++++++++|||||++++++.+
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~--------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--------KRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--------HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh--------hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 578899999999999999994 458999999998644221 22335678899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..|+||||++||+|.+++.......+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccc
Confidence 99999999999999999999875555699999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC--hhHHHHHHhhcCccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG--SHVVDWVRQKKGIQV 940 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~ 940 (1058)
++...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+...+...
T Consensus 333 a~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----- 404 (576)
T 2acx_A 333 AVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----- 404 (576)
T ss_dssp CEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----
T ss_pred ceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----
Confidence 98765432 2334579999999999999889999999999999999999999998653321 1122211111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAML 984 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l 984 (1058)
........+. .+.+++..||+.||++|| +++|++++-
T Consensus 405 -~~~~p~~~s~------~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 405 -PEEYSERFSP------QARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp -CCCCCTTSCH------HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred -cccCCccCCH------HHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 1111222222 234577889999999999 788888753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=366.95 Aligned_cols=258 Identities=20% Similarity=0.223 Sum_probs=203.4
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.++||+|+||+||+|. ..+++.||+|++.+.... .....+.+.+|+.+++.++|||||++++++.+
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--------KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--------HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh--------hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 679999999999999999994 457899999998543221 11223568899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||++||+|.++++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999999975 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK----ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
++....... ......+||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ......+....
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~-- 289 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMNHK-- 289 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTHH--
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--hhHHHHHHhcc--
Confidence 987655432 2334678999999999987665 78899999999999999999999975421 11111111111
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHHHh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDE--RPTMKDVAAMLKE 986 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPt~~~v~~~l~~ 986 (1058)
...........+. .+.+++..||..+|.+ ||+++||+++-..
T Consensus 290 ~~~~~p~~~~~s~------~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 290 NSLTFPDDNDISK------EAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp HHCCCCTTCCCCH------HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred ccccCCCcccccH------HHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 0001011111222 2334677899999988 9999999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=354.90 Aligned_cols=272 Identities=28% Similarity=0.374 Sum_probs=204.7
Q ss_pred HHHHhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc--CCCccccee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI--RHKNIVRFL 777 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~ 777 (1058)
..+.++|.+.+.||+|+||.||+|... ++.||||++... ....+.+|.+++... +||||++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--------------~~~~~~~e~~~~~~~~~~h~~i~~~~ 97 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT--------------EEASWFRETEIYQTVLMRHENILGFI 97 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG--------------GHHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc--------------ccchhhhHHHHHHHHhhcCCCeeeEE
Confidence 345689999999999999999999776 899999998422 134455566666555 899999999
Q ss_pred eEEEcC----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccC-----CCCeEeCCCCCCcEE
Q 043053 778 GCCWNR----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDC-----VPPIVHRDIKANNIL 848 (1058)
Q Consensus 778 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrDikp~Nil 848 (1058)
+++... ...++||||+++|+|.++++. ..+++..++.++.|++.||+|||+.+ .++|+||||||+||+
T Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nil 174 (337)
T 3mdy_A 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174 (337)
T ss_dssp EEEEESCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEE
T ss_pred EEEccCCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEE
Confidence 999877 667999999999999999975 36899999999999999999999752 238999999999999
Q ss_pred EcCCCCeeeeccccceeccCCCcc--cccccccCcCCccCccccccCCCCcc------cchhhHHHHHHHHHhC------
Q 043053 849 IGLEFEPYIADFGLAKLVDDGDFA--RSSNTVAGSYGYIAPEYGYMMKITEK------SDVYSYGVVVLEVLTG------ 914 (1058)
Q Consensus 849 l~~~~~~kl~DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvvl~elltg------ 914 (1058)
++.++.+||+|||+++........ .......||+.|+|||++.+.....+ +|||||||++|||++|
T Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~ 254 (337)
T 3mdy_A 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254 (337)
T ss_dssp ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence 999999999999999876543211 11235579999999999887766655 9999999999999999
Q ss_pred ----CCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 915 ----KQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 915 ----~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
..||....+............ ......+........ ......+.+++.+||+.||++|||+++++++|+.+...
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 255 VEEYQLPYHDLVPSDPSYEDMREIV-CIKKLRPSFPNRWSS-DECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHH-TTSCCCCCCCGGGGG-SHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccccccHhhhcCCCCchhhhHHHH-hhhccCccccccchh-hHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 677765444333332222211 112222222111110 11222345588999999999999999999999988765
Q ss_pred h
Q 043053 991 R 991 (1058)
Q Consensus 991 ~ 991 (1058)
.
T Consensus 333 ~ 333 (337)
T 3mdy_A 333 Q 333 (337)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.06 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=208.3
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||.||+|...+++.||||++... ....+.+.+|++++++++||||+++++++. .
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 79 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG------------SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC------------cccHHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence 688999999999999999998888889999998532 123578999999999999999999999986 4
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++.......+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 5689999999999999999865444789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......++..|+|||+..+..++.++||||||+++|||++ |+.||.... .......+.... .
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~-----~ 228 (279)
T 1qpc_A 157 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLERGY-----R 228 (279)
T ss_dssp EECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTC-----C
T ss_pred ccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--HHHHHHHHhccc-----C
Confidence 87755332 22334557889999999988889999999999999999999 999997542 222222222211 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.......+. .+..++..||+.||++|||++++++.|+++...
T Consensus 229 ~~~~~~~~~------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 229 MVRPDNCPE------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccccH------HHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 111112222 233477889999999999999999999987654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.47 Aligned_cols=261 Identities=21% Similarity=0.267 Sum_probs=205.0
Q ss_pred cHHHHHhhcccc-ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCccc
Q 043053 698 SVEQVLKCLVDA-NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIV 774 (1058)
Q Consensus 698 ~~~~~~~~~~~~-~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv 774 (1058)
..+.+.++|.+. +.||+|+||.||+| +..+++.||||++.... ........+.+|+.+++++. ||||+
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~~iv 92 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR---------RGQDCRAEILHEIAVLELAKSCPRVI 92 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEE---------TTEECHHHHHHHHHHHHHTTTCTTBC
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhh---------cchHHHHHHHHHHHHHHhccCCCCEE
Confidence 356677788887 89999999999999 55579999999985432 22344678999999999995 69999
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC---
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL--- 851 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~--- 851 (1058)
++++++.+.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp CEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTT
T ss_pred EEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCC
Confidence 9999999999999999999999999999766567899999999999999999999999 9999999999999998
Q ss_pred CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHH
Q 043053 852 EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 931 (1058)
++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......
T Consensus 170 ~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~ 244 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--QETYLN 244 (327)
T ss_dssp BCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred CCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHH
Confidence 7899999999998765432 23346799999999999999999999999999999999999999975421 111111
Q ss_pred HHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+... ............+.. +.+++..||+.||++|||+++++++
T Consensus 245 i~~~--~~~~~~~~~~~~~~~------~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ISQV--NVDYSEETFSSVSQL------ATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHT--CCCCCTTTTTTSCHH------HHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhc--ccccCchhhcccCHH------HHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111 111111111222222 3347788999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=375.13 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=202.6
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|...+.||+|+||.||+|....+..||||++.... ...+.|.+|++++++++||||+++++++.+
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT------------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC------------CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 5788999999999999999988878889999985321 225789999999999999999999999876
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.++++......+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccc
Confidence 6789999999999999999865456789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+.... .
T Consensus 328 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~~~~-----~ 399 (452)
T 1fmk_A 328 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGY-----R 399 (452)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTC-----C
T ss_pred eecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-----C
Confidence 87654322 22234457889999999998899999999999999999999 999997542 222222222211 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
.......+. .+.+++..||+.||++|||++++++.|+++..
T Consensus 400 ~~~~~~~~~------~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 400 MPCPPECPE------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCCH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 111112222 23347888999999999999999999988754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.37 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=205.1
Q ss_pred hhccccceeccccceEEEEEE-----ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-----MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|...+.||+|+||.||+|. ..+++.||||++... ......+.+.+|++++++++||||+++++
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE----------SGGNHIADLKKEIEILRNLYHENIVKYKG 90 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccc----------ccchhHHHHHHHHHHHHhCCCCCeeeeee
Confidence 568999999999999999997 357899999998543 22334578999999999999999999999
Q ss_pred EEEcC--CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 779 CCWNR--NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 779 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
++.+. ...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k 166 (302)
T 4e5w_A 91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 166 (302)
T ss_dssp EEEC---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred EEecCCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEE
Confidence 99876 5679999999999999999764 46689999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC----------CCC
Q 043053 857 IADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI----------PDG 925 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~----------~~~ 925 (1058)
|+|||+++....... ........||..|+|||++.+..++.++||||+|+++|||++|+.|+.... ...
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence 999999987765432 123345568889999999998889999999999999999999999874321 011
Q ss_pred hhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
.............. ........+. .+.+++..||+.||++|||++++++.|+++.
T Consensus 247 ~~~~~~~~~~~~~~--~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 247 MTVTRLVNTLKEGK--RLPCPPNCPD------EVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GHHHHHHHHHHTTC--CCCCCTTCCH------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHhccC--CCCCCCCCCH------HHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111111111110 1111111222 2334788899999999999999999998763
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=354.63 Aligned_cols=261 Identities=21% Similarity=0.291 Sum_probs=208.3
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+.++|.+.+.||+|+||.||+| +..+|+.||||++....... .......+.+.+|+.++++++||||++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA-----SRRGVSREEIEREVSILRQVLHHNVITLHDV 83 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSS-----CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccc-----cccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 45688999999999999999999 45579999999985442211 1122346789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC----Ce
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF----EP 855 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~----~~ 855 (1058)
+.++...++||||+++|+|.+++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++ .+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~ 158 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHI 158 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCE
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCE
Confidence 9999999999999999999999976 35789999999999999999999999 999999999999999888 79
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... .......+...
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~ 233 (321)
T 2a2a_A 159 KLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANITSV 233 (321)
T ss_dssp EECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTT
T ss_pred EEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhc
Confidence 999999998765532 2335569999999999998899999999999999999999999997542 11111111111
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
....++......+. .+.+++..||+.||++|||++|++++-
T Consensus 234 --~~~~~~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 234 --SYDFDEEFFSHTSE------LAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp --CCCCCHHHHTTCCH------HHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred --ccccChhhhcccCH------HHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 11111111111222 234578889999999999999999854
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=361.22 Aligned_cols=253 Identities=23% Similarity=0.268 Sum_probs=187.9
Q ss_pred HHhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.++|.+.+.||+|+||.||+|.. .+++.||||++... ...+.+.+|++++++++||||+++++++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~~ 117 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-------------VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------------CHHHHHCCCTTBCCEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------------hhHHHHHHHHHHHHhCCCCCCcceeeeE
Confidence 346799999999999999999954 56889999998432 1245688999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC---CCCeee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL---EFEPYI 857 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~---~~~~kl 857 (1058)
.+++..++||||+++|+|.+++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++. ++.+||
T Consensus 118 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl 192 (349)
T 2w4o_A 118 ETPTEISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKI 192 (349)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEE
T ss_pred ecCCeEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEE
Confidence 999999999999999999999976 35689999999999999999999999 9999999999999975 889999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+...
T Consensus 193 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~i~~~-- 266 (349)
T 2w4o_A 193 ADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MFRRILNC-- 266 (349)
T ss_dssp CCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HHHHHHTT--
T ss_pred ccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HHHHHHhC--
Confidence 9999998765432 23356799999999999999999999999999999999999999975432211 11111111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
............+. .+.+++.+||+.||++|||+.|++++-
T Consensus 267 ~~~~~~~~~~~~~~------~~~~li~~~L~~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 267 EYYFISPWWDEVSL------NAKDLVRKLIVLDPKKRLTTFQALQHP 307 (349)
T ss_dssp CCCCCTTTTTTSCH------HHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CCccCCchhhhCCH------HHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 11111111112222 234578889999999999999998853
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.26 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=209.7
Q ss_pred HhhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccce
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRF 776 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 776 (1058)
.++|.+.+.||+|+||.||+|... +++.||||++... ........+.+|+.++++++||||+++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----------ASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----------SCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc----------cCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 368999999999999999999443 4788999998532 223345678999999999999999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEE
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nil 848 (1058)
++++.+++..++||||+++|+|.++++... ...+++..++.++.|+++||+|||+. +|+||||||+||+
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence 999999999999999999999999997532 24578999999999999999999999 9999999999999
Q ss_pred EcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChh
Q 043053 849 IGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSH 927 (1058)
Q Consensus 849 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~ 927 (1058)
++.++.+||+|||+++...............||+.|+|||++.+..++.++||||+|+++|||++ |..||.... ...
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~ 248 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQ 248 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHH
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC--HHH
Confidence 99999999999999986654433333344567889999999998899999999999999999999 899997542 222
Q ss_pred HHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 928 VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 928 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
....+..... +......+. + +..++..||+.||++|||+.++++.|++....
T Consensus 249 ~~~~~~~~~~-----~~~~~~~~~---~---l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 249 VLRFVMEGGL-----LDKPDNCPD---M---LFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHHHHHTTCC-----CCCCTTCCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHHHcCCc-----CCCCCCCCH---H---HHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 2222222110 111112222 2 33477889999999999999999999887553
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=360.23 Aligned_cols=268 Identities=23% Similarity=0.234 Sum_probs=203.2
Q ss_pred cHHHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccce
Q 043053 698 SVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRF 776 (1058)
Q Consensus 698 ~~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 776 (1058)
+..++.++|.+.+.||+|+||+||+| +..+++.||||++...... .......+.+.+|++++++++||||+++
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~hpniv~~ 93 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR------QINPKDVERIKTEVRLMKKLHHPNIARL 93 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH------C---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhc------ccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence 46788899999999999999999999 5567899999998644221 1123456789999999999999999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcC--------------------------------------CCCCCHHHHHHH
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------------------------------GNALEWELRYQI 818 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i 818 (1058)
++++.+.+..++||||+++|+|.+++.... ...+++..++.+
T Consensus 94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 173 (345)
T 3hko_A 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173 (345)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence 999999999999999999999999985210 122467788899
Q ss_pred HHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC--CeeeeccccceeccCCC--cccccccccCcCCccCcccccc--
Q 043053 819 LLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF--EPYIADFGLAKLVDDGD--FARSSNTVAGSYGYIAPEYGYM-- 892 (1058)
Q Consensus 819 ~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~--~~kl~DfGl~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-- 892 (1058)
+.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++...... .........||+.|+|||++.+
T Consensus 174 ~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 174 MRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 99999999999999 999999999999998776 89999999998764322 1122345679999999999865
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCC
Q 043053 893 MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPD 972 (1058)
Q Consensus 893 ~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~ 972 (1058)
..++.++|||||||++|||++|+.||..... ......+.... ...........+. .+.+++..||+.||+
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVND--ADTISQVLNKK--LCFENPNYNVLSP------LARDLLSNLLNRNVD 320 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC--CCTTSGGGGGSCH------HHHHHHHHHSCSCTT
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcc--cccCCcccccCCH------HHHHHHHHHcCCChh
Confidence 6788999999999999999999999975421 11111111111 1111111111111 234578889999999
Q ss_pred CCCCHHHHHHHH
Q 043053 973 ERPTMKDVAAML 984 (1058)
Q Consensus 973 ~RPt~~~v~~~l 984 (1058)
+|||+.+++++-
T Consensus 321 ~Rps~~~~l~hp 332 (345)
T 3hko_A 321 ERFDAMRALQHP 332 (345)
T ss_dssp TSCCHHHHHHSH
T ss_pred HCCCHHHHhcCh
Confidence 999999998853
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=357.01 Aligned_cols=269 Identities=28% Similarity=0.366 Sum_probs=210.4
Q ss_pred HHHHhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcc--cCCCccccee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGS--IRHKNIVRFL 777 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~ 777 (1058)
..+.++|.+.+.||+|+||.||+|... |+.||||++... ..+.+.+|++++.. ++||||++++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--------------~~~~~~~e~~~~~~~~l~h~ni~~~~ 102 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--------------EERSWFREAEIYQTVMLRHENILGFI 102 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--------------GHHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--------------hHHHHHHHHHHHHHhhcCCCcEEEEE
Confidence 456689999999999999999999774 899999998422 24567888888887 7899999999
Q ss_pred eEEEcCC----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhccc--------ccCCCCeEeCCCCCC
Q 043053 778 GCCWNRN----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLH--------HDCVPPIVHRDIKAN 845 (1058)
Q Consensus 778 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivHrDikp~ 845 (1058)
+++.... ..++||||+++|+|.++++. ..+++..++.++.|+++||+||| +. +|+||||||+
T Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~ 176 (342)
T 1b6c_B 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSK 176 (342)
T ss_dssp EEEECCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGG
T ss_pred eeecccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHH
Confidence 9998776 67999999999999999975 46899999999999999999999 77 9999999999
Q ss_pred cEEEcCCCCeeeeccccceeccCCCcc--cccccccCcCCccCccccccC------CCCcccchhhHHHHHHHHHhC---
Q 043053 846 NILIGLEFEPYIADFGLAKLVDDGDFA--RSSNTVAGSYGYIAPEYGYMM------KITEKSDVYSYGVVVLEVLTG--- 914 (1058)
Q Consensus 846 Nill~~~~~~kl~DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltg--- 914 (1058)
||+++.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~ 256 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence 999999999999999999876554321 123455799999999998765 234689999999999999999
Q ss_pred -------CCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 915 -------KQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 915 -------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
..||....+.......+..... .....+....... .......+..++.+||+.||++|||+.+++++|+++
T Consensus 257 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVC-EQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHT-TSCCCCCCCGGGG-TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccccccCccccCcCcccHHHHHHHHH-HHHhCCCCccccc-chhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 7888765443333333332221 1122222221111 112222345588999999999999999999999998
Q ss_pred hhhh
Q 043053 988 KHER 991 (1058)
Q Consensus 988 ~~~~ 991 (1058)
..+.
T Consensus 335 ~~~~ 338 (342)
T 1b6c_B 335 SQQE 338 (342)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 7653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=347.86 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=209.2
Q ss_pred hhccccc-eeccccceEEEEEEe---cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDAN-VIGKGCSGVVYRADM---DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+ .||+|+||.||+|.. .++..||||++... ......+.+.+|++++++++||||++++++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 78 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----------TEKADTEEMMREAQIMHQLDNPYIVRLIGV 78 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----------cchhHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4555655 999999999999954 36788999998532 233456789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+ ..+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 79 ~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~D 153 (287)
T 1u59_A 79 C-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD 153 (287)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred e-cCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECc
Confidence 9 456689999999999999999754 46789999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||+++....... ........||+.|+|||++.+..++.++||||+|+++|||++ |+.||.... .......+....
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~i~~~~- 230 (287)
T 1u59_A 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGK- 230 (287)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTC-
T ss_pred ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHhcCC-
Confidence 999987754332 122334457899999999988889999999999999999998 999997542 233333333221
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~ 993 (1058)
.+......+. .+..++..||+.||++||++.+++++|+.+..+...
T Consensus 231 ----~~~~~~~~~~------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 231 ----RMECPPECPP------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp ----CCCCCTTCCH------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred ----cCCCCCCcCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1111222222 233477889999999999999999999998766543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=370.92 Aligned_cols=276 Identities=16% Similarity=0.204 Sum_probs=202.5
Q ss_pred hhccccceeccccceEEEEEEecC------CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDN------GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|.+.+.||+|+||.||+|.... ++.||||++.....................+..|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 489999999999999999996544 47899998743311000000000001123445667778888999999999
Q ss_pred eEEEcC----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc--C
Q 043053 778 GCCWNR----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG--L 851 (1058)
Q Consensus 778 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~--~ 851 (1058)
+++... ...|+||||+ ||+|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++ .
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSC
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCC
Confidence 998765 3479999999 99999999864 46799999999999999999999999 999999999999999 8
Q ss_pred CCCeeeeccccceeccCCCcc-----cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh
Q 043053 852 EFEPYIADFGLAKLVDDGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS 926 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 926 (1058)
++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~- 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP- 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH-
Confidence 899999999999876543211 11234569999999999999999999999999999999999999998543322
Q ss_pred hHHHHHHhhc--C-ccccCCCCC-CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 927 HVVDWVRQKK--G-IQVLDPSLL-SRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 927 ~~~~~~~~~~--~-~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.......... . ....++.+. ...+. .+..++..||+.||++||+++++++.|+++..+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPG------EIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCH------HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHH------HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 2222111111 0 011111110 11122 2344777899999999999999999998876543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=359.85 Aligned_cols=252 Identities=21% Similarity=0.279 Sum_probs=202.7
Q ss_pred HhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
.++|.+.++||+|+||+||+|.. .+|+.||||++...... .....+.+.+|..++..+ +||+|+++++++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--------~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI--------QDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH--------HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--------cchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 36899999999999999999954 46889999998644221 123357788999999988 799999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+.+..|+||||++||+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF 165 (353)
T 2i0e_A 91 QTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADF 165 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeC
Confidence 9999999999999999999999864 5689999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+...
T Consensus 166 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~----- 236 (353)
T 2i0e_A 166 GMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIMEH----- 236 (353)
T ss_dssp TTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC-----
T ss_pred CcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--HHHHHHHHHhC-----
Confidence 9998643322 23446689999999999999999999999999999999999999997542 22222222211
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~ 983 (1058)
........+. .+.+++..||+.||++||+ +++++++
T Consensus 237 -~~~~p~~~s~------~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 -NVAYPKSMSK------EAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -CCCCCTTSCH------HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -CCCCCCCCCH------HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111112222 2345778899999999995 4677654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=356.05 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=210.2
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
++|.+.+.||+|+||+||+|.. .+++.||||++... ......+.+.+|+.+++++ +||||+++
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----------ATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC----------CCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 6899999999999999999953 45689999998533 2233457899999999999 69999999
Q ss_pred eeEEEcCC-CceEEEEecCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCC
Q 043053 777 LGCCWNRN-NRLLMYDYMPNGSLGSLLHERTG--------------NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRD 841 (1058)
Q Consensus 777 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrD 841 (1058)
++++...+ ..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987755 48999999999999999986432 2288999999999999999999999 999999
Q ss_pred CCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 043053 842 IKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDP 920 (1058)
Q Consensus 842 ikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~ 920 (1058)
|||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||+|+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987655433333445668899999999999999999999999999999998 9999976
Q ss_pred CCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 921 TIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.... ......+..... .......+. .+..++..||+.||++|||+++++++|+.+.+..
T Consensus 254 ~~~~-~~~~~~~~~~~~-----~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKID-EEFCRRLKEGTR-----MRAPDYTTP------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCS-HHHHHHHHHTCC-----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchh-HHHHHHhccCcc-----CCCCCCCCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 5332 222222222211 111111222 2344778899999999999999999999886543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=372.49 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=205.1
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+|.+.+.||+|+||.||+|. ..+|+.||||++..... ......+.+.+|+.+++.++||||+++++++..
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--------~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--------RSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--------HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 578999999999999999995 45899999999854321 122345789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGL 162 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccc
Confidence 9999999999999999999975 46799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++...... .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .......+.... .
T Consensus 163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~---~- 233 (476)
T 2y94_A 163 SNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--VPTLFKKICDGI---F- 233 (476)
T ss_dssp CEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--SHHHHHHHHTTC---C-
T ss_pred hhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--HHHHHHHHhcCC---c-
Confidence 98775543 2345679999999999888765 689999999999999999999997542 222222221111 0
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
......+. .+.+++..||+.||++|||+++++++-
T Consensus 234 --~~p~~~s~------~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 234 --YTPQYLNP------SVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp --CCCTTCCH------HHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred --CCCccCCH------HHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 11111122 234578889999999999999999854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=366.40 Aligned_cols=256 Identities=22% Similarity=0.301 Sum_probs=197.6
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC--CCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR--HKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~ 781 (1058)
+.|.+.+.||+|+||.||+|....++.||||++.... ......+.+.+|++++++++ ||||+++++++.
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT---------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc---------ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 4599999999999999999977779999999985331 23345688999999999997 599999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
.++..|+||| +.+|+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG 199 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG 199 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCS
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecC
Confidence 9999999999 5688999999874 5788999999999999999999999 999999999999995 6899999999
Q ss_pred cceeccCCCcccccccccCcCCccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-----------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 930 (1058)
+++..............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+..
T Consensus 200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~ 279 (390)
T 2zmd_A 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279 (390)
T ss_dssp SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH
T ss_pred ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH
Confidence 9987654432233445679999999998765 36888999999999999999999999754221111111
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
..... .........+. .+.+++..||+.||++|||++|++++...
T Consensus 280 ~~~~~-----~~~~~~~~~~~------~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 280 IIDPN-----HEIEFPDIPEK------DLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp HHCTT-----SCCCCCCCSCH------HHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HhCcc-----ccCCCCccchH------HHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 11100 01111111222 23457888999999999999999987543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=355.77 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=192.9
Q ss_pred hhccccceeccccceEEEEEEe----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||.||+|.. .+|+.||||++...... ........+.+|+.++++++||||++++++
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-------RNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-------hhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 6899999999999999999965 57999999998643211 122335678899999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+..++..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEe
Confidence 99999999999999999999999864 5689999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
||+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 165 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~--- 237 (327)
T 3a62_A 165 FGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--RKKTIDKILKCK--- 237 (327)
T ss_dssp CSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTC---
T ss_pred CCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCC---
Confidence 99987543322 22345679999999999999899999999999999999999999997542 112222121111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAML 984 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l 984 (1058)
.......+. .+.+++.+||+.||++|| ++.+++++-
T Consensus 238 ---~~~p~~~~~------~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 238 ---LNLPPYLTQ------EARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp ---CCCCTTSCH------HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred ---CCCCCCCCH------HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 111112222 234477889999999999 677877753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=358.09 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=181.1
Q ss_pred Hhhcccc---ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCccccee
Q 043053 703 LKCLVDA---NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFL 777 (1058)
Q Consensus 703 ~~~~~~~---~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 777 (1058)
.++|.+. +.||+|+||+||+| +..+++.||||++... ....+.+|+.+++++. ||||++++
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~~e~~~l~~l~~h~niv~~~ 72 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------------MEANTQKEITALKLCEGHPNIVKLH 72 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------------GHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------------hhhhHHHHHHHHHHhcCCCCeeEEE
Confidence 4556654 78999999999999 5567999999998422 2467889999999997 99999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC---C
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF---E 854 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~---~ 854 (1058)
+++.++...|+||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 147 (325)
T 3kn6_A 73 EVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLE 147 (325)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CE
T ss_pred EEEEcCCEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCccc
Confidence 9999999999999999999999999873 6799999999999999999999999 999999999999998766 8
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC--ChhHHHHH
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD--GSHVVDWV 932 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~--~~~~~~~~ 932 (1058)
+||+|||+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........
T Consensus 148 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 225 (325)
T 3kn6_A 148 IKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225 (325)
T ss_dssp EEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH
T ss_pred EEEeccccceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH
Confidence 9999999998765432 2334567899999999999999999999999999999999999999754321 11112222
Q ss_pred HhhcCcc-ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 933 RQKKGIQ-VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 933 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
....... ..........+ ..+.+++..||+.||++|||+++++++
T Consensus 226 ~~i~~~~~~~~~~~~~~~s------~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 226 KKIKKGDFSFEGEAWKNVS------QEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTTTCCCCCSHHHHTSC------HHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHcCCCCCCcccccCCC------HHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 2211110 00000000111 234457888999999999999999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=372.85 Aligned_cols=262 Identities=19% Similarity=0.245 Sum_probs=204.1
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC-CcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH-KNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~ 781 (1058)
++|.+.++||+|+||.||+|. ..+++.||||++... ....++.+|+++++.++| ++|..+..++.
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------------~~~~~~~~E~~il~~L~~~~~i~~i~~~~~ 73 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------------TKHPQLLYESKIYRILQGGTGIPNVRWFGV 73 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT-------------CSSCCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------------cccHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 679999999999999999994 578999999986422 112457899999999987 55666666667
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE---cCCCCeeee
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI---GLEFEPYIA 858 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill---~~~~~~kl~ 858 (1058)
..+..++||||+ +++|.+++... ...+++..++.|+.||+.||+|||+. +||||||||+|||+ +.++.+||+
T Consensus 74 ~~~~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~ 148 (483)
T 3sv0_A 74 EGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYII 148 (483)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred eCCEEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEE
Confidence 778889999999 99999999854 46799999999999999999999999 99999999999999 688999999
Q ss_pred ccccceeccCCCcc-----cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh-hHHHHH
Q 043053 859 DFGLAKLVDDGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS-HVVDWV 932 (1058)
Q Consensus 859 DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~ 932 (1058)
|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+
T Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence 99999877654321 123366799999999999999999999999999999999999999986543321 111111
Q ss_pred HhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
...... .....+....+. ++..++..||+.||++||++++|++.|+++...
T Consensus 229 ~~~~~~-~~~~~l~~~~p~------~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 229 SEKKVA-TSIEALCRGYPT------EFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHH-SCHHHHHTTSCH------HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhcccc-ccHHHHhcCCcH------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 111100 000111112222 234577889999999999999999999987554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=351.69 Aligned_cols=249 Identities=23% Similarity=0.282 Sum_probs=193.3
Q ss_pred HHhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGC 779 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 779 (1058)
..++|...++||+|+||+||+|.. .+|+.||||++.... ........+..|+..+.++ +||||++++++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~ 125 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF---------RGPKDRARKLAEVGSHEKVGQHPCCVRLEQA 125 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC---------CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc---------cChHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence 457899999999999999999954 589999999875331 2223344555666666555 89999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+.+++..++||||+ +|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~D 200 (311)
T 3p1a_A 126 WEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGD 200 (311)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECC
T ss_pred EEeCCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999 67999998765 46799999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
||+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+... .....+...
T Consensus 201 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~~~~~~---- 267 (311)
T 3p1a_A 201 FGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQLRQG---- 267 (311)
T ss_dssp CTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHHHHTTT----
T ss_pred ceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHhcc----
Confidence 99998765432 2345569999999998876 7899999999999999999997766421 111111111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...+......+. .+.+++.+||++||++|||++|++++
T Consensus 268 ~~~~~~~~~~~~------~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 268 YLPPEFTAGLSS------ELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CCCHHHHTTSCH------HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccccCCCH------HHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111111112222 23457888999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=353.85 Aligned_cols=251 Identities=18% Similarity=0.332 Sum_probs=199.3
Q ss_pred hhccccceeccccceEEEEEE-ecCC-------cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNG-------EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVR 775 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 775 (1058)
++|.+.+.||+|+||+||+|. ..++ ..||+|++... .....+.+.+|++++++++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~ 76 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----------HRNYSESFFEAASMMSKLSHKHLVL 76 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-----------GGGGHHHHHHHHHHHHTSCCTTBCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-----------cHHHHHHHHHHHHHHHhCCCCCEeE
Confidence 578999999999999999994 3344 47999988432 2344678999999999999999999
Q ss_pred eeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC-
Q 043053 776 FLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE- 854 (1058)
Q Consensus 776 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~- 854 (1058)
+++++.+++..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 152 (289)
T 4fvq_A 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDR 152 (289)
T ss_dssp EEEEECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBG
T ss_pred EEEEEEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcc
Confidence 999999999999999999999999999864 34589999999999999999999999 9999999999999998887
Q ss_pred -------eeeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCCh
Q 043053 855 -------PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS 926 (1058)
Q Consensus 855 -------~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 926 (1058)
+||+|||++..... .....||+.|+|||++.+ ..++.++||||+|+++|||++|..|+..... ..
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-~~ 225 (289)
T 4fvq_A 153 KTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQ 225 (289)
T ss_dssp GGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HH
T ss_pred cccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-hH
Confidence 99999999865432 123458899999999887 6789999999999999999996555443221 11
Q ss_pred hHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 927 HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
......... .......+.. +.+++..||+.||++|||+++++++|+++..
T Consensus 226 ~~~~~~~~~-------~~~~~~~~~~------l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 226 RKLQFYEDR-------HQLPAPKAAE------LANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHHHTT-------CCCCCCSSCT------THHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHHHhhcc-------CCCCCCCCHH------HHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111111 1111111222 2347778999999999999999999988764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=351.12 Aligned_cols=268 Identities=21% Similarity=0.250 Sum_probs=199.0
Q ss_pred HHHHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
....++|.+.+.||+|+||.||+|. ..+++.||||++..... ......+.+.+|+.++++++||||+++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~hp~iv~~~~ 101 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS--------SDPVFRTRMQREARTAGRLQEPHVVPIHD 101 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG--------GSHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc--------cCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 3456789999999999999999995 45789999999854321 23344678999999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++..++..++||||+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~ 176 (309)
T 2h34_A 102 FGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLV 176 (309)
T ss_dssp EEEETTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred EEeeCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEe
Confidence 999999999999999999999999864 5689999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
|||++........ .......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+....
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~-- 251 (309)
T 2h34_A 177 DFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--SVMGAHINQAI-- 251 (309)
T ss_dssp SCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--HHHHHHHHSCC--
T ss_pred cCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--HHHHHHhccCC--
Confidence 9999986654322 223355699999999999998999999999999999999999999975321 11111111110
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHhhhhhhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-TMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-t~~~v~~~l~~~~~~~~ 992 (1058)
..........+.. +..++.+||+.||++|| +++++++.+++......
T Consensus 252 -~~~~~~~~~~~~~------l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 252 -PRPSTVRPGIPVA------FDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp -CCGGGTSTTCCTH------HHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred -CCccccCCCCCHH------HHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0011112222332 23467789999999999 99999999987755443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=346.23 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=205.2
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| +..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---------LSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc---------CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 368999999999999999999 55679999999985432 12334578899999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC---eeee
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE---PYIA 858 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~---~kl~ 858 (1058)
+++..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 999999999999999999998764 5689999999999999999999999 9999999999999987665 9999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
|||.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... .......+.... .
T Consensus 151 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~-~ 224 (284)
T 3kk8_A 151 DFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGA-Y 224 (284)
T ss_dssp CCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTC-C
T ss_pred eceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--hhHHHHHHHhcc-c
Confidence 999998765432 2335679999999999999999999999999999999999999997542 222222222111 1
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
. .........+. .+.+++..||+.||++|||++|++++-.
T Consensus 225 ~-~~~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 225 D-YPSPEWDTVTP------EAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp C-CCTTTTTTSCH------HHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred c-CCchhhcccCH------HHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 1 11111112222 2334778899999999999999998543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.95 Aligned_cols=268 Identities=21% Similarity=0.257 Sum_probs=200.1
Q ss_pred HHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC---CCccccee
Q 043053 702 VLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR---HKNIVRFL 777 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~ 777 (1058)
..++|.+.+.||+|+||+||+|. ..+++.||||++...... .........+.+|+.++++++ ||||++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGG------GGGGGLPISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCC------TTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccc------ccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence 34789999999999999999995 567999999998543211 112223456778888877775 99999999
Q ss_pred eEEEcCC-----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 778 GCCWNRN-----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 778 ~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
+++.... ..++||||+. |+|.+++.......+++..++.++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~ 156 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG 156 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTT
T ss_pred eeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCC
Confidence 9998755 3689999997 5999999876556699999999999999999999999 99999999999999999
Q ss_pred CCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
+.+||+|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......
T Consensus 157 ~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~ 232 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIF 232 (308)
T ss_dssp SCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHH
T ss_pred CCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 99999999999866433 2334567999999999999999999999999999999999999999754221 1111111
Q ss_pred HhhcCc--cccC-------CCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 933 RQKKGI--QVLD-------PSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 933 ~~~~~~--~~~~-------~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...... .... .......+..... ...+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111000 0000 0000000000000 0123457888999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=356.28 Aligned_cols=263 Identities=23% Similarity=0.347 Sum_probs=206.0
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|.+.+.||+|+||.||+|.. .+++.||||++... .......++.+|+.++++++||||++++
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----------CSEQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS----------CCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc----------cchhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 6899999999999999999963 35778999998532 2334457889999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCC-----CCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTG-----NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
+++.+....|+||||+++|+|.+++..... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 176 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCS
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecC
Confidence 999999999999999999999999986432 4589999999999999999999999 99999999999999844
Q ss_pred ---CCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhH
Q 043053 853 ---FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHV 928 (1058)
Q Consensus 853 ---~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 928 (1058)
..+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||... .....
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~ 254 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEV 254 (327)
T ss_dssp STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHH
T ss_pred CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--CHHHH
Confidence 4699999999986654443334445678999999999998899999999999999999998 99999754 22223
Q ss_pred HHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 929 VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
...+..... +......+. .+..++..||+.||++||++++++++++.+.....
T Consensus 255 ~~~~~~~~~-----~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 255 LEFVTSGGR-----MDPPKNCPG------PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HHHHHTTCC-----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHHhcCCC-----CCCCCCCCH------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 332222211 111112222 23347788999999999999999999998876544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=374.01 Aligned_cols=257 Identities=19% Similarity=0.265 Sum_probs=204.4
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...++||+|+||.||+|.. .+|+.||||++.+... ......+.+.+|++++++++||||+++++++.+
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~--------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL--------KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh--------hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence 5788899999999999999954 5799999999864432 122335788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+..|+||||++||+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.+|.+||+||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeec
Confidence 999999999999999999997643 45799999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...........
T Consensus 334 Gla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~~-- 408 (543)
T 3c4z_A 334 GLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLEQ-- 408 (543)
T ss_dssp TTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHHC--
T ss_pred ceeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhhc--
Confidence 9998765433 223456899999999999999999999999999999999999999976532211 11111111100
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM-----KDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~-----~~v~~~ 983 (1058)
........+. .+.+++..||+.||++||++ +++.++
T Consensus 409 -~~~~p~~~s~------~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 409 -AVTYPDKFSP------ASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -CCCCCTTSCH------HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -ccCCCcccCH------HHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 1111122222 23347778999999999975 566553
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.50 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=200.7
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+| +..+++.||||++..... ........+.+|+.++++++||||+++++++.+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--------EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--------HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc--------chhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 67999999999999999999 556788999999854321 122345788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccc
Confidence 99999999999999999999864 5689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... .......+... .
T Consensus 156 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~------~ 223 (279)
T 3fdn_A 156 SVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--YQETYKRISRV------E 223 (279)
T ss_dssp ESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHT------C
T ss_pred cccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--HHHHHHHHHhC------C
Confidence 8654432 2235578999999999999999999999999999999999999997432 11111111111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.......+.. +.+++..||+.||++|||++|++++-
T Consensus 224 ~~~~~~~~~~------~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 224 FTFPDFVTEG------ARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp CCCCTTSCHH------HHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCCCCcCCHH------HHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1111122222 23477889999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=351.32 Aligned_cols=262 Identities=23% Similarity=0.378 Sum_probs=197.2
Q ss_pred hhccccceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+.+|+.++++++||||++++++
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN---------SSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C---------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc---------cchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 67899999999999999999443 35589999985331 233445789999999999999999999999
Q ss_pred EEcCCC-----ceEEEEecCCCChhhhhhhc----CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc
Q 043053 780 CWNRNN-----RLLMYDYMPNGSLGSLLHER----TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG 850 (1058)
Q Consensus 780 ~~~~~~-----~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~ 850 (1058)
+.+... .++||||+++|+|.+++... ....+++..++.++.|+++||+|||+. +|+||||||+||+++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEc
Confidence 987553 49999999999999998532 246799999999999999999999999 999999999999999
Q ss_pred CCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHH
Q 043053 851 LEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVV 929 (1058)
Q Consensus 851 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 929 (1058)
.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||..... ....
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~ 259 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMY 259 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--HHHH
Confidence 999999999999987655443334445567889999999999999999999999999999999 8899975422 2232
Q ss_pred HHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
..+.... .+......+. .+..++..||+.||++|||+++++++|+++...
T Consensus 260 ~~~~~~~-----~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 260 DYLLHGH-----RLKQPEDCLD------ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHHTTC-----CCCCBTTCCH------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCC-----CCCCCccccH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2222211 1111122222 234477889999999999999999999988654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=353.66 Aligned_cols=263 Identities=26% Similarity=0.415 Sum_probs=202.0
Q ss_pred hhccccceeccccceEEEEEEecC-----CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDN-----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|...+.||+|+||.||+|.... +..||||++... ........+.+|+.++++++||||+++++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----------YTEKQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC----------CCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 567888999999999999995432 245999998532 23344668999999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++.+.+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~ 189 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVS 189 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEEC
Confidence 999999999999999999999999864 46789999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhc
Q 043053 859 DFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 859 DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|||+++....... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .......+....
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--~~~~~~~~~~~~ 267 (333)
T 1mqb_A 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAINDGF 267 (333)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTTC
T ss_pred CCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHCCC
Confidence 9999987654321 112223446789999999998899999999999999999999 999997542 222222222211
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~ 993 (1058)
........+. + +..++.+||+.||++||+++++++.|+++......
T Consensus 268 -----~~~~~~~~~~---~---l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 268 -----RLPTPMDCPS---A---IYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp -----CCCCCTTCBH---H---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -----cCCCcccCCH---H---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 1111112222 2 33477889999999999999999999988765443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=345.04 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=205.1
Q ss_pred hhccccceeccccceEEEEEEecC----CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDN----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|...+.||+|+||.||+|.... +..||||++... ......+.+.+|+.++++++||||++++++
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD----------CTLDNKEKFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT----------SCHHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc----------cCchHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 678999999999999999995432 346999998533 223346789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+.+ +..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 156 (281)
T 3cc6_A 82 IEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGD 156 (281)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECC
T ss_pred EcC-CCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCc
Confidence 864 4578999999999999999764 45689999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
||++........ .......+|+.|+|||+..+..++.++||||||+++|||++ |+.||..... ......+.....
T Consensus 157 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~~~~~~- 232 (281)
T 3cc6_A 157 FGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLEKGDR- 232 (281)
T ss_dssp CCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHHHHTCC-
T ss_pred cCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHHhcCCC-
Confidence 999987654332 22334557889999999998899999999999999999998 9999975422 233333322211
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~ 993 (1058)
.......+. .+..++..||+.||++|||+.++++.|+++.....+
T Consensus 233 ----~~~~~~~~~------~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 233 ----LPKPDLCPP------VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp ----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCH------HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 111111222 233477889999999999999999999998765443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.25 Aligned_cols=255 Identities=23% Similarity=0.257 Sum_probs=203.7
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
.++.++|.+.+.||+|+||.||+| +..++..||+|++.... ....+.+.+|++++++++||||+++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~i~~~~~ 73 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-----------VEDVDRFKQEIEIMKSLDHPNIIRLYE 73 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-----------CSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-----------cchHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 356789999999999999999999 55568899999985331 223578999999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE---cCCCCe
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI---GLEFEP 855 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill---~~~~~~ 855 (1058)
++.++...++||||+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||++ +.++.+
T Consensus 74 ~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~ 148 (277)
T 3f3z_A 74 TFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPL 148 (277)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCE
T ss_pred EEecCCeEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcE
Confidence 999999999999999999999999764 5689999999999999999999999 99999999999999 788899
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||++....... ......||+.|+|||++.+. ++.++||||+|+++|||++|+.||.... .......+...
T Consensus 149 ~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~ 222 (277)
T 3f3z_A 149 KLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT--DSEVMLKIREG 222 (277)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC
T ss_pred EEEecccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhC
Confidence 999999998765433 23455799999999987654 8999999999999999999999997542 22222222211
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
. ...........+. .+.+++..||+.||++|||+.+++++-
T Consensus 223 ~--~~~~~~~~~~~~~------~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 223 T--FTFPEKDWLNVSP------QAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp C--CCCCHHHHTTSCH------HHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred C--CCCCchhhhcCCH------HHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 1 0011000001111 234578889999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=347.22 Aligned_cols=255 Identities=25% Similarity=0.328 Sum_probs=197.9
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+.++|.+.+.||+|+||+||+| +..++..||+|++... ......+.+.+|++++++++||||++++++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 88 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD----------RSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG----------GCCSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecc----------ccchhHHHHHHHHHHHHhCCCchHHhHHHh
Confidence 45689999999999999999999 5567899999998543 122346789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE---cCCCC
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI---GLEFE 854 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill---~~~~~ 854 (1058)
+.+....++||||+++|+|.+++... ....+++..++.++.|+++||+|||+. +|+||||||+||++ +.++.
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~ 165 (285)
T 3is5_A 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSP 165 (285)
T ss_dssp EECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCC
T ss_pred eecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCC
Confidence 99999999999999999999998653 246799999999999999999999999 99999999999999 45678
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHh
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1058)
+||+|||+++...... ......||+.|+|||++. ..++.++||||+|+++|||++|+.||..... .........
T Consensus 166 ~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--~~~~~~~~~ 239 (285)
T 3is5_A 166 IKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--EEVQQKATY 239 (285)
T ss_dssp EEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred EEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--HHHHhhhcc
Confidence 9999999998665432 234567999999999875 4688999999999999999999999975421 122111111
Q ss_pred hcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 935 KKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
... ..... ....+ . .+.+++..||+.||++|||++|++++
T Consensus 240 ~~~--~~~~~-~~~~~---~---~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 240 KEP--NYAVE-CRPLT---P---QAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCC--CCCC---CCCC---H---HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CCc--ccccc-cCcCC---H---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 01100 01111 1 23357888999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.94 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=183.7
Q ss_pred HhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+|. ..+|+.||||++..... ......+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--------YKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--------hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence 4689999999999999999995 46899999999854321 12233578999999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+.+..++||||+++++|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg 157 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFG 157 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeec
Confidence 999999999999999999999864 36789999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... . ...... .
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~---~~~~~~---~ 227 (278)
T 3cok_A 158 LATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--T---LNKVVL---A 227 (278)
T ss_dssp TCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCS---S
T ss_pred ceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--H---HHHHhh---c
Confidence 998765332 12234568999999999998889999999999999999999999997543221 1 111110 1
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+.......+. .+.+++.+||+.||++|||+++++++
T Consensus 228 ~~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 228 DYEMPSFLSI------EAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCCCCTTSCH------HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccCCccccCH------HHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1111111222 23457888999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=360.94 Aligned_cols=250 Identities=18% Similarity=0.238 Sum_probs=195.2
Q ss_pred ccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCc
Q 043053 708 DANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR 786 (1058)
Q Consensus 708 ~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 786 (1058)
..+.||+|+||.||+| ...+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-----------GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECC-----------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-----------ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 3678999999999999 4567999999998532 123457899999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE--cCCCCeeeeccccce
Q 043053 787 LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI--GLEFEPYIADFGLAK 864 (1058)
Q Consensus 787 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill--~~~~~~kl~DfGl~~ 864 (1058)
++||||+++|+|.+++... ...+++..++.++.||++||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 162 ~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLAR 237 (373)
T ss_dssp EEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence 9999999999999998753 35689999999999999999999999 99999999999999 567789999999998
Q ss_pred eccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCC
Q 043053 865 LVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944 (1058)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1058)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.... ....+.
T Consensus 238 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~--~~~~~~ 310 (373)
T 2x4f_A 238 RYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--DAETLNNILACR--WDLEDE 310 (373)
T ss_dssp ECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTC--CCSCSG
T ss_pred ecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcc--CCCChh
Confidence 775533 2334569999999999988889999999999999999999999997542 111111111111 111111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 945 LLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 945 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.....+. .+.+++.+||+.||++|||++|++++-.
T Consensus 311 ~~~~~~~------~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 311 EFQDISE------EAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp GGTTSCH------HHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred hhccCCH------HHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 1111222 2345788899999999999999998543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=358.88 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=203.8
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++.++|.+.+.||+|+||+||+| +..+++.||||++......... .......+.+.+|+.++++++||||++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 97 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC---WIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTS---EEEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhccccc---ccchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 56789999999999999999999 5678999999998644221100 0011234567889999999999999999999
Q ss_pred EEcCCCceEEEEecCCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 780 CWNRNNRLLMYDYMPNG-SLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
+.+.+..++||||+.+| +|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 98 ~~~~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 98 FENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp EECSSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEEC
T ss_pred EeeCCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999999777 99999976 35699999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ...
T Consensus 173 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~ 238 (335)
T 3dls_A 173 DFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------TVE 238 (335)
T ss_dssp CCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------GTT
T ss_pred ecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------HHh
Confidence 999998775543 2335679999999999888776 7899999999999999999999964211 000
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.. .. .....+. .+.+++..||++||++|||+++++++-
T Consensus 239 ~~-~~--~~~~~~~------~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 239 AA-IH--PPYLVSK------ELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp TC-CC--CSSCCCH------HHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred hc-cC--CCcccCH------HHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00 00 0111122 234577889999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=366.99 Aligned_cols=259 Identities=22% Similarity=0.231 Sum_probs=201.9
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.++||+|+||+||+|.. .+|+.||||++.+.... .....+.+.+|+.++..++||||+++++++.+
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~--------~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML--------KRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--------HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh--------hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 6799999999999999999954 57999999998543211 12234568899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||++||+|.+++... +..+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 99999999999999999999864 35789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY-------MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
++....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||..... ......+...
T Consensus 209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~ 285 (412)
T 2vd5_A 209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--AETYGKIVHY 285 (412)
T ss_dssp CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTH
T ss_pred heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhc
Confidence 987654332 2234568999999999887 35688999999999999999999999975421 1111111111
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDER---PTMKDVAAMLK 985 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R---Pt~~~v~~~l~ 985 (1058)
.. ....+......+. .+.+++.+||. +|++| |+++|++++-.
T Consensus 286 ~~-~~~~p~~~~~~s~------~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 286 KE-HLSLPLVDEGVPE------EARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HH-HCCCC----CCCH------HHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred cc-CcCCCccccCCCH------HHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 00 0001111112222 23457788999 99998 58999987643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=352.63 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=196.9
Q ss_pred HhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||+||+|. ..+|+.||||++... .......+.+.+|++++++++||||+++++++.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 72 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES---------EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR 72 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC---------CC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc---------ccchHHHHHHHHHHHHHHhCCCCCccchhheee
Confidence 4689999999999999999994 456999999988533 123344678899999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++..++||||+++++|.++++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 73 RKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cCCeEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence 99999999999999999998875 35689999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC---
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG--- 937 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~--- 937 (1058)
+++...... .......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||...... .....+.....
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 223 (311)
T 4agu_A 148 FARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--DQLYLIRKTLGDLI 223 (311)
T ss_dssp TCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCC
T ss_pred CchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhcccc
Confidence 998765432 22345578999999999876 66799999999999999999999999754221 11111111000
Q ss_pred ---------ccccCCCCCCCC----chhH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 ---------IQVLDPSLLSRP----ESEI---DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 ---------~~~~~~~~~~~~----~~~~---~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...........+ .... .....+.+++..||+.||++|||++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000 0000 001123458889999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=350.52 Aligned_cols=266 Identities=19% Similarity=0.258 Sum_probs=203.4
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.++|.+.+.||+|+||.||+| +..+++.||||++... ...+.+.+|++++++++|++++..++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~e~~~l~~l~~~~~i~~~~~~ 73 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------------TKHPQLHIESKIYKMMQGGVGIPTIRWC 73 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------------CCCHHHHHHHHHHHTTSTTCCCEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc-------------ccchHHHHHHHHHHHhcCCCCCCeeeee
Confidence 4478999999999999999999 4578999999986322 1224578999999999988877777766
Q ss_pred -EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE---cCCCCee
Q 043053 781 -WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI---GLEFEPY 856 (1058)
Q Consensus 781 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill---~~~~~~k 856 (1058)
...+..++||||+ +|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+|
T Consensus 74 ~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~k 148 (296)
T 4hgt_A 74 GAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEE
T ss_pred cCCCCceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEE
Confidence 5566779999999 99999999854 45699999999999999999999999 99999999999999 7889999
Q ss_pred eeccccceeccCCCcc-----cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC-hhHHH
Q 043053 857 IADFGLAKLVDDGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG-SHVVD 930 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~-~~~~~ 930 (1058)
|+|||+++........ .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence 9999999877654321 12345679999999999999999999999999999999999999998653321 11111
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
....... ....+......+. .+..++..||+.||++|||++++++.++++..+..
T Consensus 229 ~~~~~~~-~~~~~~~~~~~~~------~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 229 RISEKKM-STPIEVLCKGYPS------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHHHH-HSCHHHHTTTSCH------HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhhcccc-cchhhhhhccCCH------HHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 1111110 0000001111222 23447788999999999999999999998876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=360.29 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=194.4
Q ss_pred hccccceeccccceEEEEEEec--CC--cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 705 CLVDANVIGKGCSGVVYRADMD--NG--EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
.|...+.||+|+||+||+|... ++ ..||||.+... ......++|.+|+.++++++||||+++++++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 159 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 159 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC----------SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC----------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4677899999999999999543 22 46899987432 2334568899999999999999999999987
Q ss_pred Ec-CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 781 WN-RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 781 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
.. ++..++||||+++|+|.++++.. ...+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~D 235 (373)
T 3c1x_A 160 LRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVAD 235 (373)
T ss_dssp CCCSSCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred EcCCCCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEee
Confidence 54 45779999999999999999764 45689999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcc--cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhc
Q 043053 860 FGLAKLVDDGDFA--RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 860 fGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .....+....
T Consensus 236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~~~ 313 (373)
T 3c1x_A 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGR 313 (373)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHTTC
T ss_pred ccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHcCC
Confidence 9999866443221 12234567889999999999999999999999999999999 67777654322 2222222221
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
. .......+. . +..++..||+.||++|||++++++.|+++....
T Consensus 314 ~-----~~~p~~~~~---~---l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 314 R-----LLQPEYCPD---P---LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp C-----CCCCTTCCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred C-----CCCCCCCCH---H---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 111111222 2 344778899999999999999999999886543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=351.80 Aligned_cols=264 Identities=26% Similarity=0.382 Sum_probs=204.7
Q ss_pred hccccceeccccceEEEEEEe-----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 705 CLVDANVIGKGCSGVVYRADM-----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.|...+.||+|+||+||+|.+ .+++.||||++... ......+.+.+|++++++++||||++++++
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----------AGPQHRSGWKQEIDILRTLYHEHIIKYKGC 101 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----------cChHHHHHHHHHHHHHHhCCCcchhhEEEE
Confidence 348999999999999988743 36899999998532 233446789999999999999999999999
Q ss_pred EEcC--CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeee
Q 043053 780 CWNR--NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857 (1058)
Q Consensus 780 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl 857 (1058)
+.+. ...++||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl 175 (318)
T 3lxp_A 102 CEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKI 175 (318)
T ss_dssp EEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEE
Confidence 9874 5578999999999999999763 489999999999999999999999 9999999999999999999999
Q ss_pred eccccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC---------C-h
Q 043053 858 ADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD---------G-S 926 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~---------~-~ 926 (1058)
+|||+++....... ........||..|+|||++.+..++.++||||+|+++|||++|+.||...... . .
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 255 (318)
T 3lxp_A 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255 (318)
T ss_dssp CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence 99999987765432 12234456888999999999888999999999999999999999999643110 0 0
Q ss_pred hHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 927 HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
........... ..........+. .+.+++..||+.||++|||++++++.|+.+..+..
T Consensus 256 ~~~~~~~~~~~--~~~~~~~~~~~~------~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 256 TVLRLTELLER--GERLPRPDKCPA------EVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHHHHHHT--TCCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhc--ccCCCCCccccH------HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 00011111100 001111112222 23447788999999999999999999998876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=358.24 Aligned_cols=253 Identities=28% Similarity=0.405 Sum_probs=201.8
Q ss_pred HhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.+.|...+.||+|+||+||+|. ..+|+.||||++.... .......+.+.+|++++++++||||+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--------KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCS--------SCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccc--------ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4679999999999999999994 5789999999985331 122334578999999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++..++||||++ |+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred ECCeEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999997 5888888654 46789999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
+++.... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..... ......+....
T Consensus 200 ~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--~~~~~~~~~~~-- 269 (348)
T 1u5q_A 200 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNE-- 269 (348)
T ss_dssp TCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSC--
T ss_pred CceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcC--
Confidence 9976543 23457999999999874 56789999999999999999999999965421 11111111111
Q ss_pred cccCCCC-CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 939 QVLDPSL-LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 939 ~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
.+.. ....+.. +..++..||+.||++|||+++++++....
T Consensus 270 ---~~~~~~~~~~~~------l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 270 ---SPALQSGHWSEY------FRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp ---CCCCCCTTSCHH------HHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred ---CCCCCCCCCCHH------HHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 1111 1112222 23477889999999999999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=364.05 Aligned_cols=262 Identities=17% Similarity=0.192 Sum_probs=204.3
Q ss_pred hhccccceeccccceEEEEEEec---------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD---------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIV 774 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 774 (1058)
++|.+.+.||+|+||.||+|... .++.||||++... +.+.+|++++++++||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------------~~~~~E~~~l~~l~h~niv 105 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------------GRLFNEQNFFQRAAKPLQV 105 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------------STHHHHHHHHHHHCCHHHH
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------------chHHHHHHHHHHhcccchh
Confidence 68999999999999999999554 3789999987421 4678999999999999999
Q ss_pred c---------------eeeEEEc-CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeE
Q 043053 775 R---------------FLGCCWN-RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIV 838 (1058)
Q Consensus 775 ~---------------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 838 (1058)
+ +++++.. +...++||||+ +|+|.+++.......+++..++.++.||++||+|||+. +|+
T Consensus 106 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iv 181 (352)
T 2jii_A 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYV 181 (352)
T ss_dssp HHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCB
T ss_pred hhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 8 6777765 66779999999 99999999875457799999999999999999999999 999
Q ss_pred eCCCCCCcEEEcCCC--CeeeeccccceeccCCCc-----ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHH
Q 043053 839 HRDIKANNILIGLEF--EPYIADFGLAKLVDDGDF-----ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 911 (1058)
Q Consensus 839 HrDikp~Nill~~~~--~~kl~DfGl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~el 911 (1058)
||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||
T Consensus 182 H~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 261 (352)
T 2jii_A 182 HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKW 261 (352)
T ss_dssp CSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 999999999999998 999999999986653221 1122345799999999999998999999999999999999
Q ss_pred HhCCCCCCCCCCCChhHHHHHHhhc-C-ccccCCCC-CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 912 LTGKQPIDPTIPDGSHVVDWVRQKK-G-IQVLDPSL-LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 912 ltg~~P~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
++|+.||....+............. . ........ ....+. .+..++..||+.||++|||++++++.|+++.
T Consensus 262 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 262 LYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSE------TLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp HHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCH------HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcH------HHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 9999999865433333333222111 1 11111000 001122 2334777899999999999999999999886
Q ss_pred hhh
Q 043053 989 HER 991 (1058)
Q Consensus 989 ~~~ 991 (1058)
.+.
T Consensus 336 ~~~ 338 (352)
T 2jii_A 336 QDL 338 (352)
T ss_dssp HHT
T ss_pred Hhc
Confidence 554
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=365.27 Aligned_cols=206 Identities=30% Similarity=0.429 Sum_probs=166.8
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCccccee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFL 777 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 777 (1058)
..+.++|.+.+.||+|+||.||+| +..+|+.||||++.... ......+.+.+|+.+++++. ||||++++
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---------~~~~~~~~~~~E~~~l~~l~~h~niv~l~ 75 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---------QNSTDAQRTFREIMILTELSGHENIVNLL 75 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----------CCHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc---------cChHHHHHHHHHHHHHHhccCCCCCCeee
Confidence 356789999999999999999999 56789999999985331 23344677889999999998 99999999
Q ss_pred eEEEcCC--CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 778 GCCWNRN--NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 778 ~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
+++..++ ..|+||||++ |+|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 76 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~ 148 (388)
T 3oz6_A 76 NVLRADNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHV 148 (388)
T ss_dssp EEEECTTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred eEEecCCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCE
Confidence 9997654 5799999997 599999976 4689999999999999999999999 99999999999999999999
Q ss_pred eeeccccceeccCCC-------------------cccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCC
Q 043053 856 YIADFGLAKLVDDGD-------------------FARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGK 915 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~ 915 (1058)
||+|||+++...... ........+||+.|+|||++.+ ..++.++||||+||++|||++|+
T Consensus 149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 228 (388)
T 3oz6_A 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228 (388)
T ss_dssp EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence 999999998754311 1122345679999999999876 67899999999999999999999
Q ss_pred CCCCCC
Q 043053 916 QPIDPT 921 (1058)
Q Consensus 916 ~P~~~~ 921 (1058)
.||...
T Consensus 229 ~pf~~~ 234 (388)
T 3oz6_A 229 PIFPGS 234 (388)
T ss_dssp CSCCCS
T ss_pred CCCCCC
Confidence 999754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.46 Aligned_cols=254 Identities=20% Similarity=0.375 Sum_probs=205.5
Q ss_pred HHHHhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
..+..+|...+.||+|+||.||+|.. .+++.||||++... .+.+.+|++++++++||||+++++
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~~~ 71 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---------------NEKAEREVKALAKLDHVNIVHYNG 71 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC---------------SGGGHHHHHHHHHCCCTTBCCEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc---------------cHHHHHHHHHHHhCCCCCEEEEee
Confidence 34568899999999999999999955 48999999988422 135678999999999999999999
Q ss_pred EEEc----------------CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCC
Q 043053 779 CCWN----------------RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDI 842 (1058)
Q Consensus 779 ~~~~----------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDi 842 (1058)
++.. ....++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl 148 (284)
T 2a19_B 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDL 148 (284)
T ss_dssp EEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred eEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 8854 34469999999999999999876567899999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 043053 843 KANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI 922 (1058)
Q Consensus 843 kp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 922 (1058)
||+||+++.++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|..|+...
T Consensus 149 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~- 224 (284)
T 2a19_B 149 KPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET- 224 (284)
T ss_dssp SGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-
T ss_pred CHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-
Confidence 9999999999999999999998765532 223456999999999999999999999999999999999999887421
Q ss_pred CCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
......... .......+.. +..++..||+.||++|||+.+++++++.+....+
T Consensus 225 ------~~~~~~~~~-----~~~~~~~~~~------~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 225 ------SKFFTDLRD-----GIISDIFDKK------EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ------HHHHHHHHT-----TCCCTTSCHH------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ------HHHHHHhhc-----ccccccCCHH------HHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 111111111 1111122222 2347788999999999999999999998876544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=348.57 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=205.0
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE-E
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC-W 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~ 781 (1058)
++|.+.+.||+|+||.||+|. ..+|+.||||++... ...+++.+|+.++++++|++++..+.++ .
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------------TKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC-------------SSCCHHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC-------------cchhHHHHHHHHHHHhhcCCCCCccccccC
Confidence 689999999999999999994 578999999987422 1234689999999999998877777666 4
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE---cCCCCeeee
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI---GLEFEPYIA 858 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill---~~~~~~kl~ 858 (1058)
.....++||||+ +|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||++ +.++.+||+
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 150 (296)
T 3uzp_A 76 EGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCCceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEe
Confidence 566679999999 89999999753 45799999999999999999999999 99999999999999 488899999
Q ss_pred ccccceeccCCCcc-----cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC-ChhHHHHH
Q 043053 859 DFGLAKLVDDGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPD-GSHVVDWV 932 (1058)
Q Consensus 859 DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~-~~~~~~~~ 932 (1058)
|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......+
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 3uzp_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence 99999876654321 1234567999999999999999999999999999999999999999864322 11222111
Q ss_pred HhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
..... ....+......+. .+..++..||+.||++|||++++++.|+++..+.
T Consensus 231 ~~~~~-~~~~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 231 SEKKM-STPIEVLCKGYPS------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHH-HSCHHHHTTTSCH------HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccccc-CCchHHHHhhCCH------HHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 11110 0000111112222 2344778899999999999999999999886654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.30 Aligned_cols=253 Identities=27% Similarity=0.384 Sum_probs=199.0
Q ss_pred HhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.++|.+.+.||+|+||+||+|... |+.||||++... ...+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------------ATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-------------C--HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch-------------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 368999999999999999999775 899999998422 235789999999999999999999999765
Q ss_pred C-CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 783 R-NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 783 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
. +..++||||+++|+|.+++.......+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecc
Confidence 4 4689999999999999999875444588999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
++...... .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||.... .......+....
T Consensus 163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~~~~~---- 231 (278)
T 1byg_A 163 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGY---- 231 (278)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHTTTC----
T ss_pred cccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCC----
Confidence 98765432 223457889999999998899999999999999999998 999997542 222222222111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.+......+.. +..++..||+.||++|||+.++++.|+++...
T Consensus 232 -~~~~~~~~~~~------l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 232 -KMDAPDGCPPA------VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -CCCCCTTCCHH------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCcccCCHH------HHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11122222222 33477789999999999999999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=358.31 Aligned_cols=198 Identities=24% Similarity=0.316 Sum_probs=176.0
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-----CCcccce
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-----HKNIVRF 776 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~ 776 (1058)
.++|.+.+.||+|+||+||+| +..+++.||||++.. .....+.+..|+++++.++ ||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------------IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------------chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 368999999999999999999 446789999999842 2234567788999999996 9999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC-----
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL----- 851 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~----- 851 (1058)
++++...+..++||||+ +++|.+++.......+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 99999999999999999 89999999876666799999999999999999999999 9999999999999975
Q ss_pred --------------------CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHH
Q 043053 852 --------------------EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 911 (1058)
Q Consensus 852 --------------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~el 911 (1058)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999865432 2356799999999999999999999999999999999
Q ss_pred HhCCCCCCCC
Q 043053 912 LTGKQPIDPT 921 (1058)
Q Consensus 912 ltg~~P~~~~ 921 (1058)
++|+.||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999999754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=358.75 Aligned_cols=252 Identities=15% Similarity=0.156 Sum_probs=202.1
Q ss_pred hhccccceeccccceEEEEE------EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC---CCccc
Q 043053 704 KCLVDANVIGKGCSGVVYRA------DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR---HKNIV 774 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv 774 (1058)
++|.+.+.||+|+||+||+| +..+++.||||++... ...++.+|++++++++ |+||+
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--------------NPWEFYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--------------CHHHHHHHHHHHHHSCGGGGGGBC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--------------ChhHHHHHHHHHHHhhhhhhhhhh
Confidence 67899999999999999999 4567899999998422 2457788888888887 99999
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhc---CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHER---TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL 851 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~ 851 (1058)
++++++..++..|+||||+++|+|.++++.. ....+++..++.|+.||++||+|||+. +||||||||+|||++.
T Consensus 131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGN 207 (365)
T ss_dssp CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECG
T ss_pred hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecc
Confidence 9999999999999999999999999999753 246799999999999999999999999 9999999999999998
Q ss_pred -----------CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 043053 852 -----------EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920 (1058)
Q Consensus 852 -----------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 920 (1058)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999866533323445567899999999999999999999999999999999999999964
Q ss_pred CCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHhhhhh
Q 043053 921 TIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDER-PTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R-Pt~~~v~~~l~~~~~~ 990 (1058)
..... ..........+ ..+.+ ..++..|++.+|.+| |+++++.+.++++..+
T Consensus 288 ~~~~~-------------~~~~~~~~~~~--~~~~~---~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 288 NEGGE-------------CKPEGLFRRLP--HLDMW---NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp EETTE-------------EEECSCCTTCS--SHHHH---HHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCCc-------------eeechhccccC--cHHHH---HHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 32211 00111111111 11222 236677999999998 5788888888876554
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=359.34 Aligned_cols=248 Identities=24% Similarity=0.248 Sum_probs=190.5
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHH-HcccCCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT-LGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~ 780 (1058)
.++|.+.++||+|+||+||+| +..+++.||||++.+.... .....+.+.+|..+ ++.++||||+++++++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--------~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL--------KKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------------CCBCCCCCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh--------hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 368999999999999999999 4457899999998654321 12234556777776 5778999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+.+..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeC
Confidence 9999999999999999999999863 5688999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 184 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~~---- 255 (373)
T 2r5t_A 184 GLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--TAEMYDNILNKP---- 255 (373)
T ss_dssp CBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--HHHHHHHHHHSC----
T ss_pred ccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcc----
Confidence 9998643322 23456789999999999999999999999999999999999999997532 112221111110
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKD 979 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~ 979 (1058)
.......+. .+.+++..||+.||++||++.+
T Consensus 256 --~~~~~~~~~------~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 --LQLKPNITN------SARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --CCCCSSSCH------HHHHHHHHHTCSSGGGSTTTTT
T ss_pred --cCCCCCCCH------HHHHHHHHHcccCHHhCCCCCC
Confidence 111112222 2344778899999999999853
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=346.68 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=201.3
Q ss_pred hhccccceeccccceEEEEEEecC----CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDN----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+|.+.+.||+|+||+||+|.... +..||||.+... ......+.+.+|+.++++++||||++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC----------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC----------CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 468888999999999999995432 235899987532 233456789999999999999999999998
Q ss_pred EE-cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 780 CW-NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 780 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
+. .++..++||||+++|+|.++++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~ 170 (298)
T 3f66_A 95 CLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVA 170 (298)
T ss_dssp ECCSSSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEcCCCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEEC
Confidence 65 456779999999999999999763 46689999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCc--ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhh
Q 043053 859 DFGLAKLVDDGDF--ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 859 DfGl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
|||+++....... ........||+.|+|||++.+..++.++||||+|+++|||++ |.+||..... ..........
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~~~~~~~~~ 248 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQG 248 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--TTHHHHHHTT
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHhcC
Confidence 9999987654332 122344567889999999999999999999999999999999 5555554322 2222222221
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
. .... ....+. .+..++..||+.||++|||++++++.|+++...
T Consensus 249 ~--~~~~---~~~~~~------~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 249 R--RLLQ---PEYCPD------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp C--CCCC---CTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C--CCCC---CccCCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 1111 111222 234477889999999999999999999988654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=345.87 Aligned_cols=262 Identities=23% Similarity=0.366 Sum_probs=206.2
Q ss_pred hhccccc-eeccccceEEEEEEe---cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDAN-VIGKGCSGVVYRADM---DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+ .||+|+||+||+|.. .+++.||||++.... ......+++.+|++++++++||||++++++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------NDPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---------cCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 5778877 999999999999943 346889999985431 233446789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+ ..+..++||||+++|+|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEcc
Confidence 9 566789999999999999999863 5689999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||+++....... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||.... .......+....
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~- 237 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKGE- 237 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTC-
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCC-
Confidence 999987654332 122233456789999999988889999999999999999999 999997542 222333222211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREE 993 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~ 993 (1058)
.+......+. .+..++..||+.||++||+++++++.|+++......
T Consensus 238 ----~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 238 ----RMGCPAGCPR------EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp ----CCCCCTTCCH------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 1111122222 233477889999999999999999999998765543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=366.30 Aligned_cols=265 Identities=20% Similarity=0.282 Sum_probs=196.1
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
..+.++|.+.+.||+|+||+||+| +..+++.||||++........ ..........+.+|++++++++||||+++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~ 207 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG---SAREADPALNVETEIEILKKLNHPCIIKIKN 207 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC-----------CCHHHHHHHHHHCCCTTBCCCCE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccc---ccccchhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 566789999999999999999999 666789999999865432111 0112223346889999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC---Ce
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF---EP 855 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~---~~ 855 (1058)
++.. +..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++ .+
T Consensus 208 ~~~~-~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 208 FFDA-EDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp EEES-SEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCE
T ss_pred EEec-CceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceE
Confidence 9854 457999999999999999976 36789999999999999999999999 999999999999997554 59
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
||+|||+++..... ......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .....+
T Consensus 282 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i 357 (419)
T 3i6u_A 282 KITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQI 357 (419)
T ss_dssp EECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHH
T ss_pred EEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHH
Confidence 99999999876543 22345679999999999753 567889999999999999999999997543322 222222
Q ss_pred HhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.... ....+......+. .+.+++.+||+.||++|||++|++++-.
T Consensus 358 ~~~~--~~~~~~~~~~~~~------~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 358 TSGK--YNFIPEVWAEVSE------KALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp HTTC--CCCCHHHHTTSCH------HHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hcCC--CCCCchhhcccCH------HHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 2211 0111111111121 2445788899999999999999998643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=371.74 Aligned_cols=253 Identities=19% Similarity=0.224 Sum_probs=195.5
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| +..+|+.||||++..... ........+.+|+.++++++||||+++++++.
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--------VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--------C-------------CCCCCSCTTSCCEEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh--------hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 367999999999999999999 566899999999854321 12233467789999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
+.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ . +||||||||+|||++.++.+||+||
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCC
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccC
Confidence 999999999999999999999764 578999999999999999999998 7 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+....
T Consensus 294 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~---- 365 (446)
T 4ejn_A 294 GLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEE---- 365 (446)
T ss_dssp CCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCC----
T ss_pred CCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--HHHHHHHHHhCC----
Confidence 9997543322 23445789999999999999999999999999999999999999997542 222222222111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAML 984 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l 984 (1058)
.......+. .+.+++..||+.||++|| +++|++++-
T Consensus 366 --~~~p~~~~~------~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 366 --IRFPRTLGP------EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp --CCCCTTSCH------HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred --CCCCccCCH------HHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 111111222 234577889999999999 999998753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=365.49 Aligned_cols=273 Identities=18% Similarity=0.197 Sum_probs=197.5
Q ss_pred hhccccceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||.||+|... ++..||||++.....................+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57999999999999999999554 67889999885331100000000001122457789999999999999999999
Q ss_pred EEc----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC--
Q 043053 780 CWN----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-- 853 (1058)
Q Consensus 780 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-- 853 (1058)
+.. ....|+||||+ +++|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 987 66789999999 99999999864 3799999999999999999999999 999999999999999887
Q ss_pred CeeeeccccceeccCCCc-----ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhH
Q 043053 854 EPYIADFGLAKLVDDGDF-----ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~ 928 (1058)
.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999987643221 111245679999999999999999999999999999999999999996433222222
Q ss_pred HHHHHhhc-C-ccccCCCCC-CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 929 VDWVRQKK-G-IQVLDPSLL-SRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 929 ~~~~~~~~-~-~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
........ . ......... ...+. .+..++..||+.||++|||++++++.|++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCC------EIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCH------HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhcccccHHHHhhccccccHH------HHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11111110 0 000000000 01122 2344777899999999999999999987754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=344.11 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=202.9
Q ss_pred HHhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.++|.+.+.||+|+||.||+|.. .+++.||||++....... .......+.+.+|++++++++||||+++++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 77 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSS-----SRRGVSREEIEREVNILREIRHPNIITLHDIF 77 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTT-----CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccc-----cccchHHHHHHHHHHHHHhCCCCCeeehhhee
Confidence 347899999999999999999954 579999999985442211 12223467899999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC----Cee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF----EPY 856 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~----~~k 856 (1058)
.++...++||||+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++ .+|
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~k 152 (283)
T 3bhy_A 78 ENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIK 152 (283)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEE
T ss_pred cCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceE
Confidence 9999999999999999999999763 5689999999999999999999999 999999999999998877 899
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|+|||.+....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+...
T Consensus 153 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~- 226 (283)
T 3bhy_A 153 LIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--KQETLTNISAV- 226 (283)
T ss_dssp ECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTT-
T ss_pred EEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--hHHHHHHhHhc-
Confidence 99999998765432 2234568999999999998899999999999999999999999997542 11111111111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.....+......+. .+.+++.+||+.||++|||+++++++
T Consensus 227 -~~~~~~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 227 -NYDFDEEYFSNTSE------LAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp -CCCCCHHHHTTCCH------HHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred -ccCCcchhcccCCH------HHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 11111111111111 23457888999999999999999984
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.68 Aligned_cols=263 Identities=19% Similarity=0.297 Sum_probs=192.9
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+|. ..+++.||||++.... .......+.+|++++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH----------EEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 71 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------------CCCCCCCHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc----------ccccchhHHHHHHHHHhcCCCCCCeeeeEEee
Confidence 578999999999999999994 4589999999985332 11112244579999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 72 EKSLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGL 146 (324)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSE
T ss_pred CCEEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcc
Confidence 999999999997 4999998764 45789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc--
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ-- 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 939 (1058)
++...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+.......
T Consensus 147 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~ 222 (324)
T 3mtl_A 147 ARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EEQLHFIFRILGTPTE 222 (324)
T ss_dssp EECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCT
T ss_pred cccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCh
Confidence 98654322 23345578999999999876 5689999999999999999999999975421 12222221111100
Q ss_pred ccCCCCC-----------CCCchhH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 940 VLDPSLL-----------SRPESEI-----DEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 940 ~~~~~~~-----------~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
..-+... ....... .....+.+++.+||+.||++|||++|++++-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred HhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 0000000 0000000 00012345888999999999999999998543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.06 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=204.9
Q ss_pred hccccceeccccceEEEEEEe-cCCc---EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 705 CLVDANVIGKGCSGVVYRADM-DNGE---VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~-~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
.|...++||+|+||+||+|.. .+++ .||+|++... ......+.+.+|+.++++++||||+++++++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 91 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----------TEMQQVEAFLREGLLMRGLNHPNVLALIGIM 91 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC----------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc----------ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 456678999999999999953 3333 7999988532 2334567899999999999999999999999
Q ss_pred EcCCCc-eEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 781 WNRNNR-LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 781 ~~~~~~-~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
.+.+.. ++||||+.+|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~D 167 (298)
T 3pls_A 92 LPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVAD 167 (298)
T ss_dssp CCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCc
Confidence 876665 9999999999999999764 46789999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCc--ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDF--ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||+++....... ........+|+.|+|||...+..++.++||||+|+++|+|++|..|+.... ........+.....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~~~ 246 (298)
T 3pls_A 168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRR 246 (298)
T ss_dssp TTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHHTTCC
T ss_pred CCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhhcCCC
Confidence 999986544321 122344568899999999999999999999999999999999666654332 22333333332221
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.......+. .+..++..||+.||.+|||++++++.|+++..+.
T Consensus 247 -----~~~~~~~~~------~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 247 -----LPQPEYCPD------SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp -----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CCCCccchH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 111111222 2344788899999999999999999999886543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=352.01 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=203.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEE--EEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVI--AVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~v--avK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||.||+| ...++..+ |||.+... ......+.+.+|+++++++ +||||++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc----------cchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 68899999999999999999 44566654 89987432 1223456789999999999 89999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCC
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKAN 845 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~ 845 (1058)
+.+++..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~ 171 (327)
T 1fvr_A 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAAR 171 (327)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccc
Confidence 999999999999999999999997642 34789999999999999999999999 9999999999
Q ss_pred cEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043053 846 NILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPD 924 (1058)
Q Consensus 846 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~ 924 (1058)
||+++.++.+||+|||+++..... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||.....
T Consensus 172 NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~- 247 (327)
T 1fvr_A 172 NILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC- 247 (327)
T ss_dssp GEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred eEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-
Confidence 999999999999999998743221 22234457889999999988889999999999999999998 9999975421
Q ss_pred ChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 043053 925 GSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEY 994 (1058)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~~~ 994 (1058)
......+... .........+. .+.+++.+||+.||++|||++++++.|+++..+....
T Consensus 248 -~~~~~~~~~~-----~~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 248 -AELYEKLPQG-----YRLEKPLNCDD------EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp -HHHHHHGGGT-----CCCCCCTTBCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred -HHHHHHhhcC-----CCCCCCCCCCH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 1221111111 11111111222 2344788899999999999999999999887665433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=355.72 Aligned_cols=266 Identities=26% Similarity=0.330 Sum_probs=205.6
Q ss_pred hhccccceeccccceEEEEEE-----ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-----MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|.+.+.||+|+||.||+|. ..+++.||||++... .....+.+.+|++++++++||||+++++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----------GPDQQRDFQREIQILKALHSDFIVKYRG 91 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----------CHHHHHHHHHHHHHHHhcCCCceeEEEE
Confidence 689999999999999999997 357899999998532 2334577999999999999999999999
Q ss_pred EEEc--CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 779 CCWN--RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 779 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
++.. ....++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~k 167 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVK 167 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEE
Confidence 9874 45578999999999999999864 24689999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC----------CC
Q 043053 857 IADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP----------DG 925 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~----------~~ 925 (1058)
|+|||+++....... ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ..
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 999999987654332 1223445688899999999988899999999999999999999999864211 00
Q ss_pred hhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 926 SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
............. .........+. + +..++..||+.||++|||+++++++|+.+.....
T Consensus 248 ~~~~~~~~~~~~~--~~~~~~~~~~~---~---l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 248 PALSRLLELLEEG--QRLPAPPACPA---E---VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp CHHHHHHHHHHTT--CCCCCCTTCCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred ccHHHHHHHhhcc--cCCCCCCcccH---H---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 0111111111100 01111112222 2 3347788999999999999999999998866543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=356.40 Aligned_cols=270 Identities=24% Similarity=0.343 Sum_probs=196.5
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHH--HcccCCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT--LGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~ 781 (1058)
++|.+.+.||+|+||.||+|.. +++.||||++... ....+..|.++ +..++||||+++++++.
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA--------------NRQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG--------------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc--------------chhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 6889999999999999999966 5899999998422 12344444444 55589999999998654
Q ss_pred c-----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccC------CCCeEeCCCCCCcEEEc
Q 043053 782 N-----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDC------VPPIVHRDIKANNILIG 850 (1058)
Q Consensus 782 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivHrDikp~Nill~ 850 (1058)
. ...+++||||+++|+|.++++.. ..++..++.++.|+++||+|||+.. .++|+||||||+|||++
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 2 22458999999999999999763 4589999999999999999999862 23899999999999999
Q ss_pred CCCCeeeeccccceeccCCCc------ccccccccCcCCccCcccccc-------CCCCcccchhhHHHHHHHHHhCCCC
Q 043053 851 LEFEPYIADFGLAKLVDDGDF------ARSSNTVAGSYGYIAPEYGYM-------MKITEKSDVYSYGVVVLEVLTGKQP 917 (1058)
Q Consensus 851 ~~~~~kl~DfGl~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~elltg~~P 917 (1058)
.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 999999999999987654321 122334579999999999876 4566789999999999999999887
Q ss_pred CCCCCCCCh-------------hHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 918 IDPTIPDGS-------------HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 918 ~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
|........ .... ...........+...............+.+++.+||+.||++|||++|+++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFED-MQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHH-HHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHH-HHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 754321110 0000 01111111112222222222112222345688999999999999999999999
Q ss_pred Hhhhhhhh
Q 043053 985 KEIKHERE 992 (1058)
Q Consensus 985 ~~~~~~~~ 992 (1058)
+++.....
T Consensus 314 ~~ll~~~~ 321 (336)
T 3g2f_A 314 AELMMIWE 321 (336)
T ss_dssp HHHHHCCC
T ss_pred HHHHHHHH
Confidence 98875443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.20 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=207.7
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|...+.||+|+||.||+| +..+++.||||++... ......+.+.+|+.++++++||||+++++++.+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 91 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----------EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 91 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETT----------TCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccc----------ccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 57899999999999999999 5567999999998533 123346789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
+...++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeeccc
Confidence 9999999999999999999974 5689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+.... .
T Consensus 166 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-----~ 236 (303)
T 3a7i_A 166 AGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--PMKVLFLIPKNN-----P 236 (303)
T ss_dssp CEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSC-----C
T ss_pred ceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--HHHHHHHhhcCC-----C
Confidence 98765533 22345679999999999999999999999999999999999999997542 122222222111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
+......+.. +..++..||+.||++|||+.+++++.....
T Consensus 237 ~~~~~~~~~~------l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 237 PTLEGNYSKP------LKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp CCCCSSCCHH------HHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred CCCccccCHH------HHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 1222222222 334778899999999999999998765443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=357.89 Aligned_cols=260 Identities=23% Similarity=0.270 Sum_probs=202.8
Q ss_pred hhccccceeccccceEEEEEEe----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 778 (1058)
++|.+.+.||+|+||.||+|.. .+++.||||++...... ......+.+.+|+++++++ +||||+++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-------QKAKTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-------EEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhh-------hhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 6899999999999999999965 47899999998654321 1223345677899999999 5999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++..+...++||||+++|+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEES
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEe
Confidence 999999999999999999999999864 5689999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|||+++....... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 202 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~ 279 (355)
T 1vzo_A 202 DFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRIL 279 (355)
T ss_dssp CSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHH
T ss_pred eCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHh
Confidence 9999987643221 23345679999999999875 3478899999999999999999999975432221 112111111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHHHh
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAMLKE 986 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~l~~ 986 (1058)
. ..+......+. .+.+++.+||+.||++|| ++++++++...
T Consensus 280 ~---~~~~~~~~~~~------~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 280 K---SEPPYPQEMSA------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp H---CCCCCCTTSCH------HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred c---cCCCCCcccCH------HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 1 11112222222 233477889999999999 89999876543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=345.08 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=203.5
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+| +..+++.||||++..... ......+.+.+|++++++++||||+++++++.+
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--------EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--------chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 67999999999999999999 445788999999854321 122345789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++|+|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGW 160 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccc
Confidence 99999999999999999999864 4689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+...... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.... .......+.. .+
T Consensus 161 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~------~~ 228 (284)
T 2vgo_A 161 SVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--HTETHRRIVN------VD 228 (284)
T ss_dssp CEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHT------TC
T ss_pred cccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--HhHHHHHHhc------cc
Confidence 8765432 2234579999999999999899999999999999999999999997532 1111111111 11
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.......+. .+.+++..||+.||++|||+++++++-
T Consensus 229 ~~~~~~~~~------~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 229 LKFPPFLSD------GSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp CCCCTTSCH------HHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred cCCCCcCCH------HHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 111122222 233477889999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=377.06 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=207.9
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||.||+|.+..+..||||++... ....++|.+|++++++++||||+++++++.+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTT------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCC------------CCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 578899999999999999998887888999998532 1235789999999999999999999999876
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..|+||||+++|+|.++++......+++..++.|+.||++||+|||++ +||||||||+|||++.++.+||+|||++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 6789999999999999999865456789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+.....
T Consensus 411 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--~~~~~~~i~~~~~----- 482 (535)
T 2h8h_A 411 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGYR----- 482 (535)
T ss_dssp TTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--HHHHHHHHHTTCC-----
T ss_pred eecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC-----
Confidence 86543221 22234457789999999998899999999999999999999 999997542 2223332222111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
.......+. + +.+++..||+.||++|||++++++.|+++..
T Consensus 483 ~~~~~~~~~---~---l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 MPCPPECPE---S---LHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCCCTTCCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCCH---H---HHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 111112222 2 3347888999999999999999999988754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.37 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=198.9
Q ss_pred HHHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
...++|.+.+.||+|+||.||+|. ..+|+.||||++... ...+.+.+|+.++++++||||++++++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-------------SDLQEIIKEISIMQQCDSPHVVKYYGS 92 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-------------SCCHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-------------HHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 345789999999999999999994 456999999988422 124678999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+...+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 168 (314)
T 3com_A 93 YFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLAD 168 (314)
T ss_dssp EEETTEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred EEeCCEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEee
Confidence 99999999999999999999999743 46789999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
||.+....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ............
T Consensus 169 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~-- 242 (314)
T 3com_A 169 FGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--MRAIFMIPTNPP-- 242 (314)
T ss_dssp CTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCC--
T ss_pred cccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCCC--
Confidence 99998765432 223455789999999999998999999999999999999999999975421 111111111111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
+.. ..+..... .+.+++..||+.||.+|||+.+++++-.
T Consensus 243 ---~~~-~~~~~~~~---~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 243 ---PTF-RKPELWSD---NFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp ---CCC-SSGGGSCH---HHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred ---ccc-CCcccCCH---HHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 000 01111111 2344788899999999999999987543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=355.90 Aligned_cols=272 Identities=24% Similarity=0.288 Sum_probs=196.6
Q ss_pred HHHHHhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 699 VEQVLKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 699 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
+....++|...+.||+|+||.||+|.. .+|+.||||++...... .......+.+.+|++++++++||||++++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS------EAKDGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcc------hhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 445568899999999999999999954 57999999998543211 11222345788999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeee
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl 857 (1058)
+++.+.+..++||||+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 153 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKL 153 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEE
Confidence 999999999999999986 899988764 45688999999999999999999999 9999999999999999999999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
+|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|..||..... ...+........
T Consensus 154 ~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~ 230 (346)
T 1ua2_A 154 ADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLG 230 (346)
T ss_dssp CCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHC
T ss_pred EecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcC
Confidence 9999998764432 233456799999999998654 578999999999999999999999975421 111222221111
Q ss_pred Cc-cccCCCC---------CCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 937 GI-QVLDPSL---------LSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 937 ~~-~~~~~~~---------~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.. ...-+.. ...+...... ...+.+++..||+.||++|||++|++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00 0000000 0000000000 12345588889999999999999998854
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=355.44 Aligned_cols=265 Identities=19% Similarity=0.250 Sum_probs=192.5
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
...++|.+.+.||+|+||+||+| +..+++.||||++.... ......+.+.+|++++++++||||++++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---------EEEGVPGTAIREVSLLKELQHRNIIELKSV 101 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------------CHHHHHHGGGCCCTTBCCEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc---------cccccchhHHHHHHHHHHcCCCCcceEEEE
Confidence 34578999999999999999999 56689999999985431 223345677899999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc-----CCCC
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG-----LEFE 854 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~-----~~~~ 854 (1058)
+.+++..++||||+++ +|.+++... ..+++..++.|+.|+++||+|||+. +|+||||||+|||++ .++.
T Consensus 102 ~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 175 (329)
T 3gbz_A 102 IHHNHRLHLIFEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPV 175 (329)
T ss_dssp EEETTEEEEEEECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCE
T ss_pred EecCCEEEEEEecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccce
Confidence 9999999999999975 999999864 5689999999999999999999999 999999999999994 4556
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
+||+|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... .........
T Consensus 176 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~ 252 (329)
T 3gbz_A 176 LKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-IDQLFKIFE 252 (329)
T ss_dssp EEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH
T ss_pred EEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-HHHHHHHHH
Confidence 9999999998765332 233455789999999998774 489999999999999999999999975421 111111111
Q ss_pred hhcCcc-----------ccCCCCCCCCchhHHH------HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 934 QKKGIQ-----------VLDPSLLSRPESEIDE------MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 934 ~~~~~~-----------~~~~~~~~~~~~~~~~------~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...... ................ ...+.+++.+||+.||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 253 VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 110000 0000000000000110 0234568899999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=369.15 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=201.7
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
..+.++|.+.+.||+|+||+||+| +..+++.||||++..... .......+.+|+.++++++||||+++++
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~~E~~~l~~l~hpniv~~~~ 103 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV---------STSSNSKLLEEVAVLKLLDHPNIMKLYD 103 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------------CTTHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc---------CchHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 456789999999999999999999 455789999999854321 1223578899999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC---CCe
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE---FEP 855 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~---~~~ 855 (1058)
++.+....|+||||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.+ +.+
T Consensus 104 ~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 178 (494)
T 3lij_A 104 FFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALI 178 (494)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCE
T ss_pred EEEeCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcE
Confidence 999999999999999999999998764 5689999999999999999999999 99999999999999764 459
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||+++...... .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||.... .......+...
T Consensus 179 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~ 252 (494)
T 3lij_A 179 KIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQEILRKVEKG 252 (494)
T ss_dssp EECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHT
T ss_pred EEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC
Confidence 999999998776532 334567999999999876 468999999999999999999999997542 22222222221
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
. ...........+. .+.+++..||+.||.+|||+.+++++-
T Consensus 253 ~--~~~~~~~~~~~s~------~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 253 K--YTFDSPEWKNVSE------GAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp C--CCCCSGGGTTSCH------HHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred C--CCCCchhcccCCH------HHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 1 1111111122222 234577889999999999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=345.73 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=204.9
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||.||+| +..+++.||+|++..... ......+.+.+|+.++++++||||+++++++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--------LKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--------CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc--------cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence 368999999999999999999 455789999998854321 23345678999999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++..++||||+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 86 DNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEecc
Confidence 999999999999999999998763 5789999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
.++...... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+.. . .
T Consensus 161 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~--~-~-- 231 (294)
T 2rku_A 161 LATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--KETYLRIKK--N-E-- 231 (294)
T ss_dssp TCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHT--T-C--
T ss_pred CceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhh--c-c--
Confidence 998765332 223346799999999999988899999999999999999999999975421 111111111 1 1
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.......+. .+..++.+||+.||++|||+++++++-
T Consensus 232 -~~~~~~~~~------~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 232 -YSIPKHINP------VAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp -CCCCTTSCH------HHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred -CCCccccCH------HHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 111112222 233477889999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=375.95 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=200.7
Q ss_pred ccccc-eeccccceEEEEEEec---CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 706 LVDAN-VIGKGCSGVVYRADMD---NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 706 ~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
+...+ .||+|+||.||+|... ++..||||++... ......++|.+|++++++++|||||++++++.
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~----------~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 406 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----------TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC----------CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC----------CChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence 33344 7999999999999543 4677999998533 22334688999999999999999999999997
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
. +..++||||+++|+|.+++... ...+++..+..++.||++||+|||+. +||||||||+|||++.++.+||+|||
T Consensus 407 ~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 407 A-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp S-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeecc
Confidence 6 5689999999999999999764 46799999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 862 LAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 862 l~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+.....
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~~~~-- 557 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKR-- 557 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--SHHHHHHHHTTCC--
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCC--
Confidence 9987643321 112223446789999999998999999999999999999998 999997653 3344443333221
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.......+. + +..++..||+.||++||++.++++.|+.+...
T Consensus 558 ---~~~p~~~~~---~---l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 558 ---MECPPECPP---E---LYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ---CCCCTTCCH---H---HHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCcCCH---H---HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 111112222 2 33478889999999999999999999887654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.96 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=203.2
Q ss_pred HHHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+.++|.+.+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|++++++++||||++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS-----------PAFRDSSLENEIAVLKKIKHENIVTLEDI 74 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------------HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecc-----------cccchHHHHHHHHHHHhCCCCCeeehhhh
Confidence 456899999999999999999994 457999999998532 11224578899999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE---cCCCCee
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI---GLEFEPY 856 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill---~~~~~~k 856 (1058)
+.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+|
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~k 149 (304)
T 2jam_A 75 YESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIM 149 (304)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEE
T ss_pred cccCCEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEE
Confidence 99999999999999999999999764 5689999999999999999999999 99999999999999 7788999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|+|||+++..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... .......+....
T Consensus 150 l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~ 223 (304)
T 2jam_A 150 ITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--ESKLFEKIKEGY 223 (304)
T ss_dssp BCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHCC
T ss_pred EccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCC
Confidence 9999999765432 2234569999999999999999999999999999999999999997542 222222222211
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
...........+. .+.+++..||+.||++|||+++++++-.
T Consensus 224 --~~~~~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 224 --YEFESPFWDDISE------SAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp --CCCCTTTTTTSCH------HHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred --CCCCccccccCCH------HHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 1111111122222 2344788899999999999999998543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=352.01 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=205.5
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| +..+++.||+|++..... ......+.+.+|+.++++++||||+++++++.
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 111 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--------LKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--------CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh--------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 368999999999999999999 555788999999854321 23345678999999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+.+..|+||||+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeecc
Confidence 999999999999999999998764 5789999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+...
T Consensus 187 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~------ 256 (335)
T 2owb_A 187 LATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--KETYLRIKKN------ 256 (335)
T ss_dssp TCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHT------
T ss_pred CceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--HHHHHHHhcC------
Confidence 998765332 223456799999999999998999999999999999999999999975321 1111111111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
........+. .+..++.+||+.||++|||++|++++-
T Consensus 257 ~~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 257 EYSIPKHINP------VAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp CCCCCTTSCH------HHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred CCCCCccCCH------HHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 1111112222 233477889999999999999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=343.57 Aligned_cols=258 Identities=19% Similarity=0.262 Sum_probs=201.2
Q ss_pred HHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.++|.+.+.||+|+||.||+|. ..+++.||||++...... ......+.+.+|++++++++||||+++++++
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-------RIPNGEANVKKEIQLLRRLRHKNVIQLVDVL 75 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH-------HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc-------ccchhHHHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 45789999999999999999994 467899999998654321 1123467899999999999999999999998
Q ss_pred E--cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 781 W--NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 781 ~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
. +....++||||+++| |.+++.......+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 76 YNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp ECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEee
Confidence 5 345779999999876 88888776667899999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK--ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|||.+................||+.|+|||+..+.. ++.++||||+|+++|||++|+.||.... .......+...
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i~~~- 228 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--IYKLFENIGKG- 228 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHC-
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHHhcC-
Confidence 999998765433333344567999999999987644 3779999999999999999999997532 11222211111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
........+.. +.+++.+||+.||++|||+++++++-
T Consensus 229 -----~~~~~~~~~~~------l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 229 -----SYAIPGDCGPP------LSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp -----CCCCCSSSCHH------HHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred -----CCCCCCccCHH------HHHHHHHHccCChhhCCCHHHHhcCc
Confidence 11111222222 23477889999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=353.33 Aligned_cols=263 Identities=23% Similarity=0.359 Sum_probs=205.1
Q ss_pred HHHHhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCccccee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFL 777 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 777 (1058)
..+.++|.+.+.||+|+||.||+|.. .+|+.||||++....... .........+.+.+|+.+++++ +||||++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL---SPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCC---CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc---CHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 45667899999999999999999955 579999999985432100 0011123356789999999999 799999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeee
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl 857 (1058)
+++......++||||++||+|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999863 5689999999999999999999999 9999999999999999999999
Q ss_pred eccccceeccCCCcccccccccCcCCccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHH
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 931 (1058)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......
T Consensus 242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~ 316 (365)
T 2y7j_A 242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--QILMLRM 316 (365)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHH
T ss_pred EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--HHHHHHH
Confidence 9999998775432 2345679999999998753 357889999999999999999999997532 1122222
Q ss_pred HHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+.... .. .........+. .+.+++.+||+.||++|||+++++++
T Consensus 317 i~~~~-~~-~~~~~~~~~~~------~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 IMEGQ-YQ-FSSPEWDDRSS------TVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHTC-CC-CCHHHHSSSCH------HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhCC-CC-CCCcccccCCH------HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 21111 00 00000011111 23457888999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.16 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=197.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|.+.+.||+|+||.||+| +..++..||+|++.... ......+.+.+|+.++++++||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh---------hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 45788899999999999999 55678999999985432 223446789999999999999999999999865
Q ss_pred ----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCC--eEeCCCCCCcEEEc-CCCCe
Q 043053 783 ----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPP--IVHRDIKANNILIG-LEFEP 855 (1058)
Q Consensus 783 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDikp~Nill~-~~~~~ 855 (1058)
....++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~ 171 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCE
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCE
Confidence 34479999999999999999864 5689999999999999999999998 7 99999999999998 78999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||++...... ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||...... ..........
T Consensus 172 kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~ 245 (290)
T 1t4h_A 172 KIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRVTSG 245 (290)
T ss_dssp EECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHHHTTT
T ss_pred EEeeCCCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-HHHHHHHhcc
Confidence 99999999754432 2234569999999998764 5899999999999999999999999754221 1111111111
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. .........+. .+.+++..||+.||++|||+++++++
T Consensus 246 ~----~~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 246 V----KPASFDKVAIP------EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp C----CCGGGGGCCCH------HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C----CccccCCCCCH------HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 11111111112 23457888999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=368.17 Aligned_cols=257 Identities=23% Similarity=0.287 Sum_probs=204.1
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
..+.++|.+.+.||+|+||+||+| +..+++.||||++..... .......+.+|++++++++||||+++++
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~E~~~l~~l~hpniv~~~~ 88 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA---------KNKDTSTILREVELLKKLDHPNIMKLFE 88 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH---------BCSCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc---------cchHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 356789999999999999999999 455899999999854321 1223578899999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc---CCCCe
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG---LEFEP 855 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~---~~~~~ 855 (1058)
++.+....|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 163 (486)
T 3mwu_A 89 ILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDI 163 (486)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCE
T ss_pred EEEcCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCE
Confidence 999999999999999999999999764 5689999999999999999999999 999999999999995 45679
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||+++...... .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... .......+...
T Consensus 164 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~ 237 (486)
T 3mwu_A 164 KIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETG 237 (486)
T ss_dssp EECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHT
T ss_pred EEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC
Confidence 999999998665432 2345679999999999876 58999999999999999999999997542 22222222221
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.. ..+.......+. .+.+++..||+.||++|||+.+++++-
T Consensus 238 ~~--~~~~~~~~~~s~------~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 238 KY--AFDLPQWRTISD------DAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp CC--CSCSGGGGGSCH------HHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred CC--CCCCcccCCCCH------HHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 11 111111111121 234578889999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=345.36 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=201.7
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| +..+++.||+|++.... ......+.+.+|++++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---------MTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT---------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc---------CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 368999999999999999999 44579999999985331 22344678999999999999999999999885
Q ss_pred c--CCCceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCCCC-----eEeCCCCCCcEEEcCC
Q 043053 782 N--RNNRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCVPP-----IVHRDIKANNILIGLE 852 (1058)
Q Consensus 782 ~--~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivHrDikp~Nill~~~ 852 (1058)
+ ....++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+. + |+||||||+||+++.+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSS
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCC
Confidence 4 567899999999999999997532 34589999999999999999999998 7 9999999999999999
Q ss_pred CCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
+.+||+|||.++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+
T Consensus 153 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i 228 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKELAGKI 228 (279)
T ss_dssp SCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH
T ss_pred CCEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--HHHHHHHH
Confidence 999999999998664432 12234568999999999998889999999999999999999999997542 22222222
Q ss_pred HhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
..... +......+. .+..++.+||+.||++|||++|++++++
T Consensus 229 ~~~~~-----~~~~~~~~~------~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 229 REGKF-----RRIPYRYSD------ELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHTCC-----CCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred hhccc-----ccCCcccCH------HHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 22211 111122222 2334778899999999999999998654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=347.63 Aligned_cols=264 Identities=28% Similarity=0.410 Sum_probs=205.9
Q ss_pred hhccccceeccccceEEEEEE-----ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-----MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|.+.+.||+|+||.||+|. ..+++.||||++... .....+.+.+|++++++++||||+++++
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----------TEEHLRDFEREIEILKSLQHDNIVKYKG 109 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----------CSHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----------CHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 578999999999999999996 347899999998532 2344678999999999999999999999
Q ss_pred EEEcCC--CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 779 CCWNRN--NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 779 ~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
++...+ ..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 185 (326)
T 2w1i_A 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVK 185 (326)
T ss_dssp EECC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEE
T ss_pred EEEecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEE
Confidence 987654 679999999999999999864 35689999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcc-cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC----------CCC
Q 043053 857 IADFGLAKLVDDGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI----------PDG 925 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~----------~~~ 925 (1058)
|+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++|..||.... ...
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCT
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccch
Confidence 9999999877543321 12234457788999999988889999999999999999999999986320 000
Q ss_pred hhHH-HHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 926 SHVV-DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 926 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.... ......... .........+ .+ +..++..||+.||++|||+.++++.|+++..+
T Consensus 266 ~~~~~~~~~~~~~~--~~~~~~~~~~---~~---l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 266 QMIVFHLIELLKNN--GRLPRPDGCP---DE---IYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHHHTT--CCCCCCTTCC---HH---HHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcC--CCCCCCCccc---HH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0000 000110000 0111111222 22 33478889999999999999999999988764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=350.69 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=201.3
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+|. ..+++.||||++... .....+.+.+|++++++++||||+++++++..
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----------EQQDREEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----------CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 579999999999999999994 478999999988432 23446789999999999999999999999873
Q ss_pred ----CCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 783 ----RNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 783 ----~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
....++||||+++|+|.+++... ....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~k 174 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPV 174 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEE
Confidence 34678999999999999999763 346789999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcc-------cccccccCcCCccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCCh
Q 043053 857 IADFGLAKLVDDGDFA-------RSSNTVAGSYGYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS 926 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~ 926 (1058)
|+|||++......... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........
T Consensus 175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 254 (317)
T 2buj_A 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254 (317)
T ss_dssp ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS
T ss_pred EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc
Confidence 9999998765321100 0112345799999999987544 68899999999999999999999964211111
Q ss_pred hHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 927 HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 927 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
......... .........+. .+..++..||+.||++|||+++++++|+.+..
T Consensus 255 ~~~~~~~~~-----~~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 255 SVALAVQNQ-----LSIPQSPRHSS------ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp CHHHHHHCC-------CCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhhHHhhcc-----CCCCccccCCH------HHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 222211111 01111111222 23447788999999999999999999988764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=352.83 Aligned_cols=257 Identities=23% Similarity=0.321 Sum_probs=193.6
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||.||+| +..+|+.||||++.... ......+++.+|++++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---------QSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---------cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 367999999999999999999 55789999999985331 23345678899999999999999999999997
Q ss_pred cCC------CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 782 NRN------NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 782 ~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
... ..|+||||+ +++|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCE
Confidence 653 359999999 8899999976 4689999999999999999999999 99999999999999999999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1058)
||+|||+++..... ....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+......
T Consensus 168 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~ 241 (367)
T 1cm8_A 168 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKV 241 (367)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred EEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh
Confidence 99999999875432 335678999999999877 67899999999999999999999999754211 111111110
Q ss_pred hcC---------------------ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 935 KKG---------------------IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 935 ~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
... .......+....+... ..+.+++.+||..||++|||++|++++-
T Consensus 242 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 242 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS---PLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC---HHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred cCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCC---HHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 000 0000000000001111 1244578889999999999999999853
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=342.12 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=198.5
Q ss_pred HHHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceee
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLG 778 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 778 (1058)
...++|.+.+.||+|+||+||+|. ..+++.||||++.... .......++.+|+..+.++ +||||+++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~ 78 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL---------AGSVDEQNALREVYAHAVLGQHSHVVRYFS 78 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC---------TTSHHHHHHHHHHHHHHHSCSCTTBCCEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc---------cccHHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 355889999999999999999994 4589999999985331 2233467888999999999 8999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC----
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERT--GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE---- 852 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~---- 852 (1058)
++.+++..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~ 155 (289)
T 1x8b_A 79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPN 155 (289)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------
T ss_pred eeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCc
Confidence 9999999999999999999999997642 36689999999999999999999999 99999999999999844
Q ss_pred ---------------CCeeeeccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCC
Q 043053 853 ---------------FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQ 916 (1058)
Q Consensus 853 ---------------~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~ 916 (1058)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||||+++|||++|..
T Consensus 156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp --------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 479999999998765432 34589999999998765 56689999999999999999987
Q ss_pred CCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 917 PIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 917 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
|+... ... ..+.... .+......+.. +.+++..||+.||++|||+++++++
T Consensus 230 ~~~~~----~~~-~~~~~~~-----~~~~~~~~~~~------~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 230 LPRNG----DQW-HEIRQGR-----LPRIPQVLSQE------FTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CCSSS----HHH-HHHHTTC-----CCCCSSCCCHH------HHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCcch----hHH-HHHHcCC-----CCCCCcccCHH------HHHHHHHHhCCCcccCCCHHHHhhC
Confidence 76422 111 1121111 11222222222 3347778999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=369.17 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=206.1
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.++|...++||+|+||.||+| +..+|+.||||++..... ......+.+.+|++++++++||||+++++++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 95 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV--------KQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhc--------ccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 5578999999999999999999 455899999999854321 2233467899999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE---cCCCCeee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI---GLEFEPYI 857 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill---~~~~~~kl 857 (1058)
.+....|+||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence 9999999999999999999999763 5789999999999999999999999 99999999999999 56789999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+|||+++...... .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... .......+.....
T Consensus 171 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~ 244 (484)
T 3nyv_A 171 IDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--EYDILKKVEKGKY 244 (484)
T ss_dssp CCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCC
T ss_pred EeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCC
Confidence 9999998765432 2345679999999999876 68999999999999999999999997542 2222222222111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
..........+. .+.+++..||++||++|||++|++++-.
T Consensus 245 --~~~~~~~~~~s~------~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 245 --TFELPQWKKVSE------SAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp --CCCSGGGGGSCH------HHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred --CCCCcccccCCH------HHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 111111111122 2345788899999999999999997543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=348.49 Aligned_cols=266 Identities=24% Similarity=0.368 Sum_probs=199.1
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||.||+| +..+|+.||||++... .......+.+.+|+.++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES---------DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC---------SSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC---------CCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 478999999999999999999 4556999999988433 123344677889999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+.+..++||||+++++|.++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred cCCEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence 99999999999999999988764 35689999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc----
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK---- 936 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~---- 936 (1058)
+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ...........
T Consensus 170 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 170 FARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-DQLYHIMMCLGNLIP 246 (331)
T ss_dssp TC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCH
T ss_pred CceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCh
Confidence 998654432 223456799999999998765 7889999999999999999999999754221 11111111000
Q ss_pred -----------CccccCCCCCCCCchhH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 937 -----------GIQVLDPSLLSRPESEI---DEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 937 -----------~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
......+......+... .....+.+++.+||+.||++|||++|++++-.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000111111100000 00123445888999999999999999998644
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=349.74 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=183.1
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+|. ..+++.||||++... ......+++.+|++++++++||||+++++++..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE----------KCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------------CCCCCCCTTBCCEEEEEES
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhh----------hcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 678999999999999999994 457899999988533 112335678899999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhc------CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHER------TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
++..++||||+++|+|.+++... ....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEE
Confidence 99999999999999999999741 245689999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCc---ccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 857 IADFGLAKLVDDGDF---ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
|+|||++........ ........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||....+. ......
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~ 239 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--KVLMLT 239 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHH
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--hHHHHH
Confidence 999999876543221 112234579999999998875 56889999999999999999999999764322 111111
Q ss_pred HhhcCcc----ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 933 RQKKGIQ----VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 933 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
....... ..++......+. .+..++.+||+.||++|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKYGK------SFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HTSSCCCTTC-----CCCCCCCH------HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hccCCCccccccccchhhhhhhH------HHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111100 011111122222 23347788999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.87 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=196.3
Q ss_pred hhccccceeccccceEEEEEEec--CCc--EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD--NGE--VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||+||+|.+. +++ .||||++..... ......+.+.+|++++++++||||++++++
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--------SQPEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--------CCHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 68999999999999999999542 333 689998854321 233456889999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+..+. .++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred EccCC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcc
Confidence 98654 89999999999999999864 35689999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcc-cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||+++........ .......+|..|+|||+..+..++.++||||||+++|||++ |+.||.... .......+....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~- 241 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKIDKEG- 241 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTSC-
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--HHHHHHHHHccC-
Confidence 9999876543321 22334567889999999988888999999999999999999 999997542 222222221111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
.........+. .+.+++..||+.||++|||++++++.|+++....
T Consensus 242 ---~~~~~~~~~~~------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 242 ---ERLPRPEDCPQ------DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp ---CCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ---CCCCCCcCcCH------HHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 11111112222 2334778899999999999999999998876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=356.77 Aligned_cols=200 Identities=27% Similarity=0.456 Sum_probs=175.1
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||+||+| +..+++.||+|++... ......+.+.+|+.++++++||||+++++++.+
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC----------CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc----------cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 57899999999999999999 5558999999998532 233456789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++|+|.++++.. ..+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 178 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCC
Confidence 99999999999999999999864 56899999999999999999999831 799999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 179 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 179 SGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred Cccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 875532 1233457999999999999999999999999999999999999999753
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=363.12 Aligned_cols=359 Identities=20% Similarity=0.238 Sum_probs=196.7
Q ss_pred ccccCCCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchh
Q 043053 18 TNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKS 97 (1058)
Q Consensus 18 ~~~~~~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~ 97 (1058)
..++++++|++|++++|.+++ +| .++.+++|++|++++|+++ .+| ++++++|++|+|++|++++ +| ++++++
T Consensus 36 ~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~-~~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~ 107 (457)
T 3bz5_A 36 ISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTN-LD--VTPLTK 107 (457)
T ss_dssp EEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCS-CCC--CTTCTTCSEEECCSSCCSC-CC--CTTCTT
T ss_pred cChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCC-eEc--cccCCCCCEEECcCCCCce-ee--cCCCCc
Confidence 344455555555555555542 33 3555555555555555555 233 4555555555555555542 22 444444
Q ss_pred hhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeee
Q 043053 98 LRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIY 177 (1058)
Q Consensus 98 L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~ 177 (1058)
|++|++++|.+. .++ ++.+++|++|++++|++++. .++++++|++|+++
T Consensus 108 L~~L~L~~N~l~--------------------------~l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~ 156 (457)
T 3bz5_A 108 LTYLNCDTNKLT--------------------------KLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCH 156 (457)
T ss_dssp CCEEECCSSCCS--------------------------CCC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECT
T ss_pred CCEEECCCCcCC--------------------------eec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECC
Confidence 444444444443 222 44455555555555555532 25556666666666
Q ss_pred ccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcC
Q 043053 178 TTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTI 257 (1058)
Q Consensus 178 ~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 257 (1058)
+|...+.+ .++.+++|+.|++++|.+++ +| ++.+++|+.|++++|.+++. .+..+++|++|++++|++++ +
T Consensus 157 ~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-i 227 (457)
T 3bz5_A 157 LNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-I 227 (457)
T ss_dssp TCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-C
T ss_pred CCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-c
Confidence 66433333 35566666666666666664 33 55666666666666666543 25566666666666666664 3
Q ss_pred CccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccC
Q 043053 258 PLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCS 337 (1058)
Q Consensus 258 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 337 (1058)
| ++.+++|+.|++++|++++.. +..+++|+.|++++|++ +.|++++|.+.+.+| +..++
T Consensus 228 p--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~L--------------~~L~l~~n~~~~~~~--~~~l~ 286 (457)
T 3bz5_A 228 D--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDL--------------LEIDLTHNTQLIYFQ--AEGCR 286 (457)
T ss_dssp C--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCCC--------------SCCCCTTCTTCCEEE--CTTCT
T ss_pred C--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCCC--------------CEEECCCCccCCccc--ccccc
Confidence 3 556666666666666666533 23444555555555432 334455555444443 35566
Q ss_pred cccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeecc
Q 043053 338 NLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLS 417 (1058)
Q Consensus 338 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 417 (1058)
+|+.|++++|...+.+|. ..++|+.|++++| ++|+.|++++|+|+++ .++.+++|+.|+++
T Consensus 287 ~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~ 347 (457)
T 3bz5_A 287 KIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLSCV 347 (457)
T ss_dssp TCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEECC
T ss_pred cCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc---ccccCCcCcEEECC
Confidence 777777777766555542 2234444443333 5667777777777764 26666777777777
Q ss_pred CccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccc
Q 043053 418 SNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL 477 (1058)
Q Consensus 418 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 477 (1058)
+|+|++ ++.|..|++++|.++|. ..+..|+.+++++|+++|.+|..+
T Consensus 348 ~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 348 NAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp SSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred CCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhH
Confidence 777663 24556666666666653 234455566666666666665443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.81 Aligned_cols=256 Identities=21% Similarity=0.262 Sum_probs=193.6
Q ss_pred hhcccc-ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 704 KCLVDA-NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 704 ~~~~~~-~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
+.|.+. +.||+|+||+||+| +..+++.||||++... .....+.+.+|++++.++ +||||+++++++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-----------PGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-----------SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-----------cchhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 567774 78999999999999 4568999999998432 223467889999999985 799999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC---eee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE---PYI 857 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~---~kl 857 (1058)
.+++..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl 155 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKI 155 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEE
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEE
Confidence 9999999999999999999999874 5689999999999999999999999 9999999999999998776 999
Q ss_pred eccccceeccCCCc-----ccccccccCcCCccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC--
Q 043053 858 ADFGLAKLVDDGDF-----ARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG-- 925 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~-- 925 (1058)
+|||+++....... .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 99999876542211 112234569999999999865 557889999999999999999999997653321
Q ss_pred -----------hhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 926 -----------SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 926 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
......+.... . ..........+ ..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~i~~~~-~-~~~~~~~~~~~------~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 236 WDRGEACPACQNMLFESIQEGK-Y-EFPDKDWAHIS------CAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp C----CCHHHHHHHHHHHHHCC-C-CCCHHHHTTSC------HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccccchhHHHHHHHHHhccC-c-ccCchhcccCC------HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111111110 0 00000001111 123457888999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=353.97 Aligned_cols=261 Identities=23% Similarity=0.262 Sum_probs=191.9
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||.||+| +..+++.||||++.... ......+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT---------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc---------CChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 468999999999999999999 56679999999985321 23344678899999999999999999999997
Q ss_pred cCC------CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 782 NRN------NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 782 ~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
..+ ..|+||||+++ +|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 166 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 166 (371)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred cccccccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCE
Confidence 655 56999999975 78888853 488999999999999999999999 99999999999999999999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+...
T Consensus 167 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~ 241 (371)
T 2xrw_A 167 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQWNKVIEQ 241 (371)
T ss_dssp EECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHC-
T ss_pred EEEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence 99999999865432 223356799999999999999999999999999999999999999975421 1111111000
Q ss_pred cCcc----------------ccCCC------------CCCCCch--hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 936 KGIQ----------------VLDPS------------LLSRPES--EIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 936 ~~~~----------------~~~~~------------~~~~~~~--~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.... ...+. ....... .......+.+++.+||+.||++|||++|++++-.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 0000 00000 0000000 1111234567899999999999999999998654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=345.74 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=200.0
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
..+.++|.+.+.||+|+||.||+| +..+++.||||++........ ..........+.+|++++++++||||+++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 82 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIG---SAREADPALNVETEIEILKKLNHPCIIKIKN 82 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC------------------CHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhc---ccccchhhhhHHHHHHHHHhCCCCCCceEee
Confidence 456789999999999999999999 556789999999864422110 0111223456889999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC---e
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE---P 855 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~---~ 855 (1058)
++..+. .|+||||+++|+|.+++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++. +
T Consensus 83 ~~~~~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 83 FFDAED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp EEESSS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCE
T ss_pred EEcCCc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeE
Confidence 987654 8999999999999999975 46789999999999999999999999 9999999999999987664 9
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||....... .....+
T Consensus 157 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~ 232 (322)
T 2ycf_A 157 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQI 232 (322)
T ss_dssp EECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHH
T ss_pred EEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHH
Confidence 999999998765432 223456999999999864 5678899999999999999999999997553322 222222
Q ss_pred HhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
..... ...+......+. .+.+++.+||+.||++|||+++++++-
T Consensus 233 ~~~~~--~~~~~~~~~~~~------~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 233 TSGKY--NFIPEVWAEVSE------KALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp HHTCC--CCCHHHHTTSCH------HHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HhCcc--ccCchhhhhcCH------HHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 22111 011111111121 234578889999999999999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=365.51 Aligned_cols=196 Identities=26% Similarity=0.327 Sum_probs=155.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+| +..+++.||||++.... ......+++.+|+.++++++|||||++++++..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---------EDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT---------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---------cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 68999999999999999999 56689999999985331 233446789999999999999999999999854
Q ss_pred C-----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeee
Q 043053 783 R-----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857 (1058)
Q Consensus 783 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl 857 (1058)
. ...|+||||+ +|+|.++++. ...+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||
T Consensus 124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp SCTTTCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEE
T ss_pred CCcccCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEee
Confidence 3 4579999998 5699999975 46799999999999999999999999 9999999999999999999999
Q ss_pred eccccceeccCCCc-------------------------ccccccccCcCCccCcccc-ccCCCCcccchhhHHHHHHHH
Q 043053 858 ADFGLAKLVDDGDF-------------------------ARSSNTVAGSYGYIAPEYG-YMMKITEKSDVYSYGVVVLEV 911 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvvl~el 911 (1058)
+|||+++....... .......+||+.|+|||++ .+..++.++||||+||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 99999987643211 0123456789999999975 566799999999999999999
Q ss_pred HhC
Q 043053 912 LTG 914 (1058)
Q Consensus 912 ltg 914 (1058)
++|
T Consensus 278 ltg 280 (458)
T 3rp9_A 278 LNM 280 (458)
T ss_dssp HTT
T ss_pred HHh
Confidence 993
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=359.16 Aligned_cols=202 Identities=24% Similarity=0.307 Sum_probs=168.7
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+| +..+++.||||++.... ......+++.+|+.++++++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---------EDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---------TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---------cChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 368999999999999999999 56678999999985321 23344678999999999999999999999997
Q ss_pred cC-----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 782 NR-----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 782 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
.. ...|+||||++ |+|.++++. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+|
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~k 169 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVK 169 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEE
Confidence 66 46799999996 599999976 46799999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcc--------------------cccccccCcCCccCcccc-ccCCCCcccchhhHHHHHHHHHhCC
Q 043053 857 IADFGLAKLVDDGDFA--------------------RSSNTVAGSYGYIAPEYG-YMMKITEKSDVYSYGVVVLEVLTGK 915 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltg~ 915 (1058)
|+|||+++........ ......+||+.|+|||++ .+..++.++||||+||++|||++|.
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 9999999876543211 123567899999999985 5667999999999999999999865
Q ss_pred CCCC
Q 043053 916 QPID 919 (1058)
Q Consensus 916 ~P~~ 919 (1058)
.||.
T Consensus 250 ~p~~ 253 (432)
T 3n9x_A 250 QSHI 253 (432)
T ss_dssp TTTC
T ss_pred cccc
Confidence 5553
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=367.69 Aligned_cols=267 Identities=23% Similarity=0.301 Sum_probs=203.7
Q ss_pred HHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccC--CCCCcccchHHHHHHHHHHHcccCCCcccce
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAAN--GCSDEKSGVRDSFSAEIKTLGSIRHKNIVRF 776 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 776 (1058)
..+.++|.+.+.||+|+||+||+| +..+++.||||++......... ......+...+.+.+|+.++++++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 345688999999999999999999 5567899999998644321100 0001112446789999999999999999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC---
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF--- 853 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~--- 853 (1058)
++++.++...|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999999764 5689999999999999999999999 999999999999998876
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
.+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.... .......+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~ 260 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQDIIKKVE 260 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHH
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH
Confidence 69999999998775532 234567999999999876 468999999999999999999999997542 222222222
Q ss_pred hhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
... ...+.......+. .+.+++..||++||.+|||++|++++-.
T Consensus 261 ~~~--~~~~~~~~~~~s~------~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 261 KGK--YYFDFNDWKNISD------EAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HCC--CCCCHHHHTTSCH------HHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cCC--CCCCccccCCCCH------HHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 211 1111111111122 2445788899999999999999997543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=348.45 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=193.8
Q ss_pred HhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
.++|.+.+.||+|+||.||+|. ..+|+.||||++... ....+.+.+|+.+++++ +||||+++++++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------GDEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------SSTTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC------------cccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 4689999999999999999995 467999999998422 12347889999999999 799999999999
Q ss_pred Ec------CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC
Q 043053 781 WN------RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE 854 (1058)
Q Consensus 781 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~ 854 (1058)
.. ....++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence 76 45679999999999999999876556789999999999999999999999 9999999999999999999
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHH
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVV 929 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 929 (1058)
+||+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||....+ ....
T Consensus 168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~ 243 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--MRAL 243 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH
T ss_pred EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHH
Confidence 9999999988654322 2233457999999999876 56788999999999999999999999965421 1111
Q ss_pred HHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
..+...... .......+. .+..++..||+.||++|||+++++++-
T Consensus 244 ~~~~~~~~~----~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 244 FLIPRNPAP----RLKSKKWSK------KFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp HHHHHSCCC----CCSCSCSCH------HHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred HHhhcCccc----cCCccccCH------HHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 111111110 001111222 233477889999999999999999854
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=360.22 Aligned_cols=199 Identities=25% Similarity=0.279 Sum_probs=174.7
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc------CCCccc
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI------RHKNIV 774 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv 774 (1058)
+..+|.+.+.||+|+||+||+| +..+++.||||++... ....+.+.+|+++++.+ .|+||+
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv 162 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------------KRFHRQAAEEIRILEHLRKQDKDNTMNVI 162 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------------HHHHHHHHHHHHHHHHHHTTCTTSCSCBC
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------------cchHHHHHHHHHHHHHHhhccccCCcCEE
Confidence 3467999999999999999999 6667899999998422 23356778888888877 577999
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE 854 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~ 854 (1058)
++++++......++||||+. |+|.+++.......+++..+..|+.||++||+|||+. +||||||||+|||++.++.
T Consensus 163 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~ 238 (429)
T 3kvw_A 163 HMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGR 238 (429)
T ss_dssp CEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTS
T ss_pred EEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCC
Confidence 99999999999999999996 5999999876666799999999999999999999999 9999999999999999987
Q ss_pred --eeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 855 --PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 855 --~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 239 ~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 239 SGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999765432 23467999999999999999999999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=358.07 Aligned_cols=244 Identities=17% Similarity=0.201 Sum_probs=187.4
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHH---HHHcccCCCccccee--
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI---KTLGSIRHKNIVRFL-- 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~~~-- 777 (1058)
++|.+.+.||+|+||+||+|. ..+|+.||||++.... .......+.+.+|+ +.+++++|||||+++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~ 144 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE--------RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC---------CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecc--------ccchHHHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence 578889999999999999995 4679999999985331 12334568899999 555666799999998
Q ss_pred -----eEEEcCCC-----------------ceEEEEecCCCChhhhhhhcC-----CCCCCHHHHHHHHHHHHHHhhccc
Q 043053 778 -----GCCWNRNN-----------------RLLMYDYMPNGSLGSLLHERT-----GNALEWELRYQILLGAAQGLAYLH 830 (1058)
Q Consensus 778 -----~~~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH 830 (1058)
+++.+++. .|+||||+ +|+|.+++.... ...+++..++.|+.||++||+|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 66655432 78999999 679999998632 122345888899999999999999
Q ss_pred ccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccC-----------CCCccc
Q 043053 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-----------KITEKS 899 (1058)
Q Consensus 831 ~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~ 899 (1058)
+. +|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++
T Consensus 224 ~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 294 (377)
T 3byv_A 224 HY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF 294 (377)
T ss_dssp HT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred hC---CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhh
Confidence 99 999999999999999999999999999986432 2335567 999999998887 899999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 043053 900 DVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKD 979 (1058)
Q Consensus 900 DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~ 979 (1058)
|||||||++|||++|+.||........ ....... ....+. .+.+++..||+.||++|||+.+
T Consensus 295 DvwSlG~il~elltg~~Pf~~~~~~~~-----------~~~~~~~-~~~~~~------~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 295 DAWALGLVIYWIWCADLPITKDAALGG-----------SEWIFRS-CKNIPQ------PVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHHHHHHHHHSSCCC------CC-----------SGGGGSS-CCCCCH------HHHHHHHHHTCSSGGGCCCHHH
T ss_pred hHHHHHHHHHHHHHCCCCCcccccccc-----------hhhhhhh-ccCCCH------HHHHHHHHHcCCCchhCCCHHH
Confidence 999999999999999999975422110 0001111 112222 2334778899999999999999
Q ss_pred HHHH
Q 043053 980 VAAM 983 (1058)
Q Consensus 980 v~~~ 983 (1058)
++++
T Consensus 357 ~l~h 360 (377)
T 3byv_A 357 AMET 360 (377)
T ss_dssp HHTS
T ss_pred HhhC
Confidence 9974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=374.07 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=198.4
Q ss_pred cceeccccceEEEEEEe---cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCC
Q 043053 709 ANVIGKGCSGVVYRADM---DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 785 (1058)
.+.||+|+||+||+|.+ ..++.||||++.... ......+++.+|++++++++|||||++++++.. +.
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 443 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 443 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG---------GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc---------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence 35899999999999944 346789999985432 233446889999999999999999999999964 56
Q ss_pred ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
.++||||+++|+|.++++. ...+++..++.|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.
T Consensus 444 ~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp EEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 8999999999999999976 46789999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 866 VDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 866 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+..... .
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~~~~-----~ 591 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKGER-----M 591 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTCC-----C
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC-----C
Confidence 654321 222334557889999999999999999999999999999998 999997542 2233333332211 1
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
......+ .+ +.+++..||+.||++||+++++++.|+++..
T Consensus 592 ~~p~~~~---~~---l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 592 GCPAGCP---RE---MYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCTTCC---HH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCC---HH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111222 22 3447788999999999999999999988754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=361.24 Aligned_cols=203 Identities=25% Similarity=0.360 Sum_probs=156.1
Q ss_pred HHhhccc-cceeccccceEEEEEEec---CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 702 VLKCLVD-ANVIGKGCSGVVYRADMD---NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 702 ~~~~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
+.+.|.+ .++||+|+||+||+|... +++.||||++... .....+.+|+.++++++||||++++
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~~~ 84 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-------------GISMSACREIALLRELKHPNVISLQ 84 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-------------SCCHHHHHHHHHHHHCCCTTBCCCC
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-------------CCCHHHHHHHHHHHhcCCCCeeeEe
Confidence 3456766 568999999999999654 5789999998422 2235788999999999999999999
Q ss_pred eEEEc--CCCceEEEEecCCCChhhhhhhcC-------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEE
Q 043053 778 GCCWN--RNNRLLMYDYMPNGSLGSLLHERT-------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 778 ~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nil 848 (1058)
+++.. ....|+||||+++ +|.+++.... ...+++..++.|+.||+.||+|||+. +|+||||||+|||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIl 160 (405)
T 3rgf_A 85 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANIL 160 (405)
T ss_dssp EEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred eEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeE
Confidence 99964 5667999999965 8888886321 23589999999999999999999999 9999999999999
Q ss_pred E----cCCCCeeeeccccceeccCCCc-ccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 849 I----GLEFEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 849 l----~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+ +.++.+||+|||+++....... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 161 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 161 VMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp ECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9 6778999999999987654221 1233456799999999998874 5899999999999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=337.27 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=195.1
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||.||+|.. .+|+.||||++..... ......+.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--------RSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc--------cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 5789999999999999999954 4799999999854321 122345789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~ 157 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGL 157 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccc
Confidence 99999999999999999999864 5689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+....... ......||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||.... .......+....
T Consensus 158 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~----- 227 (276)
T 2h6d_A 158 SNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--VPTLFKKIRGGV----- 227 (276)
T ss_dssp GGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCC-----
T ss_pred ccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHhhcCc-----
Confidence 98765432 2234568999999999887765 689999999999999999999997532 122222222111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.......+. .+..++.+||+.||++|||+++++++-
T Consensus 228 -~~~~~~~~~------~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 228 -FYIPEYLNR------SVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp -CCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred -ccCchhcCH------HHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 111111122 233477889999999999999999853
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=370.23 Aligned_cols=347 Identities=22% Similarity=0.231 Sum_probs=223.8
Q ss_pred ceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCC
Q 043053 220 EELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTN 299 (1058)
Q Consensus 220 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 299 (1058)
+.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+.+..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 34555555555 3444332 35666666666666555555566666666666666555555555555555555555555
Q ss_pred cccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCC
Q 043053 300 QISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPP 379 (1058)
Q Consensus 300 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 379 (1058)
+++.+ .+..|.++++|++|+|++|++.+..+..|..+++|++|+|++|.+.+..+.
T Consensus 91 ~l~~~------------------------~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 146 (477)
T 2id5_A 91 RLKLI------------------------PLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR 146 (477)
T ss_dssp CCCSC------------------------CTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT
T ss_pred cCCcc------------------------CcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChh
Confidence 55544 444455555566666666666555555555566666666666666655566
Q ss_pred CccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCC
Q 043053 380 EIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGL 459 (1058)
Q Consensus 380 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 459 (1058)
.|.++++|+.|+|++|+++++.+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|..+....+|
T Consensus 147 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L 226 (477)
T 2id5_A 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226 (477)
T ss_dssp SSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC
T ss_pred hccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc
Confidence 66666667777777776666666666666777777777777666666666667777777777766655555555555567
Q ss_pred CeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhcc
Q 043053 460 QVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSC 539 (1058)
Q Consensus 460 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~ 539 (1058)
+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus 227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~------------------ 288 (477)
T 2id5_A 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE------------------ 288 (477)
T ss_dssp SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEEC------------------
T ss_pred cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceEC------------------
Confidence 77777777776444456667777777777777777666667777777777777777776432
Q ss_pred CCCCCCCCccccccccccEEecCCCcccCCCC-cccccCcceeEEEecccccccCCCccccccCCCccccCCcccccCCC
Q 043053 540 NGLTGPIPAQISALNKLSILDLSHNKLEGNLN-PLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRK 618 (1058)
Q Consensus 540 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~ 618 (1058)
|.+|.++++|+.|||++|+|++.++ .+..+++|+.|++++|+|+|.++..+.+++.....+.++...|..|.
T Consensus 289 -------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 289 -------PYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp -------TTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred -------HHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 3345667777888888888777654 45777888888888888888887666666666667778888887664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=340.35 Aligned_cols=252 Identities=29% Similarity=0.390 Sum_probs=195.6
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
+|....+||+|+||.||+| +..+++.||||++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 91 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-----------DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-----------CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-----------chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence 3455669999999999999 4567899999988422 223457899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC-CCCeeeeccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERT-GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-EFEPYIADFG 861 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-~~~~kl~DfG 861 (1058)
+..++||||+++++|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg 168 (295)
T 2clq_A 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFG 168 (295)
T ss_dssp TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecc
Confidence 99999999999999999998643 33567889999999999999999999 9999999999999987 8999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK--ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ 939 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1058)
.++...... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... ....+.....
T Consensus 169 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~--- 241 (295)
T 2clq_A 169 TSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMF--- 241 (295)
T ss_dssp TCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHHHHHH---
T ss_pred cccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHhhccc---
Confidence 998765432 2233557999999999987643 788999999999999999999999643221 1111111111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 VLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...+......+.. +..++.+||+.||++|||+++++++
T Consensus 242 ~~~~~~~~~~~~~------~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 242 KVHPEIPESMSAE------AKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCCCTTSCHH------HHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCHH------HHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122222222222 3347788999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=349.26 Aligned_cols=267 Identities=19% Similarity=0.288 Sum_probs=206.7
Q ss_pred HhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccC------CCCCcccchHHHHHHHHHHHcccCCCcccce
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAAN------GCSDEKSGVRDSFSAEIKTLGSIRHKNIVRF 776 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 776 (1058)
.++|.+.+.||+|+||.||+|.. +|+.||||++......... ..........+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999977 8999999998654321100 0000011223889999999999999999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhh------hhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEE
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSL------LHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILI 849 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill 849 (1058)
++++.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||+|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999999 665446789999999999999999999999 8 99999999999999
Q ss_pred cCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCCCCCCCChh
Q 043053 850 GLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITE-KSDVYSYGVVVLEVLTGKQPIDPTIPDGSH 927 (1058)
Q Consensus 850 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 927 (1058)
+.++.+||+|||.+...... ......||+.|+|||+..+. .++. ++||||+|+++|||++|+.||...... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HH
Confidence 99999999999999876543 23456799999999998877 6666 999999999999999999999765332 22
Q ss_pred HHHHHHhhcCccccC-CCCC------------CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 928 VVDWVRQKKGIQVLD-PSLL------------SRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 928 ~~~~~~~~~~~~~~~-~~~~------------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
....+.......... .... ...+. .+.+++..||+.||++|||++|++++-
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSN------EDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCH------HHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCH------HHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 322222211100000 0000 11111 234578889999999999999999853
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=360.44 Aligned_cols=345 Identities=27% Similarity=0.412 Sum_probs=208.9
Q ss_pred CCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhccccCCChhhhcccccchhhh
Q 043053 47 CVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMR 126 (1058)
Q Consensus 47 l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~ 126 (1058)
+.+|+.|++++|.++ .+|. +..+++|++|+|++|++.+ +|. +.++++|++|++++|.+. .++. ++++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~-~~~-~~~l~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCC-chh-hhccccCCEEECCCCccc-cChh-hcCCCCCCEEE
Confidence 455666666666665 4553 5666666666666666653 333 666666666666666665 3333 66666666666
Q ss_pred cCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCC
Q 043053 127 AGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLS 206 (1058)
Q Consensus 127 l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~ 206 (1058)
+++|. +..++. ++.+++|++|++++|.+.+ ++ .++++++|+.|++.+ .+.+.. .+.++++|+.|++++|.+.
T Consensus 119 L~~n~--l~~~~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~~-~~~~~~--~~~~l~~L~~L~l~~n~l~ 190 (466)
T 1o6v_A 119 LFNNQ--ITDIDP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFGN-QVTDLK--PLANLTTLERLDISSNKVS 190 (466)
T ss_dssp CCSSC--CCCCGG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEEE-SCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred CCCCC--CCCChH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecCC-cccCch--hhccCCCCCEEECcCCcCC
Confidence 66654 333433 6666777777777776653 22 467777777777753 333222 2677777777777777766
Q ss_pred CCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCcccccc
Q 043053 207 GSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLA 286 (1058)
Q Consensus 207 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 286 (1058)
+. ..+..+++|++|++++|.+.+..+ ++.+++|++|++++|.+++. ..+..+++|+.|++++|.+.+..+ +.
T Consensus 191 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~ 262 (466)
T 1o6v_A 191 DI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS 262 (466)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred CC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh
Confidence 32 246677777777777777765433 56677777777777777643 346667777777777777765443 66
Q ss_pred ccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhh
Q 043053 287 NATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKL 366 (1058)
Q Consensus 287 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 366 (1058)
.+++|++|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..| +..+++|++|
T Consensus 263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 336 (466)
T 1o6v_A 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336 (466)
T ss_dssp TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence 66677777777776665433 5555566666666666554433 5556666666666666664433 4455566666
Q ss_pred hccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCC
Q 043053 367 LLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG 423 (1058)
Q Consensus 367 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 423 (1058)
++++|.+++. ..+.++++|+.|++++|++++..| +..+++|++|++++|.+++
T Consensus 337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 6666655543 345555666666666666655544 5555666666666665553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=348.08 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=201.7
Q ss_pred HhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
..+|.+.+.||+|+||+||+|. ..+|+.||||++.... ........+.+|++++++++||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 86 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---------EKEGFPITALREIKILQLLKHENVVNLIEICR 86 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSS---------CSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccc---------ccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence 4789999999999999999994 4689999999885432 22334567889999999999999999999997
Q ss_pred cC--------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 782 NR--------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 782 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
.. +..++||||+++ +|.+.+... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~ 161 (351)
T 3mi9_A 87 TKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDG 161 (351)
T ss_dssp EC--------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred ccccccccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCC
Confidence 64 357999999975 888877654 35689999999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCc--ccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH
Q 043053 854 EPYIADFGLAKLVDDGDF--ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 930 (1058)
.+||+|||+++....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .....
T Consensus 162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~ 239 (351)
T 3mi9_A 162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLA 239 (351)
T ss_dssp CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH
T ss_pred CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHH
Confidence 999999999987653221 223345678999999998876 4579999999999999999999999975421 12222
Q ss_pred HHHhhcCccccCCCCCC----------------CCchhHHHH------HHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 931 WVRQKKGIQVLDPSLLS----------------RPESEIDEM------LQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~----------------~~~~~~~~~------~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.+...... ..+.... ......... ..+.+++.+||+.||++|||++|++++-
T Consensus 240 ~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 240 LISQLCGS--ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp HHHHHHCC--CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHhCC--CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 22211110 0010000 000001111 1245689999999999999999998853
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=356.36 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=190.9
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+|...++||+|+||.||+|.. .+|+.||||++... ...+.+|++++++++|||||++++++..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---------------~~~~~~E~~il~~l~hpniv~l~~~~~~ 118 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---------------KRFKNRELQIMRKLDHCNIVRLRYFFYS 118 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------------TTSCCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc---------------chhHHHHHHHHHHcCCCCccceeeEEec
Confidence 3688999999999999999955 57999999988422 1122479999999999999999999854
Q ss_pred CC------CceEEEEecCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC-C
Q 043053 783 RN------NRLLMYDYMPNGSLGSLLHE--RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE-F 853 (1058)
Q Consensus 783 ~~------~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~-~ 853 (1058)
.. ..++||||+++ ++.+++.. .....+++..++.++.||++||+|||+. +|+||||||+|||++.+ +
T Consensus 119 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~ 194 (420)
T 1j1b_A 119 SGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 194 (420)
T ss_dssp EETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTT
T ss_pred cCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCC
Confidence 21 25789999976 77776653 2356799999999999999999999999 99999999999999965 5
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
.+||+|||+++...... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...+
T Consensus 195 ~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~ 270 (420)
T 1j1b_A 195 VLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEII 270 (420)
T ss_dssp EEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH
T ss_pred eEEeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Confidence 68999999998765432 22346789999999998764 789999999999999999999999975421 11222222
Q ss_pred Hhhc------------Ccc-ccCCCCCCCCchhH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 933 RQKK------------GIQ-VLDPSLLSRPESEI---DEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 933 ~~~~------------~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.... ... ...+.....+.... .....+.+++.+||+.||++|||+.|++++-
T Consensus 271 ~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 271 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 1100 000 00011110000000 0012345688899999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=375.72 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=203.9
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCC 780 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 780 (1058)
.++|.+.++||+|+||.||+| +..+++.||||++.+.... .....+.+..|..++..+ +||+|+++++++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~--------~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI--------QDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH--------HTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc--------cHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 467999999999999999999 5567899999998644221 223356788999999988 699999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
.+.+..|+||||++||+|.++++.. ..+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+||
T Consensus 412 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DF 486 (674)
T 3pfq_A 412 QTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADF 486 (674)
T ss_dssp BCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCC
T ss_pred EeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeec
Confidence 9999999999999999999999874 5699999999999999999999999 9999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
|+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.. ..
T Consensus 487 Gla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~---~~- 558 (674)
T 3pfq_A 487 GMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIME---HN- 558 (674)
T ss_dssp TTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHS---SC-
T ss_pred ceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--HHHHHHHHHh---CC-
Confidence 9998643322 23456789999999999999999999999999999999999999997542 2222222211 11
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM-----KDVAAM 983 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~-----~~v~~~ 983 (1058)
.......+. .+.+++..||+.||++||++ +||.++
T Consensus 559 --~~~p~~~s~------~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 559 --VAYPKSMSK------EAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp --CCCCTTSCH------HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred --CCCCccCCH------HHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 111112222 23457788999999999997 666654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=347.57 Aligned_cols=260 Identities=22% Similarity=0.351 Sum_probs=196.7
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||.||+|.... .||||++.... ......+.+.+|+.++++++||||+++++++.++
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIER---------DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCS---------CCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCC---------CCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 578999999999999999997653 48999885432 1222345677899999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++++|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++ ++.+||+|||++
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred CceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 9999999999999999999864 35789999999999999999999999 999999999999998 789999999998
Q ss_pred eeccCCC---cccccccccCcCCccCcccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHH
Q 043053 864 KLVDDGD---FARSSNTVAGSYGYIAPEYGYM---------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931 (1058)
Q Consensus 864 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 931 (1058)
+...... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~ 254 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--EAIIWQ 254 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--HHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 7543211 1122334568999999998764 4578899999999999999999999975421 122211
Q ss_pred HHhhcCccccCCCCC-CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 932 VRQKKGIQVLDPSLL-SRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 932 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
+.... .+... ...+.. +..++..||+.||++|||++++++.|+++.....
T Consensus 255 ~~~~~-----~~~~~~~~~~~~------l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 255 MGTGM-----KPNLSQIGMGKE------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHTTC-----CCCCCCSSCCTT------HHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred hccCC-----CCCCCcCCCCHH------HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111 11111 112222 2346778999999999999999999998876543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.67 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=195.6
Q ss_pred HhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-----------SEEELEDYIVEIEILATCDHPYIVKLLGAYY 86 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-----------CHHHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence 36899999999999999999954 56899999998532 2234678999999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
.++..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 162 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG 162 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999999999998764 45689999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCcccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYG-----YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
++....... .......||+.|+|||++ .+..++.++||||||+++|+|++|+.||....+ ...........
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~ 238 (302)
T 2j7t_A 163 VSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKSD 238 (302)
T ss_dssp HHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSC
T ss_pred CCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--HHHHHHHhccC
Confidence 975432211 122345689999999987 366788999999999999999999999975421 11111111111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.... ......+. .+..++..||+.||++|||+++++++
T Consensus 239 ~~~~---~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 239 PPTL---LTPSKWSV------EFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CCCC---SSGGGSCH------HHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred Cccc---CCccccCH------HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 00111111 23447888999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=350.74 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=182.2
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||.||+| +..+|+.||||++.... ......+.+.+|+++++.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 378999999999999999999 56789999999985331 23344678889999999999999999999987
Q ss_pred cC------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 782 NR------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 782 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
.. ...|+||||+ +++|.++++. ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCE
Confidence 54 5579999999 7899999875 5689999999999999999999999 99999999999999999999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1058)
||+|||+++..... ....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+..
T Consensus 172 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~ 244 (367)
T 2fst_X 172 KILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILR 244 (367)
T ss_dssp EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHH
T ss_pred EEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH
Confidence 99999999865432 335679999999999876 6789999999999999999999999975421 111111111
Q ss_pred hcCcc---ccC-----------CCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 935 KKGIQ---VLD-----------PSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 935 ~~~~~---~~~-----------~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
..+.. ... ..+...+...... ...+.+++.+||..||++|||++|++++-
T Consensus 245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 10000 000 0000000000111 12345688899999999999999998763
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=344.05 Aligned_cols=253 Identities=22% Similarity=0.261 Sum_probs=197.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 781 (1058)
++|.+.+.||+|+||+||+| +..+++.||||++... ..+.+.+|++++++++ ||||+++++++.
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--------------KKKKIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--------------CHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--------------chHHHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 68999999999999999999 5678999999998422 2477899999999997 999999999998
Q ss_pred c--CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-Ceeee
Q 043053 782 N--RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-EPYIA 858 (1058)
Q Consensus 782 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~ 858 (1058)
+ ....++||||+++++|.++++. +++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 102 ~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 102 DPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp CTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEE
Confidence 7 5667999999999999999853 78899999999999999999999 999999999999999777 89999
Q ss_pred ccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc-
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK- 936 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~- 936 (1058)
|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..................
T Consensus 174 Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~ 250 (330)
T 3nsz_A 174 DWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250 (330)
T ss_dssp CCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred eCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCC
Confidence 999998765432 2345578999999999876 67899999999999999999999999654332222211111000
Q ss_pred ---------CccccCC----------------CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 ---------GIQVLDP----------------SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ---------~~~~~~~----------------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.....++ .......... ...+.+++..||++||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV--SPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGC--CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhhHHHHhccccccchhhhhhhccccchhhhccccccccC--CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 0000000001 1234458889999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=337.48 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=187.7
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||+||+| +..+|+.||||++.... ......+.+.++...++.++||||+++++++.+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---------NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc---------CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 68999999999999999999 45689999999985431 122334455566666888999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHE--RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
++..++||||+++ +|.+++.. .....+++..++.++.|++.||+|||++ .+|+||||||+||+++.++.+||+||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Df 154 (290)
T 3fme_A 78 EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDF 154 (290)
T ss_dssp SSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred cCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999975 99888764 2356799999999999999999999985 28999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCcccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYG----YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|+++...... ......||+.|+|||++ .+..++.++||||+|+++|||++|+.||..................
T Consensus 155 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (290)
T 3fme_A 155 GISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred CCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence 9998765432 22344699999999995 5667889999999999999999999999754222222222211111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
........+. .+.+++..||+.||++|||++|++++-.
T Consensus 232 -----~~~~~~~~~~------~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 232 -----PQLPADKFSA------EFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp -----CCCCTTTSCH------HHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred -----CCcccccCCH------HHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 0000111222 2345778899999999999999998543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=346.27 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=185.2
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 781 (1058)
.+|.+.++||+|+||.||+|. ..+++.||||++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----------EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----------SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----------chHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 478999999999999999994 567999999988422 2334578899999999996 999999999985
Q ss_pred c--------CCCceEEEEecCCCChhhhhhhc-CCCCCCHHHHHHHHHHHHHHhhcccccCCCC--eEeCCCCCCcEEEc
Q 043053 782 N--------RNNRLLMYDYMPNGSLGSLLHER-TGNALEWELRYQILLGAAQGLAYLHHDCVPP--IVHRDIKANNILIG 850 (1058)
Q Consensus 782 ~--------~~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDikp~Nill~ 850 (1058)
. ....++||||+. |+|.+++... ....+++..++.++.|++.||+|||+. + |+||||||+||+++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~ 172 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLS 172 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEEC
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEEC
Confidence 2 334689999996 6999998752 346799999999999999999999998 7 99999999999999
Q ss_pred CCCCeeeeccccceeccCCCcc----------cccccccCcCCccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCC
Q 043053 851 LEFEPYIADFGLAKLVDDGDFA----------RSSNTVAGSYGYIAPEYG---YMMKITEKSDVYSYGVVVLEVLTGKQP 917 (1058)
Q Consensus 851 ~~~~~kl~DfGl~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvvl~elltg~~P 917 (1058)
.++.+||+|||+++........ .......||+.|+|||++ .+..++.++|||||||++|||++|+.|
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 252 (337)
T 3ll6_A 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252 (337)
T ss_dssp TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 9999999999999876543211 111245689999999988 566788999999999999999999999
Q ss_pred CCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 918 IDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
|...... ....... ........+.. +..++..||+.||++|||++|++++|+++...
T Consensus 253 ~~~~~~~-----~~~~~~~-----~~~~~~~~~~~------~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 253 FEDGAKL-----RIVNGKY-----SIPPHDTQYTV------FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp C-----------------C-----CCCTTCCSSGG------GHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcchhHH-----HhhcCcc-----cCCcccccchH------HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9643211 1111111 11111111222 23477889999999999999999999988654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.33 Aligned_cols=257 Identities=12% Similarity=0.038 Sum_probs=180.5
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc--CCCccccee---
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI--RHKNIVRFL--- 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~--- 777 (1058)
..|...+.||+|+||.||+|. ..+|+.||||++..... ......+.+.+|+.+++.+ +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~ 133 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE--------NSRSELERLHEATFAAARLLGESPEEARDRRRL 133 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST--------THHHHHHHHHHHHHHHHHHHC----------CB
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc--------ccccHHHHHHHHHHHHHHhcccChhhhhhceeE
Confidence 458899999999999999995 55899999999864321 1234456788885544444 699988755
Q ss_pred ----eEEEcCC-----------------CceEEEEecCCCChhhhhhhcCCCCCCHHHH------HHHHHHHHHHhhccc
Q 043053 778 ----GCCWNRN-----------------NRLLMYDYMPNGSLGSLLHERTGNALEWELR------YQILLGAAQGLAYLH 830 (1058)
Q Consensus 778 ----~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~i~~~l~~LH 830 (1058)
+++..+. ..|+||||++ |+|.++++... ..+++..+ ..++.||++||+|||
T Consensus 134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 4444332 2699999998 79999998642 34466666 788899999999999
Q ss_pred ccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCcccccc--CCCCcccchhhHHHHH
Q 043053 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVV 908 (1058)
Q Consensus 831 ~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl 908 (1058)
++ +|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++
T Consensus 212 ~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 212 SK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp HT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred HC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 99 9999999999999999999999999999876431 114457799999999987 6789999999999999
Q ss_pred HHHHhCCCCCCCCCCCChhHHHHHH-hhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 909 LEVLTGKQPIDPTIPDGSHVVDWVR-QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 909 ~elltg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
|||++|+.||....+.......... ................+. .+.+++.+||+.||++|||+++++++-
T Consensus 284 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD------FVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp HHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCH------HHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred HHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCH------HHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 9999999999866432211000000 000000000000111122 234478889999999999999998743
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=347.12 Aligned_cols=255 Identities=23% Similarity=0.268 Sum_probs=171.6
Q ss_pred HHhhcccc-ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 702 VLKCLVDA-NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 702 ~~~~~~~~-~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
+.++|.+. ++||+|+||+||+| +..+|+.||||++... ..........++.+.||||++++++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------------~~~~~e~~~~~~~~~h~~i~~~~~~ 90 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---------------PKARQEVDHHWQASGGPHIVCILDV 90 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---------------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---------------HHHHHHHHHHHHhcCCCChHHHHHH
Confidence 44678885 57999999999999 5557999999998421 1122223334566789999999999
Q ss_pred EEc----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC---
Q 043053 780 CWN----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE--- 852 (1058)
Q Consensus 780 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~--- 852 (1058)
+.. ....++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~ 167 (336)
T 3fhr_A 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKD 167 (336)
T ss_dssp EEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTT
T ss_pred HhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCC
Confidence 876 34479999999999999999876566899999999999999999999999 99999999999999864
Q ss_pred CCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
+.+||+|||+++..... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......... ...
T Consensus 168 ~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~ 242 (336)
T 3fhr_A 168 AVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-GMK 242 (336)
T ss_dssp CCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred ceEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-hHH
Confidence 45999999999866542 2335568999999999988889999999999999999999999997543221100 000
Q ss_pred Hhhc-CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 933 RQKK-GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 933 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
.... .............+. .+.+++..||+.||++|||++|++++-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~------~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 243 RRIRLGQYGFPNPEWSEVSE------DAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp --------CCCTTTSTTCCH------HHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HhhhccccccCchhhccCCH------HHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0000 000011111111222 2334778899999999999999998654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.92 Aligned_cols=257 Identities=23% Similarity=0.280 Sum_probs=203.6
Q ss_pred HHHHhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
..+.++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+.+|++++++++||||+++++
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS---------AKNKDTSTILREVELLKKLDHPNIMKLFE 88 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---------BSSSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccc---------cchHHHHHHHHHHHHHHhccCCCccEEEE
Confidence 55678999999999999999999954 579999999985432 12334678999999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC---CCe
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE---FEP 855 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~---~~~ 855 (1058)
++.+.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.+ +.+
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 89 ILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred EEeCCCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccE
Confidence 999999999999999999999998764 4689999999999999999999999 99999999999999764 469
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+|||++....... ......||+.|+|||++.+. ++.++||||+|+++|+|++|+.||.... .......+...
T Consensus 164 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~ 237 (287)
T 2wei_A 164 KIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETG 237 (287)
T ss_dssp EECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC
T ss_pred EEeccCcceeecCCC---ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcC
Confidence 999999998665432 22344689999999987754 8899999999999999999999997542 22222222221
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
. ...+.......+. .+.+++..||+.||++|||+++++++-
T Consensus 238 ~--~~~~~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 238 K--YAFDLPQWRTISD------DAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp C--CCCCSGGGTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred C--CCCCchhhhhcCH------HHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 1 1111111111222 234578889999999999999999853
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=357.85 Aligned_cols=345 Identities=29% Similarity=0.446 Sum_probs=208.9
Q ss_pred cccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEE
Q 043053 119 LSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSL 198 (1058)
Q Consensus 119 l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L 198 (1058)
+.+|+.|++.++. ...+| .+..+++|++|++++|.+.+. +. ++++++|++|++++|.+.+..+ ++++++|++|
T Consensus 45 l~~l~~L~l~~~~--i~~l~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 117 (466)
T 1o6v_A 45 LDQVTTLQADRLG--IKSID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117 (466)
T ss_dssp HHTCCEEECCSSC--CCCCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred hccccEEecCCCC--CccCc-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence 4555555555554 33444 255566666666666666533 22 6666667777776666664433 6666777777
Q ss_pred EccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccC
Q 043053 199 FLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVS 278 (1058)
Q Consensus 199 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 278 (1058)
++++|.+++. +. +..+++|++|++++|.+.+. ..+..+++|++|+++ |.+.+.. .+..+++|++|++++|.+.
T Consensus 118 ~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~ 190 (466)
T 1o6v_A 118 TLFNNQITDI-DP-LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS 190 (466)
T ss_dssp ECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECCC--GGGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCC-hH-HcCCCCCCEEECCCCccCCC--hhhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC
Confidence 7777766643 22 66666777777777666642 236666677777765 3443322 2666666777777776665
Q ss_pred CCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCccccc
Q 043053 279 GSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLF 358 (1058)
Q Consensus 279 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 358 (1058)
+. ..+..+++|++|++++|++.+..+ ++.+++|++|++++|++++. ..+..+++|+.|++++|.+.+..+ +.
T Consensus 191 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~ 262 (466)
T 1o6v_A 191 DI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS 262 (466)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred CC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh
Confidence 43 235666666666666666665543 55566666666666666543 345666666666666666664333 55
Q ss_pred ccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchh
Q 043053 359 QLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMI 438 (1058)
Q Consensus 359 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 438 (1058)
.+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|++|+|++|++++..| +..+++|+.|
T Consensus 263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 336 (466)
T 1o6v_A 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336 (466)
T ss_dssp TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence 56666666666666664333 5666666666666666665543 5666666666666666665444 5566666666
Q ss_pred hccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCC
Q 043053 439 DLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495 (1058)
Q Consensus 439 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 495 (1058)
++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 6666666653 346666666666666666665554 5666666666666666664
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=356.50 Aligned_cols=362 Identities=20% Similarity=0.257 Sum_probs=186.8
Q ss_pred ccccccccchhhhHHhhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCcccc
Q 043053 87 KIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLG 166 (1058)
Q Consensus 87 ~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~ 166 (1058)
..+..++++++|++|++++|.+. .+| .++++++|++|++++|. +..+| ++.+++|++|++++|++.+. + ++
T Consensus 33 ~~~~~~~~l~~L~~L~Ls~n~l~-~~~-~l~~l~~L~~L~Ls~n~--l~~~~--~~~l~~L~~L~Ls~N~l~~~-~--~~ 103 (457)
T 3bz5_A 33 TDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN--ITTLD--LSQNTNLTYLACDSNKLTNL-D--VT 103 (457)
T ss_dssp TSEEEHHHHTTCCEEECCSSCCC-CCT-TGGGCTTCSEEECCSSC--CSCCC--CTTCTTCSEEECCSSCCSCC-C--CT
T ss_pred ccccChhHcCCCCEEEccCCCcc-cCh-hhcccCCCCEEEccCCc--CCeEc--cccCCCCCEEECcCCCCcee-e--cC
Confidence 33444455555555555555554 233 34455555555555544 22332 44445555555555544432 1 44
Q ss_pred CCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEE
Q 043053 167 KLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMI 246 (1058)
Q Consensus 167 ~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 246 (1058)
++++|++|++++|.+++ ++ ++.+++|++|++++|.+++. + ++.+++|++|++++|...+.+ .+..+++|++|
T Consensus 104 ~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L 175 (457)
T 3bz5_A 104 PLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTL 175 (457)
T ss_dssp TCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEE
Confidence 44455555555554443 22 44444555555555544431 1 444444555555544332222 24444445555
Q ss_pred EeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccC
Q 043053 247 DFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLE 326 (1058)
Q Consensus 247 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 326 (1058)
++++|++++ +| ++.+++|+.|++++|.+++. .+..+++|++|++++|+++++ | ++.+++|+.|++++|+++
T Consensus 176 ~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~ 246 (457)
T 3bz5_A 176 DCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLT 246 (457)
T ss_dssp ECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCS
T ss_pred ECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCC
Confidence 555554443 22 44444445555544444432 244444444444444444442 2 444444444444444444
Q ss_pred CCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCcccccc
Q 043053 327 GSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIG 406 (1058)
Q Consensus 327 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 406 (1058)
+.. +..+++|+.|++++| +|+.|++++|.+.+.+| ++.+++|+.|++++|.+.+..|.
T Consensus 247 ~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~--- 304 (457)
T 3bz5_A 247 ELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC--- 304 (457)
T ss_dssp CCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---
T ss_pred CcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---
Confidence 332 223333444443333 23344555555544443 34556666666666655444332
Q ss_pred CccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCccccccccccccc
Q 043053 407 GLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKI 486 (1058)
Q Consensus 407 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 486 (1058)
...+|+.|++++| ++|+.|++++|+|++. + ++++++|+.|++++|+|++ ++.|..|
T Consensus 305 ~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L 360 (457)
T 3bz5_A 305 QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKI 360 (457)
T ss_dssp TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGS
T ss_pred CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccc
Confidence 2334444444433 6778888888888874 3 7788888888888888874 2466777
Q ss_pred ccccccCCCCCCCcccCCcccccccccCCcccCCCChhh
Q 043053 487 ILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMEL 525 (1058)
Q Consensus 487 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~ 525 (1058)
++++|.+.|. ..+..|..+++++|+++|.+|..+
T Consensus 361 ~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 361 PALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp SGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred cccCCcEEec-----ceeeecCccccccCcEEEEcChhH
Confidence 7888888764 345667778888888888777664
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=352.10 Aligned_cols=275 Identities=20% Similarity=0.204 Sum_probs=194.8
Q ss_pred HHHHhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
..+.++|.+.+.||+|+||.||+|...+|+.||||++...................+.+.+|++++++++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 44557899999999999999999977779999999986543211100001122334789999999999999999999999
Q ss_pred EEcC-----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCC
Q 043053 780 CWNR-----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFE 854 (1058)
Q Consensus 780 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~ 854 (1058)
+... ...|+||||++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNND 172 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCC
Confidence 8543 24699999997 5898888754 45789999999999999999999999 9999999999999999999
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ........
T Consensus 173 ~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~ 248 (362)
T 3pg1_A 173 ITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLNKIVE 248 (362)
T ss_dssp EEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred EEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 999999999754432 22345678999999998876 67899999999999999999999999754211 11111111
Q ss_pred hhcCc--------------cccCCCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 934 QKKGI--------------QVLDPSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 934 ~~~~~--------------~~~~~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..... ..........+...... ...+.+++..||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00000 00000000000000000 1124458889999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.41 Aligned_cols=263 Identities=23% Similarity=0.309 Sum_probs=203.5
Q ss_pred HHHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceee
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLG 778 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~ 778 (1058)
...++|...+.||+|+||.||+|. ..+|+.||||++........ .........+.+.+|+++++++. ||||+++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF--SAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTC--CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEeccccccc--CHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 445789999999999999999994 45789999999854321000 00011234577889999999996 999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++..+...++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999999864 5789999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHH
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY------MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 932 (1058)
|||++....... ......|++.|+|||++. ...++.++||||+|+++|||++|+.||.... .......+
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~ 241 (298)
T 1phk_A 167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMI 241 (298)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH
T ss_pred cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--HHHHHHHH
Confidence 999998765432 233557899999999875 4567889999999999999999999997532 12222222
Q ss_pred HhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 933 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.... .. .........+ . .+.+++.+||+.||++|||+++++++
T Consensus 242 ~~~~-~~-~~~~~~~~~~---~---~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 242 MSGN-YQ-FGSPEWDDYS---D---TVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHTC-CC-CCTTTGGGSC---H---HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hcCC-cc-cCcccccccC---H---HHHHHHHHHccCCcccCCCHHHHHhC
Confidence 2111 11 1111011111 1 23457888999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=369.50 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=203.8
Q ss_pred hhccccceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.+.||+|+||.||+|... .+..||||++... ......+.+.+|+.++++++||||++++++
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC----------TSDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST----------TCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc----------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 67899999999999999999553 3567999987432 233456789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+. ++..|+||||+++|+|.++++.. ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEe
Confidence 85 46689999999999999999864 45689999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.... .......+.....
T Consensus 535 FG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--~~~~~~~i~~~~~- 610 (656)
T 2j0j_A 535 FGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGER- 610 (656)
T ss_dssp CCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHHTCC-
T ss_pred cCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCC-
Confidence 999987654332 22234557889999999998899999999999999999997 999997542 2223332322211
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
+......+. .+.+++..||+.||++|||+.++++.|+.+..+
T Consensus 611 ----~~~~~~~~~------~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 611 ----LPMPPNCPP------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCccccH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 111122222 233478889999999999999999999988654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=346.44 Aligned_cols=263 Identities=24% Similarity=0.280 Sum_probs=198.6
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+|.+.+.||+|+||.||+| +..+++.||||++... ......+.+.+|++++++++||||+++++++..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----------EHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT----------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc----------cCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 58999999999999999999 5568899999998532 233445788999999999999999999999976
Q ss_pred C-----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeee
Q 043053 783 R-----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857 (1058)
Q Consensus 783 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl 857 (1058)
. ...|+||||+++ +|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 97 ~~~~~~~~~~iv~e~~~~-~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLMET-DLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp SSTTTCCCEEEEEECCSE-EHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred CCccccceEEEEEcccCc-CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEE
Confidence 4 357999999974 99999975 4589999999999999999999999 9999999999999999999999
Q ss_pred eccccceeccCCCc-ccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 858 ADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
+|||+++....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .........
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~ 248 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGIL 248 (364)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHH
T ss_pred EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHh
Confidence 99999987654321 112345679999999998654 458999999999999999999999997543211 111111100
Q ss_pred cCcc----------------ccCCCCCCCCchhH--HHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 936 KGIQ----------------VLDPSLLSRPESEI--DEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 936 ~~~~----------------~~~~~~~~~~~~~~--~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.... ...+.....+.... .....+.+++.+||+.||++|||++|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0000 00000000000000 0011345688899999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=344.54 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=195.5
Q ss_pred HhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||.||+|. ..+|+.||||++... ........+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 79 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----------DKPLFALRTLREIKILKHFKHENIITIFNIQR 79 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc----------ccchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence 3689999999999999999994 457999999998432 23344677889999999999999999999887
Q ss_pred cC-----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 782 NR-----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 782 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
.. ...++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp CSCSTTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEE
T ss_pred ccccCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEE
Confidence 54 56799999997 599999876 4689999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcc--------cccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChh
Q 043053 857 IADFGLAKLVDDGDFA--------RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSH 927 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~ 927 (1058)
|+|||+++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ..
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~ 230 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY--RH 230 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HH
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc--HH
Confidence 9999999876542211 11234578999999998654 6789999999999999999999999975421 11
Q ss_pred HHHHHHhhcCccccCC---------------CCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 928 VVDWVRQKKGIQVLDP---------------SLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 928 ~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
....+.........+. .....+..... ....+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111111000000000 00000000000 01123458889999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=352.24 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=192.3
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
..++|.+.+.||+|+||+||+| +..+|+.||||++.... ....+|+++++.++||||+++++++
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---------------~~~~~E~~il~~l~hpnIv~l~~~~ 69 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---------------RYKNRELDIMKVLDHVNIIKLVDYF 69 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---------------TSCCHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---------------chHHHHHHHHHHcCCCCccchhhee
Confidence 3468999999999999999999 56789999999884221 1123799999999999999999998
Q ss_pred EcC--------------------------------------CCceEEEEecCCCChhhhhhh--cCCCCCCHHHHHHHHH
Q 043053 781 WNR--------------------------------------NNRLLMYDYMPNGSLGSLLHE--RTGNALEWELRYQILL 820 (1058)
Q Consensus 781 ~~~--------------------------------------~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ 820 (1058)
... ...++||||+++ +|.+.+.. .....+++..+..++.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIY 148 (383)
T ss_dssp EEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence 543 236899999984 88888764 2357799999999999
Q ss_pred HHHHHhhcccccCCCCeEeCCCCCCcEEEc-CCCCeeeeccccceeccCCCcccccccccCcCCccCccccccC-CCCcc
Q 043053 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIG-LEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEK 898 (1058)
Q Consensus 821 ~i~~~l~~LH~~~~~~ivHrDikp~Nill~-~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 898 (1058)
|+++||+|||+. +|+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.+
T Consensus 149 qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~ 222 (383)
T 3eb0_A 149 QLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPS 222 (383)
T ss_dssp HHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred HHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcc
Confidence 999999999999 999999999999998 68899999999998765432 23355789999999988765 48999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC------------ccc-cCCCCCCC------CchhHHHHHHH
Q 043053 899 SDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG------------IQV-LDPSLLSR------PESEIDEMLQA 959 (1058)
Q Consensus 899 ~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~------------~~~-~~~~~~~~------~~~~~~~~~~~ 959 (1058)
+||||+||++|||++|+.||..... .......+..... ... .-+..... +.... ..+
T Consensus 223 ~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 298 (383)
T 3eb0_A 223 IDLWSIGCVFGELILGKPLFSGETS-IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP---SLA 298 (383)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCC---HHH
T ss_pred hhhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCC---HHH
Confidence 9999999999999999999975421 1122221111000 000 00000000 00001 124
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHH
Q 043053 960 LGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 960 ~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+++.+||+.||++|||+.|++++
T Consensus 299 ~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 299 IDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhhCCCHHHHhcC
Confidence 558888999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=343.87 Aligned_cols=197 Identities=20% Similarity=0.282 Sum_probs=173.4
Q ss_pred hhccccceeccccceEEEEEEe--cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCc------ccc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM--DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKN------IVR 775 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~ 775 (1058)
++|.+.+.||+|+||+||+|.. .+++.||||++.. .....+.+.+|+++++.++|++ |++
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------------~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN------------VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------------SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec------------CCchhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 6899999999999999999954 4789999999842 2234577889999999987654 999
Q ss_pred eeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC----
Q 043053 776 FLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL---- 851 (1058)
Q Consensus 776 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~---- 851 (1058)
+++++...+..++||||+ +++|.+++.......+++..+..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccc
Confidence 999999999999999999 88999999876556789999999999999999999999 9999999999999987
Q ss_pred ---------------CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCC
Q 043053 852 ---------------EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQ 916 (1058)
Q Consensus 852 ---------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~ 916 (1058)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 668999999999865432 234579999999999999999999999999999999999999
Q ss_pred CCCCC
Q 043053 917 PIDPT 921 (1058)
Q Consensus 917 P~~~~ 921 (1058)
||...
T Consensus 233 pf~~~ 237 (339)
T 1z57_A 233 VFPTH 237 (339)
T ss_dssp SCCCS
T ss_pred CCCCC
Confidence 99754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.47 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=191.5
Q ss_pred HHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.++|...+.||+|+||.||+|. ..+++.||||++.. .....+.+.+|+.++++++||||+++++++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 71 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------------TEEKLSTILSEVMLLASLNHQYVVRYYAAW 71 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------------cHHHHHHHHHHHHHHHhcCchHHHHHHHHH
Confidence 56789999999999999999995 46899999999842 223457899999999999999999999988
Q ss_pred Ec-------------CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcE
Q 043053 781 WN-------------RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNI 847 (1058)
Q Consensus 781 ~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Ni 847 (1058)
.+ ....++||||+++|+|.++++.. ...+++..++.++.|+++||+|||+. +|+||||||+||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Ni 147 (303)
T 1zy4_A 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNI 147 (303)
T ss_dssp EECCCCCC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred HhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhE
Confidence 65 34568999999999999999864 45678899999999999999999999 999999999999
Q ss_pred EEcCCCCeeeeccccceeccCCCc------------ccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhC
Q 043053 848 LIGLEFEPYIADFGLAKLVDDGDF------------ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTG 914 (1058)
Q Consensus 848 ll~~~~~~kl~DfGl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg 914 (1058)
+++.++.+||+|||+++....... ........||+.|+|||++.+. .++.++||||+||++|||++
T Consensus 148 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~- 226 (303)
T 1zy4_A 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY- 226 (303)
T ss_dssp EECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred EEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence 999999999999999986543210 1223455689999999998764 68999999999999999998
Q ss_pred CCCCCCCCCCChhHHHHHHhhcCc-cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 915 KQPIDPTIPDGSHVVDWVRQKKGI-QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 915 ~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
||... ............. ....+......+. .+..++..||+.||++|||+++++++-
T Consensus 227 --p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 227 --PFSTG----MERVNILKKLRSVSIEFPPDFDDNKMK------VEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp --CCSSH----HHHHHHHHHHHSTTCCCCTTCCTTTSH------HHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred --ccCCc----hhHHHHHHhccccccccCccccccchH------HHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 55421 1111222221111 1111222111111 223478889999999999999999854
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=346.45 Aligned_cols=201 Identities=24% Similarity=0.278 Sum_probs=172.7
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CC-----ccc
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HK-----NIV 774 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv 774 (1058)
+.++|.+.+.||+|+||+||+| +..+++.||||++.. ......++.+|+.+++.++ |+ +|+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv 119 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN------------KKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS------------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec------------cHHHHHHHHHHHHHHHHHHhcccccceeEE
Confidence 3578999999999999999999 556789999999842 2234567788999988885 55 499
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc--CC
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG--LE 852 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~--~~ 852 (1058)
++++++...+..++||||++ |+|.+++.......+++..+..++.|++.||+|||.+ ..+||||||||+|||++ .+
T Consensus 120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTS
T ss_pred EeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCC
Confidence 99999999999999999996 5999999876556799999999999999999999952 12999999999999995 47
Q ss_pred CCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 853 FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 853 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 198 ~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 78999999999876432 23567999999999999999999999999999999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=340.18 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=194.6
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC--CCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR--HKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~ 781 (1058)
++|.+.+.||+|+||.||+|...+++.||||++.... ......+.+.+|++++++++ ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS---------CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc---------ccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 5799999999999999999987889999999985331 23345678999999999997 599999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
.++..++||| +.+++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++ ++.+||+|||
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg 171 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG 171 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeecc
Confidence 9999999999 5688999999864 5789999999999999999999999 999999999999996 5899999999
Q ss_pred cceeccCCCcccccccccCcCCccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-----------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 930 (1058)
+++...............||+.|+|||++.+ ..++.++||||||+++|||++|+.||............
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 9987654332223345679999999998765 46788999999999999999999999754322111111
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
..... .........+. .+..++.+||+.||++||++++++++..
T Consensus 252 ~~~~~-----~~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 252 IIDPN-----HEIEFPDIPEK------DLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHCTT-----SCCCCCCCSCH------HHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHhcc-----cccCCcccchH------HHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 11110 11111112222 2334778899999999999999998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=352.94 Aligned_cols=200 Identities=23% Similarity=0.294 Sum_probs=172.5
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC--------CCcc
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR--------HKNI 773 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~ni 773 (1058)
.++|.+.+.||+|+||+||+| +..+++.||||++.. .....+.+.+|++++++++ |+||
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS------------AEHYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------------CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec------------CCcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 368999999999999999999 566789999999842 2334678899999999996 7889
Q ss_pred cceeeEEE----cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE
Q 043053 774 VRFLGCCW----NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI 849 (1058)
Q Consensus 774 v~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill 849 (1058)
+++++++. .....++||||+ +|++.+++.......+++..++.++.||++||+|||+++ +|+||||||+|||+
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll 180 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL 180 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEE
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeE
Confidence 99999987 456789999999 667777776654567999999999999999999999853 89999999999999
Q ss_pred cCCC-------------------------------------------------CeeeeccccceeccCCCcccccccccC
Q 043053 850 GLEF-------------------------------------------------EPYIADFGLAKLVDDGDFARSSNTVAG 880 (1058)
Q Consensus 850 ~~~~-------------------------------------------------~~kl~DfGl~~~~~~~~~~~~~~~~~g 880 (1058)
+.++ .+||+|||+++..... .....|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~g 255 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQ 255 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCS
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCC
Confidence 9775 7999999999876432 234579
Q ss_pred cCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 043053 881 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI 922 (1058)
Q Consensus 881 t~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~ 922 (1058)
|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999999999999999999999999999999997654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=346.05 Aligned_cols=259 Identities=24% Similarity=0.302 Sum_probs=194.5
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||.||+| +..+|+.||||++.... ......+.+.+|+.++++++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT---------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc---------cchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 368999999999999999999 56689999999985331 23345678899999999999999999999998
Q ss_pred cCCCc------eEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 782 NRNNR------LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 782 ~~~~~------~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
..+.. ++||||++ |+|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~ 183 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCEL 183 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCE
Confidence 76654 99999997 58888874 3489999999999999999999999 99999999999999999999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHh
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1058)
||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .........
T Consensus 184 kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~ 257 (371)
T 4exu_A 184 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKV 257 (371)
T ss_dssp EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHH
T ss_pred EEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH
Confidence 99999999865432 235578999999999877 67899999999999999999999999754211 111111110
Q ss_pred hcCc-cccC------------CCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 935 KKGI-QVLD------------PSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 935 ~~~~-~~~~------------~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.... .... ......+...... ...+.+++..||+.||++|||++|++++-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 0000 0000 0000000000000 12345588899999999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=338.66 Aligned_cols=259 Identities=22% Similarity=0.313 Sum_probs=197.5
Q ss_pred hhccccceeccccceEEEEEEe--cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc---CCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM--DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI---RHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~ 778 (1058)
++|.+.+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+.+++.+ +||||+++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~ 81 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---------EEGMPLSTIREVAVLRHLETFEHPNVVRLFD 81 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC---------TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc---------cccCCchhhHHHHHHHhhhccCCCCeEeeee
Confidence 6899999999999999999965 5688999999854321 112234566777777766 8999999999
Q ss_pred EEE-----cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 779 CCW-----NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 779 ~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
++. .....++||||++ |+|.+++.......+++..++.++.|+++||+|||+. ||+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 82 VCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 157 (326)
T ss_dssp EEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred eeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCC
Confidence 987 4566799999998 5999999876556799999999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
.+||+|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.
T Consensus 158 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~ 232 (326)
T 1blx_A 158 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKIL 232 (326)
T ss_dssp CEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHH
T ss_pred CEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHH
Confidence 9999999999865432 233456789999999999988999999999999999999999999975421 11111111
Q ss_pred hhcCc---cccC---------------CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 934 QKKGI---QVLD---------------PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 934 ~~~~~---~~~~---------------~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..... .... ............ .+.+++.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE---LGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCH---HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcCCCCcccCccccccchhhhcccCcchhhhccccCCH---HHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11000 0000 000000011111 23357888999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=350.25 Aligned_cols=258 Identities=21% Similarity=0.305 Sum_probs=191.0
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.+|...++||+|+||+||+|....+..||+|++.... ....+|+++++.++||||+++++++...
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~---------------~~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---------------RFKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT---------------TSCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc---------------chHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 5799999999999999999987777779999884321 1123799999999999999999999654
Q ss_pred CC------ceEEEEecCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc-CCCC
Q 043053 784 NN------RLLMYDYMPNGSLGSLLHE--RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG-LEFE 854 (1058)
Q Consensus 784 ~~------~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~-~~~~ 854 (1058)
.. .++||||++++ +.+.+.. .....+++..++.++.|+++||+|||+. +|+||||||+|||++ .++.
T Consensus 105 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~ 180 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGV 180 (394)
T ss_dssp SSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred CCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCc
Confidence 33 68999999874 4443331 2246789999999999999999999999 999999999999999 7899
Q ss_pred eeeeccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 855 PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 855 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+...++
T Consensus 181 ~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~ 256 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIK 256 (394)
T ss_dssp EEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH
T ss_pred EEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH
Confidence 9999999998765432 23356789999999988764 589999999999999999999999975421 112222111
Q ss_pred hhc----------CccccCCCCCCCCchhHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 934 QKK----------GIQVLDPSLLSRPESEID------EMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 934 ~~~----------~~~~~~~~~~~~~~~~~~------~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
... .................. ....+.+++.+||+.||++|||+.|++++-
T Consensus 257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 100 000000111100000000 011345688899999999999999999853
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=359.89 Aligned_cols=301 Identities=22% Similarity=0.208 Sum_probs=158.5
Q ss_pred CccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecc
Q 043053 194 ELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMIS 273 (1058)
Q Consensus 194 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 273 (1058)
+++.|+|++|.+++..+..|.++++|++|+|++|.+.+..|..|.++++|++|+|++|++++..+..|.++++|++|+++
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 112 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS 112 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence 34444444444443333444444444444444444443334444444444444444444443333334444444444444
Q ss_pred cCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccC
Q 043053 274 DNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASV 353 (1058)
Q Consensus 274 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 353 (1058)
+|.+.+..+..|..+++|++|+|++|.+.++.+..|..+++|++|++++|++++..+..|..+++|+.|++++|.+.+..
T Consensus 113 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~ 192 (477)
T 2id5_A 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR 192 (477)
T ss_dssp TSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEEC
T ss_pred CCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeC
Confidence 44444444444444444444444444444444444455555555555555555444455556666666666666666555
Q ss_pred cccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCc
Q 043053 354 PAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCT 433 (1058)
Q Consensus 354 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 433 (1058)
+..|..+++|++|++++|.+.+.++..+....+|+.|+|++|+|+++.+..|..+++|++|+|++|.+++..+..|..++
T Consensus 193 ~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 272 (477)
T 2id5_A 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272 (477)
T ss_dssp TTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCT
T ss_pred hhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccc
Confidence 55555555556666655555544444444445666666666666655545566666666666666666655555566666
Q ss_pred ccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCC
Q 043053 434 ELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFS 494 (1058)
Q Consensus 434 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 494 (1058)
+|+.|+|++|+++++.|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 273 RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp TCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred cCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 6666666666666555556666666666666666665544445555555555555555554
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=339.85 Aligned_cols=253 Identities=24% Similarity=0.295 Sum_probs=192.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+| +..+|+.||||++.... ......+.+.+|+.++++++||||+++++++..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 94 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 94 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---------cchHHHHHHHHHHHHHHhcCCCCcccHhheEec
Confidence 67899999999999999999 55679999999985331 233446788999999999999999999999987
Q ss_pred CCC------ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 783 RNN------RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 783 ~~~------~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
... .++||||++ |+|.+++.. .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 95 ASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp CSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEE
T ss_pred ccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEE
Confidence 654 499999997 599888753 489999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
|+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+...
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~i~~~ 239 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKV 239 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--HHHHHHHHHH
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence 9999999765432 234578999999998876 6789999999999999999999999975421 1111111110
Q ss_pred cC----------------------ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 KG----------------------IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 ~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+ .....+......+.... .+.+++.+||+.||++|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASP---QAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCH---HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCH---HHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 00000111111111112 23457888999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=343.34 Aligned_cols=267 Identities=20% Similarity=0.250 Sum_probs=187.0
Q ss_pred cHHHHHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccce
Q 043053 698 SVEQVLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRF 776 (1058)
Q Consensus 698 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 776 (1058)
......++|.+.+.||+|+||.||+|. ..+|+.||||++... ......+.+|++.++.++||||+++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~~~~~l~~l~h~niv~~ 84 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------------PRFRNRELQIMQDLAVLHHPNIVQL 84 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC------------TTCCCHHHHHHHHHHHHCCTTBCCE
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC------------ccccHHHHHHHHHHHhcCCCCcccH
Confidence 345667899999999999999999994 467999999987422 1223466788888999999999999
Q ss_pred eeEEEcCCC-------ceEEEEecCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHhhccc--ccCCCCeEeCCCCCC
Q 043053 777 LGCCWNRNN-------RLLMYDYMPNGSLGSLLHE--RTGNALEWELRYQILLGAAQGLAYLH--HDCVPPIVHRDIKAN 845 (1058)
Q Consensus 777 ~~~~~~~~~-------~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivHrDikp~ 845 (1058)
++++..... .++||||+++ +|.+.+.. .....+++..+..++.|++.|++||| +. +|+||||||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~ 160 (360)
T 3e3p_A 85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPH 160 (360)
T ss_dssp EEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGG
T ss_pred HHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHH
Confidence 999976433 6899999986 55554442 23567899999999999999999999 77 9999999999
Q ss_pred cEEEcC-CCCeeeeccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 043053 846 NILIGL-EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIP 923 (1058)
Q Consensus 846 Nill~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~ 923 (1058)
|||++. ++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 161 NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 161 NVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp GEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 999997 8999999999998765432 23355789999999988654 489999999999999999999999975421
Q ss_pred CChhHHHHHHhhcCc----------cccCCCCCCCCchhH---------HHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 924 DGSHVVDWVRQKKGI----------QVLDPSLLSRPESEI---------DEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 924 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~---------~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
........+..... ............... .....+.+++..||+.||++|||++|++++-
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 238 -AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred -HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 11111111110000 000000000000000 0122345688999999999999999998753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=341.03 Aligned_cols=198 Identities=20% Similarity=0.270 Sum_probs=172.0
Q ss_pred HhhccccceeccccceEEEEEEe-cCC-cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCc------cc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM-DNG-EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKN------IV 774 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv 774 (1058)
.++|.+.+.||+|+||+||+|.. .++ +.||||++.. .....+.+.+|+.++++++|++ ++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN------------VGKYREAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------------CHHHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc------------cccchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 36899999999999999999954 445 7899999842 2234578889999999997765 99
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE-----
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI----- 849 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill----- 849 (1058)
.+++++...+..++||||+ ++++.+++.......+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccc
Confidence 9999999999999999999 66888888776556799999999999999999999999 99999999999999
Q ss_pred --------------cCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 043053 850 --------------GLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 915 (1058)
Q Consensus 850 --------------~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~ 915 (1058)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 236 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence 56789999999999865432 23457999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 043053 916 QPIDPT 921 (1058)
Q Consensus 916 ~P~~~~ 921 (1058)
.||...
T Consensus 237 ~pf~~~ 242 (355)
T 2eu9_A 237 TLFQTH 242 (355)
T ss_dssp CSCCCS
T ss_pred CCCCCC
Confidence 999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=339.29 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=188.3
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|...+.||+|+||.||+|. ..+++.||||++... .....+++.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----------DPQSVKHALREIKIIRRLDHDNIVKVFEILGP 79 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECT
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----------ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccc
Confidence 689999999999999999994 456999999988422 23446788999999999999999999998743
Q ss_pred --------------CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEE
Q 043053 783 --------------RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 783 --------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nil 848 (1058)
....++||||++ |+|.+++.. ..+++..++.++.|+++||+|||+. +|+||||||+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 152 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLF 152 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEE
T ss_pred cccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEE
Confidence 356789999997 599999964 5689999999999999999999999 9999999999999
Q ss_pred Ec-CCCCeeeeccccceeccCCCc-ccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043053 849 IG-LEFEPYIADFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG 925 (1058)
Q Consensus 849 l~-~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 925 (1058)
++ .++.+||+|||+++....... ........+|..|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 230 (320)
T 2i6l_A 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-- 230 (320)
T ss_dssp EETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred EcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--
Confidence 97 567999999999986643211 122344567999999998765 6789999999999999999999999975421
Q ss_pred hhHHHHHHhhcCcc------------------cc-CC-----CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 043053 926 SHVVDWVRQKKGIQ------------------VL-DP-----SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVA 981 (1058)
Q Consensus 926 ~~~~~~~~~~~~~~------------------~~-~~-----~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~ 981 (1058)
......+....... .. .+ ......+ ..+.+++.+||+.||++|||++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~li~~~L~~dP~~Rpt~~ell 304 (320)
T 2i6l_A 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGIS------REAVDFLEQILTFSPMDRLTAEEAL 304 (320)
T ss_dssp HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCC------HHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhh------HHHHHHHHHHcCCCccccCCHHHHh
Confidence 11111111100000 00 00 0000111 1244588899999999999999998
Q ss_pred HHH
Q 043053 982 AML 984 (1058)
Q Consensus 982 ~~l 984 (1058)
++-
T Consensus 305 ~hp 307 (320)
T 2i6l_A 305 SHP 307 (320)
T ss_dssp TSH
T ss_pred CCc
Confidence 753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=334.81 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=179.2
Q ss_pred HhhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+..+..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---------NKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS---------CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc---------cchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 46899999999999999999954 579999999985331 12223345555666788889999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEEcCCCCeeeecc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILIGLEFEPYIADF 860 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~Df 860 (1058)
+++..++||||+ ++.+..+... ....+++..++.++.|+++||+|||+ . +|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred cCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence 999999999999 5455555443 35678999999999999999999998 5 8999999999999999999999999
Q ss_pred ccceeccCCCcccccccccCcCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 861 GLAKLVDDGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 861 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
|++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .........
T Consensus 170 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~ 245 (318)
T 2dyl_A 170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-EVLTKVLQE 245 (318)
T ss_dssp TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHHS
T ss_pred CCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-HHHHHHhcc
Confidence 9997654432 223456999999999984 5567889999999999999999999997542221 111111111
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
. ....+. ....+. .+..++..||+.||.+|||+++++++-
T Consensus 246 ~--~~~~~~-~~~~~~------~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 246 E--PPLLPG-HMGFSG------DFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp C--CCCCCS-SSCCCH------HHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred C--CCCCCc-cCCCCH------HHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 1 100111 011222 233477889999999999999999854
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=347.76 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=185.9
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 782 (1058)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +|||||++++++.+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--------------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 80 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--------------FCDIALMEIKLLTESDDHPNVIRYYCSETT 80 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--------------GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--------------HHHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 356667899999999998887778999999988422 235678999999886 79999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCC-----CCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC-----
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNA-----LEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE----- 852 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~----- 852 (1058)
++..|+||||+. |+|.+++....... ..+..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 81 ~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~ 156 (434)
T 2rio_A 81 DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTA 156 (434)
T ss_dssp SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHS
T ss_pred CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCccccc
Confidence 999999999996 59999998643211 12334578999999999999999 99999999999999754
Q ss_pred --------CCeeeeccccceeccCCCcc--cccccccCcCCccCcccccc-------CCCCcccchhhHHHHHHHHHh-C
Q 043053 853 --------FEPYIADFGLAKLVDDGDFA--RSSNTVAGSYGYIAPEYGYM-------MKITEKSDVYSYGVVVLEVLT-G 914 (1058)
Q Consensus 853 --------~~~kl~DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~ellt-g 914 (1058)
+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |
T Consensus 157 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g 236 (434)
T 2rio_A 157 DQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236 (434)
T ss_dssp CCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred ccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC
Confidence 48999999999877653211 12335679999999999865 568899999999999999999 9
Q ss_pred CCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 915 KQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 915 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+.||...... ........... +........ .....+.+++.+||+.||++|||+.+++++-
T Consensus 237 ~~Pf~~~~~~---~~~i~~~~~~~----~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 237 KHPFGDKYSR---ESNIIRGIFSL----DEMKCLHDR--SLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp CCTTCSTTTH---HHHHHHTCCCC----CCCTTCCCH--HHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCCCCCchhh---HHHHhcCCCCc----ccccccccc--cchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 9999754221 11222211111 111111111 1122345688999999999999999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.92 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=198.1
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC--CCcccceee
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR--HKNIVRFLG 778 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~ 778 (1058)
+.++|.+.+.||+|+||.||+| +..+++.||||++........ ......+.+.+|+.++++++ ||||+++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-----GELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCE-----EECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhh-----hhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 3468999999999999999999 566899999999864432110 01112355678999999996 599999999
Q ss_pred EEEcCCCceEEEEecCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc-CCCCee
Q 043053 779 CCWNRNNRLLMYDYMPN-GSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG-LEFEPY 856 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~-~~~~~k 856 (1058)
++..++..++||||+.+ ++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++ .++.+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence 99999999999999986 8999999863 5789999999999999999999999 999999999999999 788999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
|+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||... . ......
T Consensus 191 L~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~---~~~~~~ 259 (320)
T 3a99_A 191 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E---EIIRGQ 259 (320)
T ss_dssp ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---HHHHCC
T ss_pred EeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----h---hhhccc
Confidence 99999998765432 234569999999999887666 67899999999999999999999632 1 111110
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. ......+. .+.+++.+||+.||++|||+++++++
T Consensus 260 ---~----~~~~~~~~------~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 ---V----FFRQRVSS------ECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---C----CCSSCCCH------HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---c----cccccCCH------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 11112222 23347788999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=335.46 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=189.5
Q ss_pred cHHHHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc----CCCc
Q 043053 698 SVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI----RHKN 772 (1058)
Q Consensus 698 ~~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~n 772 (1058)
+.+.+.++|.+.+.||+|+||.||+| +..+++.||||++........ ........+.+|+.++.++ +|||
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~~h~~ 99 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW-----SPLSDSVTCPLEVALLWKVGAGGGHPG 99 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-------------CCCCHHHHHHHHHHSSCCCSS
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccc-----ccchhhHHHHHHHHHHHhhcccCCCCC
Confidence 34556688999999999999999999 456789999999854422110 0112234556788888888 8999
Q ss_pred ccceeeEEEcCCCceEEEEe-cCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc-
Q 043053 773 IVRFLGCCWNRNNRLLMYDY-MPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG- 850 (1058)
Q Consensus 773 iv~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~- 850 (1058)
|+++++++...+..++|||| +.+++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++
T Consensus 100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDL 174 (312)
T ss_dssp BCCEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEET
T ss_pred eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeC
Confidence 99999999999999999999 7899999999874 5689999999999999999999999 999999999999999
Q ss_pred CCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCChhHH
Q 043053 851 LEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVV 929 (1058)
Q Consensus 851 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 929 (1058)
.++.+||+|||+++...... .....||..|+|||++.+..+. .++||||+|+++|||++|+.||... .
T Consensus 175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~--- 243 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----Q--- 243 (312)
T ss_dssp TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---
T ss_pred CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----H---
Confidence 88999999999998765432 2355699999999998776664 5899999999999999999999632 1
Q ss_pred HHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...... .......+. .+.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~-------~~~~~~~~~------~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 EILEAE-------LHFPAHVSP------DCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHTC-------CCCCTTSCH------HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHhhhc-------cCCcccCCH------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 111112222 23347888999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=343.89 Aligned_cols=198 Identities=23% Similarity=0.333 Sum_probs=169.8
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-----------CC
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-----------HK 771 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ 771 (1058)
++|.+.+.||+|+||+||+| +..+++.||||++... ....+.+.+|+.++++++ ||
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 86 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------------KVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------------ccchhhhhHHHHHHHHhhcccccchhccccc
Confidence 57999999999999999999 4578999999998422 234577889999999886 89
Q ss_pred cccceeeEEEcCC----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcE
Q 043053 772 NIVRFLGCCWNRN----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNI 847 (1058)
Q Consensus 772 niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Ni 847 (1058)
||+++++++...+ ..++||||+ +++|.+++.......+++..+..++.||+.||+|||+++ +|+||||||+||
T Consensus 87 ~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NI 163 (373)
T 1q8y_A 87 HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENV 163 (373)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGE
T ss_pred hHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHe
Confidence 9999999998654 678999999 889999998766667999999999999999999999952 899999999999
Q ss_pred EEc------CCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 848 LIG------LEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 848 ll~------~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
|++ ..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 995 3447999999999876432 23457899999999999999999999999999999999999999754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=334.78 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=177.0
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHH-HHcccCCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK-TLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~ 781 (1058)
++|...+.||+|+||.||+|.. .+|+.||||++... .......++.+|+. +++.++||||+++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST----------VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECC----------CCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecc----------cCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 5788999999999999999954 58999999998532 12223455566665 788889999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhh---cCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHE---RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
+++..++||||+++ +|.+++.. .....+++..+..++.|+++||+|||+. .+|+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEEC
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEc
Confidence 99999999999985 88888763 2256789999999999999999999985 289999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCcccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHh
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG----YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQ 934 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1058)
|||+++...... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... .....
T Consensus 169 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~ 241 (327)
T 3aln_A 169 DFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQLTQ 241 (327)
T ss_dssp CCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CC
T ss_pred cCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHHHH
Confidence 999998664432 22344699999999998 45678899999999999999999999997532111 11111
Q ss_pred hcCccccCCCCCCCC-chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 935 KKGIQVLDPSLLSRP-ESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 935 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
.. ....+.+.... ..... .+..++..||+.||++|||+++++++-..
T Consensus 242 ~~--~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 242 VV--KGDPPQLSNSEEREFSP---SFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp CC--CSCCCCCCCCSSCCCCH---HHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred Hh--cCCCCCCCCcccccCCH---HHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 11 11111111100 01112 23447888999999999999999885443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=345.97 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=184.8
Q ss_pred hccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 783 (1058)
+|...++||+|+||+||.....+|+.||||++.... ...+.+|+++++++ +|||||++++++.+.
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--------------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--------------FSFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--------------EEECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--------------HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 588889999999999776666779999999985331 12346899999999 799999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC---C--CCeeee
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL---E--FEPYIA 858 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~---~--~~~kl~ 858 (1058)
...|+||||++ |+|.+++.... ....+..++.++.||++||+|||+. +|+||||||+||+++. + ..+||+
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred CEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 99999999996 59999998653 3445556678999999999999999 9999999999999953 2 357899
Q ss_pred ccccceeccCCCc-ccccccccCcCCccCccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHH
Q 043053 859 DFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 859 DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~ 933 (1058)
|||+++....... .......+||+.|+|||++. ...++.++||||+||++|||++ |..||..... .. .....
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--~~-~~~~~ 242 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--RQ-ANILL 242 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--HH-HHHHT
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--HH-HHHHh
Confidence 9999987654321 12334567999999999987 4567889999999999999999 9999964321 11 11111
Q ss_pred hhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 934 QKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.... ..... +.... -..+.+++.+||+.||++|||+++++++-
T Consensus 243 ~~~~-----~~~~~-~~~~~--~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 243 GACS-----LDCLH-PEKHE--DVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp TCCC-----CTTSC-TTCHH--HHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred ccCC-----ccccC-ccccc--cHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 1111 11111 11111 12244588999999999999999999753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=356.73 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=194.0
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
....+|.+.+.||+|+||.||+| +..+|+.||||++... ......+.+.+|++++++++||||++++++
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----------~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v 80 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----------LSPKNRERWCLEIQIMKKLNHPNVVSAREV 80 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----------CCHHHHHHHHHHHHHHHHCCBTTBCCEEEC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----------CCHHHHHHHHHHHHHHHhCCCCCCCceeee
Confidence 44578999999999999999999 5567999999988532 233446789999999999999999999998
Q ss_pred EEc------CCCceEEEEecCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC
Q 043053 780 CWN------RNNRLLMYDYMPNGSLGSLLHERT-GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE 852 (1058)
Q Consensus 780 ~~~------~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~ 852 (1058)
+.. ++..++||||++||+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 81 ~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~ 157 (676)
T 3qa8_A 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPG 157 (676)
T ss_dssp CTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECC
T ss_pred ecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecC
Confidence 765 667799999999999999998643 33689999999999999999999999 99999999999999977
Q ss_pred CC---eeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHH
Q 043053 853 FE---PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVV 929 (1058)
Q Consensus 853 ~~---~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 929 (1058)
+. +||+|||.+....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ...
T Consensus 158 g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~ 230 (676)
T 3qa8_A 158 PQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPV 230 (676)
T ss_dssp SSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHH
T ss_pred CCceeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chh
Confidence 65 8999999998765432 2345679999999999999999999999999999999999999996431 111
Q ss_pred HHHHhh--------cCcc------ccCCCC--CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 043053 930 DWVRQK--------KGIQ------VLDPSL--LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVA 981 (1058)
Q Consensus 930 ~~~~~~--------~~~~------~~~~~~--~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~ 981 (1058)
.|.... .... ...... .......... .+.+++..||++||++|||+++++
T Consensus 231 ~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~--~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp HSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHH--HHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhH--HHHHHHHHHccCCHhhCcCHHHHh
Confidence 111000 0000 000000 0111111222 234588899999999999998844
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=340.06 Aligned_cols=335 Identities=20% Similarity=0.235 Sum_probs=223.8
Q ss_pred CCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhh
Q 043053 216 LKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQ 295 (1058)
Q Consensus 216 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 295 (1058)
+++++.|++++|.+....+..|..+++|++|+|++|.+++..+..|+.+++|++|++++|.+.+..+..|..+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 46667777777766644444456666777777777776655555666666666666666666665566666666666666
Q ss_pred hcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCC
Q 043053 296 LDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISG 375 (1058)
Q Consensus 296 L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 375 (1058)
|++|+++.+.+..|..+++ |++|++++|++++..+..+..+++|++|++++|.+++
T Consensus 124 L~~n~l~~l~~~~~~~l~~------------------------L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPK------------------------LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTT------------------------CCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred CCCCccCcCCHHHhcCCCC------------------------CcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 6666666544444444444 4444444444444444444444555555555555443
Q ss_pred CCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCcccccc
Q 043053 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSS 455 (1058)
Q Consensus 376 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 455 (1058)
. .+..+++|+.|++++|.++++ ...++|++|++++|.+... |.. ..++|+.|++++|.+++. ..+..
T Consensus 180 ~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~ 246 (390)
T 3o6n_A 180 V---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLN 246 (390)
T ss_dssp C---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGG
T ss_pred c---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcC
Confidence 2 244456666666666666532 2335677777777777643 222 236777777777777753 46777
Q ss_pred CCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHH
Q 043053 456 LSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIAL 535 (1058)
Q Consensus 456 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l 535 (1058)
+++|++|++++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|++++|+++ .+|..
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~----------- 313 (390)
T 3o6n_A 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERN----------- 313 (390)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGG-----------
T ss_pred CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCcc-----------
Confidence 7888888888888877777778888888888888888874 4556677888999999999887 33333
Q ss_pred hhccCCCCCCCCccccccccccEEecCCCcccCCCCcccccCcceeEEEecccccccCCCccccccCCCccccCCccccc
Q 043053 536 NLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCS 615 (1058)
Q Consensus 536 ~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~ 615 (1058)
+..+++|+.|+|++|+++... +..+++|+.|++++|+|++.+. ...+..+....+.+++..|.
T Consensus 314 --------------~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~c~ 376 (390)
T 3o6n_A 314 --------------QPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCK 376 (390)
T ss_dssp --------------HHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCSCCC
T ss_pred --------------ccccCcCCEEECCCCccceeC--chhhccCCEEEcCCCCccchhH-HHHHHHHHhhcccccCceec
Confidence 345678999999999998763 6778899999999999998543 34677777778888888888
Q ss_pred CC
Q 043053 616 SR 617 (1058)
Q Consensus 616 ~~ 617 (1058)
++
T Consensus 377 ~~ 378 (390)
T 3o6n_A 377 ID 378 (390)
T ss_dssp TT
T ss_pred cc
Confidence 65
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.03 Aligned_cols=236 Identities=12% Similarity=0.088 Sum_probs=180.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+|.+.+.||+|+||.||+| +..+++.||||++.... .......+.+.+|+..+++++||||+++++++.+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG--------VLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC--------CSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccc--------ccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 67999999999999999999 44569999999986432 1223456889999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||++|++|.++++. . .....+.+|+.|+++||+|||+. ||+||||||+||+++.++.+||+++|
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~- 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA- 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-
T ss_pred CCcEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-
Confidence 9999999999999999999964 2 35556889999999999999999 99999999999999999999998543
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|++| ++.++|||||||++|||++|+.||........... ...........
T Consensus 175 ---------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~~~~~~~~~~ 224 (286)
T 3uqc_A 175 ---------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AERDTAGQPIE 224 (286)
T ss_dssp ---------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CCBCTTSCBCC
T ss_pred ---------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HHHHhccCCCC
Confidence 3333 67899999999999999999999986533210000 00000000000
Q ss_pred -CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 943 -PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 943 -~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
.......+. .+..++.+||+.||++| |++|+++.|+++.....
T Consensus 225 ~~~~~~~~~~------~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 225 PADIDRDIPF------QISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHCTTSCH------HHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hhhcccCCCH------HHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 001111122 23447888999999999 99999999998876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=356.30 Aligned_cols=240 Identities=21% Similarity=0.255 Sum_probs=190.7
Q ss_pred hhccccceeccccceEEEEEEec--CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD--NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+.+|++++++++||||+++++++.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS----------GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS----------CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc----------CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 68999999999999999999553 6899999988532 23344678899999999999999999999998
Q ss_pred cCCC-----ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 782 NRNN-----RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 782 ~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
..+. .|+||||++|++|.+++.. .+++..++.|+.||++||+|||+. +||||||||+|||++.+ .+|
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~k 221 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLK 221 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEE
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEE
Confidence 7665 6999999999999998753 689999999999999999999999 99999999999999875 999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.......
T Consensus 222 l~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------- 283 (681)
T 2pzi_A 222 LIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------- 283 (681)
T ss_dssp ECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------
T ss_pred EEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------
Confidence 9999999876542 3557999999999987654 889999999999999999998886421110
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHHhhh
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT-MKDVAAMLKEIK 988 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-~~~v~~~l~~~~ 988 (1058)
... ..........+..++.+||++||++||+ ++++.+.+..+.
T Consensus 284 --------~~~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 --------LPE-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --------CCT-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------ccc-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 0111111123445888999999999995 555666665544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=336.61 Aligned_cols=244 Identities=18% Similarity=0.202 Sum_probs=179.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC-Ccccce-----
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH-KNIVRF----- 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~----- 776 (1058)
+.|...++||+|+||+||+| +..+|+.||||++.... .......+.+.+|+.+++.++| ++....
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~--------~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE--------RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSC--------C----CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCC--------CccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 45778899999999999999 56789999999885331 1222346789999999999987 321111
Q ss_pred ----e------------eEEEc-----CCCceEEEEecCCCChhhhhh-----hcCCCCCCHHHHHHHHHHHHHHhhccc
Q 043053 777 ----L------------GCCWN-----RNNRLLMYDYMPNGSLGSLLH-----ERTGNALEWELRYQILLGAAQGLAYLH 830 (1058)
Q Consensus 777 ----~------------~~~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH 830 (1058)
. .++.. ...++++|+++ +|+|.++++ ......+++..++.++.|+++||+|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 1 11111 12346777766 679999985 222456788999999999999999999
Q ss_pred ccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCcccc----------ccCCCCcccc
Q 043053 831 HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYG----------YMMKITEKSD 900 (1058)
Q Consensus 831 ~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~D 900 (1058)
+. +||||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|
T Consensus 229 ~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D 299 (413)
T 3dzo_A 229 HY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD 299 (413)
T ss_dssp HT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred hC---CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence 99 9999999999999999999999999998865432 345567 999999998 5556888999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 043053 901 VYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980 (1058)
Q Consensus 901 vwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v 980 (1058)
||||||++|||++|+.||........ ....-... ...+. .+.+++..||+.||++||++.++
T Consensus 300 vwSlGvil~elltg~~Pf~~~~~~~~-----------~~~~~~~~-~~~~~------~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLPNTDDAALGG-----------SEWIFRSC-KNIPQ------PVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHHHHHHHHHSSCCCCTTGGGSC-----------SGGGGSSC-CCCCH------HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhhh-----------HHHHHhhc-ccCCH------HHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999999999975422110 00000000 11222 23457788999999999999999
Q ss_pred HHH
Q 043053 981 AAM 983 (1058)
Q Consensus 981 ~~~ 983 (1058)
+++
T Consensus 362 l~~ 364 (413)
T 3dzo_A 362 MET 364 (413)
T ss_dssp TTS
T ss_pred HhC
Confidence 875
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=354.57 Aligned_cols=335 Identities=21% Similarity=0.238 Sum_probs=228.4
Q ss_pred CCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhh
Q 043053 216 LKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQ 295 (1058)
Q Consensus 216 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 295 (1058)
+.+++.|++++|.+....+..|..+++|++|+|++|.+++..+..|+.+++|++|+|++|.+.+..+..|+.+++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 45667777777777655555566677777777777777766666667777777777777777666666666666666666
Q ss_pred hcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCC
Q 043053 296 LDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISG 375 (1058)
Q Consensus 296 L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 375 (1058)
|++|.|+++.+..|+.+++|++|++++|.+++..|..|..+++|+.|++++|.+ ++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l------------------------~~ 185 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL------------------------TH 185 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCC------------------------SB
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCC------------------------CC
Confidence 666666655444455555555555555555544444455555555555555444 43
Q ss_pred CCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCcccccc
Q 043053 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSS 455 (1058)
Q Consensus 376 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 455 (1058)
. .+..+++|+.|++++|.++++ ...++|+.|++++|.+....+.. .++|+.|+|++|.+++ +..+..
T Consensus 186 ~---~~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~ 252 (597)
T 3oja_B 186 V---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLN 252 (597)
T ss_dssp C---CGGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGG
T ss_pred c---ChhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--Chhhcc
Confidence 2 134455666666666666532 33456777777777766433222 2567777777777775 356777
Q ss_pred CCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHH
Q 043053 456 LSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIAL 535 (1058)
Q Consensus 456 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l 535 (1058)
+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|.
T Consensus 253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~------------ 318 (597)
T 3oja_B 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVER------------ 318 (597)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGG------------
T ss_pred CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCc------------
Confidence 8888888888888877777778888888888888888875 4666677888999999999887 3443
Q ss_pred hhccCCCCCCCCccccccccccEEecCCCcccCCCCcccccCcceeEEEecccccccCCCccccccCCCccccCCccccc
Q 043053 536 NLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCS 615 (1058)
Q Consensus 536 ~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~ 615 (1058)
.+..+++|+.|+|++|++++.+ +..+++|+.|++++|+|+|.+. ...+..+....+.+++..|+
T Consensus 319 -------------~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~C~ 382 (597)
T 3oja_B 319 -------------NQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCK 382 (597)
T ss_dssp -------------GHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCCCCC
T ss_pred -------------ccccCCCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCCCChhH-HHHHHHHhhhccccccccCC
Confidence 3456778999999999998763 6778899999999999998753 34677777888889999998
Q ss_pred CC
Q 043053 616 SR 617 (1058)
Q Consensus 616 ~~ 617 (1058)
.+
T Consensus 383 ~~ 384 (597)
T 3oja_B 383 ID 384 (597)
T ss_dssp TT
T ss_pred cc
Confidence 74
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.69 Aligned_cols=236 Identities=21% Similarity=0.264 Sum_probs=179.5
Q ss_pred HHHhhcccc-ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHH-cccCCCccccee
Q 043053 701 QVLKCLVDA-NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL-GSIRHKNIVRFL 777 (1058)
Q Consensus 701 ~~~~~~~~~-~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~ 777 (1058)
.+.++|.+. +.||+|+||.||+| +..+++.||||++.. ...+.+|+.++ +..+||||++++
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------------~~~~~~e~~~~~~~~~h~~i~~~~ 77 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------------CPKARREVELHWRASQCPHIVRIV 77 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------------SHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----------------cHHHHHHHHHHHHhccCCCchhHH
Confidence 455677776 78999999999999 557899999999831 24567888888 555899999999
Q ss_pred eEEEc----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC--
Q 043053 778 GCCWN----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-- 851 (1058)
Q Consensus 778 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-- 851 (1058)
+++.. ....++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 154 (299)
T 3m2w_A 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKR 154 (299)
T ss_dssp EEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS
T ss_pred hhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCC
Confidence 99876 56689999999999999999886566799999999999999999999999 9999999999999998
Q ss_pred -CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH
Q 043053 852 -EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 852 -~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 930 (1058)
++.+||+|||++..... ..++.++||||+||++|||++|+.||....... .
T Consensus 155 ~~~~~kl~Dfg~a~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~-- 206 (299)
T 3m2w_A 155 PNAILKLTDFGFAKETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--I-- 206 (299)
T ss_dssp TTCCEEECCCTTCEECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC----------
T ss_pred CCCcEEEecccccccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh--h--
Confidence 78899999999875432 235678999999999999999999997542211 0
Q ss_pred HHHhhcCccccCCCCCCCCchhH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEI-DEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~ 986 (1058)
. ... ...........+.... .....+.+++..||+.||++|||++|++++...
T Consensus 207 -~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 207 -S-PGM-KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp ---CCS-CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -h-HHH-HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 0 000 0000000011110000 001123457888999999999999999986543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=328.88 Aligned_cols=310 Identities=19% Similarity=0.179 Sum_probs=221.8
Q ss_pred CCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEE
Q 043053 168 LSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMID 247 (1058)
Q Consensus 168 l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 247 (1058)
+.+|+.|++.+|.+....+..+..+++|++|+|++|.+++..+..|..+++|++|+|++|.+.+..+..|..+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 56777777777777643334456777777777777777755556677777777777777777766666677777777777
Q ss_pred eecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCC
Q 043053 248 FSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEG 327 (1058)
Q Consensus 248 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 327 (1058)
|++|.++...+..|+++++|++|++++|.+.+..+..|..+++|++|++++|++++.
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----------------------- 180 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV----------------------- 180 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-----------------------
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-----------------------
Confidence 777777654444456677777777777776665566666666666666666666543
Q ss_pred CCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccC
Q 043053 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGG 407 (1058)
Q Consensus 328 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 407 (1058)
.+..+++|+.|++++|.+.+ +...++|++|++++|.+... |.. ..++|+.|++++|.+++. ..+..
T Consensus 181 ----~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~ 246 (390)
T 3o6n_A 181 ----DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLN 246 (390)
T ss_dssp ----CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGG
T ss_pred ----ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcC
Confidence 13344556666666666553 12234566667777766643 222 236788888888888764 56788
Q ss_pred ccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccc
Q 043053 408 LKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKII 487 (1058)
Q Consensus 408 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 487 (1058)
+++|++|+|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~ 324 (390)
T 3o6n_A 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324 (390)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEE
Confidence 8888888888888887778888888888888888888885 5666778888999999999887 5677788888999999
Q ss_pred cccccCCCCCCCcccCCcccccccccCCcccC
Q 043053 488 LSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 488 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
|++|+|+... +..+++|+.|++++|++.+
T Consensus 325 L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 325 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CCSSCCCCCC---CCTTCCCSEEECCSSCEEH
T ss_pred CCCCccceeC---chhhccCCEEEcCCCCccc
Confidence 9999987542 6678899999999999874
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=318.96 Aligned_cols=308 Identities=24% Similarity=0.422 Sum_probs=206.8
Q ss_pred cccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCc
Q 043053 164 SLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSL 243 (1058)
Q Consensus 164 ~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 243 (1058)
.+..+++|+.|++++|.+.. ++ .+..+++|++|++++|.+++ ++. +..+++|++|++++|.+.+. ..+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITDI--SALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence 34566777777777777753 33 36677777777777777764 333 67777777777777777642 356777777
Q ss_pred cEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCc
Q 043053 244 KMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQN 323 (1058)
Q Consensus 244 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N 323 (1058)
++|++++|.+.+..+ +..+++|++|++++|......+ .+..+++|++|++++|.+.+..+
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~----------------- 172 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP----------------- 172 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG-----------------
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh-----------------
Confidence 777777777764333 6667777777777775443322 35666666666666666554322
Q ss_pred ccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccc
Q 043053 324 QLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403 (1058)
Q Consensus 324 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 403 (1058)
+..+++|+.|++++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|++|++++|++++..+
T Consensus 173 ---------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~- 238 (347)
T 4fmz_A 173 ---------IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP- 238 (347)
T ss_dssp ---------GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred ---------hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-
Confidence 5556666666666666664322 5566666677777776664433 6667777777777777776544
Q ss_pred cccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccc
Q 043053 404 EIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSL 483 (1058)
Q Consensus 404 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 483 (1058)
+..+++|++|++++|.+++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..+..+..+++|
T Consensus 239 -~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 313 (347)
T 4fmz_A 239 -LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313 (347)
T ss_dssp -GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred -hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence 77777777777777777653 4567777777778887777754 357777888888888888877777777778888
Q ss_pred cccccccccCCCCCCCcccCCcccccccccCCccc
Q 043053 484 NKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 484 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 518 (1058)
+.|+|++|++++..| +..+++|+.|++++|+|+
T Consensus 314 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp SEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 888888888876555 777788888888888775
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=316.53 Aligned_cols=308 Identities=23% Similarity=0.398 Sum_probs=230.7
Q ss_pred cccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCc
Q 043053 140 ELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKL 219 (1058)
Q Consensus 140 ~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 219 (1058)
.+..+++|++|+++++.+. .++ .+..+++|++|++++|.+++..+ +..+++|++|++++|.+++ + +.+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-I-SALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTC
T ss_pred cchhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-c-hHHcCCCcC
Confidence 3557899999999999997 444 48999999999999999985433 9999999999999999985 4 468999999
Q ss_pred ceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCC
Q 043053 220 EELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTN 299 (1058)
Q Consensus 220 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 299 (1058)
++|++++|.+.+. +. +..+++|++|++++|......+ .+..+++|++|++++|.+.+..+ +..+++|++|++++|
T Consensus 113 ~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 9999999999854 33 8999999999999997664444 48999999999999999986554 889999999999999
Q ss_pred cccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCC
Q 043053 300 QISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPP 379 (1058)
Q Consensus 300 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 379 (1058)
.+.+..+ +. .+++|+.|++++|.+.+..+ +..+++|++|++++|.+++..+
T Consensus 188 ~l~~~~~--~~------------------------~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~- 238 (347)
T 4fmz_A 188 QIEDISP--LA------------------------SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP- 238 (347)
T ss_dssp CCCCCGG--GG------------------------GCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred ccccccc--cc------------------------CCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-
Confidence 9876432 44 44455555555555553322 4455556666666666554332
Q ss_pred CccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCC
Q 043053 380 EIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGL 459 (1058)
Q Consensus 380 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 459 (1058)
+..+++|++|++++|.++++ ..+..+++|++|++++|++++. ..+..+++|+.|++++|++++..+..|..+++|
T Consensus 239 -~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 313 (347)
T 4fmz_A 239 -LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313 (347)
T ss_dssp -GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred -hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence 66667777777777777654 3566777777777777777654 346677777777777777777777777777777
Q ss_pred CeeecCCCccccCCcccccccccccccccccccCC
Q 043053 460 QVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFS 494 (1058)
Q Consensus 460 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 494 (1058)
++|++++|++++..| +..+++|+.|++++|+|+
T Consensus 314 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp SEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 777777777775544 667777777777777764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=320.77 Aligned_cols=199 Identities=15% Similarity=0.117 Sum_probs=162.5
Q ss_pred HhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC---------CCcc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR---------HKNI 773 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------h~ni 773 (1058)
.++|.+.+.||+|+||+||+|.. +|+.||||++........ ........+.+.+|+.+++.++ ||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLV---NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCB---TTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCcccc---ccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 47899999999999999999976 689999999965422100 0123344578899999999886 5555
Q ss_pred cceee-----------------EEEc-------------CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHH
Q 043053 774 VRFLG-----------------CCWN-------------RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823 (1058)
Q Consensus 774 v~~~~-----------------~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~ 823 (1058)
|++.+ ++.+ ++..|+||||+++|++.+.+.. ..+++..++.++.||+
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT 171 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 55554 4443 6778999999999987777743 5689999999999999
Q ss_pred HHhhccc-ccCCCCeEeCCCCCCcEEEcCCC--------------------CeeeeccccceeccCCCcccccccccCcC
Q 043053 824 QGLAYLH-HDCVPPIVHRDIKANNILIGLEF--------------------EPYIADFGLAKLVDDGDFARSSNTVAGSY 882 (1058)
Q Consensus 824 ~~l~~LH-~~~~~~ivHrDikp~Nill~~~~--------------------~~kl~DfGl~~~~~~~~~~~~~~~~~gt~ 882 (1058)
.||+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ..+||+
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 9999999 88 999999999999999887 8999999999876542 347999
Q ss_pred CccCccccccCCCCcccchhhHHHH-HHHHHhCCCCCC
Q 043053 883 GYIAPEYGYMMKITEKSDVYSYGVV-VLEVLTGKQPID 919 (1058)
Q Consensus 883 ~y~aPE~~~~~~~~~~~DvwSlGvv-l~elltg~~P~~ 919 (1058)
.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 999999988766 889999998777 778899999984
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=342.62 Aligned_cols=310 Identities=20% Similarity=0.186 Sum_probs=222.1
Q ss_pred CCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEE
Q 043053 168 LSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMID 247 (1058)
Q Consensus 168 l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 247 (1058)
+.+++.|++++|.+....+..+..+++|+.|+|++|.+++..|..|+.+++|++|+|++|.+.+..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 45666677777766644444556667777777777777655556666777777777777776666666666667777777
Q ss_pred eecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCC
Q 043053 248 FSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEG 327 (1058)
Q Consensus 248 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 327 (1058)
|++|.+++..+..|+++++|++|++++|.+.+..|..|..+++|++|+|++|.+++.
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----------------------- 186 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV----------------------- 186 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-----------------------
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-----------------------
Confidence 777766655455556666666666666666665555666666666666666665543
Q ss_pred CCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccC
Q 043053 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGG 407 (1058)
Q Consensus 328 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 407 (1058)
.+..+++|+.|++++|.+.+ +....+|+.|++++|.+....+.. .++|+.|+|++|.+++. ..+..
T Consensus 187 ----~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~~--~~l~~ 252 (597)
T 3oja_B 187 ----DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDT--AWLLN 252 (597)
T ss_dssp ----CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCCC--GGGGG
T ss_pred ----ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCCC--hhhcc
Confidence 13344566666666666653 223345667777777766433222 25788888888888863 67888
Q ss_pred ccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccc
Q 043053 408 LKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKII 487 (1058)
Q Consensus 408 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 487 (1058)
+++|++|+|++|.+++..|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+
T Consensus 253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~ 330 (597)
T 3oja_B 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330 (597)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEE
Confidence 8899999999999988888888889999999999999986 5677788899999999999998 6777888899999999
Q ss_pred cccccCCCCCCCcccCCcccccccccCCcccC
Q 043053 488 LSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 488 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
|++|+|.+.. +..+++|+.|++++|++.+
T Consensus 331 L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 331 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp CCSSCCCCCC---CCTTCCCSEEECCSSCEEH
T ss_pred CCCCCCCCcC---hhhcCCCCEEEeeCCCCCC
Confidence 9999998653 6677899999999999984
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-33 Score=310.09 Aligned_cols=258 Identities=31% Similarity=0.497 Sum_probs=217.8
Q ss_pred Ccccccccccccccc--cCcccccccccchhhhccc-cCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccce
Q 043053 337 SNLQALDLSHNSLTA--SVPAGLFQLQNLTKLLLIS-NDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNF 413 (1058)
Q Consensus 337 ~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 413 (1058)
.+++.|+|++|.+.+ .+|..+..+++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++..|..|..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 467778888888877 6777888888888888884 7887778888888888888888888888778888888888888
Q ss_pred eeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCC-CCCeeecCCCccccCCccccccccccccccccccc
Q 043053 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLS-GLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNL 492 (1058)
Q Consensus 414 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 492 (1058)
|+|++|.+++..|..|..+++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+..+. |+.|+|++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 88888888888888888888888888888888877888888887 888888888888888888888876 8888888888
Q ss_pred CCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCC-CC
Q 043053 493 FSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGN-LN 571 (1058)
Q Consensus 493 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~ 571 (1058)
+++..|..|..+++|+.|++++|++++.+|. +..+++|++|||++|++++. +.
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------------------------~~~l~~L~~L~Ls~N~l~~~~p~ 262 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK--------------------------VGLSKNLNGLDLRNNRIYGTLPQ 262 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG--------------------------CCCCTTCCEEECCSSCCEECCCG
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc--------------------------ccccCCCCEEECcCCcccCcCCh
Confidence 8888888888888999999998888753332 35678899999999999864 46
Q ss_pred cccccCcceeEEEecccccccCCCccccccCCCccccCCcccccCCCCCC
Q 043053 572 PLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSC 621 (1058)
Q Consensus 572 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~ 621 (1058)
.+..+++|+.|++++|+++|.+|....+..++..++.+|+++|+.|...|
T Consensus 263 ~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp GGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred HHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCCCC
Confidence 78889999999999999999999988899999999999999999887776
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=303.94 Aligned_cols=290 Identities=21% Similarity=0.258 Sum_probs=133.9
Q ss_pred ccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEee
Q 043053 170 KLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFS 249 (1058)
Q Consensus 170 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 249 (1058)
+|+.++++++.+. .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.+.+..|..|..+++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4455555555444 3443332 345555555555544444445555555555555555554444445555555555555
Q ss_pred cCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCC
Q 043053 250 LNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSI 329 (1058)
Q Consensus 250 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 329 (1058)
+|.++ .+|..+. ++|++|++++|.+....+..|..+++|++|++++|.++. .+..
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~~ 165 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN----------------------SGFE 165 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG----------------------GGSC
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc----------------------CCCC
Confidence 55544 2222222 344444444444443333334444444444444444331 0123
Q ss_pred ChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCcc
Q 043053 330 PSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLK 409 (1058)
Q Consensus 330 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 409 (1058)
+..|..+ +|+.|++++|++++ +|..+. ++|++|+++ +|.+++..+..|..++
T Consensus 166 ~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~------------------------~n~i~~~~~~~l~~l~ 217 (332)
T 2ft3_A 166 PGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLD------------------------HNKIQAIELEDLLRYS 217 (332)
T ss_dssp TTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCC------------------------SSCCCCCCTTSSTTCT
T ss_pred cccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECC------------------------CCcCCccCHHHhcCCC
Confidence 3344444 55555555555553 333222 344444444 4444444444444444
Q ss_pred ccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccc------cccc
Q 043053 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGR------LVSL 483 (1058)
Q Consensus 410 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L 483 (1058)
+|++|+|++|++++..+..|..+++|+.|++++|+++ .+|..+..+++|++|++++|+|++..+..|.. ...|
T Consensus 218 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l 296 (332)
T 2ft3_A 218 KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYY 296 (332)
T ss_dssp TCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCB
T ss_pred CCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccc
Confidence 4444444444444444444444444444444444444 23444444555555555555554433333332 2345
Q ss_pred cccccccccCC--CCCCCcccCCcccccccccCCc
Q 043053 484 NKIILSKNLFS--GPIPSSLGLCSSLQLLDLSSNQ 516 (1058)
Q Consensus 484 ~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~l~~N~ 516 (1058)
+.|++++|++. +..|..|..+++|+.|++++|+
T Consensus 297 ~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cceEeecCcccccccCcccccccchhhhhhccccc
Confidence 56666666655 4555566666666666666653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=303.14 Aligned_cols=289 Identities=20% Similarity=0.282 Sum_probs=146.4
Q ss_pred CccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecc
Q 043053 194 ELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMIS 273 (1058)
Q Consensus 194 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 273 (1058)
+|+.++++++.++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|+++++|++|+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 3444455444444 3333322 344445555554444433444444445555555444444444444444444444444
Q ss_pred cCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccc--
Q 043053 274 DNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTA-- 351 (1058)
Q Consensus 274 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-- 351 (1058)
+|.++. +|..+. ++|++|++++|++++.. +..|..+++|+.|++++|.+..
T Consensus 109 ~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~------------------------~~~~~~l~~L~~L~l~~n~l~~~~ 161 (330)
T 1xku_A 109 KNQLKE-LPEKMP--KTLQELRVHENEITKVR------------------------KSVFNGLNQMIVVELGTNPLKSSG 161 (330)
T ss_dssp SSCCSB-CCSSCC--TTCCEEECCSSCCCBBC------------------------HHHHTTCTTCCEEECCSSCCCGGG
T ss_pred CCcCCc-cChhhc--ccccEEECCCCcccccC------------------------HhHhcCCccccEEECCCCcCCccC
Confidence 444442 221111 33444444444433332 2233333333334444333321
Q ss_pred cCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccC
Q 043053 352 SVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD 431 (1058)
Q Consensus 352 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 431 (1058)
..+..+..+++|++|++++|.++. +|..+. ++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..
T Consensus 162 ~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 238 (330)
T 1xku_A 162 IENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238 (330)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred cChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccC
Confidence 233333344444444444444442 222222 45666666666666665666666666666666666666555556666
Q ss_pred CcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccc------cccccccccccccCCC--CCCCcccC
Q 043053 432 CTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGR------LVSLNKIILSKNLFSG--PIPSSLGL 503 (1058)
Q Consensus 432 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~Ls~N~l~~--~~~~~~~~ 503 (1058)
+++|+.|+|++|+++ .+|..+..+++|++|++++|+|++..+..|.. ...|+.|++++|++.. +.|..|..
T Consensus 239 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence 666666666666666 35556666666666666666666555555533 2566677777777653 55667777
Q ss_pred CcccccccccCCc
Q 043053 504 CSSLQLLDLSSNQ 516 (1058)
Q Consensus 504 l~~L~~L~l~~N~ 516 (1058)
+.+++.++|++|+
T Consensus 318 ~~~l~~l~L~~N~ 330 (330)
T 1xku_A 318 VYVRAAVQLGNYK 330 (330)
T ss_dssp CCCGGGEEC----
T ss_pred ccceeEEEecccC
Confidence 7777777777774
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=302.88 Aligned_cols=269 Identities=20% Similarity=0.282 Sum_probs=180.9
Q ss_pred CccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhcc
Q 043053 242 SLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAW 321 (1058)
Q Consensus 242 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~ 321 (1058)
+|+.|++++|.+++..+..|.++++|++|++++|.+++..|..|..+++|++|+|++|+++.+.+. +. ++|++|+++
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~-~~--~~L~~L~l~ 131 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPN-LP--SSLVELRIH 131 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSS-CC--TTCCEEECC
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCcc-cc--ccCCEEECC
Confidence 444444444444443344444444444444444444444444444444455555555544422111 11 233333333
Q ss_pred CcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCc
Q 043053 322 QNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLI 401 (1058)
Q Consensus 322 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 401 (1058)
+|++++..+..|..+++|+.|++++|.++. .+..+..|..+ +|+.|++++|+++++.
T Consensus 132 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~~~~~~~~l-~L~~L~l~~n~l~~l~ 188 (332)
T 2ft3_A 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLEN----------------------SGFEPGAFDGL-KLNYLRISEAKLTGIP 188 (332)
T ss_dssp SSCCCCCCSGGGSSCSSCCEEECCSCCCBG----------------------GGSCTTSSCSC-CCSCCBCCSSBCSSCC
T ss_pred CCccCccCHhHhCCCccCCEEECCCCcccc----------------------CCCCcccccCC-ccCEEECcCCCCCccC
Confidence 333333333344444555555555554431 12455666666 7888888888888653
Q ss_pred cccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccc
Q 043053 402 PREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLV 481 (1058)
Q Consensus 402 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 481 (1058)
. .+. ++|++|+|++|++++..+..|..+++|+.|++++|++++..+..|..+++|++|+|++|+++ .+|..+..++
T Consensus 189 ~-~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~ 264 (332)
T 2ft3_A 189 K-DLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLK 264 (332)
T ss_dssp S-SSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCT
T ss_pred c-ccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCc
Confidence 3 332 78999999999999988899999999999999999999988889999999999999999998 7888899999
Q ss_pred cccccccccccCCCCCCCcccCC------cccccccccCCccc--CCCChhhhhhHHHHHHHhhccCC
Q 043053 482 SLNKIILSKNLFSGPIPSSLGLC------SSLQLLDLSSNQLT--GSVPMELGQIEALEIALNLSCNG 541 (1058)
Q Consensus 482 ~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~l~~N~l~--~~~p~~~~~l~~l~~~l~ls~N~ 541 (1058)
+|+.|+|++|+|++..+..|..+ .+|+.|++++|++. +..|..|..+..+.. +++++|+
T Consensus 265 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~-l~l~~n~ 331 (332)
T 2ft3_A 265 LLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA-IQFGNYK 331 (332)
T ss_dssp TCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTT-EEC----
T ss_pred cCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhh-hhccccc
Confidence 99999999999998888877653 67999999999997 667778887777763 7777763
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=300.75 Aligned_cols=289 Identities=19% Similarity=0.247 Sum_probs=225.1
Q ss_pred CcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhc
Q 043053 218 KLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLD 297 (1058)
Q Consensus 218 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 297 (1058)
+|+.++++++.+. .+|..+. ++|+.|+|++|.+++..+..|+++++|++|++++|.+++..|..|..+++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 5666666666665 3444332 456666666666665555556666666666666666665555556666666666666
Q ss_pred CCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCC--
Q 043053 298 TNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISG-- 375 (1058)
Q Consensus 298 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-- 375 (1058)
+|+++.+ |..+. ++|++|++++|++++..+..+..+++|++|++++|.+..
T Consensus 109 ~n~l~~l-------------------------~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 161 (330)
T 1xku_A 109 KNQLKEL-------------------------PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161 (330)
T ss_dssp SSCCSBC-------------------------CSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred CCcCCcc-------------------------Chhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC
Confidence 5555422 22222 689999999999998777788999999999999999964
Q ss_pred CCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCcccccc
Q 043053 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSS 455 (1058)
Q Consensus 376 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 455 (1058)
..+..|.++++|+.|++++|.++.+.. .+. ++|++|++++|++++..|..|..+++|+.|++++|++++..+..|..
T Consensus 162 ~~~~~~~~l~~L~~L~l~~n~l~~l~~-~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 238 (330)
T 1xku_A 162 IENGAFQGMKKLSYIRIADTNITTIPQ-GLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238 (330)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCCSCCS-SCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred cChhhccCCCCcCEEECCCCccccCCc-ccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccC
Confidence 678889999999999999999997643 332 89999999999999888999999999999999999999888889999
Q ss_pred CCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCC------cccccccccCCcccC--CCChhhhh
Q 043053 456 LSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLC------SSLQLLDLSSNQLTG--SVPMELGQ 527 (1058)
Q Consensus 456 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~l~~N~l~~--~~p~~~~~ 527 (1058)
+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|... ..|+.|++++|++.. ..|..|..
T Consensus 239 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence 999999999999998 788899999999999999999998888877543 788999999999963 55677777
Q ss_pred hHHHHHHHhhccCC
Q 043053 528 IEALEIALNLSCNG 541 (1058)
Q Consensus 528 l~~l~~~l~ls~N~ 541 (1058)
+..+. .+++++|+
T Consensus 318 ~~~l~-~l~L~~N~ 330 (330)
T 1xku_A 318 VYVRA-AVQLGNYK 330 (330)
T ss_dssp CCCGG-GEEC----
T ss_pred cccee-EEEecccC
Confidence 66665 37788774
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=302.61 Aligned_cols=248 Identities=29% Similarity=0.462 Sum_probs=125.7
Q ss_pred CcceeecccccccC--CCCccccCcCCccEEEeec-CCCcCcCCccccccCCcceeecccCccCCCccccccccccchhh
Q 043053 218 KLEELFLWQNSLVG--AIPEEIGNCTSLKMIDFSL-NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQL 294 (1058)
Q Consensus 218 ~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 294 (1058)
+++.|+|++|.+.+ .+|..|.++++|++|+|++ |.+.+.+|..|+.+++|++|++++|.+.+..|..|..+++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 45555555555554 4455555555555555553 55554445445555555555555444444444444444444444
Q ss_pred hhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccc-cchhhhccccCC
Q 043053 295 QLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQ-NLTKLLLISNDI 373 (1058)
Q Consensus 295 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l 373 (1058)
+|++|+++ +.+|..|..+++|++|++++|++++.+|..+..++ +|++|++++|.+
T Consensus 131 ~Ls~N~l~------------------------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 131 DFSYNALS------------------------GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp ECCSSEEE------------------------SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred eCCCCccC------------------------CcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCee
Confidence 44444433 34444455555555555555555544454444444 444444444444
Q ss_pred CCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCcccc
Q 043053 374 SGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSL 453 (1058)
Q Consensus 374 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 453 (1058)
++..|..|..++ |+.|+|++|++++..|..|..+++|++|+|++|++++..|. +..+++|++|+|++|+|++.+|..|
T Consensus 187 ~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred eccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence 444444444444 55555555555555555555555555555555555543333 4445555555555555554555555
Q ss_pred ccCCCCCeeecCCCccccCCccccccccccccccccccc
Q 043053 454 SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNL 492 (1058)
Q Consensus 454 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 492 (1058)
..+++|++|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred hcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 55555555555555555544443 444455555555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-34 Score=342.13 Aligned_cols=374 Identities=19% Similarity=0.149 Sum_probs=243.3
Q ss_pred CCCceecccCccccccCCcc-ccCCCccceeeeeccccccc----cCccccCCCCccEEEccCCcCCCCCCCCcC-CCC-
Q 043053 145 SNMTALGLADTQVSGSLPAS-LGKLSKLQTLSIYTTMISGE----IPAEIGNCSELVSLFLYENSLSGSIPPEIG-KLK- 217 (1058)
Q Consensus 145 ~~L~~L~l~~~~~~~~~~~~-l~~l~~L~~L~l~~n~i~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-~l~- 217 (1058)
++|++|++++|++++..... +..+++|++|++++|.+.+. ++..+..+++|++|+|++|.+.+..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45566666666665433333 55566677777777766542 345556667777777777766543232222 233
Q ss_pred ---CcceeecccccccC----CCCccccCcCCccEEEeecCCCcCcCCcccc-----ccCCcceeecccCccCCCc----
Q 043053 218 ---KLEELFLWQNSLVG----AIPEEIGNCTSLKMIDFSLNSLSGTIPLSIG-----GLSELEEFMISDNNVSGSI---- 281 (1058)
Q Consensus 218 ---~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~l~~n~l~~~~---- 281 (1058)
+|++|+|++|.+++ .++..+..+++|++|+|++|.+++..+..+. ..++|++|++++|.+++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 57777777776663 2355566677777777777776644333332 2346777777777766533
Q ss_pred cccccccccchhhhhcCCcccCcCCCcccc-----cchhhhhhccCcccCCC----CChhhhccCccccccccccccccc
Q 043053 282 PANLANATNLVQLQLDTNQISGLIPPEIGM-----LSKLTVFFAWQNQLEGS----IPSTLASCSNLQALDLSHNSLTAS 352 (1058)
Q Consensus 282 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~-----l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~ 352 (1058)
+..+..+++|++|++++|.+++..+..+.. .++|++|++++|.++.. ++..+..+++|+.|++++|.+.+.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 444555677777777777766544444432 34677777777777654 456677788888888888888753
Q ss_pred C-----cccccccccchhhhccccCCCCC----CCCCccCCCCCcEEEccCccccCCccccccC-----ccccceeeccC
Q 043053 353 V-----PAGLFQLQNLTKLLLISNDISGS----IPPEIGNCSSLVRLRVGNNRIAGLIPREIGG-----LKTLNFLDLSS 418 (1058)
Q Consensus 353 ~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~ 418 (1058)
. +..+..+++|++|++++|.++.. ++..+..+++|++|+|++|.+++..+..+.. .++|++|+|++
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~ 322 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCC
Confidence 2 22223477888888888888753 4556677888889999988887554444443 26888999999
Q ss_pred ccCCCC----CCCcccCCcccchhhccCCccCCCCcccccc-----CCCCCeeecCCCcccc----CCcccccccccccc
Q 043053 419 NRLSGS----VPDEIGDCTELQMIDLSHNTLQGSLPNSLSS-----LSGLQVLDVSDNRFSG----QIPASLGRLVSLNK 485 (1058)
Q Consensus 419 N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~ 485 (1058)
|.+++. ++..+..+++|+.|++++|++++..+..+.. .++|++|++++|++++ .+|..+..+++|++
T Consensus 323 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~ 402 (461)
T 1z7x_W 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 402 (461)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred CCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccE
Confidence 888754 3455667788889999988887654544443 6788999999998875 67777888888999
Q ss_pred cccccccCCCCCCCccc-----CCcccccccccCCccc
Q 043053 486 IILSKNLFSGPIPSSLG-----LCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 486 L~Ls~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~ 518 (1058)
|+|++|++++.....+. ...+|+.|++.++.+.
T Consensus 403 L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 403 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp EECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred EECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence 99999988753211111 1235666666666655
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-34 Score=339.87 Aligned_cols=267 Identities=18% Similarity=0.147 Sum_probs=132.5
Q ss_pred CccccCCCCCceecccCccccccCCccccC-----CCccceeeeecccccccc----CccccCCCCccEEEccCCcCCCC
Q 043053 138 PAELGDCSNMTALGLADTQVSGSLPASLGK-----LSKLQTLSIYTTMISGEI----PAEIGNCSELVSLFLYENSLSGS 208 (1058)
Q Consensus 138 ~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~-----l~~L~~L~l~~n~i~~~~----~~~l~~l~~L~~L~L~~n~l~~~ 208 (1058)
+..+..+++|++|++++|.+.+..+..++. .++|++|++++|.+++.. +..+..+++|++|+|++|.+++.
T Consensus 106 ~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 185 (461)
T 1z7x_W 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA 185 (461)
T ss_dssp HHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchH
Confidence 444455555555555555554333333222 334555555555555422 33344455666666666655433
Q ss_pred CCCCcC-----CCCCcceeecccccccCC----CCccccCcCCccEEEeecCCCcCcCC-----ccccccCCcceeeccc
Q 043053 209 IPPEIG-----KLKKLEELFLWQNSLVGA----IPEEIGNCTSLKMIDFSLNSLSGTIP-----LSIGGLSELEEFMISD 274 (1058)
Q Consensus 209 ~~~~~~-----~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~-----~~~~~l~~L~~L~l~~ 274 (1058)
.+..+. .+++|++|++++|.+++. ++..+..+++|++|++++|.+++... ..+..+++|++|++++
T Consensus 186 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~ 265 (461)
T 1z7x_W 186 GVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265 (461)
T ss_dssp HHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcC
Confidence 222222 134566666666655542 23444555666666666665553221 1122355666666666
Q ss_pred CccCCC----ccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCccccccccccccc
Q 043053 275 NNVSGS----IPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT 350 (1058)
Q Consensus 275 n~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 350 (1058)
|.++.. ++..+..+++|++|+|++|.+++..+..+... .....++|+.|++++|.++
T Consensus 266 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~-------------------l~~~~~~L~~L~L~~n~l~ 326 (461)
T 1z7x_W 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET-------------------LLEPGCQLESLWVKSCSFT 326 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH-------------------HTSTTCCCCEEECTTSCCB
T ss_pred CCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH-------------------hccCCccceeeEcCCCCCc
Confidence 655532 34444455566666666665544322222211 0001124444444444444
Q ss_pred cc----CcccccccccchhhhccccCCCCCCCCCcc-----CCCCCcEEEccCccccC----CccccccCccccceeecc
Q 043053 351 AS----VPAGLFQLQNLTKLLLISNDISGSIPPEIG-----NCSSLVRLRVGNNRIAG----LIPREIGGLKTLNFLDLS 417 (1058)
Q Consensus 351 ~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls 417 (1058)
+. ++..+..+++|++|++++|.+++..+..+. ..++|++|+|++|++++ ..+..+..+++|++|+|+
T Consensus 327 ~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~ 406 (461)
T 1z7x_W 327 AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 406 (461)
T ss_dssp GGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECC
T ss_pred hHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECC
Confidence 32 222333334444444444444432222222 14577777777777774 456667777788888888
Q ss_pred CccCCC
Q 043053 418 SNRLSG 423 (1058)
Q Consensus 418 ~N~l~~ 423 (1058)
+|++++
T Consensus 407 ~N~i~~ 412 (461)
T 1z7x_W 407 NNCLGD 412 (461)
T ss_dssp SSSCCH
T ss_pred CCCCCH
Confidence 887764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=302.69 Aligned_cols=196 Identities=16% Similarity=0.082 Sum_probs=136.2
Q ss_pred eeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeEEEcCCCceE
Q 043053 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNNRLL 788 (1058)
Q Consensus 711 ~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 788 (1058)
..+.|++|.+..+ ..-.|+.||||++........ ....+.+...++|.+|+++|+++ .|+||+++++++.++...||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGI-LTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTC-SCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEeccccccc-chhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4567888877776 555699999999854322111 11112334457899999999999 69999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccC
Q 043053 789 MYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDD 868 (1058)
Q Consensus 789 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~ 868 (1058)
||||++||+|.+++++. ++++.. +|+.||++||+|+|++ |||||||||+|||++.+|.+||+|||+|+....
T Consensus 320 VMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999999863 556653 5899999999999999 999999999999999999999999999987654
Q ss_pred CCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 043053 869 GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 918 (1058)
Q Consensus 869 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~ 918 (1058)
.. ......+||+.|||||++.+. +..++|+||+|+++|++.++..|+
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 32 234567899999999998764 567899999999998887665443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-29 Score=284.92 Aligned_cols=281 Identities=16% Similarity=0.165 Sum_probs=163.9
Q ss_pred CCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhh
Q 043053 215 KLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQL 294 (1058)
Q Consensus 215 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 294 (1058)
.|+.....+++++.++ .+|..+. ++|++|++++|.+++..+..|.++++|++|++++|.+++..+..|.++++|++|
T Consensus 29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 3444455666666666 3444433 366666666666665555556666666666666666665555556666666666
Q ss_pred hhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCc-ccccccccchhhhcccc-C
Q 043053 295 QLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVP-AGLFQLQNLTKLLLISN-D 372 (1058)
Q Consensus 295 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N-~ 372 (1058)
+|++|+|+++.+. .|..+++|++|++++|++++..+ ..+..+++|++|++++| .
T Consensus 106 ~Ls~n~l~~~~~~------------------------~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~ 161 (353)
T 2z80_A 106 DLSYNYLSNLSSS------------------------WFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161 (353)
T ss_dssp ECCSSCCSSCCHH------------------------HHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSS
T ss_pred ECCCCcCCcCCHh------------------------HhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcc
Confidence 6666665544333 34445555555555555543222 23444555555555555 2
Q ss_pred CCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccc
Q 043053 373 ISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNS 452 (1058)
Q Consensus 373 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 452 (1058)
+.+..+..|.++++|++|++++|++++..|..|..+++|++|++++|++....+..+..+++|+.|++++|.+++..+..
T Consensus 162 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 241 (353)
T 2z80_A 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE 241 (353)
T ss_dssp CCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-
T ss_pred ccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccc
Confidence 44444445555555555555555555555555555555555555555554332223334555555555555555443332
Q ss_pred c---ccCCCCCeeecCCCcccc----CCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCC
Q 043053 453 L---SSLSGLQVLDVSDNRFSG----QIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 453 ~---~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
+ .....++.++|++|.+++ .+|..+..+++|+.|+|++|+++...+..|..+++|++|++++|++.+..|
T Consensus 242 l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 242 LSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp -----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 2 234556667777766654 356677888888888888888885444446889999999999999987554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-29 Score=274.41 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=197.1
Q ss_pred cEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCc
Q 043053 244 KMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQN 323 (1058)
Q Consensus 244 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N 323 (1058)
+.++++++.++ .+|..+. ++|++|++++|.++...+..|..+++|++|+|++|+++..
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~------------------- 67 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK------------------- 67 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEE-------------------
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcc-------------------
Confidence 45666666666 3343332 4566666666666644444455666666666666655422
Q ss_pred ccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCC-CCccCCCCCcEEEccCccccCCcc
Q 043053 324 QLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIP-PEIGNCSSLVRLRVGNNRIAGLIP 402 (1058)
Q Consensus 324 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~ 402 (1058)
+..+..+..+++|++|++++|.+. .+|..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+++..+
T Consensus 68 ---~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 143 (306)
T 2z66_A 68 ---GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 143 (306)
T ss_dssp ---EEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECST
T ss_pred ---cCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccch
Confidence 112456667788888888888888 467778888888888888888886655 578888999999999999988888
Q ss_pred ccccCccccceeeccCccCCC-CCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccc
Q 043053 403 REIGGLKTLNFLDLSSNRLSG-SVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLV 481 (1058)
Q Consensus 403 ~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 481 (1058)
..|..+++|++|+|++|.+++ ..|..+..+++|+.|++++|++++..|..|..+++|++|+|++|++++..+..+..++
T Consensus 144 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 223 (306)
T 2z66_A 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223 (306)
T ss_dssp TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCT
T ss_pred hhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcc
Confidence 888999999999999999876 5788888999999999999999987788899999999999999999877777888899
Q ss_pred cccccccccccCCCCCCCcccCCc-ccccccccCCcccCCC
Q 043053 482 SLNKIILSKNLFSGPIPSSLGLCS-SLQLLDLSSNQLTGSV 521 (1058)
Q Consensus 482 ~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~ 521 (1058)
+|+.|+|++|++.+..|..+..++ +|++|++++|++++..
T Consensus 224 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 224 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp TCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred cCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 999999999999988888888884 8999999999998653
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-32 Score=328.19 Aligned_cols=402 Identities=13% Similarity=0.070 Sum_probs=195.5
Q ss_pred CcccCCEEeccccCCCCcccccccc-chh-hhHHhhhhccc-cC-CChhhhcccccchhhhcCCCccccCC----CCccc
Q 043053 70 KLHNLEELILNSNQLTGKIPVELSN-CKS-LRKLLLFDNAL-AG-NIPAELGRLSNLEEMRAGGNKDIVGK----IPAEL 141 (1058)
Q Consensus 70 ~l~~L~~L~L~~n~~~~~~p~~l~~-l~~-L~~L~L~~n~~-~~-~~p~~l~~l~~L~~L~l~~~~~~~~~----l~~~l 141 (1058)
++++|++|+|++|.+.+..+..+.. +++ |++|+|++|.. .. .++..+.++++|++|++++|. +.+. ++..+
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~-~~~~~~~~l~~~~ 188 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESS-FSEKDGKWLHELA 188 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCE-EECCCSHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECcccc-ccCcchhHHHHHH
Confidence 4566666666666555444444444 233 66666655541 10 122223345555555555553 1122 11223
Q ss_pred cCCCCCceecccCcccc----ccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCC---CCCCCCcC
Q 043053 142 GDCSNMTALGLADTQVS----GSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLS---GSIPPEIG 214 (1058)
Q Consensus 142 ~~l~~L~~L~l~~~~~~----~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~---~~~~~~~~ 214 (1058)
..+++|++|++++|.+. +.++..+.++++|+.|++++|.+.+ ++..+..+++|++|+++.+... ...+..+.
T Consensus 189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~ 267 (592)
T 3ogk_B 189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV 267 (592)
T ss_dssp HHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC
T ss_pred hcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhh
Confidence 34555555555555554 1223333445555555555555542 4444555555555555532221 12223444
Q ss_pred CCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCC-ccccccCCcceeecccCccCCCccccccccccchh
Q 043053 215 KLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIP-LSIGGLSELEEFMISDNNVSGSIPANLANATNLVQ 293 (1058)
Q Consensus 215 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 293 (1058)
.+++|+.|+++++... .++..+..+++|++|+|++|.+++... ..+..+++|++|+++++......+..+..+++|++
T Consensus 268 ~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~ 346 (592)
T 3ogk_B 268 FPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKR 346 (592)
T ss_dssp CCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCE
T ss_pred ccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCE
Confidence 4555555555543222 334444455555555555555443222 22344555555555522111112222233444444
Q ss_pred hhhcC---CcccCcCCCcccccchhhhhhccCcccCCCC-ChhhhccCcccccccccccccccCcccccc-cccchhhhc
Q 043053 294 LQLDT---NQISGLIPPEIGMLSKLTVFFAWQNQLEGSI-PSTLASCSNLQALDLSHNSLTASVPAGLFQ-LQNLTKLLL 368 (1058)
Q Consensus 294 L~L~~---N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L 368 (1058)
|+|++ +..... ..|.++... ...+..+++|++|+++.|++++..+..+.. +++|+.|++
T Consensus 347 L~L~~g~~~~~~~~----------------~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l 410 (592)
T 3ogk_B 347 LRIERGADEQGMED----------------EEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRL 410 (592)
T ss_dssp EEEECCCCSSTTSS----------------TTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEE
T ss_pred EEeecCcccccccc----------------ccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEE
Confidence 44441 000000 012333221 112344667777777777776655555554 666777777
Q ss_pred c----ccCCCCC-----CCCCccCCCCCcEEEccCc--cccCCcccccc-CccccceeeccCccCCCC-CCCcccCCccc
Q 043053 369 I----SNDISGS-----IPPEIGNCSSLVRLRVGNN--RIAGLIPREIG-GLKTLNFLDLSSNRLSGS-VPDEIGDCTEL 435 (1058)
Q Consensus 369 ~----~N~l~~~-----~~~~~~~l~~L~~L~L~~N--~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L 435 (1058)
+ .|.+++. ++..+.++++|++|+|++| .+++..+..+. .+++|++|+|++|++++. .+..+..+++|
T Consensus 411 ~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L 490 (592)
T 3ogk_B 411 VLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNL 490 (592)
T ss_dssp EECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTC
T ss_pred eecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCccc
Confidence 5 5555542 1222455677777777643 25443333333 366777777777776642 23344566777
Q ss_pred chhhccCCccCCC-CccccccCCCCCeeecCCCccccCCcccc-ccccccccccccc
Q 043053 436 QMIDLSHNTLQGS-LPNSLSSLSGLQVLDVSDNRFSGQIPASL-GRLVSLNKIILSK 490 (1058)
Q Consensus 436 ~~L~l~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~ 490 (1058)
+.|++++|.+++. ++..+..+++|++|+|++|+++......+ ..++.+....+..
T Consensus 491 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~ 547 (592)
T 3ogk_B 491 QKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPS 547 (592)
T ss_dssp CEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECC
T ss_pred CeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecC
Confidence 7777777776543 33344567777777777777765433323 2344444444433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-31 Score=325.83 Aligned_cols=425 Identities=14% Similarity=0.124 Sum_probs=282.8
Q ss_pred CccccCCCCCcEEEccCCcC---CCCCCCCCC------------CCCcccEEecCCCCCCCCCChhhcCc--ccCCEEec
Q 043053 17 PTNLSSFKHLQTLVISDANL---TGSIPFDIG------------DCVGLIVLDFSSNNLVGTLPSSLGKL--HNLEELIL 79 (1058)
Q Consensus 17 p~~~~~~~~L~~L~l~~~~~---~~~~p~~l~------------~l~~L~~L~l~~~~i~~~lp~~l~~l--~~L~~L~L 79 (1058)
+..+.++++|++|+|++|.. .+.+|...+ .|++|++|+|++|.+++..+..+..+ .+|++|+|
T Consensus 66 ~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L 145 (592)
T 3ogk_B 66 DRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKL 145 (592)
T ss_dssp HHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEE
T ss_pred HHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEEC
Confidence 44567899999999998654 234555555 68999999999999987777778774 45999999
Q ss_pred cccC-CCC-ccccccccchhhhHHhhhhccccCC----ChhhhcccccchhhhcCCCccc---cCCCCccccCCCCCcee
Q 043053 80 NSNQ-LTG-KIPVELSNCKSLRKLLLFDNALAGN----IPAELGRLSNLEEMRAGGNKDI---VGKIPAELGDCSNMTAL 150 (1058)
Q Consensus 80 ~~n~-~~~-~~p~~l~~l~~L~~L~L~~n~~~~~----~p~~l~~l~~L~~L~l~~~~~~---~~~l~~~l~~l~~L~~L 150 (1058)
++|. +.. .++..+.+|++|++|+|++|.+.+. ++..+.++++|++|++++|... ...++..+..+++|+.|
T Consensus 146 ~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L 225 (592)
T 3ogk_B 146 DKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSV 225 (592)
T ss_dssp ESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEE
T ss_pred cCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEE
Confidence 9996 221 2334445899999999999998765 4556678999999999988721 12344456779999999
Q ss_pred cccCccccccCCccccCCCccceeeeeccccc---cccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccc
Q 043053 151 GLADTQVSGSLPASLGKLSKLQTLSIYTTMIS---GEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQN 227 (1058)
Q Consensus 151 ~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~---~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 227 (1058)
++++|.+. .++..+.++++|+.|+++.+... ...+..+..+++|+.|+++++... .+|..+..+++|++|+|++|
T Consensus 226 ~L~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~ 303 (592)
T 3ogk_B 226 KVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYA 303 (592)
T ss_dssp ECSSCBGG-GGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTC
T ss_pred eccCccHH-HHHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCC
Confidence 99999987 47788999999999999864332 345567889999999999987544 67888889999999999999
Q ss_pred cccCCCC-ccccCcCCccEEEeecCCCcC-cCCccccccCCcceeeccc-----------CccCCCcc-ccccccccchh
Q 043053 228 SLVGAIP-EEIGNCTSLKMIDFSLNSLSG-TIPLSIGGLSELEEFMISD-----------NNVSGSIP-ANLANATNLVQ 293 (1058)
Q Consensus 228 ~l~~~~~-~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~-----------n~l~~~~~-~~~~~l~~L~~ 293 (1058)
.+.+... ..+..+++|++|+++ +.+.+ .++..+..+++|++|++++ |.+++... ..+..+++|++
T Consensus 304 ~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 382 (592)
T 3ogk_B 304 LLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEY 382 (592)
T ss_dssp CCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSE
T ss_pred cCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeE
Confidence 9764433 336889999999999 44443 3344446789999999994 55653322 23445788888
Q ss_pred hhhcCCcccCcCCCcccc-cchhhhhhcc----CcccCCC-----CChhhhccCccccccccccc--ccccCcccccccc
Q 043053 294 LQLDTNQISGLIPPEIGM-LSKLTVFFAW----QNQLEGS-----IPSTLASCSNLQALDLSHNS--LTASVPAGLFQLQ 361 (1058)
Q Consensus 294 L~L~~N~i~~~~~~~~~~-l~~L~~L~l~----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~~l~ 361 (1058)
|+++.|.+++..+..+.. +++|+.|++. .|.+++. ++..+.++++|+.|++++|. +++..+..+..
T Consensus 383 L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~-- 460 (592)
T 3ogk_B 383 MAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQ-- 460 (592)
T ss_dssp EEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHH--
T ss_pred EEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHH--
Confidence 888878877655544443 5666666664 4555543 22234556666666665322 33322222221
Q ss_pred cchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCC-ccccccCccccceeeccCccCCCC-CCCcccCCcccchhh
Q 043053 362 NLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGL-IPREIGGLKTLNFLDLSSNRLSGS-VPDEIGDCTELQMID 439 (1058)
Q Consensus 362 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~ 439 (1058)
.+++|+.|+|++|++++. .+..+.++++|++|+|++|.+++. .+..+..+++|+.|+
T Consensus 461 ---------------------~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 519 (592)
T 3ogk_B 461 ---------------------YSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLW 519 (592)
T ss_dssp ---------------------SCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEE
T ss_pred ---------------------hCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeE
Confidence 244555555555555432 233345555666666666655422 222233455666666
Q ss_pred ccCCccCCCCcccc-ccCCCCCeeecCCC
Q 043053 440 LSHNTLQGSLPNSL-SSLSGLQVLDVSDN 467 (1058)
Q Consensus 440 l~~N~l~~~~~~~~-~~l~~L~~L~L~~N 467 (1058)
|++|++++.....+ ..++.+....+..+
T Consensus 520 ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 520 VQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp EESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred CcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 66666554322222 23455544444433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-29 Score=283.01 Aligned_cols=278 Identities=19% Similarity=0.206 Sum_probs=156.4
Q ss_pred CCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceee
Q 043053 192 CSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFM 271 (1058)
Q Consensus 192 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 271 (1058)
|+.....+++++.++ .+|..+. ++|++|++++|.+++..+..|..+++|++|++++|.+++..+..|+++++|++|+
T Consensus 30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 344445666666666 4555443 3677777777776655555666777777777777777666666677777777777
Q ss_pred cccCccCCCccccccccccchhhhhcCCcccCcCC-CcccccchhhhhhccCcccCCCCChhhhccCccccccccccccc
Q 043053 272 ISDNNVSGSIPANLANATNLVQLQLDTNQISGLIP-PEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT 350 (1058)
Q Consensus 272 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 350 (1058)
+++|.+++..+..|..+++|++|+|++|+++++.+ ..|..+++|++|++++|+ .+.
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~-----------------------~~~ 163 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD-----------------------TFT 163 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS-----------------------SCC
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCc-----------------------ccc
Confidence 77777776555556777777777777777665433 234444444444433331 233
Q ss_pred ccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCccc
Q 043053 351 ASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIG 430 (1058)
Q Consensus 351 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 430 (1058)
...+..+..+++|++|++++|.+++..|..|..+++|++|++++|+++.+.+..+..+++|++|++++|++++..+..+.
T Consensus 164 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 243 (353)
T 2z80_A 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243 (353)
T ss_dssp EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC---
T ss_pred ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccc
Confidence 22233333444444444444444444444555555555555555555444333344455555555555555544333222
Q ss_pred ---CCcccchhhccCCccCC----CCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCC
Q 043053 431 ---DCTELQMIDLSHNTLQG----SLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495 (1058)
Q Consensus 431 ---~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 495 (1058)
....++.++|++|.+++ .+|..+..+++|+.|++++|+++...+..|..+++|+.|+|++|++.+
T Consensus 244 ~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 244 TGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp ---CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence 23344555555555543 255667777777777777777773333335677777777777777764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=272.06 Aligned_cols=281 Identities=21% Similarity=0.222 Sum_probs=166.9
Q ss_pred cEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCc--CCccccccCCcceeecc
Q 043053 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGT--IPLSIGGLSELEEFMIS 273 (1058)
Q Consensus 196 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~l~ 273 (1058)
+.++.+++.++ .+|..+. ++|++|+|++|.+....+..|..+++|++|+|++|.++.. .+..+.++++|++|+++
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 34555565555 4444332 4566666666666644334456666666666666666522 23444556666666666
Q ss_pred cCccCCCccccccccccchhhhhcCCcccCcCC-CcccccchhhhhhccCcccCCCCChhhhccCccccccccccccccc
Q 043053 274 DNNVSGSIPANLANATNLVQLQLDTNQISGLIP-PEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTAS 352 (1058)
Q Consensus 274 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 352 (1058)
+|.+. ..+..+..+++|++|++++|++++..+ ..|..+ ++|++|++++|.+.+.
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l------------------------~~L~~L~l~~n~l~~~ 141 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL------------------------RNLIYLDISHTHTRVA 141 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTC------------------------TTCCEEECTTSCCEEC
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhc------------------------cCCCEEECCCCcCCcc
Confidence 66665 244456666666666666666655433 233334 4444444444444443
Q ss_pred CcccccccccchhhhccccCCCC-CCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccC
Q 043053 353 VPAGLFQLQNLTKLLLISNDISG-SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD 431 (1058)
Q Consensus 353 ~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 431 (1058)
.+..+..+++|++|++++|.+++ ..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..
T Consensus 142 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp STTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred chhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 44444444444444444444443 34556666677777777777777666667777777777777777777666666777
Q ss_pred CcccchhhccCCccCCCCccccccCC-CCCeeecCCCccccCCc--ccccccccccccccccccCCCCCCCcccCC
Q 043053 432 CTELQMIDLSHNTLQGSLPNSLSSLS-GLQVLDVSDNRFSGQIP--ASLGRLVSLNKIILSKNLFSGPIPSSLGLC 504 (1058)
Q Consensus 432 l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 504 (1058)
+++|+.|++++|++++..|..+..++ +|++|+|++|++++..+ .....+...+.+....+.+....|..+.+.
T Consensus 222 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g~ 297 (306)
T 2z66_A 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 297 (306)
T ss_dssp CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTTC
T ss_pred cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCCc
Confidence 77777777777777777777777774 78888888887765322 112234455566667777776667766653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=266.32 Aligned_cols=238 Identities=24% Similarity=0.250 Sum_probs=159.2
Q ss_pred CCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcc-cCCCCChhhhccCcccccc
Q 043053 265 SELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQ-LEGSIPSTLASCSNLQALD 343 (1058)
Q Consensus 265 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~ 343 (1058)
++|++|++++|.+++..+..|..+++|++|+|++|+++++.+..|..+++|++|++++|. ++...+..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 344444444444444444444455555555555555554445555555555555555554 4445556666677777777
Q ss_pred cccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCC
Q 043053 344 LSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG 423 (1058)
Q Consensus 344 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 423 (1058)
+++|++++..+..+..+++|++|++++|.+++..+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|++++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 77777776656666677777777777777776666667778888888888888887777778888888888888888887
Q ss_pred CCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccC
Q 043053 424 SVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGL 503 (1058)
Q Consensus 424 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 503 (1058)
..|..|..+++|+.|++++|++++..+..|..+++|+.|++++|++....+. ..-...++.+..+.|.+....|..+.+
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHhCC
Confidence 7788888888888888888888876667788888888888888888643322 122234566666777777666666543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=273.29 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=180.1
Q ss_pred ccccchhhhhhccCcccCCCCChhhhccCccccccccccccc-ccCccccc-------ccccchhhhccccCCCCCCCCC
Q 043053 309 IGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT-ASVPAGLF-------QLQNLTKLLLISNDISGSIPPE 380 (1058)
Q Consensus 309 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~ 380 (1058)
++..++|+.|++++|.+ .+|..+... |+.|+|++|.+. ..+|..+. .+++|++|+|++|++++..|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34444555555555555 344444433 677777777773 23444443 5677777888888877777776
Q ss_pred c--cCCCCCcEEEccCccccCCccccccCc-----cccceeeccCccCCCCCCCcccCCcccchhhccCCccCCC--Ccc
Q 043053 381 I--GNCSSLVRLRVGNNRIAGLIPREIGGL-----KTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGS--LPN 451 (1058)
Q Consensus 381 ~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~ 451 (1058)
+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+.+++|+.|+|++|++.+. .+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 5 7788888888888888877 7777776 7888888888888877778888888888888888887653 233
Q ss_pred cc--ccCCCCCeeecCCCccccC--Cc-ccccccccccccccccccCCCCCC-CcccCCcccccccccCCcccCCCChhh
Q 043053 452 SL--SSLSGLQVLDVSDNRFSGQ--IP-ASLGRLVSLNKIILSKNLFSGPIP-SSLGLCSSLQLLDLSSNQLTGSVPMEL 525 (1058)
Q Consensus 452 ~~--~~l~~L~~L~L~~N~l~~~--~~-~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~ 525 (1058)
.+ ..+++|++|+|++|+|++. ++ ..+..+++|+.|+|++|++++..| ..+..+++|+.|++++|+|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 34 7888888888888888731 12 334567888888888888887664 45667788899999988887 555432
Q ss_pred hhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCCcccccCcceeEEEecccccc
Q 043053 526 GQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTG 591 (1058)
Q Consensus 526 ~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~ 591 (1058)
. ++|+.|||++|+|++.+. +..+++|+.|++++|+|++
T Consensus 273 -------------------------~--~~L~~L~Ls~N~l~~~p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 -------------------------P--AKLSVLDLSYNRLDRNPS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -------------------------C--SEEEEEECCSSCCCSCCC-TTTSCEEEEEECTTCTTTC
T ss_pred -------------------------c--CCceEEECCCCCCCCChh-HhhCCCCCEEeccCCCCCC
Confidence 2 678888888888888744 7888888888888888875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=267.22 Aligned_cols=237 Identities=22% Similarity=0.270 Sum_probs=204.5
Q ss_pred CCCCCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHH
Q 043053 22 SFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKL 101 (1058)
Q Consensus 22 ~~~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L 101 (1058)
....+++|+|++|+++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|+|++|++. .+|..++++++|++|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 3478899999999988 78888888999999999999998 89988999999999999999988 788889999999999
Q ss_pred hhhhccccCCChhhhcccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeecccc
Q 043053 102 LLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMI 181 (1058)
Q Consensus 102 ~L~~n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i 181 (1058)
++++|.+.+.+|..++.. .++..++.+++|++|++++|+++ .+|..++++++|++|++++|.+
T Consensus 156 ~L~~n~~~~~~p~~~~~~----------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l 218 (328)
T 4fcg_A 156 SIRACPELTELPEPLAST----------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218 (328)
T ss_dssp EEEEETTCCCCCSCSEEE----------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCC
T ss_pred ECCCCCCccccChhHhhc----------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCC
Confidence 999988887888766542 12234667888999999999888 8888899999999999999998
Q ss_pred ccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccc
Q 043053 182 SGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSI 261 (1058)
Q Consensus 182 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~ 261 (1058)
. .+|..++.+++|++|+|++|.+.+.+|..|+.+++|++|+|++|.+.+.+|..+..+++|++|+|++|.+.+.+|..+
T Consensus 219 ~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l 297 (328)
T 4fcg_A 219 S-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297 (328)
T ss_dssp C-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGG
T ss_pred C-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHH
Confidence 8 466678899999999999999888899999999999999999998888889889999999999999999988999999
Q ss_pred cccCCcceeecccCccCC
Q 043053 262 GGLSELEEFMISDNNVSG 279 (1058)
Q Consensus 262 ~~l~~L~~L~l~~n~l~~ 279 (1058)
+.+++|+.+++..+.+..
T Consensus 298 ~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 298 AQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp GGSCTTCEEECCGGGSCC
T ss_pred hhccCceEEeCCHHHHHH
Confidence 999999999988876653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-28 Score=263.69 Aligned_cols=248 Identities=23% Similarity=0.248 Sum_probs=164.9
Q ss_pred hhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccC-CCCCCCCCccCCCCCcEEEc
Q 043053 314 KLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISND-ISGSIPPEIGNCSSLVRLRV 392 (1058)
Q Consensus 314 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L 392 (1058)
+|++|++++|++++..+..|..+++|++|++++|.+++..+..+..+++|++|++++|. +....+..|..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 33444444444444444455556666666666666665555566666666666666665 55555667777777777777
Q ss_pred cCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccC
Q 043053 393 GNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQ 472 (1058)
Q Consensus 393 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 472 (1058)
++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|+|++|++++..+..|..+++|++|++++|++++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 77777777777777777777777777777766666677777788888888877766666677788888888888888777
Q ss_pred CcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccc
Q 043053 473 IPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISA 552 (1058)
Q Consensus 473 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~ 552 (1058)
.|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++....+.. .-...+ ..+..+.|.+....|..+.+
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l-~~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWL-QKFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHH-HHCCSEECCCBEEESGGGTT
T ss_pred CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHH-HhcccccCccccCCchHhCC
Confidence 7777888888888888888888766667788888888888888887544322 111222 23456666666666665543
Q ss_pred --cccccEEecCC
Q 043053 553 --LNKLSILDLSH 563 (1058)
Q Consensus 553 --l~~L~~L~L~~ 563 (1058)
+..++..++.+
T Consensus 271 ~~l~~l~~~~l~~ 283 (285)
T 1ozn_A 271 RDLKRLAANDLQG 283 (285)
T ss_dssp CBGGGSCGGGSCC
T ss_pred cChhhcCHHHhcc
Confidence 33344444433
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=279.51 Aligned_cols=229 Identities=23% Similarity=0.246 Sum_probs=175.5
Q ss_pred cchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhcc
Q 043053 290 NLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLI 369 (1058)
Q Consensus 290 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 369 (1058)
++++|+|++|+|+++.+..|..+++|++|++++|+|+++.+..|.++++|++|+|++|+++...+..|..+++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 34444444444444444445555555555555555555555566666777777777777775555556667777777777
Q ss_pred ccCCCCCCCCCccCCCCCcEEEccC-ccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCC
Q 043053 370 SNDISGSIPPEIGNCSSLVRLRVGN-NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGS 448 (1058)
Q Consensus 370 ~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 448 (1058)
+|+|+...+..|.++++|+.|+|++ |.+..+.+..|.++++|++|+|++|++++. | .+..+++|+.|+|++|+|++.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEE
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCccc
Confidence 7777766666788888888888888 566666666788899999999999998854 3 478889999999999999988
Q ss_pred CccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCC
Q 043053 449 LPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGS 520 (1058)
Q Consensus 449 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 520 (1058)
.|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 889999999999999999999988888999999999999999999988888889999999999999998743
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=278.17 Aligned_cols=247 Identities=20% Similarity=0.241 Sum_probs=124.0
Q ss_pred ccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeeccc
Q 043053 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISD 274 (1058)
Q Consensus 195 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 274 (1058)
...++.+++.++ .+|..+. ++|+.|+|++|.+.+..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 345555555555 4454333 4556666666666555555555556666666666655555555555555555555555
Q ss_pred CccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCccccccccc-ccccccC
Q 043053 275 NNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSH-NSLTASV 353 (1058)
Q Consensus 275 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~ 353 (1058)
|.++...+..|..+++|++|+|++|+|+.+ .+..|..+++|+.|++++ |.+....
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------------------------~~~~~~~l~~L~~L~l~~~~~l~~i~ 188 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESI------------------------PSYAFNRVPSLMRLDLGELKKLEYIS 188 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEE------------------------CTTTTTTCTTCCEEECCCCTTCCEEC
T ss_pred CcCCccChhhhcccCCCCEEECCCCCccee------------------------CHhHHhcCCcccEEeCCCCCCccccC
Confidence 555544444444444444444444444433 333444455555555555 2232222
Q ss_pred cccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCc
Q 043053 354 PAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCT 433 (1058)
Q Consensus 354 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 433 (1058)
+..|..+++|++|+|++|++++. | .+..+++|+.|+|++|+|+++.|..|.++++|++|+|++|++++..+..|..++
T Consensus 189 ~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 266 (452)
T 3zyi_A 189 EGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA 266 (452)
T ss_dssp TTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred hhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCC
Confidence 22233344444444444444422 1 244455555555555555555555555555555555555555544455555555
Q ss_pred ccchhhccCCccCCCCccccccCCCCCeeecCCCccc
Q 043053 434 ELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470 (1058)
Q Consensus 434 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 470 (1058)
+|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 267 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 267 SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 5555555555555444444444555555555555443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=276.48 Aligned_cols=246 Identities=20% Similarity=0.255 Sum_probs=119.9
Q ss_pred ccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeeccc
Q 043053 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISD 274 (1058)
Q Consensus 195 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 274 (1058)
...++.+++.++ .+|..+. ++++.|+|++|++.+..+..|.++++|++|+|++|.+.+..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 445666666665 4554443 4566666666666655555566666666666666666555555555555555555555
Q ss_pred CccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccc-cccccC
Q 043053 275 NNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHN-SLTASV 353 (1058)
Q Consensus 275 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~ 353 (1058)
|+++...+..|..+++|++|+|++|+|+.+ .+..|..+++|+.|++++| .+....
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~------------------------~~~~~~~l~~L~~L~l~~~~~l~~i~ 177 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESI------------------------PSYAFNRIPSLRRLDLGELKRLSYIS 177 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEE------------------------CTTTTTTCTTCCEEECCCCTTCCEEC
T ss_pred CcCCeeCHhHhhccccCceeeCCCCccccc------------------------CHHHhhhCcccCEeCCCCCCCcceeC
Confidence 555544444455555555555555544433 3334444455555555542 222212
Q ss_pred cccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCc
Q 043053 354 PAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCT 433 (1058)
Q Consensus 354 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 433 (1058)
+..|..+++|++|+|++|+++. +| .+..+++|+.|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|..++
T Consensus 178 ~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 255 (440)
T 3zyj_A 178 EGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255 (440)
T ss_dssp TTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCT
T ss_pred cchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCC
Confidence 2223333333333333333331 11 234444455555555555444444444455555555555544444444444444
Q ss_pred ccchhhccCCccCCCCccccccCCCCCeeecCCCcc
Q 043053 434 ELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469 (1058)
Q Consensus 434 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 469 (1058)
+|+.|+|++|+|+++.+..|..+++|+.|+|++|.+
T Consensus 256 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~ 291 (440)
T 3zyj_A 256 SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291 (440)
T ss_dssp TCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCE
T ss_pred CCCEEECCCCCCCccChhHhccccCCCEEEcCCCCc
Confidence 444444444444444444444444444444444444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=275.58 Aligned_cols=248 Identities=22% Similarity=0.233 Sum_probs=205.7
Q ss_pred ccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEee
Q 043053 170 KLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFS 249 (1058)
Q Consensus 170 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 249 (1058)
..+.++..+..++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|.+.+..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4567777777776 6777665 689999999999998888999999999999999999998888899999999999999
Q ss_pred cCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCC-cccCcCCCcccccchhhhhhccCcccCCC
Q 043053 250 LNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTN-QISGLIPPEIGMLSKLTVFFAWQNQLEGS 328 (1058)
Q Consensus 250 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 328 (1058)
+|+++...+..|..+++|++|++++|.+....+..|..+++|++|+|++| .+..+.
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~----------------------- 177 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS----------------------- 177 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC-----------------------
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeC-----------------------
Confidence 99999877788999999999999999999888888999999999999884 444333
Q ss_pred CChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCc
Q 043053 329 IPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGL 408 (1058)
Q Consensus 329 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 408 (1058)
+..|.++++|++|+|++|+++. +| .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|+++.+..|.++
T Consensus 178 -~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 254 (440)
T 3zyj_A 178 -EGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254 (440)
T ss_dssp -TTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred -cchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence 3345566666666666666663 33 35667777777788887777777888888888888888888888888888888
Q ss_pred cccceeeccCccCCCCCCCcccCCcccchhhccCCccC
Q 043053 409 KTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446 (1058)
Q Consensus 409 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 446 (1058)
++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 88888888888888777778888888888888888875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=262.43 Aligned_cols=237 Identities=25% Similarity=0.330 Sum_probs=203.5
Q ss_pred CCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhhhccccCCChhhhcccccchhhh
Q 043053 47 CVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMR 126 (1058)
Q Consensus 47 l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~ 126 (1058)
..++++|+|++|+++ .+|..++++++|++|+|++|++. .+|..++++++|++|+|++|.+. .+|..++++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 467889999999988 88888888999999999999888 88888888888888888888887 7777777777777777
Q ss_pred cCCCccccCCCCccccCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCC
Q 043053 127 AGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLS 206 (1058)
Q Consensus 127 l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~ 206 (1058)
+++|. ..+.+|..++.. ..+..|.++++|++|++++|.++ .+|..++.+++|++|+|++|.++
T Consensus 157 L~~n~-~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 157 IRACP-ELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EEEET-TCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred CCCCC-CccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence 77654 234445443321 12334567999999999999998 88999999999999999999999
Q ss_pred CCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCcccccc
Q 043053 207 GSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLA 286 (1058)
Q Consensus 207 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 286 (1058)
.+|..++.+++|++|+|++|.+.+.+|..|..+++|++|+|++|.+.+.+|..++++++|++|++++|++.+.+|..+.
T Consensus 220 -~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~ 298 (328)
T 4fcg_A 220 -ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298 (328)
T ss_dssp -CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGG
T ss_pred -cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHh
Confidence 4777899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhcCCcccCc
Q 043053 287 NATNLVQLQLDTNQISGL 304 (1058)
Q Consensus 287 ~l~~L~~L~L~~N~i~~~ 304 (1058)
.+++|+.+++..|.+...
T Consensus 299 ~L~~L~~l~l~~~~~~~l 316 (328)
T 4fcg_A 299 QLPANCIILVPPHLQAQL 316 (328)
T ss_dssp GSCTTCEEECCGGGSCC-
T ss_pred hccCceEEeCCHHHHHHH
Confidence 999999999998877644
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-28 Score=270.25 Aligned_cols=249 Identities=21% Similarity=0.216 Sum_probs=180.3
Q ss_pred ccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccC-CCCChhhh-------ccCcccccccccccccccCccc
Q 043053 285 LANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLE-GSIPSTLA-------SCSNLQALDLSHNSLTASVPAG 356 (1058)
Q Consensus 285 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~ 356 (1058)
++..++|+.|++++|.+ ..|..+... |+.|++++|+++ ..++..+. .+++|++|+|++|++++..|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 44455566666666666 334433332 666666666663 23444443 5778888888888888777776
Q ss_pred c--cccccchhhhccccCCCCCCCCCccCC-----CCCcEEEccCccccCCccccccCccccceeeccCccCCCC--CCC
Q 043053 357 L--FQLQNLTKLLLISNDISGSIPPEIGNC-----SSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGS--VPD 427 (1058)
Q Consensus 357 ~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~ 427 (1058)
+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|+|+++.+..|+.+++|++|+|++|++.+. .+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 6 6788888888888888866 7777766 7888888888888888878888888888888888887653 222
Q ss_pred cc--cCCcccchhhccCCccCC---CCccccccCCCCCeeecCCCccccCCc-ccccccccccccccccccCCCCCCCcc
Q 043053 428 EI--GDCTELQMIDLSHNTLQG---SLPNSLSSLSGLQVLDVSDNRFSGQIP-ASLGRLVSLNKIILSKNLFSGPIPSSL 501 (1058)
Q Consensus 428 ~~--~~l~~L~~L~l~~N~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 501 (1058)
.+ ..+++|+.|+|++|+|++ .....+..+++|++|+|++|++++..| ..+..+++|+.|+|++|+|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 33 778888888888888873 222445677888888888888887665 45666788888888888888 566666
Q ss_pred cCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccC
Q 043053 502 GLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEG 568 (1058)
Q Consensus 502 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 568 (1058)
. ++|++|++++|+|++. | . +..+++|+.|+|++|++++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p-------------------------~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-P-------------------------S-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-C-------------------------C-TTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCC-h-------------------------h-HhhCCCCCEEeccCCCCCC
Confidence 5 7888888888888742 2 2 4567888888888888875
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-28 Score=275.30 Aligned_cols=180 Identities=19% Similarity=0.251 Sum_probs=107.3
Q ss_pred ccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCccc-CCcccchhh
Q 043053 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIG-DCTELQMID 439 (1058)
Q Consensus 361 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~ 439 (1058)
++|++|++++|++++..+.. +++|++|++++|+++++.+..|..+++|++|+|++|.+++..+..+. .+++|+.|+
T Consensus 99 ~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 175 (317)
T 3o53_A 99 PSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (317)
T ss_dssp TTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence 34444444444444332222 34566666666666666565666666666666666666655555443 556666666
Q ss_pred ccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCccc-
Q 043053 440 LSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT- 518 (1058)
Q Consensus 440 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~- 518 (1058)
|++|+|++. + ....+++|++|+|++|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++
T Consensus 176 L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 176 LQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp CTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred CCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence 666666643 2 22336667777777777763 3344666677777777777776 35566667777777777777776
Q ss_pred CCCChhhhhhHHHHHHHhhc-cCCCCCCCCc
Q 043053 519 GSVPMELGQIEALEIALNLS-CNGLTGPIPA 548 (1058)
Q Consensus 519 ~~~p~~~~~l~~l~~~l~ls-~N~l~~~~~~ 548 (1058)
+.+|.++..++.++. ++++ .+.+++..+.
T Consensus 252 ~~~~~~~~~~~~L~~-l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 252 GTLRDFFSKNQRVQT-VAKQTVKKLTGQNEE 281 (317)
T ss_dssp HHHHHHHHTCHHHHH-HHHHHHHHHHSSSSC
T ss_pred cCHHHHHhccccceE-EECCCchhccCCchh
Confidence 566666776666653 5555 4455554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-28 Score=273.14 Aligned_cols=267 Identities=20% Similarity=0.194 Sum_probs=147.3
Q ss_pred ccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeeccc
Q 043053 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISD 274 (1058)
Q Consensus 195 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 274 (1058)
++.++++.+.+...+...+..+++|++|+|++|.+.+..+..|..+++|++|+|++|.+++..+ +..+++|++|++++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 3344445544442233334445566666666666665555556666666666666666654333 55555566666665
Q ss_pred CccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCc
Q 043053 275 NNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVP 354 (1058)
Q Consensus 275 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 354 (1058)
|.+++.. ..++|++|++++|+|++..+. .+++|+.|++++|++++..+
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---------------------------~~~~L~~L~l~~N~l~~~~~ 137 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRVSCS---------------------------RGQGKKNIYLANNKITMLRD 137 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEEEEC---------------------------CCSSCEEEECCSSCCCSGGG
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCcCcc---------------------------ccCCCCEEECCCCCCCCccc
Confidence 5554211 224455555555554433221 13445555555555554444
Q ss_pred ccccccccchhhhccccCCCCCCCCCc-cCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCc
Q 043053 355 AGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCT 433 (1058)
Q Consensus 355 ~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 433 (1058)
..+..+++|++|+|++|.+++..+..+ ..+++|++|+|++|.|+++. ....+++|++|+|++|++++. |..+..++
T Consensus 138 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~ 214 (317)
T 3o53_A 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFM-GPEFQSAA 214 (317)
T ss_dssp BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEE-CGGGGGGT
T ss_pred hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcc-hhhhcccC
Confidence 455555555555555555554444444 24566666666666666542 222366666666666666643 33366666
Q ss_pred ccchhhccCCccCCCCccccccCCCCCeeecCCCccc-cCCcccccccccccccccc-cccCCCCCCC
Q 043053 434 ELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS-GQIPASLGRLVSLNKIILS-KNLFSGPIPS 499 (1058)
Q Consensus 434 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls-~N~l~~~~~~ 499 (1058)
+|+.|+|++|+|++ +|..+..+++|+.|++++|++. +.+|..+..++.|+.|+++ .+.+.+..|.
T Consensus 215 ~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 215 GVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp TCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred cccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 67777777776663 4556666677777777777766 5556666666667777666 3334444433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-26 Score=271.18 Aligned_cols=269 Identities=28% Similarity=0.316 Sum_probs=204.6
Q ss_pred CCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeec
Q 043053 193 SELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMI 272 (1058)
Q Consensus 193 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 272 (1058)
.+++.|++++|.++ .+|..+. ++|+.|+|++|.++ .+|. .+++|++|+|++|++++ +|. .+++|++|++
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 35899999999998 6777665 78999999999988 4454 56889999999999884 444 6788888888
Q ss_pred ccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCccccccccccccccc
Q 043053 273 SDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTAS 352 (1058)
Q Consensus 273 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 352 (1058)
++|.+++... .+++|+.|++++|+|+.+.+ .+++|++|+|++|++++
T Consensus 109 s~N~l~~l~~----~l~~L~~L~L~~N~l~~lp~----------------------------~l~~L~~L~Ls~N~l~~- 155 (622)
T 3g06_A 109 FSNPLTHLPA----LPSGLCKLWIFGNQLTSLPV----------------------------LPPGLQELSVSDNQLAS- 155 (622)
T ss_dssp CSCCCCCCCC----CCTTCCEEECCSSCCSCCCC----------------------------CCTTCCEEECCSSCCSC-
T ss_pred cCCcCCCCCC----CCCCcCEEECCCCCCCcCCC----------------------------CCCCCCEEECcCCcCCC-
Confidence 8888875333 45667777777777664321 12567777777777764
Q ss_pred CcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCC
Q 043053 353 VPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC 432 (1058)
Q Consensus 353 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 432 (1058)
+|. ..++|+.|++++|.|++ +| ..+++|+.|++++|.|+++.+ .+++|+.|++++|.++. +|.. +
T Consensus 156 l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~-l~~~---~ 220 (622)
T 3g06_A 156 LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPT----LPSELYKLWAYNNRLTS-LPAL---P 220 (622)
T ss_dssp CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS-CCCC---C
T ss_pred cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCC----ccchhhEEECcCCcccc-cCCC---C
Confidence 343 23567777888888875 44 446788888898888886532 24788899999998884 4432 4
Q ss_pred cccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccc
Q 043053 433 TELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDL 512 (1058)
Q Consensus 433 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 512 (1058)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|..+++|+.|+|
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 788999999999986 45 45688999999999998 4555 5678999999999998 67888999999999999
Q ss_pred cCCcccCCCChhhhhhH
Q 043053 513 SSNQLTGSVPMELGQIE 529 (1058)
Q Consensus 513 ~~N~l~~~~p~~~~~l~ 529 (1058)
++|++++.+|..+..+.
T Consensus 292 ~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 292 EGNPLSERTLQALREIT 308 (622)
T ss_dssp CSCCCCHHHHHHHHHHH
T ss_pred cCCCCCCcCHHHHHhcc
Confidence 99999987777765544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=269.67 Aligned_cols=266 Identities=30% Similarity=0.389 Sum_probs=136.6
Q ss_pred CCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecc
Q 043053 146 NMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLW 225 (1058)
Q Consensus 146 ~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 225 (1058)
+++.|++++|.++ .+|..+. ++|+.|++++|.++ .+|. .+++|++|+|++|.++ .+|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence 4566666666665 5555544 45666666666555 3333 3455666666666555 3333 44555555555
Q ss_pred cccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcC
Q 043053 226 QNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLI 305 (1058)
Q Consensus 226 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~ 305 (1058)
+|.+.+. |. .+++|+.|++++|++++ +|.. +++|++|+ |++|+|+++
T Consensus 110 ~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~------------------------Ls~N~l~~l- 156 (622)
T 3g06_A 110 SNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELS------------------------VSDNQLASL- 156 (622)
T ss_dssp SCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEE------------------------CCSSCCSCC-
T ss_pred CCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEE------------------------CcCCcCCCc-
Confidence 5555532 22 34455555555555543 2221 24444444 444444432
Q ss_pred CCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCC
Q 043053 306 PPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCS 385 (1058)
Q Consensus 306 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 385 (1058)
|. .+++|+.|++++|+++++ | ..+++|+.|++++|+|++ +|.. .++|+.|++++|.++. +|.. ++
T Consensus 157 ~~---~~~~L~~L~L~~N~l~~l-~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~ 221 (622)
T 3g06_A 157 PA---LPSELCKLWAYNNQLTSL-P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PS 221 (622)
T ss_dssp CC---CCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CT
T ss_pred CC---ccCCCCEEECCCCCCCCC-c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CC
Confidence 11 122333344444444432 2 234556666666666663 3322 2455555666665553 2221 25
Q ss_pred CCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecC
Q 043053 386 SLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVS 465 (1058)
Q Consensus 386 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 465 (1058)
+|+.|+|++|.|+++ | ..+++|++|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|+
T Consensus 222 ~L~~L~Ls~N~L~~l-p---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 222 GLKELIVSGNRLTSL-P---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCEEEccCCccCcC-C---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 566666666666653 2 334566666666666653 332 3455666666666666 345556666666666666
Q ss_pred CCccccCCcccccc
Q 043053 466 DNRFSGQIPASLGR 479 (1058)
Q Consensus 466 ~N~l~~~~~~~~~~ 479 (1058)
+|++++..|..+..
T Consensus 293 ~N~l~~~~~~~l~~ 306 (622)
T 3g06_A 293 GNPLSERTLQALRE 306 (622)
T ss_dssp SCCCCHHHHHHHHH
T ss_pred CCCCCCcCHHHHHh
Confidence 66666555544443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=274.70 Aligned_cols=195 Identities=14% Similarity=0.163 Sum_probs=149.5
Q ss_pred ccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCC
Q 043053 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 785 (1058)
+...++||+|+||+||+|... ++.+|+|+......... ........+++.+|++++++++||||+++..++...+.
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~---~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 413 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDE---RLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN 413 (540)
T ss_dssp ----------CCEEEEEEECS-SCEEEEEEECCCTTSCH---HHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT
T ss_pred CCCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccch---hhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc
Confidence 355779999999999999544 78899998744321100 00112235678999999999999999977777777888
Q ss_pred ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 786 RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
.|+||||++||+|.++++. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++.
T Consensus 414 ~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred cEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEE
Confidence 8999999999999999975 458999999999999999 9999999999999998 999999999998
Q ss_pred ccCCCccc-----ccccccCcCCccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 043053 866 VDDGDFAR-----SSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPID 919 (1058)
Q Consensus 866 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltg~~P~~ 919 (1058)
........ ......||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 75532111 1235679999999999876 567888999999999998888877763
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-26 Score=273.16 Aligned_cols=149 Identities=21% Similarity=0.188 Sum_probs=72.0
Q ss_pred ccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCcccccc-CccccceeeccCccCCCCCCCcccCCcccchhh
Q 043053 361 QNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIG-GLKTLNFLDLSSNRLSGSVPDEIGDCTELQMID 439 (1058)
Q Consensus 361 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 439 (1058)
++|+.|+|++|.+++..|..|+.+++|+.|+|++|.|++..|..|. .+++|++|+|++|.|++..+ +..+++|+.|+
T Consensus 120 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~ 197 (487)
T 3oja_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLD 197 (487)
T ss_dssp SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEE
Confidence 3344444444444444444444445555555555555544444443 44555555555555543321 22345555555
Q ss_pred ccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCC-CCCCCcccCCccccccccc
Q 043053 440 LSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFS-GPIPSSLGLCSSLQLLDLS 513 (1058)
Q Consensus 440 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~ 513 (1058)
|++|.|+++ |..|..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|++. +.+|..+..++.|+.|+++
T Consensus 198 Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 198 LSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 555555542 2235555555555555555552 4444555555555555555554 3344445555555555554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-29 Score=308.45 Aligned_cols=432 Identities=14% Similarity=0.143 Sum_probs=236.8
Q ss_pred cccCCCCCcEEEccCCcCCCC---CCCC------------CCCCCcccEEecCCCCCCCCCChhhc-CcccCCEEecccc
Q 043053 19 NLSSFKHLQTLVISDANLTGS---IPFD------------IGDCVGLIVLDFSSNNLVGTLPSSLG-KLHNLEELILNSN 82 (1058)
Q Consensus 19 ~~~~~~~L~~L~l~~~~~~~~---~p~~------------l~~l~~L~~L~l~~~~i~~~lp~~l~-~l~~L~~L~L~~n 82 (1058)
.+.++++|++|+++++..... .|.. ...+++|++|+|++|.+++..+..+. .+++|++|+|++|
T Consensus 61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~ 140 (594)
T 2p1m_B 61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC 140 (594)
T ss_dssp HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence 456778888888888753211 1211 13467788888888887766666665 6788888888888
Q ss_pred -CCCCc-cccccccchhhhHHhhhhccccCCChhhhc----ccccchhhhcCCCc-ccc-CCCCccccCCCCCceecccC
Q 043053 83 -QLTGK-IPVELSNCKSLRKLLLFDNALAGNIPAELG----RLSNLEEMRAGGNK-DIV-GKIPAELGDCSNMTALGLAD 154 (1058)
Q Consensus 83 -~~~~~-~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~----~l~~L~~L~l~~~~-~~~-~~l~~~l~~l~~L~~L~l~~ 154 (1058)
.+... ++..+.++++|++|+|++|.+.+..+..+. .+++|++|++++|. .+. ..+...+..+++|++|++++
T Consensus 141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~ 220 (594)
T 2p1m_B 141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNR 220 (594)
T ss_dssp EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCT
T ss_pred CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCC
Confidence 44422 444455778888888888776654444333 45577777777664 010 01111123456777777776
Q ss_pred ccccccCCccccCCCccceeeeecc-------ccccccCccccCCCCccEE-EccCCcCCCCCCCCcCCCCCcceeeccc
Q 043053 155 TQVSGSLPASLGKLSKLQTLSIYTT-------MISGEIPAEIGNCSELVSL-FLYENSLSGSIPPEIGKLKKLEELFLWQ 226 (1058)
Q Consensus 155 ~~~~~~~~~~l~~l~~L~~L~l~~n-------~i~~~~~~~l~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 226 (1058)
|...+.++..+.++++|+.|++..+ .+. .++..+.++++|+.| .+.+... +.++..+..+++|++|+|++
T Consensus 221 ~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~-~l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~ 298 (594)
T 2p1m_B 221 AVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYS-GLSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSY 298 (594)
T ss_dssp TSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHH-HHHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTT
T ss_pred CCcHHHHHHHHhcCCcceEcccccccCccchhhHH-HHHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccC
Confidence 6222235556666666777664333 222 233355666666666 2332221 12333334556666666666
Q ss_pred ccccCCCCc-cccCcCCccEEEeecCCCcCcCCc-cccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCc
Q 043053 227 NSLVGAIPE-EIGNCTSLKMIDFSLNSLSGTIPL-SIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGL 304 (1058)
Q Consensus 227 n~l~~~~~~-~l~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 304 (1058)
|.+.+.... .+..+++|++|++++| +...... ....+++|++|+++++.-.+ ..+.+.+++.
T Consensus 299 ~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g---------------~~~~~~l~~~ 362 (594)
T 2p1m_B 299 ATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFV---------------MEPNVALTEQ 362 (594)
T ss_dssp CCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTC---------------SSCSSCCCHH
T ss_pred CCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccc---------------cccCCCCCHH
Confidence 664422111 2345666666666665 3321111 12235666666663321000 0011222222
Q ss_pred CCCccc-ccchhhhhhccCcccCCCCChhhh-ccCcccccccc--c----cccccc-----Ccccccccccchhhhcccc
Q 043053 305 IPPEIG-MLSKLTVFFAWQNQLEGSIPSTLA-SCSNLQALDLS--H----NSLTAS-----VPAGLFQLQNLTKLLLISN 371 (1058)
Q Consensus 305 ~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~l~~~-----~~~~~~~l~~L~~L~L~~N 371 (1058)
....+. .+++|+.|.+..|++++.....+. .+++|+.|+++ + |.+++. ++..+..+++|++|+|++
T Consensus 363 ~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~- 441 (594)
T 2p1m_B 363 GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG- 441 (594)
T ss_dssp HHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-
T ss_pred HHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-
Confidence 111121 244455555555555444333443 46667777776 3 344421 111234566777777765
Q ss_pred CCCCCCCCCccC-CCCCcEEEccCccccCCccccc-cCccccceeeccCccCCCCCCC-cccCCcccchhhccCCccCCC
Q 043053 372 DISGSIPPEIGN-CSSLVRLRVGNNRIAGLIPREI-GGLKTLNFLDLSSNRLSGSVPD-EIGDCTELQMIDLSHNTLQGS 448 (1058)
Q Consensus 372 ~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~ 448 (1058)
.+++..+..+.. +++|+.|+|++|.+++.....+ .++++|++|+|++|.+++.... .+..+++|+.|++++|+++..
T Consensus 442 ~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~ 521 (594)
T 2p1m_B 442 LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFG 521 (594)
T ss_dssp SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHH
T ss_pred cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHH
Confidence 554433334443 6778888888888765544444 5678888888888888543322 334578888888888887543
Q ss_pred Ccccc-ccCCCCCeeecCCCcc
Q 043053 449 LPNSL-SSLSGLQVLDVSDNRF 469 (1058)
Q Consensus 449 ~~~~~-~~l~~L~~L~L~~N~l 469 (1058)
....+ ..+++|+...+..+.-
T Consensus 522 ~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 522 ACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp HHHHHHHHCTTEEEEEECSSSC
T ss_pred HHHHHHHhCCCCEEEEecCCCc
Confidence 33334 5567777777766643
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-29 Score=307.22 Aligned_cols=131 Identities=16% Similarity=0.145 Sum_probs=58.3
Q ss_pred CcccCCEEeccccCCCCccccccc-cchhhhHHhhhhc-cccCC-ChhhhcccccchhhhcCCCccccCCCCcc----cc
Q 043053 70 KLHNLEELILNSNQLTGKIPVELS-NCKSLRKLLLFDN-ALAGN-IPAELGRLSNLEEMRAGGNKDIVGKIPAE----LG 142 (1058)
Q Consensus 70 ~l~~L~~L~L~~n~~~~~~p~~l~-~l~~L~~L~L~~n-~~~~~-~p~~l~~l~~L~~L~l~~~~~~~~~l~~~----l~ 142 (1058)
.+++|++|+|++|.+.+..+..+. .+++|++|+|++| .+... ++..+.++++|++|++++|. +.+..+.. ..
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~-i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESD-VDDVSGHWLSHFPD 181 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCE-EECCCGGGGGGSCT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCc-cCCcchHHHHHHhh
Confidence 455666666666665544444443 4566666666655 33211 23333355555555555554 22222111 12
Q ss_pred CCCCCceecccCcc--cccc-CCccccCCCccceeeeeccccccccCccccCCCCccEEEcc
Q 043053 143 DCSNMTALGLADTQ--VSGS-LPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLY 201 (1058)
Q Consensus 143 ~l~~L~~L~l~~~~--~~~~-~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~ 201 (1058)
.+++|++|++++|. +... +...+.++++|++|++++|...+.++..+..+++|+.|+++
T Consensus 182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~ 243 (594)
T 2p1m_B 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTG 243 (594)
T ss_dssp TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECS
T ss_pred cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccc
Confidence 34455555555543 1111 11111234455555555442111244444444555555443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=274.03 Aligned_cols=193 Identities=21% Similarity=0.246 Sum_probs=155.9
Q ss_pred hhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccc
Q 043053 333 LASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLN 412 (1058)
Q Consensus 333 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 412 (1058)
|..+++|++|+|++|.|++.. ..++|++|++++|.|++..+. .+++|+.|+|++|.|++..|..|+.+++|+
T Consensus 76 l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 147 (487)
T 3oja_A 76 LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQ 147 (487)
T ss_dssp CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEE
T ss_pred cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCC
Confidence 455566666666666666422 126677777777777755443 357899999999999999999999999999
Q ss_pred eeeccCccCCCCCCCccc-CCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccc
Q 043053 413 FLDLSSNRLSGSVPDEIG-DCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491 (1058)
Q Consensus 413 ~L~Ls~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 491 (1058)
+|+|++|.+++..|..+. .+++|+.|+|++|.|++..+ +..+++|+.|+|++|+|++. |..+..+++|+.|+|++|
T Consensus 148 ~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N 224 (487)
T 3oja_A 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNN 224 (487)
T ss_dssp EEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTS
T ss_pred EEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCC
Confidence 999999999988888886 79999999999999997533 44689999999999999964 445889999999999999
Q ss_pred cCCCCCCCcccCCcccccccccCCccc-CCCChhhhhhHHHHHHHhhc
Q 043053 492 LFSGPIPSSLGLCSSLQLLDLSSNQLT-GSVPMELGQIEALEIALNLS 538 (1058)
Q Consensus 492 ~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~l~~~l~ls 538 (1058)
.|++ +|..+..+++|+.|++++|++. +.+|.++..+..+.. ++++
T Consensus 225 ~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~-l~~~ 270 (487)
T 3oja_A 225 KLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT-VAKQ 270 (487)
T ss_dssp CCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHH-HHHH
T ss_pred cCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcE-Eecc
Confidence 9995 6778999999999999999998 677888888877763 5554
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=234.29 Aligned_cols=209 Identities=21% Similarity=0.245 Sum_probs=130.6
Q ss_pred hhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccc
Q 043053 333 LASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLN 412 (1058)
Q Consensus 333 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 412 (1058)
+..+++|+.|++++|.+.. + ..+..+++|++|++++|.+++. ..+..+++|++|+|++|.++++.+..|..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 4455566666666666552 2 2355566666666666666542 3566666666666666666666666666666666
Q ss_pred eeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCccccccccccccccccccc
Q 043053 413 FLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNL 492 (1058)
Q Consensus 413 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 492 (1058)
+|+|++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|+
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 66666666666666666666666666666666666555566666677777777776665555556666677777777777
Q ss_pred CCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCcccccc
Q 043053 493 FSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISAL 553 (1058)
Q Consensus 493 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l 553 (1058)
+++..+..|..+++|+.|++++|++.+..|. + ..++++.|.++|.+|.+++.+
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~-------l-~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG-------I-RYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCCTTT-------T-HHHHHHHHHTGGGBBCTTSCB
T ss_pred CCccCHHHHhCCcCCCEEEccCCCccccCcH-------H-HHHHHHHHhCCCcccCccccc
Confidence 7666666666677777777777766654442 1 134555566666655555443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.2e-25 Score=237.86 Aligned_cols=230 Identities=22% Similarity=0.299 Sum_probs=192.1
Q ss_pred cccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhh
Q 043053 288 ATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLL 367 (1058)
Q Consensus 288 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 367 (1058)
+..+..+++..+.+... ..+..+++|+.|++.+|.++.. ..+..+++|++|++++|.+++ + ..+..+++|++|+
T Consensus 18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~ 91 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLI 91 (272)
T ss_dssp HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEE
T ss_pred HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEE
Confidence 44566777777776654 3456677778888888877743 357888899999999999885 3 4677888999999
Q ss_pred ccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCC
Q 043053 368 LISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG 447 (1058)
Q Consensus 368 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 447 (1058)
+++|.+++..+..|.++++|++|+|++|+++++.+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++++
T Consensus 92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 171 (272)
T 3rfs_A 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS 171 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence 99999998888788999999999999999998888888999999999999999998888888899999999999999998
Q ss_pred CCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhh
Q 043053 448 SLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQ 527 (1058)
Q Consensus 448 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 527 (1058)
..+..|..+++|++|++++|++++..+..|..+++|+.|+|++|++.+. +++|+.|++..|.++|.+|.+++.
T Consensus 172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~ 244 (272)
T 3rfs_A 172 LPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGS 244 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSC
T ss_pred cCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccc
Confidence 8888889999999999999999988777888999999999999988753 557899999999999999988876
Q ss_pred hHH
Q 043053 528 IEA 530 (1058)
Q Consensus 528 l~~ 530 (1058)
+..
T Consensus 245 ~~~ 247 (272)
T 3rfs_A 245 VAP 247 (272)
T ss_dssp BCG
T ss_pred cCC
Confidence 654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=236.64 Aligned_cols=208 Identities=26% Similarity=0.273 Sum_probs=159.0
Q ss_pred hhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEcc
Q 043053 314 KLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVG 393 (1058)
Q Consensus 314 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 393 (1058)
+|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 34444444555544444556666667777777777765555566667777777777777776666778888888888888
Q ss_pred CccccCCccccccCccccceeeccCccCCCC-CCCcccCCcccchhhccCCccCCCCccccccCCCCC----eeecCCCc
Q 043053 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGS-VPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQ----VLDVSDNR 468 (1058)
Q Consensus 394 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~----~L~L~~N~ 468 (1058)
+|+++++.+..|..+++|++|++++|++++. +|..|..+++|+.|++++|++++..+..|..+.+|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 8888877777788888888888888888764 478888888888888888888877777787777777 88999999
Q ss_pred cccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCC
Q 043053 469 FSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 469 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
+++..+..+.. .+|+.|+|++|++++..+..|..+++|+.|++++|++++..|
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 98655555544 489999999999998777788999999999999999987654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=235.66 Aligned_cols=203 Identities=20% Similarity=0.218 Sum_probs=84.7
Q ss_pred cceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCccccccccc
Q 043053 267 LEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSH 346 (1058)
Q Consensus 267 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 346 (1058)
|++|++++|.+++..+..|..+++|++|+|++|+++++.+..|..+++|++|++++|++++..+..|..+++|++|++++
T Consensus 30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 109 (276)
T 2z62_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (276)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence 33333333333333333333333333344434333333333333333333333333333333333444444444455544
Q ss_pred ccccccCcccccccccchhhhccccCCCCC-CCCCccCCCCCcEEEccCccccCCccccccCccccc----eeeccCccC
Q 043053 347 NSLTASVPAGLFQLQNLTKLLLISNDISGS-IPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLN----FLDLSSNRL 421 (1058)
Q Consensus 347 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~Ls~N~l 421 (1058)
|++.+..+..+..+++|++|++++|.+++. +|..|.++++|++|+|++|+++++.+..|..+++|+ +|++++|++
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l 189 (276)
T 2z62_A 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189 (276)
T ss_dssp SCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCC
T ss_pred CCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcc
Confidence 444433333344444444444444444432 244444445555555555555444444444444444 444444444
Q ss_pred CCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccc
Q 043053 422 SGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470 (1058)
Q Consensus 422 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 470 (1058)
++..+..+.. .+|+.|++++|++++..+..|..+++|+.|++++|+++
T Consensus 190 ~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 190 NFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp CEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred cccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 4333333222 24444444444444433333444444444444444443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=226.30 Aligned_cols=179 Identities=24% Similarity=0.291 Sum_probs=130.7
Q ss_pred cccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeecc
Q 043053 338 NLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLS 417 (1058)
Q Consensus 338 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 417 (1058)
+.+.+++++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+|+.+.+..|..+++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4566777777777 3555443 567777777777776666677777777777777777777766667777777777777
Q ss_pred CccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCC
Q 043053 418 SNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPI 497 (1058)
Q Consensus 418 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 497 (1058)
+|++++..+..|..+++|+.|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 77777666667777777777777777777766677777777777777777777655566777777777777777777766
Q ss_pred CCcccCCcccccccccCCcccC
Q 043053 498 PSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 498 ~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
+..|..+++|+.|++++|++++
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~ 195 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKR 195 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSC
T ss_pred hhHhccCCCcCEEECCCCcCCc
Confidence 6677777777777777777763
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=227.25 Aligned_cols=203 Identities=22% Similarity=0.276 Sum_probs=167.7
Q ss_pred hhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCc
Q 043053 316 TVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNN 395 (1058)
Q Consensus 316 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 395 (1058)
+.+++++++++. +|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|.++...+..|.++++|++|+|++|
T Consensus 19 ~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n 95 (270)
T 2o6q_A 19 NSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDN 95 (270)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSS
T ss_pred CEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCC
Confidence 344444444443 233222 46788888888888666667778888888888888888777777888899999999999
Q ss_pred cccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcc
Q 043053 396 RIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPA 475 (1058)
Q Consensus 396 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 475 (1058)
+++++.+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+.
T Consensus 96 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 175 (270)
T 2o6q_A 96 KLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEG 175 (270)
T ss_dssp CCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChh
Confidence 99988888889999999999999999988888889999999999999999987777789999999999999999877777
Q ss_pred cccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCC
Q 043053 476 SLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSV 521 (1058)
Q Consensus 476 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 521 (1058)
.|..+++|+.|+|++|++++..+..|..+++|+.|++++|++....
T Consensus 176 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 176 AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred HhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 8889999999999999999877778999999999999999997544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=229.46 Aligned_cols=205 Identities=25% Similarity=0.275 Sum_probs=133.6
Q ss_pred ccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchh
Q 043053 359 QLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMI 438 (1058)
Q Consensus 359 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 438 (1058)
.+++++++++++|.++ .+|..+. ++++.|+|++|+|+++.+..|..+++|++|+|++|.|++..+. ..+++|+.|
T Consensus 8 ~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L 82 (290)
T 1p9a_G 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTL 82 (290)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEE
T ss_pred ccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEE
Confidence 3444555555555554 2333332 4566666666666666666666666666666666666644332 566667777
Q ss_pred hccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCccc
Q 043053 439 DLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 439 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 518 (1058)
+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+
T Consensus 83 ~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (290)
T 1p9a_G 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (290)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred ECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence 77777766 35566666777777777777776655566777777777777777777666666677777777777777776
Q ss_pred CCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCCcccccCcceeEEEecccccccCC
Q 043053 519 GSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLP 594 (1058)
Q Consensus 519 ~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 594 (1058)
+ +| +..|..+++|+.|+|++|+|+..+..+...+.|+.|++++|+|.|.+.
T Consensus 162 ~-l~------------------------~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 162 E-LP------------------------AGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp C-CC------------------------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred c-cC------------------------HHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCc
Confidence 2 22 223456677777777777777777667777778888888888877663
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=227.83 Aligned_cols=179 Identities=25% Similarity=0.256 Sum_probs=101.5
Q ss_pred hccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccce
Q 043053 334 ASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNF 413 (1058)
Q Consensus 334 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 413 (1058)
..+++++.+++++|+++ .+|..+. ++++.|+|++|.|++..+..|.++++|+.|+|++|.|+++.+. ..+++|++
T Consensus 7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~ 81 (290)
T 1p9a_G 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGT 81 (290)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCE
T ss_pred cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCE
Confidence 34445555555555555 3443333 4555555555555555555555556666666666665544322 45556666
Q ss_pred eeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccC
Q 043053 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLF 493 (1058)
Q Consensus 414 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 493 (1058)
|+|++|+|+ .+|..+..+++|+.|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus 82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 666666665 4455555566666666666666655555566666666666666666555555555566666666666666
Q ss_pred CCCCCCcccCCcccccccccCCccc
Q 043053 494 SGPIPSSLGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 494 ~~~~~~~~~~l~~L~~L~l~~N~l~ 518 (1058)
++..+..|..+++|+.|+|++|+|+
T Consensus 161 ~~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 161 TELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CccCHHHhcCcCCCCEEECCCCcCC
Confidence 6555555555666666666666665
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.5e-23 Score=228.13 Aligned_cols=200 Identities=25% Similarity=0.274 Sum_probs=104.8
Q ss_pred ccchhhhccccCCCCCCCCCc--cCCCCCcEEEccCccccCCcc----ccccCccccceeeccCccCCCCCCCcccCCcc
Q 043053 361 QNLTKLLLISNDISGSIPPEI--GNCSSLVRLRVGNNRIAGLIP----REIGGLKTLNFLDLSSNRLSGSVPDEIGDCTE 434 (1058)
Q Consensus 361 ~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 434 (1058)
++|++|++++|.+.+..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|++.+..+..|..+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 345555555555555555544 555555555555555554322 22334555555555555555555555555555
Q ss_pred cchhhccCCccCCC---C-ccccccCCCCCeeecCCCccccCCcc----cccccccccccccccccCCCCCCCcccCC--
Q 043053 435 LQMIDLSHNTLQGS---L-PNSLSSLSGLQVLDVSDNRFSGQIPA----SLGRLVSLNKIILSKNLFSGPIPSSLGLC-- 504 (1058)
Q Consensus 435 L~~L~l~~N~l~~~---~-~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-- 504 (1058)
|++|+|++|++.+. . +..+..+++|++|+|++|+++ .++. .+..+++|++|+|++|+|.+..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 55555555554421 1 122345555666666666554 2222 13445566666666666655555555444
Q ss_pred -cccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCCcccccCcceeEE
Q 043053 505 -SSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLN 583 (1058)
Q Consensus 505 -~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ 583 (1058)
++|++|+|++|+|+ .+|..+ . ++|+.|||++|+|++.+. +..+++|+.|+
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~-------------------------~--~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~ 300 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGL-------------------------P--AKLRVLDLSSNRLNRAPQ-PDELPEVDNLT 300 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCC-------------------------C--SCCSCEECCSCCCCSCCC-TTSCCCCSCEE
T ss_pred cCcCCEEECCCCCCC-chhhhh-------------------------c--CCCCEEECCCCcCCCCch-hhhCCCccEEE
Confidence 46666666666665 333221 1 456666666666665422 45556666666
Q ss_pred Eeccccc
Q 043053 584 ISYNKFT 590 (1058)
Q Consensus 584 l~~N~l~ 590 (1058)
+++|+|+
T Consensus 301 L~~N~l~ 307 (310)
T 4glp_A 301 LDGNPFL 307 (310)
T ss_dssp CSSTTTS
T ss_pred CcCCCCC
Confidence 6666654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-24 Score=246.51 Aligned_cols=262 Identities=21% Similarity=0.206 Sum_probs=165.7
Q ss_pred EEEeecCCCcCcCCccccccCCcceeecccCccCCCcc----ccccccc-cchhhhhcCCcccCcCCCcccccchhhhhh
Q 043053 245 MIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIP----ANLANAT-NLVQLQLDTNQISGLIPPEIGMLSKLTVFF 319 (1058)
Q Consensus 245 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 319 (1058)
.++++.|.+++.+|..+...++|++|++++|.+++..+ ..|..++ +|++|+|++|+|++..+..|..+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~------- 74 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQI------- 74 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHH-------
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHH-------
Confidence 45778888887777766666678888888888876666 5666676 77777777777776555544443
Q ss_pred ccCcccCCCCChhhhcc-CcccccccccccccccCccccccc-----ccchhhhccccCCCCCCCCCc----cC-CCCCc
Q 043053 320 AWQNQLEGSIPSTLASC-SNLQALDLSHNSLTASVPAGLFQL-----QNLTKLLLISNDISGSIPPEI----GN-CSSLV 388 (1058)
Q Consensus 320 l~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~----~~-l~~L~ 388 (1058)
+... ++|++|+|++|++++..+..+... ++|++|+|++|.|++..+..+ .. .++|+
T Consensus 75 -------------l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 141 (362)
T 3goz_A 75 -------------LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141 (362)
T ss_dssp -------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCC
T ss_pred -------------HhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCcee
Confidence 0111 445555555555544333333222 455555555555544333222 22 25677
Q ss_pred EEEccCccccCCccc----cccCcc-ccceeeccCccCCCCCCCccc----CC-cccchhhccCCccCCC----Cccccc
Q 043053 389 RLRVGNNRIAGLIPR----EIGGLK-TLNFLDLSSNRLSGSVPDEIG----DC-TELQMIDLSHNTLQGS----LPNSLS 454 (1058)
Q Consensus 389 ~L~L~~N~l~~~~~~----~~~~l~-~L~~L~Ls~N~l~~~~~~~~~----~l-~~L~~L~l~~N~l~~~----~~~~~~ 454 (1058)
+|+|++|+|++..+. .+..++ +|++|+|++|++++..+..+. .+ ++|+.|+|++|.|++. ++..+.
T Consensus 142 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 777777777654333 334444 777777777777765554433 33 4778888888877752 344555
Q ss_pred c-CCCCCeeecCCCccccCCc----ccccccccccccccccccCCCCCC-------CcccCCcccccccccCCcccCCCC
Q 043053 455 S-LSGLQVLDVSDNRFSGQIP----ASLGRLVSLNKIILSKNLFSGPIP-------SSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 455 ~-l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~-------~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
. .++|++|+|++|++++..+ ..+..+++|+.|+|++|.+.+..+ ..+..+++|+.||+++|++.+..+
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 5 3478888888888876544 234566788888888888554433 467788899999999999987655
Q ss_pred hhhh
Q 043053 523 MELG 526 (1058)
Q Consensus 523 ~~~~ 526 (1058)
..+.
T Consensus 302 ~~~~ 305 (362)
T 3goz_A 302 IPIS 305 (362)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=6.3e-22 Score=212.33 Aligned_cols=183 Identities=22% Similarity=0.266 Sum_probs=166.0
Q ss_pred CcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeec
Q 043053 337 SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDL 416 (1058)
Q Consensus 337 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 416 (1058)
.+.+.++++++.++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|.|+++.+..|..+++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 45678899999998 5776665 68999999999999888889999999999999999999998989999999999999
Q ss_pred cCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCC
Q 043053 417 SSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGP 496 (1058)
Q Consensus 417 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 496 (1058)
++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999988888899999999999999999988888899999999999999999977777899999999999999999988
Q ss_pred CCCcccCCcccccccccCCcccCCCC
Q 043053 497 IPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 497 ~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
.+..|..+++|+.|++++|++.+...
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 88899999999999999999986533
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=223.40 Aligned_cols=202 Identities=22% Similarity=0.212 Sum_probs=149.0
Q ss_pred cCcccccccccccccccCcccc--cccccchhhhccccCCCCCCC----CCccCCCCCcEEEccCccccCCccccccCcc
Q 043053 336 CSNLQALDLSHNSLTASVPAGL--FQLQNLTKLLLISNDISGSIP----PEIGNCSSLVRLRVGNNRIAGLIPREIGGLK 409 (1058)
Q Consensus 336 l~~L~~L~Ls~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 409 (1058)
+++|++|++++|.+.+..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|+|++..+..|..++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 4557777777777777677666 667777777777777775444 2344678888888888888888778888888
Q ss_pred ccceeeccCccCCCC----CCCcccCCcccchhhccCCccCCCCcc----ccccCCCCCeeecCCCccccCCccccccc-
Q 043053 410 TLNFLDLSSNRLSGS----VPDEIGDCTELQMIDLSHNTLQGSLPN----SLSSLSGLQVLDVSDNRFSGQIPASLGRL- 480 (1058)
Q Consensus 410 ~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l- 480 (1058)
+|++|+|++|++.+. .+..+..+++|++|+|++|+++. ++. .+..+++|++|+|++|+|++..|..+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 888888888887541 12334678888888888888874 333 35677888888888888887777777666
Q ss_pred --ccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccE
Q 043053 481 --VSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSI 558 (1058)
Q Consensus 481 --~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~ 558 (1058)
++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.
T Consensus 249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~--------------------------~~~l~~L~~ 298 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ--------------------------PDELPEVDN 298 (310)
T ss_dssp CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC--------------------------TTSCCCCSC
T ss_pred CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch--------------------------hhhCCCccE
Confidence 58888888888888 5566664 7888888888888742 21 245678888
Q ss_pred EecCCCcccC
Q 043053 559 LDLSHNKLEG 568 (1058)
Q Consensus 559 L~L~~N~l~~ 568 (1058)
|+|++|+++.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 8888888864
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.86 E-value=7.3e-24 Score=240.68 Aligned_cols=258 Identities=15% Similarity=0.126 Sum_probs=138.3
Q ss_pred ecccCccccccCCccccCCCccceeeeeccccccccC----ccccCCC-CccEEEccCCcCCCCCCCCcCCC-----CCc
Q 043053 150 LGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIP----AEIGNCS-ELVSLFLYENSLSGSIPPEIGKL-----KKL 219 (1058)
Q Consensus 150 L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~----~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~L 219 (1058)
+.++.|.+++.+|..+...++|++|++++|.+++..+ ..+..++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 3455555555555554445555555555555554443 4444555 55555555555554444444443 555
Q ss_pred ceeecccccccCCCCccccC----c-CCccEEEeecCCCcCcCCccccc-----cCCcceeecccCccCCCccccccccc
Q 043053 220 EELFLWQNSLVGAIPEEIGN----C-TSLKMIDFSLNSLSGTIPLSIGG-----LSELEEFMISDNNVSGSIPANLANAT 289 (1058)
Q Consensus 220 ~~L~L~~n~l~~~~~~~l~~----l-~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~l~~n~l~~~~~~~~~~l~ 289 (1058)
++|+|++|.+++..+..+.. + ++|++|+|++|.+++..+..+.. .++|++|++++|.+++..+..+.
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~--- 159 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI--- 159 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH---
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH---
Confidence 55555555555444433222 2 45555555555555443333222 13455555555555432222221
Q ss_pred cchhhhhcCCcccCcCCCcccccc-hhhhhhccCcccCCCCChhh----hcc-Cccccccccccccccc----Ccccccc
Q 043053 290 NLVQLQLDTNQISGLIPPEIGMLS-KLTVFFAWQNQLEGSIPSTL----ASC-SNLQALDLSHNSLTAS----VPAGLFQ 359 (1058)
Q Consensus 290 ~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~----~~l-~~L~~L~Ls~N~l~~~----~~~~~~~ 359 (1058)
..+..++ +|++|++++|++++..+..+ ..+ ++|+.|+|++|.|++. ++..+..
T Consensus 160 -----------------~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~ 222 (362)
T 3goz_A 160 -----------------QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222 (362)
T ss_dssp -----------------HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred -----------------HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence 1111222 44444444444444444333 333 4777788888877753 3334444
Q ss_pred -cccchhhhccccCCCCCCC----CCccCCCCCcEEEccCccccCCcc-------ccccCccccceeeccCccCCCCCCC
Q 043053 360 -LQNLTKLLLISNDISGSIP----PEIGNCSSLVRLRVGNNRIAGLIP-------REIGGLKTLNFLDLSSNRLSGSVPD 427 (1058)
Q Consensus 360 -l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~L~Ls~N~l~~~~~~ 427 (1058)
.++|++|+|++|.|++..+ ..+..+++|++|+|++|.+.++.+ ..+..+++|++||+++|.+....+.
T Consensus 223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~ 302 (362)
T 3goz_A 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI 302 (362)
T ss_dssp SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence 3477777777777775443 345667788888888888655443 3566777888888888888755443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-22 Score=216.47 Aligned_cols=178 Identities=18% Similarity=0.228 Sum_probs=88.4
Q ss_pred cchhhhhcCCcccCcCCCcccccchhhhhhccCcc-cCCCCChhhhccCccccccccc-ccccccCcccccccccchhhh
Q 043053 290 NLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQ-LEGSIPSTLASCSNLQALDLSH-NSLTASVPAGLFQLQNLTKLL 367 (1058)
Q Consensus 290 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~ 367 (1058)
+|++|++++|+|+++.+..|..+++|++|++++|+ ++.+.+..|.++++|++|++++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 34444444444443333334444444444444443 3333334445555555555555 555543334444455555555
Q ss_pred ccccCCCCCCCCCccCCCCCc---EEEccCc-cccCCccccccCccccc-eeeccCccCCCCCCCcccCCcccchhhccC
Q 043053 368 LISNDISGSIPPEIGNCSSLV---RLRVGNN-RIAGLIPREIGGLKTLN-FLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442 (1058)
Q Consensus 368 L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 442 (1058)
+++|.+++ +|. |..+++|+ +|++++| +++++.+..|.++++|+ +|++++|+++.+.+..|.. ++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 55555543 332 45555555 6666666 55555555555566666 6666666555333333333 5555555555
Q ss_pred Cc-cCCCCccccccC-CCCCeeecCCCccc
Q 043053 443 NT-LQGSLPNSLSSL-SGLQVLDVSDNRFS 470 (1058)
Q Consensus 443 N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~ 470 (1058)
|+ ++++.+..|.++ ++|+.|++++|+++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 53 554444555555 55555555555555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=218.67 Aligned_cols=153 Identities=16% Similarity=0.094 Sum_probs=117.5
Q ss_pred ccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCccc--------chHHHHHHHHHHHcccCCCccccee
Q 043053 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKS--------GVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
|.+.+.||+|+||.||+|...+|+.||||++......... ...... .....+.+|++++++++ | ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~-~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKK-VKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------C-CCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhh-hhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 4566999999999999996688999999998643211110 000000 23567999999999999 4 6666
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeee
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYI 857 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl 857 (1058)
+++. .+..|+||||++||+|.+ +.. .....++.|+++||+|||+. +|+||||||+|||++ ++.+||
T Consensus 168 ~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 168 KVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp CEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEE
T ss_pred eEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEE
Confidence 6554 356799999999999998 432 12447999999999999999 999999999999999 999999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccc
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGY 891 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 891 (1058)
+|||+++. +..|+|||++.
T Consensus 234 ~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp CCCTTCEE---------------TTSTTHHHHHH
T ss_pred EECCCCeE---------------CCCCCHHHHHH
Confidence 99999863 34578999754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=5.5e-22 Score=219.48 Aligned_cols=192 Identities=26% Similarity=0.404 Sum_probs=111.2
Q ss_pred cccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhh
Q 043053 360 LQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMID 439 (1058)
Q Consensus 360 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 439 (1058)
+++|++|++++|.+.. ++ .+..+++|++|+|++|.++++.+ +..+++|++|+|++|++++. ..+..+++|+.|+
T Consensus 40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~ 113 (308)
T 1h6u_A 40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD 113 (308)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEE
T ss_pred cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEE
Confidence 4444444444444442 22 35555556666666665555433 55556666666666665532 2455566666666
Q ss_pred ccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccC
Q 043053 440 LSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 440 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
+++|++++. + .+..+++|++|++++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|++++
T Consensus 114 l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 114 LTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD 187 (308)
T ss_dssp CTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc
Confidence 666666543 2 25666666666666666654332 5566666666666666664332 6666667777777666653
Q ss_pred CCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCCcccccCcceeEEEecccccc
Q 043053 520 SVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTG 591 (1058)
Q Consensus 520 ~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~ 591 (1058)
..+ +..+++|+.|+|++|++++.+ ++..+++|+.|++++|++++
T Consensus 188 ~~~---------------------------l~~l~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 188 ISP---------------------------LASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CGG---------------------------GGGCTTCCEEECTTSCCCBCG-GGTTCTTCCEEEEEEEEEEC
T ss_pred Chh---------------------------hcCCCCCCEEEccCCccCccc-cccCCCCCCEEEccCCeeec
Confidence 211 345666777777777776654 36667777777777777764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-22 Score=215.82 Aligned_cols=196 Identities=15% Similarity=0.201 Sum_probs=135.6
Q ss_pred CccEEEeecCCCcCcCCccccccCCcceeecccCc-cCCCccccccccccchhhhhcC-CcccCcCCCcccccchhhhhh
Q 043053 242 SLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNN-VSGSIPANLANATNLVQLQLDT-NQISGLIPPEIGMLSKLTVFF 319 (1058)
Q Consensus 242 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~ 319 (1058)
+|++|++++|++++..+..|.++++|++|++++|+ ++.+.+..|..+++|++|++++ |++++
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~---------------- 95 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY---------------- 95 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE----------------
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE----------------
Confidence 56666666666665555556666666666666664 5544444555555555555555 55544
Q ss_pred ccCcccCCCCChhhhccCcccccccccccccccCcccccccccch---hhhcccc-CCCCCCCCCccCCCCCc-EEEccC
Q 043053 320 AWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLT---KLLLISN-DISGSIPPEIGNCSSLV-RLRVGN 394 (1058)
Q Consensus 320 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~ 394 (1058)
..+..|..+++|++|++++|++++ +|. +..+++|+ +|++++| .+++..+..|.++++|+ .|++++
T Consensus 96 --------i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~ 165 (239)
T 2xwt_C 96 --------IDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN 165 (239)
T ss_dssp --------ECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCS
T ss_pred --------cCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCC
Confidence 444556666666777777777664 444 55666666 7777777 77766667788888888 888888
Q ss_pred ccccCCccccccCccccceeeccCcc-CCCCCCCcccCC-cccchhhccCCccCCCCccccccCCCCCeeecCCC
Q 043053 395 NRIAGLIPREIGGLKTLNFLDLSSNR-LSGSVPDEIGDC-TELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN 467 (1058)
Q Consensus 395 N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 467 (1058)
|+++.+.+..|.. ++|++|+|++|+ ++++.+..|..+ ++|+.|++++|+|+++.+. .+++|+.|+++++
T Consensus 166 n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 166 NGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 8888666666666 788888898885 887777888888 8899999999988864443 5677888888776
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=9.7e-22 Score=210.88 Aligned_cols=154 Identities=24% Similarity=0.323 Sum_probs=99.0
Q ss_pred cchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhcc
Q 043053 362 NLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLS 441 (1058)
Q Consensus 362 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 441 (1058)
+.++++++++.++ .+|..+. ++|+.|+|++|.|+++.+..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4556677777776 3444443 466777777777776666667777777777777777766666666666667777777
Q ss_pred CCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCccc
Q 043053 442 HNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 442 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 518 (1058)
+|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence 77666666666666666666666666666555555566666666666666666555555555666666666666555
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=3.9e-22 Score=220.72 Aligned_cols=213 Identities=24% Similarity=0.374 Sum_probs=162.2
Q ss_pred ccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhc
Q 043053 289 TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLL 368 (1058)
Q Consensus 289 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 368 (1058)
.++..+.+..+.+.+.. .+..+++|++|++.+|.++.. + .+..+++|++|++++|++++..+ +..+++|++|+|
T Consensus 19 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L 92 (308)
T 1h6u_A 19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL 92 (308)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred HHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEc
Confidence 44555566666665432 345667777777777777653 3 57778888888888888875433 777888888888
Q ss_pred cccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCC
Q 043053 369 ISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGS 448 (1058)
Q Consensus 369 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 448 (1058)
++|.+++. ..+..+++|++|++++|+++++. .+..+++|++|++++|++++..+ +..+++|+.|++++|++++.
T Consensus 93 ~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~ 166 (308)
T 1h6u_A 93 SGNPLKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL 166 (308)
T ss_dssp CSCCCSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred cCCcCCCc--hhhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC
Confidence 88888753 36888888888888888888753 38888888888888888886544 78888888888888888864
Q ss_pred CccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccC
Q 043053 449 LPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 449 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
.+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++.. .+..+++|+.|++++|++++
T Consensus 167 ~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 167 TP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp GG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred hh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 43 8888888888888888875443 778888888889888888655 37888889999999998873
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-23 Score=236.81 Aligned_cols=253 Identities=18% Similarity=0.231 Sum_probs=144.8
Q ss_pred ccEEecCCCCCCCCCChhhcCc--ccCCEEeccccCCCCccccccccchhhhHHhhhhccccCC-Chhhhcccccchhhh
Q 043053 50 LIVLDFSSNNLVGTLPSSLGKL--HNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGN-IPAELGRLSNLEEMR 126 (1058)
Q Consensus 50 L~~L~l~~~~i~~~lp~~l~~l--~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~-~p~~l~~l~~L~~L~ 126 (1058)
++.|+++++.+. |..+..+ .++++|++++|.+.+..+. +..+++|++|++++|.+.+. +|..+.++++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 444555554443 3334444 4555555555554433222 33455555555555544432 444455555555555
Q ss_pred cCCCccccCCCCccccCCCCCceecccCc-ccccc-CCccccCCCccceeeeecc-ccccc-cCccccCCC-CccEEEcc
Q 043053 127 AGGNKDIVGKIPAELGDCSNMTALGLADT-QVSGS-LPASLGKLSKLQTLSIYTT-MISGE-IPAEIGNCS-ELVSLFLY 201 (1058)
Q Consensus 127 l~~~~~~~~~l~~~l~~l~~L~~L~l~~~-~~~~~-~~~~l~~l~~L~~L~l~~n-~i~~~-~~~~l~~l~-~L~~L~L~ 201 (1058)
+++|. +.+..+..++.+++|++|++++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|++|+|+
T Consensus 125 L~~~~-l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 125 LEGLR-LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp CTTCB-CCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred CcCcc-cCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 55553 22334445555566666666665 44432 4445666667777777766 66543 455566667 77777777
Q ss_pred CC--cCC-CCCCCCcCCCCCcceeeccccc-ccCCCCccccCcCCccEEEeecCC-CcCcCCccccccCCcceeecccCc
Q 043053 202 EN--SLS-GSIPPEIGKLKKLEELFLWQNS-LVGAIPEEIGNCTSLKMIDFSLNS-LSGTIPLSIGGLSELEEFMISDNN 276 (1058)
Q Consensus 202 ~n--~l~-~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~l~~n~ 276 (1058)
+| .++ +.++..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......++.+++|++|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 77 343 2345555667777777777777 555556667777777777777774 33222235667777888888777
Q ss_pred cCCCcccccccc-ccchhhhhcCCcccCcCCCcccc
Q 043053 277 VSGSIPANLANA-TNLVQLQLDTNQISGLIPPEIGM 311 (1058)
Q Consensus 277 l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~ 311 (1058)
+.. ..+..+ .++..|++++|++++..|..++.
T Consensus 283 i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 283 VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 332 233333 34777778888888887777664
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-24 Score=247.09 Aligned_cols=250 Identities=21% Similarity=0.262 Sum_probs=118.8
Q ss_pred CCCCcCCCCCcceeecccccccCCCC----ccccCcCCccEEEeecCCC---cCcCCccc-------cccCCcceeeccc
Q 043053 209 IPPEIGKLKKLEELFLWQNSLVGAIP----EEIGNCTSLKMIDFSLNSL---SGTIPLSI-------GGLSELEEFMISD 274 (1058)
Q Consensus 209 ~~~~~~~l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~L~~n~l---~~~~~~~~-------~~l~~L~~L~l~~ 274 (1058)
++..+..+++|+.|+|++|.+.+..+ ..|..+++|++|+|++|.+ ++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 44555666777777777777765433 2355677777777777533 33334333 4556666666666
Q ss_pred CccCC----CccccccccccchhhhhcCCcccCcCCCcccc-cchhhhhhccCcccCCCCChhhhccCcccccccccccc
Q 043053 275 NNVSG----SIPANLANATNLVQLQLDTNQISGLIPPEIGM-LSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSL 349 (1058)
Q Consensus 275 n~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 349 (1058)
|.+.. .++..+..+++|++|+|++|.|+...+..+.. +..+. .|++. +..++|++|+|++|++
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~-----~~~~~-------~~~~~L~~L~L~~n~l 171 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELA-----VNKKA-------KNAPPLRSIICGRNRL 171 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHH-----HHHHH-------HTCCCCCEEECCSSCC
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHh-----hhhhc-------ccCCCCcEEECCCCCC
Confidence 66665 24445555666666666666654332222221 00000 00000 0015666666666666
Q ss_pred cc-cCc---ccccccccchhhhccccCCCC-----CCCCCccCCCCCcEEEccCcccc----CCccccccCccccceeec
Q 043053 350 TA-SVP---AGLFQLQNLTKLLLISNDISG-----SIPPEIGNCSSLVRLRVGNNRIA----GLIPREIGGLKTLNFLDL 416 (1058)
Q Consensus 350 ~~-~~~---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L 416 (1058)
+. .++ ..+..+++|++|+|++|+|+. ..+..+..+++|+.|+|++|.|+ ...|..+..+++|++|+|
T Consensus 172 ~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L 251 (386)
T 2ca6_A 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 251 (386)
T ss_dssp TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred CcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEEC
Confidence 52 222 233344445555555554441 12224444555555555555553 233444444555555555
Q ss_pred cCccCCCC----CCCcc--cCCcccchhhccCCccCC----CCcccc-ccCCCCCeeecCCCccc
Q 043053 417 SSNRLSGS----VPDEI--GDCTELQMIDLSHNTLQG----SLPNSL-SSLSGLQVLDVSDNRFS 470 (1058)
Q Consensus 417 s~N~l~~~----~~~~~--~~l~~L~~L~l~~N~l~~----~~~~~~-~~l~~L~~L~L~~N~l~ 470 (1058)
++|.|++. ++..+ +.+++|+.|+|++|.|++ .+|..+ .++++|+.|++++|+++
T Consensus 252 ~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence 55554432 22222 124444444444444443 133333 33444444444444444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.1e-24 Score=245.34 Aligned_cols=265 Identities=22% Similarity=0.213 Sum_probs=152.8
Q ss_pred cCCccccCCCccceeeeeccccccccC----ccccCCCCccEEEccCCcCC---CCCCCCc-------CCCCCcceeecc
Q 043053 160 SLPASLGKLSKLQTLSIYTTMISGEIP----AEIGNCSELVSLFLYENSLS---GSIPPEI-------GKLKKLEELFLW 225 (1058)
Q Consensus 160 ~~~~~l~~l~~L~~L~l~~n~i~~~~~----~~l~~l~~L~~L~L~~n~l~---~~~~~~~-------~~l~~L~~L~L~ 225 (1058)
.++..+..+++|+.|++++|.+++..+ ..+..+++|++|+|++|.+. +.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 455556666666666666666665433 33556677777777765433 3334333 566677777777
Q ss_pred cccccC----CCCccccCcCCccEEEeecCCCcCcCCccccc----c---------CCcceeecccCccCC-Ccc---cc
Q 043053 226 QNSLVG----AIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGG----L---------SELEEFMISDNNVSG-SIP---AN 284 (1058)
Q Consensus 226 ~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~----l---------~~L~~L~l~~n~l~~-~~~---~~ 284 (1058)
+|.+.+ .++..+..+++|++|+|++|.+++..+..+.. + ++|++|++++|.++. ..+ ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 777665 24445666677777777777765433333332 2 667777777776652 222 34
Q ss_pred ccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCccccccccccccc----ccCccccccc
Q 043053 285 LANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT----ASVPAGLFQL 360 (1058)
Q Consensus 285 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~l 360 (1058)
+..+++|++|+|++|+|+.... ....+..+..+++|+.|+|++|.++ ..+|..+..+
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~-------------------~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~ 243 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGI-------------------EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHH-------------------HHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred HHhCCCcCEEECcCCCCCHhHH-------------------HHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccC
Confidence 5556666666666666652100 0011224455556666666666653 3445555556
Q ss_pred ccchhhhccccCCCCC----CCCCc--cCCCCCcEEEccCccccC----Cccccc-cCccccceeeccCccCCCCCC--C
Q 043053 361 QNLTKLLLISNDISGS----IPPEI--GNCSSLVRLRVGNNRIAG----LIPREI-GGLKTLNFLDLSSNRLSGSVP--D 427 (1058)
Q Consensus 361 ~~L~~L~L~~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~l~~~~~--~ 427 (1058)
++|++|+|++|.|++. ++..+ +.+++|++|+|++|.|++ ..|..+ ..+++|++|+|++|.+++..+ .
T Consensus 244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~ 323 (386)
T 2ca6_A 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVD 323 (386)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHH
T ss_pred CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHH
Confidence 6666666666666543 33444 337788888888888876 345555 557888888888888876553 2
Q ss_pred cc-cCCcccchhhccCC
Q 043053 428 EI-GDCTELQMIDLSHN 443 (1058)
Q Consensus 428 ~~-~~l~~L~~L~l~~N 443 (1058)
.+ ..+++++.+++..+
T Consensus 324 ~l~~~l~~~~~~~l~~~ 340 (386)
T 2ca6_A 324 EIREVFSTRGRGELDEL 340 (386)
T ss_dssp HHHHHHHHHTCCEECCC
T ss_pred HHHHHhhhcCcchhhhc
Confidence 22 23445554555443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=3e-21 Score=217.88 Aligned_cols=239 Identities=20% Similarity=0.197 Sum_probs=105.7
Q ss_pred EEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCC-ccccccCCcce-eeccc
Q 043053 197 SLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIP-LSIGGLSELEE-FMISD 274 (1058)
Q Consensus 197 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~-L~l~~ 274 (1058)
+++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|++.+.++ ..|.++++|.+ +.++.
T Consensus 13 ~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 4455555555 4444331 345555555555553333445555555555555555433322 23444444333 23333
Q ss_pred CccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCccccccccc-ccccccC
Q 043053 275 NNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSH-NSLTASV 353 (1058)
Q Consensus 275 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~ 353 (1058)
|++..+.+..|..+++|++|++++|+|.. ..+..+....++..|++++ |++....
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~------------------------~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKH------------------------LPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSS------------------------CCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred CcccccCchhhhhcccccccccccccccc------------------------CCchhhcccchhhhhhhcccccccccc
Confidence 44443333333444444444444433333 3333333333444444433 3343322
Q ss_pred cccccccc-cchhhhccccCCCCCCCCCccCCCCCcEEEcc-CccccCCccccccCccccceeeccCccCCCCCCCcccC
Q 043053 354 PAGLFQLQ-NLTKLLLISNDISGSIPPEIGNCSSLVRLRVG-NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD 431 (1058)
Q Consensus 354 ~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 431 (1058)
+..|..+. .++.|+|++|+|+.+.+..| ...+|++|++. +|.++.+.+..|.++++|++|||++|+|+.+.+..|.+
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~ 224 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT
T ss_pred ccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc
Confidence 22333322 34444455555443322222 23445555554 34455444455555555555555555555444444554
Q ss_pred CcccchhhccCCccCCCCccccccCCCCCeeecCCC
Q 043053 432 CTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN 467 (1058)
Q Consensus 432 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 467 (1058)
+++|+.+++ +.++ .+| .+..+++|+.++++++
T Consensus 225 L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 225 LKKLRARST--YNLK-KLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp CCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred chHhhhccC--CCcC-cCC-CchhCcChhhCcCCCC
Confidence 444444443 2233 233 2455555555555443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.84 E-value=5.2e-23 Score=231.49 Aligned_cols=222 Identities=17% Similarity=0.168 Sum_probs=121.4
Q ss_pred cceeeeeccccccccCccccCC--CCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCC-CCccccCcCCccEEE
Q 043053 171 LQTLSIYTTMISGEIPAEIGNC--SELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGA-IPEEIGNCTSLKMID 247 (1058)
Q Consensus 171 L~~L~l~~n~i~~~~~~~l~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~ 247 (1058)
++.++++++.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|++++|.+.+. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 566777666654 3344555 6677777777777654443 44567777777777766543 455566667777777
Q ss_pred eecCCCcCcCCccccccCCcceeecccC-ccCCC-ccccccccccchhhhhcCC-cccCcCCCcccccchhhhhhccCcc
Q 043053 248 FSLNSLSGTIPLSIGGLSELEEFMISDN-NVSGS-IPANLANATNLVQLQLDTN-QISGLIPPEIGMLSKLTVFFAWQNQ 324 (1058)
Q Consensus 248 L~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~-~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~l~~N~ 324 (1058)
|++|.+++..+..++.+++|++|++++| .+++. .+..+..+++|++|++++| .+++.
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~-------------------- 184 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK-------------------- 184 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH--------------------
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH--------------------
Confidence 7777666555666666666666666666 45432 3444555555555555555 44421
Q ss_pred cCCCCChhhhccC-ccccccccccc--cc-ccCcccccccccchhhhccccC-CCCCCCCCccCCCCCcEEEccCcc-cc
Q 043053 325 LEGSIPSTLASCS-NLQALDLSHNS--LT-ASVPAGLFQLQNLTKLLLISND-ISGSIPPEIGNCSSLVRLRVGNNR-IA 398 (1058)
Q Consensus 325 l~~~~~~~~~~l~-~L~~L~Ls~N~--l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~-l~ 398 (1058)
.++..+..++ +|++|++++|. ++ +.++..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.
T Consensus 185 ---~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~ 261 (336)
T 2ast_B 185 ---HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 261 (336)
T ss_dssp ---HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCC
T ss_pred ---HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCC
Confidence 0233455566 66666666663 33 2233344445555555555554 333344444555555555555553 21
Q ss_pred CCccccccCccccceeeccCc
Q 043053 399 GLIPREIGGLKTLNFLDLSSN 419 (1058)
Q Consensus 399 ~~~~~~~~~l~~L~~L~Ls~N 419 (1058)
......+..+++|++|++++|
T Consensus 262 ~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 262 PETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp GGGGGGGGGCTTCCEEECTTS
T ss_pred HHHHHHHhcCCCCCEEeccCc
Confidence 111113444555555555554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.6e-21 Score=218.47 Aligned_cols=241 Identities=18% Similarity=0.194 Sum_probs=187.7
Q ss_pred ceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCC-ccccCcCCccE-EEee
Q 043053 172 QTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIP-EEIGNCTSLKM-IDFS 249 (1058)
Q Consensus 172 ~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~-L~L~ 249 (1058)
+.++-+++.++ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.++ ..|.++++|++ +.+.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 56777888887 778766 3689999999999995555689999999999999999866554 56889998876 6677
Q ss_pred cCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcC-CcccCcCCCcccccchhhhhhccCcccCCC
Q 043053 250 LNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDT-NQISGLIPPEIGMLSKLTVFFAWQNQLEGS 328 (1058)
Q Consensus 250 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 328 (1058)
+|+++...+..|.++++|++|++++|++....+..+....++..|++.+ |++..+.+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~--------------------- 147 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN--------------------- 147 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTT---------------------
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccccc---------------------
Confidence 8999988889999999999999999999987777777777777777754 455544333
Q ss_pred CChhhhccC-cccccccccccccccCcccccccccchhhhccc-cCCCCCCCCCccCCCCCcEEEccCccccCCcccccc
Q 043053 329 IPSTLASCS-NLQALDLSHNSLTASVPAGLFQLQNLTKLLLIS-NDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIG 406 (1058)
Q Consensus 329 ~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 406 (1058)
.|..+. .++.|+|++|+|+. ++...+...+|++|++.+ |.++.+.+..|.++++|++|+|++|+|+.+.+..|.
T Consensus 148 ---~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~ 223 (350)
T 4ay9_X 148 ---SFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 223 (350)
T ss_dssp ---SSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT
T ss_pred ---chhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc
Confidence 344433 57778888888884 555666667888888874 677766667889999999999999999988777777
Q ss_pred CccccceeeccCccCCCCCCCcccCCcccchhhccCCc
Q 043053 407 GLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNT 444 (1058)
Q Consensus 407 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 444 (1058)
++++|+.+++ +.++ .+| .+..+++|+.++++++.
T Consensus 224 ~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 224 NLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp TCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred cchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCCc
Confidence 7777766555 3454 455 37888999999987764
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=195.14 Aligned_cols=175 Identities=25% Similarity=0.324 Sum_probs=89.4
Q ss_pred ccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCcc
Q 043053 341 ALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420 (1058)
Q Consensus 341 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 420 (1058)
.++++++.++ .+|..+ .++|++|++++|++++..+..|..+++|++|++++|+|+++.+..|..+++|++|+|++|+
T Consensus 11 ~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 11 TVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp EEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 3445555554 233322 2345555555555554444445555555555555555555544455555555555555555
Q ss_pred CCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCc
Q 043053 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSS 500 (1058)
Q Consensus 421 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 500 (1058)
+++..+..|..+++|+.|++++|+|++..+..|..+++|++|++++|++++..+..|..+++|+.|+|++|++.+
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----- 162 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----- 162 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-----
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-----
Confidence 554444445555555555555555555444445555555555555555554444444555555555555554432
Q ss_pred ccCCcccccccccCCcccCCCChhh
Q 043053 501 LGLCSSLQLLDLSSNQLTGSVPMEL 525 (1058)
Q Consensus 501 ~~~l~~L~~L~l~~N~l~~~~p~~~ 525 (1058)
.+++|++|+++.|+++|.+|.++
T Consensus 163 --~~~~l~~L~~~~n~~~g~ip~~~ 185 (208)
T 2o6s_A 163 --TCPGIRYLSEWINKHSGVVRNSA 185 (208)
T ss_dssp --CTTTTHHHHHHHHHCTTTBBCTT
T ss_pred --CCCCHHHHHHHHHhCCceeeccC
Confidence 22344555555555555444444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.5e-20 Score=189.30 Aligned_cols=181 Identities=20% Similarity=0.227 Sum_probs=159.2
Q ss_pred hhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCC
Q 043053 364 TKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHN 443 (1058)
Q Consensus 364 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 443 (1058)
+.++.+++.++. +|..+ .++|++|++++|+++++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 456778888874 45444 368999999999999998888999999999999999999888888999999999999999
Q ss_pred ccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCCh
Q 043053 444 TLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPM 523 (1058)
Q Consensus 444 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 523 (1058)
++++..+..|..+++|++|++++|+|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++.+..|.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 166 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 166 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence 99988888899999999999999999987777899999999999999999988888899999999999999999876552
Q ss_pred hhhhhHHHHHHHhhccCCCCCCCCcccccccc
Q 043053 524 ELGQIEALEIALNLSCNGLTGPIPAQISALNK 555 (1058)
Q Consensus 524 ~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~ 555 (1058)
+ ..++++.|+++|.+|.+++.++.
T Consensus 167 -------l-~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 167 -------I-RYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp -------T-HHHHHHHHHCTTTBBCTTSSBCT
T ss_pred -------H-HHHHHHHHhCCceeeccCccccC
Confidence 2 25788899999999988877665
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.80 E-value=3e-20 Score=220.33 Aligned_cols=188 Identities=26% Similarity=0.353 Sum_probs=145.2
Q ss_pred hhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEcc
Q 043053 314 KLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVG 393 (1058)
Q Consensus 314 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 393 (1058)
+++.|++++|++++ +|..+ .++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 56666666666665 34333 267888888888888 466 346788888888888886 555 655 89999999
Q ss_pred CccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCC
Q 043053 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473 (1058)
Q Consensus 394 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 473 (1058)
+|+|+++ |. .+++|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~l-p~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTML-PE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSCC-CC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCCC-CC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 9999885 43 67889999999999986 454 56889999999999987 555 65 88999999999998 66
Q ss_pred cccccccccc-------cccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhH
Q 043053 474 PASLGRLVSL-------NKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIE 529 (1058)
Q Consensus 474 ~~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 529 (1058)
|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 66 654 77 99999999998 5787788899999999999999988887776554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.7e-19 Score=210.94 Aligned_cols=134 Identities=31% Similarity=0.464 Sum_probs=60.7
Q ss_pred cccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeecc
Q 043053 338 NLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLS 417 (1058)
Q Consensus 338 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 417 (1058)
+|+.|+|++|+|++ +|..++ ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|+++ |. |.. +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~i-p~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLSTL-PE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCC-CC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCCc-ch-hhc--CCCEEECC
Confidence 56666666666654 444332 44555555555555 233 2234555555555555542 22 332 45555555
Q ss_pred CccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCC
Q 043053 418 SNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFS 494 (1058)
Q Consensus 418 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 494 (1058)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~ 193 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE 193 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC
Confidence 555543 222 33444444444444443 222 23444444444444443 333 32 34444444444443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.7e-19 Score=187.20 Aligned_cols=128 Identities=21% Similarity=0.300 Sum_probs=60.8
Q ss_pred cEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCC
Q 043053 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN 467 (1058)
Q Consensus 388 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 467 (1058)
+.+++++|.++.+ |..+. ++|++|+|++|+|+++.+..|..+++|+.|+|++|+|+++.|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~i-P~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTEI-PTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSSC-CSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCcC-CCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 3455555555543 22221 34555555555555444445555555555555555555444555555555555555555
Q ss_pred ccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCccc
Q 043053 468 RFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 468 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 518 (1058)
+|+...+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 554333333444444444444444444444444444444444444444443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3e-19 Score=195.66 Aligned_cols=173 Identities=27% Similarity=0.384 Sum_probs=119.0
Q ss_pred hhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccc
Q 043053 333 LASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLN 412 (1058)
Q Consensus 333 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 412 (1058)
+..+++|+.|++++|.+... + .+..+++|++|++++|++++..+ +..+++|+.|++++|+++++ ..+..+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCC
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCC
Confidence 34566666667776666632 2 35566677777777777765433 67777777777777777653 2377777777
Q ss_pred eeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCccccccccccccccccccc
Q 043053 413 FLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNL 492 (1058)
Q Consensus 413 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 492 (1058)
+|+|++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..+ +..+++|+.|+|++|+
T Consensus 116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence 777777777653 4566777777777777777754 467777777777777777775444 7777777777777777
Q ss_pred CCCCCCCcccCCcccccccccCCcccC
Q 043053 493 FSGPIPSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 493 l~~~~~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
|++. + .+..+++|+.|++++|+++.
T Consensus 190 i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 190 ISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred CCCC-h-hhccCCCCCEEECcCCcccC
Confidence 7753 3 37777788888888887763
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.5e-19 Score=197.96 Aligned_cols=193 Identities=22% Similarity=0.293 Sum_probs=151.5
Q ss_pred cccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhh
Q 043053 288 ATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLL 367 (1058)
Q Consensus 288 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 367 (1058)
+.++..+.+..+.+.+. ..+..+++|+.|++++|.++.. ..+..+++|+.|++++|++++..+ +..+++|++|+
T Consensus 23 l~~~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~ 96 (291)
T 1h6t_A 23 FAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF 96 (291)
T ss_dssp HHHHHHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHHHHHhcCCCcccc--cchhhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEE
Confidence 34556666776666654 2345677777777777777755 247778888888888888886444 77888888888
Q ss_pred ccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCC
Q 043053 368 LISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG 447 (1058)
Q Consensus 368 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 447 (1058)
+++|.+++. ..+..+++|++|+|++|+|+++ ..+..+++|++|++++|++++. ..+..+++|+.|++++|++++
T Consensus 97 l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~ 170 (291)
T 1h6t_A 97 LDENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 170 (291)
T ss_dssp CCSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred CCCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc
Confidence 888888752 3488889999999999998875 4688889999999999999865 578888999999999999987
Q ss_pred CCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCC
Q 043053 448 SLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGP 496 (1058)
Q Consensus 448 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 496 (1058)
..+ +..+++|+.|++++|++++ ++ .+..+++|+.|+|++|++...
T Consensus 171 ~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 171 IVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred chh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 554 8889999999999999985 44 488889999999999998753
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.6e-19 Score=212.70 Aligned_cols=199 Identities=22% Similarity=0.278 Sum_probs=122.9
Q ss_pred cccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhh
Q 043053 288 ATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLL 367 (1058)
Q Consensus 288 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 367 (1058)
+..+..+++..+.+.+..+ +..+.+|+.|++.+|.+... + .+..+++|+.|+|++|+|.+..+ +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 3445566666666654432 44556666666666666543 2 46666677777777777665333 56666666667
Q ss_pred ccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCC
Q 043053 368 LISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG 447 (1058)
Q Consensus 368 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 447 (1058)
|++|.|++. ..+..+++|+.|+|++|+|+++ ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++
T Consensus 94 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 94 LDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred CcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence 776666642 2566667777777777777654 3466667777777777776644 456666677777777777765
Q ss_pred CCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCccc
Q 043053 448 SLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLG 502 (1058)
Q Consensus 448 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 502 (1058)
..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+.....+.
T Consensus 168 ~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~ 218 (605)
T 1m9s_A 168 IVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS 218 (605)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCS
T ss_pred chh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccc
Confidence 444 66667777777777766642 2466666666666666666654333333
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.7e-19 Score=187.31 Aligned_cols=157 Identities=20% Similarity=0.225 Sum_probs=75.9
Q ss_pred chhhccCCccCCCCc-cccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccC
Q 043053 436 QMIDLSHNTLQGSLP-NSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSS 514 (1058)
Q Consensus 436 ~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 514 (1058)
+.|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 114 (220)
T 2v70_A 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114 (220)
T ss_dssp SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence 344444444443322 2344444444444444444443344444444444444444444444444455555555555555
Q ss_pred CcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCC-CCcccccCcceeEEEecccccccC
Q 043053 515 NQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGN-LNPLAQLDNLVSLNISYNKFTGYL 593 (1058)
Q Consensus 515 N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~l~~L~~L~l~~N~l~~~~ 593 (1058)
|+|++..| ..|.++++|+.|+|++|+|++. +..+..+++|+.|++++|+|+|.+
T Consensus 115 N~l~~~~~-------------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 115 NRITCVGN-------------------------DSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SCCCCBCT-------------------------TSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CcCCeECH-------------------------hHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 55443222 2234445555555555555554 244555666777777777777776
Q ss_pred CCccccccCCCccc-cCCcccccCCC
Q 043053 594 PDNKLFRQLSPTDL-AGNEGLCSSRK 618 (1058)
Q Consensus 594 ~~~~~~~~~~~~~~-~~n~~~c~~~~ 618 (1058)
+..+...++..... .++ ..|..|.
T Consensus 170 ~l~~l~~~~~~~~~~~~~-~~C~~P~ 194 (220)
T 2v70_A 170 YLAWLGEWLRKKRIVTGN-PRCQKPY 194 (220)
T ss_dssp GGHHHHHHHHHSCCBCCC-CEEEESG
T ss_pred chHHHHHHHHhcCccccC-CccCCCh
Confidence 65444333332222 333 3566553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=7.4e-19 Score=183.93 Aligned_cols=152 Identities=20% Similarity=0.270 Sum_probs=121.1
Q ss_pred hhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCc
Q 043053 365 KLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNT 444 (1058)
Q Consensus 365 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 444 (1058)
.+++++|.++ .+|..+. ++|+.|+|++|+|+++.+..|..+++|++|+|++|+|+++.|..|..+++|+.|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4455555555 3444333 567888888888887777778888888888888888887778888888888888888888
Q ss_pred cCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccC
Q 043053 445 LQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 445 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
|+++.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 887766778888888888888888887778888888888888888888888777888888999999999999874
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.1e-19 Score=203.70 Aligned_cols=177 Identities=24% Similarity=0.184 Sum_probs=136.1
Q ss_pred cccccccccccccCcccccccccchhhhccccCCCCCCCCCcc-CCCCCcEEEccCccccCCccccccCccccceeeccC
Q 043053 340 QALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIG-NCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSS 418 (1058)
Q Consensus 340 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 418 (1058)
+.+++++|+++ .+|..+. ..++.|+|++|+|++..+..|. ++++|+.|+|++|+|+++.+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46777777777 3565544 3477788888888777777776 788888888888888887777888888888888888
Q ss_pred ccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccc---cccccccccccccccCCC
Q 043053 419 NRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL---GRLVSLNKIILSKNLFSG 495 (1058)
Q Consensus 419 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~ 495 (1058)
|+|+++.+..|..+++|+.|+|++|+|+++.|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 88887777778888888888888888887777888888888888888888875444445 567888888888888886
Q ss_pred CCCCcccCCcc--cccccccCCcccC
Q 043053 496 PIPSSLGLCSS--LQLLDLSSNQLTG 519 (1058)
Q Consensus 496 ~~~~~~~~l~~--L~~L~l~~N~l~~ 519 (1058)
..+..|..++. |+.|+|++|++..
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred cCHHHhhhccHhhcceEEecCCCccC
Confidence 66667777776 4788999998874
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=8e-19 Score=183.64 Aligned_cols=156 Identities=21% Similarity=0.240 Sum_probs=129.1
Q ss_pred hhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCcc-ccccCccccceeeccCccCCCCCCCcccCCcccchhhccC
Q 043053 364 TKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIP-REIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442 (1058)
Q Consensus 364 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 442 (1058)
+.+++++|.++. +|..+. ..+++|+|++|+|+++.+ ..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 356666666663 444443 346788888888887744 4578888899999999988888888888889999999999
Q ss_pred CccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCC
Q 043053 443 NTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 443 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
|+|+++.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|++++|++.+..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99988888888999999999999999988888889999999999999999998889999999999999999999986544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=7.9e-19 Score=210.64 Aligned_cols=194 Identities=25% Similarity=0.344 Sum_probs=170.5
Q ss_pred ccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEE
Q 043053 311 MLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRL 390 (1058)
Q Consensus 311 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 390 (1058)
.+.++..+.+..+.+....+ +..+++|+.|++++|.+.. ++ .+..+++|+.|+|++|.|++..+ +..+++|+.|
T Consensus 19 ~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 92 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL 92 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred HHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence 45667788888888886543 6789999999999999985 44 58889999999999999997655 9999999999
Q ss_pred EccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccc
Q 043053 391 RVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470 (1058)
Q Consensus 391 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 470 (1058)
+|++|+|+++ ..+..+++|++|+|++|+|++. ..+..+++|+.|+|++|+|+++ ..+..+++|+.|+|++|+|+
T Consensus 93 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~ 166 (605)
T 1m9s_A 93 FLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 166 (605)
T ss_dssp ECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred ECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence 9999999975 3799999999999999999864 4689999999999999999975 67999999999999999999
Q ss_pred cCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCC
Q 043053 471 GQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGS 520 (1058)
Q Consensus 471 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 520 (1058)
+..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.
T Consensus 167 ~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 167 DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred Cchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 7666 89999999999999999864 4689999999999999999854
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=8.4e-19 Score=198.66 Aligned_cols=160 Identities=26% Similarity=0.239 Sum_probs=138.9
Q ss_pred hhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCcccccc-CccccceeeccCccCCCCCCCcccCCcccchhhccC
Q 043053 364 TKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIG-GLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442 (1058)
Q Consensus 364 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 442 (1058)
+.+++++|.++. +|..+. ..++.|+|++|+|+++.+..|. .+++|++|+|++|+|+++.+..|..+++|+.|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 578899999984 666554 4689999999999999888888 999999999999999988888999999999999999
Q ss_pred CccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcc---cCCcccccccccCCcccC
Q 043053 443 NTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSL---GLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 443 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~ 519 (1058)
|+|+++.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99998888889999999999999999998888999999999999999999997665556 568999999999999985
Q ss_pred CCChhhh
Q 043053 520 SVPMELG 526 (1058)
Q Consensus 520 ~~p~~~~ 526 (1058)
..+..+.
T Consensus 178 l~~~~~~ 184 (361)
T 2xot_A 178 LPLTDLQ 184 (361)
T ss_dssp CCHHHHH
T ss_pred cCHHHhh
Confidence 4334443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=214.00 Aligned_cols=223 Identities=22% Similarity=0.281 Sum_probs=129.3
Q ss_pred CcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeec
Q 043053 337 SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDL 416 (1058)
Q Consensus 337 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 416 (1058)
+.++.|+|.+|.+.. .+. ..|+.++|+.|.|. .+++..|++. ..+..|..++.|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCc-chh-----hHhhcCccCccccc--------------Ccccccccee-cChhhhccCCCCcEEEC
Confidence 345666666666653 221 12344445554443 2345556665 56788999999999999
Q ss_pred cCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCC
Q 043053 417 SSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGP 496 (1058)
Q Consensus 417 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 496 (1058)
++|.+. .+|..+..+++|+.|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..|..+.+|+.|+|++|.|+ .
T Consensus 232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-T 307 (727)
T ss_dssp TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-c
Confidence 999998 66777779999999999999999 68889999999999999999999 78999999999999999999998 6
Q ss_pred CCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCC--------cccC
Q 043053 497 IPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHN--------KLEG 568 (1058)
Q Consensus 497 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N--------~l~~ 568 (1058)
+|..|..+++|+.|+|++|+|++.+|..+..+......++|++|.+++.+|.. |+.|++++| .|.+
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~ 381 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQ 381 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------
T ss_pred cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccc
Confidence 78889999999999999999999999999887776667999999999988764 667888888 2222
Q ss_pred CC-CcccccCcceeEEEeccccc
Q 043053 569 NL-NPLAQLDNLVSLNISYNKFT 590 (1058)
Q Consensus 569 ~~-~~~~~l~~L~~L~l~~N~l~ 590 (1058)
.. ..+..+..+....+++|.+.
T Consensus 382 ~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 382 STEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp --------------------CCC
T ss_pred cccchhhcccccceeeeeccccc
Confidence 11 12334455555666666654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.4e-20 Score=221.22 Aligned_cols=217 Identities=19% Similarity=0.196 Sum_probs=157.9
Q ss_pred cccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccc
Q 043053 262 GGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQA 341 (1058)
Q Consensus 262 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 341 (1058)
..+++|+.|+|++|.++ .+|..++++++|+.|++++|... ..+..+ +..+++.+..|..+..+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l----------~~l~~l-l~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCL----------LTIILL-MRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHH----------HHHHHH-HHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhh----------hhHHHH-HHhcccccCCHHHHHHHHhccc
Confidence 55778888888888887 67888888888888888666421 111111 1122344566778888888888
Q ss_pred cc-cccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCcc
Q 043053 342 LD-LSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420 (1058)
Q Consensus 342 L~-Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 420 (1058)
|+ ++.|.+ .+|+.+.+++|.|+...+ ..|+.|+|++|+|+++ |. |+.+++|+.|+|++|+
T Consensus 414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HCGGGHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSC
T ss_pred Ccchhhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecCccc
Confidence 88 676654 356777778887764322 2478888888888875 44 8888888888888888
Q ss_pred CCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCC-cccccccccccccccccccCCCCCCC
Q 043053 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI-PASLGRLVSLNKIILSKNLFSGPIPS 499 (1058)
Q Consensus 421 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~ 499 (1058)
|+ .+|..|+.+++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|+|++.+|.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 88 667788888888888888888886 55 7888888888888888888766 78888888888888888888765543
Q ss_pred c---ccCCcccccccc
Q 043053 500 S---LGLCSSLQLLDL 512 (1058)
Q Consensus 500 ~---~~~l~~L~~L~l 512 (1058)
. +..+++|+.|++
T Consensus 552 ~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 552 QERLAEMLPSVSSILT 567 (567)
T ss_dssp TTHHHHHCTTCSEEEC
T ss_pred HHHHHHHCcccCccCC
Confidence 2 233677777753
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=5.4e-20 Score=219.54 Aligned_cols=217 Identities=19% Similarity=0.212 Sum_probs=168.3
Q ss_pred cCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhh
Q 043053 238 GNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTV 317 (1058)
Q Consensus 238 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 317 (1058)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|... ..+..+ +..+.+.+..|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l----------~~l~~l-l~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCL----------LTIILL-MRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHH----------HHHHHH-HHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhh----------hhHHHH-HHhcccccCCHHHHHHHHhccc
Confidence 67899999999999998 78999999999999999776421 011111 1122334566777888888888
Q ss_pred hh-ccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCcc
Q 043053 318 FF-AWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNR 396 (1058)
Q Consensus 318 L~-l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 396 (1058)
|+ +..|.+ .+|+.+.+++|.++...+ ..|+.|+|++|.|++ +|. |+.+++|+.|+|++|+
T Consensus 414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HCGGGHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred Ccchhhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence 87 555543 467778888888874322 247889999999986 565 8999999999999999
Q ss_pred ccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCC-ccccccCCCCCeeecCCCccccCCcc
Q 043053 397 IAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSL-PNSLSSLSGLQVLDVSDNRFSGQIPA 475 (1058)
Q Consensus 397 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~ 475 (1058)
|+ .+|..|+.+++|++|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..|+.+++|+.|+|++|+|++.+|.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 99 457789999999999999999986 56 7899999999999999999876 88999999999999999999876553
Q ss_pred c---cccccccccccc
Q 043053 476 S---LGRLVSLNKIIL 488 (1058)
Q Consensus 476 ~---~~~l~~L~~L~L 488 (1058)
. +..+++|+.|+|
T Consensus 552 ~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 552 QERLAEMLPSVSSILT 567 (567)
T ss_dssp TTHHHHHCTTCSEEEC
T ss_pred HHHHHHHCcccCccCC
Confidence 2 234778887754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.2e-18 Score=179.44 Aligned_cols=156 Identities=24% Similarity=0.247 Sum_probs=122.4
Q ss_pred chhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccC
Q 043053 363 LTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442 (1058)
Q Consensus 363 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 442 (1058)
-+.++.+++.+. .+|..+. ++|+.|+|++|+|+++.|..|..+++|++|+|++|+|+.+.+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 344555556555 3444333 6788888888888887777888888888888888888766667778888888888888
Q ss_pred CccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCC
Q 043053 443 NTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 443 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
|+|+++.+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+..+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 8888777777888888888888888887 677888888888888888888887777788889999999999999986543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.9e-18 Score=178.29 Aligned_cols=153 Identities=25% Similarity=0.318 Sum_probs=132.2
Q ss_pred ccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccC
Q 043053 339 LQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSS 418 (1058)
Q Consensus 339 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 418 (1058)
-+.+++++++++ .+|..+. ++|++|+|++|.|++..|..|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 456888888887 4666554 7888999999999988888899999999999999999888888889999999999999
Q ss_pred ccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCC
Q 043053 419 NRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495 (1058)
Q Consensus 419 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 495 (1058)
|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 9999888888889999999999999998 477888999999999999999987777788889999999999999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.6e-18 Score=183.37 Aligned_cols=148 Identities=21% Similarity=0.190 Sum_probs=107.9
Q ss_pred ccccceeccccceEEEEEEe-cCCcE--EEEEecCcccccccC---------CCC----CcccchHHHHHHHHHHHcccC
Q 043053 706 LVDANVIGKGCSGVVYRADM-DNGEV--IAVKKLWPTTMAAAN---------GCS----DEKSGVRDSFSAEIKTLGSIR 769 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~~~---------~~~----~~~~~~~~~~~~E~~~l~~l~ 769 (1058)
|.+.+.||+|+||.||+|.. .+|+. ||||++......... ... .........+.+|+..+.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999965 77999 999987543211000 000 001112347889999999999
Q ss_pred CCcc--cceeeEEEcCCCceEEEEecCC-C----ChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhccc-ccCCCCeEeCC
Q 043053 770 HKNI--VRFLGCCWNRNNRLLMYDYMPN-G----SLGSLLHERTGNALEWELRYQILLGAAQGLAYLH-HDCVPPIVHRD 841 (1058)
Q Consensus 770 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivHrD 841 (1058)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.|++||| +. +|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 8864 334432 367999999942 4 56655432 234567789999999999999 88 999999
Q ss_pred CCCCcEEEcCCCCeeeeccccceecc
Q 043053 842 IKANNILIGLEFEPYIADFGLAKLVD 867 (1058)
Q Consensus 842 ikp~Nill~~~~~~kl~DfGl~~~~~ 867 (1058)
|||+|||++. .++|+|||+|....
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999998 99999999997653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-18 Score=186.26 Aligned_cols=169 Identities=24% Similarity=0.358 Sum_probs=79.4
Q ss_pred ccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhh
Q 043053 287 NATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKL 366 (1058)
Q Consensus 287 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 366 (1058)
.+.+++.+++++|.++++. .+..+++|+.|++++|+++.. + .+..+++|+.|+|++|++++..+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 3445555666666655442 344445555555555554432 2 34455555555555555553222 4444555555
Q ss_pred hccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccC
Q 043053 367 LLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446 (1058)
Q Consensus 367 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 446 (1058)
+|++|++++. +. +.. ++|+.|+|++|+|+++ ..+..+++|++|+|++|+|++. + .+..+++|+.|++++|+++
T Consensus 91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 5555555432 11 111 4455555555555443 1344445555555555554432 1 3444444555555555444
Q ss_pred CCCccccccCCCCCeeecCCCccc
Q 043053 447 GSLPNSLSSLSGLQVLDVSDNRFS 470 (1058)
Q Consensus 447 ~~~~~~~~~l~~L~~L~L~~N~l~ 470 (1058)
+. ..+..+++|+.|++++|+++
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEE
T ss_pred ch--HHhccCCCCCEEeCCCCccc
Confidence 33 33444444444444444444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.8e-18 Score=183.75 Aligned_cols=170 Identities=25% Similarity=0.309 Sum_probs=97.5
Q ss_pred ccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEE
Q 043053 311 MLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRL 390 (1058)
Q Consensus 311 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 390 (1058)
.+.++..+++.+|.+++.. .+..+++|+.|++++|+++. ++ .+..+++|++|+|++|+|++..+ +.++++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 4566667777777776543 46666777777777777663 33 45556666666666666664333 5566666666
Q ss_pred EccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccc
Q 043053 391 RVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470 (1058)
Q Consensus 391 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 470 (1058)
+|++|+|+++.+ +.. ++|++|+|++|++++. ..+..+++|+.|++++|+|++. + .+..+++|++|++++|+++
T Consensus 91 ~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 666666655422 222 5566666666666532 2355555666666666665543 2 4555555666666666555
Q ss_pred cCCcccccccccccccccccccCCC
Q 043053 471 GQIPASLGRLVSLNKIILSKNLFSG 495 (1058)
Q Consensus 471 ~~~~~~~~~l~~L~~L~Ls~N~l~~ 495 (1058)
+. ..+..+++|+.|+|++|++.+
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred ch--HHhccCCCCCEEeCCCCcccC
Confidence 43 445555555555555555553
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.5e-18 Score=194.10 Aligned_cols=102 Identities=11% Similarity=0.130 Sum_probs=54.5
Q ss_pred cccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccc-eeeccCccCCCCCCCcccCCcccchh
Q 043053 360 LQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLN-FLDLSSNRLSGSVPDEIGDCTELQMI 438 (1058)
Q Consensus 360 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L 438 (1058)
+++|++|+|++|+++.+.+.+|.+|++|+.|+|.+| ++.+.+.+|.++.+|+ .+++.+ .++.+.+.+|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 445555555555555444455555555555555555 5545555555555555 555555 4444445555555555555
Q ss_pred hccCCccCCCCccccccCCCCCeee
Q 043053 439 DLSHNTLQGSLPNSLSSLSGLQVLD 463 (1058)
Q Consensus 439 ~l~~N~l~~~~~~~~~~l~~L~~L~ 463 (1058)
++++|+++.+.+.+|.++++|+.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 5555555544445555555555544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.5e-17 Score=171.00 Aligned_cols=151 Identities=19% Similarity=0.276 Sum_probs=85.5
Q ss_pred cccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhh
Q 043053 360 LQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMID 439 (1058)
Q Consensus 360 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 439 (1058)
+++|++|++++|.++ .+| .+..+++|++|++++|.++.. ..+..+++|++|++++|++++..+..++.+++|+.|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 344444444444444 222 355555555555555554432 3455566666666666666554555566666666666
Q ss_pred ccCCccCCCCccccccCCCCCeeecCCCc-cccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCccc
Q 043053 440 LSHNTLQGSLPNSLSSLSGLQVLDVSDNR-FSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 440 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 518 (1058)
+++|++++..+..+..+++|++|++++|+ ++ .+| .+..+++|+.|++++|++++. + .+..+++|+.|++++|++.
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC---
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcccC
Confidence 66666665555666666666666666665 43 333 466666666666666666642 2 5666667777777777664
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=171.18 Aligned_cols=155 Identities=21% Similarity=0.306 Sum_probs=111.2
Q ss_pred hhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccc
Q 043053 333 LASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLN 412 (1058)
Q Consensus 333 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 412 (1058)
...+++|+.|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..|..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356667777777777777 344 56677777777777776652 23677777888888888888776677777888888
Q ss_pred eeeccCccCCCCCCCcccCCcccchhhccCCc-cCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccc
Q 043053 413 FLDLSSNRLSGSVPDEIGDCTELQMIDLSHNT-LQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491 (1058)
Q Consensus 413 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 491 (1058)
+|+|++|++++..+..+..+++|+.|++++|+ ++. +| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 88888888876667777778888888888887 654 44 57778888888888888874 33 6777788888888888
Q ss_pred cCCC
Q 043053 492 LFSG 495 (1058)
Q Consensus 492 ~l~~ 495 (1058)
+|.+
T Consensus 192 ~i~~ 195 (197)
T 4ezg_A 192 TIGG 195 (197)
T ss_dssp ----
T ss_pred ccCC
Confidence 7753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.3e-18 Score=191.23 Aligned_cols=283 Identities=13% Similarity=0.067 Sum_probs=183.4
Q ss_pred CCCcceeecccccccCCCCccccC-cCCccEEEeecCCCc--CcCCccccccCCcceeecccCccCCCccccccc-----
Q 043053 216 LKKLEELFLWQNSLVGAIPEEIGN-CTSLKMIDFSLNSLS--GTIPLSIGGLSELEEFMISDNNVSGSIPANLAN----- 287 (1058)
Q Consensus 216 l~~L~~L~L~~n~l~~~~~~~l~~-l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~----- 287 (1058)
+.+|+.|.++++ +.......+.. +++|+.|||++|++. ..... .++.+..+.+..|.| ....|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I---~~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFV---PAYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEE---CTTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---ccccccccccccccc---CHHHhccccccc
Confidence 677888888865 22111123333 678899999998887 22222 222344555555533 3456666
Q ss_pred ---cccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccc----cccCccccccc
Q 043053 288 ---ATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSL----TASVPAGLFQL 360 (1058)
Q Consensus 288 ---l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l----~~~~~~~~~~l 360 (1058)
+++|+.|+|.+ .++.+.+.+|.++++|+.+++.+|.+..+.+.+|.++.++..+.+..+.. ......+|..+
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~ 175 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG 175 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence 78888888877 77777777788888888888877777777777777777777666655322 22223334444
Q ss_pred ccch-hhhccccCCCCCCCC----CccCCCCCcEEEccCccccCCccccc-cCccccceeeccCccCCCCCCCcccCCcc
Q 043053 361 QNLT-KLLLISNDISGSIPP----EIGNCSSLVRLRVGNNRIAGLIPREI-GGLKTLNFLDLSSNRLSGSVPDEIGDCTE 434 (1058)
Q Consensus 361 ~~L~-~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 434 (1058)
.+|+ .+.+.... .++. .--...++..+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+.+|.++++
T Consensus 176 ~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~ 251 (329)
T 3sb4_A 176 EPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKY 251 (329)
T ss_dssp CCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTT
T ss_pred cccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCC
Confidence 4444 22221110 0000 0011334455555543211 111111 23678888888888888777788888888
Q ss_pred cchhhccCCccCCCCccccccCCCCC-eeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccc
Q 043053 435 LQMIDLSHNTLQGSLPNSLSSLSGLQ-VLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDL 512 (1058)
Q Consensus 435 L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 512 (1058)
|+.|+|.+| ++.+.+.+|.++.+|+ .|++.+ .++...+.+|.++.+|+.|+|++|.+..+.+.+|.++++|+.++.
T Consensus 252 L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 252 LLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 888888888 7777778888888888 888887 676666788888888888888888888788888888888888763
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.3e-18 Score=209.71 Aligned_cols=224 Identities=24% Similarity=0.210 Sum_probs=80.3
Q ss_pred chhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEc
Q 043053 313 SKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRV 392 (1058)
Q Consensus 313 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 392 (1058)
+.++.|.+.+|.+... +. ..|+.++|+.|.|.+ +++..|.+. ..+..|..+++|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQ-----ALLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCcc-hh-----hHhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence 5678889988888863 22 235556666666553 233344444 44555555566666666
Q ss_pred cCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccC
Q 043053 393 GNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQ 472 (1058)
Q Consensus 393 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 472 (1058)
++|.|..+ |..+..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|+ .+|..|+++++|++|+|++|.|+ .
T Consensus 232 s~n~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~ 307 (727)
T 4b8c_D 232 SNLQIFNI-SANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-T 307 (727)
T ss_dssp TTSCCSCC-CGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred CCCCCCCC-ChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-c
Confidence 66666533 333335566666666666665 45555566666666666666665 34555666666666666666664 4
Q ss_pred CcccccccccccccccccccCCCCCCCcccCCcc-cccccccCCcccCCCChhhhhhHHHHHHHhhccC--------CCC
Q 043053 473 IPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSS-LQLLDLSSNQLTGSVPMELGQIEALEIALNLSCN--------GLT 543 (1058)
Q Consensus 473 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N--------~l~ 543 (1058)
+|..|+.+++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|..+.. +++++| .|.
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~-------l~l~~n~~~~~~~~~l~ 380 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRF-------IEINTDGEPQREYDSLQ 380 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------
T ss_pred cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccce-------eEeecccccccccCCcc
Confidence 5555666666666666666666555555443321 123556666666665554432 223333 444
Q ss_pred CCCCccccccccccEEecCCCcccC
Q 043053 544 GPIPAQISALNKLSILDLSHNKLEG 568 (1058)
Q Consensus 544 ~~~~~~~~~l~~L~~L~L~~N~l~~ 568 (1058)
+..+..+..+.+++...+++|-+.+
T Consensus 381 ~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 381 QSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ---------------------CCCG
T ss_pred ccccchhhcccccceeeeecccccc
Confidence 4555556677777888888887753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=4e-17 Score=166.75 Aligned_cols=132 Identities=25% Similarity=0.314 Sum_probs=102.3
Q ss_pred cEEEccCccccCCccccccCccccceeeccCccCCCCCCC-cccCCcccchhhccCCccCCCCccccccCCCCCeeecCC
Q 043053 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPD-EIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSD 466 (1058)
Q Consensus 388 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 466 (1058)
+.+++++|+++.+ |..+. .+|++|+|++|+|++..+. .|..+++|+.|+|++|+|+++.|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~~i-p~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKEI-PRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSC-CSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCcC-ccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 6788888888755 43332 2788888888888766664 477888888888888888877788888888888888888
Q ss_pred CccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCC
Q 043053 467 NRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 467 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|++++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 88887777778888888888888888887777788888888888888888876544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=162.77 Aligned_cols=131 Identities=24% Similarity=0.363 Sum_probs=120.7
Q ss_pred hhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccc-cccCccccceeeccCccCCCCCCCcccCCcccchhhccC
Q 043053 364 TKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR-EIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442 (1058)
Q Consensus 364 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 442 (1058)
+.+++++|.++ .+|..+.. +|++|++++|+|+++.+. .|..+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67899999997 56665543 899999999999988775 599999999999999999999999999999999999999
Q ss_pred CccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCC
Q 043053 443 NTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPI 497 (1058)
Q Consensus 443 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 497 (1058)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++.+..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 9999988889999999999999999999999999999999999999999998643
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.4e-16 Score=178.55 Aligned_cols=269 Identities=10% Similarity=0.098 Sum_probs=117.1
Q ss_pred CCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeec
Q 043053 193 SELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMI 272 (1058)
Q Consensus 193 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 272 (1058)
..++.+.+.+ .++.+....|.++ +|+.+.+..+ +.......|.++ +|+.+++.. .+..+....|.++++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4455555543 2332334445543 4566655543 443334444442 455555543 333333444444444444444
Q ss_pred ccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCccccccccccccccc
Q 043053 273 SDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTAS 352 (1058)
Q Consensus 273 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 352 (1058)
.+|.++ .+...+|. ..+|+.+.+.+ .++.+...+|.++++|+.+++..| ++.+
T Consensus 188 ~~n~l~------------------------~I~~~aF~-~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I 240 (401)
T 4fdw_A 188 SKTKIT------------------------KLPASTFV-YAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTI 240 (401)
T ss_dssp TTSCCS------------------------EECTTTTT-TCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEE
T ss_pred CCCcce------------------------EechhhEe-ecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCc
Confidence 444444 33333333 23333333332 233344445555555555555543 3322
Q ss_pred CcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCC
Q 043053 353 VPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC 432 (1058)
Q Consensus 353 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 432 (1058)
...+|.+ .+|+.+.+ .|.++.+...+|.+|++|+.+++.+|.+.. +.+..+.+.+|.++
T Consensus 241 ~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c 299 (401)
T 4fdw_A 241 GQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGC 299 (401)
T ss_dssp CTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTC
T ss_pred ccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCC
Confidence 2333333 34444444 233333444455555555555554444330 00002333344444
Q ss_pred cccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCc-cccccc
Q 043053 433 TELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCS-SLQLLD 511 (1058)
Q Consensus 433 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~ 511 (1058)
++|+.++|.+ .++.+...+|.++.+|+.++|..| ++.....+|.++ +|+.+++++|.+....+..|.+++ +++.|+
T Consensus 300 ~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~ 376 (401)
T 4fdw_A 300 PKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIR 376 (401)
T ss_dssp TTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEE
T ss_pred ccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEE
Confidence 4444444442 233333444444444444444332 333333444444 455555555444444444555442 455555
Q ss_pred ccCCcc
Q 043053 512 LSSNQL 517 (1058)
Q Consensus 512 l~~N~l 517 (1058)
+..|.+
T Consensus 377 vp~~~~ 382 (401)
T 4fdw_A 377 VPAESV 382 (401)
T ss_dssp ECGGGH
T ss_pred eCHHHH
Confidence 555543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-16 Score=177.07 Aligned_cols=149 Identities=13% Similarity=0.084 Sum_probs=102.1
Q ss_pred ccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCc---ccchHHH--------HHHHHHHHcccCCCccc
Q 043053 706 LVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDE---KSGVRDS--------FSAEIKTLGSIRHKNIV 774 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~---~~~~~~~--------~~~E~~~l~~l~h~niv 774 (1058)
|.+.+.||+|+||.||+|...+|+.||||+++............. ....... ..+|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 788999999999999999888899999998764322110000000 0001111 23466666666544432
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF- 853 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~- 853 (1058)
...-+. ....++||||++|++|..+... .....++.|++.+|.|||+. |||||||||.|||+++++
T Consensus 177 vp~p~~--~~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIA--QSRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEE--EETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEEC
T ss_pred CCeeee--ccCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCC
Confidence 211111 1235899999999888766432 12356889999999999998 999999999999998876
Q ss_pred ---------Ceeeeccccceecc
Q 043053 854 ---------EPYIADFGLAKLVD 867 (1058)
Q Consensus 854 ---------~~kl~DfGl~~~~~ 867 (1058)
.+.|+||+-+....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 38999999876543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.63 E-value=6.1e-16 Score=176.41 Aligned_cols=271 Identities=13% Similarity=0.174 Sum_probs=189.0
Q ss_pred CCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEE
Q 043053 168 LSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMID 247 (1058)
Q Consensus 168 l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 247 (1058)
+..++.+.+-++ ++.....+|.++ +|+.+.+..+ ++.+....|.++ +|+.+.+.+ .+.......|.+|++|+.++
T Consensus 112 ~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 467777777654 444556678875 7999999877 665666778885 799999986 67767778899999999999
Q ss_pred eecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCC
Q 043053 248 FSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEG 327 (1058)
Q Consensus 248 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~ 327 (1058)
++.|.++.+....|. ..+|+.+.+.++ +..+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++.
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~ 261 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTN 261 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccE
Confidence 999999976667776 589999999854 77677788888888988888764 56566666665 55666655 334444
Q ss_pred CCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccC
Q 043053 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGG 407 (1058)
Q Consensus 328 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 407 (1058)
+...+|.++++|+.+++.+|.+. .+.+..+.+.+|.+|++|+.++|. |.++.+...+|.+
T Consensus 262 I~~~aF~~c~~L~~l~l~~~~~~-------------------~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~ 321 (401)
T 4fdw_A 262 IASRAFYYCPELAEVTTYGSTFN-------------------DDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGG 321 (401)
T ss_dssp ECTTTTTTCTTCCEEEEESSCCC-------------------CCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTT
T ss_pred EChhHhhCCCCCCEEEeCCcccc-------------------CCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcC
Confidence 55555666666666655555443 011113455667777777777777 3466666677777
Q ss_pred ccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCC-CCCeeecCCCccc
Q 043053 408 LKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLS-GLQVLDVSDNRFS 470 (1058)
Q Consensus 408 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~ 470 (1058)
+.+|+.++|..| ++.+.+.+|.++ +|+.+++++|.+..+.+..|.+++ +++.|++..|.+.
T Consensus 322 c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 322 NRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 777777777544 555666677777 777777777777666666666663 5667776666543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=5.7e-16 Score=154.66 Aligned_cols=132 Identities=22% Similarity=0.246 Sum_probs=78.7
Q ss_pred CCCcEEEccCcccc-CCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeee
Q 043053 385 SSLVRLRVGNNRIA-GLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLD 463 (1058)
Q Consensus 385 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 463 (1058)
++|++|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|+.|++++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45566666666665 34455556666666666666666544 4555666666666666666655555555566666666
Q ss_pred cCCCccccCCc-ccccccccccccccccccCCCCCC---CcccCCcccccccccCCccc
Q 043053 464 VSDNRFSGQIP-ASLGRLVSLNKIILSKNLFSGPIP---SSLGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 464 L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~ 518 (1058)
+++|++++..+ ..+..+++|+.|+|++|++++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 66666654221 455666666666666666664433 35666666666666666665
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=9.5e-16 Score=153.03 Aligned_cols=131 Identities=21% Similarity=0.184 Sum_probs=67.8
Q ss_pred cchhhhccccCCC-CCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhc
Q 043053 362 NLTKLLLISNDIS-GSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDL 440 (1058)
Q Consensus 362 ~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 440 (1058)
+|++|++++|.++ +.+|..+..+++|++|++++|.|+++ ..|..+++|++|+|++|++++.+|..+..+++|+.|++
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 3344444444443 23344444445555555555555443 44555555555555555555444444445555555555
Q ss_pred cCCccCCCCc-cccccCCCCCeeecCCCccccCCc---ccccccccccccccccccCC
Q 043053 441 SHNTLQGSLP-NSLSSLSGLQVLDVSDNRFSGQIP---ASLGRLVSLNKIILSKNLFS 494 (1058)
Q Consensus 441 ~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~ 494 (1058)
++|+|++..+ ..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 5555554221 455566666666666666654333 35556666666666666655
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.1e-15 Score=169.75 Aligned_cols=331 Identities=13% Similarity=0.085 Sum_probs=150.0
Q ss_pred cCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccC
Q 043053 160 SLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGN 239 (1058)
Q Consensus 160 ~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 239 (1058)
....+|.++.+|+.+.+..+ ++.....+|.+|++|+.++|.++ ++......|..+++|+.+.+..+ +.......|.+
T Consensus 62 Ig~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~ 138 (394)
T 4fs7_A 62 IGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKG 138 (394)
T ss_dssp ECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred hHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeec
Confidence 33444555555555555432 33333445555555555555433 33233344555555555554432 22233334444
Q ss_pred cCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhh
Q 043053 240 CTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFF 319 (1058)
Q Consensus 240 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 319 (1058)
+..+...... .+.......|.++++|+.+.+.++. ..+....|.++.+|+.+++..| ++.+...+|.++..|+.+.
T Consensus 139 ~~~~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~ 214 (394)
T 4fs7_A 139 CDFKEITIPE--GVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENME 214 (394)
T ss_dssp CCCSEEECCT--TCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCC
T ss_pred ccccccccCc--cccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceee
Confidence 4322222211 1111223445555555555554432 2233444555555555555443 3334444455555544444
Q ss_pred ccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccC
Q 043053 320 AWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAG 399 (1058)
Q Consensus 320 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 399 (1058)
+..+... +.+.+....+|+.+.+..+ ++.+...++..+.+|+.+.+..+... +....|..+..++.+....+.+.
T Consensus 215 ~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~- 289 (394)
T 4fs7_A 215 FPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP- 289 (394)
T ss_dssp CCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC-
T ss_pred cCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec-
Confidence 4333221 1122223344555544332 22233334444555555555444332 44445555555555555544332
Q ss_pred CccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccc
Q 043053 400 LIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGR 479 (1058)
Q Consensus 400 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 479 (1058)
...|.++.+|+.+.+..+ ++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+++..| ++.....+|.+
T Consensus 290 --~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~ 364 (394)
T 4fs7_A 290 --EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQG 364 (394)
T ss_dssp --TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTT
T ss_pred --cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhC
Confidence 234555555555555443 33344455555555555555433 44444455555555555555544 44344445555
Q ss_pred cccccccccccccCCCCCCCcccCCccccc
Q 043053 480 LVSLNKIILSKNLFSGPIPSSLGLCSSLQL 509 (1058)
Q Consensus 480 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 509 (1058)
+.+|+.+++..+ +. .+..+|..+++|+.
T Consensus 365 C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 365 CINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp CTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred CCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 555555555443 11 12234555555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.58 E-value=7.2e-15 Score=168.45 Aligned_cols=319 Identities=13% Similarity=0.083 Sum_probs=250.9
Q ss_pred ccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCc
Q 043053 180 MISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPL 259 (1058)
Q Consensus 180 ~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 259 (1058)
.++.....+|.+|.+|+.+.|..+ ++.+....|.+|++|+.+++.++ +.......|.++++|+.+.+..+ +......
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 455566678999999999999754 66566778999999999999765 55566678999999999888755 4445566
Q ss_pred cccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcc
Q 043053 260 SIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339 (1058)
Q Consensus 260 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 339 (1058)
.|.++..++....... ..+...+|.++++|+.+.+.++ +..+...+|.++.+|+.+.+..| ++.+...+|..+..|
T Consensus 135 aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L 210 (394)
T 4fs7_A 135 AFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL 210 (394)
T ss_dssp TTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred eeecccccccccCccc--cccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence 7777655444433332 2245578999999999999765 45577889999999999999776 666777899999999
Q ss_pred cccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCc
Q 043053 340 QALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSN 419 (1058)
Q Consensus 340 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 419 (1058)
+.+.+..+... +...++...+|+.+.+..+ ++.+....|.++..|+.+.+..+... +....|..+..++.+....+
T Consensus 211 ~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~ 286 (394)
T 4fs7_A 211 ENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSV 286 (394)
T ss_dssp CBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSS
T ss_pred ceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCce
Confidence 99998877554 3344555678888888654 34466678999999999999887544 66788999999999998877
Q ss_pred cCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCC
Q 043053 420 RLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPS 499 (1058)
Q Consensus 420 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 499 (1058)
.+ ....|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++.....+|.++.+|+.+.+..| +..+...
T Consensus 287 ~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~ 360 (394)
T 4fs7_A 287 IV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGAN 360 (394)
T ss_dssp EE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTT
T ss_pred ee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHH
Confidence 54 3457888999999999876 66677789999999999999755 76566788999999999999887 7767788
Q ss_pred cccCCcccccccccCC
Q 043053 500 SLGLCSSLQLLDLSSN 515 (1058)
Q Consensus 500 ~~~~l~~L~~L~l~~N 515 (1058)
+|.+|.+|+.+++..+
T Consensus 361 aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 361 AFQGCINLKKVELPKR 376 (394)
T ss_dssp TBTTCTTCCEEEEEGG
T ss_pred HhhCCCCCCEEEECCC
Confidence 9999999999998754
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.6e-15 Score=153.25 Aligned_cols=126 Identities=26% Similarity=0.389 Sum_probs=59.1
Q ss_pred ccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCcc
Q 043053 341 ALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420 (1058)
Q Consensus 341 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 420 (1058)
.+++++|+++ .+|..+. ++|++|+|++|.|+ .+|..|.++++|+.|+|++|+|+++.+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4555555555 2343322 34444444444444 333444444444555555554444444444444444444444444
Q ss_pred CCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccc
Q 043053 421 LSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470 (1058)
Q Consensus 421 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 470 (1058)
|+++.|..|..+++|+.|+|++|+|+++.+..|..+++|+.|+|++|.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 44444444444444444444444444433334444444444444444443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.6e-15 Score=151.38 Aligned_cols=128 Identities=27% Similarity=0.315 Sum_probs=90.9
Q ss_pred cEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCC
Q 043053 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN 467 (1058)
Q Consensus 388 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 467 (1058)
+.+++++|.|+.++ ..+. ++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~~ip-~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKVLP-KGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSSCC-SCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCcCC-CCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45666666666543 2221 46777777777776 45566777777777777777777666667777777777777777
Q ss_pred ccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccC
Q 043053 468 RFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 468 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
+|++..+..|..+++|+.|+|++|+|+...+..|..+++|+.|++++|++..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 7776666677777777777777777776666677788888888888888874
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.9e-15 Score=148.65 Aligned_cols=133 Identities=21% Similarity=0.273 Sum_probs=98.9
Q ss_pred CcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCC
Q 043053 387 LVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSD 466 (1058)
Q Consensus 387 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 466 (1058)
.+.+++++|+++.+... + .++|++|++++|++++..+..|..+++|+.|++++|+|+++.+..|..+++|++|++++
T Consensus 9 ~~~l~~~~~~l~~~p~~-~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTG-I--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSSCCTT-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCccCCCC-C--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 45677777777654322 2 25677777777777766666677777777777777777776666677788888888888
Q ss_pred CccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCC
Q 043053 467 NRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 467 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 88876666667778888888888888887666677888899999999999886554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.5e-15 Score=148.16 Aligned_cols=127 Identities=21% Similarity=0.252 Sum_probs=60.9
Q ss_pred CCCcEEEccCcccc-CCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeee
Q 043053 385 SSLVRLRVGNNRIA-GLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLD 463 (1058)
Q Consensus 385 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 463 (1058)
++|+.|++++|.++ +..|..+..+++|++|++++|.+++. ..+..+++|+.|++++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34444444444444 33344444444455555555544433 3444445555555555555444444444455555555
Q ss_pred cCCCccccC-CcccccccccccccccccccCCCCCC---CcccCCccccccccc
Q 043053 464 VSDNRFSGQ-IPASLGRLVSLNKIILSKNLFSGPIP---SSLGLCSSLQLLDLS 513 (1058)
Q Consensus 464 L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~ 513 (1058)
+++|++++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555432 12444555555555555555554333 345555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=5.9e-15 Score=148.61 Aligned_cols=129 Identities=23% Similarity=0.297 Sum_probs=67.2
Q ss_pred cccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCc
Q 043053 340 QALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSN 419 (1058)
Q Consensus 340 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 419 (1058)
+.+++++|+++. +|..+. ++|++|++++|++++..+..|..+++|++|++++|+|+++.+..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~~-~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSS-CCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCcc-CCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 445555555552 333222 34555555555555444444555555555555555555554445555555555555555
Q ss_pred cCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCcccc
Q 043053 420 RLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSG 471 (1058)
Q Consensus 420 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 471 (1058)
+|++..+..|..+++|+.|++++|+|+++.+..|..+++|++|+|++|++.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 5554444445555555555555555554444444555555555555555543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.7e-15 Score=147.76 Aligned_cols=127 Identities=21% Similarity=0.260 Sum_probs=81.5
Q ss_pred ccchhhhccccCCC-CCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhh
Q 043053 361 QNLTKLLLISNDIS-GSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMID 439 (1058)
Q Consensus 361 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 439 (1058)
++|++|++++|.++ +.+|..+..+++|+.|++++|.+++. ..|..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 44555555555555 44555566666666666666666655 5566666677777777776655666666666777777
Q ss_pred ccCCccCCC-CccccccCCCCCeeecCCCccccCCc---ccccccccccccccc
Q 043053 440 LSHNTLQGS-LPNSLSSLSGLQVLDVSDNRFSGQIP---ASLGRLVSLNKIILS 489 (1058)
Q Consensus 440 l~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls 489 (1058)
+++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 777777653 23567777777777777777765444 356667777777765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=7.8e-15 Score=147.52 Aligned_cols=132 Identities=17% Similarity=0.203 Sum_probs=86.6
Q ss_pred ccCCCCCcEEEccCccccCCccccccCcc-ccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCC
Q 043053 381 IGNCSSLVRLRVGNNRIAGLIPREIGGLK-TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGL 459 (1058)
Q Consensus 381 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 459 (1058)
+.++.+|+.|++++|+++.+ +. +..+. +|++|+|++|.|++. ..|..+++|+.|++++|+|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 45556666666666666644 33 33333 677777777776654 456667777777777777776544555777777
Q ss_pred CeeecCCCccccCCcc--cccccccccccccccccCCCCCCC----cccCCcccccccccCCccc
Q 043053 460 QVLDVSDNRFSGQIPA--SLGRLVSLNKIILSKNLFSGPIPS----SLGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 460 ~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~ 518 (1058)
++|++++|+|+ .+|. .+..+++|+.|+|++|++.. +|. .+..+++|+.||+++|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 77777777775 4444 56677777777777777763 444 3777788888888888765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=2e-14 Score=144.55 Aligned_cols=132 Identities=18% Similarity=0.148 Sum_probs=80.3
Q ss_pred ccccccchhhhccccCCCCCCCCCccCCC-CCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCccc
Q 043053 357 LFQLQNLTKLLLISNDISGSIPPEIGNCS-SLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTEL 435 (1058)
Q Consensus 357 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 435 (1058)
+..+.+|++|++++|+++.. +. +..+. +|+.|+|++|.|+++ ..|..+++|++|+|++|+|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 34445555555555555532 32 33333 666666666666654 456666666666666666665544445666677
Q ss_pred chhhccCCccCCCCcc--ccccCCCCCeeecCCCccccCCccc----ccccccccccccccccCC
Q 043053 436 QMIDLSHNTLQGSLPN--SLSSLSGLQVLDVSDNRFSGQIPAS----LGRLVSLNKIILSKNLFS 494 (1058)
Q Consensus 436 ~~L~l~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~ 494 (1058)
+.|++++|+|+. +|. .+..+++|+.|++++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 91 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 777777776653 443 5666777777777777776 34443 666777777777777654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=7.4e-16 Score=158.33 Aligned_cols=137 Identities=22% Similarity=0.263 Sum_probs=77.7
Q ss_pred hhccCcccccccccccccccCcc------cccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCcccccc
Q 043053 333 LASCSNLQALDLSHNSLTASVPA------GLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIG 406 (1058)
Q Consensus 333 ~~~l~~L~~L~Ls~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 406 (1058)
+.....++.++++.+.+.+..|. .+..+++|++|++++|.+++ +| .+..+++|+.|++++|+|+. .|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchhh
Confidence 44556677777777777765554 55555556666666665554 33 55555666666666666653 244455
Q ss_pred CccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCc-cccccCCCCCeeecCCCccccCCc
Q 043053 407 GLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLP-NSLSSLSGLQVLDVSDNRFSGQIP 474 (1058)
Q Consensus 407 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~ 474 (1058)
.+++|++|+|++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+++..|
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 55566666666666654 22 35555566666666666554222 345555666666666666554433
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.45 E-value=4.4e-16 Score=160.01 Aligned_cols=156 Identities=19% Similarity=0.290 Sum_probs=134.5
Q ss_pred ccccccchhhhccccCCCCCCCC------CccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCccc
Q 043053 357 LFQLQNLTKLLLISNDISGSIPP------EIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIG 430 (1058)
Q Consensus 357 ~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 430 (1058)
+.....++.++++.+.+.+..|. .|..+++|++|+|++|+|+++ | .+..+++|++|++++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-C-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-c-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 45567889999999999988887 899999999999999999985 5 8999999999999999998 6777888
Q ss_pred CCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCc-ccccccccccccccccccCCCCCCCc---------
Q 043053 431 DCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIP-ASLGRLVSLNKIILSKNLFSGPIPSS--------- 500 (1058)
Q Consensus 431 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~--------- 500 (1058)
.+++|+.|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|+.|++++|++.+..|..
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 88999999999999997 45 68999999999999999985333 47889999999999999998766553
Q ss_pred -ccCCcccccccccCCcccC
Q 043053 501 -LGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 501 -~~~l~~L~~L~l~~N~l~~ 519 (1058)
+..+++|+.|| +|+++.
T Consensus 169 ~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HHHHCSSCSEEC--CGGGTT
T ss_pred HHHhCCCcEEEC--CcccCH
Confidence 78889999887 788863
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.39 E-value=5.7e-13 Score=132.79 Aligned_cols=108 Identities=22% Similarity=0.263 Sum_probs=75.4
Q ss_pred cceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCccccccccccccccccc
Q 043053 411 LNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSK 490 (1058)
Q Consensus 411 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 490 (1058)
.+.|++++|.++. +|..+. ++|+.|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4566666666663 444332 5667777777777766666777777777777777777766666667777777777777
Q ss_pred ccCCCCCCCcccCCcccccccccCCcccCCC
Q 043053 491 NLFSGPIPSSLGLCSSLQLLDLSSNQLTGSV 521 (1058)
Q Consensus 491 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 521 (1058)
|+|++..+..|..+++|+.|+|++|+++...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 7777666667788888888888888887543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=130.87 Aligned_cols=105 Identities=23% Similarity=0.279 Sum_probs=68.0
Q ss_pred ceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccc
Q 043053 412 NFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491 (1058)
Q Consensus 412 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 491 (1058)
+.+++++|+++ .+|..+. ++|+.|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45555555554 3344332 55666666666666655666666666666666666666554455666677777777777
Q ss_pred cCCCCCCCcccCCcccccccccCCcccC
Q 043053 492 LFSGPIPSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 492 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
+|++..+..|..+++|+.|+|++|++..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 7776555567777888888888888873
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.38 E-value=7.6e-13 Score=131.86 Aligned_cols=86 Identities=23% Similarity=0.294 Sum_probs=43.5
Q ss_pred CCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeec
Q 043053 385 SSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDV 464 (1058)
Q Consensus 385 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 464 (1058)
++|+.|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|+|+++.+..|..+++|++|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 44455555555555554555555555555555555555444444445555555555555555444444555555555555
Q ss_pred CCCccc
Q 043053 465 SDNRFS 470 (1058)
Q Consensus 465 ~~N~l~ 470 (1058)
++|.++
T Consensus 110 ~~N~~~ 115 (170)
T 3g39_A 110 LNNPWD 115 (170)
T ss_dssp CSSCBC
T ss_pred CCCCCC
Confidence 555444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.9e-12 Score=146.77 Aligned_cols=134 Identities=14% Similarity=0.244 Sum_probs=66.3
Q ss_pred CCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccC
Q 043053 377 IPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSL 456 (1058)
Q Consensus 377 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 456 (1058)
...+|.++.+|+.+.+.++.. .+...+|.++.+|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++
T Consensus 257 ~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C 333 (394)
T 4gt6_A 257 ETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGC 333 (394)
T ss_dssp CTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred ccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCC
Confidence 344555556666665554432 2444555556666666654 3344345555666666666666543 444445556666
Q ss_pred CCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcc
Q 043053 457 SGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQL 517 (1058)
Q Consensus 457 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 517 (1058)
.+|+.+.+..+ ++.....+|.++.+|+.+++.+|.... ..+..+.+|+.+.+..|.+
T Consensus 334 ~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 334 EQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 66666666433 443444556666666666666554321 3445556666666665544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.36 E-value=8.1e-13 Score=132.12 Aligned_cols=86 Identities=26% Similarity=0.348 Sum_probs=45.3
Q ss_pred CCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeec
Q 043053 385 SSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDV 464 (1058)
Q Consensus 385 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 464 (1058)
++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|+|+++.+..|..+++|++|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 44555555555555555555555555555555555555444444455555555555555555444444555555555555
Q ss_pred CCCccc
Q 043053 465 SDNRFS 470 (1058)
Q Consensus 465 ~~N~l~ 470 (1058)
++|.+.
T Consensus 113 ~~N~~~ 118 (174)
T 2r9u_A 113 YNNPWD 118 (174)
T ss_dssp CSSCBC
T ss_pred CCCCcc
Confidence 555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.4e-12 Score=147.48 Aligned_cols=135 Identities=15% Similarity=0.226 Sum_probs=86.7
Q ss_pred cCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccC
Q 043053 352 SVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD 431 (1058)
Q Consensus 352 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 431 (1058)
+...+|..+.+|+.+.+..+... +...+|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 44455666666776666554433 556677777888888775 4566666777888888888888754 55566677888
Q ss_pred CcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccC
Q 043053 432 CTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLF 493 (1058)
Q Consensus 432 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 493 (1058)
+.+|+.+.+..+ ++.+...+|.++.+|+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 333 C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 333 CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 888888888654 665667788888888888888776541 3455666777777766654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=4.1e-11 Score=128.94 Aligned_cols=146 Identities=12% Similarity=0.013 Sum_probs=114.0
Q ss_pred HHHHhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceee
Q 043053 700 EQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLG 778 (1058)
Q Consensus 700 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~ 778 (1058)
...+..|......|.|+.+.||++... ++.+++|+..... ......+.+|+++++.+. +..+.++++
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~-----------~~~~~~~~~E~~~l~~l~~~~~vP~v~~ 77 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRY-----------KGTTYDVEREKDMMLWLEGKLPVPKVLH 77 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGG-----------TTSTTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCccc-----------CCCHHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 456678888889999999999999765 6889999875321 011345889999999885 677889999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhccccc--------------------------
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHD-------------------------- 832 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------- 832 (1058)
++...+..|+||||++|.+|.+.+.. ......++.+++++++.||+.
T Consensus 78 ~~~~~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 78 FERHDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp EEEETTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred EEecCCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 99888888999999999999876421 112346888999999999981
Q ss_pred ------------------------------CCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 833 ------------------------------CVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 833 ------------------------------~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..+.++|||++|.||+++.+..+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01368999999999999876566799998764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=9.9e-14 Score=156.57 Aligned_cols=89 Identities=19% Similarity=0.132 Sum_probs=37.4
Q ss_pred cCCcccchhhccCCccCCC----CccccccCCCCCeeecCCCccccCC----cccccccccccccccccccCCCCCCCcc
Q 043053 430 GDCTELQMIDLSHNTLQGS----LPNSLSSLSGLQVLDVSDNRFSGQI----PASLGRLVSLNKIILSKNLFSGPIPSSL 501 (1058)
Q Consensus 430 ~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 501 (1058)
..+++|++|+|++|.|++. ++..+...++|+.|+|++|.|+... ...+...++|++|+|++|+|+......+
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 3344455555555544321 1334444455555555555554321 1222334555555555555543322222
Q ss_pred cCC---c--cccccc--ccCCccc
Q 043053 502 GLC---S--SLQLLD--LSSNQLT 518 (1058)
Q Consensus 502 ~~l---~--~L~~L~--l~~N~l~ 518 (1058)
..+ . .|+.+. +.+|.+.
T Consensus 260 ~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 260 RDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHCC------CEEECCCC----CH
T ss_pred HHHhcCCCccchhhHhhhcCCccC
Confidence 221 1 155555 5555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.7e-13 Score=154.64 Aligned_cols=139 Identities=18% Similarity=0.218 Sum_probs=69.0
Q ss_pred cccceeeccCccCCCCCCCcc-cCCcccchhhccCCccCCCCcccc-----ccCCCCCeeecCCCccccC----Cccccc
Q 043053 409 KTLNFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHNTLQGSLPNSL-----SSLSGLQVLDVSDNRFSGQ----IPASLG 478 (1058)
Q Consensus 409 ~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~~~~~~ 478 (1058)
++|++|+|++|.|+......+ ..+++|+.|+|++|.|+......+ ...++|+.|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 345555555555432211111 123445555555555543222222 2345566666666665431 222234
Q ss_pred ccccccccccccccCCCC----CCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccc
Q 043053 479 RLVSLNKIILSKNLFSGP----IPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALN 554 (1058)
Q Consensus 479 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~ 554 (1058)
..++|++|+|++|.|... ++..+..+++|+.|+|++|.|++.....+ ...+...+
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l---------------------~~~L~~~~ 239 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL---------------------ARAAREHP 239 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH---------------------HHHHHHCS
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH---------------------HHHHHhCC
Confidence 455555566666655432 13344556677777777777763211111 12234456
Q ss_pred cccEEecCCCcccC
Q 043053 555 KLSILDLSHNKLEG 568 (1058)
Q Consensus 555 ~L~~L~L~~N~l~~ 568 (1058)
+|+.|||++|.|+.
T Consensus 240 ~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 240 SLELLHLYFNELSS 253 (372)
T ss_dssp SCCEEECTTSSCCH
T ss_pred CCCEEeccCCCCCH
Confidence 77788888887764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.17 E-value=2.5e-11 Score=136.54 Aligned_cols=103 Identities=24% Similarity=0.300 Sum_probs=79.9
Q ss_pred hhcccc-CCCCCCCCCccCCCCCcEEEccC-ccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCC
Q 043053 366 LLLISN-DISGSIPPEIGNCSSLVRLRVGN-NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHN 443 (1058)
Q Consensus 366 L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 443 (1058)
++++++ .+++ +|. +..+++|+.|+|++ |+|+++.+..|.++++|++|+|++|+|+++.|..|.++++|+.|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455665 6663 555 77778888888885 8888877778888888888888888888888888888888888888888
Q ss_pred ccCCCCccccccCCCCCeeecCCCcccc
Q 043053 444 TLQGSLPNSLSSLSGLQVLDVSDNRFSG 471 (1058)
Q Consensus 444 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 471 (1058)
+|+++++..|..++ |+.|+|++|.+..
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 88876666666665 8888888888863
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.11 E-value=6.7e-11 Score=132.94 Aligned_cols=103 Identities=21% Similarity=0.182 Sum_probs=62.6
Q ss_pred eeccCc-cCCCCCCCcccCCcccchhhccC-CccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccc
Q 043053 414 LDLSSN-RLSGSVPDEIGDCTELQMIDLSH-NTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491 (1058)
Q Consensus 414 L~Ls~N-~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 491 (1058)
++++++ +|++ +|. +..+++|+.|+|++ |+|+++.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455554 5552 444 55555666666654 6666555556666666666666666666655566666666666666666
Q ss_pred cCCCCCCCcccCCcccccccccCCcccC
Q 043053 492 LFSGPIPSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 492 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
+|++..+..|..++ |+.|+|++|++..
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 66655555555554 7777777777764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.11 E-value=7.1e-10 Score=126.19 Aligned_cols=313 Identities=12% Similarity=0.087 Sum_probs=150.7
Q ss_pred cCCCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcce
Q 043053 142 GDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEE 221 (1058)
Q Consensus 142 ~~l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 221 (1058)
....+|+.+.+.. .++.....+|.++.+|+.+.+..+ ++.....+|.++ +|+.+.+..+ ++......|..+ +|+.
T Consensus 43 ~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~~ 117 (379)
T 4h09_A 43 KDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLDD 117 (379)
T ss_dssp GGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCSE
T ss_pred ccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cccc
Confidence 3344555555543 233344455666666666666433 333344455554 4555555433 332233334433 5666
Q ss_pred eecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcc
Q 043053 222 LFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQI 301 (1058)
Q Consensus 222 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i 301 (1058)
+.+..+ +.......|.++ +|+.+.+..+ ++......|..+.+++.+.+..+.........+ .... +.
T Consensus 118 i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~-~~~~--------~~- 184 (379)
T 4h09_A 118 FEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYV-LYNK--------NK- 184 (379)
T ss_dssp EECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTE-EEET--------TS-
T ss_pred ccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccce-eccc--------cc-
Confidence 666543 222223334333 4444444332 332344445555555555554433221100000 0000 00
Q ss_pred cCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCc
Q 043053 302 SGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI 381 (1058)
Q Consensus 302 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 381 (1058)
.....+.....+..+.+.. .........+..+.+|+.+.+..+ +..+...+|..+.+|+.+.+..+ ++.+...+|
T Consensus 185 --~~~~~~~~~~~~~~~~~~~-~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF 259 (379)
T 4h09_A 185 --TILESYPAAKTGTEFTIPS-TVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLL 259 (379)
T ss_dssp --SEEEECCTTCCCSEEECCT-TCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTT
T ss_pred --ceecccccccccccccccc-ceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcccc
Confidence 0000111111111111111 111223344555556666555443 33244455556666666666554 444555566
Q ss_pred cCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCe
Q 043053 382 GNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQV 461 (1058)
Q Consensus 382 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 461 (1058)
.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.
T Consensus 260 ~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~ 337 (379)
T 4h09_A 260 QNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALST 337 (379)
T ss_dssp TTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCC
T ss_pred ceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCE
Confidence 66667777766543 55455566677777777777666666566666777777777777544 55455566777777777
Q ss_pred eecCCCccccCCccccccc
Q 043053 462 LDVSDNRFSGQIPASLGRL 480 (1058)
Q Consensus 462 L~L~~N~l~~~~~~~~~~l 480 (1058)
+.+..+ ++.....+|.+.
T Consensus 338 i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 338 ISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CCCCTT-CCEECTTTTTTS
T ss_pred EEECCc-cCEEchhHhhCC
Confidence 777544 443444555544
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.3e-10 Score=124.93 Aligned_cols=137 Identities=16% Similarity=0.069 Sum_probs=99.7
Q ss_pred hccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCc--ccceeeEEEc
Q 043053 705 CLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKN--IVRFLGCCWN 782 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~ 782 (1058)
.+....+.+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--------------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~ 86 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--------------ALNELQDEAARLSWLATTGVPCAAVLDVVTE 86 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--------------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--------------cchhhhHHHHHHHHHHhCCCCCCeEEEeccC
Confidence 44443333466679999998777888999986321 1245788999999886544 5568888887
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccC-----------------------------
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDC----------------------------- 833 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------- 833 (1058)
++..++||||++|.++. ... .+ ...++.++++.++.||+..
T Consensus 87 ~~~~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (264)
T 1nd4_A 87 AGRDWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD 156 (264)
T ss_dssp SSCEEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred CCCCEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence 77889999999998884 211 11 2256677777888887642
Q ss_pred --------------------------CCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 834 --------------------------VPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 834 --------------------------~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
.+.++|||++|.||+++.++.+.|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.08 E-value=9e-10 Score=125.33 Aligned_cols=316 Identities=10% Similarity=0.084 Sum_probs=177.3
Q ss_pred cccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCc
Q 043053 164 SLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSL 243 (1058)
Q Consensus 164 ~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 243 (1058)
++....+|+.+.+... ++.....+|.+|.+|+.+.|..+ ++.+....|..+ +|+.+.+..+ +.......|..+ +|
T Consensus 41 ~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DL 115 (379)
T ss_dssp TGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CC
T ss_pred ccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cc
Confidence 3445566777777543 44455567788888888888654 554455667666 5676666543 443334445543 67
Q ss_pred cEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCc
Q 043053 244 KMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQN 323 (1058)
Q Consensus 244 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N 323 (1058)
+.+++..+- +......|.+. +|+.+.+..+ ++.+....|..+.+++.+.+..+.........+ ..+
T Consensus 116 ~~i~lp~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~-----------~~~ 181 (379)
T 4h09_A 116 DDFEFPGAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYV-----------LYN 181 (379)
T ss_dssp SEEECCTTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTE-----------EEE
T ss_pred ccccCCCcc-ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccce-----------ecc
Confidence 777776542 22333344433 4555544432 232334455555555555544433221110000 000
Q ss_pred ccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccc
Q 043053 324 QLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403 (1058)
Q Consensus 324 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 403 (1058)
.. ......+.....+..+.+..+.-. .....+....+|+.+.+..+ +..+....|.++..|+.+.+..+ ++.+...
T Consensus 182 ~~-~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~ 257 (379)
T 4h09_A 182 KN-KTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSF 257 (379)
T ss_dssp TT-SSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTT
T ss_pred cc-cceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcc
Confidence 00 011223344444554444433222 34445556666766666544 33355566777777777777665 5556666
Q ss_pred cccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccc
Q 043053 404 EIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSL 483 (1058)
Q Consensus 404 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 483 (1058)
+|.++.+|+.+.+..+ +..+...+|.++++|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.....+|.++.+|
T Consensus 258 aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 335 (379)
T 4h09_A 258 LLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKAL 335 (379)
T ss_dssp TTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred ccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCC
Confidence 7777777777777554 44455666777777777777777777666677777777777777644 554445667777777
Q ss_pred cccccccccCCCCCCCcccCCc
Q 043053 484 NKIILSKNLFSGPIPSSLGLCS 505 (1058)
Q Consensus 484 ~~L~Ls~N~l~~~~~~~~~~l~ 505 (1058)
+.+.+..+ ++.+...+|.++.
T Consensus 336 ~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 336 STISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CCCCCCTT-CCEECTTTTTTSS
T ss_pred CEEEECCc-cCEEchhHhhCCC
Confidence 77777554 4445555666553
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.6e-09 Score=122.12 Aligned_cols=142 Identities=13% Similarity=0.183 Sum_probs=106.1
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecC--cccccccCCCCCcccchHHHHHHHHHHHcccC--CCcccceeeEEEcC-
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLW--PTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR--HKNIVRFLGCCWNR- 783 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~- 783 (1058)
.+.++.|.++.||++... +..+++|+.. ... .......+.+|+.+++.+. +..+.++++++.+.
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~----------~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~ 111 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSK----------LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES 111 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC--------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCC----------CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC
Confidence 567899999999999776 4678888764 221 1112356788999999997 45688888888766
Q ss_pred --CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccC----------------------------
Q 043053 784 --NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDC---------------------------- 833 (1058)
Q Consensus 784 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------- 833 (1058)
+..|+||||++|..+.+... ..++...+..++.+++++|+.||+..
T Consensus 112 ~~g~~~~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3dxp_A 112 VIGRAFYIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK 187 (359)
T ss_dssp TTSSCEEEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence 34799999999988865221 23677888899999999999999731
Q ss_pred ---------------------------CCCeEeCCCCCCcEEEcCCCC--eeeecccccee
Q 043053 834 ---------------------------VPPIVHRDIKANNILIGLEFE--PYIADFGLAKL 865 (1058)
Q Consensus 834 ---------------------------~~~ivHrDikp~Nill~~~~~--~kl~DfGl~~~ 865 (1058)
.+.++|||++|.||+++.++. +.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997763 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=8.7e-10 Score=121.19 Aligned_cols=183 Identities=19% Similarity=0.164 Sum_probs=120.1
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCc--ccceeeEEEcCC-
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKN--IVRFLGCCWNRN- 784 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~- 784 (1058)
.+.++.|.+..||++. +.+++|+... ......+.+|+++++.+. +.. +.+++.+.....
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~-------------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~ 87 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH-------------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSET 87 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS-------------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSS
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC-------------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCC
Confidence 4568999999999873 5678887521 123578899999998884 332 344544443333
Q ss_pred --CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhccccc------------------------------
Q 043053 785 --NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHD------------------------------ 832 (1058)
Q Consensus 785 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------ 832 (1058)
..|+|||+++|.++.+... ..++..++..++.++++.++.||+.
T Consensus 88 ~~~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 88 YQMSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp CSCSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred CCcceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 2489999999988875432 2356666777788888888777751
Q ss_pred -------------------------CCCCeEeCCCCCCcEEEcC--CCCeeeeccccceeccCCCcccccccccCcCCc-
Q 043053 833 -------------------------CVPPIVHRDIKANNILIGL--EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY- 884 (1058)
Q Consensus 833 -------------------------~~~~ivHrDikp~Nill~~--~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y- 884 (1058)
..+.++|+|++|.||+++. +..+.|+||+.+..-.... . ......+
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--D----l~~~~~~~ 237 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--D----FISLMEDD 237 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--H----HHTTCCTT
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--H----HHHHHhhc
Confidence 1146899999999999998 4567899999987543211 0 0000111
Q ss_pred --cCccccc------cC--------CCCcccchhhHHHHHHHHHhCCCCC
Q 043053 885 --IAPEYGY------MM--------KITEKSDVYSYGVVVLEVLTGKQPI 918 (1058)
Q Consensus 885 --~aPE~~~------~~--------~~~~~~DvwSlGvvl~elltg~~P~ 918 (1058)
..|+... +. ......+.|++|.++|.+.+|..+|
T Consensus 238 ~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 238 EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2232110 00 0112368999999999999998776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.82 E-value=1.4e-10 Score=129.50 Aligned_cols=205 Identities=16% Similarity=0.165 Sum_probs=114.9
Q ss_pred CCcEEEccCCcCCC-C-------CCCCCCCCCcccEEecCCCCCC---------CCCChhhcCcccCCEEeccccCCCCc
Q 043053 25 HLQTLVISDANLTG-S-------IPFDIGDCVGLIVLDFSSNNLV---------GTLPSSLGKLHNLEELILNSNQLTGK 87 (1058)
Q Consensus 25 ~L~~L~l~~~~~~~-~-------~p~~l~~l~~L~~L~l~~~~i~---------~~lp~~l~~l~~L~~L~L~~n~~~~~ 87 (1058)
.++.|.+......+ . ++.++..+++|+.|.+.+.... +.+...+..+++|+.|+|++|.-. .
T Consensus 108 ~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~ 186 (362)
T 2ra8_A 108 SLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-S 186 (362)
T ss_dssp GCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-B
T ss_pred hcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-e
Confidence 45666666544331 1 2334555677777777554221 134455667788888888877312 2
Q ss_pred cccccccchhhhHHhhhhccccCCChhhhc--ccccchhhhcCCCccccCCCCccccCCCCCceecccCccccccCCccc
Q 043053 88 IPVELSNCKSLRKLLLFDNALAGNIPAELG--RLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASL 165 (1058)
Q Consensus 88 ~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~--~l~~L~~L~l~~~~~~~~~l~~~l~~l~~L~~L~l~~~~~~~~~~~~l 165 (1058)
++. + .+++|++|+|..|.+.......++ .+++|++|+++.+.+.... +..+. .+...+
T Consensus 187 l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~-----------------~~~~~-~l~~~l 246 (362)
T 2ra8_A 187 IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGF-----------------DGDMN-VFRPLF 246 (362)
T ss_dssp CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTC-----------------CSCGG-GTGGGS
T ss_pred ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEecccccccc-----------------chhHH-HHHHHH
Confidence 333 3 367777777777766533333333 4566666655322100000 00000 000111
Q ss_pred --cCCCccceeeeeccccccccCccc---cCCCCccEEEccCCcCCCC----CCCCcCCCCCcceeecccccccCCCCcc
Q 043053 166 --GKLSKLQTLSIYTTMISGEIPAEI---GNCSELVSLFLYENSLSGS----IPPEIGKLKKLEELFLWQNSLVGAIPEE 236 (1058)
Q Consensus 166 --~~l~~L~~L~l~~n~i~~~~~~~l---~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 236 (1058)
..+++|+.|++.+|.+.+..+..+ ..+++|++|+|+.|.+.+. ++..+..+++|+.|+|++|.+++.....
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~ 326 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKE 326 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHH
Confidence 246778888887777765433333 2577888888888888753 2344456788899999888877544444
Q ss_pred ccC-cCCccEEEeecCC
Q 043053 237 IGN-CTSLKMIDFSLNS 252 (1058)
Q Consensus 237 l~~-l~~L~~L~L~~n~ 252 (1058)
|.. + ...++++.++
T Consensus 327 l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 327 LQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHC--CSEEECCSBC
T ss_pred HHHHc--CCEEEecCCc
Confidence 433 2 3668888776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.77 E-value=7.5e-10 Score=123.60 Aligned_cols=137 Identities=12% Similarity=0.075 Sum_probs=67.4
Q ss_pred cccCCCccceeeeeccccc---------cccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCC
Q 043053 164 SLGKLSKLQTLSIYTTMIS---------GEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIP 234 (1058)
Q Consensus 164 ~l~~l~~L~~L~l~~n~i~---------~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 234 (1058)
++.++++|+.|.+...... +.+...+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.+.....
T Consensus 134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l 210 (362)
T 2ra8_A 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVV 210 (362)
T ss_dssp THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHH
T ss_pred hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHH
Confidence 3445566666666443211 122233456677777777766311 2232 3 26677777777666653333
Q ss_pred cccc--CcCCccEEEeecC--CCcCcC-----Cccc--cccCCcceeecccCccCCCcccccc---ccccchhhhhcCCc
Q 043053 235 EEIG--NCTSLKMIDFSLN--SLSGTI-----PLSI--GGLSELEEFMISDNNVSGSIPANLA---NATNLVQLQLDTNQ 300 (1058)
Q Consensus 235 ~~l~--~l~~L~~L~L~~n--~l~~~~-----~~~~--~~l~~L~~L~l~~n~l~~~~~~~~~---~l~~L~~L~L~~N~ 300 (1058)
..+. .+++|++|+|+.+ ...+.. ...+ ..+++|+.|++.+|.+.+..+..+. .+++|++|+|+.|.
T Consensus 211 ~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~ 290 (362)
T 2ra8_A 211 EDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV 290 (362)
T ss_dssp HHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSC
T ss_pred HHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCC
Confidence 3333 5677777777531 111110 0111 2356666666666665532222222 34555555555555
Q ss_pred ccC
Q 043053 301 ISG 303 (1058)
Q Consensus 301 i~~ 303 (1058)
|.+
T Consensus 291 L~d 293 (362)
T 2ra8_A 291 LTD 293 (362)
T ss_dssp CBH
T ss_pred CCh
Confidence 543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.1e-06 Score=94.50 Aligned_cols=135 Identities=18% Similarity=0.117 Sum_probs=93.9
Q ss_pred eeccccce-EEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEEcCCCce
Q 043053 711 VIGKGCSG-VVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 711 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 787 (1058)
.+..|..| .||+.... .+..+++|+-.. .....+.+|+..++.+. +--+.++++++.+++..|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~ 96 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG--------------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAW 96 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET--------------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC--------------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEE
Confidence 45556655 69998554 456788887521 23467889999998885 334678888888888899
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhccccc-----------------------------------
Q 043053 788 LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHD----------------------------------- 832 (1058)
Q Consensus 788 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------- 832 (1058)
+|||+++|.++.+..... ......++.++++.++.||..
T Consensus 97 lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE 170 (272)
T ss_dssp EEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred EEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence 999999998877654321 111233455555555555531
Q ss_pred --------------------CCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 833 --------------------CVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 833 --------------------~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
..+.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112479999999999999877778999998753
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.33 E-value=9.6e-08 Score=100.81 Aligned_cols=92 Identities=22% Similarity=0.244 Sum_probs=53.8
Q ss_pred ccCCcccch--hhccCCccC---CCCccccccCCCCCeeecCCCcccc--CCcccccccccccccccccccCCCCCCCcc
Q 043053 429 IGDCTELQM--IDLSHNTLQ---GSLPNSLSSLSGLQVLDVSDNRFSG--QIPASLGRLVSLNKIILSKNLFSGPIPSSL 501 (1058)
Q Consensus 429 ~~~l~~L~~--L~l~~N~l~---~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 501 (1058)
|...+.|.. ++++.|+.. ..++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 344444544 555555332 1112222456667777777777765 2345555667777777777777653 233
Q ss_pred cCCc--ccccccccCCcccCCCC
Q 043053 502 GLCS--SLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 502 ~~l~--~L~~L~l~~N~l~~~~p 522 (1058)
..+. +|++|+|++|++++.+|
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhcccCCcceEEccCCcCccccC
Confidence 3333 78888888888887666
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=2.2e-06 Score=93.85 Aligned_cols=136 Identities=19% Similarity=0.195 Sum_probs=92.1
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCC---cccceeeEEE-cCC
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK---NIVRFLGCCW-NRN 784 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~ 784 (1058)
.+.++.|....||+. |+.++||+-. .......+.+|+++++.+.+. .+.+++.+.. ..+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-------------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g 86 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-------------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDG 86 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-------------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-------------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCC
Confidence 456889999999998 5667888742 122357889999999999742 3566777664 345
Q ss_pred CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhccccc--------------------------------
Q 043053 785 NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHD-------------------------------- 832 (1058)
Q Consensus 785 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------- 832 (1058)
..++||||++|.++.+... ..++......++.++++.++.||+.
T Consensus 87 ~~~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~ 162 (306)
T 3tdw_A 87 NPFVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFP 162 (306)
T ss_dssp CEEEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGG
T ss_pred ceEEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccc
Confidence 5689999999988876321 1123333344444444444444432
Q ss_pred -------------------------CCCCeEeCCCCCCcEEEcC---CCC-eeeecccccee
Q 043053 833 -------------------------CVPPIVHRDIKANNILIGL---EFE-PYIADFGLAKL 865 (1058)
Q Consensus 833 -------------------------~~~~ivHrDikp~Nill~~---~~~-~kl~DfGl~~~ 865 (1058)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 163 ~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 163 LLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2236799999999999987 455 48999998764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.23 E-value=8.2e-08 Score=101.34 Aligned_cols=66 Identities=24% Similarity=0.359 Sum_probs=33.7
Q ss_pred CccccceeeccCccCCCC--CCCcccCCcccchhhccCCccCCCCccccccCC--CCCeeecCCCccccCCc
Q 043053 407 GLKTLNFLDLSSNRLSGS--VPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLS--GLQVLDVSDNRFSGQIP 474 (1058)
Q Consensus 407 ~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~ 474 (1058)
.+++|+.|+|++|+|+++ +|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+..|
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 345555555555555542 234444555555555555555542 2233333 56666666666654333
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.17 E-value=1.1e-07 Score=95.65 Aligned_cols=18 Identities=17% Similarity=0.043 Sum_probs=11.6
Q ss_pred ccCCcccccccccCCccc
Q 043053 501 LGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 501 ~~~l~~L~~L~l~~N~l~ 518 (1058)
+...+.|++|+|++|.+.
T Consensus 147 L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 147 LEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHCSSCCEEECCCSSHH
T ss_pred HHhCCCcCEEeccCCCCC
Confidence 334466777777777764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=4.8e-06 Score=93.45 Aligned_cols=84 Identities=6% Similarity=-0.037 Sum_probs=56.0
Q ss_pred ccee-ccccceEEEEEEec-------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-C--Cccccee
Q 043053 709 ANVI-GKGCSGVVYRADMD-------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-H--KNIVRFL 777 (1058)
Q Consensus 709 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~ 777 (1058)
.+.| +.|....+|+.... +++.+++|........ .......+.+|+.+++.+. + -.+.+++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~--------~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~ 96 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDV--------PVFPTYRLDHQFEVIRLVGELTDVPVPRVR 96 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGC--------CSSSCCCHHHHHHHHHHHHHHCCSCCCCEE
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcc--------ccCchhHHHHHHHHHHHHhhcCCCCCCcEE
Confidence 4567 88999999998654 2667888875322100 0001245678888888885 3 3567788
Q ss_pred eEEEcC---CCceEEEEecCCCChhh
Q 043053 778 GCCWNR---NNRLLMYDYMPNGSLGS 800 (1058)
Q Consensus 778 ~~~~~~---~~~~lv~e~~~~gsL~~ 800 (1058)
+++.+. +..|+||||++|.++.+
T Consensus 97 ~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 97 WIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred EEccCCCccCCceEEEEecCCCChhh
Confidence 877655 34689999999987764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.08 E-value=1.8e-07 Score=94.03 Aligned_cols=16 Identities=0% Similarity=-0.062 Sum_probs=7.6
Q ss_pred CCCCccEEEccCCcCC
Q 043053 191 NCSELVSLFLYENSLS 206 (1058)
Q Consensus 191 ~l~~L~~L~L~~n~l~ 206 (1058)
..++|++|+|++|.+.
T Consensus 63 ~~~~L~~L~Ls~n~i~ 78 (185)
T 1io0_A 63 TNTYVKKFSIVGTRSN 78 (185)
T ss_dssp TCCSCCEEECTTSCCC
T ss_pred hCCCcCEEECcCCCCC
Confidence 3444455555555444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.05 E-value=4.9e-07 Score=88.29 Aligned_cols=84 Identities=13% Similarity=0.118 Sum_probs=46.5
Q ss_pred CcccEEecCCCCCCCCCChhhcCcccCCEEeccccC-CCCccccccccc----hhhhHHhhhhcc-ccCCChhhhccccc
Q 043053 48 VGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQ-LTGKIPVELSNC----KSLRKLLLFDNA-LAGNIPAELGRLSN 121 (1058)
Q Consensus 48 ~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~-~~~~~p~~l~~l----~~L~~L~L~~n~-~~~~~p~~l~~l~~ 121 (1058)
..|++||+++|.|++.--..+.+|++|++|+|++|. +++..-..++.+ ++|++|+|++|. +++..-..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 357777777777765555556677777777777773 553333333332 345555555553 44333334444555
Q ss_pred chhhhcCCCc
Q 043053 122 LEEMRAGGNK 131 (1058)
Q Consensus 122 L~~L~l~~~~ 131 (1058)
|++|++++|.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 5555555444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.93 E-value=1.7e-06 Score=84.39 Aligned_cols=34 Identities=12% Similarity=0.034 Sum_probs=15.5
Q ss_pred ccceeeeeccccccccCccccCCCCccEEEccCC
Q 043053 170 KLQTLSIYTTMISGEIPAEIGNCSELVSLFLYEN 203 (1058)
Q Consensus 170 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n 203 (1058)
+|+.|++++|.|+......+..|++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 3444444444444443344444444444444444
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.92 E-value=3e-05 Score=86.37 Aligned_cols=139 Identities=15% Similarity=0.233 Sum_probs=78.4
Q ss_pred ceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC--CCcccceee------EEE
Q 043053 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR--HKNIVRFLG------CCW 781 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~------~~~ 781 (1058)
+.++.|..+.||++...+| .+++|+.... ...+..|+.+++.+. .-.+.+++. +..
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---------------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~ 101 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---------------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK 101 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---------------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---------------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE
Confidence 4566778899999977655 4889987421 133444555555543 112333332 122
Q ss_pred cCCCceEEEEecCCCChh-----h---------hhhhcCC-C-----------CCCHHHH--------------------
Q 043053 782 NRNNRLLMYDYMPNGSLG-----S---------LLHERTG-N-----------ALEWELR-------------------- 815 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~-----~---------~l~~~~~-~-----------~l~~~~~-------------------- 815 (1058)
..+..++||||++|.++. + .+|.... . ...|...
T Consensus 102 ~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 181 (346)
T 2q83_A 102 HGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKE 181 (346)
T ss_dssp ETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred ECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccC
Confidence 355678999999987653 0 1121100 0 0123211
Q ss_pred -----------HHHHHHHHHHhhcccc----------cCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 816 -----------YQILLGAAQGLAYLHH----------DCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 816 -----------~~i~~~i~~~l~~LH~----------~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
..+...+.+++++|+. ...+.++|||+++.||+++.++.+.|+||+.+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 182 DPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223345666653 123489999999999999888899999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=5.6e-05 Score=82.18 Aligned_cols=137 Identities=16% Similarity=0.194 Sum_probs=91.7
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC---CCcccceeeEEEcCCC
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR---HKNIVRFLGCCWNRNN 785 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~ 785 (1058)
.+.|+.|....+|+.... ++.++||+... .....+.+|+..++.+. ...+.+++++....+.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~--------------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~ 105 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINER--------------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH 105 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEG--------------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCc--------------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc
Confidence 467899999999999764 67788887531 12567899999998884 3578889998887788
Q ss_pred ceEEEEecCCCChhh-----------hhhhcCC-C-------------------CCCHHHHH---HHHHH----------
Q 043053 786 RLLMYDYMPNGSLGS-----------LLHERTG-N-------------------ALEWELRY---QILLG---------- 821 (1058)
Q Consensus 786 ~~lv~e~~~~gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~~~---------- 821 (1058)
.++||||++|..+.. .++.... . .-+|.... ++..+
T Consensus 106 ~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~ 185 (312)
T 3jr1_A 106 SFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLI 185 (312)
T ss_dssp EEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCC
T ss_pred eEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCC
Confidence 899999999986532 1222111 0 12454332 11111
Q ss_pred ------HHHH-hhcccc-cCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 822 ------AAQG-LAYLHH-DCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 822 ------i~~~-l~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++. ...|.. ...+.+||+|+.+.||+++.++ +.|.||+
T Consensus 186 ~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 186 FGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred hHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111 122321 2246899999999999999887 8899974
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=4.1e-05 Score=87.16 Aligned_cols=82 Identities=12% Similarity=0.121 Sum_probs=50.7
Q ss_pred cceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC--Cc-ccceeeEEEcCC
Q 043053 709 ANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH--KN-IVRFLGCCWNRN 784 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~n-iv~~~~~~~~~~ 784 (1058)
.+.+|.|.++.||++... +++.++||...+..... ........+++..|+++++.+.. +. +.+++.+ +.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~----~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~ 108 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVV----GESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 108 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-----------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhccc----CCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC
Confidence 467899999999999543 46889999864321000 00111234567789998887742 43 4455543 355
Q ss_pred CceEEEEecCCC
Q 043053 785 NRLLMYDYMPNG 796 (1058)
Q Consensus 785 ~~~lv~e~~~~g 796 (1058)
..++||||+++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 678999999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00023 Score=76.92 Aligned_cols=79 Identities=18% Similarity=0.235 Sum_probs=57.1
Q ss_pred hccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC---CcccceeeEEE
Q 043053 705 CLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH---KNIVRFLGCCW 781 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~ 781 (1058)
+...++.+|.|..+.||+.+..+|+.|+||+-... .......|.+|+..|+.+.- --+.+++++.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~-----------~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~- 83 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDD-----------APALDGLFRAEALGLDWLGRSFGSPVPQVAGWD- 83 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTT-----------CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCC-----------CcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-
Confidence 34556789999999999999999999999975322 12224568899999988852 2345555542
Q ss_pred cCCCceEEEEecCCCCh
Q 043053 782 NRNNRLLMYDYMPNGSL 798 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL 798 (1058)
..++||||++++..
T Consensus 84 ---~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 ---DRTLAMEWVDERPP 97 (288)
T ss_dssp ---TTEEEEECCCCCCC
T ss_pred ---CceEEEEeecccCC
Confidence 35899999988754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00039 Score=79.61 Aligned_cols=76 Identities=11% Similarity=0.140 Sum_probs=46.5
Q ss_pred CCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccC--cCCccCccccccC---CCCcccchhhHHHHHH
Q 043053 835 PPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG--SYGYIAPEYGYMM---KITEKSDVYSYGVVVL 909 (1058)
Q Consensus 835 ~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwSlGvvl~ 909 (1058)
+.++|||++|.|||++.++ ++++||+.+..-... + ....... ...|++|+..... ......++.+....+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~--Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-F--DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-H--HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-H--HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4899999999999998776 999999988753211 0 0000000 1345666544311 1112345567788888
Q ss_pred HHHhC
Q 043053 910 EVLTG 914 (1058)
Q Consensus 910 elltg 914 (1058)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00055 Score=74.41 Aligned_cols=71 Identities=11% Similarity=0.087 Sum_probs=44.5
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcc-cceeeEEEcCCCce
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNI-VRFLGCCWNRNNRL 787 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~ 787 (1058)
.+.|+.|....+|++ +.+++|+..... .......+|+.+++.+....+ .+++++ +++.-+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~------------~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~ 83 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT------------EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGV 83 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----------------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCc------------cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCE
Confidence 678999999999998 457788764221 001123467777777753233 355543 344568
Q ss_pred EEEEec-CCCCh
Q 043053 788 LMYDYM-PNGSL 798 (1058)
Q Consensus 788 lv~e~~-~~gsL 798 (1058)
+|+||+ +|.++
T Consensus 84 ~v~e~i~~g~~l 95 (301)
T 3dxq_A 84 MVTRYIAGAQTM 95 (301)
T ss_dssp EEEECCTTCEEC
T ss_pred EEEeecCCCccC
Confidence 999999 66554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00055 Score=75.65 Aligned_cols=31 Identities=42% Similarity=0.398 Sum_probs=27.1
Q ss_pred CCeEeCCCCCCcEEEcCC----CCeeeecccccee
Q 043053 835 PPIVHRDIKANNILIGLE----FEPYIADFGLAKL 865 (1058)
Q Consensus 835 ~~ivHrDikp~Nill~~~----~~~kl~DfGl~~~ 865 (1058)
+.++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 489999999999999875 6789999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0005 Score=75.54 Aligned_cols=142 Identities=12% Similarity=0.096 Sum_probs=77.3
Q ss_pred cceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCc--ccceeeE------E
Q 043053 709 ANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKN--IVRFLGC------C 780 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~ 780 (1058)
.+.|+.|....+|+....+| .+++|..... ...+.+..|+.+++.+.... +.+++.. .
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-------------~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~ 92 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR-------------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 92 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC----------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC-------------CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEE
Confidence 34577888899999977656 5778877421 11245567777777664212 2333321 1
Q ss_pred EcCCCceEEEEecCCCChhhh--------------hhhcC-C--CC-------CCHHHHHHH------------HHHHHH
Q 043053 781 WNRNNRLLMYDYMPNGSLGSL--------------LHERT-G--NA-------LEWELRYQI------------LLGAAQ 824 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~--------------l~~~~-~--~~-------l~~~~~~~i------------~~~i~~ 824 (1058)
...+..++||+|++|..+... ++... . .+ ..|.....- ...+.+
T Consensus 93 ~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~ 172 (322)
T 2ppq_A 93 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 172 (322)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred EECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHH
Confidence 223456899999998754220 11110 0 00 112221100 001223
Q ss_pred Hhhcccc----cCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 825 GLAYLHH----DCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 825 ~l~~LH~----~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
.+++++. ....+++|+|+++.||+++.++.+.++||+.+.
T Consensus 173 ~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 173 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3333332 123489999999999999987666899998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0014 Score=74.95 Aligned_cols=73 Identities=12% Similarity=0.235 Sum_probs=49.4
Q ss_pred cceeccccceEEEEEEecC--------CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCc-ccceeeE
Q 043053 709 ANVIGKGCSGVVYRADMDN--------GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKN-IVRFLGC 779 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~ 779 (1058)
.+.|+.|....||++...+ ++.+++|+.... ...+.+.+|+.+++.+...+ ..++++.
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-------------~~~~~li~E~~~l~~L~~~g~~P~l~~~ 144 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-------------ETESHLVAESVIFTLLSERHLGPKLYGI 144 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-------------CCHHHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-------------CcHHHHHHHHHHHHHHHhCCCCCcEEEE
Confidence 4578889999999997653 578888876211 11245567999888886333 3566665
Q ss_pred EEcCCCceEEEEecCCCCh
Q 043053 780 CWNRNNRLLMYDYMPNGSL 798 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL 798 (1058)
+.+ .+||||++|.++
T Consensus 145 ~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 145 FSG----GRLEEYIPSRPL 159 (429)
T ss_dssp ETT----EEEECCCCEEEC
T ss_pred eCC----CEEEEEeCCccc
Confidence 532 489999987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0016 Score=72.71 Aligned_cols=141 Identities=16% Similarity=0.155 Sum_probs=83.3
Q ss_pred cceeccccceEEEEEEec--------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeE
Q 043053 709 ANVIGKGCSGVVYRADMD--------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGC 779 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 779 (1058)
.+.+..|....+|++... +++.+++|+... .......+.+|.++++.+. +.-..+++++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~------------~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~ 122 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA------------ILQGVDSLVLESVMFAILAERSLGPQLYGV 122 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------------CCHHHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC------------ccchHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 356778888999999764 247888887521 1112456679999998885 3334566665
Q ss_pred EEcCCCceEEEEecCCCChhhh-----------------hhhcC---CCCC--CHHHHHHHHHHHHHH------------
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSL-----------------LHERT---GNAL--EWELRYQILLGAAQG------------ 825 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~~i~~~------------ 825 (1058)
+.+ .+||||++|.++..- ++... .... -|.++.++..++...
T Consensus 123 ~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 123 FPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp ETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred cCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 543 399999998765421 11110 1112 245555555544321
Q ss_pred -------hhcc----cc-cCCCCeEeCCCCCCcEEEcCC----CCeeeecccccee
Q 043053 826 -------LAYL----HH-DCVPPIVHRDIKANNILIGLE----FEPYIADFGLAKL 865 (1058)
Q Consensus 826 -------l~~L----H~-~~~~~ivHrDikp~Nill~~~----~~~kl~DfGl~~~ 865 (1058)
++.| .. .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1222 11 122378999999999999876 7899999987753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0031 Score=69.29 Aligned_cols=141 Identities=13% Similarity=0.125 Sum_probs=80.5
Q ss_pred ceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCC--cccceeeE-----EEc
Q 043053 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHK--NIVRFLGC-----CWN 782 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~ 782 (1058)
..++ |....||++...+|+.+++|...+. ....+.+..|+.+++.+... .+++++.. ...
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~------------~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~ 98 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE------------RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH 98 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT------------TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC------------CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEE
Confidence 4566 8888999997777778899987422 11245677788888777522 24444443 112
Q ss_pred CCCceEEEEecCCCChhh-----h---------hhhc----C---CCCCCHHHH----------------------HHHH
Q 043053 783 RNNRLLMYDYMPNGSLGS-----L---------LHER----T---GNALEWELR----------------------YQIL 819 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~-----~---------l~~~----~---~~~l~~~~~----------------------~~i~ 819 (1058)
.+..++||||++|.++.. + ++.. . ....++... ...+
T Consensus 99 ~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 178 (328)
T 1zyl_A 99 QGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKAT 178 (328)
T ss_dssp TTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHH
T ss_pred CCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHH
Confidence 344578999998865421 0 1110 0 011222111 0111
Q ss_pred HHHHHHhhccc-ccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 820 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 820 ~~i~~~l~~LH-~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
..++..++..- ......++|||+++.||+++ + .+.++||+.+..
T Consensus 179 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 179 DELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11122222111 11234789999999999999 4 899999987653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0043 Score=71.14 Aligned_cols=74 Identities=16% Similarity=0.117 Sum_probs=47.2
Q ss_pred cceeccccceEEEEEEecC-CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcc-cceeeEEEcCCCc
Q 043053 709 ANVIGKGCSGVVYRADMDN-GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNI-VRFLGCCWNRNNR 786 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~ 786 (1058)
.+.|+.|-...+|++...+ ++.+++|+..... .. .-...+|..+++.+...++ .++++++. +
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-----------~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~-- 176 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-----------DE-IINREREKKISCILYNKNIAKKIYVFFT--N-- 176 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-----------CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-----------hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--
Confidence 4578899999999997764 4778888763211 00 1112578888888864444 56666652 2
Q ss_pred eEEEEecCCCCh
Q 043053 787 LLMYDYMPNGSL 798 (1058)
Q Consensus 787 ~lv~e~~~~gsL 798 (1058)
.+||||++|.++
T Consensus 177 G~v~e~I~G~~l 188 (458)
T 2qg7_A 177 GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEECCCSEEC
T ss_pred eEEEEeeCCccC
Confidence 469999998655
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.00012 Score=72.70 Aligned_cols=82 Identities=16% Similarity=0.217 Sum_probs=35.5
Q ss_pred CCCcEEEccCc-cccCC----ccccccCccccceeeccCccCCCCC----CCcccCCcccchhhccCCccCCC----Ccc
Q 043053 385 SSLVRLRVGNN-RIAGL----IPREIGGLKTLNFLDLSSNRLSGSV----PDEIGDCTELQMIDLSHNTLQGS----LPN 451 (1058)
Q Consensus 385 ~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~----~~~ 451 (1058)
++|++|+|++| +|... +..++..-..|+.|+|++|+|.... .+.+...+.|+.|+|++|+|... +.+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 44555555553 44321 1223334455555555555554221 12222334455555555554421 222
Q ss_pred ccccCCCCCeeecCC
Q 043053 452 SLSSLSGLQVLDVSD 466 (1058)
Q Consensus 452 ~~~~l~~L~~L~L~~ 466 (1058)
++..-+.|++|+|++
T Consensus 121 aL~~N~tL~~L~L~n 135 (197)
T 1pgv_A 121 STLVTQSIVEFKADN 135 (197)
T ss_dssp HTTTTCCCSEEECCC
T ss_pred HHhhCCceeEEECCC
Confidence 333334455555543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0024 Score=71.58 Aligned_cols=74 Identities=8% Similarity=0.098 Sum_probs=43.9
Q ss_pred cceeccccceEEEEEEecC---------CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCc-ccceee
Q 043053 709 ANVIGKGCSGVVYRADMDN---------GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKN-IVRFLG 778 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~ 778 (1058)
.+.++.|....+|++...+ ++.+++|+..... ........|..+++.+...+ +.++++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~------------~~~~~~~~E~~~l~~L~~~g~~P~~~~ 105 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV------------DELYNTISEFEVYKTMSKYKIAPQLLN 105 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG------------GGTSCHHHHHHHHHHHHHTTSSCCEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc------------cceecHHHHHHHHHHHHhcCCCCceEE
Confidence 3567888889999997653 2678888763221 11112367888888775333 446665
Q ss_pred EEEcCCCceEEEEecCCCCh
Q 043053 779 CCWNRNNRLLMYDYMPNGSL 798 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL 798 (1058)
.. .-++||||++|.++
T Consensus 106 ~~----~~~~v~e~i~G~~l 121 (369)
T 3c5i_A 106 TF----NGGRIEEWLYGDPL 121 (369)
T ss_dssp EE----TTEEEEECCCSEEC
T ss_pred ec----CCcEEEEEecCCcC
Confidence 44 24789999998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0052 Score=67.78 Aligned_cols=31 Identities=39% Similarity=0.540 Sum_probs=27.7
Q ss_pred CCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 835 PPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 835 ~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888999999987764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.33 E-value=0.00027 Score=70.32 Aligned_cols=90 Identities=16% Similarity=0.045 Sum_probs=42.1
Q ss_pred ccCCCCccEEEccCCcCCCCCCCCcC----CCCCcceeecccccccCCCC----ccccCcCCccEEEeecC---CCcCc-
Q 043053 189 IGNCSELVSLFLYENSLSGSIPPEIG----KLKKLEELFLWQNSLVGAIP----EEIGNCTSLKMIDFSLN---SLSGT- 256 (1058)
Q Consensus 189 l~~l~~L~~L~L~~n~l~~~~~~~~~----~l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~L~~n---~l~~~- 256 (1058)
+..-+.|+.|+|++|.+.+.....|+ .-+.|+.|+|++|.|.+... +.+..-+.|++|+|++| .+...
T Consensus 66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g 145 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 145 (197)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHH
Confidence 33444555555555555433222222 23455555555555543222 22333445666666544 22211
Q ss_pred ---CCccccccCCcceeecccCccC
Q 043053 257 ---IPLSIGGLSELEEFMISDNNVS 278 (1058)
Q Consensus 257 ---~~~~~~~l~~L~~L~l~~n~l~ 278 (1058)
+...+..-+.|+.|+++.|.+.
T Consensus 146 ~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 146 EMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHhCCCcCeEeccCCCcc
Confidence 1223344466777777666543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.004 Score=57.75 Aligned_cols=55 Identities=22% Similarity=0.370 Sum_probs=28.0
Q ss_pred eeeccCccCC-CCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCcc
Q 043053 413 FLDLSSNRLS-GSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469 (1058)
Q Consensus 413 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 469 (1058)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555554 12332221 2455555555555555555555555566666665554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.14 E-value=0.0047 Score=57.26 Aligned_cols=56 Identities=18% Similarity=0.354 Sum_probs=39.9
Q ss_pred eeecCCCccc-cCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCccc
Q 043053 461 VLDVSDNRFS-GQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 461 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 518 (1058)
.++.+++.++ ..+|..+. .+|+.|+|++|+|+.+.+..|..+++|+.|+|++|++.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5667777765 24554433 35777788888887777777888888888888888885
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.92 E-value=0.027 Score=56.18 Aligned_cols=102 Identities=19% Similarity=0.164 Sum_probs=67.3
Q ss_pred ChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccc
Q 043053 797 SLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSN 876 (1058)
Q Consensus 797 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~ 876 (1058)
+|.++++.+ +.+++++++|.++.|.+.+|..+-... .-..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------
Confidence 799999876 689999999999999999987762110 101333457999999999988764 1110
Q ss_pred cccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 043053 877 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 917 (1058)
Q Consensus 877 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P 917 (1058)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123566888753 3456778899999999998864443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.56 E-value=0.047 Score=61.60 Aligned_cols=140 Identities=13% Similarity=0.138 Sum_probs=83.0
Q ss_pred cceeccccceEEEEEEecC--------CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeE
Q 043053 709 ANVIGKGCSGVVYRADMDN--------GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGC 779 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 779 (1058)
.+.+..|....+|+....+ ++.+++++..... .......+|..+++.+. +.-..++++.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t------------~~~idR~~E~~~l~~L~~~gi~P~l~~~ 142 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV------------GKFYDSKVELDVFRYLSNINIAPNIIAD 142 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-------------CCCCHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc------------chhcCHHHHHHHHHHHHhcCCCCCEEEE
Confidence 4567888899999997653 5778888753211 11122357888888775 3334455553
Q ss_pred EEcCCCceEEEEecCCCChhh--h------------h---hh--c---------CCCCCCHHHHHHHHHHHHH-------
Q 043053 780 CWNRNNRLLMYDYMPNGSLGS--L------------L---HE--R---------TGNALEWELRYQILLGAAQ------- 824 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~--~------------l---~~--~---------~~~~l~~~~~~~i~~~i~~------- 824 (1058)
+ .-+.||||++|.++.. + + |. . ...+.-|.++.++..++-.
T Consensus 143 ~----~~~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~ 218 (424)
T 3mes_A 143 F----PEGRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNF 218 (424)
T ss_dssp E----TTEEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC-
T ss_pred c----CCCEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccch
Confidence 3 2388999999876421 0 0 10 0 0111124444444333211
Q ss_pred ------------Hhhccc---------------------ccCCCCeEeCCCCCCcEEEcCCCCeeeecccccee
Q 043053 825 ------------GLAYLH---------------------HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKL 865 (1058)
Q Consensus 825 ------------~l~~LH---------------------~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~ 865 (1058)
.+++|. ......++|+|+.+.||+ +.++.+.++||..+..
T Consensus 219 ~~~~~~~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 219 QIDKELYSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred hhccccHHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 122221 111247899999999999 7788999999988764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.05 E-value=0.72 Score=51.76 Aligned_cols=30 Identities=23% Similarity=0.386 Sum_probs=25.0
Q ss_pred CeEeCCCCCCcEEE------cCCCCeeeecccccee
Q 043053 836 PIVHRDIKANNILI------GLEFEPYIADFGLAKL 865 (1058)
Q Consensus 836 ~ivHrDikp~Nill------~~~~~~kl~DfGl~~~ 865 (1058)
.++|+|+.+.||++ +++..++++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 3456799999988764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.06 E-value=1.3 Score=44.00 Aligned_cols=122 Identities=14% Similarity=0.144 Sum_probs=81.5
Q ss_pred HHHHHcccCCCcccceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeC
Q 043053 761 EIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840 (1058)
Q Consensus 761 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 840 (1058)
|+..+.. .||++++. .+-.+++.+.+.++. ..+..+|-.- ...+...+++++.+|+...++++.. +|-
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~--~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf 103 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDI--NDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRTR-----YTF 103 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECC--CTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGSS-----EEC
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEc--CcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcCc-----eEE
Confidence 3444433 58988876 455555544444443 3334333321 3478899999999999999888876 899
Q ss_pred CCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccch-hhHHHHHHHHHhCCCCCC
Q 043053 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDV-YSYGVVVLEVLTGKQPID 919 (1058)
Q Consensus 841 Dikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv-wSlGvvl~elltg~~P~~ 919 (1058)
-++|+|++++.++.+++.-.|+...+ +|.- .+ ..|. -.+=+++..+++++..|+
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~~-----~~-ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPLP-----VS-EAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTTB-------------------SCCC-----CC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEecceEEEcCCCCEEEEEccCccCC-------------------CCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999999999877753222 2210 11 1122 347788889999998875
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.27 E-value=1.1 Score=31.81 Aligned_cols=29 Identities=17% Similarity=0.284 Sum_probs=13.9
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHHHhcc
Q 043053 645 KVAIALLITLTVAMAIMGTFALIRARRAM 673 (1058)
Q Consensus 645 ~~~i~~~~~~~~~~~~~~~~~~~~~rr~~ 673 (1058)
.++.+++.++++++++++.++++.+||+.
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 35555555555544444444444444443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.64 E-value=2.2 Score=42.64 Aligned_cols=114 Identities=10% Similarity=0.071 Sum_probs=78.4
Q ss_pred CCCcccceeeEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhh-cccccCCCCeEeCCCCCCcE
Q 043053 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLA-YLHHDCVPPIVHRDIKANNI 847 (1058)
Q Consensus 769 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivHrDikp~Ni 847 (1058)
.||++ -..+-.+++.+.+.++.-+++.=...++ ..+...+++.+.+|+.... +++.. +|--++|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceE
Confidence 58888 4444456666666666554433233332 3688899999999999999 88876 8899999999
Q ss_pred EEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchh-hHHHHHHHHHhCCCCCC
Q 043053 848 LIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVY-SYGVVVLEVLTGKQPID 919 (1058)
Q Consensus 848 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw-SlGvvl~elltg~~P~~ 919 (1058)
+++.++.+++.-.|+-. -++|.-.. ..|.| .+=+++..++.++..|+
T Consensus 116 ~f~~~~~p~i~hRGi~~-------------------~lpP~e~~------ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKE-------------------SLPPDEWD------DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETT-------------------TBSSCSCC------HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcc-------------------cCCCCCCC------HHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999998777532 22332111 11222 47778888998887774
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.14 E-value=1.8 Score=30.63 Aligned_cols=27 Identities=22% Similarity=0.283 Sum_probs=11.6
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHhc
Q 043053 646 VAIALLITLTVAMAIMGTFALIRARRA 672 (1058)
Q Consensus 646 ~~i~~~~~~~~~~~~~~~~~~~~~rr~ 672 (1058)
++.+++.++++.+++++.++++++||+
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 444444444444444444444444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1058 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-26 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-24 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-23 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-13 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 7e-06 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 2e-66
Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 27/282 (9%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG G G VY+ +AVK L T +F E+ L R
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ---------LQAFKNEVGVLRKTR 62
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H NI+ F+G ++ + SL LH E I AQG+ YL
Sbjct: 63 HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYL 120
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY 889
H I+HRD+K+NNI + + I DFGLA + + ++GS ++APE
Sbjct: 121 HA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 890 GYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLL 946
M + +SDVY++G+V+ E++TG+ P + D + G L P L
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIFMVGRGYLSPDLS 232
Query: 947 SRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988
+ M + + C+ DERP + A ++ +
Sbjct: 233 KVRSNCPKAMKR---LMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-62
Identities = 69/278 (24%), Positives = 127/278 (45%), Gaps = 29/278 (10%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G G V+ + +AVK L + S D+F AE + ++
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL------------KQGSMSPDAFLAEANLMKQLQ 66
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H+ +VR + ++ +YM NGSL L +G L + A+G+A++
Sbjct: 67 HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY 889
+HRD++A NIL+ IADFGLA+L++D ++ + + APE
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEA 181
Query: 890 GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRP 949
T KSDV+S+G+++ E++T + P + + + + R + + RP
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------MVRP 232
Query: 950 ESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
++ +E+ Q + LC P++RPT + ++L++
Sbjct: 233 DNCPEELYQ---LMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 3e-59
Identities = 67/320 (20%), Positives = 129/320 (40%), Gaps = 51/320 (15%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+ +G G GVV++ +G V+A K + + K +R+ E++ L
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHL----------EIKPAIRNQIIRELQVLHEC 61
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
IV F G ++ + ++M GSL +L + + ++ ++ + +GL Y
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTY 119
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
L I+HRD+K +NIL+ E + DFG++ + D +N+ G+ Y++PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 173
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT--------------------------- 921
+ +SD++S G+ ++E+ G+ PI P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 922 -IPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALL--CVNASPDERPTMK 978
P S+ +D ++LD + P + + C+ +P ER +K
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 979 DVAAM--LKEIKHEREEYAK 996
+ +K E ++A
Sbjct: 294 QLMVHAFIKRSDAEEVDFAG 313
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 3e-59
Identities = 71/306 (23%), Positives = 123/306 (40%), Gaps = 53/306 (17%)
Query: 710 NVIGKGCSGVVYRA------DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
IG+G G V++A + ++AVK L + + ++ F E
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----------EASADMQADFQREAA 68
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGN--------------- 808
+ + NIV+ LG C L+++YM G L L + +
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 809 -------ALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861
L + I A G+AYL VHRD+ N L+G IADFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921
L++ + D+ ++ A ++ PE + + T +SDV++YGVV+ E+ +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ---- 241
Query: 922 IPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVA 981
P + V V D ++L+ PE+ E+ + LC + P +RP+ +
Sbjct: 242 -PYYGMAHEEVIYY----VRDGNILACPENCPLELYN---LMRLCWSKLPADRPSFCSIH 293
Query: 982 AMLKEI 987
+L+ +
Sbjct: 294 RILQRM 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-59
Identities = 72/283 (25%), Positives = 115/283 (40%), Gaps = 36/283 (12%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IGKG G V D G +AVK + + +F AE + +R
Sbjct: 13 QTIGKGEFGDVMLGD-YRGNKVAVKCI-------------KNDATAQAFLAEASVMTQLR 58
Query: 770 HKNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
H N+V+ LG L ++ +YM GSL L R + L + + L + + Y
Sbjct: 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
L VHRD+ A N+L+ + ++DFGL K + +T + APE
Sbjct: 119 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPE 170
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948
K + KSDV+S+G+++ E+ + + P IP VV V + +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGY--------KMDA 221
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK-HE 990
P+ + + V C + RP+ + L+ IK HE
Sbjct: 222 PDGCPPAVYE---VMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-58
Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 29/278 (10%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG G G+V+ N + +A+K + E + + F E + + +
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTI------------REGAMSEEDFIEEAEVMMKLS 58
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H +V+ G C + L++++M +G L L + E + L +G+AYL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYL 117
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY 889
++HRD+ A N L+G ++DFG+ + V D + SS + +PE
Sbjct: 118 EE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEV 173
Query: 890 GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRP 949
+ + KSDV+S+GV++ EV + + + S VV+ + G ++ P L S
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDIS--TGFRLYKPRLAST- 229
Query: 950 ESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+ C P++RP + L EI
Sbjct: 230 --------HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-58
Identities = 78/306 (25%), Positives = 120/306 (39%), Gaps = 43/306 (14%)
Query: 711 VIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH 770
IGKG G V+R GE +AVK + AEI +RH
Sbjct: 10 SIGKGRFGEVWRG-KWRGEEVAVKIF------------SSREERSWFREAEIYQTVMLRH 56
Query: 771 KNIVRFLGCCWNRNNRL----LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGL 826
+NI+ F+ N L+ DY +GSL L+ T + E ++ L A GL
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGL 113
Query: 827 AYLHHDCV-----PPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD--FARSSNTVA 879
A+LH + V P I HRD+K+ NIL+ IAD GLA D + N
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 880 GSYGYIAPEY------GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV- 932
G+ Y+APE + +++D+Y+ G+V E+ D V
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 933 --------RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984
R+ Q L P++ +R +S + + + C A+ R T + L
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTL 292
Query: 985 KEIKHE 990
++ +
Sbjct: 293 SQLSQQ 298
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 9e-58
Identities = 61/278 (21%), Positives = 118/278 (42%), Gaps = 29/278 (10%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G GVV +A+K + E S D F E K + ++
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMI------------KEGSMSEDEFIEEAKVMMNLS 57
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H+ +V+ G C + ++ +YM NG L + L E + + ++ + + YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYL 116
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY 889
+HRD+ A N L+ + ++DFGL++ V D ++ S + + PE
Sbjct: 117 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEV 172
Query: 890 GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRP 949
K + KSD++++GV++ E+ + + + S + + Q G+++ P L S
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQ--GLRLYRPHLASE- 228
Query: 950 ESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+ + C + DERPT K + + + ++
Sbjct: 229 --------KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-57
Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 29/278 (10%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G+GC G V+ + +A+K L P TM+ ++F E + + +R
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------------PEAFLQEAQVMKKLR 70
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H+ +V+ ++ +YM GSL L TG L + A G+AY+
Sbjct: 71 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY 889
VHRD++A NIL+G +ADFGLA+L++D ++ + + APE
Sbjct: 130 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEA 185
Query: 890 GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRP 949
+ T KSDV+S+G+++ E+ T + P + + V+D V + R
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGY-----------RM 233
Query: 950 ESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+ + C P+ERPT + + A L++
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 8e-57
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 47/301 (15%)
Query: 710 NVIGKGCSGVVYRA------DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
+G G G V A D +AVK L P R++ +E+K
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP----------SAHLTEREALMSELK 78
Query: 764 TLGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGN-------------- 808
L + H NIV LG C L++ +Y G L + L + +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 809 --ALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV 866
AL+ E A+G+A+L +HRD+ A NIL+ I DFGLA+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 867 DDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS 926
+ ++APE + T +SDV+SYG+ + E+ + P +P S
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 927 HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
+++ + PE EM + C +A P +RPT K + ++++
Sbjct: 256 KFYKMIKEGFR--------MLSPEHAPAEMYD---IMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 987 I 987
Sbjct: 305 Q 305
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 61/288 (21%), Positives = 114/288 (39%), Gaps = 31/288 (10%)
Query: 707 VDANVIGKGCSGVVYRA---DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
++ +G G G V + + +AVK L ++D AE
Sbjct: 10 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---------DPALKDELLAEAN 60
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
+ + + IVR +G C + +L+ + G L L + ++ + +++ +
Sbjct: 61 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVS 117
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG-DFARSSNTVAGSY 882
G+ YL VHRD+ A N+L+ + I+DFGL+K + ++ ++
Sbjct: 118 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942
+ APE K + KSDV+S+GV++ E + Q + GS V + + +
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTAMLEKGE------ 227
Query: 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
+ P EM + LC + RP V L+ ++
Sbjct: 228 --RMGCPAGCPREMYD---LMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 2e-56
Identities = 67/290 (23%), Positives = 120/290 (41%), Gaps = 29/290 (10%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+ +G G G VY +AVK L E + + F E + I
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTL------------KEDTMEVEEFLKEAAVMKEI 70
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
+H N+V+ LG C ++ ++M G+L L E + + + + + Y
Sbjct: 71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
L +HRD+ A N L+G +ADFGL++L+ GD + + APE
Sbjct: 131 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 186
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948
K + KSDV+++GV++ E+ T P I D S V + + + + R
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYR--------MER 237
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVD 998
PE +++ + + C +P +RP+ ++ + + E +V+
Sbjct: 238 PEGCPEKVYE---LMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 3e-56
Identities = 71/299 (23%), Positives = 116/299 (38%), Gaps = 33/299 (11%)
Query: 696 NFSVEQVLKCLVDANVIGKGCSGVVYRA----DMDNGEVIAVKKLWPTTMAAANGCSDEK 751
F+ E + C+ VIG G G V +A+K L S
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK----------SGYT 67
Query: 752 SGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALE 811
R F +E +G H N++ G +++ ++M NGSL S L + G
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-T 126
Query: 812 WELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF 871
+L G A G+ YL VHRD+ A NIL+ ++DFGL++ ++D
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 872 ARSSNTVAGSYG---YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV 928
+ + G + APE K T SDV+SYG+V+ EV++ + + + V
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDV 242
Query: 929 VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
++ + Q R +D + L C + RP + L ++
Sbjct: 243 INAIEQDY-----------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 7e-56
Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 33/284 (11%)
Query: 712 IGKGCSGVVYRA---DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G G G V + +A+K L + + E + + +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----------GTEKADTEEMMREAQIMHQL 66
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
+ IVR +G C +L+ + G L L + + ++L + G+ Y
Sbjct: 67 DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKY 124
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD-FARSSNTVAGSYGYIAP 887
L VHRD+ A N+L+ I+DFGL+K + D + + + + AP
Sbjct: 125 LEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 888 EYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLL 946
E K + +SDV+SYGV + E L+ G++P G V+ ++ Q K +
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGK--------RM 231
Query: 947 SRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990
P E+ + C ++RP V ++ +
Sbjct: 232 ECPPECPPELYA---LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 8e-56
Identities = 75/298 (25%), Positives = 116/298 (38%), Gaps = 35/298 (11%)
Query: 710 NVIGKGCSGVVYRA----DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
VIG+G G VY + AVK L G F E +
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----------ITDIGEVSQFLTEGIIM 82
Query: 766 GSIRHKNIVRFLGCCWNRNNRLLM-YDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
H N++ LG C L+ YM +G L + + T N + L A+
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAK 141
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNT--VAGSY 882
G+ VHRD+ A N ++ +F +ADFGLA+ + D +F N
Sbjct: 142 GM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942
++A E K T KSDV+S+GV++ E++T P P + D +L
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP----DVNTFDITV-----YLLQ 249
Query: 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE--REEYAKVD 998
L +PE D + + V L C + + RP+ ++ + + I E Y V+
Sbjct: 250 GRRLLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 304
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-55
Identities = 70/289 (24%), Positives = 117/289 (40%), Gaps = 32/289 (11%)
Query: 705 CLVDANVIGKGCSGVVYRA-----DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFS 759
C+ VIG G G VY+ +A+K L R F
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----------GYTEKQRVDFL 57
Query: 760 AEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQIL 819
E +G H NI+R G +++ +YM NG+L L E+ G +L
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGML 116
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV-DDGDFARSSNTV 878
G A G+ YL + VHRD+ A NIL+ ++DFGL++++ DD + +++
Sbjct: 117 RGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 879 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938
+ APE K T SDV+S+G+V+ EV+T + + + V+ +
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGF-- 230
Query: 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
R + +D + + C RP D+ ++L ++
Sbjct: 231 ---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 8e-55
Identities = 70/277 (25%), Positives = 118/277 (42%), Gaps = 34/277 (12%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG+G VY+ D + +A +L + + R F E + L +
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---------RQRFKEEAEMLKGL 65
Query: 769 RHKNIVRFLGCC----WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
+H NIVRF + +L+ + M +G+L + L ++ ++ +
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILK 123
Query: 825 GLAYLHHDCVPPIVHRDIKANNILI-GLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
GL +LH PPI+HRD+K +NI I G I D GLA L + V G+
Sbjct: 124 GLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPE 178
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
++APE Y K E DVY++G+ +LE+ T + P + ++ V
Sbjct: 179 FMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPA 232
Query: 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
S E+ E+++ C+ + DER ++KD+
Sbjct: 233 SFDKVAIPEVKEIIEG------CIRQNKDERYSIKDL 263
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-54
Identities = 56/278 (20%), Positives = 112/278 (40%), Gaps = 31/278 (11%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG G G + +G+++ K+L +M + +E+ L +
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---------TEAEKQMLVSEVNLLREL 60
Query: 769 RHKNIVRFLGCCWNRNNRLLM--YDYMPNGSLGSLLHE--RTGNALEWELRYQILLGAAQ 824
+H NIVR+ +R N L +Y G L S++ + + L+ E +++
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 825 GLAYLH--HDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSY 882
L H D ++HRD+K N+ + + + DFGLA++++ + G+
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTP 178
Query: 883 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942
Y++PE M EKSD++S G ++ E+ P + ++ +
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAG-----KIRE 228
Query: 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
P DE+ + + +N RP+++++
Sbjct: 229 GKFRRIPYRYSDELNE---IITRMLNLKDYHRPSVEEI 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 4e-54
Identities = 71/273 (26%), Positives = 107/273 (39%), Gaps = 28/273 (10%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+G G V A + E +AVK + ++ EI +
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----------KRAVDCPENIKKEICINKML 60
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
H+N+V+F G N + L +Y G L + G + + G+ Y
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVY 118
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
LH I HRDIK N+L+ I+DFGLA + + R N + G+ Y+APE
Sbjct: 119 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 889 YGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947
+ E DV+S G+V+ +L G+ P D DW +K
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------TYL 226
Query: 948 RPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
P +ID AL +L N P R T+ D+
Sbjct: 227 NPWKKIDSAPLALLHKILVEN--PSARITIPDI 257
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 8e-54
Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 32/272 (11%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+GKG G VY A + + ++A+K L+ + EK+GV E++ +
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--------EKAGVEHQLRREVEIQSHL 63
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
RH NI+R G + L+ +Y P G++ L + + + + + A L+Y
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 121
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
H ++HRDIK N+L+G E IADFG + T+ G+ Y+ PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPE 174
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948
EK D++S GV+ E L GK P + + + ++ ++ P ++
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFTFPDFVTE 229
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDV 980
A + + +P +RP +++V
Sbjct: 230 ---------GARDLISRLLKHNPSQRPMLREV 252
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-53
Identities = 66/303 (21%), Positives = 112/303 (36%), Gaps = 52/303 (17%)
Query: 711 VIGKGCSGVVYRA------DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
V+G G G V A +AVK L S R++ +E+K
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE----------KADSSEREALMSELKM 93
Query: 765 LGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTG---------------- 807
+ + H+NIV LG C L+++Y G L + L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 808 -----NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862
N L +E A+G+ +L VHRD+ A N+L+ I DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI 922
A+ + ++APE + T KSDV+SYG+++ E+ + P I
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 923 PDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAA 982
P ++ ++ + +P +E+ + C +RP+ ++ +
Sbjct: 271 PVDANFYKLIQNGF--------KMDQPFYATEEIYI---IMQSCWAFDSRKRPSFPNLTS 319
Query: 983 MLK 985
L
Sbjct: 320 FLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-53
Identities = 71/309 (22%), Positives = 119/309 (38%), Gaps = 46/309 (14%)
Query: 710 NVIGKGCSGVVYRA-DMDNGE--VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
+VIG+G G V +A +G A+K++ F+ E++ L
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----------YASKDDHRDFAGELEVLC 65
Query: 767 SI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER--------------TGNALE 811
+ H NI+ LG C +R L +Y P+G+L L + T + L
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 812 WELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDF 871
+ A+G+ YL +HRD+ A NIL+G + IADFGL++ +
Sbjct: 126 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV- 181
Query: 872 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931
++A E T SDV+SYGV++ E+++ G +
Sbjct: 182 --KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAEL 235
Query: 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991
++ L +P + DE+ + C P ERP+ + L + ER
Sbjct: 236 YE-----KLPQGYRLEKPLNCDDEVYD---LMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 992 EEYAKVDML 1000
+ Y +
Sbjct: 288 KTYVNTTLY 296
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-52
Identities = 69/297 (23%), Positives = 118/297 (39%), Gaps = 35/297 (11%)
Query: 703 LKCLVDA------NVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKS 752
L CL+ +G G GVV R + D +AVK L P + +
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--------SQP 52
Query: 753 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEW 812
D F E+ + S+ H+N++R G +++ + P GSL L + G+
Sbjct: 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH-FLL 110
Query: 813 ELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG-DF 871
+ + A+G+ YL +HRD+ A N+L+ I DFGL + + D
Sbjct: 111 GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 872 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931
+ + APE + SD + +GV + E+ T Q + +GS ++
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHK 226
Query: 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988
+ + + L RPE ++ V + C P++RPT + L E +
Sbjct: 227 IDK-------EGERLPRPEDCPQDIYN---VMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 3e-52
Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 35/288 (12%)
Query: 697 FSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVR 755
F + K D IG G G VY A D+ N EV+A+KK+ + + +
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--------QSNEKW 59
Query: 756 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELR 815
E++ L +RH N +++ GC + L+ +Y + L E L+
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEI 117
Query: 816 YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
+ GA QGLAYLH ++HRD+KA NIL+ + DFG A ++ +
Sbjct: 118 AAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168
Query: 876 NTVAGSYGYIAPEY---GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWV 932
N+ G+ ++APE + K DV+S G+ +E+ K P + + +
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSAL 223
Query: 933 RQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ + E + C+ P +RPT + +
Sbjct: 224 Y-----HIAQNESPALQSGHWSEYFRNF--VDSCLQKIPQDRPTSEVL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 3e-52
Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 34/277 (12%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G G G VY+A + + + A K + + + + EI L S
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVI-----------DTKSEEELEDYMVEIDILASC 66
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
H NIV+ L + NN ++ ++ G++ +++ E L + L Y
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNY 125
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
LH I+HRD+KA NIL L+ + +ADFG++ + ++ G+ ++APE
Sbjct: 126 LHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPE 180
Query: 889 Y-----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943
K+DV+S G+ ++E+ + P P +R I +P
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLKIAKSEP 232
Query: 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
L++P S + L N D R T +
Sbjct: 233 PTLAQP-SRWSSNFKDFLKKCLEKN--VDARWTTSQL 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-51
Identities = 64/294 (21%), Positives = 114/294 (38%), Gaps = 39/294 (13%)
Query: 710 NVIGKGCSGVVYRA------DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
+G+G G+VY + +A+K + R F E
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----------AASMRERIEFLNEAS 75
Query: 764 TLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTG--------NALEWELR 815
+ ++VR LG L++ + M G L S L
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 816 YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 875
Q+ A G+AYL+ VHRD+ A N ++ +F I DFG+ + + + D+ R
Sbjct: 136 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 876 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935
+++PE T SDV+S+GVV+ E+ T + P + V +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSNEQVLRF 247
Query: 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989
V++ LL +P++ D + + + +C +P RP+ ++ + +KE
Sbjct: 248 ----VMEGGLLDKPDNCPDMLFE---LMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-50
Identities = 66/294 (22%), Positives = 114/294 (38%), Gaps = 32/294 (10%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEV----IAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
V+G G G VY+ + GE +A+K+L E
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----------ATSPKANKEILDEAYV 64
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
+ S+ + ++ R LG C +L+ MP G L + E N + + A+
Sbjct: 65 MASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAK 122
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
G+ YL +VHRD+ A N+L+ I DFGLAKL+ + + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944
+A E T +SDV+SYGV V E++T IP S + + + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGE-------- 230
Query: 945 LLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHEREEYAKVD 998
L +P ++ + + C D RP +++ ++ + + Y +
Sbjct: 231 RLPQPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 281
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-49
Identities = 67/286 (23%), Positives = 109/286 (38%), Gaps = 32/286 (11%)
Query: 711 VIGKGCSGVVYRA----DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
IG+G G V++ + +A+K T VR+ F E T+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----------SDSVREKFLQEALTMR 63
Query: 767 SIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGL 826
H +IV+ +G N ++ + G L S L R + L+ + L
Sbjct: 64 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTAL 121
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIA 886
AYL VHRDI A N+L+ + DFGL++ ++D + ++S ++A
Sbjct: 122 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMA 177
Query: 887 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLL 946
PE + T SDV+ +GV + E+L P + V + + + L
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGR----IENGERL 228
Query: 947 SRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992
P L +L C P RP ++ A L I E +
Sbjct: 229 PMPP-NCPPTLYSL--MTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-49
Identities = 50/281 (17%), Positives = 105/281 (37%), Gaps = 28/281 (9%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
++G+G V A ++ A+K L + K + E + +
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDVMSRL 65
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
H V+ + Y NG L + + G+ E R+ A+ ++
Sbjct: 66 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYT----AEIVSA 120
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
L + I+HRD+K NIL+ + I DFG AK++ +N+ G+ Y++PE
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948
+ SD+++ G ++ +++ G P + + I L+ +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------NEYLIFQKIIKLEYDFPEK 232
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989
+ ++++ LL ++ +R +++ H
Sbjct: 233 FFPKARDLVE----KLLVLD--ATKRLGCEEMEGYGPLKAH 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (445), Expect = 6e-49
Identities = 66/306 (21%), Positives = 123/306 (40%), Gaps = 33/306 (10%)
Query: 678 DSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKL 736
D+ + D W Q+ P Q + + VL +G G GVV+R + G A K +
Sbjct: 2 DNYVFDIWK-QYYP-QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV 59
Query: 737 WPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNG 796
+++ EI+T+ +RH +V + N +++Y++M G
Sbjct: 60 -----------MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 108
Query: 797 SLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856
L + + N + + + + +GL ++H + VH D+K NI+ +
Sbjct: 109 ELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNE 164
Query: 857 I--ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG 914
+ DFGL +D S G+ + APE + +D++S GV+ +L+G
Sbjct: 165 LKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
Query: 915 KQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDER 974
P G + + +R ++ D ++ S I E + LL + P+ R
Sbjct: 222 LSPF-----GGENDDETLRN---VKSCDWNMDDSAFSGISEDGKDFIRKLLLAD--PNTR 271
Query: 975 PTMKDV 980
T+
Sbjct: 272 MTIHQA 277
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-48
Identities = 60/272 (22%), Positives = 122/272 (44%), Gaps = 31/272 (11%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG+G SG VY A D+ G+ +A++++ + ++ ++ EI +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQM-----------NLQQQPKKELIINEILVMREN 74
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
++ NIV +L + ++ +Y+ GSL ++ E + + Q L +
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEF 131
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
LH + ++HRDIK++NIL+G++ + DFG + RS T+ G+ ++APE
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPE 186
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948
K D++S G++ +E++ G+ P + +R I L
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--------NPLRALYLIATNGTPELQN 238
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDV 980
PE ++ + + L ++ ++R + K++
Sbjct: 239 PE-KLSAIFRDFLNRCLDMD--VEKRGSAKEL 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 1e-47
Identities = 68/301 (22%), Positives = 118/301 (39%), Gaps = 48/301 (15%)
Query: 710 NVIGKGCSGVVYRA--------DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAE 761
+G+G G V A + +AVK L D +E
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----------DATEKDLSDLISE 68
Query: 762 IKTLGSI-RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNA----------- 809
++ + I +HKNI+ LG C ++ +Y G+L L R
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 810 ---LEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV 866
L + A+G+ YL +HRD+ A N+L+ + IADFGLA+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 867 DDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGS 926
D+ + + ++APE + T +SDV+S+GV++ E+ T P
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPG 240
Query: 927 HVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKE 986
V+ + + + + + +P + +E+ + C +A P +RPT K + L
Sbjct: 241 VPVEELFKL----LKEGHRMDKPSNCTNELYM---MMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 987 I 987
I
Sbjct: 294 I 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (425), Expect = 4e-47
Identities = 64/279 (22%), Positives = 114/279 (40%), Gaps = 28/279 (10%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
++G+G S VV R + AVK + T + + ++E +R++ E+ L +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS--AEEVQELREATLKEVDILRKV 66
Query: 769 R-HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLA 827
H NI++ L++D M G L L E+ L + +I+ + +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVIC 124
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
LH IVHRD+K NIL+ + + DFG + +D G+ V G+ Y+AP
Sbjct: 125 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAP 178
Query: 888 EY------GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941
E ++ D++S GV++ +L G P + +R I
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-----WHRKQMLMLRM---IMSG 230
Query: 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ S + + ++ L L V P +R T ++
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQ--PQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-46
Identities = 58/337 (17%), Positives = 111/337 (32%), Gaps = 46/337 (13%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G+G G+V+R + + + K + K + EI L R
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV------------KVKGTDQVLVKKEISILNIAR 59
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H+NI+ + +++++++ + ++ L + + L +L
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFL 118
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPY--IADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
H I H DI+ NI+ I +FG A+ + GD R + + Y AP
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR---LLFTAPEYYAP 172
Query: 888 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947
E ++ +D++S G +V +L+G P + I + +
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPF-----LAETNQQIIEN---IMNAEYTFDE 224
Query: 948 RPESEIDEMLQALGVALLCVNASPDERPTMKDV--------------AAMLKEIKHEREE 993
EI LL R T + +++ +KH R
Sbjct: 225 EAFKEISIEAMDFVDRLLVKE--RKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYY 282
Query: 994 YAKVDMLLKGSPAAANVQENKNSSGVLATSSSKPAVT 1030
+ + L +AA + S +K V
Sbjct: 283 HTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVA 319
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (427), Expect = 2e-46
Identities = 57/309 (18%), Positives = 109/309 (35%), Gaps = 33/309 (10%)
Query: 675 DDDDSELGDSWPWQFTPFQKLNFSVEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAV 733
+D D D W ++ P Q + V +G G GVV+R + G V
Sbjct: 2 NDYDKFYEDIWK-KYVP-QPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 59
Query: 734 KKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYM 793
K + + + + EI + + H ++ ++ +L+ +++
Sbjct: 60 KFI-----------NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108
Query: 794 PNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853
G L + + + A +GL ++H IVH DIK NI+ +
Sbjct: 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKK 164
Query: 854 EPYI--ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 911
+ DFGLA ++ + + + APE + +D+++ GV+ +
Sbjct: 165 ASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221
Query: 912 LTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASP 971
L+G P D + + ++ D S + + LL P
Sbjct: 222 LSGLSPFAGE--------DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE--P 271
Query: 972 DERPTMKDV 980
+R T+ D
Sbjct: 272 RKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 2e-46
Identities = 55/272 (20%), Positives = 99/272 (36%), Gaps = 26/272 (9%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+V+G G V A D +++A+K + G S EI L I
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAK----------KALEGKEGSMENEIAVLHKI 64
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
+H NIV + + L+ + G L + E+ +++ + Y
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKY 122
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
LH + + + + + I+DFGL+K+ D G +T G+ GY+APE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAPE 179
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948
++ D +S GV+ +L G P + Q I + S
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPF-----YDENDAKLFEQ---ILKAEYEFDSP 231
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+I + + L+ + P++R T +
Sbjct: 232 YWDDISDSAKDFIRHLMEKD--PEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (413), Expect = 1e-45
Identities = 68/286 (23%), Positives = 113/286 (39%), Gaps = 30/286 (10%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++G G V+ A D+ +AVK L F E + ++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--------RDPSFYLRFRREAQNAAALN 65
Query: 770 HKNIVRFLGCCWNRNNRL----LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
H IV ++ +Y+ +L ++H + + +++ A Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQA 123
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK-LVDDGDFARSSNTVAGSYGY 884
L + H I+HRD+K NI+I + DFG+A+ + D G+ + V G+ Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 885 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944
++PE + +SDVYS G V+ EVLTG+ P G V Q DP
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSVAYQ---HVREDPI 232
Query: 945 LLSRPESEIDEMLQALGVALLCVNASPDERP-TMKDVAAMLKEIKH 989
S + L A+ + L N P+ R T ++ A L + +
Sbjct: 233 PPSARHEGLSADLDAVVLKALAKN--PENRYQTAAEMRADLVRVHN 276
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 64/300 (21%), Positives = 109/300 (36%), Gaps = 46/300 (15%)
Query: 710 NVIGKGCSGVVYRA------DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIK 763
+G+G G V A +AVK L + +E+K
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----------GATHSEHRALMSELK 68
Query: 764 TLGSIRH-KNIVRFLGCCWNRNNRL-LMYDYMPNGSLGSLLHERTG-------------- 807
L I H N+V LG C L ++ ++ G+L + L +
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 808 NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVD 867
+ L E A+G+ +L +HRD+ A NIL+ + I DFGLA+ +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 868 DGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSH 927
++APE + T +SDV+S+GV++ E+ + P +
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 928 VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
+++ + P+ EM Q L C + P +RPT ++ L +
Sbjct: 246 FCRRLKEGT--------RMRAPDYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (398), Expect = 2e-43
Identities = 71/289 (24%), Positives = 113/289 (39%), Gaps = 36/289 (12%)
Query: 710 NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG+G GVVY+A + GE A+KK+ E G+ + EI L ++
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRL---------EKEDEGIPSTTIREISILKELK 58
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
H NIV+ + +L+++++ L G LE LL G+AY
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYC 116
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY 889
H ++HRD+K N+LI E E IADFGLA+ R + Y AP+
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDV 171
Query: 890 GY-MMKITEKSDVYSYGVVVLEVLTGKQP-----------------IDPTIPDGSHVVDW 931
K + D++S G + E++ G P + +V +
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ V +P +DE L +L ++ P++R T K
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD--PNQRITAKQA 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-43
Identities = 59/297 (19%), Positives = 109/297 (36%), Gaps = 35/297 (11%)
Query: 690 TPFQKLNFS-VEQVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGC 747
T F++ N + +G G VV + + G A K +
Sbjct: 1 TVFRQENVDDYYDTGE------ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTK----- 49
Query: 748 SDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTG 807
S + R+ E+ L I+H N++ N+ + +L+ + + G L L E+
Sbjct: 50 SSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 109
Query: 808 NALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP----YIADFGLA 863
E + Q L +++ I H D+K NI++ P I DFGLA
Sbjct: 110 LTEEEATEF-----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164
Query: 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 923
+D G+ + G+ ++APE + ++D++S GV+ +L+G P
Sbjct: 165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-- 219
Query: 924 DGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ ++ S + + LL + P +R T++D
Sbjct: 220 ------TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD--PKKRMTIQDS 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (394), Expect = 1e-42
Identities = 62/281 (22%), Positives = 109/281 (38%), Gaps = 35/281 (12%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G G G V+ NG A+K L + + + + E L +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--------VRLKQVEHTNDERLMLSIV 61
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
H I+R G + ++ DY+ G L SLL + Y AA+
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLA 116
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
L + I++RD+K NIL+ I DFG AK V D + T+ G+ YIAPE
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE 171
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948
+ D +S+G+++ E+L G P S+ + + ++ P +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTP-----FYDSNTMKTYEKILNAELRFPPFFN- 225
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989
E ++ L L+ + +R ++ +++K+
Sbjct: 226 ------EDVKDLLSRLITRD--LSQRLG--NLQNGTEDVKN 256
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-42
Identities = 65/293 (22%), Positives = 106/293 (36%), Gaps = 41/293 (13%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+ +G+G VY+A D + +++A+KK+ S+ K G+ + EIK L +
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR------SEAKDGINRTALREIKLLQEL 57
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
H NI+ L +++N L++D+M + Y L
Sbjct: 58 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY-----MLMTLQG 112
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
L + I+HRD+K NN+L+ +ADFGLAK + R+ + Y APE
Sbjct: 113 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPE 170
Query: 889 -YGYMMKITEKSDVYSYGVVVLEVLTGKQP--------------------IDPTIPDGSH 927
D+++ G ++ E+L + PD
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 928 VVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ D+V K L S + L L L N P R T
Sbjct: 231 LPDYVTFKS----FPGIPLHHIFSAAGDDLLDLIQGLFLFN--PCARITATQA 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 155 bits (393), Expect = 7e-42
Identities = 60/282 (21%), Positives = 107/282 (37%), Gaps = 29/282 (10%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+IG+G G VY D G++ A+K L + G + + + + +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI-----MLSLVSTG 64
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
IV + + D M G L L + G E ++R+ GL +
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRF-YAAEIILGLEH 122
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
+H+ +V+RD+K NIL+ I+D GLA + G++GY+APE
Sbjct: 123 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPE 175
Query: 889 Y-GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947
+ +D +S G ++ ++L G P H +D + +++ D
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----- 230
Query: 948 RPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989
L++L LL + + R A +E+K
Sbjct: 231 ----SFSPELRSLLEGLLQRD--VNRRLGCLGRGA--QEVKE 264
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 1e-41
Identities = 65/307 (21%), Positives = 121/307 (39%), Gaps = 39/307 (12%)
Query: 710 NVIGKGCSGVVYRA--DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEI---KT 764
IG+G G V++A + G +A+K++ T + G+ S E+ +
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---------EEGMPLSTIREVAVLRH 63
Query: 765 LGSIRHKNIVRFLGCC----WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILL 820
L + H N+VR C +R +L + + L + L + + E ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAG 880
+GL +LH +VHRD+K NIL+ + +ADFGLA++ + +V
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVV 177
Query: 881 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT-----------IPDGSHVV 929
+ Y APE D++S G + E+ K + +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 930 DWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALL--CVNASPDERPTMKDVAAM--LK 985
DW R + S ++P + + LG LL C+ +P +R + + +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
Query: 986 EIKHERE 992
+++ +E
Sbjct: 298 DLERCKE 304
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 1e-41
Identities = 53/290 (18%), Positives = 93/290 (32%), Gaps = 32/290 (11%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG G G +Y D+ GE +A+K T E K ++
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------------HPQLHIESKIYKMMQ 60
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
+ + C + +M + SL L + + + Y+
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 830 HHDCVPPIVHRDIKANNILI---GLEFEPYIADFGLAKLVDDGD-----FARSSNTVAGS 881
H +HRD+K +N L+ YI DFGLAK D R + + G+
Sbjct: 120 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 882 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941
Y + ++ + + D+ S G V++ G P +K +
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991
L SE L C + D++P + + + + H +
Sbjct: 237 IEVLCKGYPSEFATYLNF------CRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-41
Identities = 60/272 (22%), Positives = 103/272 (37%), Gaps = 31/272 (11%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG-S 767
++GKG G V+ A + A+K L + + + E + L +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD--------VECTMVEKRVLSLA 59
Query: 768 IRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLA 827
H + + N + +Y+ G L + + + GL
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQ 117
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
+LH IV+RD+K +NIL+ + IADFG+ K GD +NT G+ YIAP
Sbjct: 118 FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAP 172
Query: 888 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLS 947
E K D +S+GV++ E+L G+ P D + +R
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--QDEEELFHSIRMDN----------P 220
Query: 948 RPESEIDEMLQALGVALLCVNASPDERPTMKD 979
+++ + L V L P++R ++
Sbjct: 221 FYPRWLEKEAKDLLVKLFVRE--PEKRLGVRG 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 9e-41
Identities = 57/290 (19%), Positives = 101/290 (34%), Gaps = 36/290 (12%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG+G G V++A + + E++A+K++ D+ GV S EI L +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRL---------DDDDEGVPSSALREICLLKEL 58
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
+HKNIVR + L++++ E + Q L
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKG 113
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
L ++HRD+K N+LI E +A+FGLA+ S V +
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDV 172
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPI------------------DPTIPDGSHVVD 930
+ D++S G + E+ +P+ PT +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
K + L +++ + L LL N P +R + ++
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN--PVQRISAEEA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-40
Identities = 64/279 (22%), Positives = 107/279 (38%), Gaps = 37/279 (13%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI- 768
V+G G +G V + + E A+K L D R E++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----------QDCPKARR-----EVELHWRAS 62
Query: 769 RHKNIVRFLGCCWN----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
+ +IVR + N R L++ + + G L S + +R A +I+ +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPY---IADFGLAKLVDDGDFARSSNTVAGS 881
+ YLH I HRD+K N+L + + DFG AK + S T +
Sbjct: 123 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYT 176
Query: 882 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941
Y+APE K + D++S GV++ +L G P + K I++
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMG 232
Query: 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ SE+ E ++ L LL P +R T+ +
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTE--PTQRMTITEF 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 71/290 (24%), Positives = 113/290 (38%), Gaps = 36/290 (12%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG+G GVVY+A + GEV+A+KK+ T E GV + EI L +
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---------ETEGVPSTAIREISLLKEL 58
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
H NIV+ L N L+++++ + L + + L L QGLA+
Sbjct: 59 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
H ++HRD+K N+LI E +ADFGLA+ R+ + Y APE
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPE 172
Query: 889 -YGYMMKITEKSDVYSYGVVVLEVLTGKQP-----------------IDPTIPDGSHVVD 930
+ D++S G + E++T + P V
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
K S+ +DE ++L +L + P++R + K
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD--PNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-40
Identities = 60/292 (20%), Positives = 108/292 (36%), Gaps = 34/292 (11%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+ IG+G G+V A D N +A+KK+ P E EIK L
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISP----------FEHQTYCQRTLREIKILLRF 63
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER-TGNALEWELRYQILLGAAQGLA 827
RH+NI+ + Y+ +G+ L++ L + L +GL
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS-NTVAGSYGYIA 886
Y+H ++HRD+K +N+L+ + I DFGLA++ D + Y A
Sbjct: 124 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 887 PEYGYM-MKITEKSDVYSYGVVVLEVLTGKQP---------------IDPTIPDGSHVVD 930
PE T+ D++S G ++ E+L+ + I +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALL--CVNASPDERPTMKDV 980
+ + + P P + + + + LL + +P +R ++
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (371), Expect = 8e-40
Identities = 48/290 (16%), Positives = 94/290 (32%), Gaps = 38/290 (13%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG+G GV++ ++ N + +A+K + E +T +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE-------------PRRSDAPQLRDEYRTYKLLA 58
Query: 770 H-KNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
I + +L+ D + G L + G + +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEP-----YIADFGLAKLVDDGD-----FARSSNTV 878
+H +V+RDIK +N LIG Y+ DFG+ K D R +
Sbjct: 117 IHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 879 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP-TIPDGSHVVDWVRQKKG 937
+G+ Y++ + + + D+ + G V + L G P + + +KK
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK- 232
Query: 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987
L + E + + N + D P + + ++
Sbjct: 233 QSTPLRELCAGFPEEFYKYMH------YARNLAFDATPDYDYLQGLFSKV 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 53/289 (18%), Positives = 108/289 (37%), Gaps = 40/289 (13%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
++G G G VY + + +A+K + ++ + E+ L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-----VPMEVVLLKKVS 65
Query: 770 --HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLA 827
++R L ++ +L+ + G AL+ EL + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVR 124
Query: 828 YLHHDCVPPIVHRDIKANNILIGLE-FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIA 886
+ H+ ++HRDIK NILI L E + DFG L+ D + G+ Y
Sbjct: 125 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSP 177
Query: 887 PEY-GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSL 945
PE+ Y + V+S G+++ +++ G P + +++ +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDE-----------EIIRGQV 221
Query: 946 LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM--LKEIKHERE 992
R + Q L L + P +RPT +++ ++++ +E
Sbjct: 222 FFRQ--RVSSECQHLIRWCLALR--PSDRPTFEEIQNHPWMQDVLLPQE 266
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 8e-38
Identities = 69/299 (23%), Positives = 104/299 (34%), Gaps = 48/299 (16%)
Query: 708 DANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG 766
D VIG G GVVY+A D+GE++A+KK+ + + E++ +
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---------------KRFKNRELQIMR 68
Query: 767 SIRHKNIVRFLGCCWNRNNR------LLMYDYMPNGSLGSLLH-ERTGNALEWELRYQIL 819
+ H NIVR ++ + L+ DY+P H R L +
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 820 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY-IADFGLAKLVDDGDFARSSNTV 878
+ LAY+H I HRDIK N+L+ + + DFG AK + G+ S +
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YI 183
Query: 879 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID-----------------PT 921
Y T DV+S G V+ E+L G+ PT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 922 IPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ + K Q+ AL LL P R T +
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT--PTARLTPLEA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 58/301 (19%), Positives = 106/301 (35%), Gaps = 44/301 (14%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
IG+G G V++A G+ +A+KK+ +EK G + EIK L +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLM---------ENEKEGFPITALREIKILQLL 66
Query: 769 RHKNIVRFLGCCW--------NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILL 820
+H+N+V + C + + L++D+ + G L + L R
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV---- 122
Query: 821 GAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDG--DFARSSNTV 878
L L++ I+HRD+KA N+LI + +ADFGLA+
Sbjct: 123 -MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 879 AGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT---------------- 921
+ Y PE D++ G ++ E+ T +
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 922 IPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALL--CVNASPDERPTMKD 979
P+ VD + ++++ + + + L+ + P +R D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 980 V 980
Sbjct: 302 A 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-36
Identities = 58/280 (20%), Positives = 95/280 (33%), Gaps = 32/280 (11%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
++GKG G V + G A+K L + A + E + L +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--------VAHTVTESRVLQNT 62
Query: 769 RHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAY 828
RH + + + +Y G L L E Y A+ ++
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSA 117
Query: 829 LHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPE 888
L + +V+RDIK N+++ + I DFGL K + T G+ Y+APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPE 175
Query: 889 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSR 948
D + GVV+ E++ G+ P ++ P LS
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP-----FYNQDHERLFELILMEEIRFPRTLS- 229
Query: 949 PESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988
++L LL + P +R A KE+
Sbjct: 230 ------PEAKSLLAGLLKKD--PKQRLGGGPSDA--KEVM 259
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-35
Identities = 64/287 (22%), Positives = 106/287 (36%), Gaps = 32/287 (11%)
Query: 710 NVIGKGCSGVVYRA----DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTL 765
V+G G G V+ D G++ A+K L T+ +K+ + E + L
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-------QKAKTTEHTRTERQVL 82
Query: 766 GSIRHK-NIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
IR +V L+ DY+ G L + L +R + + +
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGE 137
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
+ L H I++RDIK NIL+ + DFGL+K + + G+ Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEY 196
Query: 885 IAPE--YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942
+AP+ G + D +S GV++ E+LTG P + I +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEISRRILKSE 252
Query: 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989
P + +++Q LL + P +R A EIK
Sbjct: 253 PPYPQEMSALAKDLIQ----RLLMKD--PKKRLGCGPRDA--DEIKE 291
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 2e-34
Identities = 54/280 (19%), Positives = 100/280 (35%), Gaps = 35/280 (12%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G G V ++G A+K L + K + E + L ++
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV--------KLKQIEHTLNEKRILQAVN 99
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYL 829
+V+ + +N ++ +Y+ G + S L YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 830 HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEY 889
H +++RD+K N+LI + + DFG AK V + T+ G+ +APE
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEI 209
Query: 890 GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRP 949
+ D ++ GV++ E+ G P + + +V P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPF-----FADQPIQIYEKIVSGKVRFP------ 258
Query: 950 ESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989
S L+ L LL V+ +R ++ + +IK+
Sbjct: 259 -SHFSSDLKDLLRNLLQVD--LTKRF--GNLKNGVNDIKN 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-34
Identities = 63/306 (20%), Positives = 107/306 (34%), Gaps = 40/306 (13%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G G V A D G +A+KKL+ + E++ L +R
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYR---------PFQSELFAKRAYRELRLLKHMR 75
Query: 770 HKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLA 827
H+N++ L D+ + L + ++ +GL
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 828 YLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAP 887
Y+H + HRD+K N+ + + E I DFGLA+ D + Y AP
Sbjct: 136 YIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAP 187
Query: 888 E-YGYMMKITEKSDVYSYGVVVLEVLTGKQP---------------IDPTIPDGSHVVDW 931
E M+ T+ D++S G ++ E++TGK + T P
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALL--CVNASPDERPTMKDVAAM--LKEI 987
+ K P L + + I L V LL + ++R T + A + +
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307
Query: 988 KHEREE 993
+E
Sbjct: 308 HDTEDE 313
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 2e-31
Identities = 54/303 (17%), Positives = 109/303 (35%), Gaps = 59/303 (19%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+G+G V+ A ++ N E + VK L P + EIK L ++
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------------KKKIKREIKILENL 86
Query: 769 R-HKNIVRFLGCCWNRNNRL--LMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQG 825
R NI+ + +R L+++++ N L T ++++R+ + +
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT----DYDIRF-YMYEILKA 141
Query: 826 LAYLHHDCVPPIVHRDIKANNILIGLEF-EPYIADFGLAKLVDDGDFARSSNTVAGSYGY 884
L Y H I+HRD+K +N++I E + + D+GLA+ G N S +
Sbjct: 142 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYF 195
Query: 885 IAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPT------------IPDGSHVVDW 931
PE D++S G ++ ++ K+P + + D+
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255
Query: 932 VRQ--------------KKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTM 977
+ + + + + + S + + LL + R T
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD--HQSRLTA 313
Query: 978 KDV 980
++
Sbjct: 314 REA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 3e-30
Identities = 62/305 (20%), Positives = 102/305 (33%), Gaps = 55/305 (18%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
IG G G+V A D +A+KKL + E+ + +
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSR---------PFQNQTHAKRAYRELVLMKCVN 74
Query: 770 HKNIVRFLGCCWNR------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
HKNI+ L + + L+ + M + E E +L
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQML 129
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
G+ +LH I+HRD+K +NI++ + I DFGLA+ +
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRY 183
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP-----------------IDPTIPDGS 926
Y APE M E D++S G ++ E++ K P
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 927 HVVDWVRQ---------KKGIQVLDPSLLSRPESEIDEMLQALGVALL--CVNASPDERP 975
+ VR L P L +SE +++ + LL + P +R
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 976 TMKDV 980
++ D
Sbjct: 304 SVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-29
Identities = 51/296 (17%), Positives = 102/296 (34%), Gaps = 46/296 (15%)
Query: 710 NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI 768
+ +G G G V A D G +AVKKL + E++ L +
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---------PFQSIIHAKRTYRELRLLKHM 74
Query: 769 RHKNIVRFLGCC-----WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAA 823
+H+N++ L N + + ++ L +++ + L + ++
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQIL 131
Query: 824 QGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYG 883
+GL Y+H + HRD+K +N+ + + E I DFGLA+ DD + +
Sbjct: 132 RGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WY 184
Query: 884 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP-------------------IDPTIPD 924
M + D++S G ++ E+LTG+ +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 925 GSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDV 980
+ + + + + + L +L ++ D+R T
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD--SDKRITAAQA 298
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 116 bits (291), Expect = 2e-28
Identities = 90/413 (21%), Positives = 162/413 (39%), Gaps = 36/413 (8%)
Query: 9 SVPLQLPIPTNL--SSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPS 66
++ PI ++ V+ N+T ++ D + L +
Sbjct: 5 TITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSID 60
Query: 67 SLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMR 126
+ L+NL ++ ++NQLT P L N L +L+ +N +A P +
Sbjct: 61 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 118
Query: 127 AGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIP 186
DI + +++ ++D + LS L +L +
Sbjct: 119 NNQITDIDPLKNLTNLNRLELSSNTISD----------ISALSGLTSLQQLSFGNQVTDL 168
Query: 187 AEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMI 246
+ N + L L + N S + KL LE L N + P I T+L +
Sbjct: 169 KPLANLTTLERLDISSN--KVSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDEL 224
Query: 247 DFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIP 306
+ N L ++ L+ L + +++N +S P L+ T L +L+L NQIS + P
Sbjct: 225 SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
Query: 307 PEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKL 366
+ L+ LT +NQLE P + + NL L L N+++ P + L L +L
Sbjct: 281 --LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRL 334
Query: 367 LLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSN 419
+N +S + N +++ L G+N+I+ L P + L + L L+
Sbjct: 335 FFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 115 bits (287), Expect = 5e-28
Identities = 78/387 (20%), Positives = 160/387 (41%), Gaps = 36/387 (9%)
Query: 191 NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSL 250
+E + L + +++ ++ L ++ L + + + + +L I+FS
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 251 NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPP--- 307
N L+ PL L++L + ++++N ++ P + L + +
Sbjct: 76 NQLTDITPL--KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 308 ---------EIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDL-SHNSLTASVPAGL 357
I +S L+ + Q G+ + L +NL L+ +S S + L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 358 FQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLS 417
+L NL L+ +N IS P I ++L L + N++ + L L LDL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 418 SNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL 477
+N++S P + T+L + L N + P L+ L+ L L++++N+ P S
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS- 304
Query: 478 GRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNL 537
L +L + L N S P + + LQ L ++N+++ L + + L+
Sbjct: 305 -NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW-LSA 358
Query: 538 SCNGLTGPIPAQISALNKLSILDLSHN 564
N ++ P ++ L +++ L L+
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 109 bits (272), Expect = 5e-26
Identities = 82/386 (21%), Positives = 152/386 (39%), Gaps = 37/386 (9%)
Query: 216 LKKLEELFLWQNSLVGAIP-EEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISD 274
L + + L + ++ + ++ T+L+ + S+ G + L+ L + S+
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 275 NNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKL------------TVFFAWQ 322
N ++ P L N T LV + ++ NQI+ + P +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 323 NQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDIS-GSIPPEI 381
+T++ S L L + L L NLT L + + S +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 382 GNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLS 441
++L L NN+I+ + P I L+ L L+ N+L + T L +DL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 442 HNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSL 501
+N + P LS L+ L L + N+ S P L L +L + L++N P S
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS- 304
Query: 502 GLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDL 561
+L L L N ++ P + + L+ L + N ++ + ++ L ++ L
Sbjct: 305 -NLKNLTYLTLYFNNISDISP--VSSLTKLQR-LFFANNKVSD--VSSLANLTNINWLSA 358
Query: 562 SHNKLEGNLNPLAQLDNLVSLNISYN 587
HN++ L PLA L + L ++
Sbjct: 359 GHNQISD-LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 107 bits (267), Expect = 2e-25
Identities = 84/384 (21%), Positives = 142/384 (36%), Gaps = 35/384 (9%)
Query: 145 SNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENS 204
+ L T V+ ++ S L ++ TL I I + + L + N
Sbjct: 22 AEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQ 77
Query: 205 LSGSIPPEIGKLKKLEELFL------------WQNSLVGAIPEEIGNCTSLKMIDFSLNS 252
L+ P + L KL ++ + +L G + + + +
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 253 LSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQIS-GLIPPEIGM 311
+I +S L G+ +L NL L+ + +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 312 LSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISN 371
L+ L A NQ+ P + +NL L L+ N L L L NLT L L +N
Sbjct: 196 LTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 372 DISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGD 431
IS P + + L L++G N+I+ + P + GL L L+L+ N+ I +
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LEDISPISN 305
Query: 432 CTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491
L + L N + P +SSL+ LQ L ++N+ S +SL L ++N + N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 492 LFSGPIPSSLGLCSSLQLLDLSSN 515
S P L + + L L+
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 103 bits (258), Expect = 3e-24
Identities = 77/398 (19%), Positives = 147/398 (36%), Gaps = 37/398 (9%)
Query: 73 NLEELI---LNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGG 129
L E + L +T + ++ + L + +I + L+NL ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 130 NKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEI 189
N+ + P L + + + + + + Q++ P + TL +
Sbjct: 76 NQ-LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 190 GNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFS 249
L N++S + + + N T+L+ +D S
Sbjct: 133 NLNRL----ELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANLTTLERLDIS 183
Query: 250 LNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEI 309
N + + L+ LE + ++N +S P TNL +L L+ NQ+ +
Sbjct: 184 SN--KVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTL 237
Query: 310 GMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLI 369
L+ LT NQ+ P L+ + L L L N ++ P L L LT L L
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELN 293
Query: 370 SNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI 429
N + I N +L L + N I+ + P + L L L ++N++S +
Sbjct: 294 ENQL--EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347
Query: 430 GDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN 467
+ T + + HN + P L++L+ + L ++D
Sbjct: 348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 2e-15
Identities = 64/362 (17%), Positives = 126/362 (34%), Gaps = 54/362 (14%)
Query: 286 ANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLS 345
++ L ++ + L ++T A + ++ SI + +NL ++ S
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFS 74
Query: 346 HNSLTASVPAGLFQLQNLTKL--LLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403
+N LT + L+NLTKL +L++N+ I P + N +
Sbjct: 75 NNQLT-----DITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129
Query: 404 EIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSL---------- 453
+ L L + + +S L
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189
Query: 454 ----SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQL 509
+ L+ L+ L ++N+ S P + +L+++ L+ N +L ++L
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTD 245
Query: 510 LDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIP--------------------AQ 549
LDL++NQ++ P L + L L L N ++ P +
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTE-LKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 550 ISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAG 609
IS L L+ L L N + ++P++ L L L + NK + + ++
Sbjct: 303 ISNLKNLTYLTLYFNNISD-ISPVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGH 360
Query: 610 NE 611
N+
Sbjct: 361 NQ 362
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.2 bits (160), Expect = 6e-12
Identities = 24/85 (28%), Positives = 37/85 (43%), Gaps = 6/85 (7%)
Query: 23 FKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSN 82
K+L L + N++ P L L F++N + SSL L N+ L N
Sbjct: 306 LKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 83 QLTGKIPVELSNCKSLRKLLLFDNA 107
Q++ P L+N + +L L D A
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQA 384
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (280), Expect = 3e-27
Identities = 43/215 (20%), Positives = 83/215 (38%), Gaps = 8/215 (3%)
Query: 711 VIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR 769
+G G V+ A DM N +A+K + + DE ++ A+ S+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 770 HKNIVRFLGCC---WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGL 826
+I++ L ++M + +L +L+ + + QI GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 827 AYLHHDCVPPIVHRDIKANNILIGLE-FEPYIADFGLAKLVDDGDFARSSNTVAGSYGYI 885
Y+H C I+H DIK N+L+ + + +A L + + + Y
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 886 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920
+PE +D++S ++ E++TG +P
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 107 bits (266), Expect = 6e-26
Identities = 56/287 (19%), Positives = 107/287 (37%), Gaps = 25/287 (8%)
Query: 232 AIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNL 291
+P+++ ++D N ++ L L ++ +N +S P A L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 292 VQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTA 351
+L L NQ+ L L +L V ++ S+ + L ++ L + +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSG 140
Query: 352 SVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTL 411
++ L+ + + +I+ +IP G SL L + N+I + + GL L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 412 NFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSG 471
L LS N +S + + L+ + L++N L P L+ +QV+ + +N S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISA 256
Query: 472 QIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518
+ N F P +S + L SN +
Sbjct: 257 ----------------IGSNDFCP--PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (262), Expect = 3e-25
Identities = 51/290 (17%), Positives = 101/290 (34%), Gaps = 16/290 (5%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
+P +L + L L N+I+ + + L L N++ P A L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 340 QALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAG 399
+ L LS N L LQ L + S+ + + L + +G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSG 140
Query: 400 LIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGL 459
+ G+K L+++ ++ ++ ++P + L + L N + SL L+ L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 460 QVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519
L +S N S SL L ++ L+ N +Q++ L +N ++
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK-YIQVVYLHNNNISA 256
Query: 520 ------SVPMELGQIEALEIALNLSCNGLT--GPIPAQISALNKLSILDL 561
P + + ++L N + P+ + + + L
Sbjct: 257 IGSNDFCPPGYNTKKASYSG-VSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 104 bits (260), Expect = 5e-25
Identities = 51/282 (18%), Positives = 102/282 (36%), Gaps = 15/282 (5%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSL 387
+P L + LDL +N +T L+NL L+LI+N IS P L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG 447
RL + N++ L + L+ L + ++ SV + + +++ + G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSG 140
Query: 448 SLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSL 507
+ + L + ++D + IP L SL ++ L N + +SL ++L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 508 QLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE 567
L LS N ++ L L + +P ++ + ++ L +N +
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL--VKVPGGLADHKYIQVVYLHNNNIS 255
Query: 568 G-------NLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQL 602
+ + +++ N + FR +
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 102 bits (255), Expect = 2e-24
Identities = 48/287 (16%), Positives = 104/287 (36%), Gaps = 14/287 (4%)
Query: 208 SIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSEL 267
+P ++ L L N + + N +L + N +S P + L +L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 268 EEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEG 327
E +S N + L + + ++ + + + + + + G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSG 140
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSL 387
L + ++ ++T ++P GL +LT+L L N I+ + ++L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG 447
+L + N I+ + + L L L++N+L VP + D +Q++ L +N +
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
Query: 448 ------SLPNSLSSLSGLQVLDVSDNRFS-GQIPASLGRLVSLNKII 487
P + + + + N +I S R V + +
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.0 bits (214), Expect = 4e-19
Identities = 57/325 (17%), Positives = 116/325 (35%), Gaps = 41/325 (12%)
Query: 52 VLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGN 111
V+ S L +P L + L L +N++T + N K+L L+L +N ++
Sbjct: 14 VVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 112 IPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKL 171
P L LE + N+ + ++P ++ +L
Sbjct: 71 SPGAFAPLVKLERLYLSKNQ--LKELPEKMPKTL-----------------------QEL 105
Query: 172 QTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVG 231
+ T + + + + L SG +KKL + + ++
Sbjct: 106 RVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-T 163
Query: 232 AIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNL 291
IP+ G SL + N ++ S+ GL+ L + +S N++S +LAN +L
Sbjct: 164 TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
Query: 292 VQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEG------SIPSTLASCSNLQALDLS 345
+L L+ N++ +P + + V + N + P ++ + L
Sbjct: 222 RELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 280
Query: 346 HNSLTA-SVPAGLFQ-LQNLTKLLL 368
N + + F+ + + L
Sbjct: 281 SNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.9 bits (206), Expect = 5e-18
Identities = 53/289 (18%), Positives = 97/289 (33%), Gaps = 16/289 (5%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLE 75
+P +L L + + +T D + L L +N + P + L LE
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 76 ELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVG 135
L L+ NQL + LR + ++ L ++ +E G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG--TNPLKSSG 140
Query: 136 KIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSEL 195
++ + +ADT ++ ++P L L L + I+ A + + L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSG 255
L L NS+S + L EL L N LV +P + + ++++ N++S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISA 256
Query: 256 ------TIPLSIGGLSELEEFMISDNNVSGS--IPANLANATNLVQLQL 296
P + + N V P+ +QL
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.5 bits (171), Expect = 1e-13
Identities = 46/259 (17%), Positives = 85/259 (32%), Gaps = 12/259 (4%)
Query: 2 VTEITIQSVPLQLPIPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLV 61
+ +Q+ + + + K+L TL++ + ++ P V L L S N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 62 GTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSN 121
L L ++ + L+ + L +G +
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKK 151
Query: 122 LEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMI 181
L +R + IP L ++T L L +++ ASL L+ L L + I
Sbjct: 152 LSYIRIADTN--ITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 182 SGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSL------VGAIPE 235
S + N L L L N L +P + K ++ ++L N++ P
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 236 EIGNCTSLKMIDFSLNSLS 254
S + N +
Sbjct: 267 YNTKKASYSGVSLFSNPVQ 285
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 99.9 bits (248), Expect = 2e-24
Identities = 36/210 (17%), Positives = 68/210 (32%), Gaps = 25/210 (11%)
Query: 707 VDA--NVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKT 764
VDA ++G+G V+ + VK + G FS
Sbjct: 1 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYG-DLHFSVLAIR 59
Query: 765 LGSIRHKNIVRFLGCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQ 824
+ + + G + +Y + N L L+ + + E ++L +
Sbjct: 60 SARNEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILE 114
Query: 825 GLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGD----FARSSNTVAG 880
+A +H IVH D+ N+L+ E +I DF + V + R +
Sbjct: 115 EVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 881 SYGYIAPEYGYMMKITEKSDVYSYGVVVLE 910
+ Y + D+ S +L+
Sbjct: 171 YFS---RTYRT------EKDINSAIDRILQ 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 1e-23
Identities = 61/265 (23%), Positives = 101/265 (38%), Gaps = 7/265 (2%)
Query: 208 SIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSEL 267
++P I + +FL N + C +L ++ N L+ + GL+ L
Sbjct: 25 AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 268 EEFMISDNNVSGSI-PANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLE 326
E+ +SDN S+ PA L L LD + L P L+ L + N L+
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 327 GSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSS 386
T NL L L N +++ L +L +LLL N ++ P +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 387 LVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446
L+ L + N ++ L + L+ L +L L+ N LQ S + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVP 261
Query: 447 GSLPNSLSSLSGLQVLDVSDNRFSG 471
SLP L+G + ++ N G
Sbjct: 262 CSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (232), Expect = 1e-21
Identities = 54/271 (19%), Positives = 89/271 (32%), Gaps = 7/271 (2%)
Query: 80 NSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPA 139
L +PV + + +++ L N ++ A NL + N A
Sbjct: 19 PQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 140 ELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLF 199
G + Q+ PA+ L +L TL + + P + L L+
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 200 LYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPL 259
L +N+L L L LFL N + SL + N ++ P
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 260 SIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFF 319
+ L L + NN+S LA L L+L+ N + + L F
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFR 254
Query: 320 AWQNQLEGSIPSTLASCSNLQALDLSHNSLT 350
+++ S+P LA L+ N L
Sbjct: 255 GSSSEVPCSLPQRLA---GRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (231), Expect = 2e-21
Identities = 65/281 (23%), Positives = 96/281 (34%), Gaps = 10/281 (3%)
Query: 335 SCSNLQAL--DLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRV 392
C N + L +VP G+ ++ L N IS C +L L +
Sbjct: 7 VCYNEPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWL 63
Query: 393 GNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSV-PDEIGDCTELQMIDLSHNTLQGSLPN 451
+N +A + GL L LDLS N SV P L + L LQ P
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123
Query: 452 SLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLD 511
L+ LQ L + DN + L +L + L N S + SL L
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 512 LSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLN 571
L N++ P + L L N L+ ++ L L L L+ N +
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTL-YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242
Query: 572 PLAQLDNLVSLNISYNKFTGYLPD---NKLFRQLSPTDLAG 609
L S ++ LP + ++L+ DL G
Sbjct: 243 ARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (216), Expect = 2e-19
Identities = 57/289 (19%), Positives = 92/289 (31%), Gaps = 30/289 (10%)
Query: 280 SIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNL 339
++P + ++ L N+IS + LT+ + N L + + L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 340 QALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAG 399
+ LDLS N+ + P L L + +
Sbjct: 83 EQLDLSDNAQ-----------------------LRSVDPATFHGLGRLHTLHLDRCGLQE 119
Query: 400 LIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGL 459
L P GL L +L L N L D D L + L N + + L L
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179
Query: 460 QVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519
L + NR + P + L L + L N S +L +LQ L L+ N
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
Query: 520 SVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEG 568
L+ S + + +P + L + L+ N L+G
Sbjct: 240 DCRA-RPLWAWLQ-KFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.2 bits (170), Expect = 1e-13
Identities = 51/243 (20%), Positives = 84/243 (34%), Gaps = 5/243 (2%)
Query: 376 SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTEL 435
++P I ++ R+ + NRI+ + + L L L SN L+ L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 436 QMIDLSHNTLQGSL-PNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFS 494
+ +DLS N S+ P + L L L + P L +L + L N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 495 GPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALN 554
+ +L L L N+++ + +L+ L N + P L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLG 201
Query: 555 KLSILDLSHN-KLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGL 613
+L L L N LA L L L ++ N + L+ L + +E
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVP 261
Query: 614 CSS 616
CS
Sbjct: 262 CSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.6 bits (158), Expect = 4e-12
Identities = 46/265 (17%), Positives = 82/265 (30%), Gaps = 32/265 (12%)
Query: 16 IPTNLSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTL----------- 64
+P + + Q + + ++ C L +L SN L
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 65 --------------PSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAG 110
P++ L L L L+ L P +L+ L L DNAL
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 111 NIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSK 170
L NL + GN+ I ++ L L +V+ P + L +
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNR-ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 171 LQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLV 230
L TL ++ +S + L L L +N L++ + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261
Query: 231 GAIPEEIGNCTSLKMIDFSLNSLSG 255
++P+ + + + N L G
Sbjct: 262 CSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 88.7 bits (218), Expect = 2e-19
Identities = 64/274 (23%), Positives = 107/274 (39%), Gaps = 13/274 (4%)
Query: 238 GNCTSLKMIDFSLNSLSG--TIPLSIGGLSELEEFMISDN-NVSGSIPANLANATNLVQL 294
+ +D S +L IP S+ L L I N+ G IP +A T L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 295 QLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVP 354
+ +SG IP + + L N L G++P +++S NL + N ++ ++P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 355 AGLFQLQNLTK-LLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNF 413
L + + N ++G IPP N + + + + G
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL--SRNMLEGDASVLFGSDKNTQ 224
Query: 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473
+ ++G L +DL +N + G+LP L+ L L L+VS N G+I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 474 PASLGRLVSLNKIILSKN--LFSGPIPSSLGLCS 505
P G L + + N L P+P+ C+
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSPLPA----CT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 87.9 bits (216), Expect = 3e-19
Identities = 67/288 (23%), Positives = 110/288 (38%), Gaps = 29/288 (10%)
Query: 190 GNCSELVSLFLYENSLSG--SIPPEIGKLKKLEELFLWQN-SLVGAIPEEIGNCTSLKMI 246
+ +L L +L IP + L L L++ +LVG IP I T L +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 247 DFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIP 306
+ ++SG IP + + L S N +SG++P ++++ NLV + D N+ISG IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 307 PEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKL 366
G SKL N LT +P L
Sbjct: 167 DSYGSFSKLFTSMTISR-----------------------NRLTGKIPPTFANLNLAFVD 203
Query: 367 LLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVP 426
+S ++ + + ++G K LN LDL +NR+ G++P
Sbjct: 204 --LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP 261
Query: 427 DEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIP 474
+ L +++S N L G +P +L V ++N+ P
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 82.9 bits (203), Expect = 1e-17
Identities = 75/267 (28%), Positives = 113/267 (42%), Gaps = 6/267 (2%)
Query: 359 QLQNLTKLLLISNDISG--SIPPEIGNCSSLVRLRV-GNNRIAGLIPREIGGLKTLNFLD 415
Q + L L ++ IP + N L L + G N + G IP I L L++L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 416 LSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPA 475
++ +SG++PD + L +D S+N L G+LP S+SSL L + NR SG IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 476 SLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIAL 535
S G L + +L +DLS N L G + G +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDK--NTQK 225
Query: 536 NLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNP-LAQLDNLVSLNISYNKFTGYLP 594
++ L+ LDL +N++ G L L QL L SLN+S+N G +P
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 595 DNKLFRQLSPTDLAGNEGLCSSRKDSC 621
++ + A N+ LC S +C
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 80.6 bits (197), Expect = 8e-17
Identities = 65/271 (23%), Positives = 107/271 (39%), Gaps = 10/271 (3%)
Query: 284 NLANATNLVQLQLDTNQISGL--IPPEIGMLSKLTVF-FAWQNQLEGSIPSTLASCSNLQ 340
+ L L + IP + L L N L G IP +A + L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 341 ALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGL 400
L ++H +++ ++P L Q++ L L N +SG++PP I + +LV + NRI+G
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 401 IPREIGGLKTLNF-LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGL 459
IP G L + +S NRL+G +P + + + L
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN--LAFVDLSRNMLEGDASVLFGSDKN 222
Query: 460 QVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519
+G +LN + L N G +P L L L++S N L G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 520 SVPMELGQIEALEIALNLSCN-GLTG-PIPA 548
+P + G ++ ++ + N L G P+PA
Sbjct: 283 EIP-QGGNLQRFDV-SAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.3 bits (191), Expect = 4e-16
Identities = 62/262 (23%), Positives = 102/262 (38%), Gaps = 6/262 (2%)
Query: 2 VTEITIQSVPLQ--LPIPTNLSSFKHLQTLVISD-ANLTGSIPFDIGDCVGLIVLDFSSN 58
V + + + L PIP++L++ +L L I NL G IP I L L +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 59 NLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGR 118
N+ G +P L ++ L L + N L+G +P +S+ +L + N ++G IP G
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 119 LSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYT 178
S L + GKIP + + + + K
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLF--GSDKNTQKIHLA 229
Query: 179 TMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIG 238
++G L L L N + G++P + +LK L L + N+L G IP + G
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGG 288
Query: 239 NCTSLKMIDFSLNSLSGTIPLS 260
N + ++ N PL
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 74.8 bits (182), Expect = 7e-15
Identities = 65/247 (26%), Positives = 106/247 (42%), Gaps = 6/247 (2%)
Query: 323 NQLEG--SIPSTLASCSNLQALDLSHN-SLTASVPAGLFQLQNLTKLLLISNDISGSIPP 379
L IPS+LA+ L L + +L +P + +L L L + ++SG+IP
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 380 EIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMID 439
+ +LV L N ++G +P I L L + NR+SG++PD G ++L
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 440 LSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPS 499
+ L +D+S N G G + + I
Sbjct: 180 TISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN-TQKIHLAKNSLAFDLG 238
Query: 500 SLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSIL 559
+GL +L LDL +N++ G++P L Q++ L LN+S N L G IP Q L + +
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS-LNVSFNNLCGEIP-QGGNLQRFDVS 296
Query: 560 DLSHNKL 566
++NK
Sbjct: 297 AYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 39.3 bits (90), Expect = 0.002
Identities = 33/125 (26%), Positives = 59/125 (47%), Gaps = 4/125 (3%)
Query: 451 NSLSSLSGLQVLDVSDNRFSG--QIPASLGRLVSLNKIILSKNL-FSGPIPSSLGLCSSL 507
++ + + LD+S IP+SL L LN + + GPIP ++ + L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 508 QLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE 567
L ++ ++G++P L QI+ L + S N L+G +P IS+L L + N++
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTL-DFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 568 GNLNP 572
G +
Sbjct: 163 GAIPD 167
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.4 bits (163), Expect = 9e-13
Identities = 48/211 (22%), Positives = 78/211 (36%), Gaps = 7/211 (3%)
Query: 236 EIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQ 295
E+ S ++ +L+ +P + + +S+N + A L T L QL
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 296 LDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPA 355
LD +++ G L L NQL+ + D+S N LT+
Sbjct: 62 LDRAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 356 GLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLD 415
L L L +L L N++ P + L +L + NN + L + GL+ L+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 416 LSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446
L N L ++P L L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.7 bits (161), Expect = 2e-12
Identities = 43/207 (20%), Positives = 68/207 (32%), Gaps = 29/207 (14%)
Query: 188 EIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMID 247
E+ + + + + +L+ ++PP++ K L L +N L + T L ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 248 FSLNSLSGTIPLSIGGLSELEEFMISDNN-----------------------VSGSIPAN 284
L+ T G L L +S N ++
Sbjct: 62 --LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 285 LANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDL 344
L L +L L N++ L P + KL N L L NL L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 345 SHNSLTASVPAGLFQLQNLTKLLLISN 371
NSL ++P G F L L N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 42/211 (19%), Positives = 74/211 (35%), Gaps = 8/211 (3%)
Query: 43 DIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLL 102
++ + ++ NL LP L K + L L+ N L L L +L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 103 LFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLP 162
L G L L + + + + +P +T L ++ +++
Sbjct: 62 LDRAE--LTKLQVDGTLPVLGTLD--LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 163 ASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEEL 222
+L L +LQ L + + P + +L L L N+L+ + L+ L+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 223 FLWQNSLVGAIPEEIGNCTSLKMIDFSLNSL 253
L +NSL IP+ L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 47/235 (20%), Positives = 73/235 (31%), Gaps = 35/235 (14%)
Query: 335 SCSNLQAL---DLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLR 391
S + + + +LT ++P L + + T L L N + + + L +L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 392 VGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPN 451
+ + + G L L LDLS N+L ++D+S N L
Sbjct: 62 LDRAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLG 118
Query: 452 SLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLD 511
+L L LQ L + N P L L K+ L+ N + L +L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 512 LSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKL 566
L N L IP + L L N
Sbjct: 179 LQENSLY--------------------------TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 8e-10
Identities = 46/190 (24%), Positives = 72/190 (37%), Gaps = 6/190 (3%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSL 387
++P L + L LS N L A L LT+L L + + G L
Sbjct: 24 ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVL 79
Query: 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG 447
L + +N++ L L LD+S NRL+ + ELQ + L N L+
Sbjct: 80 GTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 448 SLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSL 507
P L+ L+ L +++N + L L +L+ ++L +N IP L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 508 QLLDLSSNQL 517
L N
Sbjct: 198 PFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 7e-09
Identities = 37/210 (17%), Positives = 61/210 (29%), Gaps = 10/210 (4%)
Query: 21 SSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILN 80
S + NLT ++P D+ +L S N L ++L L +L L+
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 81 SNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAE 140
+LT +L L D + L + + + + +P
Sbjct: 64 RAELTKLQ-----VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 141 LGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTT-MISGEIPAEIGNCSELVSLF 199
+LP L + ++ + L +L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 200 LYENSLSGSIPPEIGKLKKLEELFLWQNSL 229
L ENSL +IP L FL N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 8e-09
Identities = 36/210 (17%), Positives = 62/210 (29%), Gaps = 7/210 (3%)
Query: 380 EIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMID 439
E+ +S + + + +P ++ K L LS N L + T L ++
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 440 LSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPS 499
L + + +L L LD+S N+ + L S +P
Sbjct: 62 LDRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS--LPL 117
Query: 500 SLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSIL 559
++P L L+L+ N LT ++ L L L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 560 DLSHNKLEGNLNPLAQLDNLVSLNISYNKF 589
L N L L + N +
Sbjct: 178 LLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.4 bits (150), Expect = 6e-11
Identities = 41/276 (14%), Positives = 84/276 (30%), Gaps = 17/276 (6%)
Query: 294 LQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLT-AS 352
L L + + + + + F ++ ++ + S +Q +DLS++ + ++
Sbjct: 5 LDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62
Query: 353 VPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLN 412
+ L Q L L L +S I + S+LVRL + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 413 FLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDN----- 467
+L+ + + ++ L G N S V +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 468 ----RFSGQIPASLGRLVSLNKIILSK-NLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522
+L L + LS+ LG +L+ L + G++
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 523 MELGQIEALEIALNLSCNGLTGPIPAQISALNKLSI 558
+ + L+I +C+ T I I
Sbjct: 243 LLKEALPHLQI----NCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 3e-10
Identities = 51/263 (19%), Positives = 95/263 (36%), Gaps = 16/263 (6%)
Query: 340 QALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRI-A 398
Q LDL+ +L V L Q + + + + E + + + + N+ I
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEV 60
Query: 399 GLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLP-------- 450
+ + L L L RLS + + + + L ++LS +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 451 NSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLL 510
+ L L+ D ++ + + LN KNL + + + C +L L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 511 DLSSNQL-TGSVPMELGQIEALEIALNLS-CNGLTGPIPAQISALNKLSILDLSHNKLEG 568
DLS + + E Q+ L+ L+LS C + ++ + L L + +G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQH-LSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 569 NLNPLAQLDNLVSLNISYNKFTG 591
L L + L L I+ + FT
Sbjct: 240 TLQLLKE--ALPHLQINCSHFTT 260
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 47/271 (17%), Positives = 91/271 (33%), Gaps = 15/271 (5%)
Query: 27 QTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTG 86
QTL ++ NL + + G+I + + L ++ + L+++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 87 K-IPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELG--- 142
+ LS C L+ L L L+ I L + SNL + G L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 143 ---DCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLF 199
D N++ + A + + LS Y + + + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 200 LYENS--LSGSIPPEIGKLKKLEELFLWQ-NSLVGAIPEEIGNCTSLKMIDFSLNSLSGT 256
+S L E +L L+ L L + ++ E+G +LK + GT
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 257 IPLSIGGLSELEEFMISDNNVSGSIPANLAN 287
+ L L L+ I+ ++ + + N
Sbjct: 241 LQLLKEALPHLQ---INCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 19/89 (21%), Positives = 38/89 (42%), Gaps = 5/89 (5%)
Query: 508 QLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLE 567
Q LDL+ L V L + IA + + P+ S ++ +DLS++ +E
Sbjct: 3 QTLDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIE 59
Query: 568 GNLNP--LAQLDNLVSLNISYNKFTGYLP 594
+ L+Q L +L++ + + +
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIV 88
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 4e-05
Identities = 42/298 (14%), Positives = 85/298 (28%), Gaps = 39/298 (13%)
Query: 53 LDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNI 112
LD + NL P G+L + + +
Sbjct: 5 LDLTGKNL---HPDVTGRLLSQGVIAFRCPRS-----------------------FMDQP 38
Query: 113 PAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQ 172
AE ++ M + V + L CS + L L ++S + +L K S L
Sbjct: 39 LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
Query: 173 TLSIYTTMISGEIPAE--------IGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFL 224
L++ E + + + E + ++ + +L
Sbjct: 99 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158
Query: 225 WQNSLVGAIPEEIGNCTSLKMIDFSLNSL-SGTIPLSIGGLSELEEFMISD-NNVSGSIP 282
+N + + C +L +D S + + L+ L+ +S ++
Sbjct: 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218
Query: 283 ANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQ 340
L L LQ+ G + L L + + T+ + N +
Sbjct: 219 LELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFTTIARPTIGNKKNQE 273
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 35/227 (15%), Positives = 75/227 (33%), Gaps = 18/227 (7%)
Query: 191 NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSL 250
+ + + +++++ ++ L + L + + E + +L ++
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 251 NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIG 310
N ++ PL E + +I + T + T+ +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 311 MLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLIS 370
+L + L G S N Q DL+ L L LT L
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP----------LANLSKLTTLKADD 182
Query: 371 NDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLS 417
N IS P + + +L+ + + NN+I+ + P + L + L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 33/218 (15%), Positives = 76/218 (34%), Gaps = 22/218 (10%)
Query: 239 NCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDT 298
+ I ++++ T+ + L + V+ +I + NL+ L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 299 NQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLF 358
NQI+ L P + + +I + + + + + L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 359 QLQNLTKLLLISNDI--------------SGSIPPEIGNCSSLVRLRVGNNRIAGLIPRE 404
L + + + S + N S L L+ +N+I+ + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 405 IGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442
+ L L + L +N++S P + + + L ++ L++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 2e-08
Identities = 34/227 (14%), Positives = 77/227 (33%), Gaps = 19/227 (8%)
Query: 337 SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNR 396
+N + +++T +V L +T L ++ +I + ++L+ L + +N+
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 397 IAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSL 456
I L P + +L+ + + + + + + S + +
Sbjct: 75 ITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 457 SGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQ 516
QI N LS + L S L L N+
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 517 LTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSH 563
++ P L + L ++L N ++ P ++ + L I+ L++
Sbjct: 185 ISDISP--LASLPNLIE-VHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 35/227 (15%), Positives = 76/227 (33%), Gaps = 18/227 (7%)
Query: 359 QLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSS 418
L N K+ ++++ ++ + + L + + + L L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 419 NRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLG 478
N++ + +L+ T N L ++S + L +
Sbjct: 73 NQI----------TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 479 RLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLS 538
++ + L I + L L LS S L + L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA-D 181
Query: 539 CNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNIS 585
N ++ P +++L L + L +N++ ++PLA NL + ++
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 44/230 (19%), Positives = 76/230 (33%), Gaps = 20/230 (8%)
Query: 71 LHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGN 130
L N ++ + +T + ++ + L F + I + L+NL + N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 131 KDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIG 190
+ L + + G VS ++ T +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAG-------LQSIKTLDLTSTQITDVTPLA 126
Query: 191 NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSL 250
S L L+L N ++ P + + Q S + N + L +
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVS----DLTPLANLSKLTTLKADD 182
Query: 251 NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQ 300
N +S PL L L E + +N +S P LAN +NL + L TNQ
Sbjct: 183 NKISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 4e-07
Identities = 45/216 (20%), Positives = 74/216 (34%), Gaps = 22/216 (10%)
Query: 145 SNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENS 204
+N + + V+ ++ + L + TLS + T ++ I + + L+ L L +N
Sbjct: 19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 205 LSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTS--------------LKMIDFSL 250
++ P + EL V AI T L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 251 NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIG 310
I +S N S LAN + L L+ D N+IS + P +
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 311 MLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSH 346
L L NQ+ P LA+ SNL + L++
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 9e-07
Identities = 30/218 (13%), Positives = 67/218 (30%), Gaps = 22/218 (10%)
Query: 286 ANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLS 345
N +++ + ++ + L +T A+ + +I + +NL L+L
Sbjct: 16 PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELK 71
Query: 346 HNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREI 405
N +T P +L +I + + + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 406 GGLKTLNFLDLSSNRL--------------SGSVPDEIGDCTELQMIDLSHNTLQGSLPN 451
L + + L S + + ++L + N + P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 452 SLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILS 489
L+SL L + + +N+ S P L +L + L+
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 6e-06
Identities = 35/213 (16%), Positives = 71/213 (33%), Gaps = 21/213 (9%)
Query: 50 LIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALA 109
I + +N+ T+ + L + L +T I + +L L L DN +
Sbjct: 21 AIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT 76
Query: 110 GNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNM------TALGLADTQVSGSLPA 163
P + E+ K++ + ++ LA L
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136
Query: 164 SLGKLSKLQTLSIY-------TTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKL 216
L +++ + L+ + N S+L +L +N +S P + L
Sbjct: 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASL 194
Query: 217 KKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFS 249
L E+ L N + P + N ++L ++ +
Sbjct: 195 PNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 6e-06
Identities = 26/218 (11%), Positives = 61/218 (27%), Gaps = 22/218 (10%)
Query: 263 GLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQ 322
L+ + +NV+ ++ A+ + L ++ + + L+ L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 323 NQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLIS------------ 370
NQ+ P + L + +++ I+
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 371 --NDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDE 428
I + + L L L N++S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 429 IGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSD 466
+ L + L +N + P L++ S L ++ +++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 7e-06
Identities = 41/201 (20%), Positives = 63/201 (31%), Gaps = 21/201 (10%)
Query: 330 PSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVR 389
T A + L +T G+ L NL L L N I+ P + + +
Sbjct: 34 TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELE 91
Query: 390 LRVGNNRIAGLIPREIGGLKTLNFLDLSS--------------NRLSGSVPDEIGDCTEL 435
L + I + + +
Sbjct: 92 LSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLT 151
Query: 436 QMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSG 495
+ LS Q S L++LS L L DN+ S P L L +L ++ L N S
Sbjct: 152 NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD 209
Query: 496 PIPSSLGLCSSLQLLDLSSNQ 516
P L S+L ++ L +NQ
Sbjct: 210 VSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 8e-05
Identities = 18/65 (27%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 39 SIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSL 98
S + + L L N + S L L NL E+ L +NQ++ P L+N +L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 99 RKLLL 103
+ L
Sbjct: 220 FIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 12/69 (17%), Positives = 28/69 (40%), Gaps = 3/69 (4%)
Query: 533 IALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGY 592
I + + +T + + L+ ++ L + + + L+NL+ L + N+ T
Sbjct: 22 IKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQITDL 78
Query: 593 LPDNKLFRQ 601
P L +
Sbjct: 79 APLKNLTKI 87
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.6 bits (128), Expect = 4e-09
Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 6/107 (5%)
Query: 414 LDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473
L L+ L+ V + + +DLSHN L+ P +L++L L+VL SDN +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL--EN 57
Query: 474 PASLGRLVSLNKIILSKN-LFSGPIPSSLGLCSSLQLLDLSSNQLTG 519
+ L L +++L N L L C L LL+L N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.3 bits (117), Expect = 1e-07
Identities = 20/122 (16%), Positives = 45/122 (36%), Gaps = 7/122 (5%)
Query: 460 QVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519
+VL ++ + + L +L+ + + LS N P+ ++L+ L++
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNA 54
Query: 520 SVPMELGQIEALEIALNLSCNGLTG-PIPAQISALNKLSILDLSHNKLEGNLNPLAQLDN 578
++ L L N L + + +L +L+L N L +L
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 579 LV 580
++
Sbjct: 115 ML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 28/114 (24%), Positives = 43/114 (37%), Gaps = 7/114 (6%)
Query: 323 NQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIG 382
L ++ L + LDLSHN L A P L L+ L +L ++D + +
Sbjct: 8 KDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALENVDGVA 62
Query: 383 NCSSLVRLRVGNNRIAGL-IPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTEL 435
N L L + NNR+ + + L L+L N L E+
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 3e-06
Identities = 26/128 (20%), Positives = 49/128 (38%), Gaps = 9/128 (7%)
Query: 244 KMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISG 303
+++ + L T+ + L + +S N + P LA L L + +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVL--QASDNAL 55
Query: 304 LIPPEIGMLSKLTVFFAWQNQLEG-SIPSTLASCSNLQALDLSHNSLT--ASVPAGLFQ- 359
+ L +L N+L+ + L SC L L+L NSL + L +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 360 LQNLTKLL 367
L +++ +L
Sbjct: 116 LPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 25/106 (23%), Positives = 40/106 (37%), Gaps = 8/106 (7%)
Query: 488 LSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIP 547
L+ + + L + LDLS N+L P + AL L +
Sbjct: 5 LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALENV 58
Query: 548 AQISALNKLSILDLSHNKLEG--NLNPLAQLDNLVSLNISYNKFTG 591
++ L +L L L +N+L+ + PL LV LN+ N
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 7e-06
Identities = 29/128 (22%), Positives = 46/128 (35%), Gaps = 11/128 (8%)
Query: 52 VLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGN 111
VL + +L T+ L +L + L L+ N+L P L+ + L L DN A
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALE 56
Query: 112 IPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSG------SLPASL 165
+ L L+E+ N+ L C + L L + L L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 166 GKLSKLQT 173
+S + T
Sbjct: 117 PSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 3e-05
Identities = 23/119 (19%), Positives = 46/119 (38%), Gaps = 7/119 (5%)
Query: 198 LFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTI 257
L L L+ + + +L + L L N L +P + L+++ S N +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDN--ALEN 57
Query: 258 PLSIGGLSELEEFMISDNNV-SGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKL 315
+ L L+E ++ +N + + L + LV L L N + L+++
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.002
Identities = 22/76 (28%), Positives = 31/76 (40%), Gaps = 3/76 (3%)
Query: 535 LNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLP 594
L+L+ LT + + L ++ LDLSHN+L LA L L L S N +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD 59
Query: 595 DNKLFRQLSPTDLAGN 610
+L L N
Sbjct: 60 GVANLPRLQELLLCNN 75
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.1 bits (136), Expect = 4e-09
Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 9/102 (8%)
Query: 432 CTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491
+EL N + + L+ L+VS+N+ ++PA RL L S N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFN 314
Query: 492 LFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEI 533
+ +P +L+ L + N L P +E L +
Sbjct: 315 HLAE-VPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 3e-08
Identities = 21/93 (22%), Positives = 37/93 (39%), Gaps = 9/93 (9%)
Query: 321 WQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPE 380
+ N I S +L+ L++S+N L +PA L +L+ N ++ +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL 322
Query: 381 IGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNF 413
N L +L V N + P ++ L
Sbjct: 323 PQN---LKQLHVEYNPLREF-PDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 5e-08
Identities = 21/89 (23%), Positives = 34/89 (38%), Gaps = 10/89 (11%)
Query: 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSL 453
N + I +L L++S+N+L +P L+ + S N L +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELP 323
Query: 454 SSLSGLQVLDVSDNRFSG--QIPASLGRL 480
+ L+ L V N IP S+ L
Sbjct: 324 QN---LKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 1e-07
Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 9/94 (9%)
Query: 416 LSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPA 475
N S + L+ +++S+N L LP L+ L S N + ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPE 321
Query: 476 SLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQL 509
L L+ + N P L++
Sbjct: 322 LPQNLKQLH---VEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 23/92 (25%), Positives = 38/92 (41%), Gaps = 9/92 (9%)
Query: 488 LSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIP 547
N S I S L SL+ L++S+N+L +P ++E L S N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL----IASFNHLAE-VP 320
Query: 548 AQISALNKLSILDLSHNKLEGNLNPLAQLDNL 579
L L + +N L + +++L
Sbjct: 321 ELPQ---NLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 20/94 (21%), Positives = 36/94 (38%), Gaps = 9/94 (9%)
Query: 270 FMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSI 329
+ N S I + +L +L + N++ +P L +L F N L +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLIASF---NHLA-EV 319
Query: 330 PSTLASCSNLQALDLSHNSLTASVPAGLFQLQNL 363
P NL+ L + +N L P +++L
Sbjct: 320 PELP---QNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 6e-06
Identities = 19/77 (24%), Positives = 31/77 (40%), Gaps = 9/77 (11%)
Query: 23 FKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSN 82
L+ L +S+ L +P L L S N+L +P NL++L + N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPELPQ---NLKQLHVEYN 334
Query: 83 QLTGKIPVELSNCKSLR 99
L + P + + LR
Sbjct: 335 PLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 23/84 (27%), Positives = 32/84 (38%), Gaps = 9/84 (10%)
Query: 512 LSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLN 571
N + + +LE LN+S N L +PA +L L S N L +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEE-LNVSNNKLIE-LPALPP---RLERLIASFNHLA-EVP 320
Query: 572 PLAQLDNLVSLNISYNKFTGYLPD 595
L NL L++ YN PD
Sbjct: 321 EL--PQNLKQLHVEYNPLRE-FPD 341
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 223 FLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIP 282
+ N+ I SL+ ++ S N L +P L L S N+++ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVP 320
Query: 283 ANLANATNLVQLQLDTNQISGLIPPEIGMLSKL 315
NL QL ++ N + P + L
Sbjct: 321 ELP---QNLKQLHVEYNPLREF-PDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 7e-05
Identities = 21/93 (22%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 199 FLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIP 258
Y N+ S I LEEL + N L+ +P L+ + S N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320
Query: 259 LSIGGLSELEEFMISDNNVSGSIPANLANATNL 291
L +L + N + P + +L
Sbjct: 321 ELPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 19/76 (25%), Positives = 31/76 (40%), Gaps = 6/76 (7%)
Query: 503 LCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLS 562
L L+L++ L+ S+P +E +L SCN LT +P +L L + + +
Sbjct: 36 LDRQAHELELNNLGLS-SLPELPPHLE----SLVASCNSLT-ELPELPQSLKSLLVDNNN 89
Query: 563 HNKLEGNLNPLAQLDN 578
L L L
Sbjct: 90 LKALSDLPPLLEYLGV 105
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 5e-04
Identities = 15/65 (23%), Positives = 27/65 (41%), Gaps = 8/65 (12%)
Query: 336 CSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNN 395
L+L++ L+ S+P +L L+ N ++ +P + L L V NN
Sbjct: 37 DRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQS---LKSLLVDNN 88
Query: 396 RIAGL 400
+ L
Sbjct: 89 NLKAL 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 0.001
Identities = 19/70 (27%), Positives = 31/70 (44%), Gaps = 7/70 (10%)
Query: 46 DCV--GLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLL 103
DC+ L+ ++ L +LP +LE L+ + N LT ++P + KSL
Sbjct: 34 DCLDRQAHELELNNLGL-SSLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNN 88
Query: 104 FDNALAGNIP 113
AL+ P
Sbjct: 89 NLKALSDLPP 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 17/77 (22%), Positives = 32/77 (41%), Gaps = 8/77 (10%)
Query: 55 FSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPA 114
+ N + S +LEEL +++N+L ++P L +L+ N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AEVPE 321
Query: 115 ELGRLSNLEEMRAGGNK 131
NL+++ N
Sbjct: 322 LPQ---NLKQLHVEYNP 335
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 14/91 (15%)
Query: 428 EIGDCTE--LQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNK 485
+ DC + ++L++ L SLP L + L S N + ++P SL
Sbjct: 31 RLRDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQ---SLKS 82
Query: 486 IILSKNLFSGPIPSSLGLCSSLQLLDLSSNQ 516
+++ N + + L L+ L +S+NQ
Sbjct: 83 LLVDNN----NLKALSDLPPLLEYLGVSNNQ 109
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.003
Identities = 15/76 (19%), Positives = 30/76 (39%), Gaps = 9/76 (11%)
Query: 144 CSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYEN 203
++ L +++ ++ LPA +L+ L ++ E+P N L L + N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYN 334
Query: 204 SLSGSIPPEIGKLKKL 219
L P ++ L
Sbjct: 335 PLR-EFPDIPESVEDL 349
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (130), Expect = 3e-08
Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 5/91 (5%)
Query: 338 NLQALDLSHNSLT-ASVPAGLFQLQNLTKLLLISNDISG----SIPPEIGNCSSLVRLRV 392
++Q+LD+ L+ A L LQ + L ++ I + +L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 393 GNNRIAGLIPREIGGLKTLNFLDLSSNRLSG 423
+N + + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 8e-08
Identities = 12/90 (13%), Positives = 29/90 (32%), Gaps = 5/90 (5%)
Query: 411 LNFLDLSSNRLSGS-VPDEIGDCTELQMIDLSHNTLQG----SLPNSLSSLSGLQVLDVS 465
+ LD+ LS + + + + Q++ L L + ++L L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 466 DNRFSGQIPASLGRLVSLNKIILSKNLFSG 495
N + + + + K
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 1e-07
Identities = 17/95 (17%), Positives = 32/95 (33%), Gaps = 21/95 (22%)
Query: 434 ELQMIDLSHNTLQGS-LPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNL 492
++Q +D+ L + L L QV+ + D + +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--------------- 47
Query: 493 FSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQ 527
S+L + +L L+L SN+L + Q
Sbjct: 48 -----SSALRVNPALAELNLRSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 17/102 (16%), Positives = 32/102 (31%), Gaps = 23/102 (22%)
Query: 432 CTELQMIDLSHNTLQG----SLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKII 487
+ L+++ L+ + SL +L + L+ LD+S+N L V
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP--- 424
Query: 488 LSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIE 529
L+ L L + + L +E
Sbjct: 425 ----------------GCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 14/92 (15%), Positives = 34/92 (36%), Gaps = 9/92 (9%)
Query: 330 PSTLASCSNLQALDLSHNSLT----ASVPAGLFQLQNLTKLLLISNDISGSIPPEIG--- 382
S L+ L L+ ++ +S+ A L +L +L L +N + + ++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 383 --NCSSLVRLRVGNNRIAGLIPREIGGLKTLN 412
L +L + + + + + L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 9/79 (11%)
Query: 50 LIVLDFSSNNL----VGTLPSSLGKLHNLEELILNSNQLTGKIPVELS-----NCKSLRK 100
L VL + ++ +L ++L H+L EL L++N L ++L L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 101 LLLFDNALAGNIPAELGRL 119
L+L+D + + L L
Sbjct: 431 LVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 15/91 (16%), Positives = 27/91 (29%), Gaps = 5/91 (5%)
Query: 290 NLVQLQLDTNQISGLIPPEI-GMLSKLTVFFAWQNQLEG----SIPSTLASCSNLQALDL 344
++ L + ++S E+ +L + V L I S L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 345 SHNSLTASVPAGLFQLQNLTKLLLISNDISG 375
N L + Q + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 17/113 (15%), Positives = 36/113 (31%), Gaps = 25/113 (22%)
Query: 383 NCSSLVRLRVGNNRI----AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMI 438
S L L + + + + + +L LDLS+N L + ++ +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES------ 420
Query: 439 DLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNK--IILS 489
+ L+ L + D +S ++ L L ++S
Sbjct: 421 -VRQPG------------CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 8e-06
Identities = 15/75 (20%), Positives = 23/75 (30%), Gaps = 5/75 (6%)
Query: 50 LIVLDFSSNNLVGT-LPSSLGKLHNLEELILNSNQLTGK----IPVELSNCKSLRKLLLF 104
+ LD L L L + + L+ LT I L +L +L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 105 DNALAGNIPAELGRL 119
N L + +
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 18/88 (20%), Positives = 33/88 (37%), Gaps = 10/88 (11%)
Query: 26 LQTLVISDANLTGSIPFDIGDCV-GLIVLDFSSNNL----VGTLPSSLGKLHNLEELILN 80
+Q+L I L+ + ++ + V+ L + S+L L EL L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 81 SNQLTGKIPVEL-----SNCKSLRKLLL 103
SN+L + + ++KL L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 11/63 (17%), Positives = 21/63 (33%), Gaps = 6/63 (9%)
Query: 535 LNLSCNGLT-GPIPAQISALNKLSILDLSHNKLEGN-----LNPLAQLDNLVSLNISYNK 588
L++ C L+ + L + ++ L L + L L LN+ N+
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 589 FTG 591
Sbjct: 67 LGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 18/78 (23%), Positives = 32/78 (41%), Gaps = 9/78 (11%)
Query: 313 SKLTVFFAWQNQLEG----SIPSTLASCSNLQALDLSHNSLTASVPAGLFQ-----LQNL 363
S L V + + S+ +TL + +L+ LDLS+N L + L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 364 TKLLLISNDISGSIPPEI 381
+L+L S + +
Sbjct: 429 EQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 12/74 (16%), Positives = 26/74 (35%), Gaps = 5/74 (6%)
Query: 194 ELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQNSL----VGAIPEEIGNCTSLKMIDF 248
++ SL + LS + E+ L++ + + L L I + +L ++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 249 SLNSLSGTIPLSIG 262
N L +
Sbjct: 63 RSNELGDVGVHCVL 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 16/90 (17%), Positives = 28/90 (31%), Gaps = 9/90 (10%)
Query: 186 PAEIGNCSELVSLFLYENSLSG----SIPPEIGKLKKLEELFLWQNSLVGAIPEEIG--- 238
S L L+L + +S S+ + L EL L N L A ++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 239 --NCTSLKMIDFSLNSLSGTIPLSIGGLSE 266
L+ + S + + L +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 12/94 (12%), Positives = 29/94 (30%), Gaps = 10/94 (10%)
Query: 386 SLVRLRVGNNRIAGLIPREI-GGLKTLNFLDLSSNRLSGSVPDEIGD----CTELQMIDL 440
+ L + ++ E+ L+ + L L+ + +I L ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 441 SHNTLQGSLPNSLSSL-----SGLQVLDVSDNRF 469
N L + + +Q L + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 17/94 (18%), Positives = 29/94 (30%), Gaps = 11/94 (11%)
Query: 481 VSLNKIILSKNLFS-GPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQI----EALEIAL 535
+ + + + S L L Q++ L LT + ++ AL L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE-L 60
Query: 536 NLSCNGLTGPIPAQISAL-----NKLSILDLSHN 564
NL N L + K+ L L +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 12/77 (15%), Positives = 27/77 (35%), Gaps = 6/77 (7%)
Query: 73 NLEELILNSNQLTGKIPVEL-SNCKSLRKLLLFDNAL----AGNIPAELGRLSNLEEMRA 127
+++ L + +L+ EL + + + L D L +I + L L E+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 128 GGNKDIVGKIPAELGDC 144
N+ + +
Sbjct: 63 RSNE-LGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 11/74 (14%), Positives = 27/74 (36%), Gaps = 5/74 (6%)
Query: 242 SLKMIDFSLNSLSGT-IPLSIGGLSELEEFMISDNNVSG----SIPANLANATNLVQLQL 296
++ +D LS + L + + + D ++ I + L L +L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 297 DTNQISGLIPPEIG 310
+N++ + +
Sbjct: 63 RSNELGDVGVHCVL 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 19/102 (18%), Positives = 31/102 (30%), Gaps = 23/102 (22%)
Query: 217 KKLEELFLWQNSL----VGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMI 272
L L+L + ++ + SL+ +D S N L G+ +L E +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA------GILQLVESVR 422
Query: 273 SDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSK 314
L QL L S + + L K
Sbjct: 423 Q-------------PGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 20/98 (20%), Positives = 38/98 (38%), Gaps = 13/98 (13%)
Query: 17 PTNLSSFKHLQTLVISDANLTGSIPFDIGD----CVGLIVLDFSSNNL----VGTLPSSL 68
L+ L ++D +++ S + L LD S+N L + L S+
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 69 GKLH-NLEELILNSNQLTGKIPVELS----NCKSLRKL 101
+ LE+L+L + ++ L + SLR +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 16/74 (21%), Positives = 24/74 (32%), Gaps = 10/74 (13%)
Query: 504 CSSLQLLDLSSNQLTGSVPMELGQI----EALEIALNLSCNGLTGPIPAQISA-----LN 554
S L++L L+ ++ S L +L L+LS N L Q+
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE-LDLSNNCLGDAGILQLVESVRQPGC 426
Query: 555 KLSILDLSHNKLEG 568
L L L
Sbjct: 427 LLEQLVLYDIYWSE 440
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.003
Identities = 15/89 (16%), Positives = 28/89 (31%), Gaps = 10/89 (11%)
Query: 171 LQTLSIYTTMISGEIPAEI-GNCSELVSLFLYENSLSG----SIPPEIGKLKKLEELFLW 225
+Q+L I +S AE+ + + L + L+ I + L EL L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 226 QNSLVGAIPEEIG-----NCTSLKMIDFS 249
N L + ++ +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 1e-07
Identities = 41/210 (19%), Positives = 77/210 (36%), Gaps = 34/210 (16%)
Query: 185 IPAEIG------NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIG 238
+P I +E + L + S++ ++ +L ++++ + + I
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65
Query: 239 NCTSLKMIDFSLNSLSGTIPLS------------------IGGLSELEEFMISDNNVSGS 280
++ + + N L+ PL+ + +S + S
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 281 IPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQ 340
L + L L L N+I+ + L+KL NQ+ +P LA + LQ
Sbjct: 126 DINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181
Query: 341 ALDLSHNSLTASVPAGLFQLQNLTKLLLIS 370
L LS N ++ + A L L+NL L L S
Sbjct: 182 NLYLSKNHIS-DLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 3e-07
Identities = 34/216 (15%), Positives = 74/216 (34%), Gaps = 22/216 (10%)
Query: 376 SIPPEIG------NCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI 429
++P I + ++ + + + + L +++ + +++ + I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 430 GDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILS 489
+ + L+ N L L++L L L + +N+ + LS
Sbjct: 65 QYLPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLK----KLKSLS 118
Query: 490 KNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQ 549
+ L L+ L L +N++T + + + +
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP----- 173
Query: 550 ISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNIS 585
++ L KL L LS N + +L LA L NL L +
Sbjct: 174 LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 19/84 (22%), Positives = 37/84 (44%), Gaps = 8/84 (9%)
Query: 520 SVPMELGQIE-----ALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLA 574
+VP + QI A I NL +T + + LN + + +++ ++ ++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQ 65
Query: 575 QLDNLVSLNISYNKFTGYLPDNKL 598
L N+ L ++ NK T P L
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANL 89
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 4e-06
Identities = 40/214 (18%), Positives = 81/214 (37%), Gaps = 18/214 (8%)
Query: 232 AIPEEIGNCTSL----KMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLAN 287
+P I S + I +L S T ++ L+ +++ + +++++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS--VQGIQY 66
Query: 288 ATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHN 347
N+ +L L+ N+++ + L L F +N+++ S
Sbjct: 67 LPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL----SLE 120
Query: 348 SLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGG 407
S GL L L L L +N I+ + L +N+I+ ++P + G
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLE--DNQISDIVP--LAG 176
Query: 408 LKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLS 441
L L L LS N +S + L +++L
Sbjct: 177 LTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 9e-06
Identities = 38/222 (17%), Positives = 75/222 (33%), Gaps = 22/222 (9%)
Query: 250 LNSLSGTIPLSIG------GLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISG 303
L S + T+P I +E + + +V+ ++ ++ Q+ + + I
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS 60
Query: 304 LIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNL 363
+ I L +T F N+L P +NL+ L +
Sbjct: 61 VQG--IQYLPNVTKLFLNGNKLTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLKK 113
Query: 364 TKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG 423
K L + ++ I + N + + L TL+ D + +
Sbjct: 114 LKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV- 172
Query: 424 SVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVS 465
+ T+LQ + LS N + +L+ L L VL++
Sbjct: 173 ----PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 46/202 (22%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 337 SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNR 396
+ +L S+T +V +L ++ +++ ++DI I ++ +L + N+
Sbjct: 24 AETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79
Query: 397 IAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSL 456
+ + + LK L +L L N+ V D ++ LS S N L L
Sbjct: 80 LTD--IKPLANLKNLGWLFLDENK----VKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 457 SGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQ 516
L+ L + +N+ + S RL L+ + L N S +P L + LQ L LS N
Sbjct: 134 PQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189
Query: 517 LTGSVPMELGQIEALEIALNLS 538
++ + L ++ L++ L L
Sbjct: 190 IS-DLR-ALAGLKNLDV-LELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 30/203 (14%), Positives = 66/203 (32%), Gaps = 16/203 (7%)
Query: 287 NATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSH 346
++ L ++ + L+ + A + ++ + N+ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 347 NSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIG 406
N LT + L NL L + D + ++ + I +
Sbjct: 78 NKLT-----DIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 407 GLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSD 466
+ + ++ +V + L + D + + L+ L+ LQ L +S
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-----PLAGLTKLQNLYLSK 187
Query: 467 NRFSGQIPASLGRLVSLNKIILS 489
N S +L L +L+ + L
Sbjct: 188 NHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 38/185 (20%), Positives = 67/185 (36%), Gaps = 14/185 (7%)
Query: 330 PSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVR 389
T +++ + +++ + + G+ L N+TKL L N ++ L
Sbjct: 39 AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNKLTD--------IKPLAN 88
Query: 390 LRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSL 449
L+ + S + + D G Q+ L + +
Sbjct: 89 LKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITD 148
Query: 450 PNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQL 509
LS L+ L L + DN+ S +P L L L + LSKN S +L +L +
Sbjct: 149 ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDV 204
Query: 510 LDLSS 514
L+L S
Sbjct: 205 LELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 45/219 (20%), Positives = 88/219 (40%), Gaps = 21/219 (9%)
Query: 11 PLQLPIPTN----LSSFKHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPS 66
+ +P P +F + ++T ++ + + + +++++
Sbjct: 7 TITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQ 62
Query: 67 SLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMR 126
+ L N+ +L LN N+LT P L+N K+L L L +N + + + +
Sbjct: 63 GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120
Query: 127 AGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIP 186
G DI G + + + + D V L KL TLS+ IS +P
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLT-------KLDTLSLEDNQISDIVP 173
Query: 187 AEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLW 225
+ ++L +L+L +N +S + LK L+ L L+
Sbjct: 174 --LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.6 bits (119), Expect = 5e-07
Identities = 47/310 (15%), Positives = 97/310 (31%), Gaps = 33/310 (10%)
Query: 208 SIPPEIGKLKKLEELFLWQNSL----VGAIPEEIGNCTSLKMIDFSLNS---LSGTIPLS 260
S+ + + ++E+ L N++ + E I + L++ +FS + IP +
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 261 IGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFA 320
+ L + + V S A A + L + + L
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 321 WQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPE 380
+ E ++ + L+++ N L + +LL + I PE
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 381 IGNCSSLVRLR-------------VGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPD 427
L L + + + + L L L+ LS
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 428 EIGDC------TELQMIDLSHNTLQGSLPNSLSS-----LSGLQVLDVSDNRFS--GQIP 474
+ D LQ + L +N ++ +L + + L L+++ NRFS +
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVV 321
Query: 475 ASLGRLVSLN 484
+ + S
Sbjct: 322 DEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.8 bits (109), Expect = 8e-06
Identities = 39/294 (13%), Positives = 91/294 (30%), Gaps = 31/294 (10%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTA----SVPAGLFQLQNLTKLLLISNDI---------- 373
S+ + L +++ + LS N++ + + ++L
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 374 SGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCT 433
+ + C L +R+ +N + + + + + + G
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 434 ELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLF 493
+ +L+ N + P S + G L+ + + S L ++ +
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 494 SGPIPSSLGLCSSLQL-----LDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPA 548
GL +L D + L S + L L+ L+ A
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 549 QIS------ALNKLSILDLSHNKLEGN-LNPLAQ-----LDNLVSLNISYNKFT 590
+ L L L +N++E + + L + +L+ L ++ N+F+
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 19/83 (22%), Positives = 37/83 (44%), Gaps = 8/83 (9%)
Query: 409 KTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG----SLPNSLSSLSGLQVLDV 464
K+L +++ SV + + ++ I LS NT+ L +++S L++ +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 465 SDN---RFSGQIPASLGRLVSLN 484
SD R +IP +L L+
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQAL 89
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 8e-05
Identities = 41/355 (11%), Positives = 102/355 (28%), Gaps = 45/355 (12%)
Query: 242 SLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSG----SIPANLANATNLVQLQLD 297
SLK+ + ++ + ++E ++S N + + N+A+ +L +
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 298 TNQ---ISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVP 354
+ IP + +L + + + + S + + LS ++ +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 355 AGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFL 414
L + ++ + N L + G NR+ +E +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR- 186
Query: 415 DLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIP 474
+ + + + L L + + S +
Sbjct: 187 ----------LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236
Query: 475 ASLGRLVSLNKIILSKNLFSGPIPSSLGLC------SSLQLLDLSSNQLTGSVPMELGQI 528
+L +L ++ L+ L S +++ LQ L L N++ L
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT- 295
Query: 529 EALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLN 583
+ L L+L+ N+ + + ++ + S
Sbjct: 296 -------------------VIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 4e-04
Identities = 9/58 (15%), Positives = 26/58 (44%), Gaps = 4/58 (6%)
Query: 53 LDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGK----IPVELSNCKSLRKLLLFDN 106
LD + ++ + L + +++E++L+ N + + + +++ K L D
Sbjct: 12 LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 7e-04
Identities = 46/308 (14%), Positives = 90/308 (29%), Gaps = 35/308 (11%)
Query: 160 SLPASLGKLSKLQTLSIYTTMISGE----IPAEIGNCSELVSLFLYENS---LSGSIPPE 212
S+ A L + ++ + + I E + I + +L + + IP
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 213 IGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMI 272
+ L + +++ + + S ++ + L GL I
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 273 SDNNVSGSIPANLANATNLVQLQLDTNQIS----GLIPPEIGMLSKLTVFFAWQNQLEGS 328
+ ++ NA L + N++ L QN +
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 329 IPSTLASCSNLQALDLSHNSLT---------ASVPAGLFQLQNLTKLLLISNDISGSIPP 379
L +L L +++ L NL +L L +S
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 380 EIGNC------SSLVRLRVGNNRIAGLIPREI-----GGLKTLNFLDLSSNRLSGSVPDE 428
+ + L LR+ N I R + + L FL+L+ NR S +E
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS----EE 317
Query: 429 IGDCTELQ 436
E++
Sbjct: 318 DDVVDEIR 325
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 9e-04
Identities = 33/307 (10%), Positives = 81/307 (26%), Gaps = 32/307 (10%)
Query: 184 EIPAEIGNCSELVSLFLYENSLSG----SIPPEIGKLKKLEELFLWQNS---LVGAIPEE 236
+ A + + + L N++ + I K LE + IPE
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 237 IGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQL 296
+ + L+++ + E +S + + + ++
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 297 DTNQISGLIPPEIGMLSKLTVFFAWQNQLE----GSIPSTLASCSNLQALDLSHNSLTAS 352
+ + L +N+LE T S L + + N +
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 353 VPAGLFQLQNLTKLLLISNDIS---------GSIPPEIGNCSSLVRLRVGNNRIAGLIPR 403
L L D+ ++ + + +L L + + ++
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 404 EIG------GLKTLNFLDLSSNRLSGSVPDEIGD-----CTELQMIDLSHNTLQGSLPNS 452
+ L L L N + + +L ++L+ N +
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDV 320
Query: 453 LSSLSGL 459
+ + +
Sbjct: 321 VDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 11/68 (16%), Positives = 26/68 (38%), Gaps = 8/68 (11%)
Query: 338 NLQALDLSHNSLTA----SVPAGLFQLQNLTKLLLISNDISG----SIPPEIGNCSSLVR 389
+++ L +++T SV A L + ++ +++L N I + I + L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 390 LRVGNNRI 397
+
Sbjct: 64 AEFSDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 18/102 (17%), Positives = 31/102 (30%), Gaps = 24/102 (23%)
Query: 35 NLTGSIPFDIGDCVG------LIVLDFSSNNLVGTLPSSL-----GKLHNLEELILNSNQ 83
L+ + D L L N + +L K+ +L L LN N+
Sbjct: 254 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 313
Query: 84 LTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEM 125
+ E +R++ G L L++M
Sbjct: 314 FSE----EDDVVDEIREVFS---------TRGRGELDELDDM 342
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 37/322 (11%), Positives = 89/322 (27%), Gaps = 32/322 (9%)
Query: 24 KHLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNL----VGTLPSSLGKLHNLEELIL 79
K L+ I+ + S+ + + + + S N + L ++ +LE
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 80 NSNQLTGKIPVELSNCKSLRKLLLFDNALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPA 139
+ + L + LL L ++ +E
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 140 ELGDCSNM--TALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVS 197
L + +A ++ L+++ + E +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 198 LFLYENSLSGSIPPEIGKLKKLEEL-------------FLWQNSLVGAIPEEIGNCTSLK 244
L + I PE + LE L + + A+ + + +L+
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 245 MIDFSLNSLSGTIPLSIG------GLSELEEFMISDNNVSGSIPANLANA-----TNLVQ 293
+ + LS ++ L+ + N + L +L+
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 294 LQLDTNQISGLIPPEIGMLSKL 315
L+L+ N+ S + + ++
Sbjct: 307 LELNGNRFSEE-DDVVDEIREV 327
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (114), Expect = 6e-07
Identities = 27/150 (18%), Positives = 50/150 (33%), Gaps = 13/150 (8%)
Query: 323 NQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIG 382
Q+E + ++ + L L + L L S+ + ++
Sbjct: 7 EQVE-QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAA-TLRIIEE 62
Query: 383 NCSSLVRLRVGNNRIAGL--IPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDL 440
N L+ L + NNR+ L + + L L+LS N L + +L+ + L
Sbjct: 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122
Query: 441 SHNTLQGSLPNS-------LSSLSGLQVLD 463
N+L + + L LD
Sbjct: 123 DGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 5e-04
Identities = 29/132 (21%), Positives = 47/132 (35%), Gaps = 11/132 (8%)
Query: 439 DLSHNTLQGSLPNSLSSLSGLQ--VLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGP 496
+L ++ L +S LD+ R + + V LN ++ +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDPDLV-AQNIDVVLN----RRSSMAAT 56
Query: 497 IPSSLGLCSSLQLLDLSSNQLTG--SVPMELGQIEALEIALNLSCNGLTGPIPAQISALN 554
+ L L+LS+N+L + + + L+I LNLS N L
Sbjct: 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI-LNLSGNELKSERELDKIKGL 115
Query: 555 KLSILDLSHNKL 566
KL L L N L
Sbjct: 116 KLEELWLDGNSL 127
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 21/124 (16%), Positives = 46/124 (37%), Gaps = 7/124 (5%)
Query: 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469
+ LDL R ++ +++ + + +L ++ L L++S+NR
Sbjct: 23 SQQALDLKGLRS----DPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRL 77
Query: 470 SGQ--IPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQ 527
+ + + + +L + LS N L+ L L N L+ + +
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137
Query: 528 IEAL 531
I A+
Sbjct: 138 ISAI 141
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.1 bits (110), Expect = 2e-06
Identities = 30/209 (14%), Positives = 61/209 (29%), Gaps = 57/209 (27%)
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEI-GNCSSLVRLR-- 391
C +D + L +P + + T+LLL N++ + G LV+L
Sbjct: 7 HCEG-TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELK 62
Query: 392 ----------------------VGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI 429
+G N+I + + GL L L+L N++S +P
Sbjct: 63 RNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSF 122
Query: 430 GDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILS 489
L ++ + + L+ ++ P+ +
Sbjct: 123 EHLNSLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV------------ 169
Query: 490 KNLFSGPIPSSLGLCSSLQLLDLSSNQLT 518
+Q+ DL ++
Sbjct: 170 ---------------RDVQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.2 bits (105), Expect = 1e-05
Identities = 37/172 (21%), Positives = 62/172 (36%), Gaps = 7/172 (4%)
Query: 184 EIPAEIGNCSELVSLFLYENSLSGSIPPEI-GKLKKLEELFLWQNSLVGAIPEEIGNCTS 242
EIP +I L L +N L + G+L L +L L +N L G P +
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 243 LKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQIS 302
++ + N + GL +L+ + DN +S +P + + +L L L +N +
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 303 GLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVP 354
L PS + ++Q DL H+ S
Sbjct: 140 CNCHL-AWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSSE 187
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.8 bits (104), Expect = 1e-05
Identities = 40/167 (23%), Positives = 65/167 (38%), Gaps = 8/167 (4%)
Query: 401 IPREIGGLKTLNFLDLSSNRLSGSVPDEI-GDCTELQMIDLSHNTLQGSLPNSLSSLSGL 459
IPR+I L L+ N L D + G L ++L N L G PN+ S +
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 460 QVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTG 519
Q L + +N+ L L + L N S +P S +SL L+L+SN
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 520 SVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKL 566
+ + +L+ P++ + + I DL H++
Sbjct: 141 NCHLA--WFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 29/192 (15%), Positives = 62/192 (32%), Gaps = 24/192 (12%)
Query: 191 NCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSL 250
+E + L + +++ ++ L ++ L + + + + +L I+FS
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 251 NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIG 310
N L+ PL + + + T+ +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 311 MLSKLTVFFAWQ----------------NQLEGSIPSTLASCSNLQALDLSHNSLTASVP 354
L + + NQ+ P LA+ + L+ LD+S N ++
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--I 187
Query: 355 AGLFQLQNLTKL 366
+ L +L NL L
Sbjct: 188 SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 7e-06
Identities = 39/200 (19%), Positives = 72/200 (36%), Gaps = 16/200 (8%)
Query: 383 NCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442
+ ++ +G + + + L + L + D + L I+ S+
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 443 NTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLG 502
N L P + +++ + + N L+ L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLA------NLTNLTGLTLFNNQITDIDPLK 125
Query: 503 LCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLS 562
++L L+LSSN ++ + LN S N +T P ++ L L LD+S
Sbjct: 126 NLTNLNRLELSSNTIS---DISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 563 HNKLEGNLNPLAQLDNLVSL 582
NK+ ++ LA+L NL SL
Sbjct: 181 SNKVSD-ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 11/60 (18%), Positives = 28/60 (46%), Gaps = 3/60 (5%)
Query: 533 IALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGY 592
+ L +T + + L++++ L ++ +++ + L+NL +N S N+ T
Sbjct: 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTDI 77
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 31/198 (15%), Positives = 66/198 (33%), Gaps = 16/198 (8%)
Query: 239 NCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDT 298
+++ T+ + L ++ + SI + NL Q+
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 71
Query: 299 NQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLF 358
NQ++ + P + + Q + + + + L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 359 QLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSS 418
+L+ + + S + +SL +L +N++ L P + L TL LD+SS
Sbjct: 132 RLELSSNTI--------SDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 419 NRLSGSVPDEIGDCTELQ 436
N++S + T L+
Sbjct: 182 NKVSD--ISVLAKLTNLE 197
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 0.001
Identities = 36/200 (18%), Positives = 77/200 (38%), Gaps = 18/200 (9%)
Query: 216 LKKLEELFLWQNSLVGAIP-EEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISD 274
L + + L + ++ + ++ T+L+ + S+ G + L+ L + S+
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 71
Query: 275 NNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLA 334
N ++ L N T LV + ++ NQI+ + P F Q L
Sbjct: 72 NQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT----DIDPLK 125
Query: 335 SCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGN 394
+ +NL L+LS N+++ + + + N ++L RL + +
Sbjct: 126 NLTNLNRLELSSNTISDISALSGLTSLQQL----NFSSNQVTDLKPLANLTTLERLDISS 181
Query: 395 NRIAGLIPREIGGLKTLNFL 414
N+++ + + L L L
Sbjct: 182 NKVSDI--SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 31/196 (15%), Positives = 66/196 (33%), Gaps = 15/196 (7%)
Query: 337 SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNR 396
+ L ++T +V L +T L I SI + ++L ++ NN+
Sbjct: 18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQ 73
Query: 397 IAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSL 456
+ + P + ++ + + + + + +L+ L
Sbjct: 74 LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 133
Query: 457 SGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQ 516
+ SG S + P L ++L+ LD+SSN+
Sbjct: 134 ELSSNTISDISALSGLTSLQQLNFSSNQ--------VTDLKP--LANLTTLERLDISSNK 183
Query: 517 LTG-SVPMELGQIEAL 531
++ SV +L +E+L
Sbjct: 184 VSDISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 36/200 (18%), Positives = 78/200 (39%), Gaps = 16/200 (8%)
Query: 263 GLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQ 322
L+E + ++ NV+ ++ + + LQ D I + + L+ LT
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 323 NQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIG 382
NQL P + ++ + + + + + +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL------TLFNNQITDIDPLK 125
Query: 383 NCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442
N ++L RL + +N I+ + +L L+ SSN+++ P + + T L+ +D+S
Sbjct: 126 NLTNLNRLELSSNTISDISALSGL--TSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 443 NTLQGSLPNSLSSLSGLQVL 462
N + + L+ L+ L+ L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (105), Expect = 7e-06
Identities = 23/149 (15%), Positives = 48/149 (32%), Gaps = 4/149 (2%)
Query: 379 PEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEI-GDCTELQM 437
P+ LR + + G + L L + + + + EL+
Sbjct: 2 PDACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 438 IDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPI 497
+ + + L+ P++ L L++S N + + +SL +++LS N
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 498 -PSSLGLCSSLQLLDLSSNQLTGSVPMEL 525
L L + +L L
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 7e-04
Identities = 25/148 (16%), Positives = 45/148 (30%), Gaps = 3/148 (2%)
Query: 411 LNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLP-NSLSSLSGLQVLDVSDNRF 469
+ L + + + L + + + L L L L+ L + +
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 470 SGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIE 529
P + L+++ LS N + SLQ L LS N L S + Q
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127
Query: 530 ALEIALNLSCNGLTGPIPAQISALNKLS 557
E + L ++ + S
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 2e-05
Identities = 24/137 (17%), Positives = 42/137 (30%), Gaps = 7/137 (5%)
Query: 331 STLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRL 390
+ + + LDL + + L + N+I L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 391 RVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG-SVPDEIGDCTELQMIDLSH---NTLQ 446
V NNRI + L L L L++N L D + L + + +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 447 GSLPNSLSSLSGLQVLD 463
+ + ++VLD
Sbjct: 129 HYRLYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 6e-05
Identities = 21/150 (14%), Positives = 47/150 (31%), Gaps = 8/150 (5%)
Query: 416 LSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPA 475
L++ + + + + + +DL + + N ++L +D SDN
Sbjct: 3 LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF 59
Query: 476 SLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIAL 535
L L ++++ N L L L++N L ++ L
Sbjct: 60 P--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117
Query: 536 NLS---CNGLTGPIPAQISALNKLSILDLS 562
+ I + ++ +LD
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.004
Identities = 12/62 (19%), Positives = 25/62 (40%), Gaps = 2/62 (3%)
Query: 535 LNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLP 594
L+L + I + L++ +D S N++ L+ L L +L ++ N+
Sbjct: 23 LDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGE 80
Query: 595 DN 596
Sbjct: 81 GL 82
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 4e-05
Identities = 39/224 (17%), Positives = 66/224 (29%), Gaps = 33/224 (14%)
Query: 184 EIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAI---------- 233
EIP+++ + L L LE++ + QN ++ I
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 234 ----------------PEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNV 277
PE N +L+ + S + + + I DN
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 278 SGSIPANLANATNLV--QLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLAS 335
+I N + L L+ N I + + + N LE
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 336 CSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPP 379
S LD+S + S+P+ +NL KL S +P
Sbjct: 200 ASGPVILDISRTRIH-SLPSYGL--ENLKKLRARSTYNLKKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 4e-05
Identities = 31/223 (13%), Positives = 64/223 (28%), Gaps = 7/223 (3%)
Query: 273 SDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPST 332
++ V+ IP++L N ++L+ ++ + L QN + I +
Sbjct: 16 QESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 333 LASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRV 392
+ S + L+ ++ P++ SL ++ +
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132
Query: 393 GN----NRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGS 448
N +G L L+ N + ++ +N L+
Sbjct: 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192
Query: 449 LPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491
+ SG +LD+S R L L L
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 4e-05
Identities = 33/224 (14%), Positives = 64/224 (28%), Gaps = 9/224 (4%)
Query: 232 AIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNL 291
IP ++ + + F L L + G +LE+ IS N+V I A++ +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 292 VQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLE----GSIPSTLASCSNLQALDLSHN 347
+ + L + + + + + + L + + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 348 SLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGG 407
T + + L L N I NN + L G
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 408 LKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPN 451
LD+S R+ + + +L+ + LP
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 41/239 (17%), Positives = 69/239 (28%), Gaps = 8/239 (3%)
Query: 186 PAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKM 245
I +CS E+ ++ IP ++ + EL L L+
Sbjct: 2 HHRICHCSNR-VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 246 IDFSLNSLSGTI--PLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISG 303
I+ S N + I + E + NN+ P N NL L + I
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 304 LIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQ--ALDLSHNSLTASVPAGLFQLQ 361
L + + N +I + + L L+ N + Q
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 362 NLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNR 420
L +N++ S V L + RI L + LK L + +
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 28/220 (12%), Positives = 54/220 (24%), Gaps = 9/220 (4%)
Query: 328 SIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSL 387
IPS L N L L +L K+ + ND+ I ++ +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 388 VRLRV----GNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHN 443
+ N + + + + V L I + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 444 TLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGL 503
+ + +L ++ N + + N
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 504 CSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLT 543
S +LD+S ++ L ++ L S L
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRA---RSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 33/240 (13%), Positives = 60/240 (25%), Gaps = 10/240 (4%)
Query: 46 DCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLFD 105
C + + + +PS L N EL +L S L K+ +
Sbjct: 7 HCSNRVF-LCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 62
Query: 106 NALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAELGDCSNMTALGLADTQVSGSLPASL 165
N + I A++ + + I E L LP
Sbjct: 63 NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 122
Query: 166 GKLSKLQTLSIYTTMISGEIPAEIGNCSELV---SLFLYENSLSGSIPPEIGKLKKLEEL 222
S + L I+ L+L +N + + E
Sbjct: 123 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182
Query: 223 FLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIP 282
N+L + + ++D S + + L +L +P
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR---STYNLKKLP 239
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1058 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.79 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.68 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.68 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.57 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.42 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.37 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.24 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.23 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.21 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.54 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.47 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.06 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.65 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.28 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.5 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.46 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.33 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.02 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=424.94 Aligned_cols=263 Identities=27% Similarity=0.387 Sum_probs=202.5
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||+||+|... ..||||++.... ......+.|.+|++++++++|||||++++++.+
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~---------~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 75 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA---------PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA- 75 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSS---------CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEccc---------CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-
Confidence 46788999999999999999765 369999985432 234457889999999999999999999998754
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.++++.. ...+++..+..|+.|||+||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla 151 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLA 151 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred cEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccce
Confidence 5689999999999999999764 46799999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccc
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQV 940 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1058)
+...............||+.|||||++.+ ..++.++|||||||++|||+||+.||....+ .......+....
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-~~~~~~~~~~~~---- 226 (276)
T d1uwha_ 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIFMVGRGY---- 226 (276)
T ss_dssp CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHHTS----
T ss_pred eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCC----
Confidence 87655443344556789999999999864 3578899999999999999999999976432 122222222221
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 941 LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 941 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
..+.....+....++ +.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 227 ~~p~~~~~~~~~~~~---l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 227 LSPDLSKVRSNCPKA---MKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CCCCGGGSCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcchhccccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 111111111111122 33478889999999999999999999887653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=425.73 Aligned_cols=254 Identities=26% Similarity=0.342 Sum_probs=204.7
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++.... .....+.+.+|++++++++|||||++++++.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----------~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----------AVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----------cchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 57999999999999999999 45679999999985331 12234678999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||++||+|.++++. ...+++..++.++.||++||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred CceeEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence 9999999999999999999975 46799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
|+..............+||+.|||||++.+..+ +.++||||+||++|||++|+.||............+..... .
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~----~ 225 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----Y 225 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT----T
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----C
Confidence 997765443344556789999999999988776 57899999999999999999999765433333322211111 0
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.+ .....+. .+.+++.+||+.||++|||++|++++
T Consensus 226 ~~-~~~~~s~------~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 LN-PWKKIDS------APLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ST-TGGGSCH------HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC-ccccCCH------HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 0111111 23457888999999999999999764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=420.35 Aligned_cols=257 Identities=24% Similarity=0.401 Sum_probs=199.6
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|+..+.||+|+||+||+|.+.+++.||||++... ....++|.+|++++++++|||||+++|++.++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~------------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG------------AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC------------cCcHHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 367888999999999999998888999999998532 22357899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++... ...+++..+..|+.|||+||+|+|+. +|+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred CceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchh
Confidence 9999999999999999998764 46789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
+....... .......||+.|+|||++.+..++.++|||||||++|||+|+..|+.... ........+.... ....|
T Consensus 149 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~~--~~~~p 224 (263)
T d1sm2a_ 149 RFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGF--RLYKP 224 (263)
T ss_dssp -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHHHHHHTC--CCCCC
T ss_pred eeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHHHHHhcC--CCCCc
Confidence 87654332 23345679999999999999999999999999999999999655543321 2223333333221 11111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
...+ . ++.+++..||+.||++|||++||+++|+++..
T Consensus 225 ---~~~~---~---~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 ---RLAS---T---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ---TTSC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cccC---H---HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1122 2 23457888999999999999999999998854
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=420.01 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=206.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++.+... .+....+.+.+|++++++++|||||++++++.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 77 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--------EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc--------cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence 57999999999999999999 456799999999864422 223346789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+|||||++|+|.+++... ..+++..+..++.||++||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 78 ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred CCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccce
Confidence 99999999999999999999864 5799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+..... ......||+.|||||++.+..++.++||||+||++|||++|+.||.... .......+... .
T Consensus 153 a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~------~ 220 (263)
T d2j4za1 153 SVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--YQETYKRISRV------E 220 (263)
T ss_dssp CSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTT------C
T ss_pred eeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--HHHHHHHHHcC------C
Confidence 9866542 2345679999999999999999999999999999999999999997542 12222211111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.......+. .+.+++.+||++||++|||++|++++
T Consensus 221 ~~~p~~~s~------~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 FTFPDFVTE------GARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCccCCH------HHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 112222222 23347788999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=419.85 Aligned_cols=250 Identities=22% Similarity=0.384 Sum_probs=204.8
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|+..+.||+|+||+||+| +..+|+.||||++... .....+.+.+|++++++++|||||++++++.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~-----------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 88 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-----------QQPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG-----------GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecc-----------cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE
Confidence 47999999999999999999 5578999999998533 12235789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++ |||||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~ 162 (293)
T d1yhwa1 89 GDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162 (293)
T ss_dssp TTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchh
Confidence 9999999999999999998875 4689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....+ ......+...... .
T Consensus 163 a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~~~~~~~~---~ 235 (293)
T d1yhwa1 163 CAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGTP---E 235 (293)
T ss_dssp CEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHHCSC---C
T ss_pred heeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--HHHHHHHHhCCCC---C
Confidence 99775433 234466799999999999999999999999999999999999999975421 1222212111111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.......+. .+.+++.+||++||++|||++|++++
T Consensus 236 ~~~~~~~s~------~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 LQNPEKLSA------IFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CSSGGGSCH------HHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCcccCCH------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111122 23457888999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-48 Score=420.55 Aligned_cols=259 Identities=23% Similarity=0.346 Sum_probs=212.8
Q ss_pred hhccccceeccccceEEEEEEe-cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+|.. .+|+.||||++... ....++|.+|++++++++|||||++++++.+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~------------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT------------CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc------------cchHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 5788899999999999999954 57899999998532 2235789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..++||||+++|+|.+++.......+++..+..|+.|||+||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence 99999999999999999999876678899999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+.... .
T Consensus 162 a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~-----~ 234 (287)
T d1opja_ 162 SRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDY-----R 234 (287)
T ss_dssp TTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTC-----C
T ss_pred eeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCC-----C
Confidence 987654332 333455689999999999999999999999999999999998777654322 222223222221 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
+......+. .+.+++..||+.||++|||++|+++.|+.+..+
T Consensus 235 ~~~~~~~~~------~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 235 MERPEGCPE------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCccchH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 222222222 234578889999999999999999999887554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=416.57 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=208.7
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|.+.+.||+|+||+||+|..++++.||||++... ....+.|.+|++++++++|||||+++|++. +
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~------------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~ 79 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG------------SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC------------cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-c
Confidence 578899999999999999998888899999998532 223578999999999999999999999875 4
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++.......+++..+.+|+.|||+||+|||+. +|+||||||+|||+++++.+||+|||+|
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence 5679999999999999988765556799999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
+....... .......||+.|||||++.+..++.++|||||||++|||+||..|+.... ........+.... .+
T Consensus 157 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-~~~~~~~~i~~~~-----~~ 229 (272)
T d1qpca_ 157 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY-----RM 229 (272)
T ss_dssp EECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTC-----CC
T ss_pred EEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcC-----CC
Confidence 98765432 33445679999999999998899999999999999999999766654332 2222333322211 11
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
......+. + +.+++.+||+.||++|||+++|++.|+++..
T Consensus 230 ~~p~~~~~---~---l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 230 VRPDNCPE---E---LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCTTCCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccChH---H---HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11122222 2 3447888999999999999999999987643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=416.09 Aligned_cols=256 Identities=20% Similarity=0.324 Sum_probs=194.0
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++.... ..+...+.+.+|++++++++|||||++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---------MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT---------SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh---------CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 57999999999999999999 55689999999985432 233446789999999999999999999999875
Q ss_pred --CCCceEEEEecCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHhhcccccCC--CCeEeCCCCCCcEEEcCCCCee
Q 043053 783 --RNNRLLMYDYMPNGSLGSLLHER--TGNALEWELRYQILLGAAQGLAYLHHDCV--PPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 783 --~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~ivHrDikp~Nill~~~~~~k 856 (1058)
+...|+|||||++|+|.+++... ....+++..++.++.|+++||+|||+.+. .+||||||||+|||++.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 35579999999999999999752 35679999999999999999999998721 1499999999999999999999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|+|||+|+...... ......+||+.|||||++.+..++.++|||||||++|||++|+.||.... .......+....
T Consensus 155 l~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--~~~~~~~i~~~~ 230 (269)
T d2java1 155 LGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKELAGKIREGK 230 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTC
T ss_pred EeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--HHHHHHHHHcCC
Confidence 99999998765432 23345789999999999999999999999999999999999999997542 222222222211
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. +.+....+.+ +.+++.+||+.||++|||++|++++
T Consensus 231 ~-----~~~~~~~s~~------l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 F-----RRIPYRYSDE------LNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp C-----CCCCTTSCHH------HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-----CCCCcccCHH------HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1 1112222222 3447788999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-47 Score=418.02 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=198.2
Q ss_pred hhccccceeccccceEEEEEEec-CC---cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-NG---EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|.+.++||+|+||+||+|... ++ ..||||++... ......++|.+|++++++++|||||+++|+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~ 95 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----------YTEKQRRDFLSEASIMGQFDHPNVIHLEGV 95 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS----------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc----------cCHHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 56777899999999999999653 33 36899987532 233456789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+.+++..++|||||++|+|.+++... ...+++..+..|+.|||+||+|||+. +||||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D 171 (299)
T d1jpaa_ 96 VTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSD 171 (299)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred EeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECC
Confidence 99999999999999999999998764 45799999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcc---cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhh
Q 043053 860 FGLAKLVDDGDFA---RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 860 fGl~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
||+++........ .......||+.|||||++.+..++.++|||||||++|||+| |+.||.... .......+...
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--~~~~~~~i~~~ 249 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--NQDVINAIEQD 249 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTT
T ss_pred cccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcC
Confidence 9999876543321 12223458999999999999999999999999999999998 899997542 22333333322
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.. +......+. + +.+++.+||+.||++|||++||++.|+++.+.
T Consensus 250 ~~-----~~~~~~~~~---~---l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 YR-----LPPPMDCPS---A---LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CC-----CCCCTTCCH---H---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CC-----CCCCccchH---H---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11 111112222 2 33478889999999999999999999887543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=417.65 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=202.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
+.|++.+.||+|+||+||+| +..+|+.||||++... .....+.+.+|++++++++|||||++++++.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-----------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 80 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-----------SEEELEDYMVEIDILASCDHPNIVKLLDAFYY 80 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-----------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 46888999999999999999 5568999999998432 23345788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+|||||++|+|.+++.+. ...+++..+..++.||++||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~ 156 (288)
T d2jfla1 81 ENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGV 156 (288)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCeEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechh
Confidence 99999999999999999998764 46799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|+...... ......+||+.|||||++. +..++.++||||+||++|||++|+.||....+ ......+.....
T Consensus 157 a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~~~~~i~~~~~ 232 (288)
T d2jfla1 157 SAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLKIAKSEP 232 (288)
T ss_dssp CEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHHHHHHHSCC
T ss_pred hhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCC
Confidence 97654321 2334567999999999873 45678999999999999999999999976532 222222222111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.....+..... .+.+++.+||++||++|||++|++++
T Consensus 233 ------~~~~~~~~~s~---~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 ------PTLAQPSRWSS---NFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ------CCCSSGGGSCH---HHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------CCCCccccCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111111112 23457888999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=419.33 Aligned_cols=254 Identities=18% Similarity=0.246 Sum_probs=204.7
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+|. ..+|+.||||++.+... ..+...+.+.+|++++++++|||||++++++.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 79 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc--------cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence 579999999999999999994 56899999999864422 123345789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||++||+|.+++... +.+++..++.++.|++.||+|||+. +||||||||+|||+++++.+||+|||+
T Consensus 80 ~~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 80 DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccccc
Confidence 99999999999999999998864 6799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+..............+||+.|||||++.+..++.++||||+||++|||++|+.||.... .......+... .
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i~~~------~ 226 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EYLIFQKIIKL------E 226 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHTT------C
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--HHHHHHHHHcC------C
Confidence 998765443344556789999999999999999999999999999999999999997542 12222211111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
..+....+. .+.+++.+||++||++|||++|+.++.
T Consensus 227 ~~~p~~~s~------~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 227 YDFPEKFFP------KARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp CCCCTTCCH------HHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred CCCCccCCH------HHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 112222222 234578899999999999999986643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=427.82 Aligned_cols=199 Identities=27% Similarity=0.461 Sum_probs=177.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++... ......+++.+|+.++++++|||||+++++|.+
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~----------~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE----------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC----------CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh----------hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 57999999999999999999 5568999999998532 233446789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
++..|+||||++||+|.+++.+. +.+++..+..++.|+++||+|||+ + +|+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence 99999999999999999999864 569999999999999999999996 5 89999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
+|+.... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 151 la~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 151 VSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred CccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9986643 2234568999999999999999999999999999999999999999754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=410.58 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=207.6
Q ss_pred hhccccce-eccccceEEEEEEec---CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANV-IGKGCSGVVYRADMD---NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|...+. ||+|+||+||+|... ++..||||++... ......++|.+|++++++++|||||+++|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----------~~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----------TEKADTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh----------cCHHHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 45666674 999999999999543 4567999998532 233456789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+.+ +..|+||||+++|+|.+++... ...+++..+.+++.|||+||+|||++ +||||||||+|||++.++.+||+|
T Consensus 78 ~~~-~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~D 152 (285)
T d1u59a_ 78 CQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD 152 (285)
T ss_dssp EES-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred ecc-CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeecc
Confidence 865 5689999999999999998654 46799999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||+++....... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ...+...+.....
T Consensus 153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i~~~~~ 230 (285)
T d1u59a_ 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKR 230 (285)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTCC
T ss_pred chhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC
Confidence 999998765432 223345568999999999999999999999999999999998 999997643 3334333333221
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
+......+. + +.+++.+||+.||++|||+.+|.+.|+.+..
T Consensus 231 -----~~~p~~~~~---~---l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 231 -----MECPPECPP---E---LYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -----CCCCTTCCH---H---HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCcCCH---H---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122222222 2 3357888999999999999999999887654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=404.97 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=209.8
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|++.+.||+|+||+||+|.+++++.||||++... ....++|.+|+.++++++|||||+++|++.++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~------------~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------------SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS------------SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC------------cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 467889999999999999999888999999998532 22357899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++... ...+++..+++++.|+|+||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a 147 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS 147 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred CceEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhh
Confidence 9999999999999999998764 46789999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
+....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... .......+.... .
T Consensus 148 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--~~~~~~~i~~~~--~--- 219 (258)
T d1k2pa_ 148 RYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHIAQGL--R--- 219 (258)
T ss_dssp CBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--HHHHHHHHHTTC--C---
T ss_pred eeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--HHHHHHHHHhCC--C---
Confidence 87655432 23345679999999999999999999999999999999998 899997553 222332222211 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
+......+. .+.+++.+||+.||++|||+++++++|.++
T Consensus 220 ~~~p~~~~~------~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 LYRPHLASE------KVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCTTCCH------HHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCcccccH------HHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111112222 234578889999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-47 Score=418.90 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=190.1
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.+.|++.+.||+|+||+||+| +..+|+.||||++..... ....+.+.+|+.++++++|||||++++++
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 76 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----------EGKEGSMENEIAVLHKIKHPNIVALDDIY 76 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------------CHHHHHHHTCCCTTBCCEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh----------hhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4467999999999999999999 456799999999854321 12246788999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc---CCCCeee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG---LEFEPYI 857 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~---~~~~~kl 857 (1058)
.+++..|+|||||+||+|.+++.. ...+++..+..++.||+.||+|||+. +||||||||+||++. +++.+||
T Consensus 77 ~~~~~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl 151 (307)
T d1a06a_ 77 ESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMI 151 (307)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EECCEEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEE
Confidence 999999999999999999999976 46799999999999999999999999 999999999999995 5789999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+|||+|+...... .....+||+.|||||++.+..++.++||||+||++|||++|+.||.... .......+...
T Consensus 152 ~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i~~~-- 224 (307)
T d1a06a_ 152 SDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--DAKLFEQILKA-- 224 (307)
T ss_dssp CCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHTT--
T ss_pred eccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHhcc--
Confidence 9999998765432 2345679999999999999999999999999999999999999997542 12222222211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
............+. .+.+++.+||++||++|||++|++++
T Consensus 225 ~~~~~~~~~~~~s~------~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 225 EYEFDSPYWDDISD------SAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCCCTTTTTTSCH------HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCccccCCCH------HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11112222222222 23457788999999999999999885
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=407.75 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=195.5
Q ss_pred ccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc--
Q 043053 706 LVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN-- 782 (1058)
Q Consensus 706 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 782 (1058)
|.+.+.||+|+||+||+| +..+++.||||++.... ......+.|.+|++++++++|||||++++++.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~---------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---------CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 456678999999999999 55678999999985432 123346789999999999999999999999865
Q ss_pred --CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCC--eEeCCCCCCcEEEc-CCCCeee
Q 043053 783 --RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPP--IVHRDIKANNILIG-LEFEPYI 857 (1058)
Q Consensus 783 --~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDikp~Nill~-~~~~~kl 857 (1058)
+...|+||||+++|+|.+++++. ..+++..+..++.||++||+|||++ + ||||||||+|||++ +++.+||
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl 156 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKI 156 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEE
Confidence 23468999999999999999864 5789999999999999999999998 6 99999999999996 5789999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+|||+|+..... .....+||+.|||||++.+ .++.++||||+||++|||++|+.||..... .......+...
T Consensus 157 ~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-~~~~~~~i~~~-- 228 (270)
T d1t4ha_ 157 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSG-- 228 (270)
T ss_dssp CCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTT--
T ss_pred eecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-HHHHHHHHHcC--
Confidence 999999864332 2345689999999998865 599999999999999999999999975422 11121111111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...+........ ++.+++.+||++||++|||++|++++
T Consensus 229 --~~~~~~~~~~~~------~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 229 --VKPASFDKVAIP------EVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp --CCCGGGGGCCCH------HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --CCCcccCccCCH------HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 111111111222 23457888999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=417.66 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=205.8
Q ss_pred hhccccceeccccceEEEEEEec-CC-----cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-NG-----EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
++|++.++||+|+||+||+|... .+ ..||||++... ........+.+|+.++.++ +|||||++
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK----------ADSSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc----------cCHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 57899999999999999999543 22 36999988533 2233457899999999998 89999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHhhcccccCCC
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERTG---------------------NALEWELRYQILLGAAQGLAYLHHDCVP 835 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 835 (1058)
++++.+++..|+|||||++|+|.++++.+.. ..+++..++.++.||++||+|||++
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~--- 183 (325)
T d1rjba_ 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--- 183 (325)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 9999999999999999999999999976432 3589999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-C
Q 043053 836 PIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-G 914 (1058)
Q Consensus 836 ~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g 914 (1058)
+||||||||+||+++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |
T Consensus 184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 999999999999999999999999999987665443334456678999999999999999999999999999999998 8
Q ss_pred CCCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 043053 915 KQPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLK 985 (1058)
Q Consensus 915 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~ 985 (1058)
+.||..... ...+...+.... .+......+. .+.+++.+||+.||++|||++||+++|.
T Consensus 264 ~~Pf~~~~~-~~~~~~~~~~~~-----~~~~p~~~~~------~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 264 VNPYPGIPV-DANFYKLIQNGF-----KMDQPFYATE------EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSSTTCCC-SHHHHHHHHTTC-----CCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCH-HHHHHHHHhcCC-----CCCCCCcCCH------HHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 999975432 233333333221 1112222222 2345788899999999999999999885
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=408.43 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=201.7
Q ss_pred hhccccceeccccceEEEEEEecCC-----cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNG-----EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|...++||+|+||+||+|.+..+ ..||||++... ..+...++|.+|++++++++|||||+++|
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~----------~~~~~~~~~~~E~~il~~l~H~nIv~~~g 76 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----------YTEKQRVDFLGEAGIMGQFSHHNIIRLEG 76 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc----------cChHHHHHHHHHHHHHHhcCCCCEeeeeE
Confidence 4678899999999999999965432 47999998533 23344578999999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++.+.+..++||||+.+|++.+++... ...+++..+.+++.||+.|++|||+. +|+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~ 152 (283)
T d1mqba_ 77 VISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVS 152 (283)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred EEecCCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEc
Confidence 999999999999999999999988764 46799999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+++....... ........||+.|||||++.+..++.++|||||||++|||++|..|+..... .......+....
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~~~- 230 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGF- 230 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTTC-
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-HHHHHHHHhccC-
Confidence 9999987654321 2233445689999999999999999999999999999999997776654322 223333333221
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.+......+. + +.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 231 ----~~~~~~~~~~---~---l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 ----RLPTPMDCPS---A---IYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----CCCCCTTCBH---H---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCchhhHH---H---HHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1122222222 2 34478889999999999999999999887654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=405.58 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=199.7
Q ss_pred ceeccccceEEEEEEec---CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCc
Q 043053 710 NVIGKGCSGVVYRADMD---NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR 786 (1058)
Q Consensus 710 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 786 (1058)
+.||+|+||+||+|.+. .++.||||++.... .+....++|.+|++++++++|||||+++|++.. +..
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---------~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~ 82 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---------NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESW 82 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh---------CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCE
Confidence 57999999999999543 35689999985331 234456789999999999999999999999864 467
Q ss_pred eEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceec
Q 043053 787 LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV 866 (1058)
Q Consensus 787 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~ 866 (1058)
++||||+++|+|.++++. ...+++..+..|+.|||+||+|||+. +||||||||+|||++.++.+||+|||+++..
T Consensus 83 ~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence 899999999999999986 46799999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCccccCCC
Q 043053 867 DDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVLDPS 944 (1058)
Q Consensus 867 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 944 (1058)
..... ........||+.|||||++.+..++.++|||||||++|||++ |+.||.... .......+.... .+.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~~~~~~i~~~~-----~~~ 230 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKGE-----RMG 230 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTC-----CCC
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--HHHHHHHHHcCC-----CCC
Confidence 54432 223345679999999999999999999999999999999998 899997542 223333333221 111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 945 LLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 945 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
.....+. + +.+++.+||+.||++|||+++|.+.|+....
T Consensus 231 ~p~~~~~---~---~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 231 CPAGCPR---E---MYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCTTCCH---H---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCcccCH---H---HHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 2222222 2 3347888999999999999999998877643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-47 Score=414.44 Aligned_cols=250 Identities=28% Similarity=0.399 Sum_probs=201.7
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.+.|+..+.||+|+||+||+| +..+|+.||||++.... .......+.+.+|++++++++|||||++++++.
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--------~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--------KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS--------SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhh--------ccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 356999999999999999999 56789999999985431 123344578999999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++..|+|||||++|++..++.. ...+++..++.++.||++||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred ECCEEEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence 99999999999999999877655 46799999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
+|+.... .....||+.|||||++.+ ..|+.++|||||||++|||++|+.||....+ ......+....
T Consensus 161 ~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~~~~~~i~~~~-- 230 (309)
T d1u5ra_ 161 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNE-- 230 (309)
T ss_dssp TCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSC--
T ss_pred cccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCC--
Confidence 9986543 234679999999999754 4588999999999999999999999975421 11111111111
Q ss_pred cccCCCC-CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 939 QVLDPSL-LSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 939 ~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.+.. ....+. .+.+++.+||+.||++|||++|++++-
T Consensus 231 ---~~~~~~~~~s~------~~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 231 ---SPALQSGHWSE------YFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp ---CCCCSCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ---CCCCCCCCCCH------HHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence 1111 111222 234578889999999999999998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.2e-46 Score=417.02 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=207.7
Q ss_pred HHHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 701 QVLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 701 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.++++|++.+.||+|+||+||+| +..+|+.||||++... .....+.+.+|+.++++++|||||+++++
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-----------~~~~~~~~~~E~~il~~l~HpnIv~~~~~ 91 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----------HESDKETVRKEIQTMSVLRHPTLVNLHDA 91 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-----------SHHHHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-----------chhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 45689999999999999999999 5568999999998532 22345789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC--CCCeee
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL--EFEPYI 857 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~--~~~~kl 857 (1058)
+.+++..|+|||||+||+|.+++... ...+++..+..|+.||+.||+|||++ +||||||||+|||++. ++.+||
T Consensus 92 ~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL 167 (350)
T d1koaa2 92 FEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 167 (350)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEE
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEE
Confidence 99999999999999999999999653 45799999999999999999999999 9999999999999964 578999
Q ss_pred eccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 858 ADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 858 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
+|||+|+...... ......||+.|||||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 168 ~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~- 241 (350)
T d1koaa2 168 IDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCD- 241 (350)
T ss_dssp CCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTC-
T ss_pred eecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCC-
Confidence 9999998776532 3345679999999999999999999999999999999999999997542 222222222111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...........+. .+.+++.+||++||++|||++|++++
T Consensus 242 -~~~~~~~~~~~s~------~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 242 -WNMDDSAFSGISE------DGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -CCSCCGGGGGCCH------HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CCCCcccccCCCH------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111222 23457888999999999999999886
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=399.99 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=200.5
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc-
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN- 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 782 (1058)
++|++.+.||+|+||.||+|..+ |+.||||++.. +...+.|.+|++++++++|||||+++|++.+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~-------------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN-------------DATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC-------------CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc-------------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 56888999999999999999875 88999999842 2345789999999999999999999999865
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
.+..|+||||+++|+|.+++..+....+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++|||+
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccccc
Confidence 45679999999999999999875555689999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
++..... .....+|..|+|||++.+..++.++|||||||++|||+| |+.||... ...+...++....
T Consensus 150 s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~----- 217 (262)
T d1byga_ 150 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGY----- 217 (262)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTC-----
T ss_pred ceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCC-----
Confidence 9865432 234568899999999999999999999999999999998 68777654 3334444443321
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
.+......+. .+.+++.+||+.||++|||+++++++|++++..
T Consensus 218 ~~~~~~~~~~------~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 218 KMDAPDGCPP------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccCCH------HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 2222222232 234578889999999999999999999988653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=408.92 Aligned_cols=259 Identities=23% Similarity=0.312 Sum_probs=208.4
Q ss_pred HHhhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.++|++.+.||+|+||+||+|. ..+|+.||||++.+.... ........+.+.+|++++++++|||||++++++
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~-----~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTK-----SSRRGVSREDIEREVSILKEIQHPNVITLHEVY 82 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSST-----TCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcc-----hhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34689999999999999999994 568999999998654321 112334568899999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC----Cee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF----EPY 856 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~----~~k 856 (1058)
.+++..|+|||||+||+|.+++... ..+++..++.++.|++.||+|||+. +||||||||+||+++.++ .+|
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEE
T ss_pred EECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceE
Confidence 9999999999999999999999874 5799999999999999999999999 999999999999998876 499
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
++|||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 158 l~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i~~~~ 232 (293)
T d1jksa_ 158 IIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANVSAVN 232 (293)
T ss_dssp ECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHTTC
T ss_pred ecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--HHHHHHHHHhcC
Confidence 99999998775542 3345679999999999999999999999999999999999999997542 122222111111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
....+......+. .+.+++.+||++||++|||++|++++
T Consensus 233 --~~~~~~~~~~~s~------~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 --YEFEDEYFSNTSA------LAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp --CCCCHHHHTTSCH------HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCCCchhcCCCCH------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111111111122 23457889999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=403.94 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=202.6
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|++.+.||+|+||+||+|...+++.||||++... ....+.|.+|+.++++++|||||+++|++. +
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~------------~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~ 83 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 83 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc------------cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence 579999999999999999998888889999998532 223578999999999999999999999985 4
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+++|+|.+++.......++|..++.++.|||+||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence 5689999999999999999876566799999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccCC
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLDP 943 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1058)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+.... .+
T Consensus 161 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~~~~-----~~ 233 (285)
T d1fmka3 161 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGY-----RM 233 (285)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTC-----CC
T ss_pred hhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcC-----CC
Confidence 87654332 333456799999999999999999999999999999999997777654322 222333333221 11
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 944 SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 944 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
......+. ++.+++.+||+.||++|||+++|+++|+...
T Consensus 234 ~~~~~~~~------~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 234 PCPPECPE------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCcccCH------HHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 12222222 2345788899999999999999999887754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.1e-46 Score=412.79 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=207.3
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.+.|++.+.||+|+||+||+| +..+|+.||||++... .....+.+.+|++++++++|||||++++++
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~ 95 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----------YPLDKYTVKNEISIMNQLHHPKLINLHDAF 95 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-----------chhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4468999999999999999999 5578999999998532 122356788999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEc--CCCCeeee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIG--LEFEPYIA 858 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~--~~~~~kl~ 858 (1058)
.+++..|+|||||+||+|.+++... ...+++..++.|+.||+.||+|||++ |||||||||+|||++ .++.+||+
T Consensus 96 ~~~~~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~ 171 (352)
T d1koba_ 96 EDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKII 171 (352)
T ss_dssp ECSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEEC
T ss_pred EECCEEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEe
Confidence 9999999999999999999988653 45799999999999999999999999 999999999999998 57899999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
|||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 172 DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~-- 244 (352)
T d1koba_ 172 DFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DLETLQNVKRCD-- 244 (352)
T ss_dssp CCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHCC--
T ss_pred ecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCC--
Confidence 999999876543 3345679999999999999999999999999999999999999997542 222222222211
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
...........+. .+.+++.+||++||++|||++|++++
T Consensus 245 ~~~~~~~~~~~s~------~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 WEFDEDAFSSVSP------EAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCSSTTTTSCH------HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCcccccCCCH------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112222222222 23457888999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=397.44 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=198.0
Q ss_pred hhccccceeccccceEEEEEEec----CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD----NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|++.+.||+|+||+||+|... .+..||||++... ......+.|.+|++++++++|||||+++++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----------TSDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----------TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 57899999999999999999543 2456899987432 234456789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+. ++..|+||||+++|+|.+++... ...+++..++.++.||++||+|||+. +||||||||+||+++.++.+||+|
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred Ee-cCeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence 85 46789999999999999988764 46789999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||....+ ..+...+.....
T Consensus 152 fG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i~~~~~- 227 (273)
T d1mp8a_ 152 FGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGER- 227 (273)
T ss_dssp --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCC-
T ss_pred chhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCC-
Confidence 999987654332 23345678999999999999999999999999999999998 8999976532 333333332211
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
+......+. .+.+++..||+.||++|||++||++.|+.+..+
T Consensus 228 ----~~~~~~~~~------~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 228 ----LPMPPNCPP------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 112222222 234578889999999999999999999887654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=406.07 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=203.7
Q ss_pred hhccccceeccccceEEEEEEe-cCCc----EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGE----VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 778 (1058)
++|++.++||+|+||+||+|.. .+|+ +||||++... ......++|.+|++++++++|||||+++|
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g 78 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------TSPKANKEILDEAYVMASVDNPHVCRLLG 78 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------------CTHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----------cCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3588999999999999999954 4554 5888887432 23345688999999999999999999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++.++ ..++||||+.+|+|.+++... ...+++..+++++.|||+||+|||++ +||||||||+|||++.++.+||+
T Consensus 79 ~~~~~-~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~ 153 (317)
T d1xkka_ 79 ICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 153 (317)
T ss_dssp EEESS-SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred EEecC-CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEee
Confidence 99864 568889999999999998764 57799999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |..||.... ...+...+.....
T Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~--~~~~~~~i~~~~~ 231 (317)
T d1xkka_ 154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGER 231 (317)
T ss_dssp CCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--GGGHHHHHHHTCC
T ss_pred ccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCC
Confidence 9999998765544444455679999999999999999999999999999999998 788887542 2334333333221
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHERE 992 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~~ 992 (1058)
+......+ .+ +.+++.+||+.||++|||++|++++++.+.....
T Consensus 232 -----~~~p~~~~---~~---~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~ 275 (317)
T d1xkka_ 232 -----LPQPPICT---ID---VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275 (317)
T ss_dssp -----CCCCTTBC---HH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred -----CCCCcccC---HH---HHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChH
Confidence 11111122 22 3457888999999999999999999988765433
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=405.88 Aligned_cols=252 Identities=21% Similarity=0.241 Sum_probs=207.5
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
+++|++.+.||+|+||+||+| +..+|+.||||++.+.... .....+.+.+|+.++++++|||||++++++.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~--------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII--------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--------HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc--------CHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 367999999999999999999 5578999999999654321 2234678899999999999999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred cccccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecc
Confidence 999999999999999999999874 5789999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+|+...... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... .......+...
T Consensus 151 ~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--~~~~~~~i~~~------ 220 (337)
T d1o6la_ 151 LCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILME------ 220 (337)
T ss_dssp TCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC------
T ss_pred cccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--HHHHHHHHhcC------
Confidence 998654432 23456789999999999999999999999999999999999999997542 22222222221
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~ 983 (1058)
....+...+. ++.+++..||++||++||+ ++|++++
T Consensus 221 ~~~~p~~~s~------~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 EIRFPRTLSP------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCCTTSCH------HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCccCCH------HHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1112222222 2345788899999999995 7888775
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-45 Score=403.45 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=208.7
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|++.+.||+|+||+||+|... +++.||||++... ......++|.+|++++++++||||++++
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~----------~~~~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----------ASADMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----------CCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh----------cChHHHHHHHHHHHHHHhcCCCCcccce
Confidence 57899999999999999999653 4578999998532 2334567899999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHhhcccccCCC
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT----------------------GNALEWELRYQILLGAAQGLAYLHHDCVP 835 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 835 (1058)
+++.+....++||||+++|+|.++++... ...+++..++.|+.|++.||+|||+.
T Consensus 83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--- 159 (301)
T d1lufa_ 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--- 159 (301)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---
Confidence 99999999999999999999999997532 23488999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 043053 836 PIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 915 (1058)
Q Consensus 836 ~ivHrDikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~ 915 (1058)
+||||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence 99999999999999999999999999998765544444455677899999999999999999999999999999999986
Q ss_pred -CCCCCCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhh
Q 043053 916 -QPIDPTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIK 988 (1058)
Q Consensus 916 -~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~ 988 (1058)
.||... ........+..... +......+ .+ +..++..||+.||++||||.||+++|+++.
T Consensus 240 ~~p~~~~--~~~e~~~~v~~~~~-----~~~p~~~~---~~---~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 240 LQPYYGM--AHEEVIYYVRDGNI-----LACPENCP---LE---LYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CCTTTTS--CHHHHHHHHHTTCC-----CCCCTTCC---HH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCC--CHHHHHHHHHcCCC-----CCCCccch---HH---HHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 566543 22233333332211 11111222 22 345788999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-45 Score=403.53 Aligned_cols=248 Identities=23% Similarity=0.301 Sum_probs=204.5
Q ss_pred hhccccceeccccceEEEEEE-ecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRAD-MDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+|. ..+|+.||||++.+... ......+.+.+|+.++++++|||||++++++.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 75 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--------VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 75 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc--------cCHHHHHHHHHHHHHHHhccCcChhheeeeEee
Confidence 679999999999999999994 56799999999864422 122346789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||++||+|..++.. ...+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+
T Consensus 76 ~~~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 76 AQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCeeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCcc
Confidence 9999999999999999999986 46788899999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+..... ....+||+.|||||++.+..++.++||||+||++|||++|+.||.... .......+... .
T Consensus 151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~------~ 217 (316)
T d1fota_ 151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TMKTYEKILNA------E 217 (316)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHC------C
T ss_pred ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--HHHHHHHHHcC------C
Confidence 9876542 335689999999999999999999999999999999999999997542 11222211111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~ 983 (1058)
.......+.+ +.+++.+||.+||.+|| |+++++++
T Consensus 218 ~~~p~~~s~~------~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 LRFPPFFNED------VKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCCTTSCHH------HHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCHH------HHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1111222222 33477789999999996 89999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.4e-45 Score=395.89 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=200.4
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+| +..+|+.||||++.... ..+....+.|.+|++++++++|||||++++++..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~ 78 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--------ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 78 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--------TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhh--------ccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence 67999999999999999999 56789999999986442 1234456789999999999999999999999976
Q ss_pred CCC----ceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 783 RNN----RLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 783 ~~~----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
.+. .|+||||++||+|.+++... +.+++..++.++.||++||+|||+. +||||||||+|||++.++.++++
T Consensus 79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 79 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp ECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEEC
T ss_pred ccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceee
Confidence 543 68999999999999998764 5799999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCC-cccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGD-FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||.+....... ........+||+.|+|||++.+..++.++||||+||++|||+||+.||....+ ....... ...
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~~--~~~ 229 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQH--VRE 229 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH--HHC
T ss_pred hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--HHHHHHH--Hhc
Confidence 999987654332 12334456799999999999999999999999999999999999999975421 1111111 111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHhhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERP-TMKDVAAMLKEIK 988 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-t~~~v~~~l~~~~ 988 (1058)
............+.. +.+++.+||++||++|| |++++.+.|.++.
T Consensus 230 ~~~~~~~~~~~~s~~------l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 230 DPIPPSARHEGLSAD------LDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCCCGGGTSSSCCHH------HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCCchhccCCCHH------HHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111111111222222 33477789999999999 8999988887654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=399.90 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=199.9
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
++|++.+.||+|+||+||+|... +++.||||++... ......+.+.+|+..+.++ +|+|||++
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----------~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----------ATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc----------cCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 57999999999999999999542 3468999998533 2233456788888888877 58999999
Q ss_pred eeEEEcC-CCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCC
Q 043053 777 LGCCWNR-NNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRD 841 (1058)
Q Consensus 777 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrD 841 (1058)
++++.++ ...++|||||++|+|.++++... ...+++..+..++.||++||+|||++ +|||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence 9998765 45799999999999999997532 24589999999999999999999999 999999
Q ss_pred CCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCC-CCCCC
Q 043053 842 IKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK-QPIDP 920 (1058)
Q Consensus 842 ikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~-~P~~~ 920 (1058)
|||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++|. .||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998766544434455678999999999999999999999999999999999975 56754
Q ss_pred CCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 921 TIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
. .....+...+..... +......+. ++.+++.+||+.||++|||++|++++|+.+.+
T Consensus 240 ~-~~~~~~~~~~~~~~~-----~~~~~~~~~------~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 240 V-KIDEEFCRRLKEGTR-----MRAPDYTTP------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp C-CCSHHHHHHHHHTCC-----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-CHHHHHHHHHhcCCC-----CCCCccCCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 3 223333333333221 122222222 23457888999999999999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=393.76 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=196.8
Q ss_pred hhccccceeccccceEEEEEEec--CC--cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD--NG--EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
++|++.+.||+|+||+||+|... ++ ..||||++.+... ......++|.+|+.++++++|||||+++|+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--------~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~ 79 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--------SQPEAMDDFIREVNAMHSLDHRNLIRLYGV 79 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--------CCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 57899999999999999999543 22 3689999854421 234456789999999999999999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
+.+ +..++||||+++|++.+++..+ ...+++..+.+++.|+|+||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 80 ~~~-~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 80 VLT-PPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred Eee-cchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeecc
Confidence 965 4678999999999999988765 46799999999999999999999999 999999999999999999999999
Q ss_pred cccceeccCCCc-ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCChhHHHHHHhhcC
Q 043053 860 FGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 860 fGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
||+++....... ........|+..|+|||++.+..++.++|||||||++|||+| |+.||... .......++....
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--~~~~~~~~i~~~~- 231 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEG- 231 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTSC-
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--CHHHHHHHHHhCC-
Confidence 999998755432 223345568889999999999999999999999999999998 89999754 2223333322211
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhh
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEI 987 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~ 987 (1058)
..+......+.. +.+++.+||+.||++|||+++|.+.|++.
T Consensus 232 ---~~~~~~~~~~~~------l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ---ERLPRPEDCPQD------IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCCCCTTCCHH------HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcccccHH------HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112222222222 33478889999999999999999988765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=402.50 Aligned_cols=254 Identities=18% Similarity=0.246 Sum_probs=205.6
Q ss_pred HHhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEE
Q 043053 702 VLKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCC 780 (1058)
Q Consensus 702 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 780 (1058)
+.++|.+.+.||+|+||+||+| +..+|+.||||++... ......+.+|++++++++|||||++++++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~ 70 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------------GTDQVLVKKEISILNIARHRNILHLHESF 70 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------------THHHHHHHHHHHHHHHSCCTTBCCEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC------------cccHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4578999999999999999999 5568999999998533 12245688999999999999999999999
Q ss_pred EcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC--CCeeee
Q 043053 781 WNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE--FEPYIA 858 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~--~~~kl~ 858 (1058)
.+++..|+|||||+||+|.++++.. +..+++..++.++.||++||+|||+. +|+||||||+|||++.+ +.+||+
T Consensus 71 ~~~~~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~ 146 (321)
T d1tkia_ 71 ESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKII 146 (321)
T ss_dssp EETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEEC
T ss_pred EECCEEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEc
Confidence 9999999999999999999999764 35789999999999999999999999 99999999999999854 489999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGI 938 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1058)
|||+++...... ......||+.|+|||...+..++.++||||+||++|+|++|+.||.... .......+....
T Consensus 147 DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--~~~~~~~i~~~~-- 219 (321)
T d1tkia_ 147 EFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAE-- 219 (321)
T ss_dssp CCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTC--
T ss_pred ccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCC--
Confidence 999998765533 2345679999999999999999999999999999999999999997542 122222221111
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 939 QVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 939 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
..++.......+. .+.+++..||.+||++|||++|++++-
T Consensus 220 ~~~~~~~~~~~s~------~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 220 YTFDEEAFKEISI------EAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CCCCHHHHTTSCH------HHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCCChhhccCCCH------HHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 1111111111122 234578899999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-44 Score=406.27 Aligned_cols=255 Identities=20% Similarity=0.213 Sum_probs=200.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.++||+|+||+||+| +..+|+.||||++.+...... ..........+|+++++.++|||||++++++.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~-----~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH-----TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh-----hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE
Confidence 57999999999999999999 456799999999854432110 111122233455778888899999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||++||+|.+++... ..+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGl 153 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 153 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred CCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeece
Confidence 99999999999999999999864 6788999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
|+..... .....+||+.|+|||++. +..++.++||||+||++|||++|+.||........ ....+.... .
T Consensus 154 a~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~---~ 224 (364)
T d1omwa3 154 ACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT---M 224 (364)
T ss_dssp CEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSS---C
T ss_pred eeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccc---C
Confidence 9877553 234567999999999986 45689999999999999999999999976533322 122222111 1
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~ 983 (1058)
........+.+ +.+++.+||++||++||| ++|++++
T Consensus 225 ~~~~~~~~s~~------~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 AVELPDSFSPE------LRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CCCCCSSSCHH------HHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCCCCCCHH------HHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11222222322 345778899999999999 6888775
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.5e-45 Score=391.07 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=204.7
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 781 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++........ .....+...+.+.+|+.++++++ |||||++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF--SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTC--CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccch--hHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 67999999999999999999 456899999999865422110 00011234567899999999997 999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++..|+||||++||+|.++++.+ ..+++..++.++.||++||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999999864 5799999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYM------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
+++...... .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+ ......+...
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--~~~~~~i~~~ 230 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSG 230 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--HHHHHHHHhC
Confidence 999876532 2345679999999998653 3468899999999999999999999975421 1222212211
Q ss_pred cCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 KGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
... .........++ ++.+++.+||++||++|||++|++++
T Consensus 231 -~~~-~~~~~~~~~s~------~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 -NYQ-FGSPEWDDYSD------TVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -CCC-CCTTTGGGSCH------HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -CCC-CCCcccccCCH------HHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 11111111222 23457788999999999999999764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=396.88 Aligned_cols=272 Identities=28% Similarity=0.307 Sum_probs=201.9
Q ss_pred HhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 703 LKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
.+.|...+.||+|+||.||+|.. +|+.||||++... ......+..|+..+.+++|||||++++++.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~------------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~ 68 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------------EERSWFREAEIYQTVMLRHENILGFIAADNK 68 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG------------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc------------chhHHHHHHHHHHHhhCCCCcCcceEEEEEe
Confidence 36788899999999999999986 4899999998422 1112233445666677899999999999986
Q ss_pred CC----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccC-----CCCeEeCCCCCCcEEEcCCC
Q 043053 783 RN----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDC-----VPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 783 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrDikp~Nill~~~~ 853 (1058)
++ ..|+||||+++|+|.+++++ ..++|..+++++.|+|.||+|+|+.. .++||||||||+|||++.++
T Consensus 69 ~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 69 DNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred CCCcceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 54 46899999999999999986 36899999999999999999999731 24999999999999999999
Q ss_pred CeeeeccccceeccCCCcc--cccccccCcCCccCccccccCC------CCcccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043053 854 EPYIADFGLAKLVDDGDFA--RSSNTVAGSYGYIAPEYGYMMK------ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDG 925 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvvl~elltg~~P~~~~~~~~ 925 (1058)
.+||+|||+++........ .......||+.|+|||++.+.. ++.++|||||||++|||+||..||.......
T Consensus 146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~ 225 (303)
T d1vjya_ 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence 9999999999877553321 2234567999999999876542 5678999999999999999998875322110
Q ss_pred ---------hhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043053 926 ---------SHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHER 991 (1058)
Q Consensus 926 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~~ 991 (1058)
................+|.+...+. .......+..++.+||+.||++|||+.||++.|+++..+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG-GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhhcccccchHHHHHHHHhccccCCCCCcccC-ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0111112222222223333322211 1122333556899999999999999999999999887653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=396.52 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=213.5
Q ss_pred hhccccceeccccceEEEEEEe------cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccce
Q 043053 704 KCLVDANVIGKGCSGVVYRADM------DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRF 776 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 776 (1058)
++|++.++||+|+||.||+|.+ .+++.||||++... .......+|.+|+.+++++ +|||||++
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~----------~~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----------AHLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----------CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc----------cCHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 5889999999999999999964 35678999998643 2334467899999999999 69999999
Q ss_pred eeEEEcCCCceEEEEecCCCChhhhhhhcC----------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeC
Q 043053 777 LGCCWNRNNRLLMYDYMPNGSLGSLLHERT----------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840 (1058)
Q Consensus 777 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 840 (1058)
++++.+++..++|||||++|+|.++++... ...+++..+.+++.||++|++|||++ +||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHr 169 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHR 169 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 999999999999999999999999997642 23689999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 043053 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 920 (1058)
Q Consensus 841 Dikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~ 920 (1058)
||||+||+++.++.+|++|||.++..............+||+.|+|||++.+..++.++|||||||++|||+|+..|+..
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999987665544555667899999999999999999999999999999999996555544
Q ss_pred CCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 921 TIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
..+....+...+.... .+......+. .+.+++.+||+.||++||||++|++.|+++-.
T Consensus 250 ~~~~~~~~~~~i~~~~-----~~~~~~~~~~------~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGF-----RMLSPEHAPA------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp TCCSSHHHHHHHHHTC-----CCCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCC-----CCCCcccccH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 4344444444444322 1111122222 23457888999999999999999999987643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=404.57 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=198.5
Q ss_pred HHhhcccc-ceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceee
Q 043053 702 VLKCLVDA-NVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLG 778 (1058)
Q Consensus 702 ~~~~~~~~-~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 778 (1058)
+.++|.+. ++||+|+||+||+| +..+++.||||++.. ...+.+|+.++.++ +|||||++++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----------------~~~~~~E~~~~~~~~~hpnIv~l~~ 72 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------------CPKARREVELHWRASQCPHIVRIVD 72 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----------------SHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----------------cHHHHHHHHHHHHhcCCCCCCeEEE
Confidence 45688776 56999999999999 557899999999832 24678899987655 7999999999
Q ss_pred EEEc----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC---
Q 043053 779 CCWN----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL--- 851 (1058)
Q Consensus 779 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~--- 851 (1058)
+|.+ +...|+|||||+||+|.+++..+....+++..++.|+.||+.||+|||+. +|+||||||+|||++.
T Consensus 73 ~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~ 149 (335)
T d2ozaa1 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRP 149 (335)
T ss_dssp EEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSST
T ss_pred EEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccc
Confidence 9865 35579999999999999999876556799999999999999999999999 9999999999999985
Q ss_pred CCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHH
Q 043053 852 EFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDW 931 (1058)
Q Consensus 852 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 931 (1058)
++.+||+|||+|+...... .....+||+.|||||++.+..|+.++||||+||++|+|++|+.||....... ....
T Consensus 150 ~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~ 224 (335)
T d2ozaa1 150 NAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPG 224 (335)
T ss_dssp TCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------
T ss_pred cccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHH
Confidence 4579999999998776543 3345679999999999999999999999999999999999999997543221 1111
Q ss_pred HHhhcCccccCCCCCCCCchhHHH-HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 932 VRQKKGIQVLDPSLLSRPESEIDE-MLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
+....... ... .+...... ...+.+++.+||++||++|||+.|++++-
T Consensus 225 ~~~~i~~~--~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 225 MKTRIRMG--QYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp ---CCCSC--SSS---CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred HHHHHhcC--CCC---CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 11111100 001 11111111 12345688899999999999999998853
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-44 Score=403.56 Aligned_cols=248 Identities=19% Similarity=0.209 Sum_probs=204.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++.+... ......+.+.+|++++++++|||||++++++.+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--------VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc--------cCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 68999999999999999999 556899999999854422 122345788999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....++||||+.+|+|.+++... +.+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeecee
Confidence 99999999999999999999764 5799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCccccC
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVLD 942 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1058)
|+..... .....||+.|||||++.+..++.++||||+||++|||++|+.||.... .......+... .
T Consensus 188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~------~ 254 (350)
T d1rdqe_ 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSG------K 254 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC------C
T ss_pred eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHHHhcC------C
Confidence 9977542 235679999999999999999999999999999999999999997542 12222212111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 043053 943 PSLLSRPESEIDEMLQALGVALLCVNASPDERP-----TMKDVAAM 983 (1058)
Q Consensus 943 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----t~~~v~~~ 983 (1058)
+......+.+ +.+++..||++||.+|+ |+++++++
T Consensus 255 ~~~p~~~s~~------~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 VRFPSHFSSD------LKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCCTTCCHH------HHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCccCCHH------HHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1112222222 33477789999999994 89999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=392.91 Aligned_cols=260 Identities=27% Similarity=0.374 Sum_probs=207.2
Q ss_pred hhccccceeccccceEEEEEEec-C-------CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCccc
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD-N-------GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIV 774 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 774 (1058)
++|.+.+.||+|+||.||+|... . +..||||++... ..+....++.+|+..+.++ +|||||
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~----------~~~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----------ATEKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT----------CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc----------cChHHHHHHHHHHHHHHHhcCCCeEE
Confidence 57889999999999999999542 2 247999998543 2334467889999999888 799999
Q ss_pred ceeeEEEcCCCceEEEEecCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeC
Q 043053 775 RFLGCCWNRNNRLLMYDYMPNGSLGSLLHERT--------------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHR 840 (1058)
Q Consensus 775 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 840 (1058)
++++++.+++..++||||+++|+|.++++.+. ...+++..+++++.||++||+|||+. +||||
T Consensus 83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHr 159 (299)
T d1fgka_ 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 159 (299)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEee
Confidence 99999999999999999999999999997643 24589999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 043053 841 DIKANNILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 919 (1058)
Q Consensus 841 Dikp~Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-g~~P~~ 919 (1058)
||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999999999999999999999998766554445566779999999999999999999999999999999998 688886
Q ss_pred CCCCCChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 920 PTIPDGSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
... .......+.... .+......+. + +.+++.+||+.||++|||++||++.|+++..
T Consensus 240 ~~~--~~~~~~~i~~~~-----~~~~p~~~~~---~---l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 240 GVP--VEELFKLLKEGH-----RMDKPSNCTN---E---LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TCC--HHHHHHHHHTTC-----CCCCCSSCCH---H---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC--HHHHHHHHHcCC-----CCCCCccchH---H---HHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 442 223333333221 1122222222 2 3457889999999999999999999988743
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=391.70 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=202.7
Q ss_pred cceeccccceEEEEEEecC----CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc-C
Q 043053 709 ANVIGKGCSGVVYRADMDN----GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN-R 783 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~ 783 (1058)
.++||+|+||+||+|.+.. ...||||++... ......++|.+|++++++++|||||+++|++.+ +
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 101 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC----------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc----------cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC
Confidence 5789999999999996543 236899998532 234456889999999999999999999999875 4
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
...++|||||++|+|.++++.. ....++..+.+++.|+|+||.|+|+. +|+||||||+|||+++++.+||+|||++
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 177 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred CceEEEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccch
Confidence 5689999999999999998864 46778899999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcc--cccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 864 KLVDDGDFA--RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 864 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+........ .......||+.|+|||+..+..++.++||||||+++|||++|+.||...... .+...++.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~~---- 252 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRR---- 252 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC----
T ss_pred hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCC----
Confidence 876544321 2233457899999999999999999999999999999999988888654322 222333332221
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
+......+ ++ +.+++.+||+.||++||++.||+++|+.+...
T Consensus 253 -~~~p~~~~---~~---l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 -LLQPEYCP---DP---LYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -CCCCTTCC---HH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCcccCc---HH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11111222 22 34578889999999999999999999988653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=397.30 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=202.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHc-ccCCCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLG-SIRHKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~ 781 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++.+.... .....+.+.+|+.++. .++|||||++++++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~--------~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~ 73 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL--------MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 73 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH--------HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc--------ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc
Confidence 57999999999999999999 5568999999999644321 1223456677777665 689999999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccc
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFG 861 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfG 861 (1058)
+++..|+||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 74 ~~~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 74 TKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred cCCceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccc
Confidence 999999999999999999999864 5689999999999999999999999 99999999999999999999999999
Q ss_pred cceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcccc
Q 043053 862 LAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQVL 941 (1058)
Q Consensus 862 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1058)
+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. .......+...
T Consensus 149 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~------ 218 (320)
T d1xjda_ 149 MCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMD------ 218 (320)
T ss_dssp TCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHC------
T ss_pred hhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHcC------
Confidence 998655432 33445679999999999999999999999999999999999999997542 22222222211
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 043053 942 DPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMK-DVAAM 983 (1058)
Q Consensus 942 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~-~v~~~ 983 (1058)
.+......+.. +.+++.+||++||++|||+. +++++
T Consensus 219 ~~~~p~~~s~~------~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 219 NPFYPRWLEKE------AKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CCCCCTTSCHH------HHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCCCCccCCHH------HHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 12222222222 34578889999999999995 77653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=393.89 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=201.4
Q ss_pred hhccccceeccccceEEEEEEe-cCCc--EEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc-CCCcccceeeE
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DNGE--VIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI-RHKNIVRFLGC 779 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 779 (1058)
++|++.++||+|+||+||+|.+ .+|. .||||++... ......+.|.+|+++++++ +|||||+++|+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~ 79 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 79 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc----------cChHHHHHHHHHHHHHHhccCCCCEeeEEEE
Confidence 6788899999999999999954 4454 4777876422 1223457899999999999 69999999999
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhc--------------CCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCC
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHER--------------TGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKAN 845 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~ 845 (1058)
+.+++..++||||+++|+|.++++.. ....+++..+.+++.|||+||.|+|+. +||||||||+
T Consensus 80 ~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~ 156 (309)
T d1fvra_ 80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAAR 156 (309)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---Cccccccccc
Confidence 99999999999999999999999753 246799999999999999999999999 9999999999
Q ss_pred cEEEcCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCC-CCCCCCCC
Q 043053 846 NILIGLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQ-PIDPTIPD 924 (1058)
Q Consensus 846 Nill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~-P~~~~~~~ 924 (1058)
|||++.++.+||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|.. ||... .
T Consensus 157 NIL~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--~ 231 (309)
T d1fvra_ 157 NILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--T 231 (309)
T ss_dssp GEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--C
T ss_pred eEEEcCCCceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--C
Confidence 999999999999999999865432 22234568999999999999999999999999999999999765 56533 2
Q ss_pred ChhHHHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhhh
Q 043053 925 GSHVVDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKHE 990 (1058)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~~ 990 (1058)
...+...+... ..+......+ ++ +.+++.+||+.||++||||+||+++|+.+..+
T Consensus 232 ~~~~~~~i~~~-----~~~~~~~~~~---~~---~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 232 CAELYEKLPQG-----YRLEKPLNCD---DE---VYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHHHGGGT-----CCCCCCTTBC---HH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHhc-----CCCCCCccCC---HH---HHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 22222222221 1122222222 22 33478889999999999999999999888643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=391.65 Aligned_cols=264 Identities=26% Similarity=0.359 Sum_probs=200.8
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+| +..+|+.||||++.... ..+...+++.+|++++++++|||||++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---------~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh---------cChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 57999999999999999999 56789999999985432 223346789999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
++..|+||||+.+ ++.+++.......+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.
T Consensus 73 ~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred ccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence 9999999999965 566666555567799999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC-cc-
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG-IQ- 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~- 939 (1058)
|+...... .......||+.|+|||+..... ++.++||||+||++|+|++|+.||....+. ............ ..
T Consensus 149 a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~ 225 (298)
T d1gz8a_ 149 ARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEV 225 (298)
T ss_dssp HHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTT
T ss_pred ceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchh
Confidence 98765433 3344567999999999877655 578999999999999999999999754211 111111111000 00
Q ss_pred ---------ccCCCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 ---------VLDPSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ---------~~~~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
................ ...+.+++.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000000011111 0234568889999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=389.85 Aligned_cols=261 Identities=24% Similarity=0.292 Sum_probs=194.3
Q ss_pred ccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcCCCc
Q 043053 708 DANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNNR 786 (1058)
Q Consensus 708 ~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 786 (1058)
..++||+|+||+||+| +..+|+.||||++...... ...+...+.+.+|++++++++|||||++++++.+++..
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS------EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh------hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce
Confidence 3578999999999999 4567999999998544211 11223346789999999999999999999999999999
Q ss_pred eEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccceec
Q 043053 787 LLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLV 866 (1058)
Q Consensus 787 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~~~ 866 (1058)
|+||||++++++..+... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 76 ~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp EEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcccccc
Confidence 999999999877766654 46788999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC---ccccC
Q 043053 867 DDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG---IQVLD 942 (1058)
Q Consensus 867 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~---~~~~~ 942 (1058)
.... ......+||+.|+|||++.+ ..++.++||||+||++|||++|..||....+ .+....+..... .....
T Consensus 151 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 151 GSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp TSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTTSS
T ss_pred CCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--HHHHHHHHHhcCCCChhhcc
Confidence 5433 23345679999999998764 4679999999999999999999999975421 111111111100 00000
Q ss_pred --------CCCCCCCchhHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 943 --------PSLLSRPESEIDE-----MLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 943 --------~~~~~~~~~~~~~-----~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
......+...... ...+.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000001111111 1234568899999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=388.94 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=209.1
Q ss_pred hhccccceeccccceEEEEEEec------CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCccccee
Q 043053 704 KCLVDANVIGKGCSGVVYRADMD------NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFL 777 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 777 (1058)
++|...+.||+|+||+||+|.+. +++.||||++... ........|.+|++++++++|||||+++
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~----------~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----------ASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----------SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc----------cChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 67889999999999999999543 3578999998532 2333456799999999999999999999
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEE
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERT--------GNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILI 849 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill 849 (1058)
+++..++..++||||+++|+|.+++.... ...+++..+.+++.|+|+||+|||++ +|+||||||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceee
Confidence 99999999999999999999999987431 24578999999999999999999999 99999999999999
Q ss_pred cCCCCeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCCChhH
Q 043053 850 GLEFEPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK-QPIDPTIPDGSHV 928 (1058)
Q Consensus 850 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~-~P~~~~~~~~~~~ 928 (1058)
++++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. .||... .....
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--~~~~~ 244 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQV 244 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CHHHH
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--CHHHH
Confidence 999999999999998766544444445567899999999999999999999999999999999985 666543 22223
Q ss_pred HHHHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 929 VDWVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
...+.... .+......+. .+.+++.+||+.||++|||+.+|+++|++..+
T Consensus 245 ~~~i~~~~-----~~~~p~~~~~------~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 LRFVMEGG-----LLDKPDNCPD------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHTTC-----CCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHhCC-----CCCCcccchH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 32222211 1111112222 24457888999999999999999999876644
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=386.16 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=196.7
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC--CCcccceeeEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR--HKNIVRFLGCC 780 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~ 780 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++........ .......++.+|+.++++++ |||||++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-----GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCE-----EECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccch-----hhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 57999999999999999999 556899999999865432211 11112345678999999997 89999999999
Q ss_pred EcCCCceEEEEecCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCC-CCeeee
Q 043053 781 WNRNNRLLMYDYMPN-GSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLE-FEPYIA 858 (1058)
Q Consensus 781 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~-~~~kl~ 858 (1058)
.+++..++||||+.+ +++.+++... ..+++..++.++.|+++||+|||+. +||||||||+|||++.+ +.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEEC
Confidence 999999999999986 5788888763 6799999999999999999999999 99999999999999855 799999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG 937 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1058)
|||+|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||... . ...+.
T Consensus 154 DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~---~i~~~--- 219 (273)
T d1xwsa_ 154 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E---EIIRG--- 219 (273)
T ss_dssp CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---HHHHC---
T ss_pred ccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----h---HHhhc---
Confidence 99999875442 2345679999999999887765 56799999999999999999999632 1 11111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 IQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. .......+.+ +.+++.+||+.||++|||++|++++
T Consensus 220 ~----~~~~~~~s~~------~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 Q----VFFRQRVSSE------CQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C----CCCSSCCCHH------HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c----cCCCCCCCHH------HHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1 1111222322 3457788999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.9e-43 Score=379.60 Aligned_cols=260 Identities=25% Similarity=0.327 Sum_probs=198.3
Q ss_pred hhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 704 KCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
++|...+.||+|+||+||+|...+|+.||||++.... ..+...+++.+|+.++++++|||||++++++..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 72 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---------EDEGIPSTTIREISILKELKHSNIVKLYDVIHTK 72 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS---------GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhh---------cChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC
Confidence 5799999999999999999988889999999985432 2234467899999999999999999999999999
Q ss_pred CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeeccccc
Q 043053 784 NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLA 863 (1058)
Q Consensus 784 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~ 863 (1058)
+..++||||+.++.+..+.+. ...+++..+..++.||++||+|||+. +||||||||+|||++.++.+|++|||.+
T Consensus 73 ~~~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 73 KRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp SCEEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CceeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccc
Confidence 999999999988766666554 47799999999999999999999999 9999999999999999999999999999
Q ss_pred eeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcC-----
Q 043053 864 KLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKG----- 937 (1058)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~----- 937 (1058)
....... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||....+ .............
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 148 RAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTT
T ss_pred eecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCChhh
Confidence 8765433 233455689999999988754 568999999999999999999999975421 1111111110000
Q ss_pred ------ccccCCCCCC--------CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 938 ------IQVLDPSLLS--------RPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 938 ------~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.......... ..+... ..+.+++.+||++||++|||++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLD---ESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhhcccccccccCcchhhhcccCC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000 000001 123457889999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-41 Score=371.76 Aligned_cols=261 Identities=19% Similarity=0.223 Sum_probs=204.3
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC-CcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH-KNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~ 781 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++... .....+.+|++.++.++| +||+.+++++.
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------------~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 71 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-------------SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-------------TTSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-------------cCcHHHHHHHHHHHHhcCCCCCCEEEEEee
Confidence 57999999999999999999 4567999999987322 112356788899999975 89999999999
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC-----CCCee
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL-----EFEPY 856 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~-----~~~~k 856 (1058)
++...++||||+ +|+|.++++.. ...+++..+..++.|++.||+|||+. |||||||||+|||++. ++.+|
T Consensus 72 ~~~~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 72 EGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred cCCccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceE
Confidence 999999999999 78999998764 46799999999999999999999999 9999999999999974 56899
Q ss_pred eeccccceeccCCCc-----ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhH-HH
Q 043053 857 IADFGLAKLVDDGDF-----ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHV-VD 930 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~-~~ 930 (1058)
|+|||+|+....... .......+||+.|||||++.+..++.++|||||||++|||++|+.||.......... ..
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence 999999998654321 123445679999999999999999999999999999999999999998654432211 11
Q ss_pred HHHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 931 WVRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
.+..... ....+.+....+.+ +..++..|++.+|++||+++.+.+.++++..
T Consensus 227 ~i~~~~~-~~~~~~l~~~~p~~------l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 227 RIGEKKQ-STPLRELCAGFPEE------FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHHHHH-HSCHHHHTTTSCHH------HHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhccC-CCChHHhcCCCCHH------HHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 1111110 00111112222322 3346677999999999999999998887654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=377.14 Aligned_cols=261 Identities=22% Similarity=0.283 Sum_probs=193.5
Q ss_pred hhccccceeccccceEEEEEEe-cC-CcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHccc---CCCcccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM-DN-GEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSI---RHKNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~ 778 (1058)
++|++.+.||+|+||+||+|.. .+ ++.||||++..... .+.....+.+|+.+++.+ +||||+++++
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~---------~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---------EEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC---------TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc---------cchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 6899999999999999999954 44 67799999864421 122234456777777666 7999999999
Q ss_pred EEEc-----CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 779 CCWN-----RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 779 ~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
++.. ....+++|||+++|.+..... .....+++..++.++.|++.||+|||++ +||||||||+|||++.++
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred eecccccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCC
Confidence 9863 235689999998876654443 3457789999999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH
Q 043053 854 EPYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR 933 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 933 (1058)
.+||+|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....+ .........
T Consensus 154 ~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~ 229 (305)
T d1blxa_ 154 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILD 229 (305)
T ss_dssp CEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHH
T ss_pred Ceeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHHHHH
Confidence 9999999998765432 334567899999999999999999999999999999999999999975422 111111111
Q ss_pred hhcC--ccccC----------CCCCCC----CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 934 QKKG--IQVLD----------PSLLSR----PESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 934 ~~~~--~~~~~----------~~~~~~----~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.... ..... ...... ...... ..+.+++.+||++||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID--ELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC--HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhCCCchhcccccccchhhhhccccccchhhccccCC--HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1000 00000 000000 000011 123457888999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-41 Score=373.11 Aligned_cols=260 Identities=20% Similarity=0.259 Sum_probs=196.9
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccce-eeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRF-LGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-~~~~~ 781 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++... ...+++.+|++++++++|++++.. .+++.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------------~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~ 73 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------------TKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC-------------TTSCCHHHHHHHHHHSTTSTTCCCEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh-------------ccCHHHHHHHHHHHHccCCCcccEEEEEEe
Confidence 47999999999999999999 5577999999987422 112457899999999987765554 55556
Q ss_pred cCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcC---CCCeeee
Q 043053 782 NRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGL---EFEPYIA 858 (1058)
Q Consensus 782 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~---~~~~kl~ 858 (1058)
+.+..++||||+ +|++.+.+... ...+++..+..++.|+++||+|||++ +||||||||+|||++. +..+|++
T Consensus 74 ~~~~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 74 EGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred cCCEEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeee
Confidence 777889999999 55777776553 46799999999999999999999999 9999999999999864 4579999
Q ss_pred ccccceeccCCCc-----ccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChh--HHHH
Q 043053 859 DFGLAKLVDDGDF-----ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSH--VVDW 931 (1058)
Q Consensus 859 DfGl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~--~~~~ 931 (1058)
|||+|+....... ........||+.|||||++.+..++.++|||||||++|||++|+.||......... ...+
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~ 228 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh
Confidence 9999998765332 12344567999999999999999999999999999999999999999765432211 1111
Q ss_pred HHhhcCccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHhhhh
Q 043053 932 VRQKKGIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAMLKEIKH 989 (1058)
Q Consensus 932 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l~~~~~ 989 (1058)
..... ....+......+.+ +.+++..||+.+|++||+++++.+.|+.+..
T Consensus 229 ~~~~~--~~~~~~~~~~~p~~------~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 229 SEKKM--STPIEVLCKGYPSE------FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHH--HSCHHHHTTTSCHH------HHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hcccC--CCChhHhccCCCHH------HHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 11100 00011111222222 3346778999999999999999998887644
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=372.27 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=197.9
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.+.||+|+||+||+| +..+|+.||||++.... ..+...+++.+|++++++++||||+++++++.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~ 79 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---------EKEGFPITALREIKILQLLKHENVVNLIEICR 79 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC-------------CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh---------cchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence 478999999999999999999 45789999999985432 23345678899999999999999999999986
Q ss_pred c--------CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC
Q 043053 782 N--------RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF 853 (1058)
Q Consensus 782 ~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~ 853 (1058)
. +...|+||||++++.+..+... ...+++..++.++.|+++||+|||+. +||||||||+|||++.++
T Consensus 80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~ 154 (318)
T d3blha1 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDG 154 (318)
T ss_dssp C----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTS
T ss_pred cccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCC
Confidence 5 3456899999988776655543 46788999999999999999999999 999999999999999999
Q ss_pred CeeeeccccceeccCCCc--ccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH
Q 043053 854 EPYIADFGLAKLVDDGDF--ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD 930 (1058)
Q Consensus 854 ~~kl~DfGl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 930 (1058)
.+|++|||+++....... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||....+ .....
T Consensus 155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~ 232 (318)
T d3blha1 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLA 232 (318)
T ss_dssp CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH
T ss_pred cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HHHHH
Confidence 999999999987654322 1223345799999999998754 689999999999999999999999975421 11111
Q ss_pred HHHhhcCccccCCCC---------------CCCCchhHHH-------HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 931 WVRQKKGIQVLDPSL---------------LSRPESEIDE-------MLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 931 ~~~~~~~~~~~~~~~---------------~~~~~~~~~~-------~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
.+...... ..+.. .........+ ...+++++.+||++||++|||++|++++-
T Consensus 233 ~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 233 LISQLCGS--ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp HHHHHHCC--CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHhcCC--CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 11111100 00000 0000111111 12345689999999999999999998753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=376.93 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=195.2
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+| +..+|+.||||++.+. ......+++.+|++++++++||||+++++++..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----------~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----------EHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh----------cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 47999999999999999999 6678999999998532 233446788999999999999999999999976
Q ss_pred CC----CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 783 RN----NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 783 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
.. ..+++|+|+.+|+|.+++.. ..+++..++.++.|+++||+|||++ +||||||||+|||++.++.+||+
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~ 151 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKIC 151 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred ccccccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEc
Confidence 43 34566677789999999975 3689999999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCc-ccccccccCcCCccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh-
Q 043053 859 DFGLAKLVDDGDF-ARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK- 935 (1058)
Q Consensus 859 DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~- 935 (1058)
|||+++....... .......+||+.|+|||++. +..++.++||||+||++|||++|+.||...... .........
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~--~~~~~~~~~~ 229 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGIL 229 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHH
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH--HHHHHHhhhc
Confidence 9999987644322 12245567999999999875 456788999999999999999999999754211 111111000
Q ss_pred cCcc----------------ccCCCCCCCCchhH--HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 KGIQ----------------VLDPSLLSRPESEI--DEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 ~~~~----------------~~~~~~~~~~~~~~--~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.... ...+.....+.... .--.++.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000000000000 000134568899999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-41 Score=376.32 Aligned_cols=255 Identities=23% Similarity=0.320 Sum_probs=191.6
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|.+.+.||+|+||+||+| +..+|+.||||++.... ..+...+.+.+|+++|++++|||||+++++|..
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---------~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~ 88 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 88 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh---------cChHHHHHHHHHHHHHHhcCCCCeeEEEEEecc
Confidence 68999999999999999999 56789999999985431 233456789999999999999999999999976
Q ss_pred CC------CceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 783 RN------NRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 783 ~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
.+ ..|+||||+ +++|..+++. ..+++..++.++.||+.||+|||++ +||||||||+|||++.++.+|
T Consensus 89 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 89 DETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred CccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccc
Confidence 54 469999999 6688887764 4699999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
++|||+|+..... .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..........
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~ 235 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVT 235 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhcc
Confidence 9999999876542 3456799999999998764 5689999999999999999999999754211 1111110000
Q ss_pred c---------------------CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 K---------------------GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 ~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. .................. .+.+++.+||..||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP---LAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH---HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCH---HHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000000000000011111 23457889999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-41 Score=366.09 Aligned_cols=261 Identities=22% Similarity=0.296 Sum_probs=203.0
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEc
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN 782 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 782 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++... ...+...+++.+|+.++++++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~---------~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD---------DDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESS---------CSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehh---------hCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 57999999999999999999 5678999999998533 1234457899999999999999999999999999
Q ss_pred CCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeecccc
Q 043053 783 RNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGL 862 (1058)
Q Consensus 783 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl 862 (1058)
....++|||++.++++..+++. ...+++..+..++.|+++||+|||++ +||||||||+|||++.++.+|++|||.
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccceeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence 9999999999999999888765 46789999999999999999999999 999999999999999999999999999
Q ss_pred ceeccCCCcccccccccCcCCccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhcCcc--
Q 043053 863 AKLVDDGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKKGIQ-- 939 (1058)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 939 (1058)
++...... .......+++.|+|||++.+.. ++.++||||+||++|||++|+.||.....................
T Consensus 148 a~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 148 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp CEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred hhcccCCC--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChh
Confidence 98775543 2334456788999999877654 689999999999999999999998543222111111111110000
Q ss_pred c-----------------cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 940 V-----------------LDPSLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 940 ~-----------------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
. ............. ..+.+++.+||++||.+|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLN---ATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCC---HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccccccchhhhccccCC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000001111 123457888999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=371.74 Aligned_cols=257 Identities=23% Similarity=0.283 Sum_probs=201.3
Q ss_pred hhccccceeccccceEEEEEEe----cCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCC-Ccccceee
Q 043053 704 KCLVDANVIGKGCSGVVYRADM----DNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRH-KNIVRFLG 778 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~ 778 (1058)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.... .+....+.+.+|++++++++| |||+++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~-------~~~~~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-------QKAKTTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-------EEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhc-------cchHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence 6799999999999999999943 25899999998654321 122345678899999999976 89999999
Q ss_pred EEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeee
Q 043053 779 CCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIA 858 (1058)
Q Consensus 779 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~ 858 (1058)
++.+....++||||+.+|+|.+++... ..+.+..+..++.|++.|++|+|+. +||||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 97 AFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEES
T ss_pred eeccCCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEe
Confidence 999999999999999999999999874 4677888999999999999999999 99999999999999999999999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhhc
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM--KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQKK 936 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 936 (1058)
|||+++....... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......... ........
T Consensus 172 DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~i~~~~~ 249 (322)
T d1vzoa_ 172 DFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRIL 249 (322)
T ss_dssp CSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHHH
T ss_pred eccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcc
Confidence 9999987654332 234456799999999988654 4678999999999999999999999765433321 11111111
Q ss_pred CccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 043053 937 GIQVLDPSLLSRPESEIDEMLQALGVALLCVNASPDERPT-----MKDVAAM 983 (1058)
Q Consensus 937 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt-----~~~v~~~ 983 (1058)
. ..+......+. .+.+++.+||++||++||| ++|++++
T Consensus 250 ~---~~~~~~~~~s~------~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 250 K---SEPPYPQEMSA------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp H---CCCCCCTTSCH------HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred c---CCCCCcccCCH------HHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1 11222222222 2334677899999999994 7888764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-40 Score=367.18 Aligned_cols=253 Identities=21% Similarity=0.259 Sum_probs=194.6
Q ss_pred hhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeEEE
Q 043053 704 KCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGCCW 781 (1058)
Q Consensus 704 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 781 (1058)
++|++.+.||+|+||+||+| +..+|+.||||++... ..+++.+|++++++++ ||||+++++++.
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--------------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~ 100 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--------------KKKKIKREIKILENLRGGPNIITLADIVK 100 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--------------CHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--------------HHHHHHHHHHHHHhccCCCCCcEEEEEEE
Confidence 68999999999999999999 5578999999998422 2467899999999996 999999999997
Q ss_pred cC--CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-Ceeee
Q 043053 782 NR--NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-EPYIA 858 (1058)
Q Consensus 782 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-~~kl~ 858 (1058)
.. ...++||||+++|+|..+. ..+++..+..++.||+.||+|||++ |||||||||+|||++.++ .+||+
T Consensus 101 ~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 101 DPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp CTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeec
Confidence 54 4579999999999998775 3589999999999999999999999 999999999999998765 58999
Q ss_pred ccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHH-------
Q 043053 859 DFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVD------- 930 (1058)
Q Consensus 859 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~------- 930 (1058)
|||+|+...... .....+||+.|+|||.+.+. .++.++||||+||++|||++|+.||............
T Consensus 173 DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 173 DWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp CGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred ccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence 999998776543 33456799999999997765 4789999999999999999999999754332111111
Q ss_pred -----HHHhhcCc--cccC---C---------CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 931 -----WVRQKKGI--QVLD---P---------SLLSRPESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 931 -----~~~~~~~~--~~~~---~---------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
+....... .... . .........+ ..++.+++.+||..||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV--SPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGC--CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhcccccCcccchhcccccccchhhcccccccccC--CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10000000 0000 0 0000000001 1134568899999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=371.17 Aligned_cols=254 Identities=27% Similarity=0.350 Sum_probs=188.4
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEEcC
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 783 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 783 (1058)
.|...++||+|+||+||+| +..+|+.||||++.... ..+.+|++++++++|||||++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---------------~~~~~Ei~il~~l~h~niv~~~~~~~~~ 85 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------------RFKNRELQIMRKLDHCNIVRLRYFFYSS 85 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---------------SSCCHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc---------------hHHHHHHHHHHhcCCCCCCcEEEEEEec
Confidence 5888899999999999999 55689999999984321 1224799999999999999999998643
Q ss_pred ------CCceEEEEecCCCChhhhhhh-cCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCC-Ce
Q 043053 784 ------NNRLLMYDYMPNGSLGSLLHE-RTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEF-EP 855 (1058)
Q Consensus 784 ------~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~-~~ 855 (1058)
...|+||||+++|.+..+.+. .....+++..++.++.||++||+|||++ ||+||||||+|||++.++ .+
T Consensus 86 ~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~ 162 (350)
T d1q5ka_ 86 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 162 (350)
T ss_dssp --CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCE
T ss_pred CccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCce
Confidence 235899999987544443321 2356799999999999999999999999 999999999999999876 89
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH-
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR- 933 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~- 933 (1058)
||+|||+++...... .....+||+.|+|||...+ ..++.++||||+||++|||++|+.||..... ...+.....
T Consensus 163 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~ 238 (350)
T d1q5ka_ 163 KLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKV 238 (350)
T ss_dssp EECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHH
T ss_pred eEecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-HHHHHHHHHH
Confidence 999999998775543 2335679999999998764 5789999999999999999999999975421 111111111
Q ss_pred ----------hh-cCc-cccCCCCCCC------CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 934 ----------QK-KGI-QVLDPSLLSR------PESEIDEMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 934 ----------~~-~~~-~~~~~~~~~~------~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
.. ... ...-+..... ...... .+.+++.+||+.||++|||++|++++
T Consensus 239 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP---EAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCChHHhhhhhccchhhccccccccCchhhhcccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000 0000000000 000111 24457888999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-40 Score=367.77 Aligned_cols=261 Identities=23% Similarity=0.265 Sum_probs=188.8
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|.+.++||+|+||+||+| +..+|+.||||++.... ......+++.+|+.++++++|||||++++++.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~---------~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~ 86 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT---------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh---------cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Confidence 468999999999999999999 55689999999985432 23344578899999999999999999999996
Q ss_pred cC------CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCe
Q 043053 782 NR------NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEP 855 (1058)
Q Consensus 782 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~ 855 (1058)
.. ...|+||||+.++ +.+.+. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 87 PQKTLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp SCCSTTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred cccccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccce
Confidence 43 4569999999765 444443 3589999999999999999999999 99999999999999999999
Q ss_pred eeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHH--
Q 043053 856 YIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVR-- 933 (1058)
Q Consensus 856 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~-- 933 (1058)
|++|||+++..... ......+||+.|+|||++.+..+++++||||+||++|||++|+.||....+. ........
T Consensus 159 kl~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~ 234 (355)
T d2b1pa1 159 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQL 234 (355)
T ss_dssp EECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred eeechhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhc
Confidence 99999998866543 2344667999999999999999999999999999999999999999754211 11111110
Q ss_pred --------------------hhcCcc------ccCCCCCC-CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 043053 934 --------------------QKKGIQ------VLDPSLLS-RPESEIDEMLQALGVALLCVNASPDERPTMKDVAAML 984 (1058)
Q Consensus 934 --------------------~~~~~~------~~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPt~~~v~~~l 984 (1058)
...... ........ ...........+.+++.+||+.||++||||+|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred cCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 000000 00000000 1111112233456789999999999999999999863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=366.52 Aligned_cols=259 Identities=23% Similarity=0.291 Sum_probs=193.9
Q ss_pred HhhccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcccceeeEEE
Q 043053 703 LKCLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNIVRFLGCCW 781 (1058)
Q Consensus 703 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 781 (1058)
.++|++.+.||+|+||+||+| +..+|+.||||++.... ......+++.+|++++++++|||||++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---------~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT---------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh---------cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 367999999999999999999 56789999999985431 23334568899999999999999999999986
Q ss_pred cC-----CCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCee
Q 043053 782 NR-----NNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPY 856 (1058)
Q Consensus 782 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~k 856 (1058)
.. ...++||+|+.+|+|.++++. ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~k 161 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 161 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred eccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccc
Confidence 43 345777888899999999964 4699999999999999999999999 999999999999999999999
Q ss_pred eeccccceeccCCCcccccccccCcCCccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCChhHHHHHHhh
Q 043053 857 IADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGSHVVDWVRQK 935 (1058)
Q Consensus 857 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1058)
++|||.+..... ......||+.|+|||+..+. .++.++||||+||++|+|++|+.||.... .......+...
T Consensus 162 l~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--~~~~~~~i~~~ 234 (348)
T d2gfsa1 162 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRL 234 (348)
T ss_dssp ECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHH
T ss_pred ccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHh
Confidence 999999875532 33456799999999986665 46889999999999999999999997542 11111111111
Q ss_pred cCccc--------------cCCCCCCCCchhHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 043053 936 KGIQV--------------LDPSLLSRPESEID-----EMLQALGVALLCVNASPDERPTMKDVAAM 983 (1058)
Q Consensus 936 ~~~~~--------------~~~~~~~~~~~~~~-----~~~~~~~l~~~cl~~dP~~RPt~~~v~~~ 983 (1058)
..... ........+..... ....+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000 00000000000000 01124568889999999999999999875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.8e-35 Score=329.43 Aligned_cols=197 Identities=23% Similarity=0.284 Sum_probs=160.5
Q ss_pred hccccceeccccceEEEEE-EecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-----------CCc
Q 043053 705 CLVDANVIGKGCSGVVYRA-DMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-----------HKN 772 (1058)
Q Consensus 705 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~n 772 (1058)
+|++.++||+|+||+||+| +..+|+.||||++... ....+.+.+|+++++.++ |+|
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 5999999999999999999 5578999999998532 233567788999888875 578
Q ss_pred ccceeeEEEcC--CCceEEEEecCCCCh-hhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccc-cCCCCeEeCCCCCCcEE
Q 043053 773 IVRFLGCCWNR--NNRLLMYDYMPNGSL-GSLLHERTGNALEWELRYQILLGAAQGLAYLHH-DCVPPIVHRDIKANNIL 848 (1058)
Q Consensus 773 iv~~~~~~~~~--~~~~lv~e~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDikp~Nil 848 (1058)
|+++++++... ...+++|+++..+.. ...........+++..+..++.||+.|++|||+ . ||+||||||+|||
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIl 158 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVL 158 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHee
Confidence 99999988653 445677777655543 333344446778999999999999999999998 5 9999999999999
Q ss_pred EcCCCC------eeeeccccceeccCCCcccccccccCcCCccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 043053 849 IGLEFE------PYIADFGLAKLVDDGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 921 (1058)
Q Consensus 849 l~~~~~------~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltg~~P~~~~ 921 (1058)
++.++. ++++|||.+..... .....+||+.|+|||++.+..++.++||||+||+++||++|+.||...
T Consensus 159 l~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 159 MEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 987653 99999999986543 224567999999999999999999999999999999999999999754
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1.8e-29 Score=278.50 Aligned_cols=257 Identities=32% Similarity=0.503 Sum_probs=208.3
Q ss_pred cccccccccccccc--cCcccccccccchhhhccc-cCCCCCCCCCccCCCCCcEEEccCccccCCccccccCcccccee
Q 043053 338 NLQALDLSHNSLTA--SVPAGLFQLQNLTKLLLIS-NDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFL 414 (1058)
Q Consensus 338 ~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 414 (1058)
+++.|+|++|.+.+ .+|..++++++|++|+|++ |++++.+|..|+++++|++|+|++|+|.+..+..+..+..|+++
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 56777777777776 3667777788888888875 77777778888888888888888888888777778888888888
Q ss_pred eccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCC-CeeecCCCccccCCcccccccccccccccccccC
Q 043053 415 DLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGL-QVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLF 493 (1058)
Q Consensus 415 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 493 (1058)
++++|.+.+.+|..+.+++.|+.+++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 888888887888888888888888888888887788888777776 778888888888878777776544 588888888
Q ss_pred CCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCC-CCc
Q 043053 494 SGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGN-LNP 572 (1058)
Q Consensus 494 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~ 572 (1058)
.+.+|..+..+++|+.+++++|.+++.+| .+..+++|+.|||++|+++|. ++.
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~--------------------------~~~~~~~L~~L~Ls~N~l~g~iP~~ 263 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG--------------------------KVGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG--------------------------GCCCCTTCCEEECCSSCCEECCCGG
T ss_pred ccccccccccccccccccccccccccccc--------------------------ccccccccccccCccCeecccCChH
Confidence 88888888888888888888888875333 245667888999999999864 467
Q ss_pred ccccCcceeEEEecccccccCCCccccccCCCccccCCcccccCCCCCC
Q 043053 573 LAQLDNLVSLNISYNKFTGYLPDNKLFRQLSPTDLAGNEGLCSSRKDSC 621 (1058)
Q Consensus 573 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~ 621 (1058)
+..+++|++|+|++|+|+|.+|....++.++..++.||+.+||.|.+.|
T Consensus 264 l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 264 LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred HhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence 8889999999999999999999877788999999999999999998888
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=8.1e-28 Score=273.56 Aligned_cols=343 Identities=23% Similarity=0.344 Sum_probs=187.7
Q ss_pred cCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccE
Q 043053 166 GKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKM 245 (1058)
Q Consensus 166 ~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 245 (1058)
..+.+|++|+++++.|+. + +.+..+++|++|+|++|++++ ++ .|+++++|++|++++|.+.+. ..++.+++|+.
T Consensus 41 ~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i--~~l~~l~~L~~ 114 (384)
T d2omza2 41 TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADI--TPLANLTNLTG 114 (384)
T ss_dssp HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCC--GGGTTCTTCCE
T ss_pred HHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCcccccccccccccccc--ccccccccccc
Confidence 345667777777777763 2 356677777777777777764 33 266777777777777777643 23667777777
Q ss_pred EEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCccc
Q 043053 246 IDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQL 325 (1058)
Q Consensus 246 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l 325 (1058)
|++++|.+++..+ ......+..+....|.+......................
T Consensus 115 L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-------------------------- 166 (384)
T d2omza2 115 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-------------------------- 166 (384)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC--------------------------
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccccccccccccccc--------------------------
Confidence 7777777664332 234455556666665554332222111111111111111
Q ss_pred CCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccc
Q 043053 326 EGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREI 405 (1058)
Q Consensus 326 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 405 (1058)
....+.............|... ....+..+++++.+++++|.+++..| +..+++|++|++++|+++++ ..+
T Consensus 167 ---~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l 237 (384)
T d2omza2 167 ---DLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTL 237 (384)
T ss_dssp ---CCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGG
T ss_pred ---hhhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chh
Confidence 1111222222233333333332 22334445555555555555554332 34445566666666666543 245
Q ss_pred cCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccc
Q 043053 406 GGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNK 485 (1058)
Q Consensus 406 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 485 (1058)
..+++|+.|++++|.+++..+ +..+++|+.|++++|++++.. .+..++.++.+++++|++++ ...+..+.+++.
T Consensus 238 ~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~ 311 (384)
T d2omza2 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTY 311 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSE
T ss_pred hcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCe
Confidence 556666666666666654332 555666666666666666432 25566666666666666653 223555666666
Q ss_pred cccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCc
Q 043053 486 IILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNK 565 (1058)
Q Consensus 486 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 565 (1058)
|++++|++++.. .+..+++|+.|++++|+|++ ++ .|.++++|++|||++|+
T Consensus 312 L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~--------------------------~l~~l~~L~~L~l~~N~ 362 (384)
T d2omza2 312 LTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS--------------------------SLANLTNINWLSAGHNQ 362 (384)
T ss_dssp EECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG--------------------------GGGGCTTCCEEECCSSC
T ss_pred EECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch--------------------------hHcCCCCCCEEECCCCc
Confidence 666666666532 25566666666666666652 11 23456667777777777
Q ss_pred ccCCCCcccccCcceeEEEecc
Q 043053 566 LEGNLNPLAQLDNLVSLNISYN 587 (1058)
Q Consensus 566 l~~~~~~~~~l~~L~~L~l~~N 587 (1058)
|++.+ ++..+++|+.|+|++|
T Consensus 363 l~~l~-~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 363 ISDLT-PLANLTRITQLGLNDQ 383 (384)
T ss_dssp CCBCG-GGTTCTTCSEEECCCE
T ss_pred CCCCh-hhccCCCCCEeeCCCC
Confidence 66543 3666667777777666
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=2.7e-27 Score=269.22 Aligned_cols=341 Identities=26% Similarity=0.347 Sum_probs=199.3
Q ss_pred CCCCceecccCccccccCCccccCCCccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceee
Q 043053 144 CSNMTALGLADTQVSGSLPASLGKLSKLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELF 223 (1058)
Q Consensus 144 l~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 223 (1058)
+.+|++|++++++++. + +.+..+++|++|++++|++++. + .++++++|++|++++|.+.+. + .++.+++|+.|+
T Consensus 43 l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~ 116 (384)
T d2omza2 43 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 116 (384)
T ss_dssp HTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred hCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccc-c-cccccccccccc
Confidence 3444555555554442 1 3445555555555555555432 2 255555555555555555532 1 245555555555
Q ss_pred cccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccC
Q 043053 224 LWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISG 303 (1058)
Q Consensus 224 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 303 (1058)
+++|.+.+.. .......+..+....|.+...................... ....+.............|...
T Consensus 117 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~- 188 (384)
T d2omza2 117 LFNNQITDID--PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANLTTLERLDISSNKVS- 188 (384)
T ss_dssp CCSSCCCCCG--GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGTTCTTCCEEECCSSCCC-
T ss_pred cccccccccc--cccccccccccccccccccccccccccccccccccccccc-----hhhhhccccccccccccccccc-
Confidence 5555554321 2233344455555555444322221111111111111111 1111222222222233333322
Q ss_pred cCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccC
Q 043053 304 LIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGN 383 (1058)
Q Consensus 304 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 383 (1058)
....+..++++..+++++|.+++..+ +..+++|+.|++++|++++ + ..+..+++|+.|++++|.+++.. .+..
T Consensus 189 -~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~ 261 (384)
T d2omza2 189 -DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSG 261 (384)
T ss_dssp -CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTT
T ss_pred -cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccc
Confidence 22344555555666666666655433 4556677777787777774 2 35667777888888888777543 3677
Q ss_pred CCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeee
Q 043053 384 CSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLD 463 (1058)
Q Consensus 384 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 463 (1058)
+++|+.|++++|++++.. .+..++.++.+++++|.+++. ..+..+++++.|++++|+++++. .+..+++|++|+
T Consensus 262 ~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~ 335 (384)
T d2omza2 262 LTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLF 335 (384)
T ss_dssp CTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEE
T ss_pred cccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEE
Confidence 788888888888887653 377778888888888888743 34777788888888888888653 377888888888
Q ss_pred cCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCC
Q 043053 464 VSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSN 515 (1058)
Q Consensus 464 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 515 (1058)
+++|+|++ ++ .+..+++|++|+|++|+|++..| +..+++|+.|+|++|
T Consensus 336 L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 336 FANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 88888874 33 57788888888888888886554 778888888888887
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=1.2e-28 Score=271.87 Aligned_cols=248 Identities=29% Similarity=0.454 Sum_probs=127.2
Q ss_pred CcceeecccccccC--CCCccccCcCCccEEEeec-CCCcCcCCccccccCCcceeecccCccCCCccccccccccchhh
Q 043053 218 KLEELFLWQNSLVG--AIPEEIGNCTSLKMIDFSL-NSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQL 294 (1058)
Q Consensus 218 ~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 294 (1058)
+++.|+|++|.+.+ .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 45556666655554 2445555555555555554 45555555555555555555555555544444444444444444
Q ss_pred hhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccc-hhhhccccCC
Q 043053 295 QLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNL-TKLLLISNDI 373 (1058)
Q Consensus 295 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~N~l 373 (1058)
++++|.+. +.+|..+..++.|+.+++++|.+.+.+|..+..+.++ +.+++++|++
T Consensus 131 ~l~~N~~~------------------------~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l 186 (313)
T d1ogqa_ 131 DFSYNALS------------------------GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp ECCSSEEE------------------------SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred cccccccc------------------------ccCchhhccCcccceeeccccccccccccccccccccccccccccccc
Confidence 44444443 3444455555555555555555555555554444433 3444444444
Q ss_pred CCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCcccc
Q 043053 374 SGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSL 453 (1058)
Q Consensus 374 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 453 (1058)
++..|..+..+..+ .+++++|.+.+..|..+..+++|+.|++++|.+.+.+| .++.+++|+.|+|++|+|++.+|..|
T Consensus 187 ~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l 264 (313)
T d1ogqa_ 187 TGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHH
Confidence 44444444443322 45555555555555555555555555555555554332 34455555555555555555555555
Q ss_pred ccCCCCCeeecCCCccccCCccccccccccccccccccc
Q 043053 454 SSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNL 492 (1058)
Q Consensus 454 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 492 (1058)
+++++|++|+|++|+|+|.+|. ++++.+|+.+++++|+
T Consensus 265 ~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 265 TQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred hCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 5555555555555555554442 3444445555555544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=3.5e-25 Score=242.81 Aligned_cols=243 Identities=21% Similarity=0.295 Sum_probs=136.4
Q ss_pred ccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcCCccccccCCcceeeccc
Q 043053 195 LVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTIPLSIGGLSELEEFMISD 274 (1058)
Q Consensus 195 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 274 (1058)
++.++=++++++ .+|..+. +++++|+|++|+++...+..|.++++|++|++++|.+....|..|..+++|+.|++++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 455555555555 4555443 4566666666666644444566666666666666666655555566666666666666
Q ss_pred CccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccc--c
Q 043053 275 NNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTA--S 352 (1058)
Q Consensus 275 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~ 352 (1058)
|+++..... ....++.|++.+|.+. ...+..+.....+..++...|.... .
T Consensus 89 n~l~~l~~~---~~~~l~~L~~~~n~l~------------------------~l~~~~~~~~~~~~~l~~~~n~~~~~~~ 141 (305)
T d1xkua_ 89 NQLKELPEK---MPKTLQELRVHENEIT------------------------KVRKSVFNGLNQMIVVELGTNPLKSSGI 141 (305)
T ss_dssp SCCSBCCSS---CCTTCCEEECCSSCCC------------------------BBCHHHHTTCTTCCEEECCSSCCCGGGB
T ss_pred CccCcCccc---hhhhhhhhhccccchh------------------------hhhhhhhhccccccccccccccccccCC
Confidence 655532221 1123444444444444 3334444445555555555554331 2
Q ss_pred CcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCC
Q 043053 353 VPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC 432 (1058)
Q Consensus 353 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 432 (1058)
.+..+..+++|+.+++++|.+.. +|..+ +++|+.|++++|.++...+..|.+++.+++|++++|.+++..+..|..+
T Consensus 142 ~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l 218 (305)
T d1xkua_ 142 ENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218 (305)
T ss_dssp CTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred CccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccc
Confidence 23344455555666666665553 23222 3566666666666666666666666666666666666666666666666
Q ss_pred cccchhhccCCccCCCCccccccCCCCCeeecCCCcccc
Q 043053 433 TELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSG 471 (1058)
Q Consensus 433 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 471 (1058)
++|++|+|++|+|+. +|..|..+++|++|+|++|+|+.
T Consensus 219 ~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 219 PHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp TTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCC
T ss_pred ccceeeecccccccc-cccccccccCCCEEECCCCccCc
Confidence 666666666666663 45566666666666666666664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=4.1e-25 Score=242.32 Aligned_cols=269 Identities=19% Similarity=0.299 Sum_probs=213.7
Q ss_pred ccceeeeeccccccccCccccCCCCccEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEee
Q 043053 170 KLQTLSIYTTMISGEIPAEIGNCSELVSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFS 249 (1058)
Q Consensus 170 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 249 (1058)
.++.++=++..++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4566666666676 6777664 689999999999996555689999999999999999998888899999999999999
Q ss_pred cCCCcCcCCccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCC
Q 043053 250 LNSLSGTIPLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSI 329 (1058)
Q Consensus 250 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 329 (1058)
+|+++. +|.. ....++.|++.+|.+....+..+.....+..++...|..... ...
T Consensus 88 ~n~l~~-l~~~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~----------------------~~~ 142 (305)
T d1xkua_ 88 KNQLKE-LPEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS----------------------GIE 142 (305)
T ss_dssp SSCCSB-CCSS--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG----------------------GBC
T ss_pred CCccCc-Cccc--hhhhhhhhhccccchhhhhhhhhhcccccccccccccccccc----------------------CCC
Confidence 999985 4433 246889999999999977777777777777777777654321 123
Q ss_pred ChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCcc
Q 043053 330 PSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLK 409 (1058)
Q Consensus 330 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 409 (1058)
+..|..+++|+.+++++|.+.. +|..+ .++|++|++++|.++...+..|.+++.++.|++++|.++++.+..|.+++
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~ 219 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred ccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc
Confidence 4566777788888888888874 44443 46788888888888888888888899999999999999988888899999
Q ss_pred ccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCcccc------ccCCCCCeeecCCCccc
Q 043053 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSL------SSLSGLQVLDVSDNRFS 470 (1058)
Q Consensus 410 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~ 470 (1058)
+|++|+|++|+|+ .+|.+|..+++|+.|+|++|+|+.+....| ..+.+|+.|+|++|+++
T Consensus 220 ~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 220 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 9999999999998 557788899999999999999987544444 34566777777777664
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.8e-25 Score=242.16 Aligned_cols=250 Identities=24% Similarity=0.260 Sum_probs=183.9
Q ss_pred CcceeecccCccCCCccccccccccchhhhhcCCcccCcCCCcccccchhhhhhc-cCcccCCCCChhhhccCccccccc
Q 043053 266 ELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFA-WQNQLEGSIPSTLASCSNLQALDL 344 (1058)
Q Consensus 266 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l-~~N~l~~~~~~~~~~l~~L~~L~L 344 (1058)
++++|+|++|+|+.+.+..|.++++|++|++++|+|..+.+..+..+..+..+.. ..|.++...+..|.++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 4455555555555444445555555566666666665555555665555555543 345566666777888888888888
Q ss_pred ccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCC
Q 043053 345 SHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGS 424 (1058)
Q Consensus 345 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 424 (1058)
++|.+....+..+....+|+.+++++|+|+++.+..|..+++|+.|++++|+|+++.+.+|.++++|+++++++|+++++
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 88888766666677788888888888888877778888888999999999999888888899999999999999999888
Q ss_pred CCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCC
Q 043053 425 VPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLC 504 (1058)
Q Consensus 425 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 504 (1058)
.|..|..+++|++|++++|++++..+..|..+++|++|++++|.+...-+ ...-...++.+....+++....|..+.+
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g- 270 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG- 270 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT-
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC-
Confidence 88899999999999999999998888889999999999999998875332 1112235667777777777666665543
Q ss_pred cccccccccCCcccC
Q 043053 505 SSLQLLDLSSNQLTG 519 (1058)
Q Consensus 505 ~~L~~L~l~~N~l~~ 519 (1058)
...++++.+.|+|
T Consensus 271 --~~l~~l~~~~l~g 283 (284)
T d1ozna_ 271 --RDLKRLAANDLQG 283 (284)
T ss_dssp --CBGGGSCGGGSCC
T ss_pred --CccccCCHHHCCC
Confidence 4555566666654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=7.6e-25 Score=237.26 Aligned_cols=248 Identities=22% Similarity=0.239 Sum_probs=180.6
Q ss_pred hhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhc-cccCCCCCCCCCccCCCCCcEEEcc
Q 043053 315 LTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLL-ISNDISGSIPPEIGNCSSLVRLRVG 393 (1058)
Q Consensus 315 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L-~~N~l~~~~~~~~~~l~~L~~L~L~ 393 (1058)
+++|++++|+|+.+.+.+|.++++|++|++++|++....+..+..+..++.+.. ..|.++...+..|.++++|++|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence 344444444444444556666677777777777777665556666666666654 3556666677788888888888888
Q ss_pred CccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCC
Q 043053 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473 (1058)
Q Consensus 394 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 473 (1058)
+|.+..+.+..+....+|+.+++++|+|+++.+..|..+++|+.|++++|+|+++.+.+|.++++|+.+++++|++++..
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence 88888777778888888888888888888777788888888888999998888888888888899999999999988888
Q ss_pred cccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCcccccc
Q 043053 474 PASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISAL 553 (1058)
Q Consensus 474 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l 553 (1058)
|..|..+++|+.|++++|++.+..+..|..+++|++|++++|++...-+. ..+......+....++++...|..+.+
T Consensus 194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~--~~l~~~l~~~~~~~~~~~C~~p~~l~g- 270 (284)
T d1ozna_ 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA--RPLWAWLQKFRGSSSEVPCSLPQRLAG- 270 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG--HHHHHHHHHCCSEECCCBEEESGGGTT-
T ss_pred hhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc--hHHHHHHHhCcCCCCceEeCCchHHcC-
Confidence 88888888899999999999888888888889999999999998865432 222222223445555555545554432
Q ss_pred ccccEEecCCCccc
Q 043053 554 NKLSILDLSHNKLE 567 (1058)
Q Consensus 554 ~~L~~L~L~~N~l~ 567 (1058)
+..++++.+.|+
T Consensus 271 --~~l~~l~~~~l~ 282 (284)
T d1ozna_ 271 --RDLKRLAANDLQ 282 (284)
T ss_dssp --CBGGGSCGGGSC
T ss_pred --CccccCCHHHCC
Confidence 344445555444
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=4.4e-23 Score=220.63 Aligned_cols=204 Identities=24% Similarity=0.219 Sum_probs=149.5
Q ss_pred chhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccC
Q 043053 363 LTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSH 442 (1058)
Q Consensus 363 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 442 (1058)
+.+.+.++++++ .+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+ | .++.+++|+.|+|++
T Consensus 12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~ 86 (266)
T d1p9ag_ 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSH 86 (266)
T ss_dssp CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCS
T ss_pred CeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccccccc
Confidence 334455555555 3444443 4677777777777777667777777788888877777643 2 346677788888888
Q ss_pred CccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCC
Q 043053 443 NTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 443 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 522 (1058)
|++++ .+..+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.+....+..+..+++|+.|++++|+|++..
T Consensus 87 N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~- 164 (266)
T d1p9ag_ 87 NQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP- 164 (266)
T ss_dssp SCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC-
T ss_pred ccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC-
Confidence 87774 5667777888888888888887766777777788888888888887777777777888888888888777432
Q ss_pred hhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCCCcccccCcceeEEEecccccccCCCcc
Q 043053 523 MELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNLNPLAQLDNLVSLNISYNKFTGYLPDNK 597 (1058)
Q Consensus 523 ~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 597 (1058)
+..|..+++|++|||++|+|+..++.+..+++|+.|+|++|+|.|.|...+
T Consensus 165 ------------------------~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~~~ 215 (266)
T d1p9ag_ 165 ------------------------AGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILY 215 (266)
T ss_dssp ------------------------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGGHH
T ss_pred ------------------------ccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcchHH
Confidence 334567788888888888888777777788889999999999988776543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=2e-22 Score=215.51 Aligned_cols=200 Identities=25% Similarity=0.232 Sum_probs=126.0
Q ss_pred CcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeec
Q 043053 337 SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDL 416 (1058)
Q Consensus 337 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 416 (1058)
..+.++|.+++.|+ .+|..+. +++++|+|++|+|+++.+..|.++++|++|+|++|+|+.+. .++.+++|++|+|
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEEC
T ss_pred CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccccc
Confidence 34444566666666 3454443 35666666666666555556666666666666666666442 3456666677777
Q ss_pred cCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCC
Q 043053 417 SSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGP 496 (1058)
Q Consensus 417 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 496 (1058)
++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|+|++.
T Consensus 85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred cccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence 766666 3455566666677777777766666666666666777777777776655555666666677777777777666
Q ss_pred CCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccC
Q 043053 497 IPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEG 568 (1058)
Q Consensus 497 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 568 (1058)
.+..|..+++|++|+|++|+|+ .+|..+ ..+++|+.|+|++|++..
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~-------------------------~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY-TIPKGF-------------------------FGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTT-------------------------TTTCCCSEEECCSCCBCC
T ss_pred CccccccccccceeecccCCCc-ccChhH-------------------------CCCCCCCEEEecCCCCCC
Confidence 6666666777777777777666 444332 345566677777776653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=9.1e-23 Score=206.15 Aligned_cols=175 Identities=15% Similarity=0.127 Sum_probs=123.5
Q ss_pred cccceeccccceEEEEEEecCCcEEEEEecCcccccccCCC--CC-----cccchHHHHHHHHHHHcccCCCcccceeeE
Q 043053 707 VDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGC--SD-----EKSGVRDSFSAEIKTLGSIRHKNIVRFLGC 779 (1058)
Q Consensus 707 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~--~~-----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 779 (1058)
.+.+.||+|+||+||+|...+|+.||||+++.......... .. ..........+|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999778899999998764322110000 00 011223456678999999999999988865
Q ss_pred EEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccCCCCeEeCCCCCCcEEEcCCCCeeeec
Q 043053 780 CWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIAD 859 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDikp~Nill~~~~~~kl~D 859 (1058)
. ..++||||++++.+.+ ++...+..++.|+++|++|||+. +|+||||||+|||++++ .++++|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 3 3489999998865543 23334567999999999999999 99999999999999865 589999
Q ss_pred cccceeccCCCcccccccccCcCCccCcc-----ccccCCCCcccchhhHHHHH
Q 043053 860 FGLAKLVDDGDFARSSNTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVV 908 (1058)
Q Consensus 860 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DvwSlGvvl 908 (1058)
||.|......... .|.... .+....|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999866433210 111110 12245678899999976543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.79 E-value=2e-18 Score=192.41 Aligned_cols=53 Identities=28% Similarity=0.362 Sum_probs=30.7
Q ss_pred CCcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCC
Q 043053 25 HLQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLT 85 (1058)
Q Consensus 25 ~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~ 85 (1058)
++++|||++++++ .+|+. +.+|++|+|++|+|+ .+|+.+ .+|++|++++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~ 91 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK 91 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc
Confidence 4566666666665 45542 345666666666666 566543 35566666666554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.78 E-value=4.9e-18 Score=189.24 Aligned_cols=152 Identities=25% Similarity=0.294 Sum_probs=91.1
Q ss_pred hhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCc-ccc
Q 043053 333 LASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGL-KTL 411 (1058)
Q Consensus 333 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L 411 (1058)
+..++.|+.+++++|.... .+.. ..++..+.+.+|.+... +. ...++...++..|.+.++ ..+ ...
T Consensus 200 ~~~l~~L~~l~l~~n~~~~-~~~~---~~~l~~~~~~~~~~~~~-~~---~~~~l~~~~~~~~~~~~l-----~~l~~~~ 266 (353)
T d1jl5a_ 200 LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDL-PE---LPQSLTFLDVSENIFSGL-----SELPPNL 266 (353)
T ss_dssp CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSEE-----SCCCTTC
T ss_pred ccccccccccccccccccc-cccc---ccccccccccccccccc-cc---cccccccccccccccccc-----ccccchh
Confidence 4556677777777776653 3322 34455666666666532 22 234566666666655432 112 344
Q ss_pred ceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccc
Q 043053 412 NFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKN 491 (1058)
Q Consensus 412 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 491 (1058)
...++..|.+.+. ...+++|++|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|.. +.+|++|+|++|
T Consensus 267 ~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N 334 (353)
T d1jl5a_ 267 YYLNASSNEIRSL----CDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYN 334 (353)
T ss_dssp CEEECCSSCCSEE----CCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSS
T ss_pred cccccccCccccc----cccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCC
Confidence 5666666666532 2335678888888888874 453 3567888888888887 45543 356888888888
Q ss_pred cCCCCCCCcccCCccccccccc
Q 043053 492 LFSGPIPSSLGLCSSLQLLDLS 513 (1058)
Q Consensus 492 ~l~~~~~~~~~~l~~L~~L~l~ 513 (1058)
+|+ .+|... ..|+.|.+.
T Consensus 335 ~L~-~lp~~~---~~L~~L~~~ 352 (353)
T d1jl5a_ 335 PLR-EFPDIP---ESVEDLRMN 352 (353)
T ss_dssp CCS-SCCCCC---TTCCEEECC
T ss_pred cCC-CCCccc---cccCeeECc
Confidence 887 455433 345555543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=1.5e-18 Score=180.19 Aligned_cols=209 Identities=23% Similarity=0.353 Sum_probs=156.3
Q ss_pred cccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhh
Q 043053 288 ATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLL 367 (1058)
Q Consensus 288 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 367 (1058)
+.++..++++.+++++.. .+..+.+|+.|++.+|.|+.. ..+..+++|++|++++|++++..+ +..+++|++++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 445566777777777653 456677778888888877754 347788888888888888875433 77788888888
Q ss_pred ccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCC
Q 043053 368 LISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQG 447 (1058)
Q Consensus 368 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 447 (1058)
+++|.++.. ..+.++++|+.+++++|.+.+. ..+...+.++.+.++++.+... ..+...++|+.|++++|.+++
T Consensus 92 ~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccccccccccccc
Confidence 888887743 3577888888888888887754 3466778888888888887643 346777888888888888875
Q ss_pred CCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccC
Q 043053 448 SLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSS 514 (1058)
Q Consensus 448 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 514 (1058)
. ..++++++|+.|+|++|++++ ++ .+..+++|++|+|++|++++.. .+..+++|+.|++++
T Consensus 166 ~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 166 L--TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp C--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred c--hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 3 337888888888888888874 33 3778888888888888888543 377888888888863
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=1.6e-18 Score=174.71 Aligned_cols=174 Identities=22% Similarity=0.306 Sum_probs=137.5
Q ss_pred ccccccccccccccCcccccccccchhhhccccCCCC-CCCCCccCCCCCcEEEccCccccCCccccccCccccceeecc
Q 043053 339 LQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISG-SIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLS 417 (1058)
Q Consensus 339 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 417 (1058)
.+.++.++++++ .+|..+. +++++|+|++|+|++ ..+..|.++++|+.|+|++|++..+.+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 346788888888 5776664 678888888888875 446677888999999999999988888889999999999999
Q ss_pred CccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccccccCCCCC
Q 043053 418 SNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNLFSGPI 497 (1058)
Q Consensus 418 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 497 (1058)
+|+|+.+.+.+|.++++|+.|+|++|+|+++.+.+|..+++|++|+|++|.+....+ ...-...++.+.+..|.+....
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCC
Confidence 999988888889999999999999999998888889999999999999998874332 2222235677788888887666
Q ss_pred CCcccCCcccccccccCCcccC
Q 043053 498 PSSLGLCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 498 ~~~~~~l~~L~~L~l~~N~l~~ 519 (1058)
|..+ ..++.++|+.|.++-
T Consensus 166 p~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 166 PSKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp STTT---TTSBGGGSCTTTCCC
T ss_pred Chhh---cCCEeeecCHhhCcC
Confidence 6544 456778888888763
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=2.4e-18 Score=178.80 Aligned_cols=211 Identities=23% Similarity=0.354 Sum_probs=168.8
Q ss_pred cccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcE
Q 043053 310 GMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVR 389 (1058)
Q Consensus 310 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 389 (1058)
..+.++..+++..+++++.. .++.+.+|+.|++++|+|+. + .++..+++|++|++++|.+++..+ +..+++|+.
T Consensus 16 ~~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~ 89 (227)
T d1h6ua2 16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITE 89 (227)
T ss_dssp HHHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCE
T ss_pred HHHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccc
Confidence 34566677788888888653 56788899999999999985 4 468889999999999999986543 888999999
Q ss_pred EEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCcc
Q 043053 390 LRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRF 469 (1058)
Q Consensus 390 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 469 (1058)
+++++|.++.+ ..+.++++|+++++++|...+. ..+...+.+..+.++++.+... ..+.++++|+.|++++|.+
T Consensus 90 l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~ 163 (227)
T d1h6ua2 90 LELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQV 163 (227)
T ss_dssp EECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCC
T ss_pred ccccccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccccccccccc
Confidence 99999998865 3588899999999999988644 3466778889999999988753 3477889999999999988
Q ss_pred ccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCCCcc
Q 043053 470 SGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPIPAQ 549 (1058)
Q Consensus 470 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~~~~ 549 (1058)
+.. ..+..+++|+.|+|++|++++. + .+..+++|++|+|++|++++. + .
T Consensus 164 ~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~--------------------------~ 212 (227)
T d1h6ua2 164 SDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S--------------------------P 212 (227)
T ss_dssp CCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G--------------------------G
T ss_pred ccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c--------------------------c
Confidence 743 3478889999999999999864 2 388889999999999988842 1 2
Q ss_pred ccccccccEEecCC
Q 043053 550 ISALNKLSILDLSH 563 (1058)
Q Consensus 550 ~~~l~~L~~L~L~~ 563 (1058)
+.++++|+.|+|++
T Consensus 213 l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 213 LANTSNLFIVTLTN 226 (227)
T ss_dssp GTTCTTCCEEEEEE
T ss_pred cccCCCCCEEEeeC
Confidence 46778889998874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=4.8e-18 Score=178.47 Aligned_cols=158 Identities=18% Similarity=0.150 Sum_probs=91.7
Q ss_pred hhccCccccccccc-ccccccCcccccccccchhhhccccCCCCCCC-CCccCCCCCcEEEccCccccCCccccccCcc-
Q 043053 333 LASCSNLQALDLSH-NSLTASVPAGLFQLQNLTKLLLISNDISGSIP-PEIGNCSSLVRLRVGNNRIAGLIPREIGGLK- 409 (1058)
Q Consensus 333 ~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~- 409 (1058)
|.+++++++|++.. |++....+..|..+++|++|++++|.+....+ ..+..+..+..+..+++.+..+.+..|.+++
T Consensus 74 f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~ 153 (242)
T d1xwdc1 74 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF 153 (242)
T ss_dssp EESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBS
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccc
Confidence 33333444443322 33333333344444444444444444442222 1233445566666677777766666776664
Q ss_pred ccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccccccccccccccc
Q 043053 410 TLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILS 489 (1058)
Q Consensus 410 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 489 (1058)
.++.|++++|+++.+.+..|.....++.+++++|+|+.+.+..|.++++|++|+|++|+|+...+..|.++++|+.+++.
T Consensus 154 ~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 154 ESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp SCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 67778888888775555544433333444567777876666677888888888888888875555567777777776664
Q ss_pred c
Q 043053 490 K 490 (1058)
Q Consensus 490 ~ 490 (1058)
+
T Consensus 234 ~ 234 (242)
T d1xwdc1 234 N 234 (242)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=8.2e-18 Score=176.68 Aligned_cols=105 Identities=22% Similarity=0.245 Sum_probs=55.0
Q ss_pred cEEEccCCcCCCCCCCCcCCCCCcceeecccccccCCCCccccCcCCccEEEeecCCCcCcC-CccccccCCcceeeccc
Q 043053 196 VSLFLYENSLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEIGNCTSLKMIDFSLNSLSGTI-PLSIGGLSELEEFMISD 274 (1058)
Q Consensus 196 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~ 274 (1058)
+.++.+++.++ .+|..+. +++++|+|++|+++...+..|.++++|++|++++|.+...+ +..|.++++++++.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 34555555555 4444332 35566666666665444445556666666666666554332 33455555555555543
Q ss_pred -CccCCCccccccccccchhhhhcCCcccC
Q 043053 275 -NNVSGSIPANLANATNLVQLQLDTNQISG 303 (1058)
Q Consensus 275 -n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 303 (1058)
|++....+..|..+++|++|++++|++..
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred cccccccccccccccccccccccchhhhcc
Confidence 34444444555555555555555555543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=1.1e-17 Score=168.31 Aligned_cols=172 Identities=23% Similarity=0.298 Sum_probs=109.7
Q ss_pred cEEEccCccccCCccccccCccccceeeccCccCCC-CCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCC
Q 043053 388 VRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSG-SVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSD 466 (1058)
Q Consensus 388 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 466 (1058)
++++.++|+++.+ |..+. +++++|+|++|+|++ ..+..|..+++|+.|+|++|++.++.+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~i-P~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKEI-PRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSC-CSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCcc-CCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 4566666666654 33221 456777777777754 3455566777777777777777776777777777777777777
Q ss_pred CccccCCcccccccccccccccccccCCCCCCCcccCCcccccccccCCcccCCCChhhhhhHHHHHHHhhccCCCCCCC
Q 043053 467 NRFSGQIPASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSSNQLTGSVPMELGQIEALEIALNLSCNGLTGPI 546 (1058)
Q Consensus 467 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~l~ls~N~l~~~~ 546 (1058)
|+|+...+..|.++++|++|+|++|+|+++.+++|..+++|++|+|++|++....+... +......+.+..|.++...
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~--~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW--FAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH--HHHHHHHHCCSGGGCBBCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH--HhhhhhhhcccCCCeEeCC
Confidence 77776666677777777777777777777777777778888888888888764433221 1222223455556555444
Q ss_pred CccccccccccEEecCCCccc
Q 043053 547 PAQISALNKLSILDLSHNKLE 567 (1058)
Q Consensus 547 ~~~~~~l~~L~~L~L~~N~l~ 567 (1058)
|.. +..++.+||+.|.++
T Consensus 166 p~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 166 PSK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp STT---TTTSBGGGSCTTTCC
T ss_pred Chh---hcCCEeeecCHhhCc
Confidence 443 334555666666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1.6e-17 Score=168.30 Aligned_cols=181 Identities=25% Similarity=0.380 Sum_probs=106.9
Q ss_pred hhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEcc
Q 043053 314 KLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVG 393 (1058)
Q Consensus 314 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 393 (1058)
+.....+..+.+++.. ....+.+++.|++++|.++. + .++..+++|++|++++|+|++..+ ++++++|+.|+++
T Consensus 19 ~~i~~~l~~~~~~~~~--~~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~ 92 (199)
T d2omxa2 19 EKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 92 (199)
T ss_dssp HHHHHHTTCSSTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHhCCCCCCCcc--CHHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccc
Confidence 3334444444444332 22345666666666666663 2 235556666666666666664332 6666677777777
Q ss_pred CccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCC
Q 043053 394 NNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI 473 (1058)
Q Consensus 394 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 473 (1058)
+|.+..+. .+.++++|++|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++.
T Consensus 93 ~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l- 165 (199)
T d2omxa2 93 NNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL- 165 (199)
T ss_dssp SSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-
T ss_pred cccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-
Confidence 77666542 366667777777776666532 235666677777777776663 2 2466667777777777776643
Q ss_pred cccccccccccccccccccCCCCCCCcccCCcccccc
Q 043053 474 PASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLL 510 (1058)
Q Consensus 474 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 510 (1058)
+ .+.++++|++|++++|++++. +.+..+++|++|
T Consensus 166 ~-~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 166 K-PLANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp G-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred c-cccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence 2 366666677777777766642 235556666543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=2.3e-17 Score=168.67 Aligned_cols=181 Identities=24% Similarity=0.327 Sum_probs=124.4
Q ss_pred hhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccc
Q 043053 318 FFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRI 397 (1058)
Q Consensus 318 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 397 (1058)
..+..+.+++.++ ...+.+|+.|++++|.++.. + ++..+++|++|+|++|+|++.. .++.+++|+.|++++|+|
T Consensus 29 ~~l~~~~~~~~~~--~~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccC--HHHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 3444444443332 13455677777777777642 2 3566777777777777777543 356777888888888888
Q ss_pred cCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCcccc
Q 043053 398 AGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASL 477 (1058)
Q Consensus 398 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 477 (1058)
+++. .+..+++|+.|++++|.+.. ...+..++.++.+++++|.+++ +..+..+++|+++++++|++++. + .+
T Consensus 103 ~~l~--~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l 174 (210)
T d1h6ta2 103 KDLS--SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PL 174 (210)
T ss_dssp CCGG--GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GG
T ss_pred cccc--cccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-c-cc
Confidence 7642 47777888888888887763 2357777888888888888774 33567778888888888888743 2 37
Q ss_pred cccccccccccccccCCCCCCCcccCCcccccccccC
Q 043053 478 GRLVSLNKIILSKNLFSGPIPSSLGLCSSLQLLDLSS 514 (1058)
Q Consensus 478 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 514 (1058)
.++++|++|+|++|+|+. ++ .|..+++|++|+|++
T Consensus 175 ~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 778888888888888874 33 577888888888764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=4.9e-21 Score=222.30 Aligned_cols=374 Identities=19% Similarity=0.151 Sum_probs=205.0
Q ss_pred CCceecccCccccccC-CccccCCCccceeeeeccccccc----cCccccCCCCccEEEccCCcCCCC----CCCCcC-C
Q 043053 146 NMTALGLADTQVSGSL-PASLGKLSKLQTLSIYTTMISGE----IPAEIGNCSELVSLFLYENSLSGS----IPPEIG-K 215 (1058)
Q Consensus 146 ~L~~L~l~~~~~~~~~-~~~l~~l~~L~~L~l~~n~i~~~----~~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~-~ 215 (1058)
+|++|+|+++++++.. ..-+..+++|+.|+|.+|.++.. +...+..+++|++|+|++|.+++. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5666677666666433 23345566777777777766532 234455667777777777766421 111222 2
Q ss_pred CCCcceeecccccccCCC----CccccCcCCccEEEeecCCCcCcCCcccc-----ccCCcceeecccCccCCCc----c
Q 043053 216 LKKLEELFLWQNSLVGAI----PEEIGNCTSLKMIDFSLNSLSGTIPLSIG-----GLSELEEFMISDNNVSGSI----P 282 (1058)
Q Consensus 216 l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~l~~n~l~~~~----~ 282 (1058)
..+|++|+|++|++++.. +..+..+++|++|+|++|.+.......+. ..............+.... .
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 246777777777765432 23455667777777777776532221111 1111222222222222110 0
Q ss_pred ccccccccchhhhhcCCcccCcCCCccc-----ccchhhhhhccCcccCCC----CChhhhccCccccccccccccccc-
Q 043053 283 ANLANATNLVQLQLDTNQISGLIPPEIG-----MLSKLTVFFAWQNQLEGS----IPSTLASCSNLQALDLSHNSLTAS- 352 (1058)
Q Consensus 283 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~- 352 (1058)
..+.....++.++++++.+.......+. .-.....+.+..+.+... ....+...+.++.+++++|++...
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 1122334445555555443321000000 001122233333333221 112344567788888888876431
Q ss_pred ----CcccccccccchhhhccccCCCCCC----CCCccCCCCCcEEEccCccccCCccccc-----cCccccceeeccCc
Q 043053 353 ----VPAGLFQLQNLTKLLLISNDISGSI----PPEIGNCSSLVRLRVGNNRIAGLIPREI-----GGLKTLNFLDLSSN 419 (1058)
Q Consensus 353 ----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N 419 (1058)
..........++.|++++|.+.... ...+...+.++.+++++|.++......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 2222334567888888888776321 2234456788888888888864322222 23457888888888
Q ss_pred cCCCCCCCc----ccCCcccchhhccCCccCCC----Cccccc-cCCCCCeeecCCCccccC----Cccccccccccccc
Q 043053 420 RLSGSVPDE----IGDCTELQMIDLSHNTLQGS----LPNSLS-SLSGLQVLDVSDNRFSGQ----IPASLGRLVSLNKI 486 (1058)
Q Consensus 420 ~l~~~~~~~----~~~l~~L~~L~l~~N~l~~~----~~~~~~-~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L 486 (1058)
.++...... +...++|++|+|++|+|++. ++..+. ..+.|++|+|++|+|+.. +...+...++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 876443222 34456788899998888642 223332 456788999999988642 33445566888899
Q ss_pred ccccccCCCCCCCc----cc-CCcccccccccCCcccC
Q 043053 487 ILSKNLFSGPIPSS----LG-LCSSLQLLDLSSNQLTG 519 (1058)
Q Consensus 487 ~Ls~N~l~~~~~~~----~~-~l~~L~~L~l~~N~l~~ 519 (1058)
+|++|+|+...... +. ....|+.|++++|.+..
T Consensus 403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred ECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 99999887432222 22 23468899999998874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.1e-20 Score=219.22 Aligned_cols=385 Identities=19% Similarity=0.154 Sum_probs=199.0
Q ss_pred ccceeeeecccccccc-CccccCCCCccEEEccCCcCCCC----CCCCcCCCCCcceeecccccccCCCCcc----cc-C
Q 043053 170 KLQTLSIYTTMISGEI-PAEIGNCSELVSLFLYENSLSGS----IPPEIGKLKKLEELFLWQNSLVGAIPEE----IG-N 239 (1058)
Q Consensus 170 ~L~~L~l~~n~i~~~~-~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~----l~-~ 239 (1058)
+|+.|+++.+++++.. .+.+..+++|++|+|++|.++.. +...+..+++|++|+|++|.+++..... +. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5788888888887643 33456778888888888887632 2344567788888888888775322122 22 2
Q ss_pred cCCccEEEeecCCCcCcC----CccccccCCcceeecccCccCCCccccccccccchhhhhcCCcccCcCCC-cccccch
Q 043053 240 CTSLKMIDFSLNSLSGTI----PLSIGGLSELEEFMISDNNVSGSIPANLANATNLVQLQLDTNQISGLIPP-EIGMLSK 314 (1058)
Q Consensus 240 l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~-~~~~l~~ 314 (1058)
..+|++|+|++|++++.. +..+..+++|++|++++|.+.......+.. .+.........+....+. ......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~--~l~~~~~~~~~~~~~~~~~~~~~~~- 159 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE--GLLDPQCRLEKLQLEYCSLSAASCE- 159 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH--HHTSTTCCCCEEECTTSCCBGGGHH-
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhh--cccccccccccccccccccchhhhc-
Confidence 346888888888876432 334556777888888877766322222111 011010000000000000 000000
Q ss_pred hhhhhccCcccCCCCChhhhccCcccccccccccccccCcccc----c-ccccchhhhccccCCCCCC----CCCccCCC
Q 043053 315 LTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGL----F-QLQNLTKLLLISNDISGSI----PPEIGNCS 385 (1058)
Q Consensus 315 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~-~l~~L~~L~L~~N~l~~~~----~~~~~~l~ 385 (1058)
.....+.....++.++++++.+....-..+ . .......+++..+.+.... ...+...+
T Consensus 160 -------------~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~ 226 (460)
T d1z7xw1 160 -------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKA 226 (460)
T ss_dssp -------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCT
T ss_pred -------------ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccc
Confidence 001123344555666666655442110001 0 1112334444444433211 11233456
Q ss_pred CCcEEEccCccccC-----CccccccCccccceeeccCccCCCCC----CCcccCCcccchhhccCCccCCCCcccc---
Q 043053 386 SLVRLRVGNNRIAG-----LIPREIGGLKTLNFLDLSSNRLSGSV----PDEIGDCTELQMIDLSHNTLQGSLPNSL--- 453 (1058)
Q Consensus 386 ~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~~--- 453 (1058)
.++.+++++|++.. .....+.....++.|++++|.+.... ...+...+.++.+++++|.++......+
T Consensus 227 ~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~ 306 (460)
T d1z7xw1 227 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET 306 (460)
T ss_dssp TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH
T ss_pred cccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcc
Confidence 67777777776532 12233444566777777777665321 1223455667777777777653211111
Q ss_pred --ccCCCCCeeecCCCccccCCcccc----cccccccccccccccCCCC----CCCccc-CCcccccccccCCcccCCCC
Q 043053 454 --SSLSGLQVLDVSDNRFSGQIPASL----GRLVSLNKIILSKNLFSGP----IPSSLG-LCSSLQLLDLSSNQLTGSVP 522 (1058)
Q Consensus 454 --~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~L~~L~l~~N~l~~~~p 522 (1058)
.....|+.+++++|.++......+ ....+|++|+|++|+|... ++..+. ..+.|++|+|++|.|+..
T Consensus 307 l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~-- 384 (460)
T d1z7xw1 307 LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS-- 384 (460)
T ss_dssp HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH--
T ss_pred ccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChH--
Confidence 223567777777777764433323 2344677777777776532 122222 345677777777777621
Q ss_pred hhhhhhHHHHHHHhhccCCCCCCCCccccccccccEEecCCCcccCCC-----Cccc-ccCcceeEEEecccccc
Q 043053 523 MELGQIEALEIALNLSCNGLTGPIPAQISALNKLSILDLSHNKLEGNL-----NPLA-QLDNLVSLNISYNKFTG 591 (1058)
Q Consensus 523 ~~~~~l~~l~~~l~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~-~l~~L~~L~l~~N~l~~ 591 (1058)
.... +...+...++|++|||++|+|+... ..+. +...|+.|++++|.+..
T Consensus 385 -~~~~------------------l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 385 -SCSS------------------LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp -HHHH------------------HHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred -HHHH------------------HHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 1111 1123345677888888888876421 1222 23467788888777753
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=2.5e-17 Score=168.33 Aligned_cols=186 Identities=22% Similarity=0.304 Sum_probs=142.7
Q ss_pred ccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhhhc
Q 043053 289 TNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKLLL 368 (1058)
Q Consensus 289 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 368 (1058)
.++...+++.+.+++..+. ..+.+|++|++.+|.++... .+..+++|++|++++|+|++.. .+..+++|++|++
T Consensus 24 ~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l 97 (210)
T d1h6ta2 24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFL 97 (210)
T ss_dssp HHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred HHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccc
Confidence 3455566666666654332 34667777778887777543 3777888888888888888533 3667888899999
Q ss_pred cccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCC
Q 043053 369 ISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGS 448 (1058)
Q Consensus 369 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 448 (1058)
++|+|++ ++ .+.++++|+.|++++|.+..+ ..+..+++|+.+++++|.+++ +..+..+++|+.+++++|+++++
T Consensus 98 ~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i 171 (210)
T d1h6ta2 98 DENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI 171 (210)
T ss_dssp CSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC
T ss_pred ccccccc-cc-ccccccccccccccccccccc--ccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence 9888885 33 588889999999999988754 468888999999999999874 34577888999999999999864
Q ss_pred CccccccCCCCCeeecCCCccccCCccccccccccccccccc
Q 043053 449 LPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSK 490 (1058)
Q Consensus 449 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 490 (1058)
. .+.++++|++|+|++|+|+. ++ .+..+++|++|+|++
T Consensus 172 ~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 172 V--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp G--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred c--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 3 38889999999999999974 44 588899999998874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=4.4e-17 Score=165.00 Aligned_cols=184 Identities=27% Similarity=0.396 Sum_probs=143.5
Q ss_pred ccccchhhhhcCCcccCcCCCcccccchhhhhhccCcccCCCCChhhhccCcccccccccccccccCcccccccccchhh
Q 043053 287 NATNLVQLQLDTNQISGLIPPEIGMLSKLTVFFAWQNQLEGSIPSTLASCSNLQALDLSHNSLTASVPAGLFQLQNLTKL 366 (1058)
Q Consensus 287 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 366 (1058)
++.+...+.++.+.+++.. ....+.++++|++.+|.++.. +.+..+++|++|++++|++++..+ +..+++|++|
T Consensus 16 ~l~~~i~~~l~~~~~~~~~--~~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L 89 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 89 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEE--CHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHHhCCCCCCCcc--CHHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence 3445566677777776543 234567777788888877754 347788899999999999986433 7888999999
Q ss_pred hccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccC
Q 043053 367 LLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446 (1058)
Q Consensus 367 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 446 (1058)
++++|.+... + .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|+++
T Consensus 90 ~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 90 LMNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp ECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC
T ss_pred cccccccccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-cccccccccccccccccccc
Confidence 9999988743 3 488899999999999998765 358889999999999999874 3 35888999999999999998
Q ss_pred CCCccccccCCCCCeeecCCCccccCCccccccccccccc
Q 043053 447 GSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKI 486 (1058)
Q Consensus 447 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 486 (1058)
+.. .++++++|++|++++|++++ ++ .+..+++|++|
T Consensus 164 ~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 164 DLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred CCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 643 48899999999999999984 43 57778887765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=2.8e-17 Score=176.47 Aligned_cols=222 Identities=19% Similarity=0.213 Sum_probs=107.3
Q ss_pred cEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCCCChhhcCcccCCEEeccccCCCCc-cccccccchhhhHHhhhh
Q 043053 27 QTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGTLPSSLGKLHNLEELILNSNQLTGK-IPVELSNCKSLRKLLLFD 105 (1058)
Q Consensus 27 ~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~lp~~l~~l~~L~~L~L~~n~~~~~-~p~~l~~l~~L~~L~L~~ 105 (1058)
++|||+++.+.......+.. ..+..+.++.+.+. ..........+|++|||++|.+... ++..+.+|++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccc-cchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 46777776553211111111 12455666666554 3333344556778888877776533 444566777777777777
Q ss_pred ccccCCChhhhcccccchhhhcCCCccccCCCCcc-ccCCCCCceecccCcc-ccccC-CccccC-CCccceeeeecc--
Q 043053 106 NALAGNIPAELGRLSNLEEMRAGGNKDIVGKIPAE-LGDCSNMTALGLADTQ-VSGSL-PASLGK-LSKLQTLSIYTT-- 179 (1058)
Q Consensus 106 n~~~~~~p~~l~~l~~L~~L~l~~~~~~~~~l~~~-l~~l~~L~~L~l~~~~-~~~~~-~~~l~~-l~~L~~L~l~~n-- 179 (1058)
|.+.+..+..++++++|++|++++|..+.+..... ...|++|++|++++|. +++.. ...+.. .++|+.|+++++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 77665666667777777777777765433221111 2335666666666542 22111 112222 234555555443
Q ss_pred ccccc-cCccccCCCCccEEEccCC-cCCCCCCCCcCCCCCcceeecccc-cccCCCCccccCcCCccEEEeec
Q 043053 180 MISGE-IPAEIGNCSELVSLFLYEN-SLSGSIPPEIGKLKKLEELFLWQN-SLVGAIPEEIGNCTSLKMIDFSL 250 (1058)
Q Consensus 180 ~i~~~-~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~ 250 (1058)
.++.. +...+.++++|++|++++| .+++.....+.++++|++|+|++| .+++.....++++++|+.|++++
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~ 234 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeC
Confidence 12221 1111234445555555443 233333334444444444444442 23332223333344444444433
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=8.2e-16 Score=164.79 Aligned_cols=233 Identities=15% Similarity=0.164 Sum_probs=163.0
Q ss_pred CcEEEccCCcCCCCCCCCCCCCCcccEEecCCCCCCCC-CChhhcCcccCCEEeccccCCCCccccccccchhhhHHhhh
Q 043053 26 LQTLVISDANLTGSIPFDIGDCVGLIVLDFSSNNLVGT-LPSSLGKLHNLEELILNSNQLTGKIPVELSNCKSLRKLLLF 104 (1058)
Q Consensus 26 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~~~i~~~-lp~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~L~ 104 (1058)
+..+.+++.... ...........|++||+++|.+++. ++..+.++++|++|+|++|.+.+..+..++++++|++|+++
T Consensus 25 ~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccc-cchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 456667666554 2333345667889999998887643 45567788999999999998877777888889999999998
Q ss_pred hc-cccCC-ChhhhcccccchhhhcCCCccccCC-CCccccC-CCCCceecccCc--cccccCCcc-ccCCCccceeeee
Q 043053 105 DN-ALAGN-IPAELGRLSNLEEMRAGGNKDIVGK-IPAELGD-CSNMTALGLADT--QVSGSLPAS-LGKLSKLQTLSIY 177 (1058)
Q Consensus 105 ~n-~~~~~-~p~~l~~l~~L~~L~l~~~~~~~~~-l~~~l~~-l~~L~~L~l~~~--~~~~~~~~~-l~~l~~L~~L~l~ 177 (1058)
+| .+++. +...+.++++|++|++++|..+.+. +...+.. +++|+.|+++++ .+++..... +.++++|++|+++
T Consensus 104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~ 183 (284)
T d2astb2 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183 (284)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECT
T ss_pred ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccc
Confidence 86 44422 2233457899999999988654332 2223433 578999999876 344333333 3568999999999
Q ss_pred cc-ccccccCccccCCCCccEEEccCC-cCCCCCCCCcCCCCCcceeecccccccCCCCccc-cCcCCccEEEeecCCCc
Q 043053 178 TT-MISGEIPAEIGNCSELVSLFLYEN-SLSGSIPPEIGKLKKLEELFLWQNSLVGAIPEEI-GNCTSLKMIDFSLNSLS 254 (1058)
Q Consensus 178 ~n-~i~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~n~l~ 254 (1058)
+| .+++.....+.++++|++|+|++| .+++.....++++++|+.|+++++ +.+.....+ ..+++ |.+..+.++
T Consensus 184 ~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~---L~i~~~~ls 259 (284)
T d2astb2 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPH---LQINCSHFT 259 (284)
T ss_dssp TCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTT---SEESCCCSC
T ss_pred cccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcc---ccccCccCC
Confidence 86 577778888999999999999996 677666677889999999999987 433222222 33444 455667777
Q ss_pred CcCCccccc
Q 043053 255 GTIPLSIGG 263 (1058)
Q Consensus 255 ~~~~~~~~~ 263 (1058)
...+..++.
T Consensus 260 ~~~~~~~~~ 268 (284)
T d2astb2 260 TIARPTIGN 268 (284)
T ss_dssp CTTCSSCSS
T ss_pred CCCCCccCc
Confidence 655555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.5e-14 Score=140.07 Aligned_cols=128 Identities=16% Similarity=0.132 Sum_probs=68.5
Q ss_pred ccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCC
Q 043053 381 IGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQ 460 (1058)
Q Consensus 381 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 460 (1058)
|.++.+|++|+|++|+|+.+ +..+..+++|+.|+|++|+|+.+ +.|..+++|+.|++++|+++++.+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 34445555555555555544 34445555555566666555532 2355555666666666666554444455566666
Q ss_pred eeecCCCccccCCc-ccccccccccccccccccCCCCC---CCcccCCccccccc
Q 043053 461 VLDVSDNRFSGQIP-ASLGRLVSLNKIILSKNLFSGPI---PSSLGLCSSLQLLD 511 (1058)
Q Consensus 461 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~ 511 (1058)
.|++++|+|+.... ..+..+++|+.|++++|+++... +..+..+++|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 66666666553211 24555566666666666654321 12355666777665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=1.7e-14 Score=139.60 Aligned_cols=127 Identities=17% Similarity=0.086 Sum_probs=82.2
Q ss_pred ccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccc
Q 043053 357 LFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQ 436 (1058)
Q Consensus 357 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 436 (1058)
+.+..++++|+|++|+|+.+ +..+..+++|+.|+|++|+|+.+ +.|..+++|++|++++|+++++.+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 34555666666666666633 45556667777777777777654 3466777777777777777755555556677777
Q ss_pred hhhccCCccCCCCc-cccccCCCCCeeecCCCccccCCcc----cccccccccccc
Q 043053 437 MIDLSHNTLQGSLP-NSLSSLSGLQVLDVSDNRFSGQIPA----SLGRLVSLNKII 487 (1058)
Q Consensus 437 ~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~ 487 (1058)
.|++++|+|+.... ..+..+++|++|++++|.++. .|. .+..+++|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 77777777764321 356777777777777777763 332 456667777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=1.1e-13 Score=127.16 Aligned_cols=101 Identities=31% Similarity=0.477 Sum_probs=52.6
Q ss_pred eeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCCccccccccccccccccccc
Q 043053 413 FLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQIPASLGRLVSLNKIILSKNL 492 (1058)
Q Consensus 413 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 492 (1058)
.|+|++|+|+. ++ .+..+++|++|++++|+|++ +|..|+.+++|+.|++++|+|++ +| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 44555555542 22 24455555555555555553 34445555555555555555542 22 25555555555555555
Q ss_pred CCCCC-CCcccCCcccccccccCCccc
Q 043053 493 FSGPI-PSSLGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 493 l~~~~-~~~~~~l~~L~~L~l~~N~l~ 518 (1058)
|+... ...+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 55332 234556666777777777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.42 E-value=1.1e-13 Score=127.00 Aligned_cols=101 Identities=25% Similarity=0.324 Sum_probs=48.3
Q ss_pred EEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCc
Q 043053 389 RLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNR 468 (1058)
Q Consensus 389 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 468 (1058)
.|+|++|+|+.+ + .+..+++|++|++++|+|+ .+|..|+.+++|+.|++++|+|++. | .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 445555555433 1 2445555555555555554 2334445555555555555555532 2 24555555555555555
Q ss_pred cccCCc-ccccccccccccccccccCC
Q 043053 469 FSGQIP-ASLGRLVSLNKIILSKNLFS 494 (1058)
Q Consensus 469 l~~~~~-~~~~~l~~L~~L~Ls~N~l~ 494 (1058)
|+.... ..+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 543221 33444555555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.37 E-value=5.6e-15 Score=163.47 Aligned_cols=94 Identities=21% Similarity=0.191 Sum_probs=52.5
Q ss_pred CCccccCCCCCcEEEccCCcCCC----CCCCCCCCCCcccEEecCCCCCCC---C-------CChhhcCcccCCEEeccc
Q 043053 16 IPTNLSSFKHLQTLVISDANLTG----SIPFDIGDCVGLIVLDFSSNNLVG---T-------LPSSLGKLHNLEELILNS 81 (1058)
Q Consensus 16 ~p~~~~~~~~L~~L~l~~~~~~~----~~p~~l~~l~~L~~L~l~~~~i~~---~-------lp~~l~~l~~L~~L~L~~ 81 (1058)
+...+.....|++|+|++|.+.. .+...+...++|+.|+++++.... . +...+..+++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 33445556667777777776532 233345666777777777664431 1 122334556677777777
Q ss_pred cCCCCc----cccccccchhhhHHhhhhcccc
Q 043053 82 NQLTGK----IPVELSNCKSLRKLLLFDNALA 109 (1058)
Q Consensus 82 n~~~~~----~p~~l~~l~~L~~L~L~~n~~~ 109 (1058)
|.+... +...+..+++|++|++++|.+.
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred cccccccccchhhhhcccccchheeccccccc
Confidence 766543 3333445566666666666543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.36 E-value=3.1e-15 Score=165.56 Aligned_cols=243 Identities=14% Similarity=0.117 Sum_probs=118.6
Q ss_pred CCCCCCCcccEEecCCCCCCCC----CChhhcCcccCCEEeccccCCCCc---cccccccchhhhHHhhhhccccCCChh
Q 043053 42 FDIGDCVGLIVLDFSSNNLVGT----LPSSLGKLHNLEELILNSNQLTGK---IPVELSNCKSLRKLLLFDNALAGNIPA 114 (1058)
Q Consensus 42 ~~l~~l~~L~~L~l~~~~i~~~----lp~~l~~l~~L~~L~L~~n~~~~~---~p~~l~~l~~L~~L~L~~n~~~~~~p~ 114 (1058)
..+.+...|+.|+|++|.|... +-..+...++|+.|++++|..... .|..+. .+..
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~-----------------~l~~ 87 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR-----------------LLLQ 87 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH-----------------HHHH
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHH-----------------HHHH
Confidence 3445566677777777766432 233445557777777776644311 110000 0112
Q ss_pred hhcccccchhhhcCCCccccCC----CCccccCCCCCceecccCccccccCCccc-------------cCCCccceeeee
Q 043053 115 ELGRLSNLEEMRAGGNKDIVGK----IPAELGDCSNMTALGLADTQVSGSLPASL-------------GKLSKLQTLSIY 177 (1058)
Q Consensus 115 ~l~~l~~L~~L~l~~~~~~~~~----l~~~l~~l~~L~~L~l~~~~~~~~~~~~l-------------~~l~~L~~L~l~ 177 (1058)
.+..+++|++|++++|. +... +...+..+++|++|++++|.+.......+ ...+.|+.|.++
T Consensus 88 ~l~~~~~L~~L~L~~n~-i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~ 166 (344)
T d2ca6a1 88 ALLKCPKLHTVRLSDNA-FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 166 (344)
T ss_dssp HHTTCTTCCEEECCSCC-CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECC
T ss_pred HHhhCCCcccccccccc-cccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecc
Confidence 23333444444444442 1110 12223344555666665555432211111 234456666666
Q ss_pred cccccccc----CccccCCCCccEEEccCCcCCCC-----CCCCcCCCCCcceeecccccccCC----CCccccCcCCcc
Q 043053 178 TTMISGEI----PAEIGNCSELVSLFLYENSLSGS-----IPPEIGKLKKLEELFLWQNSLVGA----IPEEIGNCTSLK 244 (1058)
Q Consensus 178 ~n~i~~~~----~~~l~~l~~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~ 244 (1058)
+|.+.... ...+..++.|+.|+|++|.+... +...+..+++|+.|+|++|.++.. +...+..+++|+
T Consensus 167 ~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~ 246 (344)
T d2ca6a1 167 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246 (344)
T ss_dssp SSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred cccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccch
Confidence 66554322 22334556666677766666531 223455566666666666665432 223345566666
Q ss_pred EEEeecCCCcCcCCcccc------ccCCcceeecccCccCCCccc----cc-cccccchhhhhcCCccc
Q 043053 245 MIDFSLNSLSGTIPLSIG------GLSELEEFMISDNNVSGSIPA----NL-ANATNLVQLQLDTNQIS 302 (1058)
Q Consensus 245 ~L~L~~n~l~~~~~~~~~------~l~~L~~L~l~~n~l~~~~~~----~~-~~l~~L~~L~L~~N~i~ 302 (1058)
+|+|++|.|++.....++ ..+.|++|++++|+|+..... .+ .++++|++|+|++|++.
T Consensus 247 ~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred hhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 677766666543332221 124566666666666532222 12 13455666666666664
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=3.1e-12 Score=122.57 Aligned_cols=104 Identities=23% Similarity=0.259 Sum_probs=72.4
Q ss_pred hhhccccCCCCCCCCCccCCCCCcEEEccCc-cccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCC
Q 043053 365 KLLLISNDISGSIPPEIGNCSSLVRLRVGNN-RIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHN 443 (1058)
Q Consensus 365 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 443 (1058)
.++.+++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|+.|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3445555554 34555666677777777655 477777777777777777777777777777777777777777777777
Q ss_pred ccCCCCccccccCCCCCeeecCCCccc
Q 043053 444 TLQGSLPNSLSSLSGLQVLDVSDNRFS 470 (1058)
Q Consensus 444 ~l~~~~~~~~~~l~~L~~L~L~~N~l~ 470 (1058)
+|+.+.+..|..+ +|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 91 ALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCcccChhhhccc-cccccccCCCccc
Confidence 7776555555544 5778888888774
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.24 E-value=6.7e-14 Score=140.38 Aligned_cols=114 Identities=23% Similarity=0.246 Sum_probs=67.9
Q ss_pred CcccccccccchhhhccccCCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCC
Q 043053 353 VPAGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDC 432 (1058)
Q Consensus 353 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 432 (1058)
++..+..+++|++|+|++|+|+.+ + .+..+++|+.|+|++|+|+.+ +..+..+++|++|++++|+|+.+ ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i-~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKI-ENLDAVADTLEELWISYNQIASL--SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSC-SSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccccc-ccccccccccccccccccccccc--cccccc
Confidence 334455555666666666666532 2 366666666666666666643 33444455677777777766643 235666
Q ss_pred cccchhhccCCccCCCCc-cccccCCCCCeeecCCCcccc
Q 043053 433 TELQMIDLSHNTLQGSLP-NSLSSLSGLQVLDVSDNRFSG 471 (1058)
Q Consensus 433 ~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ 471 (1058)
++|+.|++++|+|+.... ..+..+++|+.|+|++|++..
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 667777777776664321 356667777777777776653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.23 E-value=3.4e-14 Score=142.56 Aligned_cols=135 Identities=19% Similarity=0.282 Sum_probs=103.2
Q ss_pred CCCCccCCCCCcEEEccCccccCCccccccCccccceeeccCccCCCCCCCcccCCcccchhhccCCccCCCCccccccC
Q 043053 377 IPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLDLSSNRLSGSVPDEIGDCTELQMIDLSHNTLQGSLPNSLSSL 456 (1058)
Q Consensus 377 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 456 (1058)
.+..+..+++|++|+|++|+|+.+ ..|.++++|++|+|++|+|+ .+|..+..+++|+.|++++|+|+.+ ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCCc--ccccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence 344577788999999999999876 35888999999999999998 4565566667899999999999853 358888
Q ss_pred CCCCeeecCCCccccCCc-ccccccccccccccccccCCCCCCCc----------ccCCcccccccccCCccc
Q 043053 457 SGLQVLDVSDNRFSGQIP-ASLGRLVSLNKIILSKNLFSGPIPSS----------LGLCSSLQLLDLSSNQLT 518 (1058)
Q Consensus 457 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~----------~~~l~~L~~L~l~~N~l~ 518 (1058)
++|+.|++++|+|+.... ..+..+++|+.|+|++|++....+.. +..+++|+.|| +.+++
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 899999999999874322 46788888999999999886543332 45677888765 55554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=3.7e-12 Score=122.02 Aligned_cols=108 Identities=19% Similarity=0.150 Sum_probs=87.9
Q ss_pred CcccccccccccccccCcccccccccchhhhcccc-CCCCCCCCCccCCCCCcEEEccCccccCCccccccCccccceee
Q 043053 337 SNLQALDLSHNSLTASVPAGLFQLQNLTKLLLISN-DISGSIPPEIGNCSSLVRLRVGNNRIAGLIPREIGGLKTLNFLD 415 (1058)
Q Consensus 337 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 415 (1058)
...+.++.+++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|.++++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34556778888877 46777888888888888766 48877777899999999999999999988888899999999999
Q ss_pred ccCccCCCCCCCcccCCcccchhhccCCccC
Q 043053 416 LSSNRLSGSVPDEIGDCTELQMIDLSHNTLQ 446 (1058)
Q Consensus 416 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 446 (1058)
|++|+|+.+.+..|..+ .|+.|+|++|.+.
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCccc
Confidence 99999986666666544 6999999999885
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=9.2e-09 Score=98.59 Aligned_cols=91 Identities=16% Similarity=0.079 Sum_probs=51.8
Q ss_pred CCcccchhhccCCccCCCCccccccCCCCCeeecCCCccccCC--cccccccccccccccccccCCCCCCCcccCCcccc
Q 043053 431 DCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFSGQI--PASLGRLVSLNKIILSKNLFSGPIPSSLGLCSSLQ 508 (1058)
Q Consensus 431 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 508 (1058)
.+..+..++..+|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+-.+....+|+
T Consensus 40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~ 118 (162)
T d1koha1 40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118 (162)
T ss_dssp TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCS
T ss_pred hccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccc
Confidence 3344444454444443 34444556666777777777766432 23455666777777777777643332333345677
Q ss_pred cccccCCcccCCCC
Q 043053 509 LLDLSSNQLTGSVP 522 (1058)
Q Consensus 509 ~L~l~~N~l~~~~p 522 (1058)
.|++++|++++...
T Consensus 119 ~L~L~~Npl~~~~~ 132 (162)
T d1koha1 119 ELWLDGNSLSDTFR 132 (162)
T ss_dssp SCCCTTSTTSSSSS
T ss_pred eeecCCCCcCcCcc
Confidence 78888887775433
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=7.1e-09 Score=99.42 Aligned_cols=67 Identities=24% Similarity=0.193 Sum_probs=30.7
Q ss_pred cccCccccceeeccCccCCCCC--CCcccCCcccchhhccCCccCCCCccccccCCCCCeeecCCCccc
Q 043053 404 EIGGLKTLNFLDLSSNRLSGSV--PDEIGDCTELQMIDLSHNTLQGSLPNSLSSLSGLQVLDVSDNRFS 470 (1058)
Q Consensus 404 ~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 470 (1058)
.+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+-.+....+|+.|++++|++.
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 3344555555555555555332 223344455555555555554332222223334444444444444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.33 E-value=7.2e-07 Score=92.84 Aligned_cols=147 Identities=12% Similarity=0.024 Sum_probs=97.9
Q ss_pred HHHHHhhccccceeccccceEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCccccee
Q 043053 699 VEQVLKCLVDANVIGKGCSGVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFL 777 (1058)
Q Consensus 699 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 777 (1058)
.....+.|...+..+.++.+.||+.... ++.++||+.... .......+.+|+..++.+. +--+.+++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~-----------~~~~~~~~~~E~~~l~~l~~~vpvP~vl 76 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSR-----------YKGTTYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGG-----------GTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCC-----------cccchhhHHHHHHHHHHHhccCCCCcEE
Confidence 4556677776666556666799998765 556678876432 1122345678888887774 43467778
Q ss_pred eEEEcCCCceEEEEecCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHhhcccccC------------------------
Q 043053 778 GCCWNRNNRLLMYDYMPNGSLGSLLHERTGNALEWELRYQILLGAAQGLAYLHHDC------------------------ 833 (1058)
Q Consensus 778 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------ 833 (1058)
++...++..++||++++|.++.+..... .. ...++.++++.++.||+..
T Consensus 77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (263)
T d1j7la_ 77 HFERHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND 149 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred EEEecCCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHH
Confidence 8888888889999999998876543211 11 2223444445555555311
Q ss_pred --------------------------------CCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 834 --------------------------------VPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 834 --------------------------------~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
.+.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1247999999999999977667799998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.06 E-value=4e-06 Score=86.47 Aligned_cols=76 Identities=20% Similarity=0.217 Sum_probs=54.1
Q ss_pred eeccccc-eEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC--CCcccceeeEEEcCCCce
Q 043053 711 VIGKGCS-GVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR--HKNIVRFLGCCWNRNNRL 787 (1058)
Q Consensus 711 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~ 787 (1058)
.+..|.. +.||+.....+..+++|..... ....+.+|+..++.+. .-.+.+++++..+++..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~--------------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~ 82 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--------------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 82 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--------------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc--------------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceE
Confidence 4455554 6899998888888889975322 1234677888777764 233667788888888889
Q ss_pred EEEEecCCCChhh
Q 043053 788 LMYDYMPNGSLGS 800 (1058)
Q Consensus 788 lv~e~~~~gsL~~ 800 (1058)
+||+|++|.++.+
T Consensus 83 ~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 83 LLLGEVPGQDLLS 95 (255)
T ss_dssp EEEECCSSEETTT
T ss_pred EEEEeeecccccc
Confidence 9999999876643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.65 E-value=7.9e-05 Score=81.56 Aligned_cols=83 Identities=13% Similarity=0.131 Sum_probs=50.3
Q ss_pred cceeccccceEEEEEEec-CCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-C--CcccceeeEEEcCC
Q 043053 709 ANVIGKGCSGVVYRADMD-NGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-H--KNIVRFLGCCWNRN 784 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~ 784 (1058)
.+.||.|....||++... +++.|+||.-.+..-. . .+.......+...|++.++.+. + ..+.+++.+ +++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~-~---g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~ 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKV-V---GESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC------CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcc-c---CCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC
Confidence 457899999999999654 4678999965332110 0 0111223345667888887663 2 345555543 456
Q ss_pred CceEEEEecCCCC
Q 043053 785 NRLLMYDYMPNGS 797 (1058)
Q Consensus 785 ~~~lv~e~~~~gs 797 (1058)
..++|||++++..
T Consensus 105 ~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 MAVTVMEDLSHLK 117 (392)
T ss_dssp TTEEEECCCTTSE
T ss_pred CCEEEEeccCCcc
Confidence 7789999997754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.28 E-value=2e-05 Score=74.95 Aligned_cols=86 Identities=16% Similarity=0.205 Sum_probs=38.5
Q ss_pred CCCCcEEEccCc-cccCC----ccccccCccccceeeccCccCCCCC----CCcccCCcccchhhccCCccCCC----Cc
Q 043053 384 CSSLVRLRVGNN-RIAGL----IPREIGGLKTLNFLDLSSNRLSGSV----PDEIGDCTELQMIDLSHNTLQGS----LP 450 (1058)
Q Consensus 384 l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~----~~ 450 (1058)
.++|++|+|+++ .++.. ....+...+.|++|+|++|.+.... ...+...+.|+.|+|++|.|+.. +.
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 355666666653 34321 1123344455666666666554211 11222334455555555554421 11
Q ss_pred cccccCCCCCeeecCCCcc
Q 043053 451 NSLSSLSGLQVLDVSDNRF 469 (1058)
Q Consensus 451 ~~~~~l~~L~~L~L~~N~l 469 (1058)
.++...+.|++|++++|.+
T Consensus 94 ~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHTTTTCCCSEEECCCCSS
T ss_pred HHHHhCCcCCEEECCCCcC
Confidence 2333344455555555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.20 E-value=1.4e-05 Score=76.08 Aligned_cols=87 Identities=13% Similarity=0.096 Sum_probs=50.2
Q ss_pred CCCCCcEEEccCccccCCcc----ccccCccccceeeccCccCCCC----CCCcccCCcccchhhccCCccCCC------
Q 043053 383 NCSSLVRLRVGNNRIAGLIP----REIGGLKTLNFLDLSSNRLSGS----VPDEIGDCTELQMIDLSHNTLQGS------ 448 (1058)
Q Consensus 383 ~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~------ 448 (1058)
..++|++|+|++|.+..... ..+...+.|++|+|++|.|+.. +..++...+.|+.|++++|.+...
T Consensus 42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~ 121 (167)
T d1pgva_ 42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM 121 (167)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHH
Confidence 34556666666666652211 2233446677777777766532 122345556677777777765432
Q ss_pred -CccccccCCCCCeeecCCCcc
Q 043053 449 -LPNSLSSLSGLQVLDVSDNRF 469 (1058)
Q Consensus 449 -~~~~~~~l~~L~~L~L~~N~l 469 (1058)
+...+...+.|+.|+++.+..
T Consensus 122 ~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 122 DMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhCCCccEeeCcCCCc
Confidence 344556677888888877654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.90 E-value=0.002 Score=67.98 Aligned_cols=133 Identities=14% Similarity=0.114 Sum_probs=76.2
Q ss_pred eEEEEEEecCCcEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccCCCcc--ccee-----eEEEcCCCceEEE
Q 043053 718 GVVYRADMDNGEVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIRHKNI--VRFL-----GCCWNRNNRLLMY 790 (1058)
Q Consensus 718 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~ 790 (1058)
-.||++...+|+.|++|+.++. ....+++..|...+..+....| +..+ ..+......+.|+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~------------~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE------------RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT------------TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCC------------CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence 4899999899999999987533 2235778888888887752222 1111 1123345568899
Q ss_pred EecCCCChhh-----h------h---hh----cC---CCCCCH----------------------HHHHHHHHHHHHHhh
Q 043053 791 DYMPNGSLGS-----L------L---HE----RT---GNALEW----------------------ELRYQILLGAAQGLA 827 (1058)
Q Consensus 791 e~~~~gsL~~-----~------l---~~----~~---~~~l~~----------------------~~~~~i~~~i~~~l~ 827 (1058)
++++|..+.. + + +. .. ....++ .....++..+...+.
T Consensus 104 ~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 183 (325)
T d1zyla1 104 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 183 (325)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred eecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 9997753321 0 0 00 00 011111 111222333333322
Q ss_pred cc-cccCCCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 828 YL-HHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 828 ~L-H~~~~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
.. ......++||+|+.+.|||+++ + ..++||+-+.
T Consensus 184 ~~~~~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 184 AHWREDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred HhccccCCceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 22 2223358899999999999974 3 4589999775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.50 E-value=0.0049 Score=66.95 Aligned_cols=74 Identities=12% Similarity=0.202 Sum_probs=49.1
Q ss_pred cceeccccceEEEEEEecCC--------cEEEEEecCcccccccCCCCCcccchHHHHHHHHHHHcccC-CCcccceeeE
Q 043053 709 ANVIGKGCSGVVYRADMDNG--------EVIAVKKLWPTTMAAANGCSDEKSGVRDSFSAEIKTLGSIR-HKNIVRFLGC 779 (1058)
Q Consensus 709 ~~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 779 (1058)
++.|+.|-.-.+|++...++ +.|.+++.- . ........+|..+++.+. +.-..+++++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g------------~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~ 113 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF------------N-PETESHLVAESVIFTLLSERHLGPKLYGI 113 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC------------S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC------------C-cchhhHHHHHHHHHHHHHhCCCCCeEEEE
Confidence 46788899999999976543 456666542 1 112344568888888886 4444567776
Q ss_pred EEcCCCceEEEEecCCCChh
Q 043053 780 CWNRNNRLLMYDYMPNGSLG 799 (1058)
Q Consensus 780 ~~~~~~~~lv~e~~~~gsL~ 799 (1058)
+. -++||||++|.++.
T Consensus 114 ~~----~g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 114 FS----GGRLEEYIPSRPLS 129 (395)
T ss_dssp ET----TEEEECCCCEEECC
T ss_pred cC----CceEEEEeccccCC
Confidence 63 27899999876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.46 E-value=0.0039 Score=65.46 Aligned_cols=31 Identities=19% Similarity=0.211 Sum_probs=27.5
Q ss_pred CCCeEeCCCCCCcEEEcCCCCeeeeccccce
Q 043053 834 VPPIVHRDIKANNILIGLEFEPYIADFGLAK 864 (1058)
Q Consensus 834 ~~~ivHrDikp~Nill~~~~~~kl~DfGl~~ 864 (1058)
+.++||+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3489999999999999988877899999875
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.33 E-value=0.00016 Score=68.48 Aligned_cols=18 Identities=17% Similarity=0.038 Sum_probs=11.5
Q ss_pred cccCCcccccccccCCcc
Q 043053 500 SLGLCSSLQLLDLSSNQL 517 (1058)
Q Consensus 500 ~~~~l~~L~~L~l~~N~l 517 (1058)
.+...++|+.|+++.|..
T Consensus 127 ~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 127 MLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHCSSCCEEECCCSSH
T ss_pred HHHhCCCcCEEeCcCCCC
Confidence 344566777777776654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.02 E-value=0.00023 Score=67.35 Aligned_cols=87 Identities=14% Similarity=0.082 Sum_probs=39.4
Q ss_pred CCCCccEEEccCCcCCCCCC----CCcCCCCCcceeecccccccCCC----CccccCcCCccEEEe--ecCCCcCc----
Q 043053 191 NCSELVSLFLYENSLSGSIP----PEIGKLKKLEELFLWQNSLVGAI----PEEIGNCTSLKMIDF--SLNSLSGT---- 256 (1058)
Q Consensus 191 ~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~L--~~n~l~~~---- 256 (1058)
.+++|++|+|++|.++.... ..+...+.++.+++++|.+.... ...+...++|+.++| ++|.+...
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 44445555555554432211 12223445555555555543221 123444555655443 34444421
Q ss_pred CCccccccCCcceeecccCcc
Q 043053 257 IPLSIGGLSELEEFMISDNNV 277 (1058)
Q Consensus 257 ~~~~~~~l~~L~~L~l~~n~l 277 (1058)
+...+...++|++|+++.+..
T Consensus 124 La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCCCcCEEeCcCCCC
Confidence 222334566677777665543
|